<SEC-DOCUMENT>0001401708-23-000052.txt : 20230228
<SEC-HEADER>0001401708-23-000052.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228162056
ACCESSION NUMBER:		0001401708-23-000052
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		130
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NanoString Technologies Inc
		CENTRAL INDEX KEY:			0001401708
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				200094687
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35980
		FILM NUMBER:		23685753

	BUSINESS ADDRESS:	
		STREET 1:		530 FAIRVIEW AVENUE NORTH
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
		BUSINESS PHONE:		206-378-6266

	MAIL ADDRESS:	
		STREET 1:		530 FAIRVIEW AVENUE NORTH
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>nstg-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:50e88ef7-7662-44f9-a77d-a0cf072223f8,g:ff6ee908-6dcd-4476-b167-ff6c214915d5,d:9959dc30b5d74d99a70a121eb09a4515--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:nstg="http://www.nanostring.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nstg-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl8zLTEtMS0xLTQ4OTA2_e0efd76b-5ec3-4c49-a4eb-573c0dd4e125">false</ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl80LTEtMS0xLTQ4OTA2_89a45d95-e5b5-4b01-9f7f-abfea15be8ba">2022</ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl81LTEtMS0xLTQ4OTA2_093dacaf-bef9-4ea9-825b-79147150c82e">FY</ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl82LTEtMS0xLTQ4OTA2_df43736f-a8d2-4443-977c-8657a2e41c35">0001401708</ix:nonNumeric><ix:nonNumeric contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5">http://fasb.org/us-gaap/2022#DeferredRevenueNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="nstg-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i043751235d134593932bc4d1798772f9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e8f6c8902ab43e899d5fe51c87bc281_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="icf955021de6a4586adc1a655a9dc0f7f_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>nstg:Lease</xbrli:measure></xbrli:unit><xbrli:context id="i8451f817802047b4ac1d9188ce3a1a70_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e05f468d67d4e158506601ffba408b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fb5a9c83554516897179bdc578a26e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d76b57e37a47d9993ee86018d00cce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic69d192ea60b4dd99f62ed25f1930652_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dcc651b739c4a8797ff28c930d6411a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386de87196f44b13b5fbbfb2f76610bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f559acbf7a94475909e3c1663266216_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id90f105c4d55494b94cc0ab76173b5fc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9f3b07c6934ad3a071ba90567014cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76e439fcce3243a282b799121be03534_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d3517a5cd04697bc20f69fca9c1aea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f27c9fc5a14f6a9ad7a0207ca76205_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340b839d193a417b9994bc351dbdcd6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b26d4493e6499daf1af61adf60e137_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc30b4ddea0947eeadd32b726a42601a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4679a98afee44ff854f9a3fe34a94e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21fa537a67cc4008a5f886347dd4fca6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27aa7b231862406db76f50681fa18e57_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a626949d3a48359028bdd61bb4b96f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c1797d70c2647f984286d05d5bef521_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a95c99a0394cb69b14efb2f1306862_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895d001213eb4fbdbfe3970d1d470a5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i920455eea78d4de0b3a820010c833f50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444d8e8a93bb4467a4ce845e986e6410_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24476a394b0d460abebd9ddff5142056_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68c123b35bc44c839c2818e081176609_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63cda06a33214436ac73d2d0c4af2fa8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187572d253d54fb6b91f8db3fcb8f370_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08fc922969543ebbe9caf9316b0f2af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9403952b5e824b5794d4bb6ed1b3c7ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfa5c83df28b49dd8e19aa82d32557ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3db979b8cc4c70acfae0b6db21e315_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="platform"><xbrli:measure>nstg:platform</xbrli:measure></xbrli:unit><xbrli:context id="i3e88f609f3f146ceaf78b4e74394ba1b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i278bf40cbb204af4a52b6898794206ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypeSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f1ce22f43b4f6ba059a7cff32daa29_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f132592e8314b41869081ee86000fca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef01beba6684f59958c4b614e147f05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82bf014bbac5492db1175791d6facd7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e1e72e2e1254b52a9ce1f62c4a096cc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18117518f24d42deab5e444d999956b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22262b3c6e443298a7bfef3925d13c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8b904e260de493cad16322d5349cd06_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c7acaf4b361496386e2cab8954e8f6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73fa25c9cfad44209056603a0dc281bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1530276adeb46edad26c44010100eaa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67acad69085c486998c2baaf6125dbb3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57df71b94ca142fdaca927a766348294_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7881895472d449e994899c6bc6580f05_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713c836ec9944621af76e4eae6676d6b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13689abdf06042ddb61fe7e5dde76571_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6199bdcbfda84b76b59695fbd415666b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b4cc48ab884deb9ac79ec4f88a41b6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0379bf7b398f48e4b7eb5e0d0e117124_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b0d645787549928cc28c4236afb570_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55d209ba775a4742bb51365dce4d0e27_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id43e18e2336e4176a4c6d0b1837d8ab8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08998380f6294f76a8041abec23394b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeeae230b2594a1b942b9d452bd93424_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i250e7fef9d9e4aa4bae1f66f612bb047_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb01752d3d024e9cbe624ff2311e1e86_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51f5ff287b4347d1befb9409e6d22447_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bf083ef64fc4b2d84ed1522343a92d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c31fff231034b729e619b1e5ddad70f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7884244270dc438fb94c45d2b041e5ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2ec65972a6419abe9a03a19e5ca95e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94493508e1514eb89d02a2be8a07f60b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79fa8408bcb64e98b3b17b2bb9a06863_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icedfeb39178b47b0973327433aeaf39c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib388af030dc445f1b7cfea35477d3be7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab1f01e51b674ab4ad411dde4e1e0d89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8071ca8672d449bd949728204b07a2fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d86a75d4d54b8b9ca2f0ed1e4dacf9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444caf10ca684a0aa194a919b86211e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f366fc7210642de991dae318729cecb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i373fc6e51acf48be9c6990e509965c68_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cda942559fe4cc4a3fca242a605e4b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47b8c1b821a4938a48a69fe46c6555a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45ebd85ce49641b1bdcfb50f620c8c7f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i809c69b254ec43d4b295def456b0bcb9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d61518cf22490287052068a75aee69_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87797cb7eb2d4e539e26bf057f66d572_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae0f86555864368b0aea5d051ac1266_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia52a0df2c7f04de89a0e5830fdb770ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d04035e9e28485eb3acf369367687f8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce94de1d746480a975bbf68e8d2ff1a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47ab74aed5247f7a85777c81bd4cb68_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837b13ea09c546889d1c1f1898e0cb63_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib14cac7c7a3349a2abe346fa98dfc66e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f8abb7a1a694dd4b9681e6a239af1f5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30a7b631fee1428b98faf94c3babda50_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f05c9834f4542e9b3cdf441d7ded71a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57da356bd80040d28979b0ee90029081_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989ed5565898409da03fcb97e7c4573a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e7328fd0fcb413d860b955b14b25b47_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c61765d11da43eaa6620b24fb7a3b84_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8421365accd4534bbc761089b030e05_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf2ffe55aec47f69e976f20986eb3dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i534ef05250b74206a3469e1b8edd612a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if93686ec4ea743a4ba48bb454b4a79e4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73ce0b36a12d45cf88cbf303484474d8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7695a3a71d2e46c78f0a9751fa7e65e4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae168f9ba93c4702893c848d0c6e17f8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4584c877dc647338dc50887089aa8d4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3446b18c3f4429b947c80eff58cea1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaf0fb528f60478594ef2414b62f9d04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d9089997454bb1a0c3539505c1c38b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if689c091da7e49acac49fa4109fec584_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51ae9afe71f74d379d16ab886a404393_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2492355e51654bb090ebf5513f607ae0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f16742116dd49ddb8104eb5bdbcfcdf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec61848f7a3942d2950cae11486a1ecc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ca246e843540f4822dd96a53d66eed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i322cd850a2794ba0ba08d821a4e1df1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9582990fa8164d3a9f1fd4b0ec0ee75a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874d8d32e3cc4d7f840e2d1ff4b5d402_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ba8b859f55484eaada3a17ad6a664c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2436c4e22c584140bdea10494b55b14d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e1c9aa8e85842fe9bf0570307ef0b9b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d931bc716374b53be3b0b9cefccbf8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc6ee5fcb0649249deb7816da0e2c05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8cc509eb60a411cbd96922835a08932_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd17be89ff4140d9a06669daa9ea9181_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fa5e6f26b86406fb5758deca06ebe9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7acddd71ba8140ab8c19a8a1975fb542_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea99fdfabbd4242aee0a5883d8beefd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if449a99cfefe4c7cb63f39a6b7429081_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40784678c00f45dfa31384ea5da6ec61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715feed5faf14f819a69f74e70a51b89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie950f8641c7a4192bee03c298f4d3e9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib11be0a2463245cfbe3d860c3f4e66f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ided2f9286c924c4f97ec0724c5a6a4e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f4bf01fc4bc4bc5812e10affa2f9f7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023ed3e85c01469e986ad2ce472a4307_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3530905bb7474ab307f49b7ea1e2b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23c3281ffb1a419384a2c48110d22e1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5057ef90f9c4541a9b859fbaa260c6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0419d16a85d2463b8a5cf1ac63c939d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7550093a293240458a48f07f2c8c4626_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7ef4b161684e7cacf3f6408767bb84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2a1951785ab40e68ae969d7cd3c9742_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf29bb1eb74475e896a6511b6cf0035_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie616f0cefcbf4b0fadfa0ca79acf005d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypesAndOtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0646dd1f77534091a7aac4d721b6769d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypesAndOtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c89b21a66a04e8d9b27819c58bef518_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypesAndOtherEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fee9a686a43435ebd9b2af3f2b0bf38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ab44c9e5dd45638f78be80ead6cb26_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifae3e7e9820c46b380d5dbba63c1ba21_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b1160c699fb41ab8078959aa2b71645_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1906cd27a926473f97dd96ae306e6ea7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if39bb1b648b84d1b8ea0e830f2e097ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad8c07047cd941898973b031735aea40_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041f0c1d8b534c149cf8210420c68583_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8879a77916d4282a46de289bb9dbdd5_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a3e574978345dfbe106d6fac6ec50f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="nstg:ConvertibleDebtTermsAxis">nstg:ConvertibleDebtTriggeringEvent1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>nstg:day</xbrli:measure></xbrli:unit><xbrli:context id="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="nstg:ConvertibleDebtTermsAxis">nstg:ConvertibleDebtTriggeringEvent2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14f75101ca484bf6bac4dc7226b1113e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i379a102945f149ae9e804e66bfdccfc8_I20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10abeac0df484f369c951c1d61608b8d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c6ea2f53ac4990ae5f60cf96224bb2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fe33f52f67b4687bbae5622f4312c40_I20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:SecuredRevolvingLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie024cf12bf5b4458adc486ea3637775c_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:SecuredRevolvingLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb55eb3463fb43ca895bce6ab03389cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:SecuredRevolvingLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2647f818e343a1b49e1a59ad9b201e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84093a4322da469e83641848f0ea172b_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id19896e0ae0e48948f3db0dc516f3674_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2faccbe8dbb44a7a885e478bce74de3a_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nstg:PublicStockOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e1f1159955427aa959883a212aa815_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37b3847550434762972bebc67656a85c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie882436ff3ec4475b183dab55fc70afc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a3e3cb294548d8844d3e900432255e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if662b112600744f887c0f7a89393ea18_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9bd905f155547fca3f7022d826550f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9ca6a450312485eb2653adb71cd9f5e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8090e4620bb54d97b89cb0dc5214c2ac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if150562d534e43d7a0be36122ba6294b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c11cf0a91ac4e2a801affae1032e3d3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e84ed8c801a4c209b5bcdc1b70b5652_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6c402dc94d04e52bc03498acfaae727_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06cb2e813155412ca9d4aa066e0dbf5f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8338f87419c456caacda88b6cd45d60_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0f72610203463a91933df13c0ef863_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i363fd23d862d49c197424ef927db40d5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdbe64c654004a0a9c1b1eb652e096c2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e02806cedd34a0fbaa454cc75f64d39_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia12bfc1b8c634d16b3b4fe87b81c81ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae43c7b0912d44d4adbf7a74d6cc5170_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35e27d21c994c8f8ed1289ffa420eba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93d18101d134e09b27b73519d3e467a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5c097161754a66a79ba216e1fe8e69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc4a5733a414b0ca670822be669b552_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if75c1d4d9c4747288ef5603464fb5fbb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39adc3163bb94109b81e6d5dad488eb1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eb61034aec1476781aa07ee2f8562ab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2dad374da0b48fa915dda42f71ff71b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60e0592e249f4ddc84797c7db1802798_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nstg:CostOfRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id359d7f10c7f4650a3ccb3e59f28b9b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nstg:CostOfRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5d477f82ff4c8699615becd441e2e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nstg:CostOfRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171d7573fd21497682c5ce64be7a7416_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad73584ddef48af83fd9e76216c9ed8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f546e62eb5d437190c5f925abdd1993_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b370a0aa7494558a2684df873b92e31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4cf23c2148a4d728f391d7591fed46a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54234098f2fe415b99bdab8bf1fb6f00_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74ec37816d5d4d1c9be1f2cc76135e4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c9b03e212c4b068eb66593b05efda9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceAndPerformanceComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838d0bd0b6124f28b27371e25ba13e46_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i846bf5f2f89540e68b6c2e2336234f13_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceAndPerformanceComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-07-01</xbrli:startDate><xbrli:endDate>2013-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ebcaf345b284e6e9623117669975e74_D20130701-20130731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-07-01</xbrli:startDate><xbrli:endDate>2013-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7999389f78ad4a51b40dceb35494cd61_D20130701-20130731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-07-01</xbrli:startDate><xbrli:endDate>2013-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic623892b482d42ae931b372405773674_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b5aa174a6345a0b151fb3b490d437d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad6d38c8f7c4d89a92280b9e15d04b8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if555a5dd86134313a260b8b540a5deb3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bc2480d9afc41299a0dc200f9614cef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e8993d263434600a013126584291fad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58bff15771ac47c3a9eb0fe25cc0fdea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35672bdf7a8344d580057c105d3a35f4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id186117bd3474f299cf9daa35048c269_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1acfbe546b94ee9add32ffe159ea86c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ef8872ca69434cb82b4ce55d15bd25_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">nstg:FederalAndStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifffa3e3faf9c444ba7d318f1c005e08d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83025943657d49539ea6888045a339de_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21a2f01c1b5040569d99fe2b4cc5881b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icccc75f297f9487aaf6af93a9682218d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis">us-gaap:ConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3ed46b1479f4064896cb2ff583b50fe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec5ee0bad2343278a6de1b6fd2cc457_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i547b52c74b7d404a86d2976b1d0d428d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc395aad27d4e279fde1f41cf731f43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b5e44fa71c4cdd99d7ef0f4caeaae9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71dfb62de0ed48e8a1bf6ac8a7dc0277_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia62e3cab8f2e4c3cb75f270e19d7bece_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab9ad4b738c40b1bad40a93b5d022f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i044b09e095b341cea037a0552518fa44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc345a5e318943deb1b776d29eab9f21_I20230227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001401708</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-27</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1"></div><div style="min-height:20.25pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc1_38f70ff5-feb4-4b67-85fb-c77566cf15a7">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:36pt;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTgwOTg2YTkyMjA3NGE1Zjk2NGE0ZDAxODMyYzFiMWIvdGFibGVyYW5nZTo5ODA5ODZhOTIyMDc0YTVmOTY0YTRkMDE4MzJjMWIxYl8wLTAtMS0xLTQ4OTA2_f9b91cc5-3203-4b7a-be64-30935ed199fd">&#253;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8xMjc_1eaf4a29-5c12-482a-b21e-906cb11049e1"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8xMjc_e8dee7ed-edb9-44f3-a3a7-df33baee943b">December&#160;31</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6MzRmYTg4MmVhNDY4NGU1OWE3MjgzMWU5NzRhMmRkZTkvdGFibGVyYW5nZTozNGZhODgyZWE0Njg0ZTU5YTcyODMxZTk3NGEyZGRlOV8wLTAtMS0xLTQ4OTA2_75a4be8c-652a-4891-946d-20a51c0e93ce">&#168;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to______</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc4_bea84820-e0f3-4d83-8d66-8c1d274e8ce2">001-35980</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><img src="nstg-20221231_g1.jpg" alt="nstg-20221231_g1.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:385px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:95%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:95%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODgz_e9340bf5-173e-4a57-a9e0-424c3d446127">NANOSTRING TECHNOLOGIES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6NTVkNTIyYjlkMGQzNGZlZGI0YjdlNzE2ZjQyNTU5ZTkvdGFibGVyYW5nZTo1NWQ1MjJiOWQwZDM0ZmVkYjRiN2U3MTZmNDI1NTllOV8wLTAtMS0xLTQ4OTA2_b2675cea-60df-454b-ba55-86440f5e782e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6NTVkNTIyYjlkMGQzNGZlZGI0YjdlNzE2ZjQyNTU5ZTkvdGFibGVyYW5nZTo1NWQ1MjJiOWQwZDM0ZmVkYjRiN2U3MTZmNDI1NTllOV8wLTItMS0xLTQ4OTA2_41c70642-43f5-45ec-a089-8c46ecf335d9">20-0094687</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc2_5605ae77-5c09-46d1-b775-d3e588c9d4c1">530 Fairview Avenue North</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcw_cc13abee-5a42-49b1-8e8b-2b50b6a8a0b8">Seattle</ix:nonNumeric>, <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcx_44be8fc0-8f14-46f6-af9c-9be9d9433075">Washington</ix:nonNumeric> <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zNTk_4a28f1cf-261b-40d3-b6a5-a2bc900fc342">98109</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV80MDQ_5adb3087-5188-4fc4-b427-885019822729">206</ix:nonNumeric>) <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc5_1de782b4-2c0d-4172-8713-301a3c90b43a">378-6266</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6ZGRhNzQyN2ZkNjg2NDAwOThlN2M0YmE5NjdiYmU1ODYvdGFibGVyYW5nZTpkZGE3NDI3ZmQ2ODY0MDA5OGU3YzRiYTk2N2JiZTU4Nl8xLTAtMS0xLTQ4OTA2_b535e568-9769-4e59-a9f5-d811ca72e046">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6ZGRhNzQyN2ZkNjg2NDAwOThlN2M0YmE5NjdiYmU1ODYvdGFibGVyYW5nZTpkZGE3NDI3ZmQ2ODY0MDA5OGU3YzRiYTk2N2JiZTU4Nl8xLTItMS0xLTQ4OTA2_bec80869-f675-40cb-bbe1-9d0648cb9961">NSTG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The NASDAQ Stock Market LLC<br/>(The NASDAQ Global Market)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zMjk4NTM0ODg3MjYz_892f4ffd-c400-4df9-a001-f1382b09bd15">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcy_ef5f7062-c64e-4878-8a0e-a3d88626f790">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODgx_e668f254-855d-4082-b22c-003d7e976b47">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcz_f8eb854a-2259-4935-a61b-1f938be8cbc6">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:20.25pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTBjZGU2NTdkZDJlNDNhMWExNDYxM2U1OWVmMjEzMzUvdGFibGVyYW5nZTo5MGNkZTY1N2RkMmU0M2ExYTE0NjEzZTU5ZWYyMTMzNV8wLTAtMS0xLTQ4OTA2_78c91226-2e76-4df1-a5c7-9c59242cee9a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#253;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTBjZGU2NTdkZDJlNDNhMWExNDYxM2U1OWVmMjEzMzUvdGFibGVyYW5nZTo5MGNkZTY1N2RkMmU0M2ExYTE0NjEzZTU5ZWYyMTMzNV8xLTMtMS0xLTQ4OTA2_61fdc293-ed2a-441d-ba9a-f155fcdeed24">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTBjZGU2NTdkZDJlNDNhMWExNDYxM2U1OWVmMjEzMzUvdGFibGVyYW5nZTo5MGNkZTY1N2RkMmU0M2ExYTE0NjEzZTU5ZWYyMTMzNV8yLTEtMS0xLTQ4OTA2_89166393-e226-4b66-aa3f-6a8d45950ab6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc3_5864d30e-d80a-454b-8d35-ad400d450231">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). (Check one):&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8yMTk5MDIzMjYyMDEz_751fc23c-87dd-45b5-88b3-19309496c08c">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting stock held by non-affiliates of the Registrant, based on the closing sale price of the Registrant&#8217;s common stock on the last business day of its most recently completed second fiscal quarter, as reported on The Nasdaq Global Market, was approximately $<ix:nonFraction unitRef="usd" contextRef="i1e8f6c8902ab43e899d5fe51c87bc281_I20200630" decimals="-3" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8yOTQy_92e8d3a9-3a3b-4afd-9a54-9f3b2b240d48">585.7</ix:nonFraction> million. Shares of common stock held by each executive officer and director and by each other person who may be deemed to be an affiliate of the Registrant, have been excluded from this computation. The determination of affiliate status for this purpose is not necessarily a conclusive determination for other purposes.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="icf955021de6a4586adc1a655a9dc0f7f_I20230221" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zMjY4_ee65dc94-729c-4aa6-9182-dc358b228250">46,791,027</ix:nonFraction> shares of the Registrant&#8217;s common stock, $0.0001 par value per share, outstanding on February&#160;21, 2023.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc0_92cd1f07-e6ff-4e6a-975c-125af6c274ae" escape="true">Portions of the registrant&#8217;s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the registrant&#8217;s 2023 Annual Meeting of Stockholders, which will be filed subsequent to the date hereof, are incorporated by reference into Part III of this Form 10-K. Such proxy statement will be filed with the Securities and Exchange Commission not later than 120 days following the end of the registrant&#8217;s fiscal year ended December 31, 2022.</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NANOSTRING TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED DECEMBER&#160;31, 2022 </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.767%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_16">PART&#160;I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_19">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_19">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_22">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_22">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_22">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_37">Item&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_37">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_37">50</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_40">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_40">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_40">50</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_43">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_43">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_43">50</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_46">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_46">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_46">51</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_49">PART&#160;II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_49">52</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_52">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_52">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_52">52</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_55">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_55">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_55">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_58">Item&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_58">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_58">54</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_82">Item&#160;7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_82">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_82">67</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_85">Item&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_85">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_85">68</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_166">Item&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_166">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_166">98</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_169">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_169">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_169">98</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172">99</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_175">Item 9C</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_175">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_175">99</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_178">PART&#160;III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_178">99</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_181">Item&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_181">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_181">99</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_184">Item&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_184">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_184">99</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_187">Item&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_187">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_187">99</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_190">Item&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_190">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_190">99</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_193">Item&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_193">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_193">99</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_196">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_196">100</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_199">Item&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_199">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_199">100</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_202">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_202">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_202">103</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_205">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_205">104</a></span></div></td></tr></table></div><div id="i9959dc30b5d74d99a70a121eb09a4515_10"></div><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factor Summary</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties, including those highlighted in the section of this report titled &#8220;Risk Factors.&#8221; The following is a summary of the principal risks we face:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred losses since we were formed and expect to incur losses in the future. We cannot be certain that we will achieve or sustain profitability.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our financial results may vary significantly from quarter to quarter which may adversely affect our stock price.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we do not achieve, sustain or successfully manage our anticipated growth, our business and growth prospects will be harmed.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future success is dependent upon our ability to expand our customer base and introduce new applications and products.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New market opportunities may not develop as quickly as we expect, limiting our ability to successfully market and sell our products.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks related to health epidemics and other outbreaks, such as COVID-19, which could significantly disrupt our operations and could have a material adverse impact on us.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business depends on levels of research and development spending by academic and governmental research institutions and biopharmaceutical companies, a reduction in which could limit demand for our products and adversely affect our business and operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our sales cycle is lengthy and variable, which makes it difficult for us to forecast revenue and other operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our reliance on distributors for sales of our products outside of the United States could limit or prevent us from selling our products and impact our revenue.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future capital needs are uncertain and we may need to raise additional funds in the future.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to develop new products, enhance the capabilities of our systems to keep pace with rapidly changing technology and customer requirements or successfully manage the transition to new product offerings, any of which could have a material adverse effect on our business and operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent on third-party manufacturers, service providers and single source suppliers for some of the components and materials used in our products, and the loss of any of these suppliers, or difficulties or delays in securing components or materials, could harm our business.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience manufacturing problems or delays that could limit our growth or adversely affect our operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect to generate a substantial portion of our revenue internationally and are subject to various risks relating to our international activities, which could adversely affect our operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Undetected errors or defects in our products could harm our reputation, decrease market acceptance of our products or expose us to product liability claims.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we experience a significant disruption in our information technology systems or breaches of data security, our business could be adversely affected.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New product development involves a lengthy and complex process, and we may be unable to commercialize on a timely basis, or at all, any of the products we develop.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The life sciences research market is highly competitive. If we fail to compete effectively, our business and operating results will suffer.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to ongoing and extensive regulatory requirements, and our failure to comply with these requirements could substantially harm our business.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to protect our intellectual property effectively, our business would be harmed.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Involvement in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others&#8217; proprietary rights, or to defend against third-party claims of intellectual property infringement, could be time-intensive and costly and may adversely impact our business or stock price.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our common stock may be volatile, and you could lose all or part of your investment.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Macroeconomic conditions, inflationary pressures and the political climate could adversely affect our operating results and growth prospects.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Complying with the laws and regulations affecting public companies increases our costs and the demands on management and could harm our operating results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Information</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K, including the &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation&#8221; section in Item&#160;7, and other materials accompanying this Annual Report on Form 10-K contain forward-looking statements that are based on our management&#8217;s beliefs and assumptions and on information currently available. The statements contained in this Annual Report on Form 10-K that are not purely historical are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements can be identified by words such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;continue,&#8221; &#8220;depends,&#8221; &#8220;expect,&#8221; &#8220;expand,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;predict,&#8221; &#8220;plan,&#8221; &#8220;rely,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;seek,&#8221; or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition, or state other &#8220;forward-looking&#8221; information. These statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. These forward-looking statements include, but are not limited to:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our future operating results and capital needs, including our expectations regarding revenue, operating expenses, sufficiency of cash on hand and operating and net loss;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the commercial trajectory of our spatial biology products, including our ability to maintain and grow sales of our GeoMx Digital Spatial Profiler, and to successfully commercialize our CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding future sales and profitability of our nCounter platform;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">statements regarding our profitability and cash flow, including our ability to realize expected cost savings and related benefits from our reduction in workforce initiated in November 2022;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations that our existing cash, cash equivalents, and short-term investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the competitive position, market size and growth potential for our business; </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding management of growth, including our ability to expand our customer base, develop new products, enter new markets and hire and retain key personnel;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the success, costs and timing of implementation of our business model, strategic plans and future product development plans;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to secure new and sustain existing strategic relationships, including with patent holders of our technologies, manufacturers and distributors of our products, and collaboration partners;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our intellectual property position and the risk or results of litigation alleging that our products infringe upon the intellectual property rights of third parties;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key scientific or management personnel;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the impact of the COVID-19 global pandemic as it relates to our ongoing operations, including our customer order activity levels and key supplier requirements; and</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the regulatory regime and our ability to secure and maintain regulatory clearance or approval or reimbursement for the clinical use of our products, domestically and internationally.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements are based on information available to us on the date of this Annual Report on Form 10-K and we will not update any of the forward-looking statements after the date of this Annual Report on Form 10-K, except as required by law. Our actual results could differ materially from those discussed in this Annual Report on Form 10-K. The forward-looking statements contained in this Annual Report on Form 10-K, and other written and oral forward-looking statements made by us from time to time, are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, and you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Factors that might cause such a difference include, but are not limited to, those discussed in the following discussion and within </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_22">Part I, Item&#160;1A &#8212; &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form 10-K. Our Risk Factors are not guarantees that no such conditions exist as of the date of this report and should not be interpreted as an affirmative statement that such risks or conditions have not materialized, in whole or in part. In this report, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;NanoString,&#8221; and &#8220;the Company&#8221; refer to NanoString Technologies, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report on Form 10-K, and although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_16"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_19"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1758"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and market technologies that unlock scientifically valuable and clinically actionable information from minute amounts of biological material, primarily for life science researchers in the fields of genomics and proteomics. Our mission is to offer an ecosystem of innovative discovery and translational research solutions that enable our customers to map the universe of biology and conduct scientific exploration that may lead to new therapies to improve the human condition. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technologies include proprietary chemistries that enable the labeling and counting of single molecules. Our product platforms are used for scientific discovery and clinical research applications, often in connection with pharmaceutical product development and human clinical trials of potential new therapies. Our proprietary chemistries may reduce the number of steps required to conduct certain types of scientific experiments, enable the collection of multiple data points in a single experiment or  allow for multiple experiments to be conducted at once. Our chemistries and instruments are also able to extract information from multiple types of biological samples, including those that are often challenging to work with using other scientific methods or platforms. As a result, we are able to develop tools that are easier for researchers to use and that may generate larger amounts of data, and faster, more consistent scientific results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecosystem of solutions consists of (i) our spatial biology platforms, including our GeoMx Digital Spatial Profiler, or &#8220;GeoMx DSP&#8221; or &#8220;GeoMx&#8221;, our CosMx Spatial Molecular Imager, or &#8220;CosMx SMI&#8221; or &#8220;CosMx,&#8221; and our AtoMx Spatial Informatics Platform, or &#8220;AtoMx SIP&#8221; or &#8220;AtoMx&#8221;, a cloud-based, open source and fully integrated informatics solution for use with GeoMx DSP and CosMx SMI, and (ii) our nCounter Analysis System, our original product platform for multi-plex bulk gene expression analysis. Our GeoMx, CosMx and nCounter product platforms include instruments, related consumables, software and services, have the versatility to detect both RNA and protein expression and are able to generate reliable and reproduceable data in a variety of biological sample types, including formalin fixed paraffin embedded, or FFPE, format.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Every living organism has a genome that contains a full set of biological instructions required to build and maintain life. A gene is a specific set of instructions embedded in the deoxyribonucleic acid, or DNA, of a cell. For a gene to be &#8220;turned on,&#8221; or &#8220;expressed&#8221;, a cell must first transcribe a copy of a portion, or sequence, of its DNA code into molecules of messenger ribonucleic acid, or RNA. Then, the cell translates the expressed information contained in RNA into proteins that form the building blocks of organisms and biological processes.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decoding of the human and other genomes, and the generation of large amounts of genetic information, or gene sequence data, have led researchers to seek to understand which genes among the decoded sequences may be expressed at any given time, and how networks of genes may work together to produce a biological condition or function. Researchers determine which genes are expressed, and in what magnitude, by measuring levels of selected RNA or proteins that may be present in a biological sample. The desire to map and interpret gene expression patterns has led to demand for technologies that can precisely and efficiently measure the expression level of hundreds of genes simultaneously.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for these new or improved technologies has been driven by researchers in areas such as cancer, immunology, neurology and infectious disease. Researchers in these fields are increasingly attempting to determine which sequences of genes or mutations are important in disease-related biological pathways so new potential treatments might be developed. For example, in the field of cancer, researchers and clinicians have learned that cancer cell behavior is impacted by multiple genes and that analysis of these factors together may be important in determining whether or not a cancer might be responsive to a certain treatment. In addition, more cancers are being detected earlier and tumor samples are becoming smaller and smaller. Tumor samples are often stored in FFPE format, a process whereby biological samples are able to be preserved for long time periods but which can complicate subsequent analysis of genetic material. Researchers and clinicians may face similar challenges with analysis of biological samples in other therapeutic areas of interest.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nCounter platform, which was commercially launched in 2008, is used to conduct what is known as bulk gene expression analysis, whereby biological samples are first reduced, or broken down, and then gene expression, specifically quantities of selected RNA or proteins, are measured at their average levels throughout the totality of the sample. nCounter can be used to analyze the activity of up to 800 genes in a single experiment.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeoMx DSP, which was commercially launched in 2019, is a pioneering product platform in the emerging field of spatial biology. While nCounter and other common gene expression analysis technologies use bulk analysis approaches, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeoMx DSP is used to analyze selected regions of an intact biological sample without the need to break down the sample, enabling researchers to see how gene expression might vary across those regions. After a researcher selects regions of interest, GeoMx arranges the biological information extracted from these regions to be subsequently quantified and analyzed, or &#8220;read out,&#8221; by a platform such as nCounter, whereby researchers can obtain information on up to 96 biological targets per selected region of interest, or by a next generation sequencer, or NGS, system, such as systems manufactured by Illumina, Inc., whereby researchers can obtain information on up to approximately 18,000 biological targets, or the RNA from every gene in the genome, per selected region of interest.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CosMx SMI, which was commercially launched in December 2022, is a new product platform in the field of spatial biology and complements our GeoMx DSP. While GeoMx offers researchers the ability to profile gene expression activity in a selected region of interest that may contain multiple cells or cell types, CosMx is designed to enable multiplexed spatial profiling of RNA and protein targets at a single and sub-cellular resolution level. While GeoMx allows for more rapid, higher throughput analysis of gene expression activity in selected regions of interest, CosMx is designed to allow researchers to &#8220;drill down&#8221; into a specific single cell or sub-cellular area in a region of interest to gather more information as desired or required. CosMx can be used to analyze up to 1,010 RNA targets, or up to 68 protein targets, at a single or sub-cellular level of resolution within morphologically intact tissue samples, and is expected after further product development to have the ability to analyze up to 6,000 RNA targets, or up to 120 protein targets.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AtoMx SIP, which was commercially launched in December 2022, is a new a cloud-based, open source spatial biology informatics platform, initially for use with CosMx, and eventually also with GeoMx. Researchers&#8217; desire for ever larger amounts of data in their spatial biology experiments has led to significant &#8220;big data&#8221; management issues, including the ability to store, access and efficiently analyze experimental data at a reasonable cost. AtoMx is designed to take advantage of significant advances in cloud computing and facilitate the easy storage of large data sets and images generated by spatial biology experiments. AtoMx also enables researchers to perform image analysis and data visualization, as well as sharing of data and analysis with collaborators, using scalable and on-demand cloud computing. We believe AtoMx will enable researchers to easily and quickly analyze the substantial scientific data and tissue images generated by spatial biology experiments, while avoiding the large computing infrastructure and security costs associated with operating in-house data centers. AtoMx is currently available to researchers using CosMx, and is expected to be made available for GeoMx users by the end of 2023.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market and sell our systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for research use, both through our direct sales force and through selected distributors in certain international markets. As of December&#160;31, 2022, we had an installed base of approximately 350 GeoMx DSP systems, which our customers have used to publish approximately 190 peer-reviewed scientific papers. As of December&#160;31, 2022, we had an installed base of approximately 1,120 nCounter systems, which our customers have used to publish more than 6,520 peer-reviewed scientific papers. We generated revenue of $127.3 million, $145.1 million and $117.3 million in 2022, 2021 and 2020, respectively, while incurring net losses of $159.5 million, $115.3 million and $110.1 million in 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized as, and operate in, one reportable segment. For additional information, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_115">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">Notes to Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report. For financial information regarding our business, see</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_58"> Part II, Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report and our audited consolidated financial statements and related notes included elsewhere in this report.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in Delaware in June 2003. Our principal executive offices are located at 530 Fairview Avenue, North, Seattle, Washington 98109 and our telephone number is (206)&#160;378-6266. Our common stock trades on The Nasdaq Global Market under the symbol &#8220;NSTG.&#8221;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K includes our trademarks and registered trademarks, including &#8220;NanoString&#8221;, &#8220;NanoString Technologies&#8221;,  &#8220;nCounter&#8221;,  &#8220;nCounter SPRINT&#8221;, &#8220;nSolver&#8221;,  &#8220;GeoMx,&#8221; &#8220;CosMx,&#8221; and &#8220;AtoMx&#8221;. Each other trademark, trade name or service mark appearing in this Annual Report on Form 10-K belongs to its holder.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1751"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Every living organism has a genome that contains a full set of biological instructions required to build and maintain life. A gene is a specific set of instructions embedded in the DNA of a cell. For a gene to be &#8220;turned on,&#8221; or &#8220;expressed,&#8221; the cell must first transcribe a copy of its DNA code, or sequence, into molecules of messenger RNA. Then, the cell translates the expressed information contained in RNA into proteins that control most biological processes. In addition to the translated RNAs, there are many types of non-coding RNAs that are involved in many cellular processes and the control of gene expression, including microRNA, or miRNA.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><img src="nstg-20221231_g2.jpg" alt="nstg-20221231_g2.jpg" style="height:293px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By analyzing the variations in genomes, genes, gene activity or expression and proteins in and between organisms, researchers can determine their functions and roles in health and disease. An improved understanding of the genome and its functions allows researchers to drive advancements in scientific discovery. As they make scientific discoveries, researchers have been able to translate some of these findings into clinical applications that improve patient care.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biological pathways are the networks of tens or hundreds of genes that work together to produce a biological function. Understanding the activation state of pathways and disruptions in individual elements provides significant insight into the fundamental basis of health and disease and facilitates data driven treatment decisions. As a result, pathway-based biology has become a widely adopted paradigm that researchers use to understand biological processes and has assisted them in the development of diagnostic tests and drugs to treat disease.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Understanding biological pathways has become particularly important in cancer research and treatment. Cancer is a disease generally caused by genetic mutations in cells. The behavior of cancer cells is extremely complex and depends on the activity of many different genes and proteins. It is often impossible for researchers to identify a single gene or protein that adequately predicts a more or less aggressive type of cancer. In some cases, researchers have been able to identify more or less aggressive types of cancer through gene expression analysis of biological pathways, enabling oncologists to determine which specific treatments are most likely to be effective for an individual patient, monitor a patient&#8217;s response to those treatments and determine the likelihood of recurrence. Cancer researchers, in part based on their research of biological pathways and gene expression, have begun to demonstrate the potential of harnessing a patient&#8217;s immune system to fight cancer. A new class of therapeutics, referred to generally as immuno-oncology drugs, have begun to come to market with the promise of long-term remissions, or even cures, in certain types of cancer.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As interest in understanding biological pathways that may be relevant to medicine has increased, academic, government and biopharmaceutical company researchers have aspired to perform analyses of a larger number of genes and samples and are seeking new methods of interrogation that would allow them to:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase the number of molecular targets that can be analyzed simultaneously in order to understand the complete biological pathway involving multiple genes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analyze the activity of genes within the existing structural integrity, or spatial orientation, of a biological sample;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide more reliable, precise and reproducible data about targeted genes and biological pathways;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maximize the amount of biologic information extracted from precious tissue or other biological samples;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">minimize the computational intensity of complex genomic and proteomic analysis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">process difficult-to-work-with specimens, such as tumor biopsies stored in FFPE format;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improve the overall efficiency of their laboratories by simplifying workflow and accelerating the rate of successfully completing their research; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create more systematic and reliable ways to help transition their research discoveries into future clinical products.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest in new methods of interrogation has led to the development of new research technologies. Certain technologies that have been rapidly adopted by researchers have focused primarily on determining the sequence of a person&#8217;s or organism&#8217;s DNA, in order to assess how differences among individuals might be predictive of health or disease. In particular, a technology known as next generation sequencing, or NGS, has become widely adopted. In recent years NGS use has </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated, as the technology has improved and the cost to sequence DNA using NGS has declined. As of December&#160;31, 2022, there were more than 23,000 Illumina NGS systems installed in laboratories globally.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While NGS has revolutionized researchers&#8217; ability to generate gene sequence data rapidly and cost effectively on large numbers of biological samples, other aspects of examining biological pathways are often still done using legacy techniques or new technologies that have proved less capable of providing multiplexed experimentation, ease of use and low cost. Together with determining a gene sequence via NGS, pathway-based research requires further analysis of the activity of multiple genes and small changes in their expression, or of how gene expression may vary depending on where certain cells are situated within biological tissue, which can be challenging for traditional scientific tools.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Researchers interested in multiplex gene expression or biological pathway analysis have traditionally performed experiments using microarrays or quantitative polymerase chain reaction, or qPCR, and protein expression experiments using flow cytometry, mass spectrometry, immunohistochemistry or enzyme-linked immunosorbent assay, or ELISA, assays. Many of these techniques have been available for decades, and while suitable for analyzing the expression of a smaller number of genes, may not be cost effective or scalable enough to study biological pathways. While these types of experiments could be repeated to analyze expression of multiple genes, they are often destructive of biological samples, creating limitations given the amounts of biological sample that may be available. Many of these methods, known as &#8220;bulk&#8221; biology or &#8220;grind and bind,&#8221; also destroy the spatial integrity of the sample, eliminating any potential analysis of differences in how genes may be expressed based on where a cell or cells are situated in tissue, or how they may be interacting with other cells or biological functions. These types of experiments may also involve library preparation and amplification steps that can be cumbersome or time consuming or that may introduce the possibility of measurement errors.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More recently, RNA sequencing, or RNA-Seq, which is done using NGS technology, has enabled researchers to look at the entirety of the gene expression within a single sample. However, NGS systems have a more complex and time-consuming workflow than traditional methods of analyzing gene or protein expression, and RNA-Seq generates large amounts of data that may be expensive to store and may not have relevance to the scientific question being explored.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both life sciences research and clinical medicine, there is a growing need for improved technologies that can easily, precisely and rapidly measure the activation state of hundreds to thousands of genes simultaneously across a large number of precious samples. Furthermore, there is an emerging desire for technologies that could enable researchers and clinicians to understand gene expression activity in tissue as it is naturally situated in the body, without the need to destroy the structure of the biological sample, in order to see if gene activity might vary depending on how, or where, cells are resident in the sample.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1744"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strategy and Solutions</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy is to offer a portfolio of technologies to genomics and proteomics researchers that are easy to use across multiple experimental scales or approaches, and that offer consistent, accurate and reproduceable scientific results in a variety of biological sample types, including those that may be more challenging to use or analyze with alternative technology platforms. Our proprietary chemistries and product platforms offer a number of specific advantages, including:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Complementary solutions that enable spatial biology and bulk gene expression analysis at multiple scales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Genomics and proteomics science has evolved to where experiments can involve studying gene expression from just a handful of data points from up to thousands of genes at a time, and may involve different types of analysis, such as bulk or spatial analysis or quantifying RNA or proteins. Our spatial biology platforms, which enable researchers to analyze intact biological samples, enable the analysis of multiple genes in a single experiment, at various scales. Our GeoMx DSP enables multiplex profiling of intact biological samples of up to approximately 18,000 RNA targets and up to approximately 100 protein targets in selected regions of scientific interest, at multicellular resolution. Our CosMx SMI offers the ability to analyze up to 1,000 RNA targets and up to 68 protein targets in specifically selected regions of a biological sample at single cell or sub-cellular resolution. nCounter, our bulk gene expression analysis solution, can profile the activity of up to 800 genes in a single experiment on multiple biological samples per day, with fewer experimental steps as compared to other multiplex bulk gene expression analysis technologies. We believe the breadth of the spatial biology and bulk gene expression research applications offered by our product platforms may provide our customers with a complete solution for their laboratories, as well as consistency of platform features, usability and performance.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Ease of use and automation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spatial biology and gene expression research requires the extraction and analysis of large amounts of data, often from studies comprising hundreds of biological samples, which can make manual or non-automated experimental approaches cumbersome, labor intensive or expensive. Our product platforms are designed to offer minimal sample preparation and automated workflow, which enables the simultaneous analysis of up to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">thousands of genes and hundreds of proteins and to do so in large numbers of biological samples, which would be challenging using manual experimental approaches.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Flexible and Efficient Biological Sample Requirements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Some biological samples, such as FFPE samples, can be challenging for scientists to work with, as the storage medium can make it difficult to extract gene expression information, or may partially degrade RNA or protein present in a sample. Biological samples may also be shared across multiple researchers, offering advantages to platforms that are able to work with smaller sample amounts. Our systems are designed to unlock biologic information from minute amounts of a variety of challenging tissue samples, including FFPE samples, cell lysates and single cells, which may be important in settings where samples are used across multiple researchers and experiments, such as pharmaceutical product development.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Robust and reproduceable scientific results. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some chemistries used in spatial biology and bulk gene expression analysis have error rates that may lead to inconsistent data across the same or similar biological samples. Our chemistries hybridize directly to target molecules in a biological sample, which allows target molecules to be counted with high accuracy. Our approaches generate digital information (1 molecule = 1 count) which provides consistent and accurate data with excellent reproducibility, even in biological samples that can be challenging to work with, offering confidence for scientists preparing scientific studies for publication or utilizing results to understand the outcomes of pharmaceutical clinical trials.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1737"></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Products and Technology</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products operate in the spatial biology and bulk gene expression markets, which exist within the larger life sciences technologies market. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecosystem of spatial biology solutions, which include our GeoMx DSP, CosMx SMI and AtoMx SIP, are designed to seamlessly work together and address researcher needs across both the discovery and translational research markets. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nCounter, our first commercially available product, was launched in 2008 and operates within the multi-plex bulk gene expression market and primarily serves the clinical, or translational, research market, often in connection with pharmaceutical product development and human clinical trials of potential new therapies. Our nCounter systems can be used for research or clinical diagnostic applications.</span></div><div style="margin-bottom:6pt;text-align:center"><img src="nstg-20221231_g3.jpg" alt="nstg-20221231_g3.jpg" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spatial Biology</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GeoMx DSP</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GeoMx Digital Spatial Profiler, or &#8220;GeoMx DSP&#8221; or &#8220;GeoMx&#8221;, which was made commercially available in 2019, is a pioneering product in the emerging field of spatial biology. nCounter and many other existing gene expression analysis technologies typically assess the average gene expression throughout the totality of a biological sample using sample reduction, or &#8220;bulk&#8221; or &#8220;grind and bind&#8221; approaches. GeoMx is designed to allow researchers to explore and quantify how the expression of large numbers of genes vary in different selected regions of interest across the landscape of a heterogeneous biological sample, retaining spatial information and providing assays that target different regions in the same sample.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><img src="nstg-20221231_g4.jpg" alt="nstg-20221231_g4.jpg" style="height:118px;margin-bottom:5pt;vertical-align:text-bottom;width:233px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><img src="nstg-20221231_g5.jpg" alt="nstg-20221231_g5.jpg" style="height:204px;margin-bottom:5pt;vertical-align:text-bottom;width:430px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The left image is the GeoMx DSP instrument, the middle image is a sample of regions of interest, or ROIs, in a biological sample that have been selected by a researcher using GeoMx DSP for further analysis, and the right image is a &#8220;volcano plot&#8221; comparing the differential gene expression across regions within the biological sample.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary technologies historically used by researchers and clinicians to analyze gene activity in selected parts of a biological sample include immunohistochemistry, or IHC, which is used to estimate amounts of protein, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in-situ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hybridization, or ISH, which is used to estimate amounts of RNA. Both IHC and ISH use fluorescent stains that provide the ability to identify typically four proteins or RNA at a time based on assigned colors. The colors aid researchers in identifying where certain proteins or RNA may reside in a sample and provide a visual approximation of amounts. These techniques are generally limited however in their ability to only look at a small number of proteins or RNA at a time and offer no ability to precisely quantify the amounts present in any given region or cell type. These limitations may lead to incomplete scientific conclusions as to the most relevant biological pathways in any given sample.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeoMx is designed to allow researchers to quantify a much larger number of RNA or proteins spatially within multiple regions of interest across the landscape of a heterogeneous section of a biological sample. Our GeoMx instrument images slide-mounted or freshly cut sample sections, allowing users to select regions of interest for subsequent quantification and analysis, or molecular profiling. The post-selection profiling or &#8220;read out,&#8221; can be performed using either our nCounter Analysis System, or an Illumina NGS system. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe GeoMx offers a number of advantages as compared to traditional spatial technologies, including the ability to profile both RNA and protein, the ability to multiplex large numbers of different RNA or proteins simultaneously in each selected region, flexibility on the selection of regions to analyze, and the ability to process 10 or more biological samples per day.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When GeoMx was first made commercially available, researchers were only able to read out information on up to 96 biological targets from each of their GeoMx-selected regions of interest using nCounter. In August 2020, we added software capabilities and consumables which enabled GeoMx region of interest data to be read out using Illumina NGS systems, which significantly expanded the number of biological targets researchers could analyze in selected regions. In 2021, our Whole Transcriptome Atlas, or WTA, became commercially available and further expanded the number of biological targets in a GeoMx region of interest that may be read out on NGS systems to approximately 18,000 RNAs. Linking GeoMx with NGS also significantly expands our total potential market opportunity. As of December&#160;31, 2022, there were approximately 23,000 Illumina NGS systems installed globally.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GeoMx DSP Instrument and Software</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GeoMx DSP instrument uses specialized optics to image slide-mounted biopsies that have been prepared using our GeoMx DSP consumable reagents, as well as with IHC or ISH technology typically available in research or commercial laboratories. GeoMx DSP then allows a researcher to select regions of interest for analysis on screen, and then prepares samples from the selected regions of interest for molecular profiling. Like nCounter, GeoMx is capable of supporting applications including gene expression and protein expression. GeoMx is fully automated and easy to use, requiring only 30 minutes of hands-on time per run and offering the ability to process up to 10 slides per day and is therefore ideal for a range of applications requiring efficient, high-precision, simultaneous quantitation of large numbers of target molecules across a set of biological samples.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GeoMx software enables the integration of the four color images acquired and the corresponding digital counts of the levels of RNA or protein as acquired using our nCounter Analysis System, or an Illumina NGS system. The GeoMx data center uniquely combines system control to visualize whole sample images at single cell resolution with automated or manual region of interest selection. The fully integrated workflow provides tracking of image data and corresponding profiling data, allowing users to easily go from data collection to data analysis. In addition to our internally developed software, in 2020 we announced a collaboration with Illumina, whereby we have developed a GeoMx application powered by Illumina&#8217;s DRAGEN Bio-IT platform in order to facilitate the analysis of data generated by our customers using NGS read out on Illumina systems.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">GeoMx DSP Consumables</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current portfolio of GeoMx DSP consumables focuses on RNA and protein profiling for immunology, immuno-oncology and neurobiology applications, targeted either for nCounter read out where a set of genes and a biological pathway may be better understood for more targeted experiments, or for NGS read-out in basic discovery applications where significantly greater numbers of genes may be of interest. GeoMx consumable products are currently designed as standardized panel products that represent important content for certain disease areas with an option for researchers to add customized content to that panel depending on the area of interest or desired number of targets for analysis. Our GeoMx assays generate high-quality results from challenging sample types, including FFPE and crude cell lysates.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant GeoMx consumable products include: </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enabled for nCounter readout</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Immuno-Oncology Panels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An immuno-oncology-focused panel menu that comprises up to 96 protein and RNA targets for analyzing the tumor and tumor microenvironment compartments in human and mouse biological samples. The standard, or core, panel offering is comprised of 18 targets, and researchers have the option of adding over 30 additional targets for analysis focused on specific applications such as immuno-oncology drug target proteins, or human immune activation proteins, and 23 additional targets for analyzing mouse samples for pre-clinical applications. In addition, we offer RNA panel content to allow for the analysis of up to 84 targets for human immune pathways.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Neurobiology Panels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A neurobiology-focused menu that comprises up to 40 protein targets to profile human neural cells. The standard, or core, panel offering comprises 20 targets, and researchers have the option of adding up to 20 additional targets for analysis focused on specific applications such as proteins implicated in Alzheimer&#8217;s disease or Parkinson&#8217;s disease.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enabled for NGS readout</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cancer Transcriptome Atlas (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An oncology and immuno-oncology focused panel was the first commercial GeoMx product to enable read out using NGS. The CTA allows for a nearly 20-fold increase in RNA targets that may be profiled as compared to GeoMx RNA panels designed for nCounter read out, providing a high-resolution spatial view of cancer biology. The CTA includes more than 1,800 genes that cover over 100 pathways critical to understanding tumor biology, the immune response and the tumor microenvironment. Biological content can be further customized with the addition of up to 60 user defined targets. The CTA panel is compatible with both fresh frozen and FFPE-embedded biological samples, allowing scientists to work with a broad spectrum of samples in their research. As part of a full end-to-end solution, we are providing library preparation reagents and NGS readout, a bioinformatics pipeline that links high-resolution, full-slide images generated on GeoMx with the massively parallel output of Illumina sequencers.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Universal:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Protein Assays. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The currently available content covers applications in immuno-oncology and future content releases are planned to cover immunology and neuroscience. These assays will provide GeoMx CTA and WTA users complementary protein content designed for NGS read out. These new protein assays have been tested for performance on both fresh frozen and FFPE-embedded biological samples. Our GeoMx Protein Assays for NGS readout expanded the protein capabilities of GeoMx from tens to now hundreds of validated proteins to be analyzed from a single sample section with spatial resolution. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Whole Transcriptome Atlas (WTA).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The WTA, a GeoMx consumable product that became commercially available for use in human and mouse biological samples during 2021, is a universal panel that provides an unbiased, spatial view of approximately 18,000 RNA targets and is designed to be read out using NGS. The WTA unlocks new pathways to be explored by researchers and is designed to broaden GeoMx RNA profiling from oncology and immunology to include neuroscience, developmental biology and other diverse fields. The WTA assay provides robust and sensitive performance both fresh frozen and FFPE-embedded biological samples, allowing scientists to work with a broad spectrum of samples in their research. WTA utilizes the same workflow and chemistry as our CTA. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CosMx SMI</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CosMx Spatial Molecular Imager, or &#8220;CosMx SMI&#8221; or &#8220;CosMx&#8221;, which was made commercially available in December 2022, is designed to combine the spatial profiling of a large number of biological targets with high-resolution imaging, which will allow researchers to both analytically measure as well as visualize the activity of selected RNA or proteins at the single cell or sub-cellular level. CosMx SMI enables the analysis of up to 1,000 RNA targets or up to 68 protein targets directly from single cells within morphologically intact biological samples and is expected, after further development, to enable the analysis of up to 6,000 RNA targets or up to 120 protein targets. CosMx SMI offers researchers the opportunity to &#8220;drill down&#8221; further into regions of interest in biological samples, as a complement to our GeoMx DSP which typically offers gene expression profiling across regions containing multiple cells.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CosMx SMI incorporates a proprietary version of our chemistry that was originally developed as part of our concluded collaboration with Lam Research, whereby we modified our core nCounter chemistry to be utilized in a NGS sequencing platform and related assays. Upon the conclusion of our Lam collaboration, in 2020 we began exploring applications for this newly developed chemistry in spatial biology, specifically whether we could conduct spatial analysis of increasingly smaller regions of interest, down to the individual cell and potentially sub-cellular level. Upon completing proof of principle research and development, we announced the expected development and commercialization timeline for CosMx SMI in December 2020.</span></div><div style="text-align:center"><img src="nstg-20221231_g6.jpg" alt="nstg-20221231_g6.jpg" style="height:121px;margin-bottom:5pt;vertical-align:text-bottom;width:176px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><img src="nstg-20221231_g7.jpg" alt="nstg-20221231_g7.jpg" style="height:137px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><img src="nstg-20221231_g8.jpg" alt="nstg-20221231_g8.jpg" style="height:134px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The left image is the CosMx SMI instrument, the middle image is a single-cell expression map of selected genes and the right image is a spatially-resolved cell type map in a biological sample.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biology takes place on several spatial scales including multi-cellular, single cell and sub-cellular levels. GeoMx DSP enables multi-cellular analysis at the whole transcriptome level to elucidate the behavior of populations of cells, such as those within a tumor or the tumor microenvironment. We have designed CosMx SMI to address the unmet need for high-plex spatial analysis at single cell and sub-cellular resolution, which may be ideally suited for targeted applications such as creating cell atlases or studying cell-cell interactions. Our GeoMx DSP and CosMx SMI platforms are designed to be synergistic, creating a spatial biology portfolio that spans the continuum from targeted to whole transcriptome analysis, and from multicellular resolution down to single cell and sub cellular applications.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe CosMx SMI offers a number of advantages as compared to competing imager platforms, including the ability to profile a high number of selected targets or &#8220;high plex&#8221;, a larger sample scan area of up to 300 square millimeters, a tunable throughput that allows researchers to process between 2 to 20 samples per week depending on the number of targets selected for study, and the ability to store, manage, analyze and share data from the large data sets generated in a cloud-based informatics environment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CosMx SMI Instrument and Software</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CosMx SMI instrument uses specialized optics to perform high-plex analysis at cellular and subcellular resolution of slide-mounted FFPE and fresh frozen, or FF, tissue samples which have been prepared using CosMx Assay Consumables. CosMx SMI allows researchers to select specific fields of view, or FOVs, up to 300 square millimeters and then uses an integrated readout to enable visualization of up to 1,000 RNA, or up to 68 protein targets. Like nCounter and GeoMx DSP, CosMx SMI is capable of supporting applications including gene expression and protein expression. The CosMx SMI uses standard histology workflows and features semi-automated options to reduce hands-on time per run. CosMx SMI workflows and integrated readout enable researchers to process up to 2 slides per week for 1000-plex RNA assays covering 100 mm2 tissue area or up to 7 slides per week for 68-plex Protein assays covering 100 mm2 tissue area.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CosMx SMI uses multi-modal cell segmentation to provide accurate cell boundary detection. This cell segmentation process uses cell membrane and protein morphology images, a machine-learning augmented cell segmentation algorithm and transcript-based segmentation refinement to achieve precise single-cell segmentation results from intact tissue. AtoMx SIP is the supported software platform for CosMx SMI. CosMx SMI is designed to seamlessly export data to AtoMx SIP to enable researchers to visualize, analyze and perform enhanced bioinformatic workflows on their collected results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CosMx SMI Consumables</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Launched in December 2022, our current portfolio of CosMx SMI consumables focuses on RNA and protein profiling for immunology, immuno-oncology and neurobiology applications. CosMx consumable products are currently designed as standardized panel products that represent important content for certain disease areas with an option for researchers to add customized content to that panel depending on the area of interest or desired number of targets for analysis. Our CosMx assays generate high-quality results from challenging sample types, including FFPE and crude cell lysates.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant CosMx consumable products include:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">For RNA:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g9.jpg" alt="nstg-20221231_g9.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immuno-Oncology Panel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An immuno-oncology-focused panel that comprises 100 RNA targets for analyzing the tumor and tumor microenvironment compartments in human biological samples. The standard, or core, panel offering is comprised of 100 targets, and researchers have the option of swapping up to 10 targets for custom RNA targets.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><img src="nstg-20221231_g10.jpg" alt="nstg-20221231_g10.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Neurobiology Panels.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A neurobiology-focused menu that comprises up to 1,000 targets to profile mouse neural cells. This panels enables research into topics such as Alzheimer&#8217;s disease or Parkinson&#8217;s disease.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><img src="nstg-20221231_g11.jpg" alt="nstg-20221231_g11.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Universal Panels.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A universal panel that comprises up to 1,000 RNA targets human biological samples. The Human Universal RNA Panel enables researchers to explore pathways at the single cell and subcellular level and provides robust and sensitive performance for real-world FFPE-embedded biological samples, allowing scientists to work with a broad spectrum of samples in their research.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">For Protein:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><img src="nstg-20221231_g12.jpg" alt="nstg-20221231_g12.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immuno-Oncology Panel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An immuno-oncology-focused panel that comprises 64 protein targets for analyzing the tumor and tumor microenvironment compartments in human biological samples. The standard panel offering is comprised of 64 targets and has demonstrated robust and sensitive performance in real-world FFPE-embedded biological samples. Content releases in 2023 are expected to cover neurobiology content for mouse biological samples and are expected to include an option to customize pre-validated protein panel content with up to 8 custom labeled antibodies through NanoString&#8217;s Protein Barcoding Service.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AtoMx SIP</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><img src="nstg-20221231_g13.jpg" alt="nstg-20221231_g13.jpg" style="height:239px;margin-bottom:5pt;vertical-align:text-bottom;width:400px"/></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AtoMx Spatial Informatics Platform, or &#8220;AtoMx SIP&#8221; or &#8220;AtoMx&#8221;, is a cloud-based, open source and fully integrated informatics solution for spatial biology. AtoMx, which was commercially launched in December 2022, is initially for use with CosMx, and is expected to be made available for use with GeoMx by the end of 2023.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AtoMx enables users to perform image analysis and data visualization and utilize scalable and on-demand cloud computing and data storage, allowing data sharing to enable global research collaboration. AtoMx provides the secure, scalable storage and analysis that spatial biology researchers need to drive their workflow from study design to peer-reviewed publication. AtoMx stores customer data in a flexible &#8220;data lakehouse&#8221; structure which can be examined using artificial intelligence and machine learning approaches. A cloud-based platform reduces or eliminates the need for laboratories to invest </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in their own costly informatics infrastructure and reduces spatial biology analysis compute times from days to hours. Users have the flexibility to apply a predefined data analysis pipeline, to customize these pipelines using their own code, and to access open-source tools developed by the bio-informatics community.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technology Access Program (TAP)</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected customers can access our GeoMx DSP and CosMx SMI through our in-house Technology Access Program, or TAP, service and may select panels that read out on either nCounter or NGS. Through TAP, customers submit biological samples to our Seattle facilities where they are imaged and profiled using our instruments and once completed, we provide a detailed report, which includes raw data and analyzed results back to the customer. We have successfully utilized TAP prior to and during our GeoMx DSP and CosMx SMI instrument and product commercial launches and believe it may be a leading indicator of potential future commercial demand for our products.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">nCounter</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nCounter Analysis System is an automated, multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using our proprietary optical barcoding chemistry that is powerful enough for use in research, yet simple enough for use in clinical laboratories. Our nCounter Analysis System is based on automated instruments that prepare and analyze biological samples using proprietary reagents which can only be obtained from us. Our research and clinical laboratory customers purchase instruments from us and then purchase our reagents and related consumables for the specific experiment they wish to conduct and for tests that they intend to run, respectively.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><img src="nstg-20221231_g14.jpg" alt="nstg-20221231_g14.jpg" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nCounter Analysis System is capable of supporting a number of applications including gene expression, protein expression, gene mutation, miRNA expression, copy number variation, gene fusions and molecular diagnostics. We believe our nCounter Analysis System offers a number of advantages, including providing a simpler and faster workflow with minimal hands-on time for multiplex analysis of up to 800 RNA, or protein targets. Additionally, because nCounter is fully automated and easy-to-use, it is ideal for a range of applications requiring efficient, high-precision, simultaneous quantitation of hundreds of target molecules across a set of biological samples. Our nCounter assays generate high-quality results from challenging sample types, including FFPE and crude cell lysates.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nCounter Instruments</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><img src="nstg-20221231_g15.jpg" alt="nstg-20221231_g15.jpg" style="height:108px;margin-bottom:5pt;vertical-align:text-bottom;width:228px"/><img src="nstg-20221231_g16.jpg" alt="nstg-20221231_g16.jpg" style="height:108px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><img src="nstg-20221231_g17.jpg" alt="nstg-20221231_g17.jpg" style="height:116px;margin-bottom:5pt;vertical-align:text-bottom;width:175px"/></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The left image is the nCounter Pro system, the middle image is the nCounter FLEX system and the right image is the nCounter SPRINT Profiler system.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently offer three versions of our nCounter Analysis System, each targeted at a distinct user segment. Our nCounter Pro is a higher throughput instrument with features appealing to larger core laboratories serving multiple researchers. Our nCounter SPRINT Profiler is designed to appeal to individual researchers running relatively smaller experiments. Our nCounter FLEX, which is targeted toward clinical laboratories, has been 510(k) cleared by the U.S. Food and Drug Administration, or FDA, and CE marked by European regulatory authorities. The nCounter FLEX system was designed and is manufactured under ISO 13485:2003, the current quality standard for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic platforms and medical devices. nCounter FLEX is enabled to run the Prosigna&#174; breast cancer assay, as well as other proprietary or laboratory developed tests, or LDTs, that may be developed. Pursuant to the terms of our License and Asset Purchase Agreement, or LAPA, with Veracyte, Inc., or Veracyte, we granted to Veracyte an exclusive worldwide license to our nCounter FLEX system for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic use and for the development and commercialization of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic tests on the nCounter FLEX system and sold to Veracyte certain assets, including our rights with respect to the Prosigna breast cancer assay. For additional information regarding our agreement with Veracyte, see &#8220; &#8212; License Agreements &#8212; Veracyte, Inc.&#8221; below.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nCounter Pro and FLEX systems comprise a Prep Station and a Digital Analyzer. The Prep Station is the automated liquid handling component that processes and prepares the samples for data collection on the Digital Analyzer. The Digital Analyzer collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files, which include the target identifier and related count numbers along with a broad set of internal controls that validate the precision of each assay. The nCounter Pro and FLEX throughput can be quadrupled using sample multiplexing for experiments targeting 200 genes or fewer. The nCounter SPRINT Profiler combines the liquid handling steps and the digital analysis through use of a special microfluidic cartridge.</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.483%"></td><td style="width:0.1%"></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g18.jpg" alt="nstg-20221231_g18.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:175px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g16.jpg" alt="nstg-20221231_g16.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:150px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g17.jpg" alt="nstg-20221231_g17.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#494949;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#494949;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">510(k)-Cleared FLEX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#494949;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SPRINT</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target customer</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core&#160;research&#160;labs</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical&#160;labs</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual&#160;researchers</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of workflow steps</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Throughput (samples per day) </span><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 - 96</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 - 96</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prep station and digital analyzer</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expandable with additional prep station </span><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diagnostic Menu</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hands-on time (minutes)</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. list price</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$249,000</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1pt dotted #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300,000</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1pt dotted #000;border-right:1pt solid #b6b6b6;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$149,000</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">nCounter Pro and FLEX throughput may be increased to up to 96 samples per day by adding a second prep station.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nCounter Consumables</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our nCounter consumables sold are standardized off-the-shelf panel products that represent important gene signatures for certain disease areas. nCounter consumables can also be customized to a specific set of genes at a customer&#8217;s request.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Panels</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer more than 50 gene expression panels for use with a broad range of sample types and species, including human, mouse, non-human primate- and other. These pre-manufactured panels contain highly-curated, thematic gene content built in collaboration with the scientific community. nCounter pre-built panels are also customizable to address specific research interests with the purchase of our custom Panel Plus product, allowing for up to 55 additional user defined genes to be added to any off-the-shelf-panel. Below are examples of our panels, which can be used throughout the research, drug development, manufacturing and clinical biomarker discovery for oncology, immunology, infectious disease and neuroscience.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Oncology Research Applications</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Panel Name</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt dotted #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Panel Description</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g19.jpg" alt="nstg-20221231_g19.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:65px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;PanCancer IO 360</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holistic view of tumor, microenvironment and immune response. Contains predefined IO signatures and automated data analysis report.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g20.jpg" alt="nstg-20221231_g20.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breast Cancer 360</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">776 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contains 23 key breast cancer pathways and processes, 10 research focused signatures and 30 novel signatures measuring tumor and immune activities and automated data analysis report.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g21.jpg" alt="nstg-20221231_g21.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:64px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tumor Signaling 360</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">780 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holistic view of dysfunctional signaling pathways for tumor, microenvironment and immune response.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g22.jpg" alt="nstg-20221231_g22.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CAR-T Characterization</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">780 gene expression panel</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Standardized panel for development collaborations and manufacturing optimization.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g23.jpg" alt="nstg-20221231_g23.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">TCR Diversity</span></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Determine usage of TCR variable regions and shifts in TCR diversity in response to cancer, infectious disease, autoimmunity, or transplanted organ.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g24.jpg" alt="nstg-20221231_g24.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Metabolic Pathways </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">768 gene expression pane</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Addresses mechanisms behind metabolic adaptation, metabolic switching and metabolic alterations as a result of disease.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g25.jpg" alt="nstg-20221231_g25.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Canine IO</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">800 gene expression pane</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For measuring the tumor and immune response to immuno-oncology treatments in dogs.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g26.jpg" alt="nstg-20221231_g26.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PanCancer Immune Profiling</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">770 gene expression pane</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Focused panel measuring the many features of immune response.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g27.jpg" alt="nstg-20221231_g27.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">ADC Development</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">770 gene expression pane</span></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Enables researchers to answer complex questions critical for the of Antibody Drug Conjugates throughout discover, preclinical and clinical development.</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Immunology and Infectious Disease Research Applications</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Panel Name</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt dotted #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Panel Description</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g28.jpg" alt="nstg-20221231_g28.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Host Response Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">785 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Study disease progression, severity, host immune response and convalescence.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g29.jpg" alt="nstg-20221231_g29.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Viral Panel Plus</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Spike-In to gene expression panels</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pre-built Panel Plus spike-in with genes covering all coronavirus for viral detection and other probes for common pathogens.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g30.jpg" alt="nstg-20221231_g30.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Immunology Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">594 general immunology genes</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All-purpose panel for broad immunology research studies.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g31.jpg" alt="nstg-20221231_g31.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fibrosis Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-depth profiling for diseases that lead to fibrotic tissue and organ damage.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g32.jpg" alt="nstg-20221231_g32.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Human Organ Transplant Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Focused content for studying organ transplant host response and organ rejection.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g33.jpg" alt="nstg-20221231_g33.jpg" style="height:63px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stem Cell Characterization Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deeply characterize and stem cell biology and optimize stem cell development.</span></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuroscience Research Applications</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Panel Name</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt dotted #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Panel Description</span></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g34.jpg" alt="nstg-20221231_g34.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:63px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Alzheimer&#8217;s Disease Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monitor progression of Alzheimer&#8217;s Disease and functional screening of potential therapeutics.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g35.jpg" alt="nstg-20221231_g35.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Glial Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive profiling for neuronal and peripheral immune cell types.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="nstg-20221231_g36.jpg" alt="nstg-20221231_g36.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Neuroinflammation Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-depth profiling of neuroimmune interactions.</span></div></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span><img src="nstg-20221231_g37.jpg" alt="nstg-20221231_g37.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Neuropathology Panel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">770 gene expression panel</span></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1pt dotted #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Comprehensive assessment of neurodegenerative pathways and processes.</span></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custom CodeSets</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work with our customers to design and develop custom gene expression CodeSets to enable them to evaluate specific genes that are the subject of their study. Our customers provide us a list of targets for which we subsequently build a unique CodeSet to their specifications. Our design process leverages full length sequences for the RNA molecules that our customers are interested in detecting and prevents cross hybridization to non-target molecules in the sample. The custom CodeSet design process occurs in four distinct steps: (1) the customer selects the genes of interest, (2)&#160;we design probes and provide a design report to the customer, (3) the customer reviews and approves the design report and (4)&#160;we manufacture, test and ship the CodeSet to the customer. The manufacturing process typically takes from three to five weeks, depending on the number of genes targeted and samples to be processed by the customer.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nCounter Software and Data Analysis</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nCounter instrument platforms also include our nSolver Analysis Software and nCounter Advance Analysis add-on to nSolver, providing an integrated data analysis program that offers researchers the ability to quickly and easily quality check, normalize and analyze their data without having to use any additional software for data analysis. The FLEX system, in addition to running any of our research applications, can also be enabled with software that runs Prosigna to generate individualized patient reports.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we announced a collaboration with ROSALIND&#8482; Bioinformatics, a provider of cloud-based genomic analysis tools, for the development of new analysis tools for data generated on our nCounter Analysis System. ROSALIND offers a cloud-based platform that connects researchers to differential expression and pathway exploration in a real-time collaborative environment.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Functionality has been built into ROSALIND&#8217;s cloud-based analysis suite that facilitates nCounter data visualization, exploration and collaboration. These new capabilities were offered immediately through early access to COVID-19 researchers performing critical host response studies on our nCounter platform. In 2021, ROSALIND created a unique data analysis solution specific to the nCounter TCR Diversity Panel, which is routinely utilized to profile T-cell receptor variable and constant regions and other T-cell markers, resulting in a TCR Diversity Score. We are working with ROSALIND to make certain features of nSolver available within ROSALIND, and we are evaluating opportunities for joint development of new analysis solutions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Molecular Diagnostics</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nCounter Analysis System has the precision, reproducibility and simple workflow required of technologies used in clinical laboratories. We believe the precision, ease of use and flexibility of the nCounter Analysis System may allow medical technicians to conduct complex molecular diagnostic tests with minimal training. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical laboratory customers use the nCounter Analysis System and our Prosigna breast cancer assay to provide clinical diagnostic services. Prosigna is based on a collection of 50 genes known as the PAM50 gene signature, which was discovered by several of our research customers. Prosigna can provide a breast cancer patient and physician with a subtype classification based on the fundamental biology of the patient&#8217;s tumor, as well as a prognostic score that indicates the probability of cancer recurrence over 10 years. Physicians use Prosigna to help guide therapeutic decisions so that patients receive a therapeutic intervention, such as chemotherapy, only if clinically warranted. In September 2013, we received 510(k) clearance from the FDA to market in the United States a version of Prosigna providing a prognostic indicator for distant recurrence-free survival at 10 years. In December 2019, we entered into an exclusive license of nCounter diagnostic assets and rights to Veracyte, Inc., or &#8220;Veracyte&#8221;. For additional information regarding our agreement with Veracyte, see &#8220; &#8212; License Agreements &#8212; Veracyte, Inc.&#8221; below.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1730"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied, and expect to continue to rely, on strategic collaborations and licensing agreements with third parties. For example, our molecular barcoding chemistry technology is in-licensed from the Institute for Systems Biology. In addition, we have licensed technology related to our diffuse large B-cell lymphoma, or DLBCL, assay from the National Institutes of Health, and we rely on other license and supply arrangements for proprietary components which require us to pay royalties on the sale of our products. Other research customers are using our GeoMx DSP, CosMx SMI and nCounter Analysis System to discover gene expression signatures that we believe could form the basis of future diagnostic products. In the future, we may consider these gene signatures for in-licensing. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Veracyte, Inc. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, we entered into a LAPA and Service and Supply Agreements, or SSAs, with Veracyte. Pursuant to the LAPA, we completed a license of intellectual property and a sale of certain assets to Veracyte relating to our nCounter FLEX system for use in clinical diagnostic applications. Veracyte also acquired certain intellectual property rights and worldwide distribution rights relating to Prosigna and our LymphMark assay, and certain clinical diagnostic assay software modules that operate with the nCounter FLEX system. Pursuant to the LAPA, we provided Veracyte a worldwide exclusive license to market and sell clinical diagnostic tests developed for our nCounter FLEX platform for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic use and for the development and commercialization of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic tests, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic devices or laboratory developed tests, for use on the nCounter FLEX platform. In connection with the transaction, Veracyte agreed to assume certain liabilities associated with the assets purchased under the LAPA, including ongoing third-party royalty obligations relating to Prosigna and LymphMark. We also assigned to Veracyte our Amended and Restated Exclusive License Agreement with Bioclassifier, LLC, effective July 7, 2010, as amended, which granted rights to certain intellectual property related to Prosigna. We also entered into a sublicense agreement with Veracyte relating to the Bioclassifier Agreement wherein we obtained certain non-exclusive rights relating to our rights to provide Prosigna to Veracyte on an ongoing basis and for other research or investigational purposes. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon consummation of the LAPA, Veracyte paid us total consideration of $50.0 million, consisting of (i) $40.0 million in cash and (ii) 376,732 shares of Veracyte common stock valued at $10.0 million. Pursuant to the LAPA, we are eligible to receive potential milestone payments of up to $10.0 million in the aggregate, to be paid upon the launch of additional clinical diagnostic tests by Veracyte for our nCounter FLEX platform.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SSAs, we agreed to supply to Veracyte nCounter FLEX systems, and to manufacture and supply Prosigna kits, LymphMark kits and any additional clinical diagnostic tests that Veracyte may develop in the future for nCounter, for a period of at least four years subsequent to the transaction date. Pursuant to the SSAs, Veracyte will pay the designated transfer prices for nCounter FLEX systems, Prosigna kits, LymphMark kits and any other nCounter-based diagnostic tests developed by Veracyte.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lam Research Corporation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, we entered into a collaboration agreement with Lam Research Corporation, or Lam, to develop a NGS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sequencing platform and related assays. Under the terms of the agreement, Lam contributed an aggregate of $50.0 million towards the project. As of December 31, 2019, all committed development funding had been received from Lam, and as of December 31, 2020 all we received had been used in our continued development activities associated with our NGS sequencing platform and related assays. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intellectual property made or conceived solely by us pursuant to the collaboration will be owned by us and licensed to Lam solely for the purposes of the collaboration. All intellectual property made or conceived solely by Lam pursuant to the collaboration will be owned by Lam and, subject to certain restrictions on use with Lam competitors, licensed to us for the purposes of the collaboration and further development and commercialization of our products and technologies resulting from the collaboration in the field of molecular profiling. Jointly created intellectual property will be jointly owned, provided that neither we nor Lam use such jointly owned intellectual property in the other party&#8217;s competitive field. Lam is eligible to receive certain single-digit percentage royalty payments from us on net sales of certain products and technologies developed under the agreement, if any such net sales are recorded. The maximum amount of royalties we may pay to Lam will be capped at $150.0 million (three times the amount of development funding actually provided by Lam). We retain exclusive rights to obtain regulatory approval, manufacture and commercialize any products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Institute for Systems Biology</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2004, we entered into an agreement with the Institute for Systems Biology pursuant to which the Institute granted to us an exclusive, subject to certain government rights, worldwide license, including the right to sublicense, to the digital molecular barcoding technology on which our nCounter Analysis System is based, including 13 patents and patent applications. Pursuant to the terms of the amended license agreement, we are required to pay the Institute for Systems Biology royalties on net sales of products sold by us, or our sublicensees, at a low single digit percentage rate, which was reduced by 50% in the third quarter of 2016 for the remainder of the license term due to the achievement of a cumulative sales threshold. Through December&#160;31, 2022, we have paid aggregate royalties of $8.5 million under the license agreement. Unless terminated earlier in accordance with the terms of the amended license agreement, the agreement will terminate upon the expiration of the last to expire patent licensed to us. The Institute for Systems Biology has the right to terminate the agreement under certain situations, including our failure to meet certain diligence requirements or our uncured material breach of the agreement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1723"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must develop and maintain protection on the proprietary aspects of our technologies in order to remain competitive. We rely on a combination of patents, copyrights, trademarks, trade secret and other intellectual property laws and confidentiality, material transfer agreements, licenses, invention assignment agreements and other contracts to protect our intellectual property rights.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we owned or exclusively licensed approximately 38 issued U.S. patents and approximately 21 pending U.S. patent applications, including provisional and non-provisional filings and 5 pre-nationalization PCT applications. We also owned or licensed approximately 312 pending and granted counterpart applications worldwide, including 123 country-specific validations of 17 European patents. The issued U.S. patents that we own or exclusively license are expected to expire between September 3, 2024 and November&#160;21, 2037. We have either sole or joint ownership positions in all of our pending U.S. patent applications. Where we jointly own cases, we typically have negotiated license or assignment provisions to obtain exclusive rights. For our material nCounter Analysis System we are the exclusive licensee. We also generally protect our newly developed intellectual property by entering into confidentiality agreements that include intellectual property assignment clauses with our employees, consultants and collaborators. Our patent applications generally relate to the following main areas: </span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our GeoMx DSP, CosMx SMI, or nCounter Analysis System biology, chemistry, methods, analytics and hardware;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specific applications for our GeoMx DSP, CosMx SMI, or nCounter Analysis System technology;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our gene expression markers, methods and gene signatures for recurrence and drug response in certain forms of cancer;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">methods and systems for the processing and analysis of spatial profiling and sequencing data;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">biological and chemical compositions, methods and hardware for enzyme- and amplification- free sequencing; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">biological and chemical compositions, methods and hardware for multiplexed detection and quantification of protein and/or nucleic acid expression in a defined region of a tissue or cell.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to file additional patent applications in the United States and abroad to strengthen our intellectual property rights; however, our patent applications may not result in issued patents, and we cannot assure investors that any patents that have issued or might issue will protect our technology. We have received notices of claims of potential infringement from third parties and may receive additional notices in the future. When appropriate, we have taken a license to the intellectual property rights from such third parties. For additional information, see the section of this report captioned &#8220;Risk Factors &#8212; Risks Related to Intellectual Property.&#8221;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own a number of trademarks and develop names for our new products and as appropriate secure trademark protection for them, including domain name registration, in relevant jurisdictions.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1716"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have committed, and expect to continue to commit, significant resources to developing new technologies and products, improving product performance and reliability and reducing costs. We are continuously seeking to improve our product platforms, including the technology, software, accessibility and overall capability. We also seek to develop additional research consumable content, new product platforms and new product capabilities. We have assembled experienced research and development teams at our greater Seattle, Washington area facilities with the scientific, engineering, software and process talent that we believe is required to successfully grow our business. As of December&#160;31, 2022, we had 193 employees in research and development.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1709"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began selling nCounter to researchers in 2008, GeoMx DSP in 2019, and CosMx SMI and AtoMx SIP in 2022. We sell our instruments and related products primarily through our own sales force in North America and through a combination of direct and distributor channels in Europe, the Middle East, Asia Pacific and South America. We have agreements with 44 distributors, each of which is specific to a certain territory. In the event a distributor does not meet minimum performance requirements, we may terminate the distribution agreement or convert from an exclusive to non-exclusive arrangement within the territory, allowing us to enter into arrangements with other distributors for the territory. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding geographic distribution of revenue, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_118">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">Notes to Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and marketing efforts are targeted at department heads, research or clinical laboratory directors, principal investigators, core facility directors and research scientists and pathologists at leading academic institutions, biopharmaceutical companies, publicly and privately-funded research institutions and contract research organizations. We seek to increase awareness of our products among our target customers through direct sales calls, trade shows, seminars, academic conferences, web presence and other forms of internet marketing.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our instruments require a significant capital investment, and our sales process involves numerous interactions with multiple individuals within an organization, and often includes in-depth analysis by potential customers of our products, performance of proof-of-principle studies, preparation of extensive documentation and a lengthy review process. As a result of these factors, the significant capital investment required in purchasing our instruments and the budget cycles of our customers, the time from initial contact with a customer to our receipt of a purchase order can vary significantly and be up to 12&#160;months or longer. Given the length and uncertainty of our sales cycle, we have in the past experienced, and likely will in the future experience, fluctuations in our instrument sales on a period-to-period basis.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have continued to invest in our commercial channel to increase our reach and productivity. For example, in 2022, we reorganized our commercial channel to realign our expanded commercial team, centralize primary points of contact with our customers, and to add roles relating to customer support and experience, given our expanding portfolio of products. We believe these changes and investments help to drive the growth of our installed instrument base, and the utilization of consumables by our installed base of instrument users.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1702"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing and Suppliers</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use third-party contract manufacturers to produce our instruments and certain raw materials for our consumables. We build our consumables at our facilities in the greater Seattle, Washington area. We develop and deliver our cloud-based software applications primarily from facilities and staff located in the greater Seattle area, and we also use certain third party cloud computing service providers for data storage and the hosting of software applications we offer to customers.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Instruments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We outsource manufacturing of our instruments. Precision System Science, Co., Ltd. of Chiba, Japan, or PSS, is our sole source supplier for the nCounter Prep Station. Korvis Automation Inc., or Korvis, is our sole source supplier for our nCounter Digital Analyzers and our GeoMx DSP instrument at its facility in Corvallis, Oregon. Paramit Corporation, or Paramit, is our sole source supplier for our nCounter SPRINT Profiler at its facility in Morgan Hill, California. D&amp;K Engineering, Inc. of San Diego, California is our sole source supplier of our CosMx SMI instrument.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities at which our instruments are built have been certified to ISO 13485:2003 standards. Our contracts with these instrument suppliers do not commit them to carry inventory or make available any particular quantities. Under the terms of our instrument supply agreements, we are required to place binding purchase orders for instruments that will be delivered to us by the supplier from the date of placement of the purchase order. Although qualifying alternative third-party manufacturers could be time consuming and expensive, our instruments&#8217; design is similar to that of other instruments and we believe that alternatives would be available if necessary. However, if our instrument suppliers terminate our relationship with them or if they give other customers&#8217; needs higher priority than ours, then we may not be able to obtain adequate supplies in a timely manner or on commercially reasonable terms.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture our consumables in our greater Seattle, Washington area facilities, certain of which have been certified to ISO 13485:2003 standards. In the past several years, we have expanded our manufacturing capacity through additional leased space as well as by relocating certain research and development functions and converting the space to incremental manufacturing labs and offices. In the future, should additional space become necessary, we believe that there will be space available near our existing facilities, however we cannot predict that this space will be available if and when it is needed.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a limited number of suppliers for certain components and materials used in the manufacture of our consumables. Some of these components are sourced from a single supplier. For example, Cidra Precision Services, LLC, of Wallingford, Connecticut, part of IDEX Health &amp; Science, is the sole supplier of the microfluidic cartridge for our nCounter SPRINT Profiler. For some components, we have qualified second sources for several of our critical reagents, including oligonucleotides, adhesives and dyes. We believe that having dual sources for our components helps reduce the risk of a production delay caused by a disruption in the supply of a critical component. We continue to pursue qualifying additional suppliers, but cannot predict how expensive, time-consuming or successful these efforts will be. If we were to lose one or more of our suppliers, it may take significant time and effort to qualify alternative suppliers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, deliver and manage our cloud-based AtoMx SIP primarily from facilities located in the greater Seattle, Washington area. In the past several years, we have expanded our information technology engineering, data management and monitoring capabilities to support the launch of AtoMx, including establishing a Network Operations Center in our greater Seattle facilities.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on certain outside software development firms to support the development and updating of AtoMx, as well as certain third party cloud computing providers for data storage and hosting. While we currently host AtoMx with a single third party cloud computing vendor, AtoMx is designed to function across multiple third party cloud computing platforms, which we believe reduces the risk of exposure to a single vendor and facilitates the management of cloud computing costs. We continuously assess and qualify additional outside software development firms and third party cloud computing providers, however if we elected or were required to work with additional vendors, we cannot predict how expensive, time consuming or successful these efforts will be. If we were to lose one of our key vendors, it may take significant time and effort to qualify alternative vendors.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1695"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the life sciences research market, we compete with companies such as Agilent Technologies, Akoya Biosciences, Bio-Rad, Bio-Techne, Standard BioTools (previously Fluidigm), Illumina, Qiagen, Thermo Fisher Scientific, Vizgen and 10x Genomics. These competitors and others have products for gene and protein expression analysis and spatial biology that compete in certain segments of the market in which we sell our products. In addition, there are a number of new market entrants in the process of developing novel technologies for the life sciences market, including those that may compete with GeoMx, CosMx or AtoMx.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have multiple competitive advantages, including the automated nature of our systems with simple, rapid and efficient workflow that requires limited human intervention or labor; the multiplexing capability of our technologies to analyze more target molecules in a single experiment; the ability to analyze both RNA and proteins; compatibility with many sample types, including difficult samples such as FFPE; and the ability to analyze small sample inputs, in some cases down to a single cell, from a wide variety of sample types.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that we compete favorably based on the factors described above, many of our competitors enjoy other competitive advantages over us, including:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater name and brand recognition, financial and human resources;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">broader product lines;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger sales forces and more established distributor networks;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial intellectual property portfolios;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger and more established customer bases and relationships; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">better established, larger scale and lower cost manufacturing capabilities.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, see the section of this report captioned &#8220;Risk Factors - The life sciences research market is highly competitive. If we fail to compete effectively, our business and operating results will suffer.&#8221;</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1675"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees are guided by our mission to map the universe of biology. Our core values of grit, authenticity, ambition, ingenuity and commitment to customers serve to guide us on our path toward achieving our mission. Our core values set the foundation for our attitudes and actions, how we conduct our business, interact with each other and our customers and evaluate employee performance. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employees</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had 703 employees, of which 193 work in manufacturing, 234 in sales, marketing and business development, 193 in research and development and 83 in general and administrative. None of our U.S. employees are represented by a labor union or are the subject of a collective bargaining agreement. As of December&#160;31, 2022, of our 703 employees, 603 were employed in the United States and 100 were employed outside the United States.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talent Acquisition and Development and Employee Engagement</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees play a key role in our ability to serve our customers and achieve our mission and we strive to attract, empower and retain high quality talent that is inspired, diverse and driven. To attract and retain top talent, we strive to create opportunities for our employees to grow and develop their careers and ensure they are supported by competitive salaries and a comprehensive benefits program. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe employee career development is an investment in our employees&#8217; skills and our future. We offer career development opportunities such as educational reimbursement, onsite training to enhance job-related skills, management development programs and opportunities to attend job related conferences and seminars. Additionally, we have an annual formal employee review program which standardizes performance evaluation across all areas in the organization and aids in supporting our employees&#8217; career and personal development, which ultimately contributes to achieving our mission. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe it is important to encourage open and direct communication at all levels in our organization and we regularly use employee experience and feedback surveys to understand whether our human capital policies are effective and where we can improve.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we provide competitive and comprehensive financial compensation and benefits for our employees and our programs are designed to meet our employees&#8217; needs. In addition to salaries, these programs (which may vary by country or region) include new employee equity grants, additional discretionary equity awards, including a discretionary annual equity grant, discretionary merit-based annual bonuses, a voluntary employee stock purchase program, a 401(k) plan which includes partial employer matching contributions, healthcare and insurance benefits, health savings and flexible spending accounts, flexible paid time off, family leave, employee assistance programs, an educational reimbursement program and health and wellness programs. In addition, we believe our employees can make a meaningful difference in their local communities and we offer all employees paid time off to volunteer in community involvement activities of their choice.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity and Inclusion</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe racism and discrimination are unacceptable. We are committed to building and maintaining a diverse and inclusive business and have diversity, equity and inclusion programs in place to help us achieve our commitment. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek diversity, equity and inclusion at every level in our organization. Our board of directors includes directors from various backgrounds, industries, skills and experience. In 2021, we added two new members with diverse backgrounds to our board of directors. Our board of directors includes four women and five men. Our senior leadership team includes leaders with diverse skills, experiences, backgrounds and genders. Our employees come from numerous countries and various backgrounds and we strive to provide a diverse and inclusive environment.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have active programs in place and continue to focus on extending our diversity, equity and inclusion initiatives across our entire workforce. As part of our program, we seek to make diversity, equity and inclusion a focus for our recruiting and hiring practices, including by ensuring we have diverse representations in our recruiting pool and interview panel. To further our commitment to create an inclusive and diverse culture, we engaged a third-party diversity, equity and inclusion consultant to assist us in our commitment.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have three employee resource groups, or ERGs, that focus on communities including women, people of color and LGBTQ+. We believe these ERGs are guided by our priorities and values and provide a way for employees with common interests to connect, obtain professional development and participate in community outreach opportunities. We may expand our ERG offerings in the future.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we joined Washington Employers for Racial Equity, or WERE, which is a new statewide coalition dedicated to racial equity and opportunity for all. As a coalition member, we have signed a Commitment to Progress, committing to own our part of the problem and setting specific improvement goals. As members of the coalition, we will listen, learn, partner, invest and work toward solutions in our own company and our communities.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1680"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation of Products</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RUO Products</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research Use Only, or RUO, products are not medical devices and are therefore not subject to the quality system regulation, or QSR, and other medical device requirements enforced by the FDA. FDA regulations state that an RUO product must be labeled &#8220;For Research Use Only. Not for Use in Diagnostic Procedures.&#8221; Manufacturers of RUO products may not represent an RUO product as safe or effective for any clinical purpose and may not provide technical support to clinical </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laboratories on using an RUO product for clinical laboratory testing. In November 2013, the FDA issued a final guidance on products labeled RUO, which, among other things, reaffirmed FDA&#8217;s position that a company may not make any clinical or diagnostic claims about an RUO product, and also stating that merely including an RUO labeling statement will not necessarily render the device exempt from the FDA&#8217;s clearance, approval, or other regulatory requirements if FDA concludes that the totality of circumstances surrounding the distribution of the product indicates that the manufacturer&#8217;s objective intent is that the product be used for diagnostic purposes. These circumstances may include, among other things, written or verbal marketing claims regarding a product&#8217;s performance in clinical diagnostic applications and a manufacturer&#8217;s provision of technical support for such activities.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2013, the FDA issued a final guidance on products labeled RUO. The guidance reaffirmed FDA&#8217;s position that a company may not make any clinical or diagnostic claims about an RUO-labeled product and also stated that merely including a labeling statement that the product is for research purposes only and is not for use in diagnostic procedures will not necessarily render the device exempt from the FDA&#8217;s clearance, approval, or other regulatory requirements if FDA concludes that the totality of circumstances surrounding the distribution of the product indicates that the manufacturer&#8217;s objective intent is that the product be used for diagnostic purposes. These circumstances may include, among other things, written or verbal marketing claims regarding a product&#8217;s performance in clinical diagnostic applications and a manufacturer&#8217;s provision of technical support for such activities.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GeoMx DSP, CosMx SMI, nCounter Pro Analysis System and nCounter SPRINT Profiler are currently labeled and sold for research use only, or RUO, and we sell them to academic institutions, life sciences and clinical research laboratories, and biopharmaceutical and biotechnology companies for non-diagnostic purposes. These products are not intended or promoted for use in the diagnosis of disease or other conditions, and they are labeled &#8220;For research use only. Not for use in diagnostic procedures,&#8221; in accordance with FDA regulations for RUO products. Accordingly, they are not medical devices subject to FDA regulation because they do not have the requisite intended use, and they therefore do not need to comply with pre- and post-market controls or other FDA requirements. Violation of any FDA regulatory requirements could result in regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, or fines, among other adverse actions.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA were to determine, based on the totality of circumstances, that our products labeled and marketed as RUO are intended for diagnostic purposes, they would be subject to FDA regulation as medical devices, which could include obtaining premarket authorization (510(k) clearance, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification, or pre-market approval, or PMA, prior to commercialization. Further, sales of devices for diagnostic purposes may subject us to additional healthcare regulation. We continue to monitor the changing legal and regulatory landscape to ensure our compliance with any applicable laws and regulations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, our customers may use our RUO products in their own laboratory-developed tests, or LDTs, or in other FDA-regulated products for clinical diagnostic use. The FDA has historically exercised discretion (i.e., has not enforced) the medical device regulations against clinical laboratories with respect to most LDTs. The FDA has indicated that it may seek to increase its regulation of LDTs. Any future rulemaking, guidance, or other oversight of LDTs and clinical laboratories that develop and perform them by FDA, if and when finalized, may impact the sales of our products and how customers use our products, and may require us to change our business model in order to maintain compliance with these laws.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we wish to label and market our RUO products for use in performing clinical diagnostics, they would be subject to FDA regulation as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic, or IVD, medical devices, and subject to applicable requirements for IVD devices. Unless an exemption applies, we would be required to obtain either prior 510(k) clearance, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification, or PMA from the FDA before commercializing the product. International sales of medical devices are subject to foreign government regulations, which vary substantially from country to country.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our RUO products are not subject to regulation in the European Union, or EU, under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Diagnostics Directive (98/79/EC), or IVDD, or the IVDR. Outside of the EU, regulations vary but generally our RUO products do not require regulatory approval. If we wish to label and market our RUO products for use in performing clinical diagnostics outside the US, they could be subject to regulation as IVD medical devices. In the EU, they would be subject to compliance with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Diagnostic Medical Devices Regulation (EU) 2017/746, or IVDR. Outside of the EU, regulatory approval needs to be sought on a country-by-country basis in order to market medical devices. Regulations in each country may vary substantially which can affect timelines of introduction.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Devices</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, medical devices, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostics, are subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act, or FDC Act, and its implementing regulations, and other federal and state statutes and regulations. The laws and regulations govern, among other things, medical device development, testing, labeling, storage, premarket clearance or approval, advertising and promotion and product sales and distribution.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDC Act defines a medical device as an instrument, apparatus, implement, machine, contrivance, implant, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reagent, or other similar or related article, including any component part or accessory, which is (1) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (2) intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes. IVDs are a type of medical device, and include tests that can be used in the screening or diagnosis and/or detection of diseases or conditions, including, without limitation, the presence of certain chemicals, genetic markers, infections, or other biomarkers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDC Act generally applies a risk-based framework to medical devices, including IVDs. Class I (low risk) devices are those for which general controls &#8211; which include registration, listing, medical device reporting, corrections and removals, and compliance with applicable provisions of QSR &#8211; are sufficient to provide reasonable assurance of safety and effectiveness. Class II (moderate risk) require special controls (e.g., analytical testing, performance standards, labeling) in addition to general controls, to provide reasonable assurance of safety and effectiveness. Class III (high risk) devices are those for which general and special controls are not sufficient to provide reasonable assurance of safety and effectiveness, and for which prior FDA approval of an application for PMA. The PMA approval pathway requires a demonstration, through data from clinical trials and other information about the device (e.g., design history, manufacturing and labeling), that the device is safe and effective for its intended use. FDA will typically inspect the device manufacturer&#8217;s facilities for compliance with the QSR regulation prior to approval. The PMA approval pathway is costly, lengthy and uncertain.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">510(k) Pathway</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Devices that are not subject to PMA requirements must, unless exempt, obtain either clearance of a 510(k) premarket notification submission, or approval of a request for &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification&#8221;. Most Class II devices must obtain 510(k) clearance, while most Class I devices are 510(k)-exempt. To obtain 510(k) clearance, a manufacturer must submit a premarket notification demonstrating to the FDA&#8217;s satisfaction that the proposed device is substantially equivalent to a legally marketed predicate device. The FDA&#8217;s 510(k) clearance pathway usually takes from three to 12 months. Certain post-market device or labeling modifications require additional FDA review and premarket authorization (510(k) clearance, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification, or PMA approval) before the modified device can be commercially distributed. If the FDA disagrees with a manufacturer&#8217;s decision not to obtain authorization of a modification, the agency may require the manufacturer to cease commercial distribution of the device until the applicable submission type has been submitted to and authorized by the agency.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Low and moderate risk tests that are subject to 510(k) premarket notification but for which no predicate can be identified are automatically classified as Class III. Through the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification pathway, FDA can reclassify such devices as Class I or Class II, either on its own initiative or in response to a request for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification. When granting a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification request for a Class II device, the FDA will establish special controls, which often include labeling restrictions and data requirements. Subsequent applicants can rely upon the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product as a predicate for a 510(k) clearance and are subject to the special controls. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> route has been used for many </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-market Requirements</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply. These include: the quality manufacturing requirements set forth in the QSR, registration and listing, the Medical Device Reporting, or MDR, regulation which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur, and the Reports of Corrections and Removals regulation, which includes the requirement that manufacturers report to the FDA corrective actions or product removals initiated to reduce a risk to health posed by the device or to remedy a violation of the FDC Act that may present a risk to health. Additionally, in order to comply with the FDC Act general prohibitions against adulteration and misbranding, manufacturers must properly label their devices and must not promote them for purposes inconsistent with their labeled intended use.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicability of Requirements</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nCounter FLEX, which is targeted toward clinical laboratories, has been 510(k) cleared by the FDA. The nCounter FLEX was designed and is manufactured under ISO 13485:2016 and the QSR, 21 CFR Part 820, the current quality standards for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic platforms and medical devices. nCounter FLEX is enabled to run the Prosigna breast cancer assay, as well as other proprietary LDTs that may be developed. In December 2019, we entered into a License and Purchase Agreement, or LAPA, and Service and Supply Agreements, or SSAs, with Veracyte. Pursuant to the LAPA, we completed a license of intellectual property and a sale of certain assets to Veracyte relating to our nCounter FLEX for use in clinical diagnostic applications. Veracyte also acquired certain intellectual property rights and worldwide distribution rights relating to Prosigna and our LymphMark assay, and certain clinical diagnostic assay software modules that operate with the nCounter FLEX. Pursuant to the LAPA, we provided Veracyte a worldwide exclusive license to market and sell clinical diagnostic tests developed for our nCounter FLEX for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic use and for the development and commercialization of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic tests, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic devices or LDTs, for use on the nCounter FLEX.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SSAs, we agreed to supply to Veracyte nCounter FLEX, and to manufacture and supply Prosigna kits, LymphMark kits and any additional clinical diagnostic tests that may be developed in the future for nCounter, for a period of at least four years subsequent to the transaction date. While we have retained limited responsibility for regulatory compliance with respect to the current version of nCounter FLEX in certain jurisdictions, under these agreements, Veracyte is responsible for worldwide regulatory compliance for Prosigna, LymphMark, and any additional diagnostic tests that may be developed in the future for the nCounter platform, and has responsibility for worldwide regulatory compliance for all future generations of the nCounter platform for use with clinical diagnostic applications.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA defines a manufacturer broadly to include any person who designs, manufactures, fabricates, assembles, or processes a finished device. More than one entity can be subject to FDA regulation as a manufacturer of a medical device, with each being responsible to comply with the requirements applicable to its activities. For example, a specification developer is an entity that develops the specifications for but does not manufacture a device. Conversely, a contract manufacturer manufactures a device at its facility according to another entity&#8217;s specifications. We are the contract manufacturer for the nCounter FLEX while Veracyte is the specification developer for and complaint handling establishment for Prosigna, LymphMark and any other diagnostic tests that may be developed for nCounter FLEX. Both specification developers and contract manufacturers are responsible to ensure that a device complies with applicable requirements. This includes compliance with the provisions of the QSR regulation that pertains to the entity&#8217;s activities. To avoid duplication, specification developers and contract manufacturers can assign primary responsibility for an activity to one of the parties (for example, complaint handling). Certain requirements, such as registration and listing, must be done by each party individually.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA enforces its requirements by unannounced inspection, market surveillance, and other means. If the FDA finds a violation, it can institute a wide variety of enforcement actions, ranging from an untitled, non-public communication to a public warning letter, to more severe sanctions such as fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions, partial suspension or total shutdown of production; refusing requests for 510(k) clearance or PMA approval of new products; withdrawing 510(k) clearance or PMA approvals already granted; and criminal prosecution. For additional information, see the section of this report captioned &#8220;Risk Factors &#8212; Risks Related to Government Regulation.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices are subject to foreign government regulations, which vary substantially from country to country. Our nCounter FLEX has been CE-marked in the EU, indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be marketed through the EU and European Economic Area member states. Outside of the EU, regulatory approval needs to be sought on a country-by-country basis in order to market medical devices. Under the SSAs with Veracyte, Veracyte is responsible for worldwide regulatory compliance for Prosigna, LymphMark, and any additional diagnostic tests that may be developed in the future for the nCounter platform and has responsibility for worldwide regulatory compliance for all future generations of the nCounter platform for use with clinical diagnostic applications.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1660"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations require the use of hazardous materials (including biological materials) which subject us to a variety of federal, state and local environmental and safety laws and regulations. Some of the regulations under the current regulatory structure provide for strict liability, holding a party potentially liable without regard to fault or negligence. We could be held liable for damages and fines as a result of our, or others&#8217;, business operations should contamination of the environment or individual exposure to hazardous substances occur. We cannot predict how changes in laws or development of new regulations will affect our business operations or the cost of compliance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_1667"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Where You Can Find Additional Information</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available free of charge through our investor relations website, www.nanostring.com, our annual reports, quarterly reports, current reports, proxy statements and all amendments to those reports as soon as reasonably practicable after such material is electronically filed or furnished with the SEC. These reports may also be obtained without charge by contacting Investor Relations, NanoString Technologies, Inc., 530 Fairview Avenue North, Seattle, Washington 98109, e-mail: investorrelations@nanostring.com. Our Internet website and the information contained therein or incorporated therein are not intended to be incorporated into this Annual Report on Form 10-K. In addition, the SEC maintains an Internet site that contains reports, proxy and information statements and other information regarding reports that we file or furnish electronically with them at www.sec.gov.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. &#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should carefully consider the following risk factors, in addition to the other information contained in this report, including the sections of this report captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and related notes. If any of the events described in the following risk factors and the risks described elsewhere in this report occurs, our business, operating results and financial condition could be seriously harmed. Our risk factors are not guarantees that no such conditions exist as of the date of this report and should not be interpreted as an affirmative statement that such risks or conditions have not materialized, in whole or in part. This report on Form 10-K also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of factors that are described below and elsewhere in this report.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_25"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Strategy</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred losses since we were formed and expect to incur losses in the future. We cannot be certain that we will achieve or sustain profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred losses since we were formed and expect to incur losses in the future. We incurred net losses of $159.5 million, $115.3 million and $110.1 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. As of December 31, 2022, we had an accumulated deficit of $809.3 million. We expect that our losses will continue for at least the next several years as we will be required to invest significant additional funds toward ongoing development and commercialization of our technology. We also expect that our operating expenses may continue to increase as we grow our business, and there can be no assurance that our revenue and gross profit will increase sufficiently such that our net losses decline, or we attain profitability, in the future. Our ability to achieve or sustain profitability is based on numerous factors, many of which are beyond our control, including the market acceptance of our products, market development and the size of our addressable markets, competition and market share captured by our products, future product development, and the profit margins achieved on the sale of our products. In addition, inflationary pressure, rising interest rates, potential economic recession and other deteriorating factors in the macroeconomic environment could adversely impact our financial results. Our operating costs have increased, and may continue to increase, due to the recent rise in inflation. We may not fully offset these cost increases by raising prices for our products and services, which could result in downward pressure on our margins. Further, our customers may choose to reduce their business with us if we increase our pricing. In November 2022, we announced certain reorganization and restructuring initiatives, under which we intend to reduce certain employee-related expenses and other operating expenses. While we expect our operating costs will be reduced in future periods as a result of these actions, we may not fully realize all of the anticipated cost savings. As a result of these and other factors, we may never be able to generate sufficient revenue to achieve or sustain profitability.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial results may vary significantly from quarter to quarter which may adversely affect our stock price.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors should consider our business and prospects in light of the risks and difficulties we expect to encounter in the uncertain and rapidly evolving markets in which we compete. Because these markets are evolving, predicting their future growth and size, and our competitive position in those markets, is difficult. We expect that our visibility into future sales of our products, including volumes, prices and product mix, including between our various platforms and between instruments and consumables, will continue to be limited and could result in unexpected fluctuations in our quarterly and annual operating results. Numerous other factors, many of which are outside our control, may cause or contribute to significant fluctuations in our quarterly and annual operating results including the ongoing impact on our business operations and financial results of higher inflation and rising interest rates, potential economic recession and other deteriorating factors in the macroeconomic environment.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These fluctuations may make financial planning and forecasting difficult. For example, in the first and third quarters of 2022, revenue did not meet expectations which adversely affected our stock price. In addition, these fluctuations may result in unanticipated changes in our available cash, which could negatively affect our business and prospects. Factors that may contribute to fluctuations in our operating results include many of the risks described in this section. Also, one or more of such factors may cause our revenue or operating expenses in one period to be disproportionately higher or lower relative to the others. Furthermore, our instruments involve a significant capital commitment by our customers and accordingly involve a lengthy sales cycle. We may expend significant effort in attempting to make a particular sale, which may be deferred by the customer or never occur. Accordingly, comparing our operating results on a period-to-period basis may not be meaningful, and investors should not rely on our past results as an indication of our future performance. If such fluctuations occur or if our operating results deviate from our expectations or the expectations of securities analysts, our stock price may be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve, sustain or successfully manage our anticipated growth, our business and growth prospects will be harmed. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant revenue growth in recent periods and we may not achieve similar growth rates in the future. Investors should not rely on our operating results for any prior periods as an indication of our future operating performance. If we are unable to maintain adequate revenue growth, our financial results could suffer and our stock price could decline. Furthermore, growth will place significant strains on our management and our operational and financial systems and processes. For example, the recent commercial launches of our GeoMx DSP and CosMx SMI platforms are a key element of our growth strategy and will require us to hire and retain additional sales and marketing personnel and resources. If we do not successfully generate demand for GeoMx DSP, CosMx SMI or other new product offerings, or manage our anticipated expenses accordingly, our operating results will be harmed.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we implemented a Company-wide reduction in workforce starting in November 2022 to help achieve a more cost-efficient organization. The reduction in workforce impacted approximately 10% of our employees and we are still assessing the full impact of the reductions, which may yield unintended consequences and costs such as the loss of institutional knowledge and expertise, attrition beyond our intended reduction in workforce, lower morale among our remaining employees and the risk that we may not achieve the anticipated benefits of such cost-saving measures, all of which may have an adverse effect on our results of operations or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future success is dependent upon our ability to expand our customer base and introduce new applications and products.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current customer base is primarily composed of academic and government research laboratories, biopharmaceutical companies and clinical laboratories (including physician-owned laboratories) that perform or will conduct experiments using our nCounter, GeoMx DSP and CosMx SMI systems. Our success will depend, in part, upon our ability to increase our market penetration among all of these customers and to expand our market by developing and marketing new research applications and product platforms. We expect that increasing the installed base of our nCounter, GeoMx and CosMx systems will drive demand for our higher margin consumable products. If we are not able to successfully increase our installed base of nCounter, GeoMx or CosMx systems, sales of our consumable products and our margins may not meet expectations. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The life sciences research market is highly competitive. If we fail to compete effectively, our business and operating results will suffer.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in the life sciences research market. We currently compete with both established and early stage life sciences research companies that design, manufacture and market instruments and consumables for gene expression analysis, single-cell analysis, polymerase chain reaction, or PCR, digital PCR, other nucleic acid detection and additional applications. These companies use well-established laboratory techniques such as microarrays or quantitative PCR as well as newer technologies such as next generation sequencing, including RNA-sequencing. For additional information regarding our competition, please see the section of this report captioned &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_1695">Business &#8211; Competition</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our current competitors are large publicly-traded companies, or are divisions of large publicly-traded companies, and may enjoy a number of competitive advantages over us, including:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater name and brand recognition, financial and human resources;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">broader product lines;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger sales forces and more established distributor networks;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial intellectual property portfolios;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger and more established customer bases and relationships; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">better established, larger scale, and lower cost manufacturing capabilities.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the principal competitive factors in all of our target markets include:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cost of capital equipment;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cost of consumables and supplies;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reputation among customers;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">innovation in product offerings;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">flexibility and ease-of-use;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accuracy and reproducibility of results; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compatibility with existing laboratory processes, tools and methods.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that our products will compete favorably or that we will be successful in the face of increasing competition from new products and technologies introduced by our existing competitors or new companies entering our markets. In addition, we cannot assure investors that our competitors do not have or will not develop products or technologies that currently or in the future will enable them to produce competitive products with greater capabilities or at lower costs than ours. Any failure to compete effectively could materially and adversely affect our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New product development involves a lengthy and complex process, and we may be unable to commercialize on a timely basis, or at all, any of the products we develop.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Few research and development projects result in successful commercial products. At any point, we may abandon development of a product candidate, which would adversely impact potential revenue and our expenses. In addition, any delay in product development would provide others with additional time to commercialize competing products before we do, which in turn may adversely affect our growth prospects and operating results. For example, our inability to successfully develop new consumables or capabilities for GeoMx or CosMx, or improved versions of AtoMx, would negatively impact our prospects for future revenue growth. AtoMx, which is a cloud-based informatics platform that has required complex software development, and which will require future development, was developed based on capabilities which are different than our historical research and development competencies. Our inability to attract and build the capabilities necessary to develop and operate cloud based software would negatively impact our ability to market and sell GeoMx and CosMx instruments and consumables.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New market opportunities may not develop as quickly as we expect, limiting our ability to successfully market and sell our products. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for our products are new and evolving. Accordingly, we expect the application of our technologies to emerging opportunities will take several years to develop and mature and we cannot be certain that these market opportunities will develop as we expect. For example, in 2019 we commercially launched our GeoMx DSP system, in 2021 we launched new assays to analyze GeoMx DSP data on next generation sequencing systems, and in December 2022 we made our newest product platform, CosMx SMI and our AtoMx SIP available to customers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeoMx and CosMx target spatial genomics, a novel market opportunity and research application for which existing research experience and applications are limited. Prior to the launches of GeoMx and CosMx, we had not previously targeted this market and, as a result, we have limited marketing and selling experience. Our limited marketing and selling experience targeting these new markets and customers may hinder the successful commercialization of GeoMx, CosMx, AtoMx and related consumables.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future growth of the market for these new products depends on many factors beyond our control, including recognition and acceptance of our applications by the scientific community and the growth, prevalence and costs of competing methods. For example, the COVID-19 pandemic disrupted our operations and the operations of the customers we service in our targeted markets, which impacted our growth and our ability to serve these markets. Our customers may be further affected by rising interest rates, inflation, potential economic recession and other deteriorating factors in the macroeconomic environment. If the markets for our new products do not develop as we expect, our business may be adversely affected. If we are not able to successfully market and sell our products or to achieve the revenue or margins we expect, our operating results may be harmed.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks related to health epidemics and other outbreaks, such as COVID-19, which could significantly disrupt our operations and could have a material adverse impact on us.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business could be adversely impacted by the effects of possible health epidemics and other outbreaks. Such effects may include, for example:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the temporary closure of our manufacturing facilities and/or those used in our supply chain processes;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the export or shipment of our products;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unavailability of components and material used in our products;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant cutback of ocean container delivery;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business closures in impacted areas;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced demand, research grants, and business activities of our customers;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations in employee resources, including because of stay-at-home orders, sickness of employees or their families or the desire of employees to avoid contact with large groups of people; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on our employees&#8217; and other service providers; ability to travel, to meet with customers and install and train customers on our systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which health epidemics and other outbreaks, such as COVID-19, including any variants that have emerged or may emerge in the future, impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of a particular virus and its variants and the actions to contain it or treat its impact, among others. We cannot at this time quantify or forecast the potential business impact of COVID-19, and there can be no assurance that the COVID-19 pandemic will not have a material and adverse effect on our business, operating results and financial condition. In addition, the COVID-19 pandemic increases the likelihood and potential severity of other risks described in the &#8220;Risk Factors&#8221; section. Although national, state and local governments introduced relief measures intended to alleviate the impact of COVID-19 related disruptions and may introduce similar measures for future health epidemics and other outbreaks, we may not qualify for or benefit from such measures.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on levels of research and development spending by academic and governmental research institutions and biopharmaceutical companies, a reduction in which could limit demand for our products and adversely affect our business and operating results.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the near term, we expect that a large portion of our revenue will be derived from sales of our GeoMx DSP, CosMx SMI and nCounter Analysis Systems, as well as related consumables, to academic and government research laboratories and biopharmaceutical companies worldwide for research and development applications. The demand for our products will depend in part upon the research and development budgets of these customers, which are impacted by factors beyond our control, such as:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government programs (such as the National Institutes of Health) that provide funding to research institutions and companies;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">macroeconomic conditions, the political climate and the impact of health epidemics and other outbreaks, such as COVID-19;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the regulatory environment;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differences in budgetary cycles;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitor product offerings or pricing;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inflationary pressures, rising interest rates, potential economic recession and other deteriorating factors in the macroeconomic environment;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market-driven pressures to consolidate operations and reduce costs; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market acceptance of relatively new technologies, such as our GeoMx, CosMx and AtoMx platforms</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, academic, governmental and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by these customers. For example, many of our customers reduced their activities in response to the COVID-19 pandemic, resulting in delays in instrument orders and lower consumable purchases. Any decrease in our customers&#8217; budgets or expenditures, or in the size, scope or frequency of capital or operating expenditures, could materially and adversely affect our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our sales cycle is lengthy and variable, which makes it difficult for us to forecast revenue and other operating results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our instruments require a significant investment and, accordingly, our sales process involves numerous interactions with multiple individuals within an organization, and often includes in-depth analysis by potential customers of our products, performance of proof-of-principle studies, preparation of extensive documentation and a lengthy review process. As a result of these factors, the significant capital investment required in purchasing our instruments and the budget cycles of our customers, the time from initial contact with a customer to our receipt of a purchase order can vary significantly, and may be up to 12&#160;months or longer. Given the length and uncertainty of our sales cycle we have in the past experienced, and likely will in the future experience, fluctuations in our instrument sales will occur on a period-to-period basis. These factors also make it difficult to forecast revenue on a quarterly basis. For example, in the first and third quarters of 2022, our revenue was lower than our forecast for reasons we did not predict, including uneven sales execution and the impact of changes made to re-align our expanded commercial team early in 2022, and a significantly different instrument order mix among our GeoMx and CosMx spatial biology platforms. In addition, any failure to meet customer expectations could result in customers choosing to continue to use their existing systems or to purchase systems other than ours.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reliance on distributors for sales of our products outside of the United States could limit or prevent us from selling our products and impact our revenue.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established distribution agreements for our instruments and related consumable products in many countries where we do not sell directly. We intend to continue to grow our business internationally, and to do so we must attract additional distributors and retain existing distributors to maximize the commercial opportunity for our products. There is no guarantee that we will be successful in attracting or retaining desirable sales and distribution partners or that we will be able to enter into such arrangements on favorable terms. Distributors may not commit the necessary resources to market and sell our products to the level of our expectations or may choose to favor marketing the products of our competitors. If current or future distributors do not perform adequately, or we are unable to enter into effective arrangements with distributors in particular geographic areas, we may not realize long-term international revenue growth.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future capital needs are uncertain and we may need to raise additional funds in the future.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents and short-term investments will be sufficient to meet our anticipated cash requirements for at least the next 12&#160;months. However, we may need or choose to raise substantial additional capital to:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand the commercialization of our products;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund our operations; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further our research and development.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future funding requirements will depend on many factors, including:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market acceptance of our products;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing additional sales, marketing and distribution capabilities;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of our research and development activities;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of regulatory clearances or approvals;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve the anticipated cost reductions from the reduction in workforce announced in November 2022;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of competing technological and market developments; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we engage in strategic transactions, such as the acquisition of, investment in or disposal of businesses, assets, products and technologies, including inbound or outbound licensing arrangements.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that we will be able to obtain additional funds on acceptable terms, or at all. If we raise additional funds by issuing equity or equity-linked securities, or convertible debt, our stockholders may experience dilution. For example, in March 2020, we sold $230.0 million aggregate principal amount of our 2.625% Convertible Senior Notes due 2025, or the notes, in a private placement to qualified institutional buyers for net proceeds of $222.6 million and in October 2020, we sold an aggregate of 5,750,000 shares of common stock in an underwritten public offering for net proceeds of $215.8 million. Future debt financing, if available, may involve additional covenants restricting our operations or our ability to incur additional debt. Any debt or additional equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through strategic transactions with third parties, such as collaborations, asset sales and licensing arrangements, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. We have in the past pursued these types of transactions, such as the License and Asset Purchase Agreement, or LAPA, with Veracyte, Inc., or Veracyte, which we completed in December 2019, and may in the future pursue similar transactions or other strategic transactions, on our own or with other advisors, that may impact our business and prospects and the value of our common stock. If we do not have, or are not able to obtain sufficient funds, we may have to delay development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support or other resources devoted to our products or cease operations, and we may not achieve the anticipated cost reductions from the reduction in workforce announced in November 2022. Any of these factors could harm our operating results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to develop new products, enhance the capabilities of our systems to keep pace with rapidly changing technology and customer requirements or successfully manage the transition to new product offerings, any of which could have a material adverse effect on our business and operating results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to develop new products and applications for our technology in existing and new markets, while improving the performance and cost-effectiveness of our systems. New technologies, techniques or products could emerge that might offer better combinations of price and performance than our current or future products and systems. Existing markets for our products, including gene expression analysis, gene fusions and copy number variation, as well as new markets, such as protein expression and gene mutations, and potential markets for our research product candidates, are characterized by rapid technological change and innovation. Competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or customer requirements. We anticipate that we will face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. It is critical to our success that we anticipate changes in technology and customer requirements and successfully introduce new, enhanced and competitive technologies to meet our customers&#8217; and prospective customers&#8217; needs on a timely and cost-effective basis. If we do not successfully innovate and introduce new technology into our product lines, our business and operating results will be adversely impacted. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and manufacture of new products typically requires new scientific discoveries or advancements and complex technology and engineering, including the design of sophisticated software. Such developments may involve external suppliers and service providers, making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components, software or services and satisfactory technical performance of such components, software or assembled products.&#160;If we do not achieve the required technical specifications or successfully manage new product development processes, or if development work and manufacturing is not performed according to schedule, then such new technologies or products may be adversely impacted and our business and operating results may be harmed. Any delays in bringing new products to market may lead our customers to purchase our competitors&#8217; products or cancel outstanding purchase orders.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we must carefully manage the introduction of new products. If customers believe that such products will offer enhanced features or be sold for a more attractive price, they may delay purchases until such products are available. If customers conclude that such new products offer better value as compared to our existing products, we may suffer from reduced sales of our existing products and our overall revenue may decline. We may also have excess or obsolete inventory of older products as we transition to new products and our experience in managing product transitions is limited. If we do not effectively manage the transitions to new product offerings, our revenue, results of operations and business will be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on third-party manufacturers, service providers and single source suppliers for some of the components and materials used in our products, and the loss of any of these suppliers, or difficulties or delays in securing components or materials, could harm our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third-party manufacturers, service providers and single source suppliers for some of the components and materials used in our instruments, such as Precision System Science, Co., Ltd of Chiba, Japan, to build our nCounter Prep Station; Korvis LLC of Corvallis, Oregon, to build our nCounter Digital Analyzer and GeoMx DSP, D&amp;K Engineering, Inc. of San Diego, California, to build our CosMx SMI. We also rely on HCL Technologies Limited of India, Seattle BioSoftware Inc. of Seattle, Washington and Amazon Web Services of Seattle Washington for software application development, cloud storage and computing services for AtoMx SIP.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our contracts with instrument suppliers do not commit them to carry inventory or make available any particular quantities, they may give other customers&#8217; needs higher priority than ours, and we may not be able to obtain adequate supplies in a timely manner or on commercially reasonable terms. We also rely on sole suppliers for various components we use to manufacture our consumable products. We periodically forecast our needs for such components and enter into standard purchase orders with suppliers. If we were to lose such suppliers, or if the products provided by such suppliers or third-party manufacturers are unable to meet our performance specifications, there can be no assurance that we will be able to identify or enter into agreements with alternative suppliers or manufacturers on a timely basis on acceptable terms, if at all. In addition, if as a result of global economic or political instability, such as the ongoing geopolitical tensions related to Russia&#8217;s actions in Ukraine, disease outbreaks such as the COVID-19 pandemic, rising interest rates, potential economic recession and other deteriorating factors in the macroeconomic environment, or other factors impacting the global supply chain, our suppliers or third-party manufacturers experience shortages or delays for materials sourced or manufactured in the affected countries, their ability to supply us with instruments or product components may be affected. For example, in December 2022, we made our newest product platform, CosMx, available to customers. Delays or shortages in the global supply chain for certain components of the CosMx instrument may require that we source certain components from alternative suppliers that may be less experienced making components at the volumes that we may require, which may increase our costs or lead to delays in shipping instruments to our customers. From time to time, certain components of our systems and reagents reach the end of their life </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cycles or are obsoleted by our suppliers, and we have to procure alternative sources for these end-of-life products. If we should encounter delays or difficulties in securing the quality and quantity of materials we require for our products, our supply chain would be interrupted which would adversely affect sales. If any of these events occur, our business and operating results could be harmed.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our agreements with third party software application developers and cloud computing service providers provide for the delivery of applications that include certain attributes or performance features, including cybersecurity measures. If we should encounter delays or difficulties in securing the delivery of applications, or updates to applications, with functionality and features as designed, the delivery of our products could be delayed, consumables sales and the pace of experimentation may be negatively impacted and the cost of delivering AtoMx to customers could be higher which may impact our gross profit margins. In addition, we, together with third party service providers, provide cybersecurity monitoring and other features designed to protect customer data that may be stored in the cloud through use of AtoMx. In the event of a data breach or other cybersecurity incident whereby customer data were, or believed or reported to be, compromised or otherwise impacted, we could face legal claims, investigations or proceedings by governmental entities or private parties, adverse publicity and harm to our reputation, loss of business, and significant fines, penalties, and other damages and liabilities. Any such event could result in material harm to our business and operating results.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience manufacturing problems or delays that could limit our growth or adversely affect our operating results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumable products are manufactured at our facilities located in the greater Seattle, Washington area using complex processes, sophisticated equipment and strict adherence to specifications and quality systems procedures. Any unforeseen manufacturing problems, such as contamination of our facilities, equipment malfunction, quality issues with components and materials sourced from third-party suppliers, failure to strictly follow procedures or meet specifications, or reduced or blocked access to our facilities as a result of health epidemics and other outbreaks, such as COVID-19, could result in delays or shortfalls in production or require us to voluntarily recall our consumable products. Identifying and resolving the cause of any such manufacturing or supplier issues could require substantial time and resources. If we are unable to keep up with demand for our products by successfully manufacturing and shipping our products in a timely manner, our revenue could be impaired, market acceptance for our products could be adversely affected and our customers might instead purchase our competitors&#8217; products or cancel outstanding purchase orders.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the introduction of new products may require the development of new manufacturing processes and procedures as well as new suppliers. For example, our GeoMx DSP systems require that we establish supply relationships with antibody providers. While all of our CodeSets are produced using the same basic processes, significant variations may be required to meet new product specifications. Developing new processes and negotiating supply agreements can be very time consuming, and any unexpected difficulty in doing so could delay the introduction of a product.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our greater Seattle area facilities become unavailable or inoperable, we will be unable to continue our research and development, manufacturing our consumables or processing sales orders, and our business will be harmed.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture our consumable products in our facilities located in the greater Seattle, Washington area. These facilities are the center for research and development, order processing, receipt of our instruments manufactured by third-party contract manufacturers and shipping products to customers. Our facilities and the equipment we use to manufacture our consumable products would be costly, and would require substantial lead time, to repair or replace. The Seattle area is situated near active earthquake fault lines. These facilities may be harmed or rendered inoperable by natural or man-made disasters, including earthquakes and power outages, which may render it difficult or impossible for us to produce our products for some period of time. The inability to manufacture consumables or to ship products to customers for even a short period of time may result in the loss of customers or harm our reputation, and we may be unable to regain those customers in the future. Although we possess insurance for damage to our property and the disruption of our business, this insurance, and in particular earthquake insurance, which is limited, may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, if at all.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to generate a substantial portion of our revenue internationally and are subject to various risks relating to our international activities, which could adversely affect our operating results.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue generated from sales to customers located outside of North America was approximately 35%, 35% and 32% for the years ended December 31, 2022, 2021 and 2020, respectively. We believe that a significant percentage of our future revenue will come from international sources as we expand our overseas operations and develop opportunities in additional areas. Engaging in international business involves a number of difficulties and risks, including:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with existing and changing foreign regulatory requirements and laws;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with anti-bribery laws, such as the U.S. Foreign Corrupt Practices Act and U.K. Bribery Act, privacy and data protection requirements, labor laws and anti-competition regulations;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export or import restrictions;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">various reimbursement and insurance regimes;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and business practices favoring local companies;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic instability, such as the ongoing geopolitical tensions related to Russia&#8217;s actions in Ukraine, resulting sanctions imposed by the U.S. and other countries, and retaliatory actions taken by Russia in response to such sanctions;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global health pandemics, such as the ongoing COVID-19 pandemic;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements and other trade barriers;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and costs of staffing and managing foreign operations; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties protecting or procuring intellectual property rights.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand internationally, our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Historically, most of our revenue has been denominated in U.S. dollars, although we have sold our products and services in local currency outside of the United States, principally the Euro. Our expenses are generally denominated in the currencies of the countries in which our operations are located, which is primarily in the United States. As our operations in countries outside of the United States grow, our results of operations and cash flows will increasingly be subject to fluctuations due to changes in foreign currency exchange rates, which could harm our business in the future. For example, if the value of the U.S. dollar increases relative to foreign currencies, our revenue could be adversely affected as we convert revenue from local currencies to U.S. dollars. Similarly, a strong U.S. dollar relative to the local currencies of our international customers can potentially reduce demand for our products, which may compound the adverse effect of foreign exchange translation on our revenue. If we dedicate significant resources to our international operations and are unable to manage these risks effectively, our business, operating results and prospects will suffer.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to additional income tax liabilities.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating our worldwide provision for income taxes. During the ordinary course of business, there are many transactions for which the ultimate tax determination is uncertain. For example, our effective tax rates could be adversely affected by earnings being lower than anticipated in countries where we have lower statutory rates and higher than anticipated in countries where we have higher statutory rates, by changes in foreign currency exchange rates, by changes in the valuation of our deferred tax assets and liabilities, or by changes in the relevant tax, accounting and other laws, regulations, principles and interpretations. We are subject to audit in various jurisdictions, and such jurisdictions may assess additional income tax against us. Although we believe our tax estimates are reasonable and we have established any required reserves in respect of such estimates in accordance with Generally Accepted Accounting Principles, the final determination of tax audits and any related litigation could be materially different from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results or cash flows in the period or periods for which that determination is made.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of our domestic and foreign earnings. Any new taxes could adversely affect our domestic and international business operations, and our business and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the legislation commonly known as the Tax Cuts &amp; Jobs Act, or the TCJA, which was signed into law on December 22, 2017, as modified by the Coronavirus Aid, Relief, and Economic Security Act of 2020, or CARES Act, significantly revised the Internal Revenue Code of 1986, as amended, or the Code. The TCJA, among other things, contains significant changes to corporate taxation, including a reduction of the federal statutory rates from a top marginal rate of 35% to a flat rate of 21%, the transition of U.S. international taxation from a worldwide tax system to a territorial system, one time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, and modifying or repealing many business deductions and credits. Also, beginning in 2022, the TCJA eliminates the option to deduct research and development expenditures currently and requires </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taxpayers to capitalize and amortize them over five or fifteen years pursuant to Code Section 174. Although there is proposed legislation that would defer the capitalization requirement to later years, we have no assurance that the provision will be repealed or otherwise modified. We have accounted for such changes in accordance with our understanding of the TCJA, as modified by the CARES Act, and guidance available as of the date of this filing as described in more detail in our financial statements. Further, the Inflation Reduction Act of 2022, or the IRA, will become effective beginning in fiscal year 2023. We do not currently expect that the IRA will have a material impact on our income tax liability. We will continue to monitor and assess the impact of the federal legislation on our business and the extent to which various states conform to the federal tax law. Any further changes in tax laws or regulations that are applied adversely to us or our customers could have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating losses to offset future taxable income may be subject to certain limitations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had federal net operating loss carryforwards, or NOLs, to offset future taxable income of approximately $623.2 million. The federal NOLs generated during and after fiscal 2018 totaling $389.3 million are carried forward indefinitely, while all others, if not utilized, will expire in various years beginning in 2025. A lack of future taxable income would adversely affect our ability to utilize these NOLs. In addition, under Section&#160;382 of the Code, a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its NOLs to offset future taxable income. We may have already experienced one or more ownership changes. Depending on the timing of any future utilization of our carryforwards, we may be limited as to the amount that can be utilized each year as a result of such previous ownership changes. However, we do not believe such limitations will cause our NOLs and tax credit carryforwards to expire unutilized. In addition, future changes in our stock ownership as well as other changes that may be outside of our control, could result in additional ownership changes under Section&#160;382 of the Code. Our NOLs may also be impaired under similar provisions of state law or limited pursuant to provisions of the TCJA amendments to the Code, as modified by the CARES Act. We have recorded a full valuation allowance related to our NOLs and other deferred tax assets due to the uncertainty of the ultimate realization of the future benefits of those assets.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of debt instruments we may enter into may restrict our ability to pursue our business strategies. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have used debt financing to provide capital for our business. Debt instruments we may enter into in the future may require us to comply with various covenants that limit our ability to, among other things:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dispose of assets;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complete mergers or acquisitions;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur indebtedness;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">encumber assets;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or make other distributions to holders of our capital stock;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make specified investments; </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in any new line of business; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in certain transactions with our affiliates.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These restrictions could inhibit our ability to pursue our business strategies and may also impose certain financial covenants that require us to achieve certain revenue targets and/or maintain certain minimum cash balances. If we default under any such debt instruments, the lenders could terminate commitments to lend and cause all amounts outstanding with respect to such debt to be due and payable immediately, which in turn could result in cross defaults under other debt instruments. Our assets and cash flow may not be sufficient to fully repay borrowings under all of our then outstanding debt instruments if some or all of these instruments are accelerated upon a default. If we are unable to repay, refinance or restructure indebtedness when payment is due, the lenders could also proceed against any collateral granted to them to secure such indebtedness or force us into bankruptcy or liquidation.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions or joint ventures could disrupt our business, cause dilution to our stockholders and otherwise harm our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire other businesses, products or technologies as well as pursue strategic alliances, joint ventures, technology licenses or investments in complementary businesses. We have not made any acquisitions to date, and our ability to do so successfully is unproven. Any of these transactions could be material to our financial condition and operating results and expose us to many risks, including:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption in our relationships with customers, distributors or suppliers as a result of such a transaction;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated liabilities related to acquired companies;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties integrating acquired personnel, technologies and operations into our existing business;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management time and focus from operating our business;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in our expenses and reductions in our cash available for operations and other uses; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">possible write-offs or impairment charges relating to acquired businesses.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign acquisitions involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures and languages, currency risks and the particular economic, political and regulatory risks associated with specific countries.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, the anticipated benefit of any strategic transaction may not materialize. Future acquisitions could result in potentially dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities or amortization expenses or write-offs of goodwill, any of which could harm our financial condition. We cannot predict the number, timing or size of future joint ventures or acquisitions, or the effect that any such transactions might have on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may fail to achieve the expected cost savings and related benefits from our reduction in workforce initiated in November 2022.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, we announced a plan to reduce our workforce in order to enable a more cost-efficient organization. The reduction in workforce reduced employee headcount by approximately 10% by the end of 2022. The full impact of the reduction in workforce is not yet known.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may fail to execute on, or achieve the stated goals of, the reduction in workforce. Our plans may also change as we continue to refocus certain key goals and priorities. These actions may take more time than we currently estimate and we may not be able to achieve the cost-efficiencies sought. In addition, the reduction in workforce may negatively impact employee morale for those who are not directly impacted, which may increase employee attrition and impact future recruiting efforts, hindering our ability to achieve our key priorities. Any failure to achieve the expected benefits from the reduction in workforce could adversely affect our stock price, financial condition and ability to achieve our key priorities, as well as lead to stockholder complaints and litigation.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to recruit, train and retain key personnel, we may not achieve our goals.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends on our ability to recruit, train, retain and motivate key personnel, including our senior management, research and development, manufacturing and sales and marketing personnel. Competition for qualified personnel may at times be significant, particularly in the Seattle, Washington area. Our growth depends, in particular, on attracting, retaining and motivating highly-trained sales personnel with the necessary scientific background and ability to understand our systems at a technical level to effectively identify and sell to potential new customers. We do not maintain fixed term employment contracts or key man life insurance with any of our employees. Because of the complex and technical nature of our products and the dynamic market in which we compete, any failure to attract, train, retain and motivate qualified personnel could materially harm our operating results and growth prospects. Further, the reduction in workforce we announced in November 2022 may negatively impact our ability to recruit key personnel and makes retention of our current personnel more challenging.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Undetected errors or defects in our products could harm our reputation, decrease market acceptance of our products or expose us to product liability claims.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products have in the past and may in the future contain undetected errors or defects when first introduced or as new versions are released. Disruptions or other performance problems with our products may damage our customers&#8217; businesses, harm our reputation and result in reduced revenues. If that occurs, we may also incur significant costs, the attention of our key personnel could be diverted, or other significant customer relations problems may arise. We may also be subject to warranty and liability claims for damages related to errors or defects in our products. A material liability claim or other occurrence that harms our reputation or decreases market acceptance of our products could adversely impact our business and operating results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale and use of products or services based on our technologies, or activities related to our research, could lead to the filing of product liability claims if someone were to allege that one of our products contained a design or manufacturing defect which resulted in the failure to adequately perform the analysis for which it was designed. A product liability claim could result in substantial damages and be costly and time consuming to defend, either of which could materially harm our business or financial condition. We cannot assure investors that our product liability insurance would adequately protect our assets from </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the financial impact of defending a product liability claim. Any product liability claim brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing insurance coverage in the future.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks related to handling of hazardous materials and other regulations governing environmental safety.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to complex and stringent environmental, health, safety and other governmental laws and regulations that both public officials and private individuals may seek to enforce. Our activities that are subject to these regulations include, among other things, our use of hazardous materials in manufacturing and in our products, and the generation, transportation and storage of waste. We could discover that we, an acquired business or our suppliers are not in material compliance with these regulations. Existing laws and regulations may also be revised or reinterpreted, or new laws and regulations may become applicable to us, whether retroactively or prospectively, that may have a negative effect on our business and results of operations. It is also impossible to eliminate completely the risk of accidental environmental contamination or injury to individuals. In such an event, we could be liable for any damages that result, which could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience a significant disruption in our information technology systems or breaches of data security, our business could be adversely affected.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems to keep financial records, manage our manufacturing operations, fulfill customer orders, capture laboratory data, maintain corporate records, communicate with staff and external parties and operate other critical functions. Our information technology systems, and those of our vendors, are potentially vulnerable to disruption due to breakdown, malicious intrusion and computer viruses, ransomware or other malicious code, or other disruptive events including but not limited to terrorism, war or other military activity, power loss, flooding, fire, earthquake, or other natural disasters. Additionally, geopolitical tensions related to Russia&#8217;s actions in Ukraine may increase cybersecurity risks. W</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e are increasingly dependent upon our and our vendors&#8217; technology systems to operate our business and our ability to effectively manage our business depends on the security, reliability and adequacy of our technology systems and data, which includes use of cloud technologies, including Software as a Service (SaaS), Platform as a Service (PaaS) and Infrastructure as a Service (IaaS). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we were to experience a prolonged system disruption in our information technology systems or those of certain of our vendors, it could negatively impact our ability to serve our customers, which could adversely impact our business. Although we maintain offsite back-ups of our data, if operations at our facilities were disrupted, it may cause a material disruption in our business if we are not capable of restoring function on an acceptable timeframe. In addition, our information technology systems, and those of our vendors, are potentially vulnerable to data security breaches and other security incidents  &#8212; whether by employees or others &#8212; which may expose sensitive data to unauthorized persons. Such data security breaches and incidents, whether resulting from hacking, social engineering, phishing, or other causes could lead to the loss of confidential information, financial assets, trade secrets or other intellectual property, unauthorized access to, or disruptions to or other interruptions of, our platforms and products, or could lead to unauthorized access to or use, modification, unavailability, disclosure, loss or acquisition of, or the public exposure of, personal information (including sensitive personal information) of our employees, customers and others, or confidential information of ourselves, our customers or of other third parties that we maintain or otherwise process, any of which could have a material adverse effect on our business, reputation, financial condition and results of operations. In addition, any such access, disclosure or other loss of information could result in legal claims, investigations or proceedings by governmental entities or private parties, adverse publicity and harm to our reputation, loss of business, and significant fines, penalties, and other damages and liabilities. In addition, these breaches and incidents and other inappropriate access, and security vulnerabilities in our software, platforms, and products can be difficult to detect. Any delay in identifying them and responding to or otherwise remediating them may lead to security breaches, incidents, and unauthorized access occurring, and increased harms of the type described above. We expect to continue to expend significant resources to protect against security breaches and incidents, and could be required to expend significant amounts to remediate and otherwise respond to security breaches and incidents, including in connection with making notifications to customers or other persons or implementing additional security measures. With the increase in personnel working remotely, we and our vendors have experienced and are at increased risk for security breaches and incidents. We are taking steps in an effort to monitor and enhance the security of our technology systems and data; however, the unprecedented scale of remote work may require additional personnel and resources, which nevertheless cannot be guaranteed to fully safeguard our technology systems or data or other data or information that we maintain or that otherwise is processed in our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain insurance that may cover certain liabilities in connection with a security breach or other security incident, we cannot be certain our insurance coverage will be adequate for liabilities actually incurred, that insurance will continue to be available to us on commercially reasonable terms, or at all, or that any insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could have a material adverse effect on our business, including our financial condition, results of operations and reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any interruptions or delays in services from third parties, including cloud computing platform providers,  and other software and hardware vendors, or from our inability to adequately plan for and manage service interruptions or infrastructure capacity requirements, could impair the delivery of our services and harm our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on software developed by or licensed from, cloud computing platforms provided by, and computer hardware purchased or leased from, third parties in order to offer our services, including HCL Technologies Limited of India, Seattle BioSoftware Inc. of Seattle, Washington and Amazon Web Services of Seattle, Washington, which provide software application development, cloud storage and computing services for our AtoMx solution. AtoMx involves the storage and transmission of our customers&#8217; and our customers&#8217; customers&#8217; proprietary and other sensitive data. We or our customers may allow these third parties to access customer data to help deliver customer benefits, to host certain of our and our customers&#8217; data, which could include sensitive or personal data, or to perform other services. In addition, we share sensitive, nonpublic business information with other vendors in the ordinary course of business. A data breach or other cybersecurity incident involving third parties we rely on may have serious negative consequences for our businesses, including damage to, loss or unavailability of, or unauthorized use of, alteration, disclosure, acquisition, or other unauthorized processing or exploitation of sensitive customer data, or confidential or competitively sensitive information regarding our business, including intellectual property and other proprietary data, make our products more vulnerable to fraudulent activity, and cause temporary or sustained unavailability of our software and systems. Further, any such event, or the belief or perception it has occurred, may result in possible claims, demands, and litigation by private parties, demands, investigations, and proceedings by regulatory authorities, fines, penalties and damages and other liabilities; result in loss of customer confidence; cause material harm to our reputation and brands; lead to further regulation and oversight by federal or state agencies, and cause adverse financial conditions.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we increase our reliance on these third-parties, particularly with respect to third-party software, hardware, data and cloud computing platforms, our exposure to damage from service interruptions and disruptions may increase. Any changes in third-party service levels or product features, or any errors, defects, infection by ransomware, viruses, or other malicious code, disruptions, or other performance problems with third-party software, hardware, data or cloud computing platforms on which our applications run, including performance problems related to cybersecurity threats or attacks, could adversely affect our reputation and may damage our customers&#8217; or other users&#8217; stored files, or their confidentiality, integrity, and availability, or result in lengthy interruptions in our services. Interruptions in and other disruptions to our services might adversely affect our reputation and operating results, cause us to issue refunds or service credits to customers for prepaid and unused subscription services, subject us to potential liabilities, result in contract terminations, or adversely affect our renewal rates.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These software, hardware, data and cloud computing platforms may not continue to be available at reasonable prices, or on commercially reasonable terms or at all. Any loss of ability to use any of these software, hardware, data or cloud computing platforms could significantly increase our expenses and otherwise result in delays in providing our services until equivalent technology is either developed by us, or, if available, is identified, obtained through purchase or license and integrated into our services.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not accurately plan for our infrastructure capacity or other requirements and we experience significant strain on our cloud computing infrastructure, our customers could experience performance degradation or service outages that may subject us to financial liabilities, result in customer losses and harm our reputation and business. As we add capacity and continue to utilize cloud computing platform providers, we may be required to move or transfer our data or our customers&#8217; data. Despite precautions taken during this process, any unsuccessful data transfer may impair the delivery of our services, which may damage our business.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant United Kingdom or European developments stemming from the United Kingdom&#8217;s withdrawal from the European Union could have a material adverse effect on us.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the United Kingdom officially left the European Union. The full effect of Brexit remains uncertain, but Brexit creates economic and legal uncertainty in the region and could adversely affect the tax, currency, operational, legal and regulatory regimes to which our business is subject. Complying with changes in regulations in the United Kingdom in addition to European Union regulations has increased our costs of compliance and result in greater legal risks. There are many ways in which our business could be affected, some of which include additional volatility in global financial markets, new or modified trade agreements or data transfer agreements between the United Kingdom and other countries, including the United States, and the possible imposition of trade or other regulatory and immigration barriers in the United Kingdom. In addition, the Europe-wide market authorization framework for our products and access to European Union research funding by research scientists based in the United Kingdom may also change and may also result in a slowdown in spending on research tools like our systems. Furthermore, we currently operate in Europe through a subsidiary based in the United Kingdom, which provides us with certain operational, tax and other benefits, as well as through other subsidiaries in Europe. The United Kingdom&#8217;s withdrawal from the European Union could adversely affect our ability to realize those benefits and we may incur costs and suffer disruptions in our European operations as a result. These possible negative impacts, and others resulting from the United Kingdom&#8217;s withdrawal from the European Union, may adversely affect our operating results and growth prospects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We intend to seek strategic collaborations and partnerships and other transactions, which may result in the use of a significant amount of our management resources or significant costs, and we may not be able to fully realize the potential benefit of such transactions.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek strategic collaborations, partnerships and other transactions to support the continued growth of our company. However, there is no assurance that we will be successful in doing so. Accordingly, we may&#160;be engaged in evaluating potential transactions including, without limitation, strategic partnerships, divestitures of existing businesses or assets, a merger or consolidation with a third party that results in a change in control, a sale or transfer of all or a significant portion of our assets or a purchase by a third party of our securities that may result in a minority or control investment by such third party. From time to time, we may engage in discussions that may result in one or more transactions. Although there would be uncertainty that any of these discussions would result in definitive agreements or the completion of any transaction, we may devote a significant amount of our management resources to such a transaction, which could negatively impact our operations. In addition, we may incur significant costs in connection with seeking strategic transactions regardless of whether the transaction is completed. In the event that we consummate a strategic collaboration, partnership or other transaction in the future, we cannot assure you that we would fully realize the potential benefit of such a transaction or that the market would not have an adverse reaction to any such transaction. The failure to fully realize the potential benefit of such a transaction, adverse market reaction to any such transaction and any other issues we may encounter in connection with the consummation of any such transaction could adversely affect our future financial results or negatively impact the value of stockholders&#8217; investment in us.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in December 2019, we entered into a LAPA with Veracyte, pursuant to which we granted to Veracyte an exclusive worldwide license to our nCounter FLEX Analysis System, or the FLEX System, for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic use and for the development and commercialization of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic tests, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic devices, or IVDs, or laboratory developed tests, or LDTs, for use on the FLEX System and sold to Veracyte certain assets, including our rights with respect to the Prosigna Breast Cancer Prognostic Gene Signature Assay, the LymphMark Lymphoma Subtyping Test and the assay software modules that operate together with the FLEX System. For additional information regarding our transaction with Veracyte please see Part I, Item&#160;1. &#8220;Business &#8212; License Agreement &#8212; Veracyte, Inc.&#8221; of this report. We cannot be certain that we will realize all of the anticipated benefits from our transaction with Veracyte and the disposition of certain of our assets pursuant to the LAPA may yet have an unforeseen detrimental impact on our business. Furthermore, transactions such as our agreement with Veracyte can be disruptive to our retained operations, divert management&#8217;s attention from day-to-day operations and potentially increase employee attrition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research reports about our business, or if they issue an adverse opinion about our business, our stock price and trading volume could decline.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business. If one or more of the analysts who cover us issues an adverse opinion about our company, our stock price would likely decline. If one or more of these analysts ceases coverage of us or fails to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_28"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our &#8220;Research Use Only&#8221; products for the research life sciences market could become subject to more stringent regulatory requirements as medical devices by the FDA or other regulatory agencies in the future which could increase our costs and delay our commercialization efforts, thereby materially and adversely affecting our business and results of operations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, most of our products are currently labeled and sold for Research Use Only, or RUO, and are not intended for the diagnosis or treatment of disease, and are sold to pharmaceutical and biotechnology companies, academic and government institutions and research laboratories. Because such RUO products are not intended for diagnostic or clinical use, and the products do not include clinical or diagnostic claims or provide directions for use as diagnostic products, they are not medical devices and not subject to regulation by the Food and Drug Administration, or FDA. In particular, while the FDA regulations require that RUO products be appropriately labeled, &#8220;For Research Use Only. Not for Use in Diagnostic Procedures,&#8221; the regulations do not subject such products to the FDA&#8217;s pre- and post-market controls for medical devices. Pursuant to the FDA guidance on RUO products, a company may not make clinical or diagnostic claims about an RUO product or provide clinical directions or clinical support services to customers for RUO products, or engage in distribution or sales practices that are not consistent with the RUO labeling. If the FDA were to modify its approach to regulating RUO products, compliance with additional or changes in regulations could reduce our revenue or increase our costs and adversely affect our business, prospects, results of operations or financial condition. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even where our products are labeled, promoted, and intended as RUO, the FDA or comparable agencies of other countries, depending on the totality of circumstances, could disagree with our conclusion that our products are intended for research use only or deem our sales, marketing and promotional efforts as being inconsistent with the RUO designation. If the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA were to disagree that our products can be marketed as RUO, our products could be subject to government regulation, and the regulatory clearance or approval and maintenance process for such products may be uncertain, expensive, and time-consuming. If the FDA determines that our sales or distribution practices are not consistent with the RUO labeling, the FDA could consider our products to be misbranded and/or adulterated under the Federal Food, Drug, and Cosmetic Act and take adverse administrative or enforcement actions against us, such as requiring a recall or issuing a and warning letter, among others, any of which could materially harm our business. In the event that the FDA requires marketing authorization of our RUO products in the future, there can be no assurance that the FDA will ultimately grant any clearance or approval requested by us in a timely manner, or at all.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we sell dual-use instruments with software that has both FDA-cleared functions, and research functions for which the FDA approval or clearance is not required. Dual-use instruments are subject to FDA regulation since they are intended, at least in part, for use by customers performing clinical diagnostic testing. In November 2014, the FDA issued a guidance document that described the FDA&#8217;s approach to regulating molecular diagnostic instruments that combine both approved/cleared device functions and research functions for which approval/clearance is not required. There is a risk that the requirements for dual-use instruments could change causing additional costs and delays for development of these products. For example, there could be enforcement action if the FDA determines that approval or clearance was required for those functions for which the FDA approval or clearance has not been obtained, or the instruments are being promoted for off-label use. There is also a risk that the FDA could broaden its current regulatory enforcement of dual-use instruments through additional FDA oversight of such products or impose additional requirements upon such products. In July 2017, FDA adopted a new regulation exempting certain clinical multiplex test systems, like the ones used with the Prosigna assay that we supply to Veracyte, from premarket notification requirements, although such instruments are still required to comply with the special controls applicable to Class II medical devices. However, these regulations will not impact the FDA clearance requirements for our nCounter Dx Analysis System intended for use with specific assays or panels for clinical or diagnostic purposes, such as Prosigna, each of which will require separate premarket notification or premarket approval.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For medical devices that we manufacture for third parties, we are subject to ongoing and extensive regulatory requirements, and our failure to comply with these requirements could substantially harm our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nCounter FLEX, for diagnostic use, which we supply to Veracyte in our capacity as a contract manufacturer, is regulated as an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic medical device. Accordingly, we and certain of our contract manufacturers are subject to ongoing International Organization for Standardization, or ISO, obligations as well as regulation by the FDA, state regulatory authorities, and other comparable national and local health authorities. These may include routine inspections of our manufacturing facilities and our records by Notified Bodies, the FDA, and other health authorities, to assess compliance with requirements such as ISO 13485 and the FDA&#8217;s Quality System Regulations, or QSR, 21 C.F.R. Part 820, which include extensive requirements for quality assurance and control as well as manufacturing and change control procedures, among others. We are also subject to other FDA regulations, such as requirements pertaining to the registration of our manufacturing facilities and the listing of our devices with the FDA. Veracyte is responsible for continued medical device reporting, for example, reporting of adverse events and malfunctions; reporting certain corrections and removals; and labeling and promotional requirements as well as for regulatory clearances for future generations of the nCounter platform for use with clinical diagnostic applications. Other agencies may also issue guidelines and regulations that could impact the development, labeling, marketing, and distribution of these products, among other activities, including the European In Vitro Diagnostic Regulation, or IVDR. If Veracyte fails to comply with FDA regulatory obligations applicable to their activities, including those obligations assumed pursuant to the SSAs, it could adversely affect the sale of the device and potentially result in other harm to our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products may also be subject to additional FDA or global regulatory authority post-marketing obligations or requirements by the FDA or other regulatory authorities to change our current product classifications which would impose additional regulatory obligations on us and our contractors. If we, Veracyte, or our contractors or suppliers are not able to maintain regulatory compliance, we may not be permitted to market our medical device products and/or may be subject to enforcement by EU Competent Authorities and the FDA and other global regulatory authorities such as through the issuance of warning letters, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution. In addition, we and Veracyte may be subject to similar regulatory regimes of other foreign jurisdictions as we continue to commercialize our products in new markets outside of the United States and Europe. Any adverse action by Notified Body, EU Competent Authority, the FDA or other global regulatory authority could significantly increase our expenses, expose us to greater liability, limit our revenue and profitability, and cause reputational harm.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to comply with an increasing number of environmental compliance regulations, including those focused upon the restriction of certain hazardous substances in our products. We have compliance programs designed to meet the requirements of environmental compliance regulations, but our failure to comply with such current or future regulations could result in the imposition of substantial fines, suspension of production, alteration of our manufacturing processes or cessation of operations that could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject, directly or indirectly, to healthcare fraud and abuse laws and other laws applicable to our commercial  practices, as well as laws and regulations relating to privacy and data protection. If we or our agents and contractors are unable to comply, or have not complied, with such laws and regulations, we could face substantial penalties.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. For as long as we manufacture nCounter FLEX and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic kits for use with nCounter FLEX for Veracyte, or if we commercialize our other instruments for diagnostic use, our operations may be directly, or indirectly through our agents, contractors, or customers, subject to various fraud and abuse laws, including, without limitation, the federal and state anti-kickback statutes and state, federal and foreign marketing compliance laws. Any misconduct could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter misconduct by our employees, agents, representatives, or independent contractors that we may work with, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other adverse actions or lawsuits stemming from a failure to comply with applicable laws and regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions, exclusion from participation in government healthcare programs, or the curtailment or restructuring of our operations. In addition, we may be subject to laws and regulations relating to privacy and data protection by both the federal government and the states in which we conduct our business as well as by foreign governments and entities. The laws that may affect our ability to operate include, but are not limited to:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-kickback Statute and state equivalents;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act and state equivalents; </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state privacy laws, such as the California Consumer Privacy Act and California Privacy Rights Act;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Foreign Corrupt Practices Act, which applies to our international activities; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the European Union&#8217;s General Data Protection Regulation and other national privacy laws.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other requirements, the GDPR regulates transfers of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the U.S. We have undertaken certain efforts to conform transfers of personal data from the European Economic Area, or EEA, to the U.S. and other jurisdictions based on our understanding of current regulatory obligations and the guidance of data protection authorities, including standard contractual clauses approved by the European Commission, or the SCCs, and the EU-U.S. and Swiss-U.S. Privacy Shield programs administered by the U.S. Department of Commerce. Despite this, we may be unsuccessful in maintaining conforming means of transferring personal data from the EEA, Switzerland, and United Kingdom, in particular as a result of continued legal and legislative activity within those regions. The EU-U.S.-and Swiss-U.S. Privacy Shield frameworks and the SCCs have been subject to legal challenge and on July 16, 2020, the Court of Justice of the European Union, or CJEU, issued a decision invalidating the EU-U.S. Privacy Shield and imposing additional requirements in connection with the use of the SCCs. The Swiss-U.S. Privacy Shield also has been declared invalid. The European Commission issued new SCCs in June 2021 that were required to be put in place. Additionally, the United Kingdom&#8217;s Information Commissioner&#8217;s Office issued new standard contractual clauses to support personal data transfers out of the United Kingdom on February 2, 2022 that were required to be used for new contractual arrangements as of September 21, 2022, and must replace prior standard contractual clauses as of March 21, 2024. On March 25, 2022, the United States and EU announced an &#8220;agreement in principle&#8221; to replace the EU-U.S. Privacy Shield with the Trans-Atlantic Data Privacy Framework. Although progress has since been made towards the establishment of this as a valid transfer mechanism, this framework has not yet been established, and it remains unclear whether it will be appropriate for us to utilize if it is established. More generally, we are assessing these developments and their impact on our data transfer mechanisms. We may, in addition to other impacts, experience additional costs associated with increased compliance burdens, and we and our customers face the potential for regulators in the EEA, Switzerland, and United Kingdom to apply different standards to the transfer of personal data from those regions to the U.S., and to block, or require ad hoc verification of measures taken with respect to, certain data flows from those regions to the U.S. We also may be required to engage in new contract negotiations with third parties that aid in processing data on our behalf. We may find it necessary or desirable to make further changes to our handling of personal data of residents of those regions. The regulatory environment applicable to the handling of the personal data of EEA, Switzerland, and United Kingdom residents, and our actions taken in response, may cause us to assume additional liabilities or incur additional costs and could result in our business, operating results and financial condition being harmed. Additionally, we and our customers may face a risk of enforcement actions by data protection authorities in those regions relating to personal data transfers. Any such enforcement actions could result in substantial costs and diversion of resources, distract management and technical personnel and negatively affect our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom maintains the Data Protection Act of 2018 and the UK GDPR, which collectively implement and complement the GDPR and provide for penalties for noncompliance of up to the greater of &#163;17.5 million, or four percent, of worldwide revenues. On June 28, 2021, the European Commission announced a decision of &#8220;adequacy&#8221; concluding that the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United Kingdom ensures an equivalent level of data protection to the GDPR, which provides some relief regarding the legality of continued personal data flows from the EEA to the United Kingdom. Such adequacy decision must, however, be renewed after four years and may be modified or revoked in the interim. We cannot fully predict how the Data Protection Act, the UK GDPR and other United Kingdom data protection laws or regulations may develop in the medium to longer term, nor the effects of divergent laws and guidance regarding how data transfers to and from the United Kingdom will be regulated.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More generally, the laws, rules and regulations relating to privacy or data protection to which we may be subject, or that otherwise apply to our business, are constantly evolving, and we expect that there will continue to be new proposed laws, regulations and industry standards concerning these matters in the United States, the EU and other jurisdictions. If our operations are found to be in violation of any of the laws or regulations described above or others that apply to us, or to which we become subject in the future, we may be subject to claims, complaints, investigations, enforcement actions, and penalties, including civil and criminal penalties, damages, fines and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect our intellectual property effectively, our business would be harmed.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on patent protection as well as trademark, copyright, trade secret and other intellectual property rights protection and contractual restrictions to protect our proprietary technologies, all of which provide limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. As of December 31, 2022, we owned or licensed approximately 38 issued U.S. patents and approximately 21 pending U.S. patent applications, including provisional and non-provisional filings and 5 pre-nationalization PCT applications. We also owned or licensed approximately 312 pending and granted counterpart applications worldwide, including 123 country-specific validations of 17 European patents. We continue to file new patent applications to protect the full range of our technologies. If we fail to protect our intellectual property, third parties may be able to compete more effectively against us and we may incur substantial litigation costs in our attempts to recover or restrict use of our intellectual property.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on obtaining patent protection for our products and processes, preserving trade secrets, patents, copyrights and trademarks, operating without infringing the proprietary rights of third parties, and acquiring licenses for technology or products. We cannot assure investors that any of our currently pending or future patent applications will result in issued patents, and we cannot predict how long it will take for such patents to be issued. As the patent and prior art landscape for translational research products grows more crowded and becomes more complex we may find it more difficult to obtain patent protection for our products including those related to digital spatial profiling, spatial molecular imaging and sequencing. Our existing patents and any future patents we obtain may not be sufficiently broad to prevent others from practicing our technologies or from developing competing products and may therefore fail to provide us with any competitive advantage. Additionally, we cannot assure investors that our currently pending or future patent applications have or will be filed in all of our potential markets. Further, we cannot assure investors that other parties will not challenge any patents issued to us or that courts or regulatory agencies will hold our patents to be valid or enforceable. We cannot guarantee investors that we will be successful in defending challenges made against our patents and patent applications. Any successful third-party challenge to our patents could result in the unenforceability or invalidity of such patents and </span><span style="color:#454647;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could deprive us of the ability to prevent others from using the technologies claimed in such issued patents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent positions of life sciences companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. No consistent policy regarding the breadth of claims allowed in such companies&#8217; patents has emerged to date inside or outside the United States. Furthermore, in the biotechnology field, courts frequently render opinions that may affect the patentability of certain inventions or discoveries, including opinions that may affect the patentability of methods for analyzing or comparing biological macromolecules including nucleic acids, such as DNA and RNA, and proteins.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, the patent positions of companies engaged in development and commercialization of genomic diagnostic tests, like Prosigna, are particularly uncertain.&#160;Various United States courts, including the U.S. Supreme Court, have rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to genomic diagnostics. Specifically, these decisions stand for the proposition that patent claims that recite laws of nature (for example, the relationships between gene expression levels and the likelihood of risk of recurrence of cancer) are not themselves patentable unless those patent claims have &#8220;sufficient&#8221; additional features which provide practical assurance that the processes are genuinely inventive applications of those laws, rather than patent drafting efforts designed to monopolize the law of nature itself. What constitutes a &#8220;sufficient&#8221; additional feature is uncertain. Furthermore, in view of these decisions, in December 2014 the U.S. Patent and Trademark Office, or USPTO, published revised guidelines for patent examiners to apply when examining process claims for patent eligibility. This guidance was updated by the USPTO in July 2015 and additional illustrative examples provided in May 2016. The USPTO provided additional guidance on examination procedures pertaining to subject matter eligibility in April </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018, June 2018, January 2019 and October 2019. The guidance indicates that claims directed to a law of nature, a natural phenomenon, or an abstract idea that do not meet the eligibility requirements should be rejected as non&#8209;statutory, patent ineligible subject matter; however, method of treatment claims that practically apply natural relationships should be considered patent eligible. We cannot assure investors that our patent portfolio will not be negatively impacted by the current uncertain state of the law, new court rulings or changes in guidance or procedures issued by the USPTO. From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability and validity of patents within the genomic diagnostic space, and any such changes could have a negative impact on our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some non-U.S. countries do not protect intellectual property rights to the same extent as the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biotechnology, which could make it difficult for us to stop the infringement of our patents. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business; the foreign court may find that our enforced patent is invalid or unenforceable.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We might not have been the first to make the inventions covered by each of our pending patent applications.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We might not have been the first to file patent applications for these inventions.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">It is possible that our pending patent applications will not result in issued patents, and even if they issue as patents, they may not provide a basis for commercially viable products, may not provide us with any competitive advantages, or may be challenged and invalidated by third parties.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not develop additional proprietary products and technologies that are patentable.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The patents of others may have an adverse effect on our business.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important products and technologies in a timely fashion or at all.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to pursuing patents on our technology, we take steps to protect our intellectual property and proprietary technology by entering into confidentiality agreements and intellectual property assignment agreements with our employees, consultants, corporate partners and, when needed, our advisors. Similarly, where permitted by applicable law, we enter into non-compete agreements with certain of our employees. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure. Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had illegally obtained and was using our trade secrets, it would be expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, competitors could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. In addition, competitors may develop their own versions of our technology in countries where we did not apply for patents, where our patents have not issued or where our intellectual property rights are not recognized and compete with us in those countries and markets. If our intellectual property is not adequately protected so as to protect our market against competitors&#8217; products and methods, our competitive position could be adversely affected, as could our business.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet registered certain of our trademarks in all of our potential markets. If we apply to register these trademarks, our applications may not be allowed for registration, and our registered trademarks may not be maintained or enforced. In addition, opposition or cancellation proceedings may be filed against our trademark applications and registrations, and our trademarks may not survive such proceedings. If we do not secure registrations for our trademarks, we may encounter more difficulty in enforcing them against third parties than we otherwise would.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, we would be exposed to a greater risk of direct competition. If our intellectual property does not provide adequate protection against our competitors&#8217; products, our competitive position could be adversely affected, as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could our business. Both the patent application process and the process of managing patent disputes can be time consuming and expensive.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical actions in the United States and in foreign countries could increase the uncertainties and costs surrounding the prosecution or maintenance of our patent applications or those of any current or future licensors, and maintenance, enforcement or defense of our issued patents or those of any current or future licensors. For example, the United States and foreign government actions related to Russia&#8217;s invasion of Ukraine may limit or prevent filing, prosecution and maintenance of patent applications in Russia. Government actions may also prevent maintenance of issued patents in Russia. These actions could result in abandonment or lapse of our patents or patent applications, resulting in partial or complete loss of patent rights in Russia. If such an event were to occur, it could have a material adverse effect on our business. In addition, a decree was adopted by the Russian government in March 2022, allowing Russian companies and individuals to exploit inventions owned by patentees that have citizenship or nationality in, are registered in, or have a predominately primary place of business or profit-making activities in the United States and other countries that Russia has deemed unfriendly without consent or compensation. Consequently, we would not be able to prevent third parties from practicing our inventions in Russia or from selling or importing products made using our inventions in and into Russia. Accordingly, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from selling our products.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on licenses in order to be able to use various proprietary technologies, including our core digital molecular barcoding technology licensed from the Institute for Systems Biology and technology relating to Prosigna licensed from Veracyte. We do not own the patents that underlie these licenses. Our rights to use these technologies and employ the inventions claimed in the licensed patents are subject to the continuation of and compliance with the terms of those licenses.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to license other technologies to commercialize future products. We may also need to negotiate licenses to patents and patent applications after launching any of our commercial products. Our business may suffer if the patents or patent applications are unavailable for license or if we are unable to enter into necessary licenses on acceptable terms.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, we do not control the prosecution, maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties. Some of our patents and patent applications were either acquired from another company who acquired those patents and patent applications from yet another company, or are licensed from a third party. Thus, these patents and patent applications were not written by us or our attorneys, and we did not have control over the drafting and prosecution. The former patent owners and our licensors might not have given the same attention to the drafting and prosecution of these patents and applications as we would have if we had been the owners of the patents and applications and had control over the drafting and prosecution. We cannot be certain that drafting or prosecution of the licensed patents and patent applications by the licensors has been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforcement of our licensed patents or defense of any claims asserting the invalidity of these patents is often subject to the control or cooperation of our licensors. Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions. Therefore, our business may suffer if these licenses terminate, if the&#160;licensors fail to abide by the terms of the license or fail to prevent infringement by third parties or if the licensed patents or other rights are found to be invalid. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Because of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license or termination of the license. If a licensor believes that we are not paying the royalties due under the license or are otherwise not in compliance with the terms of the license, the licensor might attempt to revoke the license. If such an attempt were successful, we might be barred from producing and selling some of our products.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of the patents we have licensed relate to technology that was developed with U.S. government grants. Federal regulations impose certain domestic manufacturing requirements with respect to some of our products embodying these patents. Additionally, under the Bayh-Dole Act, the U.S. government has certain rights to inventions developed with such grants.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Involvement in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others&#8217; proprietary rights, or to defend against third-party claims of intellectual property infringement, could be time-intensive and costly and may adversely impact our business or stock price.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received notices of claims of infringement and misappropriation or misuse of other parties&#8217; proprietary rights in the past and may from time to time receive additional notices. Some of these claims have led and may lead to litigation. We </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cannot assure investors that we will prevail in such actions, or that other actions alleging misappropriation or misuse by us of third-party trade secrets, infringement by us of third-party patents and trademarks or other rights, or the validity of our patents, trademarks or other rights, will not be asserted or prosecuted against us.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, on May 6, 2021, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint, on May 19, 2021, they filed an amended complaint, and on May 4, 2022 they filed a second amended complaint, against us in the U.S. District Court for the District of Delaware. Further, on February 28, 2022, 10x Genomics, Inc. and President and Fellows of Harvard College filed a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint, and on May 12, 2022, an amended complaint, against us in the U.S. District Court for the District of Delaware. In addition, on March 4, 2022, 10x Genomics, Inc. filed suit against us in the Munich Regional Court in Germany. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The complaints allege infringement of certain patents described in the complaints, and seek, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees). We have evaluated the plaintiffs&#8217; claims and do not believe that our activities infringe any patent rights held by the plaintiffs, and we intend to vigorously defend ourselves. If the plaintiffs prevail in these pending litigations, we may be prohibited from selling the alleged infringing products and services in the United States, Germany, and potentially elsewhere or be ordered to pay significant damages or both, either of which would have a material and adverse impact on our business. Even if we ultimately prevail in these litigations, litigation is costly, time-consuming and will divert our management&#8217;s attention, which could also have a material and adverse impact on our business. For additional information regarding these pending litigations, please refer to the section of this report titled &#8220;Legal Proceedings.&#8221;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation may also be necessary for us to protect or enforce our patent and proprietary rights, to defend against third-party claims or to determine the scope, coverage and validity of the proprietary rights of others. For example, on October 20, 2022, we filed suit against 10x Genomics, Inc. in the U.S. District Court for the District of Delaware alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe our U.S. Patent No. 11,473,142, &#8220;Chemical Compositions and Uses Thereof," and, on January 24, 2023, our additional infringement claims against 10x Genomics with respect to a second NanoString patent, U.S. Patent No. 11,377,689, were consolidated into this case. Litigation could result in substantial legal fees and could adversely affect the scope of our patent protection and reduce our ability to compete in the marketplace. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us. If we resort to legal proceedings to enforce our intellectual property rights or to determine the validity, scope and coverage of the intellectual property or other proprietary rights of others, the proceedings could be burdensome and expensive, even if we were to prevail. Any litigation that may be necessary in the future could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results or financial condition.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in our existing and targeted markets. Our success depends in part on our non-infringement of the patents or proprietary rights of third parties. We develop complex products that integrate a wide range of technologies which may impact our ability to do so clear of third-party rights and therefore may need to license other technologies or challenge the scope, coverage and validity of the proprietary rights of others to commercialize future products. As we develop new technologies such as those related to digital spatial profiling, spatial molecular imaging and sequencing, for example, and move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as part of a business strategy to slow our entry into such markets, impede our successful competition and/or extract substantial license and royalty payments from us. In addition, we may be unaware of pending third-party patent applications that relate to our technology and our competitors and others may have patents or may in the future obtain patents and may claim that use of our products infringes these patents. Our competitors and others may now, and in the future, have significantly larger and more mature patent portfolios than we currently have. In addition, future litigation may involve patent holding companies or other adverse patent owners who have no relevant product revenue and against whom our own patents may provide little or no deterrence or protection. Therefore, our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are aware of a third party, Genomic Health, Inc., that has issued patents and pending patent applications in the United States, Europe and other jurisdictions that claim methods of using certain genes that are included in Prosigna, which we manufacture for Veracyte. We believe that our manufacture of Prosigna does not infringe any valid issued claim. We could incur substantial costs and divert the attention of our management and technical personnel in defending against any of these claims. Any adverse ruling or perception of an adverse ruling in defending ourselves against these claims could have an adverse impact on our stock price, which may be disproportionate to the actual impact of the ruling itself. Parties making claims against us may be able to obtain injunctive or other relief, which could block our ability to develop, commercialize and sell products, and could result in the award of substantial damages against us. In the event of a successful claim of infringement against us, we may be required to pay damages and obtain one or more licenses from third parties, or be prohibited from selling certain products. We may not be able to obtain these licenses at a reasonable cost, if at all. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. In addition, we could encounter delays in product introductions while we attempt to develop alternative methods or products to avoid infringing third-party patents or proprietary rights. Defense of any lawsuit or failure to obtain any of these licenses on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">favorable terms could prevent us from commercializing products, and the prohibition of sale of any of our products could materially affect our ability to grow and gain market acceptance for our products.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course of this kind of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our agreements with some of our suppliers, distributors, customers, collaborators and other entities with whom we do business require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results, or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees&#8217; former employers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our employees were previously employed at universities or other life sciences companies, including our competitors or potential competitors. Although no claims against us are currently pending, we or our employees may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. A loss of key research personnel work product could hamper or prevent our ability to commercialize certain potential products, which could severely harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products contain third-party open source software components, and failure to comply with the terms of the underlying open source software licenses could restrict our ability to sell our products.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products contain software tools licensed by third-party authors under &#8220;open source&#8221; licenses. Use and distribution of open source software may entail greater risks than use of third-party commercial software, as open source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. Some open source licenses contain requirements that we make available source code for modifications or derivative works we create based upon the type of open source software we use. If we combine our proprietary software with open source software in a certain manner, we could, under certain open source licenses, be required to release the source code of our proprietary software to the public. This would allow our competitors to create similar products with less development effort and time and ultimately could result in a loss of product sales.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we monitor our use of open source software to avoid subjecting our products to conditions we do not intend, the terms of many open source licenses have not been interpreted by U.S. courts, and there is a risk that these licenses could be construed in a way that could impose unanticipated conditions or restrictions on our ability to commercialize our products. Moreover, we cannot assure investors that our processes for controlling our use of open source software in our products will be effective. If we are held to have breached the terms of an open source software license, we could be required to seek licenses from third parties to continue offering our products on terms that are not economically feasible, to re-engineer our products, to discontinue the sale of our products if re-engineering could not be accomplished on a timely basis, or to make generally available, in source code form, our proprietary code, any of which could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We use third-party software that may be difficult to replace or cause errors or failures of our products that could lead to lost customers or harm to our reputation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use software licensed from third parties in our products. In the future, this software may not be available to us on commercially reasonable terms, or at all. Any loss of the right to use any of this software could result in delays in the production of our products until equivalent technology is either developed by us, or, if available, is identified, obtained and integrated, which could harm our business. In addition, any errors or defects in third-party software, or other third-party software failures, could result in errors, defects or cause our products to fail, which could harm our business and be costly to correct. Many of these providers attempt to impose limitations on their liability for such errors, defects or failures, and if enforceable, we may have additional liability to our customers or third-party providers that could harm our reputation and increase our operating costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will need to maintain our relationships with third-party software providers and to obtain software from such providers that does not contain any errors or defects. Any failure to do so could adversely impact our ability to deliver reliable products to our customers and could harm our results of operations.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_34"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our common stock may be volatile, and you could lose all or part of your investment.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock has fluctuated and may continue to fluctuate substantially. The trading price of our common stock depends on a number of factors, including those described in this &#8220;Risk Factors&#8221; section, many of which are beyond our control and may not be related to our operating performance. These fluctuations could cause stockholders to lose all or part of their investment in our common stock. Factors that could cause fluctuations in the trading price of our common stock include the following:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated quarterly variation in our results of operations or the results of our competitors;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of new products, significant contracts or commercial relationships;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in our pending litigations with 10x Genomics, Inc. and its co-plaintiffs;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse regulatory announcements;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of new or changed securities analysts&#8217; reports or recommendations for our stock;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or our involvement in, litigation;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and uncertainty in U.S. and international markets resulting from the spread of COVID-19 and its variants and related containment and mitigation measures, rising interest rates, potential economic recession and other deteriorating factors in the macroeconomic environment;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the research market;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing disruptions;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any future sales of our common stock or other securities;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any change to the composition of the board of directors or key personnel, including developments relating to our reduction in workforce announced in November 2022;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant acquisitions or divestitures, strategic partnerships, joint ventures or capital commitments;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions and slow or negative growth of our markets; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other factors described in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock market in general, and market prices for the securities of life sciences companies like ours in particular, have from time to time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock, regardless of our operating performance. In several recent situations where the market price of a stock has been volatile, holders of that stock have instituted securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit against us, the defense and disposition of the lawsuit could be costly and divert the time and attention of our management and harm our operating results and negatively impact the trading price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of our common stock in the public market could cause our stock price to fall.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price could decline as a result of sales of a large number of shares of our common stock or the perception that these sales could occur, including by our officers, directors and their respective affiliates. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We register the offer and sale of all shares of common stock that we may issue under our equity compensation plans. In addition, in the future, we may issue additional shares of common stock or other equity or debt securities convertible into common stock in connection with a financing, acquisition, litigation settlement, employee arrangements or otherwise. For example, in March 2020, we sold $230 million aggregate principal amount of 2.625% Convertible Senior Notes due 2025 in a private placement to qualified institutional buyers for net proceeds of  $222.6 million and in October  2020, we sold an aggregate of 5,750,000 shares of common stock in an underwritten public offering for net proceeds of $215.8 million. Any such future issuance could result in substantial dilution to our existing stockholders and could cause our stock price to decline.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion over the use of the proceeds to us from our March 2020 convertible notes offering and October 2020 underwritten public offering and may apply the proceeds to uses that do not improve our operating results or the value of your securities.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have broad discretion over the use of proceeds to us from our March 2020 convertible notes offering and October 2020 underwritten public offering and investors will be relying solely on the judgment of our board of directors and management regarding the application of these proceeds. Our use of the proceeds may not improve our operating results or increase the value of the securities offered pursuant to the foregoing fundraising transactions.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our convertible notes may require a significant amount of cash, and we may not have sufficient cash flow or the ability to raise the funds necessary to satisfy our obligations under the notes, and our current and future indebtedness may limit our operating flexibility or otherwise affect our business.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance any current or future indebtedness, including the notes, or to make cash payments in connection with any conversion of notes or upon any fundamental change if note holders require us to repurchase their notes for cash, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not generate cash flow from operations in the future sufficient to service our indebtedness and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring indebtedness or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations. In addition, our existing and future indebtedness could have important consequences to our stockholders and significant effects on our business. For example, it could:</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it more difficult for us to satisfy our debt obligations, including the notes;</span></div><div style="margin-bottom:3pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-bottom:3pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital and other general corporate purposes;</span></div><div style="margin-bottom:3pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="margin-bottom:3pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrict us from exploiting business opportunities;</span></div><div style="margin-bottom:3pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less indebtedness; or </span></div><div style="margin-bottom:3pt;padding-left:72pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our availability to borrow additional funds for working capital, capital expenditures, acquisitions, debt service requirements, execution of our business strategy or other general purposes.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions relating to our notes may dilute the ownership interest of existing stockholders, or may otherwise depress the price of our common stock.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the notes are converted by holders, we have the ability under the indenture for the notes to deliver cash, common stock, or any combination of cash or common stock, at our election upon conversion of the notes. If we elect to deliver common stock upon conversion of the notes, it would dilute the ownership interests of existing stockholders. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, certain holders of the notes may engage in short selling to hedge their position in the notes. Anticipated future conversions of such notes into shares of our common stock could depress the price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware or Washington law could make an acquisition of us difficult, limit attempts by our stockholders to replace or remove our current management and limit our stock price.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions of our certificate of incorporation and bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our stock. Among other things, the certificate of incorporation and bylaws:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the board of directors to issue up to 15,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that the authorized number of directors may be changed only by resolution of the board of directors;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that all vacancies, including newly-created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">divide the board of directors into three classes;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that a director may only be removed from the board of directors by the stockholders for cause;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and may not be taken by written consent;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing in a timely manner, and meet specific requirements as to the form and content of a stockholder&#8217;s notice;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prevent cumulative voting rights (therefore allowing the holders of a plurality of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that special meetings of our stockholders may be called only by the chairman of the board, our chief executive officer or by the board of directors; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that stockholders are permitted to amend the bylaws only upon receiving at least two-thirds of the total votes entitled to be cast by holders of all outstanding shares then entitled to vote generally in the election of directors, voting together as a single class.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&#160;203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any &#8220;interested&#8221; stockholder for a period of three years following the date on which the stockholder became an &#8220;interested&#8221; stockholder. Likewise, because our principal executive offices are located in Washington, the anti-takeover provisions of the Washington Business Corporation Act may apply to us under certain circumstances now or in the future. These provisions prohibit a &#8220;target corporation&#8221; from engaging in any of a broad range of business combinations with any stockholder constituting an &#8220;acquiring person&#8221; for a period of five years following the date on which the stockholder became an &#8220;acquiring person.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complying with the laws and regulations affecting public companies increases our costs and the demands on management and could harm our operating results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we incur and will continue to incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act and rules subsequently implemented by the SEC and The Nasdaq Global Market impose numerous requirements on public companies, including requiring changes in corporate governance practices. Also, the Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. Our management and other personnel must devote a substantial amount of time to compliance with these laws and regulations. These burdens may increase as new legislation is passed and implemented, including any new requirements that the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 may impose on public companies. These requirements have increased and will likely continue to increase our legal, accounting, and financial compliance costs and have made and will continue to make some activities more time consuming and costly. For example, as a public company it is more difficult and more expensive for us to obtain director and officer liability insurance, and in the future we may be required to accept reduced policy limits and coverage or to incur substantial costs to maintain the same or similar coverage. These rules and regulations could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors or our board committees or as executive officers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rules implemented by the SEC pursuant to the Sarbanes-Oxley Act require, among other things, that we assess the effectiveness of our internal control over financial reporting annually and assess the effectiveness of our disclosure controls and procedures quarterly. In particular, Section&#160;404 of the Sarbanes-Oxley Act, or Section&#160;404, requires us to perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on, and our independent registered public accounting firm to attest to, the effectiveness of our internal control over financial reporting. Our compliance with applicable provisions of Section&#160;404 requires that we incur substantial accounting expense and expend significant management time on compliance-related issues as we implement additional corporate governance practices and comply with reporting requirements. For example, management concluded that our internal controls over financial reporting were not effective as of December 31, 2019 and 2018, resulting in extensive remediation efforts during 2020 and 2019, including increased staffing and investments in additional technology and other expenses. While we have since remediated the material weakness, maintaining adequate internal control over financial reporting will continue to require significant management attention and the incurrence of additional expense.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, investor perceptions of our company may suffer as a result of material weakness findings in our internal controls, and this could cause a decline in the market price of our stock. Irrespective of compliance with Section&#160;404, any failure of our internal control over financial reporting could have a material adverse effect on our stated operating results and harm our reputation. If we are unable to avoid future material weaknesses, our operations, financial reporting, or financial results could be harmed, and any such material weakness findings could result in an adverse opinion on our internal control over financial reporting from our independent registered public accounting firm.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_37"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1B. &#160;&#160;&#160;&#160;Unresolved Staff Comments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_40"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Properties</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leased properties include <ix:nonFraction unitRef="lease" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="nstg:NumberOfOperatingLeases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80MC9mcmFnOjkzOWIwMjQ1N2RmNTQ0MDc5YWQ2MTFiMTliY2YxMDY1L3RleHRyZWdpb246OTM5YjAyNDU3ZGY1NDQwNzlhZDYxMWIxOWJjZjEwNjVfMjE5OTAyMzI1NjQxOA_e3b79b33-0571-4540-9178-d9dd5a409dc3">five</ix:nonFraction> long-term operating lease agreements for approximately 162,322 square feet of space used for general office, laboratory, manufacturing, operations, and research and development purposes in the greater Seattle, Washington area. The long-term operating leases in the greater Seattle, Washington area expire beginning in 2026 through 2032 and include options to renew at the then fair market rental for each of the facilities. The lease agreements contain rent abatement periods, scheduled rent increases and provide for tenant improvement allowances.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our landlords hold security deposits of approximately $1.4 million. We believe that our existing facilities are adequate to meet our business requirements for the near-term and that additional space will be available on commercially reasonable terms, if required.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_43"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2021, 10x Genomics, Inc. and Prognosys Biosciences, Inc., or &#8220;Prognosys&#8221;, filed a complaint, and on May 19, 2021, an amended complaint, and on May 4, 2022, a second amended complaint, against us in the U.S. District Court for the District of Delaware. The amended complaint alleges that certain of our products, services and components sold by us for use in connection with our GeoMx DSP system (the &#8220;Identified GeoMx Products&#8221;) infringe seven patents owned by Prognosys: (a) U.S. Patent No. 10,472,669, &#8220;Spatially encoded biological assays,&#8221; (b) U.S. Patent No. 10,961,566, &#8220;Spatially encoded biological assays,&#8221; (c) U.S. Patent No. 10,983,113, &#8220;Spatially encoded biological assays,&#8221; (d) U.S. Patent No. 10,996,219, &#8220;Spatially encoded biological assays,&#8221; (e) U.S. Patent No. 11,001,878, &#8220;Spatially encoded biological assays,&#8221; (f) U.S. Patent No. 11,008,607, &#8220;Spatially encoded biological assays,&#8221; and (g) U.S. Patent No. 11,293,917, &#8220;Systems for analyzing target biological molecules via sample imaging and delivery of probes to substrate well&#8221; (the &#8220;Asserted Prognosys Patents&#8221;). The amended complaint seeks, among other relief, injunctive relief and unspecified damages (including treble damages and attorneys&#8217; fees) in relation to our making, using, selling, offering to sell, exporting and/or importing in the United States the Identified GeoMx Products, as well as the alleged infringement by others of the Asserted Prognosys Patents through their use of the Identified GeoMx Products. We have evaluated the plaintiffs&#8217; claims and do not believe that our activities infringe any patent rights held by the plaintiffs. On November 17, 2021, the Court granted our motion to dismiss the plaintiffs&#8217; claims of pre-suit indirect infringement and willful infringement with leave to amend the complaint. Discovery is in progress. A claim construction hearing was held on February 17, 2023. A trial is scheduled for November 2023. We intend to vigorously defend ourselves in this litigation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, 10x Genomics, Inc. and President and Fellows of Harvard College, or &#8220;Harvard&#8221;, filed a complaint, and on May 12, 2022, an amended complaint, against us in the U.S. District Court for the District of Delaware. The complaint alleges that certain of our products, services and components sold by us for use in connection with our CosMx SMI system (the &#8220;Identified CosMx Products&#8221;) infringe five patents owned by Harvard: (a) U.S. Patent No. 10,227,639, &#8220;Compositions and Methods for Analyte Detection,&#8221; and (b) U.S. Patent No. 11,021,737, &#8220;Compositions and Methods for Analyte Detection,&#8221; (c) U.S. Patent No. 11,293,051, &#8220;Compositions and Methods for Analyte Detection&#8221;, (d) U.S. Patent No. 11,293,052, &#8220;Compositions and Methods for Analyte Detection,&#8221; and (e) U.S. Patent No. 11,293,054, &#8220;Compositions and Methods for Analyte Detection&#8221; (the &#8220;U.S. 10x CosMx Case&#8221;). The complaint seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees) in relation to our making, using, selling, offering to sell, exporting and/or importing in the United States the Identified CosMx Products. We have evaluated the plaintiffs&#8217; claims and do not believe that our activities infringe any patent rights held by the plaintiffs. Discovery is in progress. A claim construction hearing is scheduled for July 2023 and a trial is scheduled for June 2024. We </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intend to vigorously defend ourselves in this litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On August 16, 2022, we filed counterclaims in this action alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe our U.S. Patent No. 11,377,689, &#8220;Chemical Compositions and Uses Thereof.&#8221; On January 24, 2023, these counterclaims were consolidated with the claims of a separate patent infringement case that we filed against 10x Genomics on October 20, 2022, as discussed below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, we were notified of a complaint, dated March 4, 2022, naming us and our wholly-owned subsidiary, NanoString Technologies Germany GmbH, which 10x Genomics, Inc. filed in the Munich Regional Court I in Germany, alleging that our CosMx SMI system and associated products and services infringe European Patent No. 2794928B1, or &#8220;EP 2794928B1&#8221;, which is owned by Harvard. The complaint seeks, among other relief, injunctive relief and damages in relation to our selling and offering to sell our CosMx SMI system and associated products and services in Germany. We have evaluated the claims and do not believe that our activities infringe any patent rights held by 10x or Harvard. A hearing is scheduled for March 2023 in this proceeding. We </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intend to vigorously defend ourselves in this litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On July 29, 2022, we, through our German subsidiary, filed a nullity action with the German Federal Patent Court in Munich requesting a judgment that EP 2794928B1, as in effect for Germany, be declared invalid and be revoked in its entirety. On February 10, 2023, the German Federal Patent Court issued a preliminary and non-binding opinion in this nullity action finding that the subject matter of the asserted independent claim 1 of EP 2794928B1 potentially lacked novelty and lacked an inventive step over prior art. The preliminary opinion further addressed Harvard&#8217;s seven patent claim limitation requests, referred to as auxiliary requests, which 10x and Harvard seek to have applied in the event that claim 1 of EP 2794928B1, as granted, proves not to be protectable. The preliminary opinion stated that the claim limitations in Auxiliary Request 1 could potentially be used to defend EP 2794928B1 over the cited prior art. The preliminary opinion further stated that Harvard would potentially not be able to use Auxiliary Requests 2 through 7 to establish novelty over the prior art. A hearing before the German Federal Patent Court is scheduled for May 2024 and a decision in the nullity action is expected following the hearing.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2022, we filed suit against 10x Genomics, Inc. in the U.S. District Court for the District of Delaware alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe our U.S. Patent No. 11,473,142, &#8220;Chemical Compositions and Uses Thereof.&#8221; On January 24, 2023, our claims from the U.S.10x CosMx Case with respect to U.S. Patent No. 11,377,689 were consolidated with the claims in this action. We seek, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees) in relation to 10x Genomics&#8217; making, using, selling, offering to sell, exporting and/or importing in the United States the Visium system and related products and services. Discovery is in progress. A case schedule has not yet been set.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the pending litigations with 10x Genomics and its co-plaintiffs, we are not engaged in any material legal proceedings. From time to time, we may become involved in litigation relating to claims arising from the ordinary course of business. Other than the pending litigations with 10x Genomics and its co-plaintiffs, we believe that there are no claims or actions pending against us currently, the ultimate disposition of which would have a material adverse effect on our consolidated results of operations, financial condition or cash flows.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_46"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_52"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on The Nasdaq Global Market under the symbol &#8220;NSTG.&#8221; Trading of our common stock commenced on June&#160;26, 2013 in connection with our initial public offering. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;21, 2023, there were approximately 18 holders of record of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This performance graph shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference into any filing of NanoString Technologies, Inc. under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the performance of our common stock for the periods indicated with the performance of the Nasdaq Composite Index and the Nasdaq Biotechnology TR Index. This graph assumes an investment of $100 on December 31, 2017 in each of our common stock, the Nasdaq Composite Index and the Nasdaq Biotechnology TR Index, and assumes reinvestment of dividends, if any. The stock price performance shown on the graph below is not necessarily indicative of future stock price performance.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><img src="nstg-20221231_g38.jpg" alt="nstg-20221231_g38.jpg" style="height:420px;margin-bottom:5pt;vertical-align:text-bottom;width:683px"/></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about our equity compensation plans as of December&#160;31, 2022. All outstanding awards relate to our common stock.</span></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)&#160;Number&#160;of Securities<br/>to&#160;be Issued Upon<br/>Exercise of<br/>Outstanding<br/>Options, Warrants <br/>and Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)&#160;Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) Number of Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining Available</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Future&#160;Issuance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Under Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Excluding Securities </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reflected in Column (a))</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2013 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,341,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2013 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,045,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by security holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147,482&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936,728&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs, which do not have an exercise price, are excluded in the calculation of weighted-average exercise price.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2013 Employee Stock Purchase Plan includes provisions providing for an annual increase in the number of securities available for future issuance on the first day of each fiscal year, equal to the least of: (a) 1% of the outstanding shares of common stock on the first day of such fiscal year; (b) 281,250 shares; and (c) such other amount as the board of directors, or a committee appointed by the board of directors, may determine.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 15, 2018, our board of directors adopted the NanoString Technologies, Inc. 2018 Inducement Equity Incentive Plan, or Inducement Plan, and, subject to the adjustment provisions of the Inducement Plan, reserved 250,000 shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan was adopted without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Inducement Plan provides for the grant of equity-based awards, including nonstatutory stock options, restricted stock units, restricted stock, stock appreciation rights, performance shares and performance units, and its terms are substantially similar to our 2022 Equity Incentive Plan, including with respect to treatment of equity awards in the event of a &#8220;merger&#8221; or &#8220;change in control&#8221; as defined under the Inducement Plan, but with such other terms and conditions intended to comply with the Nasdaq inducement award exception or to comply with the Nasdaq acquisition and merger exception. On February 27, 2023, our board of directors approved an amendment to the Inducement Plan to increase the number of shares of the Company&#8217;s common stock available for issuance pursuant to equity awards granted under the Inducement Plan from 250,000 shares to 425,000 shares. For additional information, see the section of this report captioned &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172">Part II</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172">&#8212;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_172">Item 9B. Other Information</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_55"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Reserved</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis together with the financial statements and the related notes to those statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. As a result of many factors, such as those set forth in the section of this report captioned &#8220;Risk Factors&#8221; and elsewhere in this report, our actual results may differ materially from those anticipated in these forward-looking statements. Throughout this discussion, unless the context specifies or implies otherwise, the terms &#8220;NanoString&#8221;, &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to NanoString Technologies, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The discussion regarding our financial condition and results of operations for the year ended December 31, 2020 and the comparison of the year ended December 31, 2021 to the year ended December 31, 2020 have been omitted from this Annual Report on Form 10-K and is incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March&#160;1, 2022, under the section titled &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1401708/000140170821000033/nstg-20201231.htm#i2c4c2c2f61194dd6bb3aee1b93efc214_55">Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_61"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and market technologies that unlock scientifically valuable and clinically actionable information from minute amounts of biological material, primarily for life science researchers in the fields of genomics and proteomics. Our mission is to offer an ecosystem of innovative discovery and translational research solutions that enable our customers to map the universe of biology, enabling scientific exploration that may lead to new therapies that can improve the human condition.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technologies include proprietary chemistries that enable the labeling and counting of single molecules. Our product platforms are used for scientific discovery and clinical research applications, often in connection with pharmaceutical product development and human clinical trials of potential new therapies. Our proprietary chemistries may reduce the number of steps required to conduct certain types of scientific experiments, enable the collection of multiple data points in a single experiment and allow for multiple experiments to be conducted at once. Our chemistries and instruments are also able to extract information from multiple types of biological samples, including those that are often challenging to work with using other scientific methods or platforms. As a result, we are able to develop tools that are easier for researchers to use and that may generate larger amounts of data and faster, more consistent scientific results.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecosystem of solutions consists of (i) our spatial biology platforms, including our GeoMx Digital Spatial Profiler, or &#8220;GeoMx DSP&#8221; or &#8220;GeoMx&#8221;, our CosMx Spatial Molecular Imager, or &#8220;CosMx SMI&#8221; or &#8220;CosMx&#8221;, and our AtoMx Spatial Informatics Platform, or &#8220;AtoMx SIP&#8221; or &#8220;AtoMx&#8221;, a cloud-based, open source and fully integrated informatics solution for use with GeoMx DSP and CosMx SMI, and (ii) our nCounter Analysis System, our original product platform for multi-plex bulk gene expression analysis. All of our product platforms include instruments, related consumables, software and services, have the versatility to detect both RNA and protein expression and are able to generate reliable and reproduceable data in a variety of biological sample types, including formalin fixed paraffin embedded, or FFPE, sample types. Our product platforms allow our customers to progress their research in areas such as oncology, immunology and neurology. We market and sell our instruments and related consumables to researchers in academic, government and biopharmaceutical laboratories for research use, both through our direct sales force and through selected distributors in certain markets.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nCounter, which was commercially launched in 2008, is used to conduct what is known as &#8220;bulk&#8221; gene expression analysis, whereby biological samples are first reduced, and then gene expression, specifically quantities of selected RNA or proteins, are measured at their average levels throughout the totality of the sample. nCounter can be used to analyze the activity of up to 800 genes in a single experiment. As of December&#160;31, 2022, we had an installed base of approximately 1,120 nCounter systems, which our customers have used to publish more than 6,520 peer-reviewed papers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeoMx DSP, which was commercially launched in 2019, is a pioneering product platform in the emerging field of spatial biology. While nCounter and other common gene expression analysis technologies use bulk analysis approaches, GeoMx is used to analyze selected regions of an intact biological sample without the need to reduce or destroy the sample, enabling researchers to see how gene expression might vary across those regions. After a researcher selects regions of interest, GeoMx arranges the biological information extracted from these regions to be subsequently quantified and analyzed, or &#8220;read out,&#8221; by a platform such as nCounter, whereby researchers can obtain information on up to 96 biological targets per selected region of interest, or by a next generation sequencer, or NGS, system, such as systems manufactured by Illumina, Inc., whereby researchers can obtain information on up to 18,000 biological targets, or the whole possible universe of potential RNA targets, per selected region of interest. As of December&#160;31, 2022, we had an installed approximately 350 GeoMx systems, which customers have used to publish approximately 190 peer-reviewed scientific papers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CosMx SMI, which was commercially launched in December 2022, is a new product platform in the field of spatial biology and complements our GeoMx DSP platform. While GeoMx offers researchers the ability to profile gene expression activity in a selected region of interest that may contain multiple cells or cell types, CosMx is designed to enable multiplexed spatial profiling of RNA and protein targets at a single and sub-cellular resolution level. While GeoMx allows for more rapid, higher throughput analysis of gene expression activity in selected regions of interest, CosMx is designed to allow researchers to &#8220;drill down&#8221; into a specific single cell or sub-cellular area in a region of interest to gather more information as desired or required. CosMx can be used to analyze up to 1,000 RNA targets, or up to 68 protein targets, at a single or sub-cellular level of resolution within morphologically intact tissue samples, and is expected after further product development to have the ability to analyze up to 6,000 RNA targets, or up to 120 protein targets.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AtoMx SIP, which was commercially launched in December 2022, is a new a cloud-based, open source spatial biology informatics platform, initially for use with CosMx, and eventually also with GeoMx. Researchers' desire for ever larger amounts of data in their spatial biology experiments has led to significant &#8220;big data&#8221; management issues, including the ability to store, access and efficiently analyze experimental data at a reasonable cost. AtoMx is designed to take advantage of significant advances in cloud computing and facilitate the easy storage of the large data sets and images generated by spatial biology experiments. AtoMx also enables researchers to perform image analysis and data visualization, as well as sharing of data and analysis with collaborators, using scalable and on-demand cloud computing. We believe AtoMx will enable researchers to easily and quickly analyze the substantial scientific data and tissue images generated by spatial biology experiments, while avoiding the large computing infrastructure and security costs associated with operating in-house data centers. AtoMx is currently available to researchers using CosMx, and is expected to be made available for GeoMx users by the end of 2023.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of and subsequent to our commercial launch of GeoMx, CosMx and AtoMx, we have provided selected customers in-house sample testing services whereby customers send biological samples to our Seattle facilities to be analyzed using our product platforms and selected consumables under our technology access program, or TAP. Upon completion of each project, the raw data and analysis report is provided to the customer.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial majority of our revenue from the sale of our products, which consist of our GeoMx, CosMx, and nCounter instruments and related proprietary consumables. Our instruments are designed to work only with our consumable products. Accordingly, as the installed base of instruments grows, we expect recurring revenue from consumable sales to become an increasingly important driver of our operating results. Our consumables include our standardized nCounter and GeoMx panel products, nCounter custom codeset products that contain a specific set of targets for scientific analysis as requested by a customer, and the Prosigna breast cancer assay which is manufactured for our partner Veracyte Inc, or Veracyte. We also derive revenue from processing fees related to proof-of-principle studies, including from our GeoMx DSP and CosMx TAP which we conduct for potential customers. For GeoMx,  CosMx and nCounter, we offer extended service contracts and generate service revenue. We also expect to generate revenue in future periods from AtoMx in the form software license, cloud computing and data storage fees.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use third-party contract manufacturers to produce our instruments and certain raw materials for our consumables. We build our consumables, including our panels, custom code sets, and reagent packages at our greater Seattle, Washington area facilities.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We focus a substantial portion of our resources on developing new technologies, products and solutions. Research and development expense totaled $70.8 million, $69.5 million and $62.9 million in 2022, 2021 and 2020, respectively. We intend to make significant investments in research and development to support our existing instrument platforms and related consumable offerings, as well as  research and development of new technologies.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue decreased 12% to $127.3 million in 2022, compared to $145.1 million in 2021. The decrease was driven primarily by decreased revenues from our sales of GeoMx systems, related to greater allocation of customer budgets to our CosMx instruments for which we booked orders in 2022 but for which no revenue was recognized until the fourth quarter, and lower consumables utilization by GeoMx customers. Sales of nCounter systems and related consumables also decreased during the period, primarily as a result of the aging of our nCounter platform, greater customer interest in newer gene expression technologies and decreased system utilization by our older nCounter customers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decreases in GeoMx and nCounter were partially offset by our revenue from our first commercial shipments of CosMx systems and related consumables during the fourth quarter of 2022. Our revenue increased 24% to $145.1 million in 2021, compared to $117.3 million in 2020. The increase was driven primarily by increased revenues from our sales of GeoMx DSP systems and related consumables. The increases were offset by declines in sales of nCounter consumables primarily as a result the COVID-19 pandemic and its impact on lab activity with our customers during 2020.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never been profitable and had net losses of $159.5 million, $115.3 million and $110.1 million in 2022, 2021 and 2020, respectively. As of December&#160;31, 2022, our accumulated deficit was $809.3 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Financial Metrics</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized as, and operate in, one reportable segment: the development, manufacture and commercialization of instruments, consumables and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Our chief operating decision maker is the chief executive officer, who manages our operations and evaluates our financial performance on a total company basis. Our principal operations and decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from the sale of our products and related services. For a description of our revenue recognition policies, see the section of this report captioned &#8220;&#8212;Critical Accounting Policies and Significant Estimates&#8212;Revenue Recognition.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product revenue consists of sales of our spatial biology and nCounter platforms, including instruments and related consumables. Our GeoMx DSP system has a U.S. list price of $295,000. Our CosMx SMI system has a U.S. list price of $345,000, which is inclusive of an initial amount of AtoMx SIP-related data storage and cloud computing services. Our nCounter Pro system, which typically consists of one nCounter Digital Analyzer and one nCounter Prep Station, has a U.S. list price of $249,000. The U.S. list price of the nCounter FLEX system is $300,000. Our nCounter SPRINT Profiler system has a reduced footprint and combines the function of the prep station with the digital analyzer in a single instrument and has a U.S. list price of $149,000.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, depending on the country, list prices are generally higher. In certain cases, customers may pay less than the list price for our various instruments. For example, some of our systems are sold to customers through independent distributors, and these distributors may purchase systems from us at a discount to list price. In certain regions outside of the US, we sell through distribution partners who typically receive discounted prices. In addition, in some cases we may sell any combination of our systems together as a bundle, or we may sell a system together with an initial order of consumables or service contracts for a single price, in which cases we may offer discounted prices for instruments as compared to list prices.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer base is primarily composed of academic institutions, government laboratories, biopharmaceutical companies and clinical laboratories that perform analyses or testing using our GeoMx DSP, CosMx SMI and nCounter Analysis systems and purchase related consumables.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our research customers, related consumables include standardized and pre-manufactured kits, or panels, that are designed to measure the expression of a pre-selected set of genes. For nCounter, we also offer custom CodeSets, which we manufacture to the specific requirements of an individual researcher, and Master Kits, cartridges and reagents, which are ancillary reagents, cartridges, tips and reagent plates required to setup and process samples in our instruments. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the LAPA with Veracyte entered into in 2019, we now sell our nCounter Prosigna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic kits to Veracyte, who then sells Prosigna to end user customers or distributors. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our average annualized consumables revenue per installed GeoMx system was approximately $71,000 for the year ended December&#160;31, 2022. Our average annualized consumables revenue per installed nCounter system was approximately&#160;$45,000&#160;for the year ended&#160;December&#160;31, 2022, which includes our nCounter consumables sales and sales of our Prosigna kits.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service and Other Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenue consists of fees associated with service contracts and fees for conducting various forms of data analysis studies, including providing services under our Technology Access Programs, or TAP, and our collaboration revenue. We include a one-year warranty with the sale of our instruments and offer service contracts, which are purchased by a majority of our customers. We selectively provide TAP services and other data analysis studies to prospective customers in order to help them better understand the benefits of our technologies, primarily of our GeoMx and CosMx systems. Collaboration revenue has historically been derived primarily from our completed collaboration with Lam and our terminated collaborations with Celgene and Merck.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue by Geography</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products through our own sales forces in the United States, Canada, certain European countries and also various countries within the Asia Pacific region, including China, Japan, Singapore, South Korea, and India among others. We also sell through distributors in other parts of the world. As we have expanded our European direct sales force and entered into agreements with distributors of our products in Europe, the Middle East, Asia Pacific and South America, the amount of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue generated outside of North America has generally increased, although there have been significant quarter-to-quarter fluctuations. In the future, we intend to continue to expand our sales force and establish additional distributor relationships outside the United States to better access international markets.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects total revenue by geography based on the geographic location of our customers, distributors and collaborators. For sales to distributors, their geographic location may be different from the geographic locations of the ultimate end customer. Americas consists of the United States, Canada, Mexico and South America; and Asia Pacific includes Japan, China, South Korea, Singapore, Malaysia, Vietnam, Thailand, India and Australia.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe&#160;&amp; Middle East</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,262&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our revenue is denominated in U.S. dollars. Changes in foreign currency exchange rates have not materially affected us to date; however, they may become material to us in the future if our operations outside of the United States expand.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of costs incurred in the production process, including costs of purchasing instruments from third-party contract manufacturers, consumable component materials and assembly labor and overhead, packaging and delivery, installation, warranty, and any follow-on servicing related costs. In addition, cost of revenue includes royalty costs for licensed technologies included in our products, provisions for slow-moving and obsolete inventory, and non-cash expenses including depreciation and amortization associated with various assets used in the production of our products and stock-based compensation expense. We provide a one-year warranty on each GeoMx DSP, CosMx SMI and nCounter Analysis System and we establish a reserve for warranty repairs based on historical warranty repair costs incurred.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="margin-bottom:6pt;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of salaries and benefits, occupancy costs, laboratory supplies, engineering services, consulting fees, costs associated with licensing molecular diagnostics rights expenses and non-cash expenses including depreciation and amortization associated with various assets used in the research and development of our products and stock-based compensation expense.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made substantial investments in research and development since our inception. Our research and development efforts have focused primarily on the tasks required to enhance our technologies and to support development and commercialization of new and existing products and applications. We believe that our continued investment in research and development is essential to our long-term competitive position and expect to continue to make investments in research and development activities, with an expected focus on spatial genomics. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have found that it has been effective for us to manage our research and development activities on a departmental basis. Accordingly, other than pursuant to terms of certain of our collaborations, we have neither required employees to report their time by project nor allocated our research and development costs to individual projects.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense by functional area was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and discovery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing, support and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and process engineering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory and medical affairs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities and overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,504&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense consists primarily of costs for our sales and marketing, finance, human resources, information technology, business development, legal and general management functions, as well as professional fees for legal, consulting and accounting services and non-cash expenses including primarily stock-based compensation expense.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_67"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Our Performance</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our financial performance has been and in the foreseeable future will continue to be primarily driven by the following factors. While each of these factors presents significant opportunities for our business, they also pose important challenges that we must successfully address in order to sustain our growth and improve our results of operations. Our ability to successfully address the factors below is subject to various risks and uncertainties, including those described under the heading &#8220;Risk Factors.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Instrument Installed Base</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future financial performance will be driven by continued adoption and utilization of our systems. As of December&#160;31, 2022, we had an installed base of approximately 350 GeoMx DSP systems and approximately 1,120 nCounter Analysis Systems. Future revenue may be impacted by the introduction of new product platforms, such as CosMx SMI, for which our first commercial instruments shipped during the fourth quarter of 2022.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to employ strategies to increase the adoption rate of our instrument platforms, including potentially expanding our sales channel in both direct and distributor territories, developing new consumable and software content and enhancing certain features for our spatial biology and nCounter platforms. As our installed base of instruments grows, we solicit feedback from our customers and focus certain of our research and development efforts on improving our systems or enabling applications, which in turn helps to drive additional sales of our instruments.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our instruments require a significant capital investment and, as a result, our instrument sales process involves numerous interactions with multiple individuals within an organization, and often includes in-depth analysis by potential customers of our products, performance of proof-of-principle studies, preparation of extensive documentation and a lengthy review process. As a result of these factors, the significant capital investment required in purchasing our instruments and the budget cycles of our customers, the time from initial contact with a customer to our receipt of a purchase order can vary significantly, and may be up to 12&#160;months or longer. Given the length and uncertainty of our sales cycle, we have in the past experienced, and likely will in the future experience, fluctuations in our instrument sales on a period-to-period basis.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recurring Consumables Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our spatial biology and nCounter instruments are primarily designed to be used only with our consumables. This closed system model generates recurring revenue from each instrument we sell. Management focuses on recurring consumable revenue per system as an indicator of the continuing value generated by each system. Quarterly, we calculate recurring annualized consumables revenue per system (also known as pull-through) by dividing related annualized consumables revenue recognized in a particular quarter (other than consumables revenue related to proof-of-principle studies) by the total number of installed systems as of the last day in the immediately preceding quarter. We calculate the average annualized consumable pull-through per instrument by dividing related consumables revenue recognized during the year (other than consumables revenue related to proof-of-principle studies) by the average total number of installed systems as of the last day in the immediately preceding quarter for each of the preceding four quarters. Historically, the majority of our systems and related consumables have been sold to research customers. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our average annualized consumable pull-through per installed GeoMx DSP system was approximately $71,000 and $97,000 for the years ended December&#160;31, 2022 and 2021, respectively. The decrease in GeoMx pull-through in 2022 was driven primarily by lower consumables utilization by a large group of more recent GeoMx customers, as compared to older customers that have owned their GeoMx systems for multiple years. Our average annualized consumable pull-through per installed nCounter system was approximately $45,000 and $55,000 for the years ended December&#160;31, 2022 and 2021, respectively. The decrease in nCounter consumable pull-through in 2022 was due primarily to the impact of the aging of our nCounter platform, greater customer interest in newer gene expression technologies and decreased system utilization by our older nCounter customers.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the installed base of our instrument platforms expands, consumables revenue is expected to increase. Our consumables revenue per installed system may fluctuate in the future, reflecting the mix and age of our installed instruments, and potential shifts in the mix, or type, of consumables sold to our installed customer base. In addition, subsequent to entering into the LAPA with Veracyte in December 2019, we are no longer selling Prosigna kits directly to third parties and are now manufacturing and supplying Prosigna kits exclusively to Veracyte at designated transfer prices, which has and will continue to result in a decrease in revenue and gross margins associated with Prosigna kits, compared to periods prior to entering into the LAPA. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our consumables revenue may continue to increase in future periods, as a result of the growth in sales of GeoMx and CosMx, the introduction of new spatial biology and nCounter consumable products, the continued growth of the installed base of our GeoMx, CosMx and nCounter and future enhancements of our AtoMx SIP and related cloud-based portal data storage and analysis fees.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Revenue Sources</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive service revenue from service contracts, which are purchased by a majority of our customers. Additionally, we selectively provide and generate revenue from services such as TAP or other proof-of-principle studies, which are designed to demonstrate for prospective customers the performance of our existing product platforms and certain new technologies that are under development. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue has been derived historically primarily from our completed collaboration with Lam, and our terminated collaborations with Celgene and Merck. We expect collaboration revenue to remain a significantly smaller portion of our total revenues in future periods due to the conclusion or termination of the substantial majority of our previous collaboration agreements.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Mix and Gross Margin</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product revenue is derived from sales of our spatial biology and nCounter platform instruments and related consumables. Generally, our consumables have higher gross margins than our instruments. Our GeoMx DSP and CosMx SMI instruments contribute a higher average gross margin as compared to our nCounter instruments. There may be fluctuations in sales mix between instruments and consumables from period to period.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future gross margins may vary from period to period depending upon the composition of revenue among our platforms, as well as our overall sales mix. For example, if consumables constitute a larger percentage of total product revenue, such a mix shift may increase our gross margins. Such gross margin increases may be offset by the mix of consumable products sold, the introduction of new instrument product platforms that become increasing components of our product sales, such as CosMx SMI, or investment in additional manufacturing capacity to support the growth of our business. In certain regions outside of the US, we sell through distribution partners who typically receive discounted prices. Future instrument selling prices and gross margins may fluctuate as we grow our volume of distribution partners in geographies outside of the United States, as we introduce new products and reduce our product costs, and from variability in the timing of new product introductions.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to employ other growth strategies in addition to introducing new product platforms, including potentially expanding our sales channel in both direct and distributor territories, developing new consumable content for our product platforms and enhancing certain features of our product platforms.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Years Ended December&#160;31, 2022 and 2021</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;Ended&#160;December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,506)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,262&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,823)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument revenue for the year ended December 31, 2022 decreased as compared to the prior year, due primarily to decreased commercial shipments of GeoMx DSP and nCounter systems. We believe the lower number of GeoMx systems shipped was due primarily to spatial biology market development trends that impacted our mix of system orders, with more CosMx systems ordered by customers than expected, as compared to GeoMx systems. For nCounter, revenue related to our nCounter Pro was stronger, while demand for our older FLEX and Sprint models reduced significantly as compared to the prior year. These revenue decreases were partially offset by revenue realized from initial shipments of our new CosMx SMI system in the fourth quarter of 2022.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables revenue includes sales of consumables for our spatial biology systems and nCounter, and also includes sales of Prosigna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic kits to our partner Veracyte. Consumables revenue decreased for the year ended December 31, 2022 as compared to 2021. This decrease was due primarily to lower nCounter consumables sales, mainly as a result of lower sales to older systems in our installed base, as well as other factors impacting demand in certain territories outside of the United States. The decrease in nCounter consumables sales was partially offset by an increase in spatial biology consumables sales.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenue for the year ended December 31, 2022 increased as compared to 2021, due to increased revenue generated from GeoMx and CosMx TAP and the growth in service contract revenue derived from our increasing installed bases of GeoMx and nCounter systems.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2021 and to a lesser extent during 2022, the COVID-19 pandemic impacted our ability to solicit and fulfill customer orders and record related revenue. While all revenue categories have been impacted due to lab closures and lower customer activity, nCounter-related consumables revenue has been impacted most substantively. A resurgence of COVID-19 or a variant thereof, could recur at any time, with a resulting negative impact on our business. As in the past, we would expect our revenue to be negatively impacted overall, and our consumables revenue to be more severely impacted as consumables revenue more closely correlates with day-to-day customer research activity. However, we cannot predict with any certainty the extent to which any resurgence in COVID-19 or a variant thereof would impact our business and it is possible that the effects of such a resurgence would have different or more severe impacts on our business than we have experienced in the past.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With consideration to these potential negative impacts on our business related to COVID-19, uncertainties arising from geopolitical and other macroeconomic uncertainties, we expect our revenue may continue to increase in future periods, primarily as a result of the shipment of CosMx systems for which we received orders in 2021 and 2022, growth in consumables sales from our increasing installed base of GeoMx and CosMx systems and the introduction of new spatial biology consumables, services, or other products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue; Gross Profit; and Gross Margin</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;Ended&#160;December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,829)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, cost of product revenue decreased as compared to 2021, due primarily to fewer shipments of GeoMx and nCounter systems, as well as decreased volume of nCounter consumable sales as compared to the same periods in prior year. These decreases were partially offset by increased investments made to support our consumable manufacturing capabilities for our spatial biology platforms, increased inventory reserves, and increased costs associated with providing service for our growing installed based of systems.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross margin for the year ended December&#160;31, 2022 decreased compared to 2021, primarily due to the impact of lower product sales volume realized as compared to relatively fixed costs of our manufacturing and operations, particularly costs related to labor and facilities. Certain of these fixed costs were capitalized during the course of 2022, and were subsequently expensed in the fourth quarter coincident with the reduction in force we concluded in November of 2022. In addition, we have experienced increased costs associated with sourcing certain materials and shipping products to our customers. These impacts were partially offset by a favorable mix of consumables revenue relative to our total revenue, as revenue from our consumables generally have higher gross margins compared to our instrument platforms.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our cost of revenue will increase in future periods, given the anticipated growth in sales of our spatial biology platforms, and due to investments in additional field service personnel that provide installation, training and other support services for our product platforms. We also expect to continue to make investments in our operations to support the growth of our business and that may improve our manufacturing efficiency and reduce production costs. We expect these investments and potential cost increases may be partially offset by certain reductions in employee and other operating costs related to our November 2022 reorganization initiatives.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our gross margin on revenue may fluctuate in future periods. Variability will depend in part on the level of our consumables revenue, for which we typically record higher gross margins and operate the manufacturing process directly, as compared to our instrument sales or service revenue, for which we typically record lower margins. Our gross margins may also vary depending on potential expenses we may incur for regulatory compliance, quality assurance or activities and investments related to expansion of our manufacturing capacity or improvements in our manufacturing efficiency. In addition, as business activity continues to recover through the pandemic, the cost and global availability of certain raw materials and other supplies have been impacted. While to date our operations, supply chain or costs have not been materially impacted, our gross margins could be affected in the future by changes in the cost or availability of certain raw materials or supplies. Notwithstanding the foregoing, we expect our gross margins may increase in the longer term as consumable sales become a larger percentage of our total revenue, which will increase utilization of our direct manufacturing facility and certain associated fixed costs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;Ended&#160;December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in research and development expense for the year ended December&#160;31, 2022 is due primarily to higher personnel-related and laboratory supply costs to support product development activities for our spatial biology platforms. In addition, personnel-related costs increased as a result of certain restructuring costs, including severance benefits, related to our reduction in workforce which was initiated in November 2022. These increases were partially offset by the capitalization of certain costs relating to internally developed software and technology, including certain professional fees associated with design and development of our AtoMx SIP.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to invest in product development activities associated with our spatial biology platforms and our AtoMx SIP. We expect research and development expense to increase modestly in future periods, reflecting the impact of increasing investments in our spatial biology and other future projects and technologies.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;Ended&#160;December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in selling, general and administrative expense for the year ended December 31, 2022 as compared to 2021, is due primarily to increased investments made to support our spatial biology-related commercial initiatives, as well as increases in advertising, travel and trade show related activities, investments in software, professional fees and certain one-time expenses associated with our November 2022 reorganization and restructuring initiatives. We have also incurred increased costs during 2022 related to ongoing legal proceedings. These increases were partially offset by lower stock-based compensation costs.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect selling, general and administrative expenses to increase in future periods as the number of sales, technical support, marketing and administrative personnel grows to support the expected growth in our spatial biology business and the introduction of new products and product platforms.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense), net</span></div><div style="margin-bottom:7pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year&#160;Ended&#160;December&#160;31,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,535)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,485%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,043)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,861)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased for the year ended December 31, 2022 as compared to 2021, due primarily to higher investment yields on our short term investments. We continue to maintain a cash preservation investment strategy and, as a result, held the majority of our cash and cash equivalents in money market or other short duration fixed income positions for which yields were very low. While we are beginning to see improvement in interest rates available for investments resulting from the Federal Reserve responding to increasing inflation and other macroeconomic factors, at this time we do not expect to see material increases in our interest income. Interest expense is derived from our Convertible Notes at a fixed rate.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net increased for the year ended December 31, 2022, due primarily to acceleration of amortization related to certain costs associated with capitalized software implementations and related licenses, as well as increased foreign exchange losses associated with the remeasurement of foreign currency transactions into our functional currency of U.S. dollars. These foreign exchange losses were driven primarily by recent volatility in foreign exchange conversion rates associated with the Euro and the British pound sterling.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157,539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents and short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,889&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152,357)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,057)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,780)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Cash Flow</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities in 2022 consisted of our net loss of $159.5 million and net increases in our operating assets and liabilities of $15.2 million, partially offset by $46.2 million of net non-cash income and expense items such as stock-based compensation, depreciation and amortization, non-cash operating lease cost, increased provisions for inventory obsolescence and bad debts and amortization of right-of-use assets.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities in 2021 consisted of our net loss of $115.3 million and net increases in our operating assets and liabilities of $16.5 million, partially offset by $41.2 million of net non-cash income and expense items such as stock-based compensation, depreciation and amortization, increased provisions for inventory obsolescence and bad debts and amortization of right-of-use assets.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our most significant investing activities for 2022 and 2021 were related to the purchase, maturity and sale of short-term investments. Because we manage our cash usage with respect to our total cash, cash equivalents and short-term investments, we do not consider cash flows related to management of our short-term investments to be important to an understanding of our liquidity and capital resources.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022 and 2021, we purchased property and equipment totaling $14.4 million and $6.3 million, respectively, which we believe will be required to support the growth and expansion of our operations. In addition, in 2022 and 2021, we have invested $8.0 million and $2.3 million, respectively, related to the development of software and technology to support AtoMx SIP.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for 2022 and 2021 consisted primarily of $1.4 million and $6.5 million, respectively, of net proceeds from the exercise of stock options and other equity awards and $2.7 million and $2.4 million, respectively, of net proceeds from the issuance of common stock under our Employee Stock Purchase Plan. These proceeds were partially offset by tax withholdings related to the net settlement of restricted stock units of $1.5 million and $2.6 million for 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, and investments are held in a variety of non-interest bearing bank accounts and interest-bearing instruments subject to investment guidelines allowing for holdings in U.S. government and agency securities, corporate securities, taxable municipal bonds, commercial paper and money market accounts. Our investment portfolio is structured to provide for investment maturities and access to cash to fund our anticipated working capital needs. However, if our liquidity needs should be accelerated for any reason in the near term, or investments do not pay at maturity, we may be required to sell investment securities in our portfolio prior to their scheduled maturities, which may result in a loss.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we issued $230.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due 2025, or the Convertible Notes, in a private offering. The Convertible Notes are governed by an indenture dated March 9, 2020 between us and U.S. Bank, National Association, as trustee. The Convertible Notes bear interest at a rate of 2.625% per year, payable semi-annually in arrears on March 1 and September 1, beginning on September 1, 2020.  Upon conversion, the Convertible Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election. We may not redeem the Convertible Notes prior to March 5, 2023, and no sinking fund is provided for the Convertible Notes. The Convertible Notes do not contain any financial or operating covenants or any restrictions on the issuance of other indebtedness or the issuance or repurchase of securities by us. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_139">Note 10. Long-Term Debt</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_139"> </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">Notes to the Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Equity Financings</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we completed an underwritten public offering of 5,750,000 shares of our common stock, including the exercise in full by the underwriters of their option to purchase 750,000 additional shares of common stock. Our total gross proceeds were $230.0 million. After underwriters&#8217; commissions and other expenses of the offering, our aggregate net proceeds were approximately $215.8 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Condition</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have financed our operations primarily through the sale of equity securities, borrowings under term loan agreements and convertible notes, licensing of intellectual property and, to a lesser extent, sales of certain assets. As of December&#160;31, 2022, we held cash, cash equivalents and short-term investments of $196.5 million, compared to $348.9 million as of December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash, cash equivalents and short-term investments, and cash generated from operations will be sufficient to meet these material cash requirements and fund our operating requirements for the next 12 months and beyond, including working capital requirements, capital expenditures and other operational investments.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assessment of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement and involves risks and uncertainties. Any future funding requirements will depend on many factors, including: market acceptance and the level of sales of our existing products and new products; the effect of competing technological and market developments; the effectiveness of our commercial sales and field service organizations; the nature and timing of any additional research, product development or other partnerships or collaborations we may establish; the cost and timing of establishing additional sales, marketing, and distribution capabilities; the cost of our research and development activities; the impact of, and anticipated cost savings resulting from, our November 2022 reorganization and restructuring initiatives; any new developments relating to the COVID-19 or related pandemic and the impact on our customer and operational activity; and the extent to which we acquire or invest in businesses, products and technologies, although we currently have no commitments or agreements relating to any of these types of transactions. We may require additional funds in the future and we may not be able to obtain such funds on acceptable terms, or at all. If we raise additional funds by issuing equity or equity-linked securities, our stockholders may experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any debt or additional equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through partnership, collaboration or licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we are unable to raise adequate funds, we may have to liquidate some or all of our assets; delay or reduce the scope of or eliminate some or all of our research and development programs, launch activities, or commercialization of our products; license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize; reduce marketing, customer support or other resources devoted to our products; or cease operations.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Cash Requirements</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal uses of cash are funding our operations, capital expenditures, working capital requirements and satisfaction of any outstanding obligations under our debt agreements. Our material cash requirements for fiscal 2023 include non-cancelable purchase commitments for long-lead time inventory, research and development items, software development for internal-use projects and property and equipment; lease payments for office, laboratory and manufacturing space; and interest payments related to our convertible notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect capital expenditures to increase in fiscal year 2023, as compared to fiscal 2022, primarily related to additional investments we plan to make in support of our manufacturing capacity and efficiency, and in software development for internal-use projects. As of December 31, 2022, we had future long-term interest payment obligations of $13.1 million, of which $6.0 million is payable within 12 months and total operating and financing lease obligations of $29.3 million, of which $7.1 million is payable within 12 months. In addition, our purchase commitments as of December 31, 2022 are $70.0 million, of which $62.1 million is payable within 12 months. We also have non-cancellable construction contracts, associated with one of our Seattle area facilities, of $5.0 million, which is due within 12 months. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_124">Note&#160;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_124">. Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_139">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_139">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_139">. Long-term Debt</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_157">Note</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_157"> 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_157">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_157">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_157"> Commitments and Contingencies</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">Notes to the Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material cash requirements may increase in the future as we invest in working capital to support the growth of our spatial biology platforms, research and development related to existing or new product platforms, and manufacturing capacity, sales and marketing and administrative activities. We cannot be certain our revenue will grow sufficiently to offset our operating expense increases. As a result, we may need to raise additional funds to support our operations, and such funding may not be available to us on acceptable terms, or at all. If we are unable to raise additional funds when needed, our operations and ability to execute our business strategy could be adversely affected.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_76"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations are based upon our financial statements which have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities, revenue and expenses at the date of the financial statements. Generally, we base our estimates on historical experience and on various other assumptions in accordance with GAAP that we believe to be reasonable under the circumstances. Actual results may differ from these estimates.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies and estimates are those that we consider the most important to the portrayal of our financial condition and results of operations because they require our most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Our critical accounting policies and estimates include those related to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenue recognition;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stock-based compensation;</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inventory valuation; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income taxes.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate the majority of our revenue from sales of products and services. Our products consist of our spatial biology and nCounter Analysis System platforms and related consumables. Services consist of instrument service contracts and service fees for assay processing.</span></div><div style="margin-bottom:6pt;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration expected to be received in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once control of a product or service has transferred to the customer, meaning the customer has the ability to use and obtain the benefit of the product or service. Revenue is recognized for satisfied performance obligations only when there are no uncertainties regarding payment terms or transfer of control.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from instruments and consumables, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic kits, is recognized generally upon shipment to the end customer, which is when control of the product has been transferred to the customer. Performance obligations related to instrument sales are reviewed on a contract-by-contract basis, as individual contract terms may vary, and may include installation and calibration services. Such services can also be provided by our distribution partners and other third parties.  Performance obligations for consumable products are generally completed upon shipment to the customer.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument service contracts are sold with contract terms ranging from 12-36 months and cover periods after the end of the initial 12-month warranty. These contracts include services to maintain performance within our designed specifications and a minimum of one preventative maintenance service procedure per year during the contract term. Revenue from services to maintain designed specifications is considered a stand-ready obligation and recognized evenly over the contract term and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">service revenue related to preventative maintenance of instruments is recognized when the procedure is completed. Revenue from service fees for assay processing is recognized upon the rendering of the related performance obligation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements with multiple performance obligations, we allocate the contract price in proportion to each performance obligation&#8217;s stand-alone selling price. We use our best estimate of stand-alone selling price for our products and services based on historical sales and adjusted for similar products, geographies, and differences in customers and review our stand-alone prices annually.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales to customers through distributors are recognized consistent with the policies and practices for direct sales to customers, as described above.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically entered into collaboration agreements that may generate upfront fees, and may enter into such agreements in the future, and in some cases subsequent milestone payments that may be earned upon completion of certain product development milestones or other designated activities. We are able to estimate the total expected cost of product development and other services under these arrangements and recognize collaboration revenue using a contingency-adjusted proportional performance model. Costs incurred to date compared to total expected costs are used to determine proportional performance, as this is considered to be representative of the delivery of outputs under the arrangements. Revenue recognized at any point in time is limited to cash received, amounts contractually due, or the amounts of any product development or other contractual milestone payments when achievement of a milestone is deemed to be probable. Changes in estimates of total expected collaboration product development or other costs are accounted for prospectively as a change in estimate.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for stock-based compensation at fair value. Stock-based compensation costs for restricted stock units, or RSUs, and for performance stock units, or PSUs, are recognized based on their grant date fair value estimated using the intrinsic method. Stock-based compensation costs for stock option awards are recognized based on their grant date fair value estimated using the Black-Scholes option pricing model. Stock-based compensation expense recognized in the consolidated statements of operations is based on awards ultimately expected to vest using actual forfeitures when incurred. We use the straight-line method of allocating compensation cost over the requisite service period of the related award, for awards with only service-based vesting requirements. For awards with service and performance-based vesting requirements, we use an accelerated method of allocating compensation cost, over the vesting period. The percentage achievement and vesting of PSU awards are contingent upon the achievement of predetermined performance goals, which include tiered revenue targets. We record compensation expense over the estimated service period for each performance goal when we believe the performance goal is considered probable, which we assess at each reporting date. Once a performance goal is considered probable, we record compensation expense ratably over the estimated service period. Any updates to our estimates during the service period are recorded cumulatively and remaining compensation expense, if any, is recognized over the remaining estimated service period.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have transitioned from granting stock options awards to primarily granting RSUs and PSUs, however, we may grant stock options in the future. Determining the fair value of stock-based awards at the grant date under the Black-Scholes option pricing model requires judgment, including estimating the value per share of our common stock, risk-free interest rate, expected term and dividend yield and volatility. The assumptions used in calculating the fair value of stock-based awards represent our best estimates based on management judgment and subjective future expectations. These estimates involve inherent uncertainties. If any of the assumptions used in the Black-Scholes option pricing model significantly change, stock-based compensation for future awards may differ materially from the awards granted previously.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory&#160;Valuation</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of raw materials, certain component parts to be used in manufacturing our products, and finished goods. Inventory is stated at the lower of cost or market. Cost is determined using a standard cost system, whereby the standard costs are updated periodically to reflect current costs and market represents the lower of replacement cost or estimated net realizable value. We record adjustments to inventory for potentially excess, obsolete, slow-moving, or impaired items. The business environment in which we operate is subject to rapid changes in technology and customer demand. We regularly review inventory for excess and obsolete products and components taking into account product life cycle and development plans, product expiration and quality issues, historical experience, and our current inventory levels. If actual market conditions are less favorable than anticipated, additional inventory adjustments could be required.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the liability method. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine whether a tax position is more likely than not to be sustained upon examination based on the technical merits of the position. For tax positions meeting the more-likely-than-not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_79"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding recent accounting pronouncements, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_115">Note&#160;2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">Notes to the Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_82"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A. &#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including changes in commodity prices and interest rates. Market risk is the potential loss arising from adverse changes in market rates and prices. Prices for our products are largely denominated in U.S. dollars and, as a result, we do not face significant risk with respect to foreign currency exchange rates.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, our exposure to market risk has been primarily limited to interest income sensitivity, which is affected by changes in the general level of U.S. interest rates, particularly because the majority of our investments are in short-term debt securities. The primary objective of our investment activities is to preserve principal while at the same time maximizing the income we receive without significantly increasing risk. To minimize risk, we maintain our portfolio of cash, cash equivalents and short-term investments in a variety of interest-bearing instruments, which have included U.S. government and agency securities, high-grade U.S. corporate bonds, asset-backed securities and money market funds. Declines in interest rates, however, would reduce future investment income. A 10% decline in interest rates, occurring on January&#160;1, 2023 and sustained throughout the period ending December&#160;31, 2023, would not be material.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Convertible Notes are based on a fixed rate; accordingly, we do not have economic interest rate exposure on the Convertible Notes. However, changes in interest rates could impact the fair market value of the Convertible Notes. Generally, the fair market value of the fixed interest rate of the Convertible Notes will increase as interest rates fall and decrease as interest rates rise. In addition, the fair market value of the Convertible Notes fluctuates when the market price of our common stock fluctuates. As of December&#160;31, 2022, the fair market value of the Convertible Notes was $182.9 million and was determined based on the estimated or actual bid prices of the Convertible Notes in an over-the-counter market. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to expand internationally our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Historically, a majority of our revenue has been denominated in U.S. dollars, although we sell our products and services directly in certain markets outside of the United States denominated in local currency, principally the Euro and the British pound sterling. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States. The effect of a 10% adverse change in exchange rates on foreign denominated cash, receivables and payables would not have been material for any of the periods presented. As our operations in countries outside of the United States grow, our results of operations and cash flows will be subject to potentially greater fluctuations due to changes in foreign currency exchange rates</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including as a result of the COVID-19 pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To date, we have not entered into any foreign currency hedging contracts although we may do so in the future.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation Risk</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have experienced increased operating costs in recent periods, which we believe are due in part to the recent growth in inflation, we do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could adversely affect our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NANOSTRING TECHNOLOGIES, INC.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page(s)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_88">Reports of Ernst &amp; Young LLP, Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV84NS9mcmFnOjAzYTU5Y2M0ZGRmMDQyMjc5NDQ3MTBmNWRkMjY0MDBjL3RhYmxlOjM3MWIwNWU0NmZjYzRhNjBiMjhkMjYwM2Q3NmQ0NjgyL3RhYmxlcmFuZ2U6MzcxYjA1ZTQ2ZmNjNGE2MGIyOGQyNjAzZDc2ZDQ2ODJfMi0wLTEtMS00ODkwNi90ZXh0cmVnaW9uOmRmMjhmNmU2NTQ3ZjQ0ZDg5NDQ0ZWU1NGI4MDU2NmQ4Xzkx_887321ff-3c01-43f6-8bd7-fd97643ed23d">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_88">69</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_94">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_94">72</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_97">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_97">73</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_100">Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_100">74</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_103">Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_103">75</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_106">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_106">76</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_109">78</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of NanoString Technologies, Inc.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of NanoString Technologies, Inc. (the Company) as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, changes in stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2022, and the related notes  (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February&#160;28, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-bottom:7pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue Recognition &#8211; Allocation of Transaction Price to Performance Obligations</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As described in Note 2 to the consolidated financial statements, the Company&#8217;s contracts for instrument sales commonly include a combination of the instrument, consumables and services. For those arrangements with multiple distinct performance obligations, the Company allocates the total contract price to each distinct performance obligation based on relative stand-alone selling price. The Company uses its best estimate of relative stand-alone selling price for its products and services based on historical sales data.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auditing the Company&#8217;s revenue recognition was complex, specifically related to the effort required to test the accounting for contracts with multiple performance obligations. This included the identification of the distinct performance obligations, determination of the stand-alone selling price and allocation of the transaction price to the distinct performance obligations.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:7pt;margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the Company&#8217;s controls to determine the distinct performance obligations, stand-alone selling price of each distinct performance obligation and the allocation of the transaction price to the distinct performance obligations.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To test the revenues recognized for contracts with multiple performance obligations, our audit procedures included, among others, reading a sample of executed contracts to understand the terms and conditions, evaluating the Company&#8217;s identification of the distinct performance obligations, and testing the Company&#8217;s allocation to the distinct performance obligations. To test management&#8217;s determination of relative stand-alone selling price for each distinct performance obligation, our audit procedures included, among others, performing sensitivity analysis, assessing the appropriateness of the methodology applied and testing the reliability and mathematical accuracy of the underlying data and calculations.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV84OC9mcmFnOjlkM2IwNjQ0YjQ2ZjRhNDc5YzYyZmViN2UyYzYwMzI5L3RleHRyZWdpb246OWQzYjA2NDRiNDZmNGE0NzljNjJmZWI3ZTJjNjAzMjlfNzY0MQ_0d0dcb71-87d5-41b2-a6af-c7f2b60d123e">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV84OC9mcmFnOjlkM2IwNjQ0YjQ2ZjRhNDc5YzYyZmViN2UyYzYwMzI5L3RleHRyZWdpb246OWQzYjA2NDRiNDZmNGE0NzljNjJmZWI3ZTJjNjAzMjlfNzY0NA_ca659b39-b3cb-4dc1-9a15-6429ce0061db">Seattle, Washington</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of NanoString Technologies, Inc.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited NanoString Technologies, Inc.&#8217;s internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), (the COSO criteria). In our opinion, NanoString Technologies, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2022, based on the COSO criteria.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, changes in stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2022, and the related notes and our report dated February&#160;28, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:12pt;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands,&#160;except&#160;par&#160;value<br/>amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNS0xLTEtMS00ODkwNg_849ac9de-2334-41d8-a86f-3ad061ad79a7">112,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNS0zLTEtMS00ODkwNg_bfe07c9c-fd8c-4f8b-ac4f-89bc75b3c301">107,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0xLTEtMS0xMDE0Nzc_b365a849-bd7c-43ca-bb23-131549f0dba8">898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0zLTEtMS0xMDE0ODU_c66ce6dc-393d-498f-9eca-62b6bf40964e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="nstg:DebtSecuritiesAndEquitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0xLTEtMS00ODkwNg_5f0d253b-f899-4800-af09-44c7a20382ef">84,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="nstg:DebtSecuritiesAndEquitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0zLTEtMS00ODkwNg_11532d76-f47d-43f8-977c-f998a06ba2f1">241,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNy0xLTEtMS00ODkwNg_d86165f6-65ec-4749-aaa9-fae1054560bf">31,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNy0zLTEtMS00ODkwNg_013e20ad-0c1b-475d-8c12-d25121e58939">40,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOC0xLTEtMS00ODkwNg_251e5c18-1c17-4f24-a867-520a22def87c">43,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOC0zLTEtMS00ODkwNg_3d17e443-1fd2-4ce3-9bec-fec0fac7d8a7">31,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOS0xLTEtMS00ODkwNg_e18b5475-748f-4ef8-b835-6f198652bc4f">14,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOS0zLTEtMS00ODkwNg_a5fec996-976a-4033-9180-79f8b2abd4db">7,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTAtMS0xLTEtNDg5MDY_ceb9463d-417f-4537-b95b-0e301c52cb2f">286,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTAtMy0xLTEtNDg5MDY_ed269ca9-e4cf-4be1-a497-c1db0c85b34a">427,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTEtMS0xLTEtNDg5MDY_3f8b0d62-1e24-454d-bd33-52d88bc3afa9">44,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTEtMy0xLTEtNDg5MDY_ec33c86f-8c91-4ffa-8dec-36fa988a5b79">27,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTItMS0xLTEtNDg5MDY_01f60487-5e88-4eba-b1e7-0f60ea81afe6">17,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTItMy0xLTEtNDg5MDY_fefdd299-d706-455d-bd03-1027dfadddc0">19,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTMtMS0xLTEtNDg5MDY_48ae6c8c-f118-4250-994d-9972a54ce684">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTMtMy0xLTEtNDg5MDY_a070f8c4-994f-49c4-a7ab-e5d74040ec6f">5,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTQtMS0xLTEtNDg5MDY_5ededa6a-7504-4a1f-8342-6a2c43ee7cfc">353,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTQtMy0xLTEtNDg5MDY_0658fcaf-a49c-487e-8441-56d8313146f4">479,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTctMS0xLTEtNDg5MDY_07e3145b-28a5-4a4d-a142-fa5c41d74178">16,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTctMy0xLTEtNDg5MDY_da843ef3-85ec-4ad6-9273-0b4f4b9c5e95">14,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTgtMS0xLTEtNDg5MDY_049ded09-1eb3-4cfb-83e7-356a51d3aadf">7,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTgtMy0xLTEtNDg5MDY_781d2962-19e8-4a89-bb36-9066a289e698">6,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and other employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTktMS0xLTEtNDg5MDY_16fe9bec-5053-48c5-836b-f12ca8a233a9">17,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTktMy0xLTEtNDg5MDY_e86c06b1-da75-4351-ae7d-8cb7d8552175">17,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjAtMS0xLTEtNDg5MDY_cf8ec8fa-031e-4b3e-aab2-f30a5f2e7582">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjAtMy0xLTEtNDg5MDY_629338e3-e81f-42fc-a9b1-67151ac50b82">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue and other liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjEtMS0xLTEtNDg5MDY_a0338993-5cea-45c3-a698-fa1497675e92">9,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjEtMy0xLTEtNDg5MDY_35d693cf-19d3-402c-bed5-c8d79863d5d9">7,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjItMS0xLTEtNDg5MDY_18046887-21ab-4c98-9d79-edf1be71f846">5,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjItMy0xLTEtNDg5MDY_e9009f90-ae5c-4621-8f33-128a0582a61a">4,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjMtMS0xLTEtNDg5MDY_7d9848d9-bd59-43b1-9eed-5f925f40053f">58,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjMtMy0xLTEtNDg5MDY_e2d95d7e-44d3-43ba-a253-a076127a0289">52,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue and other liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjQtMS0xLTEtNDg5MDY_44cca372-2dc7-4742-9c88-e927902cf471">3,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjQtMy0xLTEtNDg5MDY_be733fad-d744-4479-911d-bce3d30841aa">3,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjUtMS0xLTEtNDg5MDY_3d613be7-34a2-4ab0-b79d-08aca3d83c3e">226,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjUtMy0xLTEtNDg5MDY_ff323046-4744-4d63-b94a-0f38b3c12ac2">225,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjYtMS0xLTEtNDg5MDY_330e48c0-c0a9-4f96-b1c9-14c7728a42ae">18,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjYtMy0xLTEtNDg5MDY_fe36d1b3-305a-4ed2-a1b6-3f2bf9a6a087">21,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjctMS0xLTEtNDg5MDY_b4a45e62-969a-4857-b5fe-b8ca4142aac2">307,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjctMy0xLTEtNDg5MDY_2662e059-fb67-4fc2-8947-af124e618198">302,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjgtMS0xLTEtNDg5MDY_b9f4b839-b02a-4855-acee-281bd8164617"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjgtMy0xLTEtNDg5MDY_70f424e0-5235-413e-8356-d7caa8c7f9eb"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8yMQ_8d931896-bbb6-499a-9749-2053ecac3c76"><ix:nonFraction unitRef="usdPerShare" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8yMQ_a7144921-14ed-4888-931e-369a57f8b458">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8zNQ_5c7d3d28-e2a0-4cf2-90b1-29f78178d6c8"><ix:nonFraction unitRef="shares" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8zNQ_6eb21f7a-02d9-4bc3-8614-6bc03995af69">15,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl81Nw_06f32b9a-e83a-4ab6-8089-4a8489782e5d"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl81Nw_df2c446d-bdee-45cf-8d73-acb0661b50c7">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMS0xLTEtNDg5MDY_51a17315-61db-4b33-a58f-1bb7d8dcb46d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMy0xLTEtNDg5MDY_385c091f-6b04-4421-8317-40293df8e168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8xOA_377fa6ff-a2b5-4a72-9498-1fbb9c8e72c4"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8xOA_a3043dd7-25ad-4500-ac16-1cedf0faa7bd">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8zMg_5a8ffb91-4d2c-41be-86dd-40e04db76d57"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8zMg_d203e568-26a5-4619-b725-29bb40308eed">150,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl81NA_10566667-f413-4e9d-8661-a63792166c7b"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl81NA_b05e8adb-71b1-436d-b427-eadd69acd544">46,719</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl82MQ_9ff25f12-9f90-4143-a55b-3613e8ec2ea8"><ix:nonFraction unitRef="shares" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl82MQ_e3702523-6dc7-4052-954d-92923078a9ca">45,729</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMS0xLTEtNDg5MDY_38481718-9e3d-4823-bf10-1bee7436090c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMy0xLTEtNDg5MDY_a2fd263c-736b-445e-911e-739631da2eee">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzItMS0xLTEtNDg5MDY_22b3ac29-ad81-4b80-9008-dd5a9f578d5f">855,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzItMy0xLTEtNDg5MDY_a3ecaa90-4284-47dd-ada3-cb4f0ff086f7">827,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzMtMS0xLTEtNDg5MDY_6e5cb5dd-00b6-4523-9e96-3dabb1c584c6">589</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzMtMy0xLTEtNDg5MDY_32829164-939b-42e9-8884-59748552f8ed">318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzQtMS0xLTEtNDg5MDY_b00e5d25-8b2a-4315-95c8-b74182903c68">809,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzQtMy0xLTEtNDg5MDY_5bfeff87-1118-423e-8bf8-87c5ed48f654">649,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzUtMS0xLTEtNDg5MDY_16801bbc-9e15-4205-afab-762787e25661">45,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzUtMy0xLTEtNDg5MDY_01f3287f-e02f-47f3-b3c8-953af8c32ef7">176,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzYtMS0xLTEtNDg5MDY_f5187ac1-c6dc-4687-af8e-b049862a680f">353,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzYtMy0xLTEtNDg5MDY_ed08f806-1d2b-4a1c-8bd6-663b311a4acf">479,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:64.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands,&#160;except&#160;per&#160;share&#160;amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNC0xLTEtMS00ODkwNg_ec9118db-e814-4e1f-a26d-6cac248a3651">107,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNC0zLTEtMS00ODkwNg_6d022805-34b9-4f3c-b051-f69dcc0cae6f">127,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNC01LTEtMS00ODkwNg_b45265e7-13b7-46da-bdf4-8f1c38ea1a5a">97,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNS0xLTEtMS00ODkwNg_a8ef693d-8710-4d29-92ba-71c55e6fe1b6">19,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNS0zLTEtMS00ODkwNg_905207b1-3146-430c-9613-12ae12c2152a">17,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNS01LTEtMS00ODkwNg_ff3af847-3745-4a40-84b9-df760353b217">19,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNy0xLTEtMS00ODkwNg_344da33f-7045-4259-958c-dfee126b5280">127,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNy0zLTEtMS00ODkwNg_d2cd6443-147a-4f74-bf72-da343f2a2196">145,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNy01LTEtMS00ODkwNg_82ea41af-42f0-4a9b-99cf-519c3668e48f">117,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfOS0xLTEtMS00ODkwNg_870f13d1-aec5-4659-b962-81a71f3faaba">50,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfOS0zLTEtMS00ODkwNg_1c078074-26a6-4fae-9385-fce5342177a9">53,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfOS01LTEtMS00ODkwNg_9ede7b9f-28b8-4bac-b0b3-b012f031a5c7">45,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTAtMS0xLTEtNDg5MDY_5e4a71b1-d647-431f-8938-8baa36054974">15,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTAtMy0xLTEtNDg5MDY_8cf2921d-7cf5-4d96-abc5-8eb0ea7951f5">14,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTAtNS0xLTEtNDg5MDY_ec2af9ba-aaef-46ce-93d0-e0270179c03d">7,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTEtMS0xLTEtNDg5MDY_4264c2f6-569d-4c2a-8a55-c1d49c4c2f74">65,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTEtMy0xLTEtNDg5MDY_2642bbf9-b03d-4d26-aa01-5077258c5d20">68,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTEtNS0xLTEtNDg5MDY_a76304e0-f988-4c3a-96fd-0314eb9611af">52,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTItMS0xLTEtNDg5MDY_0d9a12aa-1165-43b9-b92b-47ecd4b73611">70,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTItMy0xLTEtNDg5MDY_e2cdc77c-b98b-4604-bfa9-7e1c57313584">69,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTItNS0xLTEtNDg5MDY_c8fbf110-a611-4944-badc-44d9f3695552">62,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTMtMS0xLTEtNDg5MDY_60e349ff-3d81-4285-9f0e-bfd8031f6d0b">143,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTMtMy0xLTEtNDg5MDY_304badf8-41ae-48cf-90a5-f3b2e862baee">115,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTMtNS0xLTEtNDg5MDY_c9616602-eb38-4956-9030-4b4d7172c956">90,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTQtMS0xLTEtNDg5MDY_b97c0e40-b5da-4550-94a7-ec1efcc9e3e6">279,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTQtMy0xLTEtNDg5MDY_86d7d955-fffa-47bc-a4c5-1d888e7a7ddf">253,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTQtNS0xLTEtNDg5MDY_8d420322-dfb8-4231-9ef9-5b95c0f17962">205,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTUtMS0xLTEtNDg5MDY_ca0f4145-11c3-4466-bb1e-b754f3e31b52">152,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTUtMy0xLTEtNDg5MDY_99211532-33d0-41d6-8294-b359487bf0a0">108,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTUtNS0xLTEtNDg5MDY_7a0e4af2-6179-4b23-a509-367cf8f657b1">88,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTktMS0xLTEtNDg5MDY_924e9acc-0ffa-44f8-954e-d53e23516199">2,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTktMy0xLTEtNDg5MDY_ba8669fe-69b7-4949-8650-ff939c7dd545">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTktNS0xLTEtNDg5MDY_54d04c4a-ba87-4ef4-a37c-8cd1e5d32db8">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjAtMS0xLTEtNDg5MDY_03d8a96b-4888-41dd-a783-f81309d8542a">7,535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjAtMy0xLTEtNDg5MDY_d55c0870-3946-42f4-b930-6be93212021c">7,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjAtNS0xLTEtNDg5MDY_641453e3-4d50-455f-bb89-71ad7aee6d6e">15,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMS0xLTEtNDg5MDY_9e9a276d-b010-44c8-ad58-c0d36eeffb92">1,917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMy0xLTEtNDg5MDY_4855e7ad-2b61-4852-a0eb-8f0a500f5d7e">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtNS0xLTEtNDg5MDY_21186b74-a572-4f85-b4f3-8809f04aa9b6">971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt and termination of revolving loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:GainLossOnExtinguishmentAndTerminationOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMS0xLTEtNzA3NzU_a4533da7-4dda-4cfe-ba22-fbee5a6c872a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:GainLossOnExtinguishmentAndTerminationOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMy0xLTEtNzA3NzU_6757c261-9df9-4c56-9c98-4598fcda4db8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="nstg:GainLossOnExtinguishmentAndTerminationOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtNS0xLTEtNzA3NzU_f024d077-6aec-48a9-9e86-9e3cdd4c7ce9">7,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjItMS0xLTEtNDg5MDY_073e8e73-544e-420b-9997-b86d4da0066d">7,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjItMy0xLTEtNDg5MDY_0c27c8e3-db9c-420b-a8f8-b4ef12121666">6,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjItNS0xLTEtNDg5MDY_29d786bc-20ea-419a-b9cc-76a8e735a85c">21,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjMtMS0xLTEtNDg5MDY_a1e575f0-20d4-4a91-81c1-f0a47c685504">159,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjMtMy0xLTEtNDg5MDY_e6db8bbc-448f-43a4-a173-6b2598049fad">115,087</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjMtNS0xLTEtNDg5MDY_09aa941e-c199-4ed0-adc7-1a009f59ad1c">109,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjQtMS0xLTEtNDg5MDY_52abb126-083a-454e-86a6-5ddfdf6f5df2">317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjQtMy0xLTEtNDg5MDY_6e742530-c631-4fdc-bdf3-ddbfabf3af7d">167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjQtNS0xLTEtNDg5MDY_469075e1-99de-415d-ad20-8f179a21b038">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjUtMS0xLTEtNDg5MDY_5f95fbd1-aa02-4531-85e5-458ab616dc7d">159,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjUtMy0xLTEtNDg5MDY_3d3799eb-0fdc-4d25-a079-b5922a0eb225">115,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjUtNS0xLTEtNDg5MDY_8b8d7e84-956f-4bcc-abb5-aaca4bc53c29">110,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share&#8212;basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMS0xLTEtNDg5MDY_5e51b840-32db-4c1e-bc42-abcfc6c072bd"><ix:nonFraction unitRef="usdPerShare" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMS0xLTEtNDg5MDY_8a92e521-aa12-4eea-b6d2-8a1f05b15d6b">3.44</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMy0xLTEtNDg5MDY_72fed3b0-037a-4af8-97a5-c9ca11f23cc8"><ix:nonFraction unitRef="usdPerShare" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMy0xLTEtNDg5MDY_f6c0d721-06e5-47b2-899c-b2ff9aca458e">2.54</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtNS0xLTEtNDg5MDY_68963622-ce3a-4cf4-8ecb-298a0be6a14f"><ix:nonFraction unitRef="usdPerShare" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtNS0xLTEtNDg5MDY_af464dba-eb02-4020-8344-888e9d2eb8d8">2.82</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing basic and diluted net loss per share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMS0xLTEtNDg5MDY_03329ca3-6224-4030-9f90-69a7107451c2"><ix:nonFraction unitRef="shares" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMS0xLTEtNDg5MDY_3e60c997-2e9b-4718-aa17-deb1a08e1100">46,406</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMy0xLTEtNDg5MDY_3b7daeb4-97fc-4e6e-9de9-db841b0c9e3f"><ix:nonFraction unitRef="shares" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMy0xLTEtNDg5MDY_4ba2fda5-2f4e-4ab6-98a5-2375eea6d11d">45,299</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctNS0xLTEtNDg5MDY_92947a73-b835-4cd6-b561-89e8f6d73c6e"><ix:nonFraction unitRef="shares" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctNS0xLTEtNDg5MDY_d8306f36-6e80-48cd-bc05-aaaa4174b37f">39,083</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzMtMS0xLTEtNDg5MDY_f098db0a-8130-4108-bd5b-0d7d46a8c860">159,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzMtMy0xLTEtNDg5MDY_242a0a55-5ecb-43da-aeb9-8c865b07a077">115,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzMtNS0xLTEtNDg5MDY_f4da29e6-dc4c-4266-80e9-17db59b6c6d4">110,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized loss on available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzUtMS0xLTEtNDg5MDY_0d4f616b-8a8c-45ba-966d-8811454e3b1f">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzUtMy0xLTEtNDg5MDY_747b2a5d-bb92-491f-9408-9cbc37cc3f40">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzUtNS0xLTEtNDg5MDY_da1699d6-6ad0-4858-8dbf-ba1cd638d5e2">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzYtMS0xLTEtNDg5MDY_86bd0468-7a64-4e54-86f8-2c80d1ed3553">159,814</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzYtMy0xLTEtNDg5MDY_444626ee-0ee2-4ba3-aad7-80f2b753da71">115,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzYtNS0xLTEtNDg5MDY_763ea2dd-e531-474c-a3dd-35814bf762f6">110,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Stockholders&#8217; Equity</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.345%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive Income<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6fb5a9c83554516897179bdc578a26e_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtMS0xLTEtNDg5MDY_c06e6fbd-09f5-4457-9478-7348fb4185c1">36,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fb5a9c83554516897179bdc578a26e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtMy0xLTEtNDg5MDY_8a679a03-9b8c-41a8-88cf-712b9004b63d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d76b57e37a47d9993ee86018d00cce_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtNS0xLTEtNDg5MDY_15e9eb40-a446-4fd1-9c9a-9c9ebd1da371">535,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69d192ea60b4dd99f62ed25f1930652_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtNy0xLTEtNDg5MDY_b12ef64f-9603-451c-82d2-a7abb3efff32">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dcc651b739c4a8797ff28c930d6411a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtOS0xLTEtNDg5MDY_a59db6d1-3fe8-4c32-9a35-3ce4772b15ae">431,952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtMTEtMS0xLTQ4OTA2_fef26843-9ff4-4219-8b9b-ff175b0103ed">104,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtMC0xLTEtOTk0MzAvdGV4dHJlZ2lvbjo5NmNhNmRiMTUzY2Q0OGViOTM3YjlmNmM0YTA4NTk2Y18zMjk4NTM0ODgzMzk0_f2b67079-f367-4db7-a297-93f7a816e08b">14.2</ix:nonFraction> million</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtMS0xLTEtOTk0MzM_128a7e3b-62c0-472b-b26b-492dc97fa565">5,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtNS0xLTEtOTk0NDU_ef6cae17-ff0a-4b53-9eaf-46606913e180">215,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtMTEtMS0xLTk5NDYx_0ca04135-e912-4055-98a9-65da40f66875">215,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of convertible notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzUtNS0xLTEtOTg1ODQ_b31175a2-0795-4ad8-9bb4-2bc59d0d53fe">58,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzUtMTEtMS0xLTk5NDAy_25e1a3c9-a044-4d80-b8f9-f4b3ab9a5899">58,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for stock options and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzYtMS0xLTEtOTgzNTg_aaf7948d-23ef-4776-912c-11ea9b363ac2">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzYtNS0xLTEtOTgzNTg_9880bf83-c875-4f65-9445-3d2a1d1eb928">18,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzYtMTEtMS0xLTk5NDA0_e48fa4e6-a425-47c3-a3d4-c1acb5974e2c">18,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzctMS0xLTEtNDg5MDY_cb87175d-4eba-4c32-be7d-d6d72ecaa04d">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzctNS0xLTEtNDg5MDY_f327b0ce-65ed-47c3-9e20-9c46b6f3c4d1">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzctMTEtMS0xLTQ4OTA2_f3edb304-8992-4cc1-b80f-17fec4a6a803">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktNS0xLTEtOTg3NDg_cc615a83-f2e6-4b8d-9aa8-08412b25f78a">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzgtMTEtMS0xLTk5NDY3_cbe3121b-bcf2-44aa-9b16-452f89ba4682">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net exercise of common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktMS0xLTEtOTg4MDc_7d4c1179-0f63-483f-9309-2c787deb32b2">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktMTEtMS0xLTk5NDY5_7d9b3cd9-b0fa-4db9-a736-a701295aa97c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholdings related to net share settlements of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzgtNS0xLTEtNDg5MDY_03ed6629-c397-4989-a15c-adb2a17834ad">2,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzgtMTEtMS0xLTQ4OTA2_1ed09313-cd7c-4607-a05f-905376e1c800">2,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktNS0xLTEtOTg0MjM_ddf5cead-708c-4019-b75b-ce9e4d73b230">18,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTExLTEtMS05OTU1MA_87208b08-80d9-4eb5-b2f8-55b0753f7e3c">18,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id90f105c4d55494b94cc0ab76173b5fc_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTktMS0xLTk4NDIz_27d9e180-b58f-47a8-bcef-1d3c8d6b7ade">110,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTExLTEtMS05OTQ3NQ_bb8ddac6-86b4-4a2e-9e08-cd585710039d">110,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b9f3b07c6934ad3a071ba90567014cb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktNy0xLTEtNDg5MDY_f6da655f-7092-41aa-8a11-8b9667305166">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktMTEtMS0xLTQ4OTA2_37ce9c4a-7eeb-4200-861f-2084a5baa1b6">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76e439fcce3243a282b799121be03534_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTEtMS0xLTk4MTUw_c2d17223-9dbc-4ef8-8fd8-370c15d7cf72">44,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e439fcce3243a282b799121be03534_I20201231" decimals="3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTMtMS0xLTk4MTUw_3601315b-e7ba-4a55-a158-46668539dcd1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d3517a5cd04697bc20f69fca9c1aea_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTUtMS0xLTk4MTUw_2e57f07f-7776-409a-a3fc-77662da94231">848,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f27c9fc5a14f6a9ad7a0207ca76205_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTctMS0xLTk4MTUw_0b183513-3f2a-4cfd-862b-3c11c8f7f51f">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i340b839d193a417b9994bc351dbdcd6c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTktMS0xLTk4MTUw_20bd5890-852f-4a59-8849-927d130e064e">542,030</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTExLTEtMS05ODE5OA_25cacfcd-2731-48a7-a273-4f35a40a463e">306,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc30b4ddea0947eeadd32b726a42601a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE1LTUtMS0xLTk4OTUz_d09d45e0-2cc6-431f-9403-5dff36974a24">58,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4679a98afee44ff854f9a3fe34a94e3_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE1LTktMS0xLTk4OTY1_6cc09835-f89e-4c19-bc6b-23087a3ea4ca">7,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21fa537a67cc4008a5f886347dd4fca6_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE1LTExLTEtMS05OTQ5OA_036fc3ad-727f-492c-827f-49bf56e02a51">51,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for stock options and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTEtMS0xLTQ4OTA2_1bb3f26e-d176-43ee-956c-7198036db5ee">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTMtMS0xLTQ4OTA2_737b4d4c-e58a-4599-871e-25603c743d97">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTUtMS0xLTQ4OTA2_82b40bae-79c0-4618-902c-5c8ed2c15abb">6,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTExLTEtMS00ODkwNg_0529c575-006d-4b9d-a40a-28172fbbe5fc">6,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholdings related to net share settlements of restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231" decimals="3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE5LTUtMS0xLTk5MDQx_e05019e6-67bf-454d-a5ea-d85a0c036c53">2,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE3LTExLTEtMS05OTUwNg_1bccc5df-35ad-4d16-be02-1e4c776471be">2,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTEtMS0xLTQ4OTA2_1113f970-9046-4f4b-945b-1b9a571859bd">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTUtMS0xLTQ4OTA2_755d28e8-2168-4542-a8a7-f88d1e69e123">2,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTExLTEtMS00ODkwNg_aaf8dc3c-e8fd-448f-877a-e5bcf03d6088">2,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIyLTUtMS0xLTQ4OTA2_4606b9e9-fce4-49de-a3e1-44b799d9e5a9">30,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIyLTExLTEtMS00ODkwNg_ad4aa1d6-04fc-4e84-908d-135cb88cc7ca">30,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1a626949d3a48359028bdd61bb4b96f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIzLTktMS0xLTQ4OTA2_32d359ce-8b7e-4793-8f32-4114a40847ef">115,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIzLTExLTEtMS00ODkwNg_50489fa7-212a-4e6d-991d-bf895ace4137">115,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c1797d70c2647f984286d05d5bef521_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI1LTctMS0xLTQ4OTA2_58f33def-2674-4f58-b34c-3622e92087cf">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI1LTExLTEtMS00ODkwNg_f50920ec-c35e-461b-bff8-5c3efac83e08">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95a95c99a0394cb69b14efb2f1306862_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTEtMS0xLTQ4OTA2_59c843a4-afe5-4dd4-83b1-14dfb196973a">45,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a95c99a0394cb69b14efb2f1306862_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTMtMS0xLTQ4OTA2_6672050a-276a-4c5c-936f-1715ab093b8b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895d001213eb4fbdbfe3970d1d470a5f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTUtMS0xLTQ4OTA2_c77041d4-f574-465b-a03c-d5a8b829f2f1">827,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i920455eea78d4de0b3a820010c833f50_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTctMS0xLTQ4OTA2_8977587f-8f18-41ee-a226-e55b62ce6673">318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444d8e8a93bb4467a4ce845e986e6410_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTktMS0xLTQ4OTA2_244989a3-c966-4372-b4aa-cd5a20ca7b68">649,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTExLTEtMS00ODkwNg_a64bb8f9-ba84-4733-af63-4edffbf1d5cc">176,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24476a394b0d460abebd9ddff5142056_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTEtMS0xLTQ4OTA2_e229e8f7-e7fc-4599-be03-a3afc61dbae0">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTUtMS0xLTQ4OTA2_8978f4f9-3ba5-4aa7-bdc7-26e1b4958b95">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTExLTEtMS00ODkwNg_c61f7c40-0e9d-48dd-b60a-316513697f7c">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholdings related to net share settlements of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMwLTUtMS0xLTQ4OTA2_b97d0581-3eb0-4f09-93fb-d2a3037d7288">1,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMwLTExLTEtMS00ODkwNg_4f1fcbc5-0f24-47ac-b124-d50eaf01ba0a">1,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24476a394b0d460abebd9ddff5142056_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMxLTEtMS0xLTQ4OTA2_340880c6-95a2-4a6f-89cd-6fbb1b00a98c">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMxLTUtMS0xLTQ4OTA2_2a10843c-256f-447a-95a8-662edd33be30">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMxLTExLTEtMS00ODkwNg_84c2ff52-f05d-4dd3-8c3c-d7547b248daa">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI4LTUtMS0xLTk4NDIz_53d9d999-c00d-4e47-95b1-58f0b34287c1">26,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI2LTExLTEtMS05OTU2Nw_4d056709-6461-47c5-af04-cf880b54f02b">26,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63cda06a33214436ac73d2d0c4af2fa8_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTktMS0xLTk4NDIz_d28c081d-a214-4b7e-b2cf-2c8c57c03d12">159,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTExLTEtMS05OTU2NQ_063da6dd-212c-4c94-a487-c30ef9e967dc">159,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i187572d253d54fb6b91f8db3fcb8f370_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMzLTctMS0xLTk5MzYz_06376eb0-b7da-4e4f-8bef-0a5a558053ba">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI4LTExLTEtMS05OTU2Mg_e4af5006-849a-4d65-98dc-3ab3015910ad">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib08fc922969543ebbe9caf9316b0f2af_I20221231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTEtMS0xLTk5NTM1_b6d13d4a-b26e-4f0e-b4b5-233a98b68da7">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08fc922969543ebbe9caf9316b0f2af_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTMtMS0xLTk5NTM3_0703788f-205b-486a-b17d-41aa4d3aeb32">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9403952b5e824b5794d4bb6ed1b3c7ba_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTUtMS0xLTk5NTM5_ebb34c83-d388-4e6c-8bcd-1f2eef1f9874">855,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfa5c83df28b49dd8e19aa82d32557ac_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTctMS0xLTk5NTQx_326173f3-84b4-4756-b216-43af91950860">589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e3db979b8cc4c70acfae0b6db21e315_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTktMS0xLTk5NTQz_8e50f7f6-1f02-4ede-a55d-a0b190268e8a">809,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTExLTEtMS05OTU0NQ_90dd5197-f444-4fce-86e4-136822e5a13b">45,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective January 1, 2021, the Company adopted Accounting Standard Update No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). See Note 2. Basis of Presentation and Summary of Significant Accounting Policies and Note 10. Long-term Debt, Net for more information.</span></div></td></tr></table></div><div style="margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQtMS0xLTEtNDg5MDY_f098db0a-8130-4108-bd5b-0d7d46a8c860">159,543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQtMy0xLTEtNDg5MDY_242a0a55-5ecb-43da-aeb9-8c865b07a077">115,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQtNS0xLTEtNDg5MDY_f4da29e6-dc4c-4266-80e9-17db59b6c6d4">110,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMS0xLTEtNzUxOTM_37dfeee4-88ac-45b9-8300-e3c242389a6a">25,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMy0xLTEtNzUxOTM_125f6d85-962e-49ea-80ef-d0d13e34354a">30,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtNS0xLTEtNzUxOTM_4a006387-25ae-487c-9bbd-7fe4cb1cc9ab">19,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMS0xLTEtNDg5MDY_0789a2bf-a96d-43bb-9098-7aef4d447fa3">8,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMy0xLTEtNDg5MDY_ccac8f5d-6115-4fb9-a3aa-968e1aec6d30">5,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtNS0xLTEtNDg5MDY_fde7fb57-8863-4f1b-9db9-685486a29750">5,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzgtMS0xLTEtNDg5MDY_df81c3e3-3c6f-4f86-af58-5a321dca6ef3">4,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzgtMy0xLTEtNDg5MDY_3443ed5c-380c-4d2e-a3db-1779aa7960f0">3,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzgtNS0xLTEtNDg5MDY_7ea3800b-64d8-4ed3-ac7c-e51b36544ff1">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:InterestAccruedOnLongTermNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMS0xLTEtNzUyMDY_64cfd684-2728-4073-85d6-cf3e64ad3c80">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:InterestAccruedOnLongTermNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMy0xLTEtNzUyMDY_bdb27ca0-d093-4cf1-bd69-80324c7ea565">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="nstg:InterestAccruedOnLongTermNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktNS0xLTEtNzUyMDY_5f9553e8-a282-4341-9bc2-3699f099edbb">8,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of premium and accretion of discount on short-term investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzEwLTEtMS0xLTc1MjE4_b6257eca-b123-4592-9116-f6ccc9c1455b">1,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzEwLTMtMS0xLTc1MjE4_d18bda7a-f69c-43ce-8716-da2c776f12ff">1,765</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzEwLTUtMS0xLTc1MjE4_30f266da-6115-424f-ad9e-e3ba8ade44fe">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for inventory obsolescence and bad debt expense (recovery)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTEtMS0xLTc1MjM0_86b5c2a7-84c8-4ad2-a3b0-91a5c5f6d7a1">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTMtMS0xLTc1MjM0_90c3ce75-4cb1-4e3c-80df-af9485be3a00">2,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTUtMS0xLTc1MjM0_1c011004-cb75-4a8f-b679-0f96f1f217ff">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of accrued interest on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:RepaymentOfAccruedInterestOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMS0xLTEtNjQ2Mzc_4e4d1f29-bbc9-4333-a091-9a4f1cf28a80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:RepaymentOfAccruedInterestOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMy0xLTEtNjQ2Mzc_f5d7ef2c-1881-4de5-92cb-4929d37b59fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="nstg:RepaymentOfAccruedInterestOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktNS0xLTEtNjQ2Mzc_da806e73-a240-41b3-897c-625d5440f3d7">2,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTEtMS0xLTY0NjQ1_29e60428-2c22-433d-88e1-3732358e3c69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTMtMS0xLTY0NjQ1_b7ba0f6e-6f48-4561-b243-faecced24cb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTUtMS0xLTY0NjQ1_0182c611-e5df-4312-a56c-9a4cc19c2b07">7,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTEtMS0xLTQ4OTA2_35766391-48ad-4939-b035-179066d64e88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTMtMS0xLTQ4OTA2_1af85e19-7be8-4d2f-bf2a-46255191f81b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTUtMS0xLTQ4OTA2_b48b26c6-1593-4b15-8b33-7445be11c63d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE2LTEtMS0xLTQ4OTA2_9e52c704-1915-4cfa-9b65-11f5075e608d">847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE2LTMtMS0xLTQ4OTA2_dd983e44-cc9f-4e95-8ae8-2d220f0f6752">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE2LTUtMS0xLTQ4OTA2_934fe796-f55b-4398-87d8-e76af2e99b19">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE5LTEtMS0xLTQ4OTA2_e9d60929-a070-4149-a22a-91da0e016cd7">7,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE5LTMtMS0xLTQ4OTA2_6fbd4222-693f-4e18-bd5c-8d680049235b">9,526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE5LTUtMS0xLTQ4OTA2_d5b1f622-ad04-48c0-a6f0-0afc1bba3acf">3,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIwLTEtMS0xLTQ4OTA2_7b722f42-3a97-461a-8cc1-2501b17b774c">15,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIwLTMtMS0xLTQ4OTA2_68180c7e-46fe-4342-b65e-a349fbdf3c74">10,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIwLTUtMS0xLTQ4OTA2_294ef778-f720-40bf-b4bf-b9e184024911">4,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIxLTEtMS0xLTQ4OTA2_9095346a-2dc6-4dc2-8788-bb5ec42809c1">6,942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIxLTMtMS0xLTQ4OTA2_8126cca4-f62b-4801-8f6c-a6b7a0a77a79">5,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIxLTUtMS0xLTQ4OTA2_3554d2ac-5208-4076-a43f-1ebb6a7d23e2">4,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIyLTEtMS0xLTQ4OTA2_2f54e0b6-d594-40f9-a892-eaa7f63b38d2">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIyLTMtMS0xLTQ4OTA2_9e8a1cb7-8714-4f33-a17b-cecb3c16f86b">8,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIyLTUtMS0xLTQ4OTA2_afc7015d-3cd2-42eb-9a6e-5c6a79df1bb0">3,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIzLTEtMS0xLTQ4OTA2_e45f4778-ef7d-4687-a8cb-24f3b436afb6">407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIzLTMtMS0xLTQ4OTA2_e969b14e-28ca-462d-8429-ff70fc254e32">914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIzLTUtMS0xLTQ4OTA2_f49107ea-3a4b-465c-880f-fec223200ae5">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and other employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI0LTEtMS0xLTQ4OTA2_39987fc6-395f-48bf-8d44-51159195ffea">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI0LTMtMS0xLTQ4OTA2_ff268d55-f7df-4330-a4d0-c7621c29e44e">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI0LTUtMS0xLTQ4OTA2_937e5af4-efa6-4ba4-936e-ab6097b3f203">936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI1LTEtMS0xLTQ4OTA2_7ebee0e1-bbc9-45af-8587-bb16a76338ec">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI1LTMtMS0xLTQ4OTA2_1e72d686-106c-46ec-9183-c925ee0c30c6">353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI1LTUtMS0xLTQ4OTA2_ab7a24b4-c889-4636-8aae-c95397b1017d">4,758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI2LTEtMS0xLTQ4OTA2_f071e4d9-c399-4806-a73a-7f34a018e11a">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI2LTMtMS0xLTQ4OTA2_53836426-2166-4c04-9c3a-cb09cd288ff3">3,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI2LTUtMS0xLTQ4OTA2_8bd752bc-47e5-4ea6-b73d-a5ba39d98c0c">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="nstg:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI3LTEtMS0xLTQ4OTA2_bca761f1-ef67-45a1-be5a-a1d5e81f3292">4,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="nstg:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI3LTMtMS0xLTQ4OTA2_7f35e44f-ad83-4827-b1e5-9bc09aa1d67f">4,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="nstg:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI3LTUtMS0xLTQ4OTA2_30291b69-ed94-4e4e-9e67-f665680abd71">3,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI4LTEtMS0xLTQ4OTA2_7fd47cce-ba28-47b2-8f53-24deadcdf7a3">128,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI4LTMtMS0xLTQ4OTA2_f1c5ae07-3ce1-4881-822b-6c84db7d71db">90,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI4LTUtMS0xLTQ4OTA2_714af7e8-2d60-4eb6-8af3-79ecdd2812e9">81,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTEtMS0xLTQ4OTA2_bd1d8244-33d1-4871-83dd-0378850c4e37">14,364</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTMtMS0xLTQ4OTA2_fe2717b1-2322-425f-9c4e-a92fc809b7bf">6,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTUtMS0xLTQ4OTA2_5b28aad0-df1d-4681-a1f8-d4e2612600bf">7,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of internal-use software assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="3" name="us-gaap:PaymentsForSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMxLTEtMS0xLTQ4OTA2_df3fb1c2-e269-4f20-aa3e-98736cd6aab7">7,952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="3" name="us-gaap:PaymentsForSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMxLTMtMS0xLTQ4OTA2_875ed1ab-ea53-404b-b6dc-c1c26b6f746d">2,299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="3" name="us-gaap:PaymentsForSoftware" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMxLTUtMS0xLTQ4OTA2_0e3d493b-3996-456d-8345-28ac778d649b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTEtMS0xLTc1MjUx_c2058428-ed2a-4dfa-ae23-7e21471209a3">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTMtMS0xLTc1MjUx_f143ef0e-4ffd-4c38-b20e-fbed3eda629d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTUtMS0xLTc1MjUx_08514cd7-87f2-4eeb-b348-d4f43c1ca14c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMzLTEtMS0xLTQ4OTA2_2b690e99-50ef-4c93-a6c0-8c2aa03cd8b2">7,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMzLTMtMS0xLTQ4OTA2_d66638bc-8255-4b12-ac72-92133a14e473">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMzLTUtMS0xLTQ4OTA2_72de91f9-0bdf-440d-a885-db8cd85daea8">21,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM0LTEtMS0xLTQ4OTA2_98c67bf1-0402-4d4c-b017-fc40861e649a">197,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM0LTMtMS0xLTQ4OTA2_21d9067b-6b95-4187-b453-b4b91e84485f">44,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM0LTUtMS0xLTQ4OTA2_f62cb79f-fb41-4ef2-84d0-177edaa49dee">116,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM1LTEtMS0xLTQ4OTA2_861440aa-b361-447c-b3cd-74e92d4c1e8b">49,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM1LTMtMS0xLTQ4OTA2_2c9bd83c-548c-401f-b8ba-9861961e1818">260,239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM1LTUtMS0xLTQ4OTA2_ba58c694-5cbe-42b2-832d-dedc4fc9a6f3">38,804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM2LTEtMS0xLTQ4OTA2_69cc7077-c7eb-4177-9968-7e1026222c9b">132,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM2LTMtMS0xLTQ4OTA2_ee50f34c-9711-466a-8d45-623ca7660498">220,222</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM2LTUtMS0xLTQ4OTA2_6f57a8f0-735b-469b-8a68-01447a3ee109">91,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of 2025 convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM4LTEtMS0xLTQ4OTA2_27e3a5eb-ee69-4046-b5f8-a1111b60613b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM4LTMtMS0xLTQ4OTA2_51c3398c-8f5e-4d8b-b5c6-db319213ac75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM4LTUtMS0xLTQ4OTA2_e0626d69-3434-4952-997f-0735eed158e8">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees paid for issuance of 2025 convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM5LTEtMS0xLTQ4OTA2_db50c1ca-a536-41d6-97bb-80784ce31f8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM5LTMtMS0xLTQ4OTA2_d635e252-73ad-422f-b974-3bbe1470208c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM5LTUtMS0xLTQ4OTA2_fe813769-afcc-4015-8557-894c75c34447">7,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQwLTEtMS0xLTQ4OTA2_f6c0fac4-cb23-4f20-801a-0749ee45717f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQwLTMtMS0xLTQ4OTA2_a92ef66d-b88e-4dce-933f-37f773c563e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQwLTUtMS0xLTQ4OTA2_d5517391-e425-431d-a462-9ba6b71d07a1">80,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees paid upon extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQxLTEtMS0xLTQ4OTA2_af27ea60-fc75-44f5-9d3f-3c0e46eca93c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQxLTMtMS0xLTQ4OTA2_c74fdf21-d88f-4b80-be8b-97f9031a5e76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQxLTUtMS0xLTQ4OTA2_c3b87fee-7c2c-46dd-8db8-e8ccbf2e3a2d">4,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQyLTEtMS0xLTQ4OTA2_170d48f1-36f7-4c9d-b544-62c07123eed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQyLTMtMS0xLTQ4OTA2_e054c29e-4306-45bc-aa96-239e38866132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQyLTUtMS0xLTQ4OTA2_2b6b4c84-e90f-473c-a67a-97bd9390dd97">215,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQzLTEtMS0xLTQ4OTA2_dcf1ad25-f91f-4e3e-b391-9b7d69dbfa86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQzLTMtMS0xLTQ4OTA2_a95e2d88-9b0c-43d1-bdba-be21a84939e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQzLTUtMS0xLTQ4OTA2_ca714c31-542b-4940-8062-23b5bb1c3289">737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock for employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ0LTEtMS0xLTQ4OTA2_4892250b-c66b-48be-8721-c1f1d0d71920">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ0LTMtMS0xLTQ4OTA2_23873641-f8d8-413c-a901-8481fa2f01df">2,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ0LTUtMS0xLTQ4OTA2_67bb3773-0d4f-442c-be63-08e31176cdd5">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax withholdings related to net share settlements of restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ1LTEtMS0xLTQ4OTA2_8c77651b-fbe0-473d-8ee7-14fc37f64c6f">1,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ1LTMtMS0xLTQ4OTA2_e1faf012-d756-450e-b4ed-3a4ede21d50c">2,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ1LTUtMS0xLTQ4OTA2_f1621f0e-db74-4459-80a0-7793024da575">2,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ2LTEtMS0xLTQ4OTA2_6c06b5f4-8280-4d8b-810f-21d869c224b1">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ2LTMtMS0xLTQ4OTA2_3a6d62ec-b72a-4d1a-a497-a3387c0174ef">6,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ2LTUtMS0xLTQ4OTA2_827f235e-56bc-435e-96c0-fd06e8ce3dc4">18,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ3LTEtMS0xLTQ4OTA2_f47901af-6144-4cbe-9994-6cf9bae3bc8f">333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ3LTMtMS0xLTQ4OTA2_f44c5871-755f-4676-a8f6-faea3676b906">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ3LTUtMS0xLTQ4OTA2_ddfd665c-a44f-4690-a794-12694714dfb9">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ4LTEtMS0xLTQ4OTA2_192b7d5f-51f6-40c1-a985-41d58a1241d6">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ4LTMtMS0xLTQ4OTA2_985bf772-1de6-4a7f-8699-0c0c8bd3c8c8">6,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ4LTUtMS0xLTQ4OTA2_78081425-08e9-4ad0-a8f9-b4b21c79a562">373,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ5LTEtMS0xLTQ4OTA2_6089ec4c-4fac-44a6-990d-7d112785e8af">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ5LTMtMS0xLTQ4OTA2_3ce35cd1-2490-4bdf-93cd-55fb555908e9">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ5LTUtMS0xLTQ4OTA2_e108c167-8bee-4886-98de-0ef22c848352">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUwLTEtMS0xLTQ4OTA2_b0363083-5f78-4639-b787-14815fe0149a">6,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUwLTMtMS0xLTQ4OTA2_ca10fcdf-d542-4a6d-a51b-7b255b230356">304,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUwLTUtMS0xLTQ4OTA2_1c6655f4-d4e7-4e99-8425-dfb9b2fa5e40">382,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, restricted cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUyLTEtMS0xLTQ4OTA2_6a1e4b4e-a618-41e1-94f8-2039c0401b59">107,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUyLTMtMS0xLTQ4OTA2_801930fb-08c2-48d1-81e4-c27d1e4324cd">411,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUyLTUtMS0xLTQ4OTA2_410bfea0-df3d-436f-8e8b-521d040f3795">29,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUzLTEtMS0xLTQ4OTA2_41390a62-bcb6-4641-b3b6-51b10dc0caf6">113,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUzLTMtMS0xLTQ4OTA2_89c883a7-78c7-4551-93ca-0fcf578d38ed">107,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUzLTUtMS0xLTQ4OTA2_affa77f4-9b47-4805-b5c1-233d45bf24b4">411,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Disclosures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzUtMi0xLTEtMTEwMDMz_849ac9de-2334-41d8-a86f-3ad061ad79a7">112,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzQtMy0xLTEtMTE5MDE0_bfe07c9c-fd8c-4f8b-ac4f-89bc75b3c301">107,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzQtNS0xLTEtMTE5MDIw_b14489fe-55fe-45d9-8eba-08d79045d5a1">411,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtMi0xLTEtMTEwMDM3_b365a849-bd7c-43ca-bb23-131549f0dba8">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzUtMy0xLTEtMTE5MDE2_c66ce6dc-393d-498f-9eca-62b6bf40964e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzUtNS0xLTEtMTE5MDIy_f5062f84-82a2-4de4-8963-6eb15f93984f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, restricted cash and cash equivalents shown in the statement of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtMi0xLTEtMTEzNzY3_ec5f5d10-300c-4d80-8dd9-77c2a0a778d6">113,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtMy0xLTEtMTE5MDE4_79cabbdc-554d-44bf-9ea6-188c146328d2">107,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtNS0xLTEtMTE5MDI0_a8279025-96c8-42f6-9cff-245221d9747e">411,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzQtMS0xLTEtNDg5MDY_b991d68d-ba63-48a3-8295-91e4205ba7fc">6,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzQtMy0xLTEtNDg5MDY_19130ed7-6b8d-4de1-95f1-9bd3c73080be">6,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzQtNS0xLTEtNDg5MDY_a055a264-f6f9-4707-8838-3f607f29da17">4,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzUtMS0xLTEtNDg5MDY_c9988375-eca9-4092-8376-ce6d2cda98ec">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzUtMy0xLTEtNDg5MDY_457a0465-7b8a-4488-b201-ef5f58fedfa8">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzUtNS0xLTEtNDg5MDY_e895fd7a-cc66-46d3-b369-b054fdd4c0a8">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments reclassified from inventory to property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:RentalInstrumentsReclassifiedFromInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzYtMS0xLTEtNDg5MDY_4b2992e0-2387-4e76-98f4-240f7ba4b2c1">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:RentalInstrumentsReclassifiedFromInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzYtMy0xLTEtNDg5MDY_c86fd537-453a-40cf-a22e-e9b9939f07ed">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="nstg:RentalInstrumentsReclassifiedFromInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzYtNS0xLTEtNDg5MDY_11b07e1a-e6c4-4818-bb9f-b83eb114e66b">854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzctMS0xLTEtNDg5MDY_a2b3205a-93ad-464e-a0a2-b44f03e4869c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzctMy0xLTEtNDg5MDY_84ec3734-5590-4fba-a58e-67b8fda61c1b">448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzctNS0xLTEtNDg5MDY_80d06a00-2d85-4a7e-ab47-ba1590a4ed72">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzgtMS0xLTEtNDg5MDY_73c2158f-fea6-41c4-97a5-2af3e3693965">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzgtMy0xLTEtNDg5MDY_3fa7dd07-4f3c-49be-9fcf-2f5f78a37c16">929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzgtNS0xLTEtNDg5MDY_c1ebc455-8969-4586-bc75-cac2f6090a7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NanoString Technologies, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_112"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTIvZnJhZzpmMzEzNDdhZDRjMGM0Y2IwOWRlN2UyMzJiYjJlZGVmMS90ZXh0cmVnaW9uOmYzMTM0N2FkNGMwYzRjYjA5ZGU3ZTIzMmJiMmVkZWYxXzczOA_4e78e67b-1dfc-43d0-8db4-39aecfb3ad69" continuedAt="i7766f61f942946c39cfe14272ce0dfe0" escape="true">Description of the Business</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7766f61f942946c39cfe14272ce0dfe0">NanoString Technologies, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on June&#160;20, 2003. The Company&#8217;s headquarters is located in Seattle, Washington. The Company&#8217;s proprietary chemistries enable the direct detection, identification and quantification of individual target molecules in biological samples by attaching unique molecular reporters to each target molecule of interest. The Company currently markets and sells <ix:nonFraction unitRef="platform" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="nstg:NumberOfPlatforms" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTIvZnJhZzpmMzEzNDdhZDRjMGM0Y2IwOWRlN2UyMzJiYjJlZGVmMS90ZXh0cmVnaW9uOmYzMTM0N2FkNGMwYzRjYjA5ZGU3ZTIzMmJiMmVkZWYxXzQ3NQ_16c043a0-71c3-46b9-aadf-265172e357cb">three</ix:nonFraction> platforms based on its proprietary technologies, its nCounter Analysis System, its GeoMx Digital Spatial Profiler, or &#8220;GeoMx DSP&#8221; or &#8220;GeoMx&#8221;, and CosMx Spatial Molecular Imager, or &#8220;CosMx SMI&#8221; or &#8220;CosMx&#8221;, all of which include instruments and consumables, to academic, government, biopharmaceutical, and clinical laboratory customers.</ix:continuation> The Company also offers AtoMx Spatial Informatics Platform, or &#8220;AtoMx SIP&#8221; or &#8220;AtoMx&#8221;, a cloud-based informatics portal for use with GeoMx DSP and CosMx SMI.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_115"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTMy_eb2ed03e-44d0-498e-b9ee-7974b249966f" continuedAt="i8d7af0e9e3c6440286fee7bf08d78784" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i8d7af0e9e3c6440286fee7bf08d78784" continuedAt="i6ea9b911ce4441abb95eff9fe77d7bd3"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Principles and Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI4MDEy_c0d365df-2d62-4d01-8bde-fa8271112b83" escape="true">The consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying consolidated financial statements reflect the accounts of the Company and its wholly-owned subsidiaries. Each of the subsidiaries operates as a sales and support office. The functional currency of each subsidiary is the U.S. dollar. All significant intercompany balances and transactions have been eliminated.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTg4_ce6dfa84-b083-4836-8737-e980295afd4f" escape="true">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and that affect the reported amounts of revenue and expenditures during the reporting period. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying consolidated financial statements include the estimation of stand-alone selling prices for its products and services, the estimation of the valuation of inventory, the estimates used in the valuation allowance for deferred tax assets and uncertain tax positions, and estimates used in certain of the inputs and calculations associated with stock-based compensation.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTE4_b6fbb8ee-043e-467e-8fcd-bb4245c030d4" escape="true">The Company considers all highly-liquid investments with purchased maturities of three&#160;months or less to be cash equivalents. The Company&#8217;s cash equivalents consist principally of funds maintained in depository accounts. The Company invests its cash and cash equivalents with major financial institutions; at times these investments exceed federally insured limits. Restricted cash consists of customer deposits which are secured through letters of credit until performance obligations have been met.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTgw_0d1db71f-06b1-413f-8925-52dcc84d3912" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its debt securities as available-for-sale, which are reported at estimated fair value with unrealized gains and losses included in accumulated other comprehensive loss in stockholders&#8217; equity. Realized gains, realized losses and allowance for estimated credit losses are included in other expense, net. The cost of investments for purposes of computing realized and unrealized gains and losses is based on the specific identification method. Amortization of premiums and accretion of discounts are included in other expense, net. Interest and dividends earned on all securities are included in other expense, net.&#160;Investments in debt securities with maturities of less than one year, or where management&#8217;s intent is to use the investments to fund current operations, or to make them available for current operations, are classified as short-term investments.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments are presented net of an allowance for expected credit losses that are remeasured each period and any impairment recognized as an expense. The Company has considered all information and factors and noted no indicators that a credit loss exists as of December 31, 2022. The Company has not experienced any significant investment credit losses to date. Accrued interest receivable is included in prepaid and other current assets and was $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="3" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyODk1ODI_6483b345-a94f-4761-98bc-c065c2eaa29d">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="3" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyODk1OTk_99bc6806-6621-48c0-aa57-063250ff1998">0.8</ix:nonFraction> million as of December 31, 2022 and 2021.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i6ea9b911ce4441abb95eff9fe77d7bd3" continuedAt="i9df54a2ad4eb41e0986fadb26fcc86a1"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTYw_164dce59-0eff-4887-9b56-4974e5ad04de" escape="true">Accounts receivable are stated net of an allowance for credit losses. The Company uses available information over the life of the receivables including analysis of past credit losses, recoveries of past credit losses, management&#8217;s expectations of future economic positions, as well as market conditions and other extenuating factors to support the allowance estimate.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI4MDA4_9026b335-5ee0-4d2c-b5b8-a543f97ccb77" continuedAt="if2c7b7e4a1864b06bb25945af0098ca6" escape="true">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. Cash is invested in accordance with the Company&#8217;s investment policy, which includes guidelines intended to minimize and diversify credit risk. Most of the Company&#8217;s investments are not federally insured. The Company has credit risk related to the collectability of its accounts receivable. The Company performs initial and ongoing evaluations of its customers&#8217; credit history or financial position and generally extends credit on account without collateral.</ix:nonNumeric> The Company has not experienced any significant credit losses to date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented more than 10% of total revenue for the year ended December 31, 2022. The Company had no customers that represented more than 10% of total revenue for the years ended December 31, 2021 and 2020, respectively. The Company had no customers that represented more than 10% of total accounts receivable as of December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if2c7b7e4a1864b06bb25945af0098ca6">The Company is also subject to supply chain risks related to the outsourcing of the manufacturing and production of its instruments to sole suppliers. Although there are a limited number of manufacturers for instruments of this type, the Company believes that other suppliers could provide similar products on comparable terms. Similarly, the Company sources certain raw materials used in the manufacture of consumables from certain sole suppliers. A change in suppliers, however, could cause a delay in manufacturing and a possible loss of sales, which would adversely affect operating results.</ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value of financial instruments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTgy_1a0ed9ec-1e43-4619-ae3f-ee8a0278d0d8" escape="true">The recorded amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities. Investments that are classified as available-for-sale are recorded at fair value. The fair value for investment securities held and for convertible senior notes are determined using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTc1_4687b36b-2bb6-4967-afcc-dcb09a974de9" continuedAt="i5adfe0c01ee74ac39d1e9d13d0dcc2f9" escape="true">Inventory consists of finished goods, raw materials, including certain intermediate manufactured items, and certain component parts to be used in manufacturing or servicing the Company&#8217;s products. Inventory is stated at the lower of cost or net realizable value. Cost is determined using a standard cost system, whereby the standard costs are updated periodically to reflect current costs and market represents the lower of cost or market (replacement cost or estimated net realizable value). The Company&#8217;s policy is to establish inventory reserves when conditions exist that suggest that inventory may be in excess of anticipated demand, obsolete, slow moving or impaired. In the event that the Company identifies these conditions exist in its inventory, its carrying value is reduced to its net realizable value.</ix:nonNumeric> Inventory reserves were $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzczMjc_b735a500-5a9f-440c-b3ac-26dd80faedec">7.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzczMzQ_4f2b132a-85ac-4599-a4a5-25aabc2d1a03">6.5</ix:nonFraction> million as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5adfe0c01ee74ac39d1e9d13d0dcc2f9">The Company outsources the manufacturing of its instruments to third-party contract manufacturers who manufacture them to certain specifications and source certain raw materials from sole source providers. Major delays in shipments, inferior quality, insufficient quantity or any combination of these or other factors may harm the Company&#8217;s business and results of operations. In addition, the inability of one or more of these suppliers to provide the Company with an adequate supply of its products or raw materials or the loss of one or more of these suppliers may cause a delay in the Company&#8217;s ability to fulfill orders while it obtains a replacement supplier and may harm the Company&#8217;s business and results of operations.</ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTM5_a03c0142-3efd-45d3-80f5-73dcf26d82f7" continuedAt="i5037e83c6fb24fd2a6ed8df4b7e19013" escape="true">Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets. Expenditures for additions are capitalized and expenditures for maintenance and repairs are expensed as incurred. Gains and losses from the disposal of property and equipment are reflected in the consolidated statements of operations in the period of disposition.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i9df54a2ad4eb41e0986fadb26fcc86a1" continuedAt="i7acbd4979ad44abe8891bf6c0882a6d8"><div style="margin-bottom:1pt"><ix:continuation id="i5037e83c6fb24fd2a6ed8df4b7e19013"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e88f609f3f146ceaf78b4e74394ba1b_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzEtMi0xLTEtNDg5MDY_ebf42e27-4063-46f8-9e4c-f461018a8cee">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prototype systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i278bf40cbb204af4a52b6898794206ca_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzItMi0xLTEtNDg5MDY_cef947b2-a529-4e66-874a-4c6645d60798">2</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i88f1ce22f43b4f6ba059a7cff32daa29_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzMtMi0xLTEtNDg5MDY_e6984498-cd83-46ff-b9fa-48396b6a1975">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f132592e8314b41869081ee86000fca_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzQtMi0xLTEtNDg5MDY_3b4bafba-8542-4c82-ad2f-d7ce8f43d3a6">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or lease term</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Internal-Use Software Costs</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTIx_aa0c6a95-eb36-488c-9120-c99bfac772c2" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain development costs incurred in connection with software development for internal-use software platforms used in operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once software has reached the development stage, internal and external costs, if direct, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over the estimated useful life of the software platforms and are included in depreciation and amortization expense within operating expenses in our consolidated statements of operations. Unamortized capitalized internal-use software development costs were $<ix:nonFraction unitRef="usd" contextRef="iaef01beba6684f59958c4b614e147f05_I20221231" decimals="5" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzk2NjA_8cfeb12c-1851-41ba-bdd5-e7e8c77a4fd6">11.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i82bf014bbac5492db1175791d6facd7d_I20211231" decimals="5" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyOTA1MjI_50844aae-ae46-4ce7-b2bd-fef64542f370">4.0</ix:nonFraction> million as of December 31, 2022 and 2021, respectively. Amortization of capitalized internal-use software costs was $<ix:nonFraction unitRef="usd" contextRef="i9e1e72e2e1254b52a9ce1f62c4a096cc_D20220101-20221231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3NDg3NzkxMDQ2MzE_6f5acb14-962a-4672-a6c3-781f0d3c043a">0.3</ix:nonFraction> million for the year ending December 31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs associated with the implementation of hosted third-party cloud computing arrangements are recorded as part of current and long-term other assets. Maintenance and training costs are expensed as incurred and are expensed on a straight-line basis over the term of the related hosting arrangement. Costs are recorded within the consolidated statements of operations based on the functional use of the software. Unamortized capitalized software implementation costs were $<ix:nonFraction unitRef="usd" contextRef="i18117518f24d42deab5e444d999956b2_I20221231" decimals="3" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzEwMjUy_f17b723b-9ce2-4613-a0f5-5b653b7209ea">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie22262b3c6e443298a7bfef3925d13c7_I20211231" decimals="3" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3NDg3NzkxMDQ0NzE_09fb2b09-efb8-41c4-bc26-d34dd69a4f66">3.2</ix:nonFraction> million as of December 31, 2022 and 2021, respectively. Amortization and write-down of capitalized software implementation costs of hosted third-party cloud computing arrangements was $<ix:nonFraction unitRef="usd" contextRef="ic8b904e260de493cad16322d5349cd06_D20220101-20221231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyOTA5NDE_1a766d9b-d86d-4399-817b-181ba7f20310">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1c7acaf4b361496386e2cab8954e8f6b_D20210101-20211231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyOTA5NTg_a88abfd8-31db-4b95-9b83-330e85af3e05">0.3</ix:nonFraction> million for the years ending December 2022 and 2021, respectively.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTUy_525ff171-1dcd-44f3-bae7-37d0260d263c" escape="true">The Company determines if an arrangement is a lease at inception of a contract. The Company&#8217;s leasing portfolio is comprised of operating and finance leases primarily for general office, manufacturing, and research and development purposes. Operating and finance lease liabilities and the corresponding right-of-use assets are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Operating lease right-of-use assets are reduced by lease incentives included in the agreement. As the existing leases do not contain an implicit interest rate, the Company estimates its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The Company includes options to extend the lease in the lease liability and right-of-use asset when it is reasonably certain that the option will be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company elected, as an accounting policy election, to use the short-term lease recognition exemption on all classes of assets. Leases with an initial term of 12 months or less are not recorded on the balance sheet and the Company recognizes lease payments as an expense on a straight-line basis over the lease term. The Company has lease office agreements with lease and non-lease components, which are generally accounted for separately. For lease equipment agreements, the Company accounts for the lease and non-lease components as a single lease component. The Company&#8217;s lease agreements do not contain any material variable lease payments, material residual value guarantees or, any material restrictive covenants.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTEz_7f425e57-14a5-449c-83f6-c7b961024d65" escape="true">The Company recognizes impairment losses on long-lived assets when indicators of impairment are present and the anticipated undiscounted cash flows to be generated by those assets are less than the asset&#8217;s carrying values. The Company has <ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzEyNTkz_1fd06f93-93ad-4ca9-9386-1e54383a8b1f"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzEyNTkz_ee171dd8-8804-4222-8af7-2e0a554c7546">no</ix:nonFraction></ix:nonFraction>t experienced material impairment losses on its long-lived assets during the periods presented.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTQ4_f682070e-46e2-4e79-9100-bc2c4c2c8bd3" continuedAt="i316b0684169644fa8fee2ff25f662ab6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted &#8220;ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-06&#8221;) effective January 1, 2021. The Company uses the if-converted method for purposes of calculating dilutive earnings per share, if the Convertible Notes are dilutive during the period. In connection with the issuance of the Convertible Notes, the Company incurred certain financing costs associated directly with the issuance of the Convertible Notes. These issuance costs were deferred and are amortized to </span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i7acbd4979ad44abe8891bf6c0882a6d8" continuedAt="i09c7bee05bde45b9b39c3baadfd2e1c2"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i316b0684169644fa8fee2ff25f662ab6">interest expense over <ix:nonNumeric contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE0ODYw_89fc7a1b-9774-496f-800d-624e0d1a3a39">five years</ix:nonNumeric> using the effective interest method.</ix:continuation> See Note 10. Long-term Debt, Net for additional information regarding the Convertible Senior Notes.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segments</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTY0_5a5fcff9-477d-46b9-8ab3-e26b4cf31a20" escape="true">Operating segments are defined as components of an entity for which separate financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company&#8217;s chief operating decision maker is the chief executive officer, who manages the operations and evaluates the financial performance on a total Company basis. The Company&#8217;s principal operations and decision-making functions are located at its corporate headquarters in the United States and the Company operates as a single operating and reporting segment.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTUz_d06b816a-37c7-4850-b317-ad5931e27f90" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the promised goods or services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of a product or service to the customer, meaning the customer has the ability to use and obtain the benefit of the product or service. The Company recognizes revenue for satisfied performance obligations only when there are no uncertainties regarding payment terms or transfer of control.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically generated the majority of its revenue from sales of its proprietary GeoMx DSP system and nCounter Analysis System, and related consumables. Services consist of instrument service contracts for maintenance, repair and other support related to customer owned instruments, and also certain service fees for assay processing and data analysis and reporting. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from instruments and consumables is generally recognized upon shipment to the end customer, which is when control of the product has been transferred to the customer. Performance obligations related to instrument sales are reviewed on a contract-by-contract basis, as individual contract terms may vary and revenue is recognized as performance obligations are satisfied. Performance obligations for consumable products are generally completed upon shipment to the customer. While the Company typically completes installation and training of its customers with field-based service personnel, these services can also be provided by distribution partners and other third parties.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument service contracts are sold with contract terms ranging from <ix:nonNumeric contextRef="i73fa25c9cfad44209056603a0dc281bb_D20220101-20221231" name="nstg:ExtendedProductWarrantyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE3OTIy_9bd293a9-e38e-4666-a9d9-bb6c41beb0d4">12</ix:nonNumeric>-<ix:nonNumeric contextRef="id1530276adeb46edad26c44010100eaa_D20220101-20221231" name="nstg:ExtendedProductWarrantyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE3OTI1_fe3f2164-b950-422e-8840-32722035583f">36</ix:nonNumeric> months and cover periods after the end of the initial <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="nstg:StandardProductWarrantyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE3OTc1_3649d67c-4885-42cd-b62f-4985963dafba">12</ix:nonNumeric>-month warranty. These contracts include services to maintain performance within the Company&#8217;s designed specifications and allow the customer to receive certain preventative maintenance service procedures during the contract term. Revenue from services to maintain designed specifications is considered a stand-ready obligation and recognized evenly over the contract term and service revenue related to preventative maintenance of instruments is recognized when the procedure is completed. Revenue from service fees for assay processing is recognized upon the rendering of the related performance obligation which is typically the delivery of data and analysis of the samples that have been processed.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements with multiple performance obligations, the Company allocates the contract price in proportion to each performance obligation&#8217;s relative stand-alone selling price. The Company frequently sells bundles of systems and consumables and, in such instances, uses its best estimate of selling price for its products based on historical sales or similar products. For service, the best estimate of selling price is based on historical stand-alone sales, as stand-alone sales data for services are more readily available. The Company reviews its stand-alone prices at least annually or more frequently if facts and circumstances significantly change.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally recognizes expense related to the acquisition of contracts, such as sales commissions, at the time of revenue recognition, which is generally in the same period products are sold, and in the case of services, revenue is recognized as services are rendered or over the period of time covered by the service contract. The Company records commission expenses within selling, general and administrative expenses.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales to customers through distributors are recognized consistent with the policies and practices for direct sales to customers, as described above.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i09c7bee05bde45b9b39c3baadfd2e1c2" continuedAt="i416f3603d4fe45e98f5ae609eeee97fe"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTk0_75cbd87e-5833-4587-9094-8da005a99638" continuedAt="ia345a3d4269e41608fef02b3506157aa" escape="true">Cost of product revenue consists primarily of costs incurred in the production process, including costs of purchasing instruments from third-party contract manufacturers, consumable component materials and assembly labor and overhead, installation, and packaging and delivery costs. In addition, cost of product revenue includes royalty costs for licensed technologies included in the Company&#8217;s products, provisions for slow-moving and obsolete inventory and stock-based compensation expense. Cost of product revenue for instruments and consumables is recognized in the period the related revenue is recognized. Shipping and handling costs incurred for product shipments are included in cost of product revenue in the consolidated statements of operations.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia345a3d4269e41608fef02b3506157aa">Cost of service revenue consists primarily of field service technicians and the cost of providing repair and maintenance services including parts used in performing those services for instruments covered under warranty and service contracts. In addition, cost of service revenue includes lab personnel labor and overhead, stock-based compensation and materials used in performing data analysis services. Cost of service revenue is recognized in the period the services are performed.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve for Product Warranties</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ExtendedProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTYy_ebd7cbb9-fc56-4962-b92c-807c9b0854ef" escape="true">The Company generally provides a <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="nstg:ProductWarrantyAccrualPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTE1_06d0194b-255b-48a1-b7d0-022b6821f079">one-year</ix:nonNumeric> warranty on both its nCounter Analysis Systems and GeoMx DSP instruments, and establishes a reserve for future warranty costs based on historical product failure rates and actual warranty costs incurred. Warranty expense is recorded as a component of cost of service revenue in the consolidated statements of operations. Warranty reserves were $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxNjU4_449e2049-a41e-4f65-9c92-34979bcc51f7">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxNjY1_8675a0e4-60cc-4289-bbe3-0db7c2be90f8">1.2</ix:nonFraction> million as of December 31, 2022 and 2021, respectively.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTQ5_e4eb41a1-7a3b-47d9-94ed-690cdf91c0ae" escape="true">Research and development expenses, consisting primarily of salaries and benefits, stock-based compensation expense, occupancy costs, laboratory supplies, contracted services, and consulting fees are expensed as incurred.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTU0_8679ada1-88f8-471f-a8bb-e686bd6abe08" continuedAt="ibc37133441654e59b16f9dc5bb5ea878" escape="true">Selling expenses consist primarily of personnel related costs for sales and marketing, contracted services, and service fees and are expensed as the related costs are incurred. Advertising costs are expensed as incurred and are included in sales and marketing expenses.</ix:nonNumeric> Advertising costs totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIyMzAz_9d9ee89c-3de8-4d7b-8f54-6d0ba89b56e4">9.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIyMzA3_64f8d10c-cd2b-4c93-8c1f-9b1632c9d3dc">4.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIyMzE0_51672898-0512-4088-a7c4-c2fdc6226ac7">3.4</ix:nonFraction> million during the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibc37133441654e59b16f9dc5bb5ea878">General and administrative expenses consist primarily of personnel related costs for the Company&#8217;s finance, human resources, business development, legal, information technology and general management, as well as professional fees for legal, accounting and other consulting services. General and administrative expenses are expensed as they are incurred.</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTk3_3234d2eb-6efb-4b92-9dd2-e4114780f8d1" escape="true">The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary balance sheet accounts are remeasured using exchange rates in effect at the balance sheet dates and non-monetary items are remeasured at historical exchange rates. Expenses are generally remeasured at the average exchange rates for the period.</ix:nonNumeric> Foreign currency remeasurement and transaction gains and losses are included in interest and other income (expense), net and were not material for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTY5_48ca9cf8-3baa-44ec-a366-dfaaae2273eb" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the liability method. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether a tax position is more likely than not to be sustained upon examination based on the technical merits of the position. For tax positions meeting the more-likely-than-not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTIy_5aa30b44-a16e-4fbd-ac97-b41bbd234074" continuedAt="i24a42d11e266494586dddf6a8fadce12" escape="true">The Company accounts for stock-based compensation under the fair value method. Stock-based compensation costs related to restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;) which are granted by the Company are calculated using the grant-date fair value using the intrinsic method and for stock options granted in prior years, stock-based compensation was estimated using the Black-Scholes option pricing model. Stock-based compensation expense is recognized based on the number of awards ultimately expected to vest, using actual forfeitures when incurred. The Company uses the </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i416f3603d4fe45e98f5ae609eeee97fe"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i24a42d11e266494586dddf6a8fadce12">straight-line attribution method over the vesting period for recognizing compensation expense for awards with a service condition. For awards with service and performance conditions, the accelerated recognition method is used over the graded vesting schedules for the awards.</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTUw_98f5d031-9611-4903-b1a0-6994e0bb768a" escape="true">In the normal course of business, the Company guarantees and/or indemnifies other parties, including vendors, lessors and parties to transactions with the Company, with respect to certain matters. The Company has agreed to hold the other parties harmless against losses arising from breach of representations or covenants, or out of intellectual property infringement or other claims made against certain parties. It is not possible to determine the maximum potential amount the Company could be required to pay under these indemnification agreements, since the Company has not had any prior indemnification claims, and each claim would be based upon the unique facts and circumstances of the claim and the particular provisions of each agreement. In the opinion of management, any such claims would not be expected to have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition or cash flows. The Company did not have any related liabilities recorded at December&#160;31, 2022 and 2021.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Loss</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTU5_411977e9-6c46-4444-8424-7f245082c941" escape="true">Comprehensive loss includes certain changes in equity that are excluded from net loss. Specifically, unrealized gains and losses on available-for-sale debt securities are included in comprehensive (income) loss.</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzMyOTg1MzQ5MTk4MDU_35193185-2dc8-4850-b2dc-0ca29b6bc0dd" continuedAt="i03c8f9215df64314a61010570369c710" escape="true">Reclassifications</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i03c8f9215df64314a61010570369c710">Certain prior year amounts related to inventory categories have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations, financial position or cash flows from operations.</ix:continuation> </span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_118"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. Revenue from Contracts with Customers</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as a single reportable segment. The Company has one sales force that sells the Company&#8217;s Spatial Biology and its nCounter Analysis systems and the consumables and services related to these platforms.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenues</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table of total revenue is based on the geographic location of end users or distributors who purchase products and services. For sales to distributors, their geographic location may be different from the geographic location of the ultimate end customer. Americas consists of the United States, Canada, Mexico and South America; and Asia Pacific includes Japan, China, South Korea, Singapore, Malaysia, India and Australia.</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzI0Njg_3d9a468a-c72c-447b-9ee3-922ae680cd97" continuedAt="i64d46d9352ed4b3286f9bd1b8fc774a8" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about disaggregated revenue by major product line and primary geographic market (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe and Middle East</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67acad69085c486998c2baaf6125dbb3_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtMS0xLTEtNDg5MDY_e2a7e056-f964-44db-9025-39d3f4d37b06">21,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57df71b94ca142fdaca927a766348294_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtMy0xLTEtNDg5MDY_ebf47be2-b2c8-4262-95e2-4a9c6fd039db">9,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7881895472d449e994899c6bc6580f05_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtNS0xLTEtNDg5MDY_60c86374-6174-4f42-b522-17fbd61073b5">6,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713c836ec9944621af76e4eae6676d6b_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtNy0xLTEtNDg5MDY_7ef51e38-f335-4eea-b0ca-7f58b798f23c">37,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13689abdf06042ddb61fe7e5dde76571_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtMS0xLTEtNDg5MDY_2ce10dcd-8023-4089-bf09-87ff69aeae95">47,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6199bdcbfda84b76b59695fbd415666b_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtMy0xLTEtNDg5MDY_31681800-abee-458b-a3ce-ec4b89025498">18,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b4cc48ab884deb9ac79ec4f88a41b6_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtNS0xLTEtNDg5MDY_0e0ba084-0015-445c-9757-ee6652910ef4">3,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0379bf7b398f48e4b7eb5e0d0e117124_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtNy0xLTEtNDg5MDY_2c36f0ed-34d8-4175-9b61-4b97c52f7b3e">70,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b0d645787549928cc28c4236afb570_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtMS0xLTEtNDg5MDY_eb784229-2856-45c1-afa7-fd3a188039c3">69,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d209ba775a4742bb51365dce4d0e27_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtMy0xLTEtNDg5MDY_5698b15f-66a4-44b8-8a21-37724b7589e2">28,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43e18e2336e4176a4c6d0b1837d8ab8_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtNS0xLTEtNDg5MDY_2ac6c39e-0a95-4ec5-8004-1aef72785056">9,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtNy0xLTEtNDg5MDY_6dc79303-c57a-4ff7-9ccd-d27012d1c046">107,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08998380f6294f76a8041abec23394b0_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtMS0xLTEtNDg5MDY_b0704f6b-2445-4dc9-a76e-4b1e19c25331">13,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeeae230b2594a1b942b9d452bd93424_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtMy0xLTEtNDg5MDY_6d1df848-d01a-4373-affb-82ae132a1f9a">4,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i250e7fef9d9e4aa4bae1f66f612bb047_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtNS0xLTEtNDg5MDY_3f2235db-425f-438e-8267-922baa3d06ae">1,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtNy0xLTEtNDg5MDY_1224b5e8-ab34-4beb-a522-eb2d795e7599">19,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb01752d3d024e9cbe624ff2311e1e86_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctMS0xLTEtNDg5MDY_71caaf52-655c-4346-975f-71088dec27cd">82,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f5ff287b4347d1befb9409e6d22447_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctMy0xLTEtNDg5MDY_0021ef5a-e1e1-4c0f-afa4-2460dfbc97fb">33,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf083ef64fc4b2d84ed1522343a92d0_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctNS0xLTEtNDg5MDY_770acdd8-08db-49af-9292-ce9652d32027">11,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c31fff231034b729e619b1e5ddad70f_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctNy0xLTEtNDg5MDY_6ec8bdc7-31d2-4554-8d52-d8883f76a3e9">127,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i64d46d9352ed4b3286f9bd1b8fc774a8"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe and Middle East</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7884244270dc438fb94c45d2b041e5ed_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtMS0xLTEtNDg5MDY_400a87b3-84fe-4e6c-b524-ea1e31c1e5c2">31,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2ec65972a6419abe9a03a19e5ca95e_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtMy0xLTEtNDg5MDY_7ed56cbe-12c7-4b96-b64c-603b6974a90d">14,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94493508e1514eb89d02a2be8a07f60b_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtNS0xLTEtNDg5MDY_22a0fd9d-0043-406d-a372-695647492f8d">9,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fa8408bcb64e98b3b17b2bb9a06863_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtNy0xLTEtNDg5MDY_1fcf93cd-8b73-4626-8d0f-99cbb67ed47f">55,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedfeb39178b47b0973327433aeaf39c_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtMS0xLTEtNDg5MDY_3bbffd9a-618b-4472-af9d-399f02d2ac1a">50,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib388af030dc445f1b7cfea35477d3be7_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtMy0xLTEtNDg5MDY_52ac9be4-9579-4394-b53a-5198a269d686">16,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1f01e51b674ab4ad411dde4e1e0d89_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtNS0xLTEtNDg5MDY_52a81548-f930-466f-b963-e31aa85034cd">5,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8071ca8672d449bd949728204b07a2fe_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtNy0xLTEtNDg5MDY_c41c56e8-971d-4760-a62b-f1f7841bc5b1">71,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d86a75d4d54b8b9ca2f0ed1e4dacf9_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtMS0xLTEtNDg5MDY_ff1e026b-5eb4-4ce6-bc65-047d27e91c67">81,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444caf10ca684a0aa194a919b86211e2_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtMy0xLTEtNDg5MDY_6ccab7d7-c50b-4a15-bbeb-5ba3ded8ccc2">31,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f366fc7210642de991dae318729cecb_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtNS0xLTEtNDg5MDY_b970ebe9-6a12-4c95-a0e7-e276f8cd6e58">14,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtNy0xLTEtNDg5MDY_bc2edf22-1631-4d77-a24c-151e6f4d3d09">127,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i373fc6e51acf48be9c6990e509965c68_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtMS0xLTEtNDg5MDY_bb7bc65b-62a7-448d-9ebd-49a8f809bb08">12,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda942559fe4cc4a3fca242a605e4b1_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtMy0xLTEtNDg5MDY_4a7a30bf-162f-41f0-96e0-9273cc4fbbdf">4,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47b8c1b821a4938a48a69fe46c6555a_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtNS0xLTEtNDg5MDY_4ff77dab-ef4c-467e-ba7f-d7b8c1d2e8b8">1,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtNy0xLTEtNDg5MDY_64708f00-189d-4be4-94a0-a5d7e6396aca">17,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ebd85ce49641b1bdcfb50f620c8c7f_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctMS0xLTEtNDg5MDY_ed7898ca-c4ca-4c75-bbdd-635cc9affe03">94,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809c69b254ec43d4b295def456b0bcb9_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctMy0xLTEtNDg5MDY_eb15e35a-1c2f-4dec-9827-954169534a1a">35,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d61518cf22490287052068a75aee69_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctNS0xLTEtNDg5MDY_77ed5737-a67e-4dba-94de-2910afed3e94">15,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87797cb7eb2d4e539e26bf057f66d572_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctNy0xLTEtNDg5MDY_5582f0fc-6dea-438a-a798-f6a9765d2386">145,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe and Middle East</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae0f86555864368b0aea5d051ac1266_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtMS0xLTEtNDg5MDY_e16d72f9-99d0-4a81-9839-3daa39e8ed00">30,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52a0df2c7f04de89a0e5830fdb770ba_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtMy0xLTEtNDg5MDY_17c448dd-1e1d-47f8-a0e6-a002cf2ea2e8">11,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04035e9e28485eb3acf369367687f8_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtNS0xLTEtNDg5MDY_cb6b06de-e421-4359-8218-cc483c763b1e">6,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce94de1d746480a975bbf68e8d2ff1a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtNy0xLTEtNDg5MDY_a2a01596-c7cd-4c43-81f2-e6c7394852b4">47,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47ab74aed5247f7a85777c81bd4cb68_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtMS0xLTEtNDg5MDY_729ef9be-220e-4b84-952a-391b888e26fc">34,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837b13ea09c546889d1c1f1898e0cb63_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtMy0xLTEtNDg5MDY_e003259f-c7fb-4be0-b0c1-6cff782a31b5">12,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib14cac7c7a3349a2abe346fa98dfc66e_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtNS0xLTEtNDg5MDY_f026126a-d490-4909-9944-67c05d950aac">2,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8abb7a1a694dd4b9681e6a239af1f5_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtNy0xLTEtNDg5MDY_b9698a94-d35f-4468-9a7c-dcde206d73bf">50,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a7b631fee1428b98faf94c3babda50_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtMS0xLTEtNDg5MDY_092124d8-da36-42bb-b971-ce26fe214a16">64,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f05c9834f4542e9b3cdf441d7ded71a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtMy0xLTEtNDg5MDY_37ee3dfa-b0dd-4484-a8bf-3c530a7a1669">23,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57da356bd80040d28979b0ee90029081_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtNS0xLTEtNDg5MDY_18546199-c2af-48aa-9035-cc14d9994137">9,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtNy0xLTEtNDg5MDY_23197d96-0118-44ba-a420-17da239566e6">97,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989ed5565898409da03fcb97e7c4573a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtMS0xLTEtNDg5MDY_b33f90e2-fe15-485a-81bb-51f222cd93d1">14,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7328fd0fcb413d860b955b14b25b47_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtMy0xLTEtNDg5MDY_28666f43-1f63-4159-bd2a-b68abda8e8c2">3,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c61765d11da43eaa6620b24fb7a3b84_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtNS0xLTEtNDg5MDY_9100fcd5-71c6-43e5-b659-42af91911383">980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtNy0xLTEtNDg5MDY_af63afe6-6e59-4e15-ae10-94458ef6d9b3">19,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8421365accd4534bbc761089b030e05_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctMS0xLTEtNDg5MDY_2bbb322c-efd4-49f4-a43f-62fd612e2940">79,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf2ffe55aec47f69e976f20986eb3dc_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctMy0xLTEtNDg5MDY_c2c24ee1-e485-4617-b5fe-de91d84623e3">26,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534ef05250b74206a3469e1b8edd612a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctNS0xLTEtNDg5MDY_ac8872d0-9eef-4779-88ce-1643249084b1">10,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if93686ec4ea743a4ba48bb454b4a79e4_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctNy0xLTEtNDg5MDY_81d0e989-e554-4e75-8785-fd12c30095cb">117,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue in the United States was $<ix:nonFraction unitRef="usd" contextRef="i73ce0b36a12d45cf88cbf303484474d8_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEwNDA_c23d7d35-eac2-486b-b8cf-b1fc0841d402">79.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7695a3a71d2e46c78f0a9751fa7e65e4_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEwNDQ_1ad83a78-7ef7-42d3-8555-4c74f6819e9b">91.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iae168f9ba93c4702893c848d0c6e17f8_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEwNTE_4ca2251e-eb3f-4fc8-8a52-30ef1c542320">77.5</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively. The Company&#8217;s long-lived assets are primarily located in the United States and not allocated to any specific geographic region.</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances and remaining performance obligations</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are comprised of the current and long-term portions of deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEzOTY_e29e2d7a-0d29-46a4-953e-3c4b4812c28b">13.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE0MDM_e2edc119-1ac3-44ba-8d1c-06f96802c937">10.3</ix:nonFraction> million as of December&#160;31, 2022 and December&#160;31, 2021, respectively, and customer deposits of $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE0NjI_ad5c0a3d-d278-4e5f-a1d9-e98bedb0bf90">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-5" name="nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE0Njk_f4e8bf40-c7a7-4383-82b4-0d651ed50f07">1.3</ix:nonFraction> million as of December&#160;31, 2022 and December&#160;31, 2021, respectively, included within the consolidated balance sheets. Total contract liabilities increased by $<ix:nonFraction unitRef="usd" contextRef="ia4584c877dc647338dc50887089aa8d4_I20221231" decimals="-5" sign="-" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE1OTI_72ef48ab-8511-4e39-a0be-447717c5803a">3.2</ix:nonFraction> million for the year ended December&#160;31, 2022 as a result of cash payments received of $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzIxOTkwMjMyNTgwMzY_f11cb759-4366-41a2-9714-aa2eb2e1cdf3">15.2</ix:nonFraction> million related primarily to new instrument service contracts associated with our growing installed base of GeoMx DSP&#8217;s, substantially offset by the recognition of previously deferred revenue and customer deposits of $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzIxOTkwMjMyNTgxMDA_a8a3c055-322a-4d88-b6d3-6c6aa0401730">12.0</ix:nonFraction> million for the completion of certain performance obligations during the period. The Company recorded contract assets of $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE5ODY_267dd237-4092-41bc-a9bc-03968e45ed90">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzMyOTg1MzQ4ODU4ODY_223c9b09-1e49-4e17-b5ed-f01e373c8486">0.7</ix:nonFraction> million as of December&#160;31, 2022 and December&#160;31, 2021 related to revenues recognized, but not yet invoiced to customers. The Company&#8217;s contractual payment terms for its contracts with customers approximate <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzI0NjQ_65869ed6-0fcc-4465-9634-dd8d8e299f82">45 days</ix:nonNumeric> on average.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unsatisfied or partially unsatisfied performance obligations related to undelivered products and service contracts were $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzIzNTY_f55ba104-3873-4dcf-9aad-2fb50eafd233">14.8</ix:nonFraction> million and are expected to be completed over the term of the related contract, or as products are delivered.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_124"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjk_8bf78a79-9856-45d2-8701-6c64043bca4b" continuedAt="i605223e4d8134db093c788c61ab2df13" escape="true">Leases</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i605223e4d8134db093c788c61ab2df13" continuedAt="i3e5651ffe2c44ef4a459e35238e3660f">The Company is obligated to make future minimum payments under <ix:nonFraction unitRef="lease" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="nstg:NumberOfOperatingLeases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzc4_e3b79b33-0571-4540-9178-d9dd5a409dc3">five</ix:nonFraction> primary operating leases which approximate <ix:nonFraction unitRef="sqft" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="0" name="nstg:AreaOfSpaceUnderLease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEyNA_812527fd-4784-480b-9974-17534628714e">162,322</ix:nonFraction> square feet of space used for manufacturing, research and development and general operations primarily in the greater Seattle area. The operating leases have terms that expire from&#160;2026&#160;to&#160;2032&#160;and include renewal options to extend the lease term at the then current fair market rental for each of the lease agreements. None of the options to extend the rental term of existing leases were considered reasonably certain as of December&#160;31, 2022. The Company&#8217;s operating leases contain rent abatement periods, scheduled rent increases and provide for tenant improvement allowances. In addition, the Company enters into finance lease right-of-use assets included in other assets and lease liabilities included in deferred revenues and other liabilities primarily for equipment used in its operations. The Company&#8217;s lease agreements do not contain any material variable lease payments, material residual value guarantees, or any material restrictive covenants. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i3e5651ffe2c44ef4a459e35238e3660f"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjY_01669cf7-9acd-4f8b-bb9a-debddd07d221" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of the Company&#8217;s lease cost (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzEtMS0xLTEtNDg5MDY_28033dc2-c5ac-410b-9ebb-0ab5109e6620">5,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzEtMy0xLTEtNDg5MDY_72696535-cba3-45bf-badc-ecd0505868d7">5,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzMtMS0xLTEtNDg5MDY_d61f8d83-98e2-41f4-aec6-ed9a1e9d7a9e">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzMtMy0xLTEtNDg5MDY_79e68bc9-f6e0-40c2-9f8c-12833b827587">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzQtMS0xLTEtNDg5MDY_30b426c1-97bd-40a7-8f14-9f3c30f66210">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzQtMy0xLTEtNDg5MDY_c33829c9-53e3-4c7d-8a5a-69f445e69d2f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzUtMS0xLTEtNDg5MDY_f7f70a0e-630c-42fe-9fd5-ef6475004b8c">5,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzUtMy0xLTEtNDg5MDY_e2c29049-bbb3-4777-bead-c2ad18ceacdd">5,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases for the year ended December 31 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.399%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzItMS0xLTEtNDg5MDY_49cedacb-f834-4b7c-857a-6244b285e644">6,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzItMy0xLTEtNDg5MDY_743dd7f1-020f-4a60-9397-403d783993f3">6,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzMtMS0xLTEtNDg5MDY_e6ce9d12-a773-4162-9520-4b9fcdccdf43">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzMtMy0xLTEtNDg5MDY_4573d879-b99d-48fa-bf7d-88eac851ca68">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzQtMS0xLTEtNDg5MDY_ff175d29-bbd5-48c3-ac36-f1c8d9a351cb">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzQtMy0xLTEtNDg5MDY_92142a03-2307-49c5-8452-7470b4284e56">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzYtMS0xLTEtNDg5MDY_50dd02b0-60e7-4157-9dcd-ce2d49c9cbd9">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzYtMy0xLTEtNDg5MDY_63b9bc20-c437-4b15-9f74-9ae615187d09">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzctMS0xLTEtNDg5MDY_a7006d65-28f8-4cce-bd50-f02f657f27c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzctMy0xLTEtNDg5MDY_c8e8cb58-4915-44e2-86cd-2c4f754833d6">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzEwLTEtMS0xLTQ4OTA2_8dab03c8-5a41-4b9c-aee3-9678fb25344a">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzEwLTMtMS0xLTQ4OTA2_87157f62-0289-4b65-b72b-4cd0443b46ee">4.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzExLTEtMS0xLTQ4OTA2_a29ed195-328f-417b-8e96-dc37d5b1bb6a">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzExLTMtMS0xLTQ4OTA2_8fbd833e-1807-4814-bf88-e2703e3d341c">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE0LTEtMS0xLTQ4OTA2_fc23cf1f-d896-48a6-8d53-294444e370e7">1.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE0LTMtMS0xLTQ4OTA2_213bc2f5-d7e8-4c01-b39d-2d161781ff1e">1.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE1LTEtMS0xLTQ4OTA2_916b738b-0f75-459c-b105-55da903c01ef">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE1LTMtMS0xLTQ4OTA2_e1f47efd-ef3f-4580-8ae8-ac2ec217549f">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjg_5ab11d80-14bc-4ad2-9456-9545d0e17b85" escape="true"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjg_9ce7a912-fffd-4d60-8525-3b42679d4878" escape="true"><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzEtMS0xLTEtNDg5MDY_b9d31669-5773-430d-9a8d-b935c6261caf">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzEtMy0xLTEtNDg5MDY_3b2db6f2-2106-4537-9ba4-4176960ee5e0">6,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzItMS0xLTEtNDg5MDY_ac913bd2-e944-40f7-b2c1-75d0dec64a76">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzItMy0xLTEtNDg5MDY_90c69e4c-ccc8-40bd-a759-acb7bb8f1f54">6,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzMtMS0xLTEtNDg5MDY_8a9f3b89-8887-41c8-9056-8bed2e08b7d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzMtMy0xLTEtNDg5MDY_33a02c83-b1d5-469e-b2cf-ff2b6983e008">7,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzQtMS0xLTEtNDg5MDY_6f04765e-18ac-49b9-9b5a-02093b9209d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzQtMy0xLTEtNDg5MDY_517fb1df-2b32-48d2-81a0-b33871b9340a">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzUtMS0xLTEtNDg5MDY_5ba7514b-563d-468c-ae66-c7a77804ea46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzUtMy0xLTEtNDg5MDY_e4411e3a-f592-46e3-aa32-d1c719cdaf34">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzYtMS0xLTEtNDg5MDY_efe3fd66-b3ef-4b6f-b2d3-0b16a5425539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzYtMy0xLTEtNDg5MDY_566b4831-5f40-49e3-b5d2-530a0f9fad54">4,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzctMS0xLTEtNDg5MDY_a99b79d0-15b6-4c41-a062-beb233fd8917">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzctMy0xLTEtNDg5MDY_5a5771a1-67e7-48f9-bf62-5506cc304337">29,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzgtMS0xLTEtNDg5MDY_97dca7fb-6a25-44e6-af9d-3e91acda92b6">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzgtMy0xLTEtNDg5MDY_e4a9da09-ef6c-4f0b-88ab-f0ceea431cf2">5,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5">Total</span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMS0xLTEtNDg5MDY_f83d2b8b-4a09-45ce-b777-74204a5083bd">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMy0xLTEtNDg5MDY_82549cb7-dd87-4bd6-bcbc-8a90be6bc8c8">23,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1NDk_58aac524-773e-4943-9743-5dd936f476fa" continuedAt="i7ec0ff22814f46f48bcb2dfff95343d9" escape="true">Short-term Investments</ix:nonNumeric></span></div><ix:continuation id="i7ec0ff22814f46f48bcb2dfff95343d9"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1Mzk_13f026fe-4154-447d-a24e-e4b7a63fc058" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consisted of available-for-sale and equity securities as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized&#160;cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtMS0xLTEtNDg5MDY_a4400130-938e-40c0-8db4-3b1f01df3e42">62,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtMy0xLTEtNDg5MDY_1c7d32d4-553c-44df-ba87-3c5bf933dca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtNS0xLTEtNDg5MDY_1146ba00-b9f3-47cc-9c2f-f993e7a184df">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtNy0xLTEtNDg5MDY_4c9b95de-d0ba-4cb3-a472-06289c4c508d">62,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItMS0xLTEtNDg5MDY_dbeeb7e6-3b9d-4c56-a2b9-82583d9dde37">22,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItMy0xLTEtNDg5MDY_bd1bb143-556a-4367-86b8-a16484b05d7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItNS0xLTEtNDg5MDY_a8a647cd-4149-499c-aa72-7d2626c6add0">230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItNy0xLTEtNDg5MDY_e98dffc2-4a25-40e2-b104-c93cd446852f">21,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtMS0xLTEtNDg5MDY_34671ce1-3aec-4ce7-be8c-871fdd546b13">84,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtMy0xLTEtNDg5MDY_af9b7941-a524-425d-b3ed-8cf9f8c79a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtNS0xLTEtNDg5MDY_9cf3cd93-27d9-4135-8229-f4984cbd88d3">589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtNy0xLTEtNDg5MDY_1585588f-ef8c-49ce-948c-f9760283ad69">84,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized&#160;cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtMS0xLTEtNDg5MDY_4acaf2ac-c33e-4b81-bbd8-b136378a3eea">177,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtMy0xLTEtNDg5MDY_0c8b682b-46d4-4f70-81c2-28f83d0c134f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtNS0xLTEtNDg5MDY_2f7a33af-bc5c-4f72-81d6-6254ec4b408a">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtNy0xLTEtNDg5MDY_d1613761-66dd-4976-9ae4-a286f1ff9173">177,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItMS0xLTEtNDg5MDY_c2318989-6530-4694-b9b8-9f1e5da919e1">33,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItMy0xLTEtNDg5MDY_1feafe49-cef4-4aa0-a3b0-a9c4faa3b68f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItNS0xLTEtNDg5MDY_3bfa1463-9c4f-449d-bb11-bd5dc0385aab">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItNy0xLTEtNDg5MDY_a4094087-4f59-419e-8555-544f781fc35e">33,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtMS0xLTEtNDg5MDY_3ff5a056-3227-441d-9302-aafa9d6d02d9">31,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtMy0xLTEtNDg5MDY_7713e5ac-a7d1-4cc8-ac56-d65d99d9e034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtNS0xLTEtNDg5MDY_557561ee-1a24-4447-b26c-7afc5c983129">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtNy0xLTEtNDg5MDY_782a4e98-dab2-41e6-838d-80804ff51b0d">31,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtMS0xLTEtNDg5MDY_a4124024-babf-45a9-b882-316de033712f">242,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtMy0xLTEtNDg5MDY_14011c34-b3a1-45dd-a8f0-014e922a440f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtNS0xLTEtNDg5MDY_e5cb6556-1c9c-4b1c-827b-6591cf860fb9">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtNy0xLTEtNDg5MDY_cc68fd95-b6dc-4527-b206-ad7854c13615">241,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1NDE_2a248ffd-b7e4-4a20-b5ff-afe0c4b7e944" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of available-for-sale debt securities by contractual maturity at December&#160;31 were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzEtMS0xLTEtNDg5MDY_e9390a9c-5425-4247-adfa-13c57b2e2ae8">81,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzEtMy0xLTEtNDg5MDY_e33ca2dc-a26c-483a-9b23-16bfe7a2e0b4">174,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one to three years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="nstg:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzItMS0xLTEtNDg5MDY_0925b473-1b6e-41be-a7d0-ce820be60fb9">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="nstg:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzItMy0xLTEtNDg5MDY_f2be01e4-4571-4a5a-ab67-2a4077ac714a">67,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzMtMS0xLTEtNDg5MDY_23e307b2-f179-4484-b443-82391515a309">84,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzMtMy0xLTEtNDg5MDY_4efe7a99-1f35-4450-a44a-aa5bc0b0b8f0">241,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has both the intent and ability to sell its available-for-sale debt securities maturing greater than one year within 12 months from the balance sheet date and, accordingly, has classified these securities as current in the consolidated balance sheets.</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1NDg_88032624-bdb3-4c07-851f-a76d94763d84" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes investments that have been in a continuous unrealized loss position as of December&#160;31, 2022 (in thousands).</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItMS0xLTEtNDg5MDY_a65c7852-a6c9-4483-9104-5bfa7ee64f44">10,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItMy0xLTEtNDg5MDY_a06bc807-4a34-4138-9a11-bcc3bb3c8ce7">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItNS0xLTEtNDg5MDY_6a3505b2-2b5e-43e2-859d-49154a8bace2">48,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItNy0xLTEtNDg5MDY_713b2e73-03c9-4445-b4da-14a143f0bb30">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItOS0xLTEtNDg5MDY_d3147663-62a2-46fd-8515-033d026fb2e7">58,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItMTEtMS0xLTQ4OTA2_1addeacc-9be3-44a1-8aa5-8eb402b0d72b">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtMS0xLTEtNDg5MDY_22cfbfaf-8c8f-4aa5-af6b-170d5a628f17">3,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtMy0xLTEtNDg5MDY_5b6260f4-8cda-402c-8864-cf07974657dc">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtNS0xLTEtNDg5MDY_82d2e1ca-e011-447f-b8b3-0867716f1ef1">17,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtNy0xLTEtNDg5MDY_52fbc5e3-b070-4193-9991-fcc73d4bcfbd">214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtOS0xLTEtNDg5MDY_a7c0b974-4048-419c-b581-d1ba18664e18">21,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtMTEtMS0xLTQ4OTA2_f4fe1cb2-6bde-46dc-a017-0b6a07c5b395">230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtMS0xLTEtNDg5MDY_b84a1c6a-7b57-4e33-999e-3f5d397e1f43">14,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtMy0xLTEtNDg5MDY_4d0889bf-c31b-4e2b-911e-daf5c2642301">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtNS0xLTEtNDg5MDY_e45949e0-38fe-4628-a299-3e8943863e7a">66,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtNy0xLTEtNDg5MDY_ad7eec02-3346-49db-95fe-fd52d9bf2a2b">521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtOS0xLTEtNDg5MDY_3d4a3699-7ac7-4fd6-a5b0-63cb60077603">80,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtMTEtMS0xLTQ4OTA2_6038bed1-ccfa-4b8c-a140-b451001ad610">589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests in securities that are rated investment grade or better. The unrealized losses on available-for-sale debt securities as of December&#160;31, 2022 were caused primarily by interest rate increases.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the individual securities in its portfolio for impairment when events indicate the fair value of the investments may be below the carrying value. The Company reviews the individual securities in its portfolio for indications that unrealized losses are credit related and require an allowance to be recorded at the present value of the future expected cash flows. The Company determined unrealized losses were not for credit losses and so did not record an allowance related to its available-for-sale debt investments for the year ended December&#160;31, 2022. The Company did not record any impairment charges related to its available-for-sale debt investments for the year ended December&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3NzE_a3a87b48-e246-4a22-aa5f-8e1a2748f4d3" continuedAt="i02cc53fa72d54e388fb3f26316982a89" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i02cc53fa72d54e388fb3f26316982a89"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3Njc_3c9b5f1e-f424-4cf7-8987-8b4e8b254f1e" continuedAt="i038bbe184bbc44e5a8eb171250caf60d" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a financial liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is used to measure fair value. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i038bbe184bbc44e5a8eb171250caf60d">The recorded amounts of certain financial instruments, including cash, accounts receivable, prepaid expenses and other, accounts payable and accrued liabilities, approximate fair value due to their relatively short-term maturities. The recorded amount of the Company&#8217;s long-term debt can be determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market, which are classified as a Level 2 financial instrument.</ix:continuation> </span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3NzQ_b37fc840-551f-4d0a-93ee-8e38eb98544b" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments by level within the fair value hierarchy were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2022</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value measurement using:</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market fund</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d9089997454bb1a0c3539505c1c38b_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtMS0xLTEtNDg5MDY_3ba5498b-49ab-4457-91c5-61f40ccab1d8">104,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if689c091da7e49acac49fa4109fec584_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtMy0xLTEtNDg5MDY_ba1f5ffb-4e02-4d5a-8366-cb31739b6390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ae9afe71f74d379d16ab886a404393_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtNS0xLTEtNDg5MDY_c24f506e-f6ec-479e-879e-323f4be699dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2492355e51654bb090ebf5513f607ae0_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtNy0xLTEtNDg5MDY_4880ad4d-554e-4f64-bb79-76037c97a91c">104,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f16742116dd49ddb8104eb5bdbcfcdf_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtMS0xLTEtNDg5MDY_fbe8bfcb-baf5-429d-8e98-2d72891d191a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec61848f7a3942d2950cae11486a1ecc_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtMy0xLTEtNDg5MDY_83e71dee-c761-4671-a7e4-652a2f2692fe">62,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ca246e843540f4822dd96a53d66eed_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtNS0xLTEtNDg5MDY_a51e26bd-0dad-4d43-bfd9-c2c6c4fddb34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtNy0xLTEtNDg5MDY_a9fd2a6b-b4b0-4321-927a-441c9c5f6fc3">62,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i322cd850a2794ba0ba08d821a4e1df1d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtMS0xLTEtNDg5MDY_5229ff1b-0277-426e-b90a-0d0683dec9ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9582990fa8164d3a9f1fd4b0ec0ee75a_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtMy0xLTEtNDg5MDY_b37eaea6-7ca8-4f82-885a-806ff30b2e73">21,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874d8d32e3cc4d7f840e2d1ff4b5d402_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtNS0xLTEtNDg5MDY_7c0f3b0e-b893-47d8-ae4c-b5b92a7c7e47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtNy0xLTEtNDg5MDY_b5cfa338-29db-4526-bd6c-3e4e049fa5aa">21,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ba8b859f55484eaada3a17ad6a664c_I20221231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctMS0xLTEtNDg5MDY_f3b0e858-eb56-406e-87c8-3151cb4a5063">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2436c4e22c584140bdea10494b55b14d_I20221231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctMy0xLTEtNDg5MDY_c5899d2a-9c79-41e4-9dba-1714212ba40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1c9aa8e85842fe9bf0570307ef0b9b_I20221231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctNS0xLTEtNDg5MDY_c03ba1c9-5e04-45aa-96c0-a14598734715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d931bc716374b53be3b0b9cefccbf8b_I20221231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctNy0xLTEtNDg5MDY_14d3a559-711f-4fb9-a6ca-0e2c083f7376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc6ee5fcb0649249deb7816da0e2c05_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtMS0xLTEtNDg5MDY_dac4c007-dad6-47f7-bbfd-a990ee32725d">104,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cc509eb60a411cbd96922835a08932_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtMy0xLTEtNDg5MDY_7c4af7cd-1e1f-481f-86ef-4d5591cb0e66">84,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd17be89ff4140d9a06669daa9ea9181_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtNS0xLTEtNDg5MDY_d174f6a0-1326-4830-8a85-430c2c3d16ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtNy0xLTEtNDg5MDY_23f86b9d-75c9-4470-b6cc-8ead05d7ddeb">188,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.788%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2021</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value measurement using:</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market fund</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fa5e6f26b86406fb5758deca06ebe9e_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtMS0xLTEtNDg5MDY_34bbd8a7-8598-401d-8cc5-a1b6abc6dd7d">98,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7acddd71ba8140ab8c19a8a1975fb542_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtMy0xLTEtNDg5MDY_be9db5a1-3e02-4b80-bbcb-4560f6ab6d3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea99fdfabbd4242aee0a5883d8beefd_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtNS0xLTEtNDg5MDY_1d6eadd8-ce0e-420f-8857-89256d74f79f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if449a99cfefe4c7cb63f39a6b7429081_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtNy0xLTEtNDg5MDY_b4b4c783-a38c-4311-8e4c-6f75c46d688c">98,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40784678c00f45dfa31384ea5da6ec61_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtMS0xLTEtNDg5MDY_736e8552-5683-447f-928d-5509ed107ead">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715feed5faf14f819a69f74e70a51b89_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtMy0xLTEtNDg5MDY_5d261da3-ab05-42a9-b7eb-60341e98bcfd">177,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie950f8641c7a4192bee03c298f4d3e9a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtNS0xLTEtNDg5MDY_82573743-bd3d-43b8-a88d-c2a7bebff378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtNy0xLTEtNDg5MDY_5c3f6387-4a96-4781-8452-1e7184caf2fd">177,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11be0a2463245cfbe3d860c3f4e66f1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtMS0xLTEtNDg5MDY_0d31aa42-4d82-4eaf-82be-55f0bded4b64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ided2f9286c924c4f97ec0724c5a6a4e3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtMy0xLTEtNDg5MDY_a23bd4ca-46f4-4b84-adf2-01f2e3f3c78a">33,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f4bf01fc4bc4bc5812e10affa2f9f7a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtNS0xLTEtNDg5MDY_ac3120d2-c937-49e6-96bc-e2b085cf5803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtNy0xLTEtNDg5MDY_1995a47c-9967-47da-8d3f-a95b4bb1005d">33,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023ed3e85c01469e986ad2ce472a4307_I20211231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctMS0xLTEtNDg5MDY_0b072587-042e-4d8a-b51c-72bf8fdb100d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3530905bb7474ab307f49b7ea1e2b2_I20211231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctMy0xLTEtNDg5MDY_21d4ffa8-6528-4cae-ba38-35fcd4ced13d">31,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23c3281ffb1a419384a2c48110d22e1c_I20211231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctNS0xLTEtNDg5MDY_d59b57d2-b434-4c54-ac83-d08552950a9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231" decimals="-3" name="us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctNy0xLTEtNDg5MDY_2703eab2-8395-4fa6-a49b-bf243f99d1d2">31,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5057ef90f9c4541a9b859fbaa260c6f_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtMS0xLTEtNDg5MDY_f0bcaa2e-0886-4300-aa89-57435decb837">98,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0419d16a85d2463b8a5cf1ac63c939d5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtMy0xLTEtNDg5MDY_bf2fcecd-486f-4902-a9c4-e4824b5b294c">241,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7550093a293240458a48f07f2c8c4626_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtNS0xLTEtNDg5MDY_08aad07f-b131-47b1-8fb2-2015456be2ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtNy0xLTEtNDg5MDY_ded25db2-9b7e-47bb-be7a-1ac2c4ef7185">340,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company issued $230.0 million of Convertible Senior Notes of which $<ix:nonFraction unitRef="usd" contextRef="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE1MzY_02e05b59-f2f8-4b0e-a6f3-1ce50ae1b861">88.6</ix:nonFraction> million was used to repay amounts owed and fees associated with the termination of its term loan agreement and revolving line of credit as described in more detail in Note 10. Long-term Debt, Net. As of December&#160;31, 2022, the fair value of the Convertible Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="i7b7ef4b161684e7cacf3f6408767bb84_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3NjM_ba262ddf-fdf8-4375-b3a1-e31e50d8da1b">182.9</ix:nonFraction> million.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_133"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90ZXh0cmVnaW9uOjkxZGE3YmM2MWM3ODRkN2JiMTQ1YzljNjBmZTMwNmI0Xzk2_3dbb67e0-4a72-4a09-b72f-8eb8748f5f5c" continuedAt="ibcac038ad7cd45b9913d30a26f932e54" escape="true">Inventory, Net</ix:nonNumeric></span></div><ix:continuation id="ibcac038ad7cd45b9913d30a26f932e54"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90ZXh0cmVnaW9uOjkxZGE3YmM2MWM3ODRkN2JiMTQ1YzljNjBmZTMwNmI0Xzkz_579a6d8e-60d6-435d-b5a4-8a646307992c" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzEtMS0xLTEtNDg5MDY_c13d08bb-9f16-4629-9bce-3ac41b145b0e">11,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzEtMy0xLTEtNDg5MDY_fa308d9b-bfbc-43b6-b378-afe4b88170bf">5,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intermediate manufactured components</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzItMS0xLTEtNDg5MDY_526c7b4f-9b83-4f99-8b54-37b283a6fdd0">14,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzItMy0xLTEtNDg5MDY_e3d71eb4-20f0-411b-8bed-028f3cea1a9f">10,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzMtMS0xLTEtNDg5MDY_38080517-f559-49a1-a63b-ae4a0143ac85">17,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzMtMy0xLTEtNDg5MDY_f6cce83d-969d-496b-b1f5-3cea851c0c76">14,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzQtMS0xLTEtNDg5MDY_0e6dc72a-3f5b-4d9c-9681-8cf90da633e9">43,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzQtMy0xLTEtNDg5MDY_7fcb7779-5935-4a6a-8f6d-281062d76145">31,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQzNg_0479c6d4-df62-4fb5-a1d4-7fad8cbc8116" continuedAt="idd3c292ed05146d2a5678386a4eae50b" escape="true">Property and Equipment&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="idd3c292ed05146d2a5678386a4eae50b"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQzNA_948bb1c8-16a9-4fa7-8b19-dac8d31e1b5c" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful&#160;Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e88f609f3f146ceaf78b4e74394ba1b_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzEtMS0xLTEtNDg5MDY_c10144d6-c1b9-4c65-8a57-cae8e40d0279">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a1951785ab40e68ae969d7cd3c9742_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzEtMy0xLTEtNDg5MDY_8a981812-c826-4336-85ba-846140bc9cd3">22,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf29bb1eb74475e896a6511b6cf0035_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzEtNS0xLTEtNDg5MDY_4c8a40d8-8e9d-46eb-a7ed-0ede67b29dea">19,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prototype instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie616f0cefcbf4b0fadfa0ca79acf005d_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzItMS0xLTEtNDg5MDY_e222b1eb-c656-495d-9810-d97f0a83506e">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0646dd1f77534091a7aac4d721b6769d_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzItMy0xLTEtNDg5MDY_07105816-b786-4970-812d-98ff6c11d4ed">10,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c89b21a66a04e8d9b27819c58bef518_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzItNS0xLTEtNDg5MDY_4a8b2273-0691-44fa-9ea1-7373cd5ae3e7">2,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i88f1ce22f43b4f6ba059a7cff32daa29_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzMtMS0xLTEtNDg5MDY_096444b9-368a-4a8c-b171-6ce1e1edde9c">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fee9a686a43435ebd9b2af3f2b0bf38_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzMtMy0xLTEtNDg5MDY_92dd5576-b805-4b60-8423-419d4520127b">18,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ab44c9e5dd45638f78be80ead6cb26_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzMtNS0xLTEtNDg5MDY_5d475949-3701-4401-8189-13648b1f18e0">5,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f132592e8314b41869081ee86000fca_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzQtMS0xLTEtNDg5MDY_8f578b48-1971-4fa6-ac00-2fc0bce8dfbb">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae3e7e9820c46b380d5dbba63c1ba21_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzQtMy0xLTEtNDg5MDY_a3f22ec3-5f4b-4d11-8185-2a194308e7db">2,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1160c699fb41ab8078959aa2b71645_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzQtNS0xLTEtNDg5MDY_9a2b049c-cf21-43a6-b637-41fe8c6c75f5">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1906cd27a926473f97dd96ae306e6ea7_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzUtMy0xLTEtNDg5MDY_fc581c27-b430-40cf-98d5-83784d761167">20,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39bb1b648b84d1b8ea0e830f2e097ff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzUtNS0xLTEtNDg5MDY_ae5f874d-5a08-4efd-b9e7-e9ff768bdbf5">19,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad8c07047cd941898973b031735aea40_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzYtMy0xLTEtNDg5MDY_15ea146d-3e71-40e9-ae6b-8385e04291fa">7,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041f0c1d8b534c149cf8210420c68583_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzYtNS0xLTEtNDg5MDY_eb672922-fd3f-42e1-b865-dd203b8e6583">7,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzctMy0xLTEtNDg5MDY_70d2af98-01ca-41b5-b30e-0c1f1dac408d">80,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzctNS0xLTEtNDg5MDY_2c341cc0-e616-4347-9cb1-81eb993c9774">55,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzgtMy0xLTEtNDg5MDY_4de78bc7-7533-4442-a032-12eac2e79e9b">36,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzgtNS0xLTEtNDg5MDY_32def9c2-db06-4be7-af64-693fe2265631">28,460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzktMy0xLTEtNDg5MDY_9b9b6dc8-6551-4d99-bfb2-a84628b56b50">44,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzktNS0xLTEtNDg5MDY_0a472cf1-810b-4302-a81e-598580e4184e">27,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prototype instruments consist of various CosMx SMI , GeoMx DSP, and nCounter instruments used in internal testing and other development activities. Depreciation and amortization expense related to property and equipment for the years ended December&#160;31, 2022, 2021 and 2020 totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQwMw_fa80de26-3dd0-4422-92a6-d9425b46f635">8.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQwNw_3aa470f8-18e9-481a-a1c5-0ebdb930ac02">5.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQxNA_5e0dbe99-2b28-41f6-be9f-8a08abe725d5">5.7</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_139"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTgx_b6bef295-6d67-421f-9a9c-8f9363d1a4de" continuedAt="if688d7b2278249538eee2325346cc6ee" escape="true">Long-term Debt</ix:nonNumeric></span></div><ix:continuation id="if688d7b2278249538eee2325346cc6ee" continuedAt="ib4c727f7efa04c1598724411319f6e91"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company issued $230.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due 2025 (&#8220;Convertible Notes&#8221;) in a private offering. The Convertible Notes are governed by an indenture dated March 9, 2020 between the Company and U.S. Bank, National Association, as trustee. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received net proceeds from the offering of $<ix:nonFraction unitRef="usd" contextRef="id8879a77916d4282a46de289bb9dbdd5_D20200301-20200331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzM5Nw_c294ad28-4777-4354-a60a-847ebfdfc243">222.6</ix:nonFraction> million. The Company used $<ix:nonFraction unitRef="usd" contextRef="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQxOA_02e05b59-f2f8-4b0e-a6f3-1ce50ae1b861">88.6</ix:nonFraction> million to repay in full all outstanding amounts borrowed, accrued interest and fees owed in connection with the termination of the Company&#8217;s amended and restated term loan agreement (&#8220;2018 Term Loan&#8221;) with Capital Royalty Group, and the fees owed in connection with the termination of the Company&#8217;s revolving credit facility with Silicon Valley Bank.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes bear interest at a rate of 2.625% per year, payable semi-annually in arrears on March 1 and September 1, beginning on September 1, 2020. The Convertible Notes may bear additional interest under specified circumstances relating to the Company&#8217;s failure to comply with its reporting obligations under, or if the Convertible Notes are not freely tradeable as required by, the indenture governing the Convertible Notes. Upon conversion, the Convertible Notes will be convertible into cash, shares of common stock or a combination of cash and shares of common stock, at the Company&#8217;s election.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes are general unsecured senior obligations and will mature on March 1, 2025, unless earlier repurchased, redeemed or converted, subject to satisfaction of certain conditions and during the periods described below. The initial conversion rate for the Convertible Notes is <ix:nonFraction unitRef="number" contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzE2NjM_0572c3fc-838d-4d46-98a0-97fac424b105">20.9161</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i03a3e574978345dfbe106d6fac6ec50f_I20221231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzE3MDA_030db5bd-e0c6-4203-90b2-11254aca05de">0.0001</ix:nonFraction> per share, per $1,000 principal amount of Convertible Notes (which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i03a3e574978345dfbe106d6fac6ec50f_I20221231" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzE4Mjg_849e2f35-7bd7-419a-a2bb-aa3e5742de19">47.81</ix:nonFraction> per share). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that may occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such corporate event or in connection with such redemption, as the case may be, in certain circumstances.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the close of business on the business day immediately preceding December&#160;1, 2024, the Convertible Notes will be convertible only under the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on June&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least <ix:nonFraction unitRef="day" contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzI3MTA_3bb49ac1-ea01-4494-bd46-ac0aa24ca9d0">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzI3NzQ_edb92aa3-a238-42f1-b51b-34866ea47a00">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzI5MjM_83bc7fb4-7421-4f08-8201-44ebe9861537">130</ix:nonFraction>% of the conversion price on each applicable trading day; (2)&#160;during the <ix:nonFraction unitRef="day" contextRef="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc2_169cd0fb-ed97-4ec4-9496-fe4240aa3f34">five</ix:nonFraction>&#160;business-day&#160;period after any <ix:nonFraction unitRef="day" contextRef="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc3_ce47c2b3-0e30-4887-aafb-7e9bd3308fd3">five</ix:nonFraction> consecutive&#160;trading-day&#160;period in which the trading price per $1,000 principal amount of Convertible Notes for each trading day of such period was less than <ix:nonFraction unitRef="number" contextRef="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzMxOTA_2ca91bed-401c-4aba-ae16-5a4069e84a0b">98</ix:nonFraction>% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3)&#160;if the Company calls any or all of the Convertible Notes for redemption, the Convertible Notes called for redemption (or, in the case of a partial redemption, if the Company makes an election to redeem all Convertible Notes, irrespective of whether they are called for redemption, to be convertible, all Convertible Notes) may be submitted for conversion at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date as set forth in the related redemption </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="ib4c727f7efa04c1598724411319f6e91" continuedAt="i73e5ff50cb144b6ba380cb88d0bd55a3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">notice; or (4)&#160;upon the occurrence of specified corporate events. On or after December&#160;1, 2024, until the close of business on the business day immediately preceding the maturity date, holders of the Convertible Notes may convert all or any portion of their Convertible Notes at any time, regardless of the foregoing circumstances. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the Convertible Notes prior to March 5, 2023, and no sinking fund is provided for the Convertible Notes. On or after March&#160;5, 2023, the Company may redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the common stock has been at least <ix:nonFraction unitRef="number" contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQ0NzY_65f961c6-6bb3-4198-83d2-ee12e375bf51">130</ix:nonFraction>% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQ1ODc_d1317097-84ef-42b1-b397-a82d3d404701">30</ix:nonFraction> consecutive&#160;trading-day&#160;period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQ4MjY_2240bf76-6af9-4c1b-86a3-9c4da0879ecd">100</ix:nonFraction>% of the principal amount of the Convertible Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of a fundamental change (as defined in the indenture governing the Convertible Notes) prior to the maturity date, subject to certain conditions, holders may require the Company to repurchase all or a portion of the Convertible Notes in increments of $1,000 for cash at a price equal to <ix:nonFraction unitRef="number" contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzUyNzQ_2240bf76-6af9-4c1b-86a3-9c4da0879ecd">100</ix:nonFraction>% of the principal amount of the Convertible Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes do not contain any financial or operating covenants or any restrictions on the issuance of other indebtedness or the issuance or repurchase of securities by the Company. The Convertible Notes indenture contains customary events of default, including that upon certain events of default, <ix:nonFraction unitRef="number" contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzU3NTA_2240bf76-6af9-4c1b-86a3-9c4da0879ecd">100</ix:nonFraction>% of the principal and accrued and unpaid interest on the Convertible Notes will automatically become due and payable. Debt issuance costs are amortized to interest expense using the effective interest method over <ix:nonNumeric contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzc1MTc_89fc7a1b-9774-496f-800d-624e0d1a3a39">five years</ix:nonNumeric>, the contractual term of the Convertible Notes, with an effective interest rate of <ix:nonFraction unitRef="number" contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzc2MDM_8997f1f3-d572-441f-a80d-f4d1c42b6650">3.3</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company monitors the provision of the Convertible Notes that allow for certain conversion rights at each quarterly reporting date in order to determine whether the Convertible Notes are convertible or subject to an event triggering potential redemption during the prescribed measurement periods. As of the date of this report, none of the outstanding convertible notes had been redeemed by the Company. Based on the closing price of our common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzg5MDQ_2be41761-db21-47a8-844b-86ffc90a613e">7.97</ix:nonFraction> on the last trading day of the year, the if-converted values of the Convertible Notes did not exceed the outstanding principal balance as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All future principal payments related to the Convertible Notes are due in March 2025. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc4_a5220c4b-bbd1-453a-89a1-84b24f2b98ce" continuedAt="ida09d09ca5f4484e88b69b72e4943449" escape="true">The outstanding balance of the Company&#8217;s Convertible Notes consisted of the following at December&#160;31 (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="ida09d09ca5f4484e88b69b72e4943449"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal of Convertible Note</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7ef4b161684e7cacf3f6408767bb84_I20221231" decimals="-3" name="nstg:OutstandingPrincipalOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzItMS0xLTEtNDg5MDY_d4cf4c75-037c-4233-baaf-dcaf38885668">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14f75101ca484bf6bac4dc7226b1113e_I20211231" decimals="-3" name="nstg:OutstandingPrincipalOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzItMy0xLTEtNDg5MDY_969cb229-5e9c-4a11-a918-5c943dc83794">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzMtMS0xLTEtNDg5MDY_60375939-5093-49ad-936b-ca086262007a">3,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzMtMy0xLTEtNDg5MDY_1d55f2b2-5ae5-430c-a731-738ae00777c3">4,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzQtMS0xLTEtNDg5MDY_91225477-c0b2-4dac-b058-d7104f56c4e2">226,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzQtMy0xLTEtNDg5MDY_b67c4a0c-ee23-4564-8be9-6107cda09cb8">225,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc5_67d78ec3-033d-4136-bddf-6f8b2ad37ec8" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Convertible Notes (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231" decimals="3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzItMi0xLTEtNDg5MDY_9a599353-ec20-4f44-a1e9-916a9599a61d">6,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231" decimals="3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzItNC0xLTEtNDg5MDY_813d9cba-e3a5-4c12-9a7b-287b6c9c9ab8">6,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231" decimals="3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzEtNi0xLTEtNzA5MTk_d88f8146-9052-4bc2-87e3-696c44f6f5a9">4,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231" decimals="3" name="nstg:AmortizationOfDebtDiscountAndIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzMtMi0xLTEtNDg5MDY_e5d42599-990c-472f-9720-621e1fc83664">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231" decimals="3" name="nstg:AmortizationOfDebtDiscountAndIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzMtNC0xLTEtNDg5MDY_5dbf6a62-86bd-475f-8127-33d0c39c8f56">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231" decimals="3" name="nstg:AmortizationOfDebtDiscountAndIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzItNi0xLTEtNzA5MTk_d9eb4aa7-fa1b-4b05-934d-59b83a634b27">8,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzQtMi0xLTEtNDg5MDY_13e552c7-995e-4115-ba5b-aaab83ec3b3f">7,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzQtNC0xLTEtNDg5MDY_68120534-beb3-47c0-9612-108ad5cfaf83">7,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzMtNi0xLTEtNzA5MjM_f165dde1-308b-4f38-ab91-f45843392d2f">13,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Agreement</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an amended and restated term loan agreement with Capital Royalty Group (the &#8220;2018 Term Loan&#8221;), under which it could borrow up to $<ix:nonFraction unitRef="usd" contextRef="i379a102945f149ae9e804e66bfdccfc8_I20181031" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzk1NjY_2bc860cd-de2e-4d0a-80f4-6dc4e050bbfc">100.0</ix:nonFraction> million, which was due and payable in September 2024.&#160;The Company borrowed a total of $<ix:nonFraction unitRef="usd" contextRef="i10abeac0df484f369c951c1d61608b8d_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzk2NDc_5f446c12-78f4-47e6-97e1-52c25ac1e7b3">80.0</ix:nonFraction> million under the 2018 Term Loan. In March 2020, the Company terminated the 2018 Term Loan agreement. The Company used $<ix:nonFraction unitRef="usd" contextRef="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzk3NjA_02e05b59-f2f8-4b0e-a6f3-1ce50ae1b861">88.6</ix:nonFraction> million of the proceeds from the Convertible Notes to repay in full all outstanding principle, interest and fees associated with termination of the loan. The termination was accounted for as debt extinguishment and the Company recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i27c6ea2f53ac4990ae5f60cf96224bb2_D20200101-20201231" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwMDAz_1b5b6189-6df3-4701-94e8-5c42fa560ebf">6.6</ix:nonFraction> million associated with the elimination of previously deferred financing costs, and for fees and penalties incurred upon termination of the 2018 Term Loan and other costs. These costs have been included as a Loss on extinguishment of debt and termination of revolving loan facility in the Company&#8217;s consolidated statements of operations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i73e5ff50cb144b6ba380cb88d0bd55a3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Revolving Loan Facility </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Company entered into a&#160;$<ix:nonFraction unitRef="usd" contextRef="i8fe33f52f67b4687bbae5622f4312c40_I20180131" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwMzM5_2ff18068-f805-4a2e-8e97-b2200c1ce05a">15.0</ix:nonFraction> million secured revolving loan facility, with availability subject to a borrowing base consisting of eligible accounts receivable. In November 2018, the Company entered into an amended and restated loan and security agreement to increase the borrowing capacity under the facility to $<ix:nonFraction unitRef="usd" contextRef="ie024cf12bf5b4458adc486ea3637775c_I20181130" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwNjE3_2cad2904-ed57-4d8d-9364-043d0c1a1273">20.0</ix:nonFraction> million, amend the borrowing base to include finished goods inventory, and extend the final maturity under the facility to November 2021.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company terminated the revolving loan facility and paid termination fees of $<ix:nonFraction unitRef="usd" contextRef="ibb55eb3463fb43ca895bce6ab03389cd_I20201231" decimals="-5" name="nstg:ExtinguishmentOfDebtTerminationFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwODQ1_9f2e551b-4b08-420b-8367-1663b4365ab9">0.5</ix:nonFraction> million. There were no amounts outstanding under the revolving loan facility at the time of termination. These costs have been included as a Loss on extinguishment of debt and termination of revolving loan facility in the Company&#8217;s consolidated statements of operations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest expense for the Company&#8217;s long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTAw_a8f94ada-ce08-4dc6-8ca2-0d07ddd029c5">7.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8d2647f818e343a1b49e1a59ad9b201e_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTA0_13103d87-1bce-4ac2-8606-65baf3bfa042">7.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i27c6ea2f53ac4990ae5f60cf96224bb2_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTEx_0904b3f0-e378-4d9d-a587-29c222c1e591">15.4</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_145"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzMxMzc_3a51d3ff-c1bb-4f94-8cb8-eee372310de3" continuedAt="i0b5a151928ff492db587b54a827f9cfe" escape="true">Common Stock and Preferred Stock</ix:nonNumeric></span></div><ix:continuation id="i0b5a151928ff492db587b54a827f9cfe"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Offerings</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company completed an underwritten public offering of <ix:nonFraction unitRef="shares" contextRef="i84093a4322da469e83641848f0ea172b_D20201001-20201031" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzcwNg_0b4f4957-9390-46fd-8a3d-109fb6487584">5,750,000</ix:nonFraction> shares of its common stock, including the exercise in full by the underwriters of their option to purchase <ix:nonFraction unitRef="shares" contextRef="id19896e0ae0e48948f3db0dc516f3674_D20201001-20201031" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzgxNg_dc27932b-adc0-49f3-b7d3-a64b1cebc70a">750,000</ix:nonFraction> additional shares of common stock. The Company&#8217;s total gross proceeds were $<ix:nonFraction unitRef="usd" contextRef="i84093a4322da469e83641848f0ea172b_D20201001-20201031" decimals="-5" name="nstg:SaleOfStockGrossConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzg5NA_7bc6a311-6db4-4e04-8de9-b3613b4f0020">230.0</ix:nonFraction> million. After underwriter&#8217;s commissions and other expenses of the offering, the Company&#8217;s aggregate net proceeds were $<ix:nonFraction unitRef="usd" contextRef="i2faccbe8dbb44a7a885e478bce74de3a_D20201001-20201031" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzEwMDg_4500071c-33ad-4971-962e-40f8964b9ddb">215.8</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock is entitled to <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:CommonStockVotingRights" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzEwNjc_1e9c3ae1-7911-4f02-997b-eae690b7fe82">one</ix:nonNumeric> vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of other classes of stock outstanding.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the amended and restated certificate of incorporation filed by the Company immediately prior to the completion of its initial public offering, the Company&#8217;s board of directors is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzE1MzY_80e13ebd-4a9d-45f6-aa50-c598afd2535a">15,000,000</ix:nonFraction> shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, redemption rights, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing change in the Company&#8217;s control or other corporate action. As of December&#160;31, 2022, no shares of preferred stock were issued or outstanding, and the board of directors has not authorized or designated any rights, preferences, privileges and restrictions for any class of preferred stock.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company&#8217;s initial public offering, warrants to purchase preferred stock were issued related to certain financing transactions. All preferred stock warrants were converted into warrants to purchase common stock upon the effectiveness of the initial public offering. In addition, the Company has issued common stock warrants to third parties in accordance with the provisions of certain debt and collaboration agreements. As of December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i61e1f1159955427aa959883a212aa815_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzMwMTk_6d79cbee-ca63-4acf-b700-0935e2bcadd2">470,510</ix:nonFraction> common stock warrants outstanding with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i61e1f1159955427aa959883a212aa815_I20221231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzMwOTg_dd9f4202-3792-4581-b0ae-34df06e4f95c">24.70</ix:nonFraction> per share and expiration dates in 2025.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_148"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2Mjg_19b6fc61-69f9-4a5c-a61c-bbca92643827" continuedAt="i2ae4fd1c6cb648b483bbc896618edeff" escape="true">Stock-based Compensation</ix:nonNumeric></span></div><ix:continuation id="i2ae4fd1c6cb648b483bbc896618edeff" continuedAt="i9bf4a107b6344342a21e382054cc397d"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Plans</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2013 Equity Incentive Plan, 2018 Inducement Equity Incentive Plan, and the 2022 Equity Incentive Plan (the &#8220;Plans&#8221;) authorize the grant of stock options, restricted stock units (&#8220;RSUs&#8221;) and other equity awards to employees, directors and consultants. As of December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i37b3847550434762972bebc67656a85c_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM3MA_74c70cf4-4f98-499a-8175-c92df25d873b">15,057,772</ix:nonFraction> shares authorized under the Plans. The Company has also granted RSUs that include service or service and certain performance conditions, or performance stock units (&#8220;PSUs&#8221;). RSUs generally vest over service periods of 1-3 years at which time award recipients receive shares of common stock equivalent to the originally awarded number of RSUs. In the case of PSUs, the number of PSUs that vest will be contingent on satisfying the service period and also based on achievement of all or part of the required performance obligations. All stock </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i9bf4a107b6344342a21e382054cc397d" continuedAt="i5f4e042ba17f4335834c38e04ba2d975"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options granted have a <ix:nonNumeric contextRef="ie882436ff3ec4475b183dab55fc70afc_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NDk_fa548721-ef1a-42f0-bc80-6798c0d7a0de">ten-year</ix:nonNumeric> term and generally vest and become exercisable over <ix:nonNumeric contextRef="i06a3e3cb294548d8844d3e900432255e_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzk5Nw_f108c92d-9788-42ba-a1e5-05fc5836b4c8">four years</ix:nonNumeric> of continued employment or service as defined in each option agreement. </span></div><div style="margin-bottom:6pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit (RSU) and Performance Stock Unit (PSU) Activity</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and PSU activity under the Plans is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-vested RSUs and PSUs</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Equivalent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average remaining<br/>contractual<br/>term (in&#160;years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic value<br/>(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtMS0xLTEtMTEyMTA0_42e76206-c044-4044-a08e-c63cbf2c68bb">1,333,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtMy0xLTEtMTEyMTA0_090718fd-9ae7-4acb-a8cc-b3295ac4cb84">41.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtNS0xLTEtMTEyOTY0_92bb9efe-6c63-41e5-82af-278555b3e0bb">2.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtNy0xLTEtMTEyOTE0_9fc76c75-be85-4780-a084-d5c80548f6ad">56,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the year:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzMtMS0xLTEtMTEyMTA0_f66a05a3-9946-4af0-9418-adc849965697">2,067,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzMtMy0xLTEtMTEyMTA0_20d74eac-cbd8-46c3-9d70-98d92c558f86">24.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzQtMS0xLTEtMTEyMTA0_970f55ff-a02c-4c3d-9493-664a88ed03a2">759,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzQtMy0xLTEtMTEyMTA0_88e6a329-ebfc-491d-8633-630aebb5dbf4">34.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzUtMS0xLTEtMTEyMTA0_43d9cc13-195f-47aa-982a-fcb3ae23f37e">260,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzUtMy0xLTEtMTEyMTA0_6c2669d4-a62a-4ef1-8717-f1217322283d">36.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9bd905f155547fca3f7022d826550f6_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtMS0xLTEtMTEyMTE0_bc326583-2aad-42ca-880a-1f418bb92997">2,380,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if9bd905f155547fca3f7022d826550f6_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtMy0xLTEtMTEyMTA0_d140966c-913c-46b7-b2cc-01222b202744">29.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtNS0xLTEtMTEyOTQ1_195f64e3-fbb5-4cba-b896-e2a4606a98c9">2.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bd905f155547fca3f7022d826550f6_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtNS0xLTEtMTEyODUz_c6ec5f12-5a79-4e8c-9178-912c6815f133">19,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the RSUs and PSUs is determined based on the closing price of the Company&#8217;s common stock on the date of grant. The fair value of vested RSUs and PSUs was $<ix:nonFraction unitRef="usd" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNzA2MTY_d87823c6-c395-42e7-a275-4041d199a93d">18.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id9ca6a450312485eb2653adb71cd9f5e_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNzA2MjE_a42785b2-d56e-46fd-92c7-5dd1a346747e">11.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8090e4620bb54d97b89cb0dc5214c2ac_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNzA2Mjk_1685c55e-d533-429b-87b5-01a2f5577d7b">7.0</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively. The intrinsic value of vested RSUs and PSUs was $<ix:nonFraction unitRef="usd" contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM2MTA_c29edcd0-5700-466b-8b4a-4a1637b251df">20.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id9ca6a450312485eb2653adb71cd9f5e_D20210101-20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM2MTU_78e068b3-293d-46db-a0d7-b64877dbf9f3">44.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8090e4620bb54d97b89cb0dc5214c2ac_D20200101-20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM2MjM_9ddfe8d6-2ae6-4486-87fa-f91dfcb6d934">12.5</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, the Company modified certain performance conditions of its PSUs for approximately 10 employees in each year which were originally granted in 2020 and 2019. These stock award modifications resulted in incremental stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM5NTc_2806bf23-7517-438b-acb3-0c866ce969ab">3.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjkwOTA_27552e52-9b72-46c5-b419-89f6a47775e2">4.7</ix:nonFraction> million for 2021 and 2020, respectively, recognized from the date of the modification over the remaining vesting period of the awards, adjusted for performance conditions and forfeitures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Option Activity</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NTA_45093632-54a8-41bd-ac0c-0c0deb5960ab" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s stock option activity under the Plans is as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average exercise<br/>price per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average remaining<br/>contractual<br/>term (in&#160;years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic value<br/>(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtMS0xLTEtNDg5MDY_9bf065ed-d96a-41c8-9b5f-d5a6189ccc47">2,017,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtMy0xLTEtNDg5MDY_add7e4b8-9284-4694-8e98-641506fdefd0">16.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtNS0xLTEtNDg5MDY_e68c600b-39ea-44a7-b694-72cb70adb727">5.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtNy0xLTEtNDg5MDY_927e6ac7-0b7d-45f3-9698-a5462c93f4ac">51,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzItMS0xLTEtNDg5MDY_d28086f8-c00a-41f4-b511-09256b63df1d">122,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzItMy0xLTEtNDg5MDY_acea953d-cbec-45a5-9571-8320871d1dc2">21.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzMtMS0xLTEtNDg5MDY_5a40fa56-9f5f-4730-8280-b1b4bc316d80">128,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzMtMy0xLTEtNDg5MDY_4ae34e5b-94ca-472b-bdd8-6f50b4675689">11.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtMS0xLTEtNDg5MDY_afd74cdd-d580-424b-a09f-ea4f842c1d9f">1,766,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtMy0xLTEtNDg5MDY_f09522f8-81ba-4578-a903-b78ab979f41e">17.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtNS0xLTEtNDg5MDY_e339fe04-02e6-4a99-8c22-d1d6f62a687c">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtNy0xLTEtNDg5MDY_972ab722-f1ab-4efc-8b49-1dd7bac12790">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctMS0xLTEtNDg5MDY_200eb4a8-a8c5-4674-b45f-ac72dd80f23f">1,766,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctMy0xLTEtNDg5MDY_881e175d-29cb-4edc-8729-1ac1b1bc7f9c">17.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctNS0xLTEtNDg5MDY_275dd4b4-7fa5-4f87-9046-4c2b12c4d658">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctNy0xLTEtNDg5MDY_2b1a663a-6933-422e-a9fd-6de267199e04">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtMS0xLTEtNDg5MDY_8334764e-593f-4de2-886c-96dc0c252d04">1,682,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtMy0xLTEtNDg5MDY_9e3b980e-2669-4e83-aca9-d5a73fa5f68e">16.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtNS0xLTEtNDg5MDY_b735b398-9a5f-47a5-9cf8-61da97d03aba">3.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtNy0xLTEtNDg5MDY_af9111c0-dc53-417a-ba4b-5131bae7eac6">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value per share of options granted with exercise prices equal to the market price on the date of the grant was $<ix:nonFraction unitRef="usdPerShare" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzE2NDg_14722c92-f981-4798-a800-f81e9bf6b2b2">18.89</ix:nonFraction> for the year ended December 31, 2020. The aggregate intrinsic value in the table above is calculated as the difference between the exercise price of the underlying options and the quoted price of the Company&#8217;s common stock for all options that were in-the-money at December&#160;31, 2022. The aggregate intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIwMDk_4b99656f-a516-4ecc-ac27-cbe7f0e67746">2.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIwMjM_d910e52c-283c-4e20-b656-963382c49817">26.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIwNDE_7cc788a4-3299-4885-a54b-7fb5d8da1c8d">39.9</ix:nonFraction> million during 2022, 2021, and 2020, respectively, determined as of the option exercise date. The fair value of options vested was $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxMzU_1e11749e-efb9-47c9-b7af-6c9622a79b17">2.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxMzk_e406c75d-0c0d-49ac-ac4e-4f90b0d66c1e">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxNDY_7ca40f2c-ee5e-44ec-a538-09af09b4fff4">4.2</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i5f4e042ba17f4335834c38e04ba2d975" continuedAt="i6fb39c32c5af4f2ebd0ab9f446c4633a"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NDM_8affb07a-5181-4f7a-a74e-5fcd87ac744a" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the Company&#8217;s stock options outstanding at December&#160;31, 2022:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if150562d534e43d7a0be36122ba6294b_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo1ZjBmY2Q3NjhmZTQ0NjI0YTcxMWFlYzAzNGQwOTA2YV80_674e36b8-a966-4f41-a03d-80100c54df03">1.92</ix:nonFraction> &#8211; $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c11cf0a91ac4e2a801affae1032e3d3_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo1ZjBmY2Q3NjhmZTQ0NjI0YTcxMWFlYzAzNGQwOTA2YV85_aaccb34e-e8c0-4e60-8ecc-df2fb8afc2a2">12.56</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e84ed8c801a4c209b5bcdc1b70b5652_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMS0xLTEtNDg5MDY_394046fa-d184-4740-8337-550fae786110">299,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6c402dc94d04e52bc03498acfaae727_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMy0xLTEtNDg5MDY_e1b8efb3-bdc0-49c8-82bd-0cc771d20a13">4.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e84ed8c801a4c209b5bcdc1b70b5652_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItNS0xLTEtNDg5MDY_b744a89b-091e-4568-ac4c-7a1dce278f07">296,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6c402dc94d04e52bc03498acfaae727_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItNy0xLTEtNDg5MDY_3a68f501-6da6-4e62-af91-462f12f1f907">4.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i06cb2e813155412ca9d4aa066e0dbf5f_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpkMTU3YTU5YTdkZmM0NDI1ODhmODk2OTQxMmFlYWY0ZV80_527a02b3-ff29-4620-9749-122712baad5d">12.77</ix:nonFraction> &#8211;&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="ib8338f87419c456caacda88b6cd45d60_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpkMTU3YTU5YTdkZmM0NDI1ODhmODk2OTQxMmFlYWY0ZV85_892f541b-c4b0-4f63-8030-da42cdb50c24">14.99</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c0f72610203463a91933df13c0ef863_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMS0xLTEtNDg5MDY_a697fbbb-1bc0-4c29-bd55-527be8d6a572">465,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i363fd23d862d49c197424ef927db40d5_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMy0xLTEtNDg5MDY_78999de4-2641-49df-b16f-6e26859fb457">2.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c0f72610203463a91933df13c0ef863_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtNS0xLTEtNDg5MDY_0b7ba4f9-0aaa-4017-9e38-1b81fbfb6376">465,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i363fd23d862d49c197424ef927db40d5_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtNy0xLTEtNDg5MDY_48fc6e30-8fdd-4eb5-9c4d-f813013039ba">2.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ifdbe64c654004a0a9c1b1eb652e096c2_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjoyZDlmYjgwZmUzYWE0Nzk3ODdmY2M4YWY3OTE1Y2RiNl80_a8d4a283-0cfd-4e88-b0cc-4ab30f351dd3">15.21</ix:nonFraction> &#8211;&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i5e02806cedd34a0fbaa454cc75f64d39_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjoyZDlmYjgwZmUzYWE0Nzk3ODdmY2M4YWY3OTE1Y2RiNl85_765c4c21-aed7-403a-8adf-d8ebab2e3399">18.55</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia12bfc1b8c634d16b3b4fe87b81c81ed_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMS0xLTEtNDg5MDY_a87b9777-c1de-477f-a945-bd8d650ab1f1">232,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae43c7b0912d44d4adbf7a74d6cc5170_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMy0xLTEtNDg5MDY_8a4e07d9-0e5e-46b1-90b6-faeb6a3c3c74">2.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia12bfc1b8c634d16b3b4fe87b81c81ed_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtNS0xLTEtNDg5MDY_a035680c-2154-4183-b5b5-57fce4eda489">224,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae43c7b0912d44d4adbf7a74d6cc5170_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtNy0xLTEtNDg5MDY_dc7e7b39-8600-4809-b3dd-fbdd89515f35">2.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ie35e27d21c994c8f8ed1289ffa420eba_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo2ZDczZDNjMzA0OGI0ZjYzYTMwZjJhNTQ3OTE5ZGZhZV80_0bc079b7-764c-4a94-b76c-b61d5857369b">18.68</ix:nonFraction> &#8211;&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="id93d18101d134e09b27b73519d3e467a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo2ZDczZDNjMzA0OGI0ZjYzYTMwZjJhNTQ3OTE5ZGZhZV85_ec0adbc8-9616-4dfe-b004-ae2c26240360">22.71</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b5c097161754a66a79ba216e1fe8e69_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMS0xLTEtNDg5MDY_5c0fc4df-faff-41b9-a526-151d4f330696">297,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifbc4a5733a414b0ca670822be669b552_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMy0xLTEtNDg5MDY_9f5a97cf-6db3-4a67-8d77-e93b535e9ee7">4.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b5c097161754a66a79ba216e1fe8e69_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtNS0xLTEtNDg5MDY_8425ed2c-3e31-46e7-b126-031ff6dd6daf">278,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifbc4a5733a414b0ca670822be669b552_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtNy0xLTEtNDg5MDY_faf96910-32e2-4561-a163-139a0442cefe">4.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if75c1d4d9c4747288ef5603464fb5fbb_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjphOTkxODlmYjgxOTg0ZDczYjdmMTg2ZWU2MzIxMTZlYl80_7d9e03f8-27d5-4f97-af19-15ae82f15c6e">23.00</ix:nonFraction> &#8211;&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i39adc3163bb94109b81e6d5dad488eb1_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjphOTkxODlmYjgxOTg0ZDczYjdmMTg2ZWU2MzIxMTZlYl85_c9316ea3-4cc0-4e3b-a338-aa058bbfdd3e">66.91</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7eb61034aec1476781aa07ee2f8562ab_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMS0xLTEtNDg5MDY_9bc0f652-7965-4b79-a6b2-52652cfabdae">471,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie2dad374da0b48fa915dda42f71ff71b_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMy0xLTEtNDg5MDY_d231d039-3298-41ce-a266-d3f208a6e64a">5.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7eb61034aec1476781aa07ee2f8562ab_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtNS0xLTEtNDg5MDY_9c4ff304-8697-4a95-9d31-9a672f71ce57">417,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie2dad374da0b48fa915dda42f71ff71b_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtNy0xLTEtNDg5MDY_9f375b57-70a0-4609-9400-3957d4743b16">5.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzctMS0xLTEtNDg5MDY_34380a48-fcb2-43ed-a25a-4d6e0eca9a83">1,766,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzctNS0xLTEtNDg5MDY_4f9ff0ee-c501-40ef-9b2b-3d8ca7c4e5ff">1,682,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NDU_a788bf30-2c7a-43d8-a2c6-32335cabaf91" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth stock-based compensation expense related to stock-based arrangements under the Plans as presented within the consolidated statement of operations for the years ended December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e0592e249f4ddc84797c7db1802798_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzEtMS0xLTEtNDg5MDY_b9139bcb-f255-46b3-a968-edd458ab20a8">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id359d7f10c7f4650a3ccb3e59f28b9b7_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzEtMy0xLTEtNDg5MDY_409b726c-68a8-4ac4-9d2c-2e80d25f2d7b">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5d477f82ff4c8699615becd441e2e5_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzEtNS0xLTEtNDg5MDY_c22546e0-0809-4275-93e1-e1905354ce6b">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171d7573fd21497682c5ce64be7a7416_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzItMS0xLTEtNDg5MDY_833bac30-e681-4c84-8770-68b5a794d8b2">5,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad73584ddef48af83fd9e76216c9ed8_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzItMy0xLTEtNDg5MDY_2704ce55-cd8f-417c-bf3a-0a5864182a98">5,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f546e62eb5d437190c5f925abdd1993_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzItNS0xLTEtNDg5MDY_fb201711-e877-4911-851e-dbd5396a1c70">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b370a0aa7494558a2684df873b92e31_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzMtMS0xLTEtNDg5MDY_282c587f-72d8-4884-9def-67d0716757bf">15,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cf23c2148a4d728f391d7591fed46a_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzMtMy0xLTEtNDg5MDY_a8d5d005-9315-43b3-bb49-6ec3f7c05c95">21,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54234098f2fe415b99bdab8bf1fb6f00_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzMtNS0xLTEtNDg5MDY_993d1085-4808-449c-92dd-0e9d8cc8d5bb">13,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzQtMS0xLTEtNDg5MDY_e4ff73f3-89c2-4256-ae21-cc883d832173">23,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzQtMy0xLTEtNDg5MDY_d6b41fe1-d46d-4c4a-8330-af3e0b37d98c">28,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzQtNS0xLTEtNDg5MDY_2d42e6d4-f634-4caf-b6cd-3c6d6ab73823">18,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, total unrecognized stock-based compensation cost related to non-vested options and RSUs was $<ix:nonFraction unitRef="usd" contextRef="i74ec37816d5d4d1c9be1f2cc76135e4c_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM0OTU_04ecaa51-f182-400d-9fbf-c1437fd69ad9">36.7</ix:nonFraction> million for awards with a service component and $<ix:nonFraction unitRef="usd" contextRef="i07c9b03e212c4b068eb66593b05efda9_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM1Mzg_e97af877-26a1-4975-ba0c-491c6991cae1">0.1</ix:nonFraction> million for awards with a service and performance component. This cost will be recognized on a straight-line basis over the weighted-average remaining service period of approximately <ix:nonNumeric contextRef="i838d0bd0b6124f28b27371e25ba13e46_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM3MDI_49143ceb-cb16-4378-bdd7-7140f3f5cf3c">2.0</ix:nonNumeric> years, for stock awards with a service component, and less than <ix:nonNumeric contextRef="i846bf5f2f89540e68b6c2e2336234f13_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM3NTM_9cdf3c2b-b611-4011-9295-33098605bbdf">one year</ix:nonNumeric> for stock awards with a service and performance component. The Company utilizes newly issued shares to satisfy option exercises. <ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM4ODU_f1f0d9b8-6027-4815-80f2-1d479ffd1b1b">No</ix:nonFraction> tax benefit was recognized related to stock-based compensation cost since the Company has not reported taxable income to date and has established a full valuation allowance to offset all of the potential tax benefits associated with its deferred tax assets.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation assumptions</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants RSUs to employees, directors and consultants and PSUs to employees and values these awards based on the grant date fair value, using the closing stock price of the Company&#8217;s shares on the date of the grant. Stock-based compensation expense is recognized based on awards ultimately expected to vest using actual forfeitures when incurred. The percentage achievement and vesting of PSU awards are contingent upon the achievement of predetermined tiered revenue performance goals. The Company assesses the probability of the awards expected to vest, based on the performance goals, and if probable, records compensation expense over the estimated service period. Updates to the expected probability are recorded cumulatively and remaining compensation expense, if any, is recognized over the remaining estimated service period.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to January 1, 2021, the company granted stock options to employees, directors and consultants. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2MzY_19938974-368d-4e81-b951-8fdb19b98191" continuedAt="i110d19a448214958949f3d5f4452c0b1" escape="true">The fair value of each employee stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt"><ix:continuation id="i110d19a448214958949f3d5f4452c0b1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.648%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzEtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpmMzUyZjdkZjRlYzU0Y2I4OWNhNDNkZmVmZGJkNDE4Ml80_d50149d9-09d5-47ed-a693-754cff819b00">0.54</ix:nonFraction>% &#8212; <ix:nonFraction unitRef="number" contextRef="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzEtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpmMzUyZjdkZjRlYzU0Y2I4OWNhNDNkZmVmZGJkNDE4Ml85_23ceaa39-a2b8-4997-810c-7e88857d1787">1.69</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzItMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjowMjhiYzBkMzM3OGI0NGZmYmE0MTIwOTM0MWEyMjlhZl80_ada6823e-ce10-4932-aec2-de5c16d5c0b3">6.08</ix:nonNumeric> &#8212; <ix:nonNumeric contextRef="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzItMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjowMjhiYzBkMzM3OGI0NGZmYmE0MTIwOTM0MWEyMjlhZl85_2cd7e771-c624-4de6-b4fe-6dbe9ad142d4">6.08</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzMtMy0xLTEtNDg5MDY_b4d3b463-8e5a-4ad7-86a3-d3d773206e69">&#8212;</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzQtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo4YmZmNDRkZmUyNDY0MGY5YTA5ZjM2MTM1Nzg2OGY5Yl80_a114aa2f-e675-4192-b00a-65bd4b1f05ae">53.0</ix:nonFraction>% &#8212; <ix:nonFraction unitRef="number" contextRef="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzQtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo4YmZmNDRkZmUyNDY0MGY5YTA5ZjM2MTM1Nzg2OGY5Yl85_b156867b-5b3d-4df4-99d8-bb152856e05b">59.6</ix:nonFraction>%</span></div></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rates are based on the implied yield currently available in U.S. Treasury securities at maturity with an equivalent term. For purposes of determining the expected term of the awards in the absence of sufficient historical data relating to stock-option exercises, the Company applies a simplified approach in which the expected term of an award is presumed to be the mid-point between the vesting date and the expiration date of the award. The Company has not declared or paid any dividends and does not currently expect to do so in the foreseeable future. Expected volatility is based on the historical cumulative volatility of the Company&#8217;s stock price.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="i6fb39c32c5af4f2ebd0ab9f446c4633a"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2013 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides eligible employees with an opportunity to purchase common stock from the Company and to pay for their purchases through payroll deductions. The ESPP has overlapping offering periods of approximately <ix:nonNumeric contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731" name="nstg:EmployeeStockPurchasePlanOfferingPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzYyNDk_0c7297de-c577-4ee3-9a73-046218ad5a2c">12</ix:nonNumeric> months in length. The offering periods generally start with the first trading day on or after March&#160;1 and September&#160;1 of each year and end on the first trading day on or after March&#160;1 and September&#160;1 of the following year, approximately <ix:nonNumeric contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731" name="nstg:EmployeeStockPurchasePlanOfferingPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY0ODI_0c7297de-c577-4ee3-9a73-046218ad5a2c">12</ix:nonNumeric> months later. Within each offering period, shares are purchased each <ix:nonNumeric contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731" name="nstg:EmployeeStockPurchasePlanPurchasePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY1NDc_a6638ada-6ee3-4d12-bb95-3c51a74e1ad8">six months</ix:nonNumeric> on an exercise date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An employee electing to participate in the ESPP (a &#8220;participant&#8221;) will be granted an option at the start of the offering period to purchase shares with contributions in any whole percentage ranging from <ix:nonFraction unitRef="number" contextRef="i3ebcaf345b284e6e9623117669975e74_D20130701-20130731" decimals="INF" name="nstg:EmployeeStockPurchasePlanContributionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY3NzQ_14d4c870-13ae-405a-aaf8-463afed85121">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7999389f78ad4a51b40dceb35494cd61_D20130701-20130731" decimals="INF" name="nstg:EmployeeStockPurchasePlanContributionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY3ODA_eac3fee3-7984-4f56-ae3f-4ecab0d41aca">10</ix:nonFraction>% (or greater or lesser percentages or dollar amounts that the administrator determines) of the participant&#8217;s eligible compensation. The participant&#8217;s contributions will be accumulated and then used to purchase the Company&#8217;s shares on each exercise date. The purchase price on the exercise date will be <ix:nonFraction unitRef="number" contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzcwODQ_1025c57e-d8c7-4b48-b791-17c76455a5cc">85</ix:nonFraction>% of the fair market value of the lesser of the Company&#8217;s share price on either the first trading day of the offering period or on the exercise date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, shares issued under the ESPP were <ix:nonFraction unitRef="shares" contextRef="ic623892b482d42ae931b372405773674_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzcyOTE_74be076a-25b2-42dc-8b29-70810e38759e">150,341</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i07b5aa174a6345a0b151fb3b490d437d_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzcyOTU_6c02e40d-b089-4756-836f-da4178b4843e">64,809</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="icad6d38c8f7c4d89a92280b9e15d04b8_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzczMDI_4826cb0c-9bf0-4734-b73d-78edb451e282">89,477</ix:nonFraction>, respectively. The Company recorded share-based compensation expense for shares issued from the ESPP of $<ix:nonFraction unitRef="usd" contextRef="ic623892b482d42ae931b372405773674_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0MDk_7a087715-d921-4e25-ab1c-048eee364cbc">2.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i07b5aa174a6345a0b151fb3b490d437d_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0MTM_2b2088c7-df5c-4a5c-b679-536c68c5c2d3">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icad6d38c8f7c4d89a92280b9e15d04b8_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0MjA_9b860ccf-c4a3-464a-9b75-9f6d00c57e88">0.9</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. A total of <ix:nonFraction unitRef="shares" contextRef="if555a5dd86134313a260b8b540a5deb3_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0OTY_cbf25ae5-db03-499b-9dbd-220dd5897f7c">2,204,647</ix:nonFraction> shares of common stock have been reserved for issuance under the ESPP, of which <ix:nonFraction unitRef="shares" contextRef="if555a5dd86134313a260b8b540a5deb3_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc1Nzk_b3c16709-352f-44da-a4bf-d59d26a56fd6">883,793</ix:nonFraction> shares were available for issuance as of December&#160;31, 2022.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_151"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzMzNA_81919b52-3734-42b0-a5ca-c877033b5f39" continuedAt="iba5024436cbf4cbebc8b791408f85523" escape="true">Defined Contribution Retirement Plan</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iba5024436cbf4cbebc8b791408f85523">The Company maintains a 401(k) defined contribution retirement plan covering substantially all of its employees. The plan provides for matching and discretionary contributions by the Company. Contributions were $<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzI1Nw_d774aafc-c2f5-4e0a-add1-fd5e642a685a">2.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzI2MQ_629647c9-8103-45c8-b1a2-ec1712438f6a">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzI2OA_3cc1358b-6e87-4313-b370-32294b01f0f4">1.7</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.</ix:continuation></span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_154"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNzE_2148130d-e5f8-4281-99b4-90265133c5c8" continuedAt="i93551f122bff4a02bb2dc8296a64aa89" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i93551f122bff4a02bb2dc8296a64aa89" continuedAt="icad6739ae8fd43938886503a7dce9c9e"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNTM_de2488bf-cd81-4d8f-a2d8-03f512d64ec3" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes for the years ended December&#160;31 consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzEtMS0xLTEtNDg5MDY_937efbe1-4a67-49fd-a65b-bc42c04f9a77">160,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzEtMy0xLTEtNDg5MDY_4d65c6e7-067b-4bd3-ac3e-c507edccdf24">116,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzEtNS0xLTEtNDg5MDY_e13fc0b6-1696-408d-ab6b-ce2110dae65b">111,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzItMS0xLTEtNDg5MDY_c11a9835-6a2b-45d0-b389-6902d462fd63">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzItMy0xLTEtNDg5MDY_3ea04c2c-0042-494e-9983-a6c526331839">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzItNS0xLTEtNDg5MDY_0eaeb5e7-40d4-465d-9d32-f91948a3c14a">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzMtMS0xLTEtNDg5MDY_b4408d33-6840-4585-898c-0b6ee49186a9">159,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzMtMy0xLTEtNDg5MDY_9603f3ae-d1c5-4b3c-b174-77d62d04ced2">115,087</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzMtNS0xLTEtNDg5MDY_2735eaf5-5dd8-4a09-acd9-df754a34d5b0">109,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNTQ_04be94fb-5068-401d-a5f0-bdb456f76b5d" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our provision for income taxes for the years ended December&#160;31 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc2480d9afc41299a0dc200f9614cef_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzItMS0xLTEtNDg5MDY_001b48ec-b840-445f-aae1-414daf5daebe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8993d263434600a013126584291fad_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzItMy0xLTEtNDg5MDY_01f70ab7-defa-4402-bed7-436370a1f5ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bff15771ac47c3a9eb0fe25cc0fdea_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzItNS0xLTEtNDg5MDY_14924ca9-210e-4d27-a43f-2d1cb3837e71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35672bdf7a8344d580057c105d3a35f4_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzMtMS0xLTEtNDg5MDY_4eb20571-fefc-4443-a08a-8ffd9131e5b4">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id186117bd3474f299cf9daa35048c269_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzMtMy0xLTEtNDg5MDY_1d40f2aa-0c23-4a81-96fa-894021f8076b">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1acfbe546b94ee9add32ffe159ea86c_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzMtNS0xLTEtNDg5MDY_a0022612-3de6-4820-88e7-c17c01251e65">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzQtMS0xLTEtNDg5MDY_96e68616-3437-47e8-9403-bd1a51d82fee">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzQtMy0xLTEtNDg5MDY_ed948eb0-6082-4922-a40e-4635b5a0e8a5">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzQtNS0xLTEtNDg5MDY_5a137cc9-ce9e-47ee-b6c0-ec6056610892">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNjc_4839c8e1-3f30-4892-b38f-bf27f5b14420" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory income tax rate to the effective income tax rate for the years ended December&#160;31 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEtMS0xLTEtNDg5MDY_a1f2cb55-d6bc-442d-b1cc-bf0205283cb6">33,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEtMy0xLTEtNDg5MDY_ffd50bbf-6165-4f2c-8add-4071fe877400">24,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEtNS0xLTEtNDg5MDY_cb3d7e97-967a-401d-b7b4-30420795d594">23,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on repatriated foreign earnings and other nondeductible items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzItMS0xLTEtNDg5MDY_c002495f-f286-4416-894b-17ad249e532e">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzItMy0xLTEtNDg5MDY_d7d38431-08b3-4c64-a7ee-d0ab805dcc5a">580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzItNS0xLTEtNDg5MDY_75c06355-708b-4232-88fa-f211ff0f11d6">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:EffectiveIncomeTaxReconciliationSection162Limitation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzMtMS0xLTEtNDg5MDY_ac76585d-9242-44b3-b73c-516db18b41cf">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:EffectiveIncomeTaxReconciliationSection162Limitation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzMtMy0xLTEtNDg5MDY_c97d2c21-6128-4676-b169-cbd941cf39d6">5,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="nstg:EffectiveIncomeTaxReconciliationSection162Limitation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzMtNS0xLTEtNDg5MDY_d0cddb0a-49e9-49d8-af77-7906d56b0eec">5,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:IncomeTaxReconciliationChangeInTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzQtMS0xLTEtNDg5MDY_ed39b20e-ecce-4309-a7dc-9619f93cb173">3,501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:IncomeTaxReconciliationChangeInTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzQtMy0xLTEtNDg5MDY_cbbd2421-25d7-4138-a5de-efeb21ce381b">2,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="nstg:IncomeTaxReconciliationChangeInTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzQtNS0xLTEtNDg5MDY_0af7992d-ccd6-447d-9231-9ddeb6bc43f0">3,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzUtMS0xLTEtNDg5MDY_3fea8448-9f7c-48df-80e6-f387c425754b">36,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzUtMy0xLTEtNDg5MDY_118ad5ed-76ff-45d0-b61f-cae2c329cc57">36,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzUtNS0xLTEtNDg5MDY_06909f75-c5e9-4929-a4bd-4377ced83161">21,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in federal and state tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzYtMS0xLTEtNDg5MDY_ef75f42a-2fb9-47b0-98b2-e3b0c15feabb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzYtMy0xLTEtNDg5MDY_4aa22498-48a5-4550-89a6-869f26f06c67">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzYtNS0xLTEtNDg5MDY_1071c529-8030-4d4a-9600-370fcb693c0b">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option exercise windfall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzctMS0xLTEtNDg5MDY_9b3796f2-321a-4872-a2fa-fedddc3c37fc">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzctMy0xLTEtNDg5MDY_16fcb68e-7ad0-4972-ba63-0bca21eba25a">9,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzctNS0xLTEtNDg5MDY_dcf187f5-3d63-481d-b519-48c6affbfa92">7,683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RTP and other true-ups</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzgtMS0xLTEtNDg5MDY_2db961f1-bb84-4dce-a845-01e97de846cb">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzgtMy0xLTEtNDg5MDY_062d1d51-71d0-4127-ab23-07d7c0f44194">2,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzgtNS0xLTEtNDg5MDY_598db505-3ff4-4a15-8aa9-c3900b14b13b">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and foreign tax, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzktMS0xLTEtNDg5MDY_64c0750e-0d46-4206-9bf6-af2510408141">3,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzktMy0xLTEtNDg5MDY_27427769-e75b-4ba1-b500-1ce47f9d59bb">3,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzktNS0xLTEtNDg5MDY_0ff9a238-362b-4eff-b354-74181758950d">2,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEwLTEtMS0xLTQ4OTA2_4e0ddf47-c330-4271-8976-003243523ce2">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEwLTMtMS0xLTQ4OTA2_42215c85-aac0-401a-960a-56c2e4ae5001">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEwLTUtMS0xLTQ4OTA2_3b672941-5e6c-4643-90b1-4b5fd689f902">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="icad6739ae8fd43938886503a7dce9c9e" continuedAt="ifc0d9d31e8c6451ca4ad26249732a5e7"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31,&#160;2022, for income tax return purposes the Company has gross federal and state NOL carryforwards totaling $<ix:nonFraction unitRef="usd" contextRef="i28ef8872ca69434cb82b4ce55d15bd25_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzUyMA_8887bf34-b15d-4752-8ceb-0f047b11ef94">860.1</ix:nonFraction> million&#160;and tax credit carryforwards of&#160;$<ix:nonFraction unitRef="usd" contextRef="i28ef8872ca69434cb82b4ce55d15bd25_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzU1NQ_eae7a2e5-9c84-4428-9074-50d720664ca2">16.2</ix:nonFraction> million. The gross federal NOL carryforwards generated during and after fiscal 2018 totaling $<ix:nonFraction unitRef="usd" contextRef="ifffa3e3faf9c444ba7d318f1c005e08d_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzY0Mw_d9eb6bab-489d-4694-990b-639a7884f50d">389.3</ix:nonFraction> million are carried forward indefinitely, while all others, if not utilized, will expire beginning in 2025 through 2037. The research and development credit carryforwards generated prior to 2018 will expire beginning in 2028. The carryforwards may be subject to limitations under the Internal Revenue Code and applicable state tax law. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not expect to utilize any of its net operating loss and tax credit carryforwards in the near term. The Company may have already experienced one or more ownership changes. Depending on the timing of any future utilization of its carryforwards, the Company may be limited as to the amount that can be utilized each year as a result of such previous ownership changes. However, the Company does not believe such limitations will cause its carryforwards to expire unutilized.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes in the Company&#8217;s stock ownership as well as other changes that may be outside the Company&#8217;s control could potentially result in further limitations on the Company&#8217;s ability to utilize its net operating loss and tax credit carryforwards.</span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="nstg:ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNjE_973937a1-4d30-46b1-89a3-516a26dcdd80" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of temporary differences and carryforwards that give rise to deferred tax assets and liabilities for the years ended December&#160;31 were as follows (in thousands):</span></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzItMS0xLTEtNDg5MDY_442c33dd-701e-4925-9b40-950229bcb3b6">146,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzItMy0xLTEtNDg5MDY_bd1f4ae2-b345-4f0f-a47f-ca3dc9574daa">131,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzMtMS0xLTEtNDg5MDY_f5030ba5-531c-4b8e-b7c0-7522ab8e16de">15,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzMtMy0xLTEtNDg5MDY_234e8889-107d-468d-a343-1a45af8048e8">12,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 capitalized costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="nstg:DeferredTaxAssetsSection174Capitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMS0xLTEtMTE0NTcz_09fae95f-12e1-4f64-8ff1-0cadd525fed7">17,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="nstg:DeferredTaxAssetsSection174Capitalization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMy0xLTEtMTE0NTg0_8c633d99-b067-4f22-ad48-165c8f50ae1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="nstg:DeferredTaxAssetsDeferredLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMS0xLTEtNDg5MDY_d147fa87-3d97-41f5-8d8b-29651c758a0a">5,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="nstg:DeferredTaxAssetsDeferredLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMy0xLTEtNDg5MDY_47066252-ff3d-4f60-9960-8350fd35b74b">6,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzUtMS0xLTEtNDg5MDY_4923071a-02bc-4e0a-a8e2-66e577f54f7b">6,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzUtMy0xLTEtNDg5MDY_f1f96eac-6598-4c9e-94ff-d1d8ff79f164">6,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzYtMS0xLTEtNDg5MDY_65c0a8de-d4df-4e5b-b96b-6bbd8f5499dd">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzYtMy0xLTEtNDg5MDY_6300e886-fbd9-4458-984a-af9f74b26167">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzctMS0xLTEtNDg5MDY_bd71d7b7-a190-4c6e-9bd5-a379333b96b0">12,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzctMy0xLTEtNDg5MDY_a66de2f9-1d20-4bba-8500-b1daddb11f67">10,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets before allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzgtMS0xLTEtNDg5MDY_8614e35f-c3d2-4700-b2bf-c5e9f8cb88de">204,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzgtMy0xLTEtNDg5MDY_de8a04ac-8ae1-49f1-87f1-c2f78ea6a364">167,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzktMS0xLTEtNDg5MDY_d046b65e-5313-47ec-a496-11800ff993df">198,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzktMy0xLTEtNDg5MDY_e1202610-1a5b-4eb7-a3d3-f8ff4f65dde5">162,817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEwLTEtMS0xLTQ4OTA2_e7d4cf7f-35c7-40a1-8e21-9024d9bfda1e">5,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEwLTMtMS0xLTQ4OTA2_7d812d6e-98a8-4fda-81f2-3679a500c7b0">4,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEyLTEtMS0xLTQ4OTA2_cfeece9c-dd9f-4971-81a9-3534e48d67c3">4,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEyLTMtMS0xLTQ4OTA2_0b7bf64d-27a0-4d54-9915-0d283bfa7839">4,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State net operating loss adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="nstg:DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTEtMS0xLTExODY4OA_53d87601-9b90-41ca-b798-085dd60a791f">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="nstg:DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTMtMS0xLTExODY5Nw_9742e70e-60bc-4887-a5c9-657038da3e5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTEtMS0xLTQ4OTA2_ac94ec33-47b6-4fb7-b849-30cc1da20a1c">5,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTMtMS0xLTQ4OTA2_52fec60a-bec0-48e4-88d5-006555435502">4,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets and liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE1LTEtMS0xLTQ4OTA2_4aaac981-6851-418b-800a-9a2c70ee42bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE1LTMtMS0xLTQ4OTA2_d3d5ab8d-7636-496e-aaa2-0c287d7171e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the amounts in the income tax rate table and deferred tax assets tables above reflect reclassifications of prior year items to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a full valuation allowance related to its deferred tax assets due to the uncertainty of the ultimate realization of the future benefits from those assets. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="nstg:ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNzU_5634fe85-c983-4ed6-80dd-2d8beb14d5ce" continuedAt="ic2d6d8d790b64df5ae28e12ed52a74d6" escape="true">The table below summarizes changes in the deferred tax asset valuation allowance for the years ended December&#160;31 (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><ix:continuation id="ic2d6d8d790b64df5ae28e12ed52a74d6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzEtMS0xLTEtNDg5MDY_1eee864d-7195-4d34-8414-dd18c95fc20d">162,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzEtMy0xLTEtNDg5MDY_33d95793-80c8-4ecf-a499-63a38e2dd573">114,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzEtNS0xLTEtNDg5MDY_b62b9721-a6b9-4358-9dd4-39cd3b33a63a">106,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of ASU 2020-06 on debt discount (equity component) deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21fa537a67cc4008a5f886347dd4fca6_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzItMy0xLTEtNDg5MDY_e0fcd561-6cbc-4b4d-bed1-df88dead5bf2">11,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzMtMS0xLTEtNDg5MDY_6d3eee11-1cda-4a36-9579-0bab0b127245">36,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83025943657d49539ea6888045a339de_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzMtMy0xLTEtNDg5MDY_5152b0e4-3cb7-4a66-9dd7-b81cff2d62cc">36,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21a2f01c1b5040569d99fe2b4cc5881b_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzMtNS0xLTEtNDg5MDY_8694c7db-f4a3-4196-8be4-694225966326">8,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzQtMS0xLTEtNDg5MDY_76b32250-99ef-4a57-9ab2-8128c4d62d86">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83025943657d49539ea6888045a339de_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzQtMy0xLTEtNDg5MDY_42490353-85e6-4dd0-865e-d60478fc5215">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21a2f01c1b5040569d99fe2b4cc5881b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzQtNS0xLTEtNDg5MDY_b3ac1d0b-8c0a-4009-b6ca-99df48be6b3d">586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzUtMS0xLTEtNDg5MDY_0d99576b-4efd-44dc-b833-163d0258ceaf">198,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzUtMy0xLTEtNDg5MDY_9d573c2f-7fc9-4e63-9ddb-63d7c63ced4b">162,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzUtNS0xLTEtNDg5MDY_aaf1d87c-9d4e-4e32-bb62-bc3e188925fc">114,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="ifc0d9d31e8c6451ca4ad26249732a5e7"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNzA_b13a3675-5028-4117-9492-36bc48fffba9" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total balance of unrecognized gross tax benefits for the years ended December&#160;31, resulting from research and development tax credits claimed on the Company&#8217;s annual tax return was as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzEtMS0xLTEtNDg5MDY_ec8ea41d-81eb-49f8-ab50-4de3cfe3f415">10,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzEtMy0xLTEtNDg5MDY_c3f598fc-8935-4cc3-817f-234e24d1b648">9,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzEtNS0xLTEtNDg5MDY_f317ef12-71ac-46a6-aa09-707a3eccb1cd">4,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" decimals="-3" name="nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzItMS0xLTEtNDg5MDY_4406bd0d-33a3-4f3e-b759-a1acc24a1869">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231" decimals="-3" name="nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzItMy0xLTEtNDg5MDY_d3c3a0e6-a49e-4f13-a273-b9f70b88951b">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231" decimals="-3" name="nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzItNS0xLTEtNDg5MDY_2fadac7a-e02f-45c4-a351-43feb6f52167">4,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzMtMS0xLTEtNDg5MDY_a0929c4a-4aac-4d54-ac18-3b245cb2ebc3">11,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzMtMy0xLTEtNDg5MDY_aca97906-6bbf-460e-9a06-597263e9c2ca">10,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzMtNS0xLTEtNDg5MDY_5bd23970-6f1c-4e17-8a93-ac6bb3fb2455">9,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies applicable interest and penalties on amounts due to tax authorities as a component of the provision for income taxes. The amount of accrued interest and penalties recorded in 2022, 2021 or 2020 was <ix:nonFraction unitRef="usd" contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzI4MDg_7fbb678b-9ca8-4b83-8dd3-178a7e5febac"><ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzI4MDg_c253e574-21d4-4dfb-9a1f-5381b6d77b81"><ix:nonFraction unitRef="usd" contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzI4MDg_eccde94c-691e-4d2c-82c2-37cbf76952bb">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t significant. The Company does not anticipate that the amount of its existing unrecognized tax benefits will significantly increase or decrease within the next 12&#160;months. Due to the presence of net operating loss carryforwards in most jurisdictions, the Company&#8217;s tax years remain open for examination by U.S. taxing authorities back to 2004.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_157"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzQ0MTY_4dd9056e-6a26-4633-9317-295f64b5d177" continuedAt="i6b0735944d1d499f9a24217b3ea445d3" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i6b0735944d1d499f9a24217b3ea445d3" continuedAt="ie4fc2a33a4e449e29307cd7b69544448"><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">10x Genomics</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2021, 10x Genomics, Inc. and Prognosys Biosciences, Inc., or &#8220;Prognosys&#8221;, filed a complaint, and on May 19, 2021, an amended complaint, and on May 4, 2022, a second amended complaint, against the Company in the U.S. District Court for the District of Delaware. The amended complaint alleges that certain of the Company&#8217;s products, services and components sold by the Company for use in connection with its GeoMx DSP system (the &#8220;Identified GeoMx Products&#8221;) infringe seven patents owned by Prognosys: (a) U.S. Patent No. 10,472,669, &#8220;Spatially encoded biological assays,&#8221; (b) U.S. Patent No. 10,961,566, &#8220;Spatially encoded biological assays,&#8221; (c) U.S. Patent No. 10,983,113, &#8220;Spatially encoded biological assays,&#8221; (d) U.S. Patent No. 10,996,219, &#8220;Spatially encoded biological assays,&#8221; (e) U.S. Patent No. 11,001,878, &#8220;Spatially encoded biological assays,&#8221; (f) U.S. Patent No. 11,008,607, &#8220;Spatially encoded biological assays,&#8221; and (g) U.S. Patent No. 11,293,917, &#8220;Systems for analyzing target biological molecules via sample imaging and delivery of probes to substrate well&#8221; (the &#8220;Asserted Prognosys Patents&#8221;). The amended complaint seeks, among other relief, injunctive relief and unspecified damages (including treble damages and attorneys&#8217; fees) in relation to the Company&#8217;s making, using, selling, offering to sell, exporting and/or importing in the United States the Identified GeoMx Products, as well as the alleged infringement by others of the Asserted Prognosys Patents through their use of the Identified GeoMx Products. The Company has evaluated the plaintiffs&#8217; claims and does not believe that its activities infringe any patent rights held by the plaintiffs. On November 17, 2021, the Court granted the Company&#8217;s motion to dismiss the plaintiffs&#8217; claims of pre-suit indirect infringement and willful infringement with leave to amend the complaint. Discovery is in progress. A claim construction hearing was held on February 17, 2023. A trial is scheduled for November 2023. The Company intends to vigorously defend itself in this litigation. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, 10x Genomics, Inc. and President and Fellows of Harvard College, or &#8220;Harvard&#8221;, filed a complaint, and on May 12, 2022, an amended complaint, against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that certain of the Company&#8217;s products, services and components sold by it for use in connection with its CosMx SMI system (the &#8220;Identified CosMx Products&#8221;) infringe five patents owned by Harvard: (a) U.S. Patent No. 10,227,639, &#8220;Compositions and Methods for Analyte Detection,&#8221; and (b) U.S. Patent No. 11,021,737, &#8220;Compositions and Methods for Analyte Detection,&#8221; (c) U.S. Patent No. 11,293,051, &#8220;Compositions and Methods for Analyte Detection&#8221;, (d) U.S. Patent No. 11,293,052, &#8220;Compositions and Methods for Analyte Detection,&#8221; and (e) U.S. Patent No. 11,293,054, &#8220;Compositions and Methods for Analyte Detection&#8221; (the &#8220;U.S. 10x CosMx Case&#8221;). The complaint seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees) in relation to the Company&#8217;s making, using, selling, offering to sell, exporting and/or importing in the United States the Identified CosMx Products. The Company has evaluated the plaintiffs&#8217; claims and does not believe that its activities infringe any patent rights held by the plaintiffs. Discovery is in progress. A claim construction hearing is scheduled for July 2023 and a trial is scheduled for June 2024. The Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intends to vigorously defend itself in this litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. On August 16, 2022, the Company filed counterclaims in this action alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe the Company&#8217;s U.S. Patent No. 11,377,689, &#8220;Chemical Compositions and Uses Thereof.&#8221; On January 24, 2023, these counterclaims were consolidated with the claims of a separate patent infringement case that the Company filed against 10x Genomics on October 20, 2022, as discussed below.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><ix:continuation id="ie4fc2a33a4e449e29307cd7b69544448"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, the Company was notified of a complaint, dated March 4, 2022, naming the Company and its wholly-owned subsidiary, NanoString Technologies Germany GmbH, which 10x Genomics, Inc. filed in the Munich Regional Court I in Germany, alleging that the Company&#8217;s CosMx SMI system and associated products and services infringe European Patent No. 2794928B1, or &#8220;EP 2794928B1&#8221;, which is owned by Harvard. The complaint seeks, among other relief, injunctive relief and damages in relation to the Company's selling and offering to sell its CosMx SMI system and associated products and services in Germany. The Company has evaluated the claims and does not believe that its activities infringe any patent rights held by 10x or Harvard. A hearing is scheduled for March 2023 in this proceeding. The Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intends to vigorously defend itself in this litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. On July 29, 2022, the Company, through its German subsidiary, filed a nullity action with the German Federal Patent Court in Munich requesting a judgment that EP 2794928B1, as in effect for Germany, be declared invalid and be revoked in its entirety. On February 10, 2023, the German Federal Patent Court issued a preliminary and non-binding opinion in this nullity action finding that the subject matter of the asserted independent claim 1 of EP 2794928B1 potentially lacked novelty and lacked an inventive step over prior art. The preliminary opinion further addressed Harvard&#8217;s seven patent claim limitation requests, referred to as auxiliary requests, which 10x and Harvard seek to have applied in the event that claim 1 of EP 2794928B1, as granted, proves not to be protectable. The preliminary opinion stated that the claim limitations in Auxiliary Request 1 could potentially be used to defend EP 2794928B1 over the cited prior art. The preliminary opinion further stated that Harvard would potentially not be able to use Auxiliary Requests 2 through 7 to establish novelty over the prior art. A hearing before the German Federal Patent Court is scheduled for May 2024 and a decision in the nullity action is expected following the hearing.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2022, the Company filed suit against 10x Genomics, Inc. in the U.S. District Court for the District of Delaware alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe the Company's U.S. Patent No. 11,473,142, &#8220;Chemical Compositions and Uses Thereof.&#8221; On January 24, 2023, the Company&#8217;s claims from the U.S.10x CosMx Case with respect to U.S. Patent No. 11,377,689 were consolidated with the claims in this action. The Company seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees) in relation to 10x Genomics&#8217; making, using, selling, offering to sell, exporting and/or importing in the United States the Visium system and related products and services. Discovery is in progress. A case schedule has not yet been set.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the pending litigations with 10x Genomics and its co-plaintiffs, the Company is not engaged in any material legal proceedings. The Company is involved in other legal proceedings from time to time arising in the normal course of business. Additionally, the Company operates in various states and local jurisdictions for which sales, occupation, or franchise taxes may be payable to certain taxing authorities. Management believes that the outcome of these proceedings and any amounts that may become payable to certain taxing authorities will not have a material impact on the Company&#8217;s financial condition, results of operations, or liquidity.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022 the Company has non-cancellable purchase obligations of $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzQyNzM_f19c9dd6-eecd-4088-b062-8e1c1d64f8a2">70.0</ix:nonFraction> million related to binding commitments to purchase inventory and other research and development items, $<ix:nonFraction unitRef="usd" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-5" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzQzNzE_901769fa-cc0b-4b90-bb00-18153a9dc5f2">62.1</ix:nonFraction> million of which is due within the next 12 months. In addition, the Company has construction contracts, associated with one of its Seattle area facilities, of $<ix:nonFraction unitRef="usd" contextRef="icccc75f297f9487aaf6af93a9682218d_I20221231" decimals="-5" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzIxOTkwMjMzMDQyMjk_e1705d9d-1a17-4a70-a64b-dc4d8e4ce303">5.0</ix:nonFraction> million, which is due within the next 12 months.</span></div></ix:continuation><div id="i9959dc30b5d74d99a70a121eb09a4515_160"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90ZXh0cmVnaW9uOmMxZjg5YWQ5MTNmYzQ1NDFhYzA0MTdmZjU1MjkwNDFkXzcxMw_6552e741-25e5-4ffa-acba-637ceb5ef2fe" continuedAt="ibcd1e7fb68434d18ab85d11dc26ce108" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="ibcd1e7fb68434d18ab85d11dc26ce108"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90ZXh0cmVnaW9uOmMxZjg5YWQ5MTNmYzQ1NDFhYzA0MTdmZjU1MjkwNDFkXzcxNg_09ae29d1-a257-450e-964e-8b7ee06eddf8" escape="true">Net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding. Outstanding stock options, restricted stock units and common stock warrants have not been included in the calculation of diluted net loss per share because to do so would be anti-dilutive. Accordingly, the numerator and the denominator used in computing both basic and diluted net loss per share for each period are the same.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90ZXh0cmVnaW9uOmMxZjg5YWQ5MTNmYzQ1NDFhYzA0MTdmZjU1MjkwNDFkXzcxMQ_83fd955b-95ea-490a-9fe9-84a8be77c59d" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock participating securities as of December&#160;31 were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3ed46b1479f4064896cb2ff583b50fe_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzEtMS0xLTEtNDg5MDY_816e2e15-2039-40d1-b59b-cc119a8570c3">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ec5ee0bad2343278a6de1b6fd2cc457_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzEtMy0xLTEtNDg5MDY_7787c723-4a65-4276-bbf0-6d2b6efad744">2,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i547b52c74b7d404a86d2976b1d0d428d_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzEtNS0xLTEtNDg5MDY_930208c7-4167-426c-bff0-493c4454f8e0">3,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecc395aad27d4e279fde1f41cf731f43_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzItMS0xLTEtNDg5MDY_866d4539-34e8-4f52-a8d1-5a3edf4d5e28">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79b5e44fa71c4cdd99d7ef0f4caeaae9_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzItMy0xLTEtNDg5MDY_f2cd10f0-e6cf-46c5-9cb8-f80fc5c357e3">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71dfb62de0ed48e8a1bf6ac8a7dc0277_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzItNS0xLTEtNDg5MDY_e888669d-be67-4f27-b9b6-ccdee5e6c48f">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia62e3cab8f2e4c3cb75f270e19d7bece_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzMtMS0xLTEtNDg5MDY_6d789c75-b470-4d32-b9f3-cb9eb573d8be">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifab9ad4b738c40b1bad40a93b5d022f5_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzMtMy0xLTEtNDg5MDY_38c68284-47f0-4af9-ac88-fd1bcb0ff871">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044b09e095b341cea037a0552518fa44_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzMtNS0xLTEtNDg5MDY_fec576fe-b4d1-4689-a843-e5ff4319b719">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjMvZnJhZzpmMDc1MmE4ODRkNzY0MDc0ODdjNzNkZWQ2MjI4ZjU2Yi90ZXh0cmVnaW9uOmYwNzUyYTg4NGQ3NjQwNzQ4N2M3M2RlZDYyMjhmNTZiXzMyOTg1MzQ4ODM2Nzc_db6bd4bd-ac5b-489d-b67d-dad84d3e25c7" continuedAt="ide22fe59d07a46d8b7e1a4d6927717e7" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ide22fe59d07a46d8b7e1a4d6927717e7">In February 2023, the Company&#8217;s board of directors approved an amendment to the 2018 Inducement Equity Incentive Plan to increase the number of shares of the Company&#8217;s common stock available for issuance under the plan for equity awards granted from <ix:nonFraction unitRef="shares" contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjMvZnJhZzpmMDc1MmE4ODRkNzY0MDc0ODdjNzNkZWQ2MjI4ZjU2Yi90ZXh0cmVnaW9uOmYwNzUyYTg4NGQ3NjQwNzQ4N2M3M2RlZDYyMjhmNTZiXzMyOTg1MzQ4ODM2NjU_cf96192e-14d7-4a3c-ba04-942a8167185c">250,000</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="icc345a5e318943deb1b776d29eab9f21_I20230227" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjMvZnJhZzpmMDc1MmE4ODRkNzY0MDc0ODdjNzNkZWQ2MjI4ZjU2Yi90ZXh0cmVnaW9uOmYwNzUyYTg4NGQ3NjQwNzQ4N2M3M2RlZDYyMjhmNTZiXzMyOTg1MzQ4ODM2NzU_e25610eb-cfe4-4e6c-8005-f194f42eb07d">425,000</ix:nonFraction> shares.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_169"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of December&#160;31, 2022, pursuant to and as required by Rule 13a-15(b) under the Securities Exchange Act of 1934, or the Exchange Act. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December&#160;31, 2022, our Chief Executive Officer and Chief Financial Officer have concluded that, as of December&#160;31, 2022, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s Annual Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f) and Rule 15d-15(f). Our internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute, assurances. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2022. In making this assessment, our management used the framework in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, COSO. As a result of that assessment, our management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of December&#160;31, 2022 has been audited by Ernst &amp; Young LLP, an independent registered public accounting firm, as stated in their report which appears in Item 8 of this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the three months ended December&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B. Other Information</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2023, our board of directors approved an amendment to the 2018 Inducement Equity Incentive Plan to increase the number of shares of the Company&#8217;s common stock available for issuance pursuant to equity awards granted under the Inducement Plan from 250,000 shares to 425,000 shares.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendment to the Inducement Plan was adopted without stockholder approval pursuant to the applicable Nasdaq Listing Rules. The 2018 Inducement Equity Incentive Plan, as amended, provides for the grant of equity-based awards, including nonstatutory stock options, restricted stock units, restricted stock, stock appreciation rights, performance shares and performance units, and its terms are substantially similar to the Company&#8217;s 2022 Equity Incentive Plan, including with respect to treatment of equity awards in the event of a &#8220;merger&#8221; or &#8220;change in control&#8221; as defined under the 2018 Inducement Equity Incentive Plan, but with such other terms and conditions intended to comply with the Nasdaq inducement award exception.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Nasdaq Listing Rules, awards under the 2018 Inducement Equity Incentive Plan, as amended, may only be made to individuals not previously employees or non-employee directors of the Company (or following such individuals&#8217; bona fide period of non-employment with the Company), as an inducement material to the individuals&#8217; entry into employment with the Company. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the 2018 Inducement Equity Incentive Plan, as amended, and related form agreements thereunder are attached as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="nstg-2022ex108.htm">Exhibit </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="nstg-2022ex108.htm">10.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="nstg-2022ex108.htm">8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="nstg-2022ex109.htm">Exhibit 10.9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="nstg-2022ex1010.htm">Ex</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="nstg-2022ex1010.htm">hibit 10.10</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hereto and incorporated by reference herein. The above description of the Inducement Plan, as amended, does not purport to be complete and is qualified in its entirety by reference to such exhibit. </span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_175"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_178"></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_181"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a Code of Business Conduct that is applicable to all NanoString employees, including all directors and executive officers. Our Code of Business Conduct is published on our Investors website at https://investors.nanostring.com/home/default.aspx under &#8220;Governance Documents.&#8221; We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendments to, or waiver from, a provision of the Company&#8217;s Code of Business Conduct by posting such information on the website address and location specified above.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 10 of Form 10-K is incorporated by reference to our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December&#160;31, 2022.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_184"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11. Executive Compensation</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 11 of Form 10-K is incorporated by reference to our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December&#160;31, 2022.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_187"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 12 of Form 10-K is incorporated by reference to our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December&#160;31, 2022.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_190"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 13 of Form 10-K is incorporated by reference to our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December&#160;31, 2022.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_193"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14. Principal Accountant Fees and Services</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 14 of Form 10-K is incorporated by reference to our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_199"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. Exhibits, Financial Statement Schedules</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) The following documents are filed as part of this report:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Financial Statements &#8212; The financial statements filed as part of this Annual Report on Form 10-K are listed on the Index to Consolidated Financial Statements in Item&#160;8.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Financial Statement Schedules &#8212; The financial statement schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or the notes thereto.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Exhibits &#8212; The exhibits required by Item&#160;601 of Regulation S-K are listed in paragraph (b)&#160;below.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;Exhibits</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed on the Exhibit Index (following the Signatures section of this report) are filed herewith or are incorporated by reference to exhibits previously filed with the SEC.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1*&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170819000225/nstg-120319ex21.htm">License and Asset Purchase Agreement, dated December 3, 2019, between the Registrant and Veracyte, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 4, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513327072/d564546dex31.htm">Amended and Restated Certificate of Incorporation of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170823000016/exhibit31.htm">Amended and Restated Bylaws of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 27, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex41.htm">Specimen Common Stock Certificate of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170819000055/nstg-ex43.htm">Form of Warrant to Purchase Common Stock dated as of October 12, 2018 is issued in connection with Amended and Restated Term Loan Agreement dated as of October 12, 2018 among the Registrant and certain of the Registrant&#8217;s subsidiaries and CRG Partners III L.P., CRG Partners III-Parallel Fund &#8220;A&#8221; L.P., CRG Partners III Parallel Fund &#8220;B&#8221; (Cayman) L.P., CRG Partners III (Cayman) LEV AIV L.P. and CRG Partners III (Cayman) UNLEV AIV I L.P., and CRG Servicing LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 11, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex43.htm">Description of Capital Stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312520067158/d890689dex41.htm">Indenture, dated March 9, 2020, between NanoString Technologies, Inc. and U.S. Bank, National Association.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 9, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312520067158/d890689dex41.htm">Form of 2.625% Convertible Senior Note due 2025 (included in Exhibit 4.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312520067158/d890689dex41.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312520067158/d890689dex41.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 9, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex101.htm">Form of Director and Executive Officer Indemnification Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex105.htm">2013 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex106.htm">Form of Notice of Stock Option Grant and Stock Option Agreement under the 2013 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex107.htm">Form of Notice of Restricted Stock Grant and Restricted Stock Agreement under the 2013 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex108.htm">Form of Notice of Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the 2013 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170820000039/nstg-ex109.htm">Form of Notice of Performance Stock Unit Grant and Performance Stock Unit Agreement under the 2013 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513256819/d428632dex109.htm">2013 Employee Stock Purchase Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex108.htm">2018 Inducement Equity Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex108.htm">, as amended</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex108.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex109.htm">Form of RSU Agreement under the 2018 Inducement Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex1010.htm">Form of Stock Option Agreement under the 2018 Inducement Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000118/nstg-2022ex101.htm">2022 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000118/nstg-2022ex102.htm">Form of Stock Option Agreement under the 2022 Equity Incentive Plan</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000118/nstg-2022ex103.htm">Form of Restricted Stock Unit Agreement under the 2022 Equity Inventive Plan</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000118/nstg-2022ex104.htm">Form of Performance-Based Restricted Stock Unit Agreement under the 2022 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513227472/d428632dex108.htm">Employment Agreement, dated May&#160;24, 2010, between the Registrant and R. Bradley Gray.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 20, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170817000061/nstg-063017xex101.htm">Amendment to Employment Agreement, dated August 4, 2017, between the Registrant and R. Bradley Gray.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170820000039/nstg-ex1014.htm">Amendment to Employment Agreement dated February 28, 2020, between the Registrant and R. Bradley Gray.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312514008813/d649809dex1012.htm">Employment Agreement, dated March 31, 2012, between the Registrant and Joseph Beechem</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312514008813/d649809dex1012.htm">, as am</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312514008813/d649809dex1012.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312514008813/d649809dex1012.htm">nded on December 27, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312514008813/d649809dex1012.htm">2012</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312514008813/d649809dex1012.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 13, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170818000058/nstg-ex1017.htm">Amendment to Employment Agreement, dated December 27, 2012, between the Registrant and Joseph Beechem.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170818000058/nstg-ex1018.htm">Amendment to Employment Agreement, dated November 7, 2017, between the Registrant and Joseph Beechem.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170820000039/nstg-ex1021.htm">Amendment to Employment Agreement dated February 27, 2020, between the Registrant and Joseph Beechem.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170818000058/nstg-ex1019.htm">Employment Agreement, dated October 17, 2017, between the Registrant and J. Chad Brown. </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170820000039/nstg-ex1023.htm">Amendment to Employment Agreement dated February 19, 2020, between the Registrant and J. Chad Brown.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000051/nstg-2021ex1021.htm">Transition Agreement and Release dated January 7, 2022, between the Registrant and J. Chad Brown.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170818000058/nstg-ex1020.htm">Employment Agreement, dated January 16, 2018, between the Registrant and K. Thomas Bailey.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170820000039/nstg-ex1025.htm">Amendment to Employment Agreement dated February 19, 2020, between the Registrant and K. Thomas Bailey.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000051/nstg-2021ex1024.htm">Employment Agreement dated January 6, 2022, between the Registrant and John Gerace.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312515091371/d832779dex1014.htm">Lease between the Registrant and BMR-530 Fairview Avenue LLC, dated October&#160;19, 2007, as amended through December 22, 2014 (including Amendment No. 1 through Amendment No. 7).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312516501709/d53508dex1013.htm">Amendment No. 8 to Lease between the Registrant and BMR-530 Fairview Avenue LLC, dated February 27, 2015.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 11, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312515091371/d832779dex1015.htm">Lease between the Registrant and BMR-500 Fairview Avenue LLC, dated December 22, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170816000025/nstg-063016xex101.htm">Amendment No. 1 to Lease between the Registrant and BMR-500 Fairview Avenue LLC, dated June 27, 2016.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312515091371/d832779dex1016.htm">Office Lease Agreement between the Registrant and Blume Roy Building LLC, dated December 26, 2013, as amended through November 18, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170816000010/nstg-q12016ex101.htm">Amendment No. 2 to Office Lease Agreement between the Registrant and Blume Roy Building LLC, dated February 1, 2016.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000051/nstg-2021ex1031.htm">Amendment No. 3 to Office Lease Agreement between the Registrant and Blume Roy Building LLC, dated July 20, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35&#8224;&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000099/nstg-202210qex103.htm">Exclusive License Agreement, dated February&#160;4, 2004, between the Registrant and The Institute for Systems Biology.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36&#8224;&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000099/nstg-202210qex104.htm">Amendment No. 1 to Exclusive License Agreement, dated February 5, 2007, between the Registrant and The Institute for Systems Biology.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000119312513227472/d428632dex1021.htm">Amendment No. 2 to Exclusive License Agreement, dated May 17, 2007, between the Registrant and The Institute for Systems Biology.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 20, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38&#8224;&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170817000088/ex10_1.htm">Collaboration Agreement, dated August 4, 2017, between the Registrant and Lam Research Corporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1401708/000140170820000039/nstg-ex1040.htm">Amendment #1 to Collaboration Agreement, effective May 28, 2019, between Registrant and Lam Research Corporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1401708/000140170822000051/nstg-2021ex211.htm">List of subsidiaries of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex231.htm">Consent of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex231.htm">Independent Registered Public Accounting Firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_205">Powers of Attorney (contained on signature page).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex311.htm">Certification of Principal Executive Officer Required Under Rules&#160;13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex312.htm">Certification of Principal Financial Officer Required Under Rules&#160;13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex321.htm">Certification of Principal Executive Officer Required Under Rule&#160;13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. &#167;1350.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="nstg-2022ex322.htm">Certification of Principal Financial Officer Required Under Rule&#160;13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. &#167;1350.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Indicates a management contract or compensatory plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K, but a copy will be furnished supplementally to the Securities and Exchange Commission upon request.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Certain portions of this exhibit have been omitted because they are not material and would likely cause competitive harm to the registrant if disclosed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission.</span></div><div id="i9959dc30b5d74d99a70a121eb09a4515_202"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;16. Form 10-K Summary</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="i9959dc30b5d74d99a70a121eb09a4515_205"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9959dc30b5d74d99a70a121eb09a4515_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February&#160;28, 2023</span></div><div style="margin-top:2pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.964%"><tr><td style="width:1.0%"></td><td style="width:11.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NANOSTRING TECHNOLOGIES, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ R. Bradley Gray</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bradley Gray</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints R. Bradley Gray and K. Thomas Bailey, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file, any and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their and his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ R. Bradley Gray</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bradley Gray</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ K. Thomas Bailey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Accounting and Financial Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K. Thomas Bailey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William D. Young</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William D. Young</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Elisha W. Finney</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elisha W. Finney</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Teresa Foy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teresa Foy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Janet George</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janet George</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kirk D. Malloy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kirk D. Malloy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gregory Norden</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory Norden</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dana Rollison</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dana Rollison</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Charles P. Waite</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles P. Waite</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>nstg-2022ex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iaa4d1f684e044021965ef23d9e159441_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.3</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGISTERED PURSUANT TO SECTION 12 OF THE </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, NanoString Technologies, Inc. (the &#8220;Company&#8221;) had one class of securities, our common stock, registered under Section 12 of the Securities Exchange Act of 1934, as amended. These securities are listed on the Nasdaq Global Market under the symbol &#8220;NSTG.&#8221;</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital stock consists of 150,000,000 shares of common stock, par value $0.0001 per share, and 15,000,000 shares of preferred stock, par value $0.0001 per share.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the rights of our capital stock. This summary is not complete. For more detailed information, please see our certificate of incorporation and bylaws, both filed as exhibits to our annual report on Form 10-K for the period ended December 31, 2022, and to the applicable provisions of Delaware and Washington law.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may be applicable to any then outstanding preferred stock, holders of common stock are entitled to receive dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our certificate of incorporation and bylaws do not provide for cumulative voting rights. Because of this, the holders of a plurality of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose. With respect to matters other than the election of directors, at any meeting of the stockholders at which a quorum is present or represented, the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at such meeting and entitled to vote on the subject matter shall be the act of the stockholders, except as otherwise provided by law, our certificate of incorporation, our bylaws or the rules of any applicable stock exchange on which our securities are listed. The holders of a majority of the voting power of the capital stock issued and outstanding and entitled to vote, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders, unless otherwise required by law, our certificate of incorporation, our bylaws or the rules of any applicable stock exchange on which our securities are listed.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidation</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rights and Preferences</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate in the future.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fully Paid and Nonassessable</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our outstanding shares of common stock are fully paid and nonassessable.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has the authority, without further action by the stockholders, to issue up to 15,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, redemption rights, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing change in our control or other corporate action. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Delaware and Washington Law and Our Certificate of Incorporation and Bylaws</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware Law</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the Delaware General Corporation Law. Section 203 generally prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at or subsequent to such time the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 203 defines a business combination to include&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any merger or consolidation involving the corporation, or any direct or indirect majority-owned subsidiary of the corporation, and the interested stockholder or any other entity if the merger or consolidation is caused by the interested stockholder&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any sale, lease, exchange, mortgage, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation or any direct or indirect majority-owned subsidiary of the corporation&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation, or any direct or indirect majority-owned subsidiary of the corporation, to the interested stockholder&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subject to exceptions, any transaction involving the corporation, or any direct or indirect majority-owned subsidiary of the corporation, that has the effect of increasing the proportionate share of the stock or any class or series of the corporation or such subsidiary beneficially owned by the interested stockholder&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may have the effect of delaying, deferring or preventing changes in control in the Company.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Washington Business Corporation Act</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of Washington, where our principal executive offices are located, impose restrictions on certain transactions between certain foreign corporations and significant stockholders. In particular, the Washington Business Corporation Act, or WBCA, prohibits a &#8220;target corporation,&#8221; with certain exceptions, from engaging in certain &#8220;significant business transactions&#8221; with a person or group of persons which beneficially owns 10% or more of the voting securities of the target corporation, an &#8220;acquiring person,&#8221; for a period of five years after such acquisition, unless the transaction or acquisition of shares is approved by a majority of the members of the target corporation&#8217;s board of directors prior to the time of acquisition. Such prohibited transactions may include, among other things&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any merger or consolidation with, disposition of assets to, or issuance or redemption of stock to or from, the acquiring person&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any termination of 5% or more of the employees of the target corporation as a result of the acquiring person&#8217;s acquisition of 10% or more of the shares&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">allowing the acquiring person to receive any disproportionate benefit as a stockholder&#59; and</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liquidating or dissolving the target corporation.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the five-year period, a significant business transaction may take place as long as it complies with certain fair price provisions of the statute or is approved at an annual or special meeting of stockholders.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be considered a &#8220;target corporation&#8221; so long as our principal executive office is located in Washington, and&#58; (1) a majority of our employees are residents of the state of Washington or we employ more than one thousand residents of the state of Washington&#59; (2) a majority of our tangible assets, measured by market value, are located in the state of Washington or we have more than $50 million worth of tangible assets located in the state of Washington&#59; and (3) any one of the following&#58; (a) more than 10% of our stockholders of record are resident in the state of Washington&#59; (b) more than 10% of our shares are owned of record by state residents&#59; or (c) 1,000 or more of our stockholders of record are resident in the state.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we meet the definition of a target corporation, the WBCA may have the effect of delaying, deferring or preventing a change of control.</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certificate of Incorporation and Bylaws</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions of our certificate of incorporation and bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our certificate of incorporation and bylaws&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the board of directors to issue up to 15,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in our control&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that the authorized number of directors may be changed only by resolution of the board of directors adopted by a majority of the total authorized number of directors&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">divide the board of directors into three classes&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that a director may only be removed from the board of directors the stockholders for cause&#59;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing in a timely manner, and also meet specific requirements as to the form and content of a stockholder&#8217;s notice&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not provide for cumulative voting rights (therefore allowing the holders of a plurality of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose)&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that special meetings of our stockholders may be called only by the chairman of the board, our chief executive officer or by the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that stockholders are permitted to amend the bylaws only upon receiving at least two-thirds of the votes entitled to be cast by holders of all outstanding shares then entitled to vote generally in the election of directors, voting together as a single class.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendment of any of these provisions requires approval by the holders of at least two-thirds of our outstanding common stock, voting as a single class.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is American Stock Transfer &#38; Trust Company, LLC. The transfer agent and registrar&#8217;s address is 6201 15th Avenue, Brooklyn, New York 11219.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>3
<FILENAME>nstg-2022ex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib5444e4e57fc4396879debfd0ab1fbbb_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.8</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NANOSTRING TECHNOLOGIES, INC.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 INDUCEMENT EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Purposes of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purposes of this Plan are to attract and retain the best available personnel for positions of substantial responsibility by providing an inducement material to individuals entering into employment with the Company or any Parent or Subsidiary of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan permits the grant of Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares.  Each Award under the Plan is intended to qualify as an employment inducement award under NASDAQ Listing Rule 5635(c)(4) and the official regulations thereunder (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inducement Listing Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As used herein, the following definitions will apply&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the legal and regulatory requirements relating to the administration of equity-based awards, including but not limited to, under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction where Awards are, or will be, granted under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units or Performance Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the written or electronic agreement setting forth the terms and provisions applicable to each Award granted under the Plan.  The Award Agreement is subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">A change in the ownership of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which occurs on the date that any one person, or more than one person acting as a group (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%)&#160;of the total voting power of the stock of the Company&#59; provided, however, that for purposes of this subsection, the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%)&#160;of the total voting power of the stock of the Company will not be considered a Change in Control&#59; or </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12)&#160;month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purposes of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt"> A change in the ownership of a substantial portion of the Company&#8217;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12)&#160;month period ending on the date of the most recent acquisition by such person or persons)&#160;assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%)&#160;of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions&#59; provided, however, that for purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&#8217;s assets&#58; (A)&#160;a transfer to an entity that is controlled by the Company&#8217;s stockholders immediately after the transfer, or (B)&#160;a transfer of assets by the Company to&#58; (1)&#160;a stockholder of the Company (immediately before the asset transfer)&#160;in exchange for or with respect to the Company&#8217;s stock, (2)&#160;an entity, fifty percent (50%)&#160;or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3)&#160;a Person, that owns, directly or indirectly, fifty percent (50%)&#160;or more of the total value or voting power of all the outstanding stock of the Company, or (4)&#160;an entity, at least fifty percent (50%)&#160;of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (iii)(B)(3).  For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Code Section&#160;409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if&#58; (i)&#160;its sole purpose is to change the state of the Company&#8217;s incorporation, or (ii)&#160;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended.  Reference to a specific section of the Code or regulation thereunder shall include such section or regulation, any valid regulation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a committee of Directors or of other individuals satisfying Applicable Laws appointed by the Board, or a duly authorized committee of the Board, in accordance with Section 4 hereof.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the common stock of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means NanoString Technologies, Inc., a Delaware corporation, or any successor thereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including an advisor, engaged by the Company or a Parent or Subsidiary to render services to such entity.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means total and permanent disability as defined in Section&#160;22(e)(3)&#160;of the Code, provided that the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time to time.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company.  Neither service as a Director nor payment of a director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company.  However, for the avoidance of doubt, although a person who is an Employee also may be a Director, a person who already is serving as a Director prior to becoming an Employee will not be eligible to be granted an Award under the Plan unless permitted under the Inducement Listing Rule.  The Company shall determine in good faith and in the exercise of its discretion whether an individual has become or has ceased to be an Employee and the effective date of such individual&#8217;s employment or termination of employment, as the case may be.  For purposes of an individual&#8217;s rights, if any, under the Plan as of the time of the Company&#8217;s determination, all such determinations by the Company shall be final, binding and conclusive, notwithstanding that the Company or any court of law or governmental agency subsequently makes a contrary determination.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a program under which (i)&#160;outstanding Awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and&#47;or cash, (ii)&#160;Participants would have the opportunity to transfer any outstanding Awards to a financial institution or other person or entity selected by the Administrator, and&#47;or (iii)&#160;the exercise price of an outstanding Award is reduced.  Pursuant to the provisions of Section 4, the Administrator may not institute an Exchange Program.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of Common Stock determined as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">If the Common Stock is listed on any established stock exchange or a national market system, including without limitation the New York Stock Exchange, the NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market of The NASDAQ Stock Market, its Fair Market Value will be the closing sales price for such stock (or the closing bid, if no sales were reported)&#160;as quoted on such exchange or system on the day of determination, as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Administrator deems reliable&#59;</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share will be the mean between the high bid and low asked prices for the Common Stock on the date of determination (or, if no bids and asks were reported on that date, as applicable, on the last trading date such bids and asks were reported), as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Administrator deems reliable&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt"> In the absence of an established market for the Common Stock, the Fair Market Value will be determined in good faith by the Administrator.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of fair market value for purposes of tax withholding may be made in the Administrator&#8217;s discretion subject to Applicable Laws and is not required to be consistent with the determination of Fair Market Value for other purposes.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the fiscal year of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that is intended to qualify, and actually qualifies, as an incentive stock option within the meaning of Section&#160;422 of the Code.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonstatutory Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a stock option granted pursuant to the Plan.  All Options granted under the Plan will be Nonstatutory Stock Options.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a &#8220;parent corporation,&#8221; whether now or hereafter existing, as defined in Section&#160;424(e)&#160;of the Code.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the holder of an outstanding Award.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award denominated in Shares which may be earned in whole or in part upon attainment of performance goals or other vesting criteria as the Administrator may determine pursuant to Section 10.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award which may be earned in whole or in part upon attainment of performance goals or other vesting criteria as the Administrator may determine and which may be settled for cash, Shares or other securities or a combination of the foregoing pursuant to Section 10.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aa) &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Period of Restriction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period during which the transfer of Shares of Restricted Stock are subject to restrictions and therefore, the Shares are subject to a substantial risk of forfeiture.  Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the Administrator.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this 2018 Inducement Equity Incentive Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Shares issued pursuant to a Restricted Stock award under Section 7 of the Plan, or issued pursuant to the early exercise of an Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section 8.  Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;16(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Section&#160;16(b)&#160;of the Exchange Act.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Employee, Director or Consultant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a share of the Common Stock, as adjusted in accordance with Section 13 of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award, granted alone or in connection with an Option, that pursuant to Section&#160;9 is designated as a Stock Appreciation Right.</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a &#8220;subsidiary corporation,&#8221; whether now or hereafter existing, as defined in Section&#160;424(f)&#160;of the Code.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Stock&#160;Subject&#160;to&#160;the&#160;Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Stock&#160;Subject&#160;to&#160;the&#160;Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the provisions of Section 13 of the Plan, the maximum aggregate number of Shares that may be issued under the Plan is 425,000&#160;Shares.  In addition, Shares may become available for issuance under the Plan pursuant to Section 3(b).  The Shares may be authorized, but unissued, or reacquired Common Stock.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Lapsed Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If an Award expires or becomes unexercisable without having been exercised in full, or, with respect to Restricted Stock, Restricted Stock Units, Performance Units or Performance Shares, is forfeited to, or repurchased by, the Company due to failure to vest, the unpurchased Shares (or for Awards other than Options or Stock Appreciation Rights the forfeited or repurchased Shares), which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated).  With respect to Stock Appreciation Rights, only Shares actually issued (i.e., the net Shares issued)&#160;pursuant to a Stock Appreciation Right will cease to be available under the Plan&#59; all remaining Shares under Stock Appreciation Rights will remain available for future grant or sale under the Plan (unless the Plan has terminated).  Shares that have actually been issued under the Plan under any Award will not be returned to the Plan and will not become available for future distribution under the Plan&#59; provided, however, that if Shares issued pursuant to Awards of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units are repurchased by the Company or are forfeited to the Company, such Shares will become available for future grant under the Plan.  Shares used to pay the exercise price of an Award or to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under the Plan.  To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as will be sufficient to satisfy the requirements of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administration of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Multiple Administrative Bodies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Different Committees with respect to different groups of Employees or Participants may administer the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Other than as provided above, the Plan will be administered by (A)&#160;the Board or (B)&#160;a Committee, which committee will be constituted to satisfy Applicable Laws.  Until and unless determined otherwise by the Board, the Compensation Committee of the Board will have full authority to act as Administrator.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Awards granted under the Plan must be approved by a majority of the Company&#8217;s &#8220;Independent Directors&#8221; (as defined under the NASDAQ Listing Rules) or the Compensation Committee of the Board, in each case acting as the Administrator.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Delegation of Authority for Day-to-Day Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except to the extent prohibited by Applicable Law and except to the extent provided by subsection&#160;4(a)(iv), the Administrator may delegate to one or more individuals the day-to-day administration of the Plan and any of the functions assigned to it in this Plan.  Such delegation may be revoked at any time.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Powers of the Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">   to determine the Fair Market Value&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt"> to select the individuals to whom Awards may be granted hereunder, subject to Section 5 (which Awards will be intended as a material inducement to the individual becoming an Employee)&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">  to determine the number of Shares to be covered by each Award granted hereunder&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">  to approve forms of Award Agreements for use under the Plan&#59;</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"> to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder.  Such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator will determine&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt"> temporarily suspend the exercisability of an Award if the Administrator deems such suspension to be necessary or appropriate for administrative purposes or to comply with Applicable Laws, provided that such suspension must be lifted prior to the expiration of the maximum term and post-service exercisability period of an Award, unless doing so would not comply with Applicable Laws&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.3pt"> to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan&#59; </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:117pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.03pt"> to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of satisfying applicable foreign laws or for qualifying for favorable tax treatment under applicable foreign laws&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt"> to modify or amend each Award (subject to Section&#160;18 of the Plan), including but not limited to the discretionary authority to extend the post-service exercisability period of Awards and to extend the maximum term of an Option&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"> to allow Participants to satisfy withholding tax obligations in such manner as prescribed in Section 14 of the Plan&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt"> to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.3pt"> to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant under an Award&#59; </font></div><div style="margin-bottom:6pt;text-indent:117pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.03pt"> determine whether Awards will be settled in Shares, cash or in any combination thereof&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:117pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.57pt"> impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by a Participant or other subsequent transfers by the Participant of any Shares issued as a result of or under an Award, including without limitation, (A)&#160;restrictions under an insider trading policy, and (B)&#160;restrictions as to the use of a specified brokerage firm for such resales or other transfers&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt"> to make all other determinations deemed necessary or advisable for administering the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">No Exchange Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein to the contrary, the Administrator may not institute an Exchange Program.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Effect of Administrator&#8217;s&#160;Decision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator&#8217;s decisions, determinations and interpretations will be final and binding on all Participants and any other holders of Awards.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units may be granted to Employees so long as the following requirements are met&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The Employee was not previously an Employee or Director, or the Employee is to become employed by the Company or any of its Parents or Subsidiaries following a bona-fide period of non-employment (within the meaning of the Inducement Listing Rule)&#59; and </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The grant of an Award is an inducement material to the Employee&#8217;s entering into employment with the Company or any of its Parents or Subsidiaries in accordance with the Inducement Listing Rule.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator, in its sole discretion and subject to the terms and conditions of the Plan, including without limitation the eligibility requirements of Section 5, may grant Options to any individual as a material inducement to the individual becoming an Employee, which grant shall become effective only if the individual actually becomes an Employee.  Subject to the terms and conditions of the Plan, the Administrator will have complete discretion to determine the number of Shares granted to any Employee.  Each Option shall be evidenced by an Award Agreement that shall specify the exercise price, the expiration date of the Option, the number of Shares covered by the </font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Option, any conditions to exercise the Option, and such other terms and conditions as the Administrator, in its discretion, shall determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Term of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term of each Option will be stated in the Award Agreement&#59; provided, however, that the term will be no more than ten (10) years from the date of grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Option Exercise Price and Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The per share exercise price for the Shares to be issued pursuant to exercise of an Option will be determined by the Administrator, provided that the per Share exercise price will be no less than one hundred percent (100%)&#160;of the Fair Market Value per Share on the date of grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt;text-decoration:underline">Waiting Period and Exercise Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the time an Option is granted, the Administrator will fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt;text-decoration:underline"> Form of Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator will determine the acceptable form of consideration for exercising an Option, including the method of payment.  Such consideration may consist entirely of, without limitation&#58; (1)&#160;cash&#59; (2)&#160;check&#59; (3)&#160;promissory note, to the extent permitted by Applicable Laws, (4)&#160;other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Option will be exercised and provided that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion&#59; (5)&#160;consideration received by the Company under a broker-assisted (or other)&#160;cashless exercise program (whether through a broker or otherwise)&#160;implemented by the Company in connection with the Plan&#59; (6)&#160;by net exercise&#59; (7)&#160;such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws&#59; or (8)&#160;any combination of the foregoing methods of payment.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt;text-decoration:underline">Procedure for Exercise&#59; Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Option granted hereunder will be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement.  An Option may not be exercised for a fraction of a Share.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Option will be deemed exercised when the Company receives&#58; (i)&#160;a notice of exercise (in such form as the Administrator may specify from time to time)&#160;from the person entitled to exercise the Option, and (ii)&#160;full payment for the Shares with respect to which the Option is exercised (together with applicable withholding taxes).  Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan.  Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse.  Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to an Option, notwithstanding the exercise of the Option.  The Company will issue (or cause to be issued)&#160;such Shares promptly after the Option is exercised.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 13 of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt;text-decoration:underline">Cessation of Status as a Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a Service Provider, other than upon the cessation of the Participant&#8217;s Service Provider status as the result of the Participant&#8217;s death or Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of cessation of the Participant&#8217;s Service Provider status (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement).  In the absence of a specified time in the Award Agreement, the Option will remain exercisable for three (3)&#160;months following cessation of the Participant&#8217;s Service Provider status.  Unless otherwise provided by the Administrator, if on the date of cessation of the Participant&#8217;s Service Provider status the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan.  If after cessation of the Participant&#8217;s Service Provider status the Participant does not exercise his or her Option within the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan.</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.53pt;text-decoration:underline">Disability of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a Service Provider as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent the Option is vested on the date of cessation of the Participant&#8217;s Service Provider status (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement).  In the absence of a specified time in the Award Agreement, the Option will remain exercisable for twelve (12)&#160;months following the cessation of the Participant&#8217;s Service Provider status.  Unless otherwise provided by the Administrator, if on the date of cessation of the Participant&#8217;s Service Provider status the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan.  If after cessation of the Participant&#8217;s Service Provider status the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.07pt;text-decoration:underline">Death of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant dies while a Service Provider, the Option may be exercised following the Participant&#8217;s death within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of death (but in no event may the Option be exercised later than the expiration of the term of such Option as set forth in the Award Agreement), by the Participant&#8217;s designated beneficiary, provided such beneficiary has been designated prior to Participant&#8217;s death in a form acceptable to the Administrator.  If no such beneficiary has been designated by the Participant, then such Option may be exercised by the personal representative of the Participant&#8217;s estate or by the person(s)&#160;to whom the Option is transferred pursuant to the Participant&#8217;s will or in accordance with the laws of descent and distribution.  In the absence of a specified time in the Award Agreement, the Option will remain exercisable for twelve (12)&#160;months following Participant&#8217;s death.  Unless otherwise provided by the Administrator, if at the time of death Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will immediately revert to the Plan.  If the Option is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Grant of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of the Plan, including without limitation the eligibility requirements of Section 5, the Administrator, at any time and from time to time, may grant Shares of Restricted Stock to any individual as a material inducement to the individual becoming an Employee, which grant shall become effective only if the individual actually becomes an Employee, in such amounts as the Administrator, in its sole discretion, will determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the Period of Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine.  Unless the Administrator determines otherwise, the Company as escrow agent will hold Shares of Restricted Stock until the restrictions on such Shares have lapsed.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided in this Section 7 or the Award Agreement, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Other Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted Stock as it may deem advisable or appropriate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Removal of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise provided in this Section 7, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the Administrator may determine.  The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  During the Period of Restriction, Participants holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Dividends and Other Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  During the Period of Restriction, Participants holding Shares of Restricted Stock will be entitled to receive all dividends and other distributions paid with respect to such Shares, unless the Administrator provides otherwise.  If any such dividends or distributions are paid in Shares, the Shares will be subject to the same restrictions on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Return of Restricted Stock to Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  On the date set forth in the Award Agreement, the Restricted Stock for which restrictions have not lapsed will revert to the Company and again will become available for grant under the Plan.</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Grant of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of the Plan, including without limitation the eligibility requirements of Section 5, Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator to any individual as a material inducement to the individual becoming an Employee, which grant shall become effective only if the individual actually becomes an Employee.  After the Administrator determines that it will grant Restricted Stock Units under the Plan, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions related to the grant, including the number of Restricted Stock Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Vesting Criteria and Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator will set vesting criteria in its discretion, which, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant.  The Administrator may set vesting criteria based upon the achievement of Company-wide, divisional, business unit, or individual goals (including, but not limited to, continued employment or service), applicable federal or state securities laws or any other basis determined by the Administrator in its discretion.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Earning Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout as determined by the Administrator.  Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be met to receive a payout.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Form and Timing of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Payment of earned Restricted Stock Units will be made as soon as practicable after the date(s)&#160;determined by the Administrator and set forth in the Award Agreement.  The Administrator, in its sole discretion, may only settle earned Restricted Stock Units in cash, Shares, or a combination of both.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Cancellation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Grant of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of the Plan, including without limitation the eligibility requirements of Section 5, a Stock Appreciation Right may be granted to any individual as a material inducement to the individual becoming an Employee, which grant shall become effective only if the individual actually becomes an Employee, at any time and from time to time as will be determined by the Administrator, in its sole discretion.    </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator will have complete discretion to determine the number of Stock Appreciation Rights granted to any Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Exercise Price and Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The per share exercise price for the Shares to be issued pursuant to exercise of a Stock Appreciation Right will be determined by the Administrator and will be no less than one hundred percent (100%)&#160;of the Fair Market Value per Share on the date of grant.  Otherwise, the Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Stock Appreciation Right Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify the exercise price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Expiration of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Stock Appreciation Right granted under the Plan will expire upon the date determined by the Administrator, in its sole discretion, and set forth in the Award Agreement.  Notwithstanding the foregoing, the rules of Section&#160;6(b)&#160;relating to the maximum term and Section 6(d)&#160;relating to exercise also will apply to Stock Appreciation Rights.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt;text-decoration:underline">Payment of Stock Appreciation Right Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">The difference between the Fair Market Value of a Share on the date of exercise over the exercise price&#59; times</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">The number of Shares with respect to which the Stock Appreciation Right is exercised.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent value, or in some combination thereof.</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Performance Units and Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Grant of Performance Units&#47;Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of the Plan, including without limitation the eligibility requirements of Section 5, Performance Units and Performance Shares may be granted to any individual as a material inducement to the individual becoming an Employee, which grant shall become effective only if the individual actually becomes an Employee, at any time and from time to time, as will be determined by the Administrator, in its sole discretion.  The Administrator will have complete discretion in determining the number of Performance Units and Performance Shares granted to each Participant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Value of Performance Units&#47;Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Performance Unit will have an initial value that is established by the Administrator on or before the date of grant.  Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Performance Objectives and Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator will set performance objectives or other vesting provisions (including, without limitation, continued status as a Service Provider)&#160;in its discretion which, depending on the extent to which they are met, will determine the number or value of Performance Units&#47;Shares that will be paid out to the Participants.  The time period during which the performance objectives or other vesting provisions must be met will be called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;  Each Award of Performance Units&#47;Shares will be evidenced by an Award Agreement that will specify the Performance Period, and such other terms and conditions as the Administrator, in its sole discretion, will determine.  The Administrator may set performance objectives based upon the achievement of Company-wide, divisional, business unit or individual goals (including, but not limited to, continued employment or service), applicable federal or state securities laws, or any other basis determined by the Administrator in its discretion.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Earning of Performance Units&#47;Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  After the applicable Performance Period has ended, the holder of Performance Units&#47;Shares will be entitled to receive a payout of the number of Performance Units&#47;Shares earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding performance objectives or other vesting provisions have been achieved.  After the grant of a Performance Unit&#47;Share, the Administrator, in its sole discretion, may reduce or waive any performance objectives or other vesting provisions for such Performance Unit&#47;Share.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Form and Timing of Payment of Performance Units&#47;Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Payment of earned Performance Units&#47;Shares will be made as soon as practicable after the expiration of the applicable Performance Period.  The Administrator, in its sole discretion, may pay earned Performance Units&#47;Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned Performance Units&#47;Shares at the close of the applicable Performance Period)&#160;or in a combination thereof.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt;text-decoration:underline">Cancellation of Performance Units&#47;Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  On the date set forth in the Award Agreement, all unearned or unvested Performance Units&#47;Shares will be forfeited to the Company, and again will be available for grant under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Leaves of Absence&#47;Transfer Between Locations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless the Administrator provides otherwise or as otherwise required by Applicable Law, vesting of Awards granted hereunder will be suspended during any unpaid leave of absence.  A Participant will not cease to be an Employee in the case of (i)&#160;any leave of absence approved by the Company or (ii)&#160;transfers between locations of the Company or between the Company, its Parent, or any Subsidiary.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Transferability of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant.  If the Administrator makes an Award transferable, such Award will contain such additional terms and conditions as the Administrator deems appropriate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Adjustments&#59; Dissolution or Liquidation&#59; Merger or Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs (other than any ordinary dividends or other ordinary distributions), the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of shares of stock that may be delivered under the Plan and&#47;or the number, class, and price of shares of stock covered by each outstanding Award, and the numerical Share limits in Section&#160;3 of the Plan.  </font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Dissolution or Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction.  To the extent it has not been previously exercised (with respect to an Option or Stock Appreciation Right) or vested (with respect to an Award other than an Option or Stock Appreciation Right), an Award will terminate immediately prior to the consummation of such proposed action.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Merger or Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a merger of the Company with or into another corporation or other entity or a Change in Control, each outstanding Award will be treated as the Administrator determines, including, without limitation, that each Award be assumed or an equivalent option or right substituted by the successor corporation or a Parent or Subsidiary of the successor corporation.  The Administrator will not be required to treat all Awards similarly in the transaction.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the successor corporation does not assume or substitute for the Award, the Participant will fully vest in and have the right to exercise all of his or her outstanding Options and Stock Appreciation Rights, including Shares as to which such Awards would not otherwise be vested or exercisable, all restrictions on Restricted Stock and Restricted Stock Units will lapse, and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%)&#160;of target levels and all other terms and conditions met, in each case, unless specifically provided otherwise by the Administrator or under the applicable Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable.  In addition, unless specifically provided otherwise by the Administrator or under the applicable Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, if an Option or Stock Appreciation Right is not assumed or substituted in the event of a Change in Control, the Administrator will notify the Participant in writing or electronically that the Option or Stock Appreciation Right will be exercisable for a period of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right will terminate upon the expiration of such period.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this subsection 13(c), an Award will be considered assumed if, following the Change in Control, the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock, cash, or other securities or property)&#160;received in the Change in Control by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares)&#59; provided, however, that if such consideration received in the Change in Control is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, Performance Unit or Performance Share, for each Share subject to such Award, to be solely common stock of the successor corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the Change in Control. For the avoidance of doubt, the Administrator may determine that, for purposes of this Section 13(c), the Company is the successor corporation with respect to some or all Awards.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything in this Section 13(c)&#160;to the contrary, and unless otherwise provided by the Administrator or under an Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, an Award that vests, is earned or paid-out upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&#8217;s consent&#59; provided, however, a modification to such performance goals only to reflect the successor corporation&#8217;s post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Withholding Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof)&#160;or such earlier time as any tax withholding obligations are due, the Company (or any of its Subsidiaries, Parents or affiliates employing or retaining the services of a Participant, as applicable) will have the power and the right to deduct or withhold, or require a Participant to remit to the Company (or any of its Subsidiaries, Parents or affiliates, as applicable), an amount sufficient to satisfy federal, state, local, foreign or other taxes (including the Participant&#8217;s FICA obligation)&#160;required to be withheld with respect to such Award (or exercise thereof).  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Withholding Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i)&#160;paying cash, check or other cash equivalents&#59; (ii)&#160;electing to have the Company withhold otherwise deliverable cash or Shares having a fair market value equal to the minimum statutory amount required to be </font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withheld or such greater amount as the Administrator may determine if such amount would not have adverse accounting consequences, as the Administrator determines in its sole discretion&#59; (iii)&#160;delivering to the Company already-owned Shares having a fair market value equal to the statutory amount required to be withheld or such greater amount as the Administrator may determine, in each case, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion&#59; (iv) selling a sufficient number of Shares otherwise deliverable to the Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld or such greater amount as the Administrator may determine, in each case, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion&#59; (v) such other consideration and method of payment for the meeting of tax withholding obligations as the Administrator may determine to the extent permitted by Applicable Laws&#59; or (vi) any combination of the foregoing methods of payment.  The withholding amount will be deemed to include any amount which the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state or local marginal income tax rates applicable to the Participant with respect to the Award on the date that the amount of tax to be withheld is to be determined or such greater amount as the Administrator may determine if such amount would not have adverse accounting consequences, as the Administrator determines in its sole discretion.  The fair market value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Compliance With Code Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Code Section&#160;409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Code Section&#160;409A, except as otherwise determined in the sole discretion of the Administrator.  Each payment or benefit under this Plan and under each Award Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.  The Plan and each Award Agreement under the Plan is intended to be exempt from or otherwise meet the&#160;requirements of Code Section&#160;409A and will be construed and interpreted, including but not limited with respect to ambiguities and&#47;or ambiguous terms, in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator.  To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Code Section&#160;409A, the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Code Section&#160;409A, such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Code Section&#160;409A. In no event will the Company or any of its Subsidiaries or Parents have any obligation or liability under the terms of this Plan to reimburse, indemnify, or hold harmless any Participant or any other person in respect of Awards, for any taxes, interest or penalties imposed, or other costs incurred, as a result of Section 409A.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">No Effect on Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing the Participant&#8217;s relationship as a Service Provider, nor will they interfere in any way with the Participant&#8217;s right or the right of the Company and its Subsidiaries or Parents, as applicable, to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator.  Notice of the determination will be provided to each Participant within a reasonable time after the date of such grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Term of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan will become effective upon its adoption by the Board (or its designated Committee).  It will continue in effect for a term of ten (10)&#160;years from the date adopted by the Board (or its designated Committee), unless terminated earlier under Section 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Amendment and Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator may at any time amend, alter, suspend or terminate the Plan.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Stockholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company will obtain stockholder approval of any Plan amendment to the extent that the Administrator (in its discretion) determines such approval is necessary and desirable to comply with Applicable Laws. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Effect of Amendment or Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No amendment, alteration, suspension or termination of the Plan will impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company.  Termination of the Plan will not affect the Administrator&#8217;s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.</font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Conditions Upon Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Legal Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Shares will not be issued pursuant to an Award unless the exercise of such Award and the issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Investment Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Inability to Obtain Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The inability of the Company to obtain authority from any regulatory body having jurisdiction or to complete or comply with the requirements of any registration or other qualification of the Shares under any state, federal or foreign law or under the rules and regulations of the Securities and Exchange Commission, the stock exchange on which Shares of the same class are then listed, or any other governmental or regulatory body, which authority, registration, qualification or rule compliance is deemed by the Company&#8217;s counsel to be necessary or advisable for the issuance and sale of any Shares hereunder, will relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority, registration, qualification or rule compliance will not have been obtained.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:55.26pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>4
<FILENAME>nstg-2022ex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icb634d2cb20346f6ac7ef7d75e83fde2_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.9</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NANOSTRING TECHNOLOGIES, INC.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 INDUCEMENT EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2018 Inducement Equity Incentive Plan (the &#8220;Plan&#8221;) will have the same defined meanings in this Restricted Stock Unit Agreement (the &#8220;Award Agreement&#8221;), which includes the Notice of Restricted Stock Unit Grant (the &#8220;Notice of Grant&#8221;) and Terms and Conditions of Restricted Stock Unit Grant, attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NOTICE OF RESTRICTED STOCK UNIT GRANT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant Name&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Address&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant has been granted the right to receive an Award of Restricted Stock Units, subject to the terms and conditions of the Plan and this Award Agreement, as follows&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grant Number</font></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Grant</font></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vesting Commencement Date</font></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of Restricted Stock Units</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Schedule&#58;</font></div><div style="margin-bottom:6pt;padding-right:2.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to any acceleration provisions contained in the Plan or set forth below, the Restricted Stock Units will vest in accordance with the following schedule&#58;</font></div><div style="margin-bottom:6pt;padding-right:2.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insert vesting schedule, e.g.,&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> One-third (1&#47;3rd) of the Restricted Stock Units will vest on the one (1) year anniversary of the Vesting Commencement Date, and one-third (1&#47;3rd) of the Restricted Stock Units will vest each year thereafter on the same day as the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date.&#93;</font></div><div style="margin-bottom:6pt;padding-right:2.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insert vesting acceleration provisions, if any, e.g.&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Notwithstanding the foregoing, in the event of (A) a Change in Control in which the Restricted Stock Units are assumed and (B) the subsequent termination of the Participant&#8217;s service either (i) by the Company without Cause (as defined below) or (ii) by Participant&#8217;s resignation for Good Reason (as defined below), one hundred percent (100%) of the Restricted Stock Units will become fully vested as of the time immediately prior to the Participant&#8217;s termination of service.</font></div><div style="margin-bottom:6pt;padding-right:2.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Cause&#8221; for termination of Participant will exist if Participant is terminated for any of the following reasons&#58; (i) Participant&#8217;s failure to substantially perform his or her duties and responsibilities to the Company (other than a failure resulting from Participant&#8217;s disability) after receiving written notice of the alleged failure and ten (10) days opportunity to cure&#59; (ii)&#160;Participant&#8217;s commission of any act of fraud, embezzlement, dishonesty or misrepresentation&#59; (iii) Participant&#8217;s violation of any federal or state law or regulation applicable to the business of the Company or its affiliates&#59; (iv) Participant&#8217;s breach of any confidentiality agreement or invention assignment agreement between Participant and the Company (or any affiliate of the Company)&#59; or (v) Participant being convicted of, or entering a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to, a felony or committing any act of moral turpitude, dishonesty or fraud against, or the misappropriation of material property belonging to, the Company or its affiliates. The determination as to whether Participant is being terminated for Cause shall be based on a good faith determination by the Board.</font></div><div style="margin-bottom:6pt;padding-right:2.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Good Reason&#8221; means the occurrence of one or more of the following events effected without Participant&#8217;s prior consent&#58; (i) the assignment to Participant of any duties or the reduction of Participant&#8217;s duties, either of which results in a material diminution in Participant&#8217;s position or responsibilities with the Company&#59; provided that, it being understood that the continuance of Participant&#8217;s duties and responsibilities at the subsidiary or divisional level following a Change in Control, rather than at the parent, combined or surviving company level following such Change in Control shall not be deemed Good </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-right:2.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reason within the meaning of this clause (i)&#59; (ii) a material reduction by the Company in the base salary of Participant&#59; (iii) a material change in the geographic location at which Participant must perform services (for purposes of the foregoing, the relocation of Participant to a facility or a location less than 25 miles from Participant&#8217;s then-present location shall not be considered a material change in geographic location)&#59; or (iv) any material breach by the Company of any material provision of the employment or similar agreement under which Participant provides employment services to the Company.  Participant will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for &#8220;Good Reason&#8221; within ninety (90) days of the initial existence of the grounds for &#8220;Good Reason&#8221; and a reasonable cure period of not less than thirty (30) days following the date of such notice.  The determination as to whether Participant resigned for Good Reason shall be based on a good faith determination by the Board.&#93;</font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Participant ceases to be a Service Provider for any or no reason before Participant vests in the Restricted Stock Units, the Restricted Stock Units and Participant&#8217;s right to acquire any Shares hereunder will immediately terminate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By Participant&#8217;s signature and the signature of the representative of NanoString Technologies, Inc. (the &#8220;Company&#8221;) below, Participant and the Company agree that this Award of Restricted Stock Units is granted under and governed by the terms and conditions of the Plan and this Award Agreement, including the Terms and Conditions of Restricted Stock Unit Grant, attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, all of which are made a part of this document.  Participant has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Award Agreement and fully understands all provisions of the Plan and Award Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and Award Agreement.  Participant further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div style="margin-bottom:6pt;margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PARTICIPANT&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;NANOSTRING TECHNOLOGIES, INC. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature&#160;&#160;&#160;&#160;By</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Print Name&#160;&#160;&#160;&#160;Title</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Residence Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT GRANT</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company hereby grants to the individual named in the Notice of Grant (the &#8220;Participant&#8221;) under the Plan an Award of Restricted Stock Units, subject to all of the terms and conditions in this Award Agreement and the Plan, which is incorporated herein by reference.  Subject to Section 18(c) of the Plan, in the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Award Agreement, the terms and conditions of the Plan will prevail.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company&#8217;s Obligation to Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit represents the right to receive a Share on the date it vests.  Unless and until the Restricted Stock Units will have vested in the manner set forth in Sections&#160;3 or 4, Participant will have no right to payment of any such Restricted Stock Units.  Prior to actual payment of any vested Restricted Stock Units, such Restricted Stock Units will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.  Any Restricted Stock Units that vest in accordance with Sections 3 or 4 will be paid to Participant (or in the event of Participant&#8217;s death, to his or her estate) in whole Shares, subject to Participant satisfying any applicable tax withholding obligations as set forth in Section 7.  Subject to the provisions of Section 4, such vested Restricted Stock Units shall be paid in whole Shares as soon as practicable after vesting, but in each such case within the period sixty (60) days following the vesting date.  In no event will Participant be permitted, directly or indirectly, to specify the taxable year of the payment of any Restricted Stock Units payable under this Award Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided in Section 4, and subject to Section 5, the Restricted Stock Units awarded by this Award Agreement will vest in accordance with the vesting provisions set forth in the Notice of Grant.  Restricted Stock Units scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in Participant in accordance with any of the provisions of this Award Agreement, unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator, in its discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested Restricted Stock Units at any time, subject to the terms of the Plan.  If so accelerated, such Restricted Stock Units will be considered as having vested as of the date specified by the Administrator.  The payment of Shares vesting pursuant to this Section 4 shall in all cases be paid at a time or in a manner that is exempt from, or complies with, Section 409A.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything in the Plan or this Award Agreement to the contrary, if the vesting of the balance, or some lesser portion of the balance, of the Restricted Stock Units is accelerated in connection with Participant&#8217;s termination as a Service Provider (provided that such termination is a &#8220;separation from service&#8221; within the meaning of Section 409A, as determined by the Company), other than due to death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and if (x) Participant is a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of such termination as a Service Provider and (y) the payment of such accelerated Restricted Stock Units will result in the imposition of additional tax under Section 409A if paid to Participant on or within the six (6) month period following Participant&#8217;s termination as a Service Provider, then the payment of such accelerated Restricted Stock Units will not be made until the date six (6) months and one (1) day following the date of Participant&#8217;s termination as a Service Provider, unless the Participant dies following his or her termination as a Service Provider, in which case, the Restricted Stock Units will be paid in Shares to the Participant&#8217;s estate as soon as practicable following his or her death.  It is the intent of this Award Agreement that it and all payments and benefits hereunder be exempt from, or comply with, the requirements of Section 409A so that none of the Restricted Stock Units provided under this Award Agreement or Shares issuable thereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to be so exempt or so comply.  Each payment payable under this Award Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).  For purposes of this Award Agreement, &#8220;Section 409A&#8221; means Section 409A of the Code, and any final Treasury Regulations and Internal Revenue Service guidance thereunder, as each may be amended from time to time.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Forfeiture upon Termination of Status as a Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any contrary provision of this Award Agreement, the balance of the Restricted Stock Units that have not vested as of the time of Participant&#8217;s termination as a Service Provider for any or no reason and Participant&#8217;s right to acquire any Shares hereunder will immediately terminate.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Death of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any distribution or delivery to be made to Participant under this Award Agreement will, if Participant is then deceased, be made to Participant&#8217;s designated beneficiary, or if no beneficiary survives Participant, the administrator or executor of Participant&#8217;s estate.  Any such transferee must furnish the Company with (a)&#160;written notice of </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">his or her status as transferee, and (b)&#160;evidence satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant&#8217;s employer (the &#8220;Employer&#8221;) or any Parent or Subsidiary to which Participant is providing services (together, the &#8220;Service Recipients&#8221;), the ultimate liability for any tax and&#47;or social insurance liability obligations and requirements in connection with the Restricted Stock Units, including, without limitation, (i) all federal, state, and local taxes (including Participant&#8217;s Federal Insurance Contributions Act (FICA) obligations) that are required to be withheld by any Service Recipient or other payment of tax-related items related to Participant&#8217;s participation in the Plan and legally applicable to Participant&#59; (ii)&#160;Participant&#8217;s and, to the extent required by any Service Recipient, the Service Recipient&#8217;s fringe benefit tax liability, if any, associated with the grant, vesting, or settlement of the Restricted Stock Units or sale of Shares&#59; and (iii)&#160;any other Service Recipient taxes the responsibility for which Participant has, or has agreed to bear, with respect to the Restricted Stock Units (or settlement thereof or issuance of Shares thereunder) (collectively, the &#8220;Tax Obligations&#8221;), is and remains Participant&#8217;s sole responsibility and may exceed the amount actually withheld by the applicable Service Recipient(s).  Participant further acknowledges that no Service Recipient (A) makes any representations or undertakings regarding the treatment of any Tax Obligations in connection with any aspect of the Restricted Stock Units, including, but not limited to, the grant, vesting or settlement of the Restricted Stock Units, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends or other distributions, and (B) makes any commitment to and is under any obligation to structure the terms of the grant or any aspect of the Restricted Stock Units to reduce or eliminate Participant&#8217;s liability for Tax Obligations or achieve any particular tax result.  Further, if Participant is subject to Tax Obligations in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the applicable Service Recipient(s) (or former employer, as applicable) may be required to withhold or account for Tax Obligations in more than one jurisdiction.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to such procedures as the Administrator may specify from time to time, the Service Recipient may withhold the amount required to be withheld for the payment of Tax Obligations (the &#8220;Withholding Obligations&#8221;).  The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit Participant to satisfy such Withholding Obligations, in whole or in part (without limitation), if permissible by applicable local law, by&#58; (i)&#160;paying cash in U.S. dollars, (ii)&#160;having the Company withhold otherwise deliverable Shares having a fair market value equal to the minimum amount that is necessary to meet the withholding requirement for such Withholding Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences) (&#8220;Net Share Withholding&#8221;), (iii) withholding the amount of such Withholding Obligations from Participant&#8217;s wages or other cash compensation paid to Participant by the applicable Service Recipient(s), (iv)&#160;delivering to the Company Shares that Participant owns and that already have vested with a fair market value equal to the Withholding Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences), (v)&#160;selling a sufficient number of such Shares otherwise deliverable to Participant, through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) equal to the minimum amount that is necessary to meet the withholding requirement for such Withholding Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences) (&#8220;Sell to Cover&#8221;), (vi) such other means as the Administrator deems appropriate, or (vii) any combination of the foregoing methods of payment.  If the Withholding Obligations are satisfied by withholding in Shares, for tax purposes, Participant is deemed to have been issued the full number of Shares subject to the vested Restricted Stock Units, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Withholding Obligations.  To the extent determined appropriate by the Company in its discretion, it will have the right (but not the obligation) to satisfy any Withholding Obligations by Net Share Withholding.  If Net Share Withholding is the method by which such Withholding Obligations are satisfied, the Company will not withhold on a fractional Share basis to satisfy any portion of the Withholding Obligations and, unless the Company determines otherwise, no refund will be made to Participant for the value of the portion of a Share, if any, withheld in excess of the Withholding Obligations.  If a Sell to Cover is the method by which Withholding Obligations are satisfied, Participant agrees that as part of the Sell to Cover, additional Shares may be sold to satisfy any associated broker or other fees.  Only whole Shares will be sold pursuant to a Sell to Cover.  Any proceeds from the sale of Shares pursuant to a Sell to Cover that are in excess of the Withholding Obligations and any associated broker or other fees will be paid to Participant in accordance with procedures the Company may specify from time to time.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant is advised to review with his or her own tax advisers the U.S. federal, state, local and non-U.S. tax consequences of the transactions contemplated by this Award Agreement.  With respect to such matters, Participant relies solely on such advisers and not on any statements or representations of the Company or any of its agents, written or oral.  Participant understands that Participant (and not the Company or any Service Recipient) shall be responsible for Participant&#8217;s own tax liability that may arise as a result of the transactions contemplated by this Award Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For clarification purposes, in no event will the Company issue Participant any Shares unless and until arrangements satisfactory to the Administrator have been made for the payment of Participant&#8217;s Withholding Obligations.  If Participant fails to make satisfactory arrangements for the payment of such Withholding Obligations hereunder at the time any applicable Restricted Stock Units otherwise are scheduled to vest pursuant to this Award Agreement or Participant&#8217;s Withholding Obligations otherwise become due, Participant permanently will forfeit such Restricted Stock Units to which Participant&#8217;s Withholding Obligation relates and any right to receive Shares thereunder and such Restricted Stock Units will be returned to the Company at no cost to the Company.  Participant acknowledges and agrees that the Company may permanently refuse to issue or deliver the Shares if such Withholding Obligations are not delivered at the time they are due.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant.  After such issuance, recordation and delivery, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:19.44pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Guarantee of Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE RESTRICTED STOCK UNITS PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OF RESTRICTED STOCK UNITS OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#8217;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#8217;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Address for Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company at NanoString Technologies, Inc., 530 Fairview North, Seattle, WA 98109, or at such other address as the Company may hereafter designate in writing.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant is Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except to the limited extent provided in Section&#160;6, this grant and the rights and privileges conferred hereby will not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution, attachment or similar process.  Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this grant, or any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment or similar process, this grant and the rights and privileges conferred hereby immediately will become null and void.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Binding Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the limitation on the transferability of this grant contained herein, this Award Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Conditions to Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If at any time the Company will determine, in its discretion, that the listing, registration, qualification or rule compliance of the Shares upon any securities exchange or under any state, federal or foreign law, the tax code and related regulations or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Participant (or his or her estate) hereunder, such issuance will not occur unless and until such listing, registration, qualification, rule compliance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to the Company.  Where the Company determines that the delivery of the payment of any Shares will violate federal securities laws or other applicable laws, the Company will defer delivery until the earliest date at which the Company reasonably anticipates that the delivery of Shares will no longer cause such violation.  The Company will make all reasonable efforts to meet the requirements of any such state, federal or </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign law or securities exchange and to obtain any such consent or approval of any such governmental authority or securities exchange.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Governs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Award Agreement is subject to all terms and provisions of the Plan.  In the event of a conflict between one or more provisions of this Award Agreement and one or more provisions of the Plan, the provisions of the Plan will govern.  Capitalized terms used and not defined in this Award Agreement will have the meaning set forth in the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator will have the power to interpret the Plan and this Award Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Restricted Stock Units have vested).  All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons.  No member of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Award Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company may, in its sole discretion, decide to deliver any documents related to Restricted Stock Units awarded under the Plan or future Restricted Stock Units that may be awarded under the Plan by electronic means or request Participant&#8217;s consent to participate in the Plan by electronic means.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event that any provision in this Award Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Award Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modifications to the Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Award Agreement constitutes the entire understanding of the parties on the subjects covered.  Participant expressly warrants that he or she is not accepting this Award Agreement in reliance on any promises, representations, or inducements other than those contained herein.  Modifications to this Award Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company.  Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Section 409A in connection to this Award of Restricted Stock Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment, Suspension or Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  By accepting this Award, Participant expressly warrants that he or she has received an Award of Restricted Stock Units under the Plan, and has received, read and understood a description of the Plan.  Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Award Agreement will be governed by the laws of Washington without giving effect to the conflict of law principles thereof.  For purposes of litigating any dispute that arises under this Award of Restricted Stock Units or this Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Washington, and agree that such litigation will be conducted in the courts of King County, Washington, or the federal courts for the United States for the District of Washington, and no other courts, where this Award of Restricted Stock Units is made and&#47;or to be performed.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>5
<FILENAME>nstg-2022ex1010.htm
<DESCRIPTION>EX-10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i727789f656dc4c3f80104daf45c1d53d_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">EXHIBIT 10.10</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">NANOSTRING TECHNOLOGIES, INC.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 INDUCEMENT EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCK OPTION AGREEMENT</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2018 Inducement Equity Incentive Plan (the &#8220;Plan&#8221;) will have the same defined meanings in this Stock Option Agreement (the &#8220;Agreement&#8221;), including the Notice of Stock Option Grant (the &#8220;Notice of Grant&#8221;) and Terms and Conditions of Stock Option Grant, attached hereto as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NOTICE OF STOCK OPTION GRANT</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Address&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant has been granted an Option to purchase Common Stock of NanoString Technologies, Inc. (the &#8220;Company&#8221;), subject to the terms and conditions of the Plan and this Agreement, as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grant Number&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Grant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vesting Commencement Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of Shares Granted&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise Price per Share&#58;&#160;&#160;&#160;&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Exercise Price&#58;&#160;&#160;&#160;&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Type of Option&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nonstatutory Stock Option</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term&#47;Expiration Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to accelerated vesting as set forth below or in the Plan, this Option will be exercisable, in whole or in part, in accordance with the following schedule&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insert vesting schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insert vesting acceleration provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Option will be exercisable for three (3) months after Participant ceases to be a Service Provider, unless such termination is due to Participant&#8217;s death or Disability, in which case this Option will be exercisable for twelve (12) months after Participant ceases to be a Service Provider. Notwithstanding the foregoing sentence, in no event may this Option be exercised after the Term&#47;Expiration Date as provided above and may be subject to earlier termination as provided in Section 13(c) of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By Participant&#8217;s signature and the signature of the Company&#8217;s representative below, Participant and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan and this Agreement, including exhibits hereto, all of which are made a part of this document. Participant has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of the Plan and Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">PARTICIPANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;NANOSTRING TECHNOLOGIES, INC.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS OF STOCK OPTION GRANT</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company hereby grants to the Participant named in the Notice of Grant (the &#8220;Participant&#8221;) an option (the &#8220;Option&#8221;) to purchase the number of Shares, as set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the &#8220;Exercise Price&#8221;), subject to all of the terms and conditions in this Agreement and the Plan, which is incorporated herein by reference. Subject to Section 18(c) of the Plan, in the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement, the terms and conditions of the Plan will prevail.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as provided in Section 3, the Option awarded by this Agreement will vest in accordance with the vesting provisions set forth in the Notice of Grant. Shares scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in Participant in accordance with any of the provisions of this Agreement, unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator, in its discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested Option at any time, subject to the terms of the Plan. If so accelerated, such Option will be considered as having vested as of the date specified by the Administrator.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Right to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Option is exercisable by delivery of an exercise notice, in the form attached as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(the &#8220;Exercise Notice&#8221;) or in a manner and pursuant to such procedures as the Administrator may determine, which will state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the &#8220;Exercised Shares&#8221;), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice will be completed by Participant and delivered to the Company. The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares together with any applicable tax withholding. This Option will be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Method of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the election of Participant&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)cash&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)check&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)consideration received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)surrender of other Shares which have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Exercised Shares, provided that accepting such Shares, in the sole discretion of the Administrator, will not result in any adverse accounting consequences to the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any contrary provision of this Agreement, no certificate representing the Shares will be issued to Participant, unless and until satisfactory arrangements (as determined by the Administrator) will have been made by Participant with respect to the payment of income, employment, social insurance, payroll and other taxes which the Company determines must be withheld with respect to such Shares. To the extent determined appropriate by the Company in its discretion, it will have the right (but not the obligation) to satisfy any tax withholding obligations by reducing the number of Shares otherwise deliverable to Participant. If Participant fails to make satisfactory arrangements for the payment of any required tax withholding obligations hereunder at the time of the Option exercise, Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time of exercise.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under Code Section 409A, an option that vests after December 31, 2004 (or that vested on or prior to such date but which was materially modified after October 3, 2004) that was granted with a per Share exercise price that is determined by the Internal Revenue Service (the &#8220;IRS&#8221;) to be less than the Fair Market Value of a Share on the date of grant (a &#8220;Discount Option&#8221;) may be considered &#8220;deferred compensation.&#8221; A Discount Option may result in (i) income recognition by Participant prior to the exercise of the option, (ii) an additional twenty percent (20%) federal income </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tax, and (iii) potential penalty and interest charges. The Discount Option may also result in additional state income, penalty and interest charges to the Participant. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the Date of Grant in a later examination. Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the date of grant, Participant will be solely responsible for Participant&#8217;s costs related to such a determination.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant. After such issuance, recordation and delivery, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Guarantee of Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#8217;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#8217;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Address for Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any notice to be given to the Company under the terms of this Agreement will be addressed to the Company at NanoString Technologies, Inc., 530 Fairview Avenue North, Seattle, WA 98109, or at such other address as the Company may hereafter designate in writing.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Transferability of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Binding Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the limitation on the transferability of this grant contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Conditions to Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If at any time the Company will determine, in its discretion, that the listing, registration, qualification or rule compliance of the Shares upon any securities exchange or under any state, federal or foreign law, the tax code and related regulations or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the purchase by, or issuance of Shares to, Participant (or his or her estate) hereunder, such purchase or issuance will not occur unless and until such listing, registration, qualification, rule compliance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to the Company. The Company will make all reasonable efforts to meet the requirements of any such state, federal or foreign law or securities exchange and to obtain any such consent or approval of any such governmental authority or securities exchange. Assuming such compliance, for income tax purposes the Exercised Shares will be considered transferred to Participant on the date the Option is exercised with respect to such Exercised Shares.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Governs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement is subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement and one or more provisions of the Plan, the provisions of the Plan will govern. Capitalized terms used and not defined in this Agreement will have the meaning set forth in the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator will have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Shares subject to the Option have vested). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons. No member of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may, in its sole discretion, decide to deliver any documents related to Options awarded under the Plan or future options that may be awarded under the Plan by electronic means or request Participant&#8217;s </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consent to participate in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that any provision in this Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modifications to the Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement constitutes the entire understanding of the parties on the subjects covered. Participant expressly warrants that he or she is not accepting this Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Agreement, the Company reserves the right to revise this Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code in connection to this Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment, Suspension or Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. By accepting this Award, Participant expressly warrants that he or she has received an Option under the Plan, and has received, read and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement will be governed by the laws of Washington, without giving effect to the conflict of law principles thereof. For purposes of litigating any dispute that arises under this Award of an Option or this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Washington</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and agree that such litigation will be conducted in the courts of King County, Washington, or the federal courts for the United States for the District of Washington, and no other courts, where this Award of an Option is made and&#47;or to be performed.</font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NANOSTRING TECHNOLOGIES, INC.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 INDUCEMENT EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXERCISE NOTICE</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NanoString Technologies, Inc.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">530 Fairview Avenue North</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, WA 98109</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Stock Administration</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Effective as of today, ________________, _____, the undersigned (&#8220;Purchaser&#8221;) hereby elects to purchase ______________ shares (the &#8220;Shares&#8221;) of the Common Stock of NanoString Technologies, Inc. (the &#8220;Company&#8221;) under and pursuant to the 2018&#160;Inducement Equity Incentive Plan (the &#8220;Plan&#8221;) and the Stock Option Agreement dated ________________, _____, (the &#8220;Agreement&#8221;). The purchase price for the Shares will be $_____________, as required by the Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Delivery of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Purchaser herewith delivers to the Company the full purchase price of the Shares and any required tax withholding to be paid in connection with the exercise of the Option.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representations of Purchaser</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Purchaser acknowledges that Purchaser has received, read and understood the Plan and the Agreement and agrees to abide by and be bound by their terms and conditions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the Shares, no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to the Option, notwithstanding the exercise of the Option. The Shares so acquired will be issued to Purchaser as soon as practicable after exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date of issuance, except as provided in Section 13 of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Consultation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser&#8217;s purchase or disposition of the Shares. Purchaser represents that Purchaser has consulted with any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that Purchaser is not relying on the Company for any tax advice.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement&#59; Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan and Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser&#8217;s interest except by means of a writing signed by the Company and Purchaser. This agreement is governed by the internal substantive laws, but not the choice of law rules, of Washington.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Submitted by&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accepted by&#58;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURCHASER&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;NANOSTRING TECHNOLOGIES, INC.</font></div><div style="margin-bottom:6pt;text-indent:468pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By</font></div><div style="margin-bottom:6pt;text-indent:468pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Print Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Its</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date Received</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>nstg-2022ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib7435ceb355e41509769c3ca9e90d656_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Form S-8 No. 333-189883 pertaining to the 2013 Equity Incentive Plan, 2013 Employee Stock Purchase Plan, and the 2004 Stock Option Plan, as amended </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Form S-8 Nos. 333-194844, 333-202768, 333-210210, 333-216584, 333-222567, 333-230201, 333-236845, 333-253737, and 333-263183 pertaining to the 2013 Equity Incentive Plan and 2013 Employee Stock Purchase Plan</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Form S-8 No. 333-222568 pertaining to the 2018 Inducement Equity Incentive Plan</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Form S-8 No. 333-265702 pertaining to the 2022 Equity Incentive Plan</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February&#160;28, 2023, with respect to the consolidated financial statements of NanoString Technologies, Inc. and the effectiveness of internal control over financial reporting of NanoString Technologies, Inc. included in this Annual Report (Form 10-K) of NanoString Technologies, Inc. for the year ended December&#160;31, 2022.</font></div><div style="margin-bottom:6pt;margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>nstg-2022ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i85f8bfcbd55a4179ab61f97550fd399c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, R. Bradley Gray, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of NanoString Technologies, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d&#8211;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 15d&#8211;15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:178.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:330.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; R. Bradley Gray</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bradley Gray</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>nstg-2022ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia6f87387aed149f5ac368b305ff64697_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, K. Thomas Bailey, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of NanoString Technologies, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d&#8211;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 15d&#8211;15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2023</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:198.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:310.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; K. Thomas Bailey</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K. Thomas Bailey</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>nstg-2022ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6cad536abc3d48148aae00e839ca6cb3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NANOSTRING TECHNOLOGIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Annual Report of NanoString Technologies, Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, R. Bradley Gray, President and Chief Executive Officer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:178.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:330.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; R. Bradley Gray</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bradley Gray</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2023</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of NanoString Technologies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>nstg-2022ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i74003d68689e4f82a3407f6465a8e3be_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NANOSTRING TECHNOLOGIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Annual Report of NanoString Technologies, Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, K. Thomas Bailey, Chief Financial Officer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:200.25pt"><tr><td style="width:1.0pt"></td><td style="width:198.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; K. Thomas Bailey</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K. Thomas Bailey</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2023 </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of NanoString Technologies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>nstg-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:50e88ef7-7662-44f9-a77d-a0cf072223f8,g:ff6ee908-6dcd-4476-b167-ff6c214915d5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nstg="http://www.nanostring.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nanostring.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nstg-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nstg-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nstg-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nstg-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.nanostring.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.nanostring.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.nanostring.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.nanostring.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000006 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinStockholdersEquityParenthetical" roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical">
        <link:definition>0000008 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://www.nanostring.com/role/DescriptionoftheBusiness">
        <link:definition>0000010 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.nanostring.com/role/SignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersNotes" roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersNotes">
        <link:definition>0000012 - Disclosure - Revenue from Contracts with Customers (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermInvestments" roleURI="http://www.nanostring.com/role/ShorttermInvestments">
        <link:definition>0000013 - Disclosure - Short-term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.nanostring.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.nanostring.com/role/LeasesNotes">
        <link:definition>0000015 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.nanostring.com/role/Inventory">
        <link:definition>0000016 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.nanostring.com/role/PropertyandEquipment">
        <link:definition>0000017 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.nanostring.com/role/LongTermDebt">
        <link:definition>0000018 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandPreferredStock" roleURI="http://www.nanostring.com/role/CommonStockandPreferredStock">
        <link:definition>0000019 - Disclosure - Common Stock and Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensation" roleURI="http://www.nanostring.com/role/StockbasedCompensation">
        <link:definition>0000020 - Disclosure - Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionRetirementPlan" roleURI="http://www.nanostring.com/role/DefinedContributionRetirementPlan">
        <link:definition>0000021 - Disclosure - Defined Contribution Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.nanostring.com/role/IncomeTaxes">
        <link:definition>0000022 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.nanostring.com/role/CommitmentsandContingencies">
        <link:definition>0000023 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.nanostring.com/role/NetLossPerShare">
        <link:definition>0000024 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.nanostring.com/role/SubsequentEvents">
        <link:definition>0000025 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000026 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresPolicies" roleURI="http://www.nanostring.com/role/FairValueMeasuresandDisclosuresPolicies">
        <link:definition>0000027 - Disclosure - Fair Value Measures and Disclosures (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersTables" roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersTables">
        <link:definition>0000028 - Disclosure - Revenue from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermInvestmentsTables" roleURI="http://www.nanostring.com/role/ShorttermInvestmentsTables">
        <link:definition>0000029 - Disclosure - Short-term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.nanostring.com/role/FairValueMeasurementsTables">
        <link:definition>0000030 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.nanostring.com/role/LeasesTables">
        <link:definition>0000031 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.nanostring.com/role/InventoryTables">
        <link:definition>0000032 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.nanostring.com/role/PropertyandEquipmentTables">
        <link:definition>0000033 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.nanostring.com/role/LongTermDebtTables">
        <link:definition>0000034 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationTables" roleURI="http://www.nanostring.com/role/StockbasedCompensationTables">
        <link:definition>0000035 - Disclosure - Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.nanostring.com/role/IncomeTaxesTables">
        <link:definition>0000036 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.nanostring.com/role/NetLossPerShareTables">
        <link:definition>0000037 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsTables" roleURI="http://www.nanostring.com/role/SubsequentEventsTables">
        <link:definition>0000038 - Disclosure - Subsequent Events (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessNarrativeDetails" roleURI="http://www.nanostring.com/role/DescriptionoftheBusinessNarrativeDetails">
        <link:definition>0000039 - Disclosure - Description of the Business Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>0000040 - Disclosure - Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersNarrativeDetails" roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails">
        <link:definition>0000041 - Disclosure - Revenue from Contracts with Customers Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails" roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails">
        <link:definition>0000042 - Disclosure - Revenue from Contracts with Customers Schedule of Disaggregated Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermInvestmentsAvailableforSaleSecuritiesDetail" roleURI="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail">
        <link:definition>0000043 - Disclosure - Short-term Investments - Available-for-Sale Securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail" roleURI="http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail">
        <link:definition>0000044 - Disclosure - Short-term Investments - Fair Values of Available-for-Sale Securities by Contractual Maturity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail" roleURI="http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail">
        <link:definition>0000045 - Disclosure - Fair Value Measurements - Company's Available-for-Sale Securities by Level within Fair Value Hierarchy (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.nanostring.com/role/FairValueMeasurementsDetails">
        <link:definition>0000046 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.nanostring.com/role/LeasesDetails">
        <link:definition>0000047 - Disclosure - Leases - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryofLeaseCostandOtherInformationDetails" roleURI="http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails">
        <link:definition>0000048 - Disclosure - Leases - Summary of Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMinimumLeasePaymentsDetails" roleURI="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails">
        <link:definition>0000049 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1">
        <link:definition>0000049 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryScheduleofInventoryDetail" roleURI="http://www.nanostring.com/role/InventoryScheduleofInventoryDetail">
        <link:definition>0000050 - Disclosure - Inventory - Schedule of Inventory (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetail" roleURI="http://www.nanostring.com/role/PropertyandEquipmentDetail">
        <link:definition>0000051 - Disclosure - Property and Equipment - (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/PropertyandEquipmentAdditionalInformationDetail">
        <link:definition>0000052 - Disclosure - Property and Equipment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalInformationDetails" roleURI="http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails">
        <link:definition>0000053 - Disclosure - Long-Term Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtLongtermdebtandleasefinancingobligationsDetails" roleURI="http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails">
        <link:definition>0000054 - Disclosure - Long-Term Debt - Long-term debt and lease financing obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofInterestExpenseDetails" roleURI="http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails">
        <link:definition>0000055 - Disclosure - Long-Term Debt - Schedule of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandPreferredStockAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail">
        <link:definition>0000056 - Disclosure - Common Stock and Preferred Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail">
        <link:definition>0000057 - Disclosure - Stock-based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationStockOptionActivityandRelatedInformationDetail" roleURI="http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail">
        <link:definition>0000058 - Disclosure - Stock-based Compensation - Stock Option Activity and Related Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationCompanysOptionsOutstandingDetail" roleURI="http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail">
        <link:definition>0000059 - Disclosure - Stock-based Compensation - Company's Options Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails" roleURI="http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails">
        <link:definition>0000060 - Disclosure - Stock-based Compensation - Restricted Stock Units (RSUs) Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationStockCompensationExpenseDetail" roleURI="http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail">
        <link:definition>0000061 - Disclosure - Stock-based Compensation - Stock Compensation Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationFairValueofEmployeeOptionGrantDetail" roleURI="http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail">
        <link:definition>0000062 - Disclosure - Stock-based Compensation - Fair Value of Employee Option Grant (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionRetirementPlanAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/DefinedContributionRetirementPlanAdditionalInformationDetail">
        <link:definition>0000063 - Disclosure - Defined Contribution Retirement Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesLossBeforeIncomeTaxesDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail">
        <link:definition>0000064 - Disclosure - Income Taxes - Loss Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail">
        <link:definition>0000065 - Disclosure - Income Taxes - Significant Components of our Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>0000066 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail">
        <link:definition>0000067 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail">
        <link:definition>0000068 - Disclosure - Income Taxes - Effect of Temporary Differences and Carryforwards (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail">
        <link:definition>0000069 - Disclosure - Income Taxes - Summary of Changes in Deferred Tax Asset Valuation Allowance (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail" roleURI="http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail">
        <link:definition>0000070 - Disclosure - Income Taxes - Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>0000071 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareDetails" roleURI="http://www.nanostring.com/role/NetLossPerShareDetails">
        <link:definition>0000072 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.nanostring.com/role/SubsequentEventsDetails">
        <link:definition>0000073 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="nstg_GainLossOnExtinguishmentAndTerminationOfDebt" abstract="false" name="GainLossOnExtinguishmentAndTerminationOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ExercisePriceRangeFourMember" abstract="true" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_PrototypeSystemsMember" abstract="true" name="PrototypeSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_InterestAccruedOnLongTermNotes" abstract="false" name="InterestAccruedOnLongTermNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ExtendedProductWarrantyPeriod" abstract="false" name="ExtendedProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nstg_EffectiveIncomeTaxReconciliationSection162Limitation" abstract="false" name="EffectiveIncomeTaxReconciliationSection162Limitation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ExtinguishmentOfDebtTerminationFee" abstract="false" name="ExtinguishmentOfDebtTerminationFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_PrototypesAndOtherEquipmentMember" abstract="true" name="PrototypesAndOtherEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_RentalInstrumentsReclassifiedFromInventory" abstract="false" name="RentalInstrumentsReclassifiedFromInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_StandardProductWarrantyPeriod" abstract="false" name="StandardProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nstg_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_DebtSecuritiesAndEquitySecuritiesFairValue" abstract="false" name="DebtSecuritiesAndEquitySecuritiesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_AmortizationOfDebtDiscountAndIssuanceCosts" abstract="false" name="AmortizationOfDebtDiscountAndIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ServiceComponentMember" abstract="true" name="ServiceComponentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_DeferredTaxAssetsDeferredLeaseLiability" abstract="false" name="DeferredTaxAssetsDeferredLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_DeferredTaxAssetsSection174Capitalization" abstract="false" name="DeferredTaxAssetsSection174Capitalization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_EmployeeStockPurchasePlanOfferingPeriod" abstract="false" name="EmployeeStockPurchasePlanOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nstg_ConvertibleDebtTermsAxis" abstract="true" name="ConvertibleDebtTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="nstg_IncomeTaxesAndTaxRelatedLineItems" abstract="true" name="IncomeTaxesAndTaxRelatedLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" abstract="false" name="ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="nstg_ConvertibleDebtTriggeringEvent1Member" abstract="true" name="ConvertibleDebtTriggeringEvent1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ExercisePriceRangeOneMember" abstract="true" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ConvertibleDebtTriggeringEvent2Member" abstract="true" name="ConvertibleDebtTriggeringEvent2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ServiceAndPerformanceComponentsMember" abstract="true" name="ServiceAndPerformanceComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ProductAndServiceMember" abstract="true" name="ProductAndServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" abstract="false" name="ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_FederalAndStateMember" abstract="true" name="FederalAndStateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ProductConsumablesMember" abstract="true" name="ProductConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" abstract="false" name="EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" abstract="false" name="ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="nstg_EmployeeStockPurchasePlanPurchasePeriod" abstract="false" name="EmployeeStockPurchasePlanPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nstg_ProductInstrumentsMember" abstract="true" name="ProductInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_NumberOfOperatingLeases" abstract="false" name="NumberOfOperatingLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nstg_OutstandingPrincipalOfConvertibleDebt" abstract="false" name="OutstandingPrincipalOfConvertibleDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" abstract="false" name="DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_ExercisePriceRangeThreeMember" abstract="true" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ConvertibleSeniorNotesDue2025Member" abstract="true" name="ConvertibleSeniorNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_EmployeeStockPurchasePlanContributionPercentage" abstract="false" name="EmployeeStockPurchasePlanContributionPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="nstg_PublicStockOfferingMember" abstract="true" name="PublicStockOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_IncomeTaxesAndTaxRelatedTable" abstract="true" name="IncomeTaxesAndTaxRelatedTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="nstg_ExercisePriceRangeTwoMember" abstract="true" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" abstract="false" name="SaleOfStockGrossConsiderationReceivedOnTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" abstract="true" name="TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ManufacturingEquipmentMember" abstract="true" name="ManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_AreaOfSpaceUnderLease" abstract="false" name="AreaOfSpaceUnderLease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="nstg_TermLoanAgreementMember" abstract="true" name="TermLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" abstract="true" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" abstract="false" name="ContractWithCustomerLiabilityCustomerDepositsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nstg_ConvertibleDebtTermsDomain" abstract="true" name="ConvertibleDebtTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_IncomeTaxReconciliationChangeInTaxCredits" abstract="false" name="IncomeTaxReconciliationChangeInTaxCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nstg_ProductWarrantyAccrualPeriod" abstract="false" name="ProductWarrantyAccrualPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nstg_CostOfRevenueMember" abstract="true" name="CostOfRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_NumberOfPlatforms" abstract="false" name="NumberOfPlatforms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" abstract="false" name="EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_SecuredRevolvingLoanFacilityMember" abstract="true" name="SecuredRevolvingLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_ExercisePriceRangeFiveMember" abstract="true" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nstg_RepaymentOfAccruedInterestOfLongTermDebt" abstract="false" name="RepaymentOfAccruedInterestOfLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nstg_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>nstg-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:50e88ef7-7662-44f9-a77d-a0cf072223f8,g:ff6ee908-6dcd-4476-b167-ff6c214915d5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_11befe85-f124-49b9-b31d-2b6eeb250b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_261dbcc5-269e-42cc-abee-ce542e6ee1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_11befe85-f124-49b9-b31d-2b6eeb250b57" xlink:to="loc_us-gaap_LiabilitiesCurrent_261dbcc5-269e-42cc-abee-ce542e6ee1af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_482aa4b5-a7fb-4a9e-bacc-3082ca0a1a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_11befe85-f124-49b9-b31d-2b6eeb250b57" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_482aa4b5-a7fb-4a9e-bacc-3082ca0a1a83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_11d89af4-6948-4c33-a5e4-48f0355def18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_11befe85-f124-49b9-b31d-2b6eeb250b57" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_11d89af4-6948-4c33-a5e4-48f0355def18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4413c9c5-45e2-46a9-90cb-38b412591918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_11befe85-f124-49b9-b31d-2b6eeb250b57" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4413c9c5-45e2-46a9-90cb-38b412591918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_970051b5-f20c-4865-badb-da66c6544882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_278b80cf-b432-482c-b2a3-f04c82655dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_970051b5-f20c-4865-badb-da66c6544882" xlink:to="loc_us-gaap_PreferredStockValue_278b80cf-b432-482c-b2a3-f04c82655dae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_85993a0d-66eb-496e-959f-633c7a243564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_970051b5-f20c-4865-badb-da66c6544882" xlink:to="loc_us-gaap_CommonStockValue_85993a0d-66eb-496e-959f-633c7a243564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4a09edc1-0e82-4f61-9080-dceb6dbbfd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_970051b5-f20c-4865-badb-da66c6544882" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4a09edc1-0e82-4f61-9080-dceb6dbbfd4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a05ad229-e69c-4176-8f15-bd5520f59888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_970051b5-f20c-4865-badb-da66c6544882" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a05ad229-e69c-4176-8f15-bd5520f59888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f2ab56a0-09d7-45a4-a566-d0c5c55ea5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_970051b5-f20c-4865-badb-da66c6544882" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f2ab56a0-09d7-45a4-a566-d0c5c55ea5dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_be24617e-cc9a-4840-9c98-e03d49f963e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:to="loc_us-gaap_AccountsPayableCurrent_be24617e-cc9a-4840-9c98-e03d49f963e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7337eff5-2380-4db0-ad4f-c19f05e19a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7337eff5-2380-4db0-ad4f-c19f05e19a45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d4386e29-e698-43a0-ad43-fa8d156c3f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d4386e29-e698-43a0-ad43-fa8d156c3f8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_d9150608-8591-4312-9ff8-ec96250d4a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:to="loc_us-gaap_DeferredRevenueCurrent_d9150608-8591-4312-9ff8-ec96250d4a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c0ae75ae-d421-4744-915f-fb9fefbb5d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c0ae75ae-d421-4744-915f-fb9fefbb5d09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_afd261ff-46b6-4ac7-88c7-a8f757f57989" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b9411e5e-e8aa-442b-9897-169e74a53acb" xlink:to="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_afd261ff-46b6-4ac7-88c7-a8f757f57989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9a1c279-2f21-42eb-b2be-e630e5f23845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_14405940-c338-4eed-9c97-b844c4ee0ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9a1c279-2f21-42eb-b2be-e630e5f23845" xlink:to="loc_us-gaap_Liabilities_14405940-c338-4eed-9c97-b844c4ee0ffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_807b90d6-1a23-46b6-b376-93a55c83ab7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9a1c279-2f21-42eb-b2be-e630e5f23845" xlink:to="loc_us-gaap_CommitmentsAndContingencies_807b90d6-1a23-46b6-b376-93a55c83ab7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_316dd508-75ab-4ec8-929b-495d1d67e2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9a1c279-2f21-42eb-b2be-e630e5f23845" xlink:to="loc_us-gaap_StockholdersEquity_316dd508-75ab-4ec8-929b-495d1d67e2c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d5fd3ddd-0ab0-4ad1-af87-81799cda28dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d5fd3ddd-0ab0-4ad1-af87-81799cda28dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_ff79e308-cbd0-4225-a78e-b15d90bd2b57" xlink:href="nstg-20221231.xsd#nstg_DebtSecuritiesAndEquitySecuritiesFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:to="loc_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_ff79e308-cbd0-4225-a78e-b15d90bd2b57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3924324e-875f-4042-b25d-f70c2d1321ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3924324e-875f-4042-b25d-f70c2d1321ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0f275833-a693-4e7c-8084-286a914e306a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:to="loc_us-gaap_InventoryNet_0f275833-a693-4e7c-8084-286a914e306a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e8a1e99c-cd2b-45f7-8229-28f4808e9614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e8a1e99c-cd2b-45f7-8229-28f4808e9614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_5999cd80-1ee8-4a7d-a492-368cc86a7dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7dbf0683-de4e-4c12-9d0d-d820b6e2e2c6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_5999cd80-1ee8-4a7d-a492-368cc86a7dbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1c02e787-ddba-4249-8f3c-256b2c46f3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cd5a4bbe-fde2-4bd5-976a-5db2d8827002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1c02e787-ddba-4249-8f3c-256b2c46f3ad" xlink:to="loc_us-gaap_AssetsCurrent_cd5a4bbe-fde2-4bd5-976a-5db2d8827002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0a20b4f7-c37a-4214-9d63-101e47dc9bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1c02e787-ddba-4249-8f3c-256b2c46f3ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0a20b4f7-c37a-4214-9d63-101e47dc9bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ff180eb1-c89e-4257-9f2d-29ca95f395aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1c02e787-ddba-4249-8f3c-256b2c46f3ad" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ff180eb1-c89e-4257-9f2d-29ca95f395aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2f140db1-7684-4fb5-ae70-8bf5c0372821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1c02e787-ddba-4249-8f3c-256b2c46f3ad" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2f140db1-7684-4fb5-ae70-8bf5c0372821" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9049b3b6-80d5-4ba3-8168-927a8ec2b946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_45e5e825-88ef-40f3-aa05-5d957b7b26e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9049b3b6-80d5-4ba3-8168-927a8ec2b946" xlink:to="loc_us-gaap_OperatingIncomeLoss_45e5e825-88ef-40f3-aa05-5d957b7b26e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_96d0e3ad-ff24-4ee9-b3cf-e23bcc979fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9049b3b6-80d5-4ba3-8168-927a8ec2b946" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_96d0e3ad-ff24-4ee9-b3cf-e23bcc979fe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eed61120-2cd6-4c65-a526-8f1a6f7cbf80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6204a2e6-1be4-4f8e-8672-e60a5d776091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_eed61120-2cd6-4c65-a526-8f1a6f7cbf80" xlink:to="loc_us-gaap_Revenues_6204a2e6-1be4-4f8e-8672-e60a5d776091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_eeaf3400-3ba1-47b3-bf4d-dd06e586e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_eed61120-2cd6-4c65-a526-8f1a6f7cbf80" xlink:to="loc_us-gaap_CostsAndExpenses_eeaf3400-3ba1-47b3-bf4d-dd06e586e225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f10392f4-9cdb-40ac-afdf-9e3a51290163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_03d6ee13-9859-4a6c-a1e6-398d4d1aaeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f10392f4-9cdb-40ac-afdf-9e3a51290163" xlink:to="loc_us-gaap_CostOfRevenue_03d6ee13-9859-4a6c-a1e6-398d4d1aaeca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_425361fe-ea8f-4357-afbc-961d30855025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f10392f4-9cdb-40ac-afdf-9e3a51290163" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_425361fe-ea8f-4357-afbc-961d30855025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eb9bfea6-bc94-409e-9174-de7b61e79b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f10392f4-9cdb-40ac-afdf-9e3a51290163" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eb9bfea6-bc94-409e-9174-de7b61e79b46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_46ea703b-14fe-44ed-a545-bdac6bb48b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63a15fde-78ba-4931-a205-ec8da2aeb623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_46ea703b-14fe-44ed-a545-bdac6bb48b0d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63a15fde-78ba-4931-a205-ec8da2aeb623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_897ba9a4-9261-4291-95d8-7444f41817b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_46ea703b-14fe-44ed-a545-bdac6bb48b0d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_897ba9a4-9261-4291-95d8-7444f41817b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ea816cc4-f123-437e-8c89-d08502888161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_680de286-124e-4fc7-912c-9540bad1d8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ea816cc4-f123-437e-8c89-d08502888161" xlink:to="loc_us-gaap_InvestmentIncomeInterest_680de286-124e-4fc7-912c-9540bad1d8d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_6b8470fa-65e1-4a38-ad2c-6d07ad1e100b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ea816cc4-f123-437e-8c89-d08502888161" xlink:to="loc_us-gaap_InterestExpenseBorrowings_6b8470fa-65e1-4a38-ad2c-6d07ad1e100b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_89a7e3c9-5889-41db-ac4d-5a06c7eaec75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ea816cc4-f123-437e-8c89-d08502888161" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_89a7e3c9-5889-41db-ac4d-5a06c7eaec75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_82e05996-2c46-4ca1-8e5b-c600ccd3a7ba" xlink:href="nstg-20221231.xsd#nstg_GainLossOnExtinguishmentAndTerminationOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ea816cc4-f123-437e-8c89-d08502888161" xlink:to="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_82e05996-2c46-4ca1-8e5b-c600ccd3a7ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_263784e6-e50d-46f0-8450-2b7b18d942cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_888bf9ca-75e4-4d4d-8235-eb7a54d16507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_263784e6-e50d-46f0-8450-2b7b18d942cb" xlink:to="loc_us-gaap_NetIncomeLoss_888bf9ca-75e4-4d4d-8235-eb7a54d16507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_98050df8-c923-4dc2-b7a5-36350728fdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_263784e6-e50d-46f0-8450-2b7b18d942cb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_98050df8-c923-4dc2-b7a5-36350728fdde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_87ae6003-7b43-4941-a9f9-359a219b873e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_87ae6003-7b43-4941-a9f9-359a219b873e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fc17468f-7ed3-4a8f-885e-c6ba14f44a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fc17468f-7ed3-4a8f-885e-c6ba14f44a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_2ad2ad00-ed16-4f49-a5fe-868cfa318def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_2ad2ad00-ed16-4f49-a5fe-868cfa318def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d6837729-7487-4d37-a961-ffe641c2ada6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d6837729-7487-4d37-a961-ffe641c2ada6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_ae6e480c-c4da-4051-9644-4198fa29a08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSoftware"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:to="loc_us-gaap_PaymentsForSoftware_ae6e480c-c4da-4051-9644-4198fa29a08c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_6d7c4a5e-e940-4100-b19f-3e603cb49f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1eaadfb5-96b7-48b1-9b2f-468ea71f80f6" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_6d7c4a5e-e940-4100-b19f-3e603cb49f5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_485b6239-8374-427f-b1e5-18c0a2b4ecf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_485b6239-8374-427f-b1e5-18c0a2b4ecf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_38f8d868-bb83-4511-8765-a62892e2d755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_38f8d868-bb83-4511-8765-a62892e2d755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4a239eaf-994f-47b4-86b9-bce4df46ad45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4a239eaf-994f-47b4-86b9-bce4df46ad45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d99e481a-e4bf-44d3-852f-6765cff7b0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d99e481a-e4bf-44d3-852f-6765cff7b0a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_26d02acc-51b2-4660-9bf4-5d3621abc7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_26d02acc-51b2-4660-9bf4-5d3621abc7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_d0f6c438-4256-401b-8201-e1b9230ecf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_d0f6c438-4256-401b-8201-e1b9230ecf8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_037e8e7f-bee9-4f3a-96cf-e4038e482ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_037e8e7f-bee9-4f3a-96cf-e4038e482ea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_f8942898-905d-4c77-803b-e34c7c55100d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_f8942898-905d-4c77-803b-e34c7c55100d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_380eb684-a18a-4bf0-8b03-168b7ca9307e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_380eb684-a18a-4bf0-8b03-168b7ca9307e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_9e8f114f-5689-435f-808c-7caa97d9be67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3bf7ebbc-9764-4600-b7c2-679fce7f9169" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_9e8f114f-5689-435f-808c-7caa97d9be67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a455c3a-217a-4e73-aa82-b8a1316cc6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_afb758bf-733b-43eb-916b-aceacc897073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a455c3a-217a-4e73-aa82-b8a1316cc6a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_afb758bf-733b-43eb-916b-aceacc897073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3f7cc244-9316-4e0d-9029-2e848d851b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a455c3a-217a-4e73-aa82-b8a1316cc6a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3f7cc244-9316-4e0d-9029-2e848d851b44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e290166-2556-4a2e-92d3-05ae20ac601f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a455c3a-217a-4e73-aa82-b8a1316cc6a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e290166-2556-4a2e-92d3-05ae20ac601f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c63c09dc-dc38-488e-8bd6-c36f497739f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a455c3a-217a-4e73-aa82-b8a1316cc6a1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c63c09dc-dc38-488e-8bd6-c36f497739f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f98fcfe-f53a-4309-9d51-3ffa6b7f1e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_NetIncomeLoss_7f98fcfe-f53a-4309-9d51-3ffa6b7f1e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8d9ecc02-d435-4d6e-a52f-4c1e498b9357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8d9ecc02-d435-4d6e-a52f-4c1e498b9357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4eeaef0b-8307-412a-bcb1-73303c3215f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4eeaef0b-8307-412a-bcb1-73303c3215f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_07e2f195-f9c8-4507-945b-b56a774a8210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_07e2f195-f9c8-4507-945b-b56a774a8210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_645f7d05-42f9-47cd-801b-d4fafa8370e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_645f7d05-42f9-47cd-801b-d4fafa8370e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_b1aa9a39-c238-4db2-9364-6cbb626a9d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_b1aa9a39-c238-4db2-9364-6cbb626a9d91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_InterestAccruedOnLongTermNotes_8dd6dac9-c106-46ad-9f61-a98cc1a2bc96" xlink:href="nstg-20221231.xsd#nstg_InterestAccruedOnLongTermNotes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_nstg_InterestAccruedOnLongTermNotes_8dd6dac9-c106-46ad-9f61-a98cc1a2bc96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_00ea6e21-03b0-46bc-ab56-fb7ec8145dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_00ea6e21-03b0-46bc-ab56-fb7ec8145dd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_e59553f4-88cd-4b1a-91e9-3a09f4023091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_InventoryWriteDown_e59553f4-88cd-4b1a-91e9-3a09f4023091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ca3102b2-5047-4693-870a-968877b38d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ca3102b2-5047-4693-870a-968877b38d9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5007fe12-a4c3-45a5-b83e-cd9f5c3e9811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5007fe12-a4c3-45a5-b83e-cd9f5c3e9811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c12a7236-066d-493e-8571-761cd335bfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c12a7236-066d-493e-8571-761cd335bfd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dbfa418f-d7b5-451d-be1c-0d650550aabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dbfa418f-d7b5-451d-be1c-0d650550aabd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f3a826fd-4d4f-4d23-88f6-db7e5d33fb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f3a826fd-4d4f-4d23-88f6-db7e5d33fb4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b7a1daff-e6ce-4ea7-98de-e4e4339d176e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b7a1daff-e6ce-4ea7-98de-e4e4339d176e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_3e3265c3-09cd-49fe-b009-764080b9fc19" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_3e3265c3-09cd-49fe-b009-764080b9fc19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f6a37435-fbd9-4bb7-803b-db395748032e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f6a37435-fbd9-4bb7-803b-db395748032e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_c4971b46-ebbd-4982-a33e-8402400a7d93" xlink:href="nstg-20221231.xsd#nstg_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_c4971b46-ebbd-4982-a33e-8402400a7d93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0d4e090f-13fd-4e47-adc5-8de1b47fd604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0d4e090f-13fd-4e47-adc5-8de1b47fd604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_RepaymentOfAccruedInterestOfLongTermDebt_e1a5e495-1095-4f48-a174-eb8f15ca875f" xlink:href="nstg-20221231.xsd#nstg_RepaymentOfAccruedInterestOfLongTermDebt"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a801df20-fc63-4e4b-b8f3-65f34b5fe182" xlink:to="loc_nstg_RepaymentOfAccruedInterestOfLongTermDebt_e1a5e495-1095-4f48-a174-eb8f15ca875f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestmentsAvailableforSaleSecuritiesDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8787dae5-3556-4323-8465-75dca1838fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7f35184-af54-4d87-a64f-8de3ab8d9195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8787dae5-3556-4323-8465-75dca1838fed" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7f35184-af54-4d87-a64f-8de3ab8d9195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b03d4480-a5eb-4586-81b1-d6bebedfddcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8787dae5-3556-4323-8465-75dca1838fed" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b03d4480-a5eb-4586-81b1-d6bebedfddcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_572a8c6a-3533-422b-b116-c81bf673c6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8787dae5-3556-4323-8465-75dca1838fed" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_572a8c6a-3533-422b-b116-c81bf673c6e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2208618a-bef5-47e9-b44f-f2489813c394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_8e215bdb-ae65-4892-8202-eedc9262bd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2208618a-bef5-47e9-b44f-f2489813c394" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_8e215bdb-ae65-4892-8202-eedc9262bd2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_deb2402c-4a41-4ede-b045-beb233abc636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2208618a-bef5-47e9-b44f-f2489813c394" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_deb2402c-4a41-4ede-b045-beb233abc636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_433c7f28-61b4-4ad8-b0f6-b0b17b44c198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e067fde4-7a9f-412f-acb8-87ef94f57d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_433c7f28-61b4-4ad8-b0f6-b0b17b44c198" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e067fde4-7a9f-412f-acb8-87ef94f57d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_73f67210-2447-41a6-8ff1-8c3e7782da7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_433c7f28-61b4-4ad8-b0f6-b0b17b44c198" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_73f67210-2447-41a6-8ff1-8c3e7782da7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac96e6ce-f46d-4232-bef7-ea3ad46d7578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_08b5b70e-59c7-45ff-a4d8-4c7c614dee6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac96e6ce-f46d-4232-bef7-ea3ad46d7578" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_08b5b70e-59c7-45ff-a4d8-4c7c614dee6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_f0ef465b-266d-4aca-a541-de1e2dc2ae2a" xlink:href="nstg-20221231.xsd#nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac96e6ce-f46d-4232-bef7-ea3ad46d7578" xlink:to="loc_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_f0ef465b-266d-4aca-a541-de1e2dc2ae2a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesDetails"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_697ffaa7-baa4-4177-8a39-cf7fd947e32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_9ff769c2-22c2-41dc-9c83-7179a55aad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_697ffaa7-baa4-4177-8a39-cf7fd947e32f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_9ff769c2-22c2-41dc-9c83-7179a55aad3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_14257d11-7537-420f-a5e7-794ce89fe4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_697ffaa7-baa4-4177-8a39-cf7fd947e32f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_14257d11-7537-420f-a5e7-794ce89fe4e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_d365565b-ae69-4532-a4b9-d424692c970d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_697ffaa7-baa4-4177-8a39-cf7fd947e32f" xlink:to="loc_us-gaap_OperatingLeaseExpense_d365565b-ae69-4532-a4b9-d424692c970d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_78be2a00-137e-453d-9638-2b31609b8e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_78be2a00-137e-453d-9638-2b31609b8e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bc9398cd-c040-4e66-a657-4f31e3efb88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bc9398cd-c040-4e66-a657-4f31e3efb88b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_07f26677-d82b-43d8-a54d-01cc4c11863b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_07f26677-d82b-43d8-a54d-01cc4c11863b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d691654b-fcbc-494e-99b7-833c90954cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d691654b-fcbc-494e-99b7-833c90954cc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4118f416-e4eb-40b3-81da-99b64f338d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4118f416-e4eb-40b3-81da-99b64f338d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_49a1f1ac-bf05-493b-bc1a-c74a802b9624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe86deec-49b3-41c8-9438-e0bae78bbf07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_49a1f1ac-bf05-493b-bc1a-c74a802b9624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5aa75cc6-247f-4ed8-a399-013fcd4fce53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4962d9c6-3969-4552-8eb4-6754fce8b002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5aa75cc6-247f-4ed8-a399-013fcd4fce53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4962d9c6-3969-4552-8eb4-6754fce8b002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ea161295-b05e-4cdb-a3f8-dd46ee4794fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5aa75cc6-247f-4ed8-a399-013fcd4fce53" xlink:to="loc_us-gaap_FinanceLeaseLiability_ea161295-b05e-4cdb-a3f8-dd46ee4794fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9bfab80e-ebbb-4c46-a76a-70ba8c060a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a9887786-fcd3-493f-b9e3-a224a7ba7884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9bfab80e-ebbb-4c46-a76a-70ba8c060a99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a9887786-fcd3-493f-b9e3-a224a7ba7884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c440a1f3-03bb-4d8d-8e5c-85d1dd3646b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9bfab80e-ebbb-4c46-a76a-70ba8c060a99" xlink:to="loc_us-gaap_OperatingLeaseLiability_c440a1f3-03bb-4d8d-8e5c-85d1dd3646b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a920b98f-a518-4923-ae8b-a361d7d9c8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a920b98f-a518-4923-ae8b-a361d7d9c8cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1af7c073-1eb4-43df-b81e-ab16139f5290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1af7c073-1eb4-43df-b81e-ab16139f5290" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_63ccb904-c0da-4dce-8e96-99db9daab3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_63ccb904-c0da-4dce-8e96-99db9daab3d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_9cc14422-360a-407b-a1b6-148d6549d4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_9cc14422-360a-407b-a1b6-148d6549d4af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6c6bd3de-4c5a-46bc-a151-deada8556485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6c6bd3de-4c5a-46bc-a151-deada8556485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_8620633f-3c2b-47a4-8197-615c693296ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_48676571-7669-48d0-8ec0-bd0684d2663e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_8620633f-3c2b-47a4-8197-615c693296ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/InventoryScheduleofInventoryDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#InventoryScheduleofInventoryDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/InventoryScheduleofInventoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_55295a2d-bf00-4676-8956-c9547d636c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4dd7e72d-ef0f-4142-b345-5d4976e4a019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_55295a2d-bf00-4676-8956-c9547d636c84" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4dd7e72d-ef0f-4142-b345-5d4976e4a019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_53fc892b-1c9b-4111-994a-1607b6e82149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_55295a2d-bf00-4676-8956-c9547d636c84" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_53fc892b-1c9b-4111-994a-1607b6e82149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8cc32290-a1ac-41f5-b59a-ab78ec5d705f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_55295a2d-bf00-4676-8956-c9547d636c84" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8cc32290-a1ac-41f5-b59a-ab78ec5d705f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/PropertyandEquipmentDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#PropertyandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/PropertyandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e6071344-8298-459c-abd7-f6e2fbaa922b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_22b262c9-7294-4dd3-873a-7f96a92c4042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e6071344-8298-459c-abd7-f6e2fbaa922b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_22b262c9-7294-4dd3-873a-7f96a92c4042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cfc554cf-54e6-4650-8379-d7ccb8781f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e6071344-8298-459c-abd7-f6e2fbaa922b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cfc554cf-54e6-4650-8379-d7ccb8781f6c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7293bb7a-2ec4-4f0c-acbc-680bc796b90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23bdb6d4-c5a9-4186-b54d-42055790ce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7293bb7a-2ec4-4f0c-acbc-680bc796b90a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23bdb6d4-c5a9-4186-b54d-42055790ce0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e1b969a8-10a6-4566-aa50-4b131823b9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7293bb7a-2ec4-4f0c-acbc-680bc796b90a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e1b969a8-10a6-4566-aa50-4b131823b9e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_82c6cce0-594f-4b2a-875f-8a335b237e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_82c6cce0-594f-4b2a-875f-8a335b237e1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_a7afc0aa-f103-45ca-b359-1d7b476a85df" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_a7afc0aa-f103-45ca-b359-1d7b476a85df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_df694b80-467e-46f6-94a7-03f37a1a4dde" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxReconciliationSection162Limitation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_df694b80-467e-46f6-94a7-03f37a1a4dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxReconciliationChangeInTaxCredits_c686b871-5c19-41f3-a7a1-d5abddfcb347" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxReconciliationChangeInTaxCredits"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_nstg_IncomeTaxReconciliationChangeInTaxCredits_c686b871-5c19-41f3-a7a1-d5abddfcb347" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_76d1e580-3b34-482b-9440-b12069baf417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_76d1e580-3b34-482b-9440-b12069baf417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_244accde-3318-431d-941f-fa9e247e00db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_244accde-3318-431d-941f-fa9e247e00db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_6a4969fa-a716-4d40-92cf-2ba8b2fe8b65" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_6a4969fa-a716-4d40-92cf-2ba8b2fe8b65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9456bc26-343c-47bb-9738-ba81abd747ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9456bc26-343c-47bb-9738-ba81abd747ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_4903f8b7-ef9c-4140-a97a-bf0c8c93f5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fa981c00-0d4b-460a-8e5f-482c0e3400ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_4903f8b7-ef9c-4140-a97a-bf0c8c93f5a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"/>
  <link:calculationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_568ef948-41c3-461f-b35e-3ddfffbfbe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_568ef948-41c3-461f-b35e-3ddfffbfbe8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_86cea34f-82e4-4bea-8f5c-4490476956fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_86cea34f-82e4-4bea-8f5c-4490476956fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_ddd42fab-24ea-402f-b8d9-1f257ae20090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_ddd42fab-24ea-402f-b8d9-1f257ae20090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_69cb0e7b-f398-491e-a195-e4787c770c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_69cb0e7b-f398-491e-a195-e4787c770c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_373961d3-b153-4fa9-ac17-1b7f05ea9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_373961d3-b153-4fa9-ac17-1b7f05ea9ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxAssetsDeferredLeaseLiability_2b63ee8e-452e-4062-90c0-bf510e632ca1" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxAssetsDeferredLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_nstg_DeferredTaxAssetsDeferredLeaseLiability_2b63ee8e-452e-4062-90c0-bf510e632ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxAssetsSection174Capitalization_3522a011-1fd3-4356-9fa4-c4fdb539ca39" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxAssetsSection174Capitalization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019c9cbf-9cbd-4138-9f02-2425dc139783" xlink:to="loc_nstg_DeferredTaxAssetsSection174Capitalization_3522a011-1fd3-4356-9fa4-c4fdb539ca39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0de28a1f-b6a3-4b24-b0c2-a984783f5ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_a2ec0a85-70ef-41d6-bcba-7f190b7969fb" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0de28a1f-b6a3-4b24-b0c2-a984783f5ade" xlink:to="loc_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_a2ec0a85-70ef-41d6-bcba-7f190b7969fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_73c90949-8d0a-4110-8b6b-e5017c654eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0de28a1f-b6a3-4b24-b0c2-a984783f5ade" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_73c90949-8d0a-4110-8b6b-e5017c654eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_7a665bc1-3140-43ce-885e-de99e7c5765d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_03feef09-9791-4898-9559-7a530f1545ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_7a665bc1-3140-43ce-885e-de99e7c5765d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_03feef09-9791-4898-9559-7a530f1545ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_183348c4-caf0-46a0-8560-a8dd93c5acda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_7a665bc1-3140-43ce-885e-de99e7c5765d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_183348c4-caf0-46a0-8560-a8dd93c5acda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c81eabed-3171-464c-8bc9-cadb86810b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_d68f20d0-efbb-4da1-bb35-1a1461530c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c81eabed-3171-464c-8bc9-cadb86810b88" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_d68f20d0-efbb-4da1-bb35-1a1461530c68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_2f026a93-2af0-4a9e-9027-cb33c2ee9b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c81eabed-3171-464c-8bc9-cadb86810b88" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_2f026a93-2af0-4a9e-9027-cb33c2ee9b35" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>nstg-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:50e88ef7-7662-44f9-a77d-a0cf072223f8,g:ff6ee908-6dcd-4476-b167-ff6c214915d5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="iddf9c60ac5944c62a57e1327a7954e01_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b531fcd3-9dc9-4b01-89d7-d7050666d414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_RevenuesAbstract_b531fcd3-9dc9-4b01-89d7-d7050666d414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_10680942-0beb-40f8-9129-bff38fb20b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_b531fcd3-9dc9-4b01-89d7-d7050666d414" xlink:to="loc_us-gaap_Revenues_10680942-0beb-40f8-9129-bff38fb20b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_d15fa4c3-7cb7-4229-99b7-b107c0781ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_CostOfRevenue_d15fa4c3-7cb7-4229-99b7-b107c0781ee2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a77b7154-814d-4ad2-8c6e-b453b6013464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a77b7154-814d-4ad2-8c6e-b453b6013464" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_26b559fb-c6ed-45e5-84f6-aa80f0bdf864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_26b559fb-c6ed-45e5-84f6-aa80f0bdf864" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f228a1a0-3dc2-4518-bc4a-4db435f5701f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_CostsAndExpenses_f228a1a0-3dc2-4518-bc4a-4db435f5701f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b907c7c6-e946-4255-b2da-2b43fddb5466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_b907c7c6-e946-4255-b2da-2b43fddb5466" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8af248ad-a064-4101-bcee-cd44ebeb5bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8af248ad-a064-4101-bcee-cd44ebeb5bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_dbc5ccbd-752c-4835-8274-347bb9444f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_InterestExpenseBorrowings_dbc5ccbd-752c-4835-8274-347bb9444f76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8a359ebc-53a5-4f96-8d64-2f49cbe64175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8a359ebc-53a5-4f96-8d64-2f49cbe64175" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_38822c73-3c86-474b-9802-11da4ede33c4" xlink:href="nstg-20221231.xsd#nstg_GainLossOnExtinguishmentAndTerminationOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_38822c73-3c86-474b-9802-11da4ede33c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_aeaf7a32-f33f-4d50-8a85-0a837718132a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_aeaf7a32-f33f-4d50-8a85-0a837718132a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_20aa966c-2cfd-481f-85ee-f6686a7cc794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_20aa966c-2cfd-481f-85ee-f6686a7cc794" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f27e6122-1428-467f-9a5f-9eea7e9b6145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f27e6122-1428-467f-9a5f-9eea7e9b6145" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0613a1d8-74c4-4d2a-bcdc-96f3b6ae3d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_NetIncomeLoss_0613a1d8-74c4-4d2a-bcdc-96f3b6ae3d97" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_52333a5a-5e14-44a9-ab3c-cac1a43736a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_EarningsPerShareBasic_52333a5a-5e14-44a9-ab3c-cac1a43736a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f162d162-15b5-43c0-8d80-107485590d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f162d162-15b5-43c0-8d80-107485590d64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_27631598-61f5-4087-af50-51bf1480d1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_27631598-61f5-4087-af50-51bf1480d1bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_885b7b20-8e18-4762-84b2-cafea65104d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_885b7b20-8e18-4762-84b2-cafea65104d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:to="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a161b1ff-105a-4dca-ae78-cb8e1920fd9e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:to="loc_srt_ProductsAndServicesDomain_a161b1ff-105a-4dca-ae78-cb8e1920fd9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:to="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_d4d3e2a4-2eef-47e0-997b-bb10593cbbee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:to="loc_us-gaap_ServiceMember_d4d3e2a4-2eef-47e0-997b-bb10593cbbee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_daaf60cb-35ed-49e8-8a1e-2fe492b2c493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:to="loc_us-gaap_ProductMember_daaf60cb-35ed-49e8-8a1e-2fe492b2c493" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended" id="if4d712c44bec41cf84a3e3395d48c8a8_ConsolidatedStatementsofChangesinStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f9d4d53c-b2f9-474b-a613-fc24f0f93f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9d4d53c-b2f9-474b-a613-fc24f0f93f21" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5b27f509-ce6d-4858-acf3-9c2d7af1c431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_SharesOutstanding_5b27f509-ce6d-4858-acf3-9c2d7af1c431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_59260928-2204-40e7-b825-ef9fe3a54d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockholdersEquity_59260928-2204-40e7-b825-ef9fe3a54d7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cd96038d-8fa3-4945-96bb-ac0a6f064196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cd96038d-8fa3-4945-96bb-ac0a6f064196" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_66219afd-2f11-4898-91fb-79b1031293ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_66219afd-2f11-4898-91fb-79b1031293ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89d5e574-54ad-403a-93ba-3d63aa8ff2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89d5e574-54ad-403a-93ba-3d63aa8ff2d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0b471b47-b57e-4fcc-9ce3-346a0ef46a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0b471b47-b57e-4fcc-9ce3-346a0ef46a08" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_abe03be1-359a-4650-a04d-9c3e69bb4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_abe03be1-359a-4650-a04d-9c3e69bb4b08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42c26efc-af3e-4cd8-b06c-a7314f24ee0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_NetIncomeLoss_42c26efc-af3e-4cd8-b06c-a7314f24ee0d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_eebed951-b826-491c-8cfb-c0c13de36014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3a2b1b0-c18c-47a6-9a57-be72b7381cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f9d4d53c-b2f9-474b-a613-fc24f0f93f21" xlink:to="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b71ac05c-f7f0-42a3-b8b1-1e89691826ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:to="loc_us-gaap_EquityComponentDomain_b71ac05c-f7f0-42a3-b8b1-1e89691826ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:to="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b17a282-c6e7-49aa-86ed-b49aac0802bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_CommonStockMember_8b17a282-c6e7-49aa-86ed-b49aac0802bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_02ca5bb7-060d-4d72-b742-b14ab36ecf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_02ca5bb7-060d-4d72-b742-b14ab36ecf7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d7173240-13fc-4e21-8b9c-2e087dbda45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d7173240-13fc-4e21-8b9c-2e087dbda45e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_507218ed-43b7-4979-8481-597e47902012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_RetainedEarningsMember_507218ed-43b7-4979-8481-597e47902012" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71db5dba-45d8-456b-82db-9d80011ec937_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71db5dba-45d8-456b-82db-9d80011ec937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6bdf3ac7-2c27-4ebc-a26f-3ccf0a705f4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6bdf3ac7-2c27-4ebc-a26f-3ccf0a705f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_151eeec9-d0b2-4405-90a8-774d4514dc93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6bdf3ac7-2c27-4ebc-a26f-3ccf0a705f4f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_151eeec9-d0b2-4405-90a8-774d4514dc93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="extended" id="icbb69978e3f74063a132edcff90dfe4c_ConsolidatedStatementsofChangesinStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5f6fe2d3-0508-459a-bdd9-5951c40d1abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5f6fe2d3-0508-459a-bdd9-5951c40d1abb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e3673913-0b35-4329-b7af-a02ed6f77472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_SharesOutstanding_e3673913-0b35-4329-b7af-a02ed6f77472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8516d56e-a905-420c-b11f-d85a358b41e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockholdersEquity_8516d56e-a905-420c-b11f-d85a358b41e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_578a0fac-3704-49ea-be28-a7e8c209ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_578a0fac-3704-49ea-be28-a7e8c209ae95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2eaf1969-37f1-463e-b3b1-61fa5fffdfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2eaf1969-37f1-463e-b3b1-61fa5fffdfcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bd568665-a050-4905-a959-518d76e86632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bd568665-a050-4905-a959-518d76e86632" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_73609b99-cda2-43da-9550-8df2cfe8314a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_73609b99-cda2-43da-9550-8df2cfe8314a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_17689353-b456-40b7-8785-984f2c2a4a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_17689353-b456-40b7-8785-984f2c2a4a7b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7d8b6f75-1dd5-4164-99f4-156e0d1e9758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7d8b6f75-1dd5-4164-99f4-156e0d1e9758" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_48846e76-0bee-42d3-9964-debb1b1c9072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_48846e76-0bee-42d3-9964-debb1b1c9072" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_4c09114b-83da-49c2-a2e5-c1419fc1b211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_4c09114b-83da-49c2-a2e5-c1419fc1b211" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1ee7eabb-811a-4afb-ac62-f9f2c56a2a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1ee7eabb-811a-4afb-ac62-f9f2c56a2a71" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_47c2f97e-9c80-4a4c-8663-3badfa150ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_47c2f97e-9c80-4a4c-8663-3badfa150ce3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_000f9002-0fd8-45c6-b4fa-430a952b0f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_000f9002-0fd8-45c6-b4fa-430a952b0f0c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_9371437d-849a-49d0-83db-c7288e568d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_9371437d-849a-49d0-83db-c7288e568d15" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_41e61024-fadd-4a7f-a188-90bd6495d404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_41e61024-fadd-4a7f-a188-90bd6495d404" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8633a4ba-9e2a-4d0a-b389-eaccc68e3901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8633a4ba-9e2a-4d0a-b389-eaccc68e3901" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3d9df1af-8322-4d5c-af6c-d50425603600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3d9df1af-8322-4d5c-af6c-d50425603600" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9966e597-0b85-4cc7-a197-295ec8d1e564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_NetIncomeLoss_9966e597-0b85-4cc7-a197-295ec8d1e564" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:to="loc_us-gaap_EquityComponentDomain_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:to="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9cb83351-bd1e-494c-bc15-8fb8b3dc0e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9cb83351-bd1e-494c-bc15-8fb8b3dc0e74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_afade2e0-9603-4a39-b90f-ec4c8fb351c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_CommonStockMember_afade2e0-9603-4a39-b90f-ec4c8fb351c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1223ab50-f4ca-4f11-8c16-436508c694de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1223ab50-f4ca-4f11-8c16-436508c694de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9da1bdc8-2db6-454e-b43d-6dc5a4b38676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_RetainedEarningsMember_9da1bdc8-2db6-454e-b43d-6dc5a4b38676" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2cbf2301-2f87-4491-badc-6760ff12e539_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2cbf2301-2f87-4491-badc-6760ff12e539_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dd1ac2ed-eb03-4cf3-8428-c4c3534c7f4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dd1ac2ed-eb03-4cf3-8428-c4c3534c7f4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e64d1445-7cd9-4bd8-9c61-e0cf0a17a452" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dd1ac2ed-eb03-4cf3-8428-c4c3534c7f4a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e64d1445-7cd9-4bd8-9c61-e0cf0a17a452" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#SignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" id="i766b908f2e034ac9b44b5d3eb4cf1fa6_SignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:href="nstg-20221231.xsd#nstg_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_959d4842-3278-4a93-88ec-33d85708598f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_InventoryValuationReserves_959d4842-3278-4a93-88ec-33d85708598f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6d424678-8310-4898-83fb-380ba8de1c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6d424678-8310-4898-83fb-380ba8de1c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_17493cf8-e0a0-49f6-a3fa-05952dd717d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_17493cf8-e0a0-49f6-a3fa-05952dd717d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_7fd6429e-83d5-4f0e-9f30-268ac673b97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_7fd6429e-83d5-4f0e-9f30-268ac673b97e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_c3b92529-7df7-468b-ad72-6ef46320db86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_AdvertisingExpense_c3b92529-7df7-468b-ad72-6ef46320db86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExtendedProductWarrantyPeriod_95c4b5d6-f234-4a34-a35a-6018a0b2a1b1" xlink:href="nstg-20221231.xsd#nstg_ExtendedProductWarrantyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_ExtendedProductWarrantyPeriod_95c4b5d6-f234-4a34-a35a-6018a0b2a1b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductWarrantyAccrualPeriod_e874239f-fd68-4b22-8995-666b56ed977a" xlink:href="nstg-20221231.xsd#nstg_ProductWarrantyAccrualPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_ProductWarrantyAccrualPeriod_e874239f-fd68-4b22-8995-666b56ed977a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_StandardProductWarrantyPeriod_a0c81b00-3502-4ec4-9cdb-aea5626460f5" xlink:href="nstg-20221231.xsd#nstg_StandardProductWarrantyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_StandardProductWarrantyPeriod_a0c81b00-3502-4ec4-9cdb-aea5626460f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f1bc8f6d-4e80-4080-a1f6-7240e096c4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_StockholdersEquity_f1bc8f6d-4e80-4080-a1f6-7240e096c4e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_670f61ff-2b19-4f6e-80a5-d0664d09d0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_670f61ff-2b19-4f6e-80a5-d0664d09d0c0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_ff402424-1f03-4dd6-aff0-48198e5555e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_InterestReceivable_ff402424-1f03-4dd6-aff0-48198e5555e2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a45e3909-376b-4152-bfa6-3f24a6355ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a45e3909-376b-4152-bfa6-3f24a6355ef3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_81e93d48-0771-4823-ac1e-a5d8ef6f90ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_81e93d48-0771-4823-ac1e-a5d8ef6f90ad" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:href="nstg-20221231.xsd#nstg_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38d2d354-fec2-4414-9e66-a04d6a6330ac_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:to="loc_srt_RangeMember_38d2d354-fec2-4414-9e66-a04d6a6330ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:to="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a63d1709-85dd-4966-a6df-f5d84d9480db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:to="loc_srt_MinimumMember_a63d1709-85dd-4966-a6df-f5d84d9480db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6419d0fd-f21c-4345-a9d3-02108078ca1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:to="loc_srt_MaximumMember_6419d0fd-f21c-4345-a9d3-02108078ca1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ace2376-0453-45bc-a78d-5a7704090bb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ace2376-0453-45bc-a78d-5a7704090bb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ManufacturingEquipmentMember_fde71f6e-7624-4a4f-8930-c9656fbbb84e" xlink:href="nstg-20221231.xsd#nstg_ManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_nstg_ManufacturingEquipmentMember_fde71f6e-7624-4a4f-8930-c9656fbbb84e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PrototypeSystemsMember_b1a07d05-bb1f-4214-9be0-33ea96080568" xlink:href="nstg-20221231.xsd#nstg_PrototypeSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_nstg_PrototypeSystemsMember_b1a07d05-bb1f-4214-9be0-33ea96080568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_502be184-9c7b-4a80-bf0c-a2f8138c0231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_us-gaap_ComputerEquipmentMember_502be184-9c7b-4a80-bf0c-a2f8138c0231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_a75fe5d5-c1d3-4208-a413-4179e1f7bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_a75fe5d5-c1d3-4208-a413-4179e1f7bc83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d672f733-f311-4de0-9cff-f5a58e385bb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d672f733-f311-4de0-9cff-f5a58e385bb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8aeeda4d-3c48-42fd-bba4-3e9d175de4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8aeeda4d-3c48-42fd-bba4-3e9d175de4f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_4447a567-6adb-421e-9eaa-9c0ae6ae915d" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8aeeda4d-3c48-42fd-bba4-3e9d175de4f3" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_4447a567-6adb-421e-9eaa-9c0ae6ae915d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3d199395-8dbd-4d7d-bd70-e2a564421d2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3d199395-8dbd-4d7d-bd70-e2a564421d2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e428154-a4d7-4d23-a8d5-8cae4889549a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e428154-a4d7-4d23-a8d5-8cae4889549a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d01f1714-3d13-44ea-884e-0476ab08c6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e428154-a4d7-4d23-a8d5-8cae4889549a" xlink:to="loc_us-gaap_SeniorNotesMember_d01f1714-3d13-44ea-884e-0476ab08c6c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dbd4e731-25eb-4e8f-adbc-08395ecc115f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dbd4e731-25eb-4e8f-adbc-08395ecc115f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_77cbc9f1-2ca2-4070-b33a-c0cb6c07b2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_77cbc9f1-2ca2-4070-b33a-c0cb6c07b2bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_78e18f1b-c6e4-45bc-bda6-35771fee03a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_78e18f1b-c6e4-45bc-bda6-35771fee03a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_96feaaf3-db5f-4229-8cde-30a1ff04b062_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_96feaaf3-db5f-4229-8cde-30a1ff04b062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8affcc73-db85-42e2-ad15-f3543dd6c99c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8affcc73-db85-42e2-ad15-f3543dd6c99c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8df22442-edb5-45f3-a0d3-08d3b05e3fe5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8affcc73-db85-42e2-ad15-f3543dd6c99c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8df22442-edb5-45f3-a0d3-08d3b05e3fe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff2411bc-189e-42e0-8c52-ecfd80be14a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:to="loc_us-gaap_EquityComponentDomain_ff2411bc-189e-42e0-8c52-ecfd80be14a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b5d64c5-f810-48cf-85b6-d6203b15ab7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:to="loc_us-gaap_EquityComponentDomain_7b5d64c5-f810-48cf-85b6-d6203b15ab7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_37438e61-47b7-4270-bb5c-5f6103faade0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7b5d64c5-f810-48cf-85b6-d6203b15ab7e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_37438e61-47b7-4270-bb5c-5f6103faade0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e48c43fb-2f3f-47d5-ab75-773637f651c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e48c43fb-2f3f-47d5-ab75-773637f651c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c9cb3bc5-0337-48ea-b220-91e5c303c699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c9cb3bc5-0337-48ea-b220-91e5c303c699" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_7a315146-ca35-4644-9d31-95b29c1664a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_7a315146-ca35-4644-9d31-95b29c1664a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#RevenuefromContractswithCustomersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="extended" id="i7a6c7e35b6824cb28402a6cdfee7a82c_RevenuefromContractswithCustomersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_08160c1f-e374-4f33-95c4-a085dd847369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_Revenues_08160c1f-e374-4f33-95c4-a085dd847369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_c23827a0-666d-458e-a7e7-310705fbbc6a" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_c23827a0-666d-458e-a7e7-310705fbbc6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9d7f2737-bba2-4cfc-af40-8dcd1ca241e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9d7f2737-bba2-4cfc-af40-8dcd1ca241e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_bd47c8e2-9a8e-4d80-99a8-43aeb6ec48b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_bd47c8e2-9a8e-4d80-99a8-43aeb6ec48b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_2dec07fa-e175-408d-a640-ee4f08887fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_2dec07fa-e175-408d-a640-ee4f08887fd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_19c49c92-cb6d-4052-90e5-dc3973c599ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_19c49c92-cb6d-4052-90e5-dc3973c599ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_fdde5de8-5b59-4e71-ad40-6b06f5ce9892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_fdde5de8-5b59-4e71-ad40-6b06f5ce9892" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_92ceb156-c384-4ae7-862f-d94ded9c5f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ProceedsFromCustomers_92ceb156-c384-4ae7-862f-d94ded9c5f94" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6d1b047e-2856-499e-bb55-b3ec0d126da3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6d1b047e-2856-499e-bb55-b3ec0d126da3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_eafb0c61-f009-426e-aa88-a69882926d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_eafb0c61-f009-426e-aa88-a69882926d24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1c5b4f09-3d2b-453c-add7-698193951d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_eafb0c61-f009-426e-aa88-a69882926d24" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1c5b4f09-3d2b-453c-add7-698193951d82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9c69e434-4a70-4f27-beea-600cf8d3271e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:to="loc_srt_SegmentGeographicalDomain_9c69e434-4a70-4f27-beea-600cf8d3271e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5504d921-996c-4eb4-a239-6d8e91d29795" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:to="loc_srt_SegmentGeographicalDomain_5504d921-996c-4eb4-a239-6d8e91d29795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cd35a599-3566-4a91-875b-25c398c038f1" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5504d921-996c-4eb4-a239-6d8e91d29795" xlink:to="loc_country_US_cd35a599-3566-4a91-875b-25c398c038f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_9a1c879d-7dc4-475f-966b-243f41a8e8f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_9a1c879d-7dc4-475f-966b-243f41a8e8f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2aa4315b-4e51-4ccd-aaf8-cfe59b7b6ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2aa4315b-4e51-4ccd-aaf8-cfe59b7b6ea1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails" xlink:type="extended" id="i33fe3cfdc5474e9aa4f46f91ac096097_RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9340a49a-e367-4c31-8877-ee6d3f3e996e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b538977-3954-4fc3-a68b-89836d1c070a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9340a49a-e367-4c31-8877-ee6d3f3e996e" xlink:to="loc_us-gaap_Revenues_3b538977-3954-4fc3-a68b-89836d1c070a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9340a49a-e367-4c31-8877-ee6d3f3e996e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:to="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_686e7d87-819a-45b3-b156-45b5bb27b1a0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:to="loc_srt_SegmentGeographicalDomain_686e7d87-819a-45b3-b156-45b5bb27b1a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:to="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_4f785994-a499-449b-bcee-2fac80aeae4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:to="loc_srt_AmericasMember_4f785994-a499-449b-bcee-2fac80aeae4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c62f6f04-30ee-4e23-9d28-f929b6e23fdb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:to="loc_srt_AsiaPacificMember_c62f6f04-30ee-4e23-9d28-f929b6e23fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_76ab764b-2b30-4135-ab19-074651cda097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:to="loc_us-gaap_EMEAMember_76ab764b-2b30-4135-ab19-074651cda097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:to="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9e534935-9973-4947-8774-0abd1e012caf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:to="loc_srt_ProductsAndServicesDomain_9e534935-9973-4947-8774-0abd1e012caf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:to="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductInstrumentsMember_0319c95d-2960-4dc4-b538-7bab8907440e" xlink:href="nstg-20221231.xsd#nstg_ProductInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_nstg_ProductInstrumentsMember_0319c95d-2960-4dc4-b538-7bab8907440e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductConsumablesMember_e2bcd769-c02d-4841-bbcc-7008d39ca3a5" xlink:href="nstg-20221231.xsd#nstg_ProductConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_nstg_ProductConsumablesMember_e2bcd769-c02d-4841-bbcc-7008d39ca3a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_07ca722e-d89e-481a-804b-7c335bc338e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_us-gaap_ProductMember_07ca722e-d89e-481a-804b-7c335bc338e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_821b87ca-cb03-48d0-87ad-8b2d37fb95d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_us-gaap_ServiceMember_821b87ca-cb03-48d0-87ad-8b2d37fb95d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductAndServiceMember_54185c87-f9b3-4bc2-a5f3-22186b293514" xlink:href="nstg-20221231.xsd#nstg_ProductAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_nstg_ProductAndServiceMember_54185c87-f9b3-4bc2-a5f3-22186b293514" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestmentsAvailableforSaleSecuritiesDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail" xlink:type="extended" id="i19a4fc1a02cb412fa601a0c473cb5ed5_ShorttermInvestmentsAvailableforSaleSecuritiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_96792737-b4a6-4c43-9428-9acee26906f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_96792737-b4a6-4c43-9428-9acee26906f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7fb16f66-8b99-4642-902e-5160757375af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7fb16f66-8b99-4642-902e-5160757375af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b98a63ce-05a2-40d3-9ce4-1b2b12d7e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b98a63ce-05a2-40d3-9ce4-1b2b12d7e716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_627456a5-c7eb-43b2-88c6-311df3b12d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_627456a5-c7eb-43b2-88c6-311df3b12d11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_cf56da99-2223-4b7f-89a2-092eebff4b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_cf56da99-2223-4b7f-89a2-092eebff4b63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_3c93a77b-eb88-4980-b37f-40eb81bb7e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_3c93a77b-eb88-4980-b37f-40eb81bb7e16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_12c2198f-b15b-46e9-a41f-ee0ce4319353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_12c2198f-b15b-46e9-a41f-ee0ce4319353" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_fef8aa0c-3e25-4fb2-a097-b458e8d126e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_fef8aa0c-3e25-4fb2-a097-b458e8d126e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a210bb74-e809-434a-bc11-d47083c190de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a210bb74-e809-434a-bc11-d47083c190de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4884e1d2-be45-4954-8b6d-8cb0bce86d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4884e1d2-be45-4954-8b6d-8cb0bce86d5e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ae0b0e79-19d8-4d40-aab2-f20eb1c88234_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ae0b0e79-19d8-4d40-aab2-f20eb1c88234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dc8ccd32-c4ec-40ca-bd39-2b270adc686b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dc8ccd32-c4ec-40ca-bd39-2b270adc686b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bff13c7b-461f-40fc-9139-93bc0ffa7e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bff13c7b-461f-40fc-9139-93bc0ffa7e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cdad15fb-b677-4ebb-a544-fefc626ba860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cdad15fb-b677-4ebb-a544-fefc626ba860" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_5b05174f-561c-457f-94a4-ba26d2f699ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_5b05174f-561c-457f-94a4-ba26d2f699ec" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail" xlink:type="extended" id="id6b83035991b4e6c8c5290096351e7dc_FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6bea9113-dffe-4249-8673-2829eb50a4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6bea9113-dffe-4249-8673-2829eb50a4d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_653ace46-2ff3-4098-9dfd-5a257657f69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_653ace46-2ff3-4098-9dfd-5a257657f69a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue_8af66a30-6bbf-4527-9b2d-2f5440fe393a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue_8af66a30-6bbf-4527-9b2d-2f5440fe393a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_53da7fe9-5699-4b82-ad4a-12fc25cc71e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_53da7fe9-5699-4b82-ad4a-12fc25cc71e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cffd4c6-20bc-40a4-aa3f-c209952eda05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cffd4c6-20bc-40a4-aa3f-c209952eda05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_94d8dbf0-37c4-4458-9973-681553440460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_94d8dbf0-37c4-4458-9973-681553440460" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4b8096cb-10e8-45e7-b3f0-3331b3dc5bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4b8096cb-10e8-45e7-b3f0-3331b3dc5bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1b7dd6af-98e7-4c27-acd2-9536bb97d076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1b7dd6af-98e7-4c27-acd2-9536bb97d076" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_028b0d46-c44d-4682-87a8-0cff148b9b50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_028b0d46-c44d-4682-87a8-0cff148b9b50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c2784b79-43ce-4f57-a51e-30ede1989607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c2784b79-43ce-4f57-a51e-30ede1989607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_7a36fe95-0b69-4e5c-af62-b890b07b1c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c2784b79-43ce-4f57-a51e-30ede1989607" xlink:to="loc_us-gaap_MoneyMarketFundsMember_7a36fe95-0b69-4e5c-af62-b890b07b1c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_57ffb2c2-966b-4ec8-a5c2-d63767cf7185_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_57ffb2c2-966b-4ec8-a5c2-d63767cf7185_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3a9b9f43-3335-4be6-8aeb-6af9d61c561d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3a9b9f43-3335-4be6-8aeb-6af9d61c561d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bcaacb42-b98d-42c5-b26d-15adec0c2d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bcaacb42-b98d-42c5-b26d-15adec0c2d1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_28b41929-4b02-46fd-b95b-7b9b070e72c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_28b41929-4b02-46fd-b95b-7b9b070e72c4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i219dc3741c984ed99fdadf5e1ed638a3_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f8b3e7a5-a6c2-407b-b5ac-6946fa8f23c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:to="loc_us-gaap_RepaymentsOfDebt_f8b3e7a5-a6c2-407b-b5ac-6946fa8f23c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_b4b2ee60-699a-4e37-8e5b-611d1c3bbc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:to="loc_us-gaap_DebtInstrumentFairValue_b4b2ee60-699a-4e37-8e5b-611d1c3bbc60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:to="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2154b60-0f44-401e-9cb5-e467547e5e39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2154b60-0f44-401e-9cb5-e467547e5e39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_9cad3f62-82e0-4f97-b685-ecb044f3ecb9" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_9cad3f62-82e0-4f97-b685-ecb044f3ecb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember_b50468d9-f0dd-4b2a-9e97-3d3e197e1306" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:to="loc_nstg_TermLoanAgreementMember_b50468d9-f0dd-4b2a-9e97-3d3e197e1306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3c08850-412c-429d-8e7b-eb0d99f92e10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3c08850-412c-429d-8e7b-eb0d99f92e10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_901ae9c8-24c7-4458-8b3a-a3fec097b1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_901ae9c8-24c7-4458-8b3a-a3fec097b1c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_07feb438-f2a9-4c78-81c1-692a7ba3236e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_901ae9c8-24c7-4458-8b3a-a3fec097b1c1" xlink:to="loc_us-gaap_SeniorNotesMember_07feb438-f2a9-4c78-81c1-692a7ba3236e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/PropertyandEquipmentDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#PropertyandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/PropertyandEquipmentDetail" xlink:type="extended" id="i0f55ef3bb87f4235be3fa69c789174b2_PropertyandEquipmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9c6a660a-21f9-4657-88bc-d1a637de4dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9c6a660a-21f9-4657-88bc-d1a637de4dd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_333f520d-65f8-4a81-9c86-9ada90fecdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_333f520d-65f8-4a81-9c86-9ada90fecdd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f8e9dcd0-f2da-47e3-892d-b9e7c7a56ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f8e9dcd0-f2da-47e3-892d-b9e7c7a56ac5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b34bff98-1c05-46ea-b993-36f36a4a6808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b34bff98-1c05-46ea-b993-36f36a4a6808" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_16e0743e-a836-4b30-a486-4c9028871db1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_16e0743e-a836-4b30-a486-4c9028871db1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ManufacturingEquipmentMember_f2abe353-3d98-43db-a058-bb0bb250356b" xlink:href="nstg-20221231.xsd#nstg_ManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_nstg_ManufacturingEquipmentMember_f2abe353-3d98-43db-a058-bb0bb250356b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PrototypesAndOtherEquipmentMember_3d39d52f-d713-4e4c-9069-1c8733cff9c4" xlink:href="nstg-20221231.xsd#nstg_PrototypesAndOtherEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_nstg_PrototypesAndOtherEquipmentMember_3d39d52f-d713-4e4c-9069-1c8733cff9c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_30cd94f6-279d-48dd-b94e-8a9ee05c5428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_ComputerEquipmentMember_30cd94f6-279d-48dd-b94e-8a9ee05c5428" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3aa89577-3795-472b-9808-bfad6cfd02a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3aa89577-3795-472b-9808-bfad6cfd02a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_b40ff878-6055-488e-a6ae-8a1774139dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_b40ff878-6055-488e-a6ae-8a1774139dae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_07c1e9b8-aaed-4c6d-8022-43bb714b4d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_ConstructionInProgressMember_07c1e9b8-aaed-4c6d-8022-43bb714b4d8f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended" id="ie8bc6606339c4a81a5074652076de090_LongTermDebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_69a30b88-469c-4063-b1e2-2a8923e98f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_69a30b88-469c-4063-b1e2-2a8923e98f1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4a205cef-6654-420c-907a-a3c77a5f4317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_RepaymentsOfDebt_4a205cef-6654-420c-907a-a3c77a5f4317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d58ff971-0bfd-448d-93d2-b278ca14306d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d58ff971-0bfd-448d-93d2-b278ca14306d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fe34f8de-b830-46d2-9867-72cd929641bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fe34f8de-b830-46d2-9867-72cd929641bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_750b8b7a-ef3b-4dab-acef-085564f4db5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_750b8b7a-ef3b-4dab-acef-085564f4db5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4c9b46cb-d17a-418b-b031-cfd1c13c75b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4c9b46cb-d17a-418b-b031-cfd1c13c75b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e32d4e14-ac97-44dd-8bd6-a58ce03a55a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e32d4e14-ac97-44dd-8bd6-a58ce03a55a6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_97a22275-2f60-45f6-ab3a-d7467daa274b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_97a22275-2f60-45f6-ab3a-d7467daa274b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b0ba2e88-792a-438d-b009-ae78e633dd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b0ba2e88-792a-438d-b009-ae78e633dd69" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_96e1e7c9-c265-4239-89de-5c807db1ff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentTerm_96e1e7c9-c265-4239-89de-5c807db1ff9a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_b68bc15d-2fa5-4079-bba4-b380297613df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_SharePrice_b68bc15d-2fa5-4079-bba4-b380297613df" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3fd8202-6555-426e-b353-852d49726d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3fd8202-6555-426e-b353-852d49726d34" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_91ae2706-c0bc-4775-983a-68cbb8d8b729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_91ae2706-c0bc-4775-983a-68cbb8d8b729" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_19243a12-7fe5-448c-91c5-37b38d92b7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_InterestExpense_19243a12-7fe5-448c-91c5-37b38d92b7bd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_1d010b63-400f-4d4d-a077-f48b31051b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_InterestExpenseBorrowings_1d010b63-400f-4d4d-a077-f48b31051b19" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a86f4ae7-7fc8-40ff-9a2a-9067d6169dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a86f4ae7-7fc8-40ff-9a2a-9067d6169dbd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExtinguishmentOfDebtTerminationFee_13762948-bb96-42bb-8075-f28cc40761fe" xlink:href="nstg-20221231.xsd#nstg_ExtinguishmentOfDebtTerminationFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_nstg_ExtinguishmentOfDebtTerminationFee_13762948-bb96-42bb-8075-f28cc40761fe" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_9870b728-7d4d-46d4-849f-22317ef10317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_9870b728-7d4d-46d4-849f-22317ef10317" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7709c8cc-f908-4064-bb6d-b72fd1f428ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7709c8cc-f908-4064-bb6d-b72fd1f428ae" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_OutstandingPrincipalOfConvertibleDebt_935ec4ea-c317-43dc-b261-d43737534a8e" xlink:href="nstg-20221231.xsd#nstg_OutstandingPrincipalOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_nstg_OutstandingPrincipalOfConvertibleDebt_935ec4ea-c317-43dc-b261-d43737534a8e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0c3071c-ff45-4003-ab37-5dbb4c69e878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0c3071c-ff45-4003-ab37-5dbb4c69e878" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_caab2d4d-d6fb-43ad-827f-d883e41b1329_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:to="loc_us-gaap_CreditFacilityDomain_caab2d4d-d6fb-43ad-827f-d883e41b1329_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fc3e1d4e-718c-4b11-a8d4-d284f2309dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:to="loc_us-gaap_CreditFacilityDomain_fc3e1d4e-718c-4b11-a8d4-d284f2309dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4bf82be1-19ce-4fda-8bdd-9fd38fa34922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fc3e1d4e-718c-4b11-a8d4-d284f2309dc7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4bf82be1-19ce-4fda-8bdd-9fd38fa34922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a311a905-bf35-459c-a2a9-2bf0487d03a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a311a905-bf35-459c-a2a9-2bf0487d03a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember_4028abbd-ccc0-4d05-aec0-3e710d4bf12c" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_nstg_TermLoanAgreementMember_4028abbd-ccc0-4d05-aec0-3e710d4bf12c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SecuredRevolvingLoanFacilityMember_3e67184f-26b2-431b-82ee-6eb6551a434e" xlink:href="nstg-20221231.xsd#nstg_SecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_nstg_SecuredRevolvingLoanFacilityMember_3e67184f-26b2-431b-82ee-6eb6551a434e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3d54ec02-9e31-465f-b74c-c0147b5bb591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3d54ec02-9e31-465f-b74c-c0147b5bb591" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_9eeca449-171f-4e50-bc46-162c9c56ea61" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_9eeca449-171f-4e50-bc46-162c9c56ea61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9f7fe926-3c82-4f2b-b023-52dcc63131e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9f7fe926-3c82-4f2b-b023-52dcc63131e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7721378d-1aad-49af-9359-5c9273e23743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7721378d-1aad-49af-9359-5c9273e23743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f487abfd-e6fd-430b-a881-ecd5a55f38eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7721378d-1aad-49af-9359-5c9273e23743" xlink:to="loc_us-gaap_SeniorNotesMember_f487abfd-e6fd-430b-a881-ecd5a55f38eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsDomain_82518a6f-1062-497b-a20b-b9e979207a62_default" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:to="loc_nstg_ConvertibleDebtTermsDomain_82518a6f-1062-497b-a20b-b9e979207a62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:to="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTriggeringEvent1Member_01c3fa1f-efde-4f58-ac91-fc86adda7586" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTriggeringEvent1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:to="loc_nstg_ConvertibleDebtTriggeringEvent1Member_01c3fa1f-efde-4f58-ac91-fc86adda7586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTriggeringEvent2Member_7c202264-f534-4531-b542-d2bf02d820fa" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTriggeringEvent2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:to="loc_nstg_ConvertibleDebtTriggeringEvent2Member_7c202264-f534-4531-b542-d2bf02d820fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a1bcd04f-ff81-48eb-a348-0a33c2d92995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a1bcd04f-ff81-48eb-a348-0a33c2d92995_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d168b93-3c84-442d-9ae9-556681a6961a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_46981f2b-de67-453b-aa83-7a3403a74ab8" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember_c6f1bb3f-99fb-458a-94c2-2dd621c3ef4b" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cb386890-8b7f-41b4-9418-db8d86816add_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cb386890-8b7f-41b4-9418-db8d86816add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_53293a07-3e8f-4e70-a2d6-81614db0dded" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_53293a07-3e8f-4e70-a2d6-81614db0dded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_f900e061-627d-448e-9e93-bffac98d5766" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_f900e061-627d-448e-9e93-bffac98d5766" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtLongtermdebtandleasefinancingobligationsDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails" xlink:type="extended" id="ibb45143c59d1420eab8f38b56af2f947_LongTermDebtLongtermdebtandleasefinancingobligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8f480fc1-cce2-4d78-a288-1983a073ad0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8f480fc1-cce2-4d78-a288-1983a073ad0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2db9c540-13b4-46a0-9b1e-dec916b8be54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2db9c540-13b4-46a0-9b1e-dec916b8be54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_OutstandingPrincipalOfConvertibleDebt_b19733a6-b31d-4d7a-a2d1-dfdceae4fe1f" xlink:href="nstg-20221231.xsd#nstg_OutstandingPrincipalOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_nstg_OutstandingPrincipalOfConvertibleDebt_b19733a6-b31d-4d7a-a2d1-dfdceae4fe1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8012c65a-985f-4ae1-87e1-74c5dbe90a38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8012c65a-985f-4ae1-87e1-74c5dbe90a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e09bccc-dece-4d1c-878e-98a8a994da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e09bccc-dece-4d1c-878e-98a8a994da8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_a3633cfa-ede8-4a84-8b70-9d3bb6994a6c" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7e09bccc-dece-4d1c-878e-98a8a994da8f" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_a3633cfa-ede8-4a84-8b70-9d3bb6994a6c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtScheduleofInterestExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails" xlink:type="extended" id="i51447b530ecf419b92b9813e8121ee0d_LongTermDebtScheduleofInterestExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_8b8a075a-d089-4ea5-b56d-3d7df3eade4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_8b8a075a-d089-4ea5-b56d-3d7df3eade4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_7cdfd3d2-37bf-4cec-bbab-810b99f8a5a3" xlink:href="nstg-20221231.xsd#nstg_AmortizationOfDebtDiscountAndIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_7cdfd3d2-37bf-4cec-bbab-810b99f8a5a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ccda1e08-5c29-4f12-b837-17a306b08b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_us-gaap_InterestExpenseDebt_ccda1e08-5c29-4f12-b837-17a306b08b15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:to="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_22571572-41a5-434c-a069-1e22fb5274de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_22571572-41a5-434c-a069-1e22fb5274de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_be2f3d24-d5d0-41b1-b1c0-f23e2b40b3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_be2f3d24-d5d0-41b1-b1c0-f23e2b40b3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_e9a59aa1-a704-47ac-a2f3-eb92bd285fb1" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_be2f3d24-d5d0-41b1-b1c0-f23e2b40b3cd" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_e9a59aa1-a704-47ac-a2f3-eb92bd285fb1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#CommonStockandPreferredStockAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail" xlink:type="extended" id="i2ce64cf73ddc4e49b29080137327c35d_CommonStockandPreferredStockAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_93ec829b-88fa-4609-9598-39e06d8a9d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_93ec829b-88fa-4609-9598-39e06d8a9d66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_e9cc0f8c-f158-4524-a7e4-c603f823b1fc" xlink:href="nstg-20221231.xsd#nstg_SaleOfStockGrossConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_e9cc0f8c-f158-4524-a7e4-c603f823b1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f9aeb3c3-0fb5-407f-ba5b-7062dc2ae8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f9aeb3c3-0fb5-407f-ba5b-7062dc2ae8ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9ad93022-c876-48e6-9b36-02441a3c60af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9ad93022-c876-48e6-9b36-02441a3c60af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockVotingRights_b83e3185-661e-42d3-afee-936245a26a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_CommonStockVotingRights_b83e3185-661e-42d3-afee-936245a26a90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4597dda9-44b0-4d35-ba07-399c40bdde46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4597dda9-44b0-4d35-ba07-399c40bdde46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3867d15f-73fa-42a9-8488-697dbf7032ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3867d15f-73fa-42a9-8488-697dbf7032ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_bea5fa72-e64b-426a-80ac-86af22127533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_406a8af3-b17e-47fd-9528-edbfc99fe18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_406a8af3-b17e-47fd-9528-edbfc99fe18a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9830ca95-cbe2-4317-9824-b8c580effa10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9830ca95-cbe2-4317-9824-b8c580effa10" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8422d41b-4be2-405f-bee9-81abd6c13dd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8422d41b-4be2-405f-bee9-81abd6c13dd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_dc9eeab4-8f69-4ff3-b30f-d084d051b1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:to="loc_us-gaap_OverAllotmentOptionMember_dc9eeab4-8f69-4ff3-b30f-d084d051b1c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PublicStockOfferingMember_85eccd1b-2cb8-4e4e-be5f-4c1c4a6bb92a" xlink:href="nstg-20221231.xsd#nstg_PublicStockOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:to="loc_nstg_PublicStockOfferingMember_85eccd1b-2cb8-4e4e-be5f-4c1c4a6bb92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_39587bfa-3692-459d-801b-9342c4953852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:to="loc_us-gaap_IPOMember_39587bfa-3692-459d-801b-9342c4953852" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7db73638-8d4a-4b33-82c2-16582ffdbabc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:to="loc_us-gaap_ClassOfStockDomain_7db73638-8d4a-4b33-82c2-16582ffdbabc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de247e14-7580-4f14-9256-971a93f70638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:to="loc_us-gaap_ClassOfStockDomain_de247e14-7580-4f14-9256-971a93f70638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7bb7b18-67d4-4db4-bdec-5662e2232463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de247e14-7580-4f14-9256-971a93f70638" xlink:to="loc_us-gaap_CommonStockMember_d7bb7b18-67d4-4db4-bdec-5662e2232463" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail" xlink:type="extended" id="id7c7511a5f0c4e2b8183d82eb60c7194_StockbasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_db1c6130-d0d5-4dd1-8ae1-8aaf574cde36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_db1c6130-d0d5-4dd1-8ae1-8aaf574cde36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_88f0f0b2-4f5c-4e71-9625-3510fac75af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_88f0f0b2-4f5c-4e71-9625-3510fac75af4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2c722a91-523a-4334-8b5c-67f8ceb6c5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2c722a91-523a-4334-8b5c-67f8ceb6c5d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30da89fd-f382-40e9-8b5d-9cc5f4f254a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30da89fd-f382-40e9-8b5d-9cc5f4f254a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4a71d431-d4ac-4a27-b5b2-611331477ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4a71d431-d4ac-4a27-b5b2-611331477ff9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_40e5889a-b6f2-47ed-aca3-80428cc98ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_40e5889a-b6f2-47ed-aca3-80428cc98ce8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a20fe548-4402-419f-b7d4-8846b5c96682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a20fe548-4402-419f-b7d4-8846b5c96682" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59e4b5a7-4d1b-49d2-ad54-f3d6ae66cfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59e4b5a7-4d1b-49d2-ad54-f3d6ae66cfdb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8b6bb76-a285-420c-9075-ff72d2e23bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8b6bb76-a285-420c-9075-ff72d2e23bdd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_204a70b3-3237-4eea-b343-bffc0a616790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_204a70b3-3237-4eea-b343-bffc0a616790" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d55cfea1-b6e4-45f1-b05f-cda5c6fec462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d55cfea1-b6e4-45f1-b05f-cda5c6fec462" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanOfferingPeriod_6d3cb015-289e-400e-9450-d7631fc2caf2" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_nstg_EmployeeStockPurchasePlanOfferingPeriod_6d3cb015-289e-400e-9450-d7631fc2caf2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanPurchasePeriod_31f50f15-af0c-429e-b203-863c7c710eef" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_nstg_EmployeeStockPurchasePlanPurchasePeriod_31f50f15-af0c-429e-b203-863c7c710eef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanContributionPercentage_38e1d94a-3469-40bf-bd29-c91749716bb6" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanContributionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_nstg_EmployeeStockPurchasePlanContributionPercentage_38e1d94a-3469-40bf-bd29-c91749716bb6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c1f35607-ed1c-4de9-b675-e42ff9ea57f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c1f35607-ed1c-4de9-b675-e42ff9ea57f2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8fbbb7ab-23b4-4b90-a59e-d948b742ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8fbbb7ab-23b4-4b90-a59e-d948b742ae93" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7d5788e5-3bd0-488c-a9de-38288644058d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7d5788e5-3bd0-488c-a9de-38288644058d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_59bfba0e-4a78-4cbc-8bbc-50736ea2371d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_59bfba0e-4a78-4cbc-8bbc-50736ea2371d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f04cae8c-f2ad-4ed9-900c-120f95354e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f04cae8c-f2ad-4ed9-900c-120f95354e5c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_28352261-d256-487b-b21a-428f85e0f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_28352261-d256-487b-b21a-428f85e0f7b3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:to="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5682776-7c09-4510-989d-219c9c39655b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5682776-7c09-4510-989d-219c9c39655b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_b97e6c8c-0108-41d9-8d56-41bf6bf54d63" xlink:href="nstg-20221231.xsd#nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_b97e6c8c-0108-41d9-8d56-41bf6bf54d63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8c97d607-aebd-4484-b458-87213789a159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8c97d607-aebd-4484-b458-87213789a159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e914da4b-bfc9-4fbf-bbd7-bba7e4ae5149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e914da4b-bfc9-4fbf-bbd7-bba7e4ae5149" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanMember_a99ef4e2-3070-44d8-822c-c7ac6e4e1aa8" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_EmployeeStockPurchasePlanMember_a99ef4e2-3070-44d8-822c-c7ac6e4e1aa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ServiceComponentMember_c82e06e8-a6dd-48be-a077-15025b7f5ed5" xlink:href="nstg-20221231.xsd#nstg_ServiceComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_ServiceComponentMember_c82e06e8-a6dd-48be-a077-15025b7f5ed5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ServiceAndPerformanceComponentsMember_77cf137c-017d-4a1a-a7e6-79782c75d9b4" xlink:href="nstg-20221231.xsd#nstg_ServiceAndPerformanceComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_ServiceAndPerformanceComponentsMember_77cf137c-017d-4a1a-a7e6-79782c75d9b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bdcb72bb-f247-4a0a-9d06-70417c38073a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_us-gaap_CommonStockMember_bdcb72bb-f247-4a0a-9d06-70417c38073a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:to="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf6071bc-467c-413c-8896-d87dc1836cfd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:to="loc_srt_RangeMember_cf6071bc-467c-413c-8896-d87dc1836cfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:to="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7df5eb1e-4676-44e0-beb8-d98c04179a71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:to="loc_srt_MinimumMember_7df5eb1e-4676-44e0-beb8-d98c04179a71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c194ff2c-d95e-44d9-b523-6c2a6882fde7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:to="loc_srt_MaximumMember_c194ff2c-d95e-44d9-b523-6c2a6882fde7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationCompanysOptionsOutstandingDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail" xlink:type="extended" id="if959275c407240fd95f1363b424bd600_StockbasedCompensationCompanysOptionsOutstandingDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b89e9afa-d2bd-45d7-a4ed-24242b122f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b89e9afa-d2bd-45d7-a4ed-24242b122f37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_66b2e4cf-633e-4614-9d20-22f12b2a9043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_66b2e4cf-633e-4614-9d20-22f12b2a9043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_531a3362-0c35-49d9-982c-c319bef13bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_531a3362-0c35-49d9-982c-c319bef13bc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_20e19030-8e37-4068-9517-803d9a9d517c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_20e19030-8e37-4068-9517-803d9a9d517c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_92ab4240-d449-4426-91ae-fe2f5a8bf5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_92ab4240-d449-4426-91ae-fe2f5a8bf5ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_52452587-b4b3-4999-837f-3f5ad158625b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_52452587-b4b3-4999-837f-3f5ad158625b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeOneMember_16247aa3-cd7a-41da-a80f-f01c1701e04a" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeOneMember_16247aa3-cd7a-41da-a80f-f01c1701e04a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeTwoMember_0ca6b79a-86bc-40d1-aa98-10e8a34c5de7" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeTwoMember_0ca6b79a-86bc-40d1-aa98-10e8a34c5de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeThreeMember_dc4b9393-670d-4ac9-8bbe-5c3f7a628727" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeThreeMember_dc4b9393-670d-4ac9-8bbe-5c3f7a628727" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeFourMember_16f9a662-db30-4a9f-a924-c90640255dcc" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeFourMember_16f9a662-db30-4a9f-a924-c90640255dcc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeFiveMember_6fdebbc7-2650-497c-add1-ae24a089b43c" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeFiveMember_6fdebbc7-2650-497c-add1-ae24a089b43c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:to="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd64eadf-af81-42f7-b692-b7a5462326d4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:to="loc_srt_RangeMember_dd64eadf-af81-42f7-b692-b7a5462326d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:to="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7d55efc-600b-49c8-a609-b144b34ac56a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:to="loc_srt_MinimumMember_e7d55efc-600b-49c8-a609-b144b34ac56a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e5f45372-2ad0-4ebc-bf07-9c5936422cab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:to="loc_srt_MaximumMember_e5f45372-2ad0-4ebc-bf07-9c5936422cab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails" xlink:type="extended" id="i854dd525a83845e8aca643ed75543f9a_StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_849fb0b0-da80-4801-9dd3-ec61948dad28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_849fb0b0-da80-4801-9dd3-ec61948dad28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c4863a72-8eb0-49f2-96c0-9857d8afe349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c4863a72-8eb0-49f2-96c0-9857d8afe349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e3fb7b6e-1936-4fc5-a756-bedd5efe3888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e3fb7b6e-1936-4fc5-a756-bedd5efe3888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2c2a37dc-5560-4ddf-8889-95b686d1bceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2c2a37dc-5560-4ddf-8889-95b686d1bceb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_452ebfe5-e103-471b-b358-532d677d09ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9d143e5-4dae-4a9b-8a68-976902c19d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9d143e5-4dae-4a9b-8a68-976902c19d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b77ca852-03f9-4ae4-840f-0dc24e130f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b77ca852-03f9-4ae4-840f-0dc24e130f21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4267e133-d7bc-4a9e-ad87-e7c84b49b4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4267e133-d7bc-4a9e-ad87-e7c84b49b4db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6eeed700-675a-46ae-a209-4094cf7f4edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6eeed700-675a-46ae-a209-4094cf7f4edd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_435918ac-d687-4939-89a4-7e0ffd350dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_bd000ba7-bf82-420f-910f-0d078e8c70d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_bd000ba7-bf82-420f-910f-0d078e8c70d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5edb6fbf-d91f-41bd-9724-57661d5ca266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5edb6fbf-d91f-41bd-9724-57661d5ca266" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_04579b07-952e-469d-9529-abff132fa29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_04579b07-952e-469d-9529-abff132fa29c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_cdd487bf-7ca6-46e4-873c-a6eafce6521c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_cdd487bf-7ca6-46e4-873c-a6eafce6521c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:to="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ac2572b-ea0e-4f6e-a27b-1e11eda493b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ac2572b-ea0e-4f6e-a27b-1e11eda493b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2eebe347-e004-43c5-9f0e-84dfee0e79fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ac2572b-ea0e-4f6e-a27b-1e11eda493b1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2eebe347-e004-43c5-9f0e-84dfee0e79fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationStockCompensationExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail" xlink:type="extended" id="i9f1a3e5e395841fdb85f2d2713c5b3b1_StockbasedCompensationStockCompensationExpenseDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_25fb46b2-6175-488c-a983-fe9ceb7769b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8fa80771-7ea2-4366-8f9b-a82ade13a0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_25fb46b2-6175-488c-a983-fe9ceb7769b3" xlink:to="loc_us-gaap_ShareBasedCompensation_8fa80771-7ea2-4366-8f9b-a82ade13a0e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_25fb46b2-6175-488c-a983-fe9ceb7769b3" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_52098a37-dddb-4ffe-97a9-641bf9abf61a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_52098a37-dddb-4ffe-97a9-641bf9abf61a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_CostOfRevenueMember_d8f6081c-5b56-4384-8d8a-6bbf2f5e4801" xlink:href="nstg-20221231.xsd#nstg_CostOfRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:to="loc_nstg_CostOfRevenueMember_d8f6081c-5b56-4384-8d8a-6bbf2f5e4801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fcb3b278-3e7a-4906-810e-7d5aeab0fd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fcb3b278-3e7a-4906-810e-7d5aeab0fd2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dca98aed-9b62-4ef8-a4ab-75f955276d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dca98aed-9b62-4ef8-a4ab-75f955276d0f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationFairValueofEmployeeOptionGrantDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail" xlink:type="extended" id="iae70166b80a945b999fc83c98ff593b3_StockbasedCompensationFairValueofEmployeeOptionGrantDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_33b54a45-b380-4b2c-96d7-9d107bbb9c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_33b54a45-b380-4b2c-96d7-9d107bbb9c02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_342ae3be-a576-406f-bfad-a75daa604ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_342ae3be-a576-406f-bfad-a75daa604ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ddb86f1-10c8-4d6d-8ea5-803d9aa9d8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ddb86f1-10c8-4d6d-8ea5-803d9aa9d8af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f6b42857-542d-43b2-96f5-6bbdc908a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f6b42857-542d-43b2-96f5-6bbdc908a93f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:to="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44e080a2-e960-4348-9806-44171bee89a7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:to="loc_srt_RangeMember_44e080a2-e960-4348-9806-44171bee89a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:to="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f5efba46-176d-4a8c-b4bb-de33f4dfd9cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:to="loc_srt_MinimumMember_f5efba46-176d-4a8c-b4bb-de33f4dfd9cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_28f863ca-f826-4437-9ec7-b83ffeba43ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:to="loc_srt_MaximumMember_28f863ca-f826-4437-9ec7-b83ffeba43ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail" xlink:type="extended" id="ib951f65c3c7c40139ee336c528514214_IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_882143ae-5ba7-4b24-8afd-f530922a6501" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_882143ae-5ba7-4b24-8afd-f530922a6501" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_76c821d6-3a44-46b7-8825-16737707e8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_76c821d6-3a44-46b7-8825-16737707e8cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b18de9bc-9fa0-436c-bbb4-6849fcf06d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b18de9bc-9fa0-436c-bbb4-6849fcf06d7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_882143ae-5ba7-4b24-8afd-f530922a6501" xlink:to="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:to="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_6a041483-9731-4ba5-911a-60c7038c15bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:to="loc_us-gaap_GeographicDistributionDomain_6a041483-9731-4ba5-911a-60c7038c15bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:to="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_3745eaf8-d743-4aa0-8a88-7c687d0cb945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_3745eaf8-d743-4aa0-8a88-7c687d0cb945" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_956dbc24-67b2-4ec5-b651-7857f9a2e61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_956dbc24-67b2-4ec5-b651-7857f9a2e61c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended" id="i91d1ab9d381d4881871404d0799ef92f_IncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5ca0b7f6-8e7a-4e55-a419-193b70b26cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5ca0b7f6-8e7a-4e55-a419-193b70b26cb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e0ab097b-71f3-41b9-9e39-54e64e5eb90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e0ab097b-71f3-41b9-9e39-54e64e5eb90a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_ae638f06-ab04-48cb-b435-b3963c3beeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_ae638f06-ab04-48cb-b435-b3963c3beeff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_aef8da47-4e75-4f87-950f-399d391e0e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_aef8da47-4e75-4f87-950f-399d391e0e72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0d739a64-15c8-4c44-914b-93cd06946047_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0d739a64-15c8-4c44-914b-93cd06946047_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_FederalAndStateMember_f4c5320b-1dee-424c-86a3-3b673bb219de" xlink:href="nstg-20221231.xsd#nstg_FederalAndStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:to="loc_nstg_FederalAndStateMember_f4c5320b-1dee-424c-86a3-3b673bb219de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_8bf32e7c-02bc-4fa9-9b44-f7f36246b68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:to="loc_us-gaap_DomesticCountryMember_8bf32e7c-02bc-4fa9-9b44-f7f36246b68d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail" xlink:type="extended" id="i69573733bb664f2b826c6d0f03c8b8ce_IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_012c943f-ac2f-4fd4-9783-8494407db43b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_012c943f-ac2f-4fd4-9783-8494407db43b" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7c75adcd-f779-4dc1-b0e2-9ec6ecee8e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7c75adcd-f779-4dc1-b0e2-9ec6ecee8e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f158cef3-d626-4351-98b8-6700d5cf58be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f158cef3-d626-4351-98b8-6700d5cf58be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_2854bb0d-1455-4735-ae25-0aad70473efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_2854bb0d-1455-4735-ae25-0aad70473efe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3e260e6f-f1e2-4128-bec3-116cac2ea523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_012c943f-ac2f-4fd4-9783-8494407db43b" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_53be5d8f-e121-4bb0-ae33-323b87179890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_53be5d8f-e121-4bb0-ae33-323b87179890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_9d77e0cf-5e78-463e-afaf-8bf6106e2ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_53be5d8f-e121-4bb0-ae33-323b87179890" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_9d77e0cf-5e78-463e-afaf-8bf6106e2ebd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9f99d87a-dc98-4c6a-af41-359e183137b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9f99d87a-dc98-4c6a-af41-359e183137b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0589716-c827-4cac-b544-f212b8b587ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0589716-c827-4cac-b544-f212b8b587ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0ca1abf3-e073-498a-a0c0-d1be6c11cae3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0589716-c827-4cac-b544-f212b8b587ad" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0ca1abf3-e073-498a-a0c0-d1be6c11cae3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended" id="i2a924a73d4ef4102a77c73d54273e083_CommitmentsandContingenciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f6f913f4-8cd9-4a52-a58c-c41da9c48731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_f3ceddca-8532-4a4d-9d49-b281638e1cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f6f913f4-8cd9-4a52-a58c-c41da9c48731" xlink:to="loc_us-gaap_ContractualObligation_f3ceddca-8532-4a4d-9d49-b281638e1cbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f6f913f4-8cd9-4a52-a58c-c41da9c48731" xlink:to="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_a96a42ca-0c29-4ec5-ba54-8425f77eeb54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:to="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_a96a42ca-0c29-4ec5-ba54-8425f77eeb54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_26534a3e-49dd-47cb-90aa-cf845f5be2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:to="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_26534a3e-49dd-47cb-90aa-cf845f5be2eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionMember_154e8cfe-44d4-47ee-a421-b95a736740f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_26534a3e-49dd-47cb-90aa-cf845f5be2eb" xlink:to="loc_us-gaap_ConstructionMember_154e8cfe-44d4-47ee-a421-b95a736740f1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/NetLossPerShareDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#NetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/NetLossPerShareDetails" xlink:type="extended" id="i8f838d2cef2b4920b30971ea5a012dd8_NetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_44e2f266-b55c-4f2a-a5f5-e5e3d5b97fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dfd0e39f-41fb-42a7-9e21-8633ba267482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_44e2f266-b55c-4f2a-a5f5-e5e3d5b97fa5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dfd0e39f-41fb-42a7-9e21-8633ba267482" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_44e2f266-b55c-4f2a-a5f5-e5e3d5b97fa5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d54b5732-9bed-4dff-999f-e601faf7048a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d54b5732-9bed-4dff-999f-e601faf7048a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4c99fa7b-2f3c-40f3-8512-935916d932a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4c99fa7b-2f3c-40f3-8512-935916d932a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_81107469-59fd-4bef-a4f0-56aa1520bcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_81107469-59fd-4bef-a4f0-56aa1520bcd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f2ae2371-289c-4314-8e37-25749b4f3be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:to="loc_us-gaap_WarrantMember_f2ae2371-289c-4314-8e37-25749b4f3be0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4802364c-c693-49e8-a0c2-323645552fbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:to="loc_us-gaap_EquityComponentDomain_4802364c-c693-49e8-a0c2-323645552fbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c2d76ffb-55ca-45ac-af9e-3d3ca4d857eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:to="loc_us-gaap_EquityComponentDomain_c2d76ffb-55ca-45ac-af9e-3d3ca4d857eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_17f400d0-4281-483b-a962-1c42992d8798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c2d76ffb-55ca-45ac-af9e-3d3ca4d857eb" xlink:to="loc_us-gaap_CommonStockMember_17f400d0-4281-483b-a962-1c42992d8798" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.nanostring.com/role/SubsequentEventsDetails" xlink:type="extended" id="i3780620015ee4390a2165d3a0c5f9e2e_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_6cf65f33-eedd-4e51-a0b8-0b247cc1912d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3454ef8b-44c9-4b12-9916-12de021ca88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_6cf65f33-eedd-4e51-a0b8-0b247cc1912d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3454ef8b-44c9-4b12-9916-12de021ca88d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_6cf65f33-eedd-4e51-a0b8-0b247cc1912d" xlink:to="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_00152196-e43f-4cab-83cd-c5ddff5be492_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_00152196-e43f-4cab-83cd-c5ddff5be492_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_35d96305-6a43-4dbb-b1af-9ba49859768a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_35d96305-6a43-4dbb-b1af-9ba49859768a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_687e4f3b-f5f7-4226-961e-c03ef45ac128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_35d96305-6a43-4dbb-b1af-9ba49859768a" xlink:to="loc_us-gaap_SubsequentEventMember_687e4f3b-f5f7-4226-961e-c03ef45ac128" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>nstg-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:50e88ef7-7662-44f9-a77d-a0cf072223f8,g:ff6ee908-6dcd-4476-b167-ff6c214915d5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5b120fdf-a6bd-4631-8c33-9df656287b2b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturing in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_c55772b3-2318-444b-aebd-ba060eb827f5_terseLabel_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on repatriated foreign earnings and other nondeductible items</link:label>
    <link:label id="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_label_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings and Other Nondeductible Amounts</link:label>
    <link:label id="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_documentation_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings and Other Nondeductible Amounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" xlink:to="lab_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecb79498-861f-4116-845a-4855bb779801_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d5b5f510-7bf0-40c3-93a4-0c56c078fb23_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_aa56fc71-e63c-4213-b5ff-ca9df896ce4a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_4f1eafd6-afb9-4fab-b748-4654485eda8e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6759aeff-fe0e-4759-8a15-3db768531dac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_950dfb5f-6054-49a5-ace5-d474c7d2c600_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2f92db0e-d0ea-452b-926c-df10e08eb64c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_495e22c1-e9a0-4bad-a80d-49a20a367a90_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_16589658-eae1-4c65-b01c-7cd66cfe70bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_3264f158-7eec-4b97-9a72-cb661051b137_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_aa36573c-dc68-40b3-bf4a-fb91bfef56ff_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f68a5e9e-ee64-4bd5-91b2-d526f356918d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e2ac5e20-8757-4be7-9e39-66635cb82424_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_f75eecd3-78e7-4386-a1b1-71779e5f9475_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_9e06f7f9-b056-4cb2-9797-06b84e90cdae_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_bc8d190f-2bca-462e-9591-f0e6e3e066ae_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Payment Terms</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_248f3dd7-ad48-40cc-adfb-51aa2f293e02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_cbdd8973-2172-4513-9b6d-ad29f026182c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_06c49a53-f851-4ea9-919f-71ee95586c72_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_d4ec9117-8254-4eff-bffe-5fa49151e695_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation satisfied in previous period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d4d5458-b12b-4888-942c-b4035df499be_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_986e8a00-e853-48f7-a0d3-4f39dc65905e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4ad9078f-8537-4675-8b93-b563a028ad47_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_22d539cd-41ce-425c-b071-4f79704cde9c_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e50a824a-aab3-4d9e-9643-c401b24137bb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_38c7bb0a-96c2-4b62-bb28-e55e29971511_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ee70644a-c5cf-4000-bc93-3a591e7bb759_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2140ae80-64d0-4e91-bfcd-9c91dca50fa9_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_8e0c6194-9284-4200-b11c-19c7301c8387_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_1a452873-fc0d-4059-81df-2a785d885e82_terseLabel_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 162(m) limitations</link:label>
    <link:label id="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_label_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation Section 162 Limitation</link:label>
    <link:label id="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_documentation_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation Section 162 Limitation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxReconciliationSection162Limitation" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxReconciliationSection162Limitation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EffectiveIncomeTaxReconciliationSection162Limitation" xlink:to="lab_nstg_EffectiveIncomeTaxReconciliationSection162Limitation" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_StandardProductWarrantyPeriod_ea089799-1d76-44b1-bbf2-ef8713756b75_terseLabel_en-US" xlink:label="lab_nstg_StandardProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard warranty period</link:label>
    <link:label id="lab_nstg_StandardProductWarrantyPeriod_label_en-US" xlink:label="lab_nstg_StandardProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Period</link:label>
    <link:label id="lab_nstg_StandardProductWarrantyPeriod_documentation_en-US" xlink:label="lab_nstg_StandardProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The standard product warranty liability period. Does not include increases or decreases in an extended warranty liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_StandardProductWarrantyPeriod" xlink:href="nstg-20221231.xsd#nstg_StandardProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_StandardProductWarrantyPeriod" xlink:to="lab_nstg_StandardProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_3d105cc2-277e-44b5-b25e-c18aeda64559_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4487662c-838b-47f7-a899-6afeba0ae2a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue_0daf0899-3448-4a16-af43-41b44d2ed34d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Owned, Mortgages, Mortgage-Backed and Asset-Backed Securities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" xlink:to="lab_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_83350739-0810-4d3a-bc7e-38df281b1bdb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_5b674ca7-5eec-4ddc-b8e5-69da9b98bf91_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_d229caae-2679-4441-8d9d-2d2ae131de57_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_77ee6e9e-d5cb-4bf3-b76b-74adee4e8083_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_9f9dd0d8-faba-4ac6-ab9e-87dae70b93dc_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees and Indemnifications</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_cdaa0b5f-43b8-4414-97aa-cb08272232a0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_0d441ef4-5dab-4a76-ad10-dfad4f8b1beb_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f91ea339-65ca-4119-8651-e22bcd5a6ceb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5ff812ae-3025-4037-9740-bd5621dd05b7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_43daed30-daf0-452c-8e50-8f19fae2f51d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_10c812a4-2747-4b9b-a166-c2d2d4569ad4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_2c21fdac-e3cc-49f8-8192-a02a946b473f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_CostOfRevenueMember_a871f783-ad09-421b-9c90-76533c2a7c05_terseLabel_en-US" xlink:label="lab_nstg_CostOfRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_nstg_CostOfRevenueMember_label_en-US" xlink:label="lab_nstg_CostOfRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Revenue [Member]</link:label>
    <link:label id="lab_nstg_CostOfRevenueMember_documentation_en-US" xlink:label="lab_nstg_CostOfRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_CostOfRevenueMember" xlink:href="nstg-20221231.xsd#nstg_CostOfRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_CostOfRevenueMember" xlink:to="lab_nstg_CostOfRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_b335a1d5-0156-4957-9be6-36c618bcab1f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_5681667b-8c3d-4217-bf0e-5620ebbee0cc_terseLabel_en-US" xlink:label="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer deposits</link:label>
    <link:label id="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_label_en-US" xlink:label="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Customer Deposits, Current</link:label>
    <link:label id="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_documentation_en-US" xlink:label="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Customer Deposits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" xlink:to="lab_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b1e4e2bd-1688-4735-ad01-90ff6fa7fa85_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_ffe27bb7-2967-47d0-98c1-9aba7d43dcad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_51281de7-1349-4c82-9851-f4a96a96c9c5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9e6c6b7a-4dd8-4aa0-b63b-5166cbe2048c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_e6c32709-cb15-4f8e-a843-e9341cad214e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5bdf90e0-247e-44c4-b37b-342eb32d1a94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_cd018353-d8f1-4e5a-9a4b-63681298332d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_ca0d4896-402f-49e5-8251-19f230bbc1dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding - Number of Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_d1cf4677-3fe2-4492-8ca8-6b3ccd24ec7d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_32595dc0-5ace-4c10-8e72-a8db813117d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_4fd26997-c526-4f91-88d4-e23c55b27432_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1a5207bf-d867-4049-bfd7-b26d90064004_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_cb610948-1989-4d90-80ca-8dcdabfc9a7f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees paid for issuance of 2025 convertible senior notes</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_3255386f-9c6f-4bf4-91d5-e9420c0cf2e6_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_71fb8d4d-b6ac-4ae9-939e-92ea9394e0cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_2466a76f-d933-4398-8b03-b48d0c228d26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_f082d5a3-554c-4c29-bc84-c9c96a107c7c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_da163dc6-38cf-4499-88f2-d98f174bfcd9_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_38f0a243-93da-4e3f-aed8-b914b9088b73_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_PrototypesAndOtherEquipmentMember_1446270e-909d-468c-87f6-448f74a819a3_terseLabel_en-US" xlink:label="lab_nstg_PrototypesAndOtherEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prototype instruments</link:label>
    <link:label id="lab_nstg_PrototypesAndOtherEquipmentMember_label_en-US" xlink:label="lab_nstg_PrototypesAndOtherEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prototypes And Other Equipment [Member]</link:label>
    <link:label id="lab_nstg_PrototypesAndOtherEquipmentMember_documentation_en-US" xlink:label="lab_nstg_PrototypesAndOtherEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prototypes And Other Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PrototypesAndOtherEquipmentMember" xlink:href="nstg-20221231.xsd#nstg_PrototypesAndOtherEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_PrototypesAndOtherEquipmentMember" xlink:to="lab_nstg_PrototypesAndOtherEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_388fcd8a-9f23-4d09-bd32-dee6a51cb11c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_4f2415c7-4c6e-47fb-935c-7917c0943829_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3bfa0c38-c1f6-4174-98db-c5858da8e6be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_13f83aa7-9f05-45f2-8b0c-b5c5824d8c31_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_49ff958e-4eb4-4074-a697-afbaabbc804d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExtinguishmentOfDebtTerminationFee_69ada803-2e18-420a-8d53-fa5b216d484e_terseLabel_en-US" xlink:label="lab_nstg_ExtinguishmentOfDebtTerminationFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt, termination fee</link:label>
    <link:label id="lab_nstg_ExtinguishmentOfDebtTerminationFee_label_en-US" xlink:label="lab_nstg_ExtinguishmentOfDebtTerminationFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment Of Debt, Termination Fee</link:label>
    <link:label id="lab_nstg_ExtinguishmentOfDebtTerminationFee_documentation_en-US" xlink:label="lab_nstg_ExtinguishmentOfDebtTerminationFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment Of Debt, Termination Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExtinguishmentOfDebtTerminationFee" xlink:href="nstg-20221231.xsd#nstg_ExtinguishmentOfDebtTerminationFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExtinguishmentOfDebtTerminationFee" xlink:to="lab_nstg_ExtinguishmentOfDebtTerminationFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_192c2712-6f51-44d0-83f8-9bb29553f72a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock_cfa7a382-c48a-47b8-83c2-7af3fa55fa55_terseLabel_en-US" xlink:label="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Deferred Tax Asset Valuation Allowance</link:label>
    <link:label id="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock_label_en-US" xlink:label="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Deferred Tax Assets Valuation Allowance [Table Text Block]</link:label>
    <link:label id="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock_documentation_en-US" xlink:label="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Deferred Tax Assets Valuation Allowance Table [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" xlink:href="nstg-20221231.xsd#nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" xlink:to="lab_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_34b13712-239c-4bf5-bda0-2256c118afea_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d51f7532-e2fe-4ecf-9835-131f0b76f7b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_be2f26a1-01a5-47d8-add0-13de197771f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_bf544d9e-0a97-430e-8e66-55d1fdef397f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments Available-for-Sale Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_deb2bcd1-557b-4fd1-bac3-f878bc15c461_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c1388149-8619-49c8-9cc6-d753567e85f8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f98da592-be42-4f32-bb85-5fc88a12cd12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_52b15a86-9406-43fe-ba88-cf1b357136a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and foreign tax, and other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_c6fe1e7a-db39-4074-a5af-b6c2f21a5342_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_3d41cbdd-1433-490e-913f-5d97948ae377_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock_f9bd5d70-5a22-4e70-aef0-f1c843cb1a76_terseLabel_en-US" xlink:label="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Temporary Differences and Carryforwards</link:label>
    <link:label id="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Effects Of Temporary Differences That Give Rise To Deferred Tax Assets And Liabilities [Table Text Block]</link:label>
    <link:label id="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Effects Of Temporary Differences That Give Rise To Deferred Tax Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="nstg-20221231.xsd#nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_d4160ebb-d827-402d-b354-467d067573f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_8968ceb0-85e5-44df-9b01-b92e231fe905_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7a0f3150-3187-41e0-8014-2ccd8d198107_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146bc937-d93b-4986-b5e3-51ad8a9eb27d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_da5b2e1e-c86f-4b64-aad3-d86d9ebe13f9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_e7e38dca-e469-4139-82ca-f24699aa0c43_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium and accretion of discount on short-term investments, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net, Amortization of Discount and Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:to="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_ee756138-ee3d-41c4-a6da-e542844c0ba8_terseLabel_en-US" xlink:label="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average remaining contractual term (in&#160;years)</link:label>
    <link:label id="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options Outstanding, Weighted Average Exercise Price, and Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_documentation_en-US" xlink:label="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options Outstanding, Weighted Average Exercise Price, and Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:href="nstg-20221231.xsd#nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="lab_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_c446e972-4ac4-4a59-8753-a8274d3e0010_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c1f3b985-5541-4f2d-92a0-eac8b4aa014e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ProductWarrantyAccrualPeriod_f0fec8e0-3b60-4e9b-a50c-083dd69fba08_terseLabel_en-US" xlink:label="lab_nstg_ProductWarrantyAccrualPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty accrual period</link:label>
    <link:label id="lab_nstg_ProductWarrantyAccrualPeriod_label_en-US" xlink:label="lab_nstg_ProductWarrantyAccrualPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual Period</link:label>
    <link:label id="lab_nstg_ProductWarrantyAccrualPeriod_documentation_en-US" xlink:label="lab_nstg_ProductWarrantyAccrualPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period of accrual amount as of the balance sheet date of the aggregate extended product warranty liability is amortized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductWarrantyAccrualPeriod" xlink:href="nstg-20221231.xsd#nstg_ProductWarrantyAccrualPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ProductWarrantyAccrualPeriod" xlink:to="lab_nstg_ProductWarrantyAccrualPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ae2b2058-d706-41d3-a390-9ca6e8160b3e_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a6e369ee-3490-4b11-8173-8ad3ee27154a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ConvertibleDebtTriggeringEvent2Member_5783d38c-b891-4c8e-9ab5-366aba1a2efb_terseLabel_en-US" xlink:label="lab_nstg_ConvertibleDebtTriggeringEvent2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Triggering Event 2</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTriggeringEvent2Member_label_en-US" xlink:label="lab_nstg_ConvertibleDebtTriggeringEvent2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Triggering Event 2 [Member]</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTriggeringEvent2Member_documentation_en-US" xlink:label="lab_nstg_ConvertibleDebtTriggeringEvent2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Triggering Event 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTriggeringEvent2Member" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTriggeringEvent2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ConvertibleDebtTriggeringEvent2Member" xlink:to="lab_nstg_ConvertibleDebtTriggeringEvent2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1a00a0a2-9f19-4941-8c6d-f4c84087651d_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_408a2190-13bd-47b4-980e-5ab0a89cef86_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0d03f158-cb38-46a0-b3fb-3b493a7ee3cb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair&#160;value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d1798ffb-5724-4d3e-ac58-8e5403238c6e_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_5fa1676b-1ed3-4d4c-b584-a0e406d1c1c3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6cfa23fa-7034-4ca3-87ee-e2081de2e26b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f3ec55f0-562a-458e-a762-d0902749cf41_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average exercise price per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ConvertibleDebtTermsDomain_0ca5b65e-60f3-4157-8bab-0e217d0ac388_terseLabel_en-US" xlink:label="lab_nstg_ConvertibleDebtTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Terms [Domain]</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTermsDomain_label_en-US" xlink:label="lab_nstg_ConvertibleDebtTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Terms [Domain]</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTermsDomain_documentation_en-US" xlink:label="lab_nstg_ConvertibleDebtTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsDomain" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ConvertibleDebtTermsDomain" xlink:to="lab_nstg_ConvertibleDebtTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1a0e239-7d05-4896-bc68-971a825fbf11_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives of the assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_c7e84d6a-34e6-407b-905c-3a9b5222efa8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful&#160;Life (Years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2734d1eb-0cd1-4b90-a834-d43c4d78ca39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1e62101d-bc69-4220-a8af-4b3953580538_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2b856b6-fc4e-4fb0-b725-9acb46e874c9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_57e9fc53-1b10-42c3-9a0e-4824efacc1bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at December 31, 2015 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4093d896-7d2e-498e-98ac-2c93ecea926e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at December 31, 2016 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_22e88b0d-0fe4-4383-bcee-e6670590198c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_cec77682-1ec7-4925-a9ac-11764bde9505_terseLabel_en-US" xlink:label="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturing in one to three years</link:label>
    <link:label id="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_label_en-US" xlink:label="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After One Through Three Years Fair Value</link:label>
    <link:label id="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_documentation_en-US" xlink:label="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities after one through three years fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:href="nstg-20221231.xsd#nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="lab_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6c1c4dfc-028d-4b32-89e6-2914d54f3940_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a021f70b-9a67-4bea-b603-5ef2d612176e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_dafef9a8-45a7-415e-9806-f0e4cbc6e0ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f264d35a-aa69-41fa-a5e1-5187b4936df7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_05e5d437-19b4-45da-8e32-790743235e20_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_4397a3f9-76a3-4c6e-aeff-e777d31b4bca_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_193e3d34-0894-48c8-9371-cf9ee698b075_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_62512c01-d5a1-4313-ab0d-732af55e2465_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_60e6793e-2434-4cff-9b09-e2621d88e335_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_4973cd57-324d-4347-a1b4-4b27072c9582_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_87c0fd22-9fe4-4223-856d-de7b057b0245_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExercisePriceRangeFiveMember_f63c6cff-85e3-4f09-bbdc-de3f85c3c925_terseLabel_en-US" xlink:label="lab_nstg_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$23.00 &#8211;&#160;$66.91</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeFiveMember_label_en-US" xlink:label="lab_nstg_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeFiveMember_documentation_en-US" xlink:label="lab_nstg_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeFiveMember" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExercisePriceRangeFiveMember" xlink:to="lab_nstg_ExercisePriceRangeFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b87eacea-835f-4121-a51c-bbdc0c0c2f4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_d56d299d-6caa-439b-b07a-8dc0e406bd28_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_9690624a-90cd-4bed-af4e-23df845b9d37_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4bfbf412-1abe-4e50-84fd-487ba27b12b4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_668c971b-25b8-46fc-aecd-2c9df2078c88_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0a346221-6872-408a-b84f-b6b69d329c85_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance cost</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_51f23738-b790-4866-bfe3-fa3533404e67_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on equity securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_InterestAccruedOnLongTermNotes_519c7178-4037-44e9-8224-909854541937_terseLabel_en-US" xlink:label="lab_nstg_InterestAccruedOnLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_nstg_InterestAccruedOnLongTermNotes_label_en-US" xlink:label="lab_nstg_InterestAccruedOnLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Accrued On Long Term Notes</link:label>
    <link:label id="lab_nstg_InterestAccruedOnLongTermNotes_documentation_en-US" xlink:label="lab_nstg_InterestAccruedOnLongTermNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense incurred, not yet paid, on all other long-term debt, which may include (1) interest on long-term notes, and (2) amortization of issuance costs not otherwise separately disclosed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_InterestAccruedOnLongTermNotes" xlink:href="nstg-20221231.xsd#nstg_InterestAccruedOnLongTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_InterestAccruedOnLongTermNotes" xlink:to="lab_nstg_InterestAccruedOnLongTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_53bdd8c3-9e57-4563-9656-88c303207741_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_0be71a86-a453-4bdc-85c7-a4f10a356575_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_085fcfcb-c61c-4d98-a9f2-9af950825ca0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_3c0762cd-68e6-4805-9cc4-b8642ec8b3c2_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_37259eed-a3be-4591-8f53-f30559d3d820_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_20654bce-8084-4718-942b-90e0eeb7c8c0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_74eb0c4e-b8fb-4243-855c-0b38edaad411_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_SignificantAccountingPoliciesTable_faa23fa9-deac-4c78-aedc-34f943325f4e_terseLabel_en-US" xlink:label="lab_nstg_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_nstg_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_nstg_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_nstg_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_nstg_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A summary of information pertaining to the Basis of Presentation and Summary of Significant Accounting Policies disclosure as a whole for which no other established gaap taxonomy identified hypercube is available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SignificantAccountingPoliciesTable" xlink:href="nstg-20221231.xsd#nstg_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_SignificantAccountingPoliciesTable" xlink:to="lab_nstg_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_08c47a70-c08f-401c-a0a1-fd8eb6af145c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b059deeb-b471-4430-8443-614211b776c9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_288f34e8-2f2b-4e23-8e26-1a551b407456_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0190431a-9f21-4208-9d7d-0534e0839459_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_SecuredRevolvingLoanFacilityMember_9e540b22-18c5-4635-965e-0d81ba23eea7_terseLabel_en-US" xlink:label="lab_nstg_SecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Revolving Loan Facility</link:label>
    <link:label id="lab_nstg_SecuredRevolvingLoanFacilityMember_label_en-US" xlink:label="lab_nstg_SecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Revolving Loan Facility [Member]</link:label>
    <link:label id="lab_nstg_SecuredRevolvingLoanFacilityMember_documentation_en-US" xlink:label="lab_nstg_SecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Revolving Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SecuredRevolvingLoanFacilityMember" xlink:href="nstg-20221231.xsd#nstg_SecuredRevolvingLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_SecuredRevolvingLoanFacilityMember" xlink:to="lab_nstg_SecuredRevolvingLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_2df766ba-25b6-43f0-876c-fcd83e293482_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_d36a728a-c4ec-43f7-8f33-6293d40004b5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_7117f582-4c59-4ba0-bd34-7447bc2c9c60_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Product Warranties</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:to="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d942d482-ccfa-4982-853d-497b02d1de3d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and other employee benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_63989388-bc02-48b0-a442-1b3de643aa27_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0db8c0a0-fe13-4eeb-ac43-60e3cc9fc13e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ee4e37de-f0eb-48bd-9c7a-90b711eb6fc5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5cb78a13-8596-4b23-9873-c798869049f4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_969680a7-3f02-455c-a362-f28e327ca61e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_ca55876c-05e1-44b9-8ab1-5a4bfb33d790_terseLabel_en-US" xlink:label="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Stock Option Plan and 2013 Equity Incentive Plan</link:label>
    <link:label id="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_label_en-US" xlink:label="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Four Stock Option Plan And Two Thousand Thirteen Equity Incentive Stock Plan [Member]</link:label>
    <link:label id="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_documentation_en-US" xlink:label="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Four Stock Option Plan And Two Thousand Thirteen Equity Incentive Stock Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" xlink:href="nstg-20221231.xsd#nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" xlink:to="lab_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d3c91f37-2391-4de2-b9c0-a7e52d77642c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_215ed92f-3b2e-4e1b-9dc4-851970816d20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Employee Option Grant</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1d299c99-1823-4538-87d8-84e9421c05dd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d2a338d4-ca31-4ccc-a1bc-023315cac8f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Components of our Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_5050b08c-27a1-4cbf-9099-b3707d8b37a6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e483841-547d-44c8-85fd-74d919096ce4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b83e0fa0-6edc-4019-acb5-98a84cad12dc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, weighted-average recognized period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_04988683-cffc-477d-9cd5-179fed891a24_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c284ede0-ff52-4926-a385-4a60b65f366a_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b172952e-2707-452a-aca2-b469c4a0aed9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at December 31, 2016</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_82fccea8-b00e-4152-8303-d5435ac23ed6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_13fc6586-803a-4c84-9c0e-0405f11ddeec_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software and computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_dfef7617-8134-4d35-b38b-d3d3ac8f30a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Available-for-Sale Securities by Level within Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_41f32bc0-3b51-4b8a-816b-d1f004cb096a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_03690fde-eca5-44c8-990b-4c058d824ec1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7169bae3-bab9-4a19-a64a-e3e5448e820d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5bca776f-2560-4336-a5b6-a0cd74c6a164_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_aca596e8-e7f6-4201-bffb-e70bc12ed4b7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_27309449-0065-4569-b71b-4d5c14ca8c94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_a19fe70a-30c4-445d-9d61-6c4606c3c803_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_18ce1c68-2785-4419-b0b3-8e6430359048_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price, Maximum (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4a3a841e-f453-44c5-a2ec-a9e276be9730_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4b980da6-1470-48a6-9af1-a0ea89d28f08_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_6b9d40d1-7a5f-42b0-a1dc-114abcd738e7_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe and Middle East</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_cf70e19f-fd50-41ff-8dcb-c82a25df6b23_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_3169b730-72ec-45ed-a8ff-c782f4115c87_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3ddf2a71-a8ca-4157-8a5c-97a9f9f5a506_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f79087df-0147-4ee2-bc81-cd210d7b7c09_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_1f8ad31b-3f25-4cfb-b20a-b3eb436e234f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_88085444-4bda-4bd4-91c3-41024b0afba9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b045b2fa-93a0-4a98-9a37-8759c3fa95a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_56d527fc-a27b-4c55-9af8-10787cae96d3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_672d9343-4b91-4ab6-8fab-143894557e5b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_44781d6e-0918-4fcc-a5ef-70babea77f6e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_217bac88-34c9-42a6-8283-09271ab6bfaf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for inventory obsolescence and bad debt expense (recovery)</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_7b4a55c9-3c8b-451f-8311-cc8a05cbfcb8_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5eb8e69f-25b2-4765-96b6-facba322f157_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_bf7a1aec-6753-4af6-a990-6bbf444d5058_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_daf57cf2-ae66-42f1-b5ed-f54ff2c8e1ea_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca2f2639-55b1-4d0d-9210-565009e74a5a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b9138c0f-52c9-45c6-a939-d92ac949366d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_0c0d5021-a8bc-460a-9412-4b3a25c6d9d3_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_91f199df-5341-4cfa-ae52-4c7220af9a25_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_810b4e64-012d-4e1b-b087-f7e6a22d5c16_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_612283b7-77aa-40fd-a94a-78416a2ee8ff_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d01c08a9-7be6-4651-ad83-62550b64a89a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding -Weighted- Average Remaining Contractual Life in Years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c74dfe7c-5921-4f56-aa2f-a7c9b076f9f4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_6c5192b5-a682-4efd-a3b5-f629056f37d2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1c3d285f-5347-476a-b969-a79114a82d53_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest as December 31, 2016</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_3417ed4f-3326-44f5-a776-00cd002f701e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and other liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanContributionPercentage_3007de55-03b8-4f26-876f-6d17fbf95072_verboseLabel_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanContributionPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution percentage of purchase shares on participants eligible compensation</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanContributionPercentage_label_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanContributionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Contribution Percentage</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanContributionPercentage_documentation_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanContributionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Contribution Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanContributionPercentage" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanContributionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EmployeeStockPurchasePlanContributionPercentage" xlink:to="lab_nstg_EmployeeStockPurchasePlanContributionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_395fc582-6ad1-4047-a192-d35ba0c4bf2d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_1881e230-cb10-4d56-b9ed-5ef2fb4297a9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_1d27e12d-99fc-4465-a03f-fdbccae1829b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_fd1d79ef-a0a8-439b-95b1-758f45dc92a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at December 31, 2016 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a4676ea6-153e-4209-b1f4-add6b8aea059_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cdc9670c-fb09-4723-ba13-2157e3116847_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockVotingRights_1360c5ec-5f96-42e2-9745-15d0082b2cf3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockVotingRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights</link:label>
    <link:label id="lab_us-gaap_CommonStockVotingRights_label_en-US" xlink:label="lab_us-gaap_CommonStockVotingRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockVotingRights" xlink:to="lab_us-gaap_CommonStockVotingRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_4556d243-4921-4b65-bdf8-6a24609da35d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_84effec6-a4b0-4941-80dd-20b1469ae1c3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e5b5e22b-61a9-41cc-8754-6c95f42a6fb3_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ServiceAndPerformanceComponentsMember_2347cd2f-fa3c-4ae3-bb2e-2902699e1924_terseLabel_en-US" xlink:label="lab_nstg_ServiceAndPerformanceComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and Performance components</link:label>
    <link:label id="lab_nstg_ServiceAndPerformanceComponentsMember_label_en-US" xlink:label="lab_nstg_ServiceAndPerformanceComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and Performance components [Member]</link:label>
    <link:label id="lab_nstg_ServiceAndPerformanceComponentsMember_documentation_en-US" xlink:label="lab_nstg_ServiceAndPerformanceComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award with service and performance components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ServiceAndPerformanceComponentsMember" xlink:href="nstg-20221231.xsd#nstg_ServiceAndPerformanceComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ServiceAndPerformanceComponentsMember" xlink:to="lab_nstg_ServiceAndPerformanceComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_75845082-58d1-4b43-86d1-50da7f9b307a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_5992eaa8-b9ac-432e-9f24-a8775fe49077_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_c2973fab-521d-4483-8d05-8b1ce1fced42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees paid upon extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_d5a25b25-7c50-4f1f-989e-81cdff9e918d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_73055317-56ec-4b7e-b567-a4ee4b282549_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_89714071-8902-4a1d-93c3-d1b69172a9ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_baee54ec-1fd2-44d6-a2af-074d6b5e3c01_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_d320063c-1665-4aec-9597-48ec6ee56011_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_98f1d8ef-1b20-4c87-a638-2cff179b09b9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share-basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d0611ec2-6cac-4ee1-bcdb-b0e44a2aff24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d77cd6ea-08ca-4380-82b9-fb3613cb2c69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_3286ee38-9e12-403a-a946-3b610a11ad06_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ManufacturingEquipmentMember_59a4c193-448d-4359-a4f3-0cf7531b3086_terseLabel_en-US" xlink:label="lab_nstg_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing equipment</link:label>
    <link:label id="lab_nstg_ManufacturingEquipmentMember_label_en-US" xlink:label="lab_nstg_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_nstg_ManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_nstg_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ManufacturingEquipmentMember" xlink:href="nstg-20221231.xsd#nstg_ManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ManufacturingEquipmentMember" xlink:to="lab_nstg_ManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f47bd334-c17b-42d4-8268-aaea3d1b71d2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6acd61e4-2e1d-47a4-b2b5-c80359e75fbc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_adc391e7-594d-447e-bfbc-d1a6f593bf0c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c96d813c-7a7e-46c8-9978-424b65cc1367_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0bbfae49-1218-4198-a5fc-8a0128f57f3d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3b472621-04e4-4c4b-82e1-6d156435da43_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_fb6f0ba2-b231-4ffd-a108-8519334d5bf6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_49f29a4e-6edc-4d42-b2e7-0325a94ab97d_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b0dc40bd-4f5f-4459-a1da-59c002ca8521_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_5be42a58-1c90-4715-a5e3-adf181c08f5a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_ff369fee-0bf8-44ee-8208-327cba97ea3e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_902096df-7979-469c-860b-621d724782a2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_84f9ab2f-b57b-4b78-bf82-09bf61521224_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExtendedProductWarrantyPeriod_e21ecf59-0294-468b-8888-a6dd7c79976c_terseLabel_en-US" xlink:label="lab_nstg_ExtendedProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended warranty period</link:label>
    <link:label id="lab_nstg_ExtendedProductWarrantyPeriod_label_en-US" xlink:label="lab_nstg_ExtendedProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Period</link:label>
    <link:label id="lab_nstg_ExtendedProductWarrantyPeriod_documentation_en-US" xlink:label="lab_nstg_ExtendedProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The extended product warranty liability period. Does not include increases or decreases in the standard warranty liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExtendedProductWarrantyPeriod" xlink:href="nstg-20221231.xsd#nstg_ExtendedProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExtendedProductWarrantyPeriod" xlink:to="lab_nstg_ExtendedProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_03c81f41-f6dc-42a8-b5ab-75fd17595dfa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax withholdings related to net share settlements of restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExercisePriceRangeOneMember_fe53af82-5d5b-49ab-a869-f4d6d0f4dbd8_terseLabel_en-US" xlink:label="lab_nstg_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.92 &#8211; $12.56</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeOneMember_label_en-US" xlink:label="lab_nstg_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeOneMember_documentation_en-US" xlink:label="lab_nstg_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeOneMember" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExercisePriceRangeOneMember" xlink:to="lab_nstg_ExercisePriceRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_82bf1c49-47b5-4155-bee0-a88605a7ba51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_973fbd44-9240-4fab-b98b-6b212b0de87f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_a18dbd1c-16a7-4d4c-8edb-0d7405fd966a_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market fund</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_bd103487-a167-4d12-b2ae-c98615a08a7f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_dece17b2-5b89-411d-86be-83517c323b71_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_b09eff5f-3dd9-4a84-9335-0e7523adb5bf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_3360c6c2-d9a2-41d4-9dbd-41cae4941cd1_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c3d10204-5ad5-4988-8ddd-c66550bb9acc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_0dbda36f-7888-49bc-827b-e61994145355_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt_febe76bc-8007-43a9-aa66-2ff83f404670_negatedTerseLabel_en-US" xlink:label="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of accrued interest on long-term debt</link:label>
    <link:label id="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt_label_en-US" xlink:label="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Accrued Interest Of Long Term Debt</link:label>
    <link:label id="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt_documentation_en-US" xlink:label="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Accrued Interest Of Long Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_RepaymentOfAccruedInterestOfLongTermDebt" xlink:href="nstg-20221231.xsd#nstg_RepaymentOfAccruedInterestOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_RepaymentOfAccruedInterestOfLongTermDebt" xlink:to="lab_nstg_RepaymentOfAccruedInterestOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1332ec50-4351-4a55-96a8-6d153514e85e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ed8365d0-8234-4097-9790-21c5fb46cc22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_cd0b4bed-1b28-4459-9523-110be1017d11_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_2244ce06-55b4-40bb-a8cc-9a0b160ccd64_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3485553d-27e3-47c4-a8eb-e8a71803db40_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_f5cb7789-70e4-445a-bd11-673a1987490a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c5d29b5e-30ec-4908-b528-6e32e71688fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_IncomeTaxesAndTaxRelatedLineItems_56a174dd-471d-440a-a001-290cc0dceed2_terseLabel_en-US" xlink:label="lab_nstg_IncomeTaxesAndTaxRelatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes And Tax Related [Line Items]</link:label>
    <link:label id="lab_nstg_IncomeTaxesAndTaxRelatedLineItems_label_en-US" xlink:label="lab_nstg_IncomeTaxesAndTaxRelatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes And Tax Related [Line Items]</link:label>
    <link:label id="lab_nstg_IncomeTaxesAndTaxRelatedLineItems_documentation_en-US" xlink:label="lab_nstg_IncomeTaxesAndTaxRelatedLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes And Tax Related [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedLineItems" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems" xlink:to="lab_nstg_IncomeTaxesAndTaxRelatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_2153ff47-83e5-4898-b150-3863a881986c_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_06fa2e55-8a22-42f7-b094-6b3d61d72905_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_656f0229-a83f-4b6c-a360-cbd2eab13914_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7159d9d1-10cd-4978-8a09-2ca4685cea1b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0ddfed55-0ff7-462e-a32b-3a2ea333ef7b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_aedfa6b1-3505-4c6c-b2a2-d3cf08124435_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution for retirement plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_1f2293f4-3f84-4564-84f2-b205fd60f8e1_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_69ed57c3-21ef-4b2b-a50a-6108b8e76e16_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_efe7d470-4653-4756-b0b7-4224f74aaf84_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExercisePriceRangeFourMember_906c22e1-5bb5-4b3a-ae99-640f7e3e29ca_terseLabel_en-US" xlink:label="lab_nstg_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$18.68 &#8211;&#160;$22.71</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeFourMember_label_en-US" xlink:label="lab_nstg_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeFourMember_documentation_en-US" xlink:label="lab_nstg_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeFourMember" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExercisePriceRangeFourMember" xlink:to="lab_nstg_ExercisePriceRangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_87c8ab12-fedd-4931-bb8a-613b796cd6e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cd95d9fc-2d14-4e47-ae63-488a724ada71_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_410f7ede-bb47-412f-b0c6-e790adceda56_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b055f531-aa97-4e68-89bd-476069559293_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_2a32e44f-e57a-4ab8-9d29-6f1c0dc508f4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9cf0f4d2-04b0-4fa9-a8a2-f22e233c8fce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6092778f-6bfb-44b4-80cc-9379be94d3ef_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_993a2d7a-f65b-4f84-a709-770b441da192_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanMember_1cf9a6be-f571-4d55-8caa-3ddb76309f04_terseLabel_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanMember" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EmployeeStockPurchasePlanMember" xlink:to="lab_nstg_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_50226472-8966-463b-80c9-23a2960fe7ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_5d982b56-3ddc-41da-82ac-56e84b479a32_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bcb3ccaa-31bd-48d6-954d-6367041f2c37_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at December 31, 2015 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_952fc790-90ba-456e-9ce2-d1bf05f0edd4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at December 31, 2016 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_e3dc5c6a-de9e-48b9-94c1-ea5bf31bf75a_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d808168c-a6e2-430f-8031-a7fc93554021_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_d696cc5b-02bf-46f8-9cd0-42a6a4ad968d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_db2bdd66-f945-4192-a52d-80d3f0adec1b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_43752806-e3e4-4d9e-9a85-a80c59930996_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_aa4c5b95-2305-42ca-8f24-a1990c093d5a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_719027c3-98fb-4d0a-81c8-78979e2020a1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b56b82e7-3974-430f-ade2-a279673078eb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_cceb1fe2-592a-46b6-b546-670604df2303_terseLabel_en-US" xlink:label="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_label_en-US" xlink:label="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities And Equity Securities, Fair Value</link:label>
    <link:label id="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_documentation_en-US" xlink:label="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities And Equity Securities, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DebtSecuritiesAndEquitySecuritiesFairValue" xlink:href="nstg-20221231.xsd#nstg_DebtSecuritiesAndEquitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_DebtSecuritiesAndEquitySecuritiesFairValue" xlink:to="lab_nstg_DebtSecuritiesAndEquitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_d028febc-6350-4424-8b5b-a7b7cfd3aa91_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_9da0cf6e-403c-4b9b-be8d-e5f2f842d2ff_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_14f1eb69-7fb6-4b8b-ad1d-4959a6abda86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at December 31, 2016 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_fdfa2997-603c-4725-8910-ad79573702a3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6328fcf9-ccb1-4665-99ba-5c2b0017d765_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_503297db-2f48-4ee7-ae4a-c1e01c91d24e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_00046a42-8683-4857-b5c6-ea22c97fe246_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity and Related Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d0f0b497-3107-4719-b70c-86c9bee49a24_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2871ce3d-9651-46d8-9b8e-fc4b47068559_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_38d894cc-3691-4feb-aa56-290e7e101dea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2f738ead-df55-4280-8926-c9a66fe36b27_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ProductAndServiceMember_e7028be3-39c6-4cd1-9fcb-06a81ecd51d1_verboseLabel_en-US" xlink:label="lab_nstg_ProductAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total product and service revenue</link:label>
    <link:label id="lab_nstg_ProductAndServiceMember_label_en-US" xlink:label="lab_nstg_ProductAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product And Service [Member]</link:label>
    <link:label id="lab_nstg_ProductAndServiceMember_documentation_en-US" xlink:label="lab_nstg_ProductAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product And Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductAndServiceMember" xlink:href="nstg-20221231.xsd#nstg_ProductAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ProductAndServiceMember" xlink:to="lab_nstg_ProductAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_efdc11a1-236d-47e5-bf8d-75737f4064f6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_403ba0d0-a3cc-4c16-8f50-150ab2b84fb3_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_22365627-60fe-48f4-9134-942b21ea1096_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty reserve</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_08887085-926c-4197-8247-c03467d945ed_terseLabel_en-US" xlink:label="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:label id="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="nstg-20221231.xsd#nstg_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_nstg_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_00e88807-17ae-45e9-9cc9-d5f2c3016421_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b2b48371-e1f0-483f-8f8e-0b10e2e1e668_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_39b1c658-193a-44d1-af0b-041080141a0f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_fa9e021b-9e89-4c16-a899-ff7a47634dfe_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_53f2343f-fb02-4d02-88be-b4fa3240285d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less:&#160;Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_e72d97f7-ea25-4140-897f-cfd8201a13f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9de1a91d-6e5a-4d88-91c4-41905b48ccc2_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ca7afb0c-79f7-47c9-90a9-ccbca089d8e7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d0a00c19-f323-42d3-a387-b3ad87a07947_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_17c74e4d-b061-41c7-a2c0-48aa998f4f66_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_a01c731f-a7d8-43b7-86f6-9293fe039cd0_terseLabel_en-US" xlink:label="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Gross Consideration Received On Transaction</link:label>
    <link:label id="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Gross Consideration Received On Transaction</link:label>
    <link:label id="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_documentation_en-US" xlink:label="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Gross Consideration Received On Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" xlink:href="nstg-20221231.xsd#nstg_SaleOfStockGrossConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" xlink:to="lab_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c6fb62f7-ed95-4c5c-8b68-791581d96069_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f0119c6a-1012-4d4b-b7f2-f87041c51665_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_4d7d04eb-a3e9-41d2-bdf7-ee1c5bab3ac5_terseLabel_en-US" xlink:label="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) In Customer Deposits</link:label>
    <link:label id="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_label_en-US" xlink:label="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) In Customer Deposits</link:label>
    <link:label id="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_documentation_en-US" xlink:label="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) In Customer Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" xlink:to="lab_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cd4288d6-91fe-48f0-bcbc-de9cebd043fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_51483121-5068-4dd7-99f1-c322c18214a7_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6dbdd1dc-540f-4cc9-9e41-27a4205c44fc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ad42a8a3-8f13-4192-90b1-3e0e4d598d0f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6f71a36c-3ded-44f1-a048-aa96493d9536_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value for options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de236740-b22d-4a37-b9f3-041376860236_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares used in computing diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e98a07a3-40fa-4003-8604-825f98afd798_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6ad24fab-d1d9-4f75-94af-41e5d707a7a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ProductInstrumentsMember_7ec5044f-7163-4b6c-807b-aa849e79c152_terseLabel_en-US" xlink:label="lab_nstg_ProductInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_nstg_ProductInstrumentsMember_label_en-US" xlink:label="lab_nstg_ProductInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product, Instruments [Member]</link:label>
    <link:label id="lab_nstg_ProductInstrumentsMember_documentation_en-US" xlink:label="lab_nstg_ProductInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product, Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductInstrumentsMember" xlink:href="nstg-20221231.xsd#nstg_ProductInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ProductInstrumentsMember" xlink:to="lab_nstg_ProductInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c81a843c-7d15-4ff0-9156-6056b03f4ede_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_19e708ba-bcdd-41c2-83a2-c787e76234cf_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_de4de0fa-f825-40ee-b6d0-dfdd9293a17c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_14c95410-214a-4da5-9538-8d4a028f35b5_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b9543818-da62-48a2-87a4-0bfc5d9ec4a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ProductConsumablesMember_49d27a50-90bd-47e4-bdf0-824804496393_terseLabel_en-US" xlink:label="lab_nstg_ProductConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_nstg_ProductConsumablesMember_label_en-US" xlink:label="lab_nstg_ProductConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product, Consumables [Member]</link:label>
    <link:label id="lab_nstg_ProductConsumablesMember_documentation_en-US" xlink:label="lab_nstg_ProductConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product, Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductConsumablesMember" xlink:href="nstg-20221231.xsd#nstg_ProductConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ProductConsumablesMember" xlink:to="lab_nstg_ProductConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_8b0456e1-6fb9-4d3e-b67c-5422456f4040_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fa0b6093-8a70-416e-abaf-035e410a806b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value, 150,000 shares authorized; 46,719 and 45,729 shares issued and outstanding at December&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_e9fd9ab5-9b8f-490f-b026-6d797e44352a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_3b507829-d68e-4907-8bd4-c107bc540eda_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_413edd91-40bd-42fc-bdb7-d591ce575084_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_339b00f1-990b-40d5-a7c2-77c9afadf5c6_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_f5a32d5a-f098-4dd9-843f-e9263c104fb6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b0d5d41a-5bf0-4924-9a3e-5e0d34b42cca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Shares Excluded from Computation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_46487e6d-2b15-4aa7-831b-c87a7089aa2a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at December 31, 2016</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_117b9694-1644-4906-ae94-e923e3e57a21_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b2ac4448-d37a-4978-9f74-ddb7c29460fc_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, finite lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a74216c-7cde-45f6-9831-1af74c524fe5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afde3f2b-4488-4732-8a07-095963461fd8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8ba6fe2d-15d8-42ad-91f0-3a756550dd2b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_11828a08-c9d3-4b76-8ee1-61ed1941df8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c4da3cdb-afee-4c4a-a35d-05f7ae81f6e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_62f756f1-4e13-471e-89d3-a808cabea5fd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_31cdbf87-18ee-4af9-9ece-f6e77d6cd86f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3894395a-d315-48f4-92e4-795202756fd8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of 2025 convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2a0b6301-7aa7-4bc2-acc0-7ebf9d45c91a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_c3e6fb96-03ed-4fd9-9b61-b1bc7f88df8a_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_6d213e2e-cba6-4a25-814f-3d039b950fd8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fada3371-ae17-41e3-8abc-afb0793de2ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_e6e0dabd-e53f-4074-8b8f-a303ba685057_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2473f92a-f7b1-48a2-b152-bcf3b9e1f8da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions_908d61ff-6448-40a2-866d-cc98d3c111be_terseLabel_en-US" xlink:label="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on current year tax positions</link:label>
    <link:label id="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increase Decreases Resulting From Current Period Tax Positions</link:label>
    <link:label id="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions_documentation_en-US" xlink:label="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits increase decreases resulting from current period tax positions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" xlink:href="nstg-20221231.xsd#nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_edd82352-1736-47c3-bd50-84e37217ec15_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a0072913-fd40-4735-b469-610d4a322fed_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_89be6c0c-2626-4775-a1b8-c4a164cb5d85_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_NumberOfPlatforms_7dd4d65e-7da7-4f31-9756-5c7b3cc8e117_terseLabel_en-US" xlink:label="lab_nstg_NumberOfPlatforms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of platforms</link:label>
    <link:label id="lab_nstg_NumberOfPlatforms_label_en-US" xlink:label="lab_nstg_NumberOfPlatforms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Platforms</link:label>
    <link:label id="lab_nstg_NumberOfPlatforms_documentation_en-US" xlink:label="lab_nstg_NumberOfPlatforms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Platforms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_NumberOfPlatforms" xlink:href="nstg-20221231.xsd#nstg_NumberOfPlatforms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_NumberOfPlatforms" xlink:to="lab_nstg_NumberOfPlatforms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_24f4b929-a242-46c6-8c57-ab0d62b89405_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4062d201-3ced-4310-a34b-b2a437880d0e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_05d9db6b-929e-4966-8b62-76215cdfb784_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_80cb5c0e-589d-4fc0-acc2-1783d42e243e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_2c6d398c-9057-4d05-8799-92451200cc9e_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_fcf01cfe-f7d5-4432-8e48-a08ce43b7e80_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_06ffa72f-3e68-413b-8500-73aedf5868ea_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2a8eb19e-07b5-4dc2-bd8c-07ecc7968ada_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability_4edb5219-5903-46ad-9172-684f1baeb0df_terseLabel_en-US" xlink:label="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, deferred lease liability</link:label>
    <link:label id="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability_label_en-US" xlink:label="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, deferred lease liability</link:label>
    <link:label id="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability_documentation_en-US" xlink:label="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, deferred lease liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxAssetsDeferredLeaseLiability" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxAssetsDeferredLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_DeferredTaxAssetsDeferredLeaseLiability" xlink:to="lab_nstg_DeferredTaxAssetsDeferredLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_98fc8837-8619-470a-8dfc-ea971254711b_negatedTerseLabel_en-US" xlink:label="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, State net operating loss adjustments</link:label>
    <link:label id="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_label_en-US" xlink:label="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, State net operating loss adjustments</link:label>
    <link:label id="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_documentation_en-US" xlink:label="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, State net operating loss adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" xlink:to="lab_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_dffcde7f-5e7f-44fe-be55-e1af54ccf191_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and other employee benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_358d2faa-5e18-4742-bbb8-27ab934dd275_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value (in&#160;thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1682ccea-13dc-4e6b-93cf-9d88720cdf36_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at December 31, 2016 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_478dcb4a-4249-4154-97b1-ca8ccd759d99_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_79460aae-1c06-4080-900b-2a1ea70de630_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_93ab853e-15a1-405a-a1d7-10a884a70541_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price percentage of fair market value of shares</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_3bde1811-b75b-4f34-90ff-62c765e5c5df_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c294ff48-f691-4855-819f-f8f243045e88_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_57153097-bd5d-4118-9462-731d4bc94767_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f05dd804-538d-467a-a695-8d37655a1562_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ce4900d2-e440-4be7-8150-00723bc3a46c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at December&#160;31, 2015 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70c49f5a-a989-4c3b-ae22-70403ad13d1b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at December&#160;31, 2016 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1269d6ab-bbee-45ff-b536-2e875cd43fe7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_e6944c0a-1e2d-4896-ac64-2defe1a5cbf6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_90e5922c-b318-47f0-af30-a5f6febb3ac4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_9d46091e-a7e7-4192-a873-ec6f4ab34ecc_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_91b55700-bd79-4976-a5f5-9f9c8e96c3eb_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_95f68afa-b0a3-47ae-a193-09f0f6217ed8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f4a51fa8-7406-48d2-b37a-7107bbc8958a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Principles and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3987362d-5e03-47ea-b7c2-fb11c84f501e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_29fb01e8-dd9c-4660-b4ae-e716cbcc1c24_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9b4011df-3081-49f6-9b22-dd1c0878b7e1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_52a87c8d-e08f-4b14-9d85-21e639b95d08_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_7f724964-819e-404b-beb9-4f6379308dbd_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_64ceed28-c47c-4864-b6e9-fcd836461264_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8905f247-2e3b-4f31-ad26-64c3b13790ce_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a0cb4f91-128c-4668-8234-e2b5606706e0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2670af09-0d2b-4640-b2de-81bb68d17141_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_08c0e3d3-0325-4b72-ae89-370be434ba44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_55ae8549-2aa3-4ce8-943f-96f85e3ff8e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod_c46e6fa9-094e-46c9-b3ba-77734a4901c8_terseLabel_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length of purchase periods, in months</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod_label_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Purchase Period</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod_documentation_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanPurchasePeriod" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EmployeeStockPurchasePlanPurchasePeriod" xlink:to="lab_nstg_EmployeeStockPurchasePlanPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e02b399b-7866-46fc-9185-a5762b874f3a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a02f5462-e0c4-4b4e-82f5-303ab5cdcc2e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6256a9f2-a7d1-44a0-8a74-a66f25be3e78_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7bbc186-989f-4a90-8335-5c0e13058149_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f2ba7973-146a-4f48-b88c-1c906372c017_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionMember_d2743786-c0cc-4b80-bbf9-0028c26a0efd_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction</link:label>
    <link:label id="lab_us-gaap_ConstructionMember_label_en-US" xlink:label="lab_us-gaap_ConstructionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionMember" xlink:to="lab_us-gaap_ConstructionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_DeferredTaxAssetsSection174Capitalization_db00ccfd-780a-4956-974c-0de8678fb376_terseLabel_en-US" xlink:label="lab_nstg_DeferredTaxAssetsSection174Capitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, Section 174 Capitalization</link:label>
    <link:label id="lab_nstg_DeferredTaxAssetsSection174Capitalization_label_en-US" xlink:label="lab_nstg_DeferredTaxAssetsSection174Capitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, Section 174 Capitalization</link:label>
    <link:label id="lab_nstg_DeferredTaxAssetsSection174Capitalization_documentation_en-US" xlink:label="lab_nstg_DeferredTaxAssetsSection174Capitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, Section 174 Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxAssetsSection174Capitalization" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxAssetsSection174Capitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_DeferredTaxAssetsSection174Capitalization" xlink:to="lab_nstg_DeferredTaxAssetsSection174Capitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_4ef84b6e-3216-4803-8b4a-fa57c28c6243_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ServiceComponentMember_8109bfbd-afa7-4e32-b8a0-80ecb7d5032a_terseLabel_en-US" xlink:label="lab_nstg_ServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service component</link:label>
    <link:label id="lab_nstg_ServiceComponentMember_label_en-US" xlink:label="lab_nstg_ServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service component [Member]</link:label>
    <link:label id="lab_nstg_ServiceComponentMember_documentation_en-US" xlink:label="lab_nstg_ServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards with a service component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ServiceComponentMember" xlink:href="nstg-20221231.xsd#nstg_ServiceComponentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ServiceComponentMember" xlink:to="lab_nstg_ServiceComponentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_03991f8a-8ff3-4b6b-8dbb-93fdc2c55cac_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_317ca701-978e-44b8-b75c-dd04a486b1b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_f1f4a6dc-d6c5-4d20-91e3-26794399638d_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_ab414273-9810-4bf8-ae46-1e46397a0b37_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_e55e80aa-b919-472b-a55d-ff9009bfeacc_terseLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1e1d51ab-cf2f-46c6-8094-ee8c4a62aff8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Preferred Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_224393c3-7d83-408b-bf1f-47fe8023f522_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_e3a4dc59-ef1e-4314-8557-d815ce454057_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_89dcce59-5c83-474d-b444-c62b18f3a5ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExercisePriceRangeTwoMember_29003097-ba0c-4ac3-bb41-a159aa8d0db7_terseLabel_en-US" xlink:label="lab_nstg_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$12.77 &#8211;&#160;$14.99</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeTwoMember_label_en-US" xlink:label="lab_nstg_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeTwoMember_documentation_en-US" xlink:label="lab_nstg_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeTwoMember" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExercisePriceRangeTwoMember" xlink:to="lab_nstg_ExercisePriceRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_70d6fea8-84a4-46ac-98a5-07361372a10f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_186a3e91-a1c3-4e3e-888c-fe2113553ef9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_32da867e-38e4-4cbb-959e-7f47e82c3f63_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_07742100-65d0-48f1-8d20-133e3d28baea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0dad1688-c2db-43b9-b241-da20718b93de_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ca42cb57-dc3a-4f4b-bcaf-6b83cc103c0d_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b522d12c-fecf-46bf-b0aa-f2cae8724904_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_6eed1cf8-6fe9-46ed-adef-bf6a71933cb2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_OutstandingPrincipalOfConvertibleDebt_d81a853b-1f52-45f9-b069-d953a2118a25_terseLabel_en-US" xlink:label="lab_nstg_OutstandingPrincipalOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Principal Of Convertible Debt</link:label>
    <link:label id="lab_nstg_OutstandingPrincipalOfConvertibleDebt_label_en-US" xlink:label="lab_nstg_OutstandingPrincipalOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Principal Of Convertible Debt</link:label>
    <link:label id="lab_nstg_OutstandingPrincipalOfConvertibleDebt_documentation_en-US" xlink:label="lab_nstg_OutstandingPrincipalOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Principal Of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_OutstandingPrincipalOfConvertibleDebt" xlink:href="nstg-20221231.xsd#nstg_OutstandingPrincipalOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_OutstandingPrincipalOfConvertibleDebt" xlink:to="lab_nstg_OutstandingPrincipalOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a912596b-a05d-48c0-8d9d-ffb586f63569_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit recognized related to share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3cceebd0-da2f-4123-b2be-d7d872eee64c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0f9047d-7e7d-4c6f-a9a3-0a13e62be999_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_762a32ff-7b8b-450c-a6c1-f7c4f9074fac_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8d3e4238-38bd-419b-9cc2-fb06efa18203_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_13e0f701-a356-4925-87a7-40a6adc93411_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ConvertibleSeniorNotesDue2025Member_8e5cf3cf-9f37-4351-b939-0f4aebc9e4b2_terseLabel_en-US" xlink:label="lab_nstg_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:label id="lab_nstg_ConvertibleSeniorNotesDue2025Member_label_en-US" xlink:label="lab_nstg_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025 [Member]</link:label>
    <link:label id="lab_nstg_ConvertibleSeniorNotesDue2025Member_documentation_en-US" xlink:label="lab_nstg_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ConvertibleSeniorNotesDue2025Member" xlink:to="lab_nstg_ConvertibleSeniorNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_5067c195-e80d-4401-8b0a-a1ae30ab45c1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_adb3f294-87f9-41f7-b30e-fa4d2db57413_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_FederalAndStateMember_5155e123-78c1-4f9e-bccb-690a4a6ca713_terseLabel_en-US" xlink:label="lab_nstg_FederalAndStateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State</link:label>
    <link:label id="lab_nstg_FederalAndStateMember_label_en-US" xlink:label="lab_nstg_FederalAndStateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal And State [Member]</link:label>
    <link:label id="lab_nstg_FederalAndStateMember_documentation_en-US" xlink:label="lab_nstg_FederalAndStateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal And State [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_FederalAndStateMember" xlink:href="nstg-20221231.xsd#nstg_FederalAndStateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_FederalAndStateMember" xlink:to="lab_nstg_FederalAndStateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4130d362-7caa-45cc-942f-45939ebd162b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_089c3487-3ac7-4930-8f7e-09a43f5a8750_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_88bccd51-8143-46c8-82ff-0548ff1fa562_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e2093e36-5288-455c-892b-3a0592e4b190_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government-related debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_10066232-e57d-4525-b900-c4f9b1157c89_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0ab2647d-d550-430d-9956-a360bd9cb039_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_e14d75ea-5be6-4592-87fa-72a692ba32e5_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_8111fbcc-86e0-4644-8adb-82e990a0a9b3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Finance Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e939fe79-4f6a-4824-9330-c540e8495ccf_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f08e4685-2ef0-433a-989c-f6b7d8c59943_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_6b3fcf79-6ed5-4492-b01b-b32543246f7d_terseLabel_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercise windfall</link:label>
    <link:label id="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_label_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Stock Option Exercise (Windfall) Shortfall</link:label>
    <link:label id="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_documentation_en-US" xlink:label="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Stock Option Exercise (Windfall) Shortfall</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" xlink:to="lab_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add8a75a-705a-416b-81d8-906c0be585e7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7e890a9d-f47f-44b7-ad86-e0d8bd4be019_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c1fd758e-4b15-4663-bc8c-f3b078bda14a_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized&#160;cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_2e02eff2-66d1-4061-9c0f-cc581e805ebd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9121d9d3-1c27-49af-adc1-e9f723153b2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits_fa91bf1f-a064-414a-b4bb-25001cf5e273_negatedLabel_en-US" xlink:label="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in tax credits</link:label>
    <link:label id="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits_label_en-US" xlink:label="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Change In Tax Credits</link:label>
    <link:label id="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits_documentation_en-US" xlink:label="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxReconciliationChangeInTaxCredits" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxReconciliationChangeInTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_IncomeTaxReconciliationChangeInTaxCredits" xlink:to="lab_nstg_IncomeTaxReconciliationChangeInTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_52120d8c-fa96-49a6-bf65-608f27a4866a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from underwritten public offering after fees and commissions</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_22889024-18c3-4257-82fa-d4445d740910_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_985f0094-5dbd-4a75-9fd9-539c9efb2e88_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7ee01417-df66-4823-b413-ce2bb497822f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e6253b5a-c25d-4260-8818-95eaadac4468_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6604a9a8-5a7b-40a2-93e2-ab3d36147d22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ConvertibleDebtTermsAxis_3fdbf92e-a635-4df1-9446-bb51410decb9_terseLabel_en-US" xlink:label="lab_nstg_ConvertibleDebtTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Terms [Axis]</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTermsAxis_label_en-US" xlink:label="lab_nstg_ConvertibleDebtTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Terms [Axis]</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTermsAxis_documentation_en-US" xlink:label="lab_nstg_ConvertibleDebtTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Terms [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsAxis" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ConvertibleDebtTermsAxis" xlink:to="lab_nstg_ConvertibleDebtTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_21a283cd-d949-4eaa-aef3-3502057e3e4b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values of Available-for-Sale Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_f6e2960e-3aea-43cb-ad75-282f58c65f76_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_f5eef6e9-5506-4b6c-be59-e568ab6c9fcd_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_cb16d1d4-0e9f-463b-83d8-512f6c7a74c7_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6c8b4da0-e8db-4aa3-91f1-d5a8e20d53f6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_acf963e6-3a2b-41d7-8955-dfacae33ab6d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of common stock, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_03017594-4579-40f6-919a-e71ec5f6a6d3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares used in computing basic net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_TermLoanAgreementMember_2f208139-cea2-4e12-9d3c-e41dc7730e09_terseLabel_en-US" xlink:label="lab_nstg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement</link:label>
    <link:label id="lab_nstg_TermLoanAgreementMember_label_en-US" xlink:label="lab_nstg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:label id="lab_nstg_TermLoanAgreementMember_documentation_en-US" xlink:label="lab_nstg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_TermLoanAgreementMember" xlink:to="lab_nstg_TermLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_22728c1e-584f-4225-b3f9-437a3ccf90d2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_ca0e13d9-5769-41dc-b926-1a988b07024a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at December 31, 2016 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_855cb272-96f5-4bb1-b120-67999b72675a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_028883a2-4372-4ef0-87f2-6a157e5d5af2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_07175a7c-2edb-49a3-9ebd-39afa08504ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at December&#160;31, 2015 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4c0120e8-5f25-41fd-b424-d41bba8cf40b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at December&#160;31, 2016 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_84748fca-f23e-4e1c-a22b-7842abd92d99_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value, 15,000 shares authorized; none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_d8672d1f-f47e-486a-8a6a-ad02a8c83bc8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_16f24284-d820-43b4-ac8f-519aa8357e2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease financing obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_236c784e-66b0-4c9f-b0fc-94ae7fe034df_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_839aa297-f377-4514-a64b-acdced8c7ebb_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_d2c3daa3-af6a-4aaa-840d-1ad0526db012_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance of Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fcc295cf-3924-456d-bcd8-48d191c16ce8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_7a712f1c-13ab-4f5f-8771-29cebe0613d5_terseLabel_en-US" xlink:label="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of issuance costs</link:label>
    <link:label id="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_label_en-US" xlink:label="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Discount And Issuance Costs</link:label>
    <link:label id="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_documentation_en-US" xlink:label="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Discount And Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AmortizationOfDebtDiscountAndIssuanceCosts" xlink:href="nstg-20221231.xsd#nstg_AmortizationOfDebtDiscountAndIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_AmortizationOfDebtDiscountAndIssuanceCosts" xlink:to="lab_nstg_AmortizationOfDebtDiscountAndIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_c36e9431-3804-4f0e-abb6-92d3e705aa3d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_69e4b2f4-0069-4937-b729-4834ad10d3f1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_65c96ee8-25c7-4aa8-aa8f-d1c1570e6914_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_30bb9fa2-5757-4dea-8e72-f028f8ab35fa_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_c17a7d24-691a-4b91-8b6f-5130dbf8f47b_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_ff168a03-b1ba-4fd5-995b-42aadba095ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Exercisable - Number of Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_12933b8f-5e53-4026-82be-d880a3c2fc2a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_98fe750e-a5aa-4604-ace3-0642a2605713_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1f0221e8-9097-4414-9758-a76e568b6b96_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_cdedc503-ebc2-48da-8ed5-beb8f59c78e9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intermediate manufactured components</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_32a12b0a-3724-4ec0-a471-2eca1546a3e9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_09c64b6d-6188-4f5b-801d-72702567652a_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_8af012ef-7cd4-44cf-abca-2d415d154ff1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6cf3696b-c036-4452-bb2c-1fb8dfd29342_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rates</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_e079a1f4-b457-466a-86a2-6a96f1c14391_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b0f287c9-474f-4769-a2ee-529b5ff8ecb0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_a0b439b3-ea2e-4e4d-a68c-b03fe8e35a84_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_9bf68c2b-0943-414f-af6d-1ab01976791a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock for employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_b4bd5d7e-f7e8-40e9-8e42-994abf96bbe0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_33d7bbe5-2538-425f-8519-e7247b675570_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_AreaOfSpaceUnderLease_d4a4f0f2-459d-4fce-96d0-19452b8661c3_terseLabel_en-US" xlink:label="lab_nstg_AreaOfSpaceUnderLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area under lease</link:label>
    <link:label id="lab_nstg_AreaOfSpaceUnderLease_label_en-US" xlink:label="lab_nstg_AreaOfSpaceUnderLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Of Space Under Lease</link:label>
    <link:label id="lab_nstg_AreaOfSpaceUnderLease_documentation_en-US" xlink:label="lab_nstg_AreaOfSpaceUnderLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Of Space Under Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AreaOfSpaceUnderLease" xlink:href="nstg-20221231.xsd#nstg_AreaOfSpaceUnderLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_AreaOfSpaceUnderLease" xlink:to="lab_nstg_AreaOfSpaceUnderLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1f8da492-4a8b-43a1-a375-93257fb92d91_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_b494aa52-4316-4a29-8d8a-f1b44a3fa23d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_613fc653-cde7-4faa-b3b3-9d563ff13dd7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_6f86dcbb-3d2b-40a3-b857-10598d1a045a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets before allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ConvertibleDebtTriggeringEvent1Member_8dac2cb4-fa45-4574-8b12-0c8aa815a3a7_terseLabel_en-US" xlink:label="lab_nstg_ConvertibleDebtTriggeringEvent1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Triggering Event 1</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTriggeringEvent1Member_label_en-US" xlink:label="lab_nstg_ConvertibleDebtTriggeringEvent1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Triggering Event 1 [Member]</link:label>
    <link:label id="lab_nstg_ConvertibleDebtTriggeringEvent1Member_documentation_en-US" xlink:label="lab_nstg_ConvertibleDebtTriggeringEvent1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Triggering Event 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTriggeringEvent1Member" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTriggeringEvent1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ConvertibleDebtTriggeringEvent1Member" xlink:to="lab_nstg_ConvertibleDebtTriggeringEvent1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_16cebb21-2d21-4eeb-8851-29d2df7b61b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_17e70280-17c7-4aa9-8ca5-38fec93543ab_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4b9daad9-cf2f-4752-b55d-fb1112ff7f95_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_3f75ba3e-1692-4a18-89ee-1302dff52ae1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3e5604f4-4a83-4391-b1eb-8abba2012099_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bbf7748c-0a72-40c2-8a69-4dd4d2bb7b8f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties recorded</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9360f771-776f-4d3a-b98c-0f74f65078a9_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bdd2f295-cc21-437d-8ba0-132c0b38853d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share-diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_b81d85c6-4d76-40e2-88be-89d0c0c59f29_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_PrototypeSystemsMember_9b10f9f1-e6af-4198-848f-fee5f2e96431_terseLabel_en-US" xlink:label="lab_nstg_PrototypeSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prototype Systems</link:label>
    <link:label id="lab_nstg_PrototypeSystemsMember_label_en-US" xlink:label="lab_nstg_PrototypeSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prototype Systems [Member]</link:label>
    <link:label id="lab_nstg_PrototypeSystemsMember_documentation_en-US" xlink:label="lab_nstg_PrototypeSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prototype Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PrototypeSystemsMember" xlink:href="nstg-20221231.xsd#nstg_PrototypeSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_PrototypeSystemsMember" xlink:to="lab_nstg_PrototypeSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb305135-2e7d-4509-861a-2206b7ad17ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vesting period and exercisable period, years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c8646841-4629-4224-9c7d-5e13063ecb81_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment and other assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_e555993e-e0ae-4303-947f-2cf7e2769946_terseLabel_en-US" xlink:label="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]</link:label>
    <link:label id="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_label_en-US" xlink:label="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:to="lab_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_db0d32ea-e9cb-49d6-860b-9b135cb00638_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_15da224b-ccd6-4a51-8ae2-456d423aacc2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d0a28cb2-c1f0-4054-a694-8596233b081c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f8bc8382-4bf2-4616-9cc4-d7a25b72de3e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_d8b4e3b9-ae70-4986-8ffe-2695b2506bb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b2f15da1-e3be-44c2-b473-b659a3c8715b_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3687223e-f7eb-41ea-9899-16f79aaf9f44_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_7f43d9f3-47bf-4da9-9dc2-b5bf9579f254_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_ExercisePriceRangeThreeMember_48d7ce5f-945e-4347-a0d6-6614f7ad617e_terseLabel_en-US" xlink:label="lab_nstg_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$15.21 &#8211;&#160;$18.55</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeThreeMember_label_en-US" xlink:label="lab_nstg_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:label id="lab_nstg_ExercisePriceRangeThreeMember_documentation_en-US" xlink:label="lab_nstg_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeThreeMember" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_ExercisePriceRangeThreeMember" xlink:to="lab_nstg_ExercisePriceRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_PublicStockOfferingMember_b7f4ee86-beb5-4913-9918-672ed052a2a7_terseLabel_en-US" xlink:label="lab_nstg_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering</link:label>
    <link:label id="lab_nstg_PublicStockOfferingMember_label_en-US" xlink:label="lab_nstg_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering [Member]</link:label>
    <link:label id="lab_nstg_PublicStockOfferingMember_documentation_en-US" xlink:label="lab_nstg_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PublicStockOfferingMember" xlink:href="nstg-20221231.xsd#nstg_PublicStockOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_PublicStockOfferingMember" xlink:to="lab_nstg_PublicStockOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f4ca5aeb-12bd-413b-a246-8b9ad3a2c81b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_86c5d56e-ce7b-47bf-91a0-090ba59704c5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ce80a3e2-a169-4dbe-9eb4-2b517f18b7c7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options grant period, years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6934b59c-857d-41fd-bd5e-5a83f685171a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0e7b217a-09e1-43bb-b7be-a5c095440db8_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_b364737b-ed78-4270-aafa-515e9f593d11_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5ee843e2-db8a-4484-bf25-4307d56a894d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_efcdfeae-ff64-4abf-94ae-37881e1ef912_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in federal and state tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d7c5be0c-606d-4063-843e-fd8ac302d9fa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_0cc857be-67f7-4cfb-a859-de33305f3e3e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_d799d741-9008-4eaf-b6e0-b39d299cf413_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of product revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_c06308a6-7ad7-478a-8a7b-9092a1aed7a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_3ff03744-6839-439e-ade6-8f62a13b001e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_6489edeb-2099-4ac5-857d-b10f4d8fb184_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_8e6443a2-976f-4dd4-bef7-2cbeb62e6b29_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overallotment option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_09956f2d-3ff6-4bcc-b762-9cddb559aaa1_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_5b56cc98-e6d9-43e1-bfbc-321ba90479c1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_8520dd8b-600e-40b1-9209-eb64e8be372a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_acf6c026-e340-4acb-94db-08f0b1595ac6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_670cc11c-8f54-43a5-a2a3-e48710c29406_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_cf9f9d32-7f62-4dc9-ba33-b5c1c8419fd9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_d27af8ca-6b18-4e39-bdfb-960b5e4949b7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and other liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_43e26477-e679-4186-bdec-ac1173593400_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at December 31, 2016</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_cb2c5f7a-332b-4c25-9164-a31e5ceb506f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_NumberOfOperatingLeases_d4e74666-d850-4387-a6a9-66a67a736bfe_terseLabel_en-US" xlink:label="lab_nstg_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating leases</link:label>
    <link:label id="lab_nstg_NumberOfOperatingLeases_label_en-US" xlink:label="lab_nstg_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Leases</link:label>
    <link:label id="lab_nstg_NumberOfOperatingLeases_documentation_en-US" xlink:label="lab_nstg_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_NumberOfOperatingLeases" xlink:href="nstg-20221231.xsd#nstg_NumberOfOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_NumberOfOperatingLeases" xlink:to="lab_nstg_NumberOfOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ad069d79-2684-4b7a-9bc2-1b7563f01922_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized loss on available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_SignificantAccountingPoliciesLineItems_2f475af1-7a43-437e-aacb-d6f1f600e730_terseLabel_en-US" xlink:label="lab_nstg_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_nstg_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_nstg_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_nstg_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_nstg_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SignificantAccountingPoliciesLineItems" xlink:href="nstg-20221231.xsd#nstg_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems" xlink:to="lab_nstg_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_c227e9ac-09c7-4263-b1bb-29d0d3aa1814_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_d3588210-4e95-4436-8917-6229b8e34f18_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_IncomeTaxesAndTaxRelatedTable_15cf1789-98dc-4fac-8a31-58c097074b87_terseLabel_en-US" xlink:label="lab_nstg_IncomeTaxesAndTaxRelatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes And Tax Related [Table]</link:label>
    <link:label id="lab_nstg_IncomeTaxesAndTaxRelatedTable_label_en-US" xlink:label="lab_nstg_IncomeTaxesAndTaxRelatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes And Tax Related [Table]</link:label>
    <link:label id="lab_nstg_IncomeTaxesAndTaxRelatedTable_documentation_en-US" xlink:label="lab_nstg_IncomeTaxesAndTaxRelatedTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes And Tax Related [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedTable" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable" xlink:to="lab_nstg_IncomeTaxesAndTaxRelatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_8857ce3a-6300-4ff9-9dc2-ac533de17e1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_10c0eed6-681c-4eea-bda2-527522e58a98_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_651b8d19-6c07-4f3a-a76c-4c5a33e4ee18_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_de43bd2e-dbb3-47a0-8e64-224fbb656d84_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_299fa615-5e31-4a09-9a97-f991de89e199_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a8310f81-28f6-44c4-b622-fb9ee85fecbe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fd882465-baab-4983-81d3-77f6625bd8bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c50312a8-bb42-4287-b52b-745f8691b140_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_6ee3021b-ee3f-4159-a459-d7ca0fa6bffb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_015c8813-f99f-40b3-8800-77cc91ef5b2a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_39fdeed2-949f-4422-a4e1-c2e773028abc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e6e1e6ca-dd8b-463b-82b7-625b34193aad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized under the Plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_5743736a-73ad-4ea8-9ebc-ec3c574c562b_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_2b123e1b-8bd0-46d9-a40f-a509e57f559a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Exercisable - Weighted- Average Remaining Contractual Life in Years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_d2b5b201-bbf3-4468-bdaf-32f96b1ce631_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8b9a4805-caf2-4dde-aee4-845f7b676161_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_fbcae902-c691-471f-8b9a-94532996a266_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_58754398-2034-4503-ae5c-3f0fa08fd1e5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_d138670c-26e3-4e63-9f4f-2e985169ee05_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_535e3571-a5e7-4ca1-a2e3-046b0a7f44b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of common stock warrant, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_b12e3e7e-cca9-45dd-9271-2ea5cab21dde_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of change in tax rate</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_63e1e37d-0d22-431b-b537-12c2e4830228_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_dfe39d1b-3c19-4118-b67b-136c0766fd4e_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a6df49e2-011d-4872-8eae-0cba7edb1d7c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_569aeaec-cf53-44c6-9509-bcfbee5b23b6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3c5c8af2-4032-48e3-96b9-95cfb3b25e6b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3b5984e8-9a56-4782-81e9-19b4b1b8dfcd_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_ff73037d-3720-404b-8397-6d7ffe03ccd3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_2c4c8981-5414-495e-8224-096f830fe93b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6f32718f-4a16-448c-8187-84b8f56b6bb2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c4fc2107-b89b-4f66-9431-2100a91e84b0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36d71c6d-8fb2-4d23-8458-8e0f0d72242b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_670b878f-fca9-4489-9e39-a4080b03fe7b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_6de7073d-7301-428b-b9f4-eaabf31003ad_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_078be2a2-4802-42db-acfe-69595eb64e59_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c1d4a362-b1b7-4657-a688-cbec06c22d81_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_40b1b91a-861c-429f-9cf6-93e8d744b56e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3d528ef2-0cef-422f-8511-36ec847588ae_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f643ccdc-2f22-4b7c-9886-825492a7439c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_b3096e35-ef5b-43d2-b24d-e6b57615825b_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_fdaa59a1-f883-4bfa-bd30-35c45584f70d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_b99c3aba-2ba9-407b-8e67-4c8dabbceed8_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cancellable purchase obligations</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForSoftware_6e4406a4-58ff-4252-8772-caf1f9a48684_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of internal-use software assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForSoftware" xlink:to="lab_us-gaap_PaymentsForSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_26f8725f-5018-4ebe-91b5-ddb29a6b6b22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_0f86e18e-1701-49cd-aca3-ee1ade86aac5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_14c6bd7b-8b5b-4d95-9610-70a36aea0272_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_dcd85f9e-5a06-4751-8702-a4d32deb9086_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_f406b4c9-a178-4281-acf6-6a3de0f5e840_terseLabel_en-US" xlink:label="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt and termination of revolving loan facility</link:label>
    <link:label id="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_label_en-US" xlink:label="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment And Termination Of Debt</link:label>
    <link:label id="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_documentation_en-US" xlink:label="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment And Termination Of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt" xlink:href="nstg-20221231.xsd#nstg_GainLossOnExtinguishmentAndTerminationOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt" xlink:to="lab_nstg_GainLossOnExtinguishmentAndTerminationOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_d316446b-33d7-449a-9605-1b7de6855df8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_AuditInformationAbstract_label_en-US" xlink:label="lab_nstg_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_nstg_AuditInformationAbstract_documentation_en-US" xlink:label="lab_nstg_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AuditInformationAbstract" xlink:href="nstg-20221231.xsd#nstg_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_AuditInformationAbstract" xlink:to="lab_nstg_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_0fdd6fab-8a62-4941-97cc-a18f8ead8edc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8dfff8fc-216f-4e6a-b149-b452086ab29b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30132faa-1567-4f1d-9228-1538b43d9b9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_e5ab6d40-fe05-4588-8a9d-5ba942be8124_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_58ba29be-0e1b-43e4-b259-f02865059f2f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6e5f77df-3e71-47eb-b16c-41ef024b9c58_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod_cd6954dc-c2b4-4b98-87e4-a31056be9935_terseLabel_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length of offering period, in months</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod_label_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Offering Period</link:label>
    <link:label id="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod_documentation_en-US" xlink:label="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanOfferingPeriod" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_EmployeeStockPurchasePlanOfferingPeriod" xlink:to="lab_nstg_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_nstg_RentalInstrumentsReclassifiedFromInventory_956a2227-e218-41a1-b959-be034357cff8_terseLabel_en-US" xlink:label="lab_nstg_RentalInstrumentsReclassifiedFromInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments reclassified from inventory to property and equipment</link:label>
    <link:label id="lab_nstg_RentalInstrumentsReclassifiedFromInventory_label_en-US" xlink:label="lab_nstg_RentalInstrumentsReclassifiedFromInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental Instruments Reclassified From Inventory</link:label>
    <link:label id="lab_nstg_RentalInstrumentsReclassifiedFromInventory_documentation_en-US" xlink:label="lab_nstg_RentalInstrumentsReclassifiedFromInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental instruments reclassified from inventory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_RentalInstrumentsReclassifiedFromInventory" xlink:href="nstg-20221231.xsd#nstg_RentalInstrumentsReclassifiedFromInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nstg_RentalInstrumentsReclassifiedFromInventory" xlink:to="lab_nstg_RentalInstrumentsReclassifiedFromInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_25a56acf-6027-4e45-9d19-6174b284b6b5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_e30f1967-b9b6-4265-bf6e-65afe33935d7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_eee7d4fe-ffc9-4e23-828e-b0287855a91b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_f5b97432-23b2-4638-91fe-133f189d1392_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_63b03f5e-7be3-4e34-88c4-7596ed3e7354_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_942bfbd3-4c83-455b-aa92-7a87fdd71a78_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>nstg-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:50e88ef7-7662-44f9-a77d-a0cf072223f8,g:ff6ee908-6dcd-4476-b167-ff6c214915d5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nanostring.com/role/CoverPage" xlink:type="simple" xlink:href="nstg-20221231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_942a5db3-a866-4b6c-95cb-c28ac4a3db86" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentType_942a5db3-a866-4b6c-95cb-c28ac4a3db86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_f0bdecb5-8375-4236-bfb5-dcdcc50e1cbc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentAnnualReport_f0bdecb5-8375-4236-bfb5-dcdcc50e1cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_80071e7c-aa6e-47a4-a5bf-99c85c3208fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentPeriodEndDate_80071e7c-aa6e-47a4-a5bf-99c85c3208fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_5e4783ee-9580-4595-9efb-b34686fd8ec6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_CurrentFiscalYearEndDate_5e4783ee-9580-4595-9efb-b34686fd8ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_1f140b0d-2866-4e0c-ac1a-9d0c48cef79f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentTransitionReport_1f140b0d-2866-4e0c-ac1a-9d0c48cef79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_83aed782-3445-4b0f-8280-3a60ea6df43f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityFileNumber_83aed782-3445-4b0f-8280-3a60ea6df43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9c58c469-46af-4445-a041-a1945951542c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityRegistrantName_9c58c469-46af-4445-a041-a1945951542c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7df4f08b-7cde-4641-a075-bbd61ecc6176" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7df4f08b-7cde-4641-a075-bbd61ecc6176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c6ab2478-3fab-4b44-b5ef-a87c825cc135" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityTaxIdentificationNumber_c6ab2478-3fab-4b44-b5ef-a87c825cc135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c88cf698-b9ce-41e7-a8bf-fc8ae1fe3195" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityAddressAddressLine1_c88cf698-b9ce-41e7-a8bf-fc8ae1fe3195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f1b9002e-f127-4543-8ec1-3879385ab735" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityAddressCityOrTown_f1b9002e-f127-4543-8ec1-3879385ab735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ef5d1d8a-81e0-4bcc-8ed6-b51006b47fd3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityAddressStateOrProvince_ef5d1d8a-81e0-4bcc-8ed6-b51006b47fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f227eed5-538d-4548-8c5c-084f15c6213b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityAddressPostalZipCode_f227eed5-538d-4548-8c5c-084f15c6213b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e540fda8-7967-4665-9ace-938d40404935" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_CityAreaCode_e540fda8-7967-4665-9ace-938d40404935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_84e6b3c5-5d9c-4a02-8494-a8d3168318cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_LocalPhoneNumber_84e6b3c5-5d9c-4a02-8494-a8d3168318cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_cbce5472-341b-48ed-a7ed-fcb78c56502d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_Security12bTitle_cbce5472-341b-48ed-a7ed-fcb78c56502d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_84bb1729-853b-4be3-a6bf-2c23b45d3998" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_TradingSymbol_84bb1729-853b-4be3-a6bf-2c23b45d3998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_d7bbb86e-978e-4cbe-8285-96f645317145" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_d7bbb86e-978e-4cbe-8285-96f645317145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_88ed1df4-a01b-4efb-a2d3-213db5dc0969" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityVoluntaryFilers_88ed1df4-a01b-4efb-a2d3-213db5dc0969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2b2c4b8f-64dd-4b64-b809-0baf9b9bd20a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityCurrentReportingStatus_2b2c4b8f-64dd-4b64-b809-0baf9b9bd20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_cc1b5939-b63f-4ea2-9618-f4ee40776c37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityInteractiveDataCurrent_cc1b5939-b63f-4ea2-9618-f4ee40776c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3369b6f4-605d-4864-8f0f-dfc0de232a72" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityFilerCategory_3369b6f4-605d-4864-8f0f-dfc0de232a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f37f763a-3215-4feb-bf71-24e33c61fda1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntitySmallBusiness_f37f763a-3215-4feb-bf71-24e33c61fda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_de9ae5e2-c99b-42b9-b6bd-a74198adb6dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_IcfrAuditorAttestationFlag_de9ae5e2-c99b-42b9-b6bd-a74198adb6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c47b82cf-84cf-4a1b-b4f9-fcd08993a6cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityShellCompany_c47b82cf-84cf-4a1b-b4f9-fcd08993a6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c8f5bc95-94d4-4f65-9cf4-63a47b0541f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityPublicFloat_c8f5bc95-94d4-4f65-9cf4-63a47b0541f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_38eed436-1a74-46e9-9cca-992a01c7c1ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_38eed436-1a74-46e9-9cca-992a01c7c1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_31d29201-778d-4e08-b1ca-368a23cb7cce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_31d29201-778d-4e08-b1ca-368a23cb7cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5e1e0918-62f3-4a89-8329-a83fad4ed817" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_AmendmentFlag_5e1e0918-62f3-4a89-8329-a83fad4ed817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_26be4bd1-dd68-41ef-991a-6d3ac350fb78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentFiscalYearFocus_26be4bd1-dd68-41ef-991a-6d3ac350fb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a32a62b2-c8cf-4478-932d-5c2c70a2c2a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a32a62b2-c8cf-4478-932d-5c2c70a2c2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_09e52689-54d5-44f7-a13b-043524545e39" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityCentralIndexKey_09e52689-54d5-44f7-a13b-043524545e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d79a62bc-60e7-48d1-81f1-ee1daf143994" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12000bbf-24bb-4c7c-9b36-7c621b63556f" xlink:to="loc_dei_EntityEmergingGrowthCompany_d79a62bc-60e7-48d1-81f1-ee1daf143994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/AuditInformation" xlink:type="simple" xlink:href="nstg-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AuditInformationAbstract_59f601ba-6ebe-4212-938c-6978dfd1a917" xlink:href="nstg-20221231.xsd#nstg_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_5f31831b-4ccc-4b15-b3e5-8d0cfba31026" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_AuditInformationAbstract_59f601ba-6ebe-4212-938c-6978dfd1a917" xlink:to="loc_dei_AuditorName_5f31831b-4ccc-4b15-b3e5-8d0cfba31026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_d4b21d68-0e42-467f-99d6-6932b0c81195" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_AuditInformationAbstract_59f601ba-6ebe-4212-938c-6978dfd1a917" xlink:to="loc_dei_AuditorFirmId_d4b21d68-0e42-467f-99d6-6932b0c81195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c0951947-bbde-4dca-83c4-546f246e2c47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_AuditInformationAbstract_59f601ba-6ebe-4212-938c-6978dfd1a917" xlink:to="loc_dei_AuditorLocation_c0951947-bbde-4dca-83c4-546f246e2c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f84aced3-6d75-4a61-aed3-574043a0a792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f84aced3-6d75-4a61-aed3-574043a0a792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_a5c53570-ff55-4aec-9bd6-2afba6506c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_a5c53570-ff55-4aec-9bd6-2afba6506c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_9484fff1-9652-49b2-9d22-61eba1d95c15" xlink:href="nstg-20221231.xsd#nstg_DebtSecuritiesAndEquitySecuritiesFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_nstg_DebtSecuritiesAndEquitySecuritiesFairValue_9484fff1-9652-49b2-9d22-61eba1d95c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_86dfd756-d5ca-456a-947f-abe4413d6317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_86dfd756-d5ca-456a-947f-abe4413d6317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d3e9862e-a980-4d69-9e98-9e0ad1f86984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_us-gaap_InventoryNet_d3e9862e-a980-4d69-9e98-9e0ad1f86984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b9d0e749-d59c-411b-94f1-e01f61f57957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b9d0e749-d59c-411b-94f1-e01f61f57957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1c19963d-c7b5-459c-afd8-ddba6ace91d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0c1cb03-86f1-4d67-a129-c3c296baced5" xlink:to="loc_us-gaap_AssetsCurrent_1c19963d-c7b5-459c-afd8-ddba6ace91d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2f556dca-4aab-41f8-84b3-4d31cabd2b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2f556dca-4aab-41f8-84b3-4d31cabd2b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_18a71e78-19fd-4a34-88a6-034590622182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_18a71e78-19fd-4a34-88a6-034590622182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_53f01839-7353-4217-bb50-e7503ee2e9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_53f01839-7353-4217-bb50-e7503ee2e9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_12b4b045-c37b-4047-bfb0-83c89e0764e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7dd28a5a-3963-4de2-80a5-e9bb48e7dc4f" xlink:to="loc_us-gaap_Assets_12b4b045-c37b-4047-bfb0-83c89e0764e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3370f346-3d2a-40c3-bfbe-902c9f1e4ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_us-gaap_AccountsPayableCurrent_3370f346-3d2a-40c3-bfbe-902c9f1e4ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8593db28-5f79-4a9d-8fe0-aea1e6451a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8593db28-5f79-4a9d-8fe0-aea1e6451a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_db6ae486-91db-48c5-b8c2-755634ed77ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_db6ae486-91db-48c5-b8c2-755634ed77ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_d2cddfa9-b4a4-431d-b20c-f06d7589cbe3" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_d2cddfa9-b4a4-431d-b20c-f06d7589cbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_cf63f39f-8088-4ef1-949b-df3c2a27c762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_us-gaap_DeferredRevenueCurrent_cf63f39f-8088-4ef1-949b-df3c2a27c762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c0818fb1-38fd-4485-a529-12d168bf6767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c0818fb1-38fd-4485-a529-12d168bf6767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_82d051f4-86c9-4c19-a28d-0482d18ea662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_531ee04d-7fff-40c3-81a7-6ff1a6001940" xlink:to="loc_us-gaap_LiabilitiesCurrent_82d051f4-86c9-4c19-a28d-0482d18ea662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_9e64a823-2d9e-458a-a42d-3ee86a096106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_9e64a823-2d9e-458a-a42d-3ee86a096106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_984043cd-6707-423b-bd30-3eba2a4f817e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_984043cd-6707-423b-bd30-3eba2a4f817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_972f1a41-0b10-4426-b32e-c2031f4992c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_972f1a41-0b10-4426-b32e-c2031f4992c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_12c6ef39-a550-4578-96ff-8a20a0292ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_Liabilities_12c6ef39-a550-4578-96ff-8a20a0292ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1b606444-a7de-41c2-b1a7-db36166bd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1b606444-a7de-41c2-b1a7-db36166bd3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7f816004-3a77-4768-bc8a-2df547b5a5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:to="loc_us-gaap_PreferredStockValue_7f816004-3a77-4768-bc8a-2df547b5a5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_61281545-de17-4c5c-bd4f-394c90d1a843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:to="loc_us-gaap_CommonStockValue_61281545-de17-4c5c-bd4f-394c90d1a843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ea1c3dfb-5e7d-42d9-9314-d3d0603864dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ea1c3dfb-5e7d-42d9-9314-d3d0603864dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_726f7821-7631-4c27-b330-6572e66ee586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_726f7821-7631-4c27-b330-6572e66ee586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f60bbaa-9611-491c-b25f-3077f1f59656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f60bbaa-9611-491c-b25f-3077f1f59656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_daed283f-b70a-4f7d-9f54-7dd5c6d9e767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7d0fd30f-6251-4850-92c1-bb3e16acfb0a" xlink:to="loc_us-gaap_StockholdersEquity_daed283f-b70a-4f7d-9f54-7dd5c6d9e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0618d544-c8d9-4343-8de4-4e0a2dff9b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da4dba76-3008-4ea9-9b10-2d799e234ff7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0618d544-c8d9-4343-8de4-4e0a2dff9b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_99dfde90-d7d4-45ae-bce5-8fd9b9b325c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_99dfde90-d7d4-45ae-bce5-8fd9b9b325c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5ec418c9-5546-4c5b-b3b4-e793dab4217d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5ec418c9-5546-4c5b-b3b4-e793dab4217d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_13d8146f-2bfd-47f2-a2a9-19be8b50763c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_PreferredStockSharesIssued_13d8146f-2bfd-47f2-a2a9-19be8b50763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_89b93eb7-1c95-4b77-8d8a-4a51cafc09e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_89b93eb7-1c95-4b77-8d8a-4a51cafc09e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4daa0116-b450-4c12-966e-efa000a40f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4daa0116-b450-4c12-966e-efa000a40f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_de53c933-8862-41a7-82d5-c5f9ddba5900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_de53c933-8862-41a7-82d5-c5f9ddba5900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b9f0c941-1176-4a40-91c1-5bd8953ae428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9a7091a-e13c-48eb-a5ea-0307d4a8c6ab" xlink:to="loc_us-gaap_CommonStockSharesIssued_b9f0c941-1176-4a40-91c1-5bd8953ae428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e73ff69b-37d3-4ef7-8e08-088670791d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c8d73d94-d3aa-4183-bf36-a603d0d1344d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c8d73d94-d3aa-4183-bf36-a603d0d1344d" xlink:to="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:to="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a161b1ff-105a-4dca-ae78-cb8e1920fd9e" xlink:to="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_d4d3e2a4-2eef-47e0-997b-bb10593cbbee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:to="loc_us-gaap_ServiceMember_d4d3e2a4-2eef-47e0-997b-bb10593cbbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_daaf60cb-35ed-49e8-8a1e-2fe492b2c493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a17e1be3-dfe1-4770-a5f3-eca6723444b5" xlink:to="loc_us-gaap_ProductMember_daaf60cb-35ed-49e8-8a1e-2fe492b2c493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_172f3318-2c63-4408-8a89-6330005a5763" xlink:to="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b531fcd3-9dc9-4b01-89d7-d7050666d414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_RevenuesAbstract_b531fcd3-9dc9-4b01-89d7-d7050666d414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_10680942-0beb-40f8-9129-bff38fb20b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b531fcd3-9dc9-4b01-89d7-d7050666d414" xlink:to="loc_us-gaap_Revenues_10680942-0beb-40f8-9129-bff38fb20b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_d15fa4c3-7cb7-4229-99b7-b107c0781ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_CostOfRevenue_d15fa4c3-7cb7-4229-99b7-b107c0781ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a77b7154-814d-4ad2-8c6e-b453b6013464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a77b7154-814d-4ad2-8c6e-b453b6013464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_26b559fb-c6ed-45e5-84f6-aa80f0bdf864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_26b559fb-c6ed-45e5-84f6-aa80f0bdf864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f228a1a0-3dc2-4518-bc4a-4db435f5701f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_f8b3424e-ab81-42b1-a689-c510b3a21046" xlink:to="loc_us-gaap_CostsAndExpenses_f228a1a0-3dc2-4518-bc4a-4db435f5701f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b907c7c6-e946-4255-b2da-2b43fddb5466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_b907c7c6-e946-4255-b2da-2b43fddb5466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8af248ad-a064-4101-bcee-cd44ebeb5bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8af248ad-a064-4101-bcee-cd44ebeb5bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_dbc5ccbd-752c-4835-8274-347bb9444f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_InterestExpenseBorrowings_dbc5ccbd-752c-4835-8274-347bb9444f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8a359ebc-53a5-4f96-8d64-2f49cbe64175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8a359ebc-53a5-4f96-8d64-2f49cbe64175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_38822c73-3c86-474b-9802-11da4ede33c4" xlink:href="nstg-20221231.xsd#nstg_GainLossOnExtinguishmentAndTerminationOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_nstg_GainLossOnExtinguishmentAndTerminationOfDebt_38822c73-3c86-474b-9802-11da4ede33c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_aeaf7a32-f33f-4d50-8a85-0a837718132a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_971afcfd-1e98-4d22-8a85-67fd124c0359" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_aeaf7a32-f33f-4d50-8a85-0a837718132a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_20aa966c-2cfd-481f-85ee-f6686a7cc794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_20aa966c-2cfd-481f-85ee-f6686a7cc794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f27e6122-1428-467f-9a5f-9eea7e9b6145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f27e6122-1428-467f-9a5f-9eea7e9b6145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0613a1d8-74c4-4d2a-bcdc-96f3b6ae3d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_NetIncomeLoss_0613a1d8-74c4-4d2a-bcdc-96f3b6ae3d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_52333a5a-5e14-44a9-ab3c-cac1a43736a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_EarningsPerShareBasic_52333a5a-5e14-44a9-ab3c-cac1a43736a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f162d162-15b5-43c0-8d80-107485590d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f162d162-15b5-43c0-8d80-107485590d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_27631598-61f5-4087-af50-51bf1480d1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_27631598-61f5-4087-af50-51bf1480d1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_885b7b20-8e18-4762-84b2-cafea65104d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33bab52c-174e-4336-bc4d-e4c3882b8d3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_885b7b20-8e18-4762-84b2-cafea65104d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48bf240c-7313-42df-9e35-6cf7f78013a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b7a3c9d-cbb9-44eb-be80-a1505500708b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48bf240c-7313-42df-9e35-6cf7f78013a0" xlink:to="loc_us-gaap_NetIncomeLoss_1b7a3c9d-cbb9-44eb-be80-a1505500708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_10400216-2152-4fdd-8e59-cac316609b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48bf240c-7313-42df-9e35-6cf7f78013a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_10400216-2152-4fdd-8e59-cac316609b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_36d9c669-cc57-4190-9d83-b34f57d4b460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_10400216-2152-4fdd-8e59-cac316609b4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_36d9c669-cc57-4190-9d83-b34f57d4b460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0e01ba1a-3d35-4881-943e-067054b0b4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48bf240c-7313-42df-9e35-6cf7f78013a0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0e01ba1a-3d35-4881-943e-067054b0b4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_18ac8809-bd25-46d7-9a8c-173737b3fe00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_18ac8809-bd25-46d7-9a8c-173737b3fe00" xlink:to="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b71ac05c-f7f0-42a3-b8b1-1e89691826ed" xlink:to="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b17a282-c6e7-49aa-86ed-b49aac0802bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_CommonStockMember_8b17a282-c6e7-49aa-86ed-b49aac0802bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_02ca5bb7-060d-4d72-b742-b14ab36ecf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_02ca5bb7-060d-4d72-b742-b14ab36ecf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d7173240-13fc-4e21-8b9c-2e087dbda45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d7173240-13fc-4e21-8b9c-2e087dbda45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_507218ed-43b7-4979-8481-597e47902012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ce7431c-e6eb-43bf-9532-84ff5ab22219" xlink:to="loc_us-gaap_RetainedEarningsMember_507218ed-43b7-4979-8481-597e47902012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6bdf3ac7-2c27-4ebc-a26f-3ccf0a705f4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71db5dba-45d8-456b-82db-9d80011ec937" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6bdf3ac7-2c27-4ebc-a26f-3ccf0a705f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_151eeec9-d0b2-4405-90a8-774d4514dc93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6bdf3ac7-2c27-4ebc-a26f-3ccf0a705f4f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_151eeec9-d0b2-4405-90a8-774d4514dc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f9d4d53c-b2f9-474b-a613-fc24f0f93f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_964c77b6-80d9-434d-adf7-15be44c565e0" xlink:to="loc_us-gaap_StatementLineItems_f9d4d53c-b2f9-474b-a613-fc24f0f93f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9d4d53c-b2f9-474b-a613-fc24f0f93f21" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5b27f509-ce6d-4858-acf3-9c2d7af1c431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_SharesOutstanding_5b27f509-ce6d-4858-acf3-9c2d7af1c431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_59260928-2204-40e7-b825-ef9fe3a54d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockholdersEquity_59260928-2204-40e7-b825-ef9fe3a54d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cd96038d-8fa3-4945-96bb-ac0a6f064196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cd96038d-8fa3-4945-96bb-ac0a6f064196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_66219afd-2f11-4898-91fb-79b1031293ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_66219afd-2f11-4898-91fb-79b1031293ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89d5e574-54ad-403a-93ba-3d63aa8ff2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89d5e574-54ad-403a-93ba-3d63aa8ff2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0b471b47-b57e-4fcc-9ce3-346a0ef46a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0b471b47-b57e-4fcc-9ce3-346a0ef46a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_abe03be1-359a-4650-a04d-9c3e69bb4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_abe03be1-359a-4650-a04d-9c3e69bb4b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42c26efc-af3e-4cd8-b06c-a7314f24ee0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_NetIncomeLoss_42c26efc-af3e-4cd8-b06c-a7314f24ee0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_eebed951-b826-491c-8cfb-c0c13de36014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_SharesOutstanding_eebed951-b826-491c-8cfb-c0c13de36014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3a2b1b0-c18c-47a6-9a57-be72b7381cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4a68fe36-e52b-4123-ba6e-cfc876b2cbe7" xlink:to="loc_us-gaap_StockholdersEquity_c3a2b1b0-c18c-47a6-9a57-be72b7381cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e89cabc1-0106-45bb-bfbc-18b9df1e0345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e89cabc1-0106-45bb-bfbc-18b9df1e0345" xlink:to="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44fbfa8a-3b4c-4a36-b6e5-fdc58feb153f" xlink:to="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9cb83351-bd1e-494c-bc15-8fb8b3dc0e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9cb83351-bd1e-494c-bc15-8fb8b3dc0e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_afade2e0-9603-4a39-b90f-ec4c8fb351c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_CommonStockMember_afade2e0-9603-4a39-b90f-ec4c8fb351c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1223ab50-f4ca-4f11-8c16-436508c694de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1223ab50-f4ca-4f11-8c16-436508c694de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9da1bdc8-2db6-454e-b43d-6dc5a4b38676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b2ed64dd-b2cb-4f77-bce7-18c7b375be92" xlink:to="loc_us-gaap_RetainedEarningsMember_9da1bdc8-2db6-454e-b43d-6dc5a4b38676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dd1ac2ed-eb03-4cf3-8428-c4c3534c7f4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2cbf2301-2f87-4491-badc-6760ff12e539" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dd1ac2ed-eb03-4cf3-8428-c4c3534c7f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e64d1445-7cd9-4bd8-9c61-e0cf0a17a452" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_dd1ac2ed-eb03-4cf3-8428-c4c3534c7f4a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e64d1445-7cd9-4bd8-9c61-e0cf0a17a452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2907232a-40ff-4673-8111-fe03b0efdbce" xlink:to="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5f6fe2d3-0508-459a-bdd9-5951c40d1abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5f6fe2d3-0508-459a-bdd9-5951c40d1abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e3673913-0b35-4329-b7af-a02ed6f77472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_SharesOutstanding_e3673913-0b35-4329-b7af-a02ed6f77472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8516d56e-a905-420c-b11f-d85a358b41e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockholdersEquity_8516d56e-a905-420c-b11f-d85a358b41e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_578a0fac-3704-49ea-be28-a7e8c209ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_578a0fac-3704-49ea-be28-a7e8c209ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2eaf1969-37f1-463e-b3b1-61fa5fffdfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2eaf1969-37f1-463e-b3b1-61fa5fffdfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bd568665-a050-4905-a959-518d76e86632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bd568665-a050-4905-a959-518d76e86632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_73609b99-cda2-43da-9550-8df2cfe8314a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_73609b99-cda2-43da-9550-8df2cfe8314a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_17689353-b456-40b7-8785-984f2c2a4a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_17689353-b456-40b7-8785-984f2c2a4a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7d8b6f75-1dd5-4164-99f4-156e0d1e9758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7d8b6f75-1dd5-4164-99f4-156e0d1e9758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_48846e76-0bee-42d3-9964-debb1b1c9072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_48846e76-0bee-42d3-9964-debb1b1c9072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_4c09114b-83da-49c2-a2e5-c1419fc1b211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_4c09114b-83da-49c2-a2e5-c1419fc1b211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1ee7eabb-811a-4afb-ac62-f9f2c56a2a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1ee7eabb-811a-4afb-ac62-f9f2c56a2a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_47c2f97e-9c80-4a4c-8663-3badfa150ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_47c2f97e-9c80-4a4c-8663-3badfa150ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_000f9002-0fd8-45c6-b4fa-430a952b0f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_000f9002-0fd8-45c6-b4fa-430a952b0f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_9371437d-849a-49d0-83db-c7288e568d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_9371437d-849a-49d0-83db-c7288e568d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_41e61024-fadd-4a7f-a188-90bd6495d404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_41e61024-fadd-4a7f-a188-90bd6495d404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8633a4ba-9e2a-4d0a-b389-eaccc68e3901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8633a4ba-9e2a-4d0a-b389-eaccc68e3901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3d9df1af-8322-4d5c-af6c-d50425603600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3d9df1af-8322-4d5c-af6c-d50425603600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9966e597-0b85-4cc7-a197-295ec8d1e564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05b7d25c-5eae-4d9d-8b90-ea94a635cf70" xlink:to="loc_us-gaap_NetIncomeLoss_9966e597-0b85-4cc7-a197-295ec8d1e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nstg-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7dcc682a-549c-4336-a4d1-ebbc6f0ab4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7dcc682a-549c-4336-a4d1-ebbc6f0ab4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16428c57-7215-46c6-a7ea-76b8b2cd905b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7dcc682a-549c-4336-a4d1-ebbc6f0ab4ef" xlink:to="loc_us-gaap_NetIncomeLoss_16428c57-7215-46c6-a7ea-76b8b2cd905b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7dcc682a-549c-4336-a4d1-ebbc6f0ab4ef" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d54f51b9-4711-4093-b377-d0a75be9838b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d54f51b9-4711-4093-b377-d0a75be9838b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1308a5b5-9da0-4983-92d2-58e8ccefb302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1308a5b5-9da0-4983-92d2-58e8ccefb302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b9530655-90f0-40fd-a368-b4f46ab193f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b9530655-90f0-40fd-a368-b4f46ab193f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_InterestAccruedOnLongTermNotes_6871da41-b3f0-4a3f-803b-44d61ed47542" xlink:href="nstg-20221231.xsd#nstg_InterestAccruedOnLongTermNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_nstg_InterestAccruedOnLongTermNotes_6871da41-b3f0-4a3f-803b-44d61ed47542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_329f3d67-f220-4556-a89a-bb3394d625ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_329f3d67-f220-4556-a89a-bb3394d625ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_b815027a-0982-4161-8aae-806d9eb5735b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_InventoryWriteDown_b815027a-0982-4161-8aae-806d9eb5735b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_RepaymentOfAccruedInterestOfLongTermDebt_7013ef6c-20ae-4c5b-a0ea-9ccfbea84708" xlink:href="nstg-20221231.xsd#nstg_RepaymentOfAccruedInterestOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_nstg_RepaymentOfAccruedInterestOfLongTermDebt_7013ef6c-20ae-4c5b-a0ea-9ccfbea84708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_672320b6-d2c3-44a1-b0f5-18a40d775de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_672320b6-d2c3-44a1-b0f5-18a40d775de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8ca5c36c-9444-47eb-b151-5af6c02815fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8ca5c36c-9444-47eb-b151-5af6c02815fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_08a5b84d-4c42-499e-b592-38e06c319cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_08a5b84d-4c42-499e-b592-38e06c319cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32c162e7-ce94-4414-8000-b674cbb581c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bce17127-57eb-426a-9718-9ac9eb6a8db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bce17127-57eb-426a-9718-9ac9eb6a8db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_170f2675-cf13-4871-ad16-10368e355a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_170f2675-cf13-4871-ad16-10368e355a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2d28f33c-46e8-44b8-93e2-df737600f6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2d28f33c-46e8-44b8-93e2-df737600f6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b55ba937-c319-4c76-8fd6-dc8ddefa3c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b55ba937-c319-4c76-8fd6-dc8ddefa3c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_eaa7de51-d40b-423b-904f-9dfb712e61a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_eaa7de51-d40b-423b-904f-9dfb712e61a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_cf4fb378-8a2f-4775-9845-3e79bf743225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_cf4fb378-8a2f-4775-9845-3e79bf743225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_282b2d99-eccf-4649-ad1c-b3fa913e9ff4" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits_282b2d99-eccf-4649-ad1c-b3fa913e9ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a5fd9d9a-0040-4bc6-9524-ce4b53200863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a5fd9d9a-0040-4bc6-9524-ce4b53200863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_253ec1bd-b2b1-4b91-9230-5fa5e3e76331" xlink:href="nstg-20221231.xsd#nstg_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99c8e2a5-4cdd-4810-88e5-ef0b3caf8756" xlink:to="loc_nstg_IncreaseDecreaseInOperatingLeaseLiabilities_253ec1bd-b2b1-4b91-9230-5fa5e3e76331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_265ebcb6-e9ae-4868-83d4-79cb9b86553b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7dcc682a-549c-4336-a4d1-ebbc6f0ab4ef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_265ebcb6-e9ae-4868-83d4-79cb9b86553b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24f297d4-f240-47ee-a65e-b0ae453db8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24f297d4-f240-47ee-a65e-b0ae453db8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_2f5d58aa-8298-4f16-9e9f-8aa396b1c168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_PaymentsForSoftware_2f5d58aa-8298-4f16-9e9f-8aa396b1c168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_c5b8872d-6303-49d7-afd4-0b0998001e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_c5b8872d-6303-49d7-afd4-0b0998001e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_03b73a64-61bb-4451-81b6-ed994b5c012c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_03b73a64-61bb-4451-81b6-ed994b5c012c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_7b5321ce-e5b2-4948-8bbd-6ba66c6c096e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_7b5321ce-e5b2-4948-8bbd-6ba66c6c096e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_b4126e30-fb44-4947-940e-42d9ee126aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_b4126e30-fb44-4947-940e-42d9ee126aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7dfdf69b-ec71-4c5a-92c4-e323155301ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_eb017b41-4f05-4664-8d86-a96a5ac5f956" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7dfdf69b-ec71-4c5a-92c4-e323155301ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5560fff0-b2b3-4f34-a1a5-8bcce4bceff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5560fff0-b2b3-4f34-a1a5-8bcce4bceff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_9abb8f15-4ccc-4674-86ac-3d854da584dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_9abb8f15-4ccc-4674-86ac-3d854da584dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_37f974e6-370b-4b64-a988-d38d764c57a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_37f974e6-370b-4b64-a988-d38d764c57a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_28c3c840-59fa-4e90-8caa-1753e4cb0580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_28c3c840-59fa-4e90-8caa-1753e4cb0580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_c634beb1-675b-45fa-b6a2-2ac893d41b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_c634beb1-675b-45fa-b6a2-2ac893d41b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ab7d6229-c091-490e-8543-2181b7c0c630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ab7d6229-c091-490e-8543-2181b7c0c630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_7e9fff75-bbf2-458c-bd28-c1240b48a735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_7e9fff75-bbf2-458c-bd28-c1240b48a735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_60355ebc-88d0-4de2-96ac-09182147eea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_60355ebc-88d0-4de2-96ac-09182147eea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_cdc324d5-6f5f-42ad-a463-ccfd312aa927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_cdc324d5-6f5f-42ad-a463-ccfd312aa927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_2c8a120d-fff4-4320-b737-7bcb39dfe9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_2c8a120d-fff4-4320-b737-7bcb39dfe9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aba5a604-9295-499a-9fd4-db2eae44ae85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_b4777edf-f5bd-4779-97c5-4a991545aaa3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aba5a604-9295-499a-9fd4-db2eae44ae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4000c664-8e84-483d-8c83-dcd58b5aa6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4000c664-8e84-483d-8c83-dcd58b5aa6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_37aa8759-a147-4824-883d-f9e5ad683d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_37aa8759-a147-4824-883d-f9e5ad683d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_da1dd10a-7261-477c-b13d-19acfe802faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_da1dd10a-7261-477c-b13d-19acfe802faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1d6d1629-53dc-4846-bc2b-92ab8f033f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_da1dd10a-7261-477c-b13d-19acfe802faa" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1d6d1629-53dc-4846-bc2b-92ab8f033f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a812037-b077-4018-ba44-511ef4a257e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_da1dd10a-7261-477c-b13d-19acfe802faa" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a812037-b077-4018-ba44-511ef4a257e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_268a5f89-619f-433b-b826-bffc7e864a1d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_1aad08cd-3370-4dcf-acc8-b1381db646fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:to="loc_us-gaap_InterestPaidNet_1aad08cd-3370-4dcf-acc8-b1381db646fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_1d0cad48-93b5-41df-af15-b02252f2f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_1d0cad48-93b5-41df-af15-b02252f2f7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_RentalInstrumentsReclassifiedFromInventory_67c0fd0e-b1d7-4ed1-b845-00a1750f9e18" xlink:href="nstg-20221231.xsd#nstg_RentalInstrumentsReclassifiedFromInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:to="loc_nstg_RentalInstrumentsReclassifiedFromInventory_67c0fd0e-b1d7-4ed1-b845-00a1750f9e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85579af2-2fe2-4ae4-8f3d-e09296da44fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85579af2-2fe2-4ae4-8f3d-e09296da44fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6340c384-f0e3-4c37-b3e5-ee43a95f9889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e6beb52e-5fa9-4ddd-95fe-b12cec86c0d6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6340c384-f0e3-4c37-b3e5-ee43a95f9889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="nstg-20221231.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2b555f78-0bf4-4c9a-91ba-04f7cb11138f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_563ab77a-7151-4309-b3fe-048a61d26270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2b555f78-0bf4-4c9a-91ba-04f7cb11138f" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_563ab77a-7151-4309-b3fe-048a61d26270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="nstg-20221231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_50540def-f52c-4373-aa5e-07e3e631754f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a217b1a6-0a4b-404f-b982-6dada379c6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50540def-f52c-4373-aa5e-07e3e631754f" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a217b1a6-0a4b-404f-b982-6dada379c6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersNotes" xlink:type="simple" xlink:href="nstg-20221231.xsd#RevenuefromContractswithCustomersNotes"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/RevenuefromContractswithCustomersNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestments" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestments"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ShorttermInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c39f458a-578c-4b64-965e-9625e2b3999a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_cbbdeb2b-6fe2-48cb-a5ba-20174de87bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c39f458a-578c-4b64-965e-9625e2b3999a" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_cbbdeb2b-6fe2-48cb-a5ba-20174de87bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a9e4c18f-01aa-4418-8def-3351849fb508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4cb4d856-c198-434c-8279-4ef41eec7ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a9e4c18f-01aa-4418-8def-3351849fb508" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4cb4d856-c198-434c-8279-4ef41eec7ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesNotes" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0ea2d5c6-90fb-4796-97b6-17c321c6ce24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8dbef123-4731-4226-9326-2109d7dde2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0ea2d5c6-90fb-4796-97b6-17c321c6ce24" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8dbef123-4731-4226-9326-2109d7dde2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/Inventory" xlink:type="simple" xlink:href="nstg-20221231.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_90a6ef13-539d-4c1c-b23f-930c282fd9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_844c4603-9337-42bd-b7e4-f26b9aefc8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_90a6ef13-539d-4c1c-b23f-930c282fd9be" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_844c4603-9337-42bd-b7e4-f26b9aefc8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="nstg-20221231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3a69b2b1-4646-4dd7-88bd-c85b880c7664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f5dec8ee-afcf-4e7e-b65c-fd4e9fccae97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3a69b2b1-4646-4dd7-88bd-c85b880c7664" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f5dec8ee-afcf-4e7e-b65c-fd4e9fccae97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebt" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_16ba7b97-eb40-4c1e-93af-8c5147c84bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c917ea6a-b476-47fe-b5a6-690acd10fb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_16ba7b97-eb40-4c1e-93af-8c5147c84bff" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c917ea6a-b476-47fe-b5a6-690acd10fb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/CommonStockandPreferredStock" xlink:type="simple" xlink:href="nstg-20221231.xsd#CommonStockandPreferredStock"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/CommonStockandPreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ea87df2d-7ba3-4f03-91e8-68cbf6cb1c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fe85b522-84f1-45a1-aabf-d14041279e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ea87df2d-7ba3-4f03-91e8-68cbf6cb1c28" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fe85b522-84f1-45a1-aabf-d14041279e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensation"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_205030bf-87e8-477f-9339-86b97e5a26cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fbbe207b-19b0-447f-9289-b178a2444da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_205030bf-87e8-477f-9339-86b97e5a26cd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fbbe207b-19b0-447f-9289-b178a2444da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/DefinedContributionRetirementPlan" xlink:type="simple" xlink:href="nstg-20221231.xsd#DefinedContributionRetirementPlan"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/DefinedContributionRetirementPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c7b50b43-c33d-4887-a90b-694aa39ba251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fa4557b1-e5b5-404c-a866-84a861cb7824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c7b50b43-c33d-4887-a90b-694aa39ba251" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fa4557b1-e5b5-404c-a866-84a861cb7824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxes" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cd574a89-b5ef-4928-af60-0e912d721514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8c9e01dc-f319-4a4f-82bd-a862a04ab64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cd574a89-b5ef-4928-af60-0e912d721514" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8c9e01dc-f319-4a4f-82bd-a862a04ab64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="nstg-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58f1e2b4-aeeb-4dcb-b3a4-7036da7193c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_012a0def-29f3-4c28-85c9-88f4e5ba0738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58f1e2b4-aeeb-4dcb-b3a4-7036da7193c9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_012a0def-29f3-4c28-85c9-88f4e5ba0738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/NetLossPerShare" xlink:type="simple" xlink:href="nstg-20221231.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_602f19a7-8155-4a24-868a-01f041d613db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0c36fa78-b498-4a6f-920f-92d5f87c887d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_602f19a7-8155-4a24-868a-01f041d613db" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0c36fa78-b498-4a6f-920f-92d5f87c887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SubsequentEvents" xlink:type="simple" xlink:href="nstg-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_af8e63bb-51e7-476d-bf6b-92a7426a43be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_db7b419f-43fd-4c0c-abd6-f32ed21ab304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_af8e63bb-51e7-476d-bf6b-92a7426a43be" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_db7b419f-43fd-4c0c-abd6-f32ed21ab304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="nstg-20221231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_84f17639-04ce-43e9-a8c1-20bb100c53ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_84f17639-04ce-43e9-a8c1-20bb100c53ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_b0132661-7c0b-4b5a-8468-63140f7f076e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_UseOfEstimates_b0132661-7c0b-4b5a-8468-63140f7f076e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_14a977ce-f0d0-46b2-aa28-e2fa043880c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_14a977ce-f0d0-46b2-aa28-e2fa043880c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_b1b8b8df-f12b-48ab-88b0-bdd7cc0b3f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_b1b8b8df-f12b-48ab-88b0-bdd7cc0b3f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_c64bfbdf-b4d9-427c-b68e-52dfd63d3c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_c64bfbdf-b4d9-427c-b68e-52dfd63d3c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_9de8781b-634d-4788-a4aa-f0aa98a76ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_9de8781b-634d-4788-a4aa-f0aa98a76ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1ce19601-b791-43ef-9aa7-945905350c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1ce19601-b791-43ef-9aa7-945905350c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_0b1fbb0d-fa94-42f0-bd94-91f7f50e43c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_0b1fbb0d-fa94-42f0-bd94-91f7f50e43c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_15a44316-550a-4eaf-bbdd-39f07f7e47a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_15a44316-550a-4eaf-bbdd-39f07f7e47a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_39d6edcc-48e6-40d0-9bf0-fb2597e9dbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_39d6edcc-48e6-40d0-9bf0-fb2597e9dbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2b30d578-6325-422a-ac4b-920bef86b693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2b30d578-6325-422a-ac4b-920bef86b693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_34e46942-1aba-4be6-96e6-1e23df3ea2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_DebtPolicyTextBlock_34e46942-1aba-4be6-96e6-1e23df3ea2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_e2b58939-ad28-42dc-984c-11e77883adda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_e2b58939-ad28-42dc-984c-11e77883adda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b6a62b43-b1a1-47f0-b1da-f6f9e1ce28fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b6a62b43-b1a1-47f0-b1da-f6f9e1ce28fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_4809b646-3335-4b77-a3c0-bd52a16a2ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_4809b646-3335-4b77-a3c0-bd52a16a2ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy_3ab4053e-4fd8-446c-a34d-f735968c709e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ExtendedProductWarrantyPolicy_3ab4053e-4fd8-446c-a34d-f735968c709e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_01832277-8964-4ab9-b23c-01d48e5b4261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_01832277-8964-4ab9-b23c-01d48e5b4261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_17d2b68c-9610-475f-a079-091bfccf6c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_17d2b68c-9610-475f-a079-091bfccf6c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_1775e57a-cd82-4649-9e9a-1a36eeeb437a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_1775e57a-cd82-4649-9e9a-1a36eeeb437a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d82f138a-6628-4f30-9fca-14cab018db7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d82f138a-6628-4f30-9fca-14cab018db7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_5ada223c-5d59-43cd-9693-7b0ee681242e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_5ada223c-5d59-43cd-9693-7b0ee681242e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_65ae6252-0e78-44fd-9b13-3f71d767e2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_65ae6252-0e78-44fd-9b13-3f71d767e2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_41a5d664-582d-4899-9f86-2b443ef460c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_41a5d664-582d-4899-9f86-2b443ef460c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_fd679995-5b53-48b6-8c2a-6204c4231a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_fd679995-5b53-48b6-8c2a-6204c4231a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b73a003b-85b2-4130-8f0d-8e01983b7d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b73a003b-85b2-4130-8f0d-8e01983b7d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_b253a792-3e3a-4fd7-ab4f-9acc03eb72fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_b253a792-3e3a-4fd7-ab4f-9acc03eb72fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_c7c5bce3-b01a-4286-a23d-cf7504d30b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7598a08-0d81-430c-9955-9d90382446b1" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_c7c5bce3-b01a-4286-a23d-cf7504d30b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4b15dae7-0a8d-40b6-9261-f9eb5ff27127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4613ff95-cbfe-4292-8e37-7698cf2cad6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4b15dae7-0a8d-40b6-9261-f9eb5ff27127" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4613ff95-cbfe-4292-8e37-7698cf2cad6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#RevenuefromContractswithCustomersTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/RevenuefromContractswithCustomersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cadceab7-4eed-40dd-ba1f-12706be3c835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_50529800-4ed9-4dfc-9a77-d30b7f4284e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cadceab7-4eed-40dd-ba1f-12706be3c835" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_50529800-4ed9-4dfc-9a77-d30b7f4284e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestmentsTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ShorttermInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6d7a589f-9a59-445b-be43-3643f0cb61b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_9a0d7de4-fb47-49b6-8672-f07902aae3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6d7a589f-9a59-445b-be43-3643f0cb61b5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_9a0d7de4-fb47-49b6-8672-f07902aae3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_db42afea-759c-4b16-8305-2145ebb29e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6d7a589f-9a59-445b-be43-3643f0cb61b5" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_db42afea-759c-4b16-8305-2145ebb29e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_23b6ab30-3a33-4408-b7b7-0e83e9009680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6d7a589f-9a59-445b-be43-3643f0cb61b5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_23b6ab30-3a33-4408-b7b7-0e83e9009680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ea8f09be-1789-4d1d-bff0-46f323234970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_00fa33bb-7009-473f-a5d8-6dc0eb899d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ea8f09be-1789-4d1d-bff0-46f323234970" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_00fa33bb-7009-473f-a5d8-6dc0eb899d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eaff072d-dc9b-4749-b7a2-60ecbeba3384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_768efc2a-99c4-4303-88e4-115f37d2c6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaff072d-dc9b-4749-b7a2-60ecbeba3384" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_768efc2a-99c4-4303-88e4-115f37d2c6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7975a56e-b4a8-4163-bed9-7b365ea875a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaff072d-dc9b-4749-b7a2-60ecbeba3384" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7975a56e-b4a8-4163-bed9-7b365ea875a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cc32cff6-0114-48f1-bf94-041a29bb8111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eaff072d-dc9b-4749-b7a2-60ecbeba3384" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cc32cff6-0114-48f1-bf94-041a29bb8111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/InventoryTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_64a25003-bae3-4181-b232-2ec2cb61423e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e816928a-52bd-4a9a-8497-7aa711e75a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_64a25003-bae3-4181-b232-2ec2cb61423e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e816928a-52bd-4a9a-8497-7aa711e75a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fdfa45cf-02b7-471e-b3c7-d8e44d5623bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_32b2c674-9b6e-41f6-9075-7ec376b998ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fdfa45cf-02b7-471e-b3c7-d8e44d5623bd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_32b2c674-9b6e-41f6-9075-7ec376b998ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_16f80055-33cf-4c1d-824b-e4469d5b788e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c626baed-a11b-4507-871c-53bceefbb6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_16f80055-33cf-4c1d-824b-e4469d5b788e" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c626baed-a11b-4507-871c-53bceefbb6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_a7ed53f5-bfc9-4fe6-91dd-231563fcbb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_16f80055-33cf-4c1d-824b-e4469d5b788e" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_a7ed53f5-bfc9-4fe6-91dd-231563fcbb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ea84dc-0281-48f7-913e-e0722da72701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_47504766-7605-4e03-8493-2c4bd34a8a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ea84dc-0281-48f7-913e-e0722da72701" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_47504766-7605-4e03-8493-2c4bd34a8a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_dc84a059-e2a7-4da2-bb44-5cc4a2890062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ea84dc-0281-48f7-913e-e0722da72701" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_dc84a059-e2a7-4da2-bb44-5cc4a2890062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1ab55877-ce09-4c45-af86-3dec0351e356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ea84dc-0281-48f7-913e-e0722da72701" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1ab55877-ce09-4c45-af86-3dec0351e356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_70921de4-7fbf-4655-8c27-e14476b2f285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ea84dc-0281-48f7-913e-e0722da72701" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_70921de4-7fbf-4655-8c27-e14476b2f285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2a788c29-fc7a-4d41-b3c7-b78ae322990d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2a788c29-fc7a-4d41-b3c7-b78ae322990d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_71b1a313-af28-4a0a-be32-9b2045b93e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_71b1a313-af28-4a0a-be32-9b2045b93e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f6b0702c-d7c7-417c-8f1d-e2a860b7d8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f6b0702c-d7c7-417c-8f1d-e2a860b7d8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock_6339bc19-ec45-4dc6-a27c-d29bc6748426" xlink:href="nstg-20221231.xsd#nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:to="loc_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock_6339bc19-ec45-4dc6-a27c-d29bc6748426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock_26723c02-1d67-4940-a8c8-10195c378269" xlink:href="nstg-20221231.xsd#nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:to="loc_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock_26723c02-1d67-4940-a8c8-10195c378269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_84300755-d84a-455d-b0b7-424ee0a4866f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8592b8dc-7131-4099-a219-c9d8edf80f89" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_84300755-d84a-455d-b0b7-424ee0a4866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fdd27483-6ada-4e14-a8f5-b3d5e4fad86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1e18ed91-3bfe-41ac-a911-e1b41a5c7f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fdd27483-6ada-4e14-a8f5-b3d5e4fad86a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1e18ed91-3bfe-41ac-a911-e1b41a5c7f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SubsequentEventsTables" xlink:type="simple" xlink:href="nstg-20221231.xsd#SubsequentEventsTables"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/SubsequentEventsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a1eabeec-6037-49bc-b6b2-cabd78cf9e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/DescriptionoftheBusinessNarrativeDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#DescriptionoftheBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/DescriptionoftheBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5e8dfc8e-b718-4bcf-a656-d91b9e6d36ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_NumberOfPlatforms_4015eb98-87cc-404c-b5fa-bdc264add1eb" xlink:href="nstg-20221231.xsd#nstg_NumberOfPlatforms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5e8dfc8e-b718-4bcf-a656-d91b9e6d36ec" xlink:to="loc_nstg_NumberOfPlatforms_4015eb98-87cc-404c-b5fa-bdc264add1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#SignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b8e6c0a1-3aae-41af-8956-8a2b999eec3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:href="nstg-20221231.xsd#nstg_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b8e6c0a1-3aae-41af-8956-8a2b999eec3d" xlink:to="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_38d2d354-fec2-4414-9e66-a04d6a6330ac" xlink:to="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a63d1709-85dd-4966-a6df-f5d84d9480db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:to="loc_srt_MinimumMember_a63d1709-85dd-4966-a6df-f5d84d9480db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6419d0fd-f21c-4345-a9d3-02108078ca1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_785452c8-604f-4adb-af76-8a2db4c659c1" xlink:to="loc_srt_MaximumMember_6419d0fd-f21c-4345-a9d3-02108078ca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ace2376-0453-45bc-a78d-5a7704090bb9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ManufacturingEquipmentMember_fde71f6e-7624-4a4f-8930-c9656fbbb84e" xlink:href="nstg-20221231.xsd#nstg_ManufacturingEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_nstg_ManufacturingEquipmentMember_fde71f6e-7624-4a4f-8930-c9656fbbb84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PrototypeSystemsMember_b1a07d05-bb1f-4214-9be0-33ea96080568" xlink:href="nstg-20221231.xsd#nstg_PrototypeSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_nstg_PrototypeSystemsMember_b1a07d05-bb1f-4214-9be0-33ea96080568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_502be184-9c7b-4a80-bf0c-a2f8138c0231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_us-gaap_ComputerEquipmentMember_502be184-9c7b-4a80-bf0c-a2f8138c0231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_a75fe5d5-c1d3-4208-a413-4179e1f7bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8115d28a-1189-4572-b7a4-5b2aa5261a5a" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_a75fe5d5-c1d3-4208-a413-4179e1f7bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8aeeda4d-3c48-42fd-bba4-3e9d175de4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d672f733-f311-4de0-9cff-f5a58e385bb0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8aeeda4d-3c48-42fd-bba4-3e9d175de4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_4447a567-6adb-421e-9eaa-9c0ae6ae915d" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8aeeda4d-3c48-42fd-bba4-3e9d175de4f3" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_4447a567-6adb-421e-9eaa-9c0ae6ae915d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e428154-a4d7-4d23-a8d5-8cae4889549a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d199395-8dbd-4d7d-bd70-e2a564421d2c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e428154-a4d7-4d23-a8d5-8cae4889549a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d01f1714-3d13-44ea-884e-0476ab08c6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e428154-a4d7-4d23-a8d5-8cae4889549a" xlink:to="loc_us-gaap_SeniorNotesMember_d01f1714-3d13-44ea-884e-0476ab08c6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbd4e731-25eb-4e8f-adbc-08395ecc115f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_77cbc9f1-2ca2-4070-b33a-c0cb6c07b2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_77cbc9f1-2ca2-4070-b33a-c0cb6c07b2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_78e18f1b-c6e4-45bc-bda6-35771fee03a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73820d25-b25d-46e3-bfe8-470ded0c350e" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_78e18f1b-c6e4-45bc-bda6-35771fee03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8affcc73-db85-42e2-ad15-f3543dd6c99c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_96feaaf3-db5f-4229-8cde-30a1ff04b062" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8affcc73-db85-42e2-ad15-f3543dd6c99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8df22442-edb5-45f3-a0d3-08d3b05e3fe5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8affcc73-db85-42e2-ad15-f3543dd6c99c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8df22442-edb5-45f3-a0d3-08d3b05e3fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b5d64c5-f810-48cf-85b6-d6203b15ab7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff2411bc-189e-42e0-8c52-ecfd80be14a0" xlink:to="loc_us-gaap_EquityComponentDomain_7b5d64c5-f810-48cf-85b6-d6203b15ab7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_37438e61-47b7-4270-bb5c-5f6103faade0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7b5d64c5-f810-48cf-85b6-d6203b15ab7e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_37438e61-47b7-4270-bb5c-5f6103faade0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e48c43fb-2f3f-47d5-ab75-773637f651c4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c9cb3bc5-0337-48ea-b220-91e5c303c699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c9cb3bc5-0337-48ea-b220-91e5c303c699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_7a315146-ca35-4644-9d31-95b29c1664a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a1e18b7c-803a-4fc0-9dc0-338d04951163" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_7a315146-ca35-4644-9d31-95b29c1664a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:href="nstg-20221231.xsd#nstg_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesTable_c420d2b9-a10c-49bb-8cd5-6df7c86cbd43" xlink:to="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_959d4842-3278-4a93-88ec-33d85708598f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_InventoryValuationReserves_959d4842-3278-4a93-88ec-33d85708598f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6d424678-8310-4898-83fb-380ba8de1c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6d424678-8310-4898-83fb-380ba8de1c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_17493cf8-e0a0-49f6-a3fa-05952dd717d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_17493cf8-e0a0-49f6-a3fa-05952dd717d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_7fd6429e-83d5-4f0e-9f30-268ac673b97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_7fd6429e-83d5-4f0e-9f30-268ac673b97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_c3b92529-7df7-468b-ad72-6ef46320db86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_AdvertisingExpense_c3b92529-7df7-468b-ad72-6ef46320db86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExtendedProductWarrantyPeriod_95c4b5d6-f234-4a34-a35a-6018a0b2a1b1" xlink:href="nstg-20221231.xsd#nstg_ExtendedProductWarrantyPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_ExtendedProductWarrantyPeriod_95c4b5d6-f234-4a34-a35a-6018a0b2a1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductWarrantyAccrualPeriod_e874239f-fd68-4b22-8995-666b56ed977a" xlink:href="nstg-20221231.xsd#nstg_ProductWarrantyAccrualPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_ProductWarrantyAccrualPeriod_e874239f-fd68-4b22-8995-666b56ed977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_StandardProductWarrantyPeriod_a0c81b00-3502-4ec4-9cdb-aea5626460f5" xlink:href="nstg-20221231.xsd#nstg_StandardProductWarrantyPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_nstg_StandardProductWarrantyPeriod_a0c81b00-3502-4ec4-9cdb-aea5626460f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f1bc8f6d-4e80-4080-a1f6-7240e096c4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_StockholdersEquity_f1bc8f6d-4e80-4080-a1f6-7240e096c4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_670f61ff-2b19-4f6e-80a5-d0664d09d0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_670f61ff-2b19-4f6e-80a5-d0664d09d0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_ff402424-1f03-4dd6-aff0-48198e5555e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_InterestReceivable_ff402424-1f03-4dd6-aff0-48198e5555e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a45e3909-376b-4152-bfa6-3f24a6355ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a45e3909-376b-4152-bfa6-3f24a6355ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_81e93d48-0771-4823-ac1e-a5d8ef6f90ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SignificantAccountingPoliciesLineItems_c272cd82-8a6d-4e75-b9af-b4631a29bbf3" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_81e93d48-0771-4823-ac1e-a5d8ef6f90ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#RevenuefromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b66dab36-3824-4b2a-b9bf-e7a0c68d4342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b66dab36-3824-4b2a-b9bf-e7a0c68d4342" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_eafb0c61-f009-426e-aa88-a69882926d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d1b047e-2856-499e-bb55-b3ec0d126da3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_eafb0c61-f009-426e-aa88-a69882926d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1c5b4f09-3d2b-453c-add7-698193951d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_eafb0c61-f009-426e-aa88-a69882926d24" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1c5b4f09-3d2b-453c-add7-698193951d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5504d921-996c-4eb4-a239-6d8e91d29795" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9c69e434-4a70-4f27-beea-600cf8d3271e" xlink:to="loc_srt_SegmentGeographicalDomain_5504d921-996c-4eb4-a239-6d8e91d29795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cd35a599-3566-4a91-875b-25c398c038f1" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5504d921-996c-4eb4-a239-6d8e91d29795" xlink:to="loc_country_US_cd35a599-3566-4a91-875b-25c398c038f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2aa4315b-4e51-4ccd-aaf8-cfe59b7b6ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a1c879d-7dc4-475f-966b-243f41a8e8f6" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2aa4315b-4e51-4ccd-aaf8-cfe59b7b6ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e1d64f3e-b749-4e32-9c63-8e93cf28cca2" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_08160c1f-e374-4f33-95c4-a085dd847369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_Revenues_08160c1f-e374-4f33-95c4-a085dd847369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_c23827a0-666d-458e-a7e7-310705fbbc6a" xlink:href="nstg-20221231.xsd#nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent_c23827a0-666d-458e-a7e7-310705fbbc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9d7f2737-bba2-4cfc-af40-8dcd1ca241e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9d7f2737-bba2-4cfc-af40-8dcd1ca241e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_bd47c8e2-9a8e-4d80-99a8-43aeb6ec48b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_bd47c8e2-9a8e-4d80-99a8-43aeb6ec48b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_2dec07fa-e175-408d-a640-ee4f08887fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_2dec07fa-e175-408d-a640-ee4f08887fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_19c49c92-cb6d-4052-90e5-dc3973c599ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_19c49c92-cb6d-4052-90e5-dc3973c599ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_fdde5de8-5b59-4e71-ad40-6b06f5ce9892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_fdde5de8-5b59-4e71-ad40-6b06f5ce9892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_92ceb156-c384-4ae7-862f-d94ded9c5f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0e1e7b8e-c36a-4cb5-ba76-c5998cf6a318" xlink:to="loc_us-gaap_ProceedsFromCustomers_92ceb156-c384-4ae7-862f-d94ded9c5f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_de8a5e6f-8f60-42f6-ab02-e2769a2d4795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_de8a5e6f-8f60-42f6-ab02-e2769a2d4795" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:to="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_686e7d87-819a-45b3-b156-45b5bb27b1a0" xlink:to="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_4f785994-a499-449b-bcee-2fac80aeae4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:to="loc_srt_AmericasMember_4f785994-a499-449b-bcee-2fac80aeae4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c62f6f04-30ee-4e23-9d28-f929b6e23fdb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:to="loc_srt_AsiaPacificMember_c62f6f04-30ee-4e23-9d28-f929b6e23fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_76ab764b-2b30-4135-ab19-074651cda097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b34cf51c-c8be-4e34-9b0f-172629cfcf32" xlink:to="loc_us-gaap_EMEAMember_76ab764b-2b30-4135-ab19-074651cda097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:to="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9e534935-9973-4947-8774-0abd1e012caf" xlink:to="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductInstrumentsMember_0319c95d-2960-4dc4-b538-7bab8907440e" xlink:href="nstg-20221231.xsd#nstg_ProductInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_nstg_ProductInstrumentsMember_0319c95d-2960-4dc4-b538-7bab8907440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductConsumablesMember_e2bcd769-c02d-4841-bbcc-7008d39ca3a5" xlink:href="nstg-20221231.xsd#nstg_ProductConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_nstg_ProductConsumablesMember_e2bcd769-c02d-4841-bbcc-7008d39ca3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_07ca722e-d89e-481a-804b-7c335bc338e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_us-gaap_ProductMember_07ca722e-d89e-481a-804b-7c335bc338e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_821b87ca-cb03-48d0-87ad-8b2d37fb95d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_us-gaap_ServiceMember_821b87ca-cb03-48d0-87ad-8b2d37fb95d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ProductAndServiceMember_54185c87-f9b3-4bc2-a5f3-22186b293514" xlink:href="nstg-20221231.xsd#nstg_ProductAndServiceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15731215-84c2-44af-b6d8-fff3838ba398" xlink:to="loc_nstg_ProductAndServiceMember_54185c87-f9b3-4bc2-a5f3-22186b293514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9340a49a-e367-4c31-8877-ee6d3f3e996e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f632db1f-898d-4570-9ea8-a574497c0436" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9340a49a-e367-4c31-8877-ee6d3f3e996e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b538977-3954-4fc3-a68b-89836d1c070a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9340a49a-e367-4c31-8877-ee6d3f3e996e" xlink:to="loc_us-gaap_Revenues_3b538977-3954-4fc3-a68b-89836d1c070a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestmentsAvailableforSaleSecuritiesDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57cbf53c-8146-4fa1-aa78-1c7d410b5725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57cbf53c-8146-4fa1-aa78-1c7d410b5725" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae0b0e79-19d8-4d40-aab2-f20eb1c88234" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dc8ccd32-c4ec-40ca-bd39-2b270adc686b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dc8ccd32-c4ec-40ca-bd39-2b270adc686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bff13c7b-461f-40fc-9139-93bc0ffa7e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bff13c7b-461f-40fc-9139-93bc0ffa7e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cdad15fb-b677-4ebb-a544-fefc626ba860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cdad15fb-b677-4ebb-a544-fefc626ba860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_5b05174f-561c-457f-94a4-ba26d2f699ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ef81c5d-6b40-4424-a7dc-63874f51d1d1" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_5b05174f-561c-457f-94a4-ba26d2f699ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3be7f67f-1763-4199-8b3c-5dcc74a3e329" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_96792737-b4a6-4c43-9428-9acee26906f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_96792737-b4a6-4c43-9428-9acee26906f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7fb16f66-8b99-4642-902e-5160757375af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7fb16f66-8b99-4642-902e-5160757375af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b98a63ce-05a2-40d3-9ce4-1b2b12d7e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b98a63ce-05a2-40d3-9ce4-1b2b12d7e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_627456a5-c7eb-43b2-88c6-311df3b12d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_627456a5-c7eb-43b2-88c6-311df3b12d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_cf56da99-2223-4b7f-89a2-092eebff4b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_cf56da99-2223-4b7f-89a2-092eebff4b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_3c93a77b-eb88-4980-b37f-40eb81bb7e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_3c93a77b-eb88-4980-b37f-40eb81bb7e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_12c2198f-b15b-46e9-a41f-ee0ce4319353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_12c2198f-b15b-46e9-a41f-ee0ce4319353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_fef8aa0c-3e25-4fb2-a097-b458e8d126e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_fef8aa0c-3e25-4fb2-a097-b458e8d126e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a210bb74-e809-434a-bc11-d47083c190de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a210bb74-e809-434a-bc11-d47083c190de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4884e1d2-be45-4954-8b6d-8cb0bce86d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d03f16fc-aca5-4753-9891-da89bc061194" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4884e1d2-be45-4954-8b6d-8cb0bce86d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f8a633c8-73cc-4b67-be74-7bd9d1c9e251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_af529303-66fe-4a69-9ca9-fc791c09f91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f8a633c8-73cc-4b67-be74-7bd9d1c9e251" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_af529303-66fe-4a69-9ca9-fc791c09f91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_e2c2fdac-f97c-4967-bd08-7f8c281606a4" xlink:href="nstg-20221231.xsd#nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f8a633c8-73cc-4b67-be74-7bd9d1c9e251" xlink:to="loc_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_e2c2fdac-f97c-4967-bd08-7f8c281606a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ed8e6b8-1a70-47fc-9e60-53fac4da7fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f8a633c8-73cc-4b67-be74-7bd9d1c9e251" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ed8e6b8-1a70-47fc-9e60-53fac4da7fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8d2bf08d-ac93-4fc8-adf8-eac4c9f8ce00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8d2bf08d-ac93-4fc8-adf8-eac4c9f8ce00" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7cffd4c6-20bc-40a4-aa3f-c209952eda05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_94d8dbf0-37c4-4458-9973-681553440460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_94d8dbf0-37c4-4458-9973-681553440460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4b8096cb-10e8-45e7-b3f0-3331b3dc5bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4b8096cb-10e8-45e7-b3f0-3331b3dc5bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1b7dd6af-98e7-4c27-acd2-9536bb97d076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e70670b-43db-4a31-a6b6-ade30ed0c0c9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1b7dd6af-98e7-4c27-acd2-9536bb97d076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c2784b79-43ce-4f57-a51e-30ede1989607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_028b0d46-c44d-4682-87a8-0cff148b9b50" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c2784b79-43ce-4f57-a51e-30ede1989607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_7a36fe95-0b69-4e5c-af62-b890b07b1c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c2784b79-43ce-4f57-a51e-30ede1989607" xlink:to="loc_us-gaap_MoneyMarketFundsMember_7a36fe95-0b69-4e5c-af62-b890b07b1c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_57ffb2c2-966b-4ec8-a5c2-d63767cf7185" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3a9b9f43-3335-4be6-8aeb-6af9d61c561d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3a9b9f43-3335-4be6-8aeb-6af9d61c561d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bcaacb42-b98d-42c5-b26d-15adec0c2d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_bcaacb42-b98d-42c5-b26d-15adec0c2d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_28b41929-4b02-46fd-b95b-7b9b070e72c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a513fad5-ff3a-42ed-8976-0cd971f9c576" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_28b41929-4b02-46fd-b95b-7b9b070e72c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3ad76bb6-b961-43a5-8123-6f72311559b6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6bea9113-dffe-4249-8673-2829eb50a4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6bea9113-dffe-4249-8673-2829eb50a4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_653ace46-2ff3-4098-9dfd-5a257657f69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_653ace46-2ff3-4098-9dfd-5a257657f69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue_8af66a30-6bbf-4527-9b2d-2f5440fe393a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue_8af66a30-6bbf-4527-9b2d-2f5440fe393a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_53da7fe9-5699-4b82-ad4a-12fc25cc71e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8b2faa5-c3d2-48f8-8191-f17eba7725ed" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_53da7fe9-5699-4b82-ad4a-12fc25cc71e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8e7c54c7-face-46f0-a3dd-a307913024ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8e7c54c7-face-46f0-a3dd-a307913024ea" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:to="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2154b60-0f44-401e-9cb5-e467547e5e39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_9cad3f62-82e0-4f97-b685-ecb044f3ecb9" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_9cad3f62-82e0-4f97-b685-ecb044f3ecb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember_b50468d9-f0dd-4b2a-9e97-3d3e197e1306" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_945f4498-323e-47c0-a04e-3c75a0c58cf9" xlink:to="loc_nstg_TermLoanAgreementMember_b50468d9-f0dd-4b2a-9e97-3d3e197e1306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_901ae9c8-24c7-4458-8b3a-a3fec097b1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e3c08850-412c-429d-8e7b-eb0d99f92e10" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_901ae9c8-24c7-4458-8b3a-a3fec097b1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_07feb438-f2a9-4c78-81c1-692a7ba3236e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_901ae9c8-24c7-4458-8b3a-a3fec097b1c1" xlink:to="loc_us-gaap_SeniorNotesMember_07feb438-f2a9-4c78-81c1-692a7ba3236e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_b7c9493d-41c9-4164-8572-1ce74de98cf8" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f8b3e7a5-a6c2-407b-b5ac-6946fa8f23c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:to="loc_us-gaap_RepaymentsOfDebt_f8b3e7a5-a6c2-407b-b5ac-6946fa8f23c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_b4b2ee60-699a-4e37-8e5b-611d1c3bbc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_eb2b7d25-ea0a-42bc-b624-a337a6a28fea" xlink:to="loc_us-gaap_DebtInstrumentFairValue_b4b2ee60-699a-4e37-8e5b-611d1c3bbc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_NumberOfOperatingLeases_68a14e23-e7e5-4ecc-909d-2088740287c6" xlink:href="nstg-20221231.xsd#nstg_NumberOfOperatingLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:to="loc_nstg_NumberOfOperatingLeases_68a14e23-e7e5-4ecc-909d-2088740287c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AreaOfSpaceUnderLease_1759388b-fa6d-4a3f-864d-b4dd2a9266b0" xlink:href="nstg-20221231.xsd#nstg_AreaOfSpaceUnderLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:to="loc_nstg_AreaOfSpaceUnderLease_1759388b-fa6d-4a3f-864d-b4dd2a9266b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_bc03b7f1-b9cd-4c02-900f-dd195cc63b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:to="loc_us-gaap_OperatingLeaseExpense_bc03b7f1-b9cd-4c02-900f-dd195cc63b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7d7e4617-94a9-49d1-a086-66b2424f5419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7d7e4617-94a9-49d1-a086-66b2424f5419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_7c58f0c1-8466-4fb0-aaa6-a2002b39e8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_7c58f0c1-8466-4fb0-aaa6-a2002b39e8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_2ef554dd-8e8d-4af2-b901-1e6f738abf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74c7fc89-650e-41ea-90c5-bf73f382193c" xlink:to="loc_us-gaap_LeaseCost_2ef554dd-8e8d-4af2-b901-1e6f738abf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesSummaryofLeaseCostandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e10941bc-a182-4344-b167-5a1d91397e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_OperatingLeasePayments_e10941bc-a182-4344-b167-5a1d91397e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_2b007a93-4de1-42a5-997d-e14e3e4e95b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_2b007a93-4de1-42a5-997d-e14e3e4e95b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_b2f44e31-1c63-48a6-b7f5-3d42a33a8ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_b2f44e31-1c63-48a6-b7f5-3d42a33a8ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9a2f52a0-94cf-47e0-8aaf-b5a090708ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9a2f52a0-94cf-47e0-8aaf-b5a090708ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d324ce6f-98ec-4392-b350-0ece039de0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d324ce6f-98ec-4392-b350-0ece039de0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_56d554b3-ac61-4f2d-8e6a-c18a9ac35748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_56d554b3-ac61-4f2d-8e6a-c18a9ac35748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fd24c3da-b58d-4eee-b9dd-30db18593688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fd24c3da-b58d-4eee-b9dd-30db18593688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_aa231109-4d68-4a49-b8b3-babf52f86038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_aa231109-4d68-4a49-b8b3-babf52f86038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d11ab7c6-12aa-4b79-9930-f3523b35b558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf0bf7b-29fa-4129-b054-47f0d86c5e7d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d11ab7c6-12aa-4b79-9930-f3523b35b558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a64b1da9-8337-4967-aa7a-4b65845c527e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a64b1da9-8337-4967-aa7a-4b65845c527e" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b2ef632d-6909-4f62-bade-36eaf2aa27d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b2ef632d-6909-4f62-bade-36eaf2aa27d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_102acf08-77d5-4899-87c1-9770ce0a4c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_102acf08-77d5-4899-87c1-9770ce0a4c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c7956889-bdc4-4125-af79-3ab876f08566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c7956889-bdc4-4125-af79-3ab876f08566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f173d134-d775-47a6-a689-5f489ca148ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f173d134-d775-47a6-a689-5f489ca148ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_07f9ec89-f81e-4010-98d3-1de21a506458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_07f9ec89-f81e-4010-98d3-1de21a506458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bbc28d77-c9c1-462b-a297-da971eb7523f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bbc28d77-c9c1-462b-a297-da971eb7523f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_449cf13d-1f71-4e12-b925-4cdced87a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_449cf13d-1f71-4e12-b925-4cdced87a3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_59ce98bd-aab4-43f4-a384-9a1855556651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_59ce98bd-aab4-43f4-a384-9a1855556651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_0cb01222-8006-4894-ba58-73968782f42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_0cb01222-8006-4894-ba58-73968782f42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7958645b-1650-453f-8fa6-19448cc08376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_52ab969e-8206-49bb-b7ee-c9a4fa19e84f" xlink:to="loc_us-gaap_FinanceLeaseLiability_7958645b-1650-453f-8fa6-19448cc08376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a64b1da9-8337-4967-aa7a-4b65845c527e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fc8b1721-ea28-4845-97c3-c93250041649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fc8b1721-ea28-4845-97c3-c93250041649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0b8093ad-6bd4-47aa-b96e-2c8715d36750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0b8093ad-6bd4-47aa-b96e-2c8715d36750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_62231d3e-3906-47c0-9b6a-d8d4b5915489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_62231d3e-3906-47c0-9b6a-d8d4b5915489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ada7bc45-723e-422c-ba1b-85c233b5b72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ada7bc45-723e-422c-ba1b-85c233b5b72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_198ef595-0b75-4ace-b8bc-dd7b9ead44d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_198ef595-0b75-4ace-b8bc-dd7b9ead44d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fab925d9-df4c-415a-a659-af8b08385f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fab925d9-df4c-415a-a659-af8b08385f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_335373d1-5f41-4bbb-9c60-b1796d43972c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_335373d1-5f41-4bbb-9c60-b1796d43972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a1276c56-4e50-456f-ad47-090f63777093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a1276c56-4e50-456f-ad47-090f63777093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4fbef1cb-5e81-4991-90a6-ccf295edf6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_2e00267d-ce2f-4b25-9630-f53201994171" xlink:to="loc_us-gaap_OperatingLeaseLiability_4fbef1cb-5e81-4991-90a6-ccf295edf6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="nstg-20221231.xsd#LeasesScheduleofFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.nanostring.com/role/InventoryScheduleofInventoryDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#InventoryScheduleofInventoryDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/InventoryScheduleofInventoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_056b347c-2adb-4074-b85b-2cff8c46967d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_83ce7988-45f7-442e-ae1f-e6d2a5937b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_056b347c-2adb-4074-b85b-2cff8c46967d" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_83ce7988-45f7-442e-ae1f-e6d2a5937b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_52fd8f8c-a47e-4fad-8279-d1d3aab8b372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_056b347c-2adb-4074-b85b-2cff8c46967d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_52fd8f8c-a47e-4fad-8279-d1d3aab8b372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_36e39fb1-a0e3-4641-be27-7ca13416102b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_056b347c-2adb-4074-b85b-2cff8c46967d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_36e39fb1-a0e3-4641-be27-7ca13416102b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a1225f08-2583-4ee7-9f4f-58e5522614e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_056b347c-2adb-4074-b85b-2cff8c46967d" xlink:to="loc_us-gaap_InventoryNet_a1225f08-2583-4ee7-9f4f-58e5522614e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/PropertyandEquipmentDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#PropertyandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/PropertyandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_97478d4a-1d96-4297-a1a0-af9ba31374a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_97478d4a-1d96-4297-a1a0-af9ba31374a0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_16e0743e-a836-4b30-a486-4c9028871db1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ManufacturingEquipmentMember_f2abe353-3d98-43db-a058-bb0bb250356b" xlink:href="nstg-20221231.xsd#nstg_ManufacturingEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_nstg_ManufacturingEquipmentMember_f2abe353-3d98-43db-a058-bb0bb250356b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PrototypesAndOtherEquipmentMember_3d39d52f-d713-4e4c-9069-1c8733cff9c4" xlink:href="nstg-20221231.xsd#nstg_PrototypesAndOtherEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_nstg_PrototypesAndOtherEquipmentMember_3d39d52f-d713-4e4c-9069-1c8733cff9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_30cd94f6-279d-48dd-b94e-8a9ee05c5428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_ComputerEquipmentMember_30cd94f6-279d-48dd-b94e-8a9ee05c5428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3aa89577-3795-472b-9808-bfad6cfd02a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3aa89577-3795-472b-9808-bfad6cfd02a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_b40ff878-6055-488e-a6ae-8a1774139dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_b40ff878-6055-488e-a6ae-8a1774139dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_07c1e9b8-aaed-4c6d-8022-43bb714b4d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0dcdd0cb-d22c-4510-805a-2a27dd899653" xlink:to="loc_us-gaap_ConstructionInProgressMember_07c1e9b8-aaed-4c6d-8022-43bb714b4d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c9c0b4-048b-4db7-b1c8-8d18f73d1a39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9c6a660a-21f9-4657-88bc-d1a637de4dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9c6a660a-21f9-4657-88bc-d1a637de4dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_333f520d-65f8-4a81-9c86-9ada90fecdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_333f520d-65f8-4a81-9c86-9ada90fecdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f8e9dcd0-f2da-47e3-892d-b9e7c7a56ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f8e9dcd0-f2da-47e3-892d-b9e7c7a56ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b34bff98-1c05-46ea-b993-36f36a4a6808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9d26277-7fd2-4e2e-acaa-19f3e0d11d4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b34bff98-1c05-46ea-b993-36f36a4a6808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/PropertyandEquipmentAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#PropertyandEquipmentAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/PropertyandEquipmentAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d5903af7-7810-44c2-85b8-e3ae464ed0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1ce0802e-6363-470e-bf42-3785a584b94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d5903af7-7810-44c2-85b8-e3ae464ed0c1" xlink:to="loc_us-gaap_Depreciation_1ce0802e-6363-470e-bf42-3785a584b94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e2d7fbbf-f59f-427d-8075-1fc840a2422d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e2d7fbbf-f59f-427d-8075-1fc840a2422d" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fc3e1d4e-718c-4b11-a8d4-d284f2309dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_caab2d4d-d6fb-43ad-827f-d883e41b1329" xlink:to="loc_us-gaap_CreditFacilityDomain_fc3e1d4e-718c-4b11-a8d4-d284f2309dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4bf82be1-19ce-4fda-8bdd-9fd38fa34922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fc3e1d4e-718c-4b11-a8d4-d284f2309dc7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4bf82be1-19ce-4fda-8bdd-9fd38fa34922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a311a905-bf35-459c-a2a9-2bf0487d03a6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember_4028abbd-ccc0-4d05-aec0-3e710d4bf12c" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_nstg_TermLoanAgreementMember_4028abbd-ccc0-4d05-aec0-3e710d4bf12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SecuredRevolvingLoanFacilityMember_3e67184f-26b2-431b-82ee-6eb6551a434e" xlink:href="nstg-20221231.xsd#nstg_SecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_nstg_SecuredRevolvingLoanFacilityMember_3e67184f-26b2-431b-82ee-6eb6551a434e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3d54ec02-9e31-465f-b74c-c0147b5bb591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3d54ec02-9e31-465f-b74c-c0147b5bb591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_9eeca449-171f-4e50-bc46-162c9c56ea61" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_708f5536-1603-4f27-bd5f-d8b2835a704a" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_9eeca449-171f-4e50-bc46-162c9c56ea61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7721378d-1aad-49af-9359-5c9273e23743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9f7fe926-3c82-4f2b-b023-52dcc63131e4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7721378d-1aad-49af-9359-5c9273e23743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f487abfd-e6fd-430b-a881-ecd5a55f38eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7721378d-1aad-49af-9359-5c9273e23743" xlink:to="loc_us-gaap_SeniorNotesMember_f487abfd-e6fd-430b-a881-ecd5a55f38eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_ConvertibleDebtTermsAxis_82518a6f-1062-497b-a20b-b9e979207a62" xlink:to="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTriggeringEvent1Member_01c3fa1f-efde-4f58-ac91-fc86adda7586" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTriggeringEvent1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:to="loc_nstg_ConvertibleDebtTriggeringEvent1Member_01c3fa1f-efde-4f58-ac91-fc86adda7586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleDebtTriggeringEvent2Member_7c202264-f534-4531-b542-d2bf02d820fa" xlink:href="nstg-20221231.xsd#nstg_ConvertibleDebtTriggeringEvent2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_ConvertibleDebtTermsDomain_c9678d4d-cd06-4f30-bf34-edca9bcf9b30" xlink:to="loc_nstg_ConvertibleDebtTriggeringEvent2Member_7c202264-f534-4531-b542-d2bf02d820fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a1bcd04f-ff81-48eb-a348-0a33c2d92995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d168b93-3c84-442d-9ae9-556681a6961a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_46981f2b-de67-453b-aa83-7a3403a74ab8" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TermLoanAgreementMember_c6f1bb3f-99fb-458a-94c2-2dd621c3ef4b" xlink:href="nstg-20221231.xsd#nstg_TermLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cb386890-8b7f-41b4-9418-db8d86816add" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_53293a07-3e8f-4e70-a2d6-81614db0dded" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_53293a07-3e8f-4e70-a2d6-81614db0dded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_f900e061-627d-448e-9e93-bffac98d5766" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6960fa03-609f-4c08-b322-e979e79648f2" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_f900e061-627d-448e-9e93-bffac98d5766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9823c4af-36ee-4bf3-8c36-9c8be9a13053" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_69a30b88-469c-4063-b1e2-2a8923e98f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_69a30b88-469c-4063-b1e2-2a8923e98f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4a205cef-6654-420c-907a-a3c77a5f4317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_RepaymentsOfDebt_4a205cef-6654-420c-907a-a3c77a5f4317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d58ff971-0bfd-448d-93d2-b278ca14306d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d58ff971-0bfd-448d-93d2-b278ca14306d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fe34f8de-b830-46d2-9867-72cd929641bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fe34f8de-b830-46d2-9867-72cd929641bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_750b8b7a-ef3b-4dab-acef-085564f4db5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_750b8b7a-ef3b-4dab-acef-085564f4db5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4c9b46cb-d17a-418b-b031-cfd1c13c75b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4c9b46cb-d17a-418b-b031-cfd1c13c75b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e32d4e14-ac97-44dd-8bd6-a58ce03a55a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e32d4e14-ac97-44dd-8bd6-a58ce03a55a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_97a22275-2f60-45f6-ab3a-d7467daa274b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_97a22275-2f60-45f6-ab3a-d7467daa274b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b0ba2e88-792a-438d-b009-ae78e633dd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b0ba2e88-792a-438d-b009-ae78e633dd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_96e1e7c9-c265-4239-89de-5c807db1ff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentTerm_96e1e7c9-c265-4239-89de-5c807db1ff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_b68bc15d-2fa5-4079-bba4-b380297613df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_SharePrice_b68bc15d-2fa5-4079-bba4-b380297613df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3fd8202-6555-426e-b353-852d49726d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3fd8202-6555-426e-b353-852d49726d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_91ae2706-c0bc-4775-983a-68cbb8d8b729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_91ae2706-c0bc-4775-983a-68cbb8d8b729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_19243a12-7fe5-448c-91c5-37b38d92b7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_InterestExpense_19243a12-7fe5-448c-91c5-37b38d92b7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_1d010b63-400f-4d4d-a077-f48b31051b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_InterestExpenseBorrowings_1d010b63-400f-4d4d-a077-f48b31051b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a86f4ae7-7fc8-40ff-9a2a-9067d6169dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a86f4ae7-7fc8-40ff-9a2a-9067d6169dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExtinguishmentOfDebtTerminationFee_13762948-bb96-42bb-8075-f28cc40761fe" xlink:href="nstg-20221231.xsd#nstg_ExtinguishmentOfDebtTerminationFee"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_nstg_ExtinguishmentOfDebtTerminationFee_13762948-bb96-42bb-8075-f28cc40761fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_9870b728-7d4d-46d4-849f-22317ef10317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_9870b728-7d4d-46d4-849f-22317ef10317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7709c8cc-f908-4064-bb6d-b72fd1f428ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7709c8cc-f908-4064-bb6d-b72fd1f428ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_OutstandingPrincipalOfConvertibleDebt_935ec4ea-c317-43dc-b261-d43737534a8e" xlink:href="nstg-20221231.xsd#nstg_OutstandingPrincipalOfConvertibleDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_nstg_OutstandingPrincipalOfConvertibleDebt_935ec4ea-c317-43dc-b261-d43737534a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0c3071c-ff45-4003-ab37-5dbb4c69e878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3f98e763-eb26-455c-9a30-2ef82883ea3c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0c3071c-ff45-4003-ab37-5dbb4c69e878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtLongtermdebtandleasefinancingobligationsDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2ac95c9d-df1d-437d-9672-294ab988ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ac95c9d-df1d-437d-9672-294ab988ba49" xlink:to="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e09bccc-dece-4d1c-878e-98a8a994da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8012c65a-985f-4ae1-87e1-74c5dbe90a38" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e09bccc-dece-4d1c-878e-98a8a994da8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_a3633cfa-ede8-4a84-8b70-9d3bb6994a6c" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7e09bccc-dece-4d1c-878e-98a8a994da8f" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_a3633cfa-ede8-4a84-8b70-9d3bb6994a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_71631893-337d-40ce-aa90-bdcdcf1e71c9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8f480fc1-cce2-4d78-a288-1983a073ad0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8f480fc1-cce2-4d78-a288-1983a073ad0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2db9c540-13b4-46a0-9b1e-dec916b8be54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2db9c540-13b4-46a0-9b1e-dec916b8be54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_OutstandingPrincipalOfConvertibleDebt_b19733a6-b31d-4d7a-a2d1-dfdceae4fe1f" xlink:href="nstg-20221231.xsd#nstg_OutstandingPrincipalOfConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c37b0cec-57c2-45ed-af3a-11227bb386df" xlink:to="loc_nstg_OutstandingPrincipalOfConvertibleDebt_b19733a6-b31d-4d7a-a2d1-dfdceae4fe1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#LongTermDebtScheduleofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_43613463-2cbb-45a8-bceb-c3b1f7c2e693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_43613463-2cbb-45a8-bceb-c3b1f7c2e693" xlink:to="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:to="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_be2f3d24-d5d0-41b1-b1c0-f23e2b40b3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_22571572-41a5-434c-a069-1e22fb5274de" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_be2f3d24-d5d0-41b1-b1c0-f23e2b40b3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ConvertibleSeniorNotesDue2025Member_e9a59aa1-a704-47ac-a2f3-eb92bd285fb1" xlink:href="nstg-20221231.xsd#nstg_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_be2f3d24-d5d0-41b1-b1c0-f23e2b40b3cd" xlink:to="loc_nstg_ConvertibleSeniorNotesDue2025Member_e9a59aa1-a704-47ac-a2f3-eb92bd285fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2448068-e82f-40ed-8daa-a52829a77b6a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_8b8a075a-d089-4ea5-b56d-3d7df3eade4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_8b8a075a-d089-4ea5-b56d-3d7df3eade4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_7cdfd3d2-37bf-4cec-bbab-810b99f8a5a3" xlink:href="nstg-20221231.xsd#nstg_AmortizationOfDebtDiscountAndIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_nstg_AmortizationOfDebtDiscountAndIssuanceCosts_7cdfd3d2-37bf-4cec-bbab-810b99f8a5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ccda1e08-5c29-4f12-b837-17a306b08b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df05b10e-92c7-48ff-90b8-d5acbbfc47e4" xlink:to="loc_us-gaap_InterestExpenseDebt_ccda1e08-5c29-4f12-b837-17a306b08b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#CommonStockandPreferredStockAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f17a86b9-e0c1-4eb9-a8bf-7a7fdf4b0fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f17a86b9-e0c1-4eb9-a8bf-7a7fdf4b0fe8" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8422d41b-4be2-405f-bee9-81abd6c13dd5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_dc9eeab4-8f69-4ff3-b30f-d084d051b1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:to="loc_us-gaap_OverAllotmentOptionMember_dc9eeab4-8f69-4ff3-b30f-d084d051b1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_PublicStockOfferingMember_85eccd1b-2cb8-4e4e-be5f-4c1c4a6bb92a" xlink:href="nstg-20221231.xsd#nstg_PublicStockOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:to="loc_nstg_PublicStockOfferingMember_85eccd1b-2cb8-4e4e-be5f-4c1c4a6bb92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_39587bfa-3692-459d-801b-9342c4953852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_40aa466e-3bb9-4e30-afaf-d0268528d18d" xlink:to="loc_us-gaap_IPOMember_39587bfa-3692-459d-801b-9342c4953852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de247e14-7580-4f14-9256-971a93f70638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7db73638-8d4a-4b33-82c2-16582ffdbabc" xlink:to="loc_us-gaap_ClassOfStockDomain_de247e14-7580-4f14-9256-971a93f70638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7bb7b18-67d4-4db4-bdec-5662e2232463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de247e14-7580-4f14-9256-971a93f70638" xlink:to="loc_us-gaap_CommonStockMember_d7bb7b18-67d4-4db4-bdec-5662e2232463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5cc5b728-b678-4b0b-a128-b05ffc114189" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_93ec829b-88fa-4609-9598-39e06d8a9d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_93ec829b-88fa-4609-9598-39e06d8a9d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_e9cc0f8c-f158-4524-a7e4-c603f823b1fc" xlink:href="nstg-20221231.xsd#nstg_SaleOfStockGrossConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction_e9cc0f8c-f158-4524-a7e4-c603f823b1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f9aeb3c3-0fb5-407f-ba5b-7062dc2ae8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f9aeb3c3-0fb5-407f-ba5b-7062dc2ae8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9ad93022-c876-48e6-9b36-02441a3c60af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9ad93022-c876-48e6-9b36-02441a3c60af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockVotingRights_b83e3185-661e-42d3-afee-936245a26a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_CommonStockVotingRights_b83e3185-661e-42d3-afee-936245a26a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4597dda9-44b0-4d35-ba07-399c40bdde46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4597dda9-44b0-4d35-ba07-399c40bdde46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3867d15f-73fa-42a9-8488-697dbf7032ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3867d15f-73fa-42a9-8488-697dbf7032ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_bea5fa72-e64b-426a-80ac-86af22127533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_406a8af3-b17e-47fd-9528-edbfc99fe18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_406a8af3-b17e-47fd-9528-edbfc99fe18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9830ca95-cbe2-4317-9824-b8c580effa10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9abcb1f2-2e54-44af-a435-603791fec8e9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9830ca95-cbe2-4317-9824-b8c580effa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04a8a0b5-6aa2-4fac-aa6b-77c55bd3ca8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04a8a0b5-6aa2-4fac-aa6b-77c55bd3ca8f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:to="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f5682776-7c09-4510-989d-219c9c39655b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_b97e6c8c-0108-41d9-8d56-41bf6bf54d63" xlink:href="nstg-20221231.xsd#nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember_b97e6c8c-0108-41d9-8d56-41bf6bf54d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8c97d607-aebd-4484-b458-87213789a159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8c97d607-aebd-4484-b458-87213789a159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e914da4b-bfc9-4fbf-bbd7-bba7e4ae5149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e914da4b-bfc9-4fbf-bbd7-bba7e4ae5149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanMember_a99ef4e2-3070-44d8-822c-c7ac6e4e1aa8" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_EmployeeStockPurchasePlanMember_a99ef4e2-3070-44d8-822c-c7ac6e4e1aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ServiceComponentMember_c82e06e8-a6dd-48be-a077-15025b7f5ed5" xlink:href="nstg-20221231.xsd#nstg_ServiceComponentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_ServiceComponentMember_c82e06e8-a6dd-48be-a077-15025b7f5ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ServiceAndPerformanceComponentsMember_77cf137c-017d-4a1a-a7e6-79782c75d9b4" xlink:href="nstg-20221231.xsd#nstg_ServiceAndPerformanceComponentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_nstg_ServiceAndPerformanceComponentsMember_77cf137c-017d-4a1a-a7e6-79782c75d9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bdcb72bb-f247-4a0a-9d06-70417c38073a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4097952b-a7d0-4e79-924c-f86ffc218c03" xlink:to="loc_us-gaap_CommonStockMember_bdcb72bb-f247-4a0a-9d06-70417c38073a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:to="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cf6071bc-467c-413c-8896-d87dc1836cfd" xlink:to="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7df5eb1e-4676-44e0-beb8-d98c04179a71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:to="loc_srt_MinimumMember_7df5eb1e-4676-44e0-beb8-d98c04179a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c194ff2c-d95e-44d9-b523-6c2a6882fde7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16ea06c1-17c3-47fb-9406-592ab11b41f1" xlink:to="loc_srt_MaximumMember_c194ff2c-d95e-44d9-b523-6c2a6882fde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a88c1b-dfc2-47a5-811e-4b005dc5b9ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_db1c6130-d0d5-4dd1-8ae1-8aaf574cde36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_db1c6130-d0d5-4dd1-8ae1-8aaf574cde36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_88f0f0b2-4f5c-4e71-9625-3510fac75af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_88f0f0b2-4f5c-4e71-9625-3510fac75af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2c722a91-523a-4334-8b5c-67f8ceb6c5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2c722a91-523a-4334-8b5c-67f8ceb6c5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30da89fd-f382-40e9-8b5d-9cc5f4f254a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30da89fd-f382-40e9-8b5d-9cc5f4f254a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4a71d431-d4ac-4a27-b5b2-611331477ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4a71d431-d4ac-4a27-b5b2-611331477ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_40e5889a-b6f2-47ed-aca3-80428cc98ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_40e5889a-b6f2-47ed-aca3-80428cc98ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a20fe548-4402-419f-b7d4-8846b5c96682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a20fe548-4402-419f-b7d4-8846b5c96682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59e4b5a7-4d1b-49d2-ad54-f3d6ae66cfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59e4b5a7-4d1b-49d2-ad54-f3d6ae66cfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8b6bb76-a285-420c-9075-ff72d2e23bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8b6bb76-a285-420c-9075-ff72d2e23bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_204a70b3-3237-4eea-b343-bffc0a616790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_204a70b3-3237-4eea-b343-bffc0a616790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d55cfea1-b6e4-45f1-b05f-cda5c6fec462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d55cfea1-b6e4-45f1-b05f-cda5c6fec462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanOfferingPeriod_6d3cb015-289e-400e-9450-d7631fc2caf2" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_nstg_EmployeeStockPurchasePlanOfferingPeriod_6d3cb015-289e-400e-9450-d7631fc2caf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanPurchasePeriod_31f50f15-af0c-429e-b203-863c7c710eef" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanPurchasePeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_nstg_EmployeeStockPurchasePlanPurchasePeriod_31f50f15-af0c-429e-b203-863c7c710eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EmployeeStockPurchasePlanContributionPercentage_38e1d94a-3469-40bf-bd29-c91749716bb6" xlink:href="nstg-20221231.xsd#nstg_EmployeeStockPurchasePlanContributionPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_nstg_EmployeeStockPurchasePlanContributionPercentage_38e1d94a-3469-40bf-bd29-c91749716bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c1f35607-ed1c-4de9-b675-e42ff9ea57f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c1f35607-ed1c-4de9-b675-e42ff9ea57f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8fbbb7ab-23b4-4b90-a59e-d948b742ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8fbbb7ab-23b4-4b90-a59e-d948b742ae93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7d5788e5-3bd0-488c-a9de-38288644058d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7d5788e5-3bd0-488c-a9de-38288644058d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_59bfba0e-4a78-4cbc-8bbc-50736ea2371d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_59bfba0e-4a78-4cbc-8bbc-50736ea2371d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f04cae8c-f2ad-4ed9-900c-120f95354e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f04cae8c-f2ad-4ed9-900c-120f95354e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_28352261-d256-487b-b21a-428f85e0f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7f1b998-09f9-4205-9897-3abbab1eae0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_28352261-d256-487b-b21a-428f85e0f7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationStockOptionActivityandRelatedInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2912917a-3b0e-4124-b8d8-ed9bd52ac000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2912917a-3b0e-4124-b8d8-ed9bd52ac000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3fceace9-9c74-4f25-adfb-0c9ec5cce941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2912917a-3b0e-4124-b8d8-ed9bd52ac000" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3fceace9-9c74-4f25-adfb-0c9ec5cce941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0716e27e-984b-4d58-8112-34f1407cefa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2912917a-3b0e-4124-b8d8-ed9bd52ac000" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0716e27e-984b-4d58-8112-34f1407cefa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_040fb912-eea9-4fa5-ae76-4aa24460fb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2912917a-3b0e-4124-b8d8-ed9bd52ac000" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_040fb912-eea9-4fa5-ae76-4aa24460fb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59cb5ab8-6f61-4c28-b684-ff8d0d43319e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2912917a-3b0e-4124-b8d8-ed9bd52ac000" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59cb5ab8-6f61-4c28-b684-ff8d0d43319e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_57896131-c1a4-4f1d-9797-ee8687539221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_57896131-c1a4-4f1d-9797-ee8687539221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2dd0dccb-53d6-49c9-ab99-4ce4807bf1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2dd0dccb-53d6-49c9-ab99-4ce4807bf1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42119cec-e486-4bd4-a0e8-0aa065228043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42119cec-e486-4bd4-a0e8-0aa065228043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7f232de2-83ad-4a33-90f8-c5cb460a2813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42119cec-e486-4bd4-a0e8-0aa065228043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7f232de2-83ad-4a33-90f8-c5cb460a2813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_a6fb9ff1-27f4-46dd-846a-d0dfc3f0e19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42119cec-e486-4bd4-a0e8-0aa065228043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_a6fb9ff1-27f4-46dd-846a-d0dfc3f0e19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ca0fc816-bdb4-4441-ba3a-fc3d10576c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42119cec-e486-4bd4-a0e8-0aa065228043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ca0fc816-bdb4-4441-ba3a-fc3d10576c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e19a2c1-5b22-46cc-9531-c7959a027c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42119cec-e486-4bd4-a0e8-0aa065228043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e19a2c1-5b22-46cc-9531-c7959a027c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17fe1bc4-057a-4140-bd97-5fdc14b12759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17fe1bc4-057a-4140-bd97-5fdc14b12759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_63b109e0-e147-4958-b13c-6cda64b37347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_63b109e0-e147-4958-b13c-6cda64b37347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_e61af9f5-6688-4a47-ac36-04edf4264857" xlink:href="nstg-20221231.xsd#nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_e61af9f5-6688-4a47-ac36-04edf4264857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5294031d-5e34-44b2-b385-1668c6c4eb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_e61af9f5-6688-4a47-ac36-04edf4264857" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5294031d-5e34-44b2-b385-1668c6c4eb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c3a5746a-1650-42d7-bad8-cf80ca58c6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_e61af9f5-6688-4a47-ac36-04edf4264857" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c3a5746a-1650-42d7-bad8-cf80ca58c6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_78a68f3c-a5d8-4dc2-94e7-8149b5f2fa77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_e61af9f5-6688-4a47-ac36-04edf4264857" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_78a68f3c-a5d8-4dc2-94e7-8149b5f2fa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_51e946f3-4490-41dd-a1d2-a608b82c8245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dae4c006-f556-4ad7-aeff-83d4653ac786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_51e946f3-4490-41dd-a1d2-a608b82c8245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_468228cc-f34b-44cb-a74b-9835f70a3a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_51e946f3-4490-41dd-a1d2-a608b82c8245" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_468228cc-f34b-44cb-a74b-9835f70a3a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_623b8225-07bc-44a1-b4b8-bd8d3e042700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_51e946f3-4490-41dd-a1d2-a608b82c8245" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_623b8225-07bc-44a1-b4b8-bd8d3e042700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c935124f-9c6a-420c-b5ec-1475b2469cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_51e946f3-4490-41dd-a1d2-a608b82c8245" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c935124f-9c6a-420c-b5ec-1475b2469cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationCompanysOptionsOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8959720f-03eb-450a-8fbb-21cc62e1c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8959720f-03eb-450a-8fbb-21cc62e1c68f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_52452587-b4b3-4999-837f-3f5ad158625b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeOneMember_16247aa3-cd7a-41da-a80f-f01c1701e04a" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeOneMember_16247aa3-cd7a-41da-a80f-f01c1701e04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeTwoMember_0ca6b79a-86bc-40d1-aa98-10e8a34c5de7" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeTwoMember_0ca6b79a-86bc-40d1-aa98-10e8a34c5de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeThreeMember_dc4b9393-670d-4ac9-8bbe-5c3f7a628727" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeThreeMember_dc4b9393-670d-4ac9-8bbe-5c3f7a628727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeFourMember_16f9a662-db30-4a9f-a924-c90640255dcc" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeFourMember_16f9a662-db30-4a9f-a924-c90640255dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_ExercisePriceRangeFiveMember_6fdebbc7-2650-497c-add1-ae24a089b43c" xlink:href="nstg-20221231.xsd#nstg_ExercisePriceRangeFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99ae69ef-71fb-4cac-839b-f913490649a2" xlink:to="loc_nstg_ExercisePriceRangeFiveMember_6fdebbc7-2650-497c-add1-ae24a089b43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:to="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd64eadf-af81-42f7-b692-b7a5462326d4" xlink:to="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7d55efc-600b-49c8-a609-b144b34ac56a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:to="loc_srt_MinimumMember_e7d55efc-600b-49c8-a609-b144b34ac56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e5f45372-2ad0-4ebc-bf07-9c5936422cab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ce185f3-839c-496c-9a1a-4dc7e5136bf5" xlink:to="loc_srt_MaximumMember_e5f45372-2ad0-4ebc-bf07-9c5936422cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_a96ba9b5-7897-471e-9e4e-376149b0300a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b89e9afa-d2bd-45d7-a4ed-24242b122f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b89e9afa-d2bd-45d7-a4ed-24242b122f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_66b2e4cf-633e-4614-9d20-22f12b2a9043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_66b2e4cf-633e-4614-9d20-22f12b2a9043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_531a3362-0c35-49d9-982c-c319bef13bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_531a3362-0c35-49d9-982c-c319bef13bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_20e19030-8e37-4068-9517-803d9a9d517c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_20e19030-8e37-4068-9517-803d9a9d517c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_92ab4240-d449-4426-91ae-fe2f5a8bf5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_2784e669-577d-4458-84df-8f006220b9df" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_92ab4240-d449-4426-91ae-fe2f5a8bf5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9cf4e244-1078-4b20-8a03-e903e61e3ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9cf4e244-1078-4b20-8a03-e903e61e3ade" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:to="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ac2572b-ea0e-4f6e-a27b-1e11eda493b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_abd8ae5b-b58b-4d12-80ed-d0df8f3d02de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ac2572b-ea0e-4f6e-a27b-1e11eda493b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2eebe347-e004-43c5-9f0e-84dfee0e79fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ac2572b-ea0e-4f6e-a27b-1e11eda493b1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2eebe347-e004-43c5-9f0e-84dfee0e79fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d4a69cd-87fa-4d25-b6a0-70fbf23e8ea7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_849fb0b0-da80-4801-9dd3-ec61948dad28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_849fb0b0-da80-4801-9dd3-ec61948dad28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c4863a72-8eb0-49f2-96c0-9857d8afe349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c4863a72-8eb0-49f2-96c0-9857d8afe349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e3fb7b6e-1936-4fc5-a756-bedd5efe3888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e3fb7b6e-1936-4fc5-a756-bedd5efe3888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2c2a37dc-5560-4ddf-8889-95b686d1bceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2c2a37dc-5560-4ddf-8889-95b686d1bceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_452ebfe5-e103-471b-b358-532d677d09ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a9dfa5f-ed76-44fb-afbe-849c5af83481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_452ebfe5-e103-471b-b358-532d677d09ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9d143e5-4dae-4a9b-8a68-976902c19d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9d143e5-4dae-4a9b-8a68-976902c19d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b77ca852-03f9-4ae4-840f-0dc24e130f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b77ca852-03f9-4ae4-840f-0dc24e130f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4267e133-d7bc-4a9e-ad87-e7c84b49b4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4267e133-d7bc-4a9e-ad87-e7c84b49b4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6eeed700-675a-46ae-a209-4094cf7f4edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6eeed700-675a-46ae-a209-4094cf7f4edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_435918ac-d687-4939-89a4-7e0ffd350dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a71f847e-58c0-4734-9c79-610f39a90c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_435918ac-d687-4939-89a4-7e0ffd350dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_bd000ba7-bf82-420f-910f-0d078e8c70d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_bd000ba7-bf82-420f-910f-0d078e8c70d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5edb6fbf-d91f-41bd-9724-57661d5ca266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5edb6fbf-d91f-41bd-9724-57661d5ca266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_04579b07-952e-469d-9529-abff132fa29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_04579b07-952e-469d-9529-abff132fa29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_cdd487bf-7ca6-46e4-873c-a6eafce6521c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c5bd490-67b5-4af9-9302-31154956820e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_cdd487bf-7ca6-46e4-873c-a6eafce6521c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationStockCompensationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41146eb6-3310-4817-8271-1d94c2b8f5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41146eb6-3310-4817-8271-1d94c2b8f5e0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_52098a37-dddb-4ffe-97a9-641bf9abf61a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_CostOfRevenueMember_d8f6081c-5b56-4384-8d8a-6bbf2f5e4801" xlink:href="nstg-20221231.xsd#nstg_CostOfRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:to="loc_nstg_CostOfRevenueMember_d8f6081c-5b56-4384-8d8a-6bbf2f5e4801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fcb3b278-3e7a-4906-810e-7d5aeab0fd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fcb3b278-3e7a-4906-810e-7d5aeab0fd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dca98aed-9b62-4ef8-a4ab-75f955276d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23c40188-9b59-4984-a932-eeb04f72bb7f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dca98aed-9b62-4ef8-a4ab-75f955276d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_25fb46b2-6175-488c-a983-fe9ceb7769b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cff2cea9-fbc4-465b-90bd-7768db95ac64" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_25fb46b2-6175-488c-a983-fe9ceb7769b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8fa80771-7ea2-4366-8f9b-a82ade13a0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_25fb46b2-6175-488c-a983-fe9ceb7769b3" xlink:to="loc_us-gaap_ShareBasedCompensation_8fa80771-7ea2-4366-8f9b-a82ade13a0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#StockbasedCompensationFairValueofEmployeeOptionGrantDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67052ce0-055f-4a55-bb28-d4801dbe3114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67052ce0-055f-4a55-bb28-d4801dbe3114" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:to="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_44e080a2-e960-4348-9806-44171bee89a7" xlink:to="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f5efba46-176d-4a8c-b4bb-de33f4dfd9cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:to="loc_srt_MinimumMember_f5efba46-176d-4a8c-b4bb-de33f4dfd9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_28f863ca-f826-4437-9ec7-b83ffeba43ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b49b5d1-acd0-4292-bd62-1e2060a59420" xlink:to="loc_srt_MaximumMember_28f863ca-f826-4437-9ec7-b83ffeba43ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e12b5db2-d247-4e27-8ad4-0abb1d2d3866" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_33b54a45-b380-4b2c-96d7-9d107bbb9c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_33b54a45-b380-4b2c-96d7-9d107bbb9c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_342ae3be-a576-406f-bfad-a75daa604ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_342ae3be-a576-406f-bfad-a75daa604ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ddb86f1-10c8-4d6d-8ea5-803d9aa9d8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ddb86f1-10c8-4d6d-8ea5-803d9aa9d8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f6b42857-542d-43b2-96f5-6bbdc908a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a421efd6-1477-4126-bc9b-acf33d02036b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f6b42857-542d-43b2-96f5-6bbdc908a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/DefinedContributionRetirementPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#DefinedContributionRetirementPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/DefinedContributionRetirementPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d430b7f0-bc32-4e2a-9438-47825361280a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_d05e3e66-abc8-4646-af03-24bb0f917b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d430b7f0-bc32-4e2a-9438-47825361280a" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_d05e3e66-abc8-4646-af03-24bb0f917b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9cb7b0c1-a46d-45b8-8ed7-7b6f723f3d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b6c532d6-f395-4c2c-a23e-12d328c59592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cb7b0c1-a46d-45b8-8ed7-7b6f723f3d06" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b6c532d6-f395-4c2c-a23e-12d328c59592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9accf455-8432-4ff3-9d1a-2f63496637ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cb7b0c1-a46d-45b8-8ed7-7b6f723f3d06" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9accf455-8432-4ff3-9d1a-2f63496637ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec1ebef3-5984-42db-98b2-453be9d11d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cb7b0c1-a46d-45b8-8ed7-7b6f723f3d06" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec1ebef3-5984-42db-98b2-453be9d11d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_635cedd4-0519-4e2f-8397-fc39d373646c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_635cedd4-0519-4e2f-8397-fc39d373646c" xlink:to="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:to="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_6a041483-9731-4ba5-911a-60c7038c15bb" xlink:to="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_3745eaf8-d743-4aa0-8a88-7c687d0cb945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_3745eaf8-d743-4aa0-8a88-7c687d0cb945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_956dbc24-67b2-4ec5-b651-7857f9a2e61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_6e2809d7-82cf-4d86-a641-f4dfbd808453" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_956dbc24-67b2-4ec5-b651-7857f9a2e61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_882143ae-5ba7-4b24-8afd-f530922a6501" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable_3f6ca70d-be23-437c-abd5-b60008945bff" xlink:to="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_882143ae-5ba7-4b24-8afd-f530922a6501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_882143ae-5ba7-4b24-8afd-f530922a6501" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_76c821d6-3a44-46b7-8825-16737707e8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_76c821d6-3a44-46b7-8825-16737707e8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b18de9bc-9fa0-436c-bbb4-6849fcf06d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_25f03865-471b-4412-88bd-0bf7cc4564f8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b18de9bc-9fa0-436c-bbb4-6849fcf06d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fb5abc8f-7f8c-4a13-9a59-fc3fe32642e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb5abc8f-7f8c-4a13-9a59-fc3fe32642e4" xlink:to="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0d739a64-15c8-4c44-914b-93cd06946047" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_FederalAndStateMember_f4c5320b-1dee-424c-86a3-3b673bb219de" xlink:href="nstg-20221231.xsd#nstg_FederalAndStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:to="loc_nstg_FederalAndStateMember_f4c5320b-1dee-424c-86a3-3b673bb219de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_8bf32e7c-02bc-4fa9-9b44-f7f36246b68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_56319d7c-8993-457e-9af8-303e24d8cf9e" xlink:to="loc_us-gaap_DomesticCountryMember_8bf32e7c-02bc-4fa9-9b44-f7f36246b68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxesAndTaxRelatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedTable_0ca678de-bd32-4283-9f05-37449134746b" xlink:to="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5ca0b7f6-8e7a-4e55-a419-193b70b26cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5ca0b7f6-8e7a-4e55-a419-193b70b26cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e0ab097b-71f3-41b9-9e39-54e64e5eb90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e0ab097b-71f3-41b9-9e39-54e64e5eb90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_ae638f06-ab04-48cb-b435-b3963c3beeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_ae638f06-ab04-48cb-b435-b3963c3beeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_aef8da47-4e75-4f87-950f-399d391e0e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nstg_IncomeTaxesAndTaxRelatedLineItems_679f643d-07db-4346-afc0-fd6bcd76e506" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_aef8da47-4e75-4f87-950f-399d391e0e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_67da4008-37b9-4db4-9381-1125948b79ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_67da4008-37b9-4db4-9381-1125948b79ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_9e2895da-1f04-4cfd-b51c-bf27098682bb" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts_9e2895da-1f04-4cfd-b51c-bf27098682bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_dcd30d09-0bf4-40e8-81e9-3aba47f1800b" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxReconciliationSection162Limitation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_nstg_EffectiveIncomeTaxReconciliationSection162Limitation_dcd30d09-0bf4-40e8-81e9-3aba47f1800b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_IncomeTaxReconciliationChangeInTaxCredits_0f8333a4-9399-49f5-ae22-11fc2381df90" xlink:href="nstg-20221231.xsd#nstg_IncomeTaxReconciliationChangeInTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_nstg_IncomeTaxReconciliationChangeInTaxCredits_0f8333a4-9399-49f5-ae22-11fc2381df90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_99c1f996-e8cf-493a-ae4c-d4cdaeca38ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_99c1f996-e8cf-493a-ae4c-d4cdaeca38ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_4a94db2d-fc00-4d80-802f-58ca1ba7ec96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_4a94db2d-fc00-4d80-802f-58ca1ba7ec96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_6758033a-efc0-477d-841c-36b80d50fcf7" xlink:href="nstg-20221231.xsd#nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall_6758033a-efc0-477d-841c-36b80d50fcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_435c74d8-d8ea-453c-bc12-df0ac972bb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_435c74d8-d8ea-453c-bc12-df0ac972bb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_09a86456-6746-40b9-a2bd-18f99210257a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_09a86456-6746-40b9-a2bd-18f99210257a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e9f365eb-4a9d-421b-82c3-1220b04d25ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_251b1d83-0180-4729-adb5-4e345ddb57b2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e9f365eb-4a9d-421b-82c3-1220b04d25ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_93a3146c-baf9-4a77-a76e-24806101775d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_93a3146c-baf9-4a77-a76e-24806101775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_9c50d0ca-b664-414b-8204-19802ec0cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_9c50d0ca-b664-414b-8204-19802ec0cdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxAssetsSection174Capitalization_3ae84d1a-bc8f-4a19-854b-cf67fe9d3871" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxAssetsSection174Capitalization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_nstg_DeferredTaxAssetsSection174Capitalization_3ae84d1a-bc8f-4a19-854b-cf67fe9d3871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxAssetsDeferredLeaseLiability_3f93fbe5-fd20-40ee-ac1c-ea883e730b86" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxAssetsDeferredLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_nstg_DeferredTaxAssetsDeferredLeaseLiability_3f93fbe5-fd20-40ee-ac1c-ea883e730b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d46c32a6-e3d8-45eb-91de-13ba8594e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d46c32a6-e3d8-45eb-91de-13ba8594e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_7cab5113-9f42-4b48-afdd-635aa2f2b9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_7cab5113-9f42-4b48-afdd-635aa2f2b9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_cbf102cb-e44c-4156-9c41-5683922a1665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_cbf102cb-e44c-4156-9c41-5683922a1665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1b3f9b51-7488-410a-8704-4c1cf2bb8303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1b3f9b51-7488-410a-8704-4c1cf2bb8303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_09b18e6f-a3c7-4005-b9a0-61a81a1d5e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_09b18e6f-a3c7-4005-b9a0-61a81a1d5e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8052f960-b925-4b2d-a81d-e337489ea5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_8052f960-b925-4b2d-a81d-e337489ea5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_27f90b11-67c0-443c-883a-643ac0d36dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_27f90b11-67c0-443c-883a-643ac0d36dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_01199223-ce75-41ae-96e4-33a1eb3f01ec" xlink:href="nstg-20221231.xsd#nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments_01199223-ce75-41ae-96e4-33a1eb3f01ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4d2bb174-9956-4d4b-bc76-4ceeb43b0ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_4d2bb174-9956-4d4b-bc76-4ceeb43b0ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1c36d176-7671-4a60-95a0-421bbb27de9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_083c9cd2-1781-4dde-baae-0b82cf439511" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1c36d176-7671-4a60-95a0-421bbb27de9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a83c2f3f-5eea-4148-abd3-5d77f68f3eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a83c2f3f-5eea-4148-abd3-5d77f68f3eeb" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_53be5d8f-e121-4bb0-ae33-323b87179890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_82b2c677-ab9a-4ef8-8541-ffb67ec6dec3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_53be5d8f-e121-4bb0-ae33-323b87179890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_9d77e0cf-5e78-463e-afaf-8bf6106e2ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_53be5d8f-e121-4bb0-ae33-323b87179890" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_9d77e0cf-5e78-463e-afaf-8bf6106e2ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0589716-c827-4cac-b544-f212b8b587ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f99d87a-dc98-4c6a-af41-359e183137b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0589716-c827-4cac-b544-f212b8b587ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0ca1abf3-e073-498a-a0c0-d1be6c11cae3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0589716-c827-4cac-b544-f212b8b587ad" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0ca1abf3-e073-498a-a0c0-d1be6c11cae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_012c943f-ac2f-4fd4-9783-8494407db43b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bc9bebce-13ce-4e44-a3be-228b11a426e3" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_012c943f-ac2f-4fd4-9783-8494407db43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_012c943f-ac2f-4fd4-9783-8494407db43b" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7c75adcd-f779-4dc1-b0e2-9ec6ecee8e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7c75adcd-f779-4dc1-b0e2-9ec6ecee8e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f158cef3-d626-4351-98b8-6700d5cf58be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f158cef3-d626-4351-98b8-6700d5cf58be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_2854bb0d-1455-4735-ae25-0aad70473efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_2854bb0d-1455-4735-ae25-0aad70473efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3e260e6f-f1e2-4128-bec3-116cac2ea523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_6074e24e-7006-457e-a2cf-c5ceee48e553" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3e260e6f-f1e2-4128-bec3-116cac2ea523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1c9ca43e-2e5d-420a-9c75-aa51bb788d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aa899530-b8a4-43cc-a3a8-033b846d1044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1c9ca43e-2e5d-420a-9c75-aa51bb788d42" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aa899530-b8a4-43cc-a3a8-033b846d1044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_17e6b3a1-db4b-408e-a1ec-f208a095eda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aa899530-b8a4-43cc-a3a8-033b846d1044" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_17e6b3a1-db4b-408e-a1ec-f208a095eda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions_3f1a1100-341d-4fe7-b5f1-782a0fe631a9" xlink:href="nstg-20221231.xsd#nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aa899530-b8a4-43cc-a3a8-033b846d1044" xlink:to="loc_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions_3f1a1100-341d-4fe7-b5f1-782a0fe631a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ef57c0db-c42d-415f-b4e7-a92cc04e9fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aa899530-b8a4-43cc-a3a8-033b846d1044" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ef57c0db-c42d-415f-b4e7-a92cc04e9fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="nstg-20221231.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b200425c-310a-433a-bb64-c4a13fd8cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_fc551dc0-b46c-440c-8fe4-a6359a9324ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b200425c-310a-433a-bb64-c4a13fd8cfed" xlink:to="loc_us-gaap_PurchaseObligation_fc551dc0-b46c-440c-8fe4-a6359a9324ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_98ec5623-0f9d-44ab-891c-849077953dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b200425c-310a-433a-bb64-c4a13fd8cfed" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_98ec5623-0f9d-44ab-891c-849077953dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b200425c-310a-433a-bb64-c4a13fd8cfed" xlink:to="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_26534a3e-49dd-47cb-90aa-cf845f5be2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis_a96a42ca-0c29-4ec5-ba54-8425f77eeb54" xlink:to="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_26534a3e-49dd-47cb-90aa-cf845f5be2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionMember_154e8cfe-44d4-47ee-a421-b95a736740f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain_26534a3e-49dd-47cb-90aa-cf845f5be2eb" xlink:to="loc_us-gaap_ConstructionMember_154e8cfe-44d4-47ee-a421-b95a736740f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f6f913f4-8cd9-4a52-a58c-c41da9c48731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_d4549c97-35df-45e9-8457-e1cf08606b1c" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_f6f913f4-8cd9-4a52-a58c-c41da9c48731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_f3ceddca-8532-4a4d-9d49-b281638e1cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f6f913f4-8cd9-4a52-a58c-c41da9c48731" xlink:to="loc_us-gaap_ContractualObligation_f3ceddca-8532-4a4d-9d49-b281638e1cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/NetLossPerShareDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#NetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/NetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_484ba46f-8cb9-435f-8ea9-2ee252d19777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_484ba46f-8cb9-435f-8ea9-2ee252d19777" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d54b5732-9bed-4dff-999f-e601faf7048a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4c99fa7b-2f3c-40f3-8512-935916d932a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4c99fa7b-2f3c-40f3-8512-935916d932a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_81107469-59fd-4bef-a4f0-56aa1520bcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_81107469-59fd-4bef-a4f0-56aa1520bcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f2ae2371-289c-4314-8e37-25749b4f3be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae3ccc58-7c8d-466a-a394-65d3031f37a9" xlink:to="loc_us-gaap_WarrantMember_f2ae2371-289c-4314-8e37-25749b4f3be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c2d76ffb-55ca-45ac-af9e-3d3ca4d857eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4802364c-c693-49e8-a0c2-323645552fbc" xlink:to="loc_us-gaap_EquityComponentDomain_c2d76ffb-55ca-45ac-af9e-3d3ca4d857eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_17f400d0-4281-483b-a962-1c42992d8798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c2d76ffb-55ca-45ac-af9e-3d3ca4d857eb" xlink:to="loc_us-gaap_CommonStockMember_17f400d0-4281-483b-a962-1c42992d8798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_44e2f266-b55c-4f2a-a5f5-e5e3d5b97fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_feb69bb2-3234-49be-a000-3861e3135eff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_44e2f266-b55c-4f2a-a5f5-e5e3d5b97fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dfd0e39f-41fb-42a7-9e21-8633ba267482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_44e2f266-b55c-4f2a-a5f5-e5e3d5b97fa5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dfd0e39f-41fb-42a7-9e21-8633ba267482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nanostring.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="nstg-20221231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.nanostring.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d54c44ed-25c9-4b50-9fa6-e61020f24568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1e890246-90df-495a-ae5c-a81834db45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d54c44ed-25c9-4b50-9fa6-e61020f24568" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1e890246-90df-495a-ae5c-a81834db45b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d54c44ed-25c9-4b50-9fa6-e61020f24568" xlink:to="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_35d96305-6a43-4dbb-b1af-9ba49859768a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_00152196-e43f-4cab-83cd-c5ddff5be492" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_35d96305-6a43-4dbb-b1af-9ba49859768a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_687e4f3b-f5f7-4226-961e-c03ef45ac128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_35d96305-6a43-4dbb-b1af-9ba49859768a" xlink:to="loc_us-gaap_SubsequentEventMember_687e4f3b-f5f7-4226-961e-c03ef45ac128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_6cf65f33-eedd-4e51-a0b8-0b247cc1912d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7db7a650-3bd0-4807-931b-8d255170eb07" xlink:to="loc_us-gaap_SubsequentEventLineItems_6cf65f33-eedd-4e51-a0b8-0b247cc1912d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3454ef8b-44c9-4b12-9916-12de021ca88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_6cf65f33-eedd-4e51-a0b8-0b247cc1912d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3454ef8b-44c9-4b12-9916-12de021ca88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>nstg-20221231_g1.jpg
<TEXT>
begin 644 nstg-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1O%7P]NM6B.JZG92^1+;VB$O(LL,AW*SHA0%#( SKDU^RD:+$BJJJJJ,  8
M%1*W0%<=1114E!1110 4452\2>)=/\'>'[S5M7OK/2]+TV%KB[O+N988+:)1
MEG=V(55 !)).!0!=HKX_^-7_  7(_9_^$1FAL=?U+QK?19'D:!9&6/=V_?2F
M.(CW1FQZ=JZ3_@G!_P %&H_^"A47C:\MO"K>%['PK<6L%N);[[5-="9926?"
M*$QY8X&[KUI\KW ^G****0!1110 4444 %%%% !1110 4444 %%%% !1110
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MMYI6O;B2(P&%9  NWKGS#U]*TEJB$?T#T5^0?_$2;XX_Z)KX5_\  ^XKT?\
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M'D@212*2DB$@C<A(R".H('].%>!_\%'_ -C/3?VUOV9M9\/O:PMXFTV&2_\
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MYW*1C(!4G#&OK3_@X._8ITSP=>:/\9/#MC'9_P!MWG]E^(XH$"I+<LK/#=$
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M#LY5#)"@/W964AI&X8;MG 5MUR:6HCXK^ ?_  ;^?&+XIZ1!J/BB^T'P!:W
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M^TS_ -%W-?DQ7ZS_ /!M-_R)'Q;_ .O[3/\ T7<UM+8B.Y^GM%%%8EA1110
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MIM.& (S@@'BJ4D*Q]!?\&SMW&EU\:("RB:1-$=5[E5.H G\-R_G7ZK5^;_\
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M )*K2#T)D?7W_!M-_P B1\6_^O[3/_1=S7Z>U\(_\$//V-/B5^Q]X6^(EO\
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M,^--9\8>&?$.J>"_%>N7,E[>B53J&GW<[L6=S&S"2-F8G)5RH[)VKX,^+_\
MP0I_:!^&,L\FFZ'I'C2QARWGZ+J4>\KV/E3^7(6_V45OQ'-:KEL3J?7G@/\
MX.2? .H6R_\ "4?#OQAI,V!N&EW-MJ"YP>AD: ]<=N_MSVEU_P '#OP(M[1I
M%TOXBSNH!$2:5;AV]OFN OYFOR7\6?L5?&'P--(FK?"WX@V0C#$R/H%T8B%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXJ_[])_\51RQ"[/NG_B)9T/_ *))JO\ X/X__C%'_$2SH?\ T235?_!_'_\
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M (Q7PM_PZR_:%_Z)/XJ_[])_\51_PZR_:%_Z)/XJ_P"_2?\ Q5'+$+L^Z?\
MB)9T/_HDFJ_^#^/_ .,4?\1+.A_]$DU7_P '\?\ \8KX6_X=9?M"_P#1)_%7
M_?I/_BJ/^'67[0O_ $2?Q5_WZ3_XJCEB%V?=/_$2SH?_ $235?\ P?Q__&*/
M^(EG0_\ HDFJ_P#@_C_^,5\+?\.LOVA?^B3^*O\ OTG_ ,51_P .LOVA?^B3
M^*O^_2?_ !5'+$+L^Z?^(EG0_P#HDFJ_^#^/_P",4?\ $2SH?_1)-5_\'\?_
M ,8KX6_X=9?M"_\ 1)_%7_?I/_BJ/^'67[0O_1)_%7_?I/\ XJCEB%V?=/\
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M%_Z)/XJ_[])_\51RQ"[/NG_B)9T/_HDFJ_\ @_C_ /C%'_$2SH?_ $235?\
MP?Q__&*^%O\ AUE^T+_T2?Q5_P!^D_\ BJ/^'67[0O\ T2?Q5_WZ3_XJCEB%
MV?=/_$2SH?\ T235?_!_'_\ &*/^(EG0_P#HDFJ_^#^/_P",5\+?\.LOVA?^
MB3^*O^_2?_%4?\.LOVA?^B3^*O\ OTG_ ,51RQ"[/NG_ (B6=#_Z))JO_@_C
M_P#C%'_$2SH?_1)-5_\ !_'_ /&*^%O^'67[0O\ T2?Q5_WZ3_XJC_AUE^T+
M_P!$G\5?]^D_^*HY8A=GW3_Q$LZ'_P!$DU7_ ,'\?_QBC_B)9T/_ *))JO\
MX/X__C%?"W_#K+]H7_HD_BK_ +])_P#%4?\ #K+]H7_HD_BK_OTG_P 51RQ"
M[/T]A_:4D_:ET[PWXT;2I-#AUFQ2>&PDN1<-;IABN7 4'/WN@QNQVK3TOQM-
MX?NV=/WD<@PZ$XSZ8KROX1^&-:^&/PD\$Z-XBTNXT36M'TBUL[NSN$V20.D2
MIR,GJ!G/?.:Z2\O\YYK^0N)LTJT\XQ4KVDJDOSM_P#SW4:D_4]$;XI6=P/F:
M2$^C+G^6:B;XCV>?^/E?R->837V:@-[S]XUX,N)L3UL'UB1ZROQ+LHA_KRWL
MJFJ>L_$MM7MS;PJT<+?>+'YF]O:O-8[WG[WYU;MK[FC_ %CQ$UR-V3[!]8;T
M.HN-7DM[NSN(W9)87RK \J>"#^&*X+XB?\'$^D_#GX@:YX>G^%>I74V@ZA<:
M=),FO(JS-#(T98#R. 2N<>]=%]K,[QK_ '>:^!?CK_P36^._C+XW>,M8TOX8
M>)[S3=6UR]O+2X2%=L\,EP[HX^;H5(/XU^K>"N.E6S#'TOLVIOYV:.RG?E3/
MK_\ XB6=#_Z))JO_ (/X_P#XQ1_Q$LZ'_P!$DU7_ ,'\?_QBOA;_ (=9?M"_
M]$G\5?\ ?I/_ (JC_AUE^T+_ -$G\5?]^D_^*K^A>6)I=GW3_P 1+.A_]$DU
M7_P?Q_\ QBC_ (B6=#_Z))JO_@_C_P#C%?"W_#K+]H7_ *)/XJ_[])_\51_P
MZR_:%_Z)/XJ_[])_\51RQ"[/NG_B)9T/_HDFJ_\ @_C_ /C%'_$2SH?_ $23
M5?\ P?Q__&*^%O\ AUE^T+_T2?Q5_P!^D_\ BJ/^'67[0O\ T2?Q5_WZ3_XJ
MCEB%V?=/_$2SH?\ T235?_!_'_\ &*/^(EG0_P#HDFJ_^#^/_P",5\+?\.LO
MVA?^B3^*O^_2?_%4?\.LOVA?^B3^*O\ OTG_ ,51RQ"[/NG_ (B6=#_Z))JO
M_@_C_P#C%'_$2SH?_1)-5_\ !_'_ /&*^%O^'67[0O\ T2?Q5_WZ3_XJC_AU
ME^T+_P!$G\5?]^D_^*HY8A=GZ0?#S_@J!#^WWX#UF.Q\(W7A6W\/W4!<S:BM
MV;MI%EX&V--NW;WSG>/0UU$6NR:3+#)$VUX,;?PKY@_8+_9P^(7[./PP\2V'
MCOPGJOA=K[4([BS-XFW[3^[*OMP2/EVK_P!]5[R=3\^T1L_>49K^7_$G'SI\
M0UHWV4+?^ I_FSAJ2:FST%/BS!.@\]7AD[X^9?\ &F/\1[,]+D?D?\*\QGOL
MDU7>]Y^]^5?#3XFQ/5ID_6&>K)\2+)>3<?DI/]*;<_%I4B*VJLTAZ._ 7\.]
M>5I>\_>_.K,%]@]:F/$V)>B=O0/K$F=9=ZF;JPFW-N+#<2>YZUR_Q9_X+'6O
M[#C:)X/U#P'?>)O.L/MT5[#JBVJ@--*IC*M&V2NW.<]&'%6UOLVY7^]Q7RW_
M ,% ?V._BE^T;X^\/ZEX'\"Z[XDTNQTO[/+=VD:M$LIFD)CR6!W!=I/LPK[?
MPKS"4^*?9)Z.D[_)W7XG51ORW/:_^(EG0_\ HDFJ_P#@_C_^,4?\1+.A_P#1
M)-5_\'\?_P 8KX6_X=9?M"_]$G\5?]^D_P#BJ/\ AUE^T+_T2?Q5_P!^D_\
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M_5>/^ 5\ZB_,B;6/SKP??WK]"_&_@VR\?^%[O2=03=;W28R/O1MU5A[@\_\
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M4#.!G-%%?J/AOP;DN$PD,QH8=>V?VG>37IS-\ORL!UU%%%?JX!1110 4444
M%%%% !1110 4444 %-N(([N!XI8UDCD4JZ.-RL#U!'<444-75F!X]\1OV-]#
M\43R7.CW#:+<2$L8MGF6['V7(*_@2!V%>->-OV6M8\%3QK<W6DR^;N*F*23H
M,=<I[BBBOYV\4N"<CP\5C,/AU"<M^5RBMU]E-17R0%SP-^R+K'C*+SH[[28+
M=7V.6>1G&,9(&S!Z^HKVKX8_LG^'? %Q'=WA;6[^,Y5[A L,9]5CYY_WBW(R
M,&BBN_PMX)R.='Z_4PZE5BU9R;E;S2;:OV=KKH!ZE1117[T 4444 %%%% !1
M110 4444 4?$?AJP\7:3)8ZE:PWEK-]Z.09'U!Z@CU'(KP_QW^P];WDDDWA_
M5/L^[D6UZI91])%Y ]BI/O117QO&7"F4YMA)U,PH1G*$7:6JDO\ MY-.WE>P
M'D_B+]G;5/#FJ/:SW&FM(F,F.1RO(SW05V'@G]BC5->@@NKK5M-M;29 X,*O
M-(,C.-I"COZT45_-_"O!^48S./JN)I<T+VMS377RDF![E\+_ (#>'_A2HDL;
M=KB_QAKRXPTON%XPHY[ 9'4FNTHHK^M,MRO"9?AUA<%35.$=E%67_#]V]7U
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E_A[0M'A>'P_X99UVM+$LG[RXN"/^6TH!7/"@A2/H>BBI91__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>nstg-20221231_g10.jpg
<TEXT>
begin 644 nstg-20221231_g10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %N 8@# 2(  A$! Q$!_\0
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M@Y!%<DH2@[21Z5.K"HKP=Q:***DT"BBB@ HHHH **** "BBB@ HHHH ****
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M6/-!W04445)H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%07M[;:;8RWE],D%O"NYY'. HH$VDKLF9@JEF(  R2>U>4^./B_':&73O"
MC+-.,J]]U1#_ + Z,??I]:Y7Q]\3;OQ+))8:4SVNE D$#A[CW;T'^S^?MP%>
ME0PMO>J?<>#B\R;]RC]_^1+<W4][<O<7<TD\TAW/)(Q9F/N345%%>@>)N%%:
M_A_POJWB>\^SZ1:-+@_/*W$<?^\W0?3K[5Z[H7PM\/\ AJ)+OQ),FHW0Y$;#
M]T#[)U;\>/85C4K1AIU['50PE6MJM%W9Y1X?\&Z[XF<?V58N\6>;B3Y(QS_>
M/7Z#)KTW1O@OIE@J3^)M1-RP.3#"?+C/L3]X_ABNBU/QS:640@TY5 4 *L8'
MRC^0^G-<;J'B;4+]CF4Q*?[IR?S_ ,,5S<U>K\/NH[XTL+0W]Y_@=U%>>&?"
ML'EZ796UM@?>50K-]3]YJR;[XB,21:(Q'JHV@_B<FN$9BS%F))/4D]:2JCA(
M[S=QRQ=1JT=%Y&Y=^+=3NOXU3GKRQ_6LZ75+Z?\ UEU*?8-@?D*J#+,%12[,
M0 JC))/05:N-+U*U@2:XTZZBC=MJL\1'/85NJ=..R1@Y5)ZZE=G9SEV+'W.:
M;6G=>'[RWMYW6:UFFM5WW-M%+NDA'<D8P<=\$X[U+?>'UM4ND@U.*XN;6%;B
M6 1,N(SM.0QX/# U7M(C]E/L8]%:NH:*NEQ:?/=W+F&X4?:#'%EH'VA]A!/7
M#*><=ZDFT2T2Z^SVVH32.EL;J3S+4*%3RO,'.\\]!CWH]I$/8SV,<,5.5)!]
MJL1:A>0G]W=2K[;SC\J=:Z9=7MO:/:J))+N:2*./I]P*2Q/0#YOT-27>CW-J
MD<D<EO>Q22>4)+23S%#]E/?)_7M0W!Z,E0FE=(LVWBC4[9L^:)/]X8_EBMVQ
M^(4\>T72,0.O1@?Y']:XV>-[:XDAG79)&Q1U/8@X(I@(/2LY8>E+H7&M5@]&
M>IQ^(]#U^ 6^HV]O<J>-DJ!O_'6Y_*N?U;X1^&]:4RZ#<OITV.$4^9'GU*MR
M/P('M7&UH66N7]BR^7,64?PN<_\ UQ6'U><-:4C=XB%16K13.8\1?#;Q%X<#
M2S6GVNU4_P#'Q:Y< =<D=5^I&/>N3KZ#T?Q^K%8[X;3P,N>/^^O\?SIVN>!/
M#'C.-IK=187[#(FMP!N/^TO1OJ.?>G'$R@[548RP,*BO0E\F?/5%=/XJ\ ZU
MX3<R7D/GV6<+=P\I_P "[J>>_P"&:YBNV,E)71YDX2IRY9JS%!*D$'!'(([5
MZ;X(^+EUI9CL/$S/=V?"I<]98A[_ -X?K]>E>8T5,Z<:BM(NC6J49<T&?7-E
M>VVHV<=W8SI<6\HW))&V0PJ>OF7P=XYU+P?>YMF,]E(V9K1S\K>X_NM[_GFO
MH;P]XCT[Q/I27VE3;T/#H>'B;^ZP['^?:O(K4)4GY'TV%QD,0K;2[&I1117.
M=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%07M[;Z=8S7E[,L-O"I
M>21CPHH$VDKLCU34[/1M-FO]2F6"WA7<[G^0'<^U?.WCGQY>^,+_ &C=;Z;$
MW[BVSU_VF]6_EV[DKX]\<W/C'5,)NATV G[/ 3U_VV_VC^@X]2>2KUL/AU!<
MTMSYK'8YUGR0^'\PHHJQ86%UJ=]%9Z? \]Q,VU(T&23_ )[UV;'EI-NR( "2
M !DGH!7I_@SX1S7L::EXK+6=IPZVN=LCCK\Q_@'MU^E=1X1\ :9X)M4U37FC
MNM4QE!U6$^B#N?\ :/X8[YOBCQU-?2-!9, @/8Y4?_%'WZ5S*4Z[Y:6W<]2&
M'I8:/M,1OT7^9T6I^*]*\-6"V&APQ0QHN$6-,?B!_4_K7G>J^(;[596,LK*C
M=0&Y/U/^168[M(Y>1BS'DDG)-$<;S2K%"C22.<*BC)8^@%>A1PM.BK[ON<>(
MQM6O[JT79%FTDRI0]1TJP3@5G(YC<,.U:'#Q\="*5:-I7"C.\;/H7ETB\-U<
MVDT9MKB&!IQ',I!D"\D#WQD_A6M>:;:Z7'%<PZ;)<6:M#,;RYF&)$.UBJ)P#
MP<'KWZ5;3Q2(8=(OKN..\5%\N6/=B:&1.-RGT92,C[IYZ<UE3ZSI[1Q1II"W
M/V5G2WDNI& $1<LH9%/)&<=:\^]23U1Z?+2@M'_7XEJ"VDL=4\1:="0%2$W<
M+ ;E_=L)$/'JI(_&KU[)8VEYJ[:?,_VN=H;QDNY%5'CW"7$?;<,@8/;.*YJ7
M6-2GTY;&6\D:V4 >7QR!T4GJ0/0FJ>!]?K5>R;=V_P"M/\B?;I*T5_6O^9OB
M72[35KS68-26=9TE,5IY;"0M(I&U\C&!N/.3G%,N]=2:YMX$"K8&&".Z,4"B
M64*J[E+'DC*XZXK#HJ_9J]V9^VE:RT-J_P#$,>JV>H076G0P?:)//BDAW%A*
M#P6);!^4L.!WZ4]-?CM]<OM0M!,AEL!;P<#<CA$7)Y_V36%11[.-K![:=[_U
M_6ITL'B-;JUM8=6NF,KV]U;RS^7_ *KS-NTG Y'R\X]:D\/QV6GW5II_V^WN
M9IKQ+EWC)$4:Q*Q4;F RQ)KEJ0J#U%2Z2LTBEB'=-JYOVEK?:5%J^HWMJW]I
M0JCQ>:H8*)&.Z7!X.,8STR:GDL_[7TFRU+67\ATCFFN)HT57EA4J$XX&XLQ
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M\_E%CW&3@GN"*PM7U&+5_L]U)$R7^S9=/QME(X5\=F(Z_2N>\JSMLG_7SO\
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M_P"5;]AI]OIT'EVR8_O,>K?6K5>#B,;.J[1T1]-A<!3H*[U8B(L:A44*HX
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M_BMX1CUW1QXDTI,W5M'_ *0BCF2,=_\ >7^6?05XA7=1JJI&YP8F@Z%3EZ=
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M[<N<]N:M>(),7R+D8$8_F:QWDQ]TU:(>Y;BO7MYMRGY>ZGO70Z?>+<PEH1N
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M89&5).#UZ5#J%O<V#"S>X:2U;$L)5CY<@/1P.E-NKF6\N6GG(+M@ *,*H'
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MIYN(+>&)Y6*RF$?*Y5B,CVZG';-:M(JJBA4 4#H ,4#!55%"H H'0 8I:**
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M ,"KPVO1P4+1<WU-,PDHJ%%=$)BI[*REU"_M[.W&9;B18D!/\3' _G4-=O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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L04445!J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>nstg-20221231_g11.jpg
<TEXT>
begin 644 nstg-20221231_g11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %N 8,# 2(  A$! Q$!_\0
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M&FB:Y-F_C7]Q.Y_UZCL?]H#\Q[]?3*\2I3E3ERL^LHUH5H*< HHHJ#8****
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M:VJC*[C^0K11%C7;&H4>@&*\Z6)_E1Z$,'_,SD[?PK*PS*<?4X_QK1B\+6Z
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M*L@HK+\0ZI)HVEB]1%9$FC$Q92=D98!FP/0&F7WB.RM19"VDCNY+V9(XHXI
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M<,.S'"EA&>W0#FO.@,G Y->H6%Y>:;+#I.HZ[HL^I10"U2SO+$D0@KM\KSU
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M95U+I\<:WNBW%Q9W&[:UL2<ID=5<=1VYYK*JWJES!>:E+-:0B" X$:8 P
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M6P\56\<2R&T==4%F+%)1,!!(N @,B'KA?<@D9(K5UJ^7PW90:?82WEH;./\
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>nstg-20221231_g12.jpg
<TEXT>
begin 644 nstg-20221231_g12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %M 8<# 2(  A$! Q$!_\0
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M77V.[D5!#!-<7"001/+,[;5C1268^@ ZUO'!+K(XY9M*]HP/HR?XI^#H0?\
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M;OM3N]2DW7<S.,Y"]%'T%5*<D;R9\M&;:-QVC.!ZUT^C>%()K.6[U22XD"V
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M?Y=:]V5@ZAD(96&00<@BO&JTI4I69]7AL3#$0YH[]4+1116)TA1110 4444
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M2Z;'JVB:8FD:3#:H & S(0.K'K_A]!5^BBNY*RLC\VE)RDY/J%%%%,D****
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MB&MI"DO4DHHHKJ/D0HHHH **** "BBB@ KA?B'_R$M(_ZYW'\XJ[JN%^(?\
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M.3%)CAT.!@_C7K7AS6X_$.@6^I1IY1D!$D9.?+<'##\Q^5=&*PKHVE'6+./
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MKH-KWCPUQ\"[/'HW_I0:\)VFO=O"_P _P,M0.JA\_A<&N?,/X/\ 79G=D?\
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M^@5]$_"8[_ -XAZ>0./^ '_"OG:OHKX8?Z-\-+VX/ 6WSGZ19_K2>Z.#-/\
M=V>'44[::-IKZ$_(SK_A0?\ BYFF?2;_ -%/7T=7SI\)T/\ PLK33_=68_\
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MV/)<;N\M6:D>L6CMM=FA;L)5VY_'I5UE5U(8!E(Z'O7.M=22*$G/G)G.U_\
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M5NNV52.">FX#^ZW?T/X5XK5_1=8N]!U6*_L'VR1GD'HZ]U/L:RQ-"->'*S?
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MD^:.SA)6WA/8?WC[G_ZU=.&P[JRN]CY#/<X45[*FS,UG5[K7=6FO[YMTLIX
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5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>nstg-20221231_g13.jpg
<TEXT>
begin 644 nstg-20221231_g13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" 'I S$# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%W9'R_PCG!R-HS[G10!X/?\ P4\87WAOQE876JZ/<W?B&^MKV.XS)$H969I
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MW,,<R?W74$?K73_V'82[EAF;>O7#@X^HK'OK"6PF"R?,K?=<=#2J8:M07/\
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MMQ) RI/A#G8Q&&[=*]7HH ^7=)TKQMHOPS\&6TFE>*K?2([^[.L6>BQR17S
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MF?YU'_:.M9S]L;_OVO\ A6WU>7=&'UF'1,[2BN0C\0:O 1YJQ3KWRFT_F/\
M"M2R\46EPPCNP;60\?/]TGZ_XU,J,XZEQKPEH;=%(K!E!4Y!Z$4M8FX4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7]C%<QC D7)4]5/<?@>*L4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ1GN$;+!??&* /(-:\;Z/\0?C1X7O?!?GZG;>';*\O+ZXCB>+Y#'P@W -G(
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M-C<R3VEQ+M7=) SD[4/!"#@ @]Z[F[\,^'[S28--O]$TVXTZUP8;6:TC:&'
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M&ID+#='(."!G^'US5)-HF\8NPSXABZE_L>'2]..IWBW3RK9K($+H(75FW'@
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M;RGI$\HWM]%ZG\J:3>PFTE=FE17)W'Q-\*VTFR6_N ?:PN#^NRK-M\0/"]R
M1JT<()P&NHW@'YR*!5<D^QG[:FW927WG1T4R&>*YA66WE26-AE71@RGZ$4^H
M-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV;:XUC1;'X,6U]J%KJBZA+&T;3Z9!OMH#';[(D8JS*5!(WJ59N,]!7::?\
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M++@M@@CO/AOX'/@32+O3V9)BTP$=T+B61YXE4+&75_E1E7"X3Y2%!XZ"71_
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M )X7&2!]&ZC\<U4\+6TNI74_BG4$*3:@@2RB<8-O: Y12#T9S\[?55_AKIJ
M.=:>\@XNM.N%/]Z("5?TY_2F?VK ."MP#Z&W?_"NEHH YL7DLO%M8W<N>A\H
MH/S;%3QZ=J5W_P ?$B647=8SOD/X]!^M;M% %:RT^VT^,K;1X+<NY.6<^I)Y
M-6:** "BBB@ HHJ&[N4L[*>ZE^Y!&TC?0#)_E0!R=W+_ &SXLFE;YK32#Y$
M[&=ES(_X*0@^KUYOX_UB\NM<EL),QVUL0$C_ +QQ]X^O6O0_#D+P^'K0S_Z^
M=/M$Y]9)#O?_ ,>8U9N]*T^_</>V4%PZC :2,,0/K7IP2BK'SU23J2<F>#5Z
M'\/-&U*(&_DN)+>RDY6'_GL?4@]![]377CPYHH((TJSR/^F*_P"%8GB_Q@-!
MVV.GHC794$DCY8E[<>OM5WN96L=5+#%.A2>))%/4.H(_6L"_\#:%?DM]E-LY
M_BMVV_IT_2N*L+GQ9K-M=7]O?W6V!0P + 2'/10!@GVK8\+>.KB2^33M>^^[
M;$F*[2&Z88?IFE9H=T:5I\.=&MIQ)*UQ<@'(21P%_0"NJAAC@A6*"-8XT&%1
M!@ ?2GT4AE74K"+4]/EM)B5$@^5UZHP.58>X(!'N*U_#.J2ZMH<<EV +R%FM
M[I1T$J'#$>Q^\/9A5*J_AYOLGC#5+4<1WEO%=J!_?4F-S^0BK"M&\;]CLPDW
M&I;N=71117$>P%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!E^)/$-AX6\/W6KZK($M[=<XSS(QX5%]R
M< 5\MZQXCU+QGXIDU'4GCGG;Y8H$?,<$9.1&H]..3U8\GH .S^-OBI]4\4C1
M+>1#9Z7A7CD!*2W#KEB>,?*C  YZLXQ7BL.KW6BZ@\%M+*Z*Q9<( "#QR.WX
M&IE'FBTGJ<]:+J0E&#U.CFC2PNGGB+S2%6VJ@^5\$$CVSFHY;VROI(]_E(C(
M"?,X+L&SA<9YSVJ.37?M6G7=I)$5=D7]WOVDI\N<>N1GD'BGZ9+:W9>XM088
MH6!VL2WE_IWZ ^U8.DXPYIZ,X/J\X4^>K=-:?UZ#EN)9(S%NGMHE?]TSC;AL
M'YL]> <#ZU2M-066Z599%C:*7"0@'YR1Q)NQ]WC@$=2:UI9A>S-!+$J!AO7
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MIM4U@J5^U2+M2%3U2&/)$:\#U8XY)K=H ;'&D,2QPHL<:#:J*,!1Z 4ZBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "@\]:** .6E\-WF@S/>>"WCBC9C)/H\Y(MICW,9Y\A
MS[ J>ZYYK1T3Q+9ZU)):[)++4[=0USIUT LT.>AP,AE/9U)4^M;%9>M^';#7
MHXOMBR17$#;K>[MW,<UNWJCCD>XY!Z$$<4 :E%<F-?U+PNPA\8[9[ 9VZ[!'
MMC0=A<(/]6?]L?(>^S@5U4<B2QK)$ZNC@,K*<A@>A!H =1110 4R:010LQ[#
MBE9PHY-4+R4R<=J:5V)NR,V1\L330]))PU1[JZ#G+ >GAZJAZ<'I6'<M!Z-]
M0"2EWU-BKDVZE#9J$-4B&D42CFI%7-<?\2/$!\/^"[EX9-EU=_Z/!SR"WWF'
MT7/XXKYVM)YK&]AN[5S'/!(LD;C^%@<@_F*UIT'45[G)7Q<:,N6USZ_5:D"U
MF>'M8AU_P]9:I;X"W,08J/X6Z,OX$$?A6GFN=JSLSM335T.X%&:X;XL>(-4\
M.>$K>\T2Z-K</>)&SA%;*E')&&!'4"L/X0^+]>\2ZAJ<>NWYNDAB1HP8D3:2
M3G[JBM%2DX<_0Q>(BJJI=3U7-&:;FC-9'0.S24F:,T@ BHWCS3\UE^)F*^$]
M7*G!%C,00>G[LT+>P-V5R::"J$L94U\NI?7T<BNEY<*RG*L)6R#7T5X(\31^
M+_#*7+E1?08CNT'9NS >C#G\QVKIJ494U?<X:&*C7ERVLS0.<TY!FI9("&KG
MO&GB-/"OAY[D8-W-F.V0]VQ][Z#K^0[UE%.3LCIG)0BY2Z'3PQYJ[&F*^2WO
M;Z21I)+N=G<EF8R'DFOJ;PR2?">DEB2390DD]_D%:5:/LTG<Y\/B57;25K&J
MHIU-!I<USG:.S2YIN:IZKJ2Z3ILM[)!+.D0RZP[=P'K\Q _6BUP;LKLO9I0Y
M7H:P+7Q;8W6M#21%<Q7F]D9)(QA2J[N6!(]0,$\JWI6WFAIK<49*6Q:28'AJ
ME!STJAFI8Y]O!Y%*Y1:J.>>*UMY)[F1(H8E+O([855')))Z"LW6_$=EH4,/V
M@2SW5R2MK96Z;YKAAV5?;N3A1U)%9EOX>OM>N4O_ !DR-&C![?1X6W00D'(:
M0_\ +9QQU^4'H"?FIB(O[0U7QD N@R3:3HC??U-DVSW0_P"F"M]Q3_ST89_N
MCHU=#I6D6.B6*V>F6ZP0@EC@DL[$Y+,QY9B>22235T# P** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** $90RE6 ((P01UKEI/#M]X>F:Z\&/&+=F
M+S:-<.1 _KY+?\L6]@"A_N@G=74LP49-0/,6Z<"F VTO'N+**>:UEM))$#-;
MS%2\9]#M)&?H33FE)J+-&:+"%)SUJ&1<BI2:8W2FA,S9TJJ>*TYDS5"5,&MH
MLQDB'-&ZF,<4TM5$DP>G!\U6S2JU*P[EQ35F(9JG$<U!XBUA= \-W=_QYD:8
MB!_B<\*/SJ;-NR&Y*,7)[(\@^+&N?VQXL-G"VZVTX&(8/60_?/YX'_ :G\1_
M#W^R?AKIFJI$PO$;?>\<A9,;<_[O ^K&J'@?06\1^,K=+D%X8V-Q<$]P#G!^
MI('XU[]J-C!JFEW%C=+NAN(VC<>Q&,CWKLJ3]DXP70\C#TGBE.K+KL>6_!+7
M]GVS0+B3C_CXM@?R<#]#C_>KU_-?,]JU[X.\8+)@BXT^X(8#C> <$?1ES^!K
MZ0MKJ*\M8KFV</#,@=&'=2,@UCB86ES+9G5EU=SING+>)X%\0_&.K:UJ-_H=
MYY/V.SU"3RMD>&^1F49.>>#6)X8\5:IX1GN)=(\G=<*%?S4W< Y'?WKU3XO:
M98P^%XKFWLK>*XDOEWRI$H=\HY.2!DY/-8'P@TRROM0U-=0L[>Z58D*B>)7"
MG)Z9%=$90]CS6T."I"K];4.;5]3>^&OC[6_%/B*XL]6-OY,=JTJ^5%M.X.HZ
MY]&-=UK_ (@L/#>E/?ZI+LC7A57EI&[*H[FGV>DZ;I\IEL-/M+61EVEX8%0D
M>F0.G KPWXE:W+KGBZXBW$VUBQ@B4'C(/S-]2?T KFC"-:IHK(]"K6GA*'OO
MFD7]9^,^N7<[#1X(+"#^$LOF2'ZD\?I6=:?%OQ?;R[YKR"[7.=DUN@'_ (X%
M/ZUZ)X$^'NG:5I4%]JEK'<ZA.@<B90RP@]  >,XZFNFU;POHNM636U_I\#*1
MA71 KI[JPY%6ZE&+Y5'0RC0Q=2/.ZEGV,'P7\3+'Q1*ME=Q?8=1(^6,ME)?7
M:?7V/ZUT?B7GPIJP_P"G*;_T U\^^)- N/"GB:6S61P87$EO,IP2O56R.A'\
MP:]JM]9.O_"^?4'P)9=/F$H XWA&5OU&:BM1C%J<-F7A<5.HITJOQ(^>]+TB
M?5]3AL+3'GSDK&&. 3@D#\<5L^#?$%QX-\4+/*KB GR;R$CDKGGCU!Y_#'>K
M'@2/'CO23C_EX'\C77?%CP>(I_\ A(=/CQ'(0MVBCHW9_P >A]\>M=DY1Y_9
MRV:/*HQG[%UX;Q9Z@]Q:FP^W^=']D\KSO.S\NS&=V?3'-?._BW7+GQCXG,L*
M.T6[R;2$#G;GCCU)Y_3M5@>*]3'@W_A'-_\ HWF[M^?FV=?+^F>?TKM/A/X.
M!?\ X2'4(^%RMHC#J>A?^@_&L(4UATYR^1V5,1+'2C2IZ+=GE>IZ5+I6ISV-
MSCSH&V/MZ9[U]):0MR_@?3TL)4AN3I\7E.Z[E#>6,9'I7AGC://CC5SC_EY:
MO>/#QQX8TL?].<7_ * *,3K"+*R^WM:D>QY6/BKXHTG7OLNNV]OLMYMES"L6
MUL9YP<^G(/0\5[)97L&H64-W9R"6"9 Z.O<&O/OB?X-&K69UK3X_],MD_?(H
MYEC'?ZK^H^@KB_"WCV]\-:#>Z<B&7>I:T8\B%R>>/3OCU'N:ETHU8*5/<M8F
M>%K.G7=T]F=?\0/B;=:'K"Z;H!A>6$?Z3)(NX!CT4<]1WKH?!-WK7B#PZ]YX
MI2W,5V/W,"P[<I_>;.<Y[>W/>O,/ 7A"3Q1KC7FHAGL8'WSL_69SSMSWSU/M
M]:]W7"J%4 *!@ #I45E"FE"._<VP<JM>3K3?N]$-%I;"42+!&'#F0,$&0Q&"
MWU(XJ;-,S2;JXSU!^:3-,S2%JD9);16R:@;HP1?:6C$1GV#?L!)"[NN,DG'O
M6G6/NK0M)O-CP>JT)] +%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I&8*I)I:HW$V]\ \"FE<3=ATDV]O:F9J(&ES5$DF:,TS-&:!C\TA-)FDS2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M96^_L+PYK6I?\2+3'O;F<W#>;,2P(5V&-QV\CZUZ1X:UA-?\,V&II_R\PJS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>nstg-20221231_g14.jpg
<TEXT>
begin 644 nstg-20221231_g14.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &$!#8# 2(  A$! Q$!_\0
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MU!S19C'4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***"<=: "BJLVIV-OQ/=PH?0N,U3D\4:/&<&]0_[JD_R%/E;%
M=&M16&?&&C#_ )>6/TC;_"E'B_13_P O9'UC;_"GRR[!=&W169%XCTB8X2_A
M!_VCM_G5Z&Y@N!F":.0?[# TK-;CN2T444@"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJMSJEA9_P#'W>00^SR
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MHM5;W3K>_CVSISV<<$5K&H^I+B<1:WD]E,)+=RA].Q^HKK-*UR&_ CEQ%/\
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MUD:A8M9R\9,;?=/]*JQ2M!*LD9PRG(K5I21"NF=?14%G=+=VXD7@]&'H:GK
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M2]3TKQ98VUC;SV^(982"1)D$9^8\<5WE%:^U=DK;&'L5S-W>O0\A.F^/9/#
M\'MI40M\B,WWF#'E@YQU_P#KU=\1>"]3TU_#4^DV2ZO#I,8CEMF(&\YR3@]B
M2?IQ7J-%5[9WT1/U:-K-O_ACS/0/#.MS_$"]U?5M)BT^SO+-XMD,BD)N"C''
M?@YXZUG:;H7CC0-.U+PWI]A#-9W)?R[QI -@(P<<]2!TQP:]=HI>V?8/J\>C
M?7\3D_AMHM_H'A%;+58?)N!.[[-P;@XQR*RO&/A364\46_BGPGL>]C4+- QQ
MY@ QGWXX(KT&BI]H^9R[ENC%P4.QY7<:'XN\?:I9CQ/9QZ7IEJ^]HE;F0]^,
MGGM[5MZQX<U&X^*6BZM:VV=/M( DD@8#9]_C&<]Q7<T4_:OH2J$>KN]_N.%L
M?#>IQ_%C5-8E@VV%Q;>7'+O!R=JCIG/8UE^ ="\0:/)J.@ZKIBIIEP9"]WO!
MSE=H"\\@_2O3J*/:NUA^PBFFGW_$\CL]+\<>%M+OO#NF:9'?6EPS"&[#@>6&
M&">O']*[OP/X;;PMX7AL)F5YRQDF*]-Q[#Z  5T-%$JCDK!"C&#NG_P HHHK
M(W"O-O'/AO[#/_:5FF+>5OWB@<(Q[_0UZ345U;17EK);W"!XY%*L#5PDXNY,
MH\RL>&1R/%*LD3%70Y5AU!KV#PSK:ZYHZ3D@3I\DRCLWK^->5ZWI<NC:K-9R
M\A3E&_O+V-7?"&M'1]<0R-BWGQ'*.P]#^%=52*G&Z,(2Y969Z_11UZ45Q'2%
M%%% !114-W=16-G+<W#;8XD+L?84 <I\0/$1TW3QIUJ^+FY'SD'E$[_G7E-7
MM7U*75]4GO9S\TK9 _NCL/RK7\$^'_[;UD/.N;6V(>3T8]EKOBE3AJ<4FZDM
M#J_ 'A<65LNK7R?Z1,O[E6'^K4]_J?Y5V]     P!T%%<4I.3NSKC%15D%%%
M%24%!X'K110!YCIWPYD\0^(-7U3QE;R1&>;-M&DPR%_#/; JQHW@N]\)_$9+
MC0[=WT6X@\N9FE!*'\3D\@'\:]&HK9UI/3H<ZP\%9]=[]3SGPCX5U?3/#OB:
MUO;7RY;[S/LZ[U._*L!T/')'6L*?P)X@7X?Z9;BR$EU8WKSR69<$2*<8[X/3
M]:]CHH]M*]Q/#0<;?UW/+[30?$&H?$32-=N=!ATNS@3:T<<BDJ-K#) QSSZ5
MJ^$=#O\ 0O%/B?4]6A6WL[IS)'*S@@J&8DG!XX/>N[J.>"*ZMY(+B-9(I%*N
MC#(8'J#0ZK:L5&A&+O?6]_PL>*^%-%M[[XMRII\Z7.EV4KWD;1G*<@;0/?)
M_P" UT7Q#T/Q1KOB.U^PZ>EYI5H%=8FE"K(_?<,@^U=WI>A:3H,<@TJRAM%D
M.7*#&[ZFM$$$9'(JI5GS<R,XX9>S<6]W?0X6;2_$'B[PAJ.E^(-/M]+D^0V?
ME/E21SS@G X _&N<T+PYK27%EI]]X*TL) X%Q?2A?WB#N,=_>O7:*E56DTD6
MZ";3;U  *  , <"BBBL3H"BBB@ KSOXF>#A?VK:UIT?^DPKF=%'^L0?Q?4?R
MKT2@@,I##(/!![U4).#NB)P4X\K/ELU[1\,?%9U?2SI=[)NN[1?D9CS)'V_$
M=*X+XA>&/^$>U]GMUQ97>7B_V3_$OX9_*L+0]7GT+6K?4+8_/"^67^\O<?B*
M]"455AH>7"3HU+,^EJ*@L;V'4;""\MFW13H'0^QJ>O-/7"BBB@ HHHH ****
M "BBB@ HHHH 1W"(6/0#-8KN7<LW4G-:&H2;8E0=6//TK.K2*ZD2+=A#OD,C
M=%Z?6M&H[>/RH%7OC)^M25#=V4M HHHI#"BBB@ HHHH HZW<W%EH-]<V:;[B
M&W=XUQG+!217C/AC28O%EJUT_B^YMO$#2$B*20CZ8YR<^W3TKVK4KY--TNXO
M98Y)$@C+E(UW,V.P%>)>*-1\#ZSI+ZCI4=QIVM$AA!&A +9YSV_$8KJH7LTO
MO.'%633;^6WW>9Z7XA\4_P#"':9I]F4EU;5)P(XH\X:4C@L<#UJ'P_X\EU63
M4;&_TJ2SU:QB,AL]V3( .@..O3\ZX'Q+'J]M_P (EK6JW$UH5MEBENQ'O:%M
MQ()![[2/R-=#X)M;#4/'<^JV_B675[N*WQ(6M/+#J>.N>V!VING%0NQ*M-U+
M+3RTVM]Y4^&GBS6+K6[RTO+6\O(IYR6GDD++:8#':<C\.U=3H_C]=6\-:OJX
MT\Q#32P,7FY\S SUQQ7+_"[5;2QU[6M*NI#'>75VWE1%3\VW=GZ5SVB>(K/1
M/"GB?1;\2I?7+N(D"$Y.,'/IBJE34I/3L9TZKA"-Y=ST*Z^)"VW@6R\2'32P
MNIS#Y'G8VX+#.<<_=].]4U^*<L.I6?\ :>@W%EIEZ0(+N1N6!_BQCI7'ZK_R
M0?1O^OYOYR5;\:>)]/\ %?A_1-&T97DOS*FZ+RR#$0NW'YG]*%2C?;JP=>=K
M\W1/U/:0<C(Z44R%#'!&A.2J@$_A3ZXCTPHHHH **** "BBB@#F=5M?LMXQ4
M?))\R_UJ"RN#:WB2=@<-]*WM9M_.L2P'S1_,/IWKFJWB[HAZ,[0'(!'0T51T
MBX\_3UR<LGRFKU8M6=BPHHHI %<CJ=U]KOI'S\H^5?I71:I<?9M/D8'#,-J_
M4UR5:TUU)D6]+M/ME\JL/D7YF^E==TZ5EZ#;>59>:P^:4Y_"M2IF[L:V"BBB
MH&>9PZU]B^-VHQZAJ/D62VPVI-/MC#;4Z G&:1M:-[\;K5-.U W-F;0G9#-N
MC9MC>AQGI5"XT+3_ !#\<-2LM6A,T'V</M#E>0B8Y'UI;'0[#P_\<K*RTJ(Q
M6_V4OM+EN2C9Y/TKMM&WGRGFWG?RYOU.KT3Q_#JFCZQ>75F;2322WFPF3<3@
M'O@=P17%>/?$3^(O ^B:O)9M9J]\VU-^\E5!&<X'H:H^/[>\T/QCJ5CIZGR?
M$$<? [L7&0/Q!_[ZK:^*5@FC>"O#ME&N5M9E3 _BPG/YFB,8J46NO^0JE2<H
M2C+I_G_D;%I\394UNSM-9T.?3K2^P+:XE;E@> 2,=.GTS2^(/BB-$\17FCQZ
M1)<SP!1$4D_UK$ XQCCK[]*YKQIXCL?&=UX>TW0?,DN!.&D'ED&(G V_ASGZ
M5K:1$C_'W56=0S1V^5)['8@S2Y(I7:Z;%^UFWRQEU6OR+,UQ8S_&#2FGM+A+
M^6S60.)@$3Y&."FW)[]Z==?$^:75[VVTC0KC4+&RR+BYC;E0."P&.E5]4&?C
M[IP'>S/_ * ]8O@KQ)8>#DU_2]=$D5WYS%%V%C*<$;1_GO1RIJ]KZ(7M'&35
M[*[U^2*OAJ2U_P"%1^()+Z*6:W^VJ62*38Q^YCG!Q^5=I;^)+O1/">AC0_#M
MYJ5O-:!QM?)B'8,0O)Y]JX313N^"_B0XQF\0X].4K9UWQ<^B?##0M*LF,=U?
MV*!I?^><>,$CW/2KG'FE:W7]"*<^2-[V]W]3JO"/Q!?Q5<WT8T>6W6SB+LPD
MW[FS]WH.:H'XK?9KJ'^UO#M_86<S[5N9?YXQ_6J>@ZYHVE> =0LO!\[7.I6M
MJT\LGDD%FX!;D<XSP/:N%UN[MKWP1:W,_B*]O]4FES-9R2%DCQGG!Z=OSJ8T
MHN3TT*G7G&"]Z[M?I8[+QUXIU6P^(>EII\%V]O$JLL,4A"WF>> !SZ=ZNZS>
MV=[X^\*S:CIUU#?7$:.J^>%$)W$X92N2<_2LWQE=PZ;XP\&W]XQCMH;=&>3!
M. ",]/K5OQ-=17WQ5\(75LV^&:-9$;&,@L2*$E9:=&#D[RN^JT^XV-:^(=Q#
MKT^D>&]&EU>XM1FX9&(5,=1P#G_&I[#XBVE_X/U#68[1UN-/'[^T9L$'ZXZ?
MAVKE?#NM6G@CQUXCM_$9:W^URF6&8H2'&YB.@[AOTK,TV.2\\+>.=<CA:*RO
M?]0&&-WSD_U%+V<>W;7N/VT[[ZZZ=K&_+\89H[>UO3X=G6PF.UYV<XW=PIQ@
MXKTV"9+BWCFB.4D4.I]01D5X[K@'_"@=)X_Y;)_-Z]7T7_D V'_7M'_Z"*SJ
MQBE=+JS:A.;E:3OHG]Y>HHHKG.LY7Q58;)DO(QP_RO\ 7L:Y^.1H95DC.&4Y
M!]Z]!U"U%[82P'JR_+['M7GCJ58JPP0<$5T4W=6(>YZ+97*WEE%.G1US]#4]
M<YX2N]T$UJQY0[U^AZUT=8R5G8I;!1114C"N*\77_GZ@MJA^2 <^[&NPN9UM
MK669_NQJ6->8S2M/,\LARSL6)K:DM;DR'6EL]Y>16\0RTC =.GO7IEK;I:6L
M<$(PD:X%<KX-L0\TUZXX3Y$^IZ_Y]ZZ^E5E=V"(4445D4%%%% !1110!Y/\
M$?4))_'5AH^J:E/IFC/"&>6(D!B<\G\0![5N>'=(G\*Z7J6J6&M2Z]8+!YEO
M;^8"#CD\\\\=J3QMX@\*_P!KKHGBRQD9/*WK=>6<(3V!'/XBN=^&BQ+XZU2V
M\/S7%QH!A.3," 3QC\>H^E=FKI]OU//T5;>[;^:^78ZS_A8UM_PK_P#X2;[(
M<^9Y7V;S.=^[&-V/3GI5;4/B)>1W-C8:5H3WFI7-LMR]OYV/+4C(&<<G%>?'
M2;L>,/\ A"-I^R'5/M'/]S;G_P!!KJ?B#%X:G\0A6U:71M9M(%*3*C;&&#M7
M(YR/;UH]G!22MOJ+VU1Q;O:UE\^I-XX\6:N_P]M[N/3KS2KB>XV2,'(:':>Y
M Z$Y'.*U=&\<M:> 3JNO6-Q;?9E2*/S"2UT2HPPR!UKD[_5]3U[X'3W&J;I9
M(KM$68KS(@8?,?SQGVJ?Q/<1^)?@_9/HKM<#36B6Z54/RD1X/UQD4^1646NH
MO:2YG-/[-SHM%^(]Q=:U9V&NZ))I:Z@-UI*S[@^>F>!UJ._^)ES#K6J:7I_A
M^>]N+!F&8WR"%/+$8X'YURVGC3_$>L:%'/XPN+RYCD5X(&L0OE$8)4D=/NX[
MUM>$/^2I^,/HW_H5)P@KNWY]RHU*DK*^[WT[!_PMZYN-'^W6'AR>98#_ *6Y
M?]W%D\?,!W]\5W^@ZO#KVA6NIVZE$N$W;6ZJ>A'YBO*/"0'_  J+Q9_UTD_]
M %=Y\,O^2=Z7_NO_ .AM45812=ELRZ%2<I+F=[J_XG5T445S':%%%% !1110
M!R/C_1OMNDB_A7,UK]['=#U_+K^=>8U[U+&DT+Q2#<CJ58'N#7B.L6#:7J]S
M9O\ \LG(4^H['\JZJ,KJQSU8ZW/4?!FK?VKX>B\QLS6_[J3WQT/Y5OUY=\/-
M2^RZ\UHYPETF /\ :'(_K7J-8U(\LC6#O$****S+"N%^)>K^390Z7$V&F/F2
MX_NCH/Q/\J[KIUKQ#Q1J1U7Q'=W&<IOV1_[HX'^-;48WE<RJRM$R0"S!5&23
M@ =Z]M\+:,NAZ##;D8F8;YCZL?\ #I7FO@32O[3\31M(N8K4>:^>Y'0?G_*O
M8JNO+[)%&.G,%%%%<QT!1110 4444 >>_&&ZNK7P_IYL[F:V9[P*6B<J2-I]
M*YSQ'IVL_#Z*PU:R\2W5[YDH5K>X8_-QGH2<C_&MWXU+O\-Z<O3-Z!_XZU<M
MJGANW\(>-=&FUN2;4M(FP0\[$[&]#[ X..XKNI6Y%\_F>97O[27RU['H'B'Q
MX^EWMGIFE:8^I:K=1"7[.K8" C/)]>M/T7X@V>I>']1U"\MI+2?2P?M5L3EE
MQZ?4C%<3XO$^D_%0:C)JDNE6MY;J(KZ.'S0HV@%<?4?K5_PQ;Z%#I_B75[C6
M)M7M)DV7FZU\O>>N1SSG/M4>SAR)V-%5J.HU?OV^_N;GA_QWK&M7UGYGAB:+
M3[UB(KM9=P4#N>/:KVC>-UU>XUZ(6)B_L<L"?-SYN-WMQ]WWZUYYH&HIH'B[
M2[;PAK<NI:=?S!9;*1"#$"><YXS@DY'I2Z5X@L_#6O>,[35!*DUX\JPHJ$[C
ME\#\=PIRI)WLOZN3&O)6YGZ[=C?\1^*#XJ^#U_J:6QM#YZQ[/,W='7G.!ZUA
M^(_$>J:9I?@^&Q6Z1%M8I6:*0J+@G;\G'4\>_P!ZHK#_ )-^O_\ K]_]F2K/
MBV5;;POX#N9<B&)49VQG PA_H:N,4G:W5_D9SE*4>9O6R_,['5?'\^F:+I<S
MZ+,-3U-F2*Q=]I4@XY)'N.W>M?POKNI:S'<KJ^B3:5-;L%(=LA\C/'%<OXYO
M_"7B'2M+;4;^6V%R7>SO8XSA,'!W#T)'Z4OPLUK4;V;5-.NKYM2L[)E$%X0?
MFSGC)YQQGFL7!>SO8Z8U'[51;NOEVZGHM%%%<QV!1110 4444 8'C/0%\1>&
M;BU _?QCS(#Z..WX]*^>&4HQ5A@@X(/:OJ:O!?B3HHT?QA,T2;8+P>?'@<9/
MWA^>?SKLPT]>4X,7#131V/PAUW[1IUQHT[9>W/FPY/5#U'X'^=>DU\Z>#-7.
MB^+;&Z)Q&9/+E_W6X/\ C^%?1?7I6>(CRSOW-<+/FA;L%%%%<YU!1110 444
M4 %%%% !111TH R[Y]]R1V7BF6L?F7*CL#DU&[;Y&;U.:N:<OS._H,5KLB-V
M7Z***R+"BBB@ HHHH **** "L\Z#I!NOM)TRS\_.?,\A=V?7.*T**=VA-)[D
M=Q;PW4#0W,231,,,DBA@?P-166FV6FQE-/M(;9&.2(8PN?RJS11=A97N5$TK
M3X[\WJ65NMTW6<1 .?QZTAT?36NGN6L+8SR#:\AB4LP]"<<U<HHNPLCFO%W@
M^+Q-H,.F6\R6$<4XE&R($< C&!CUK7M=&L+65+A+.W%TJ!3.L0#G QUZU>HI
M\SM8GDBI<UM0HHHJ2PHHHH **** "BBB@!&4,I5N01@UQ\\1AN'C/\+$5V-<
MYK<7EZ@6'1U!_I6E-ZV)D2Z!-MN)(CT9<CZBMZN4TV3RM1A;U;!_'BNKHJ+4
M([%(ZE&FHM:S?+TVMZ^U7:Y?6_\ D*2?0?RJWI6K[<07;<=%<]O8T.&ET%]1
M/$4WSQ0CL-QK&CC,LR1KU9@!5S6)?-U.4@Y"X44NB1>;JB9Z("QK1:1%NSJ(
MT$42HO 4 "G445SEA1110!$+2W6Y-PL$0G88,H0;B/KUH-K;FY%P8(C.!@2[
M!NQ]>M2T4!8XJ/P#<3^,H]:UG69+^*WE:2VMV3 C).0.O0?TKL)[6WNE5;J"
M*8*<@2(&P?7FI:*J4G+<B,(QO;J5(=*T^WO&NX+*WCN'^]*D0#'\:F6UMUN6
MN%@B$[#!E"#<1]>M2T4KLJR(C:6[7(N#!$9P,"4H-P'UZU#+I6GSWBW<UE;R
M7*_=F:(%A^/6K=%%V%D5UT^R6!X5M(!$YRT8B7:Q]2,<TDFF6$RHLME;NL:[
M4#1*0H]!QP*LT478617@T^RMF8VUI!"6&&,<07(].!4$6A:3 KB'3+-!(<N!
M OS'WXJ_11=A9%6[TRQOXDCOK."X2,Y198PP7Z9Z4_[#:;XG^RP[H0%C;RQE
M .@'I4]%%V%D5+W2M/U+;_:%E;W6W[OG1AL?G4PM+<6OV801^1C;Y6P;<>F.
ME2T47861 UC:/;+;O:PM IRL1C!4?ATJ95"J%4!5 P !TI:*0PHHHH *X7Q#
M;?9M9EP,+)\X_'K^N:[JN9\7P?+;W '0E#_,?UK2F[2%+8R= N?LVM0DG"N=
MA_'_ .OBN\KS.-S'(KKU4@BO2HG$L*..C*"*JJM;BB9^HZNFFWEO'.O[J4'+
M#JIX_2M%'61 Z,&5AD$'K7*^,_\ 66O^ZW\Q5#0]??37$-QE[8G\4]Q_A2Y+
MQN@OJ;WBVZ\C1_*!^:9POX#DUPM=%XNO4N9[587#QB/>"#US_P#JK$L8/M.H
M00_WY #^=:TU:(GN=_H5I]CT:WC(PQ7>WU/-:% &  .@HKF;N[EA1112 ***
M* "BBB@"M>:=9:C&$O[2&Y4=!+&&Q^=-BTZWL[&2VTR&*R#*0IAC "DCK@=:
MMT4[L5E>YQWAGP)+I'B";6M7U635+YH_*CD=,;5Z9Z]<#%=->Z5I^HE3?V5O
M<E?NF6(-C\ZMT4Y2E)W9,:<8JR1";.V-G]E-O%]GV[?*V#;CTQTIMII]G86Y
M@L;6&WB8Y*11A03]!5BBE=E612M='TVQN&GL["V@E;[TD<2JQ_$"K$=I;Q3/
M+%;Q)))]]U0 M]3WJ6BB["R1 EC:10O#':PI%)]]%C 5OJ.]20PQ6\0B@C2*
M->B(H 'X"GT4@L@HHHH&%%%% !1110 5YQ\2;#RM0MKY!@3(4<^XZ?H?TKT>
MN:\?6@N?"TDF,M;NL@_/!_G6E-VDB)J\3RVQNFL=0@NH^&AD5Q^!KW6*19H4
MD0Y5U# ^QKP(U[-X2NOMGA6QD)RRQ[#]5X_I6U=:)F5%[HD\1:U_8.G)>&/S
M4\U4=>^#UQ[U<L-0MM3LTNK*421..".WL?0USOQ%_P"15_[;I_6O/_#_ (CN
MO#][YL/SPO\ ZV$GAA_0^]1&GS0NMRY5.65F>K^)+[^S?#E[<@X98B%_WCP/
MYUX<?SKT7QMXAM=4\)VIL)=RW$PWJ>JX&2"/RKSKDUM1C:.IC6E=GJ?PUT[[
M/H,EXRX>ZD.#_LKQ_/-=E5#0[,6&A6=L!@QPJ"/?&3^M7ZY)N\FSIBK12"BB
MBI*"BBB@ HHHH BGM;>Z4+=01S*IR!(@8 ^O-$]I;W2!+JWBF53D+(@8 _C4
MM% K(KW6GV=[;B"\M89X5Z1R1AE'X&EM[*UM+7[-:VT4,&,>6B +^53T4[L+
M+<I6NC:98SF:RT^V@E;J\42J3^(%.DTK3YKP7<MC;O<@8\YHE+8^N,U;HHNP
MLBN+"S6V-NMI ("<F(1C:3].E)<:;8W=HMK=6<$UNN-L3Q@JN.F!VJS11=A9
M%272M/FLTM)K&W>V082%HE*K]!CBI+2RM;" 0V-O%;Q9SLB0*/R%3T478604
M444AA1110 4444 %<!\7=+%UX9AOT7+V<HR?]AN#^N*[^LSQ)8#4_#.H69&3
M+ P7_>QD?J*NG+EDF9U(\T&CYJKZ/\):E_:_A/3KQFW.\(5S_M#@_J*^<",<
M&O9_@_?&?PQ<VC'FVN"1]&&?YYKMQ,;PN>?A)6G;N>@T445YYZ@4444 %%%%
M !1110 4R9ML#GT4T^H;LXM9/I36X&36EIZXMR?5JS:U;(8M$_'^=7+8B.Y/
M11169845AZGXNTO2M2-C/]HEF1!)+]GMWE$*GH7V@XS5YM7M6T!M7MY!):_9
MS<*X!&Y0N<\^U ' _$?XD2Z/<OHF@,!>A0;BX(!\D$9 '^UCGVKF?A?<>([_
M ,:1727%]<6)W_;)9G9HV^4X&3QG..G-<%<W,FH7$MW=O^]NYC)*Y/3<<DU]
M3:;8VVFZ;!9V$:QV\*!451QBNFI%4X*-M680;G)N^B+-%%%<QN%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5B^(4_U#_45M5E:^,V<9]'_ *&J
MC\0GL8",4D5AU# UV@.5!]:XFM1=?N%0+Y<9P,9YK6<6]B4[$.M_\A1_H/Y5
MG&I[NY:[N#+( K$8(%052T0@)]:VO#B9FG?T4#_/Y5BUH:1J*V,Q60?NY,9(
MZBE+5 MSJ:*1'61 R$,I&01WI:YS0**** "BBB@ HHHH *BN;F"SMWGNIDAB
M099Y&  'U-97BCQ18>%=*:\OWRS<10J?FD;T'^->,R7'BGXIZP8X@5M4;.S)
M6& >Y[G]:VITG-7>B.:M75-\J5Y=CN==^,ND6#M#H\#ZA(./,SLCS]>I_*N1
MD^*'C/6)2NE6ZQC^[;6QD(_$YKM_#?PMT#27_P!/0ZE>( 6,PQ&/HO?\<UW4
M,$-M$([>)(D7HJ*% _ 5ISTH:1C?U,E3Q%36<K>2/##KGQ0)W!-4Q[68Q_Z#
M0OQ(\<Z.X_M.)F4=1=6FW/X@"O8+W7]-MM>MM,FODCO'&X0'.6!!QVQV-:9,
M-PA4[)5/4'!!H=5=8(%AY?9J,\TT/XU6%RRQ:[9/:,>#-"=Z?B.H_6O1K#4;
M/5+1;G3KF.XA;H\;9'_UJY;Q)\-?#FL0O+Y T^?'^NMAM&?=>AKS&\TSQ1\+
M]56ZM)BUJ[8$J F*4>C+V/\ D&CDIU/@T8O:5J/\35=T?0%%<SX,\;6/B^Q)
MBQ!>Q#]];D\CW'J*Z:N:47%V9VQDIKFCL%%%%(H**** "BBB@ K(\3Q^9HKM
MW1U8?R_K6O5#7%W:)<CT3/ZU4=T)[' 5Z#HTGFZ+:M_TS _+BO/:U[+Q)=6-
MFEO''$RIT+ YZ_6MYQ<EH2G8N^-/]9:_[K?TKEC6CJNKS:JT9G1$\L$#9GO6
M::J"LK">X$GOVK5\,1>9X@AST0,WZ?\ UZR:N:3J3:5J"W"H'7!5A['TIRU6
M@'I5%06=[!?VRSVSAT;\P?0U/7&:!1110 445SOCZ1X_ VHF-V0LJ(2IP<%U
M!Y^A- '0[E]1^=&Y?4?G7#:CX)\.PZ;*\>E0JX3(.6X/YUC?\(MHO_0/B_,_
MXU<8W%<]2W+ZC\Z-R^H_.O+?^$6T3_H'Q?F?\:/^$6T3_H'1_K_C5>S8N9'J
M6Y?4?G1N7U'YUY;_ ,(MHG_0.C_,_P"-'_"+:)_T#H_S/^-'LV',CU+<OJ/S
MHW+ZC\Z\M_X1;1/^@?'^9_QH_P"$6T3_ *!T?Z_XT>S8<R/4MR^H_.C<OJ/S
MKRW_ (1;1/\ H'1_F?\ &I;/PGH4FHV\;Z=$58MD9//RGWI.FT@N>F[E]1^=
M&Y?4?G7!W7AKP=9S"*YT^!'(SCYC@?G41T3P0&Q]CMNF>-]9<T5NQGH.Y?4?
MG0&!Z$5P5OX<\'75P8(=.@,H)&PAP>.O4TW4O#^F:#?:%>:/:K:3OJL4+/&Q
M^9&!#*>>0::L]@/0****!A1110 50UR#[3H%]%C.Z!\?7%7Z9,N^"1?[RD?I
M36C \#/6O4?AO-YGAN2,G_53L![9 ->7N-KLOH2*VM!\67GAZWFAM889%E8,
M?,!X.,=C7;4BY1LCCA)1E=G<_$7_ )%7_MNG]:\GKI-<\9WVNZ?]DN8((TW!
M\Q@YR/J:YLT4XN,;,*DE)W0F>,=JL:9!]JU:T@QGS)D4_B158U-97;V%_!=Q
M!6>%PZANA(K7H9+<]_ P,"BL?P]XCM/$-D)+<[)U'[V$GE#_ %'O6Q7FM-.S
M/0335T%%%%(84444 %<=XT^(UCX.NX+26UEO+F5/,V1L%"KG&23]#78UX-\9
M_P#D?(O^O%/_ $)JJ$>:21%27)!R['0_\+VM/^@#<?\ ?\?_ !-'_"]K3_H
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M^PXKJQG SUJZU3F?*MD9X>CR+FE\3$V+OWX&[&,^U+116!U'DOBK_DN6E_\
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M?V)\2CU\1:?_ -^1_P#$5Z#14^T?9?<7[%=W][//O[$^)/\ T,6G_P#?D?\
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M^@3'_P" ;?\ Q-<?HWQDN=(T6TT\:5#,+:(1B0S%=P'0XQ5[_A>US_T!8/\
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MY.3S75>%--V1M?2CYG^6/V'<UTNT(F>[.AAB6"!(HQA44*/PI]%%<IH%%%%
M!7'^--.VR1W\8X;Y)/KV-=A4%]:1W]E+;2_=D7&?0]C51ERNXFKH\MCD>&5)
M(SAT(*GT(KTW2[]-2TZ*Y3JPPP]&[BO-+NVDL[J2WF7#QM@UK^%M8_L^^\B=
ML03G!)_A;L:WJ1YE=$1=F>@4445S&@5S7Q$4M\/]5(Q\L:N<G'"NI/Z"NEKF
M_B",^!=0S_TS_P#1BT <?KWF7]G%-;Q2%/)7JA%5&L+KO&P^JG_"O0[[_D&R
M?[M6:UYV38\P-A<_\\V/X&HS871ZH0/H:]3HHYV%CR@Z=='^#Z\&F'3+H?\
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M^SM.NKA^WFD1C^M>37/A;Q):,1/HE\I'7%NQ'YBH8_#^O3-MBT>^)ST%L_\
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M%"_= 'T%&MQ'*?9O&G]S0_\ OJ:C[-XT_N:'_P!]35UE%.XSDOLWC3^YH?\
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M #_6W_?)_P * ,1M$TM]N_3[9MHP,Q#@>E:FERKI<T1MD6.)./+48&WTJ?\
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M[R.6D8LQZDU-:6<MY)MC'R]V/05LHJ*N2W<9;VTEU,(XADGJ?3WKI[.SCLX
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M1Z;K\ DT^X5GQEHFX=?J/ZUJ5R--.S.I-/5!1112&%1S3Q6T1EN)4BC7J[L
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M+&WM_P#51#/J>35BBDY-CL@HHHJ1A1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI/136=9*T_A.]1 +NQ@UO=/';Q$*\ *LP5.?ER<X';-,#T&"^M+DJ+>ZAE+
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MDMX_+C\T)N# 9(^\HR1UJS:W%WK^B:YKUC&ZW,UH;6S7&&78I+8]]Y8?\!%
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M>6VV-P<89L8'/K0!LT45F6OB+3+R^6TAG83."462)T\S'7:6 #?A0!IT444
M%%%% !1110 4444 %(RJZE7 8'J",YI:*  @$8(R#VIK11M'L9%*?W2./RIE
MS<PV=K)<74JQ0QJ6=V. HK#C\40WOB+3K+3Y-T=PDS2K)$R.-H4J0&QP<GGO
M0!T&T;=N!C&,8H"@*%  4#  %9L'B+2[G4/L<-T&F+,J_(P5V'4*V,,1Z T7
M?B+2[*]-K/<D2J0'VQLPCSTW$#"Y]Z -%(TB7$:*@ZX48H:)'96=%9EZ$C)%
M8EIKZQMJ\FIRJD-I??9XMJG)!1"!@<DDM6VTBI$9'(1%7<2W&![T #11NP9T
M5BO0D9Q0L:+MVHHVC"X'0>E9UEXBTO49S#:7.Z38753&R^8H_B7(^8>XS6=X
M6UZ?79[V:21A"DKI%";5TV*KE02Y^\3CD=J .B\J/84V+M;JN.#52+2K:/4K
MN]P7DNQ&'5\%1L! P/QK/;Q+''XP?1'ADP+=)!(L+GYF8C!(& , <U7T?Q?:
M7,(34IUCN&NI8!MC;8")&506Z D <$T =(44L&*C*]#CI2>5&9/,*+OQC=CG
M\ZS[_P 0:9IMSY%Y<[),!F 1F$8/0L0,*/<XJ]+/'#;/<2,!$B%V8<_*!G-
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MFBC90\9!#!AN(!&<@\^E9G]D:M<:7JIGL?*FNM7@N4B5P?W:M$2<^H"G/T-
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M:[B@%Y-9><+BWC8 XE.X[">/E/';(H V'\1VT5C'/+;7B2RRF&.U:$B5W'.
M._'.<X]Z:?$]B-/^TE+C>)Q;&V\O][YIZ)M]<<]<8K-UFSU'5CIVIK974#6D
ML@:VCN%29HV &X$' /'3/3O35TA!I-R\NB7UR;JX5Y(Y[I6G&U<"0'. 1CH#
MF@#7F\0P0:?#<S6MXDDTODQVQBQ*S\\ 9QT!.<XJ_978O;59A#-!DD&.9-K*
M0<<BN:2ROY/#@AUC3KF_ N6:%//47$,8^XVX$9<>QSCUK7\.1ZA%HZKJID,O
MF/Y8E8-((\_*'(X+8ZT@*O\ PD=KI]G>W=W-<3Q1:@;7'E#*,2H"@#J 3UZU
M=T[6X-1NY[7R;BVN855VAN(]K%3T8>HX-8,FC7YLKI/LQ+/KZ72C(YB#H=WY
M UL+97 \<27QC/V8Z<L(?/\ 'YA./R-,"UJ.I_V>4 L;RZ+ D_9HMVT#UR1^
M536%_;ZG817EF^^&494D8/T([&L'7+.\FUZ.26SNKZP\C;'%;3^7Y<N[EF^9
M<Y&,'G&#5KP=8W.F^%K:UO83#,C2%D+;L9D8CGOP12 W**** "BBB@ HHHH
M**** "BBB@#(L_$EG?:K<6%O'<-);2/'._E_)&5&>6Z<]N]-L_%%C>W<,*1W
M"1W)(M[B2+;'.1S\I^@)&<9[5#I6E3+::[!<(8#>WL[(_&2K* &XK)T;0KB-
M]-M-1LM29K%E/G->AH 4& RKG)SZ8[TP-^\\0P6%T8[NTO(X1((S=&+]T"<
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M]Z(R;=;"2)I,]&,B$#\@:QIM*N(?#]ZT[0VLT6L/>P&X<+&_[W*@GL&Z?C3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFU"SU+3&B^UVH=/+F)"2(^,@D<@Y4$'VK/N/#E[=Z'K*W$L/]H:J!NVD^7&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>nstg-20221231_g15.jpg
<TEXT>
begin 644 nstg-20221231_g15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "+ 24# 2(  A$! Q$!_\0
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MF8_,#% #\F"!NW?>.,5R?7\-[3V7/K>VSW?387,C8DTTSC]_=7$H[JK!%/U
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M1TNL-;RK,O\ >1@P_2LF6CUG]DVUCD^,%E*%R\=I.^X\G[H']:_1*SXL[?\
MZYK_ "K\_?V1[8Q_%J;(XCTR8C_ON,5]_P ;F.QB*\$1KVSVJ_L(R?Q%GD]
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M,^CO"WC'X8?#73Y[.Q\4K*)9FGD9D=G=B .NWL !5F^_:<\ :>I"ZA>W+?\
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I0Z7K&N"WMAB*W-Z_E*/0+G KW6B@"*UMQ:VZ1*S,%& S')HJ6B@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>nstg-20221231_g16.jpg
<TEXT>
begin 644 nstg-20221231_g16.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" $- FT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z1HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***J27$BRLHQ@&@"W16;+?3)TV_E5*[UFY
MAM)I%V HC,./04[ ;]%<HNL731HWGL-R@\ 4O]K7?_/PWY"K]FR>8ZJBN5_M
M6[_Y^&_(4?VK=_\ /P_Y"CV;#F.JHKE/[5N_^?A_TI#JMW_S\/\ I1[-AS'6
M45R7]JW?_/R_Z4?VM=_\_+_I1[-AS'6T5R']K7?_ #\R?I1_:UW_ ,_,GZ4>
MS8<R.OHKC_[6N_\ GYD_2D_M:[_Y^9/SH]FPYD=C17&_VM=_\_4OYTG]KW?_
M #]2_G1[-AS([.BN,_M:Z_Y^I?SI/[6NO^?J7_OJCV;#F.THKBO[7NO^?J;_
M +ZH_M:Z_P"?J;_OJCV;#F.UHKB?[7NO^?J;_OJD_M>Z_P"?J;_ONG[-AS';
MT5P_]KW7_/U-_P!]T?VM=?\ /U/_ -]FCV;#F.XHKAO[6NO^?J?_ +^&C^UK
MK_GZG_[[-'LV',=S17#KK<T)\V6YG*1_,PWDY YJS_;E_P#\]O\ QT5+BT-:
MG7T5Q_\ ;E__ ,]O_'12?V[J'_/?_P =%*PSL:*XW^W=0_Y[_P#CHH_M[4/^
M>_\ XZ*5@.RHKC/[>U#_ )[_ /CHH_M[4/\ GO\ ^.BG8#LZ*XO^WM1_Y[_^
M.BD_M[4?^?C_ ,='^%*P':T5Q1U[4?\ GX_\='^%$.N:C)<;&N#C'91_A18#
MM:*IZ7-)/8J\S;FR1FKE( HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/
ME_X^'^M:%4)?^/A_K3 IW%9.J'&E79_Z8O\ ^@FM:XK*U7_D$WG_ %P?_P!!
M-,"E#S:P_P#7-?Y5(*9!_P >D'_7-?Y4_.*Z3)[BTE)NI-U #C3306I"PH$%
M(:-PI"PH *0TF12;A0 4E!84A:F 9I*"U)N% !13=PI"PH =2&F[Q2;J '9I
M":;NI"PI@.)I,TPO32X]: ),TFZHS)0'H 9?,1I]S_UR;^5:Q%8M^V--N3_T
MR;^5;9K&IN:0V&8I*<:0UF6-Q24XTV@!#24ZDH 2D-+2&@!":?:?\?@^E,J2
MS_X_!]* .TT;_D'+_O&K]4='_P"0>OU-7JEB"BBBD 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5"7_CX?ZU?JA+_Q\/\ 6F@*EQ65JO\ R"+S_K@__H)K5N*R
MM4_Y!%Y_UP?_ -!-,"C"<64'_7)?Y5Y[XC^(&H:/X@NK""UMWCAV[6?=DY4'
MG!]Z]!A_X\8/^N2_RKQ3QW_R.E__ , _] %;3;2T(6LC4;XJZH/^7*T_\>_Q
MJ/\ X6SJO_/E:?\ CW^-<1(>*K,:RYY=R^5'H ^+&JG_ )<K/_Q[_&D_X6OJ
MO_/E:?\ CW^-< 'Q2!Z7/(.5'H!^*VJ_\^=I^3?XTT_%;5O^?.T_)O\ &N!W
MT%Z?/+N/E1WO_"U-6/\ RZVGY-_C3A\4-6/_ "ZVGY-_C7G^^GK+1SR[ARH[
M[_A9NK'_ )=K7\F_QII^)NK?\^UK^3?XUPOFTOFT<\NX<J.W/Q.U<?\ +M:_
MDW^-1GXG:O\ \^]I_P!\M_C7%&3K32]/GEW"R.U/Q.UC_GA:?]\M_C2'XG:S
M_P \+3_OAO\ XJN*WTF^CFD*R.U_X6=K/_/"T_[X;_XJF/\ %#640MY%IQ_L
M-_C7';JCF;]TWTI.<NX<J/1=/\?:O>V$T[1VRF-<@!#_ (UEO\4-:5B/(M./
M]AO_ (JJ'AU<Z+>>T5<Q,V)F^M<L:U1R:N39'9GXH:U_SPM/^^&_^*II^*&M
M?\\;3_OAO_BJXLM2;JOVL^X[([0_$[6C_P LK3_OAO\ XJMSPCXUU/6]=6TN
MTMUBV,Q,:$'(_&O+MU=?\.#GQ2O_ %R;^57"I-R2;%9'KM\V=+NO^N3?RKH#
M7.7Q_P")5=?]<F_E71FNFIN$!IIIIU(:R+&]J0TZFT --%+2&@!*0T&DH 0U
M-9?\?@^E1&I;'_C\'TH [72/^0>O^\:NU2TG_D'K]35VI8@HHHI %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 50E_U[_6K]4)?^/A_K30%2XK+U3_D$WG_ %P?
M_P!!-:EQ67J7.DW?_7!__035"Z&=!_QX6_\ UR7^5>*^/&4>-;_+ ']WW_V%
MKVJ#_CPM_P#KDO\ *OGCXJ#/CZ]'KL_]%K6L]B4[2*4SK@X-5&?FL+80WWC6
MA:$! K$G'O6-BTRV7I-]6HK:W=?GW_@P_P *F%E:?W9?^^Q_A2L49^^D+UI_
M8[+^Y-_W\'^%(;.S_N3?]_!_A3L!F;Z7?6C]CL_[DW_?P?X4?9+(?P3?]_!_
MA19@9WF4DMPL499CP*T?LMG_ ')O^_@_PJ&?3[.< $3#_MH/\*=A&(VIS2-M
MA 'IQFII$U..V\]TD6+@;RF!STY_ UI0:580R*Q25MK9(WCG]*ZK6O$<6LZ&
MNFRV@C0"(!T;!^16 [8YW&K21+N<':6^JWX)M(Y90O4HF<<9[>P/Y4NH66L:
M8,WT$\ W;<R(0,X!Q]<$'\176Z'JKZ!;RP61;RY V0Y!Y92F>GHQJE=2&]FE
MDO)[B<R@AO-D#9R,9Y'7@?D*+*P:G("[N2.)&(]JFBEN2P\PN5-;2:58QC $
MN/\ ?'^%22VMK%;.T8DW!3C+C_"LV,W?#/.BW^>T-<G.?WS?6NK\*<Z'J)_Z
M8_UKD+D_OV^M<,/BD2)NI-U,S1FM1D@-=C\-S_Q5"_\ 7)_Y5Q8-=C\-SGQ4
MO_7)_P"573^- >NWW_(+N?\ KDW\JZ0]ZYJ]_P"07<_]<F_E72'K794W%#82
MDI:::R+$I#2FDH 2DI:2@!*0TIIIH 0U/8_\??X5#4UC_P ??X4 =II/_'@O
MU-7:HZ0<Z>O^\:O5+$%%5;K4;:S8+/(%8]%[TJW\++D'BD!9HJF^J6J?>DQ3
M/[;L?^>WZ4[,"_16?_;=C_SV_2C^V['_ )Z_I19@:%%9_P#;=C_SU_2C^V['
M_GK^E%F!H45G_P!MV/\ SU_2D_MVQ+%1+R "1CUS_A19@:-%9_\ ;=E_ST_2
MC^V[+_GI^E%F!H45G_VW9?\ /2C^V[/_ )Z468&A16?_ &U9_P#/2E_MJS_O
MT68%^BJ']LV?]^C^V;/^_19@7Z*H?VS:?WZ/[8M/[YHLP+]%4?[8M/[YI/[9
MLPP!DP3TXHLP+]%4O[6M/^>GZ4?VM:?W_P!*+,"[15/^U;7^_1_:EK_?HLP+
ME%5/[3M?[_Z4?VE;?W_THL!;HJNM]"W0D_A3X[A)'VKG/N*0$M%%% !1110
M4444 %9\O_'P_P!:T*H2_P#'P_UIH"G<5F:C_P @N[_ZXO\ ^@FM.XK,U$?\
M2RZ_ZXO_ .@FJ%T,VW/_ !+[?_KDO\J^>_BAS\0+W_@'_HM:^@K<_P#$NM_^
MN*_RKY]^*'_(_P!]_P  _P#1:UM/8C[1P\TOER=,TZ*_$9Y4TR>(R29!I!9,
MY^]^E8EFE'KT:+CRF/TIX\1P_P#/-_TK/_LR0<K(!D8/%-&D.?\ EH/RHN/4
MU/\ A(H.\<@_ 4#Q%;GC9)GZ#_&LTZ1(5 ,HP.G%"Z0ZL&64 CIQ1<-33_X2
M&USRLO\ WR/\:4:_:$9Q-C_<'^-9)TAR>91GZ4O]EN%*B7@]1BG<-35.OV7K
M-_WP/\:0Z[9@\^</J@_QK)_LD_\ /3]*5M,9^6ESQCI1<-34&O6AZ"8_\ '^
M-)_;]KZ2_P#?(_QK,73&0Y67!^E)_99_YZ?I1<-35_MZVQDK*!Z[1_C2?V_:
M_P!V4^GRC_&LPZ:Q0*93M!R!BD&ED'(D_2BX:FH=?ME)!27(]AQ^M(VMPSQM
M&B2988R0,"LUM,9V+-+DGDDBG)I[PY(EX[C'6I;T%J=[X2.=#U'_ *X_UKC[
MD_OV^M==X2/_ !)=1_ZXG^=<A<G_ $A_K7!#XI"ZD=&:;FC-:C'BNR^&Q_XJ
MI?\ KD_\JXP&NQ^&W_(U+_UR?^573^-"/7KS_D&W'_7)OY5TIZUS-Y_R#+C_
M *Y-_*NE-=M3<("4AHH-9%B&DI::: "FTM(: $-(:6DH 0U/8?\ 'U^%05/8
M?\?7X4 =GH__ "#Q_O&KU4-'_P"0>/\ ?-7Z@1QOBF79K$2YZ[:T8C^Y'TK$
M\8/CQ% O^Y6S#_J1]*:&]BC>=ZSS5^\[U0JA!2TE+0 4444P%%5HS_Q-9Q_T
MPB_]"DJS5:/_ )"L_P#UPB_]"DH M444M, I112T@"E HHH 6BBG 4  I112
MT@ 5%)_Q]0?\"_E4PJ*4?Z5!]6_E0!.!2XHI:8!BE% I: '"G"F"GB@#0MON
MU=MO^/@?0U2MONU=MO\ CX'TJ6(NT445(PHHHH **** "J$W_'P_U_I5^J$O
M_'P_U_I30%.XK-O^=.N?^N3?R-:5Q6=>_P#'C<?]<F_E5"Z&1:_\@VV_ZXK_
M "KY]^*)V^/;X^R?^BUKZ M.=,M?^N*_RKQGX@:/!>^,[V25G!PG"D?W!_A6
MT]B%K(\M,J[^?6K<#J0#SCZ5O?\ "/V2-]UF^K5H6NBV 4 VZD?[Q_QK"YJD
M<YYT0P#G\JD$L7O^5=O;:+I94;K",_5F_P :N+H>D8_Y!T/_ 'TW^-!7*>>^
M;%[_ )4GG1>_Y5Z+_8FD#_F&P_\ ?3_XTO\ 8ND?] R#\V_QIARL\W\V$^OY
M4;XCZ_E7I/\ 8ND?] R#\W_QI1I&D?\ 0+M_S?\ ^*H#E9YKF+W_ "II:(>O
MY5Z;_9&D?] NW_-__BJ3^Q](/_,+M_S?_P"*H#E9YB985Z[ORIAN[<==W_?-
M>H'1-'/72K?\W_\ BJ;_ &#HO_0*M_S;_&@7*SS#[9;?[7Y4OVNW_P!K_OFO
M3QH&B_\ 0*M_S;_&G#0-%_Z!5O\ FW^-&@69Y>+JW_V_^^:&N(&4JN[<>!Q7
MJB^']$_Z!5O^;?XU#JF@:/%I-S)%ID"2+&2K MD''7K4NP<ISOA+C2=1'_3$
M_P ZY"Y_X^'^M==X7.W3M1'_ $Q/\ZX^Y/\ I#_6N&'Q,S(J6D%)6HR1:['X
M;?\ (TK_ -<G_E7&K79_#CCQ0G_7-_Y5=/XT!ZY=_P#(-N/^N;?RKI37,W?_
M "#;C_KFW\JZ8]:[:FXH"4E(S;1G&>U-9U4D%U_.LRQQI#3/-3^^OYTAF0 D
MNH ZY-%@'TTU$EU#*@:*:-U;H5;(-*9D#!=Z[B,@9ZB@!YI*:9%_O+^="L&)
M'H<4 .JQ8?\ 'U^%5JLZ?_Q]?A2 ['1_^0>/]\U?JAH__(/'^^:OU+$>>^,V
MQXGMA_NUO0_Z@?2N>\;''BJT^JUT$7^H'TH6Y3V*5WU-42*O774U2[U1(8HQ
M110 8HHS2T )58DPW\DC(Y5XD4%5+<@MGI]15JB@"'[2G]R;_ORW^%+]I3^Y
M-_WZ;_"IJ*8$7VE?^><W_?EO\*7[2O\ SSF_[\M_A4E+0!']J7_GG-_WY;_"
MFM>*%_U<W_?E_P#"IZ,9H Q[G79;>&5DT^YF91^[41L-YSTR1QQD_A69_P )
MCJ?_ $+ES_W\_P#L:ZLQAEP14/E '!%0XMO<#F_^$QU+_H7;G_OY_P#8TH\8
M:E_T+MS_ -]__8UTGEKZ4OE+Z4N5]P.='C#4NWAVY_[[_P#L:T](UBZU2Z_T
MO2YK'RAE3(<A\^^!6@(U'85(!BGRON!.&R>E/%1(<]:D%4 X4ZFBE% #J<M-
M%*.M &A;?=J];?\ 'P/I5"V^[5^V_P"/@?2DQ%VBBBI&%%%% !1110 50F_X
M^'^O]*OU0F_X^'^O]*: IW%9]W_QYS_]<V_E6A<50N>;6;_</\JH70P[/_D%
MVO\ UQ7^5>3^-#_Q5U[](_\ T 5ZO9?\@NU_ZXK_ "KRCQK_ ,C=>_2/_P!
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MY 1'YAZ2$'CD<I@@^F>AKIK8$&3/J/Y"JYL(SNS$/F<.>>X[U:A4J7)_B/\
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MJOSU1F&89/\ =-4+H8%G_P @NU_ZXK_*O)_&G_(W7OTC_P#0!7K-B,Z7:_\
M7%?Y5RNN>!/[7U>:^^W&+S=OR>5G& !US[5M--K0E.S/,@.14T?6NW'PT/\
MT$C_ -^/_LJ>/AQ@_P#(1/\ WY_^RK'DD:<R.4@/%6T/%=,G@ I_R_D_]L?_
M *]2CP,1_P OQ_[]?_7I\DA\\3E\TM=1_P (41_R^_\ D+_Z]'_"&'_G\/\
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M4T4HH ?4;PHYRPYQC-/I:8$'V6/TI1:Q^GZU-2T 1"VC]/UIPMH_3]:DI10
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M  ('^%)_PONT_P"@1)_X$#_XFCGCW"YZ"-'O_P"[;_\ ?P_X4O\ 8M^>UO\
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M_"6:C_SX0_\ @2O^%<]3A1RH.9G0?\)7J'_/A#_X$K_A2_\ "5:A_P ^$/\
MX$C_  KGP:7-/E079O\ _"5ZC_SX0_\ @2O^%+_PE>H_\^$/_@2/\*Y_-+FC
ME079T'_"5:A_SX0_^!*_X4H\5ZA_SX0_^!(_PKGZ4&CE079T'_"5ZCG_ )!\
M/_@2O^%*/%>H=]/B_P# E?\ "N?S1FGRH+LZ+_A*M0_Y\(?_  )'^%2CQ1>?
M\^D7_?\ 6N9W4ID HY4%V=*/%-]_SY0_^!"TS_A+=0-U' EA"SR*S#-P ."!
MCIU^:N8DN0@ZU2M[TS>([) >/F_FM)Q2!-GJ5O)XAD4%M'B&1D?Z6/\ XFK
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MI-,)I@!IA-&ZFEJ0 332:,TQC0 $TQCQ0332: #--)I":832 4FF$T$TPF@
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M>&H?^>K4<Z'RG-EJ:6KHCX:A_P">K4T^&X!_RT:ES!RG/;JL63?OQ6Q_PCD
MZNU;&B:-:07 81*[ \%QG^=/G#E-?PK8RV]A<W,RE!,!L!ZD#//ZU/I'_'S)
M]36G<S>78LS'M63H;;YF/J34WN[AT._T'_D%C_?;^=:59VA?\@T?[[5HUF]P
M/)OBF_\ Q45HO_3-?_0C3+=,VZ_2F_%+GQ=9C_IFO\S5RTB_T=?I3B4]BIL^
M:IT6I&B^:G*E62(!2BGA:<%I@, I<4X+3MM $>*0BI-M)MH A(IC+4Y2FE*
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MDBV>FV\4S*C1QJI#'&.*'U*QC;:]Y;J?0RJ/ZU6HR7;1MJ#^U=._Y_K;_O\
M+_C4@O[(C(NX/^_J_P"-%F(=MI"M)]NL^UW!_P!_!_C0;VS_ .?J#_OX*+,
MVT;:3[;9_P#/U!_W\'^-)]LL_P#GZ@_[^"@!=E)MH^UVG_/U#_W\%'VJU_Y^
M8?\ OX*!B;:0I3OM-K_S\0_]]BD^T6W_ #\1?]]B@!NVDV4V6\@CY$BOZ[3G
M%0'4H/[U2Y) 3[*-E5SJ4']ZD_M* #AJ7,@+&RDV5!_:4/\ >I/[2A]:.9 3
M[*3RZA_M*#^]2?VG!_>_2CF0$WETGEU#_:=OZ_I2?VI;_P![]*.9=P)O*I#%
M4?\ :=N?XJ/[2M_[U',NX%;5XB-%OO\ KWD_]!-:5G,8).?NFLS5=1MCHUZ"
MX'^CR<GM\IK4.PK]Y?SIII[ 6+[$D)*\YK#F2KTDNU2N]<?6J,LD9_Y:)_WT
M*JP%*0579:M.T?\ ST3_ +Z%0LT?_/1/^^A3L,@*TTI4^8O^>B?]]"DS%_ST
M3_OH46"Y7V5<TY0LN3P*BW0_\]$_[Z%.66)>DJ#_ ($*+"+&K7QE7R8NG>I-
M 7:QS5(M"?\ EHG_ 'T*O:;<V\+$O/&H]2X%%@.[T6>)-/VO(JG>>":T/M4'
M_/5/^^J\+\2ZW-_;DHT^[S"%7!C?(SCGI6*^OZD/^7F3_OJLWN/E/0/BG!&V
MM:/=Q.K>8QB;!Z$'(_F?RJ_9Q?Z.OTKR&379?[3LI-3N2+:.8%V<\+VS7KVF
M:C87=LIM+VWG!'!BE5OY&JB)Z"/#\U((ZN,H/(I-@JR2MY=+Y=6=E&R@"MLH
MV58V4;* *^RDV59V4;* *WETACJULHV4 5/*H\GVJWLI=@H I^1[4AMZO;11
MM7U% &<;7/:JTED?M(('.W^M;6U?44W:OV@'(^Z?YTAD=I*?+\N3@TYHN2:D
M/E?WE'XTAEC Y=?SH JO&!4+)5IYH.\J?]]"HC-;?\]H_P#OH4]0*Y2D\NK'
MFVW_ #VC_P"^A1YMM_SVC_[Z%%F!7\N@19:K(FM/^>\?_?8IPGLP?]?%_P!]
MBC4#5M&6WMAZXJG<.9+NW)[R_P#LC5']OMNGVB+_ +[%--U;O<VVV:,GS.@8
M?W6HLQ'06WW16E8_ZQOH*RK::/ ^=?SK7L5.YFP0,=2*B0%RBBBH&%%%% !1
M110 44E** *]Q-)&O[J(N:YW4Y-=N 5MH=H_W@*ZDKFF;*:8'E&H^$_$M^Q+
M+G/_ $U'^-<AKOPB\47]PDUM'"2%VL'F KZ&\NCRZKF8CY8E^!OC:0_\>UOC
MU^TK6U_PJ3Q@8U06<0"@ ?Z0G^-?1WEBCRQ2N/4^;#\'/%[=;2+_ ,"$_P :
MDC^#?BH#YK:+_O\ I_C7T?L%&P>E%P/G/_A3OBC_ )]XO^_R_P"-'_"F_%!_
MY=XO^_R_XU]&;*792N.[/G$_!GQ.1_J(?^_Z_P"--'P:\4C_ )=H?^_Z?XU]
M'[/:EV#TIW"Y\XCX.>)_^?6'_O\ )_C2_P#"G/$__/M#_P!_4_QKZ-V"C8*5
MPNSYT7X.^)Q]V"(?29?\:</@]XH_YY1_]_E_QKZ)V#THV"BX79\\?\*=\3_W
M(O\ O\O^-(?@]XH_N1?]_P 5]$;!Z4;!Z4@NSYT/P=\4'K%&?I./\:8?@QXF
M/6-!_P!O _QKZ.V#THVCTH"Y\X_\*3\2'J$'_;<?XTG_  H_Q,?XT'_;Q7T?
MM%&T4K!<^;_^%'^)_P"_&?\ MO1_PH[Q,?XXO^_]?2&T4;118+GS?_PHWQ-_
MSTB'_;Q2CX&^)O\ GM'_ .!!KZ/VBC:*+!<^<&^!OB5E(:6,@]09^M1_\*'U
M_P#Z8?\ ?ZOI/:*-@HL%SYK;X$^(0/D6$_\ ;45F:A\!O&)D#6D5N1MP0TX'
M-?5&VC;3"Y\DCX!>.Y&VM#;*">IN!6]'^S]XC*C+6Z_66OIC;1MH"Y\UC]G[
MQ"/X[7_O[2_\*"\0CO:G_MK7TGBC% 7/FW_A0FO_ -VV_P"_M2+\!-<(Y6W_
M ._M?1V** N?.R? +6/XOLX_[:58A^ 6IHP+36X&>@:OH*B@+L\A@^$^H11*
MGF0\#'WJ&^%&H$?ZR'_OJO7J* YF>*7_ ,&M0O;1X2\(W#J6K"7]GC4S_P O
M5LOXFOHBB@+L^<+S]G[Q1&RMINI6G .Y6F=?Y U53X#>.=V)+ZRQW/VM_P#X
MFOIFBG=A<^=5^ GB3:/,U*#=CG$S_P"%+_PH3Q!_T$HO^_KU]$T4787/G;_A
M0FO=]4C_ ._CTH^ FM'KJR#_ (&]?1&!2;11<+L^>?\ A0.K=]6C_%GII^ &
ML=M4A_[^/_A7T1M%&T>E 79\Z-^S[K)_YBT0_P"VC_X4@_9[UCOJ\?\ WV_^
M%?1FT>E&T>E 79\[#]GG5C_S%X_^^V_PI#^SKK!Z:U'_ -]-_A7T5M%&!2"Y
M\ZC]G+5^^MQ_FU _9NU(]=:B'X-7T7@48H"Y\YG]FW5/X=<@_$-43?LVZU_#
MK=J?J'KZ1Q1B@+GS4?V;M<_Z#-I^3_X4@_9MUHGG6+3\G_PKZ6P*,"@+GS@O
M[-.IG[VMVWX(U/'[-%__ -!NW_[X:OHS%&* N?.H_9JOEY&M6^?]QJ8_[-^J
M#[NK6Q^N[_"OHW%&* N?.'_#..KCIJ5H?^^O\*0_LYZT.FH69_%O\*^D,48H
M"[/ER;]G/Q4)V,%]8%"<@,[@C_QVMG0/@9XFTW4;:>YN;+;"X?\ =NQ)(^H%
M?15%.[ Y/2=%U>P51).K =LUU$'F;!YH&[VJ2BANX@HHHI %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
2%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>nstg-20221231_g17.jpg
<TEXT>
begin 644 nstg-20221231_g17.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "W 1,# 2(  A$! Q$!_\0
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MH^G_ /'UK-M^[_YZ7*+0!TGF4^N&O/C%X)T__CZ\4:3#_P!OB5E/^T1\/?\
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MU"_\JZTO4O-_YYV?D7?_ *)D:OC"\\<:EJ%_J$LLL?FR)#O\M-OW45:?X/\
M'&L:/JWFV%_Y,O\ N*W_ *$M7[/$?W3/WS]'?"7QB\*ZA<?99;JYTV[_ .>>
MH6SVW_CS?+7I"3PW%OYL7[ZOS9MOBIKUQKT4MU=1WDNS_EHBK_Z#7J/@_P".
M$VC_ .JEN=-_Z9QONA;_ (#_ /8U<8U?MAS'VQ3:\;\*_'K^T(/]*BCO(O\
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M .S6Q_PQIH-O_K=9OO\ MGL_^)HYBSY%\^C[57UO_P ,D^#[?_E_U+_OM/\
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M_P!>[Q-_Z$RT0_\ !33P?_RU\!^+8?\ @%LW_M2CE#F/KKR*?Y-?*Z?\%'/
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%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>nstg-20221231_g18.jpg
<TEXT>
begin 644 nstg-20221231_g18.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "? 6L# 2(  A$! Q$!_\0
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M49S^?I7R7H:9U"Z;U8UV.E7MWI-P)[.X>WE'\2'&?8CO5N*Z!<^CJ*\W\/\
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MY_&N@^,/%6GRH4L[6'3O+\LEARQXSP,?C7WG1322V061\:ZM\0_!.I2-)<_
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MD_\ 0-M?^_*_X4G_  C.D'KIEI_WY7_"B[ ^5I_VF/A3;)\GPOF<>G]D1?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>nstg-20221231_g19.jpg
<TEXT>
begin 644 nstg-20221231_g19.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ] #P# 2(  A$! Q$!_\0
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CAKPY:>%M)BL+-3L7YGD;[TC'JQ]S6K114'U48J"48K1'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>nstg-20221231_g2.jpg
<TEXT>
begin 644 nstg-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &X! (# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI*
M %HI*,T +1110 44E+0 44E&: %HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$KQ&.?[2<_\  15F'XK>(8<%KE)/]Y:^%T_X*)>&?X_#&I ?[++6A;?\%"O
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M2^Y_I<^3Q678G!O][#3OT^\TJ*2EKZ4\T**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHI* %JM<7B6LD*R''FOL7Z^E2R2
M+&I=V"*.K,<"O)OC5\1+33?"-\^D3_:M:LL75N(N0&0Y()]UR/QKBQ..PF"Y
M7BJJ@F[*[MN:1HU:J;I0<K:Z'KM07%Y!:*6FF2)1U+-BOG30_P!HR[^)'A^#
M4-(ECM(G4"2-.7C;NI]#FLR\U2[U!M]U<RW#?[;$U^5YUXCX3+:T\+1H2E.#
M:?-[J37EJ_P1]1@<@GBJ<:TJB49:JVNGY'OVH?$;P_IV=]^LA](ANK NOC5I
M<+$06MQ/Z'@5XLY$:%V(11U9C@"N>UCXA>&/#\!FU'Q#IUK&."6N5)_('-?G
M=7Q(SS&2Y<)32_PQ<G^-_P CZ"'#^!I*]1M^KL>[3?'!]Q\K31CMO:JI^-^H
M=M.M\?[YKYGNOVF/A=:@E_&FG$CLI8G^59LG[6GPJCX_X2NW;_=5O\*P>?<;
M5M8PJ_*G_P#:FRR_*(Z-1_\  O\ @GU6OQPO^^G0?@YJU;_' \>=IO'^P]?)
M4?[6GPJ?_F;+9?\ >5O\*U+;]I3X7W6/+\::=D]F9A_2FL_XVH:RA5^=._\
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M .&^9\O6H5</+DJQ:?F/HI!2UWF 4444 %%%% !1110 4444 %%%% !1110
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M^]^?J>'G&3?5[XC#KW>J[?\  _([NBDW4M?LY\>%%%% !1110 4444 %%%%
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MS'X>^$[7PSK$MQ!-(=T9#[CP!7EWQ7\5_P#"5>)I&B;-K;?NHO0XZFMGQ/\
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MYZ=X5^$GBO5K**6QT.ZEBD&X2D;0:[?3/V;?'-U-$S6UI;19^;SY>?RK-?\
M:J\6:+HEIIUK'9*T,8C61HR3@< ]:Y34OVC/'VK9#:]) A_@A4*/Y5^=UZO&
M]>I*%&.'HPOHVY2=NGE?Y'SF79%DV8K^T,0YU7+?FLDWUVULNFII>(K6?PKK
M5UI=TBF>V;8S*>#[UF?VT\AV*(R3V)S7$:AKM[K%W)=7MU)<7$AR\CMDFH(V
M>1@$#,_^SG-?HV'G5C1@L0TYI+F:V;MJUY7.A<)Y%2;E3PROTYG)K\ST@:';
M:E;AKB 12GO'Q6+J'@F>,%K602C^ZW!JIH[>)E91:VMU,O\ =>,D?G7H.@Z/
MXBU# NM'DM\_\M-PQ^5:.M2^U)(_,\=4S[AVM.MAL1"=)MODYKI+LHR?,ODS
MR*\@FLY"D\;1-_M"J;M7T--\-)M4A\N[$)4COU%>1^+OA[<:)-.;0_:(XR=R
M#DC_ !K&-6G4;5.5['UF2<<83,7&CC(^RJ/;^5^CZ>C^\XYVJM(U.D8\YZU!
M(U)L_1VQDC'FJTC5([56D:LFS%LCD:JLC5+(U5I&K%F#(I#560U-(U5I&K%F
M,B"0U5D-3R-561JQ9A(Z'X9^&9?&7Q%\.Z/%%YQNKR,.@[H&!;] :_7FUMH[
M&WAMXAMBAC6-%] !BOS[_8*\!_\ "0?$Z]\131[[;1H,(Q/25^ 1^ -?H;:V
M[WEU%"@R\KA0/J:_DOQ4S#Z[G5'+Z>OLHZ_XI:_E;[S[7(Z7LZ$JLNK_  1[
MK\)M.^P^$89&7#SN7_#M7:U2TBQ73=,M;51A8HPN/PYJ[7[]E&#67Y?0PG\D
M4OG;7\3\XQ=;ZQB)U>[84445ZYR#?+7S-^T;\8W8YQ3J**5K %%%%, KC?BM
MI_V[PA<,HRT)$F?8=:[*J>K62ZEIMU:N,K+&RD?A7DYM@_K^ KX7^>+7SMI^
M)U86M["O"KV:9\MM&LBE9!NC8;64]P:_([XQ^&)?!OQ7\4:1*@C,-Z[*J]-K
M'<,?@:_7B\MWM+J6!QAXW*D?0U^?/[?W@?\ L7XC:7XDAB5;?5K?RY"O>5.I
M/X5_/OA;C_J.>5<#4T]K%_\ @4=?RYC](SRE[3#QJQZ/\&?,4=6X^U4HVJU&
MW2OZV1\3$NQM5F-JI1M5J-JWB;Q9=C-6HVJC&U68VK9&\2]&U68VJC&U68VK
M5,WBR\C>]6(VJBK58CDK5,V3+ZM5B"X>%@58@UGK)4RR5JF5*,:D7":NGW.B
ML_$#QX$B!QZBN@T_6+:Y3<K,I'52*X%9*L6VH2VN[RSC=UXK:,^Y\?C.#\GQ
MKYG!P?\ ==OP=U^!W\E_:N"'B\T>XJFNBV.K.X2)[9P,Y7I7'-JEPY_UI'TK
M0T_QA>:?A3LE3T;K^=5SQ9Y^(X9_LS"2_L-R5;HW4:7W6Y7Z,N:CX-O;8%X2
MMPGMUKFKF.2WD*2HT;>C#%>AZ3XR@U!E1[>:)SQD(2OYUT,_A-M>AQ)8-,K#
MA]N"/QK.7):_-8^5H\99ME%58?/,.VOYEH__ )%_*QXA(U5I&KN?%_PQU'0<
MRQ1M)$PSL/W@*X*0E6(/!'4&N=O2Z/U/+\UPF;4O;82?,NO=>36Z(Y&JM(U2
M2/UJM(U9-G>V12-561JFD:JTC=:Q9@R&1JJR&IY&JK(U8LQDR"1JK2&II&JM
M(U8LPD>F_LQ>%6\8?'+PS:>4)H;>8W<RMTV(,_X5^J3=6QT[5\0?\$\_ _G:
MEXB\73Q*4A5;*V<]0QY;'X8K[N\/Z>=4UFRM5&[S)0"/;/-?R!XD8QYIQ)#!
M4M?9*,?^WI:O\TOD?<9/!4,(ZLNMW\D>_P#@73SIGA73H2,-Y88_CS704R&)
M8(4C485%"C\*?7]*8/#QPF&IX>.T(I?<K'YA6J.M4E4?5MA111788C?+4N'*
M@N!@-CFG444K) %%%%,!&&Y2/6OF?Q9IYTWQ'J-N?X921^/-?3->(_&32OLG
MB"&[5<)<1^G<5^0>)F!>(RJ&)BM:<OPEI^=CZWANMR8J5)_:7XK^F?GI_P %
M$O"IDTWPKXC3GR7>S<8['D&OBF,U^I?[3_@<^/?@GXBL(UW7,$?VN'"Y;<G.
M!]:_+&(G^(88<$>AKV?"S,5C,A6&;]ZC)Q^3]Y?FU\CJSJC[/%<_22_X!=C:
MK,1JG&U68VK]F1XT2]&U68VJE&U68VK9&\2]&U68VZ52C:K,;5LC>++L;5:1
MJH1M5E&K9,WBS1M5,TT<:_><@"O:_"<K>$--^SV*(D\@S-<$99O8'L*\-MYS
M#(D@ZJP->TV-T+VQAG7I(@->3F4IJ,4MF?GW&,ZOL:5._P"[=[^;6US<U[P^
MOBC26:[;S;\INCF;[P/8?2I/@WXWU?2(A96&H".6V;;+93'Y6 /45T<.M:9I
M_@\ZG>B-1 A4^K,.@KYREUR=M8FU&!S;S/(74QG&.:\>6!JYEA9483Y6G>+Z
M7[-=NXN ZWMHUZ&/I>TPZTL^CZ\KZ/KIM\S[ZT?QDFM6N_\ U<Z_?3/0^U1:
MPT6K6<MM-\R.,?2OF[X/_%+4]7\16^G7%N)2RG=.G!P/45[K)>$]Z\6EA<3A
MTHXJ*4UV=T_->I\KQ9A</E68SP^%FY4I)-7W2?1^:[]58\BU[53X7U::U\DO
M/']QF^[[&J?@.XDOO$TUS,YDE"%F)]ZT/BXH;5+25%WRNA! ZG'2D\ Z%)H>
MFR3W/_'[=-O<?W1V6OC,[K2E[2-6?PV45Z_Y+K\C^B/#G*\%2RVAC<)2M.K'
MWY/5Z-KY)OHCJ]=D^U:3>1GG,;'!]A7)_ '1-1^*+7VG7.DQ3:*,H]Q<#*H<
M_P )]:V/$&H"QT/4+ACA8X&)/X5ZQ\"4M?#WPKT5+4*IN(_.D8?Q,QS660X>
MG5PU:I4A>2E'E>JL]6]OD>AQ]G5?)J5&GAI<KJ<R?HK?CV.%^(W@G2OAY?6>
MCZ+ (+-8=Q8#EV[DUQTB"92KJKKZ,,BO:/B=80ZY%%=,-SQC;N'45\\6OC2R
M;7KO1KMA:W]O(4 <X63T(-?>X>O[:;I.[FE?U6U_\S^5L5D^,K4)YK17/3YF
MG9WE%[ZK?5;/4]G\+:INT.",<>7\N!3?$D::UH=_8R#<EQ"R8_"N:\+W9C,L
M.>#\PKGOB=\8-.\ V4D4<BW6KNN([=#G:?5O2NRG2<I^XM3YK#PQ.*KQH8=.
M4NG^9\UZ7K5II']H>&M>A:;2FG;+Q_ZRWD!QO7_"JVH_#:[DADNM$O+?7;-1
MN_T=P)0ONG7-<WJ5])J-]<W<QS-/(TCGW)R:@L=6N=%O8KRSE:"XB;<&0X_/
MUKZEQ:UBS^A)8>K"]2C*TGNGK%O\UZKYIE&7*L01@@X(/454D-=Q\4+>&34;
M#6+>-8HM6M5N&11@"3HWZ\_C7"2-4<W,KFE&LJ]*-1*U^G9]5\F0R&JDS?*:
ML2-6U\._"DWCKQ]H6@PQM*U[=(CJO79G+'\LURXBM##TI5JCM&*;?HM67RN4
ME%;L_2C]EGPB/!WP-\-6K1-#<7$/VJ97X.]SG^6*^H?@GI_G:O>79'RQ1[5/
MN:\PL;./3;&VM(N(K>)8D^B@ ?RKWKX0:5]A\,_:&7:]RY?GT' K^.^#83SS
MBB6.J+[4ZC_&WXM'VN<36$RWV2ZVC_F=U2T45_5I^7!1110 4444 %%%% !1
M110 4444 %(W2EI#0!XY\:-$,&H6VI(OR3+Y;G_:%>"_%SP+#\2?ASKOAZ5=
MS75NWE>HD RI'IR*^OO&NA#Q#X=NK7&90N^,^C"OG*16A<JPVLIP0?45_*W'
MV7U<FSN.98?3G:FGVDGK^-G\S].R/$1Q>"=">\='Z/;_ "/Q@N[&?2+ZYL;I
M#'<VLK0R(>S*<&G1M7T;^W)\)6\&_$*/Q390[=+USYI2HXCG Y'MD5\W1M7]
M4Y'FU+.LNHYA1VFKM=GU7R=T?)XBC+#5I4I="[&W2K4;51C:K,;5]"F1%EV-
MJLQM5&-JLQM6R9NF78WJQ&U44:K$<E:IFR9>5ZZ3PK!]H2ZD'WHP#CVKE%>N
MJ^'VI1V?B!(YN8KE3$P/3FMHMW]UV9Y>;M+ U)2ASJ-FXIV<DFFU?I=)EB;2
M3/,TDD^,GH*06-G#R\P)^M6?&GA.YT6=[JW+RV3'/<E/;Z5RR;Y.BLQ]A7!+
M#8ENU2L_DK'UN5\09-BL)"KEF%BX6LKMMKR:Z-'0^?I\73!/TK>\&>.+'PKK
M!O)++[4GEE F!U/>N+AT^[FQLMW/X5=C\.W\G_+,*/\ :-5'+XMWDY2]6=6.
MQ\\QPM3!2HQC3FK/E5G9^>YZE=?M$W.TI9:1#"O8LW]*P;[XZ^)[K(26&W7_
M &$YKG]'\$RZCJ=I:SW26\<TJQL^/N@G&:^A[?\ 9+\&Z3&L^L^,&9<9*AT5
M?YYKY_.LZRGAR5.&.34IWY4HN3=O0^,PO"&6QUIX:.G?7\V?/-U\3/$MT^Z3
M69Q[!L"M30_B8)7$.I#>Q./.3G\Q7O'_  @WP!\*_-=:I#?3+U!N2Y_(4R3X
MQ? SPO\ +IN@QW<J_P 2VG7\37ST..)5/^1=EE>I_P!N**_$VS#A'*LPH^RQ
M$81MLXV37I;];GA7C3P?]JLGUG3(7>$#=*$0[<?WJ\V>2OJ;Q!^V)H$^EW&F
MZ9X2\JWF0Q%IM@4*1@D 5\P:]#':ZE*(3^XD_>1_[I[5]=D^89AF-.=7'X3Z
MO9JR<E)M=]-CBP&%EE"AEU2NZVC<9-6T6G*]7=J_W%%VJO(U*[U!(U>VV>NV
M,=JKR-3Y&JO(U9-F39'(U5I&J21JKR-6+9BV12-565L D#)J61Z]._9I^%<G
MQ;^*VFV+H3I=DPN[U\<!%.0OU)KR\PQU'+<+4QF(=H03;^7^>Q-.G*M-4X;L
M^X_V1/AJ?AS\'=.^T1>7J6J?Z;<9'(W?='TQC\Z^H/A3H9U;Q/',RYAM1YC>
MF>PKB8HDAC2.-0D:+M50,  < 5[Y\*_#O]B^'4FD7;<7?[QL]0.PK^0.%L/5
MXHXDEF&(5US.I+[_ '5]]EZ(^TS2M'+\O]E#=KE7ZL[6BBBOZQ/RP**** "B
MBB@ HHHH **** / OBIHITKQ1+(JXANAYB_7O7S%^UY\-V^(GP;U+[/%YFHZ
M6?ML&T<G;]X?3&:^X/BUX?.K>'S=1KF>S.\>Z]Z\'FACN(GBE4/%(I1U89!!
M&"*_DSBBA5X7XE6.PZLN95(_-ZK[[KT9^J995CF&7^SGNERO]#\7XFR >E6H
MVKT+]HSX7S?"?XK:KI@C*Z?=.;JR?'!C8YQ^!S7G,;5_86 QE',,+3Q=!WA-
M)KT9\3.$J,W3ENB[&U68VJE&U6(VKTT5$O1M5F-JHQO5F-LULF;IEV-JLQO5
M!'JPDE:IFR9?5JF5ZHK)4RR5HF:IEY9*E62J*R5*LE:7-%(NB2G>;5,2>]+Y
ME.Y7,:-G-$MW 9ANA#C>N>JYYKV@>,/AKH<:^38K<N .D6_G'O7@YDIIDQ6%
M6DJUKM_(\+,LJIYHX>UJ3BHWTC*U[]SW.;X]:)IX*Z=H.?0X"_TK&OOVBM68
M$6FG6T*]MV213? _[,_B_P ?:+:ZM8M9P6%R-T<DTAR1G':O0-._8EO-N_5?
M%$%J!]X11[OU)KX/&<5<,Y=4E3KXF//%V:5Y.ZZ629ST."<OTE]7YO.3;_-G
MFL'QDDUR=%UE1$5X62,?*/K53Q=X1MM<LVU+2V1I@-Q6,\2#_&O:H_V8OAAH
M*[M:\7>:R]5^THF?PK0L-2^ WP[C>.*_CN7_ +NYY,_3M7''Q"RZ<?9X+"UJ
MRZ<E-V_&QYE?@:>#Q2Q^45HT)]8MW@UU7=?C\CXPE8JQ!X8'!'I5:1NM=Y\9
M)- U+Q5<:OX70QZ+=ME(L8*,.OTS7GDCU^@4JKK4H57%QYDG9[JZO9^:ZGTM
M&O&M#FCT;3]4[/\ $21JK2-3W>JTC4VRI,9(U5I&J1VJM(]8MF#9%(U5V5II
M%CC&Z1R%5?4DX%22-7L_[(WPK?XF?%JTGN(M^D:.1=W+$94L/N+[Y.*\;-,Q
MHY5@JN.KOW::;_R7S>@4J4J]2-*.[/NO]G7X=CX9_"/0M)>/9>21"YN<CGS'
MY(/TZ5]'_!O13>:U/?NO[NW3:I/]XUYVJ] H]E4?RKZ&^'N@_P!@^&K>-AB>
M;][)]37\E\$X2KG_ !!+,L3KRMU)>K>B^_\ !'V&<UHX+ >QAO+W5Z=3J*6D
M'2EK^JS\O"BBB@ HHHH **** $KB/BQHIU3PPTR+F6U;S!ZX[UW%075LEW;R
M0R#<DBE2/8UY6:X&&9X&K@Y[337SZ/Y,ZL+7>&K0K1Z,^5)HTN(WBD&Z.12C
M#U!&#7Y/?'KX?2?#'XL:]HI39;><9[8]C&YR.:_7?Q)H[Z#K5W92#'EN=I]5
M/0U\>_M[?"EO$'A.R\9V$&^\TD^5=;1RT![_ (&OYP\/LTED'$$LOQ/NQK>X
M_*:?N_C=?,_2\VHK%855J>MM?D?",;59C:J,;<"K4;5_82/AHEV-JLQM5*-J
ML1M6R9LF7XVJQ&U48WJPC5JF;)EZ-JL(U48VJ=7K5,V3.M\!^'_^$F\0P6C<
M0K\\G^Z.U>[:AHT<=NAM4$:Q+MV+Z"O*/@7=Q?\ "5RVCX$US$1$2?XA_#^-
M>J>/M0DT'PQJ4S*T<RH4"L,')XKP\:Y5*RI]#\DXHJ8C$YK3PBVTM_V\]7_7
M8XSQ7ILVN:4([:<L8CO$:M\K?_7K(\-_"'Q+X@9&^R_8[<]9IS@8]O6N*TF7
M5)I%6P%U+)GA80S?I7T7\'/"/Q(N)(WOREEI)Y;[9]XCV%=,I5,#2:4U;SW/
M>K?7N'\&Z6&K0?5<VDODNOS.E\ ?#VP\!6;"$_:+V0?O;AAR?8>@KJ9+@(I9
MF"HHR23P*S_B;JD?PWTD:C)'+J-OG:QA'W3[^U?-_CCXUZKXKA>TME_LZQ;A
MEC/SN/<UYE&C5QK]I?1]3\\PF2YIG^(=>H]&_>DVOP2_!+0];@\?Z!XF\07$
M,<J?:;=O+C:3@./5:WVDQ@YP/7/6OEKP=X=N_&7BC3M%L)%CN[R79&[' !]:
M^_?A-^SQH?PYMXKC5;J;7=4 !9KART:GV6OB.(.&J"Q#KQKM.6O*U=_)W6A_
M3F!XLP_#.7TLLC1YG"-E9VT[RT>[OMJ^QX1XUT^;5M*ETU08_.'SDG! KK_@
MIK%YIGAS^P;\YDLCB&3/#Q]ORJ7XK1)'XZU'8%57(8*O  ^E<YIE\VGWL<JG
M !P?I7IY?@*>!P_L:;;3UU[]S\%XFXSQ_$,W#%TX+E?N\J::\KW=SUFZOA,C
M(W*L,&OC#X_Z'<:#\09YFR(;H"6&1>/P^HKZO^U^8JL#D$9S7S)^TSXI@U3Q
M%9Z9'&0]BA+RL,;BW8>U?0Y?3Y:ZDET9Q<(X[$_7W0IZPDO>7339_)NWS.!M
M/BAXFTVS:UM]5D2)EVY(!8#V-<E>7<MS,\LTC2RL<L\AR3^-/AAFO9EAMXGG
MF8X58U))-=A'I.G_  ]M1>:W''?:Y(N;?2R<K#_MR_X5]"^2G\*U9^J3>&P,
MG[*FN>72*2;]?+S>B. :0-T-59F^5OI7HZZA%\1/#^K+/I]K!K%A%]I@DM$V
M&2,'YE('7K7+>#/"[^*-2#2MY&EVW[V\NGX6-!R1GU/3%9^TT;>EB8XQ*$Y5
MERN&ZW\U;O?IYZ&C\1/]'T'PC;MQ*MB79>X#-Q_*O/Y&KH_'?B1?$WB*XNXE
MV6B@0VZ?W8U&%_Q_&N7D:LHZ15R,)"5.A%3WU;^;O^I'(WYU]5?L!?#?^V?&
M.I^+[J+-OI<?D6S,.#*W4@^H'\Z^5K>VGU"\@M+9#+<7#K%&B]2Q. *_5KX"
M_#.+X4_"_1]"" 7?E^==L!@M*W)S].GX5^0>)N>++,F>$IO]Y7]U?X?M/]/F
M?2Y/A_;XCG>T=?GT/2]/LWU"]M[:,9>9P@_$U]-:78IIFFVUJ@PL*!,5X]\'
MO#_]H:V^H2+^YM1A?=C7MNT5\QX992\+@:F/FM:CLO\ #'_-W^XQXDQ7M*T<
M/':._J_^ +1117[2?'!1110 4444 %%%% !1110 4444 %%%% "&O"OBKX7.
MBZY]LB3%K=?-P. _<5[J:QO%?AZ+Q-HT]E(,.1F-O[K#I7QG%F1K/LMG0BOW
MD?>CZKI\UH>QE6.^HXE3?PO1^G_ /C+XS?#&S^+?P^U/P]=*HFD0O;2D<QR@
M?*17Y1Z[H5]X5UR^T?4H6M[ZSE:&6-A@Y!Z_C7[.7]C-IUY-;3KLFB8JP^E?
M'G[;W[/[:]8GQ]H%MNU"T3;J4$8YEC'23'<BOQWPWXD>2XZ638U\M.H_=O\
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MLG?!<?"/X;PR7L(77]6 N;LD?,@(^6/\!7S;^Q5^S^WC+7D\;:Y;YT73Y/\
M0X9%XN)A_%]!7Z QQM)(JHNYV.U5'?VK^8/%#B=8JJLAP<KJ+O4:[](_+=^=
MET/KLEP7*OK53KM_F=#X#\-MXD\00P[2;>(^9*>V!VKZ(C58U5%&U5& !VKE
M_AWX57PQHJ"0?Z9/AY3Z>@KJ\"OON"<@_L/+4ZJM5J:R\NT?DM_-L^4SK'?7
M<1:#]V.B_5BT445^A'@!1110 4444 %%%% !1110!%-"L\;QN-R."K#U!KYQ
M\9>'W\.:]<6I4^46WQ-ZJ:^DMM<5\3_"G_"0:.9X$S>6H++ZLO<5^;<=9"\Y
MRUU*2O5I7:\UU7ZKS1]%D>.^IXCEF_=EH_T9\$_MB?!G_A:'PY?4;"'?KVB@
MSP;1\TD?5T_K7YM(Q!PP*L#@@]0?2OVB9>JLOLRM_(U^<O[8WP&?X9^,&\2Z
M3;[?#FKR%BJ#BWF/5?8'J*^/\+>)E2D\AQ<N[IM_>X_JOGY'TV=X/_F*A\_\
MSY_C:K,;U1C:IXVK^F$SY.++\;U8CDJC&]3QO6B9LF7D>ITDJBLE3I)6J9JF
M75DJ99*HK)4RR5HF:IEU9*D62J2R5()*NY=RX)/>E\RJ@DI?,I\Q7,6_-IID
MJMYE)YE',',=WI7QI\9Z!H-OHVF:Y<6.GVX(2.' ZG)YK#U3Q[XBU=BUYK=]
M.>^9F _0USQD]ZO:/>6=O(YO$WKCY>,\UY/U'!X=RK4\/'F>K:BKMO?6QUT+
MXBI&E.IRI]6]$59YY;ILR/),W^T2QIJV-Q+]R!S[[:WV\56%OQ#:Y_ "K&CZ
M]<:Q<,D=NL<"_>?^E7&MB:C4:=*WJST,30RC TI5L5C+J/\ +%_GYF9=V+V?
MA<B4;7:0.1Z5RTCUVWC:<0Z:D>?F=^/PK@I)*].O[K4?(_.LEKRQ-"==_:G)
MKT!WJO(].D>J\CUQMGMMC7;WJM(U/=JKR-C-9-F+8)'+=3Q00H99Y6"1QJ,E
MF)P *_4+]F'X/)\'_AG:6L\8&LZ@!=7SXY#$<)^ KYD_8C^ I\4ZXOCO6[<-
MI.GOBPBD7B:8?Q_05]]PQ/<3(B*6D<[54=237\N>*'$OURO'(<&[QB[U+=9=
M(_+=^=NQ]ADN#Y(O$U.NWIW.I^&_AH^(?$$9=<VMN1)(>QQT%?0(48XX%<WX
M#\,KX7T*.)A_I4GSS-[^GX5THK](X,R+^P\LC&HK59^]+R[+Y+\;GQ^<8[Z[
MB6X_#'1?Y_,*6BBOO#PPHHHH **** "BBB@ I*6B@#R_XR^&?M%K%J\"YDB^
M2; ZKV->*:SI%KK^DW>FWT2S6=W$T,J,,@J1BOK.\LX[ZUFMYEW12J59?K7S
MCXL\.R^&=:FLY!\F=T3?WE[5_-7B1D,\+BHYOAE93:O;I-;/Y_FC]%X>QRK4
MGA*F\=O3_@'X^?&GX87?P?\ B)J6@7"-]F5S+9S$'$D).5(/?'2N+C:OTL_:
MP^!:_&'P(USI\0_X232@9K1N\JX^:/\ 'M7YHO'+:SR0SQM#-$Q22-A@JPX(
M/XU^X<$\30XDRR-2;_?0M&:\^DO26_K==#Q\PP;P=9I?"]OZ\BW&U6(VJDC5
M/&]?HJ9P)E^-ZG1ZHH]3K)6J9LF7DDJ=9*HI)4RR5HF:IFMI>J3Z5?6]Y:R&
M.XMW$B,O4$'-?>'PY^(7AKXQ^#K>XO\ 3[2XU*% EW$ZC.X=\>]?G\LE;OA;
MQAJG@_4DOM*N6MIA]X#[KCT([UQXO"K%15G:2V9X.<99_:-).FTJD=F_R_X/
M0_0FWBT;1O\ CPTRUM2.ACB -1W7B!W/WJ\4^&WQ;U/QII,EU?6,< 1M@>,G
MYSW-=-/XBN),A%6/WZFOFI4/9RM/<_"\:L5AZ\J%7XEOK<Z/Q-);:SH]W97[
M+]FFC*-O/ XZU\1:M;II^IW5M'*LT<4K(LBGA@#P:]-^+WQ,D=I-&L;AF;I<
MS*>G^R*\>1B[!5!=CP HR37T>7TI4H.3V9^L<(8#$X/#SKUY:5+-+]?G^1U_
MPRU232_B%H%S"?WB728_$U^D$VNLR@EN2*^"/@S\+=>U+QAI>I7>GRVFF6\@
ME:68;=V.F/6OK;7O%-KH6GSWU[.L%K"I9G8_I7DYM&->K!1U:/)XFS"G+%PA
M0ES.UG;76[LO4\+_ &K/$EWX>\?:/J5A/Y<TEN1)&>0X![BN7T'XU:1?0JNI
M!K"X'4XW(?I7FWQ6^(4OQ$\77.I-E;9?W=NA[(._XUQ;25ZM/!P]C"%3=(]^
MEP]A\7@:4,9&U1+=;J[O;SM<]]\?_'RW7P^-,\/S-)=2J5DNL8"+Z#WKRRU^
M(DCV,=MJ^G6VMI#Q%)<<2*/3=W%<@TE1,]=$*%.G'E2/3P>28+ T?8TX];WZ
MW]5;\#LKCXG7EO$\6D6-GHJL,%[:,>9_WT:XJZN)+B9Y99&EE<Y:1SDG\:8T
ME0-)5I*.QZ5+#TL/?V<;-_?\WN:&A^(;OPWJD=_9,%FCR"&&5<'JI'<&KOB;
MX@W^OV(L$AM]-T[=O:ULTV*[>K>M<W(]5W>LI)-W,IT*4ZBJRBG)=1LC56D:
MGR-UK>^'/@'5/BCXRT_P[I,;/<73@/(HR(H\_,Y]@*YL17IX:E*M6ERPBFVW
MLDMS5)SDHQU;/>?V'?@R?&7C&3QCJ<.[2=';%ON'RRW';Z@5^A$4;SRJD8W.
MYVJH[DUS/P\\"Z=\-_!^F^'=+C"6UG&%+8P9&_B8^Y->T_"/PF=0U ZM<)FW
MMSB('^)O7\*_C',,7B>/N(U[*ZA?EC_=@MV_Q;\W8^]@J>3X)SGNM7YOL>D^
M"_#Z>&_#]O:X_>D;Y3ZL:Z"F[:=7]683"TL%0AAJ*M&"27HC\JJU)5IRJ3W>
MH4445UF04444 %%%% !1110 4444 %%%% !1110 E&VEHH \T^*W@DZE;_VM
M9QYN8A^^1>KKZ_45XQ-"EQ#)%*BR1.I5XW&0P/!!KZP:,,"",@\$5XG\3/ )
MT6X?4K%"UC(<R(H_U;?X5_/GB%PFVY9Q@H_XTNG]Y?K]_<^]R'-$TL'6?^%_
MI_D?E+^UM^S?)\*]<E\2Z% S>%[^0LZJ,_9)">5/^R>U?/$;U^R6N:'8>)-)
MNM,U.UCO=/ND,<T$BY5E-?FY^TM^S+J/P6U9]3TQ)+[PC<OF*<#+6I/\#^WH
M:^K\/^.8YE".4YG*U>.D9/[:[?XE_P"3>H9IEKHR=>BO=>Z[?\ \71ZGCDJ@
MC\"IT>OW9,^>3+ZR5*DE45>IDDK1,U3+RR5*LE45D]ZD62M+EJ1>$E/64J1@
MX/8CK5)9*?YE5<NYV_AWXE:GH82*1OMEL/X).H^AKT?0_B1HVL;5:;[),?X)
MN!^=>!^8:=Y@KHA7G'S/BLTX1RO-&ZG+[.;ZQT^];/\ /S/I>\TVPUN'$\,-
MS&W\7!_6N.U;X1V-T6>QN'MF[(W*UY7IOBC4]'8&TO98A_=W9!_"NPTGXSWU
MOA+ZU2Z']Z/Y6KH]M2J?&CXK_5OB#)6Y97B.:/:]O_)97C^)0U7X::YIVYEA
M6[C'\41_I4GAGPG-')]JOX6C*_<C<8.?4UZKH_BB#5+..=HI+0N,A)>M:;1P
M7RX8)*IK6-&"?,CR,3QGFOLI83%02>S:T?FNJ^X\PU[4DTC3WE8_.1M1?4UY
M;-<--(SL<LQR:]C\>?#.;6O]*T^X(EC7BU?[I^A]:\6O;>:QN)+>XC:*:,X9
M&'(KEQ4I<VJT/O\ A"O@JN%E*A.]1_$NJ[+T\]AK25$TE,9ZA9_>O/<C[QL<
MSU [TC25"TE9MF;8.]>H?L\_ K4?CCXP2W"/#H%FP>_O,<!?[BG^\:H_ _X&
MZY\<O$RV.GJUKI4+ WNI,OR1+W ]6/I7Z<?#WX>Z+\,?"UIH.A6JVUG OS-C
MYY6[NQ[DU^.\=<;T\AI/ X)\V*DO_ $^K\^R^;TW]K+<NEBI>TJ? OQ-3P_H
M-AX7T6STG2[=+2PM(Q%%$@P !_6O7OA-X)-W,-8O(_W*?ZA&'WC_ 'JY[P!X
M)E\57PDE4II\1S(W][_9%>^6MO':P1PPH(XD&U57H!7Y?P#PK/&UEG&/5XIW
MC?[4N[\D_O?H=N>9FJ$/JE!ZO?R78EV@4M%%?TF?G84444 %%%% !1110 44
M44 %%%% !32N<^].HH \.^*7@PZ+J!U"U3_0K@Y8#^!O\*\E\;>#=+^('AF_
MT'6(%N+&\C*,&'*G'##T(-?8&J:?;ZM9RVMR@DAD7# U\\^,/"EQX4U1H)!N
MMV.89>S#_&OYAXZX8JY1BEFV7Z0;OI]B7Z)O5=GIV/TG),RCBZ7U6O\ $OQ7
M^9^/'QD^$>K_  7\:7&BZE$S6K$O9WF/DGB[$'U'<5Q4;U^L7QD^#^C?&?PC
M-HVJH$G4%[6\4?/!)V(/IZU^87Q*^&FN?"?Q3<:'KMLT4J$F&<#Y)T[,IK]H
MX'XSI<28=4,0U'$P7O+^9?S+]5T?D>3F.7RP<^:'P/;R\C!CDJ=)*H1O4ZO[
MU^JIGDIE]9*F22J*R>]2J_O6B9HF7UDJ19*HK)TJ59*M,T4BZ)*>)*IB3WI_
MF>]7<NY;\RE\RJOF>]'F4[E<Q:\RD\ZJV_WI/,%%Q<Q8,E,:2H3)5G2]-N=9
MNEM[9,GNW91ZFA7;LC*I6A1@YU'9+=DNFV$VK72P0J23U;LH]:])T[2XM)LU
MACP HRS>I]:DT30(=#M1%&-\K??D[DUS?CCQ4EG&UC:OF=AB1E_A'I]:]&$5
M0ASSW/RG&YA6XAQ2PF%_AK^N9_HOU.;\7:P-2U-EC.88?E7W]37//)36?WJ%
MI*\F<W.3DS]*P]&&%HQHT]HJPZ22H)'I'>H'>L6S5L))/>O3/V??@;J7QO\
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M"FK):)+H?G$I.3<I/5BT4FZEK0D**** "BBB@ HHHH **** "BBB@ HHI*
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M?K-Z&'?N=7W_ .!^8H%.I**_9#Y 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 2N)^*VKWNA^'8I[*=K>8SJI9>N.>*[>O/OC9_R*L7_7PO\C7R
M7%E6I0R+%U*4G&2@[-:-?,]3*XQGC:49*ZN>8_\ "P_$?_05E_2C_A8?B/\
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MU>/KWX:^!Y-:L+:&ZN5GCB$<V=N&/M3_ (1?$N'XG^%UOS&MM?PMY=U;*?\
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M8^&HCYNH:K=1A8%Y8*#UQ5\ZM\9M2C:(:-I.ELW G,PDQ[XJ7P-\#9[/Q/\
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M;0G]Y-'&2B?..I[5^C< UHT,YE4E;2E6WV?[N6C]=K'R?$T'4P"@KZSAMO\
M$BQKG@SXL?$2U;2]<U#3="TN4[9Q9'>TB^E>K^#?"-CX&\,6NBZ>#]GMHRNY
MNK'')-;K?>/UIK?=;_=/\J^=S#B#%9CAXX/DA3HQ?-R0CRQYMKO=MVTU;MT/
M4PN5T<+4E7YI3J-6YI.[MV71+T/DGX*^&?%GB#5O&;>&O$D>@I%J#"99(=_F
M$LV#[5O>"[.?PO\ '"*P^(#-J^LSINTS4G;,0]@O8UT'[+VEWFG7WCLW=I/:
MB74=T?G1E=XW-R,]:F_:7T.]6\\)^)=-M)KNXTV\ <0(68)G.>*_<<=F[QG$
MV*R.;A&G6I\BG%1C-2]E%K]XK-IR]UIMIIV/SO#8'ZOE%',8\SE3ES.+;<6N
M=I^Z]$[:II;ZE3]KRUD70_#=_P _9[2^W2_CBO;O#U[%J.@Z;=0,&AEMT="/
M3 K)\5^%[+XE>"I--OE9(KR%75F&&C?&0<>N:\?\)Z]XV^!\)T+6="N/$&AP
ML?LU]9?,ZKGIBOSNC17$'#]#+*$TL3A9SM"34>>$VF^5NR<HM;7O8^IG-Y9F
M=3&5(MT:T8^\DWRRCIK;6S74^AMP7+$X Y-?/GP)*ZQ\:OB#K5N<V;OY2L.F
M=U7=>^*/C#XB6+Z1X1\+WNG?:@8Y-1U!?+$2G@X!KT+X3_#6W^&/A==.23[1
M>2MYMU<=Y'/]*B&'?#.3XRGC9)8C$J,(P33<8J2E*4K-I;))/5ZE2J?VQCZ$
ML.G[*DW)R::3;5DE??>[Z'F7[7'_ !Z>#/\ L)_X5[]#_P >\7^XO\J\*_:K
MTN]U*U\'BSM)[LQZCN?R8R^T>IQTKW6'_41>NQ?Y5Q9S*,N&<HBGJG7O_P"!
MHZ,O36;XYM:?N_\ TEGSI^U99#4O%7@"S,CPBXN&C,D?WER0,CWKIF_9CMLG
M_BL_$/\ W^%87[45O>KXD\#:A:Z?=7\=E.TTJVT1<@ @XXK:/[3 ))'@S7/_
M  &;_"OO:,N()<.Y6LBEHHU.>W)O[1VOS:['S-198LUQCS):MQY?BVY5?8ZC
MQUH2^&?@?KNF+<S7BVVG.@GN#F1_<UG_ ++_ /R1G0OK)_Z%3]<\52_$/X*^
M)+V'2KRQEDM98UM9XR)21Z+3_P!FJRN-/^#^B074$EM.OF;HYD*L/F[@U\AB
MHUJ/"V+HXO2M]:CS+2]_9ROMIOVT/<H^SGG-"=#X/8NV^W,K;G(?LWP1W6N_
M$2&9%DBDU!U=&&006.16=X2DE^!?Q>O/#-PY'AO729;-V^['(>@_I6[^SIIM
MYI_B+QXUU:S6RRZ@S1M+&5#C<>1GK77?&[X>#Q_X/D%LNW5[$_:+.4?>##G;
M^-?29AFF'I\28K+\9*^&Q,:<)/I&7)'DFO.$M_*YY6%P=6>4T<507[ZE*4EY
MKF=X_P#;R_&QQO[,,;0W7CQ'&UEU3D?@:]#^('PG\._$J%5U>T_TF,8CNXCM
MD3\:\W_9/M=3AT[Q1-JUI/:W,UXC'SHRA8A<$C/6M34_C=XC\+:S?VNL>";Z
M6SCE(M[FS4OO3L2!7!GF#S2OQ7BJF3U$JM/DUC-1;]R*?+=KF\TNATY;7P=/
M):,<?#W)\VCBW]IO6RT.'U_3O%7[-5_8ZC:ZU+K/A.:8126]R<F,'M]?\*^E
MK&\34+&VNXO]7/&LJ_0C-?._BJX\5_M#7.GZ1'X?FT'PW#.L]Q<7@PSX]!^=
M?1%C:)I]C;VL7^K@C6-?H!BO,XQG[3"X1X_D^O>][3DY?ATY.?E]WGW\[;G9
MD,>6M76&YOJVG)S7W^URWUY=OGL3T445^7'V85UGPM_Y'2Q^C?RKDZZSX6_\
MCI8_1OY5]#P[_P CG"?]?(?FC@Q_^Z5?\+_(^A****_NP_%@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *\^^-G_ "*L7_7PO\C7H%8GBSPO!XMTU;.X
MD>*-7#ADZY%?.<1X*MF648C"8=7G.+2Z:G?@*T,/BJ=6ILF?-=%>S_\ "D-+
M_P"?RX_2C_A2&E_\_EQ^E?S)_P 0WXB_Y]Q_\"1^C?ZP8#^9_<>,45[/_P *
M0TO_ )_+C]*/^%(:7_S^7'Z4?\0WXB_Y]Q_\"0?ZP8#^9_<>,45[/_PI#2_^
M?RX_2C_A2&E_\_EQ^E'_ !#?B+_GW'_P)!_K!@/YG]QXQ17L_P#PI#2_^?RX
M_2C_ (4AI?\ S^7'Z4?\0WXB_P"?<?\ P)!_K!@/YG]QXQ17L_\ PI#2_P#G
M\N/TH_X4AI?_ #^7'Z4O^(;\0_\ /N/_ ($@_P!8,!_,_N/&,T5[/_PI#2_^
M?RX_2C_A2&E_\_EQ^E/_ (AOQ%_S[C_X$A?ZP8#^9_<>,45[/_PI#2_^?RX_
M2C_A2&E_\_EQ^E+_ (AOQ#_S[C_X$A_ZP8#^9_<>,45[/_PI#2_^?RX_2C_A
M2&E_\_EQ^E/_ (AOQ%_S[C_X&A?ZP8#^9_<>,45[/_PI#2_^?RX_2C_A2&E_
M\_EQ^E+_ (AOQ%_S[C_X$A_ZP8#^9_<>,45[/_PI#2_^?RX_2C_A2&E_\_EQ
M^E'_ !#?B+_GW'_P)!_K!@/YG]QXQ17L_P#PI#2_^?RX_2C_ (4AI?\ S^7'
MZ4_^(;\1?\^X_P#@2#_6# ?S/[CQBBO9_P#A2&E_\_EQ^E'_  I#2_\ G\N/
MTH_XAOQ%_P ^X_\ @2#_ %@P'\S^X\8HKV?_ (4AI?\ S^7'Z4?\*0TO_G\N
M/TH_XAOQ%_S[C_X$@_U@P'\S^X\8HKV?_A2&E_\ /Y<?I1_PH_2_^?RX_2E_
MQ#?B+_GW'_P)!_K!@/YG]Q0^!?\ S%?^ ?UKUBN:\'^";7P?]H^S322^?C=Y
MG;%=+7]'\(Y;B,HR:C@L6K3C>]G?>3>_S/S_ #3$4\5BYUJ6SM^2"BBBOL#R
M@HHHH **** "BBB@ HHHH *\O^.7_(-T_P#ZZFO4*XWXC>#[KQ=:VL5K+'$T
M3ECYE?'\782OCLDQ&&PT'*<DK)==4>ME56%'&4ZE1V2_R/ :*]#_ .%)ZO\
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M/]3.(/\ H#E^'^8?VO@?^?J//**]#_X4GJ__ #]6_P"M'_"D]7_Y^K?]:/\
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M/_A2>K_\_5O^M'_"D]7_ .?JW_6C_4SB#_H#E^'^8?VO@?\ GZCSRNL^%O\
MR.EC]&_E6O\ \*3U?_GZM_UK;\&_"_4?#OB"VOI[B%XX\Y5,YKV\CX3SS#YI
MAJU7"R48SBV]-$FO,X\9FF"J8:I"-5-M/\CU*BBBOZ_/RH**** "BBB@ HHH
MH **** "BBB@ HHHH **** "DQ2T4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F*6BB@ HHHH ***
M* "BBB@ HHHH **** "DQ2T4 )BBEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEH
MH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 3'O12T4 %%
M%% !1110 4444 %%%% !1110 FVBEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEH
MH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 3%&*6B@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>nstg-20221231_g20.jpg
<TEXT>
begin 644 nstg-20221231_g20.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "( (@# 2(  A$! Q$!_\0
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M8+;[K&9JG@_XNW,T5U=W^IZA<RZ9<:RS)K*W$L-I;Y$LLH60F,*P*X?!W*5
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M+\O^'/U?)9?OYTGM*/XH\Z\!>/(O 'QTT?Q7#=O;V&GZXMQ+-:*,M:^;B55
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MN44.5'0,X&Y\#@;B=H  P!BN.M;AK699%YQU'J/2O8_A'\+5^(T5WKNKW_\
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77(VWJSYF4I3;E)W;"BBBD2%%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>nstg-20221231_g21.jpg
<TEXT>
begin 644 nstg-20221231_g21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4ZS/$'B/
M3O"^GM>ZE<K;0#@9Y9S_ '5'4GV%2ZWK%MX?TFZU&\?9;VZ%VP,D^@ [DG
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#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>nstg-20221231_g22.jpg
<TEXT>
begin 644 nstg-20221231_g22.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #P# 2(  A$! Q$!_\0
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CZ9IENMK9P+M1%_4D]R>YK1HHKZ%)15EL?&2E*<G*3NV?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>nstg-20221231_g23.jpg
<TEXT>
begin 644 nstg-20221231_g23.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "  ((# 2(  A$! Q$!_\0
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MP?$WPSI%M8_;Y)8I+B>266-$M(<E?-3<I9WW?+M4CCFN;_:,U"&/X(^%[9I
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92A54>@ Z5/117RV^K/J@HHHI %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>nstg-20221231_g24.jpg
<TEXT>
begin 644 nstg-20221231_g24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #X# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>nstg-20221231_g25.jpg
<TEXT>
begin 644 nstg-20221231_g25.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %F 60# 2(  A$! Q$!_\0
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MFQZ5+%0GI+1G244 YZ44CK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,)W>D33O?$FF>&H6L/#427%WTDNFY /U[_3I7'7,]Q?7+7%_.]Q,W5G.:C5
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MQJ5BW LD>1U"] :M6.H1PM;!HMDMHA2SC))5I&X,C-TZ'/->]&>$Q37,K/\
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MY+6XCN(#B2-MPKT_3;Z/4M/BNHCPZ\C^Z>XJ6>GA*O-'E>Z+5%%%([0HHHH
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MVD]V9;6VJ3\W&I./9,__ %J;_9#M]^^N"?\ >K7"4NRG<7LUU,?^R'7[E]<
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ME<2R#S93ZL?_ *V!4Y;AU6K7>R-<VQ7U>A:.\M/\S<KG?$FH.SKIEH?WLO\
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ME=\MSSH?"B9!4Z"H4J=*S9JB914E-2G5F4%?,_Q-U-=4^(.HR1MNCA98%_X
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M-0NA:VCR'KC"CU-7_#5B;33!)(/WLYWMG]*Q[: ZYK2I_P NEN<N?[Q]*[
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MXTMS.G!UIFII.G)IE@D*\OU=O[QJ]116A["2BK(****!A1110 4444 %%%%
M 1GK7EOCGPB=.F?5--3_ $:0YFC4?ZL^H]C^E>I4V2-)HVCE4.C##*PR"*TI
MU'"5T85Z$:\.5GSX#D<5+!.\#%3)-]GDP)X8Y-HE4'./_KUTOC#P=)H<S7M@
MK/8.<E>IB/I]*Y4'(KU(RC4C='S4X3H3L]SM;74FU2V>UMMCF\C,%OIT9_=V
M<0ZR/_M8YS7/:[!I5O>)%HMP;F)4P\A;.6S].*J66H7.G-,;0H//C:*4.FX,
MI&"*VO#47DZ;J.H65LMUJ%LJ"",IN\O)P7V]\5DHNFV^ATNHL0E'KW[6.=Z=
M>*0CD$<$=".U;\DNH^*(DCGAA>_@W$S$K&\X_NA< $BL$@JQ##!!P0>U;1E?
M<Y)PY7=:HZ[0/'<MK$MCKR?;+3H)2,N@]_7^==2-/@OK;[7H5PMS W\&>1[?
M_KKR>K6G:E>Z1<BXTZX>%^X!X;V([USU<-&6L=&==+&-+EJ:K\3T#F-BCJ8V
M'52,4ZJ5AX]L-118/$=J(GZ>?$,C_$?K6VNE)=P?:-&NX[J$],,#^%>?.E*&
MZ.Z/+45Z;O\ F4:*6:.:V;;<Q-&?<<&FA@>AK,5FMQ:***!!1110!S(I12"E
M%?GK-T+2BFTX5++0X4ZHV=5ZD"I;6&YOGV6-O),W<J.!]34J$I.T5<M!0A:6
M01P(TLC=%09S6Y;^$W6,3:U=I;1=T4\_G5D:OI^E1F'0K4,_0S..O]37K8?)
MZU36I[J_$<I1@O>9!:>&A'$+K7YA!".1$#R?:G7VO;H?LFD1BUM@,;@,$C^E
M9MS<3WTWFWDK2-V!Z#Z"HZ^EP^$HX:-J:^?4XZF)<M(Z(0+CW)ZFG4X12,JD
M(Q#'"G'4^@JXMC#'#;M>SM$UTY2$HFY0?]H]N>*ZCGC"4GH,MK;>JK/ 464_
MNYW)"D]E_'UJSJ%Q&;<I<1$VJ@1FT  EM) .&4]2#US4-QJ=L+J=+J6Y$YA-
MM+8$$QD@8#+V [YK/)EED62ZE,\JKL61P-P4=!GO]:>QTMQI1LMQQFNYSNO;
MN2Y8#"EP!@?A_.D)P,F@G YK6T/0VU*03W(*VRG@?W__ *U+<YXQE5E;J3>'
M=$-Y*MY=K^Y4YC0_QGU^E=B!BD1%C0*BA548  Z4M6E8]>E35.-D%%%%,U"B
MBB@ HHHH **** "BBB@ HHHH ;+$DT31RJ'1QAE89!'I7EGB_P $R:47O]*1
MI+/.7C')B_Q%>JTA 88(R*TIU)4W='/7P\*\;2/GL'(XJ2&>>VF$UI/+;R@8
M#Q.5./3BO0?%7P_$Q>^T% DGWGMN@;_=]#[5YVZO%(T<R-'(IPRL,$&O3A.-
M1:'SM6C4P\M?O.ITSQ6S6T=F8F^VJ@BM@Y7R2Y;_ %K$\AAG\<U/J.@)+!!"
MED+24P^=-=SR%?+VDA]X/J<8(ZUQQ (P>E:%AJ\EDEQ%<Q-?07,8CE224[L
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MBFHG72PK>LS.TO0[73%#*/,FQS(W7\/2M.BBK/0C%15D%%%%!04444 %%%%
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MV)  .@%+110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>nstg-20221231_g26.jpg
<TEXT>
begin 644 nstg-20221231_g26.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ $$# 2(  A$! Q$!_\0
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-<:45""LD%%%%,T/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>nstg-20221231_g27.jpg
<TEXT>
begin 644 nstg-20221231_g27.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %, 4P# 2(  A$! Q$!_\0
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MQ[?J7Q:T^V8K!Y1/LQD/Z<?K7.WGQBN&R+<2?\!15'YG)KRVEQ2U?4]BGD.
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MM)[VX$-M&9)#T IF,I)*[(:UM)\.:AJ[KY$16-CP[#K]!U-=YX1^&#W&RYU
M KUW,/E_ =_KTKTI(])\-P[8U!FQCU=O\*7F?,XW/(0E[/#KFD<+X>^$R1[)
MM1Z]?WHR?^^>@_&NVBT[0-!4;EC:0=-_SM^ [5G7NOWEV2L)\B/T0\G\:R_+
M+')Y-3SKH?/57B<2^:O/Y(Z"X\5JHVV5MGT9S@?D*S9]=U*XX\_RQZ1C'Z]:
MJ"*J$6N:;-) L%PLHF:1%=.0&0993Z' /Y47DS-4J-/H77DGE_ULTC_[S$TS
MRCWK#/B:[;PW<ZVNF!+18Q+;M)-S(N[&6 'R\<]ZIZCXDO8=-L;A+RRA2XGD
MCDN$MI'50J;AA3@GH>>E'*P=>*6AU'E4>561<Z_-:^ XM7NUBM[N:) @8X3>
MYPIY[<[O85ER>-)H=+T&]*1R1W6_[<4&=BI@.PQV!Y^E/E8.O%'5!77[K$'V
M-68=2U"V.8KJ3 [,VX?D:YB#7]5N;/2I[:TLYO[1>1%4RLF-N\ANAXVJ/Q-7
M3XCL8S(+@2(RW+V\:1QM(TI0#<0%!.!G'X46:%[2$EJ=3!XJO8B/M$<<P[\;
M36@NM:/J:^7?PJI/'[Y,C\^U<C'J%C.MN4N8P;E=\*L=K./8'FIFBJDV9NC2
MEJM/0T]7^'FDZO;EK0KSTW'</P;J*\S\0_#C4-)<M"I*=@QR#]&_QQ7>6UW=
M6,FZUF:,]P#P?J*W[+Q1#<+Y&JQ*H88+XRI^HK6,K&M/$8G#_"^9'SE-!+;R
MF.>-HW'56&*97O\ XA\ :;KEKYU@$R1E5SP?]T]OY5X]K_A6^T*=Q)&YC7KD
M?,OU_P 16T9)GM8;,*>(TV9@TM%%:6.UR"BBBJL9MDD$\EM,LT#E'4Y!%>Q?
M#[QXEQ$MC?OM X!)^X?_ (D_I7C-36MU+9W*3P-M=3^?M0X*2.'%8>.(A9[G
MU<#D9%%<+\/O&,>K64=G<OB0#;&6/(/]T_TKNJY)1<79GR=2G*G)QD%%%%29
MA1110 4444 %!( )/ '4T5R7CWQ)'HND21AOG9<M@\X[+^/\J4G97-\/0GB*
MJIPW9Q7Q,\:%W-E8R$<$+CL.[?4]O:O*:FN[J6^NY+B=MSR-D^WM458I=6?K
M&!PD,'05*/S$I:**JQU.0445JZ%H5QKE\L4*L(P0&8#/X#WI[&%2K&G%RD]$
M1Z/HMUK-V(K=3MR SXSC_$^U>W^$_ =EHEF)KY%# ;BK']6/].E7_#GAJQ\+
M:8LUPJ+(B]^=GT]3[U3U35YM2DVIF.W!X3U]S4R=M6?#XW,:N.FZ=)V@NIM+
MXBMFU!+>)?W!^7S.G/;CTJIXBTS;-]LB'RMQ(/0^M8B1UU>DW*W]@UM<?,RK
MM.?XE]:E/G5F>74IK#M5*>W4Y=8ZQM?N;J'4-,L;:]&GI>.X:Y\M7(*KD(-W
M&3SU]*ZJZLFM+EHFZ=5/J*JW6FVNHVQM[^VBN(2<E)4##/T-2E9ZF\Y\\=&<
M/JR:C=^,(+WPTJ7<EM:#>YGVQN!(X>,X&"21[8(I]KX!E&I_VC#*UC(M_P#:
MECSN61& +(P!P""SJ".U=Y;64-I;I!:Q)#$@PB(H"J/8"N'TG4+G58]3M->O
M[F">-I8O,2>.((\;$CRT7#GY1DEN#TY%:ILXY))ZER7POIVFV$]K?ZY-#I<B
M/#';33(B1!^2 2,G';.<4K/X9T1K2WU+57N)"1/ ]U,TG!4INR/E"D$CTK#L
MK+5]9\/6/F6<B:HFH1W[330;XI$E!&[' ^56&5SQMK2U'P!J?EQ6NEW@$"Z:
MUO*SX43MYH?81@E5(+#(Z<55NYGS=4C4630!?0:+':R2-8R*8T6"1XX6*Y&6
MQM'#=SWJO:S>$+A+N[A,/E6_F-+(X98\2?*Q&>"&VXXJ6'PSJ-OXNEU2.WB:
M&4QD WTBB,"((08P-K=.IJC!X4U6#2;ZTEL5:TE,9CL;>_;]VX8LTD3,OR<[
M2$)QQUHLA\S[&IIUAH<BZ1+I=TC16D<B6:)*"&& &Z\DC],\UE7?A&^MH$?1
M+J&:<QSQRM<2-'GS7WEU9,D,"!]156_T;Q1]C666$FYM=,F7?#MW%I)1N V]
M7\H=0.3TJ!'-C'JDWAF"YLK2Y@@L[03JZ>9=,Q!=5;GA3R>^*+"YEU0LNB79
M\0P_V[%)/:V]K' )I+=9HY0J[I&9L[D.>A]A4.@:UJ\VO?8)QAKR07J!U)$-
MJ5.%'H>%_$FNC\%:Y>:_#.;I<+9I';REEP6N #YA^G0?G6^VGVXO#=B!!<&/
MRS+M^;;G.,^F:94==4RHT5-BLGNKA(8AEW.![5=:.MW1;!;2W:[G #,,@G^%
M::-)U>6-QUS/#X<T9$B7>XX53_$>Y-09TSQ79&*9-LRCI_$GT/<5BZQ=MJ%X
MTA^XORH/05F*9()%DA=D=3D,IP15I&4:6E[^\<GXS^'UQI,[3V:;D8Y 4?*W
MT]#[5P9!4D$8(ZYKZ3TW5K?7+9K#4T0RL,$'H_N/0UYMX^\ O93->6*[E8Y!
M_O>Q]_YUO"?1GJX3'-/V5;?N>:44I4J2&&"."#VHK>QZS8444M58AR+^C:I+
MI.H)/&Q"Y&\#T]?J*^B/"VOQZ]I22!PTR*-^/XO1OQKYHKL? 'B>31M6CB=B
M8R>%SU'=?ZCWJ*E/F1Y6.H>TCSK='T#14<$Z7-NDT+;DD4,I'<5)7 ?/!111
M0 4444 0W=REG9RW$OW8UR??VKYV\=Z_)K.MR1[B4C8EL'@M_P#6'%>H_$[Q
M$--TLV\3XDQG'JQZ#\.37@[$LQ9CDDY)/>LG[TO0^YX<P2C%XF:U>PE%%%,^
MN<@HHIR(TDBI&"S,< #N:9DY%K2]-FU2^2W@'7EFQPH]:]_\)>&;3PSI*W%P
MHC=5S\W\ ]3[G_ZU8?PU\'I86@O;M,MG/(^\W^ _G6OKVK&_N/(@;_1XS_WT
M?6IOU/B,TQLL75]A3?NK<@U35)-4N.ZPJ?D3^I]ZKQI38XZLQI6;U.-6@N6(
MY$JW:2/;3K+'U7MZCTJ.-*L(E"1G.5U9FU=P)J%FLL6"P&5/\Q60L=:&FS>4
MWE,?E;I[&I+VV"R>8H^5NH]#6C5U<X8R<'R/;H4%CJK%H>FPZE+J$=C;K>S?
MZRX$8WMQC[W7H*TE2GA*$ARD0B.E\NK 2G;*=B'(K>72>55K91Y=.PN8J&.H
MWA5\;U!P<C(S@U>,=,:.@.8RK73;6P65;.!81-*TT@4?>=NI/O4C)5UDIGDE
MV"J,D]*92D16-C]IN 7'[M.6]_:I];NOW?V6+_@>/Y5?)6PL^.6[>YKRKQ=X
MDO+34I98DE5+-7>.$@H;R4+EF/\ TR0')/<D"J1GS7?,SI7CJM)'46CZY;ZK
M;Q@R(+C 5L<*\@4%PG/S!2<'TJ])'5HZ%*YFLK(P9"58'(([5U>D:G#K=D^G
MZDH:4K@@_P#+0>H]ZYR1*@#/!,LL3%70Y##M56N$DIHY3X@>#)-*O'N;==R-
MEL@??'K]1WK@L5]*H;?Q7H30S869>O'W&[$>QKPCQ7H$NAZI(C1E$+$8_NGT
M^G<5T4I7T>YZ&#Q3DO9SW1A4445T)'H-A2J[1NKH2&4Y!'8TTTF:JQ#DCW7X
M9>)1J6GBRE/S@%D!/0_Q#^OYUW]?-?A#6)-)UN)E?:&88Y_B'3\^GXU]&V5W
M'?645S"<I*H8>WM7#B*?+*_<^=Q5+V=339D]%%%<QR!3)I5@@>5SA44L?H*?
M7-^.-373O#TF6P7!)_W5&3_04I.RN;4:;JU(TUU/%_'^M/JFO.A/$9+-_O'_
M  &!7*5)/,]Q<232G+R,68^YH@ADN+A(H(9)W8\1QJ2S>P J(JR/U:G&.'HJ
M"V2(\T5ZA!\/=/\ %L'F66E:KX8NU7E;F,O!)],X8'\JX'Q%X>O/"VM-IFH2
M02R! X>!]P*G.,]P>.AJ['G4,SI5I^S6DNW]:&;7:_#KPR^KZLEQ(GR*<*?3
MU;\.GU-<A:VSW=U%!$,O(P45]#>#=)@\/^&A<.NW,>?^ C_$\_C2?8Y\WQOL
M*'+'XI:%O7KU--T^/3[/Y"RXX/W4_P#KUS,24ZXN'O;R2XEZNV<>@["LW7KF
M2UTPB,W4(DRK75M$)#;]]Q7J1ZX%0]6?*07LH:[]3*U?7[FVU*&\LW2734_<
MB2.3]VDQ;#&?'(4#I[UUFE:E#J&FK?*K0P.Q$;2X7>,X##V/;-<5X3\.W-UJ
M[ZC=ZA<S^8@+W$)C:VOX^1@@+G/8@\CUK1\57EI=W=II\EU%81PRJ\%U(B36
M[M@C8RY^5AG(W<9%.RV,/:2UDR]H_C))]4OH-44V?D,Q,<B;?LR [09&/!+G
MD!<UVJ+GI7&^'?#1U"4:CXEMY+FYMY\V<MVJ"78 /O!/E(W;BH.<5W"+2:1*
MD[:@J>E:<+B> J_)Q@U25*GBRC C\:I:&-35#6B*,0:4)5J10ZAAUJ,+56,^
M>Z&!:7;4@2G".BQ/,1;:-M3>71Y=,7,0;::4J<I32M ^8K,GM4]M#MS(W7M3
MECW-[=Z6=L+L7\: ;OH4;R0S2?[(Z5B:SHMKK.G3VET"JSQF)I(\!PI(R ??
M%;K)4#I31HFK6/+?$EK#I8B%Y ZI9Y&D:?8L0RA -T[LO./7T'J371:-J4UW
M;)#J@@CO",H8G!2X3 /F(,YV\CKWK:U;1X=1\F1@%N;5C);3<YC;&.Q&0>X[
MBO++U)/#NM3ZCK-R;NZM[KSHE$6;N=0NSJ#B.$LQP"/SJ@ORL]&D2JLB58MK
MI+RU\P%!(HQ-&CAO*?&2IQW&:YV?QIH_G)%;M<7+/*L(\F!L!FZ#)P/?CM6A
MJI)&YIM^^EZ@DZY*='7U6M#Q[X?AUS1#>PKN(0;B.Z]F_#^59$J5T?A2^$T,
MFFW'S  E >ZGJ*;NGS()-Q:G'='SQ<0O;7#PRC#H<&EM;6XOKJ.VLX7FGE.U
M(T&2QKL/B/X>.DZNTD:G9G&<=5/W3_3\*X^UNI;&]AN[9BDT$BR(P[$'(KNB
M^:-T>U&K[2GS1.M3P18:$BW/CK5X[(8R+"U(DN']CCA?U^M8GB_18_#_ (GE
MM+5B]E*BSVKDYW1,,C^H_"NBN=1\!ZUJ?]MZG;:H-0E(,VFVZ@I-)Z@]<$^X
M-4_%VE^)-9:Y\3:EI?\ 9EA"B1003,%9(P<*H7KWST'>LXRES>\<,:DU-.;_
M *\CDE8JP93@@Y!KWKX8Z[_:6CFWD/S*-ZCT[,/SY_&O U.17;_#763IVN(C
MOB/<&/T/#?T/X5K6ASP96*CST[]CWZBBBO(/%"O(OC!JN2+1&[A,#_OH_P!*
M]<8A5)/  R:^<O']^;WQ&V6R%!8_5CG^6*B6K2/H,AH^TQ7._LG+5T/ATZQH
MUE<^*M)E@B2P=87\X;B^_L!C\^0>:YZNZTG6]#T_PO::#XLT?4(87G%\)XFQ
MYY_A.TXRN..]6D?69C4DJ?+%7ONO+J:%_P",[3Q&#8^,[/5=%NT0'S[&1PN#
MW:(]O?FO-"$$TGE,S1[CL9_O$9X)]Z].U[5]&BLO$GB'3-<AU&[U:)+2WMQ$
M8WMD/##:3D_*!S@<BO,(QA15'FY;&.KC%Q7;SZVOJ=M\-]#;5-<64CY5.P?S
M8_E_.O7_ !3=B&WAL(3C< S =E'0?Y]*P_A7HPLM'^TN,-MQ^)Y/]!1J5U]N
MU6:8?=+87Z#@5EYGC8ZM]8QC[1*^^."%I9W6.-%W.[G 4#N37$6^J76J^(KI
M[4LLL#A5O=*E$ZO&3\N^(\,!GDCD&MKQCK0TG1BD%S;QWDW^J@FB,GG@=5P/
M7-2>"]+E@<W9LVT^*6,/Y4,Q\B0GJ?+8;HR/3ISWH2.&K+FERHLSM-X2T?3]
M.TXQSW-[=&(3W1V1J[;G+-M'&3D #UK,\/>$;6Y\27HO=-L(98'4WEJ(A-#*
M'!*O&3\T9X.5Z>W2F:[?WKZTJ:LLC:)<72(N8TDM&M\<NSCYE?=T.1C]:[_1
MM#T[1+=H=+ME@1VW.<EF8^I)))IF#U?H:,$2QHJ1J%10 J@8  [5:1:CC6K*
M+2)<A56I M %2*N:I(QE(Y_Q!XPL]$MYX(94DU"/;M@96[X/)^GO6#:_%&%M
M6B74+5;2R*'S) 2[!\>PZ=JY/QW<WT7C"X&J11Q.5!B$9R&CY"G/KUZUR-]>
MJRGFN&56I[2RV/M\%DF'J4(N:NY+>_==.GYGTKI]_;:I817MC)YEO,-R/M(R
M/H>:X3Q1\2I])U:>UL+>$Q6QVR22Y.YAUP ?PKF_"UW\0'TBU&GK(=/$>("(
MH\;>V"1S7,>)_M7G7O\ :&1=>;^]SC[V>>G%>_A</&5I3L[]#XO$0C2Q,Z*U
M46U<]=@^(4%SX$&OQVQ$ID,'D$\>9]?3'/Z5C>'OB?<7OB2UTO4[>'%VVQ'A
M!!0GIG).<GBN7T?GX.'VU4_^@"N/\V_B\2POH^XWZR(;<*H8[^,8!Z\UT0PU
M-J:MW,>A].7M[;Z=9R75[((H(QEW()QSCM7#:E\3([:_N$LK5+NV"CRI=Q0E
ML<DY'3\JY6:_^(TNA3?VW!<?9C$QN-]O&N%[DX''%<JU^ICZUX&,]I1FHQ?W
M'TN1Y=1QE)U:BOK:WW?,]J\+^.=.UR.WM))!'JDBDO J-C(SD@],8YZUT;#/
M6O O =QJ,OCRT&C-")B&\PSC*^7_ !>^<>E?0++5TVW'4Y<YP-/!8A1I[-7M
MV_X'8K,M0.M7&6H76M3QDRDZURGC'PZVM:>HMD)E29))(XY!";@+G"F3!( )
MST[5V$BU6D6K16YYOX4U>\DWB2ST_2M(M"\4@4D8E!QM#D@-ZDX].M1>(H?[
M-\7PW\0M5N+V+RXKJ\8+%;!1SC'+.03C)' QFKMUIL&D^(9C/ITVK2,P?3;>
M)/DMU(^;@@1IAOXNIS6A/<OJ6AWR-9VTNH6P8-:']XJR;=RC) SP1R!BJ0UL
M9OAN^N=0T^X:ZF6Z6*Y>.*[5-JSH,'< .,9)''I6O;W#V-]%<QG#1L#]1W%8
M6D:7?+#IVH1:A=R&49NX+D[4"E3PL>/E(;'3'&>M;<JUI'8UB[K4V?'VE1:U
MX;6ZAPP"\MC^!NA_ XKP"2-HI&C<89201[U]'^'9$U+0)K"?G8#&?]T]/ZUX
M3XMT]M/UZ9&&-Q.?J#@_R_6M\,]X=CIPD^5NFS4\$ZIJ\-O>V?A^#3HKN.)[
MIKZXCS)&B@9"G!_4=ZT=-T&U\2:3I>H>,=:U&:]UJX>&R"$,L9!QD@]LCMCJ
M*Y+P_KL_AW5TOK>-)AM,<L,GW94;@J:[2^TW4_$6GZ3?+)I_@_2K-2=.26Z(
M<YY+@\'Z=#_.JJ1<97V\QUDXRNM+]3SN[M7T_4[JQF(+VTS1,1W*G']*L:5<
M_9=4@ES@!\-]#P:L^)?#^H>']23^T9H[I;Q3-%=Q/O6<$\G/KZ_6LH5U0M*)
MLI*43ZB\/7GV[0;68G+;-K?4<?TK2KA_A?J!N]!>-FR1M?\ ,8/ZK7<5XU2/
M+-H\::M)HH:Y.;?0[N0'!\LJ/J>/ZU\RZS<&ZUJ[E)SF0@?0<#^5?17C2Y%O
MX<D+' 9P#]!D_P!*^:78O(S'JQR:QWD?8<.PM3G,% 9U#MM4D MCH/6O81;Z
M!KFN2WNFZ[IEV5TDV%A876$VOC"DANO.>@[UYSX-T:+Q!XOL-.N@S6\CEI0I
M()55+$9'KC'XUUD^C>%?$.BWU_>Z9+X3CTRY$1E5&<SH>@*$?>]^?QJS7-*D
M744;M-+I9[^6_3H8/C71H_#6B:!HT]O NJ".2XO)4 +'<V%7<.H&#7/Z7:_:
M]3MX",J\@#?3O^E)JYTUM6==#DN9;"-56)[D_.>.>.PSGBMCP59F[\1(%&2J
MG;]20H_G3>B.F@W2P[E)ZZO[SW2S4:1X*# 8=HRWXMT_+(_*N6B'2NI\52+;
MZ3!;)QN< #V4?_JKF8169\G1=TYOJS-UG1K[4F_<R65Q;E0#97UOO0G^\&'(
M/YU*R1:)X42TN8I(FNG6U$4$S2E&D.W",_89SCC&*VHA7+>.]7A@\G3YX+"1
M/)>Z<W[%5.WHJ$='/./I014LM1/#NCNNJZ4;#76NHXA([A28D,*?NPBPCY<%
MCDL>XXKTB,5QO@71K2UCEU"TM+FTCF18H(I[L3[(Q\V%P3M&YCQD_A7:QBF8
M=":-:L(,5%&*G44&;8Y14P&!38Q3Z9DSD/&?@"Q\2V]S=P)LU9HPL,S2L%XZ
M CIC\.]<MIGP7^SZM9S:I?1WEFJDW$*AD);' ![C/T/%>L45/*KW/4HYOC:%
M'V,)Z?TM'T\K%;3M.M=*L([+3XA#;Q#"("3CG/>O!O'XQKVKX_Y^6_G7T%7S
M_P#$(8\0:M_U\'^8KT<#_$9YCDY2<I.[+NB'/P;F_P!G5?\ V05SV@MM^(^D
MG_I]A_\ 0A70Z!D_!V[]M5'_ * M<WHIQ\0]*(_Y_8/_ $):]"/V_F!]'W]C
M;ZGI\UE>(7@G4I(H8KD>F1S7F.J?!D7.MRMIEZMEIQB!C1MTC!^XY/3OG/>O
M5J*^?<4]SMPF88G!W]A*U_N^[:YQO@OX>6'AFV@N+J-)]60L6N$=L#.1@#CC
M'M79444)6,,1B*N)J.I5=VQCK4+"K)&14+"F8(JN*K2+UJXXJM(*M%(Y+Q?H
M5OJL-G<W$#3_ &&?S#&B%F=",,H (.>AS[5@>&=5T"76I8M&M]2^T7<8>22X
M9Y%"ID#)9B5[@9Q7H%Q'OC=,LNX$94X(^E>8W:W&A6+VUM<:/HZQRB7ROM;2
MW-T5<$[CQG=SG@]<8JQG:RBJ<HJ\S+)&'0Y5@&!]15245LC5,O>%;KR-:,1/
MRSH5_$<C^M<=\7=+$.I?:D&-Q#_F,']1^M;UG-]FU.WF/1) 3],\U9^+%A]H
MT1)@.BNI^HPP_D:J#Y:J?<J#Y:J9X6>E=7XLN4\8W&BRZ(MS=WJV2P36$4);
MR2G<8['-<K7H'AW^UA\,;C_A"E)U4WI%Z8B/.$6WY=G?'TYZXKMK:6D=E9VM
M(YWQ)-JEMX=T71=5T>?3UL3*T<LP/[XN03C(QQZ?2L =*]$O8M<LOAAJR^.9
M9"T[Q?V=%<R!YA)N^8CG(&.WUKSF/[HS3H2NF13E>YZM\'[XK=FW)X(=,?DP
M_K7L%>!_"^Z\CQ)&N<9E3]<J?YU[Y7G8N-JAQ5U:9Q/Q1G,7AHJ#U20_^.X_
MK7S_ %[I\6WQH('^PW\UKPNN..[/LLDTPE_,Z'P9I]]>ZM<3Z?JATK[%:O<2
MW0R2J#M@=<Y%;?ACQWXNUW6H-*&KVSFX8A6O+=2IP"<<#OBN<\+ZW>:#JDEW
M:6GVV$P,EW;E25DA/WMWH.G-=3I^MZ'86LFO^%O E\;F#<?M#R/);V[8Y/4C
MC/H,>U:&.-3=27-!2NM-M'YW.#U!YY=:OGO%1+AKB0RK&,*K;CD =AFNV^%5
MOYOB$,1G$B?ID_TK@C*]Q-)<2MNDE<N[>I)R:]+^$$>=6W?]-#^B'_&E+X3?
M%-PP<O0] \7R;KVVC_NH3^9_^M6/".E:/BMLZTH](A_,UGQ5FSYJEI21;B%6
MA#',FR:-9%/574$56BJ[%3(D/L;*VL8!!96\5O$"2(XD"J">3P*T$%5HZM)0
M<\BQ&*F45$G2IEZTS&1,HPM+0.E%!F%%%-=UCC9Y&"HHRS$X 'K0 ZO /B*,
M>(M6_P"N_P#A7L=GXRT*_OUL[:_5IF.U058!CZ D8KQ[XD#'B35?^NH_D*]'
M!1E&K9H:+/ASGX/:A[:H/_0$KFM)./'^E_\ 7]!_Z&M=+X8.?A#JRX^[J2'\
MU2N7TYMGCK3F/\-[ ?\ QY:[X;S^8SZ<HKG=>\<Z'X<N/(U&=S*,;DB3<4ST
MS6QIFIV>L:?%?:=.L]O*,JZ_YX->$X22YFM"2U1114 %1N*DICT 5W%5I!Q5
MIZKR=ZM%%245YSK2O:^)M0,\6H6L;*CVATNS!-PY'S%W"G+9[,0,>M>CR5Y_
MXYT'5=;O(X=-LD:!T'G7,EXR8&3\JIR ?]K:>M7T&;.EF].BVAU48O3"OG@8
M^]CGIQ2RBF:-8OIVB6]I);Q6YA!41Q2M(H&3_$P!)[GWJ27O6T2T4)173^,$
M^V>"UD//W&_,8_K7,S5U&J_O/A\">T,9_442TE%^8WNCYT8;6(]#BNB\&^'-
M>UW4)&\/7+69AQYMRLYCV ].G)Z'I6#=+MNYE]'8?K6KX9L_$=Y=3#PJ]RLR
M*&D^SS>7QGC/(S7J5/@T.^?PF[KH\-Z'YT.N7&J>)-::-E$TY>.*)B.""W+8
M_$&N$C^Z,UZM:Q?%18&@O;&#4;9E(:&_\I@?QR#^M>41GJ#P0>1Z5A0>K5[_
M #,Z3\SI?!<Q@\11L.P!_)@:^DP<BOF+PPV-=B^A_E7TU$<PH?51_*N;'+WD
M<^)^(\^^+O\ R Q_N'_T):\-KW?XLQ[M !_Z9O\ I@UX37!#J?6Y,_\ 9%ZG
M4>"=6T[3_P"UK/5;N2P34;,VZ7B1ES$2>>!S@UTMAXSTFQ\1Z7IVF:G)!X>T
MJRD$C,A47LA4YRN.YZ9[Y]:\Q-&*TY;FE? PJS<FWK_E:XW(::1U7:K.2%]!
MGI7J'P>.-2/_ %T;_P! KS&O1OA%+MUK;_TT_FI%*:]TG'QMA9+R/7KX:1]J
M_P")AY'G;1_K.N*B4:%_#]E_.L3Q:N-7C;^]$/YFLR$UG8^3C2O!.[.S4:/_
M  _9ZD TW^'R?PKE86!. <XZU=C-!+I^9T ^P]O+J0?9NVRL6.K<1H,G'S-(
M>5VVTX;.V*J1U,M!FT3T4#I102%>:?$7Q8&+Z+I\GR+_ ,?,BMU/]S_'\JZ'
MQQXJ&@Z?]GM&_P!/N%^3_IFO][_"O"=1N9;JX%I;;I9I6 .WDLQ/3ZUZ&$H<
MSYY#2+>C17_B#Q+:V&DLR?O QE7C8H.2Y/8"M3X@74-[KFISVSB2)I0%8=#C
M _I6LT$?@?P^=)MV4ZS?(#J$RG/E(>D0/\__ -5<4(KK7M6ATS3(S*\CA54?
MQ'U/L*]"+4Y<_1?U<9U?A3)^$VM^@OHC_P"@UQZW*V?B>WNI,[(9XY&P,\ @
M_P!*^@M"\&6&C^$/["<><DRYN7[NYQEAZ8P,?05XOXU\)W.A:F\;@L ,I(!Q
M*GK]1W%94*T)SDNX7-/X@Z4\U\^HVTGVBTU _:;:9>C ]5^HS5+X=^-Y/"NJ
M_9KUF.F7+ 2J<GRF_O@?S]OI1X*\1VP@?PWX@?\ XEETV893UM93T8>Q[_\
MZZS_ !7X<N-'U*6*9/WD?)*]'7LP]JU44TZ-0#Z3CD2:)9(G5T<!E93D$>H-
M.KQOX4^//LTD?A[5Y?W+G%I*Y^X?[A/H>WY5[)7BUJ,J4^5B"D..]+3'-8B
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M@>RD2*XN[BXGN=S?N)UN7>"2,@<JK,2#D'.1D$XIFJ:Q8W.I+?V&I7>CZO\
MN[66RDMPTDH9OE!C;K@L3N4XP:U!9MHN@+I>EWD7]H,CM"]SC]Z^=S':.V3V
MZ9JEO<:.,UG4;*YU*XO8+F]MKI+H&01*)XXQ&?+6253C;SG !]\5U^GV2Z9I
M-O:*V_RTPSX^\QY9OQ))K"T>?4-=O;J#68+)4M)8S/";<I(TFW(/#D$ XP2.
M:Z25JUIKJ7$Z#P;;;[RXNF'$:[%/N>O\J\T^*.J_;=>>)6RH<_DORC^IKUB
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M/*D@DG<-H!7;CFK^C^&]1L==?5VOEC>:XF\ZV\L%6B9V8?,.2V2#STY%4KW
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MXU;$3JO78AL****YA!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M->-)4*2*KJPP589!KD/$'PZT[5HR;95B?KL;[OX'J*[&BKC.4'>+*C)QV/GS
M7OAYJ6E2,4C;9VW=#]&''YXKD[BUFMGVW$3QG_:%?5S(KH5=0RD8((R#7/:K
MX)TC4XRHA$!/78,J?JIX_*N^GC>DT=,<0_M'S92UZOK/PA<9?3R&'_3,X/\
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C****D04444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>nstg-20221231_g28.jpg
<TEXT>
begin 644 nstg-20221231_g28.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ $<# 2(  A$! Q$!_\0
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M^M>A?#S_ $7XE>'H(E8&WU&<;NVU@PP/P'ZU\QQ;*&%S3!XZ"LZMD_.SBO\
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2]K7=^B6R2[)=$%%%%=IP'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>nstg-20221231_g29.jpg
<TEXT>
begin 644 nstg-20221231_g29.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "1 )(# 2(  A$! Q$!_\0
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M?VAO#/PH6'3D+WU]>:>]Q;G3PLAB)XB;!^4J?F/_  'IS7EWA/\ ;>MF6/\
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M$ZV;*.92/[,U(EE3/:.8<@>@<-]:^C_$EG;:Q));W<$=Q .-D@R,^OL:YO\
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>nstg-20221231_g3.jpg
<TEXT>
begin 644 nstg-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &B!(T# 2(  A$! Q$!_\0
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MUS_D7M1_Z]9?_0#0!>HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JCKG_(O:C_ ->LO_H!J]5'7/\ D7M1_P"O67_T T 7J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^6@4445B=(4444 %%%% !1110 4444 %%%% !1139)$AB>25@J(I9F/8#J:
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.N?\B]J/_7K+_Z
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M@ HHHH **** "J.N?\B]J/\ UZR_^@&KU4=<_P"1>U'_ *]9?_0#0!>HHHH
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MCHHJ)S<Y<S-:5-4H<D?ZZA1114&@4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;5^_H,_THNNP6-:VF^T6L4PX$B!_S&:DJCH;^9X>TY_[UK$?_'!5ZI&%%%%
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MHJGL-(****W&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %4=<_P"1>U'_ *]9?_0#5ZJ.N?\ (O:C_P!>LO\ Z :
M+U%%% !1110 4444 %9&M^%=%\1M$VLV"7#PC"2!V1U'IN4@X]LUKT4TVG=$
MRC&:M)71G:-H&E^'K1K;1K..UB9MS!<DL?4DY)_$UHT44-MN['&*BK15D%%%
M%(84444 %4I]'L;G6+75)H-U[:(R0R[V&P,,,,9P<^XJ[133:V$TGN%%%%(8
M4444 %%%% !1110 4444 %%%% !1110 44ASVI: "BBB@ HHHH **** "BBB
M@ HHHH *HZY_R+VH_P#7K+_Z :O51US_ )%[4?\ KUE_] - %ZBBB@ HHHH
MQI_^/NZ_WQ_(5#4T_P#Q]W7^^/Y"H: "BBC- !11FB@ HHHH **** "BBB@
MQ24M% "44N*2@ I*4TE !1110 52U;_CQ:KM4M6_X\6H ZBS_P"/&#_KFO\
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MHH **** "J*ZUI[ZPVE+<@WJ+N:+:>!C/7&.AZ9JS<W$=I:RW$QVQQ(78^@
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M379T4EA$H\M]+6Z?TPL<WXDM;B?Q#X>D@@DDCAN6:1D0D(/EY)'2GWEM.WQ
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MW_\ 6HY&!N45A'Q'_P!,!_WU_P#6I/\ A)?^F*_]]?\ UJ.1@;U%8'_"3?\
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M )5A1A*/-?JS*G%J]^X^BF>9_LM^5)YG^R_Y5N:CZ@/_ !_K_P!<C_,5)O\
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MH1R/Q!JN+=_^?J?_ ,=_^)KP_4?B?XGAFP-2'_@*O_Q55!\5?%/_ $$E_P#
M5?\ &GRL+H]^$#?\_$W_ ([_ (4H@;_GO-_X[_A7@0^*GBG_ *":_P#@*O\
M\53A\4_%'_03'_@*O_Q5%F%SWSR6_P">TOYK_A2^4W_/:7]/\*\$_P"%I^*/
M^@F/_ 5?_BJ4?%+Q/_T$_P#R57_XJBS"Y[V(F_YZR?I_A3O+/_/23]/\*\#'
MQ2\3_P#03_\ )5?\:=_PM+Q-_P!!/_R67_&G9A<][\L_WW_,?X4NP_WW_,?X
M5X1_PM/Q!Y./M[[\??\ )7&?I_\ 7J/_ (6AXF_Z"K?^ R_XT687/>]A_OO^
M8_PI=G^VWZ?X5X(/BAXF/_,5;_P&7_&C_A:'B7_H*-_X#+_C19@>^!/]MOT_
MPK&\0:)+JZQ"+4;JT,>>87*Y^N*\=_X6CXE_Z"C?^ R_XTO_  M'Q+C_ )"6
M?K;+_P#%4G&ZLQ:'HG_"$W__ $,>H?\ ?UO\:9<>$+NUM9;FX\2WR0PH9)',
MC?*H&2>OI7GO_"T/$O\ T$%_\!E_^*H_X6AXD_Z"(_\  9?_ (JL_8P_E0K(
M],\">(O#UQ<?V9IGB)]5O)<R8E$A. .<;AP!7H#\ ?6OGJS^*'B%I@IU)_HM
MLG^-=-;?$/7DN;<37*2QNX#;[<9Q^!K11MHAGOR?ZM?H*=38F#0HP.05!!IU
M(84444 %%%% !1110 4444 %4=<_Y%[4?^O67_T U>JCKG_(O:C_ ->LO_H!
MH O4444 %%%% 'SG\4_^2F:K_NP_^BEKC\UV'Q5_Y*9JG^Y#_P"BUKCZ "BB
MDH *2BB@ -)2TE  :2EI* "BBB@ HHHH **** &-_P ?"?[K?TI^:C;_ (^$
M_P!T_P!*DH 7-&:2B@ K2T3_ (_?PK-K2T3_ (_3]!7-BOX+,JW\-GU3:_\
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M7O&GG_29?^N:_P S7@G@4_\ %9V'^\W_ *":]YTX_P"D2_\ 7-?YFMH?"P-
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M "%+G_KHW\ZJ9JSJ9SJ=Q_UT/\ZJ5*V).D\"_P#(Y6'^\W_H)KWG33_I$O\
MUS7^9KP;P/\ \CA8_P"\?_037O&F?\?$O_7-?YFMH?"PZFE334%Y="TMVF96
M8*N<*,D\C_&LO_A)+<R%1'*<'!.P\<9_K3&;)IIK(&OQL?\ 52;<*<X['/\
MA39?$$,08R12@*NXG;2NAFN:TM"_X_?^!I_.LB&7S8@_0'I6OH7_ !^?\#3^
M=,3.V/0UQ'AE]UK='_INU=N>AK@_"IS9W?\ U\/_ #J5N);#KT9G-5\5/?2(
MDWSLJY.!N.,FJB7,+@%9%YZ9.,_3/6JNADF*4"HC<P*P5IHPQ.,;A_GM0UU"
MB[FD7 QR.>OTHN@"%PD05L@C.?E/K4HE3U/_ 'R::D\4A CE1B1D!6!XJ44
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M+@48% $^E'_2A_O'^==D3B6V_P!]:XO3&Q=#_>/\ZZ]Y )+;G^):!'U?9?\
M'A!_US7^535!9?\ (/M\?\\E_E4]9E!1110 4444 %%%% !1110 51US_D7M
M1_Z]9?\ T U>JCKG_(O:C_UZR_\ H!H O4444 %%%% '"^,? ^E:[JYO;BV(
MG:(!Y$<J7QP,^O  KF?^%8:1_P \IO\ OZ:]@HH \?\ ^%8:1_SRF_[^FC_A
M6&D?\\IO^_IKV"B@#Q__ (5AI'_/&;_OZ:/^%8:1_P \9O\ OZ:]@HH \?\
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M^F2/NUZX88SU13^%(((E.5C4'V%%P"%BZ D8S4E'2BD 4444 %%%% !1110
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MQC_=I>\GJ!'I^FVD?B!8XH=D;VZN55B.23[UU&@((;V^ACR(UV$*23@\_P"
MKG['CQ,5_N0A/R9JZ+1.=2U _P"Y_P"S5K+81M4445B 51US_D7M1_Z]9?\
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M8F.1(EGP"3SG+UZ5X C\;:DT\OC$VD<!4>0MG$48'/.[<#GCTH&>E1?ZE/\
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MA@S2 Q98&;UJLT#KZUT)M,]J8UB#VHL,R]*.-4MMQZ2?T-3^+K5HM1FDZI,
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MWKGTKM**!W.,ET'7)/\ EC9 >GG-_A55_">MOU2R_P"_C?X5WM%.["[//O\
MA#M:]++_ +^-_A1_PANM>EE_WVW^%>@T47879Y]_PANM?].7_?;?X5I:/X;U
M2RND:X-J(PP9BC,3P<UU]%%V%PKE;KPW?6^I75QI?V9X[F0R,DI92&/7D5U5
M%(1QK:+K9.?LEI_X$'_XFD_L77/^?*T_\"3_ /$UV=%/F8'&?V+KG_/G:?\
M@2?_ (FC^Q-<_P"?.T_\"3_\379T4^9@<9_8FN?\^=I_X$G_ .)H_L36_P#G
MSM/_  (/_P 379T4<S XW^Q=;[6=G_X$'_XFGKHNM8YMK,'_ *[M_P#$UU]%
M',P.0.B:T2I^SV?!S_KV_P#B:#HNN'I!9#_MLW^%=?12NP.,;0-=;_EE8_\
M?UO\*;_PCNN?\\[#_OXW^%=K11S,=SBQX>UP?\L[#_OXW^%/&A:ZOW4L!_P-
MO\*[&BCF8CE+;2=<MYC(8K%BP _UC=OP]ZZ&PCN8X3]L\H.>T6<#\ZM447;
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MRK*JVHZ"8_[6_HOY4?:W]%_*H**Y_:2[B)_M;^B_E1]K?T7\J@HH]I+N!/\
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M_/G!^;__ !55:2E]?Q7_ #\8O9P[+[BT;U/^?.#\W_\ BJ:;R/\ Y\H/S?\
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MFFG_ &KCO^?K^\/8TOY5]R&FTTC_ * EI_W]G_\ CE)]CTC_ * =I_W^G_\
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M ..TATK0/^A>L_\ O_<__':GH-/^U,=_S]?WB^KT?Y%]R*YTG0/^A=L_^_\
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M$_Z>/_'/_KT?V%_T\?\ CG_UZUJ*7U2CV_,+(R/["_Z>/_'/_KT?V#_T\_\
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M'_\ 7I/^$:_Z>_\ R'_]>MVBE]1P_P#+^+_S#E1A?\(S_P!/?_D/_P"O2?\
M",_]/?\ Y"_^O6]11]1P_P#+^+_S#E1@?\(Q_P!/?_D+_P"O1_PC'_3W_P"0
MO_KUOT4?4,-_+^+_ ,Q<J,#_ (1?_I\_\A?_ %Z3_A%O^GS_ ,A?_7KH**7]
MGX;^7\7_ )ARHY__ (1;_I\_\A?_ %Z3_A%?^GS_ ,A?_7KH:*/[/PW\OXO_
M ##E1SW_  BG_3Y_Y"_^O2?\(I_T^?\ D+_Z]=%12_L_#?R_B_\ ,.5'._\
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MB/\ Y _^RH_X03_J(_\ D#_[*NNHI?V5@_Y/Q?\ F')$Y#_A!/\ J(_^0/\
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M +*D_P"%<?\ 45_\E_\ [*NXHI_V7A/Y/Q?^8<J.'_X5Q_U%?_)?_P"RI/\
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MX59_U&/_ "5_^SKT&BC^S<+_ "_B_P#,.5'GO_"J_P#J,?\ DK_]G1_PJO\
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MO_H!J]5'7/\ D7M1_P"O67_T T 7J*** "BBB@ HHHH **** "BBB@ HHHH
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M!XU+=,E2!F@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!G:_?W.EZ!>7EA:27MS%'F*")"S.Q.!P.2,G)]@:\=\.ZAKNDZM<:QJ
MW@;5M8U>9RPNYDD7RQZ*OED#Z^G QW]SHI@>8>,-/US4G\.^,M*TF7[;:*IG
MTY@3(@SN Q@$]2#QGD<4[PKI^M^(_B/)XLUO2I=)AMX/*MX)E(8DKM[@'H6.
M<#J*]-HHN!P'QBTZ^U3P?:PZ;9W%Y*M^CF.WB:1@OER#. .F2/SK>UZ'63X'
M9= (344@3;')&K;\ ;D(88R1G\:Z&BD!XA#H6N^,+S2=.N?"R:';6L@>_N1:
MB 7##&6QM SC. ,\L>W3V^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *HZY_R+VH_P#7K+_Z :O56U*W>[TJ[MHB \T#QJ6Z9*D#- %FBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** .(^)^IZ[:Z'%8^&K&]GGO
M"PEGM86<Q(,9&5!P3GK[&N=\#ZQ?:";/2K7X?:E:K<31QW-_+YF3D@%V)B'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>nstg-20221231_g30.jpg
<TEXT>
begin 644 nstg-20221231_g30.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !W '<# 2(  A$! Q$!_\0
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3\TG=G8DHJR"BBBI&%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>nstg-20221231_g31.jpg
<TEXT>
begin 644 nstg-20221231_g31.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #\# 2(  A$! Q$!_\0
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MVB):MA-7T]4VQR(S!1<HJ_==&(W!< Y!XRU?1MYXJBM?$D5B49HCO1=V7$>
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**E"C!0IJR1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>nstg-20221231_g32.jpg
<TEXT>
begin 644 nstg-20221231_g32.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #T# 2(  A$! Q$!_\0
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M2*$9"],<84G QG Z5SO[4-S,OQ/C4.R*--C08.,J6?(^A->\> O#>E:S\/\
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'45Y!],?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>nstg-20221231_g33.jpg
<TEXT>
begin 644 nstg-20221231_g33.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "6 (\# 2(  A$! Q$!_\0
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-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>nstg-20221231_g34.jpg
<TEXT>
begin 644 nstg-20221231_g34.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  W #P# 2(  A$! Q$!_\0
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..K6E4>IT5%%%?:'.?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>nstg-20221231_g35.jpg
<TEXT>
begin 644 nstg-20221231_g35.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #T# 2(  A$! Q$!_\0
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M"F3KT89 .:\T\>_!6X\6>']8\0^)K2#2M9L?ETNQT6 74,Y!!C+#;YDCLV$
M^4( ,  FM_X=_#>SN[RUUBUT+3[.>UE%EJMG=2&ZA\R(@F2TE(+(0V<@!0QZ
M\KFOR^G4Q2Q+YUHW=;IOH[IWTTVTTVO:Q^]XFAELL G"6L5R7T:5GS))IQ3>
MMG*S3:L[7N]+XE?$W3[\PZ%X8U_2SJ%ZEW"]PMPK?9I4MWDBW8/RJS(5+?AU
MIG@W4YO&WAG3-5U6V_LS5+^&:Z2QDP7-H9"(RXQ@@!EYQR#[FO'OBAX.\?\
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M2R+6VU9[<6B7-HB#RY7BD8,)!]U@JD$@,,!L!_CKQU%I-NT43++>2#]W&>0
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BYDE<]7<]R?\ ZPXK8HHKY64I3DY2=VS[:$(TXJ$%9(__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>nstg-20221231_g36.jpg
<TEXT>
begin 644 nstg-20221231_g36.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  [ #T# 2(  A$! Q$!_\0
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G*B7YG=N7D;NS'N:VJ**^ZI4H4(*G25HK9(^)J5)UINI4=V]VS__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>nstg-20221231_g37.jpg
<TEXT>
begin 644 nstg-20221231_g37.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ": 'L# 2(  A$! Q$!_\0
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MNV>L:MH]W"NO36BV\PD82 A2NR-3A0 ,Y(<]SC'2N-\R^%G73G7I:T:WRO\
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M9+BVF0/'+&<JRD9!!KXA\-Z;/I^G6L-_>+=W"J$$I4)YA QP,\GC/?G->W_
MSQN=,U >&;M_]$N2SV+8^Y)RSQD^A&2/?([@5Y.!SNE3Q:P,W=/9^?;Y_F>_
MEM9TOW4G>+V_KLSW:BBBONCZ4*^"?C5\16^)GQ$O[Z*7?H]BS6.FK_"44XDE
M'^^X/H<*H/2OJ_\ :"\</X#^%NJW=N5^WW86QM0X)'F2G;DX(. "3D=.M? ^
ML;K?22D7SC*1[7PQ<%@"#GJ2*]O+Z5E*L^FQ\9Q!B')PPD7OJ_T(([B34M8N
M+:1 UC$BL8Y8]K)(&X.[WX(]J]'^%_P[OOBKXL71;.5K.VCC\^^OE7/V>+.
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MMG@GQ)_;VF".<JM_;!4F7=NW<?+(/9AS^8KQ$321:-'<AU6XT]6AG68$B0#
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M<V<4KQKG"DJ#@5V\'U/95<3@^B=U^7GY=2\-[LI1/S^^(#7$GB_QGYSL\_\
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MW%3:QY]]):6UE-Y4H_THN5R !PGYDD8]* &ZBNH:AYMF8(K>S<XDNC)NS'W
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B._O5NBO5I4845[J/K,+@J&#5J4?GU"BBBMSN"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>nstg-20221231_g38.jpg
<TEXT>
begin 644 nstg-20221231_g38.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML:S<^%(M \(Z/;R:K+I^CV>H/:WTBV@W6Y5RD21"-A)-(TK3((XT^DOV(?\
M@KW^W]^VW_P02\5?M7?L[?!^S\=?M%^#=7D\*3Z?9V""/4+Q'LW;4DM%*J[K
M97B3&%,*\T3!5VGRP ?JU17X+_M9_P#!5S]L?]AK]I7]D>_T#]K?Q'XE\2?$
M"WM+']I'X/\ B_4=)U*WT34FDT\3VA^PVL2Z?=8O9CY<95H_*A+(%8J_L_\
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M#.GW^G0W%QK+V#D_N%NC"R*C.BSJQ.[8\>X%0#]BJ*_$?3OVNO\ @J7\"_\
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MXV\+66L_\(YKB;;K3_M$2R>5)P,XW<-@;EPV!G ] K\;O^"@/[5G_!570?\
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MMZ)H19&=(5BLH;& LOF*+N6VD2 (3("65E /ONOAKP;_ ,%J-.UG_@L)>_\
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M3I/BK\3;RU\-7GB1M*C>VTRZ']H)-J?V<KY1D?\ LYML97REDN =I50A\_\
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MU?6/@Z-)FU"#PIJ6BZ9F)I/#*ZB(Q<16J3E([AR4RY.T*K%L$D _7:BOQ4\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML?",.GZAH'@[XB6;:;X1A_L2[TD6DDTL4,DA@6:.4BWM&C*_NX]^TM78:?\
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M7TZZN&55NK!5E5E4^6^4WY('[+44 ?D/_P $38/^"YO[%GP.MO\ @FU\6O\
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M+?%=II-]X.L/!FEPZ7<V\D&HSK/=?N"US.WV#$@^2(+*%CC0H9).X_X*J_\
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M_P %EOVD/V3-7^/_ (I^%'P[^"%AJFE^$] \$1VMM=W6H0:BM@FJ7<\T$CW
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M\1"?PG>-<Z9;:<+;_0TBF95\YV65W=P OSJJ[@F]@#])**** "BBB@ HHHH
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MZBNL>!?$TD!D2PU%$=-DRK\S02QN\;@<C*N S1J#M?\ !*'_ ()Z:G_P2_\
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MZ@+V5O:2S/\ 9F1'D:2<Q%69$191ND7^@G]F;_DV_P"'W_8D:3_Z1Q5\Q?\
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MC3Q;\0''@OQ_HNL::OAF\T:XN+"26^FN)KE)K4HMK<9A>+S"7B"JV21^YE%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M KZMJ^DZ#ITNKZYJ=O96D"[I[J[G6..,9QEF8@ ?6K%?CU_P4Q_:F\/^+_\
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M%/C9X-9SH_C'PU8:YI1DQN-M=VZ3Q9QQG9(M '2T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYFNS:U/:J*\5_P"%7_MLZ#_R!OVGM!UP#[J:YX-CM_P)MV)/UH_MO]OS0?\
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M_P 9\9YAD."DI+#J+IS3NJJVJ./2T)-)6^).ZT.[HHHK]&/UD**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOV7(OVQ?!/CR*U\"KI5W?:OJ&M)]DDT46F\7L-ZC\V\MNT4JRJWW3&2"1@D
M]5HKY*T/_@K1X';P)X+_ &BOB'\!/%WA'X+?$76;33?"/Q2UV>T6(_;'V6%[
M?6:RF>PLKMM@AGD!QYT1F2 /D?6M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ J"'3=.MKV?4[>P@CN;E4%S<)$ \H3(4,P&6QDXSTR:GHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M57M]7TF[U&XTBUU.WEN[-4:[M8YU:2 ."4+J#E0VUL9ZX..E?.?_  6$^.'[
M0/[-O_!,OXQ_'']ENRDE\=>'?"37&BS0V@G>R4S1)<7BH00S6]N\UP-P*YAR
MP(R*^-/V2/@K\ _VZOAM\3/C?_P3\_:2\>#QBO@#PM>^$?B';?%'5'U0^(!9
MWDDMKJYEN66<O.@BN+>X1D17)C5 $( /U?HKYA_;R_X)^?$7]O3QQX;TR^_;
M1^*GPC\#^&--GF-M\%O%C:-JVMZG.X4F[N&BD46T$42^7&%8N]S*24\M=_RW
M^R=^P5K7[.W_  69T?X:?#K]O_\ :8^)'AOX<_"6X\3_ !!T[XK?%N76+ ZC
MJDTEAI%F8(HH(]WE0ZE=$2B3F*W90N,D _4*BOSC_8.\26/_  6*^-_[1GQZ
M^-FN^(+OX=> _B==?#;X2>&=)\2WNFVMA'I\,;W>L#[)+$7O;A[B)TN&)D@1
M52,I\V[SSX8_\%F/BI^SE_P2C_:>\6?&O71XJ^*G[*?Q#U;X<VVM:JH9_$4X
MO5LM'U&Y5<;V9I5\[&#(+61\@N2 #]7Z*_+W]JKX;_&#]A+_ ()-:)_P4@\
M_%7Q7JWQ[\!Z/H/B_P >Z]KOB>\GA\8BXFMO[6TR]MFD, LC'<S>3$D:_9O(
MA\GRRI)_1WX,?%/PW\<_@]X4^-G@UG.C^,?#5AKFE&3&XVUW;I/%G'&=DBT
M=+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB!.L^*KB;7]9D88+SW;>8"1V/E^6"/4&O5J9!!#:P);6T2QQQH%C1!@*H&
M.PQ3ZZ<GRVGD^54,%3=U3C&-^KLK-OS;U?FSKR#**.0Y)ALNI.ZHPC"_5M*S
MD_.3NV^K;"BBBO2/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O#/C+_ ,60_:5\*_'BW_=:-XI"^&?%I'"I(QW6=PWT8;"QZ*H'>O<Z
MY3XW_"_3?C-\*=<^&VI%5&IV3);3,/\ 4SK\T4G_  &15/T!%?/\39=B,PRJ
M3PO\>DU4I?\ 7R#ND_*>L)?W9,^7XPRK%9IDLG@_]YHN-6C_ -?*;YHQ;Z*:
MO3E_<G(ZNBO-_P!E+XHZC\4O@Y977B8,GB#19I-(\202'YX[VW.QRWNPVO\
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M40K])4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XG^V9-+XUM_!
M_P"SII\K>;XZ\2Q)J2QGYAIMJ1/<MQTQA/KS7M4,,5O"EO;Q*D<:A41!@*!P
M !V%>)?#O_BZW[8_B_XAO^\TWP)I<7AS26ZJ;N0^;=./1E_U9]B*]OKY/AS_
M &_'8W-7M4G[.'_7NA>'W.JZLEW4EZGP_"7_  I9EF.=/55:GL:;_P"G6'<J
M?W.LZ\D]G&2?F%%%%?6'W 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7AGP9_XLA^TIXK^ T_[K1O%(;Q-X2!X5)&.V\MU
M^C#>%'15)[U[G7S-_P %.-8TOPG\-_#OC/3=<ET[Q59:U)'H%Q:G$IBEA9+E
M<]EVE,GUVCO7Q/'6(CE&5QSU?%@Y<^]N:$O<J0N^LHN\5UJ1@?G?B3BH9#DL
M.)%\> E[2UTN>G+W*M.[TO.,KP76K&F?3-%>+?L(?'C_ (7A\"K+^UKWS=;\
M/[=.U?<V7DVK^ZF/<[T R>[*]>TU]#D><8/B#**&8X5WIU8J2\K[I^:=T_-,
M^IX;S[ <49#ALVP3O2KP4UW5]XOSB[Q?9IA1117JGMA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGG=N!S[YH ]OHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7])G]>!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5DGM.K-= HHHKZP^W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;X@>
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MF7P9\/\ PMKLUN^JFVN;R.\O=0OEMI)8H&=H+>*& 2.Z(LK2;'F\J( ^7_\
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M HHHH **** "O#OVI[JY^+7CCPO^R?HEPXCUR8:KXQDA8@P:1;N#L)'W?-D
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MH0XFT_4+<[9["Y7[D\3=58'\QD'@UUE%<V,P>%S#"SPV)@ITYIJ47LTSDQ^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>*_M?:WJOB^/0/V8O"%X
M\6I^/+WR]3GA/S6>DQ8>YE/IN V 'ALL.M>SW-S;V5M)>7<Z111(7EED;"HH
M&223T %>(_LM6UQ\6_'7BC]K#6X'$6MS'2?!T<JX,.DV[D;P#T\V4%B.Q4XX
M-?)<4SGCHT<EI.TL2VIM;QHQLZK\N9-4D^DJB?0^'XTJ3S&-#AZB[2QC:J-;
MQP\+.O+RYDXT4]U*JGT9[-H.AZ5X9T2S\.:'9I;V5A:QV]I;QCY8XD4*JCV
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M=P"Z\]ACE8F&1G(_++_@N#\%_P!F3XSGXL_M;> O&D=K\;O"UMX%F_9W\8>
M]6W:OJVKSR7"Q6%D+=BUZ)>"%0,8]OF A5?/[)W]A8ZI93:;J=E%<VUQ&T<]
MO/&'21",%64\$$<$'K7EWPK_ &'?V2O@A\7-:^./PE_9\\(>'O$NNP017>HZ
M/X;M+9XUB5U_=&*)3&7$AWD'Y\+G.!0!\T_$K_@G;_P4G^+/QGTO]J[X<_\
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M'Q6\-?"3PQIWBC5TV:KXDL=!MX;^]7(.);A$$D@R!PS'I73T %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \0\<?\6H_;/\ #'C=?W>F?$+1I="U,_PB^@Q+;.W^TR_NA]#7
MM]>4_MG^"]2\5_ ;4=;\.@C6?"MQ#K^C2 9*3VK>82.Y/E^8 !W(KO?AYXTT
MWXC>!-'\>Z.1]FUC38;N)<YV!T#%3[@D@^X-?)9/_P )W$&-R]_#-QKP])^[
M42]*D>=_]?4?#Y!_PE<4YCE;TA4<<33]*GN58KTJP]I+SK(V:***^M/N HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ***\N^./[13>!M8@^%7PMT'_A)?'NI
MQYL-$A;]W9H?^7BZ<']U$,YP2"W'0'<//S/-,%D^$>(Q4K1T2T;<I/:,8J[E
M*3T44FVSRLYSK+L@P+Q>-GRQ3222;E*3TC"$5>4YR>D8Q3;>R-;XY?'[PG\$
M-)MUO;:?5==U1_)T#PUIPWW6HS'@!5&2J9QER,#MDX!Y3X4? 'Q9XF\7P?'G
M]IFY@U+Q.@W:)H$)W6'AU#R%C7)#S=,R'/(X)P&K6^!O[.J^ =6N/BA\3->_
MX2;Q[JB?\3'79U^2V4_\N]JI'[J(=. "WL,*/4*^?PN5XW/,3#'9Q'EA%WIT
M+IJ+6TZMM)U>J6L*;^'FDN<^7P62YCQ)BX9EGT.2G!J5'#734&M54K-752LM
MXQ5Z=)_#S37M HHHK[ ^]"BBB@#AOCY\#]&^.'A!-+DOI--UG39Q=^'->MN)
MM.NUY5U(YVD@!E[CT(!&/^SK\<-9\<F_^%OQ5L4TSQ[X9Q'K=B.$O(^ EY!_
M>B<$$X^Z6'0%<^HUY?\ M%? _5_'8L/B?\+;]-,\>^&<RZ'J!X2[CY+V<_\
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MBX2S:OG?#N'Q5=6JVY:B[5:;<*L?^W:D9+Y!1117MGT84444 %%%% !1110
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MNR+ QP>"I\D(W?5MMZN4I.[E*3UE*3<I/5ML****[ST@HHHH **** "BBB@
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M3_[?_=UHKTJ0C4?G6^[?HHHKZP^X"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#A?VE/V<OA3^UI\%=:_9_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6YFU9XF:?62;5!/X:;<W[U1*!1117VA^@A1110 4444 %%%% !1110 4444
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MHHGSYUFQ]69P4SV5:^3XE_V'%X+-5M2J>SG_ ->ZUH/Y*I[*;[*+]3X?B_\
MX3<=E^=K:C55*I_UZQ#5-_*-7V-1OI&#]5[?1117UA]P%%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEU?X*T)0;ZKF35UYJ]T^C1SWPC^(%E\5/ACH7Q$L-H35],BN'1#Q'(5&]/\
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M^6:*_L3_ %#X'_Z%>&_\$4O_ )$_._[5S3_G_/\ \"E_F?U,45\L_P#"I_\
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M8DSWPB*/PH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC^&(=JZ/3/A=\,]%(.C?#K0K0@\&VTB&/'.?X5'>CVO \/\ ESB9?]Q*4?\
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M/#TI2>'B^>I351K]Y5T2GS0LK7^"]V[MJR7VG">%5?+IN4Y)<[T3LMH]K/\
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M:?[(7^G?L4_'#_A-_"=OR/A5\4KLRF&,?\L['41AXL#A(Y,1KU8L:ZCX2_\
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MX)Z_'G1^/!__  4U^,D('W/[:N+74<#WWQKFOT+_ %6Q,_@XCI+_ !X&JO\
MTFM,_I_ZEXDK?&TOEAU^N(1WW_#=OP>_Z%?QK_X25Q_A1_PW;\'O^A7\:_\
MA)7'^%<#_P ,D?\ !1S1N?#'_!5"XF0=+?6OA!I<^[ZR!PP[]!Z>E'_"I_\
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M?\/JO^"F?_1RO_EFZ-_\AU\LT5_=?^H? _\ T*\-_P""*7_R)^6_VKFG_/\
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MDD])3NK;:[[GQ/7]&WP]_P""?'[$/PN\M_!O[+?@N*6+'E75[HD=Y.F.XEN
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M-P?[S.,*O2<ZG_IJG,]587-'MA:GS2C_ .E21^(]%%%?ZFGX&?J9_P &TO\
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MO[4TOS+G19WQ#.PRT#'^!\?HW?ZT? [X':A\3=0&K:JLEOHMO)B:8<-<,/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=L?P9\**/0>';8?^R5(OP3^#2*%3X2>& !T T"W_ /B*Z>BOZ(>7X![TH_\
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MG"87&4_9XBG&<>TDFON9I2K5J$N:G)Q?=.WY'Q5_P6)^"?@[PI_P3L^(.O\
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M-_X'TB4G^)].CS^>W-;5%?8U\'A,4K5J<9>J3_,\.G7K4?X<FO1M''7O[/\
M\'K_ "9O ]NA]8)9(L?]\,*K?\,^>"[?_D#:QKVG8Z?8M9D7'_?6:[JBO)GP
MKPU.7-]3II]U",7]Z29VQSC-8JWMYM=G)M?<SQWXM_#7XE>&/"<U_P"!OB+X
MCU*)587]I>ZAYDGDXY*84$X[CKBOGFONBO&OB]^R_P#\)+X@BU[P$\%I]KG
MU&VD^5(\]94 _5?7IWK\C\2/#;&8Q1QN4<T^71TG)RM?K#F;_P"WE\UU/M>%
MN*J%"^'QMHWU4[)?*5E]S^1Y1\'M"\=^)/%*Z/X)U&]M%E"_VC<6MT\*I#GG
M<R_H.<FOHG3_ ( ?"VSG^V7N@/J-Q_%/J=U).S?4,=OZ5K?#WX>^'_AMX?30
M=!@]&N;EQ\\[]V8_R'0"MVOK^"O#S!9%E<8YE&-:L];22E&'E!._SEU?D>)G
M_$]?,,8WA6Z<%IH[.7G*WX+H5-*T+1-#B\C1-&M;-,8V6MNL8_)0*MT45^DT
MZ=.E!0@DDNBT1\K*4IRYI.["BBBK)(-3TS3]:T^;2=5LX[BVN(RDT,JY5U/8
MT:9IFGZ+I\.DZ59QV]M;QA(88EPJ*.PJ>BL_8TO:^UY5S6M>VMM[7WM?6Q7/
M/DY+Z;VZ7[A1116A(4444 %?'GQ"_P""(7[ 6I>'W_X0#X&_V=J467BW^*]5
MD2?_ &&WW3;<]B.AZ\5]AT5VX;-<ZP&&JT,!C*V'55)2=&K.E)VO9\T)1=XW
M=NUWW9#I8:=6%2K2C/EV4XJ2\]))K7J?GI\(O^",W[+'C3Q!+_PE?P0GL--L
M)S'>>9KVHJ\KCK&G^D?FW0#IS7UQ^S3^Q5^S-^Q]_;7_  SI\-/^$=_X2+[-
M_;'_ !.;V[^T?9_-\K_CZFDV;?.E^[C.[G.!CU.BN7+<SXMPV42P&89QB\9&
M;O+V^(JU$[.Z7+.<HI*R:TW5][6Z,<LNQ.+5>CA:5&VRA",;=]4DW?\ +0**
M**@R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KY._X*"_!O]J#X_>*=+\,?#7X=/=^&='@\X7!U
MBSA%U=N/F;9),K81<*,@<L^."#7UC17SG%?#.$XOR6>68JK.G3FTY>S<5)I.
M]FY1DK7LWI?3>UT_DN-^#\#QWP]4R;&5JE*E4<7)TG&,I*+NHMRA-<K:3=E=
MV6MKI_F)_P .\OVPO^B0?^7!I_\ \D5]%?\ !/KX-_M0? 'Q3JGACXE?#I[3
MPSK$'G&X&L6<PM;M!\K;(YF;#KE3@'E4SP":^L:*^ X<\$^&>%LZHYG@<3B/
M:4W=7E3<6FK-22I)M--IV:?9IZGY?PE]'7@_@OB&AG.6XS%*K2=TI3I.,DTT
MXR2HIN,DVG9I]FG9A1117[$?OH4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !15>_P!7TG2Y;6#4]4M[9[VX
M^SV:3SJAGEVL_EH"?G;:CMM&3A6/0&K% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ:TOX3>+/'5[I-H7T_PCX)T>2^U+5)R0L<,4: [06(W2-A47+$\8/R9^Q_\
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M&_1I[4V"SZ_<26;:;83V+'+:E:B*]DFO0I#).J>=-OPGZ$5\'> /V5? ;_\
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M:?&3XP>)/B7XIT%ITE;2+C5KD-%9N\9*-)';16XDVDJ)-X4L &/U70 4444
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M:Y_3])\:-_P7\U'XOGX6>,U\'R?LM6OA"/Q<_@W4!IC:U'XDN+QK47)A\O\
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M_1ENYF:22VAGGT]=I8F/S7!)D\PFM\6O$GC/]A3_ ()V?LV_\%(;;QIJ]_\
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M%>-1$L?T)_P3[UWX]^*/V&OA%XE_:CCE7XB:A\.](N/&(N(!%-]O>UC:4S(
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M;>--Y(0+)P2RE>!_X(T_ /X<?L[_ +&O_"*_#W]H3PA\2YM;\::SXB\1^(/
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M7VA:E=Z+,YA%_:2$(SQ^8&0M$_F1L"&"$5^;O[:%K^QW^R?^S-\+?VO/V#/
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MN.U=S\8-5T2_OO\ @DE/?7]K,;J[L)H&ED5O-/\ PBD&'7/7YVCP1_$R]R*
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MO)$F^7R+6W1I#'&A#23,%BB#*9'0,"?Q&_;Q_:N^"7[4?_!"K]H+QGX!\?\
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M[W3(_%%A!$LTTMF\\:AG2%TE:%]DRQN&,>,D?"7[/?[=.I7O_!&C]K3]L_\
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MM'A\8:?J!^'\6I03P^(K233X+-I"%W;K59Y,RS(K! K'[P%;'Q1^/GP<M?\
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M!WQ9M=#O="U+]J?25UK2_$4<,EG=6 V)<">.;*/#MD57#@KAP#UKRS_@O?\
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MPGJ^KZ+XY\"10S^*_!/C'0;C2=3L;:9=T-T(KA5$UNX(Q-$73D D$@'E[O\
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MCX80R307FJIX8U"2ZLKJ*4PR6T]HD#3P2K*/+(D15RRG=M96/B'[.-SI4_\
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M3M>-@'1@58 @BNOH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBT1^H9+DV7</951RW 0<*-)<L(N4I671<TW*32Z7;LK):)(JZWH>B>)=)N-
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MDT[P_I,-E UQ,Y>:8QPJJF1W)9FQEF)))-;E% !1110 5^6?_$-+_P!7I_\
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M ?V=?V??A3JIUWX7? KP;X;OF0HUYH'ABTLY2I&"-\,:G!';-=E10!R/CKX
M? CXH:[;^*/B9\%/"/B+4[-%2TU'7?#=K=SP*&W!4DEC9E ;D 'KS4?Q>_9T
M_9\_:"M[&T^/7P)\&^-XM+F,NF1>+_#%IJ2VDAQEXA<1N(V.!RN#P/2NRHH
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)%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>nstg-20221231_g4.jpg
<TEXT>
begin 644 nstg-20221231_g4.jpg
M_]C_X  02D9)1@ ! 0$ E0"5  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %C B<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT9[515#1]:MM<M1-;/G^\O=:OU@;A1110 4444 %%%% !1110 4444 %%%%
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M?NA3[IO]%D_W:DHY*^;YS556J2^/[PU75JLS+0;!J17JKNYJ1).U,1:W4X5
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MZTP)O,YI/,/UJ+\:02!B0@,C#J$&<?7T_&@"EK7BC2O#4/G:KJ5MI\6,[IY
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M%Y/#YMP+<90+8@QQDY8'=(Q&?X?NEN17<>%/@[?7H\R\FXDW$PPIS@L6Y8\
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MF14FEU6_9I'& 2H)4'AL\ALX[TWX WD-U\&1>_:O+O;SQ3K&HP*48QR,9IE
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MMGAG_@EG^SAX?96?P7/K+K_%J6J7+Y^H5U'Z5K";HMQG']#GK48XF*U/Q?\
M%OB;3=$U$2Z?>+=7Z-^\6!<H?JW3\LUR>K>*-4\4RI#;6SQG_GG;!F9L=/\
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M2T2/_OJ:-?ZUY[??MN>'X\_8?!_B"[/8SO:P#_T:Q_2O.OBI^U-??$KP=?\
MAR#PE'I-O>M%ONY]3\Z1%25).$6( D[,?>[U4:<KK0B52%GJ?5EJGE6=O'TV
MQ(OY*!4E?&=W^T_\3[M=L6I:#IPQC-KHNYOKF65Q^E8=Y\;OB=J!/F^/M3B4
M]5LK2TMQ^&V'(_.M?9R(]M!'W4L3O]U&;Z FKLFD07%FGVU2B8Y60[1WZY^M
M?G'JOCKQ'?*?[4\=^))E[B;7IXE_)'4?I7%ZGJWA-F+:GJMC=OW:_OS<-_X^
M[4>R?5B]LNB/TQU+Q)X!\-L6U+7] T]EZF[U&",C_OILUX7<?'#X?VOQL\;W
MP\2R7&C7V@V&G1:EX>5[K]\CRNZ*\2L P#+D].<=:^,E\;^ ]//^CW.FJ<X_
MT6VW'_QU:CO/C3X8LXPWF7CIG:"EFX7/ID@4O9QV<AJM434HQU1]UZ;^UEX!
M\*Z;]AL+'Q;KJ[S)YMY"NXD^\LJX''3%5)_VY(+5#'I?@:]1"<_Z1?P0 GU(
M17KX'N/VAM!CSY-AJ$_U5$_]FK,N/VCH1_Q[Z#(?^NUR!_)30HT8JUQSJUZD
MG*6[/N76/VT_%&I@+%X1T-%4Y7[=>376TXZX"(,_C7/WW[6OQ+O!MAN-!TY.
M@%OI;N1]#),1^E?%8_:!UJ_F2&QT*U,DCB-%WO(2Q. .,<DUT']J?%6^U2?3
MX].TVRGB@6<E@"NTD@ ,6())!&/:J7LNB,[5>KL?2=]^T'\3M1SYGC6[M@?X
M;*SM81^?E$_K7/7WQ!\8ZMD7GC/Q)<@]5_M6:,?E&RBOG3QEXD\5:#X2T;5Q
MXH\RXOR!+:0VL2&#*DXSR3@C%-\*ZU>:QHL-SJ>K:A<3R%B?]*D1<9(X"%?3
MO6=2M3I*_*WZ*X<E1Z\Q[9>6W]H'=>R7%^?6]N))_P#T-C5+[-I&G<^586OO
MMC0UY;+!83D%[>2?CGSIG?/_ 'T37%Q^%=*O)9/-41LT[*I,O &$;&&<<8;U
M_P#K*&*YOL->M@]@WNSWZX\;:!8\2ZY81>WVE/Y U':>-M)U-@-/EN-4).!_
M9]G-<9/_  !#7SKJTVF6FEN8?#K6MPS&,2S02>4 2<%6:0G=CGI^=?KA_P $
MY;[[5^R+X2"C)MY;V''J1<R'^M7[=]BOJ\>Y\<V&D>*=8_Y!O@#QGJ(/1H=
MN%7\W516O)\+?BK_ &;<WR?"GQ$EM;Q--(UW);0$*H))VM+NZ#IBOTSF-]+=
M0W C:$0JW[HW("/G'WAM/09QS6?KWB328=#U"'5M5TS3S)#)&1)>(H *D<EB
M/6I]M(KV$#\6--^,EOXH^)WPYEATZ2Q6Q\0V=QYLDH;(\Y 1@#CK7[G*<J#7
M\Z%C=KHNO:=<;A_HE[&X8'^Y("#^E?T3:7<B\TVTN!TEB1_S -3*3E%-E1BH
MSLNW^9:HHHK(V"BBB@ HHHH **** "BBB@ HHHH *_%[]JZ87'[17C5NI_MN
MX'Y;A7[0U^)7[1=[]N^/GC*0=&UZ^Z^SN*Z*.[,:FZ//6')%1R+GVJQ)'\Q/
MZ5"Y_*NDS*[+MJ)NX[5,R^G%0R#T- $;>G:HVSGT'6I/US4;#KS3&1.WR^M,
M.>IJ1QC%-8<9QUH&1X/7.#Z4A/K2MGZ"HGD5,[G4?4@4"'A<Y'6FMU_&HFO(
M5Q^]!/\ LY/\J8MXKMMCCED/HJ'/ZT#+.[V[U3OV_>6G_7<?^@M6M8>']?U9
M@NG^&]3O">GEV[-G_OD&NEM?V>_BMKBP2V?P_P!8=4D#_O+9TR,$<%@O//XT
MKH5CSS66_P!&7CO4'AP?Z9[YKW5/V*?B_K,86?18-+&<YO+RWB'X[I"?TKHM
M!_8!^(L<@=]:\.6['^%M21O_ $%#1S(9R?A>0?84SU(QP:?XDQ]D;G  KVJQ
M_8C^(]G;XCU_PVY]/M@_^(%<_P"*/V/_ (QQP,MM%H.HCTAU"/)_-A1S+N38
M^4?$<F[7+,CG]U+_ #2H%;J.]>J:U^RC\9H=4!E\#2SR6\3,5M;B.3>K$#*X
M8YP5YQTR/6N,USX;^./#.X:QX(UVPV]6>RDV_GM JU)!8YVD^]VYILMT(&(F
MAG@/=9(B"*9]LMVQB9/Q.#^M:)DCR?4BHY#BGKM<?*0P]CFD:(M[T7 IS9Z#
M!%56Z^OK6B]N23QQ0ECG&?K2&4K=BLGIFNCT=B&STK.6P YSS6IIZ;&-0QG4
M6TV #FM**XPO6L**3[O/XU;\XJM9"-!KKGK5^SU".Q\/^*[QPSI#I?S*O4AK
MJW0@?@WZUS!N>35JZOEM_A[XT=O^6EK:0#U.Z^MV('X1G\J3V'%:H^I/AKX1
M\7_%;P/!XPTG2+2S\.7%Q):17%]?_O#*K;2OEHC'D\ U8D^%?CR/X\:+\*[B
M3P_8:QJFE/JPO \\\,,:[OE8;5;=\AXQQFN)^#?[<GA;X9? 7P[X&?1=:N+V
MPN;BZN)[=8E1W>1F3!9P< -Z=:I:M^WH+K]I*V^+5MX5E:2UT Z-'8W%XBG>
M=V9MP5A_$3MP:SYJC*]E#L>T>/\ ]GWQ#X1^%_C7Q;_PEELA\,VTCO;C2P5N
M)4X*JQE.!DCG'>M;X>?LX_\ "1?"WP+XGU3Q3J$U[XHMH9GMHA#;1VI< _*P
MC8LO(SGGI7SCX^_;VUKQE\/?%'A&+PU9V%AXB@,%S-+?O-)'E@=RC8HSQCGU
M-9VG_MS>/K?POX=\/V=AH2VNA6<5C:.8)G<(B@!CB0#<<#) YP/2E^\+]G'L
M?1NE?L[:'=?MF7WPPN];\1W_ (8M/#2:HX;43%,UPS+U>-5^7#= *Z[QU^S[
M\/X_@K\2]?.EK/J&BZ;<MI\QNI]R,L9V3',F&)(!Z8&.IS7QA;_M%?%74_B5
MJ7CRWNWC\1ZCIJZ3//:Z/O0VZX 4*0P!^4?-UJWJWQ.^-WBW2+_39;G7Y-.U
M&%K:ZM[?24@6>)OO(Q$0.#CUI<LNK&HKHCQ#17WZK9F4+)^\4GS5$@_$'(/X
MUWLT$44C2);+#R0[)$(XRPY4J !@51M_@SXL6163P_J<;*<AI)EB*GUR6&*O
MM\$O%DR@RV,2IZ76KQG]/,-3[-]S0;JDK:,S1W,JVFQB")#DAL=$]0>>3Z5Q
MWB2ZTR3RC:3*TI8F0J[[>O\ M?AC'O7?VW[/^L2M\\FAVQZ8EN&<_P#CJ-76
MZ/\ "B/P[HLUMJ5GX8U"X>Y65;R2&\:2- I7RPJ*@*DD,3[4>S7<-3YW^T1_
M\]%_.M/PYJ4.EZ_IM]/:-?6]M<1S26X0D2*K E>AZU[79_L_KY9>7Q2S(,Y\
MC321^&9!_*NGT_\ 97O]0 ,'_"57H(R/L^@.!CV.XT^2/<+,X:Z^-UK_ ,3C
M[#X3:,W=[!=QLRMQY?E]>%ZF,_\ ?56F_:0U_P#MZ?4;/P[:PB2W2W"2(!C:
M[-GE_P#;/Y"O4=-_8QURZ8!?"_CBXSSN>S6W4\9ZM&:W]._87\1W#J$^'GB"
M09P7O-5@B'UP"IJO=[D\OD?(>LZIJVOV%O:RVD,0C<NS>:HR3GH!G'4^M7M%
MU;4=&TZ.V%G:RE<[9&N6'!.<$!?4GO7VE:?\$^_$\SJ!X'LX%_O7>M.WZ+-_
M2NRT/_@G/J\BC[9:>$[ 9[B>Y8?@W!_.E[A5CX";Q-JJ[CY>G1YZ<2OC_P >
M%<_=75_--(S:VT1=R_EV^4120!P-W'  _"OUE\/_ /!/'PS9Q+_:>JVLDG<6
M&B6L0_ NKFN]TS]BOX=Z;&BD:C-M':6*'/\ WZC6ES4^P'XL?V=+???U"]N\
MG)&=V3^.:[;PWJOQ$T;14TG0];\<66DJS.MEIMU=10AF.6(6, <GDU^Q]I^R
MK\.K5@3IE]-C_GIJMSC\A(*UH?V=?AS"0?\ A%K6;'_/Q)+-_P"AL:.>/8#\
M7;CPEX[UXEKRV\9:AN_BO;J[(/\ WVPJK_PI'6YL-/X8.>[7EQ&/SWR5^W]I
M\%O %B<P^"]!4^K:?$Q_5:V[7P9X?L<?9M"TVWQT\JSC7'Y"CVBZ(#\/;/\
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MK":^BOA]I::)X"\-Z='.UU'::;;0+.R;#(%B50Q7)QG&<9KH*Y>9FY\_Z?\
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M*G>ISWK]1O!3^9X-T%O[UA;G_P AK05(VJ***1F%%%% !1110 4444 %%%%
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>nstg-20221231_g5.jpg
<TEXT>
begin 644 nstg-20221231_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" .,!X # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_/\ _$C_ ,)D_P#QRC_B+_\ V._^?_XD?^$R?_CE 'ZCT5^7'_$7_P#L=_\
M/_\ $C_PF3_\<H_XB_\ ]CO_ )__ (D?^$R?_CE 'ZCT5^7'_$7_ /L=_P#/
M_P#$C_PF3_\ '*/^(O\ _8[_ .?_ .)'_A,G_P".4 ?J/17Y<?\ $7_^QW_S
M_P#Q(_\ "9/_ ,<H_P"(O_\ 8[_Y_P#XD?\ A,G_ ..4 ?J/17Y<?\1?_P"Q
MW_S_ /Q(_P#"9/\ \<H_XB__ -CO_G_^)'_A,G_XY0!^H]%?EQ_Q%_\ ['?_
M #__ !(_\)D__'*/^(O_ /8[_P"?_P")'_A,G_XY0!^H]%?EQ_Q%_P#['?\
MS_\ Q(_\)D__ !RC_B+_ /V._P#G_P#B1_X3)_\ CE 'ZCT5^7'_ !%__L=_
M\_\ \2/_  F3_P#'*/\ B+__ &._^?\ ^)'_ (3)_P#CE 'ZCT5^7'_$7_\
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M_P"QW_S_ /Q(_P#"9/\ \<H_XB__ -CO_G_^)'_A,G_XY0!^H]%?EQ_Q%_\
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M[XD?^$R?_CE)_P 1?W['?_/]\2/_  F3_P#'*5F!^H]%?EQ_Q%__ +'?_/\
M_$C_ ,)D_P#QRC_B+_\ V._^?_XD?^$R?_CE 'ZCT5^7'_$7_P#L=_\ /_\
M$C_PF3_\<H_XB_\ ]CO_ )__ (D?^$R?_CE 'ZCT5^7'_$7_ /L=_P#/_P#$
MC_PF3_\ '*/^(O\ _8[_ .?_ .)'_A,G_P".4 ?J/17Y<?\ $7_^QW_S_P#Q
M(_\ "9/_ ,<H_P"(O_\ 8[_Y_P#XD?\ A,G_ ..4 ?J/17Y<?\1?_P"QW_S_
M /Q(_P#"9/\ \<H_XB__ -CO_G_^)'_A,G_XY0!^H]%?EQ_Q%_\ ['?_ #__
M !(_\)D__'*/^(O_ /8[_P"?_P")'_A,G_XY0!^H]%?EQ_Q%_P#['?\ S_\
MQ(_\)D__ !RC_B+_ /V._P#G_P#B1_X3)_\ CE 'ZCT5^7'_ !%__L=_\_\
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M_/\ _$C_ ,)D_P#QRC_B+_\ V._^?_XD?^$R?_CE 'ZCT5^7'_$7_P#L=_\
M/_\ $C_PF3_\<H_XB_\ ]CO_ )__ (D?^$R?_CE 'ZCT5^7'_$7_ /L=_P#/
M_P#$C_PF3_\ '*/^(O\ _8[_ .?_ .)'_A,G_P".4 ?J/17Y<?\ $7_^QW_S
M_P#Q(_\ "9/_ ,<H_P"(O_\ 8[_Y_P#XD?\ A,G_ ..4 ?J/17Y<?\1?_P"Q
MW_S_ /Q(_P#"9/\ \<H_XB__ -CO_G_^)'_A,G_XY0!^H]%?EQ_Q%_\ ['?_
M #__ !(_\)D__'*/^(O_ /8[_P"?_P")'_A,G_XY0!^H]%?EQ_Q%_P#['?\
MS_\ Q(_\)D__ !RC_B+_ /V._P#G_P#B1_X3)_\ CE 'ZCT5^7'_ !%__L=_
M\_\ \2/_  F3_P#'*/\ B+__ &._^?\ ^)'_ (3)_P#CE 'ZCT5^7'_$7_\
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M"?\ \*V^_P#E?0![%17C?_"7?'HS^7_PAGPGW!=W_(VWWT_Z!]._X2CX]_\
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M .A,^$__ (5M]_\ *^C_ (2CX]_]"9\)_P#PK;[_ .5] 'L5%>._\)1\>_\
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M)_PY_P!E'TW_ -(=1K^6^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$HHHK,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?VN?\$4#_QJ/_9S_P"Q TG_ -)D
MK^*.O[6_^")__*(_]G/_ +$#2?\ TG6@#ZAHHHH **** "BBB@ HHHH ****
M "BBB@#QWXF?\GM?"C_L7O$?_H>F5[%7COQ,_P"3VOA1_P!B]XC_ /0],KV*
M@ JMK'_(+N/]PU9JMK'_ ""[C_<- %FBBB@ HHHH **** *H_P"0NW_7$?\
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MB@ HHHH **** "BBB@ HHHH **** "BBB@#\D_\ @\W_ .43_AS_ +*/IO\
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M?_RB/_9S_P"Q TG_ -)UK^*2O[6_^")__*(_]G/_ +$#2?\ TG6@#ZAHHHH
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MK?\ K:Q^5O@K1?B#?_M<Z=:0ZA\/'\>?\+B\3?:+FZT:YET5S_PCNGEMEO\
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M ,HG_#G_ &4?3?\ TAU&OY;Z_J0_X/-_^43_ (<_[*/IO_I#J-?RWT %%%%
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MR>BM7Q1X,U#P=>^1?V\D+]BRD!OI657S52G.G+EFK,]",E)704445F4%%%%
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M $AU&OY;Z_J0_P"#S?\ Y1/^'/\ LH^F_P#I#J-?RWT %%%% !1110 4444
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M"2/8"OI*V4X'53J>:.GFDY:1/--!\._V;?(TC!-PXSWKJM4C6RTR269E8 9
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M*** "BBB@ HHHH *_M;_ .")_P#RB/\ V<_^Q TG_P!)UK^*2O[6_P#@B?\
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MX;,VG>!H6YAU!CL6YU=D;E9/,26"$\$1"1_^6P"^^52TV]/S_P R97=K]/\
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M^N5S_P"E4U:2E<D]EHHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _)/_@\W_P"43_AS_LH^F_\ I#J-?RWU_4A_
MP>;_ /*)_P .?]E'TW_TAU&OY;Z "BBB@ HHHH **** "BBB@ HHHH ****
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M7&=P[U:\37JS,PV[FQC ' KFO@?JMW?*;$R;87.WZ"O0]?\ A=YJK)8,\C<
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M0=?U#X9>,;A4N&\FY_=2^NWC_ 5W9Y&MA\'&=2"EJG_FF:5*E.5^5G=_$/\
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MB/\ V<_^Q TG_P!)UK^*2O[6_P#@B?\ \HC_ -G/_L0-)_\ 2=: /J&BBB@
MHHHH **** "BBB@ HHHH **,T9H \?\ B5_R>Q\*?^Q>\1_^AZ97L%>/_$K_
M )/8^%/_ &+WB/\ ]#TRO8* "JVL?\@NX_W#5FJVL?\ (+N/]PT 6:*** "B
MBB@ HHHH JC_ )"[?]<1_P"A&K551_R%V_ZXC_T(U:H ****  \BO$_!/[)V
MH^"/"GQ<L=/\97^DZA\2_$-WKUGJNG6R)<Z$\T$$2[1)O21D:'=EE 8-C'>O
M;**5ORM^7^0[V/DCQC^P)XZ^/%_=:I\2?&7@J;7+'PMJ_AO2KWPWX;ET]ICJ
M-N()9[TR7$C2A0JN(D*)N)/4+CU?QG^SC?:[^Q]>?#OPYKEKX<UK4/#<>@KK
ML5@&:%?)6)Y5C# [BF[;EOE)!YQ7KT_^H?\ W34.F_\ 'A;_ /7-?Y4N5--=
M]/S_ ,V/F:L^W_ _R/BOXM?\$5O"-QH&F6WPQU>Z\"W47AK4/"&HRWMS>ZQ'
M?Z9=6ZH(A'-<XB,<T<4J[,#Y6&.>.J_:"_X)<V/QU^+VE^)(_%U[H%G)X5U+
MPYKUG:6PW:G+<Z>;&*^20M^[FBB9E.0P=0BG[HKTCX[_ +0WBC3/C+H_PQ^'
M.CZ-JGC75-+EUZYN];GD@TO1[".18@\GEJ9))))#L1$ Z,S$ 8/"?&7]HKX_
M?##]F7Q/XRG\$_#O2]:^']OJ%WK%O?:G=36.MV]M#YT<]A)"ID19%#*5G0,C
M C! R3FNG+^NJ?YLJ/-=1CO_ )V_R1N_LE?L:Z]\%OB9?^,_%VN^&-4UZ3PY
M8^$[>/PYH9T>R^Q6C.Z2RQM+(7G9I",@A$4!54#-?06HZC!I&GW%U=2QP6UK
M&TLLCG"QHHRS$^@ )KY%^-G[3?[1'P8_91N/BA/H_P %;Z&QL(]2GL4NM30O
M'+Y814<H?F'F')(QQ5[6OVX_&WP4_:,^'?P]^)GA_P (S6?C/3;J\U37-!N;
MC[+HY-S!;68:.==S)+)-Y;L2 C/'Q@G&FKERO?\ IF<8Z<R_K9?Y'=?L/6-Q
MX^TSQ7\6M2C9KKXH:F;S2))!B2/081Y>FIC)"JT>Z?"$JQN2_#.U>W77_(3M
M_P#<D_\ 9:^--2_X*&^-M5\?:;X/\*Z/\-?#LTGB?Q+X>%WXEU*>"QCM](-N
ML941J/WDGG?=SA0G&:9)_P %%O'GBCP[\,H])T?X:Z/X@\7:]KV@W>I:UK$_
M]@-_9@8-<VDT:AI8IV3Y-V".0<D&HO\ H_O_ .''RZV]5]U_\C[4EC6>,J1N
M5A@CVKS7]GW]D/P+^S%?Z[=>#]*DL)O$,PENC).TN%4L5C3<?E12S8 ]:\3^
M'_[9OQ@^+R:YX9\*^$?A]KGBWPOXE.C:OXCMM9E;PG:6_P!B2\$X?'VAY?WB
MP-$@.R3)9@M>T_L=_M"R?M.?LZZ#XUNM-ATFYU#[1!<Q03^=:M+;SR0/+!*0
M/,@=HB\;D#*,IK>%:K&$J<).TK77?JKF$Z,')5)I75[/L>!?%?\ ;H\::5^T
M-\4?"]AX^^ /@/3OA\UHEM;^,A.VH:F););EI/EO(0J L4!6-NG<\5E/_P %
M(/&GC3Q/\/[&WUCX1_"6+Q5X @\873>/!.S-/)<M"8(/])MOD"KO!8%BK+D"
MM[QC^R/\.?CO\=OC1X1\3VNE^+[KXJ6EEJZW%GIL<TW@^&&U6WMII+IB?+E>
M>!I( G),#G&%)JK>_L5_&A_'OA/Q=JE]\%OB'XFTSP:OA35YO$FE72PWDD=V
M\J7L2H'V/)&5\Q>F_.TXP*Y8J2:4_G]S_6QM+57CV_5?I<E^)7[;/COPC\2/
M /A*/XB?L^Z7_P )%X7N_$%UXGU2.<:1J+QW4<4<5DOVY.-DFXDRN25)  Z2
M>!_^"AGC#QQ\,]-TO2=+\'^(/B)XA\;7G@S1=2LY9T\-:G':Q&>?5H^6D:WB
MB# QI(Q:1"JR8.X=KHO[%5UX\^+?AGQ9\1-(^&]Y!I/A"]\-76@:?I9N--#3
M74<JO )U^5/*3:P*Y)8]JY+P7_P3L\6?#3X>Z/H>@^,-(A;X4>)9M7^%TLUD
M[C3--EB='T>^4$>9 %D>%9(R'6,1GEDPUQOU_KWO\NWYCZ_U_+_G_5CTK]E#
MXV^+?''C/Q=X7\6:M\+O$5QX<:-H=5\&:F"KEV<2V]S8O-+-;2Q.N,LY5PW&
MTJPKW"2);D;7567T89KYY_9:_92\2>"_C[XI^*GC2;P-:^(_$6E0:''IGA'3
M7MK&&"*>6<S2RRXEGGDDE;)95"A0!G)-?155V(MJUT*.L>(M/\.K";^^L[(7
M4@AA,\RQ^;(>B+N/+'T'-7@<BOG?_@H3^PA_PV[X&T^WLO%5]X3\0: MQ+I5
MW'$L\"SNJ[3)&>H#HF2OS!2X&"01[%\']7U?6_AOI,VO:/-H.M)!Y%[8R3)-
MY4L9*,4="0T;%=R-P2K*2%.0.BK3HJE"4)7D[W5MNVO6YC3G5=649QM%6L[[
M]].ATU%&:,US'0>:?M8^)/"?A7X36]UXTTB76]%;Q#HENEM&NYEO)=4M8[27
M[R\1W+0R'GHAX/0^EUPG[1?C/5? GPYAO]%\-'Q9>-K6E6C6 C:39#-J%O#-
M<856/[B-WFSC \K)( R.[S0 4444 %%%% !5:U_Y"-U_P#^56:K6O_(1NO\
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MFD:3'/9W$D<;+A222HR.AYXS7T^,HK-<!.+7OI:-=S"5%4YW3W,SXI_\$_\
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M=%T[7Q'HNK/JUH;6[\Q%BDD:*)H[A'AD#)M*LN&5B#7 _L_>"?VA?V?/V?\
M4O .E> _A^UYIT.K2Z+KT_B^5X9;B:XFGMC-;?8PRIF10V)#C:>N:K_ ?X8_
M%O\ 9V_9J^(EY'X+TJV^(]Q9?V_/K[^(6\3:AXUU*) TB21BWMQ'NCC,,,:$
MI&'0*N%.YQWU[$RLEIW_ ,CT[X[?!GQD/CIHOQ2^&IT6;Q18Z3+X>U+2?$$L
MUM8:M8/*)DVS1)(T,T4HW!O+<,KLIQPPQ=8_9_\ B;\4OV6?BUX<\;>)M-O/
M&'Q.L+VUM+6TCE.B>%TEM?L\-M"S*)I$'^LDD90SN[D(HPM>U_"+XKZ-\:?A
MUH_B30[ZSO;'6+*"]C-M<).L8E0.%++QD9Q^%=-1R63B_P"KZE0J6:G'^K'A
M?[1_[/.K?&?]A_5/A?I]S:VFL7^C6VFI=W$;_95>(Q$L=H+;3Y9Q@9Y%4_BI
M^R:WQ>_:/M?$NKM!/X3D\!:AX/U"Q*NMU*]S<02B1"!@*JQ-SG<&*D=,U] 4
M4]W=_P!75OU",G%)+I_P/\C\\?#O_!,CXD^#_P#A%+W5K'X4?%Z_T'Q'XFU6
MZM_%D<\%K>Q:DT MYC_HUP/M*)!^\^3!9R5..*[#X;?\$P8]*U_P%)XFT?P+
M>Z#I/B?7O%.I>%%TXWFBZ6VH6L<,=KI\<L87RXW4R$LD?S2N55<@5]O56N/^
M0G;?[K_TH6G]>G^0I._Y_??_ #/FW]KS]F;Q9XO^$_A[P)\(M%\&^'? [7\D
MGBC0Q<S>'4U:S*D_9(I;.WD,22R']]M56=-RAAN)KT'2OA=J7B_]EE_ FN:7
MI?@>ZNM)?2!;>%;B2>STN+:8XQ;N\43;53;P47'(]ZT_VIOC.WP.^#]YJ5C'
M]L\1ZI-%H_AVQ&-U_J=RWEV\8!ZJ&.]\9(CCD;!VXKF/V%=/^,&F_#34$^,E
MQ;7&MF_8V91XGD6#:,[C$ A&_=M[[<9KLP])QIRQ,9I.+6CW;\EU2./$5%*I
M'#RBVI)ZK9>OJ)^Q/^R7I?[&7PUO-#M;BZUK4-4O&O+[4GL_):<[0J1@9)6-
M%'RKD@,[D8+&O9?[2_Z=[K_OC_Z]>#_M"?\ !0;P]^SG^T9X3\ ZSI-]M\3>
M2'U8RK';6?G2F&/(;[PWCYSD! 03FOH('BGC88AR6(Q&]3WD]-?/06#J4%%T
M*#TAIUT^\J_VE_T[W7_?'_UZ/[2_Z=[K_OC_ .O5K-%<1V&?I=_MLP/)N#\S
M'A/]HUXQ^WSX4\0?$WX&1:'X9U#3['4[[5;7_B5ZEJTFCQ>*8D8O)I8NH\RQ
M-.BD90$D*0?E+$>W:3_QXC_??_T(USGQF^"/A7]H+P--X=\8:/;ZSI,LJ3K&
M[M');S(=T<T4J%9(I48962-E93T(J9QYE8<7;<_/W5?$X^%OA_4O!NGZ'\3/
MA;KUMXP\&ZE<>#M1UY-5L;"VN=0\II["\AD=FAG>.1)8WDP&C/R*&.?I?]LJ
MYF^(G[0OP=^&>IWVK:;X'\9-J]QK45I-):OK;VEO&\%B9T(=8W\R21D5E9Q#
MC. P/5M_P3S^$UQ\.]6\,W'A_4+VQUR[MKZ^NKK7M0GU.XFMGWV[&^><W0\I
MN4 E 7)P!DYT&_8>^'-Q\+YO!][IVN:KHLE^FJ1MJ7B/4;Z]L[I/N36]W-.U
MQ;NO8Q2(1D^IS4K/?O?\$OPL*.COY6_/4\2^(7Q$\&_\$\O"GC+0/ FO^)+C
M5-1N=-2W\/W*7FNVG@A[WS8UO65$EN([9O*DE:-F8%X\*$WU\M:9^W%-H?\
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M] L54G7G4JS=Y3Z_?_F7AXPHPA3IJRC_ ,#_ "-'X(>"_"OQ<_8X^'>C^)-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5O&^F_$Z;7M;^(GQ&^%UW!\.KUM(72=/CMF=3J&G3B%=L=Y(T<+JTC#=!(H
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MP)/?_@(F7QMK;_APHHHH KZ7_P >K?\ 723_ -#->1?\$^O^3/O!?_7*Y_\
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M/X3^ ?C=X/UZ'7M:T.YGO/#%CI$,M[>>,X&A=;S2H8(E:0NZ+DDH3#) I?8
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MGPQ.T8^8C(KI+_\ : \'Z7XN\3:'=Z]96>I>#M,@UG65N<PQZ?:3>;Y<SR,
M@4^3+_%QMYQD9_-O5/@_XT^+7[2VL:#\0O"6N7WD_$'PEH>KWZZ?-]CUNV@T
MC58FU"*3!'ELLL+,V?W<K%2<@9]>^ ?P9UKQY^T)\?\ P?\ %/PK<:]8Z5X.
MT'05O-2L'FT_Q7';2:A+;SHSY69]C0>:O.)0P(Y%)M<LFNFWGHG^I3A:U^R^
M^]OR/J+Q'^V+\-_"'P C^,.H>*+6W^'-QIEOJ,6L^3*R2P3,!$ZQA#(V[<,
M+GGI1\:/AI'\;O#7AKQEX/U.TM_$_AMUUGP[JB@M;WT3QG?:S%<.UI<1MAE4
M\,(W )0 _$_A3X??$#XL? _]E'X5Z/X&L]0M?"WA6'Q?XGM?$\EUI.FL883:
MVEE))';RMYOFS/+Y)3I I.!BO0/V#/BO\1_A2OP5^#7BBW_LNZ\.:GXE\)ZT
MC022Q:G;Z?;)/I\UM/*B,\7D2Q?.H&XJ00""!>G-+R>GFEH_Q,Y725OGZO\
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M%-1L["Q\/IK-[<W,GB.\A$GVG6(1<,TD<,JM#&K' F,)D"X(+?65U_R$;?\
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MH **** "BBB@#\D_^#S?_E$_X<_[*/IO_I#J-?RWU_4A_P 'F_\ RB?\.?\
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M%S?7-UY<+.NX0KN(+8/!)X/M73?M:>--/%SH,=LTD=HJ*)H6.5=P "P';G/
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MC=+ME@;&?[P[$?7K6;7S52G*G)PFK-'T2=U=!11168!1110 4444 %?VM_\
M!$__ )1'_LY_]B!I/_I.M?Q25_:W_P $3_\ E$?^SG_V(&D_^DZT ?4-%%%
M!1110 4444 %%%% !1110 4444 >/?$O_D]KX4_]B]XC_P#0],KT2V^)OAN\
M\92^'8?$&BR>((5WR:8E]$UY&H .3#NW@8(.2.A%>=?$TX_;7^%/_8N^(_\
MT/3*^,-'T'P[\(KC0_%ENOPN^+W@=OB'!+I^OZ9)/H_Q#T^_N=2:)TFQDWK0
MS2[9(W:(O"KAHR%%)/WU'N$E[O,C]*=/U2UU:%I+6X@N8U9HR\4@=0RG#+D=
MP1@CL:P[GXE>'=5UR_\ #]KK^BW.O6D3//IL5]$]Y"H )+1!MZ@9'4=QZU\J
M_LC>)+ZR_88^*EGX4OK8^-!K?C%M(MK:9/M#7@O;PQ;$SG=OVX!]JR?AAI7[
M-WA3]F7X+^))K/2[KQ5<7FFII5]I8W^)[W6Y"$F$KQD7$C^8TQN$D)4*LF\8
M7A1=[?+\1R5KKS:^X^W&U.WCU".U:XA6ZE1I4A+@2.BX!8+U(!(R>V1ZTS3=
M=L=9DNDL[RUNFLY3;W"PRK(8)  2CX/RL 0<'GD5^9$G[3VK?"W_ (*(ZG\6
M/B5X,^(GAF^M/AQXE<6NJ6T*Z;IEA:7EI]EA@:.=][2M@O(%RTMU&N-H&,;]
MC'XH^//V._B%K4?_  K;XC3^,/C!X(E\2OI^M6=O:'Q%XPMI&EN4MO\ 2&#9
MM[I,AF0E+/UX!&[BI=TW\[O]%]]ARC;[U^E_S^X_5.TU*VO;FXAAG@EFM6"3
M(CAFA8@, P'*DJ0<'L17&?M(_!=/CW\']6\/1WC:3JLB+<Z1J: ^9I5_$1);
MW"D$,-DBKD*5+*67(W&OEC_@CM<W5EX]_:'T_4-+\=6^J?\ "8VNH:E?>)[2
M.WN+V[GTJS:8[4ED"#=DK&/E2-HP.X'W"WW3]*N2LD^Z3^]7)ZV/,/V6OVCK
M'X^_!?\ MRZDM;'7/#\\VB^*K%90W]B:K:X6[MG(X^1OF!!(*,K D$$Y'P^_
MX*'_  2^+'BS3]#\-?$GPUK6JZK(8K."TF:3[2P!)V-C:>%/(..*^(/A5^T9
MX)_9A^*GQ6N[GQOX9TUO&WCWQ'HWC#1+O58TNK/!D.G:FL#,&CC!W0RNJD,L
MT+D8C9QZ#_P3+_:*S\'?A?X:U#]HCX.ZH#H4=D/!=OI<=OK@D$+!;?S3?NWF
MICYOW&3M/RK65.3E'F?9/[U?\"JB2DTN[7W,^C]"_P""D'P-\3^()K73?BAX
M8OI(897:.WF:0 1;C(V0NTA0IR03]TUX7\8/^"B_P-\7_MF_!/5-.^*7A&YT
M_P +Q^(Y-7G%WMCTU6T^+!F) \O.0?FQP0>E=1_P25\*_$JP_9G^']YK'C3P
M[>>#FTF8VVAQ>&)+6^M\W$H3==FZ8-MP<_N5W>U>8^'_  S:>-?^"F6O:+K%
MFM[I.L^-?$%I=6LZ;HKJ%_".E(Z$'AE()!_&M-=5Y7_%+]0LOQ/NVY^+GAFR
M\;:+X:DUS3%U[Q%:37^F6'GJ9[VWBV&25%')1=Z9;I\PJWX,\?:)\1=,FO=!
MU:PUBSM[J:RDGLYEFC2>&1HY8RRG&Y'5E([$$5\>_P#!,[]FVUN?#OQ47Q-J
MNL^)+C1=5O\ X6Z3=W;M#=6/ARP<K;VJ2J0^X^:Q>4$,Y5#QM%=Q_P $C?!&
MF_#;]E;4O#^CZ?'I>D:+XU\2V=C9HI"6\$>KW2HHW<D;0.3DGK0OTO\ U\FO
MF2XM)OL[?@_U1]15B_$+XAZ/\*O!U]K^OWT.FZ5IZ;YII,GJ0%55&2SLQ"JB
M@LS,  20*Y+XM_M6>!_@U>#3M2UA+[Q),PBM/#VEJ;[6+Z1AE4CM8\R<Y&78
M+&H(9V5>:POA]\$=?\?^+['QU\3KQKC4K1_M>B^$X6CDTGPK)@A9-P4-<W@0
MX:9V*(Q81*@RS5*+CNB8R4OA9CCPCXE_;%D6_P#$B:IX3^%;',7A2[LS;:EX
MF08(DU#=B2W@9O\ ETP&=1^](#&(>I>,?A+X=^*_@_3=)\0:5;ZAIUC<6FH6
M]N28XX9[=UEA<!",;'52!TXQC'%?F7^PE^TO\<?VD?C_ *+X"^)'B?Q=X5^&
MNMS:M<Z#J[2)9W_C*XL+^0-:6]XA\U8T4;G4E7DC3Y<(&S8^$/QE\5?%;Q=X
M)L_%&H?M">,+.3PCJMX;?P%KD]K,LZ>(KRW26X,=Q!N A1(UR6P%Q@=:NM1Y
M'!)I\ROITTOKYJPJ<G)3;37*[:]=;:>1^G7Q%^&^@_%SP9?>'?$VDV6M:'J2
M>7<VEU'OCD ((/L00"&&"I (((!KS#P]_P $]/A#X=T7Q!9KX6EU,^*;:*RU
M2[U?5[W5+ZZMHI%DC@^TW,SS+"LBAA&KA=W.,G->6>'?">I?M#?M"Z_\-[SQ
ME\2/#/@WX:^&=&GM;.S\07-CKNHW5\D[M/>WJ/Y\AB6(1A/,*ERY;<0N(?C[
M\.?%>G_LX'^S?BU\3/B%>> (=1M$M_!TUO::YJ>H*X6U-[/'*H?[*,+*C +(
MWSR(2-AP<K:FJBVU'^M=3Z8^+GP2\*_'GP#-X6\7:/;ZYH%P\4LEG,SJCM$Z
MR1DE2#\K*IZ]J\O\1?\ !,GX'Z[IIA_X0#2[6X_LB]T+[3:SW%M<2V5V/W\$
MLL<BO+&QP=KL=I'RXKOOV6O'MQ\4?V;_  +XBNM8TWQ#>:QH=G=7.I:>A2UO
MIFA4R21J0"JE]QP0".F!TKOJZ/:5*:=)-VOJNCZ:HY_9PG:;6JV?5>A\K?\
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M_P 8S>$_!OAN[DGU6TGNI&FO':<-),^!B<N@*;'PHZCJ:^N0=J\U!IAQ9_\
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M[P[?P:W?1'$EI9M;N)I%.UN50L?NMTZ'I0!W&D0-:Z5:QO+Y[QQ(K29_UA
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MHHKS3T2H/^0ZW_7 ?^A&J5E\/]#T_P 6W.OV^CZ9#KEY$(9]02V1;J9!T5I
M-S 8'!/85<3_ )#1_P"N &?^!&KE4I26S)E&,MT<9\8_V??!O[06G6-GXRT"
MQUZWTVX^TVRW .8GZ'!4@X(ZKT/&0<5U]K:1V-M'##&D4,*A$1!M5% P !V
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM:W_ &-/#7AN[G\-:CXB_P"$@OY;4"VD$:P!3D_,0<N=PVI@;L'D8KT'P/\
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M/O!?_7*Y_P#2J:@#V6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/C'79KE?M$L8^50Q+<#_ /51X1U"YT;65MFB=5F'!88KZ'A6OB:#B\4F[O\
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M=YFYF'I7T?/2=_9:IZMCO)0YJGW'.ZIX+O->U5KA?WGDK\JGL?\ (%=K\/?
M5O?Z[8W5Y<7>R,".2-/E*GC(Z=\5J_#.PF?5&)!:W50[N1A4X. 3TKN?%4.G
M^&;./4%NK7;&"\I619 QQ\O0^E?EN/P>2X[&4ZE+$RA6YK.VEM^K5D?&9GFE
M.=5482UD[>AYE\<O#>F6EK=:?;WEW=6-U(I2.1@ZI)MX4X ZC)XKD_'_ ,'I
M/AE\-62'5IO+O6!DMT^Z[>G3I@54FUB;Q5XM6&":[ATI9OM$Q 91(PR!M_ ^
M]>A>/+_1[[0(_-FN)Y(P JRY93^G6M>&>$*/L<55QGOMM\LI=EU]6>UE>'E0
MI1A4=]3SO2]$T^R\(+!&%;<F23W-;/PR\6>'?#16.XLH7=N"[CI^-8-WIW]E
M685=S+(!VKE]3L;B3S!;JQ56/&W=@5[,L8\/.$Z<5>.EK'KUN6<4TSUGQ?XT
M\/Z5JL,UBR+/*<NL? '(QVJS<ZY%XBL=S(NYA@$5X;I%NUQJ\,+#]Y*ZJ,>I
M->O1>";S2M)(696DC3>4[@?G]*][*<UQ&)<YJFN7L+D@DKZ=B3Q?X.MSH\D,
M<V^8KDJ/SR*\+,,T5RT<O!4U[%>^)KJ&V^6#SBJX3!P0:XP_#J\O(FG>15+<
ME2O)_6O%XDHQQCC]5B[VU.B/-L]6<SI=K))(L:KYC'LM=/X?U9M##^8&1A]U
M<=ZF\!6;Z7?3VSPK)-W;IMZUOZQI4>GIYT@5VD].U>;EN5U*%+VJ;NMS2,;2
MNSSB[U62]UB:9@48MD''%=9X(\>2>!-6AU2./>Z JP'<9S_2M?1?#5OKMF[?
M9UD+.%Z9('-9EW\/VA%W;-YGF1D; >N,9Z=ZX\\X:J8W"\R5[['/B\/"KJOG
MZ'TO^Q5^W9#IW[1NBPZT%TWPO+:&R:5E9A"^6<.V,]>%Z=Z_17Q<-!\9Z-!<
M6FO1RZ?&PEF@AG7;,,@@$$9X(SQZ5^1?[/?Q+\,>';VWT/Q!X?M7$DV)I611
MN&.^1T_^M7UUX)\>^#6\2_V?9P:98V]PT=G:R!%CC.U\AM_ YSZ\]*_EGB+@
M+$XW&3KX>$HRHQ;E9)KE6[/@L\E]6O2H8=V:Z?G_ )W/L63Q&)H8([&Q*V<T
M2NKN!M52...M?%O[;O[ ZZGXQ/C#P+MM=6O0TEU:@86Y?@D@<'DDDG/>OMGP
MUIVI(D6GWTEJ]G$B+&R+\S$=><].!Q[UR7QNT74='^)_A?4M.A%PMHLL5Q;J
M/]:C&/)_  _G7YIPOGV)RG-%4P4^62N]]';74XY5,12H_6H2<6K+;:_2RZ'Y
M3:UK>I6&NW7A?Q%"UC>6J[6A8XZ@'(_/]:Z3X?VW_"CKFWU/P_,8KY2?,E./
MWBG.1].E?<GQ*_8&\)?M*^)[SQ1KMO=6.K7*;"(Y &C*X4$\9Z*/SK\]]>U#
M5?#7Q$U+P[<6LFH6VBLT0EBA9G8<$,<9Z9Q7]A\&^*F5\1P> S:"YU&TI2V5
MSZG+,V]O!<RY6E?LGYK7\SD_%&MMJWCZXNM'MI-.M[R3+;/E$GKCV^M>G^$O
MB''\-(5O(K>2]W6\L$MO(P*N70H#VZ%LUYMKOBRU6Z"Q^=OA;<V]64K^!'%4
M[WQK/K<"K;1NR[@2P''!S7W^4X?+<!AZN&PLE/F5KK70^@<H22:=SIOAOX<7
M6M5F%W*UJ]\SSPMG$<3$D[3WQR*U/$6E&UD:U\Y)BOREE! STJAX-\1QW]]#
M;LAVKC?D?=KMO%]_I]I;VJQPPN58,V,< >OUKZG*LMBZ?/3JODM9KIH<LIS5
M:Z=UV.*U+PU;CP=)'<-,?G"KGD!2#G]:N:7^R3'XOTRYDT75;>::*+S%@;(9
MCQP,@4SQ]XT8V"BVC3J. ,Y->_\ @+X%:'X6T70-=U;Q(UC=:A;_ &@16JEO
M+.6&#M)].GO7Q_$V58.IBO88=RC)Q;7*KW:U=S:',G>1\/WGA35-,U22WDL;
MA)XSM*E#D&O:/A7X9COO#"C4(QYF-GS]5XK[ T'X3^&?B"^M:EKFDW$>I26J
MW&F3QL%M[QBQY<;3M.,_>.:^=OCN;KX:^%]0FOM#2T^U?ZFXMP,*1V+#/7-<
M_!>99="E4J5')3CI*,THZ_W;O4TJQFM%UZH]#^ ?C#Q1;VWA_1]+OMEGI>J+
MY3!L!=\H/S<\@8_*O?&^*MC\ /'%WIUOX^:XCUX+]M\A'$-LS %MPV\X)/3-
M? _PL^+=QIW@U6L]0F6^,GF- =P .<CGI75^.=ME\"H_%][J'G76I7)B@MQ_
MK."X8GOC<OIWKR^(<MX>QL72QU)0A-N,5&*O*4G=-NW3?L51JU82M'<W?V\?
MV6M,T[QVVN:3KME?6FJ.LD?V9OD<XY^4\CH>M>3WG@A=7\.3+"R6\UOAE*C#
M*01@C^55/"&IS75M'>:E=21PS9,<..@Y_P *GO\ XAQZ86A$3$,P223/)]!^
M>*^IX+R*GEF4_5\QJ<[EIJDO=V6G>VX593DWRHAT;6/$?B3Q=:_\))(TTT,*
MVMO.QW+M&?YYKMOB-X=N-*\(FWCAC:&5<2-_M'_'FLW6M%U,:%"EO$UPM]L>
M-4X:,Y!#9[8X_*L'6O%?B;1M8.F^(&W0PH'5MVXM]3GFO;RN,<MA/+W2<:5_
M=DM4T_R.##PDY\L4DD]%Y&-X9\)WGA&Y>6.\FM;.ZPLR*<*R]\UU.O3V,=HS
MQ2QK&H  !^\:X;XC_$O_ (2#1FT^SW(&/[R0G#''&*XJUN)C;?/,TF.@9NE>
M)B,\RS+*LZ6$@I.2UEYGH.3DN;JB[KTDEQJC-N#H>5 [5U?P,U.:#Q&VGK,L
M9OR$"N<!S6/\,DTV?6)!J=QY,87Y2R[ANKZ-^%_[%Z>-[>UU)L36MWS9K9C_
M $AVQE2 ,D<X/3L:_.\ZXFH9>GC_ &JBUM%]7^HXPE.>Q0_:R_8;\9_ [2]#
M\1:=875Y8ZU81WDDUD/,6$NH8YVYQ][OTKP/PWX&U;QMJ)6+S&EW8<O(!L/O
MFOTR_9LOOV@?V8M.\3>#?$MYIFJ>#[[35:!=;<7,UM#(D@PA,@VL%QGC/ X%
M>7^(?A=\)?!FG:Q>:7?1S>)+RW:7]_,LMIYK EAMP A#' ):OR3*/$_-JM65
M#$.-2\ERR@VTTWU72WS/2K8*"5XL^9[+X2:I\$[6/4M1;[8TV/LZAPR;O?!]
MJJZKXOOO&FL^;?>9)(F-I/88Z#VK8UK5M2M[BWM]3FDFM8W/EKOS%%D_P]AW
MJ&+5[/[9;^=Y>[.UV ZC_.*_J/A3*ZZPRJ8RNI3OTVMV1Y+J-R;2+.IZMNTM
M4\O!5>W>O)K+P%>>,/$UQ+-)Y:22%5"]J]V\6WNE7NBQK9K#N7G(')KS>ZU.
M;P]<F:(JFTYP/YU]+GU.E4E3^L:P78G#27*U;4I^&/A@OASQDD=S)YD(^Z&X
MP<_TKTG4/BAH/@FV"WRQ33PH514&2/\ ]=>2Z[X[N_$=P_EM^_QU)[>QKSC4
M;B\AUIA<LS;NA)KY7'<14LIH26"I73>['+#^T>I](>'OBNOC+0/)6VCM97W8
M/8INZ]:X'XA>%[_3;:10/W,HW COU_PK.^!^N6][J,\$\Q$BIMC7L1P3FN_\
M;WC/INY8R\<:[8U R4%>MA<=2S3*?K51ZQZ_\ RC%4IVV[GS[86TEIK$87*-
MNP/8U[=9ZI/#X09;R1ON9P>=W%<'X?\ AS=Z[?37Q=4B\PX)Y+'\_I75:EI]
M\NCM9I;22C>?WCC ;D=,UY>4PJ8:,ZBO:2=O,ZY2B]6RA#&WB33V7A P(ZUR
MWC#X8_VKH%U:W/ER2$;H' Y5QTKTCPK\&M:O? ^J:TWEV=EIQ4.6E4'D,<CG
M/\)K6TW3--CL#Y\<;Q>3EII"#D\?GWIX/"TLR52@Y*\-))^>NP1Q+5FCX;O[
M"33;MX)5VR1G!'I4->I_M"> OL6HMJUK#LMY&Q)C]#_*O+*_(,QP<L+7E1ET
M_%'TE&ISP4@HHHKA-0HHHH *_M;_ .")_P#RB/\ V<_^Q TG_P!)UK^*2O[6
M_P#@B?\ \HC_ -G/_L0-)_\ 2=: /J&BBB@ HHHH **** "BBB@ HHHH ***
M* /&_BFZK^VG\*]Q91_PCOB/D#I\^F5X;\&OB%\2_P!D?X!0_!W0_A1XF\2>
M-]!GGT_0-<6U"^%=0AEG>2&^NKH.#"JI)F6+!DW(57.Y37NOQ+_Y/:^%/_8O
M>(__ $/3*]AZU/+J/F=K'R#X1\:>+/V)_&?Q-TZ;X9^-?B#'XV\03>*M#O\
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MGC7Q-X)C\+V<-[J?BS3IX;VQUGSG\RQMVFBC9(%B 9H8P84<C:1DBM'XY_\
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M_/0_]\'_  H_M>W_ .>A_P"^#_A5FB@"M_:]O_ST/_?!_P */[7M_P#GH?\
MO@_X59HH K?VO;_\]#_WP?\ "J]OJUN+^X^<\[?X3Z?2M&JUK_R$;K_@'\J
M#^U[?_GH?^^#_A1_:]O_ ,]#_P!\'_"K-% %;^U[?_GH?^^#_A1_:]O_ ,]#
M_P!\'_"K-% %;^U[?_GH?^^#_A7)?'W4?$MQ\#O&"> 9+<>-FT>Z&@FY4>2+
M[RF\C?O&W;YFW.[C'6NVKB_VCO"5]X^^ 'C70]-\0_\ "):AK&B7EG;:WYAC
M_LF22%E6XW*RD>62&R&!^7J* .DTK5/^)9;_ &I_])\I?-PIQOQ\V./7->+?
MMS?M(>./@#X&T?4/ '@Z3QA>7U^+>Z7[/-,MK'MR,I'\V7/RANB]3FO<=(@:
MUTNVC>7SWCB16DS_ *P@ %OQZU8(S71A:T*553J1YDNCTO\ <88JE*I2<(2Y
M6^JZ&1X;\1MJ?AVQNKRUDT^\N;>.6>U8%FMI&4%D)QSM.1GVKYO_ &D?@'\'
M/V^OBJNE7'C*9?%W@F%[>ZMM)ND,T<;L"5=61@=K=2O()P>PKZG(R*^:_BA_
MP3^T_2[3XA>)/AC>7'A?XB>-8&1=0DNY/*MM\RRSK'C)B\XKRPR5)R,=*[LI
MKTZ==U.=TY?9:V5W;7RL<.:49SHJ'(IQZI[NW;SN=?\ "G4/AG^QOH/A/X4P
M^);>SOKA7&G6NH7(-W>L[LS,>  6<M@8 )X%>L7-Y:WEO)%*!)%(I5T:,LK@
M]01CH:_,O]C3]F#Q!K?_  4!NK'XIV/B77M2\))]M_M*6662UDGA*>0[32 -
M)&<Y0 CE>1@$5^H.,+71Q!@Z>&KQ4*GM)27-*72[UT_X)AD>*J8BC+FAR1B[
M)=;+N><_"/PO\/\ X4ZKJGA[P9;:!I+0_P"EW^GZ=L$L4CGAY(URRY&,9 &.
ME=9XJ\90^%_"^I:DMO=7O]G6DMU]F@C+2S[%+;$'=FQ@#U(KP/X&_LX_#GP1
M^VWXZ\5:'XR;5?&%]$\FH:+]KC<Z:9G5I"P'S$%E& WW <=Z]$_;'TKX@:_^
MS]K5I\,I8H?%5PJ1Q,95CD\HL!+Y3M\JR;<[6)&#W!Q7/6H0EBH0YV^;ENY7
M6^]WV\S>C7G'#3DHI.-[*-GM^OD>%?LC_P#!1CQS^U#\=K33Q\.VTOP/<6TQ
MFU%?.F-E+&,_--M$9RVU-@&X%LY.*^O_ .UH#_$W_?!_PKY'_95T_2?^"9'[
M/UG#\6/%T>GWWB_4C/'9'?/%82%1NC38&)P,-))PNX]>A/OW[0?A&W^.?P7U
M;PC8^)ET&Z\66+1V-[;RCS&'#90 @LI'#;3RK'GFNK.*&'EBU]6CRT;V4E=I
MVW>N]NMNQS976K1PK=>7-4WY79-7V7E<ZG0_'^B>*?M/]F:I8:C]CE,%Q]EF
M$WD2#JC[<[6'H<&O'/VZ?'GQ<\,>!]%D^#>F0ZIJ4FH!-1#6ZS21P[3MPKD#
M:6X9NJC&,4S]A/\ 85L_V,M U;_B>7.NZQX@,37TQ3R;=?+#;1&F2?XR2S$D
M\>E>_GI7#.6'PV+O0M5A';F6CTZH[H1K8C#6K7IR?9ZKYGS;\9_V-&_:%^,O
MPY^(&L>*=2T'5/",,#WFFV2&2"257$K")\_N\OE6;#;D ''6OH/3M4A%A#EC
MDH,@(>/TKR[PI^VUX)\:_M)ZM\*K.74?^$ETE)#([VVVUE>,*TD:/G.Y0P)R
M #S@FO6-)_Y!=O\ ]<U_E4XZIB;0I8A627NJUM'J/ T\/>=2@[MO5WZH\K_;
M'\8_$#P]\#-1NOA79IJ'BQ)8A'&8!+(L);]XT:-A7<#H#QC/I72_ CQ+XDU/
MX.>';CQQ;PV/BR:QC?5(($.R.8CD<9 /3(' .17;T5SRQ"=!4>57O?FZ[;>A
MNL._;.MS/:UNGKZE?^UK?^\W_?!_PI/[4MQ_$?\ O@_X59HSBN<Z"O\ VM;_
M -YO^^#_ (55NM5A_M"U^9OXL_(?3Z5I56NO^0C:_P# _P"5 !_:T']YO^^#
M_A1_:T']YO\ O@_X59HH K?VM!_>;_O@_P"%']K0?WF_[X/^%6:* *W]K0?W
MF_[X/^%']K0?WF_[X/\ A5FB@"AI>HPF';N.6E?'RGGYC7E'_!/K_DS[P7_U
MQN/_ $JFKU[2_P#CU;_KI)_Z&:\B_P""?7_)GW@O_KE<_P#I5-0![+1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'Y)_P#!YO\ \HG_  Y_V4?3?_2'4:_EOK^I#_@\W_Y1/^'/^RCZ;_Z0ZC7\
MM] !1110 4444 =5\'O +?$CQU9Z>=RP9WSL!G8@ZG]1^=?8'CW^S=(\)M%"
MVVUAC 2%8]OE^P_'^=>4_L^>"%\$>&;*9K>4>(-68RB.1=NV$$C'7OA3TKTO
M7XS/-Y-W T:L.CI][_&OUCA2>%PF!G0<H^UJ*]M]'L?(YICH5<2J-]CRG3?M
M.O:PBV:LK;L#'&,5Z+XOUM],^'T=A>,MW=28;>_SLG3N>E;'@;0=-T>:21DC
M4OG!5>:R]?\ !_\ PD&LR,K/Y.?O'T^E=$N#8/!WE'FG)Z>1S.3O:/0\[35)
MKN6%97;RHR!MW?*!76>']*BFN%FMY-IC'RE3UJOJ_@M=(D;8-['U/6M3P9IW
MD1M*L>P-U!:JRK*Y8::HRBM#94Y/WF;7BC7KB+3%9I&D;&,;LXJD?%WB;6?#
M<D-K<WEM#,!O6,L@<>C8ZCBLS6]:CBGD6ZD6&.,_+D\M73:7X@A6SCCCDC\G
M'/K7OO#T<PK.&(GHA3HJRY=T<QX,^%-WXJ\Z:_DCACCP>3RQ-:/CGX.6'@ZU
M@N(KJ19)$)**YR>G!YZ5O6.IWD!D_LV)KAS_ ,LU3=T]:X;Q0OBG7=;D?4<6
MB0KD;NF/RK'&8/ X/">[2<I=[7)C!QE?\!_A[6X](;RW4LL@Z 5-K_BJSCDC
MGDC\I8APW>MSP%X"BO\ 2?MVISN^7"*D462,YY[>E<M\3/A]9C5)H8KQGQ\P
M / X^OO6=2GBZ.!55)6>RZ^1O3J)NW4X[Q9\4O[2U56A),*\#/\ %U_*O0_A
MIXET_6-*0,T;3=&5B-RU%\*/A]X-OK>2+7&\F\C[.VT$>HYK'\0> -#T[4Y9
M-#UR&-HVP(_-^]^M?G67\:5<+F$H8RF]^VQA+&TI3=-J2MY:';75C%=7;?98
MUD;'5!GGZUG:_P" ;*.T^UZ@Q4+R%W[5'U%4O 'Q!70YOLMXRQRAA^\X*G\3
M5KQMJ=OXJQ''>1NF=Q"MU/X5^H*M@:^%=9V<GM'M\C2'O226P:!#I=JZO;^6
MJ@?>4C\ZYWXOZLVK:;##$\DFQ\]RS<&MS3+2RM[)8I&6-NF<\&JLD=IK>K+:
MPC_5\NQZG_.:XJZE/#_5X62EV.A15[HY#P)92>$4DU*3*R9PI(Y[5T?B#XLQ
MZS8JLL!DD('.[H?RJ_XT\'W$FD-]G4-M&=HZUYY)HTUJ@\R-HO3=GDUXF,J8
MO*J'L**?*UJ%UHRQ_P )5*\\B[=N>V*O6OA*XU)89(2MP;C.55LE<<<^E8]K
M"MK=QL^&R?F KTCP9>0:'<1HJGR[]E".1W_^M7FY37^OXB%'$2<49U+RUN1^
M$O \FEW,DEWMA9A\@(W5?T[X/6_QD\2,RS+#INGKMGD1>)']!_WT.:Z'XE+;
M_P#"-23QHT,L4>U)&)&X^U9OPE^('_"-:3:0_9]MO I\X X:4^I_3\J_0IX'
M"4*BP=5)PM?76_J3&I-T_<6ID_$3X,V_PNN+6:SCDD@+@@ECR0:U1XEU">Q5
M8;@1I@DQ$Y&?;ZU@?%_XS7'BFX-HL)AM86+*#UR?_P!0KA-,\372,R^<QXX)
M-?.XK/,'@\3*GA'[KWMIJ%./N^^M>IVDGVRVMIF;S)F9BW+%P>3QCMU IFEW
M,>K2A?)\NXSA@W!JMX?\32W5OY>Y9)5/3UJ_:Z5>:I$]PJ>7,K8! K3#^]:<
M&Y7UL]?N.JG!15[[]R;6/A_]IB\QV4,HY YK0\/> K=;:.X*A5;D C@UB6WC
M#5[Z4V9L_P!XS;2_J/RKHQ+>0V&R4F%?0#BO6POU.4W4C!M)?B2]8Z6-36_$
M]O>6*VUK"JS1IL)!R#^E>;^--,N)56-\KSGJ<$UI6^M-I.O+#.K!/[Q'!-;7
MB/0Y/$ECYD*L ,?-CMZU.+D\?3?=:6782A&"L<9;> );OP!?:DD>V73YECD)
MZ,K!CGVZ8K(T3P[-J\NV&.1U0\LJY KZ,\"_"ZRL?"GDR,T]K?1[;G#$AO7O
MQ]>U5_#FHZ#H$\UC9PQKY<F&D:,'<,?C7BX'@:4,5SUYI1>J]>QS?6$]D>::
M?931RJJ+)M48.:WEGN$>WM(4:62Y8(JJ,DD\=*U?$NBXO9/LS*J[=R\?>%<?
MJ,&H0ZC;WL-QY,UJ=Z8->UFF&Q&$P\X4%>33L^AI4DZM%J%KV_$]@FTC5?A3
MX;$%\T7V;5"K2IPTBE>0I[XRV"*\?^(7BVXO9;FQAVB.X;[D;_*H QT_&LWX
MD>/M>\26\"W.H2"/<<H&SUQWZUJ:)X,C?2XKA"S2$!F+<EJ_.N&LIS"IAYX/
M%)6YN9Z:M^I\WE>2RBO:XAJ]];+J>G?";Q5H-QH$,%Q:VR3Q* VZ-<_RK>^(
M>A:3/X8>2&.W7^)"JCG\:\=\,ZS:Z-J[1W38CN%\LM_=SCFM?QIXC^QA;>UO
M!-:[<JN_.*_3L/G4(Q]A5CLK76S]3T)QE]:5)+1[,NW5E'=VWELJG;P">U5[
M6PMM/TN2.-82S-^]?(Z=Q5/PO=S7L2^9SN/Z8I/%EBJ64AC$@8C^ UOS15)X
MJ$4[+8[%3Y)6OMJ<Q+86:^*?.M55FC<%0!QN]:]477EGTF*-HX5O'CV-)P,C
M_P#57C,$4@;<I(D5LYZ&N@M_&DD;0PR1M(VX+D#FO/R7,H4G.4E;FZ=#;V?M
M4GL;UHC6VI;=N[!SR.E7M3L;@:?O6'Y7Z''!J2/1[A[%+I5RIYR.U5H?$,=T
M$AFF6-5XPS8_2O>]G3HTI>TTOLP>OO0^9R6ERM%K\S[560YR2>O6IO$MO<>)
M+"*.-/*EA)8R+)PP[#;BO0G\%^%9? MUJ3:HJZFLH6*&/!9@2!SSP/?VJK<Z
M=9VVGPK$T3[HP6.[GD<U\SE=-9E&I3C)Q4)==+_YHJ6(;2:W.5^&VK-I*74;
MSQVLD*$IYO20CW/>F^#_ (B6<'Q%\S5VC\N7*[V88!XZUB^)--O(M7VVJK)"
MQK-\9>&8[2%;IQ^\5?G4?SK&6,Q6%3L[QALNAI./*I2;O=$GQUU_39O'*SZ2
M8VAE3+>60<'/M5K4?CE-JW@#3]%\K[+)9LN+A'VM\I!4C R#D>M<KX&6TO/&
MMC'=;OL,TP27CHOKFOI?]K?X#_!FR^$,6K> /$UK<Z]9ND4]JD_FFX8LJG W
M'INSP.U?D.9<58E8^<*$''ZQ[KLKKMJ^AY6(QE*A4IT:D6^;JE=+U/4?V!?^
M"@5U>ZI8^%?'6L7#6<&U;&^>8^:[= KL3ELD*.3WK]$(;B.Y6/5I+F/R?+^1
MR< (1ZFOP6U/P/J7A/1K;4=SC;M=MA(9#QSD5U&@_M!^)]0LX[+4/$^O+8J
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M)<;=S?=RN#7C\.^'.%R?%3P%91\GY=#"M4G5M9Z#]"AU[Q7JD-C#=7#!3O\
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M!1110 4444 %5K7_ )"-U_P#^56:K6O_ "$;K_@'\J +-%%% !1110 5Y_\
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MSVMU =J'!C/<YK)@^$^@WVM))JG[NW7 $:DC'ZT>*_$-WXK\:6\UFWDJH(N
M@P']/RYI_B)7TZV:13MFP3EN_I7M8ET*L7.K34^1[O\  YO9RMV9T.J_"GP7
MI-JMUIJA+P'*%79F_$$XKRSQU#'K6JM(PCCAM2(AL7E^^35C4?B/?06_E_+N
M(QNZL*RO#6EV7B6XD@O+YK2ZDYA=SF-C_M8!/Y5\CQ-GF"5!0A"RW:2'"G)Q
MY7+4ZK3_ (9:3K]@LR8C&.?+8G^=0W/PPTT7>FZ?#<77VBZF<NP VJN!MP?7
M.<UWGPET[4_ W@_5[74M'M+NQO\ ]VMP[Y9&&U@4PWL.H]:X7Q%IFH6&IV]U
M#,9 TAV*?OH1C].E<.7UL!F5&->.'4>6:5TT^9+>Z6Q-6E*4E&+MJ==<^ =4
M^%.F,P875FPY.>5^O%<3KVIRZF\C>=LW#  /2M3Q-\3M:?2FMKYI?+*X/_UZ
MR/%_C#1]7TK3_P"S=-^RW5NG[]CR)CQSU]OUKW,YS:GAY1HT[\CZ=BHRJ49^
M\KW,6U\)W>IW0^9&]23TKT/PEH)L= N-$\07S)I.H1[K=E.1;R_WN>Q"D?4]
M*AT/PS-\1[*W@T9O+U*==D$3\>8_]W/3]:Q?B!X;\1>%;V;2M;CBBNK,[)=I
M^X<9]3ZUYN88# 5T\+4NYN*DFNGF=D:<;\R(_"'A6ULF=;IXVE+8&.U6_$R0
M:%<1E>LG( K/\%363,ZK(K7"G9&@SN8^H[5H^,=!O-(@CFNH+A$7H[#Y03BO
M2I8O"0PRHW7/ZZA[2G&5F[&;J?BN2PTV21+=_E4\L.OZUSOA31)/$OG7EQ(L
M<=PV"<98]N/RKI=/O#J<+0R1[E X/K4O@;2YAJ3::T3+',Y\O SU/_UZSJT(
MU91G5=XK[KESBE%M[&QH'PFCMX?M$4#,HZ,Q-;6A?&*#X>7SV<W.?O1C[RGV
M_P#UUE^*O&4GA&V\I4\WS#MS_CS7'^'_ (?>(OC'XN2WLK22:ZF!( X5% )S
MR>G!KLS7/\!E,%[)J,M+WV.2#]HK37R/1#\2$37&U1555F8L<=\UH>-OBKI^
MLZ1& WRPCG/4UP.IZ)<>&+J^TFZ_X^-/<PR8Z9'%<#JR3"^8AEQU .>E56XH
MJPH*M"TE)77S*E1IQ:DCTRV\26]^=\<FT.>F:;;74(U%_,D*L1D'/!KS2UN9
MH)/E/WNGM7T9X!^%6B:5\*KK6M>EG;48UW06L7WI/3)((Y^M?/UN*IPI>U5*
M4Y+6R5_Z17M>AYG?Z_<:9?Q_V?&MQOX<DGBM^UOM:TQ_/^S^6J N /XNHXKS
MV_\ $-Q-KSR0QK"@;Y8_2MC7OBHWV3RX;<PSLN)&/W?PYKV,KSZ$J$L1B&X=
M4D2ZC:U1#\1-=N_B#J^GP7$/V.W1Q&9NG4@'-6OBW\)M+\+:7;7.@W_VF2"(
M/=EC\I; /R_KG-<C9^)98)?+?$D;'GVK<O\ X>76O:*;BUW>21N\LGAOI7S.
M(P<LTQ3QT7*;47[JT]'IV.>I2;J1FI6BMUW*_A/P1_PFFE--%/)--&N7AC'S
MX_&M+1?A1>>&M,DUAVC:WF;RRHSE?K^5;'@;2'\+:?;WUI((VC(8X[8SD&KV
MI_$V6XADTE;>1I+I<'/W2^<[ORXKQ>&<VPM3,'A\12Y7JE*[OS+OZGGX;,9R
MQ7LHI./Y&/JMM]CT.1HY&5L$C%<CINISW%NT;;I9&.6;/-=+XHL;JWT=4N(_
MLY?C/8G\*W/!WAJUT;P_&6$<GF#<[]_>OT:66U,75]FGR\JN[GN5ES16IYYK
M$'V&+S)=S#H!G@53\.1_\)'J#6\"G+<$>E=AXFM+.XM;F.,[QN.,]JS?A@ZZ
M=J4T/E.%9MQE1<D8S7ERRR#KQHRMR]2I4URE.X\,S:(VV2,M+Z5U'P?\4KX0
MU:9KJ-(XY%.=XX?V/\_PK=\97NGZY=VKPJRM"N')[FJ&B^#[OQU>W,.GPJ_D
M1>8Y) "+TR?SKJQ&#PV75'B%)6CWV,_91Y>9Z,O>']7_ .$C\0R1V>J20VD(
M,DBQX89.?4>U)/H]K=:C.;^XNKIF(,)+X*9SV! ]*[7]DKX":+\6->N=)L=2
MNK/Q$ZC,I($<6<]25^HKJ?VD_P#@G]XL_9MN[/5-;UK3=5MKPGR!9W"NP'&,
MCKW]*^8P_'7#]3,5E>*C&.)E)V4EHT^JZ%>QFUSV]TX*'XW:EX,@L-+6YF6.
M#(%PIPP0XZ_05[Q^S?\ &75-7TG7O"NNK)J>B>(+8VXDD S:R/@K(#UX!/!X
MYZ5X!/X(LO$.@/([M)*I;=C'\/:JOAKXJZUX8MH]$LQ#%!:ED$Y!WN&.[GGM
MG'3M7KX[ABC@%)X7#PG"JTU_=:U33\F3&3EL]CF/C?:KIU]MZ21S-&?;KC^E
M<KHWAF/QR#II;Y;E"O'48&0?S%=]\8-#NKV"W6%HKB2Z'FLR]4'/7WKAX+"\
M\+7*O'\KIR"GW@>E=F(IJM6]K./N;-6^\*<7/WEH?//C;PO-X,\57VES9,EG
M,T1/][!QFLFO7OVG=,GUB[L]=9?,:5/)F<#D8Z$_4L:\AK\JSC!K#8N=*/PW
MNO1['TM&ISP4@HHHKS#4*_M;_P"")_\ RB/_ &<_^Q TG_TG6OXI*_M;_P""
M)_\ RB/_ &<_^Q TG_TG6@#ZAHHHH **** "BBB@ KSGXV_M>_"K]FE8O^%A
M?$;P1X(,_P#JEUS6K>Q:3_=61P3^ KI?BOJUCH/PO\17NJ:M<:#IMGIES/=Z
ME VV73XEB8O,AP<,B@L#@X(Z&OS;_9-^,WP$G\:> +C6OV6O$VE>'_CEJ!M/
M#'Q+\=6EEKMWXJO"C/"]V\DDMU URBL\1D 5AV3@5,=9<J_JY6BCS,_1OX3_
M !P\%_'KPRFM>"?%?AWQ=I,GW;S1M1BOH3_P*-B.Q_*NJKPF]_X)O_".Q^(^
MG^,O"GA>V^'/B[3Y8F&J^#P-&DO(D;)M[B.$"*XA89#+*C<'@@X->[5>G0D*
M***0'CWQ+_Y/:^%/_8O>(_\ T/3*]AKQ[XE_\GM?"G_L7O$?_H>F5[#0!Y_^
MU!^T#I_[+_P0USQIJ%I/J0TM$2UT^!PDVI7,LBQ06\9/ >25T0$\#=GM7B5_
M_P %2/#M]IGP">/PSJ_V;X]3W5CYKSQK_P (O/ @62.Y'5B+AA =O\1STKI?
MVW_V=?&W[4'CCX7Z'H>KGPOX2T'67\3:UK,"VUQ=QW5H@-A!';W"/&ZF9S(S
M,I"^0O0D&OEV]_X)G?%SPY\46TS[5;>)O"/AK4O$OB30?$-Y=VMG=-=ZK9P3
M+&UO"BK'LU*)VW(H4++G'%3&6K<MOT7^>OW%.-TE'?\ S_RT^\^@/B3_ ,%/
M(?"_C[XD>&= \"WWB35? >N:#X>MC_:L5I;ZS=ZH[QX61E8Q+!(C(Y8')!P*
M=XD_X*,:YX!\'^/$\1?"V\T[QUX'NM(@_L*#7H;BTU)=4G$%J\=[Y:JOSEMZ
MM&"NW^($&O"?'7_!/7XH:_\ "W6I-8\(Z7XJUCQ))X2UG7=+M=<CL_[4O;;4
M+R[U.%)B4"[1<(J.2N_;U%6-0_X)N^*/&O@GXF6^C?#UOA]X=\>3^'(YO!VH
M>)QJ#7DMCJ"RW.H&X2601%K7$01)-S>4"=IQFK6T??\ 1?K<FZ?O+M^O^7H?
M4'PD_:V\1:_\=)OAWX\^'I\$^)9]#D\0Z6EGKL6L0ZC;12I#,-RI&8Y%>2/"
MLN&#$AOE(KY=\??&+5OVU/VQ+'X5_$[P/)JGP\-U&J:'H^I721V5TJ^<6U.:
M'$=Q-;_('@1S#$S<^8X4K]">./A5X(_89\'ZE=_"GPCI=O\ $[QX8M#T**:2
M:]N+ZX+?(7,DC2?9;<,]Q*%8 1Q.?O%0?8O@/\&-.^ WPTL?#NGS7%ZT+RW-
MW?73;[C4;J:1I9[B1N[/(['T484850!V8/%1H2YW'F=G;5JSZ-6[')B\/*M'
MDC*RNKZ)W75?,XKXQ_$WP[^P=\"]"M=!\.I<0SZA;Z!H.D17<=E#+=7#-L$M
MS*=L2$AV:1\G.>&9@#YQ\;?^"DVN?LY? 7Q1XH\:_"'Q-I/B#PWJ5EIL>DV]
M['=6NLO>DK;&RO BI.2^V-D"JZR,%(.5)]7_ &R?!NO>//@U+INC>"?"'Q(M
M9[F,:OX8\0E4AUBQY\R.&1\QQW .UD:4;,K@E<AA^>WQ _9F^*NM?&;3?"'P
M_P# EQH?A'PUK&@^/M5^&=]XH@U VZ6<\L<+1W4DCPVTES*HD2%9"C+ITK-M
M9E!Y(RE.;E4>[6K]5?\ 7^M3I4%"*C!;+;;T/L/PWXQF_8O^''@WPFFEW7C[
MXO?$J6ZU22QMY!9G6-2<?:+^ZFFD!\BVA#1QAGWLL:P1@.0*?\*_C5KOP:^#
M&H:#I?P'\5Z'XDTC6DTZP\,6][]JTJ<WCO,L\&HA3%'9(-Y<[%$!&S8,H#1\
M>:-\4?'OQ"\$_%JQ^&LVC^+/ /V_3)_".HZ_9/)K>FWHB$DD%S$[PQS1O!&R
MK(RJPW@E<@UJ2:K^T%XQ\,^*-=U7P9X=@TR^N(+.T\ 2ZE$^HR:<(Y4NW.H1
MNL*74S/&47>8T2+!;>Y*QK9]_P"OZ_X8T]UV*'CW_@IYI7@#]E";XBS>#=<N
M]?M]>F\+/X3MKB)[R;4[>1UN((9O]7(J+%+('& RIT4\#H_C?_P43\%_!CX;
M_#3Q''9ZUX@B^*U]IMIH<6G6KR 1WDD*"XGD ,<,48G0DN1EB%7)-?/OPJ_X
M)W_%;4O'GA&WN-7?X6^ ?!,NK^(/#FGV'V#6+K1;F_80)ISBXCFB=8;<W+F4
M!B6NR QP372>$?V*_B;X6_82T_X/W"V^KS^!?'VGRZ%J,]Y#&VJ:!;:Q!>QR
MR! %CE2'>GE  9A&, BKAJU?NONO9_Y^A+LMO/[]U_7<[KX\_MW>.OAI^UMI
M_P ,?"_PAU7QH=1M5DAO5OA90;C&9#+),R,D<"[2A8!FWX&WG-8/[6GQ)^,=
MI^SAJE]XOAT'X<Z+K>MZ)IDTGA[5)KK4M"TZXOHX;^2>[*)&O[IOEEB \L.2
M2"N:^D/CYX!U;XG_  ;\1:#H.L2>'M8U6R>"UU% =ULY[\<@'H2.0"2.17SK
M\(?V6?V@O@U\$V\*WWC;X<?%C2YEG6?1/%FF74/G13L0;8ZA&TF8(U/RA[-V
M895FY##OQ$</4H1J4[1E&R<=7S6U<K]+[6.'#2KT\0X5+RB[M/33LO.V]S+_
M &C/A?\ #?\ 8:\->)M5^$C2>#?B?JW@C69M&T'1Y))+?7FM;?S?M<UMAEDF
M@)!65BK$R%27W8J'P;^QO^SC\-KGX,?%J2;[)XYU">PM])\3PZA-/?>,;RZB
M)"W1RXNC+EG+,,H%R&15XN?!:]\%_L8:QJ&I:W^SSXG^&#:A +6X\0V/_%4V
MBVT>?E>:W>::WA+LH2+8N[<"5&T[>L_9L\#_ ++R^(KCQYX!7P)#KFCPM+=2
MBZ,4V@"<G>6M)F!L#)AA@QQ,1D=#SQTY3B_<;UTT^>GSN=E2,)1]]+37\M?E
M8^:/ /P.\%_"[_@F5X:^,6BZ3:Z%\6K74$N].UVU=H=0U6^DU9H4M9'R3,EP
M&\IHVR&5NF0"/6? ?P!^'W[8%U\<-<^-4$6LZUX7\6ZCI<,NH7+0R>#--ME5
MK22TY'V4F/%SYZ@%V;=D@ #V[X5_L"_!'P#XDT_Q5X7\$Z+%<PRM?V%Q'<2W
M-K#)(2_G0QM(T*L2Q8.B@C<2",UL?%[]B/X4_'SQDOB#Q=X)TG6]66..&2>7
MS$^UI&VY$G5&59U4]%E##!(Q@D5E[R>F_P"6W^7D4W%_UOO_ )GSK\=;*3QQ
M\7_V2O%/AOXE^+M5\&ZQ?2:?I]NQ6*+4_-T6^==3N"8UDEG*A"H;:BDLVW+9
M'R3\!_A-XL_8H^+EK--J.HZYXNUCXI7^GZK\0;35H;VUO=$6RO6DMEB$SSM-
M"41I+=XD6&2W4ASNR?U(U;Q)\*_&WQDT7PC=77AV^\:>"W_M32M-)7[1I;^2
MT6^-1PK"&1AM'(5NF.:^?]4_89^'?[$7[27Q*_:DU&2XO[K4+:XGN+2*S#2H
M]RT:288MM.XA5!"I@'YF8 UZ^'A4<)X9MQY[-)J[D[JR3\^^UCS<14I1E"O&
M/-RIQ;3TBM;NW6VGW'S=^R1X.UZ[?2](M8O^%<WWQ$^#]_JL7B!=7>Z7Q[+Y
M]J_]L7YWEK2=(Y=Q#%VQ>.H?$>VO3_V4OVY_#O[)OPA\%>%=4UFX^(E]K&KW
M,+W&DSO-%HT;R1JL8,P5Y.26"J "&)%?0'["_P ,O@KXV^%MYXT^'/@.R\-V
MOC".>PU""2$B14$C^9;J-S)'$79CLBPA)SCCCNO@S^R)\/?V>[./3_#?AZTA
MADNWU+?=9NI8YP%575Y,LNT<#&,"N[#XS#X?#U,'C(-M2O966NN[WTNMM-.Q
MPXG"UZ^(AB\)-)-;N^VFR\_,POVPOV&M%_;'OO"MSJFMZMH[>&+AIE%IM(N$
M<H67YONM\@PXY&3P<U4_;A^+OQ3^#'ASPLWPM\)#Q5->7WD7^8'N&@0 ;%*J
M00'.09#PNWGK7O5Q(L,+.WW4!8_05XS^RC^W#X4_:^U3Q-:>';75K63PS,J2
M&]B"">-BP21<$X!*-\K88<9%<>%Q&(E!3G#VE.ET>RYN_7<ZL31H*;A&7)4J
M=5N[?\ \]_X*(?MQ^(OV5?"7@^WT"UTD^*_$DGF36MZK2I!$@4.!M*@YD=4S
MNXSG!KZ(7P_#\3_AM;V?BS1+&9=4LHSJ.F7"K<0(Y4%XSG(8*V1GVS4'Q"^"
M?A'XLW^EW7B3P]I6M7&AS_:;&2[@65K9^#E<_0<=.!Z5P7[<?QU\:_L_?"*W
MUGP+X5;Q5JDE]';RQ>3+.MK$0Q,ACC^=N0J\="V3P*(RIXB%'#8:'+4N[RO:
M[;TU\B7&I0E5KXB7-3LK*U_73S/4K7P;INE>$5T.PM8=.TR.W-I%!:H(4@CV
M[<(!PN!TQ7B?[,O[ FF_LM_#OQMH>A^*=;FN/&&\"^D"K)I_[MTC>,+UD7>6
M+GEB!TQ7L_PZUW4/%'@/1=2U;39-'U2^LH;B[L7;<UG*Z!FC)[E22/PKFOVA
M_P!IOPC^RYX4M=8\87\EC:7MR+6 10--)*Y!)PJ@G  ))[ 5ST*N+O+"TFVY
M-72UNUJCHK4<,XK$55916C>EDSC_ -@_]F'6?V5_A;?Z+K7BN;Q3/>ZA)=HY
MWB*V4@+M0.Q/)!9O]IC7N%9/@CQ!9^+/"5CJFG7$=WI^I1"ZMID^[-%)\Z,/
M8J0:YW]I+XJCX(_ CQ5XJ\ZUAFT73I9[<W.?*:?&(E;'/S2%%X]>U9UIUL7B
M;S^.3MM;7;9&E.-+"X?W/@BK]]-SK-9UJS\.:;/>WUU;V=I;H7EFFD$<<:CD
MDD\ 5\K_ !3_ &A/B+^T+XN\'ZE^SSK>B:YX1L]0-MXD<A%:%PZ'$RS .(3&
M6(,8W$],C%<5\*OA_P"-/^"I7[%,/_"=>)(]'O(=?>>QOK&U4K=Q1 H5G@4J
MO#LX'(^XK<]_H_\ 9(^ _P /_P!GGPAJ&@>!KJUOI8;@#6+A;Q;BXDN54*?.
MP3L;@_)@ <X%>Q]7P^7J;J/GK1;7+:\$MKM]?+LSR?;U\=**A[E*2O>]I/K9
M+\_(]97[H^E+1FBOFSZ(X3]HOQGJW@+X=P7^B^&_^$KO7UK2K1K'RV?9#/J%
MO#-<84$_N(W>;.,#RLD@#-=W7$_M IXT?X?P_P#"!-9KKW]L:69#<[/+^P_;
MX/MH^?C=]E\_;WSC'.*[:@ HHHH **** "JUK_R$;K_@'\JLU6M?^0C=?\ _
ME0!9HHHH **** "O$?VPOBYX^^%OA36+KPAX&7QM'::'=7JZ>8GD_M.=(W(M
MOESMW8 Q@EMV #7MU<A^T GBR3X&^,%\!M:KXV;1KL:"USM\D7WE-Y&_?\NW
MS-N=W&.M '3Z5.USI=M(\7DO)$K-'C'ED@9'X=*L57TSSQIEO]IV_:?*7S<=
M-^!G'XUX+\'?VDOB-XX_:]\9>"=:\!R:3X/T1':QU@QR+YNUE",7;Y)/-!+
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MX&16>?1K8M1]DW%+HMGZGF5LMC&<:T9N*72^C]3F["$7NHVMN>#-(JD@\#)
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MF49&X\Y'W2.:XO\ 8GUS3=3T[4--\2>(K_1]'OVP$B+,J2< -M!';/YU]7?
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M/ZU^N9+E-'^SU3<%HK7?D9U9<LTFSSOP[X,AM=1AFN;?=M.Y5R.WK7I>N?&
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MG\2OBIXGLM8F^+7@/PO\.UM7B2P.G>)QJZW8;(8NQAB$9#;0!SNW5ZU7P?\
M\$^_A5\._P!LU5^(6O?%KXH?&_Q)X-U-(;K1O&D/]AP^$M4B 8;]$CCACAN
M""&E63'56[U]X#BMI*QE$****DH\>^)9Q^VS\*?^Q>\1_P#H>F5B>&_VX;WQ
MY\1=>T3PS\(_B1X@TWPWX@E\.7VNP2:5#8I<1,HE8++>),T:;@21'DX. :VO
MB:,_ML?"G_L7?$?_ *'IE>9_LJ?L8WGAOXI_$CQCXBOOB)HMY>?$'4M8T[3K
M7Q3=0Z5?VC>7Y4C6<4ODLKX.0ZY)'(J4_?L]K/\ -?\ !"7PZ;W_ $9W%M^W
M_P"%=1M5M;/1?$]YXL;Q/<>$SX7B@A_M5+R!3+([*91&L M]L_FE]IC=.YVU
MG:?_ ,%&? _C+X?>!=2TRP\27EY\0I[^SBTA+6-=0T9K%9#?F]0R 0BV:/9)
M\Q.]T"AMPKRKPU\*OB=HG[3EG^T=-X)NO[2\4ZD?"NJ^$(C!]NTWPX76.VOR
M=VQKQ)46:4!R3!)Y8),2BNI\ ?LBOX(_:W_:2\96_A=K.W\9:-8QZ'=&8&&X
MGDM9?M_DQ[B(VDE2W,AVKO95))YI:J%^MOQ5M/G_ ,#H-VYK?U_2_'?J=%\+
M/^"C^F_$&#P=JFJ?#GXB>#?"?CZ>&UT/Q#J\5C)8W,T^?LZ2"WN998/-QA6E
M15W%5)!8"M7P7_P4"\.^,_BYI_AMO"OC?2=(U[5[WP_HGB;4;".#2]:U"T#M
M-!$#)]H7_53['DA1)/)?:Q&"? ?A?X:^(7Q:_9"^%GP/D^%_COPA?:'+HP\1
MZWKL5M:V-E;V-Q'/*;=XIY'FE=H51%"@$.6) 7!Z[X2:SXO^-/[:J^)OB9\-
M_B=IL?AN^O=/\%6;:=:_\(_H<!#1MJ4\ZW#/-=7$8(5MFV&.78%W,['33FLN
M[^[34G6UWY??J>K? >PE_: ^-&K?%C5+>>/2]%DN_#G@FWFC*#[&'1;G4MK?
M\M+F:)EC=<9MDC/65@/=J\=_;A\7^//!7P%NK[X>V>K76J+>6R7SZ1917VJ6
M=@9 +F:SMYB(YKA4SL1\CG.UB I^<?#7[:_B;0?AKK]GX7^)4/Q"U35-?T+P
M]H;^+/#LFC^(/#$^IR>6TFI6GDVRRPH,O"4B3>59"S8W5$7S-I>7XE6[GW-K
MNM6_AS1;S4+MF6UL8'N)F5&D9412S$*H)8X!X )/:O'?V(_#FH:GX0\0?$C7
M+62QUKXN:F/$36;\&PLA#';V$)&>'%I%"S],R.Y*J215'P_\ _BQX<UB^TVY
M^-^M:UH&M:<4^V7FDZ;#K>CWRNI$EFT=L+=H73>K1SPNRG:0YR17S'J'QI^*
MGPK_ &,_VA/B;JGQK\7ZI=?#;6M9T#3UO-)T@06T%K=Q1+=%8K-2\XC+]24)
M/W#P*?,NO:_W#46[>J7WGKW[>MK\3/CE\<_!WPX^$GB+_A'[W2K23Q#XIOOM
M4ENME;EQ%9)E%)DD>03L(\XVQ,6'S(:^KM&MI[/1[6&ZN/M5U%"B2S;=OFN
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MM+'UHS="BO9U5\,9*.VB>][7U:Z]3R<=4P=.455JOVE-_%)-[ZM=MMCZ_P#
M?[.O@GX9^.]:\3Z#X=T_2]>\1G=J%W"IWW&3N/4X7+?,0H&3R<FMSQY\0M#^
M%_AJ?6O$6K6.BZ7;8$MU>3+%$A)P 6/J:RO@-\3IOC+\'/#OBFXTFZT*;7+)
M+I["YSYEN3V/ X/4' R".!61^T]^SIX;_:@^%\GAGQ1)>6^GK<1W<<]K.(9;
M>5,[6!(*]&888$<^N*^4LY8E0Q<GH[-[M6TT].A]-I'#\^%2U5UT6O<[K2=:
MM?$6CP7VGW$-Y97D0E@GA</'*C#(92."".]2:1_R"K?_ *YK_*L3X8_#K3/@
M_P##72?#.A1R+I>AVB6MJKR;W**.,L>I/7/O7CW[$?QY^)WQBU;QA:^/O!)\
M*6>BW2PZ9+Y,D/GKEPT?SD^9M"J?,7"G=26$YXU*M)^[#NTFTWII^97UKDE"
MG47O2[:I66NI]"45\^_"WX]?%3Q1^V/XJ\(:WX#;3? .EQN;#6?)D42[=OEM
MYI.R3S,L=JC*8Y[U]!9K/$X65"2C-K5)Z.^_ZFF'Q,:R<HIZ-K56V.%_:%_9
MX\-?M._#Q_#/BB"XFT]ITN8VMYC#-!*F<.K#H<%AR",,:X']J3Q[IO[!W["G
MB"\\-6\D3>%]&_LWPY91JT\US?28@M(449:1WGDC&T DY/%>\9KY'_:F\0^.
M-$_:HT?4/&6F^%W^ ?AY[;5I+S4X(I5M+N,$I,O67[4LY7RP@(Q@XS6V'HU\
M7!X6,[)7E9O=_P!U=9/H8XBK1PLUB90NW9-I=//R[GQ;X0^)^G_ /X2>+_@E
MJ&J>+-/DG\2^#_%'AX^*M+O-&O=5ENK^UCU,0QW2H[)]LAED^4;1]H/O7V%_
MP5&\'2?$#XP_L\:3'X(\._$9;GQ)J3/H&NW@M+"["Z9,VYW:*893[P!C.2.W
M6NT_:"_8)^"/_!2+4?!OCSQ-8P^*K73[4+93V\^(-0M#*LPB?C.T2H&PI5@0
M1D=!T-]_P3I^"-SX9L_#LOPW\/SZ-#?OJT5O(LC>1=>7Y9F1BVY6*$KP>AQ6
M.)A348J-^;[2:M9II6^Y?>;8>I4<Y2E;EMHT[WNM_O9XE^P_\7[7]E/X/_'2
M/Q-X7O?#,7P]\:EI_#6AW U33M%MKQ+5X$L9,1@PA9A+(NR,1LTGR@ 9[C_@
MHI^U#JOP(\6_";2['XC:/\,=$\:7^H0ZCKUYI":H%$-IYT,:(S!1O;C=SQ7-
M_M6_L%^.-6T/2? OP7UC2?AS\,[[3+[3=:L[5  C72O'+</&0?M),;X"LW#+
MU&<CN_V=_ R_M/?#+]G'XJ27$F@S>$M#>[72HU$RS_:K%;<QM(=I79C/W>3P
M<48G#QC3IRC-.Z5TMU;37UW%AZ[E4G&46K-Z]'?MZ'SAKO\ P4+\>:;X7TB&
M;XKZ'I_A.^^(!\.V?Q.F\)B.'6;,:8]TXCM';9NCNE-OYJY1MA(&0:['X<?M
MP?$CQ/\ !WXO:AX)U^S^.&F^$SIZ:)XRTCPTRQR2S2%+^%+2%B+R2R0"0I"0
MQ+>6?F!%?5?QB^ 4?Q<^(GP[\0-JLVGM\/M8EU9(4A$@OR]K+;F-B2-@ E+9
M /W<=Z\'\*? .3Q3^T'\=M)^&_CSQ9X*T>\N=.O[M]-MXFL=)\3 ":9[8LQ$
MBR1"'[7;LNQC)U5F8URZZ_UT7_!VL=<K:-?UJ_\ @'/_  O_ &Q?'VO_  6^
M)6J>"_'7A/X\76@Z3;WNE&ST633?$&GW,C[98;K2E 9D2,&5 I61V1XMN<&K
MG[/'[2_Q(^,_AWQGI_P_^*WPV^*VLQ:+%<:<^L:3-X<U3P_J#R^6R7NGJI8V
MZH'<$A7\R-HSP0P[R']ACQ3XH\3^(/%WBOXJ7?\ PL+4M!3P[IFO>%M$30_[
M'MTN5N@?*>6X,[&9!N$CE"A9 HWL3D^-OV!_B!\4GUS7?$/Q@M8_B%<>&9_"
MFC:_HGA1=-32+2XEBEN7:+[4[S2OY*JK>:@C#,44,=U/K?R_S_X';YDK:WG_
M )?\$WOV%_C)XP\<^-OBCX5\0^)--^(&G^ ]6@T^U\5V&E+IL5Y=/$7N[)HD
M9HV>V?:&=#_RU"M\RFNG_P""?7_)GW@O_KE<_P#I5-4_['OP&\0?LZ_#I?#.
MH:WX2U'1--"P:19Z#X8;1(K&-2P?<&N9S*SM\Q<D$G).XDFH/^"?7_)GW@O_
M *Y7/_I5-5R$K]3V6BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!^2?_!YO_P HG_#G_91]-_\ 2'4:_EOK^I#_
M (/-_P#E$_X<_P"RCZ;_ .D.HU_+?0 4Z"(SRJB_>8@"FUV_[/W@0?$'XEV=
MI(&\F/=.Y Z;%+#\\5U8'"SQ->%"&\FD34FH1<GT/H_X,>&H_!OPRTZU@#-)
M(BS2,5QAG )'T!S7?^*_!\<OAY&;YI-@8G/3C(K T#Q&NG136XC7R5)53CIC
M@53\:_$FZ_L=T3[VPKGVQ@?I7]&T:V$PN!5!NZ4;6]#X^M"4JCG\[G(ZCY,%
MUPS3;3RJC.*Z?PM_9L=W;W3KB"W;?(V,[![_ *5Y<=5FMIO-5VW9STKV#X<?
M'OPU>>"I-!\4:>O[YL_:80%*=/0CTK\:SCBRMA8R5&ES)Z>:\_,VIW:LSVKX
M6Z+:_&[QS;V^F7EK'%J4HR)) NQ&/)QZXKF?^"C?@2U\#^*(_#ND0K<6^A#R
MY+E8MK,V<$'&3QM/?O72?!+3? OAW2H=:LK>XUNW:< &"XD3[/MPW)5ASSTJ
MK^T/;V_B.UU+5;.22:SOY'<"7YI(LDG!SGU]:K+<#F_%$XXS&3<,/2BU!67O
M26C;UO?IL9SDJ:M'?J?(5CI[ZC<+"N5_O$CH*[70?#\>@I')#;M<,K#<^W<!
M6MX0\$-XAAF:-8X8X3AI&X Z_P"!KKKC2X_#[0HQ69V7Y5 ^4CIFOT+(N&8J
M/M9:=F#FEH]SDK_7X=4M/L\8/F,,8 Z5F?\ "I)+I5GW,TF<+UVK73:1HRR:
ME.?).?O<#Z5L>%?B+H5_"VFS,;>96ZOQG'X^U>Q&AAZT^7&35]DM@K5^7W:>
MIDMX*CT*W^RW+,LH 96]?I575;VUTF%XYIHUDABS@/[58^)_C?[#;+!#-&RY
M^4GKCZ]:T/'?AW0]7^%VEWUFK37@CC$[H<@M@;AU]>*^;XHXCH936A0H0YN;
MW7;\#"G6FVK]3@/ WQ7U3X=^.+;6M.NE:XM90\8*C;@$'!'3M7V?^WOXX\/_
M +6?PG\&^-?"^CV=I9QVOV'6+B.U2-TO06(7<H[HN>2/ZU\)QM:Z9XGMX+BU
M9;5V 8,2.#CFOT:\ ?%7X7W/[-^D_#K2= #6%Y=+J,U]+,P9+E4= 3AC\NUC
M[>U?E.(PCQG$>%S&IA95/9<W,]DH-:MZZVW2.WX:<ES;GRQ8>'='MM&\F18,
M^7D.LG(/H15#PE\28?#\%W8R06\T,R_>*#>IZ@@XSU XS4?QW^('@>"22VT*
M&^N-0^T9:[8[8]F/N !B#R,YQFO(#XY;4-06&W1@W08ZDU^Q5N)L)BH)4H65
M[*ZLW;:R.7ZO&I!PJZGJ^K_$J:XTB2TL5C6>=0K8P<GNV:P;GP-<Z3I+7TTF
M]F^]GN3SG_/6F^'/#]]ING[YIH3<3'< P^[^E9/B;QK?7"?89KA0D;XVC')'
MX5Z6+KJ5+VN+3YFO=71&D:<59P*\]E)J=LT:LN[^%AWKG;_P5<V]VRMA_P#:
M]*ZK1G977E9".P[5UGAS6I/"FL&^-G#=+L*E)5RH.*^?JX%8FGSI7:-,1S*/
M-3C=]CS?3=$M;16\PYE5<X//-=9X0^)=KINC-:S-)#L;AE..3UX[UES^'H-1
MU4>3N,W4'/!^M-\3> ]5T[3O.DM8RI&[,8/U]!79@_K&%;K8>.V]D:5.1+WO
MN.DT&\M_&WB]8\YCC&=S'EL__JKU[X%? /3_ (T>.6\/W&HZ?I*S#9&S%69C
MTXSCU_E7S;X,T*^N;^WDL?,6;=C.3TR.*]$L_%.K_#'Q-9ZE:W#6]]:L&5SC
MY3P>A_K756QF*J9=6G0C:I).TGLF]ON.''4:M6'+0ERNVAVW[<O_  3=U3X!
M26%WI32:CI]]\HF*$?/R?4^A[UYK\'O"VJ?#VV62<)Y5P>%QT_SBNR^)_P"T
MQXR^,FEV]OKNNM=6]H=T2;57!Y] /4UQ.K_$.XT&.&.X\R:&,<D 5^?\)Y?F
M66RAB,TK)M/5KS.'#T\7&C[*J];FKXRM(O%^H2+<(%C0$X)_E].*\^TCX<)I
M_B62:&YE,:D[-I(QU[YKHF\7-JZLT7RPS#);NU:6AVT.Q9.&4]J_2L1[#%U5
M*/>]SW*=Z<+,VOA3\)=4^(WC&*RMM8^RLL;.9IKQHEB0$9(.>2/3CZU-\2_@
M(/"?Q&N-+M]0C\5-;Q+)/<12?:-F0IP3D_WJ\\^)/CVZTN[CATUIK81\M)&V
MUNW'TKC[?QIJEE-++'>7,<DW$A+G,GXU^=Y]7EA\X]K0:E!*S35]>]SRYX2H
MZ_MX2Z;6/2_$VG:;9Z:LAMH4V\<+AJRSHM]?:1(UG=7MQ;R1XBB:Y=%7W&"?
M\BN;L?'$::9)#>)))))T<\X'YUZQ\.+VSN?!:1K,JL$[C'09Z_G^=?287#X#
M/:DH5X)12TVW.J<G&#<D<7\,O#%P4:2\C6:ZCQ&"!N( ]ZV]9^(UY\.'/[G=
M#<<[6XY'X>]3^%]6MUU"Z@9BBW$K,K*,_E57XM6L.N>&I(HT^:'YE8]3CUKV
M\/AZ.#R^V"DHRCLNY7M+S4;:&3IGQ2?Q#JLDUQY<;2=,8YK>U&]DN=-4INVN
M,'C!KQWPP[3:BL+?+M;'2O6([R6TT#<L9?:./I7+E695L13DJS^9T1\T5O#V
M@*DLC8^;)Q@XQ67X_:^TZ,2)+(R \CDXK&M_'5QIE\9EY7/*UKW?Q'L[]/,N
M(-XV_<;IDUQ5<TPTL-*E!VE^9G4KMIM&%H/Q.N=$F#_>_OY/7\*WO^$HN/&L
M1N(V,+QGE5]*YFX@M=1D:2-@NX[PN.!WKU+P9:P-IUG;V<*RW5T5A6-1\SNW
M'ZFHR>6(K<U*O52@E<F-9)W:U,'2O@]?>+_ .K>+!]GF32Y1&;7?^^?Y<YV]
M<<=?<5FZA\8;KR#'8VJVZ!<%FP=I] ,5]2_ ']E"3X@>+[X?VC)INDZ/;_:]
M4N6_U%L@V[B_;C<.M>!?M17'@/2?$CZ3X!^T7&G0G$MU.,&5^<D?,W%?'9IQ
M5B<KS2>5X>7-*24FTOA3VN^XJ=.<FYS?N]#%T'XX3QZ:B30AKF%/+$BG[PZ=
M,=>M:WAB87]NEZ&.Z3)QWKS?PAX/O/''B*'3[&/=//G')P, DD_@#79Z7;WO
MA&:;3Y#'YEI*T3$'()'&1[5]=D/$.(Q551Q3ORK3OZETN7G<%ON7/'_Q$ET=
M8K3;]\9RJ]/\YKG;?QI<<-':R-N/4@C(_*M9(H]>U7$ZLWEY9N.U4/&7EZ)I
M'G0JR_/L (P?K^E>MF%;$5&\0YVBCH]FHJR"X\;WTUH?]&;R^F2Q']*D\,V.
ML>+=5^:2.&WAY<\':.@S^.*X/5/$-S=+Y9D;:.<#BM#P1\0I_!VH2/-NFMYP
M$D3/)'M7@X?/,//$1CB)OE!RT]T[[Q!X>M=)U58[X1YSE)5^Y(/K_GK78>"!
MH0D<7C0[C_J1QAC_ )Q7F^I?$&V\4:DNQ6CA083?UJK<::+I66&:2,^NX]:^
M@HXZA1K2GAHJ42/9\\/,[SXB06]MK#6^B[)6F485#PK$5F^$?A'JGA^[-[?1
MQ74<GS,@/*_I7<?LN?'C2?A/X2U30_%OAQ=7T^_1@E[$OF7*,=V,9QP-WKV%
M=7X&\??#'Q5HUU'JNN&WNE9F3S7\KRTR<+@-S]?:OG*G%5"G7G/,<-.#B_<M
MJI+O_P .?-8W.,3A92A.A)I6LUK>_P"5CQ[6M<MXKYHX[?:&YP>@KG;CQ$NA
M:HUW<X:+[H7V[5[1=>/OA3X9^&4EO#9S:_XAO4(!5_\ 5/N_BPXP,#TKQ_PY
MX+C\18;4LNB]%4G _'K77@\TK9E-JA!Q=]&U9'HY?FD\2I?NW!+2[ZF3X]\7
M:3K=O'-;3+YR'<JXY0?G6QX;DTOXB^'DCFF_?0_*5/6KGB3PQIN@!5CM8AN&
M#E<\55B\(V>DVOVJU_T>6;D[6[_R[UWRPU>GBY2K\LE;WE^IZG(I+FN55^"F
MIWEQ(;'-Q&IXP#_]>M#QKX0M_#?@2SG-XQU87 AN+)EQL7#'<#G)'0=!UKL/
M ?C+4/"NAMY]G]LC7)#(3O8<]JP[?XQZ3K_Q#MKZ2WBF6$_-;R<*W!&#^=<^
M;9'@E0C7H7C4W2[^1QU:<YO3I^/D6M&TNTO?"ZAXHFCGCY8]1QZ5POA+PI)'
MJ4T,&6#2$+[UUOBZVO+?2;JZA>.V5@9(DS@ 'TXKGOAN]X\<=P9EWQG?\P')
M_*O5K2]HZ-.I3Y6EJ=^'<O9N3W_(TM3^'][!/]H6?>8>)(AV_6L34-/B5SN7
M']XFN[\6?&&*TTZ6&*S5;NX7;))ZGV_.O/8[V753(J0R/)UPHZ9K/,J>%C-1
MP^K+H\[7[S0ZOX>6\EHJW44H6,'.QNC5[C\(?VLO$GP2O;J/1]2^QW5['Y8^
M4,I4X[GIT[5\\^#O$MQIC_8Y(&7<<?,,8S6YK.AWUZ(X[9D:\F(")DY)ZUEB
M,+A\3EKPZIJ6J;BUHW?L][G)6HIN[9]#3?M$^*-9\-R:5-K6H1W"3?:$D$S&
M:-_ER-V0W1>F>]1V/[0TUSJ"KXDDFOBJ-$C[/,N+C(P0>[?B3UKPN\U;Q5X9
MN((-26-IH5#*=N-ZG(R3C.>M=OX6^*WA_2]!:74KZ*+558'F-3Q[9_&O SN4
M)1^ISPD:<9JSDE=Q?=61/LW;WG=?F=WX(_9HUKXLZQ=75C'<:3HJN7B>YLO]
M)#.20J(>>W7/I7GO[7'['6O_  '@MKEM6TW4I+N-IFA@N \T0&,!E'1CD<5Z
M)IO_  4ED\*:=IL>@Z>LU_HX=+:YE4",[B/F(Y#8V@C(->.>-_B5K/Q5\37F
MI:G>R2W5ZY=^?E&?0=!^%>!DF'S[$YG*GB*S>$@DH:).3VUZ_,Z/9I03BK/]
M#S+PO\2GM+55\R6.XCR&VG;GZU])?L*_!3PE^T;/XFNO$VI.;_1[7[1;V+7)
M@%P<@<,&![DXP>E?-OBWP'_8X:YMQN7.6-8>B>-=4\+ZTLEA=W%K))A"T3E2
MR_A7KY]',%0^JTZG)*ZL_1K\UH*6CU/T/^!'A;X-_$/PWJ7A?Q/IMWX7U94:
M;2M=LYVF;< 24>+<@8$*!DL<;CZ<_+_Q+T>X\,>-+[33?27EC;SO';SD;3*@
M. 2,G!(]ZZ7]G_Q':Z#X[TVZUEYGLVC*2/U*DJ0..!U(_"NF^/7@".?PW>7_
M .[CM[ZY1K*YW'#)N)8#\"M?282C]6Q<J,I2BYQBU&]X-]>6_7NOF<O-9^]8
M\*/Q4U#X=WYCL/)N%G&'AF19$?T.&!&1D\XSS73>'_V@-1AMO.6'[#<1<[8D
M&UOPP/Y5R]]\/VTB_6XD;>N,H<Y605FQ^,+:]O&M(556C^\2*)X1TJTY5=.=
M6:>MT=4J,)M-&?XU36/B'XBN]8NH9-T[9)VG@5D>'K01W+*RR,W3"J>*[Y?&
MEK"/)FC7?&.H.,U:\$:5:ZEJK,T:K')\V4&3G!KEPG#F%C4A#"R7^1$H6O)[
M(YFXT&:SCWJ6;9\P![8]*WM%^(4$42V\S[7"8VL<5Z%9>%[5;!O+C61Y"H(D
M.TA<\X_#-<#XI\)6>GZLQB5?FDXP>G-?22P%? ?O:+6NC)A6IU'RR1G>,/$<
M-SI,T%JIFN)5(P%Z9K(\ >%-0T&Z^TR;?)F^\A]??\JU-=N+7PJNZ1%+2#MU
MZ5/IOBVUU72&A61LL,!E[5X\HTYXKVE:5I16EC1V^R7]0T2P\3Z5J#374>GW
MUG&&A@D;(N.0, DCZ\"NL^'W[5=U\-/V=];\$QZ'9S2:M_R][0)$!QG)VY/X
MGO7G=M%+XJU*/]WM\@8)/IS3?&T46FV*(KHQ;HR\JU>1FF0TL=3E5Q-Y0337
M35>AR2P$)755N2O=+L>:WD+?:=T@967K[U8AGC62-F^?NV>XK2F@6Z1ED/IR
M:RCIKH&;>NU>A'>OF)Y3+VJK1U2=]3JIW<+K8]/A^)GAFR\'/8R:>LDS_,LR
MG#(0.GZ_I7.:;XP.HV>Q5\K<2#EJXR27RBNY0WK6EX7D%QJ@.#Y<?)45Z&#S
M&K+%N,59,5&GR/FAU.@U^P:XL-OWG4<#VK#\$>(O^$1\9VUU,LLD-NX?$,K1
M2*0>"K+R#7;ZK?VTD"B-.<$DXZ<5Q&BZ5_;/BM?+98U:;=G&>,U6?86%2M"$
M)[NS^952,9Z=SW#XQ_MK:]\9?AO'X9N&FAMHF7'FS%I)% PH8D9/&.IYKSOX
M9Z':PW<LDZK))T16Y45U)\#>'I-$NTU*18[A5+12L=F#@^A^G%</X4TO[+K
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M(*-\V<U^EGC7QEI/PW\(W^N:Y>6^FZ3I<+3W5S,<)"B]2?\  <D\"O!?&_\
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M<B5&;EN=G<:[J'@7Q+>26,<;6,[ E#]T-W]\9)K9T'7/^$H\30W%QAGX^4#
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M??M._$+X?^#_ (.V2?$*\FD_:$\%:):7=_J#&>;P/?&."*75AP L=R)O* ;
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MM=30@$OY$,A D(;8&QDA23[UZW\/-=U*Y\!Z-+XCBAM=?DLH6U&&W#-%%<%
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MK^J:6DNHVEO&J+Y9D(7_ $=R^T.F65E9<@&NB^"/[7WQ _:G_;\\ ZE]IO\
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M.C&5=JI#6T.:UM$NVFNOF<E2+J591P]X3TO+EO?5OYZ:'D?P^_X*.:?\+?V
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M;06X ?(W 9-?MH.E&**?,W'E?]?U8'\7,%%%%2 4444 %%%% !1110 4444
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MKU/P'I_VG2Q=73)<2^8%8S?-L3/H?YU'>6NFZYJRVL#0QPQR,"0!\QS7L8S
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M1INFZMH\Q!EM[Z-9(6(.02&XX/>M+1-(L]!TBVL=/MX+2QM(UB@AA0+'$BC
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MOPU_;MM;W]H/2?@[XBTJ\C\=#2XI-2N[9 ;!;S[,L\L:<[M@&</C;GBO@/\
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MGXF\%>/X[3496UW4&N]6@U>$-;S/N\M4,,D"P=\AH^F#FNI_X)]_\F?>#/\
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M/3WGATS4+2XFE>.9(%8PK<B8.K;=F^+;D':#,;M*_5O\+V_)"EN[=$OQM?\
M-GOG[/G[17AW]I+PI>ZEH/\ :5I<:1>R:7JVF:E:M:ZAH]Y'@O;SQ-]UP&4Y
M!96# JQ!!KNI;B. H)'1#(=B!CC<?0>IX/'M7E7[+WQ]N/VC],\3:Y9^$=0\
M,^%%U(VWA_5+Z-K>X\30K&N^^%LZ*\41DRL9DRSJF[ ! KS+X/?LN>.OAK^T
M9%K_ (X6W^+2W%U</8>)[C5YK>[\.(Y8J@TQR;4*!E?-@*R#?@)M+$:+>S[?
MU_3_ #%I;0]$_:$_;8\)_LY^*(]'U+3_ !1KVH1:>^LZE%H6F&].AZ:C;6O;
MK!&R$$-]W<[;&VH=IQTGQ:_:1\+_  >^ %_\2[Z>YU+PO9V,6H1R:9%]IFOH
MY2@B$*@C>TA= HR,[A7S#^TOXOB_9R_:\^*VN>(['6+C3OBC\.K/1O#+66F3
MWO\ :&HVKWRM8+Y2-MED^U0LH<@,"QS\IK0U;X?>'?#W_!-;PG\+/B1I_B[6
MF\%:!X=B\66'AJ66.]L8T,):4O&59X8VB9I!"2^Q&P"<5,=8.7FOS=_NLOO'
M*RFET_X"_P V?2GP2^,L_P 9M)O+N;P7XU\%M9RB(6_B2SBM9K@$9WH(Y9 5
M'3)(.>U=Q7R[_P $_P"X6?XA_$3_ (0FXU6Z^![1Z:WA6;4);N9GO2DW]H>2
M]T3.T6X0_?\ E#[]O&:^HJM^1$;]0HHHI%!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?DG_P 'F_\
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M*R2 HR;&SD,!F;^_%=+Z^A44FG?^M5^ESZ?^".I^&/CA^U#\1M9T#XC?$O\
MMSP/K,.BZ[X2O;H0Z7ISI;@IY=J\9_<W",LRRJV7(R& W+7T57Q[_P $I?AC
M+>W_ ,5?C!KWQ&\#?$;QU\4];BBUQ_!RNNBZ#_9T1M(M/B\PF8O&H;>TH5B6
M^Z!@G["K1[+T7Y$WNVPHHHJ0/'OB7_R>U\*?^Q>\1_\ H>F5[#7CWQ+_ .3V
MOA3_ -B]XC_]#TRO8: "JVL?\@NX_P!PU9JMK'_(+N/]PT 6:*** "BBB@ H
MHHH JC_D-M_UQ'_H1JU54?\ (;;_ *XC_P!"-6J "BBB@ KYV^-/BOQ9\7?V
MM[/X1Z#XJU#P'HNG^%_^$IU?5M)2!]6O&DNFMX+>!IXY(XD!CD>1S&Q;**-O
M)KZ)KXS_ &N?C%X-\9_M8^%?!O@;Q'XDT/\ : A>72M.N](BB6$6;QBXNXKU
MKB&6%[>.)!+@QLPD\L)AGYN&'J57>G%M1U=NB[_)V(J5H4U:;2;T7K_PQL^-
M?$'Q4^'^L?#WX-2?$>WU+6?'.M:E$WC)-/@35K'2+2U6XV-%CR#?MO5/-$8C
MV_/Y6>*Y;]JZZ^-G[+WP2^Q^&/B])XBU+7O%WAVS\/7NNZ;:R:G:)<W:QW%M
M=M%&D4L$N JNL2.@=QN8J#7JUO\ \$[O#NG_  Z6UC\3^+!XW376\5'QP9XF
MUHZJT0A:XP8_(\LP@0FW\OR?* 39@ U3L?\ @G/HOB$R:QXK\:>,/&'BV^UC
M2-8GUZ]-M!,8],G,]I9QPPQ)!#;AV=F6- SL[,6)((RUNO57_"_]?YF\7%:^
MOWZG@?[2/[=OCCQ7?:\OA7Q%J'A&%O!.D23VD$-M)=Z!JTGB-=.OEW2(X\V-
M=\>&#+P& Y!KW;1+CQG^S)^U%X1\(W?C[Q'\2/#_ ,1M.U$6T7B*.U^VZ7?V
M<2SJR3VT$2^1)&65E=&*NJD-@E:/C%_P2\\&_%?XD?$+Q9;Z[XF\-ZQ\1M,T
M^QO/[/D@:"TFL[Q+M+N&*6-U$SO'&'W!E<(,C/-=M\)_V39O"/Q3C\<>+O''
MB3XC>*[&PETO3+S58+2TBTJVE9'E6*"UBBCWR-&FZ1E+D*%R!P:6R^?ZV)J6
MOIMI^AY+^RUIWBK]MSX+_&/P=\<KC2[Z\T[QS=Z1Y6@EH;;388H[6:"*"1E#
MN8V?/F.,LV3C! 'TA\$?@QHG[/WPQTOPCX=AFBTG2498O.D\R1RS%V9F[LS,
M2<8&3P!5'X+_  &TOX(:EXTNM-NKZZD\<>(9_$=X+EE(AGECBC9(]JC" 1*0
M#DY)YKNJV^L5?8JA=\NCMTO9)OU.?V%/VKK6][57\KWL<'H_[,W@;0OC/>?$
M*U\.V,/B_4(C%/J*[MS @*2%SM#$  L &(X)KLKEO^)G;_[C_P#LM6JJW'_(
M4M?]U_\ V6IJ5IU+.HV[*VO9="J=&%.Z@DKZOU/!OAU\&OB]H?[:GB7Q5K7C
M1+WX;WT#K8Z3YS-LR%\M!$5VQE"&RX)+9YZFN.UK_@KY\/O"7Q%\8:#KFD>(
M['_A%;HV<<R6XF.H2*Y1U5 1L((+#>1N4$CTKZTKD?'OP'\&_$[2K^RU_P ,
MZ+JEOJCQRW:S6J$W#I]QF;&25[$G(!([UZE''8:I.^-IW5DER^[:W7S=NYYE
M; XBG"V$G9W;?-K>_3R1H>#O&&E_%OX?:?K6DW#7&DZ]9+<VTP!1FBD7(.#R
M#@_A7EO[&W[$&C_L;)XF&EZYJVL?\)'=+.PO"H6W1-VU0!]YOG.YSRW''%<C
M\-?VK/%'A_\ :8\;>"==\$VOA7X;^!]-ENK75%C>-8;: +MDS]QT=-Q"QC*!
M<'->O?L^_M*^$OVI?!%QKGA"^EO+*WG:TF$L#0R0R  X96&>592#W!%.M1Q>
M&ISA"_LI<K=K-6>L;M=2:.(PN)G&4K>TC=+H[K>R['COQ]_X*L^ /@3\7$\+
M26U[KR1PNU[?:7+%-':2C<!#MW?,^Y<,,C;D9KB_V9?^"NGA?XB^,4T?Q1X:
MF\)ZIX@U*.VT^:U7[1#<K(=L1F;"LK;B%R RG<,$#->$W'[ /QN^!>E^)FTW
MP;X/\80>(M4CMF@FBCOF:!)'D68+(5$<;E@&.=XVCIUKZ2_:<TCX1_LB2>$_
MBKXL\#^?XNCAM]+M;;2QNMX)8X20PC9A&/*52%8\@ 8YKZBI@,GA".'HIU9S
M5DXR5^9)/5;).^N^Q\[''9I.<J]5J$8.[4HZ6>FCZ_\ !/6O%/[)/P]UGQ7J
MWCF7P+HFM>,)X78/=)N2YEC.8R58E Y*J/,V[L#K7D/P-T6\_:I\&WOB;]H[
MX=Z/H-QX%U$RZ1=7D;V*1P@!I-ZL_P T:LJ\L2C]<<5Y#\ ;#XN7G@#XU?$C
MQ1JWBC2(/$GAR>]TFPMKC[1-(9<RQW%M#O)C6-,(IP,ASW7G!\&V?Q<^-O\
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M7T%Q-!NW(<3QQ-%MSC][C# D5[#K_P <_"GABV$EYK5K&Q1)/)!+S;7 *G8
M6&00>1TKC/VHOASX,\3_  &TO2?B1J3)H]GKNA2+>,N7EOH]2M6M%^Z_^MN!
M%&>.1(>1U&]K?[,'A/Q)XMOM8OK6ZN)K_F2$W#+$K< L N#DX]<>U>;4ES3;
M9[F'IJG345^)WFGW\.J6,-S;R+-;W""2.13E74C((K+\6?#W1?',EHVK:=;W
MS6,GFP&0?ZL_U!P.#P<5ROP+\7>(M<N-5L-7\.KH=CI;+#8A$9%V#(V#/WL
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MF_"/]E31/@KX?M;'1M8\2O(=4FUG6+R[NTGNO$UU,I622^<I^\S\N @0+L0
M!1MKYO\ #7_!1KXM1_LUZ+\;M<\$?#R/X:ZAJL=I=6ECK=VVN6UO)J/V!956
M2W6&1PY5R@<;AD*2<9^T]:U^Q\,:7-?:E>6NGV4"[I;BYE6**,>I9B /QJ4D
MDW]_X?\  %HW;^NO_!/$?AM_P3I^'WPY\4M?+-XDUK3;6VOK+1M#U743<:7X
M:@O<_:HK*+:#&L@)7YV<JGRJ57BM?X(_L2^&?@CXJL-7CUCQ9XFN-!M9-/\
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M\8RW\B#Q?\(]1\)>(889(9&BO8A-;N%QYB=S^8/Y4ZS^'DMEI;.LW[S(W =
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M?![0_AA+?OI-O)$VH.&E\R0O@#.%7/11D\>]=-Y2_P!U?RH A_M2V_Y^(?\
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M#\_#'P/:Z.U]-J#6Y9C*XV_>.<*,G"CL,FNEH *K6O\ R$;K_@'\JLU6M?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUT>;3)HTV_N26#G)Z[F/M7%V?PQN+NU;<R1R8X Y(%5=)\2_+#<,I*AL,O\
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MAOASX:D\*>#+&QFFDN)(8\L[C!!/./PSC\*XKPCX1UBWU?P_)H^J6/\ 85G
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M:? 1$C*FPR$@-G&3@]1^%>MA>)<JG"&)J2<>;1.2LK]K]'ZGEUJDFN5;''>
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M4;]O+RN9\+SE.%:;CR^^[?<M3Z@HHHIGU04444 %%%% !1110 4444 %%%%
M'CWQ+_Y/:^%/_8O>(_\ T/3*]AKQ[XE_\GM?"G_L7O$?_H>F5[#0 56UC_D%
MW'^X:LU6UC_D%W'^X: +-%%% !1110 4444 51_R&6_ZXC_T(U:JJ/\ D,M_
MUQ'_ *$:M4 %%%% !1110 V;_5-]#4>F_P#(.M_^N:_R%23?ZIOH:CTW_D'6
M_P#US7^0H FHHHH **** "JMQ_R%+7_=?_V6K55;C_D*6O\ NO\ ^RT 6JKV
M>FV]@9#!##"96WOL0+O;U..IJQ10%EN%%%% !1110!POBOP3K7B76M'N].U=
MK&ULYF:>(%AO_>$DX'#9&1AN*YFY\*^,=%O]<UQK+3[[5O,5+&4*K2+'N.2H
MX_AP,'FO5+"98=-+.RJJL[$DX &XU5\+^--,\:6TTNFW4=TD+;'*@@J?H>?Q
MKJIXB<8[)I>1YN(P=*<]9-2>N_E;1>1Y?8^(O^$TT#6+/QY'$LFD[;N.*+]W
M<J .3M4].0/^!'-9/@WQE'XI^*RLLK0>&X;8K]BNG7RDA2, +L)*DA\'N:[_
M ,/>'_"&N?$?5;VSF6ZU95:.ZA+$QKGY6(!&#G&#U%9_CKX ^%?)N+U[@Z(I
MQEQ(%AC.>NUN.>F,XKMC7I)N+35UVVOV1Y=3"XAQ4X23Y7J[ZNVUW^AE>/?C
M#H'C3X=ZC#:6@DGBPD<,X$;(O3S4QV'H,'\Z\Y\/6&J^.[&QT.VMVEA@G=XI
M@C;82PR^]AQ@\=>1VZU:^*2:%9:FNGZ3:W*3Z>J027+./+N0%^_CU.0<]ZCT
M2VUW2OAY?W5FCKINH3+'/+%)AD$8;.1U"G/)]O0UZ5&G&G2O#J]+GBXG$3K5
M[5-;+7E/,_VCO%>A_"+X<:I_PEVB)K,/]K:5I\,(B2;[-?OJ=LEK.-Q Q%.8
MW)Y^[T/2JVKWEQK>H7%S,J/,N/.>*((I/3<P4  D^PR:G^->MW6C^";:YM-#
MD\03KK&G0RVZ*\C^1->P133D#.?)B=Y<\8\O)(ZUL>+?B/:ZM'JEKI.AZ5H^
MGZDT8;R=SS,L;97YR<#) )  !/K7E9M%JJF^Q]!P[4BZ#C'N=1X:N_\ A1GP
MHM_%&GW5G=:]XBE^SVTAC9Q9P+S*I!P-^X#.?PS7??!?XD^)O$7QQO--UG5+
M PBQ$KV,/^KC<JIVIQG<N?FY[U\\V6L36=A=VJXDANT 9&&X(00V]1V88QGT
M)'>N\^!7CV'X01ZAXFU#1[K4(I2MC;W"N $D/S.N6[[<'/T'>O+/H#Z\HJOI
M.I1ZSI5K>1+(L=U$DR!UVL P!&1V//2K% !5:U_Y"-U_P#^56:K6O_(1NO\
M@'\J +--EC6=&1E5E888$9!![4ZB@#)\+^!='\%6,UMI.GVMC!<.9)$B3 =C
MZ_X=!7@?Q%\5VGB7Q<]UX%LK'2]1\(F5KRXD@CM_-13M^0G@C=N&,!CD8KZ(
MUG6[/P]I[W5]=06=K'C=+,X1%SP,D\5\=_'JZCUSXMZQ-8O8W5K<,LD;:?\
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M4ZI<CWU/6?A_IM]I]A]HD\UX9,%ER< ?3I6;\:?!T?B!XWL$19&.6 [XK?\
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MQY)ZU^Q8G(J_-S-1;G)-R:]Z*MT\O(XY4];(Y7PZ]WH]M,UUILMREQ&%1BI
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MV9-.*;<KF^=8@>%)). H'8>E5PT?B36(8W7]RW'UK:T[2;)[%5:#>T@W%V)
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M[+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG&FK/[S6TO29IRD*QM)(3\H'<U] ?L2?LR3_ !K\:76FW4<MI--\MKN./-D
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MI*YT7A6);^\:XO)A)<,O5OX:VM>U"QL[>*%9A--GDCM7G7B1+FRN2OFLNX\
M5I_"'P>WB#QC:/KDTEKI*LWF3/EMIVG'RC)ZX[5SRSZI0IRP\*3E+K979RR<
M7/T.\'P\'B+PQ]I*]"=I[GI7<>&/V:K/P5\/H]8U":1K[45/D(,?*,<'I[BD
M\3Z/IWA]-/:;Q-;SZ7*2B);02(P48_O#T-=5XV\<^&_%?PY_LW2=5FN[O2+&
M5OWJD9&T%0,J/N[:^(\1<RPM;#TI4XR<=5.T6E==[^9E3C4E+FN8'[3'Q;\)
MZ7\-?#6A>&[I?^)="YGB'^L>4MEB>W4FO!;#Q]?^*[6XT_S&AM[@_O(EZ/\
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M]C?QG9QW&J^&[8ZA<*I-]%<3D*K+\JD; 3L.2"<$YR3Q7O5! 56M?^0C=?\
M /Y59JM:_P#(1NO^ ?RH Y+QO\<]-\"_$'1_#MS:WDMQJVW$L:C9%N8HN>YR
M1SCI73>*O#]GXK\/7FF7PW6E_$T$BAMI(8=CZU8N-(M;N\AN)K6WEN+?/E2O
M&&>+/7:3R/PKQO\ ;+T>_P!6TOP[]AL]4N]MXV[[)D[20NW( /S'G:W0<^M
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M!7/^'5\2?!_2M:T^*ZTS[8J+<P6OFK)(!_RTE"\<!1T/7&<>OJ'PJ\=KX_\
M!UO=M)&UXG[NZ5 0$D'L?48/XUXV(E*+]K%)]+V_$^EP,85(K#SE)/5VO\FO
MU,OQS/JGA+PA&+.U_MZ^M;>*-_-C,F_!(:0J.2?8>M9_PF\-WW@VYFU;7M4A
MMVUL I92-Y821CNQ@G&X9Q@5W=M>PW>O2+%)'(8H0KA6!V'<>#Z&L?XB_"G3
M_B4;)KZ2XC-BQ9?*8#<#C(/'? Y'(KDIUE;V<M$]V>G6PKYE7IZN*T5]#>T_
M5[;6(#+:7$-S&&*EHG#J".HR.]6JXWX/^'=!\+6=_9Z+J U!A.6N"90S(V,
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MACUOV9XN8XS%QC!T%S<S2?DOD?,/A/QQ<^&M6G^V"8Q[-L@8_,IZ=?QJ]?\
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MP3Z_Y,^\%_\ 7*Y_]*IJ /9:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MEJ/PJT/Q-<ZXUO->L/*C!SYHPP))(SU&.*\7^)'AG4K;Q/<W-]@*F&']U@
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MUT'1K&\N+[6HKM=00!=/4EIFN">-N1T'RGJ.AKRGP_)K/A>.U1HYK%YT6.;
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M!LW^J;Z&H]-_Y!UO_P!<U_D*DF_U3?0U'IO_ "#K?_KFO\A0!-1110 4444
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M6M'%Q>316MK)()+J14"K_$214OA;PU<>,=4CL;5?](F;$8)V@G\<5[+^R?\
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M=_Q_ ]C#X'V351]49U?VM_\ !$__ )1'_LY_]B!I/_I.M?Q25_:W_P $3_\
ME$?^SG_V(&D_^DZUZ!V'U#1110 4444 %%%% !1110 4444 %%%% 'CWQ+_Y
M/:^%/_8O>(__ $/3*]AKQ[XE_P#)[7PI_P"Q>\1_^AZ97L- !5;6/^07<?[A
MJS5;6/\ D%W'^X: +-%%% !1110 4444 55_Y#3?]<!_Z$:M557_ )#3?]<!
M_P"A&K5 !1110 4444 -F_U3?0U'IO\ R#K?_KFO\A4DW^J;Z&H]-_Y!UO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW/0UEV]^T)7&"<]3720VJZ[HKJSJTF.1GK7=B<PK8R"C-KFCLT12BDM-RO\
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M.OKGBOF/X!_M Z+X7\/0^&_%:SPV.2+*_M4_>6[$;3E01NSA>2:]R^,'PO\
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M(/-_MRVTP2:-:</\LT^\;&^3IM/WU]:C\"?&EO%'Q(U3PG_PB/C73AHD ?\
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MUYI0@TG56(7_ (]IMQ\PG=G[HSM8TO@7]HD^,/!WBKQ!_P (%\2M)_X1_/\
MQ+M2T007VJ;4)_T6/S#YN>@Y7GBO1UTN%!@>8/82M_C5>WTV-KZX4^:<;?\
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M7^T@WC/X?^(M?_X0'XE:5_PCI8?V;J.BB#4-4VKN_P!%B\P^;GH.1D\4R_\
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M8CG0,",'@=NG/:OPW-\@Q^=556P,VH4YJ32>CUZH\?/,MJXRG%49I./1_P#
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MBBB@ HHHH **** "BBB@#\E/^#S?_E$[X=_[*/IG_I#J-?RW5_4C_P 'F_\
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ME=ZS+;7D-YJI^T&]E@;.6R2%;&._ZUY[\)/$]GXHB_=W5OHNH6^T1X<1K/\
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M65]R?9ZN=SZ4\#^*;/2="DC^V!@THD13RV.<UP'Q$DM]?UFZ^QA56X'!*]\
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MW'_7,T 6J*** "BBB@ HHHH JC_D,M_UQ'_H1JU54?\ (9;_ *XC_P!"-6J
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M;Y02!S6W\/+"'1=0:WE;OO0GO6S\4[>*ZT&YV2JR-M=%(.Y2&Y_2O%EA9XG
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M3 %5I&RR]>?YTD19I0*^2P>(Y9WCJ7*.AZS\,-%&M:>;N;Y(8QG(')%9NO\
MA>WT+QQ-'*5"WD>003RW^15[X87%Y8V!AC_>13<%?K6]%\+]2\5_$_0X+Z2.
MVAN)]JN>0H"L3Z]A7Z9BJU*CD_UKD;E#5_+<FG4ES79Y%XCT5],O)HPWRY(
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M_91],_\ 2'4:_ENK^I'_ (/-_P#E$[X=_P"RCZ9_Z0ZC7\MU !1110 4444
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MLZZGX5^+OBQ-!U"^@TMKRUFVW$S!45@OR@DX R?>M>V^'ECX&\3S6\OB'1Q
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M)&LE?M%Q_J1SN']X^U6_[/\ ^GBX_P"^A_A0!8HJO_9__3Q<?]]#_"C^S_\
MIXN/^^A_A0!8HJO_ &?_ -/%Q_WT/\*/[/\ ^GBX_P"^A_A0!._W#]*@TC_D
M%6__ %S7^5,.FE4;_2+GI_>'^%1:58,VF6Y^T7 S&IP&'I]* -"BJ_\ 9_\
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MBBB@ HHHH **** "BBB@#\E/^#S?_E$[X=_[*/IG_I#J-?RW5_4C_P 'F_\
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MXAU5M,D6*6.2)F/\0(R*O://#-=V\F/-C5M[\]<5Z)\:/V"OC%H6@6VH:KX
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M0HHHH **** "O[6_^")__*(_]G/_ +$#2?\ TG6OXI*_M;_X(G_\HC_V<_\
ML0-)_P#2=: /J&BBB@ HHHH **** "BBB@ HHHH **** /'OB7_R>U\*?^Q>
M\1_^AZ97L->/?$O_ )/:^%/_ &+WB/\ ]#TRO8: "JVL?\@NX_W#5FJVL?\
M(+N/]PT 6:*** "BBB@ HHHH JC_ )#+?]<1_P"A&K551_R&6_ZXC_T(U:H
M**** "BBB@!LW^J;Z&H]-_Y!UO\ ]<U_D*DF_P!4WT-1Z;_R#K?_ *YK_(4
M34444 %%%% !56Z_Y"=O_N2?^RU:JK=?\A.W_P!R3_V6@"U1110 4444 %%%
M% %;2?\ CQ'^^_\ Z$:LU6TG_CQ'^^__ *$:LT %%%% !1110!YI^UCH?A#Q
M#\)[:W\<:E<:5H:^(=$F2>$X8WD>J6LEG']UN'N5A0\=&/*_>'I=>:_M8>)_
M"OA'X3V]YXQT637M';Q#HENEJBABMW+JEK':3<LO$5PT4AYZ)T/0^E4 %%%%
M !1110 56M?^0C=?\ _E5FJUK_R$;K_@'\J +-%%% !1110 5Y]^UCHWA?Q'
M^S#\0M/\;:A-I/@Z^\.WT&MWL)Q):6;0.)I%^5N50L?NMTZ'I7H->?\ [5_B
M+PWX1_9B^(.J>,-)DU[PGIWAV^N=8TU "U_:) [30@$J,L@8<D=>HH [;0HH
M8-%LTMV\RW6!!$Q_B0*,'\JM55T.6&?1K1[>/RK=X4:-#_"I48'X#%6J "BB
MB@ HHHH I_\ ,=/_ %P'_H1JY5/_ )CI_P"N _\ 0C5R@ HHHH **** $?[A
M^E0:1_R"K?\ ZYK_ "J=_N'Z5!I'_(*M_P#KFO\ *@"Q1110 4444 %5KK_D
M(VO_  /^56:K77_(1M?^!_RH LT444 %%%% !1110!6TK_CU;_KK)_Z&:\C_
M ."?7_)GW@O_ *Y7/_I5-7KFE?\ 'JW_ %UD_P#0S7D?_!/K_DS[P7_URN?_
M $JFH ]EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M..]>8:QJUQ<WTDD:HL+'Y0>HKMXFP&7U*?L*DE-2T:>IM3K6^/1G[!_L*?\
M!4KQE\4_!.GV;7UE<7EB"EQ!=<.-J@D9'\/ISGK7QU_P5[\0K\=OB%_:ZQQK
MJ%O*QFMX@=D1)&2#Z<'OVKY1^'WCS4O!.N_:;&:3SCPY4X!7N/U->^V_QJ/C
M'2?L+:?)+;W5N(_E8?)(%^;CKR2/RK^9<)X-X/)L_CC\JBH*J[7T25][G;C,
MWJ3P_)-WY3UK_@F3^QUIMS\)-<UCQ-9Z;J:^)"([5'+>9;JN]7SC'WLJ?7CM
M7EOQ1^&>J? CXCZCHDD2P_O"UK*>08S\PQ],@4WP9^TOJG[.,3?V3,UM)G(M
MY@3#+CL0,<?XUD^-/C!KWQJUE]>U:XCN+@I\H_AB''"@GV'Y5^X\"\+YSE7$
MM:M5Q,:N'J1OH[M-;:=#\TP>'Q_]H2KR7NRO=WT:Z:=U_F8/BC2)+C30'D9I
M%Y8G\:Y'_A(X[;3GAD;<W(45Z1X=TI_&D$US/<1VT:GYD[MP*\UNO"-C#XLN
MOM$S1V4(+%CU8=L<>M?I_$%5T(_6X;6LSZZCB/94Y.IT+/PIU;2[*^FW-#%<
M%G:17/UQT]:K?%_5K76+.18(Q)+(-JJ/FP<5RNOZ!I6K:X;C3Q,D$?&6(RY'
M?I5C04:UU0OMW0J!]X5\_@\XJ5L$L/*"C?\ +O8[\-)5$JKW:V(? 'P]U(^7
M<+(T,S'&SL17HEOX??2PK7(5I6X+=JD^&=LWC3Q+<:?'=6]CY<?FAY_NGIQ^
MM8FO^.-/2TNA'(S72.4V@'YF''!_"N[+ZV6T8RAS7E'6S,_;IS=-=!^KZO#X
M?EW-'GSAG%7H_#$?C725F\Z%GE)00C.5  Y/YUS7B?4['5_!$#1F62^\PF0,
MWW>.U,^'OB.;3K'Y8Y)+J1]B01JQ8],\_P">E?/RX@HU:RC5]VES6?I_D85*
MTZD;1TU"\\!ZCX0O ELVPQOYBJ>=V.<\?YYIVM>+II/#LT?G7$>H;MKJ%7;M
MYZ=^:]$T/Q9-8^)[/[.L/VH*\$\-PC':) %8'I[_ )5-=>'+?_A( TECI[1R
MMM^=,C/MS6F*P./J5Y2RO6AI9IVUZKT",E)*5SP6UBNK^988]\TCL"J?WC74
M^.?A?=> O"NGZA>?NYM2Z0\_*OS?KD5]I_LY_LX>!?B;X8U)KB2'P]KNDGSM
M/NXUS()>V, G^(]*^:_VZ=(\=>"?B0OAWQQ"T%S8+NA?'R3J<X=>3QR1]0:_
M)\RSK,:&<1RZM#E:WO\ :7]U[-=^J/05&G.#D>!RQ;+P26\K1OG@YKLO!FD:
MI-%),ZM*C+D/[^M<BT(E;_6,#GC'>O5/"OC>WT/PY^\6-9$@VY_#^M?J'#]%
M5&U7?(K7,US6TU,72O$,Z,XOF;?"Q5<]P*Q_%GBY+F6+;\RJX+ &N^\/>"[+
MQ'X2^TSKYUQ>EWW C]V,\?S_ $KRWQ!IATO69K./]\V=JX&<FO2S>IB<'0A4
MEK"7WE1K._+'H>X>&/B-H.K^%XK:."/[4%_> <'CO7V1^R#_ ,%;M)_9^^&/
M]B6OA&QN+@MMDDFCW*R\>C9SQ7POX-^%FG:-H+W%])-<7TB\1@86,GGT]/2L
M633=2TG4Y%A;=#G/EOG./3M7SO%O#>%XEHPPV>X;VE.*O%)M7\]&+"5G1J.5
M%ZGZ%?M(_&_P;^V1X7NK[2?"MEHNO7$)D6]A7;\W4J1N(YZ=.]? .MV,<?BB
M/2M0^6ZAG.]@?N[3VK:^!WCCQ GC*XL[.XOH;&ZC99(E)P>&XJCXH_9\U+5M
M7O[RSE"WI=F2 GYF.3WXKX_P]R?$Y+'$86A!O#1?,HMMM+MJ[VT-:U=5)*3W
M-/Q5J5M8Z)+&I'E*I'F,?F;VZUR\?B!]/TF18569&&<9Y'T[5QVMV6KZ5?-9
MZI#<0S1'F.8X(JUX=N3;6TJL>O45^E1XHCF-:])65MS*G'EER&YI/CNWDL6C
MW8D_NFN=.@WFI:K-<QJV&.3]*FTK3XXKX,H*\[F<^E:6J>(/L+LD4BMMX/N:
MUGB)3BHU7L='M.70W?#?CNZ\,Z5]G :-6 &,CDUC7>I+<:@UR\;L\C;C[#J3
M7(ZIK-Q=WGF;CU->M>"_"=G<>!(/MJ2?;;@%PY/ 7^'C'<&HH9G4Q=6."IW;
M6R]#FE4C!<S6Y)'\5;32-!PT>YV _>(>GZ]16'X(MK?XAWMQ(S+MA_O?QMQ_
MC69XP\*?8)6MX]N\_-M'W2/7_/K7.>$O$%]X9UQ8H?D7=F5#WKTYYG-UX1Q4
M;QCHT.-N6]-;GM'@?QSJWP0TK6].TNQMFMM= %PS#,BX*G YQCY0:X74[I=2
MO9M0O)(VN+IB\A]#UQ6EXN^(HETK<T>VY9=N3W]Z\MO[^2]=M[-[5P9EB<#@
M9-8?52?,UYNW^1AA\/2I3E42M*3N_P COM!^(%E8S-;RMM53PX'%=I'XLTG6
M[2-H?+,<0^8G^(UX*K^6[$5H:=KOV6X88QYG'UK'*N+JBG[)Q3BS>4>>6IZ%
M<7%Y::BTVF+NM6.7B/3'M71>"?C38>';:2WU*&6$,=Y&,ECC_P"M6#X3\;V+
M6RQS-Y<O0=ZIZCJT::E)(B%XBVT':>:^B^N1HQC5HU%=WT[%3C&:<9'ITOA[
M5/BMX?O/$EA>Z5:V5BG-M.S"XV]><<=\5S'@3Q#'XAE\N.-?.C(^5NX]?H<&
MN.F\--JUTGVAIK6.ZPP"MCS5[9'UKO-'^%R^%M.?48;D2;T"[&(SM&<?SKBX
M<EF<\74Q&(JJI3OIHE9'FT:-2FYJK4NGLK6M_F-\9M'H>H)<*T;1*/G*= >X
M_/-1ZQ=>']0^%<NH+?LNJ1R'S(6[@;L <=P!7"^-/'L<\4VGV\/S%R9"P[_Y
MS6?8> =<TZ"WU:XTZX>SDD78TB?NY.N!^E>-Q9Q!&#=*A4Y=?O[K4VKP2C&#
ME9W^_P CNOB0W@;[!I&H:7=:E_;&T"ZBN5557@\C:/I3;?7;?4-.CD67=[]J
MZ'XB^$9O&-Q_:][I<</V]%C18DV*N% P 23VSZ<U4F\!6^@R3V+1>6UNQ0IP
M?3I75P=3Q$L)'V3YE--WO?KM\C6C+V<$IW.!U2&VL]<BNFD\N%I )#'R0">:
MIZG%=>(_&/DZ2S7$2N1&W]Y<\'\JZSQ'X!CL0SPKO=1DJW:J7@._C\+>)5FF
M78MP-N_M&W;^==U3+YQQ2A7?+%[]O4[/:)PYH]BIXATC4H6BAU"/R;B/!5A_
M%CIFM^W\4KXWU+1=(MH6\RS^:9CC:!D_XU?^(5Y<>(K)6T^"XNK>Q1FENA&=
M@W<_>QC_ /57)_"W54T(R7T,RK=;SD-G/!Z?I6E/$4*&+="A.\;Z]=CGC'W-
M%J>J^-+*STFS^UPR[QN"-'CY5XS_ )^M<M>:W'Y'F*J\GD9Z5Q7CKXO3:IYE
MO#^Y21MTB@YR>E7_  )8-XEMA#)(NUAD^U>M//(U\1[##:^?F9T:48KFGN6O
M%MQ'J.CRJ%'S ,,#\:^DM;_:NTOQO\#?#_ABV\/Z?"VG6,5O/)M(EN"(U4G.
M['8_G7A<_P .[Y]!FDL=OV6UR7=SV'7'-8'P_P#%46GI=7%TJ2PV[$HC=&Z\
M?I7QG$R^I5X8^LGS132[.^A4G&I[L3Z%_::^*EKX#_9U\+Z;X3TA?#,BW N+
MATR6NF^<[VR6Y&X],<5\JV7C&^O=<GNM0DDNKJ9MYE<Y.<8KOO''Q.U7]HF>
M&UFF2"UTN';! Q^4#CWZU@:9\([BYLVD7>\D(W,!TQ7Q'!?#U:G6J8JA!<S;
MD^K5W>UQ5*_V4]BW+XLU#Q-IT,"[)%B;(C'4@8JU<>*X=/NO)N%9-P+<]5J;
M0+>'PU%LF'E2>IKDOBKXCM9[Z'[*RRO&N79>@S7ZS6Q%7"X7ZW5J>]=73,J<
MI+=:';N8+K2I#NC:*5=P4#J:YO2?AO:^*]0=5D\E8QOD(].X_G7-Z=X^D6U1
M?L\S1QJ <=#5S2_BF_A_45N;-&W]&7. WL:PK9CA\7.G4K)<J-Y4I/5,ZB_\
M%6?ANVV1-NCD0L,>W%9>E> ?M%H69E#R'*CU^M#>.KKQQ<M+)'&GEC C7@#]
M:L:=\2(;&^CL[I=DBCAO[M='M,!.LG:T.AIS3C!=RK:1WWA$7"9:*SNF4W [
M2 '(S^(!J'XB_%G3]'\,S7;R>;)"FR%<=6QA1] <4[Q=X\^U64T+7 E\S+F9
MLX11S_3]:^<?B/XW;Q9J0CB8_8;5F$2_WCT+?C@5\AGN;4,N4J>"LW/5W_,Z
M</AU6FF^ABZ[K,WB+5IKRX;=),Y8^W/2J-%%?ETYRE)RENSWMM$%%%%2 444
M4 %%%% !7]K?_!$__E$?^SG_ -B!I/\ Z3K7\4E?VM_\$3_^41_[.?\ V(&D
M_P#I.M 'U#1110 4444 %%%% !1110 4444 %%%% '@'[2GQ0\/?!W]K'X4Z
MWXHU>ST+2/[%\06OVR[?RX?-9M.*H6Z!B%8@'KM/I6__ ,-_?!;_ **5X3_\
M#EKV C<.:38/0?E0!Y!_PW]\%O\ HI7A/_P.6J^L?M__  3&EW!?XG^#HD"'
M<\E^JJH]23TKV?8/0?E7-?&3X7Z?\:/A9KWA/4YKFUT_Q!926-Q+;%5FC1Q@
ME2P(!^H- '#?\-^_!;_HIGA+_P #EH_X;]^"W_13/"7_ ('+7K5K+#<PJ\31
MRQGHRD$'\14FP>@_*@#R'_AOWX+?]%,\)?\ @<M'_#?OP6_Z*9X2_P# Y:]>
MV#T'Y4;!Z#\J /(?^&_?@M_T4SPE_P"!RT?\-^_!;_HIGA+_ ,#EKU[8/0?E
M1L'H/RH \:7]O?X+G4&D_P"%F>$=OE!?^/T>I_QJ?_AOWX+?]%,\)?\ @<M>
MO;%_NC\J-@]!^5 'D/\ PW[\%O\ HIGA+_P.6C_AOWX+?]%,\)?^!RUZ]L'H
M/RHV#T'Y4 >0_P##?OP6_P"BF>$O_ Y:/^&_?@M_T4SPE_X'+7KVP>@_*C8/
M0?E0!X_+^WY\%C$W_%S/"/W3R;Y>*BTW]O\ ^"ATZW*_$[P?(AC4JZ7ZLKC
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MEKU[8/0?E1L'H/RH \8TG]O_ ."9L1L^*'@V5=[X:/4%93\QSS['@^X-6/\
MAO[X*_\ 13/"/_@<M=Q\(_A?I_P;\$1>'].FN+BUANKN\#W#*TA:YN9;EQP
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MZ#\J /(?^&_?@M_T4SPE_P"!RT?\-^_!;_HIGA+_ ,#EKU[8/0?E1L'H/RH
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M&1EVLW!RW '/'2OQ#BF-;.L)&CEE^9?%*',G%=[QLU;U/0RN#H^_4E?U._\
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M56E[*_W'VI\7OV2=+U[X6:+JGB)HM-OKZU2ZAD2(;U61 X![MP1Z5\^?%?X
MZY\!_L37$\=UHU\ ;>Y1@-ZGKE<DC'(Y]*^^OBK\=?@G\4O!VFV,?BR'[9IN
MGVMNTF5:)=L*K@+OQQC%?-O[9?Q%\->-O!6EZ!I%]9W=S(PCMI(Y5;RT^8%F
M /RG..*_+^ \\J8?"X>.%=3ZS4G:=.46DDWT;Z?,F6%]D^6&R6AY[8Z5H/\
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MRFC&$'RN2J-S=[O?\6]CP*TY^TMU.W\#3>&?&DGV/Q-KT^GV\2DN)U#,_P!
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M*/#>IV=K<>(M)NQK$4.IPS7+@VS[4,,46X[SELX7)K/#I^R2ZMN__@;_ $_
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M$FY1O+CWS>:JB,))R<BKII.K&+VO%>J;LV^S\NNYG4YE3<EV;?DTMO,^G_\
M@H3X2_:$_9Y\"_$7X^WW[1U]X<O/#>IJW@KP!H^GP3>'M5M_-2.TT^Z26/[1
M<7ET25)C<!6<;00N:]__ .%_>*/C-^V]X/\ AQ875WX8M?!?A2#QQXU@@V^9
M<W%UO@L],9B"5C#+/*^.3Y48S@FOECQ[JG[2?B7]NO7O'WCK]D_QM\4=!\$Z
MS+#\,]/M?&VB66B:1;I\BZHUO)+OEOY>6$DF?*1@J*IR:^@_AK#??##_ (*W
M^*+W7+*32XOCA\/M+N],25Q)Y5_I9E2[LMZ_*72*YBDXX8!R,@&LHWY8_/\
M])>_7S*EN_E^+5_N/@K]FG]IKPQ\=[9H_'W_  47^*'P_P#B1JWB;4M+;PA8
MWVG1K8NNHS06T"+)9NWS((\9<_>K[.\=?\+8_;>_:W\;_"'PC\7O%'PG\!_!
M/3M+M=:UW0;>UD\0>)]7NK?SP/.FC>.&&.':6"(2[R=@!7HW_!+/]E&^^!/[
M)6EZ)X\\(Z5I_BJVUO6+QUEAM[B94FU.YGA?S$W DQNC=<C.#@BN.^-7P_\
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MVZ*:ROK\YF59F=9?,()!RN< 42\N[_6WXI+YF?YV7Z7^[70]E_X)!_M0:O\
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M^U6)7$L;KA@"<9QC!KPKQO\ \$S/%'[;/[=WQ,^)?Q"\6?%CX5Z7H-O:>$O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,_+NZUU_A<W7C0S?V;YD4D49>4H=N!W&?Z>U0>$/!\/B+Q#]EO?FDCRPV_\
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M6H:_J0^SO=VBL$#_ #'!W>RU]@:1^S_>?LQ? 35+CQ1JEM>,;A8_]%O(YA;
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MO\*_05F5['$'%F+S-*E)V@NG?U/8P>!A05^H4445\F=P4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **\W_;*\4:AX'_9"^*NM:3=S6&JZ/X/U>]LKJ(X
MDMIH[*9XY%/]Y6 (]Q7\??\ P_/_ &NA_P U^^('_@8O_P 30!_:917\6?\
MP_0_:[_Z+]\0/_ M/_B:/^'Z'[7?_1?OB!_X%I_\30!_:917\6?_  _0_:[_
M .B_?$#_ ,"T_P#B:/\ A^A^UW_T7[X@?^!:?_$T ?VF45_)/\,_VJ_^"DGQ
M2L[*^M?B)\5-)TB^<*FHZU=Q:9:JI./,+3!3Y>?X@"*]>7QS^V=X>TQ9O$G[
M;5K8S\^;;Z3J$VMM" 3U:WA*=N@:NVAEN+K+FI4Y27=)G/5QE"G_ !)I>K/Z
M>J*_G;^//_!1_P"-'Q8^%/ACP7X?_:.D\'^(M%"WD^NV.D:P;C5D\E8RLV^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y/^WI_
MR8W\9O\ L1=<_P#3?/7\+=?W2?MZ?\F-_&;_ +$77/\ TWSU_"W0 445]<?L
M&?L(6?C?0+?XG_$:UN/^$)BN?)T;1D?RKGQ9<JV" 2/EM$;B60<G.Q>22O1A
M,+5Q-54:*NV8XC$0HTW4J.R1P_[)W_!/GQ3^TMIZ^(M0NH?!O@&.;R9->OXB
MQO'! :*SA&&N9!SD*0BX.Y@< _=_P4^&_P +_P!F:UFL_ ?@ZXAU)]J-XKUV
M&*\U=E#8<H'4P6ZD$'$:DE2,G(S4OB;QG>>*]9MYM4M;*&&U06NF6%A"+:ST
MV)<[(;>!/EC0#'R@#)Y)))IOCG3Y_"NJ:;IZI:W4-S-(M\C,ZR0+L!0>6V"-
MQ.?FQ\H!&0>/U[*N#,+@E"6+]ZI)Z+?[EY?/0_-\TXBKXJ?L:3]G%[=V=1\4
M[2?Q+JL!U*_NKG6X9W1I]2N_/8Q8C'R2,QQ&"-Q4%5 QCK7G*7?B+5_$R>%Y
M%T^X\(SVS2&4$_:[NZ&[*!3GY&3 P3P<]:S]9\;ZWXN^.MGI-J][:^$_#MF+
MF:W6U"6]Q,=R&/S" 63 W8&>2.>!3_B%XQTGX3^";[Q/J4\EIIMJ/*",_P ]
MW,?F$,:GDN03T& !R1Q7T5.K!X><L0_9QA*U]D^^FNE^AX^'HUXR4:GO.=K+
M5[_J4?%_A)_B);3SZ;J#6<L<?V.VN;91YEI(I(VOCIMP!V(K-T6)-3L]-M9&
MUK5-2\/PO9RZA)MC!E;:KI(O\7\+@X/ SZUT_P -].L?%.DKK6@/#:R>+$@D
M&\E/M[%ODW G:LAW$;B>HQW!JGI$VN0^,_$^B:AH]UI;Z#>/:B7)9]^,';@#
M[I'!SCH<FM[X>HTZC7-+735-+9]EMO\ (V59+FI)ZKIL^B.R_P"$MU;PG!:R
M6>KZ]_8]C9R2)X>=/M=CJ2RE8PQMG!A9QLQD8/S,<BO&_CW^RM\(?VB_&WB.
MUTZUM_@_XPT^VM;M]2MK>1?"-U/*HWP2Q?,UJ5.W#0%T&6RA)X[WXGZKK_A#
MPAIEYX=M;76M1U*1$$-S.R&]D(W.(B 5&$#L2S+VQD\&M\5;YM8N-%77/#NI
M:E8Z+IQUIEL;E)(;66,$F%_F02.JY(+#'UQ7S&=93@:VE2/*T[R:32;:W4K-
MNV^NAZF5YAB**CR.ZU5K]O+UT^9^>/QT_9]\7?LX>.)/#_C#1[C2;[;YL#G$
MEO?19PLT$JY26,XX9"1G(.""!Q-?J'H7CCX;_M5>%8/!_C34+_6M%\06J7FF
M6$$;O<>$A]U[VUD*!(I3A3)#N\N;(# -M(^$/VN_V4/$/['_ ,79?"^N^7=V
MUQ;QZCI&IP*1;ZO92C,4\>>1D<,A^9'5E."#7Y;FF5RPDN:+YH-M)^G<^\P.
M81Q*LTXR6Z9Y77[A?\&0G_)SWQR_[%>P_P#2MJ_#VOW"_P"#(3_DY[XY?]BO
M8?\ I6U>2>@?T=4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!^2G_!YO_RB=\._]E'TS_TAU&OY;J_J1_X/-_\
ME$[X=_[*/IG_ *0ZC7\MU !1110 4444 %%%% !1110 4444 %%%% !1110
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MJOW>23SV[UY;XT^.>AO^T+I_B;=#JD#N);R$HK(XQMY7D>G45]8_'GX=^$?
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MK*"KYD&0,=:^@OV"-(TOPGXRN-<U2."ZN-+A+V\$J @N?ESSG^]Z5YCH7AM
MRW#?:)F'3*=*W=/UV\\':A%J%O#)Y(.'0C;YE1F'#4*N!<*JO?IM==OF5&+A
MK?4^J;+X^_$'6?&O_"17&J7VF:/9N)6?S&@@5%.[8N,+DCCCU%>?_MI_M_Q_
MM 6EUI+PW303K&(II;]I-H7U!'?COQ7E_C'QMJ7QH99-0FFM;-1LCLK:4QQH
M/?;C/;D^E>>^,?AY::,C&VGD#GLYW#'U)KR,PX#H8BK0S26%IT_9JT8QT??5
MK?8?MI0]SFW,>Q\,6>H:DJ+<1KYAZ[NGZU],_L7_  ZT?38-<U_Q %C\*Z/
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MGD*A<''!ZUG.T5=:^FOX%5*DN5N&Z[GS7XC^'FO>#$5M8T75M)5I#$#>6<D
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MT^>/PG -6?19[TWE[KJP;#,S[V5I00I8PPCY5W$# )KO/^"F_P"R!<_!VW\
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MC)-:'4FFKH]RHHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!Y/^WI_P F-_&;_L1=<_\ 3?/7\2_[+OP6G_:-_:/\"^ K
M>8VTGC#7K/2#/MW"V6:94:4CT126/LIK^VC]O3_DQOXS?]B+KG_IOGK^.?\
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M '#; %/S'Y<@C.<9Y_XHZY+X8^)'PWTNXMUO+?7M1NKJXLQ)NRMO#^[9U7G
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M;XNNWR/O^'ZW/AVHI\J>E^Q_1U1117RY[P4444 %%%% !1110 4444 %%%%
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MP*[;]E#XV:?^SC^T#X9\;:GX;@\76OAZZ%U_9DUW):I.PX!\R/YU*YR""""
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MYA0RL>&_V3C/0NU?XDV^I>)VM([:+2[J0^;+;J%,-S&^!NA3[RJK## 9P3U
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MZ5\\V+LLOS*OY5]"?&SXQP2>#)K?5;M3>R X$LN<@]SFOES5/B'I^F22?O\
MS.>%3YOU%>!DN'^HWPN(ES<CM>UKG7R3K1]U;GI_@_PS<>,-0$-NN&4<[:TE
M^&,,GB%Y+R:&.&U7+^;*L8)^IXKQK0/VI=8\$VEU'HT,-M)<\-+*OF,![<#'
M2N'\2?$/6O%4\C7^I7EQYWWU:9BI_#-?H'^L&54,/",:;G+=K9'51RVI:TK)
M'T#XV^-OA/P45%GMO;A<JT-NNU0<?WL8->7^-_VG-=\30-:V;+IMF<@+$2)"
M#V)!P>/:O,\T5X&8<68W$-QIOV<7TCI^)Z5+!TX+74FN+F2]F:261I&[L3R:
MAHHKYF4FW=G4%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH **** /R4_X/-_^43OAW_LH^F?^D.HU_+=7]2/_!YO_P HG?#O_91],_\
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M>SFG]GXJMS4JBMZ_\$F&'G\4KE&P\.2Z1+&[?-A@3^%=7XAN2?"%],?]8\#
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M_#W_ *;+>@#W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M._MJZ7\4H[?X9_#^Y6?P)H-U]IU'55A,<GBK4579]HY)9;:,96%.,[FD8;F
M7%_:N_;^;Q]X3NO /PWL[SPQX!G;_B8W$[+_ &MXI8$$-=NO"Q J"L"?(.K;
MFY'S'7YOQ1Q(L?/V6&NJ:^]^OD?I61Y##!KVE367Y?\ !"OW"_X,A/\ DY[X
MY?\ 8KV'_I6U?A[7[A?\&0G_ "<]\<O^Q7L/_2MJ^-/I#^CJBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,_VK
M/V.?AG^W!\-[?PA\5O".G^-/#=K?QZI#8WDDJ1QW*))&DH,;*V0LL@ZX^8U\
M[_\ $.O^Q7_T0'PG_P"!=[_\?K[4HH ^*_\ B'7_ &*_^B ^$_\ P+O?_C]'
M_$.O^Q7_ -$!\)_^!=[_ /'Z^U** /BO_B'7_8K_ .B ^$__  +O?_C]'_$.
MO^Q7_P!$!\)_^!=[_P#'Z^U** /BO_B'7_8K_P"B ^$__ N]_P#C]'_$.O\
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MI_X%WW_Q^D_XAU_V*S_S0'PI_P"!=]_\?K[4HH ^*_\ B'7_ &*_^B ^%/\
MP+OO_C]'_$.Q^Q6/^: ^%?\ P+OO_C]?:E%%P/BO_B'7_8K_ .B ^%/_  +O
MO_C]'_$.Q^Q7_P!$!\)_^!=]_P#'Z^U** /BO_B'8_8K_P"B ^$__ N^_P#C
M]'_$.Q^Q7_T0'PG_ .!=]_\ 'Z^U** /BO\ XAU_V*_^B ^$_P#P+O?_ (_1
M_P 0Z_[%?_1 ?"?_ (%WO_Q^OM2B@#XK_P"(=?\ 8K_Z(#X3_P# N]_^/T?\
M0Z_[%?\ T0'PG_X%WO\ \?K[4HH ^*_^(=?]BO\ Z(#X3_\  N]_^/T?\0Z_
M[%?_ $0'PG_X%WO_ ,?K[4HH ^*_^(=?]BO_ *(#X3_\"[W_ ./T?\0Z_P"Q
M7_T0'PG_ .!=[_\ 'Z^U** /BO\ XAU_V*_^B ^$_P#P+O?_ (_1_P 0Z_[%
M?_1 ?"?_ (%WO_Q^OM2B@#XK_P"(=?\ 8K_Z(#X3_P# N]_^/T?\0Z_[%?\
MT0'PG_X%WO\ \?K[4HH ^*_^(=?]BO\ Z(#X3_\  N]_^/T?\0Z_[%?_ $0'
MPG_X%WO_ ,?K[4HH ^*_^(=?]BO_ *(#X3_\"[W_ ./T?\0Z_P"Q7_T0'PG_
M .!=[_\ 'Z^U** /BO\ XAU_V*_^B ^$_P#P+O?_ (_1_P 0Z_[%?_1 ?"?_
M (%WO_Q^OM2B@#XK_P"(=?\ 8K_Z(#X3_P# N]_^/T?\0Z_[%?\ T0'PG_X%
MWO\ \?K[4HH ^*_^(=?]BO\ Z(#X3_\  N]_^/T?\0Z_[%?_ $0'PG_X%WO_
M ,?K[4HH ^*_^(=?]BO_ *(#X3_\"[W_ ./T?\0Z_P"Q7_T0'PG_ .!=[_\
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MV*_^B ^$_P#P+O?_ (_1_P 0Z_[%?_1 ?"?_ (%WO_Q^OM2B@#XK_P"(=?\
M8K_Z(#X3_P# N]_^/T?\0Z_[%?\ T0'PG_X%WO\ \?K[4HH ^*_^(=?]BO\
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MB(_X=*?M2'_FW?XT_P#A'7__ ,:H_P"'2G[4?_1N_P :?_".O_\ XU7]N]%
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MX.E_A9\;]&^*W@OXY_#2W\!:/\1+&YAD\2^"8I'O+UF#)'Y\3-N\S8Y(D$F
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M=8I3(&4H>22<<T ?>U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>nstg-20221231_g6.jpg
<TEXT>
begin 644 nstg-20221231_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $UA<FEE($)E
M=F5R;'D   60 P "    %   $*:0!  "    %   $+J2D0 "     S8X  "2
MD@ "     S8X  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112%E7[Q
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M2C%&* #:O][]*-H_OC]:,48H -G^TOYT;/=?SHQ1B@ V'V_,4;&]/UHQ28H
M78W]TTFQO[I_*C%&/>@ VGT/Y4E.R?4_G1N;^\?SH ;13]S_ -XTFYO7]* &
MT9IVX^WY"C)]%_*@!M)FGY_V5_*C(_N#]: &9HIW']S]:/E_NG\Z &YI,TXA
M3V;\Z38O7YOSH 3\*7!JPMQ@<Y/U I?/0]5'_?- %;'O^5* /0U8\V+^ZO\
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M #<48IV*,4 -Q28I^*,4 ,Q1BG8HQ0 W%&*=BC% #<48IV*,4 -Q28I^*,4
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M <E3UYK@K_5+R&R9!<SV\R274D<AF\M6VR$*N-IW'V]*Z#PU*T]_JDTGWI#
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M/R[6V(!F9^22JL!M_'FMF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHI#0 H<\@' H$I!P'P?K35ZFL"^L6?\
MM6?R6,P=&@< YX5>5H Z032#I(WYTOVB;_GHWYU@ZY(S200O\D+*S&4JS?,.
MB_*1CK4?FW$OA_3"\LBR22Q+(P)#$9YH Z/[3+_?S]11]ID[[3_P$5AVTLUM
M#JD<;/-]G8F$2$L?N XSWYIFG73_ &VVC6\:[6> R2;B#L88Z8Z#DC% &_\
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M\NM(OX62[\CS8E;KYD?3\UR* (?%=FGB#P98:I;\RV3A2W_3-^1^3<?C7<^
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M>]8<W^L_&@#5MO\ CW7Z5+45M_Q[K]*EH *6DHH 6BBB@ HHILCB.,L?P]Z
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M,6@V+(AX$I'3\3Q^56?#?A#4H-3?4M=OVNIGSB,DD)GW-=A!;*B!8(@JCT&
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M2&I"M,(JAC:2EI*8PI*6DH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO/$ULV?M.C:S!_OV+'^6:R9O$>A9/F2S0?\ 7:VD7^8KT(Z]HT_W-3M3GUE
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M6XOB1:?\M=-D'^[(#_,"@!\=IXUAQB+1;C_@4B?T-6XK[QC;_P"L\-6<^/\
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MH 2C%+10 448I: "EI*6@ I:!10 HHI*6@"CJ/\ K[/_ *[?TJ\GW!5#4?\
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M\TF[IC '_P!>B;B*&+URY_D*65=]ZL*](E"#Z]_UI5Q/J#'^!3@?[H__ %4
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M **** "BBB@ HHHH **2B@ HHHH **** "BBB@ HHHH 2BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1124 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 +124M !1110!0O_\
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M^E'F3#[T'_?+B@"6BH_.(^]%*/\ @.?Y4ANHA]XE?]Y2* ):*C%Q"WW94/\
MP(4\,#T(- "T444 %%%% !1244 +2444 +2444 %%%% !1110 4444 %%%%
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M'H<T4 %%%% !1110!1OO^/VS_P!\_P JNK]T?2J-[_Q_6?\ OM_*KR_='TH
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M\%HJ 8&* ,K3]#BM\$KN;^\:V8K94' J=8\5IZ7HEYJLFVTB)4'YI&X5?QH
MSECQ70:/X3O=2VR2C[-;G^-QRWT%=7H_A.RTW;).!<W YW./E7Z"MZ@#/TS1
M++28\6L0WX^:1N6/XUH444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %'7K110!&UO"_WXD;
MZJ*A;3;-^L"C_=X_E5JB@"@VC6C= Z_1O\:A?08C]R9Q]0#6K10!B-H#_P $
MZGZKBHFT2Z'3RV^C5T%% ',MI5XO6 GZ$&H6LYT^]!(/^ FNLHH XTI@_,,?
M6DVUV14-]X _45$]I;O]^",_\!% '([*3RZZIM*LV_Y8@?[I(J%M$M3]TR+]
M&H YHQTGE5T#: O\$[#_ 'ES43:#,/N31M]010!A&$4TPBME]%NUZ*C?1O\
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M[=?)0\#ZGO76Q11P1K'"BHBC 51@"G44 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU$*'D_4]OPKJ-,T:RTF+;:1 -CYI&Y9OQJ_0!%;6L%G (;6)8HUZ*HQ4M%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
6%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>nstg-20221231_g7.jpg
<TEXT>
begin 644 nstg-20221231_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $UA<FEE($)E
M=F5R;'D   60 P "    %   $*:0!  "    %   $+J2D0 "     S8S  "2
MD@ "     S8S  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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MR*SDK2:.FC/VE*,WU29[W<?M(^$+9"SZ;KC ?W8(?_CM4#^U1X('72]?_P#
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MSJI4--.S-8RC)<T7='UI_P -4^"/^@7X@_\  >'_ ./4?\-4^"/^@7X@_P#
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MW(Y%C.;"V'W+:(_*GTKHA4=.-N9I^3U/,J0J5ZG/1C9/>^B?:W7YE.?PW?\
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MPA=:,\%Y:VLC:==0B:.0+D*#V/H:Y:L6FMT=<:E.HKTY*2[H****109HHHH
M*Z3X<_\ )4O"O_89L_\ T<E<W72?#G_DJ7A3_L,V?_HY* /ORBBB@#YM_:Y_
MYE'_ +??_:%?."RR+&45V"MU7/!KZ3_:SADGD\'QPQM([&\ 51DD_N*\!O\
MPKK.F0K)>64B*PSP,D?7%-)O5&<JD(M1DU=F12JN:<8RC8D5E/HPQ5_1=*DU
MG6(+*-M@D;#/V4>M"3;L5*2C%R>R*()"[03MSG J[INC:AK$YATVUDG<#)"B
MNIN/$&BZ'<-9:1I"R-"?+DFE.[S&'&15>[\5ZWJD(AA$=E$.AM4V-^8K3E@M
MV<:K8BHOW<++NW^B,^Z\$>([*V>XN=*F2)!EFQTK![X(P?0UVVGS:Q9Z8VIK
MKLYNHI,+9SN75QZD&K%S;67C?2+FZMK06FO6:[Y4CX6X'HJ^M3'DJ74-UW(6
M)JTF_;).-[75U;U3Z>:."W%0<&O0;Q89/!^ASQ>8NF+A;YHNTGJ:\]((8AA@
MC@@]JV_#WB.^T836L)66TN1ME@E&Y2/4>A]ZZL$Y*O&,=WHGV?<TQE*52*E#
M=:_UY]CHK]&M?#L6J6^KK/IS7!AALF.70#^*MCP8_AK6IWL-:AN#<2(3 T1.
M ?4U@2>$-/U*))-!UI)6<9-J_!1O2IK+PGXP\+ZI%>P6H29%(7<01@^U1B\%
M6JRJQYGS-^Z[I:^;W>SN<DL71C1Y*4U&72^FOG^I5\7:-8QV+W.C%I4MI#%=
MRD\%\\8_"D\<DC3M#2XYG^QJ0>^VH_[/BEU6>3Q)J2V$#/YLT"'/FMZ!1QFL
M;Q)KK:[J@F5=EO"@BMT/54'3-34HU<+>A6:<E;5=>M_,>'4YSA=WY;MOU6U^
MORZ&8N[>NS._/R[>N:]1T[33X@TRVA\;Z?-%(@"V]\APS#_;]:YCP7;16]EJ
M7B&>-9O[,1=L+#(9FX!_"H0VK:LS7%Q>7!#G(0.=J^P%*#4%=]33$0EBIN%-
MVY?M=;^7RW.DU7X1^(["82:')'J=NW*&)AD#T-8\OA/Q<2T%QI4T97J7XJH%
MUJSY@U.^AV\@+,P'\ZZZUNKOQSX0)OM;FL;W22?-G:0@3J>@X/6J2I5'[J:9
MS5*F.PD4ZLXRC>S=G==M$S MH(O ZR:A<W45QJ<D92&!#_JR>YIWB\C6= TC
M7XER%B%O<R?WI:GT_P"'D\LDSZQ+OCD0M;W DW!O<U<LX?#P\+/X5O=<59FF
M\]90ORK)TVU,9.3E3M9+N3.=.$X5XRYY7UMVV>BVL<G8HI R*FO+<;?W:[G;
MA5'<^E7KOPIKFCJS26QEA4;EECY#KZU<\*I#$;C7M;B=;.P^[&ZX+2'[M*5"
M<)\LU8].6,I>R=2#YO3OV$U&P_X171[2'3GE76;Q/-EFC./*3^X:K1:[::_:
MQZ3XQ7RY%/[C48P-ZG_;/<5N7T]G?Z,==N=31KNXG"FQ"X*+ZYKE?$4%EM62
MU8$$<BJ^LQJ02B]FU:UE_P $RC@[P3J_'O=;I^7DMBS=?#G4HV#Z.\>K1-RC
MVYX_&N7U'2[[2KHP:E;26\O]V08S3X-2OK1=EI>W$"CH(Y2O\JZ^UO)/$GP_
MO(=3_>W%FX>*Y?EL?W2:;<9Q48Z6)Y\1A[.JU*-[;6?^1D^%K&2.*ZUP+"ZV
M"[EBF&5D/I5'4=0O=5N6FU&Y:7><B,GA!Z =A6]X33^TO!NN64?^OAB\V-1U
M?Z5R$<A4G?UZ'-:.I36'4''7H_SOW-*/OXBHY;K3Y6-*T, <1RK\I]*MZEHY
MMH5FC^:-AD$=JR4DY!':MBWU;S+=H9QE<8&:XCN.?D&&KI_ ,!&JW%]*QBM[
M>!BTAZ$XX7\:Y\6SWFHI;6P+/*X50!GK70^)[J+1;!/#.FGY4 :\E!SYLGM[
M5I#3WGT./%/G7L([R_!=6<U=3_:KV:<#;YCDX':KFD:%?:Y,Z6,19(^99#]U
M![UFYQ7:ZSYV@>"]-LK7=;S7F7N'0X,@["E&S=V57J.FHTZ>\M$7="T?6/"\
M\K/"NI:/<+Y=VL9W*N?XL>HJM?FP\->((8]!DDELY$#F1N>M9?A[4=:TF\6>
MRDFFB;Y9(78E74]L5W6@7NG7.CW6D:U8+827DY^S3NN0,_PY[5T4W"5.:?2S
M7??6W](\RM7KX&<JDHJ2E:]M_6W=>6Z*NJM%JEB&4AB5R*X*]@GTRX2\M7:*
M6)LJZG!!KO?%OAB?PO#:7.DPRRQ-E9802V,?Q9KAKHW^N3Q6]I:2?O6VJ,<9
M^M<=&2KQ<Z*;2\M=[:]CT</BZ.*HJK%^Z^YK^.!%J.FZ3K40S/-#MNG[N_K7
M&"NL\:SQ6UOIVBP,"]I%BY"G(\RN3[5K5^(6!35!+IK;TOH7K0(R_-2W-N -
MRU5BDV-[5KVZI/"0WI69VF]I"0Z;X%LKN.8VDM_=O#/<C@J@Z8-<O$+'^WV_
MM*26YM=Y!=&^9_0UUL]T$TNST?6;/[0LAS;QH=FW/1C7/>)?"UUX9O(X;IE+
M2#>H4_=%;8BA5@XJ>G-%62?SO_F>/AYQ]K*$W:4[V]+]'OH=;X#TQ=-UJ^?=
M<65Q);L]FF[F5/0UQFH6VH7%_/<SB7S2YR#U6M3PS)>Q:W9:BTDLYM'!P23\
MOI]*] \06OV34(_$^BQI/:7#;I5*Y$<AZ@CTK*$9JBU>\ET%%2PV);J:N:LG
MTNNGS/._#_C;Q#H&H6YMKQY0C;5BF.5&>M=MXR\':/>2VFK6.J0:3=7R^9.D
MA^3<1V]*X_Q/HUR;J.[CA^>\?]VD8ZL?05LFZTOPYHL>@>+H&U&XN2'D._YK
M/\:UHSE->\_=_7U,,71Y:U.MA])=5&UVORT,Y? BR3JD_B:QRY^50W+_ $J]
MK4-EX2NO[+\)B5[N1%^T7['[G^YZ5F2:$/"_C"RNFQ<:=\MS$[<_NSTKM+[0
M)7-Q=PJ%"@3AR<K(K<@"M(^S2:;47>VM]WLM.K-TG.I!UZEX25XJUE)W2MIO
M8D\/3;;58]>N+C4(Y%VK(3EHR?>I;C1='\.M:W<E]#=PPW'GXC&9V)_A)]*H
M6NN7%H_V2UM%D>8A2".E;EM:3V%TUO!]FDO)DS&CH&VM58?#^UFN>UV_=;?;
MOU27XG'F&%]FY5*>BZQ77SV]VQ#>>'5GUJ>#1M1A2'5T$S6]T,O%G^[Z&JOA
MNWT[2-5U&UU.Z\UK,AHW5L;@.HHU'Q-/!IMI:W=DCWMC.V9T7#,S<8SZ53N-
M)@FTNY@GC==3W"0S@\ 'G%=,,%%4YUZT7!2DX\T7?E::]^W;OZG/+"8BWU=3
M;4DMK)^OFDK%6^\-Z+K=Q>:CI6KC35N 2?// ]C6VVBZ@+.$Z%=PSHL8669#
ME< <XKG4L1%I$UI-LE0G.2O2N5MY=0L99Y[&_DACMB&,6\[6&>F*UIUZ6'JS
MITTIJ2U:TN?:Y=5Q&"BZ5*7M(N-N66EK=FM?7N=3HVO:K?WS6D\KP(K$'(^]
MBM>XT>6[8Q:E<1V$$GS)).?O?2M.Y\3);/%J;+:NFIVX^R*L(Q&P'.??-<U>
M0?V_IZW5ZLD<ZGG>^5Q["FH4Z.'E%R5W?KO_ %^(\'5KU<#44N6F[M:.[=NW
M31_?KKH:D%O'I6;;2(D$!&9)R.7;Z^E4;Q9I;>4>8B22]7'<CH*B35(DLQ96
MK$!?O%CFKFE6 U'4[:&8[8L&0L?5>167U]ODHTFU%;H[)YA]2PM/V<G[*.KN
M]6^O_ ];%F]UI[/P_9Z3O3[;=*7G7'W0.,&N6\7ZC>7.C01ZS+YDMN=MJ8AC
M8/>MZ[U:2XU:26.",OG&"F3QQ6=JJ17&BW<EW'YDSC$2 <AJWJ5L/7BH\SYE
M>S:\M?FST*.,H5*$HSDW4E=W:LOGKJ[61Y]=ZA?:D8UNYI+AU^5,\GZ5W&B^
M$H-%C2[U55GU(PF6&QSR#V)K4\+^$[;PQ'!J6L;7U1EW1V[C*Q ]":RO$VF&
M6>XUC^TG-PQX*G''H/2N6BDG[6K:3ZIO7UUZGS^%G]:G[:=IT]4[NTGZ7_,S
M?^$MU?2KB.XEO4O$=BTMA)\T:>V.U1^*=)T^ZTJ#Q+H"-%;73E9K8C/E..OX
M51\.>&+OQ+JQB4^5;Q_/<W#\!%[FMF7QRFC7S:9HMM$^BQ-Y;QR*&,O9FS[U
MS.2DKRT70\?$*$<0OJ<+26ZZ6\_-]#AZ*Z;Q;H-M8QVFKZ1DZ=J*ET3J8CW4
MUS-<\HN+LSNHU8UH*<0HHHJ34*Z3X<_\E2\*?]AFS_\ 1R5S==)\.?\ DJ7A
M7_L,V?\ Z/2@#[\HHHH ^?OVI=9OM*C\,+82+%YWVO>^T%ACR>A[=3TKP#2?
M&6NZ2Y^R7NX-U$J[P?SKW[]J:U%TOA?)P5^UX_\ (-?-\]B\#=.*I2DMF8SH
M4IWYXIW.M3Q%H?B%6M?%=DMM,X^748!RI]-O2M;PGX$U2UU?[9I7EZEI\RE1
M+$V64>I':O.?+#*=U=SX)UG6_ NCQ>)],U*V-E-=?9IK!GS(P]=O8>]35Q+I
MI.R<KV70XZF!?)*-&5D]UNOEV.2>S/\ PD%U;D<K<,AS]:[9=)BTZUC)4,Y&
M:B\:^'+K3?&7]I65E*]GJ$:W@D4?*&?DBK,-V+QD\QL'&"#VJI1E%VDCIPM:
M%>E&<'?0$LO,MW=T'(XXKG4NYO#_ (AM]2L^)(GP1V*G@Y_"NU+@6OEJ<BN)
MU\KN< ]C23:=T;RA&<7&6S(O'>DP6.LK>Z?S97RB1#VW'K7+,2O3BNVUX_:O
MAIH+\*;4LIS_ !9JEX<\$WGB&$S;H[>+.$\T[3(?1?6NA4G4JJ,6E?J]$OF<
M&'KQI8:]5_"VON9S*7<\87RY63:<@KP0?K5VY\2:U=ONN=5O)#C;DS-T_.NS
MU;0/"ME:BYAL[_\ <_NIXG?'SCJ0<5EV=KX)U+]S)+?:?</Q&2P9 ?\ :R.E
M0[S>LKM:;WM\]OQ)CBJ-2/M/9O3R..9F=BSDLQZDG.: C$9 X]:U==T"Z\/:
MA]GNP&1OFBF3E)5]0:SLG&,\5%DFU,]"$XSBI0=TSLK.-K7X:RFV&_[9+B?V
M /%=KX:T^VOM%B6"/;*% (QUKB/!5U#>Z7J?ARXE6*6^53;2R'Y48<X_&M30
MO$%[X8OC:W*LES <%&_G53UBF<F&?+5J4Y;WOZI_U8Z;7M _X]].A7-Y<L%4
M8Z51\7>'UMM)BTG3%\J" 9F(X,C=\UUUEK5II^FC5]= ;49VS%G^!?45D>(?
M$VDW:*;9LR2$ D^I[T/W(VZLF%\36YW\$=%YOJ_ET.-\&BYDL]6T>>:2.!XC
M()F8G80/NCTJ'PWX#?5[,3%>YY/7KUKH_P"R6TG1[\2W=M<B=@X-NV=H]#6I
MX8U^'3M.49 XJ/:1J4XRB[HK#14:]6VFJ_(FU;2];T+P/IUOIEX1/#*S,7&X
M[>PYKD#KTWB2VE\/>+IEBDE8&UNT0*%<=%('8UZ1K6O0-:0O(01(*\C\836<
MMPWD\=^*WG4E&5KZ')AL'1JT>>R4KMIK=.YB:II6J:-<O;W<#-Y9P)8AN1OH
M:BAT36=091'93A6Z,ZD+^=:'A[QM?:)=P_:E74+&-OFMYAD?G6QX\UG6],U@
M00:I(MG=PK/'"H $:L/NUG&,7'F9UUJU:-948):K=];;Z(HCP (T O-5MXIU
MYE17!V"H=6U33=*T%M"T&9KI97$D]TPVG/\ ='M7*L[EB6D8D]23UI*7.DO=
M5BHX>;:=6?-;6UK*Y=TC5KK0]3BOK!]LD9Z'HP]#763V7A/Q.WVNVOGTO4)_
MOV97,>[N0?>N' S4R6[-R ?PI1G96>J+JX=5)<\9.,NZ_4ZB7X;:W$V8)K*6
M(_=<3CD4]/ 6J1Q;]2N[.WMQU99@6_*N7W7,/"3R*/3>:B>6:0_O)G;ZL:KF
MI]OQ,_9XK9U%_P" _P#!.O\ M^@>$X9)=!N7U/4I5V+-*FT6_J1ZUQKN\LC2
M2,6=CEB3U-)BALA:B4N8VHT52N[W;W;$KTLZG;ZA\+8'U.U6[O5D,<<QX,:@
M\5YC7=^&M0CNO"-U!=V^^&Q.]BG4 ]"?QK2EAU7;3FXV[;ONE_6IQYC3YHPG
M:_+)/S.HT&T@32X J L5Y..]0>)=.$5E;F]O2UEY^^6(+RON#6?H>N2P0)')
M"S"0_NN/O?2NBD\.ZAKUN9-09;"V RRR\,P]JAPFVX1^>W0UQ4J'*I5)6[=_
MD:5IXL?6?AV8]%>.+4K>4Q"6?D2Q]!G/>N3UK6]4T?PO+83?9+6YC89: ABV
M[N#276N:;HENVA?V:3I3GY[L<2J>Y%9$_@:/50=1T+5XWTKO)>28>/V(K6G"
ME04G05DVF_-^>VF]ET;/#6'HTZB=6/)&ZM=;]M5U\GJ<45EDW3,'<$_-(>>?
MK3:]$:/0-!\*/I-Q.;V>ZF#-+",B-?;WJFGA?PGJRB'1-7N8;@#YFOE"I^=<
MZUI^T?=]=?N/8CCXV<I0:C?1V=K=_(X>MKPRGV_Q!8:>YPMQ,L9/IFGZ]X0U
M3P^OFSJMQ:'I=0'=&?QK'M+J6QO8;NV;;+"X=#Z$55N5^\=:J1K4FZ,KWV9T
M?CG4'N/%D\0^0Z>WV:,J>H4\&J5Q?7VMW\!U";S)&VQAV/;H*V-<L[?Q5H[^
M)-)79=PJ/[0@'8_W_P :I^'M1T6#2;BUUBV9VFP5G3[T?TKK5=T5.5FVUHU:
MZ^_\4CAI2BJ$7&%Y1T:ZKO\ Y^9U&C6[^'=0N(9!'.3'M)4Y'-:&B:VFDZD(
MI"9+"Y.RXB89!!]/QJ"SMH+328)LJ;.<XCE)R_XU?TS189_$-NK9DMMVZ0C^
M$>M<ZG.I.-:4KM[NUMM]/+J:U(8>>'D[\UUK;NNENC7YFKK21>%(_M,2B]O'
M!>V5QQ;*>F*\4U9[B[OIKF^<RSRMEV/>O>7DMM6%V+F-I?*/EJ_8#MFO+_&O
MAF32;DD#=$_*L*S=2,FXP5DF3E]#V46Y_P 3:3?WV]!EY.]W\(K6XN92]Q'=
MF!&/41^GTKO/#$Z:7I4/A_6YI)I'A$T>X?*P(SMW5R-CI)U[X8H]M+%"+.YS
M*DK8W#/45?UNZE35#=7UQ,NGP6T8ME51MD;'(S736I.I1:AK\-[*[7:U_M>F
MRN>-7<*TU0E)I1FWINM5;E\]26XG6_GDO[+;:SJ2K0$_ZLCICZU3T7Q!_8WB
M2&]U=#+\Y,D@;)7CM5J*#3]6LY""87GP1(."IJU?Z)8WN@Q6^H6T]K+;X"WD
M(RLGNU>Y">6X:[H+6]G&6CMY._?H[ZGJU)K"PM*_*[Q3=FTGT??Y'/2:V]WK
M5U]G^>%IVE#..QZ5V%EJ+WFB->7*[5MV$98#[^?4UROC/1I;6XAO/#,'VG2S
M;HLDD'.''4FD\/:Q)<^"-7L!+F?S4E6/'10>:52IAZBEAZ,+1M\3WWO=V;O\
MC*56$J%*M3>J:NNJ6S3^1TFNF.VTB2;Y0K+@&O(;J0S7&T$@.P'!KT"9I/%7
MANZNG65+:RCR&3IO'8URNA>&FU"W&JZG<)9Z9%( [L<,^#R%'<UX,Z<HRY>6
MS6_]=#TYXW#V:B]8Z/K=_P!=#;\6ZA)I$FF>&N&BTY5<OCEMPS4UU,TT"/:R
MDI(,E<]*A^)%K:W6MSZQ:3YM9(T%MG_EH  *T? .B7<UF)M5C1-.E3>DSGD^
MPK6I3J3J)/;OV1I@$ZF%ISJRM=7ZO6^UEK=O2QG:?I-Q?29A5BRG) ZFNO;4
M1:>'=0N1;-;20E(XV<8SZXJTGB"PLG-AI%JJRKP)R/F-2VD%F'>Q\87,DPO6
M#6\*KPA]#]:OZO1A[TI/F5]>@L=A$\.JDXRNI626K=M;6OY:]C!TZRNGOEOM
M/B,R,O[QL945T5KHD4NM627'EJ[-Y@ .0>.AK2O-3.D6ILH;:.TA08:.,?>]
M#6+I%_"^N07,Z$1J_P O/0UTX>4*+C"<>9O:[V]%ZG=A*N(EAFI4TW-/D5[M
M76CTV=]?,BU&%M3U6=+A]K(Q7=Z@=JQ]2TJ*.QEA=BR,/D_WJV=2B6VUN66^
ME81ELKY?;/K5?6I%M+87>H$6]K 08A)PTI[$5Q58RA>7)K%Z]C7#THJ5.%1*
M+ND[[7:_!G)^)[Z31?!MIHH)2\E/F2RQ\90_PDUP..*].\>ZM:>*M.TG^S+%
M5F)5&\D9WGU-<EXN\-3^'+F#SXS$)DR$8<CUI/#U/9*IRV22T[7*Q6 ]A5J2
M4KO1O5-Z_F;'@F,:IX;U#2-1F1;29@8-S?,)<< >U<GJL4MA</I]U L=Q:ML
M?W-=#X/\+W,]]:ZG>W<&G6D4JR*;E]OF8YX%-^(6DW<7B*ZU=C%<6=Y+F.X@
M.Y,XZ9]>*FI!2IQ=MCP*>*IT\7*E2>DEK_B3Z>JZ>1QX/-.HHKG.\*Z3X<_\
ME2\*_P#89L__ $<E<W72?#G_ )*EX5_[#-G_ .CDH ^_**** /"/VFH'^S>&
M[L_ZF)[B-S[OY6W_ -!->&1VZ7(*E<CM7TI\==,_MC2+"QC'F7#).\$.<;W'
ME\_AG]:^6)KVZT:1[:XA>.X7Y2K*1S[5K[-\G.MNIS4\1&=6=)O6-ON:3*>J
M6ZV<Q3//I5KPAI2ZKK1FN1NLK%?/N%]5%=1I'A72M?\  =Q>W4K#5S,)/.)P
MD,0Z@^]=;H]GX?:SACT+2IK/P_<+Y.H:U*V0Y[@#MS7G?7Z5.2E434;M7Z:?
MB_*P8ASE3G"CK*RT]?UL<&OB[6KG4Y9X+IGLU;%O!+RJH.@_*NECFT;Q;'YO
MG1Z/K:##AN(9?I[UH>(OAI!X<T)-3TC4!J=G<2%+=8UR<=JP9/ 5Q-#']IND
MM;N1<QQ9Y)[<UVX7$K%1<J?O+;737YG#B*6%HJ+C+DET:W^:ZKN5];&IZ#;A
MKZ$B"3A)E.5:N0=KG6+Q;6RC:>:4X55KT72= U'P]X9U"\\:2FZL!^[&G[O,
M=O\ :![54AU[P;-IXT_0%D\/FYXDN[A=[+]"*N/LIN5I;:-=;A]=KQC;DYK[
M27PV[]_N,+7TCEM]"\+1'S+BU;;</'TRQ_I4NO7LO]O6VE::Y$&CJ$C,?\1_
MO?6NFMO">D>&?%5K;QWO]IS2VLDWV]#F-V*\#V-<%X=U*.U\1.NIG89I"LDK
M?P<]:4:T:E+VCB[/H]-%_F.C"'M>6]U%7[ZRO?[M3:(NM0G:.2=G:3YF5NYK
MG-9THVDI5Q@^E=II(T7^TKJ[GUN-?LSG8-O^M%<QXBU>'5M1EDB C7H!6ZPL
MISY:*5F]/GM:]K_U<[*->E.\8*UO)HNZ7,^M_#V^T^\(DELI/,MY7Y,: <J#
M7$@Y%=IHR?9O >I[DE=Y91M"(?3U]*XL<<'@^E7B\-6P_*JL;-HRPEN>JH[7
M_34569'5T)5E.5([&N]LO$_AO6[6 ^+[6Z;4+==BW%N0/,'^U[UP0'4Y'%"L
M,\&N6,I17DS>M0A6LVVFMFG9GJ^LW>C^.[>W&E:DNDRVB>4D5V>90/3WKE9_
M!OBN$GRK"2YBSA98V&&_6N4:3D'.&'0CM5N/Q!JT*;(M1N57T$AJW.,]9+7R
M.:&&K4%RT)^[VEK^*U^\]!T'PMK5EX/U3S(#]MEE %L6!91_>KC+G4;G3YI;
M-Y,O$VUB/6J^F^*-6TW54OXKR5I5/.YR=P]#73SKX5\8LUPES_8>H'YI1-\R
MS,?3'2DUSM<KVZ&,'7PM64ZVL9:W2V?YV)_$^KS6VBZ6PY#IDFN'O+QKJ4NY
MKT9]*T>Y\(V^BZWXAAM[JWE+6SA"^X-V..U)I_P_T2UNKP:A?_;!8P^;*$&W
M/&0,&M*E-M\W30C#XRG0H-R3LGO9VU>FNVIQWAOPEJ/B6Y06\?E6F_;+=/PJ
M5UOBGP[)K&M*^IWUMI=O:P+!%).W^N"CJN/6N:FU?6/%6K0:7HZ^0K'RK>VA
M.P-]?4UC:B+Z*^>SU221I;9C&R.V[:1VK)5:4;TUJ]SH=#$U:BJN2C;96NU?
MS[G4"7P3:XBCL-0NG7Y9)<C:WNM3#PSX:\1D?\(WJ)TV;H+:_/S2-Z#%6/ _
M]F=-0560COVJEJ^A+J/BJ&Q\.@-<W$F(/FV\]N>U#JQBFYI6-'@Y+6G4DI>M
M_P #F;O2KK2]1DLKZ)HIHS@@CK[BK6Y+6S+D9(' KM88I-;MK_0O$4:KK>DY
M5)003(1_#GO7GUU*=S1OU4E6'N*EI64HNZ>QKAZTIWA45I1W_P T5VO&F;YE
M49_NTP\G@9)Z 4W: >*ZWP=9P6EO=Z_J*#R[1/\ 1 XRLLO]VB,>9V+K552@
MY;_JR+3? ]W<6XN-7NX=(@<9C:Y/^L^F*N/X#MKRVE?1-<M;J>-"QM1]]\>E
M:VC^%=4\8V<NK:C,QBSN6-C\J^P%9>JV<7A#6]/OH 0890T@4XW*#R*M2IWM
M8YIT\4XN:G9]DE;T[G#RQ/#(T<JE64X(/8UN>#M9CTC7T^V+YEC<CR;F,]&0
M\<_3K71>(/!E]K'BIKC2X0;>^C^U[B<+&IYQFH[?P+I$+9U+Q##%CJ@0Y;VI
MJG.,KKH1+%X>M1Y9/XELKMK[CJ;[6;7P/I%GIL,,&H7#@R07>,HJDYP#ZU*E
M[J&HWUO]KE:<3()5 /"BLWQ5I$6K>%M.O=&!%AIB^2Z'[RD]S6QX=$5AI\ W
M@DK]YCG'M2E&%*/)!/=O?>_Z)G-EF'BH^T7Q7?-=:W_3N0^+-"BN-):= !(J
M]*YRUTIO^$!-K:1EFU"==_U!XQ6EXO\ %4$32P6\@DRA!QV-2V-[;VGA705N
M9Q!]J6213C^,=*4*\L/>I&*E;H]O^"=&8RDHP4?YOR39AZ]ID7AJW@M9D47.
MT$J.:S+*ZTV>XC&JQ,]KGYU3@TNLZM)-K*7&H_Z0RMEUSU'I5?5+S3K_ %-9
M])M&L[?:,Q,<_-ZU":@HQE[SE'5K11?9>G1G13=9Q5.JM6M6MO\ ,Z<>(IK>
MZC3[,9O#./*:!EX7/&X^XKC_ !5X?;0-341-YMC<KYMK-V=#721ZQ=:Q;Q:5
M)&B0,-JA%QN;M6JVD!-+'A+7KR.>Z\KSK; ^:!^T>:]&=##PP]*$':4E)J-[
MVBGU?F>8I/!34FDKW3BG=M+[7KK\SA/#&OOX?U7S67S+6<>7<P]G2MC6_",L
M$IU/PZ#J&D2_.7B_Y99ZJ?I7*_9)4U#[',NV42;&&>^:[_Q%JTGA6.+2="OQ
M%# B2&W9<[V89.:YJ2O%WZ'=5A-UT\/;F:;=]FE^NNA?T]5\4:"MGI5O):6F
MGKYMV]QQNQV6NFTB>*QT_P"SZ#;R7LMQ'NFD)!\M*\KNO%FLZ_Y=K+*D*-P5
MMUV;_K71Z9I>MZ6Z7%C=/'*5 VD\$>AJL/##I3]I4ESO9O97W;6YR4\!6BKN
M5M4U'=;ZW>[\NQNQWEQ$9!%)M5F^91QG'K1KEQ)XA\-W-Q<M&CV[;0@[CVK'
MN'U75?$;)#"JWDJ?)$#M5L=36+J&N2VS3VMPAAF!Q)&W&#6.*P:HN,X23ND[
MK\4UT?0]!-5:E]I]>]O^#W+'AFU?4-'UNS639':P&<+ZFM'6!<ZE\/=!U,*6
M2&4I-&.B@&LOP)=;I=?B4_//8E4^M3>!_$K*7\/:E$TUG<?NV11DJWJ*['BY
M^PA3O9+;LM[M^;[]KGEXBG+V\ZD5?D:?R:UL6X+JWUG5/-MD:W;:%6(=*V-6
MNYI=/CTN_N'MV"X6-3PX]ZKR647@J:Z&K:?)-<2G%G*AXVGI^-9XNEN+61M0
M+&<'*EQAE]JYZ-6+KQFFG&GHKVO?NMU9/J]3NP\Z=:SA%."V;UOYKT_,R)=5
MU'PT_EZ=.RPH<M;L<H_U%=WX7U73M9M[&6]TRWMX;G(OI+==K9[#Z&N-U=]&
MN5BCM2WGLH#NQX!KO[7PA%!\/A#:N5:Y990X/7'I7=CZ<)454P\[<\7ZQDM&
M_1O8Y<;AHU80DE:4G_5UY;E;Q#X=TNSM;\2:J=/MRVZ"UA; F3T(]:X#Q])%
M]ET^WLX);6VC3<L#]SC[U=1%X8UZ\ODN+*+[:(7!"SMTQZ9K+^*=K>2S6M[>
MZ9):O@1LPY4^WM7G2E54?915XZ-O;6UMGO?YG)AZ/U?%0C.JI/6ZNM'Z>G<L
M#Q -#\!>&1)IUG>K)O)^TIN(YZ"G7^IW>HZ=]JBG00N<I;P\)#[ 5A^+-J:5
MHD*_ZJ./Y!VJ#1M7BT^(^>P,8;=Y7]ZJJ3UY)/1V1]#DM'#\LI.-I2<FI7LU
MK]WZ]C:T2"2[U>UAD#J\CY+=^*Z[5@+OQ7#<2?*(60'W"U#X0O8)X3XDOK<0
MPQL5MTQ_K&]*2WU*UFUA;J\0R1-)N:W!YQGI3J1<8/EU6_K;U(<?;XR;IN\8
M)J^VKWMYVM<VO&-NYG%S"1(ET 5Q_#@5A6T MEA68@,[\'WK:UB^@D2Y-C!(
M;;[R1$Y9!Z"JD-N--TPW-WR]VG[N)N2@]?:O1P\(T[8EV=U>S:T\GOU['O95
M"EED*<W53FM$K_9\^K:6Z5G]Y2UR[71UF:SM9+R]OU 3S.8TQ22ZAK&I:?;'
MQ!:6$J(,"-Q]U?:I]9C8>'=-NXL[G8AO45SC6^I7C[59M@YP?2L9XJHZLO9Q
M^+6WK^9Y=*JL75JN,>?FG*R>MM;:?)%G5-9ATWP_,BVD5E(KEK4QK\WL:R_#
M?C)_$NJ0:3XKMXKR!@=LS+F12!QS5GQ#%!)X?<W*\Q)\K,><USOAFV_L;2I?
M$UPA9US':1XX9NAJL16J3J*2C9-+YI=_0[>(82]C&GR*-UHEO?S?K^!G>([G
M4=7\036\R']RQ2&W7HBCI@5J>$-0A>"[\,^()O(M+@$PF4<0S=C6+<K=V-];
M:E<2_OKAC*1GE>>AJ;4;^PU.\GN+D8?ROW908^:N=4TKN3M+L^QQ/+:<L+[&
M;Y9JWY7NO,HZWHMWH&IO97RX8<HX^[(O8BLX]*[O1KL>,/#,^B:EA[VR3S+&
M;^(^JD]QBN&92CLC?>4D&N6<4M5LSCP]64[PJ?%'?S[/YD?2NF^'!S\4O"O_
M &&;/_T<E<T1BNC^''_)4_"G_89L_P#T>E9G4??]%%% 'BO[0FM/H\GA\PQD
MS31W:)(#CRS^YYKR./Q392_9#XMTM-0,/'VU0 4SZCO7J?[1=N+K5/!\+[O+
MD>[5MHY_Y8UY?9Z:D$"S1V<E]"LA62-%R0/>NK%/#87"0J77--.ZZO5I+MT/
M#QRPBF_:I\SZK1[=^A>UNUM;G1;3P[X:F!M=8;SVNG&W!_N_2O5;#P=9VOPI
MF\-6ZB6,6F7?UE/6O.-8AM/M&@-IB?Z,?E!DX$3'U]*]0T74;Z2&32+J"/<@
M^6[A.58>F:^,SS"SJSH^Q?+&ZE;[M?\ @'HY/44L(I.[>JUWWZF7X-C33S!I
M&H6_V>=+<+;1RGB0XY/M6/\ V':RW^IZ;/M;458R1&1\!!WYKL[R_P!(MFLI
M]4VSWT;A-S?P#->>_&:WNKB^2[\+1//(B@71@Y+ ],8J\%*M/%5,-%2BFKK>
MUT];?W7^)I7]C0G&M*ROHW^1SL5]_9*ZA9NWG"93'(';>!]*R]<U;PA9?"]=
M 32Q=:RTA,,X4 Q$GKG],5G:?X;UZYB+WEQ;Z<2,[;Q]K&K#^ ;=+69]>UN"
MWU *'M-C_(Q^M>WB<'%I3FFG=/32[V5^MB8XVA?EC*YO> =2TW2M&3PKJ5A,
MNKS_ +Z>2=<>2@YP">Q%>;^.[$6GB>:Y@BV6EV3) 1T(]JZW4(KN#PKJ^N7F
MJIJFI,$@%Q&V3&G3'Y5G^$KZUO/#%POC"W%QI-HNV"?K)&_91[5VX?#NG3Y)
MOWI:O6Z]%Y'E.LE7EBJ2O%6C9:-];^IP*2.#MCR2W  [UW&GZ5HVC^'X[OQ'
M;&;49<F"UW8+#U;TJNNM^'=*D \.::;VXFZ/=+S$?]FM*R\+WM]?"_UF;?))
M@DL>@]*W53DY5)W2Z7\[Z'=*-3%:6<(_<WY>2,\^,==TVV(L(DMK'_G@4!&/
M3-;?B34/#NC3:>9?"T=Q)>6BSRL7QDFM[4=&M=3T.2&V@ 6!<;P.M4_%'AJ3
M4KG2Y47]U%8JA;W]*UJ8JK7<JDW=Z'/6PE&->G&*M?FO9M7LNMCC+[1]'\16
M$EUX55H;Z$;Y=./4IW*GN1Z5QA!!((P1U%=CJVFR:#>Q7=A(4GA;<"I].U2^
M-+.'4--LO$EE&J&Y7%XJC&V2N9VFKK='5%RP\XTY.\9;-[I]G^AQ-*%-;VC>
M&WU*U^V7$R6MGOV>;(<9/H*U%\-^'[C-O'JXBN\X42'"_G6OU:7L_:76O2^I
M<\72A+E?X*YQI7%)TKM+KX;ZC%;&2RO["_D[0VTH9S^%<I>Z==Z=<^1?6TEO
M+C.R12#6#A*.Z-*6(HUOX<KD(FD#JX=MRG*G/(-=GX+UU[[Q'<Q:S>DOJ%LT
M(EE/WW ^0$^_3\JXFE1VCD5T)5E.01V-)6YE*2O8*]&-:FX/J::+<:/JDF_S
M+2]MG)7(PRFJ<LDMQ-)/,S/(YW.Y[FNRM]=TCQ;;+8^)T6TOPNV'44'WFZ#?
M[50U#P1K^C[76T:]M7X6:W&]&_$5VJ-*KR*2LDK<R6OE?T.>&*47R5O=EY[/
MT9A6U[-;']VQ%/?49C,DJ2.DB'*NIP0?K0+6X@F*W%NT6[LXQ42VLEQ,([9&
MDD9MJQJ,L?PI2P4W05:.JU7W'9[2)TO@&YEF^(%C+*Y=BS&1W.<\=2:P-3 D
MUZ_"$ &YDQS_ +1KJ;"Q?0T&D612;7=24(YZBV7Z_P!ZM30[GP[I&IG3;73T
MU6=3B::X'\??'XUAR^XDW8\U5G[>52G%RNDDO)=?)=NYREAX8N[]0($W,1P!
MWKK?$_AR^T[PKINFPVDS0K()GV(2=W>O3M"UK2[:X22;2(8-G=!TI?&/BZ&]
MC']D,% ]J45&*=WN:5UB:CIRA3M;5\S5F_*U]BKX3O=+M_" @,RQR1+EHR<'
M\J\;\=WHU/73';?,"VU .YKK=6US0;Z-8=>CFTR7H)[,<R'_ &L5F1^"I-)Q
MK^XZW;(P>WCM/G(;MO':FJ5WH[H/K\:=E7BXOMT?H]BSXTUB]$&@>'K &+R;
M)3+M.&+?6I]!\%7&I1^=<1Y*\DDYH\3I+'XUTF_U&V-K]LM5+ CA&_NUZAIT
ML%OH\<4"9)&68=Z,0[U&5E\:2PT72V=W^+.&ABN/"]RRWZ";3)N)4[?6N5\1
MZ1K-KJXBT4-)I]V/,MW0Y2-3V)[5Z3XEMA)H=R70X93MSW-<_-H^J2:9I=AI
MUT\%B]N&N8QUW9IQDG3:DMOZL%?FIU8JBES2O=N^R7]=/F<4G@*2&ZC?Q1JD
M%K!(00T4@D8^HP*U?'V@F*RL+[P_=+?Z59IMVH<O'[X]*WSX$L] N(=7MQ]M
M* EH)FRK$_6O/Y=7N=!\23:C8(L:2,?-M<Y1E[BLXU5S.'+IWN9U,+B>>-95
M+N/2UD_\GYEFSD\/:K9QIJ$I@GW?-*O/%1V?AV"^U86UG=#RF;".>XKKM1\-
M>%?$,-I=VZ-I<L]L9F^SC]TC>C'M6%IVEZ1I5]'*VJ&>6$G!0_*16RPZA2J)
MRU>L=M_S7Y''#'QE"3I\REKHU>S(KG2[S2!*8WC=;4Y,J-G;5^SBU/5-7T_6
MKBR$4-O'NDN<Y,O^U1J/_"*RVVRXO+JTCD.9!; L)/K6MJTL,6EZ/HFG7IBT
M2ZA ?4#PR+_</O6=2I6]I[2%DM;^EO+17^?WG'6Q%6<8*<?>=U=IK2VOJ^R.
M AUC28/$VIWFIV'V^.60M"-V-ISG-;'B:R'C'3T\3Z,H,RKY=U9)RT07@$#O
MQ7)ZIIGV/4KJ*UW2VL4A6.4C[P[&GZ#K5SX>UB*]M6( .V1.SH>HK&DXMN;^
MU;^K'NU*4I0A4I?%%:7ZI]'_ %H/TR'9(DX."IR/K7K&@ZY8Z[!';22>1<1C
M!']ZN9U'PNNJ2?VMX9DADMKI=XLT/SHW<8KGDBU71+_SI;.:W>/E@XQ@5K[*
M?-RI&U#$4ZZM%Z]NJ^1Z)XCTVRD,9L[QH[V [T=>""*R=*ETCQSK367B2S6"
M_MT,DU\G_+55[8K+3Q+:7D9N)I DRCD$]:A\)2QMK6J:O-F*R6V=!*> 7(X%
M7"4M:#VOK_PYSYGAU[#VM[2MHT]?3_@!=:AX:\-+J+^&[J2^FO5,*HZ%1 OJ
M#WKD=+U2\T>]6[T^7RYQ_$1FJ>=S%O4U8MXP?O=*YYVG'D:T-J6%A"#C+WK[
MWZG9Z?K&N>)A')J5R"L,H\JXDX"OV!JAXEDUBTUB<ZS"WG,<M,B_NW]P>E9$
MMQ(M@UK'.1 YW-&.Y]:TM-\;:A96T=E?1QZC;)@)'/SM'I73&K&I3C2G"*Y=
M%)*SMV?<YEAZF'FYTHJW;;3R?Z&=:V=_J%S&T5K,8MP+2;#M"]^:]ZT+4;/4
M=-M+33)V>&!<;,?]]5Y7XOU/5M-L(%MM1MH[.]C#&UM6!V>QK;\'ZJ/"WAFW
MO+T_O=28_9F'\*CK3O1=-PC>Z>K\ETL_,YYU*E>,:T79MVBEWZWOV5]CL?%E
MY=0R0W6DAU$1 54XW#WK%@\23ZQJR6FL6S26ZC=)&R<#WS712>);&YMX/("D
M@?-4_F0LIFBA1W8?.,?>'I7)+D4I57#FE9I:VWTW\NAIBLMI3HOD@G-+1O\
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M (NFIYUXDMRFIR.9?-!Z'L!6/$R1S(\B;T4Y*^M=]IO@]]=WO=&2&RMU+S7
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M,?K7@OQ'L[S5-37^PE>YM5C ;UW]\4O>;22;_3U.>6*HQFX2E9KN<WH%Y(/
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M=:5X/CUZ(2F"\N/+2U5<[SZUS33:7X^F7?(FE:^V$!8[89<>I]:Z+Q9K&N^
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M:CTMM<UO4I D3 6R;1FX([4E&,ZG,VUY=/4RJ2Q.%A:-I+97O?R7F5=96/\
MX2'0=#G90NG+Y4Y!ZD\\U[CI5M;"UMTM2MO:VQW.P&?-&.E>/W TGQQ</?ZM
M =%U27_520_<<]BQ[54/B?Q%X)N_[-U@F6!AF.0<K(OJ#6F(49OFCMZFN7XA
MTDJ4ERS71];[VZ/<W_BT;2]F\Z!%^4]A7*^")+>VT'4YG3<Z2 L/]CO65K_B
M=]7D)4;5/:K'P^NXTUJYL[GF*[MW14[%R.#44FU-6=GW#,(\V&EY:G0>*K;2
MM1L[2?08\Q-'N9R<D>U>?W=J8)=R?*RG(([&NETH3V5G+97# %)C$5[@UH7'
M@^?5M_V":"'RTW,96P#]*ZL5%4<)"=:5][-[M=W\]$;87#_5Z<:<;M6OKK>Y
M>T6YN?&NC6[6)0:UI8V.C-M\]/[Q/M6K!8:K*-\0M<J<'$P)_ 5SWP]6#3-'
MUG4YR!)'*+4/G@ ]:CTRT\K6+B;3VDEC3C=DD ]>*I4J<J*JS>K=M_Q*PN%E
M["HZ51)*5DFMM+OU3Z=C?NQ>Q9DNK"; X#!#\Q]J@T2:*ZO&.J^')9K>)23/
M(NWRO?ZU;;6]>G5(Y+QF2,Y7Y?NUH:??W.J->:3-J(>&>V>9B1A@RC(%%&E0
MQ-)P3=NNVNOK<[I3Q.'PLIM)2AK*UGI=:J^]EK;OIL>=:]XQ7,UEX;B-G;.2
M))"/FD/K[57^'LTLOQ2\*>=-))C6;/&YB?\ ELE<W(S/*Y<Y;<<FNI^&]S&/
MB+X6A,"ESK5H?,[C]\E>?.3;T,HPA.I*I)ZN[N]VS[RHHHI$GB?[1EA]MM]
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MM=!X)EL;36PFL#=:W*^4^#TSWHH*/M+3V>FBN_DNYTXJ[H\T=>5J5EUM_P
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MFL_7_#WV/PFM_;?9[L:I*#YN[+H['H!TKF]'TS4M.\906D>^"YB=3)VPO?\
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M=;%8BG"]2'+?K>Z5^K.GU?Q!IEW?QVL4"W%K&,E,9$C>M>4^)=.D@OWOK-3
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M>!J4JMTX1E?7?39=VC:LK^UMIOL)4E9LR1$\\>@KI=/NHK6R2;A[@@@ _P
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M:^LT5KR"9@3M[D5X^8XBOE]&,L/&UW:[VBWLW?S-ZGL,7^XE-:].K2W,;0/
M_A_2/"NLZOK=E!-/,NR6)%^52O\ <';-6O"NGOKVB1W>B7EO;V5LVV*P=<K[
MAQ[U%XVU:QT.SE(TVX:348TE3:24B8_>S2^&'T"".#^Q9'CN[XK(8\Y6-EZ@
M_6OGL:YXC"2KO64VFG965EJM'IZG72H*E.*C)V2:M>_Y]CE-7UW4?"37GA2V
MM;2SN]=N<M<0KM6)&X)%<QJWPCDTO6H#I^J1:G;/AI9$.3N[@UZ1\<&M=.M=
M%\1P1@:Q:W 2.0C*A<$D,.]<;IVNE+JWFMU,KW<GF7*IPJ$]2*^TR.C/%X*G
MC\)2Y(:J2;3YFEK*^ZTV=]=K'-&'))J<N:7?]!NMVGE20K;P+&;< JP'0BJ6
MOJ/$/AXZTMO&FI6;^7.D8P95_OFNYU@65XB"#&Z0 ?C7,:AIE[X1UB 7$!EA
MU&/RY(UYRA[UK"K%2]G)_$8XRBVE6I_%#7U75?,X=)([J+*MQCI6=JRK#82$
M=QQ6WK_A'4M!,EUIR"ZTW[RE#EHQ_=(KG;2"]\1:A!86\#@2, S,, #N<T2A
M*+Y6C:GBJ-2G[6,M/R]33\21G_A!]#SP3&2!Z\UQA&*]0\5>&;N]DM-/LKF%
MK338O*C?>/FSR?UKE-1\!:[863WIMUFMEY+QL"?RK2I"7-L<."Q5!4DG-7;;
M^]G.1*'GC5NC. ?IFNU\6Y%UI-ETM[:'$/N*X<@@]PP_2N[U59=>\$Z3JUBO
MF2Z:!;W*@98L3P<5,=8R1T8AJ%:E.6UVOO6G^1J:5:K]E7:O)K-\76445N"X
M <BJ2>([K3T6WDB99L<)CFKL&D3ZG;G5?$\[6ED/]7$WWI_;VK.*Y]CHJ5Z=
M./,WOMY^A<\*>)KJQ^&FJQS0I>0VTZB(7 W+&".0*P;N_P#"FH7 NI;*YM_E
M_>10G )]JT?^$[GT>,V6@:=%#I1.7MYT#&3W)-5M<TJRU;1I=<\-J%C<C[99
M]X6'\0]N:[J=916RG96L_P UZ'C0I>RK2G.+ASO1I^FC[,B@N/A_(N9K'58B
M.QE#9_*I#XSL=,4V_A_1[<Q?\]+E-S_G7&#Y03US3XY=L;CRPS$##G.4^E<O
MM';W?R/2>#IM^^W+R;=C7U#7=6UB,QWMW(T&<B#/RK]!5.PTVXU/4(K*R3?+
M(<#V]ZBAN)IFQ(Y?:.K')KKM)EAT#PG<WOF;KK4OW$9 P8?<&KIT:E2+J-:+
M=E5)*A34::U>B7G_ %J7M(TK0O"^JP7%[JHN9E.&,!X3U!J35-)_LK7CJUC(
MMUH]VVZ.:/D1G^Z:R;+2(9H1E02W4^M;GAQ-3TO5HM/L8A=6-T^V>!AE0I[C
MT-3SQ:Y6K(YJE&K0;Q*GS-+5/1-?H^QVNG"+4;:W/FE$B.XJI^_[&K,&A:='
M<RO/<2+%+DG!^[]*Y]]!OO#NMR364IN]'+\E#DPG^[CVK>FNK0VJBUD#[^N3
MR*FI4J^S]G>T6O\ @G=A<1A\32]K3E?^NO8\R\92O:7TT$#EK<'Y">XJCI:"
MS\ W^H9;==/]G('YUK_$!K4"-8F!?'S8JUHUOJ?B#X4QV=M;1E([W:'QM[=:
MK#4?:U(TY/1[M]//S.?&8F>'4)Q=O>2?H>8@?**2NSN]"T+2+61;JX-[=]-D
M? 0TD'_"%7,,=I/;7-E.W#7;2$JOOBMYX.<(N4FM':U]==A_7(VYHPDUZ''4
M;36_J_A:;1M2CC,@N+.XYM[I/NR"KX\(SG:J+N=Q\H'>N-IIV9TTZD*D%.+T
M.-8$'FE4YX-=W+X&T[38E;Q%K*V4[=;;;DC\:K7?@%9[5KGPKJ46L)&,RJG#
M(/IWJ_92.;Z]0O9O3O9V^_8X^KFC0)<:]I\$PS')<QJP/<%AFJK*R,R.I5E.
M"".AI]I<?9;Z"X'6&17_ ".:A:,ZIIN#2['4^,OM-SXVN=,CD?[/:2;((E/"
MCVJ :OK^A3 07MPB#K"S$JP]"*Z35=)FNO%EIJEJ QNK7[5*"<?*!S^-2M=6
M-Q=+>BTWI",^41DL:[JE5PB\/"*E.33NGJNR^9Y>'E3J4(QY>:T==M_^"9<&
MK:3XU<Z?K-G!IM^PQ;7%NNU6;T;ZUS<,USX7UV2.[MHY)[=MK1RC(JS- R:U
M%<11F)A.'5".G/ J_P#$>(/KT=ZW^ONHP\X]&Q7/6IMQ<:FZT9I3A&G55)?!
M-;=G_D<Q>77VN[DG*A#*^=B]%SV%;FJ:5#HOANV>[$IOKGYXV5OD %<WBI))
MIYE43322*OW0S9"_2N7][%I4Y.*ZVZKL>@Z<6DNQV_B)_MGA;1-:L%$J01F&
M\9?X'["HM,\06,D:I<*I)[OVK"\.>))=!FDCDC%SI]P-MQ;-T<>H]#[UM7'A
M?2O$%J][X-GVS*-SZ;*WSH/4$]:[*DG7L^J5ON//IS^I_NZB]V^CZ:]'V_([
MS0--@\2W2Q1ONVKD<\ "NTTW1]-:S:*2#++QQ7SGINKZEH>H;1+-;R(<,A)!
M%>O>%_B#;RI&EV0K=V/>N2T^9MO0])6M[ID^//!401[FT0C!SQVKG]6NKSQC
MHMEY=G+/JNFC9<2#H8QT_2O>A8Z7XJM!$ETD*.N&<GI7D^M:.?"VL2_V?=E@
M&*[U. X]ZUI5H1FZ<U>Z_I_\ YZ]!U.6I'XH[?Y>C.@\!?$<Z9X,GTJ9MC(#
MM)['TK@A9W_COQ4]O&Q*[M\A]5KH=+OH=4'V:_T8S-@J+J,;%C!ZL?6JMU<Z
M?X7T2X'A6]^U:C++Y$KJ.0GK[5U_5X2E>G=K73K9''6QLN7V,%:J].Z7G?\
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MRK1?LYP46^EVWVOHG<R]7U>#1?!K:2]A!;:M>(L<@C'S(!W;ZUZ%X'T!M?\
M!-CI6J:?*L.F022"\20 )(>5(^E>5W'A+3KR1I(_%UO>7CG"*4.YV[#)-:OB
M/P5XM\&^&K&:75[@SZ@=LEA!(Q*#MG'K6&:X-U84Z-.7*[MK=^KT]7OH=6#K
MTES2;U>]U;TM<S3H42?$33X+K5HM96:3=/*G.T#LWO7<_"R2[U+XDZX8["SO
MTC78K78!\E0<#;7G_A[1=2\.>.-,AUVTDLS=M\IEXR#WKI_A\8+3XM7NCZI-
M-:K>3%4D1MN2#D?@:,QBY9/-0ES:;KR]"Z>N86?\NGWGH>DZ=X/T[Q9K?]K7
M$-I>1C-Q/"2B$'^%36;\1-!TO6-*A\4ZQ+<P^&[*T\BQM5(\R1SPK_0UZ9XL
MT30KG3)?M]C'<EH6"P1*/,F../K7E)T"WN?AK/X=\0ZW)9S;OM5LEQ_RQ /$
M6*^%RVM[>2Q"E*]TGULMFXV_I+8]6:MH>7>&?'][X;TF[TB*U@N-/O"1*LRY
M8 UG>(M!ETR"UU!)A/97P+0,.V.H_"NV\8>!=*M? -IXCTB"6W1AY4HD.?,<
M=6'H*PK9?[?^&;6T9)GTERRQ]R&Y)%?IF!Q%*O1G&DK:N_>Z/%Q*]A4C56S=
MGZ/9_>+IZF;X/7Q;GRM10#U VBM?1MDUBD6X;U'YU@^ ;V![B[T2^?$5]&1"
M#T\[L35>"XO-"UF2QO@5GMWVN#W]ZZ9ZQ4A8=\E:I2>]^9>C/3O#-[:)?/;Z
ME"+F!HV4QD9Y(XK!T'0/$L_B:XT_PY?;(HRTAMIF_=E?2M;1[W2IE6YAE6.X
M8<JWK577-2ET<27VFW6R[93RAZ^U<56%51E*@[3:LK[?<=52$:D>6237F>G>
M)/#3:XNEVDTNG6-VT(4[%^;/M7-_$#^T_#^HP1SZ9&VG+&JK/".I'J*Z_P -
M/H>LWVB->VTXU:&V6XCE?(5FQR/_ *U:ZQZ=J7B3483/]H;@>7*<HI'7 KX^
MABWAL4U5C)*$6Y^;;M=>04/;QIJI0DGK[OHO/N>:3ZQ-XIM+?4M5B2STRT "
M1(,&8CVK'OO$%U?71:WC*1 81/[@KUCQ/X!T_6&65;O[ D/1%'R?E7+S>&=%
MA9H[>^5I5. V.#7U^!Q6'Q-)1POP^=U^+.#GE"HZV)3Y]59*]E\N^]SC[-[R
M[8VENFZ60$]*X[Q18:C?7*:;9V,LT^3N(4X'OFO:?#7AZTNM0AN](UM4O[1F
M$T+0':RGWK3U=7OQ/H'A_4[ WK'9(OE[98U;[S9KR\3G%/#5W&6L5H][W6[V
MM;5:G6I5:DK4ENKZK;UZ_(\3U[0+F^\):<]A<1ZCJ6FC9+! ?FA3OFN?LI8;
MSY9&\J4<,K<'-=Z/A/K'A+7+FXEU4VEFARE]U%PY_A*UC71T/5]0DBU:"31]
M24[?MS1E8Y/<"OH,%C,/CIKV$EJNNJ_X?\CCC"M@8VJ+FCO=;KY=O0S]#LM1
M.L1BPCDG,7[R1(Q]Y!U_2M^U\,7&N>)UGFNX=*TR]/F0VS'#LO<+6SX$OA\/
M+Z>3Q#=0-I.HH0DVW+2C_9/:CXBC1_$^G:3?^!H)[AK$X\Z)\"%/0BM:V(Q5
M.?U&I37)IR3Z-WU;VTZ79$YT\14C4H3M?1ORZ)7TO?[CG]>N[O6[ZXT:V1K3
M3K5O)VKUE [M5GP\^MZ3;)86;1/!O C,XSY7TK:T)[>QM?,N[8RM(<ECR<UU
M^GPVOV.:]MHXV;RV 1AT]ZFI5E3FY17-;H]GW7H=:P='V2I):;^=^_J>7ZFV
MK:!XQGNO-:.]F "3CI(/:K'A^QU"U\5.=5TVV_XG2>7#=:A&6B\SU%=5+JFF
M:E!INJ:Q;F6#1W,16)=S2R$\#%=<-9&N7FG7LUM%8:6#LM!<1AF\_P"@Z<5\
MYF6*JTE["G14;IMROJDEHDUOZ&F'K+V/-.5VG9Z=?0Q=+@L_".A>(&M--L=0
MU/2525A N(Y<GGCVKA+WXF>)O$5G)>WD4%MX<>]2&7(_>1 G!'TK?\2V][H_
MB6_M]/WL\J[I73[LA/0&M)/"^@VOABRT77=*G-YJI\Y]C?*2.<X[5PTXP4Z>
M.DN:4G'E[I)*^EUVO==]37ZO&.&J1EMJY>;?]:'GVC0II/BJ]T^,&"&27SK9
M@#B2.N_G,UW"/*8.%'.VN.E\77MEXADT::RM[BTA/V:(;0) GINKI;W3KNRN
M!!HMPMK<O&&.G2MN;![[NE?82C"4^6$M>W7Y=SS*.+J4:<?K,&E9>]NOGV9C
MZI920(;V:18T7N:\EUR<ZEKA6 >8SOM7;WKT36_#GC/7)(K:Y@CAA9MK,)AA
M1ZUGZ9X'NO#5]JEY=F&ZDLH2]N%8$L?[V*E0DY\K3-*F98:*M":;Z)/Y'/\
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MY93[>E=OX:\2V^B">VO76&=E_=D]"/7-?:U7/=/3^MSR\+*%6HWB-:W7F_\
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M(R0:F_(E;=FW+]9J23;48NUD[:[]#FCJGA]6Q+X%9!W/G-D4P>$=#\231?\
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M^;&8;_/'F3=(ZZJ%1\W,MU]WW'#C*;PD4UK"Z]59WM?L^GF<]X*>.*WNI)
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M]JN=N3VK.#DI+E=F>HH\SL5?"^L)H&M(MP2UC<_NKN(C(9353Q7HIT'Q!-;
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M(?M;_P#,H_\ ;[_[0KYOH *93BWI3<YH 4,11N/K244 *#G@UUNC^+81IO\
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MZG-;W@^*2/QAIQCSM:4"7!Q\O>L;2DN6+LWU.G%).BW;;7[M3IH-=LM'@O\
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MZ$[RG#JGK;3?7]3@[?P->/<^(-3DU=9YXW+.(O\ 6*1W&>U9/CV3Q#H^N?\
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MGM5O6?%&J:1J$VCV:PS7$)!CG1!M5?0CO5SPWJEIXEN4O==8#5M*5V:7&/M
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MSC\Q6\5"E44EK;I8XX8FO6H^]&.OGIYKN>R^#KB"\\,Z;8:U:K%J#GS)&/\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>nstg-20221231_g8.jpg
<TEXT>
begin 644 nstg-20221231_g8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $UA<FEE($)E
M=F5R;'D   60 P "    %   $*:0!  "    %   $+J2D0 "     S8X  "2
MD@ "     S8X  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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MO))(07V*C1-O=O0 >M5_^$YT!(5:ZOA:R-$LIAF0AU##(&,<GV&:Y*ST:_\
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M>PCN(IT99EDC+R,6 V@,?O*,<FIK;3)-2T2XTR1+?49[.W",)%/F.2Q)3<P
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M3O\ +_)_D;T7"#<]_4Z6W26:UC_M"*/S5.2HY (Z$5!JLOV+2YY8(H]S8!W
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MEIZC#-<:9<PVWE^<\3+'YF=N['&<=J\>\17.OZ)>:?\ VA;OD221/-$W[H*
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M-P1%);6HC"+DGG'MCWJEI&G0V6N"\OKY+62ZM1*UFEPTLB!B3G=_$"2,>U;
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ME+*%9_-W'(.[IBL[4]/-E<D21JL9)$94\, /YYJ2RGLWTIK2_N)(-K[HR@;
MR.I[8]JTE[RN!NZQJ-FL*Q^2EY(X)1<!E!'<GM7,7=W)8Z'//IJF346=ELH5
M.5B/&2V>..3SZ5=:RTZWFAB&HJ^'#.DJ$(RD9[=\8[UA^,Q)8S3FTM8GTY(U
M2:-IFCDR2 &0KU'U]ZXL0VE"$-Y273\EW*M^[G*]K)O_ (?U[DMK$FKZJ^MZ
MO)%JENUJ?LB9/E@JH5FV'[K;MPX[5D7BZ)I>J64LD"KY)^9$0!%. PW*.01U
M'K6'8>)-6MX/L\LR7:*3Y1F4DHO7!.><5;275?%$<=I]E\^Y23SI&P$DE0G:
M".@(7UYXQV%=_P!2<=7[M[[-7MJNUNIY,LPA5@HQ7,U;=.U_OOK;[O,-1:*V
M\47":4P6(QA5DM0&1MP&68= "3@CC'%=YX!T.30-(D^WC&I39D-LSK\H!(7'
MID8SS46FZ7I6B:>FFW<4=Q#<'+8?*A<\L6[G(Z#TKHI&LI)I+Z[MMBV9'EW
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MFFM%OH6DTUWZ:F;%-_9:&3RY8(0S1I:L-QE<G(8-[U6UB]960>0]M^[Y7S
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MVO;M=?AJ82PM.NG-)*6GKYK31M;;LX5ETO3[:UFTS4XA=[Y8;^9"61EE!(Y
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MB+92.)D<OG&>>QJK%"Q7R-6B%W;27*S>7<JS;'^]B/V':M/4$%YJF+0,J21
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MA>VJ87EYI-K76VMO..GWJW30ZEXI?#>E6-I:ZDBI<7(C9K<@$;02W;^(]?\
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M1@.(8TWM*GW>?8556+JQUNEH]'9FL;0>ZN2NVDFWC74+F"21'2*25R%,D@'
M/KWXISZ=&FBSP>&Y(;(RNS^9$@8;B?F./4\UG:7>_P!MO"9+2SO+0OO,J+AD
MD&>64]/K5VUT?3]%N)Q!</;Q7N$2W\S"JW<KZ$YJZ=1.+;T[]/0S<5)V2[_\
M$Y/_ (1Z^U>QAFT5[W3'@C=66Z8*SON))=1S\W\JKFYN(;9XYM$N5M[B,@M:
MYW%L8&,< YSP:[ZSTBVTQ[B>U1WGF4;V=R2Y48'6L]+BVMK2R_M2V?3IMS3^
M3$Y90W/!(ZY]*RJ0C!0;LHQZ:6ULK7MLC*CAG&2C2DU96LMG9:.W2WD><K?2
M+I/GS(TQC(M8IKZ/.5[.4Y.0<"FZCHXU;5K>+75M=.@>7<;ZUL%(E;IL9FQM
M )+?C7IH@6SEEU1+C?;W3K+-Y^3L4# "#MSS69=M_:>IWEK=,@LK91='$(8;
M2.JG'7&:UE7Y9OEC>[;LO/9[[;WZ>1I##2<$I3M9)=MMUI\O.V[9Q=SX>MH=
M-T\RWS06!1TAMFM=OF2;\F5B#@[@1R:MVL=S;W$)TVWGM+<WL<$9M$7!C)WF
M0. 3@XPPZ5U5GIT^I6ENZW#IIV"\4F\9"=0"I&.@Q2VFBVPT]AI=_"\4SR/&
MMO)E9!W4<X[?A7/'%XFG%-0;:TL]M=W:Z6]NC\MPJ8&G-+FJ*_626K]?^']3
MG?$\YT?7HM3E+^=LV"5;;*LIYP.RMSC/<9J>$MJ&MV0U"PF@O_,-S:13G:LW
MRY+<<# P,'TK5T_6[B:U>TN)ECFLU\V=01))%CGRV![X(K!N(?#>F-9^)+Z2
M[MGD9IWMH=TC,6;;TY(!W<TZ<J52G&-:4E.*M=/KV].CWNKV+J4:\:EJ*BXR
M:=K;[?G:ZM:S-'Q MR;KSYHQ'+]HC8PQ2;B0./NCK]>E)<O=WNH2".*-&<F2
M$;#Y8'(P<=6^4Y_"LV:?PCKFF2:]!J!MK=F%A*-1<Q&+#8  /(R1^//O5E88
MA>1SZCJPA@C9D5(5*@DG +9X*XQWS7G5,%[*HXU)>\];-63>^F]][;+N:4%)
MUY8A;:*R>UKJ[732SZ_":\P8^'K06KV_RDO/&RY<\\$>E5XW$EO,)XT,CMO1
MRH!#$\G/0C':I;'1S/KUV(-7AG@CV13V1@QM(!.5?KD\>W%0VHEM;!=-;3;J
M.=9CYCR)YQ*X.&4]/;\:RG0J)KFT=K6[Z?<OGUN=%/&4HUI4_>]YMIO;1*]N
MR\G:^HOV;3K"0W]S%#>VS7"LN\;2DR\(P!]L]*T]9DBNU@N?/-LDDGV4I.'&
M]L\# _G638WWGW$T<%O<L+:2.22.Y@\MONDKSGG'I5?6;SQ!=7%G;6#(MM)<
MBYOYI""((E&=@5N3NZ9'0UV0E.C>E435UL_3O_PY4W&:]K3=[/IOOV_X8M/!
MJ-O:2&[$:-+.RM$CJQ4<;!QST_\ KU=A;4(]5L](NM+DO=/=2)KC 5+9@-PS
MW8')'%+JOV+1M%CUM].U"ZD$ZR&&",23-N;&"/09S5'4I=7-Z;74;F90]P$A
M>)!\\9&XG:#G@9!-6L/&+]I!/II?2S_0Q]JH0]BY6MUW>_=_=N1>(+E+:T>*
MTAEB-X/W<?DA42.(Y9<'KZ]*S+$QZQIJWFIO;6NJ%V$4$;AV&#PS'C P,XKI
M=8U/4FT:VU#PU]EG69XUA-Y&0(8\XD8MUSCIFL2^DTV*Z1;B\M!%)-B.\BE"
M,6((9?7 Q]*O%5(RFDTU;33I?;8RC:,;-Z2TV?Y]+=[K??8S]=\+Q"RBMKX*
M([EE$EY%(<2*YYRH.5 R._-48;W4=.\%V$^N)/=QV=_+;QE<,LGS 1,JC)Q@
M'KTQ6IJNHP3Z*]KI<T-UJ)PP$REV>,8V@#CJ.<CI4)MKG4=&GO;^5K>]LT0R
MF2%F#+NX"X^7YAQGM6BE.2;:WV76S6_1V\UU=B'&'.E3ELM]U>^W77R?34Z?
M3W6_OH6E57ANXS,HERV%(S\I^H_"F2!FM$NDMDC3B.!S*.-I/('7-4[2\GN0
M+4.T=T%9XHER%2('=MW>H_E5BX"W<DLD%KY442C>8SO"^_I@US8Z'M*4<1'M
M9V[]]NEO^"=^$;A/V<W_ %Z7Z_,:MW*EQ(TK-+D$2J6RK\8!..H'%2Z9I,UQ
MJL<NFW,,5I"!Y\>UR)=_+@JW&#VJBI$<OSK@@CY3TZC@^U;27,<NA7X>4W%P
M'#O$&XC!/RGCH,"HR^4YS3<KWWNMK:;_ '?B:8V,(Q:2M;]?Z9F26T4'BQK3
MRI_*5BH2-Q&H4KN&T?Q'C&!3K:\G6[65X,+'.\J1ALG [%C^HHMI/)5]0:$R
MM9H9(5/(=L'$88]&)/6H;K6[&6/9+&T=Y<(DLD(8/]F9N?+^4=\9/3M7LT84
MJ$W#;]?^&N>=.4ZB4GJ7KB-M0U026D#0FZ.8R&VG@C+_ $KKSF"V/EJ9&1>%
M'!8@5Q.GZ@UMJ4#QB:98SY>&C(Y;DJISR:A-W*U[))$7A>1B"J,1U/(KJ<>>
MUMC'8V]:N&N9K**:"1!M\R6,L!L!X^][5!#J"1V$D.F7/FB0,!YD@\P/T 4#
MU%8K:@%Q%-(J;]RO]J!5BN1AT8_PD\?G6M%;VLTMNNG1_9Y[USYX4 ^7C[Q'
MIFN?VEZJIK9>6_\ PQJHKV?,S:M-3$=FDCY>SC@R]RSY8..JD=<UJHX>-74_
M*PR#[5S^IP_8K6.WM8[B)8%!CE091V/&&'>M:YA%SI92[C.=@9DC;'(YP#]:
MQA44JDH:Z#G"T(R[DK>3?6CK'(KQN"NY<,*Y?[-=017,FGS;K>()NE0[3($!
M! (].]5+R^MXV22UN'M_,0E8UE4",]"I'OUS3X-2>/2)[.4)*K@)&B$ \YRV
M1UYQ79%;I,RLUJ1:]#-9SZ;<:;.TL]V511-(%+$GJ&Z@@'TK'GU*!=-FT_3K
M;4!>-(X\\S $RHV25W?>)Y_"NU6SN[6-+B6WCO;K"1Q,%&8>.I]<'O6%IMA?
MSZK>PZYI5A%:V\K31W,4I+&4],9'&1UQS7E0A3HUK<M]=NGETW[G35=2M1TE
M;3?K^9Q(C35;V[U1YC<VRM&]QYT;%RSG:0H7'( Z]*Z2]LX_#VK&PGU/4+'2
M+Z,$S^83)&ZDG[X'0CKFN;T32VU,,8/,59+@O=1*Y6)8N0L6[@DYP>1TKJ([
M6[O)]/FU*;[8]AO$RQH#&T3878!W'OC->O'$SJ8CV=VHPZ6796OO:5[OIHU=
M'@PP5J7M8V;D^C??7Y6?<QX8?#]YKUJ$6<"=46!=0/REE/!+=V;@BNKFB*Z6
MEJ5N[JYM2PEFF?>0NXG!(_#\*9I,D5CN@M[!7M].7>F(C)+,HZ!5/*D9ZU:T
M[5G:280VIDBOBSI'/\C$YQ@D]>G2N)RKRK\R;U[VV6R\M]=>^^YZ]*G2ITN5
MI:+I?=[_ )::;6V*QTV5&A6./SM\8<NJ$J WX]JV]&LK:\LX[B0RRF.3Y#(<
M;2O'RX[>U%GX;C6S7[1)(D['+F)]N!_<^E;-O EK;QP1#"1KM%=4YW5B"2N1
MUV>/^T)-]Q))*C (JIA8@.>_4UUU5-1LOMMFT:",2'[K.F[%1"2B]0.:DU">
MZ@</(+*2.$(+T+OE&<$8'3FII);>XOD:TA,DD[QEWD"L?0C8>1Q6C<:$D5D!
M8';*DBRCS"6!*_Y[5@0P+>ZA':N?+>8F19F4[^>1D?A57@G>*W[?J4DY+5[#
M'>SCNK\0M'!>L)(K.X*;W4,>1L)Y'%<TEOK5S8ZAI4&GRSSQW'FW\RML\Y>"
M%R?NDCL.W%=QJE]HFD2)!)#%<7UI&)-KC]YLZ;@<<_A6!IT^IW.M7%Q:WUE8
MPW-YF\D@1FD#* 50A_E V]2/6L8RI<[YDK1::T?Q7W=M^]N]GOJ<^*HRJJ-K
MW=UNMK;)/\^VA4O]3UV;2GL[6>22*[E>W?S+<ATRH8*K*""H7Y<]<FJ>EV]I
MI.DR27+%WU6S6-;,VS*L8'R)DDY^7GW.:?/<Z8NL&73M3U&X4R/+%'9-^\@<
MGYQAB"P?IBMS5K2?5=3M1>V<XM8H/,N+B0&,LI'!R. PS]VM:DHSI0_=VO>]
MXV=^NCUU?R\WI?#"7=2<E-V6RO?T\OZZ=&:;I=EX?\J&15O?*:-B0O[N)AGE
M2.2>W/I5JXNHKV2.UM8YXK2+!DDEPRJSG.?PJG-)&S.8D 4GY<CE5'3/K5Y;
M!-.%GJ-PL4_F@J Y("J1D].O&:U]G&-FEJ=W,]BO<)Y4GEP-*(HWW!I!C&>-
MP(['%:>BWBW%S]DU!_.C<*R+.-VV0'@#/M3;**V,UP=3BC$"!IDW9^4%N ".
M,>U06"7-YK"2Q)C$WF-A3M0'OSZXJI6<6F(M7UG)9R:E+))'<ZE=PN(GD0I&
MD0_A;G&?>JWA?1;#3%DBO5M9<,IMY?*POS#<0I/7FH1%/%J#6^LSW)21B%42
M8V@M^J_6H[U42\,4/F3I&-NZ7.2>G'MZ8KGI152"E:URIKEDXW+>GZ#9QO:C
M3KZ[>;+$31C"!020KKTQD_C2-9:;X=C,>O7]S>R7,3,]L%)C?#;B0HZ?GZU2
M@G>W\S[)))&SJ%R'"G.>?UK13Q+<HK+/''<DCY2R[=O'(QWIU,-&3VN1]I2Z
MH36+FTM[*RU739I1!<8B#0_W3SU[<\5?T;67VPVLX:9FE,8E+#IC(^M8=](V
MH;)6FMQ';GS+6Q:'"J<;<,PZ<\BH#!<+;Q^?$\,FPR20L>8^<?X5E0ITJ"]A
M%**_5^1K+FFN9W9V.JPK&RWOEABJ^7*S.1MC/4C'>H-+FAU+1VL3B%PA4HN2
M53H#S3M%N/[3TDPW4>44>7DG[XQR<5B>3?6'BR2U6*:*R2R,L=\LJX+;L")E
M/4_I7/43I5N:VEGMW\_N-(R4J?*WK=#-2L7BGN+:X=H[9]J&01M@J%QVZ\=:
MJR:?8?VK#:^9;W-M-L2".1"&QCGD]0>XKK=-U W<<,+1R2$Q9DF(& P."IQW
MK+U#3#9LFYU%JN3'+( S1$]5&>N[I[5M*$,3%3ZVT)4I4FX/YG*^(-.N)-$^
MT6>KVRM'(8)6A=TBMY#E5; ^9N2!@\5G"SA\*Z7%=>+2TJ6K!;95)EMP'4!I
M-H&0-WZFNJ2W$^DWITM%359(P"D8'[V)3]T@\ G.#WK)\0Z0JZ3IRSQ":[:,
MVSQ6^XJ1N#B(A3_]?BB<Z]*')#16M9=V^FUNNO;H<$Z'/B/:M7]?+RZ][76I
M-;ZQ;Z5>0R2%K"TTZ4Q*9)"(I%?DD=R/3/0U!+_9NF:Y<'2]99X]2&2AN=ZM
MMX[].OXYK,D:?4]#CEAG6:]ANGDO($E\YH8U^7[IX8#@D<XJ'5A;ZKHNC/;W
MEFDDQ80W5M:'&\G.%X!CR!@E@#QQ7E3P_L\)S5)MW?1ZKUWT_P"&/6I3A7Q:
MHQA9QU]?2UOZ[G<WHA=]/$0(N+/8JW,,X(4D?<;O@_RJI?2ZU8ZH=1TS]XT5
MK*W]C0%1'=2GH[2'E?I[>]1QO#816IBDD.H(/+D\N([;EF'4@>F<9-3:?IT7
MAVTLK)II6DMW*E[N;S7D1\L68]< G@5Q>TJ1E*5)K3[NEM;::7OI?0SI48RG
M4BXI2;N[-W_NMKT]4;2:E-+JU@LUUY274#*]I&@?RY0,G,@Z8Z5DV]LHABL=
M997DT^21HHW8LTHYVL'..>:I,++4FEMX+BYN;^,NT(A4P)YG?YO?'Y5O3ZI$
MVF&^OM.EB?3Y%#F;Y1GNRM_$,G\:]ANK.@I/1]?Z0XQA"I;=?UW,&:"P_LI8
MKJ]9H9I=MM:)%CRP/F*DC@GGK6[:ZC<0^&8GU&T.R5A%'&\@#%#T+'Z4^WU,
M>(;1QHADL989$=WFM_O*>H'U ZTWP_+<7T]]#J<\EQL8$P36VP1YSC:>XQ54
MZ;IRT>K7G;3Y^@2J*:U6B?S_ *W,?5<6=O'=KIDYBE>-4V?,(QTP<=1QR:T+
M2&*YMC':Z>CRM+O5BY*IC'#-U'4\5N7&DPS)*%9T#P^4(PQ"*!TXK! OQY[1
MF5H/+82-"0JL5'49^Z:F4%&I[27Q.Z_RZ:?U=FD:G-3Y([+7^M?ZZ%C^R8OM
M%R]O]F,MN^5CR0J9'\6?3J,5CQ1Q2F*-R59EPC@#"D,>2.XQ6B+IX[E(=.E+
MI<!7;S1YGF,PQ@]\4EQIPM+>-9+11,#YLIS^Z*Y^[N/3Z5RT9.,KT4[QO>VJ
MM?IZZ=MM#>:NK5'O:W?Y_P!>I5Q9S.CF+RECW!E5BWF^FVK&GS3)&UC<P02(
MH.Z"7Y9",$\>M3Q6-UIOFWPBA$BQ%U!DR!SR /IWJC;R?;+:\2?_ )9HT\>1
M\P8GL?2M:-&JJ2Q#TE&^G=?I_F14J0<W26SM\G^IJ1:JFJ:=/;-:F"!8B#)N
M!5/[HY[UGVOVRYN5C@N$A>./=(K )@XYR.YQWJ?3X$)%G-%Y:W$.^9VFZ@="
MO;MS6%=W<=O<-';R;I3*\2JKCKC/WCC(V\Y%<^,JTZDU52?*ETO>_P#P[0HS
MCA:4G5:7X^6EM_0V;*_EA6P\B*618@X=$YW GTZ_C2ZKJ4%W<)9Z?'<3W5TA
M6*%XR(867GYCCY3^E4;:_6TMA-8BW6[;Y(Y))"5P><E1R?3BH;&&XMM3>9V5
M(Y)ED^VR3GS9%(P<)C@!N*QIU.>AI)65KKK;175_QZ=18BIR5%*$6[O=:VOK
MLD_+MIKY%.]O=3T^* 7BPQ7:WK/'&BY9CLZ84<C/]*U(-4N-3O'^V7]_:J(1
M</:QQ 8'W-H/7[W/TK9T.&[#XUC3CFU3]U>W$BR2/R<].G%5QXH@?6;F"RLU
MO;E0A!B3:1">"2Q]#VKU.2=7>7FM]K=5\_OL>6O>E&K>R332VZ;/UWM;3Y%;
M4Y;:TNAJ>OW$LEG)+]DMTA?<J;L ,WH>#SVKF;[3)[O79([6XDBA@BES(DH+
M#/IQT&/;-='JNC7L9AT[P=.+&&2"25"]NL]MYF\'<Q.3NZXJJUU<6MVRZC8V
ML44:XNVLY5.XA<_O/[H[X-16C]7M.E*^]VU?1Z6VMUTO=:^1*JRO&A53:;6W
MKW7FUV=DS)B\0R3:C JZ:8960JZ2'Y)X^,'I@Y')&*AT[3VTJ!+K1)#Y^J.L
M,]N]EM,(=\Y^3H/7\*VM,U6UU&>WLK&6"\CB<M83O,3+(I'S,C' .WIQZ4ZY
MUZ32O$PLVU,6NG6>VXO)KA1E@>"K,>G)'3UJZ,H4:KI4E:#NY)W:>M_U7HC6
MI0C"G>H_?OH]FNFOGI_D1Z_#:6FL^4^E:@UNEQ'+-<!]VYL +Y:'.\9&#CI6
M?KD<NF^)+N_M;I+J:ZE3%H^X.L9ST;L,]NU9=VVK_P#"Q+FYUR)M5L%E$MG)
MI[MO1<C&S!QQP".I]:ZZXT[[/K5O/+X@O1*8#9PPR1K)B60EED<8SN7H,\5T
M5/9\L%"RC*Z::;3:L];/1:/M?3YS[.I&M)3=W&S372Z?=6OKUO;UVY";3[S4
M[;SV@:$R7HCCD\TR^4-N7  XVYQUK>CTRXU7Q;->&UGLI+*U)AM)$'V>9\X\
MT,O).,_+TJ+7XS'J*V=UI#ZU%"L2"<LEMLE+A9&!&,L1AO3%=%XETF*;7='>
MVN&@NUD9X8S&6CE9%X#$'Y0/UJ)S5;E6GNIK16Y7T<7?U5GZD4L)6H+VE7>5
MGO\ %;I)=-_F><R>&(QXFDTH,]U+>VQMA&TSHUL"-XXQA"&Q\PYK;A\">(8?
M#5VEU=S/&;Q)(-,#B0)& %8;\Y8DC=S_ #-=2NC:@]W_ &Q?6_G:B)$0"WD$
M8$8'S<]USV/-,LM,L=<\+W&F7Z%+/[0TEK$LSI*51L@G)S][/'2NF.8/E;2L
MTE=OK:^O;]?O(A@E)6K/W6VK:.ROZ]O-=B&)+?38;?2-4\110:DHEN5MRYVR
M(V0H<-U XX^M9.HW<6I:<(WUA6N;: 6\95U2RNI ?F*A<GCIFM#560V-M]EA
M74+Y%V-&L0=54'<26(SCIWQ7-Z7H:^*M,A>]\*1--8121K,#]EE1V;_EFN=H
M&,\^OUKSXXI8F*5ERR]'=6V_'7MN>G/!TU!WN[67WWUUWVTW[%6TOF>[U&R5
MK>*"-A%;6=K;-L#,PVEB.F6))[\UCQZ;<V^HQO,(=3-]!Y<\UHC@NZR$(JC
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MH15H?;]3MK1;7_2 ?,2XDFEV^7GIE1U'I^%-MHY-)U>&U>9MH<,=SA$;<,'
M[\UI&3=T]T)VZ'36WG?9T^U!!-CY]GW<^U2T=>E9>J:[#IT@B5#/+U9%.-H]
M36"3D]!&I15>QOH-0M_-MFW#."#U!JO<ZS#9O(+J*:-$<*)"F5;/<>U'*[V
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M+JU_7WG-4]O9RB^9^96GO+::VFMYWMM*NM4 DOI;MF97(RJE$)XY 8= :L>
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MG6JJRO;NL?S,SCY9,A@P'3M69;?#M-=O'_X2346B:+5Q/]BN0I^T(GRJ<;N
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M],N-5U![B\@DDM;(@VT$4^%N3P=S#L0>*/$/ARXUIK:\MYHXKRU=)+;SE++
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M*<8W;2>]KI6^%)M<RV;N[O[C>LK<KX-MM3DUH-JFLW,IMBRB)6.-H 5Q\X
MQN&.?QIFN7FE:1X-\B#49YM0::.VGU4W2I+NP7"<C&!T '.._%5/'E]-J]OH
MWA8ZC;)>0VRIL** TD:Y:0'J@('&*?X9TF[N;74M-E%C>0Q2!8EU&*,[9"O,
MI R7)! !'/'%<<9J*4(7Y&[*R=K;/=::ZKYZGOM*L_K4)1NFVT[-W6D;6MJM
MFMM+6N4?#_@FYT@_VYK=X8=!M8\337*@QRQR+E\#.=IW  CG/-=3XCO="LM
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M5?AT2LK').I.KAVH?:TU[>=]6O+J97C+4+>QDMYU\C3EN"(H)+A"8SNP2[*
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M)M)+K=?K:VO^1Q?4H8:GS7=VTM;WLEIOW\OO+U]:)?Z?/:2/(B3QM&S1MM8
MC&0>QKSN1O$?AN:WB\-0W6H0W%T$==0GR B#&T%L;21R,>E>@ZG'>2Z9.FFS
M+!=%#Y4CIN"GZ5YWJVD7GB+PTQ\1:M!+=M=I-IPA!BELSC:=I4_.W<'I65>*
M=I<UFK_UZ%4*G++EE&Z?]=T;?A76-4U(ZA>_V+:6D,CY)27YF<+\VXXP><<B
MNBL[Z*ZD6#R4+LGF2F(AT5O0D=^]8VIZ+#8:;'Y=Y/$[QI!-(8]ZNHY<L@X!
M;G)]339M*M=+DMK[P[9@"-?F:.0D'(_B7OQW[5FY\EW*6W3?3[B:<9U59P2O
MMK_7W"(NNFREATMXQ?#4"9C=2>:(8CGE>G;' J&[T&^M],AMXK!);V\:3[7<
M6,GV=%)YW$=3GI756=U'<VL,P"HTZ[@N1D_XU8+!<;B!DX&375#E=%0Z;Z:>
MGGI^9R/#J$FH773O;OOIJ<J_AO0+VZTQ->M8Y-55!+''),SDLB[2>N&P#WJ'
MQ!X>BTO2[*30X+.SM[6Y22\>16+^0!AMI'.[I6OJ!AEUL076Y(OLK,9?+ "9
M8#B3J#[4MXEQIENLZ7:M81EI;O[0#(WEA>B8K%WK)TK7]>_H/EA[-RA+WEUM
MU7?;;1F->Z=;:?#=S:%J6-2EMI+BV@NF+QDLN [+C)%<-J&F3W]P8=&L],BD
MAC6X:\-V%WS%@'PA/R1@YQUZ8KHM6\=^;K42Z2MI8R/%LBGU"U?>^2"I7'/E
MD9SG&*T9O#T^IV5U/83Z%>QW;Q_9PUH-B1 Y=0ZG+9;D&M(\U&HXIN.U[?\
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MI<-@VTL9ZJZ\$\+UQQ^M>I:?#KOF:A>6,D=_I-Q:QK8WZ2'[0A/$AV$8P,9
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MT*XFLHI=8O[FZ2%C*\MLXAVJ ?E/JI]*S_[8M;*XA70[M)Y+I@9+1Y&^5 F
M,X/Z5#;76LZG8+;_ -I2,T:O!<M#&IC,F3E?FY& 0*NS6'V4QQV8AL9;:!09
M,KF;Y<LO/WLGWKEG%J<94E=]FFW?UTOI?=_@;RI35I046H*R;UD[/9-OJGO?
M?N-TC6K;7-!:\LH_L:P![<P26X8ED;YF0GEE&3S6M;G1Y=VFS1V,MN;=6D9E
M56?<<#*X]JY[P=+I=C#9:?H\RVOFD@6\\.2&.6?')VYY.#275IJ^HK<:8D5K
M<(K-$LEXOE2W&TG(PO\  ,\&NZC&<&ZEN5JRM\[=_P --C6K5C[&+G'G=NBN
M]5Y?B]40ZGJ&J:?XIM;32XK=[.XCD(@@3>[.G1E8G"X&1CUK3T?6[+2-"N[F
MWU*YO[^['VYK6\F+F')"E%P/E .>*JVMG/;+]IGCV741:**2TN"\:Q@C.<\Y
MR<5J6'AJXOUEO-1#6USY7E6XW F/!/S<>M8\[@W1I1O.VZV7Z/\ 7ON8X[VT
MTG3;7-?=?"EHWZ[6BWKZ;1W5KJ'B2ZBU>#6)+;3(8\&WM9BJR'J[/QG*D$ =
MZDGUNYEU^T>SL;O5=+NW%L?*0-'"<9\U\\@>]*VGFVM+'2[N6ZBMK-_,\V(D
M&8K\V<CH,YX/6M6VF$%U"VE0++9W;EYY&FQY)QP O]*VER-QO4TOJGH_^&\O
M0<*,XQO-/NGUN_1VT6EA[2:K%82;HT6XF<K%Y:;EASW;U%9FI^'(;VWAU6]-
MO>W]K;O'YQB!#*?O $?2M4^(M.6SN9[F7R5MF"3HX^9">F0/6J%E<K::JL&G
M2^98.)'9=I)WC^%?2E6C!)*3;4M-_P ;=?Z1NX\S<G"_1K=6Z[Z?\ YS6;&^
M\165O!#"S7%D^ZVGCA4- 2N,9/0$<?E5G1=1UK4/$$MO<^&I=/ELX1'%<SLK
M1R#IO4@8!]A706U_#;Z>9=.MKBZ,UR%EC9L.A;J>>N/2K5K8:7H40,9$01"-
MTDA)P6SW]S6=+#-TU*4[]>FENSM<TJM>W]U625N6VC?FC*L]2NK".YDU&TC%
MPI =$4#:G/SE@.0>N.U9;ZU)8:>EGIEG:V\5U(P5?F?S&;G:![],\ 9%=9<:
MAI5U;30SSQ21%0L@SP0>*K:K<:#X6TM=2U%(;2VM2J++Y>2FXA1C SSD4>QK
M.T:=7W5OW^_]?P[85(WI\E5-:+WMG=>B2L^MM=?F4KA8-+T?[;=I;Z>D4.RS
M0I\\#,.5'/))JZ7NY;&PU#3_ #G(C&^W?Y2X/J.QI\FAZ7_9=S;WN9[6XD,K
M_:)-VTMW!/3VJII^LZ3#/#I.DWULL5C$//AD<[XD(.SK_NGK77.C1C&[;Y^_
M7=:_?8<)24W)12C_ ,#K\EW%%SK.GPW5P]@US)<2?Z-;PL,1\'[Y[<XR:B\.
MPWURK7.H/]EU!Y ]]9!_-CB;&-J-Z8[BK4M_-J5C>S:5J=M'#&RA+A%W[=O+
M@CZ5>M]6L9IHXH)TDDE&?D'H._I^-**C"T7/[]]_\_PT)ITYIN5W)?@OP[?<
M48=!TS3_ +4CE(DOKD2A%.P;AC 'Y5"UE>W7]H1W5U=0VRJ1'(0-P.<[E ]J
MSVUBPF35);;5#=Q29>"389?(D P0@]!CM4OA?Q%.^CHVI0K%!"I+7#,1\O\
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M3H;R4_9;1;EP80C S*IP P8#@U+JFIWUIJ5C<6'V:ZT=R8+B-74,C9^\#T(
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MI\C0U>_M$A$$L)O"951H8R"R]\XSVKGK[Q7:SR7%I=Q"ZTRXWH)9,1CY1]T
M_>.<<^XJVNFZI)J5VDR6S*IS'+/@M(".6XY&.E.NM/U5],DMX4LYD+YMY8HU
M/E+D?+ANO&<FM8SJ.<I5%;M;_@7O^AURC#EBH._]>>Q7TCQ-H$,ALI&07=G;
MJ\[M&H,(/"H2.Y'3UK2MM72XU"6YM[N:9&M/-CT_R</P2-PSZXZ5IMIE@?,D
MEL[??)M,KF-<L5Z$GOCMZ5AS^'C80_VC8R7FHWRHR+FYV^8K'IGVSD5I"C53
M7-)-+UN_Q_S/)G3JSK.=THWNE9_FFNGD)8SC7M,:[GAAT^>.0R2[X]RD8.-Q
M/MUI]I]BU&SLET35;1)4*7,Q@ S+&,C)7.0,Y&3Z5;M19Z3#8:)=--/+.&*M
M(I;<1R=Q''?%3Q^&=&BOI;V/3H%NIH/L\DP7#-'G.S/IFDJ%Y/GBM5NFUKZ?
MJG\CMJ3=2/)=J/X_>K?<8^GZM/<:E:)?-;2R132Q-,\319;^%4SU.*U;.>^D
MUES<1/#%Y +(S956SV/?CK5B^T:TOK6&&2,*;=@T$@'S1,.ZGL:RKH^([K7[
M.*VVV6G1L6FD*AVDV]CSP&'H,U?LOWBO)J[OY;6M_7<OVEH/1.VGGZ_UV-6:
M?3;RV@FG>)XC(/*9S@;A4MWI]M?[6F!+!2JNK8(!'-<]XCCA@T'4K[5?M%O9
MVY#>5#M;*J>JCC&<TZ:;3YTM-'TZ>ZM[NXMS?6P!8#&.-S<@#)'%9<TY-J<%
M;3RN[]OR*VE[K:MUW7G]W4OW-I_9<326\NQ2!'"!#N,1Z<8]>YJ""UOI]*F_
MM&2&&:,EK.>=0TD/'+'/?W':L"PU>.+0K2PE\0W5Q+ISF2ZU%'5_-=6.8"3C
M=UQT["IK'5](NHI/[0BNK@7$DSJUT04C3:"PSV&/:LI1HP<IJ;V;:3;LNNU_
MDEU,O:N<U3EI)6?37=*Z[7[FM>:-/J%E&7O4U'R6$JJ1C+8XP0>AJUIMMJR?
M:UO&AC@D0>0D9YC;'..P%9-OXB\-:+?K%9*(HKH?/< G9\D>1C/WOE_NUA3^
M/-/N[FX\]VNF97%N;,,!''D89LXZ\'/UK?DC!IP=WVO_ )ZFW,Y*\U;SL=QI
MD0LK>)]3EMSJ#@12RHWWR.@Y[XJS8P6$+7(T]8U9Y2T^P\ESUS[UYS=>*IM(
ML;F^MM$MYHOM9(*7*L9GR%+#=R" =V.A]JU"]XNM7]_:"\GGM6CAFAMH<&3?
MALKD@8'>M$J\+)4]/*WYW7<Y/;1=/FJ/WNWSWU2=K*^GRN;-MJEG#IL]C#?W
M5W+OEC,CG]XAYYYQP.@-1Z3J<\+6T<33WD"Q;9]X :#:/O<?>R>.*Y[4+FPE
MDU/5+C48XVM9&B6)HF#K(QP.,98?3/>M"TN8K5#<VNJV+NH19,-MRS]$&>.2
M/K7"ZN,=;6DU%?UTU^3-Z-3#SYH/1]&[6:_37\%?R+.F6OAS5IKRSMU:.Z-R
M;EF)V2.XXW\=<=.:OBXTK0M0O)Y)[IY2B"?(+*,#K@# /K5328(](GF$"0K.
MDS>:\K[I)QC.T,>^>*?<:S+.9%^PO:+("K, &:8XZ CZ]:FIBH4:2:>JT^%O
M\%YFLH5'+EF]9;>MNOR\_N*UW?7\EA/_ &?NUJ*.5I758@LL?&Y(T!X/IDUL
MV7FWMO::U)!/IMQ)"#/:38+@8^X>< YK.\-:HE[?3VT\ MWFA!CSN\QPORL6
M/;FH[NUA6Y>P64W$L:$Q,\F F.0A'\1[YIRQ#]DJTHWOZK9Z66^O]:&6"E[>
M%U+37I:ZZO5[=M=M2![B.]TJXG2VODNI,NTK*)&A'(X&<'N*DLWM[ZU@MK&V
M,,TB;"\L@&01\Q*CJ>.E365HL]G^\,,=Q*0\:R2$F15.6_=^HJ%FFU!?M>AV
M]R8[E@#NB5 JD[20>O'7BL+3FHKE6NO2]OG\M?,[W5I0J^S<];>?2VNGJ30W
M<5I<SV=U:+*;>8&-YY!]S'+=. .G--LHI["Y,UXD,]H)3.[^;N:W=C[=L8XJ
M$7"_V7?7>G:5<W.J6)%DPDB(\Y0PR5!)ROOBJ\E]XE\N\>QTJ*SB8I(_VCY6
M"DC.T@<D#/%='U>:BJG17?33K9][:(X^6$YJ,I-R3WN];^B2M^.BOYJ\FG:G
MK]]'9ZJME+:W<7VC[*2K8VY4$XZ'G-7KFXMKTG2+2UN)[>:X!F9B0'4G)9&!
MZ UE^%]'M?#%Y,\VI"]2YNYIYIY(MFUG (3&3G _KTK:L;P01W<=A(\\DTY:
M %"?)4^V!A<]A649J+:3MJ_7H]/78Z'&7N\M/2VO9/STUUU-6XT*TNU>.Z7S
MH"JA8)/F1"!C./Y^M<UI_@[0;BTBMK.VBEL;)E>)[.8(CS1N6 .T]0>#DD59
MO=8U"%K+46M9HH(VV73,"4V8Y;:.^>]4Y[?48_$FE:/X:TR6VT"2,W5U>QR;
M$ .0(U'KT./>NJ7LYM3A&[W\_P ?._Z'G573I3<6DYZ=%?>V_9*__#FMI376
MK:C-?7EY$8;69E6V1"#"0,$,W\7K6U>1PWECDEY(QB1?);EL<C%8^D)8V5Y+
M9B\N;DMN&^9MR/SD@$=QTIFI:Y<6&+31]-6>-7$(=9-JH>., >].E*$8-3DG
M>]WY_P##&\*=6*2>ZU^3?FV^I1U#45\37HT^'1[AH47,E[(=BQ-D' _O5JL@
M@NIH+IO*,L0AMR[#:Y ^]C'!S5&[T.6&^3S9'^PF)I)YR0=C#V[Y^E3W\<5A
MHPDMQ)?O<S*-YC,A&>AP.F!63=2I+6%FO/=VWMYWW7Z6-J<J2NE)M7MJFK;.
MU^J7^?RA6VL%N/)U.P5IK.(LTK;=KD]#SSG/0UG?8DA66YTG0IYC(6D>+SB/
M-?']_L*T-.,UW8JMN8E1&0S+>P,K"+DD$GWY%:ULMO\ 9;99KFW@>.3>J6TN
MU6ST&.^<U%.#;49;=M-;/:XYU8IR:3377U6Z.<^SNVGW:1Q6VGN"RF60!O*=
M@."HX8\8SUIDOA.:_P!/TB2S\B>&+*/#/G:BL3ND7ONK;N+K4%N+\"PM9+:.
M=#EP4RF/G<D\$BJ[Z/JA N=+U+:&A8J^W[Q;D *>%[5TT^>E/35.]^_;U=EH
MOS(J1C4AKHU:W;OZ+75D$7@FV.LI>7K6\ILI%N+<HI5XY ""6P>1@]#6\-4M
M;Q7;31'>7,(!,>=K*#]>E<U8VFN0:SJ6J32016WV9$E6*V+3R2IR2.<$$<5I
MVFG;-"N'AO'M9;QO-2:9MLB+UVDGD8HIN"?N)JZ_+;1O?Y:Z=C)N/M'&37-O
M\N^G3YDT*W+>(9)OLT<$,";6!'WE.3D8[FI;N_>Y-B]A,RB<MF(KM+KW.3W%
M8CZO=3I-=VEI<23$BS81+^\B8,,L?;G-6;C4[M]0CTR>=;*41L6D"Y^4#[P8
MUA*3I1<7?5_>[KT6W];HZ93A=2;6W5^3^^[^9$UHTDXEN6FF:)=TT$I_>"/&
M,\=Z=8(\NH3WFD:E#):R(L<5D^-J,!G*\9W9Z\D4[3GO+MEF348?F4VX=VRQ
M[@D=R:O-I>D1S16+EHFC4R;02JDMQG/K^-<E/#\R4K:7O[UKW>UGZ&E9RDU&
M3TL]M;/\M-2OI=AK!LVDNFL_M3H!,C(#O;L7(ZD"J^N:?=2^);6:*\N(X8(V
MFDA@W [S\H( X(]0>:FTLZ;I^N7^YYDGAVK++(_RS$C@[1W P*V9M3MF2:*.
MZ6&8,8E9QPKXR/K7ITU&$>7FL]M7=[6^\X8T[4XP5Y)6U[VMOWVU.?@U.UBB
MDA.GW4K0WAW/=*$);CYQCJ#GCUK1\36LUQ#"+"Q$]W,PB6=AE8%SDEAZ51T2
MVU6?4UN=62*Y@DB""15499>0_P")K4^U"TU2_NKF[N&MU\N,0&+Y8SC[P/?-
M.E*"4F](O1*W1>N^FIHW.25K\RO?[[;+;]=R&?2X+*:.Z^TRK&DVZ6WB0,KD
MC !'IGFL7Q5K6EB^M8]3FN'M;OS+9;6*V9F=P,DD] .F":W6TNSDD^T27[A9
M+D2KY<FT,2,;#Z@U2U'3=+OK=+>P?=,KFW\Z.;)@;!&2"><9Z5C.E+E_=I)7
MON][Z/2^G6P<J7.TWS2ZVOTMLVO0GU./;HUK:Z;F680%K:WG)VSE4^57;MSB
ML.#3HYDOK?5M&:VU!X(993!.-DK <K$3\VT<]>O-:O\ PBTID1YKX7$L4>%W
M9&\[ ,G!XR16%9L?&%WH-Z8+-KZPNY$OI1'*@!BR,1DXSR>_%6DW*4JL%>]H
MO\+_ / _ R=-3<+OX=;?+7\VG9O3KK94['6[S]_I-M>MI%BZ 6MS- 6FEF)W
M%4R-K+@;?;BK/A>VO)+?4K32[RX*3 7"R.0&0DG*9 &TY.?PK>GU:VO=0U*#
M4Y-/DM=-E!=HIMTEOD<;U'()]*Y[PS)81W>OVNG3CS'A26>5K=H5F=B<$.W7
M X(]ZPKPGS:W<==?EM_P5]P2J)N%**TEO:S7:SUO:U]M58C":=I>L0:??Q%+
MF\G\FVF)RLK=2<KQG/8UT%EH$DVH(6ECN=/DC.71<@GH0<U1:VMK2/4='OII
M)/,1+N!WE!*LQ VH!V!'KS6]< 7W@R[@N?.T]/L[1F5&\I@-OWE/;ZUE3P5*
M%=J6M[/J_EKZ?/I8ZW7FZ/)&-HI6U=[[K;TMU?F4+P:=_9#V=]8SQ6L=\(?,
MN)-I9CP'4CK]*YR>S&G:?)H'B&\N+=5N3::1J%C(TD\0=22TFT87';/T]SKZ
M&PCT&:S DCLX]GD7%S)NDGFP#G)&,' YP*GMM4U*X2X:ZC5'3%RSP+\BHO#1
MLW\3=37>JG+K3TMLO^!OV9A3E[2+YEN[7:?1[WVUUL7=&BA\/PM:)J'F6,$$
M?DH\1+H6_C9N^2<_X5B:/<7>G^)+/3+:\O;M;J:87;?9R8(MH)X8_=))X]:L
M:KJ!N;&WN[6X"7]U+$\<5NQR\&< LO/%;,(LX+.6STV_VWDSF)IXEW[)0,G(
MZ#Z4KUE)5);:WWZO3=[O\#EEAX4]:+=XWTWOUTU25K:>6FB*.MZ!-;Z++'HZ
MFZU)@PM6F V(V,X8CHI/ZUA:G9>*8M/MF6*SP)ECG\BX)$*D@/MSSGK]:U+>
M/Q ^K6>V;^Q+8!_M2SE93>2L,+M/\.",_C5M(KA()].NHR+U96:VNC&5BF=@
M2.%[#H<US5,/&2Y>6WST79=S>I*5?]W)RM*][6^?W[:=GL8USX?TZTN);_2Y
MEELUAV"U2(DQ9Y)]@2">?7%<U]MT^]\50:2-.BM[6>X#LT6G@QQL1]]B1W(
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M<0S+I-E*"]S:W=R\BQNPQ+N&,@D8.W!Y&!7UAX7-@?"^G_V-=QWECY($$\0
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MM+BN[NPB1Y7MXX9!MPI#,HZ#GJ*P?%+V_AK1WEM]"BO'AO8Y;42R!%,CM\S
MDY^49/\ 2NAN-2L;)WTBTNX;.ZCC#HKC("D^G>IYXH-9TJ.1(K>X8$20F>/*
MJX[X/3O3I48TY)<SYEKN^UM%=:+Y>1>)C.I3=DE?:_3S_IF!JVLK!=1M'9?9
MOLCH?-# ;HFY;  SQZ=ZYV]FDU#PS*8Y;>XUF*Z$]M>RVJR/Y7F;=^,<$ D5
M7EOY],U"YN[V68+=7TL+V\ARDH&#YB')( /'7%;'AJ>+Q+J6HS/<3V%O<,(;
M2QE=5?$1(=ECQG:3SGO6G)6IT[74N;6[7+??1>:\KZ;['/1FH5(^]:2;OL]-
M]E;IIJO7</#?@V\L8K_1[PO-!-"%?4IB)OM:$\*P;T!(QTQ6KI'@^PTJX-GI
MU[L^S8:.-85#0 ]E.. ?:MAM(DBO;::VG=@CCS!+(2,!<<"E&I&2YGCM;3,Z
MRF$N,$# R"V.U75JN<FZETV^[UTZ=CIITU"/+!W2UV6FO7N5H_#UA8S7%R;E
MA?7BF(W$K@DD]@#Q^%9VGZ9JVAW;0A8]0C5]Z7=P5B6%&&#&JCH!C]:N1^';
MDWTEVTL:-,ZR2Q\LI;&&(ST/I6J^DV\BSK(9'2=0K*S9 QTQZ5RRA6JU-(62
MV=]?NL_OW-.;D27/OO9+[K[_ '=CDM2NKCPY;7%_J.AQW<U\5\[[/<;8R01@
M?-WZG-0ZW8^'[33+"_CU,VMM,Z1V-NC$(\_)0+M[\$8/'%:^IG4&\-WEKIE_
M$DF1%:7CP?:"C@Y.],8.,8K"FUJ-O%6G:7J%@EX;2Q$L.]5474A'5(CPK C/
ML#6UZ,TG+=Z6OJOG^6NHIRJTTHP77O:^FOS23>U][^5"/PS?:C;Z:GAZ\L(9
M;>=Y+\^;F6)VPP#8R22V?ESCVJYX;T[Q[I0U)_$<FBKI@1Y%CC:29F<\EB6_
MAP/N^]:<>G>$_$L']LSVL4'S9+PS@>:W?E#\Q!&/PJ2WL](TRUOYEU@?9VA,
M"Q*Y;R@QSRO)W<UUPK*&'5&+O^EGT;=SE=&TW/EV5EJW?3KY_H5?#5AKUQ--
M=W<=G-I5]8^8BDE91-D@(H'RJFW'/O7)3^'?'-II>D26(M="GL4:%('N(KAW
M$C9=Q,XX*J/U[]^B6_U31O$5G9MXPL?L<CLEKIC67[V14C *[^IP?FZ5=\2:
MW<ZEX?T^6U73;>*\G>"8:E+MWI@J?+;IEO?GFH]K3IZP4>:23O97[?-]+[7L
M=%#G<XTY/N^6^]E]]M>AQMYX N_#FA^(-;M]3:XLY[6+RGWF>6WC0EI)$8DY
M!!)XQU/2ETW0]:O/!]HGV_3M1M;T%K:_NT\F::.3!/EQKAE8#CDYXK;TY=>\
M,,L<%G%%IEK;[!%Y1,/EJ.S#/X>M94DFN7FI6?BSQE;I;6&G3!X+7R\0VOS!
M1(K'#$D'OQZ4ZN(Y*$O;W;TUUET:6EEM:\NG>[L<4\2X5.:G%^[9Z1WN^CW?
M3K=+9+4J:C//!-<>&M$@DEN;MN7GN!M61!R/-(R,G!]<C(Q4.E^,;[3H;SPS
M?ZY<6^I:>QF-REOF(%D&("XR6"GJY S7IT^G6VHWDU_+IJ7FZ%3;S0A01ST!
M]>^:S_%'@K2=2NH5;29Y9]0S#)=1GBV7&<L._/KFN7!SJ-IQO*-KZKWN;R;Z
M.VS[G=+EC%1J66J6EWUW:[J^VE[;G+>$]$U3P=X9N-5OYK3Q#<S,LD$<!8NQ
M<@JTC/R,$\X'O6W8^/9O$%K);7-A:6EUY1E@W2"=2Z-AB!CH,=?QK*TOP%;>
M&-%UGPX/M=TDWER1W<;!I [$9Q&#D*" >33X=-OY+;4=.L8Y+[5&B,(6^3[,
MI0-@YV=%(S@CK4UX33G*"24K*ZL]=$K^=E;JD5+V%23Y]6VVW:UTM[)[KJNI
MTFA>)]*\7 R0LR17D;6\5P\H5;@K]YHD/7!SSCM6C)I:_P#"/O%9Z7#>W$<H
MXU*,9E93C>3CDXZ&N4;X1+'?:7;65PL.BQQN;V!V,DA<G($3$?(,YR>N/6MR
M_P!,O[7P]JB:]K,!AQ(MBH&Q43;\@?)^8C&<YKKLZ-G?1Z^E^^BV\MR'R5'*
MW3;S73O]W3S-W5-(:\$=Q9/';:A''Y<<K+O54)&X;>G(XJ#5&\/M]KM=7:W0
MQQ)+<-)\@50< [NWYUS'@K7U%K'-J]^VIWIM8_*DMXUVR1#(+HJD\9&#[UT2
MP>'?$[6]W<PJ\US"?+AN,H[(#SE"<XHJ1JM?NTFT^M]M==CAJU)I1]BT[[W=
MM.NU_(IVMEX-O;J;2K>6">XA*RLGFMN0/RN&]#VQ70Z=I=KI%NT=IN5#R=[E
ML8]S6+?:1%8V_P!MN6M[.&V#-+-;Q;6"+]P<#)Q5I)-/\6:#!<_:98[590X>
M.;9NVGHQ]#W!K.C%RGS3A;L[>6ITUH4(2O1^)K7:_3\[+[D97BZXO;E89O#N
MJ9D@*O);(X =,Y+ _P 1'IWK,\+^*;Z;7KB&YTGRD=H_.U)H]D<YY& >A<=Q
MQ6_8:9I]E?62PZ8MI&C.D(DE.5('&T9Z$9K1&A6\[2-J:I=,T@<?+M P<KP.
M,CUK"E[6<F]K]OD[N^NVEMM6R)86G3G*:;5[==_SM9WV>WX1W^E)J,=TVH@V
MX4@++!(0S1J=V#4NE:SI-W;PQZ=<1A6&(HS\I./0'FK:6446H37H>3?*@5E9
MR4 '<#M65=ZOI$:RW%I!%>75GMV)&H#9?@!3C&2!^E;MJG;5)M]>J_ 4JE22
ML]&W9*_]:V3=C0FGFN+*[7[&24)14E;:)!ZY["K%F(ULH1"%6,(-H5MP QZ]
MZANK5-1LHQ<F2 <.RJ^"..5-<OXJ?^Q]/MK?38Y$T^TAENI8K67:S*@+;02>
MAYIRE[)\\]=E][+J32BDENUMYV7W=6^B.TJG<RW\<S_9K>*6,0LR!I-I:3LO
ML/>L*/Q&TW@NUN_#%L+R[N+6.2VMW<D+N'&\^@/!-/T>XU+4M62;5M/:+9%@
M,DF8XGQAU'<\YJ)8B/-&*W;6VWS=OZ\A<T5*47T\GUVM_5D4KR76M9U#14DM
M(H[%7;^UO+O-IM9%&4VGC>">#C_Z]=3!J-O<7]Q9QLWG6VWS 5P.1D8/>N=O
MH[:V:#1M//DQ>8WF++ SJS8W E^W/>H/$UUH;74,>JW]M#<VNG37/FI(=T4>
MW:T@0?>%3'$2DVK)6WMK=]M]+:*_X&53G5).#7,MXW\KVO9:O=:;?AUEY9VV
MHV<MI>Q)/!*NV2-QD,/>N<B?2-0\9I!;V+_:;&/:9MY01[.  O<<UIZ%9V!M
M+74[*9KDSV<2+<9.)(P,J<=NM0ZI?6^AZ@MT+-6GO6$6X,=TF!P *JM.<>22
MTN]=&]+7Z;>I$HUZG)[-J.MVO+L@F\*64NL-?@E5:,HUKM7R2Q;)<KC[Q]:Y
MNQ\"E)C/JUZ;:5IB($20;?O< +TY%=U!/)-8I.8'CD9-WDN?F!QT-9,S:KJ6
M(X[>*RDA*.))EWX/<#\.]*HH13<4[S72^N_W;^73L:RBJE-U&KI+IH_EJO\
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MO^'ZD4;7UUJJ7H=$C>W6UB:=C\[9^8X7@G\*N7D$VE)!*-3)E1>8Y&)#-MX
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M_P#@%*]\'/J6I1RZK=2:9-=1G(L& 5K@$D2'N3C!]*UUTJYM[V11=1W]X+<
M>9@-G[N['0G%63';ZGI4>II?7&HVTD2^3]GXW9&TMCW]/K5>WT^[CFN;ZWDD
MFN(MBX6?*RA1]W;V^GK6%2E%S:<>MU;^K=VO\S>E+D@N5I='V_KN4=1EO'OK
M/3K>PN8YH8MLKQ9" D9&,<?4U#-IUS>16T=SJ%Y<0VY>$*I(24[<_,!R=I
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M#N<\9KB?)2E9Z-[6_KY?,ZUAXZ5.5--MZNWD[:]N_8U/$NBZ7<R)J-U!*;U
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M@?VK:@U2TN;LV]O,LC!2=RD%3@X(!]1Z5Z4^6;;O;7^MS2GS4WM?J4+9//\
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M1Y<BD\;F]15R?PW.$@73;\0*N[?OB5]V0?F'OSCZ5>72+1;R0'9Y4D(C%OC
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M<9MM*VJOI=[OS^\,-".&HN%UYZ*S:U;[Z]ORU+/A&Y35=)G2YGAO LO";#E
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MX>7GY')'#N<K4?<Y7;1+7\]G^*V9NW%Y>VEJEI+ITNIS"R9WE4*L<L@'*'/
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M_#OB*UL86O=/N ?+):V+).BD_NU)/4D$C'-=8NEZ9IT?]I:3:JTENC*J12$
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M0D2VFMP+:Z=L_O.C $'KMZ>E<1XH\9#P]JEO9W_A:?4[>8K;6=Y;:BKS3OM
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MI+F6;5!?3HL<T"-$BJQ0(Y4X+#],FM9-6L-(TZU?5!%]OEC!D6$"1VZ9.1U
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M+N&]FN8@\<L]FCL(TE4<-[DCC I8]0O+*P@;PM;V46GO\TAN"^]3NPQ(Z\C
M%5-.5++35M;;=#(K"15C'$CELEFQSD>G2I+E5,Q^SQ.L97YGD!);GEO89KTH
MX.G&LJJW2MLO+Y_*YQ2C[1\\TN;:_5+LF;%UJ5AJ^@ZA ;.X6.#<R00D+).%
M^;* 5@W>HPV-C=W5H+[35AN(Q>"Y!<M%* 6*C/R\G&35H6=[!8K=*CJA+ .H
M.Y<C!R/2K!DTN_T?4%U#2UNII;4K(D2[GG11\JY/5B1P._%:3IP46^7F*M-R
MTDUZ%33)M!.M:E9W2M=R_:D,#S,7=AM&-IP,*,\<U!?:'I-_:P:9):70^R-+
MY(>^9.&.26)]?2I["&QELXVT>TN)IF2..]+G=(FT<0O@_*1QD#%5I582.)%V
MD,00.@/I40IJJN:3]UI>[I967]?<%+FBDY1M+7\?ZU.AGU[^R--*VUA=7$A<
M10K%'OW'@9Z\C^E1Z5XAL41K62&8>:1N,H!!F?/[HCJ#QWK6TN*TN].LY%3)
MMAM0D$8;&"17+W7AYI[QH;B/4HFCNG>+4(I@K.7'H!T&,9/O7GX>C3HK67NK
M9K71_P#!_ Z:LI-<L(Z]4W;8N:A!JFK265U8+:QV%K@M;&4CD'D,!Q@ <5>>
MXT^;3;EY=0MFF"@FYE0*%&[Y0<]>>/RJBD^HZ9#-8R.C9'G2.0&,:D\KCH?_
M *]<]J$%O<VA6Z"^7'(LR$INV.IRIQ6OL'*@ZTU[W+MMT_#]#FE6E2YJBT2U
MM=:6OUVUZZVT1U=U;OJ$T,FGQQIN D:9\*7;[I.T^E/-G'I^K6\%FR+,V<2R
M-NQZIM'3CI]:I^%;6;7=(CO?$$96Z ,;0"0,J8;((8=<C!_&KM[-I\6IRN(V
MAO(Y%"2$_*S%>"1GH*YL+0]K%U)K>ST:>WY??<[YU](J/X^??O\ =8OZKJ;V
M,UO'&%'F$Y9U)'3H".^:QTU*:XM+R\O1+OLPKJ+6#=(!W0#KD^E/O;J74M-C
MMDGAN+GS^J?*IP,C&>M<_P"((FN/#NIV4UQ-+#<#%PUN65RP&<!A].U>BY4Y
M4.::T_'?\SF49*?+%V??Y'565T4D>YO[3:S O#.RJK,&&0G^]VQ4<DUE8;IT
MM;M);BU+"")?F4#K@=0:Q_#_ -GO_#<'VC4O]&1?+C1FW?.$Z[CSD?YZUHQW
M-PKV,DFQYHBPCDW86:/;R2QKRXXB5.,H-6OWW[:K\KZLZIT/:QYH2UMOTVT:
M_7H79],B?1TDMHY"Q D=)9"ADX_Y:'O@5CK+##8R02%.'\T!E#K<@\+CGC&*
MI3^)/[2FU/3HKZ0ZA:VOG>3+'Y=LQ8$JADJK<WES8V]OJ=ZED;&WTT)J%J9
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M_)&."<YR*Z+2+J*?3XDC9BT2!&WIL)( YV]JYAP);2XTN-3*C;H[%UB/F0R
M$G<?X03TQ5BRTR-9]->_OYK769E5BN<-(B#F/TQWI8>M4JSO+Y^O]:];IF2K
M*56=*UN5Z;W^?3LUJM'L7/$,&G:9:PW\LMS:+"Y5/LH)RSG'*C^=-U74(+K1
M;L6P O;2 ,Z2+AHU;J"<=QZ5:TBTU^*U3^VM1MIYUED)\B':KH3\@.>F._\
MDU%!I.J'1[^/4=35KJZSB1(_EA'H.Y&*NI14H2Y%:^_GII;71K^NXZJE2<G3
M=];NV[TMHWI=V5KJWWDS2P6?A-7L=\<0@!B$ W-S_=!Y)YJEX1N+O4])F75+
M2<1"9Q']K3#D!B,$'^=.T#0=*&CVX@N&U"%)O/BD9B KCC@=A[5HZCIMQJ%Q
MY;W92P>%HYH$7#,3T8-U&*=.GS.,]DET>CT[;?=]XJ=5U5SO9ZK6^^][:/\
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M&*;<7EPWE37,T_VGDJS* J?[H'7.:RM%M=0M8;RZO4M+JXU;RY2C7 #,"Q.
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M4-V)[3%M<K)&JQJ41&)AB!;^)AR3QFH+F6Y?7I=,47*6-N(ITN7N 5DD;D(
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M*AGL;'4WM]8D'G(MD_FG:K\R. <8*G&#76:2KZGI+RV-W</J-POV9WV*DQP
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M*"H=N4W=@WI6?IVG:;%J=Y?3>7)GAW>9OGZ!<#IBM6Q,%]<QP:?;B"$)F<L
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MR1TS4?B'3Y-8LX9X;A(=\0\F*90K.QYVG=_G(K!T2_U1M*M=&\7Q1!946)D
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MV=]UY'B8G#SG1Y:_Q2EKU]//56V]=#G&\S5-/TXPE5:^OMLB6L;NZ2%!\Q[
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M<*ZJG&=W;/(/.*J:?XE;5M9U:&*Y6?5H+8!%VO&C*YW9*G@#M54XQE2G7O\
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MKNR>_P#EU-#0+R&3[3?WUT9K6*<)81>1L,/R\J,<L3[U3U"2&#5)[J^DM_[
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MT0)*N.#QZ9[51CUE;.&R@@LKB>6ZG-O)+%  (G ^\X'05C2>$-5UB]U2ZO\
M46TP3P1P6DE@OES0X;=(<]"'('OCTKNI\TH**EK9V=M/*^J[ZG-6O&[4>O\
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MM;>OG]QVX>=25*\J?*_TV3_*_3<\AOM0:?7))9UN(C<7 )MRS>9&J\*H.!C
M-=-H]S:MJ#1II%\+FXC:68F8[1M49(;J<@?K7?:GI>F7=A<+KVVX25MP63&Z
M(D?=4CD'BJ4XM9-&CDMK)H1'MB@1^?-4X'0'GIUKKQM:E5I*#C:U[)-JR_%/
MT:[(\_"X2M3JN:GO:[LM7VZ6^3[LSM%NK"RFM1*^Z&&*2>,W46)8$QG8O<X]
M:FU@ZA>ZD+JS@9]-\I9%G9^#N QM7L/7-4]2MBVN6UX;!YX8G!F59P%A (!
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MTD$A1Y".6.WTJHZS0R-'"22RX=XR<2 \]_K5>.2)-01XI)VECP@<6FT0<?,
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M3GM730WMG9-!8S7RM.X'EF5OFDSTQZFN!?0+:36FL#K4#7C/NG1 ^7!.><<
MYQQGO4WS#1]7DOOL<DFF2QK:7,F\JL8P 02,[NHXHPU)T9*,8V;W7]=W:VG4
MR]LZ]#VE3W?QM_PRO?T(/&GB)6U+99S11R1?++&)]K3+U'('J.@YJ3P=>Q7V
MN-JD=GJT%Y=3>5<BZCPD:*H.%R<B//<\UO6D5O;VMK';:4ETD:R2G?;?.S#G
MY2>!D]*SXX]4DU:6ZUZYF5;BU,AM(XB(X$'1=W=R<<'WYK1^S=&,HQO*.[=K
MN]GNK67??YCIPG&K)3EI*UM].FSOJ_D6?%$-E'=I.^O_ &,:L19"%IL+*S#
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MDYZ@]P:JE47+&G726F]_P_#YFDHU>>4H;?.]_2VW^>Q9U32+#Q)I!TK5$G>
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M6J6NC7/CA+:[TWYXXUOY;O)159#A<X^\>>YK&\:3:9K!@THQ7;Q7\SO(T>[
M:,!E;>#A.>F:ZBSGA2WOO$%_<?Z/+#EK?:&$:J,_4DC^'UKS;PS=V&L7L4EM
MJ=[-'!;&>.YN;I4$BRN<K+"!N^3'RL>,?A7!BZ;J4N:RMO\ /=:]_P#@FC49
M-4I7U:6^FFK7H=%INAQZ-#+=?9M2,TMO B7D]UYN[8#@GT/./\*V+&\ LKI;
MB.ZDW*HDF).P(W<'N0>M5M8TIKW5M!U%]5E31[! [65L/++RYP)&]4QD;?\
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MTFU'45N;J-V=GN$\KS.?E(1<\8X_"O/Q$.5Z.Z:5_+H[?(UA:?NR7??KVO\
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MJ6I0"_M[B\CC1)[B08.-V5C.#@?7K5VYLX='60R6\G^DIF18V B=R,!2>I
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M<F,D'U'-9%C97U]K6HK>$W%OM#6B&,#>@SPV3D9SC)ZXS6QX9\.266KRZO\
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M:5*G"I)V<G:UKZZ7O:^B77;774Z)U:M2HXI:*VO=:[;6U^:MV/._#FN2Z?\
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MT_>2SMMP<^<@Q@=^.]6XC/;ZHT,$,US9HX! 0?,V!\Q/ZYKF-1TW^R_&VIW
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MLE\T<OGJR,\>X##?,N#P..X[5S5:DN9)+?\ 3\3HI4U.]WL=!8_V1K%ND]B
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MW,TDA!1?W;1QCY1R,GU[=36+8PIX4T.?5?$'V??=3K-JFII;[4N 3A3L[$9
MX YJ*['C>ZOA)#K]G/:M,VZS,'V<?97&TN9#SN7D@#OSSTKJ;G2?[*^'SZ7I
M5U=S>7;[(+E]MQ+DG(<[N&QG/X54Y*O&_-HEZF?,Z+<YP=U??]$3VNKQ6EIM
M-LJE7RXC8?*I&0Y^M9ES=R:KKFG2PE;-&.V82H2TJ]@A''7CFG::-2M]/-S=
M!M3:2V$1G90/,*\!F0>I].E3ZXFK"W232]8@M+B(PR3Q- ) (@?G"KU!/8]J
MXH+FIJG+6"Z-=.F[5]#T7:'O)>\^SZ]5UZ]SH(;2VM-[Q1K'N)=F_F:R-5U
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M:CK%UJ&H:2;34M-9Q:I;3SE%:7=B8-E< !>A[Y%;EAH>CZ'-=:EI=R()[C9
ML,,@7,<8PH4$<$9R2.M0ZDD[IZV7Y:Z/;_AC;D4Y)05X?/?O?9['26\WVCQ(
M9TLD5D#6\DH0%^.1ENH'M7*^/M.6XNK"P:ZN4FU+4(UFO+:$9AA4[MC,""H)
MQ@^U;.C:_/\ :;FV>VG;[-=+'-=21_)*&7(\MA]['<D<54U*T\SQ7-=R-<LS
MNL21&0K%\IR&4'@-SUK:I*4J7M$F^NO33R,*U'VW[N-K]/5/[RWI%MHP\0>)
M7DEOI9%G03_;P1%'E -L)/5<#MWJ94\/:G/=#2XU-S$A,SVJ '<%  ?'5@,8
M![5=\0B4:)(5=70R L6/09X _'%<YIBS^'[S7+VUECEGU*YAD^SRJ(TC81X<
M\<YXZ_2I<XSJ>RG&U^ZOW[>AK3A.,%.+O9OK:W]7*=SX7E\56VGPZ[9O=16T
M[03V\-R\"I&P^^PZN>AQQ@UO27=EX3U'R 8[<7]S%#"9P55CMQM#=S@59A\1
M+>V\T]A>VLUK,@>UNXOFC&3C#$=ZQ=<M-0\3ZQ87D<=I-H^F;[B*>"X!=[A3
MMSW!4 MQU!'6K<J?)HO>CU7S\WTT70BI34JBJ<JUM_P]_GT^9TWB"^LM T6Z
MUBY2&-;8>8\KH3CH,\#)/TJHVNO;--</%<3QW"(]HD:@A@1U'IG.<&M"2!M3
M@L9XG:-%(=EE7EUQT(Z4U#?0VTUK)=V[WKJYM"Z^W!8#L#Z5I-2E*\'R]GI;
M;_@_@)I\DDWK;YK\UI8HZ'<.-2E3SIK@3#,A>/!C8>OI4EQ9:? M[=Z<T<;A
M@;I ?E? ^Z<\ <^E9T-EK<=D9=<7S;P6X,TEA)LCD<?[/7O3$UK35GBTV'4&
M-Z?],GAD5@QA!PW;##MBN>+FUR25VKV;W[:7=_TMH:SA2E*-1KMVLG;[KVNC
M5M9IKE+B:Q2&TC4)EA%R2!\P]QCH:BU)[K6_#WVNSMY[:2,B:)67$H*MT ]P
M/UJR+.[NM-NDMM2,27)#6\OEY:,'J,'C';%20W$EA:7EQJM]%]C0_NY%7:8U
MQ@Y_&NJM&]14^:U^V^GD^FNMEO8XY5)+2*[Z]M.IRE_JEI-:'5KPMJ,MO>&U
M!TX*9=.\Q0#YG/!7OGI7<:?;Q6NFV\%NYDBCC54<D'<,=>*Y3PWH2PV>I6UC
MIWV&UN;G?)+<JKM>'C<YQ][<.YKLE540*@"JHP !P!71%6E):_/[M-=%I>RT
MU[W)C%**=[W_ *U!E#J5895A@@]ZY$O=:5>745A#A?."[Q&7(7'"XKJ+Z8VV
MGW$X!)BB9\#O@9KA/#&MS^)K:UN;+4/LVJ+*/M*RP9$T8!.P<X';YN.E3.K*
M$DEM^?E^1M3BFG<M>*S?0>"[W[0[-<PS!K8M,D3NH(Z$\=,UY-J'A_5M8GLI
M]*NI[76%<7BY(>)Q_>RIP_IT]:]KU>TNY[6ZO+ZVL9#%;A8HYR#&3U9B3Z<]
M:\RO]?U..XLI="TY1875NR)J=BIQO3+/&Z\A(L8*GOC\!OA95:LY<L5Y7M>Z
M[^3VMV.>O:E)2YMNU]NO6VETT[7O\CJ_"&JZG;V<VC^*-6AUN[:4!E*+"\2L
M!\I X^7G/)YI?&7AK,BP0S+'ITHD:ZM3"&6Z0K@QYZKZY')K@-%L/$TGAN?5
MWO-.M?/D,+%+78;1BV2S.2"V[Y?N_3BO6;>34-6LK%KV2"VNXXF=]LN59>BO
M]&ZXZBN;,,/*BG5NG/HOY6]';1?+MOYG1@\1"I44.BZ]U^-O/N?,<^K/<W@O
M7MEMH]/>%8M.CA5LHI(;+GD''3WQZ5VC-;7EK;>(]!TY)I TL?V:39YAE; '
MF2'OMS^%5O$WA.UE\21:1;#[ L]U+'+<E_,FND(W!HUZG!SQV'/-:,6G6<7B
M#2C%-;6>CZ<H2&]GE#I?2NF&7 ^Z5 Y[Y[TEC9RA"M4ULI.VR>G+9N^M^F[[
MZ;=N.6'E1G2P</WNFB=[6]ZVW5[VLEZW1W&B:,VF>&?#\%[?6EHND(3*D*NB
MR2$DX'7<H#]#W^M8CZCINH>)I'T:P#WTEN!F_D,:NCG[IS\O\(]N:SI_'^G:
MMK_]EI-<2Z??2I"\B+Y?DN<!6C YP2,'([5;\46?B+6_$D%\-W]GQR&V\RU<
M"1$'*,2,YP?H>?>O)JU?:OVM3??JEW?S7XNQT\L\-2E=J*L]WM9V=[+K9V37
M76P>+?L%G-#YI9+^21));?2I8B1)N^\<#</X<COQ78>&?#4VN>'GU#7!<0Z[
M<B-;N=6VF548E.,8&5(!P*Y6Z\/W-Q*_]M)$MI%;9_MH'==A0"00H & W!]1
M6QX9T**]N-&31?$MQ=0:==&Z,DO*RJ0,Q *0!CWSR3Q54JKJ3YDVKI+T[-7Z
M^;^9T8C#4UAW2;5GN]7?K;3IY=.VAROB)=66\OK2.:*[MKB:X247 9XK=5P%
M&],<A<C'.,^U5=&\#VFH6+QZ?&(8+-S)!<VV]81/@ EB,$DJ,<]\5WOQ1M9=
M!T>/5[:\+A)&22WNHBUO)O8<R%1N&!T]ZJ>%=/E@N-7TZ'2;J.Q:/R)=1AEX
M>5B"#''T.!U;J,#.*]>E*K0HSA-V4OAZM6WVT5KVOU/$G356<*E+64+N6RO=
MZ+7?R6MOF=A8W>EZ%9PW4T]PZM!L4L"WEJF,C'4\]^:XN437FN"QN;ZZU?3;
M^:2<S0;9'@4_ZMPQ^X$R> ,\5U?BG0GL/#=K=Z;-BYTI1OEDB\QIHNC@J/O$
MC/'K7&02P:7K8N+47%A?G#!9;=?E0KA8PO7!QGMR:Q]A*I^[Z[M]//SNW_D$
ML2J,/:=':*2W\O*R7Y7*FL:8D6MS2M<R75J8A"P$7G7$L?3YL]R#C<.WI4M]
MJVBSZ@GAFSN-0TF735'E6B+M+)G.%P<$#CD]SWKKK?3)EURQU6XD$TYMW9XG
M)$FTC"A.R@]P>:X[7--TN]\9>0]N=.N+A"9-CD[OFR CKRIX)/.,UP2^KU:C
MIU:G+[M]OM=;K[NNMSFQ$<1*2C2A>STOKV:=U9Z/S5U<LOJ5U<V]IIVOV&FR
M)?.]O/:QR;GC7!Y/ W<8STP37'Z[(O@K4M-D\/O>&QL]3"2VKLKE-P!(C0_,
M5(+=3CGCUK?\;:-%KNL374@\^&RN/+NWP8V6,+G"8P'R<')R>!SBN#\2W.@:
MW+:^5?+9R.S;[V^W+<1.JX +*<,#QCCC%+#<L:RCKR-NZ2;_  3OY=[=]CZK
M#TZ<8733DD]6[V;;ZM/9;?)66AM^//"\.B^,?[1\.W>F6D\2"X@AE(5GF9SN
M8M(V",$Y[<8Q7G>N^'FN+NQNM8UJU6^U2>=[N1"'AA"$#?\ N\\$ANW:M[5+
M:WUSP)I&H2ZWJ%[>WEV]B\=W>ILMW/*D_)N*L5SZ#UKD8XK?2+'5M*,1FU1I
M/LXO;:[)B$8Y9-@&7R1C)XK[G+Z56DG.=5<RO]G6VJU;>R>OG;S/GYOGY:7*
MV_DMW>RLNW5W.N^'VM0^&?$TGAB\DL;NUOI(U>[M)3(I8+\JJQZ@L1G\:]>@
M:SM;'4I-'B6WO=-N$0SQ7&[8[=5\H],+^'-?/\O@Z6T\,Q:I%?6PGMHQ<31F
M1>6+<1H1R7502R]J[[PEXJMY&UW5+JRD?7-0V7L<2R&WB=,JI1-P/;DDDYP,
M8KFQV'@ZCQ=.7-T:Z.=U9N^BNNNR1R5TYT>6,$Y1UW2=K-63^?34]4GO#H=U
M8:[>0:98FYL'CCO=3F"3+,3E8E7J<CG\>W0N\1-::@]E+;B&ZO[Y8O/LYAE"
M&QR4'S \9%7-/.E:[:6=GJ^EP1::C$6_VR17W._*J V<MWJK+ING:9XU>#5?
MW-G$D;6\\)((;/\ RT., 9'&*^<A&,DH*&B\[V?W;;JYU7DX1J3LIV5_\[]_
MDM"];211V\EKI'-M'=B-=IVEF4="3R>>_M6K;>&[DW5NUZT<D(RTB9Z'KCWY
MJ"YU.*]CN[0112)*^8)X4XR3@$^O?FI9/$-U!$+40HEQ!((V.<JP'&.?6O8]
MZUD<YTY&V,A1C X KAR)+FY:$*/M'F'!E'SR$]F[8Q73VVNVTBN+L&TEC.'C
ME[9.!S44FB0IJ%O=6D2D!RTFYS]=P]ZX*M.LYP<':SOKU-Z4Z<8R4UN<Y=W-
MS<9A@GD*0J 'B7;C'\0';K6WX=N=A6T?4FNL1@@3)B0MU)ST-<O<QWR:I$+=
M9?*9IEN JE@ HSRX]_SKHO"J@7$X+Y*C[NS]=W]*)4(4:KDJFLM;/\;&KG*=
M%)QT75?J9^KQ74&K74VGW $T3&;Y7ZY7[NW^,@9('3I5*+3K[6]1,,]]IYDD
MC.9I+;,VUEY4 _<(XR!6W>):WWB&6V8HRW$>Q9(9 K1M@Y.?7MP:BN=!T_0X
M1>P;1J6W:C@D<]&8+ZX-=$^9S27]?U^AR6BUJ<2+2XBU34M)MRVHVSH\,;9,
M@4X^Z>.,GKCIBKFF7$^C:6TNI6UU?,L8.TR*@"L""JIU4(/SKJ8-(U">59HR
MO+%DN%D  &>H ZDUGZC!')=3F[DMYVE %R(.&8ITSGO[BMI0C.:DDKZ=^ENS
M,:<)0BXJ3Z]NM^Z-70M>QHJ7EU^[L4M?,C'WW?')QC[V .0.E$-\OB6XD\B"
M!7BMMR+<(3DL,H<X''3(K.U"*7_1FN(;:/R0/(6)@#$K#H!U&?6IX]5OK>9@
M?,=MF/);E IZ$8Y/'>N9X64G\3M>^_W=.GJ=,:C2O97M;_-[]1MC=F&WM?M$
M5JMP83%=B)&VQ_-\S GMCUYJKJ<5I<11PV^FI:N9 Z7)0;V /&"1Q4D&H/9L
M[VD:QI(JJ5;)3(Y/6M^"^@UF%;2Z@CWM#O!S\H.<8'?-5'"T:,N>,>EOEZ;!
M.I*I\3.,TK3+6'2=1AU.UM+V[N79UN3&=V"<_-]#C&#S4/AW['I_B-XM1NDN
MX&BV*\,8"L0,%67&1R.#WK?U'2FTP1"61&,RXRH/RD=?SK*OI$NVL-/FGTZS
MW.Q26>W\QY&0%L<=!COD=*J47*#YI>Z[;ZV_&[[-?(R<(PDI4X^\K[:7_3SO
MT.B^Q.VN"WCU2[GCN&,VS=M6"/'"KBKU];27[W$<-IY09&BDG?AFPORE?7FN
M6\.0+H;K<)*&C^S!0MN&:#S&))D&[D9]/:K5SJ]Y>\RW#(NS!1"5!/?I7GX>
M@\7&4ZT;7>S2Z*R_S.RI)4>6,'LOS=S,;6(KC5K<L+J._P#L#J+1"1+)$I.6
M\O/.2,9]ZU_"MO!?>'?[8-M.MP\1<1W2?/&<?ZME[@5;TE-*U/51=WUI')JW
MV9K8713#>23G8#]:V-UC9Z5=?8G")'E7:,;RK8QSZFLZF!;KQ<Y72VOVZ+;6
MV]]S!\LI<]MG=6Z-JS=_/]3G_#;7T&F+=^)'BO99BT320P$!BQ_A'9<<'WKJ
M+(/;V&+J.* 1YPJ'Y54'C]*XN*658FC#AHY,G:20IQSNXZ<C]:TKW5WOH647
M02-L 6\49W.,9Y/;TXKMIT:SG^\Z+]?^!_F7-P4+0.HMKJ"\B,EM()$#%=R]
M,BI:XN&^F@M)&@,D1<J/,\U<+CD+C'I4VG:A*-0MIY+B:7>PBE+CY5#= /?-
M=3I,P.GO;.._LWMYLA6'4=0?6N5U:V:SO#C:LF04<$[F7H"<\;LUV-9/B&!'
MTUII)VC$0.%QE6)X&14TY6=@,FRU6QL(A.HEEO'0"89(4GUYXS5<ZY>S6LL4
MLS'> 0R *RG/3Z8K.F8,_,0B8=0"3_.GVEN]U=)%&4#L?EWG )].*Z>6*U8B
M:"QNKPA[:"1U+$B3N.?[WK72+I%S8:?<)I=VJ7,K!A+.@8+SSGUXS3HYWTC3
M4MIO+ENMK>1#$,;\#(7G^9KD;SQM<6>@"#Q#%:O>M$TDB1%P,!N!TZCCZUYV
M(QD(ODO_ %YG13H3FKI:%FXM)IO$NHVVGQ-<(ELDR@)Y:%R<%5?H>Y-9>@^&
M[DZG<S7-I9PPF-71MAEDAD.01NZ9&3T^E:OAJ_UB/1H[;4;1K*>=8FBNM@*2
ME\L5"CE2!@<]Z+*YN8&,%M<21Q2.%8X^[GO['BN6A&;PTZMO9S?;R;MVO?<=
M1<]51;YDN^N_471=8LIWM].@5]5N;5#+]LMPJQ2.6*\A3QG%&LI(E\6E3RRT
M:%D X0XZ9[]ZS?"6GQ65K--"D<%[8_+=  O(2<E3N "OUZUJ6=S+?:I;"[)F
MWS?,)#E3Q@\56!I^TJ.O..U[.R_K_AC2O:G%4XO\[_B:&I7EW;^';2*=\33_
M 'CT;:.<?RS6+:S>1/'-$HWQL"-[?*.W\Z[*Y7[7'=6UQ#Y$*)A)VP1R.2/3
M%86E:&);S=.T3V\;$##9\W(X.!T'>O5A)*+N<9?@U^:2.5I(K>/R4;=NEQE^
MV!W!]:QY[BXOXYYGAFEC+DH58E%. #_]:M.X\,;-KVDGFNK8"SGY57\N<5K6
MNG)"\<TIWSK%Y;,HVJ1G/W>E3S0CJ@,?0=/+7"7,JR%0FY'\T%=W0].M:VLV
MSW>FM&DBQ_,I+.Q4  \\BI#=6-B5M_-BA.<",<8SSTJG/K%M/;2 VEQ<0281
M=L1(ER.WM6<TZ@XOE=S(C\/WNAZ5JVI>'XK:[\07R)S+(PAE*<+P3Q\I_$U=
MU'3&\B&ZMX?+NSQ,+=N,D<G/H#WK1T<2BQ_?"5/G.R.4 %%[#CM6/=W<5K=+
M]FBN[>W:60RW"G@28QRIY(KSL33HTZ/)+IM_G?\ 4VIU)1J<ZZOHG;7R7](K
MV\%Q=QW-X[Y54;]^2<@[>"H([$>E<SJ=W+I=M(+K4]^I:D2MG)=QB21#D'"@
M<E%ZX]SUIWB'7M:GUBVTWP]/%(UQ $2.6W?(F!SOD=3A4*AA]>OK5V6UDU31
M;"SUGPU/!=Z@QM_M&FRK+]BX/[WS1R!@#/UQ7FT8.7*K73>MGZ_\"^[N]V;U
M,5%N5EK'3R73?O\ U8NSPV]M?Z0-1U"ZNY)K:4W5M:H'M;R3:H9FSTP<D"JN
MKZMIVG2,+?2]3G)MGG@:V@:57V#D-G@-Z"H_#4=ZEK% )]-O[FVEDB2XLW9H
M6D3.%<9RK# R>]:EC%JTVEO:7"1O<R#=<):'$<,V06 8\FM*CA5C:<-M+;W?
MSUL_)/OL.BIJ"<96<DFWT_R^]_B9DFGZ;KDBRW.FM;7$D<?F-"[QSL$^<+@<
M*<CG\JLZS!;ZK>6<>G3R)(9//"V[(I=NZMD'/O6AK-]<^19G1[N/3[@7$;7W
MGVWF,\(X93CH2/\ (K U3[)9:M/I7AEK:-UC"M!- [>4'RS%6'.2K=C7+6HP
MY82<K\K]+7\MG\UOT'5KRBXVAU25WIK9-[KT5MW8T;CQ/<7WB%M'=M/>*&.*
M1VBE/F"4OQ'M(QR!D&F:GJ*#Q +=+@KJ'D&]> VY25(\[0=W0XQC'6J6B6UQ
MI-M9Z29[>>1V01SQ0@%5 SR?O$#OGD>U6O&%AK&KQM')%HES;6]LTSPSLZM+
M(I#1'>,83<.1FNIQ59/G;Z:]+HSJ>UIINGWO;K\[=&^G;1FEJ-]?7%KHKVK6
MZ0R?OKS[3;[O/BV_,BCLY]>E1:GJETMI<6^D64?EI'LMK.%U1I\J?E/&%Y&*
M@T;5(DU75;76GO;@SP17Q9US;1[@%,4#\%AD>WZ&H[/2[2/4+.UT:.:VTR&5
M_.AP6=FD).=V<J W-55AB)N*IR377HWIW^7S^6LPC%--MZ;M+2]NSVU?WI:F
M/! GB 1ZO=6^J6%Q8_Z))I]Q\B1-LVLP(^^/]KUK;\-Z4=+M&B-W+?1"Y::%
MC,#*I[1COMQGK46O:?J.B:+$+C7;R2\N=56*&]@L5E,,+OD1,,X"X&"WO3O$
MT^OVU]!+HWAR.^BD8F6-;E8IHG# !AZ@BIQ5.I'WN9+9>79?/IWN:T\2G34:
MEVX]?7R1T*^(@KQ)Y4C*#^_:1=I3)P./K6'K-KY>OIXDTI;\7;M]FG@BQ(+J
M(= H)PN#SQR<&HK[3WU"\L(YK^YMR+MF3?<I&]R<$^4R]65>NVM31F%QX/DN
M'TZ[LI@[J\-R?)D^5\;O8'&1[41GB'!1BO=2W=[Z?>VPIRA&UURR?2Z?Y:'0
M:9:/8Z;%;RRB5D&"X0(#SZ"K=8GA[5+6?3MOF-'(MP\+1S3!W#@]"1WQ@X]Z
MVZ]BDDH**Z?,XZEW)R?4X#7K_P .^&EU"VEENKG48(5O9%:-Y6V/)LR,<'DU
M0N_M2ZZB6\.H(]A:_:)K>9 +.]#MM7+]0R@DX_E6MX@UTIXNBT>"WU"=[E06
MDMX598 ,\L<Y !QU&.:Y&+7)]-U&YMM7U+5;YDL84NM0NDVVD<I?Y-L8!)+=
M"P]#Z&O,7LZ<I.G'9-6Z.W_!MU]2H_NX0I-^XFN^G]+Y'17NC7;66I7FDVTV
MIWNH2K(D<][B&'#!2B' VC;DX[U-?PQ6GBJQ@NKB_P#MMU:2V]K8V;D6JHN&
M/F=@W8$UFVNHP&WU*YT.SU&ZN+W6#;.;DX@LID0@RJN?]4",D?X5T6G6'B4W
M\<NH_P!F3XL%S>P,R^;<=#E.A3;T]ZTITY0?M(_%;5^7W:^5R_;1FN5?#?U6
M_>_7J6['3(Y[:ZT^>>=HKNW92(7(1%;(PKC^*LV[MFT-['0?#VJQ0W(LC!&+
MAEEG Z+*V3E@#^'&*Z/2;C(GLS!'"]JP79&>"",YKF+WPSITLD^N37)LM3-M
M)"+F!Q),L8)8A6[_ $IQIWIQA#OOVL]?U_R+J0C4J.51]NN_5;?+R[G2VPO+
M?1+.W>X.I7.Q8IKN,*F3C#28Z#GG%<KX[UM-%L;*WE:\O)?/$#6ZHA-T'4_P
MG[V/3_\ 74]Q/I+7%BT6NW%M;V%N7N+%!L\W>H96D/;IGZFN/U2ZU6\U2WDT
MK3;R2VNI8YVO;Q4DAM0ZL04).YO<@#&<4ZLI-2M-*RUO*WR7FWM?4=-PI3IW
M@Y1>_1^7KYV_$ZVW:WLXX)-,L0)%@\R**X4+L<KT4#H3T]LUF2%-9T-;2Z6^
MTG4KZW$GD0RK');!NF/H>_'6N@T2U@ANFW*EQ+<VV"$?<I(R>1T7/K3)_#2R
M3Z;-=7UQI]R+@,HM2,L!G]R3@_)CK7GPBY1B][_^2_?IO\SJJ3BG+JNW?SOO
MHBYHL%G86BWD"!+*UMBK2R(?,<KRSG'7.*W+"^@U/3X;VS??!.@=&((R#[&N
M:M+MV2/3/M.ZT9RK32+\Q&?N$]B?6M+PI<7\^C,FJVMM:3P3R0B&VD+JJ*V$
MY]<8_P \5Z6"JPE#E2U_7K9''B**I6BEHMO)="QJFEV\]NAVP0I$VYW* %4Z
MM@]JJ2:Q#=7%BVGRR26A93Y\)W)("/E /<>M;%W)'':2&55=2I78Q'SY_AY]
M:Y#PZ&UH6%UIUVNG+8R,DMO!#M2>($@+M/W0#W%%:RJ*$-&_R73^O,5.3M[R
MNE?T^?4[*:9+>%Y96"H@R2:Y+Q3KVG#1[;4IM;NM,M+2ZC:Y2&'>TRL=HC88
M)VG/)%6_%&LQV44Z^<S)'"1)"D6_D].?7VK+MK*Y_M>YMK#6X?+N[:!QI^Q!
M/:]S*<G)!QTQ_*KJ59\WN:I;^O;UV^\SJ4^6@VU[SVV_6V_J:[^%]"U.2RE7
M>\NEI)% ZS,3'YBX;/J?KTITF@"UN([B*3.U526X?B81H,XW@9.3U!JC//=>
M$M<DN[^ZO=1L=6N(H8XXK<'[(Y&W)Q_"3R2>E:]OXFTJYU@Z6MW&+IH?/2)L
MAFCSM+<CIGBHDJ5U"2L]E:_37[K?+IO8SI0C2:G"-K*WIY?AH<QK=IKMU/?W
M>DZO!%#<6I-B7B02-)C.S<W09_*H;2:SN([>XN(K"/6V6-;R6%DW' /EC)[G
M)P:ZF=+(75Q;-82MYSA3($W*"RD9'I@5QVF^$K*;3)H=6L4RMZ'.V$L)NT;G
MH=PQ]!@5P2I-3;CN[W:?FN_S.R+G[7X?=M?7^:UDK+I;?S6VII#6KWPUHM[)
MXFO[:\M(Y23-<*$$2L0%A.,[F'2KRZO8E!>VGG6\\J,WDCYE)(PI;MV[5@W4
MWB?4=):'_A'#INH1*9S=R*EQ')ME"E-@ZLR#(XX_6M?7/$UMI=];VNEVMLNJ
MRP+=3I>$P+#:[OWDA?H"OIG-='LZLG;F^];>FVOS,8XO#QDXVZ>>N_??[KF;
MIVK>(-1N=334WM[;3H%^S)!.P::1LY\_<,<%>B]>*WQ=Z)MAL-3MXDGU,>4T
M17=YJJN06QP!CGFL?POI$FC^!Y#>QVR3O=R36TL5S]I$BNV5(9^N0>GX]:UH
MK>*XUR2XC13?B-8;BSDF'$1_Y:;!T)'%:4(5(UES:M+_ #L[ZZK\3:$H2HMZ
MJ^OSTTZ:?UYF#XX\%VU]>+J.G7$MK<?V>;* A0;>%2X)8#LQ!QGTKDM:^'^K
MZ5KEMJ UZZ@M1N=DGF!B#  (G!!*'H5)-=9X,BU3_A(]4BO1]HM8F9 C;HU#
M?> "-UZ 9'3FF:SHVM^)KS[-XF:UAT-7)N8S&P:6//$8/13G'S YXJ95)2;G
M&;7-9;=.N_\ FOS-J56SY'!2Y&WKWMI:^^_FOF7;.33H(]'AUCP^7O4=1.Z@
M/'9.!PV3T7/ P.*V=34:S?WFF:EI\'EVRK=:?<2+YH,@!P^WU5NW>J;V]RD^
MFC4+5)+.9VCDFN)UC: 8PB@#[^2/PK:\1Z?-J'A34+#3U4SS6S11 R&,9(P!
MN'(^HKHPL90@TTK6TTL_Z_X)RXMQG+FUOK=;K^O^ <J=430[+1H]>UG3H[Z:
M%I/MDD1C,KJ/G;;T'&.M6/#6JO:^&[F>.PO;Y+B[:5#!*9C)'(W#J>,#'.!T
MK!M](O;O5;:WU^UNH'TQ8XE#79D@NE\K:[$'DKUSGK75Z;K-O9QV\$MQY"P1
M&..#:JI/QE=AZ< =*XZ56%.M>7G?M_5M>_0U@Y3H+GCJWIKTUWTWT]#F]-F3
M0[Q?"5C#$+0V,E_*LUTWVB/,IP0K#D$]\_\ UVK?+_PDTFE'3W::"T%TLLB
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M=7FE\5>)]'NY+AOLMX'MWN+A7WJRY(1>JJI[<]:RM2^'7V>UAN(+AYIXC+O
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M0^06#JH+HP^[GM4SO>Z CO;.TCE>]N" BPE)(\#$@]_4UG1:C-,X6&Q6U0Q
M+.0,PJ<\Y/!''2M#7;![_32L*AI8V#JI_BQVK'>"[>5[.>%DA:5)F9GPD: #
MY03Q^%.-FM0*UI:-=RS-91+</;L'$KN<3$GH1TZ5/:V:7;-): VUU:.&6WDY
M"@$]_<YJS87$MEKDT*H6M97)"Q,'"$\@G'3(JQ+/;WFDW.HQQ/%+)$T ;;O(
M&<#Y>G6E.2A>?]?,J-Y-1(=98:CH*7*(IDB;YPLF?+/\0]ZPK&=4+P2-%$DZ
ME!.X7,)(QN!/L>G>G6EE>/HL>V:6Z@3()&,;USN+#MTJKJ-I?IH$MQ:Z89]T
M97+E1C=T?#=<<<=ZF4U]7<H:]5_3_4?+RSY6/AFB6P-M:%GC\S:TDD?ER'9Q
MR/3/(-6)(8/L)D?S1<R'<AQE&!/08'WL5#HDMMJ^G 75ZYU(0'S(6B52S(!D
MC P.U;'AS6-..C)-%"/M;H));>$F1P,D \TYUH48)K1+^OST)C>3LW=O\2II
MEM<0ZM"@B EC<%Q*N-H]<^^:[#R4CCD$4:KOR2%XW&N7U.2"?6;ERS1-"B,&
M9-P#+[?C6EI^K"VL"FIF19HL%F89W!CP1CK7'+&4I22<K[Z]O+^NQT/#U.6Z
M7;3^OZU,JWLVG@!DECMK%',<B--EB0<MSCKQ4ATRYN+F06L2+$X*H3."H4XP
M0!SZ&E\0I-=3$6FC27T,L00SQW CV9;D@'H0.<UD0"".>*W:62)9 !&T$N))
M2HSA6/7..:4\=*,HM6<9;6UT[Z!"E&<9:V:[[>A<CL;IY)(X(>(V"R,CE$+#
MOSWK<TO0H88()KJ-A<J=Y^?@'^50K;_;]#O);NS>TGF8NR*_F$[?NL![CM52
M_P!=DDM#;6[' C&^?'S'(]!]TYKT.9U%[IS;'4LP12S$  9)/:L/^UH]6TNZ
MB6013(K-M3YB5'<9XY_2KJW &@JXGB9O(XDD.%)QC)S6':79L;_;JT.5DA$:
MX12",\D8['TJ8QW QYR#,<!@G5=V"V#SR>YI]LKK)')&"TGF#8$)W @\\8I;
M]XY+^0V_$60$&W;@8Z8I(([F>Z18&8S,^%8-W ]:Z)14X<LMAQDXNZ-+QM=6
MMC-9R37?V>>X)BCRI.<<D\=/_KU2T2UOM1FO-7O[Z0VPW2VQWKY62,'MG@@=
M:Z74;>S:SL;C6@Q>U=77'/SXQSCK65-+)K%^\=B&B+Q!"I)VJ <G=CCD5Y]/
M#*\WTEN7*HVH_P!T?K&IVT6@QP7<LDMW&JMNA!?:WJ2/:L[2KBVU1(]1M(%N
M+95Y\C+$MT#%3[]JD?38WU@:?;3L-N [N,Y;'.,>U6K9&LIKBQ1GM"(]ZQP2
M X(.<*/4@5G/#.G+VL']E^OE^O8VC54H\C[_ /#_ -:EFU@N+73-2V)*9]VW
M]VHCZ=U]JP[25XKR.<2QAQEUW@L-WH0.YKH+5KG3])O+VY@!EDPP(R&?/]X=
MNM9 ABO9HX[=YBK1JDC[-Q#DYY/<?X5M@%RT$K61&(=ZK=SK+&5K[3(GNX=K
M2I\Z,.OX>]1_V-8>:LBVZHRL'&SCD=*2YU"+2[>".X9I92  $7EL=3BLE_$-
MW<PRM91PIY0+,6;)*@\8'?BM5&3U1@=+6'K][=6UQ;+:I(<?O"4SAL'&TX[<
MU)8Z^DRQ1W<4D4K##,4PF1[UI6]Y;W:!K>57!ST//!QTI).+U0&)#H;74R76
M9K/(;<K-F0'/KZ8J:RTRT-TT2WEQ,;0C]VSD!#G(^M7;C4X[>^C@;9L/^L<R
M >63]T8]ZG-S$EZMMR)70N,+P0/>B4INUMAJW4Q]4GOM7AN+#1;Y+ L&C%\
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MJZTUK(T%JF70KOD(RJ9/0_A6+?W6GZ;+K&J>);F[;2[JW DM;N$-#"B_*VT
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M>GVKZ/>W%A=6]DHMECBS&@5\DD=6<Y(Y/4YKH=0T(WVDKJ/B.\^QZD3Q&KK
M ^<A <XR<=#D5K>!-<CU6_>WCG59H+9'N8?.5F=C_&4'W:Z<'6A23EA;Z2:?
MO)IZO7S2VUZ=WOP4955RPJ3WNU>_-I;K=[W;[^FRX+4_"UEX5NS-X8N;C2)]
M2>*TCA>'S#(QQ\H'8G#$'L:Q/'][;Z7X6?PY9VCSWELAM9;J?=*;9&7<JEVQ
MAV]L\ U['XH\0Z3H6H"^UR8PPP,D,3);M(?-?[N0 >!UKR_QGX?G\4>)KJW.
ML02ZBD4<UEIS*8]H/#.><,20W8D =!7'JJCJ7>C=NUU9*^E[*]M79+UL_=PZ
MY\3"I7F^6RNO6]WW;?EVV.=\/6#67PP+V^GVVIWUM>!SI\H9C;1N '?'\.0"
M<GMS73:BX.AI+<ZG_9_VJ\MX].MGM/-C)QMV1Q]<%<]3BL+1/#VIW7BJ[&OZ
MW)IUPD\$MS#&^U;F%25QE?X0!@#'?GK7?K96":E+JK++($E$5NZ1[E^49!QV
MZG!JOKSI06(F[M-N^M[NRMJ_A;>KMMOY+-Z=*C4DI-*+27DD[6>VZ_,S[F""
MT34$MS=P7=O=!F02*1*K'&"J\8"C@>E6+K5[G4KBVD@226&YMI%FG639)&(U
MR-O. 2.A&>>M5O$-GKD^LV$ED8UA7<^5DVR+P. O0Y&>_;%8,T-[X2TT?;],
MA;1[%KEH)8+]B\22##'RR.2<Y/.%S3]LL3AU#G7.K67->]]U9]=K)MN[TTLC
MQZE&I@:DZZ2:?5QMHMMFFV[NUK+;1N]^E\,>(WTZ"?49KJ5KV:&*WCBNU!+8
M.>64GY]O;\Z[1[:SL_#;&^DD,R,TJAY%#X) R0!V';&:\LT9+[3EL8M#T26X
MTR%<V]R9/.$+.?F9U&"%P20Y/3O6R#<7^F[+6UA@:27[0C6W()9B,DL>G!]_
M:NZK2GAH*7/I=+T[\V]K6T];-=^=8WW_ 'X.3>J48O:VEN_FW;IJ;6G7<]N-
M0_LX'[2TGVFX$2*[ !MH&TC.''.?:K4=V!I'V?1DMXR)&N;HZ; P;#-\NT$=
M21AO05Q]Y<I8:A)*L6V\&V.ZNS)F1A'C&X^BYZ]/RKK[K6G-IIT?A>87\^5N
MI&BN!MV*/F7 ^\.^W/>HDW!1G*+LUI=:Z>6K_I:&]"O3KTI2I]-]&M>VMO/2
MQ9M7N\I)$&LIBN7,GR% QR"?0=J[R+?Y*>;C?M&[;TS7)W%[!-(+^V)D2\A6
M2:WEB^ZO0-^![5T]B7:QA:65)G*@F1!A6^E=E1W299#:W#"ZN8+BYCFD0[PB
M)@HAZ ^M3VMR+NW694DC#9^61<$<^E4+>PO8]8GN6G587?.S[Q9<<#VYK5K)
MO5JPVCBM8-Q#<2+.9D-P69D,NY2N>!BK UZYA")'+$BI @"O&2&.!D\5J^(/
M(^SI]JMFDC.09HR-T?IC/K6,;!)6BGD$D%O/<>4%("MC P3Z\CTKHCRR2;0B
MYK]S,%LT25_M&PF1(&(R,#-4)K6>/0TDE8K#*[>;$P(+$\8^F/6NFDBBTU9+
MBVM9)I96&X)RQ/3//2L-)-5O]8^S:U%';V\LA:")6ZHO()/][/4>E>=BY>TI
M.C!.YU8?W)JI+89)"]A-#+/:V[6@5(?+&/W2Y&T''&:N:K'8IX@BDOBJ1/ 0
M^0WS=AR*J>*;^RO-%N8(;/[7*LR!48A S*P.03UVU<EC$VGP6TWF/J,<)DB"
MMD^F<G@GZUGAH_5ZCA-ZO7\;+^ON"HY58*=MM":6\LM6MGTZRD97*_NV*L%^
M7'>L/SB;F9XC.WRE3*6.Y >2PXX&1CZ4EZCP@/-O\Y69/*:7=M^7J-OW>O2K
M']IC3XXX;:Y:4G+3-(N<MC 7GM7K*-EH<I5N+:X%A&YC>17C$BE=H1,]>!_/
MWKJ+>R>/2&2":999%WAI/F9#CL#7.61&JSK%<E1(6RTK/U&<A%7TR*T8KB_A
MGCEOV9WC5V$$9"A% /+^WI4U(N4>5C3L[A]ONU8,QN%5Y566.>,?*@7YL<\^
MO%7['2M. ANK+?LSOCPYQR,=#4>E:E9>(&,OV9A/9L 2Z\*Q'\)[UK@!5 4
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M%0^WH3FN>$XU;I=';9C:L:NHW:(L\%U')' 823.&V@G^Z#ZU@)=QV=W'<:;
M\DDB?O/-.XY*\)GUXS[U9N((-,F3^U<74?D[8V<DDL.<8Z#TS4>+^YN"L4%M
M'YR>=&K8!4XQ\K#J14SC.<4J;MKKYV_S-(.,'[ROH7()M,U6\*WD!2\>/8T<
MH(QCT]^?K4+7\$FCW-C>O]F5#Y*R0Y<*,94Y[UCO+<0W*?: T<L;ABSI\^<8
MY/?CFEEM;.30XC=72V8EF,95\[;O'(# <C\*UKJ48<T'M\_U1,.5NTE^AT7A
MFW@M-+%O'=_;)TQYTYCV%R>G'TKG-4O9;J_D,DA98W94! X&>G%:4LATFSD>
MQ(47"*T3F-BP4=02>G7BK]AH*17$$\A#QI",(1_&>2U9X6I[G--*[[%58J,K
M1NUY[D7A_2(T475P 9OX4SG8#T)'8XKH*ABM88)I98HPKS$&0C^(BILU4I<S
MN9&)JM[+]M-JM]!91A0Y<GYV]AZ=*?:Z[;3Z?FZECCF97^3).0._XUG^(7C.
MH%A,GFQQ@(B+ELYYW'&.G2LVW1G@:+!C5]SR2&/=E%P0!Z\^F*UY8\G,] 2;
M=D:7A^SADU4S2PPRO!;A8I0G^J#\E5SR >]/N- TOQ+'/%>0M/%;W2S6SNVY
M8Y%'WD^GH:7PS$@FN9_/.%.-H.%(Z[L5/_:TODL^FV<<5KD@3S,$3/KCZ_G7
MD0ITZB5?I=Z];-[7[?Y'94NI.G;6R_#4FU>8O;_8K=?M%VH60@J"5 _BP>"?
M;WKBHKE9+^YGL[B\BCG:-98WN=Q253EHMN?E..:[.]9M/MY[J&=#>SJI".X(
M&!SM![8R:X[Q-81206^OZ5)'/;-(L@M+6UYFG)*M(2.3Z<],9IXRC34'4D^G
M]=MSEERSBHR3:3OHVG^&NVR+-VH&LWTMUJ<EQ;7<J>4UR^U+12,;4(Q@$XY]
M:6W\-W\C:0=+^S2Q:9>*DCW,[MF%5Q\F.K#_ &JAUGPL?$?AE[![AX+@LERU
MM*HN/+4/DJHR!@XX.<C-=<--CU:QMQ=P2V0M[@3)'%)LW%>A;'4>U<N!M6J*
ML[IN_P#E_5]3>-9SH*T>565K[ZZ^O8S=5L+*QO-&M8_$%UIA$LK16<<PS>DC
M)4[LDXZ\=*P?$WAZQM+W3KS^U+&Q$$<T-]?S-LNCYR[%9&'&_<0,L,].:U/$
M>FV^JZI);-;REV!_>J2LHRI#>4W\.5.,BJ^F>%],T?09[-+&%EN)U"07H\_<
MV0<R9R=W3KZ"G[:U5V6BT]+?YZ*QC]0BE&UEII^&EOEOV,2WUFUU/PS8VNGR
M^1KA^5[35F,DLT41\N1CMXW$<UU+RV^G6>H_VG'<21L"'F&<&/&.3VJO'J%M
M#J?V/[)9/JDL<A\A%6.:.,GYL8YVD\Y[FHWDDE:*U2=UA?.T3D"/ [$CKZ5R
MXAPG47(M'NGINONOK_5STJ'-&ER5I+3KY*WST.<\)0VE_=RW-JK1#1YS9:4T
MR2(\=O(GS9.3OY_B[?E6]:SPZS=6>HPWVZ32WFMS<1LS+'P,[NS5IZ7I^G20
MO+-<*G!DFBQCY?0GTR.U<9XQLO$J7VH+X3\R_L=0@$<=O;SB.2U(7_6*>X)Z
M@\UM.4ZEI*R3VL^E[K;_ (!G)J@I-IRZO3K_ %Z]S?\ %$.H7=];?8A9ZA"T
M0M[P7$C@$D9 " 8.[N?2I?#\TZ>(KO1-"DTIK'1K:*$Q)O66*4G)5N,%<9QB
MJ]M>EY;#3-00:1JTCLL4<TXE>Y=(P2^5R >O7%=-8Z;/IEDERMQ-J-UC]X0R
MKYV>,D]\#O5QI7E)3AI>]_Q];K3H8N%-13IR2=[M>;_ LZOIL=U"[QIFZ*84
M!L%P#G;]*Y&[OHE-A:2:1]K%O.TL[1A#Y6" ')8\=>OM70:Q:Z7<WEMK[)YM
M]I)=(B)F54+X#!@.#^-8\VF:7JMC=W6I6"W-IJ8,=RR28(7/"\$9'?-5B'"-
M93C'F[K96OO=+H_O&EB)4'&.FNE_3L_Z^9D^5IMCJ5U#JE[+JVNV%K-=Q[G5
MKA89#Q$G 7!XQWY]ZTY5TB\M])U./37M]2M3OA\Z/$EN'4%L@'!/USTK-TBV
MN(-<N]-U37[*8V5@&^SVFG[%2/?B$F7JV!P5YIEI!'#\2#%J6L76Z&W>XM;.
M"-HT,0P"6.,.=V<<]*YJM)QJ\T7JUNW^FRV_-BH.#@G./7;I?YWU-S4)9;V.
M86.H6,]QIY$1DGDR%8\@NH^ZPK/TGP[IFJ^)(M6U=!=SV\7,LDY,:MOW @9P
M3GO^%;GB R1V9_L:UMK2:\Q-)-<6X(9AV8=SBN6T"\(\7+IEW(]['=QM#)<?
M9]D19?FP@48&/4_G4-JGC$HSU?3[EOVV[FTIVAS2OKI96[ZNV^GK8]$N;2-0
MXBLEN$O'"W(9N"I&"2#U^E<WIU^?#=BMM// ;032;5ER'";^W7-:UEK42Q+;
MPV]S.D((>1L$[1GGWSBN?U_P;I'B5K:?39);:ZDC*QS!"Z(%).&&>#DUZ+FZ
MD;T))?Y_=K=_B8SA*":DM>E]?FU=;?D:6LK+KT.G'2)HUMV+;D\O)W 93)7[
MJAAD^M9MO!)_9L%QXBO++^T(U:22XLH0(HYAP6W'YMQ&/_U5M^&=.CT^XN85
M#[X L;.8RBR'&68=CD_E5JZ\+:1>O>-<6V_[6 )1N( P.H'8U:C/$07,[=/N
M?E\_P'*:I2M'6RT^>O\ D9TE_:-%?>5*D=M'"9;J6(_O6;;G*J.1T/&.:RM"
MUK2[:Z^S/?26UG;6L-Z+JZN%C$JN2,,AQMY(_P XK0N/!.E:?)+?6QEMF^R+
M"]RLC--\A^4YSV^E8$^B:_>Z';_VI;Z3>7%U"ELUOJ2!C.1+N\PR(,_<Z+ZU
M/+R2Y9=_^&]-QSE>'-#M^/7U]?P1K>(/$<MA9W[ZK83FT^SO+#<0QAF.UAA
M ><]<YQ6EX>6U>QM+74KBVDO@3<PP;PLBJ>02F<Y (S573K@ZVABO+:\TUHK
MI_+@OH0N8T&,KM/"'M]*Y&/PSKWA^:Z\0M%IVK7?V58H+BUE,$D[M+R,GY0
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MOHS>&6U-W6YB6V^U0>6C.SH<8*J.3G(J70=$2*YEUB2]O+E[T)+%#.YV6RE
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MFJWEBES9Q6\\^L:BRQ+/(?WD1'"E@W&X+Z?G6T_AF'3]2@LXF6>3[(8%5B4
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MQ6$1C: 'WY R21T_"M$6?]D:@CZE&#&-Q0 9#D#C]:1=*D>:V%VGD"Y;[V0
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M>6V.  OR@]\GMQ7/+:WB8Q;REM@< J<J W''UKI;_4[D%K.WMIEN&8JCX'(
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M'M55,1.,G-I.GNM.KZWUTOY>1SQP\:E10F]7NNMXV:\OPOL[FYXALKCQ%/\
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M2,HY# #'NI%9%[<:SJ>JZD(TAU:_:V*2(T+0(51L!CG&WGDD5UX7VCE:RO\
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MATW7;L:WKEC:6RVZ1SA<1M),&RK@'GH>U2^(?!DLFHF_T(0RP,XFG@)"H_\
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M1U:-[@M@LI9CTY]@.*5:G*<+0W]32E)1E>6QHW&KZ=J4#W=I'-:7+2^659@
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MEU)9E:= )!\B+)DX<DY(/],5:U*VAMM4_M"6_EMI[6>. V=K9K-Y>["I[[0
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M[;O9^6Z5K?TB<504GR*6BT=K*VUN[WN]3RJS\-ZS'I]Y)XSU>VMEAN0EM'#
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M/O>UB84%SJ%/H<7(;S3O&47CB[MHKR"\L_LT48D+QQQE\A@1R2< ].,U[;8
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M-+N+PK=2/%)O2.4 %HW/]WMD=:Y3QC?>,FUV 6^J'3?]&#O8[8S'E'^_O/\
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MB.G1.D,4<CA3OSG<N<,.>XKE[NSGT_Q+!>:UKYCOV!B\M'*PW)8':/+Q@D#
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M>YZ8%8]U<^(?[:U6XT-[6XC7RA!;33'+;?\ 6 +V/3FM[2UFNH8[O5(1'<2
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M97YOO_%/?OYJQORZAXX@2RT[2KJWTM+65[.RE2%6AO)!@( '&$R,GCCFO3/
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M7N^O]6T9U)N--\16M_IOF>8%7R;J(95H]RYQ['!KQ_QUX4MM)U*&/2QIZ3P
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MR;63SI=\JYDD3.(QNXR3CBL^PGNI[[4-4N]2C\/;[IT$7V8L\DKQ<%=QYYY
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M ,;?UK(E\.6WAO6I8-0FM7@N49[2_P!ID>WDB&YDV\XSDU?\%ZEXBEUJ=O%
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M>1,:[LT^IS5U-:7"Q0)&S6\#%!9*AWN1QD$'ISWI?%^B:1JGAAM.U2TAFMV
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&BK;N0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>nstg-20221231_g9.jpg
<TEXT>
begin 644 nstg-20221231_g9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %L 8 # 2(  A$! Q$!_\0
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M;Q7!NTVXVW &7M9?ED3\.X]QD5YU2A.GJ]CW,/C*5?1.S[&_1116!VA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115>_O[73+&6\U"=+
M>WA7<\CG  _SV[T;B;25V6.G6O-/&OQ<M-),EAX<\N]O!\K7&<Q1'V_O']/K
MTKC/'?Q2O/$32:?HQ>TTSE6;I)<#W]%]OS]!Y[7HT<+]JI]QX>*S+[%'[_\
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MOXDFSU*="E3^"-CUS4/C9<-E+.)4]'CC_P#BC_2N>O/BSKUR,)-(@]1)M_\
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M\RW-M%/'G9*@=<]<$9J2O!>FAUIIJZ"BBB@85%<6L%W"8KJ%)HSU5UR*EHH
M\]\4_"?3M71Y=/ BEQPCGIQ_"W4?0Y%>*^(O!6J>'[ETF@D95Y.5^8#U]Q[C
MBOJRJFHZ79ZM:FWOX%E0]">JGU![5W4<9.GI+5&<J:D?'==)X5\5OHWB+2;S
M4S-=6>F"016Z$#:'#9Q_P)LYKMO'GPIDL=]]I?SQ9R6"]/\ > Z?[PX]>M>4
MS026TS13H4D4X*D=*]F$Z=>&AS.+@SO=.U::&\D\=ZZ[1*"8-+L(F*+.0,!
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MC*L1L;CD>AX'/M5_6==GUTP2WT$'VN-2LMU&FU[CT+XX)'3. 3WS2<'*6O\
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MR,H,KN#MP.=I(Z GC/;.:[9=&UG2]3M;NUN193:K-//<O;A9+&*V )Y &U^
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M7J0PE&24HMG1'#J3OT-+P_I$NO>(;+3802;B4*Q!QM7JQ_!03^%?4X 50%&
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M:CJM_J/_ !^W4DH'(4G"C\!Q71'#R>Y2BS)?[M6-(FCM]=L)IF"QQW,;,Q/
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M<)N@D61?53G%6K"ZN=-OA<V%W/9R$XD:!L;Q[@\'\:Y,SF&47-N@CD4DN%.
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M^$8!./SK=B5DA19.&"@-]:Q]9MC%,+M1\C ++CL>Q_I7T539,^/I_$TRA12
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MA7SE7=?#3Q*=)U9;>=_W+9!&>JGK^1^;\ZC%4^>&FZ)KPYHW1Z?XP'^D6O\
MNM_,5RDB>O6NL\7%7-HZD$%6P0>HXKF'7/:N2E\".!%-AD55=>HJZXP<]JKR
M)W%;HHJ.M5V&#5QQ4$B9JT,J,N*@E6K;+G@U"R]C5IC*;+7IOPK_ .0/??\
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MDPN,J/8X7.1T/N*QH;74[G2Y]5M[)I;"WE,4LB<E" "21UP 1STK=\#>*O\
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M%F+,223DD]Z2G[11M%=)\>:GA;1SKWBBQTX#Y)909/\ <'+?H#7TPJA5"J
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M'M]JL:?83ZGJ,%E:INFGD"(/<]_I49 KU+X2>&N9-?NH_6*UW#\&<?\ H/\
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M95X_[Z.!_.O2W\9>#])R=,L6N)%^ZR0X_P#'GYK(U'XIZG/\NFVL-FN/O/\
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M:LZ9PTIX1?JW].M>FZ1\.M'T_:]X&OYAU,O"?@H_KFNKCC2*-4B1411A548
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C%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170506784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NANOSTRING TECHNOLOGIES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-0094687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Fairview Avenue North<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Seattle<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">378-6266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NSTG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 585,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,791,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the registrant&#8217;s 2023 Annual Meeting of Stockholders, which will be filed subsequent to the date hereof, are incorporated by reference into Part III of this Form 10-K. Such proxy statement will be filed with the Securities and Exchange Commission not later than 120 days following the end of the registrant&#8217;s fiscal year ended December 31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001401708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170491072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Seattle, Washington<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810161589872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 112,250<span></span>
</td>
<td class="nump">$ 107,068<span></span>
</td>
<td class="nump">$ 411,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents, Current</a></td>
<td class="nump">898<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_DebtSecuritiesAndEquitySecuritiesFairValue', window );">Short-term investments</a></td>
<td class="nump">84,282<span></span>
</td>
<td class="nump">241,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">31,506<span></span>
</td>
<td class="nump">40,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">43,273<span></span>
</td>
<td class="nump">31,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">14,565<span></span>
</td>
<td class="nump">7,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">286,774<span></span>
</td>
<td class="nump">427,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">44,457<span></span>
</td>
<td class="nump">27,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">17,581<span></span>
</td>
<td class="nump">19,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">5,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">353,412<span></span>
</td>
<td class="nump">479,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">16,619<span></span>
</td>
<td class="nump">14,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">7,884<span></span>
</td>
<td class="nump">6,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and other employee benefits</a></td>
<td class="nump">17,494<span></span>
</td>
<td class="nump">17,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent', window );">Customer deposits</a></td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue and other liabilities, current portion</a></td>
<td class="nump">9,588<span></span>
</td>
<td class="nump">7,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">5,518<span></span>
</td>
<td class="nump">4,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">58,860<span></span>
</td>
<td class="nump">52,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue and other liabilities, net of current portion</a></td>
<td class="nump">3,754<span></span>
</td>
<td class="nump">3,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt, net</a></td>
<td class="nump">226,622<span></span>
</td>
<td class="nump">225,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">18,362<span></span>
</td>
<td class="nump">21,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">307,598<span></span>
</td>
<td class="nump">302,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 15,000 shares authorized; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 150,000 shares authorized; 46,719 and 45,729 shares issued and outstanding at December&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in-capital</a></td>
<td class="nump">855,694<span></span>
</td>
<td class="nump">827,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(589)<span></span>
</td>
<td class="num">(318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(809,296)<span></span>
</td>
<td class="num">(649,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">45,814<span></span>
</td>
<td class="nump">176,962<span></span>
</td>
<td class="nump">$ 306,948<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 353,412<span></span>
</td>
<td class="nump">$ 479,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">46,719,000<span></span>
</td>
<td class="nump">45,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">46,719,000<span></span>
</td>
<td class="nump">45,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Customer Deposits, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_DebtSecuritiesAndEquitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities And Equity Securities, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_DebtSecuritiesAndEquitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810171310704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 127,262<span></span>
</td>
<td class="nump">$ 145,085<span></span>
</td>
<td class="nump">$ 117,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of product revenue</a></td>
<td class="nump">65,475<span></span>
</td>
<td class="nump">68,304<span></span>
</td>
<td class="nump">52,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">70,841<span></span>
</td>
<td class="nump">69,504<span></span>
</td>
<td class="nump">62,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">143,129<span></span>
</td>
<td class="nump">115,503<span></span>
</td>
<td class="nump">90,097<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">279,445<span></span>
</td>
<td class="nump">253,311<span></span>
</td>
<td class="nump">205,363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(152,183)<span></span>
</td>
<td class="num">(108,226)<span></span>
</td>
<td class="num">(88,047)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,409<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="num">(7,535)<span></span>
</td>
<td class="num">(7,490)<span></span>
</td>
<td class="num">(15,408)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(1,917)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(971)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_GainLossOnExtinguishmentAndTerminationOfDebt', window );">Loss on extinguishment of debt and termination of revolving loan facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,143)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="num">(7,043)<span></span>
</td>
<td class="num">(6,861)<span></span>
</td>
<td class="num">(21,778)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
<td class="num">(159,226)<span></span>
</td>
<td class="num">(115,087)<span></span>
</td>
<td class="num">(109,825)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(317)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (159,543)<span></span>
</td>
<td class="num">$ (115,254)<span></span>
</td>
<td class="num">$ (110,078)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share-basic (in dollars per share)</a></td>
<td class="num">$ (3.44)<span></span>
</td>
<td class="num">$ (2.54)<span></span>
</td>
<td class="num">$ (2.82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share-diluted (in dollars per share)</a></td>
<td class="num">$ (3.44)<span></span>
</td>
<td class="num">$ (2.54)<span></span>
</td>
<td class="num">$ (2.82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used in computing basic net loss per share (in shares)</a></td>
<td class="nump">46,406<span></span>
</td>
<td class="nump">45,299<span></span>
</td>
<td class="nump">39,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used in computing diluted net loss per share (in shares)</a></td>
<td class="nump">46,406<span></span>
</td>
<td class="nump">45,299<span></span>
</td>
<td class="nump">39,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 19,306<span></span>
</td>
<td class="nump">$ 17,623<span></span>
</td>
<td class="nump">$ 19,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of product revenue</a></td>
<td class="nump">15,271<span></span>
</td>
<td class="nump">14,636<span></span>
</td>
<td class="nump">7,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">107,956<span></span>
</td>
<td class="nump">127,462<span></span>
</td>
<td class="nump">97,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of product revenue</a></td>
<td class="nump">$ 50,204<span></span>
</td>
<td class="nump">$ 53,668<span></span>
</td>
<td class="nump">$ 45,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_GainLossOnExtinguishmentAndTerminationOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Extinguishment And Termination Of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_GainLossOnExtinguishmentAndTerminationOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170468576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (159,543)<span></span>
</td>
<td class="num">$ (115,254)<span></span>
</td>
<td class="num">$ (110,078)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized loss on available-for-sale debt securities</a></td>
<td class="num">(271)<span></span>
</td>
<td class="num">(401)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (159,814)<span></span>
</td>
<td class="num">$ (115,655)<span></span>
</td>
<td class="num">$ (110,140)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170565072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at at Dec. 31, 2019</a></td>
<td class="nump">$ 104,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 535,954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,000<span></span>
</td>
<td class="num">$ (431,952,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock net of issuance costs</a></td>
<td class="nump">215,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Exercise of common stock warrant, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(110,078,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,078,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at at Dec. 31, 2020</a></td>
<td class="nump">306,948,000<span></span>
</td>
<td class="num">$ (51,012,000)<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">848,891,000<span></span>
</td>
<td class="num">$ (58,543,000)<span></span>
</td>
<td class="nump">83,000<span></span>
</td>
<td class="num">(542,030,000)<span></span>
</td>
<td class="nump">$ 7,531,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(115,254,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,254,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at at Dec. 31, 2021</a></td>
<td class="nump">$ 176,962,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">827,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(318,000)<span></span>
</td>
<td class="num">(649,753,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">128,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (159,543,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,543,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at at Dec. 31, 2022</a></td>
<td class="nump">$ 45,814,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 855,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (589,000)<span></span>
</td>
<td class="num">$ (809,296,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810171353680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 45,814,000<span></span>
</td>
<td class="nump">$ 176,962,000<span></span>
</td>
<td class="nump">$ 306,948,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,765,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,543,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">128,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">$ 1,440,000<span></span>
</td>
<td class="nump">6,453,000<span></span>
</td>
<td class="nump">18,751,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Stock Issued During Period, Value, Restricted Stock Award, Gross</a></td>
<td class="num">(1,504,000)<span></span>
</td>
<td class="num">(2,585,000)<span></span>
</td>
<td class="num">(2,012,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,385,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="nump">2,669,000<span></span>
</td>
<td class="nump">2,428,000<span></span>
</td>
<td class="nump">2,190,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to Additional Paid in Capital, Warrant Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Stock Issued During Period, Value, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">26,061,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,963,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(271,000)<span></span>
</td>
<td class="num">(401,000)<span></span>
</td>
<td class="num">(62,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(159,543,000)<span></span>
</td>
<td class="num">(115,254,000)<span></span>
</td>
<td class="num">(110,078,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,012,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">855,694,000<span></span>
</td>
<td class="nump">827,028,000<span></span>
</td>
<td class="nump">848,891,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,765,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,543,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">1,440,000<span></span>
</td>
<td class="nump">6,452,000<span></span>
</td>
<td class="nump">18,751,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Stock Issued During Period, Value, Restricted Stock Award, Gross</a></td>
<td class="num">(1,504,000)<span></span>
</td>
<td class="num">(2,585,000)<span></span>
</td>
<td class="num">(2,012,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="nump">2,669,000<span></span>
</td>
<td class="nump">2,428,000<span></span>
</td>
<td class="nump">2,190,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to Additional Paid in Capital, Warrant Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">$ 26,061,000<span></span>
</td>
<td class="nump">$ 30,385,000<span></span>
</td>
<td class="nump">18,963,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (58,543,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding</a></td>
<td class="nump">46,719,000<span></span>
</td>
<td class="nump">45,729,000<span></span>
</td>
<td class="nump">44,441,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">840,000<span></span>
</td>
<td class="nump">1,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,890,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Exercise of common stock warrant, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">$ (589,000)<span></span>
</td>
<td class="num">$ (318,000)<span></span>
</td>
<td class="nump">$ 83,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(271,000)<span></span>
</td>
<td class="num">(401,000)<span></span>
</td>
<td class="num">(62,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(809,296,000)<span></span>
</td>
<td class="num">(649,753,000)<span></span>
</td>
<td class="num">(542,030,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (159,543,000)<span></span>
</td>
<td class="num">$ (115,254,000)<span></span>
</td>
<td class="num">(110,078,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,531,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170573440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (159,543,000)<span></span>
</td>
<td class="num">$ (115,254,000)<span></span>
</td>
<td class="num">$ (110,078,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">25,908,000<span></span>
</td>
<td class="nump">30,173,000<span></span>
</td>
<td class="nump">19,374,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">8,116,000<span></span>
</td>
<td class="nump">5,871,000<span></span>
</td>
<td class="nump">5,738,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating cash flows from operating leases</a></td>
<td class="nump">4,089,000<span></span>
</td>
<td class="nump">3,450,000<span></span>
</td>
<td class="nump">3,238,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_InterestAccruedOnLongTermNotes', window );">Amortization of deferred financing costs</a></td>
<td class="nump">1,477,000<span></span>
</td>
<td class="nump">1,429,000<span></span>
</td>
<td class="nump">8,881,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium', window );">Amortization of premium and accretion of discount on short-term investments, net</a></td>
<td class="nump">1,706,000<span></span>
</td>
<td class="num">(1,765,000)<span></span>
</td>
<td class="num">(121,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for inventory obsolescence and bad debt expense (recovery)</a></td>
<td class="nump">4,023,000<span></span>
</td>
<td class="nump">2,040,000<span></span>
</td>
<td class="nump">886,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_RepaymentOfAccruedInterestOfLongTermDebt', window );">Payment of accrued interest on long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,593,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,143,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment and other assets</a></td>
<td class="nump">847,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Loss on equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">7,414,000<span></span>
</td>
<td class="num">(9,526,000)<span></span>
</td>
<td class="num">(3,949,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(15,271,000)<span></span>
</td>
<td class="num">(10,520,000)<span></span>
</td>
<td class="num">(4,909,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(6,942,000)<span></span>
</td>
<td class="num">(5,443,000)<span></span>
</td>
<td class="nump">4,321,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,396,000<span></span>
</td>
<td class="nump">8,687,000<span></span>
</td>
<td class="num">(3,170,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(407,000)<span></span>
</td>
<td class="num">(914,000)<span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and other employee benefits</a></td>
<td class="nump">256,000<span></span>
</td>
<td class="nump">2,497,000<span></span>
</td>
<td class="num">(936,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits', window );">Contract With Customer, Liability, Increase (Decrease) In Customer Deposits</a></td>
<td class="nump">479,000<span></span>
</td>
<td class="num">(353,000)<span></span>
</td>
<td class="num">(4,758,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue and other liabilities</a></td>
<td class="nump">2,674,000<span></span>
</td>
<td class="nump">3,336,000<span></span>
</td>
<td class="nump">2,033,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(4,828,000)<span></span>
</td>
<td class="num">(4,262,000)<span></span>
</td>
<td class="num">(3,160,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(128,606,000)<span></span>
</td>
<td class="num">(90,549,000)<span></span>
</td>
<td class="num">(81,662,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(14,364,000)<span></span>
</td>
<td class="num">(6,348,000)<span></span>
</td>
<td class="num">(7,457,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Purchase of internal-use software assets</a></td>
<td class="num">(7,952,000)<span></span>
</td>
<td class="num">(2,299,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to Acquire Intangible Assets</a></td>
<td class="num">(750,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">21,218,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">197,363,000<span></span>
</td>
<td class="nump">44,664,000<span></span>
</td>
<td class="nump">116,284,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(49,500,000)<span></span>
</td>
<td class="num">(260,239,000)<span></span>
</td>
<td class="num">(38,804,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">132,497,000<span></span>
</td>
<td class="num">(220,222,000)<span></span>
</td>
<td class="nump">91,241,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of 2025 convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">230,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Fees paid for issuance of 2025 convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,403,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(80,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Fees paid upon extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,845,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">215,765,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">737,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from issuance of common stock for employee stock purchase plan</a></td>
<td class="nump">2,669,000<span></span>
</td>
<td class="nump">2,427,000<span></span>
</td>
<td class="nump">2,190,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Tax withholdings related to net share settlements of restricted stock units</a></td>
<td class="num">(1,504,000)<span></span>
</td>
<td class="num">(2,585,000)<span></span>
</td>
<td class="num">(2,012,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,440,000<span></span>
</td>
<td class="nump">6,452,000<span></span>
</td>
<td class="nump">18,751,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Repayment of finance lease obligations</a></td>
<td class="num">(333,000)<span></span>
</td>
<td class="num">(236,000)<span></span>
</td>
<td class="num">(135,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">2,272,000<span></span>
</td>
<td class="nump">6,058,000<span></span>
</td>
<td class="nump">373,048,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, restricted cash and cash equivalents</a></td>
<td class="num">(83,000)<span></span>
</td>
<td class="num">(67,000)<span></span>
</td>
<td class="nump">188,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, restricted cash and cash equivalents</a></td>
<td class="nump">6,080,000<span></span>
</td>
<td class="num">(304,780,000)<span></span>
</td>
<td class="nump">382,815,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash, restricted cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of year</a></td>
<td class="nump">107,068,000<span></span>
</td>
<td class="nump">411,848,000<span></span>
</td>
<td class="nump">29,033,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of year</a></td>
<td class="nump">113,148,000<span></span>
</td>
<td class="nump">107,068,000<span></span>
</td>
<td class="nump">411,848,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">6,038,000<span></span>
</td>
<td class="nump">6,038,000<span></span>
</td>
<td class="nump">4,571,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for taxes</a></td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
<td class="nump">357,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_RentalInstrumentsReclassifiedFromInventory', window );">Instruments reclassified from inventory to property and equipment</a></td>
<td class="nump">665,000<span></span>
</td>
<td class="nump">525,000<span></span>
</td>
<td class="nump">854,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">448,000<span></span>
</td>
<td class="nump">524,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">$ 2,126,000<span></span>
</td>
<td class="nump">$ 929,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase (Decrease) In Customer Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_InterestAccruedOnLongTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense incurred, not yet paid, on all other long-term debt, which may include (1) interest on long-term notes, and (2) amortization of issuance costs not otherwise separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_InterestAccruedOnLongTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_RentalInstrumentsReclassifiedFromInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental instruments reclassified from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_RentalInstrumentsReclassifiedFromInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_RepaymentOfAccruedInterestOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Accrued Interest Of Long Term Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_RepaymentOfAccruedInterestOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165341392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of the Business</a></td>
<td class="text">Description of the BusinessNanoString Technologies, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on June&#160;20, 2003. The Company&#8217;s headquarters is located in Seattle, Washington. The Company&#8217;s proprietary chemistries enable the direct detection, identification and quantification of individual target molecules in biological samples by attaching unique molecular reporters to each target molecule of interest. The Company currently markets and sells three platforms based on its proprietary technologies, its nCounter Analysis System, its GeoMx Digital Spatial Profiler, or &#8220;GeoMx DSP&#8221; or &#8220;GeoMx&#8221;, and CosMx Spatial Molecular Imager, or &#8220;CosMx SMI&#8221; or &#8220;CosMx&#8221;, all of which include instruments and consumables, to academic, government, biopharmaceutical, and clinical laboratory customers.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810247595936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Principles and Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying consolidated financial statements reflect the accounts of the Company and its wholly-owned subsidiaries. Each of the subsidiaries operates as a sales and support office. The functional currency of each subsidiary is the U.S. dollar. All significant intercompany balances and transactions have been eliminated.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and that affect the reported amounts of revenue and expenditures during the reporting period. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying consolidated financial statements include the estimation of stand-alone selling prices for its products and services, the estimation of the valuation of inventory, the estimates used in the valuation allowance for deferred tax assets and uncertain tax positions, and estimates used in certain of the inputs and calculations associated with stock-based compensation.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly-liquid investments with purchased maturities of three&#160;months or less to be cash equivalents. The Company&#8217;s cash equivalents consist principally of funds maintained in depository accounts. The Company invests its cash and cash equivalents with major financial institutions; at times these investments exceed federally insured limits. Restricted cash consists of customer deposits which are secured through letters of credit until performance obligations have been met. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its debt securities as available-for-sale, which are reported at estimated fair value with unrealized gains and losses included in accumulated other comprehensive loss in stockholders&#8217; equity. Realized gains, realized losses and allowance for estimated credit losses are included in other expense, net. The cost of investments for purposes of computing realized and unrealized gains and losses is based on the specific identification method. Amortization of premiums and accretion of discounts are included in other expense, net. Interest and dividends earned on all securities are included in other expense, net.&#160;Investments in debt securities with maturities of less than one year, or where management&#8217;s intent is to use the investments to fund current operations, or to make them available for current operations, are classified as short-term investments.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments are presented net of an allowance for expected credit losses that are remeasured each period and any impairment recognized as an expense. The Company has considered all information and factors and noted no indicators that a credit loss exists as of December 31, 2022. The Company has not experienced any significant investment credit losses to date. Accrued interest receivable is included in prepaid and other current assets and was $0.9 million and $0.8 million as of December 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of an allowance for credit losses. The Company uses available information over the life of the receivables including analysis of past credit losses, recoveries of past credit losses, management&#8217;s expectations of future economic positions, as well as market conditions and other extenuating factors to support the allowance estimate. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. Cash is invested in accordance with the Company&#8217;s investment policy, which includes guidelines intended to minimize and diversify credit risk. Most of the Company&#8217;s investments are not federally insured. The Company has credit risk related to the collectability of its accounts receivable. The Company performs initial and ongoing evaluations of its customers&#8217; credit history or financial position and generally extends credit on account without collateral. The Company has not experienced any significant credit losses to date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented more than 10% of total revenue for the year ended December 31, 2022. The Company had no customers that represented more than 10% of total revenue for the years ended December 31, 2021 and 2020, respectively. The Company had no customers that represented more than 10% of total accounts receivable as of December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to supply chain risks related to the outsourcing of the manufacturing and production of its instruments to sole suppliers. Although there are a limited number of manufacturers for instruments of this type, the Company believes that other suppliers could provide similar products on comparable terms. Similarly, the Company sources certain raw materials used in the manufacture of consumables from certain sole suppliers. A change in suppliers, however, could cause a delay in manufacturing and a possible loss of sales, which would adversely affect operating results.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value of financial instruments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recorded amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities. Investments that are classified as available-for-sale are recorded at fair value. The fair value for investment securities held and for convertible senior notes are determined using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of finished goods, raw materials, including certain intermediate manufactured items, and certain component parts to be used in manufacturing or servicing the Company&#8217;s products. Inventory is stated at the lower of cost or net realizable value. Cost is determined using a standard cost system, whereby the standard costs are updated periodically to reflect current costs and market represents the lower of cost or market (replacement cost or estimated net realizable value). The Company&#8217;s policy is to establish inventory reserves when conditions exist that suggest that inventory may be in excess of anticipated demand, obsolete, slow moving or impaired. In the event that the Company identifies these conditions exist in its inventory, its carrying value is reduced to its net realizable value. Inventory reserves were $7.3 million and $6.5 million as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company outsources the manufacturing of its instruments to third-party contract manufacturers who manufacture them to certain specifications and source certain raw materials from sole source providers. Major delays in shipments, inferior quality, insufficient quantity or any combination of these or other factors may harm the Company&#8217;s business and results of operations. In addition, the inability of one or more of these suppliers to provide the Company with an adequate supply of its products or raw materials or the loss of one or more of these suppliers may cause a delay in the Company&#8217;s ability to fulfill orders while it obtains a replacement supplier and may harm the Company&#8217;s business and results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets. Expenditures for additions are capitalized and expenditures for maintenance and repairs are expensed as incurred. Gains and losses from the disposal of property and equipment are reflected in the consolidated statements of operations in the period of disposition.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prototype systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or lease term</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Internal-Use Software Costs</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain development costs incurred in connection with software development for internal-use software platforms used in operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once software has reached the development stage, internal and external costs, if direct, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over the estimated useful life of the software platforms and are included in depreciation and amortization expense within operating expenses in our consolidated statements of operations. Unamortized capitalized internal-use software development costs were $11.8 million and $4.0 million as of December 31, 2022 and 2021, respectively. Amortization of capitalized internal-use software costs was $0.3 million for the year ending December 31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs associated with the implementation of hosted third-party cloud computing arrangements are recorded as part of current and long-term other assets. Maintenance and training costs are expensed as incurred and are expensed on a straight-line basis over the term of the related hosting arrangement. Costs are recorded within the consolidated statements of operations based on the functional use of the software. Unamortized capitalized software implementation costs were $1.9 million and $3.2 million as of December 31, 2022 and 2021, respectively. Amortization and write-down of capitalized software implementation costs of hosted third-party cloud computing arrangements was $1.3 million and $0.3 million for the years ending December 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception of a contract. The Company&#8217;s leasing portfolio is comprised of operating and finance leases primarily for general office, manufacturing, and research and development purposes. Operating and finance lease liabilities and the corresponding right-of-use assets are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Operating lease right-of-use assets are reduced by lease incentives included in the agreement. As the existing leases do not contain an implicit interest rate, the Company estimates its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The Company includes options to extend the lease in the lease liability and right-of-use asset when it is reasonably certain that the option will be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company elected, as an accounting policy election, to use the short-term lease recognition exemption on all classes of assets. Leases with an initial term of 12 months or less are not recorded on the balance sheet and the Company recognizes lease payments as an expense on a straight-line basis over the lease term. The Company has lease office agreements with lease and non-lease components, which are generally accounted for separately. For lease equipment agreements, the Company accounts for the lease and non-lease components as a single lease component. The Company&#8217;s lease agreements do not contain any material variable lease payments, material residual value guarantees or, any material restrictive covenants.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes impairment losses on long-lived assets when indicators of impairment are present and the anticipated undiscounted cash flows to be generated by those assets are less than the asset&#8217;s carrying values. The Company has not experienced material impairment losses on its long-lived assets during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted &#8220;ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-06&#8221;) effective January 1, 2021. The Company uses the if-converted method for purposes of calculating dilutive earnings per share, if the Convertible Notes are dilutive during the period. In connection with the issuance of the Convertible Notes, the Company incurred certain financing costs associated directly with the issuance of the Convertible Notes. These issuance costs were deferred and are amortized to </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest expense over five years using the effective interest method. See Note 10. Long-term Debt, Net for additional information regarding the Convertible Senior Notes.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segments</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity for which separate financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company&#8217;s chief operating decision maker is the chief executive officer, who manages the operations and evaluates the financial performance on a total Company basis. The Company&#8217;s principal operations and decision-making functions are located at its corporate headquarters in the United States and the Company operates as a single operating and reporting segment.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the promised goods or services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of a product or service to the customer, meaning the customer has the ability to use and obtain the benefit of the product or service. The Company recognizes revenue for satisfied performance obligations only when there are no uncertainties regarding payment terms or transfer of control.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically generated the majority of its revenue from sales of its proprietary GeoMx DSP system and nCounter Analysis System, and related consumables. Services consist of instrument service contracts for maintenance, repair and other support related to customer owned instruments, and also certain service fees for assay processing and data analysis and reporting. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from instruments and consumables is generally recognized upon shipment to the end customer, which is when control of the product has been transferred to the customer. Performance obligations related to instrument sales are reviewed on a contract-by-contract basis, as individual contract terms may vary and revenue is recognized as performance obligations are satisfied. Performance obligations for consumable products are generally completed upon shipment to the customer. While the Company typically completes installation and training of its customers with field-based service personnel, these services can also be provided by distribution partners and other third parties.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument service contracts are sold with contract terms ranging from 12-36 months and cover periods after the end of the initial 12-month warranty. These contracts include services to maintain performance within the Company&#8217;s designed specifications and allow the customer to receive certain preventative maintenance service procedures during the contract term. Revenue from services to maintain designed specifications is considered a stand-ready obligation and recognized evenly over the contract term and service revenue related to preventative maintenance of instruments is recognized when the procedure is completed. Revenue from service fees for assay processing is recognized upon the rendering of the related performance obligation which is typically the delivery of data and analysis of the samples that have been processed.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements with multiple performance obligations, the Company allocates the contract price in proportion to each performance obligation&#8217;s relative stand-alone selling price. The Company frequently sells bundles of systems and consumables and, in such instances, uses its best estimate of selling price for its products based on historical sales or similar products. For service, the best estimate of selling price is based on historical stand-alone sales, as stand-alone sales data for services are more readily available. The Company reviews its stand-alone prices at least annually or more frequently if facts and circumstances significantly change.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally recognizes expense related to the acquisition of contracts, such as sales commissions, at the time of revenue recognition, which is generally in the same period products are sold, and in the case of services, revenue is recognized as services are rendered or over the period of time covered by the service contract. The Company records commission expenses within selling, general and administrative expenses.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales to customers through distributors are recognized consistent with the policies and practices for direct sales to customers, as described above.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product revenue consists primarily of costs incurred in the production process, including costs of purchasing instruments from third-party contract manufacturers, consumable component materials and assembly labor and overhead, installation, and packaging and delivery costs. In addition, cost of product revenue includes royalty costs for licensed technologies included in the Company&#8217;s products, provisions for slow-moving and obsolete inventory and stock-based compensation expense. Cost of product revenue for instruments and consumables is recognized in the period the related revenue is recognized. Shipping and handling costs incurred for product shipments are included in cost of product revenue in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenue consists primarily of field service technicians and the cost of providing repair and maintenance services including parts used in performing those services for instruments covered under warranty and service contracts. In addition, cost of service revenue includes lab personnel labor and overhead, stock-based compensation and materials used in performing data analysis services. Cost of service revenue is recognized in the period the services are performed. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve for Product Warranties</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally provides a one-year warranty on both its nCounter Analysis Systems and GeoMx DSP instruments, and establishes a reserve for future warranty costs based on historical product failure rates and actual warranty costs incurred. Warranty expense is recorded as a component of cost of service revenue in the consolidated statements of operations. Warranty reserves were $1.0 million and $1.2 million as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses, consisting primarily of salaries and benefits, stock-based compensation expense, occupancy costs, laboratory supplies, contracted services, and consulting fees are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling expenses consist primarily of personnel related costs for sales and marketing, contracted services, and service fees and are expensed as the related costs are incurred. Advertising costs are expensed as incurred and are included in sales and marketing expenses. Advertising costs totaled approximately $9.3 million, $4.8 million and $3.4 million during the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of personnel related costs for the Company&#8217;s finance, human resources, business development, legal, information technology and general management, as well as professional fees for legal, accounting and other consulting services. General and administrative expenses are expensed as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary balance sheet accounts are remeasured using exchange rates in effect at the balance sheet dates and non-monetary items are remeasured at historical exchange rates. Expenses are generally remeasured at the average exchange rates for the period. Foreign currency remeasurement and transaction gains and losses are included in interest and other income (expense), net and were not material for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the liability method. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether a tax position is more likely than not to be sustained upon examination based on the technical merits of the position. For tax positions meeting the more-likely-than-not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for stock-based compensation under the fair value method. Stock-based compensation costs related to restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;) which are granted by the Company are calculated using the grant-date fair value using the intrinsic method and for stock options granted in prior years, stock-based compensation was estimated using the Black-Scholes option pricing model. Stock-based compensation expense is recognized based on the number of awards ultimately expected to vest, using actual forfeitures when incurred. The Company uses the </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">straight-line attribution method over the vesting period for recognizing compensation expense for awards with a service condition. For awards with service and performance conditions, the accelerated recognition method is used over the graded vesting schedules for the awards.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company guarantees and/or indemnifies other parties, including vendors, lessors and parties to transactions with the Company, with respect to certain matters. The Company has agreed to hold the other parties harmless against losses arising from breach of representations or covenants, or out of intellectual property infringement or other claims made against certain parties. It is not possible to determine the maximum potential amount the Company could be required to pay under these indemnification agreements, since the Company has not had any prior indemnification claims, and each claim would be based upon the unique facts and circumstances of the claim and the particular provisions of each agreement. In the opinion of management, any such claims would not be expected to have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition or cash flows. The Company did not have any related liabilities recorded at December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Loss</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss includes certain changes in equity that are excluded from net loss. Specifically, unrealized gains and losses on available-for-sale debt securities are included in comprehensive (income) loss.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165137056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Short-term Investments</a></td>
<td class="text">Short-term Investments<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consisted of available-for-sale and equity securities as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized&#160;cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized&#160;cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of available-for-sale debt securities by contractual maturity at December&#160;31 were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one to three years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has both the intent and ability to sell its available-for-sale debt securities maturing greater than one year within 12 months from the balance sheet date and, accordingly, has classified these securities as current in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes investments that have been in a continuous unrealized loss position as of December&#160;31, 2022 (in thousands).</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,061&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests in securities that are rated investment grade or better. The unrealized losses on available-for-sale debt securities as of December&#160;31, 2022 were caused primarily by interest rate increases.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the individual securities in its portfolio for impairment when events indicate the fair value of the investments may be below the carrying value. The Company reviews the individual securities in its portfolio for indications that unrealized losses are credit related and require an allowance to be recorded at the present value of the future expected cash flows. The Company determined unrealized losses were not for credit losses and so did not record an allowance related to its available-for-sale debt investments for the year ended December&#160;31, 2022. The Company did not record any impairment charges related to its available-for-sale debt investments for the year ended December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165240864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a financial liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is used to measure fair value. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recorded amounts of certain financial instruments, including cash, accounts receivable, prepaid expenses and other, accounts payable and accrued liabilities, approximate fair value due to their relatively short-term maturities. The recorded amount of the Company&#8217;s long-term debt can be determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market, which are classified as a Level 2 financial instrument. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments by level within the fair value hierarchy were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2022</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value measurement using:</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market fund</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,576&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2021</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value measurement using:</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market fund</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company issued $230.0 million of Convertible Senior Notes of which $88.6 million was used to repay amounts owed and fees associated with the termination of its term loan agreement and revolving line of credit as described in more detail in Note 10. Long-term Debt, Net. As of December&#160;31, 2022, the fair value of the Convertible Senior Notes was $182.9 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165324320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesThe Company is obligated to make future minimum payments under five primary operating leases which approximate 162,322 square feet of space used for manufacturing, research and development and general operations primarily in the greater Seattle area. The operating leases have terms that expire from&#160;2026&#160;to&#160;2032&#160;and include renewal options to extend the lease term at the then current fair market rental for each of the lease agreements. None of the options to extend the rental term of existing leases were considered reasonably certain as of December&#160;31, 2022. The Company&#8217;s operating leases contain rent abatement periods, scheduled rent increases and provide for tenant improvement allowances. In addition, the Company enters into finance lease right-of-use assets included in other assets and lease liabilities included in deferred revenues and other liabilities primarily for equipment used in its operations. The Company&#8217;s lease agreements do not contain any material variable lease payments, material residual value guarantees, or any material restrictive covenants. <div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of the Company&#8217;s lease cost (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases for the year ended December 31 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.399%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5">Total</span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165325984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory, Net<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intermediate manufactured components</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,273&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165207552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment&#160;&#160;&#160;&#160;<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful&#160;Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prototype instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,457&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prototype instruments consist of various CosMx SMI , GeoMx DSP, and nCounter instruments used in internal testing and other development activities. Depreciation and amortization expense related to property and equipment for the years ended December&#160;31, 2022, 2021 and 2020 totaled approximately $8.1 million, $5.9 million and $5.7 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165235008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-term Debt<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company issued $230.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due 2025 (&#8220;Convertible Notes&#8221;) in a private offering. The Convertible Notes are governed by an indenture dated March 9, 2020 between the Company and U.S. Bank, National Association, as trustee. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received net proceeds from the offering of $222.6 million. The Company used $88.6 million to repay in full all outstanding amounts borrowed, accrued interest and fees owed in connection with the termination of the Company&#8217;s amended and restated term loan agreement (&#8220;2018 Term Loan&#8221;) with Capital Royalty Group, and the fees owed in connection with the termination of the Company&#8217;s revolving credit facility with Silicon Valley Bank.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes bear interest at a rate of 2.625% per year, payable semi-annually in arrears on March 1 and September 1, beginning on September 1, 2020. The Convertible Notes may bear additional interest under specified circumstances relating to the Company&#8217;s failure to comply with its reporting obligations under, or if the Convertible Notes are not freely tradeable as required by, the indenture governing the Convertible Notes. Upon conversion, the Convertible Notes will be convertible into cash, shares of common stock or a combination of cash and shares of common stock, at the Company&#8217;s election.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes are general unsecured senior obligations and will mature on March 1, 2025, unless earlier repurchased, redeemed or converted, subject to satisfaction of certain conditions and during the periods described below. The initial conversion rate for the Convertible Notes is 20.9161 shares of common stock, par value $0.0001 per share, per $1,000 principal amount of Convertible Notes (which is equivalent to an initial conversion price of approximately $47.81 per share). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that may occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such corporate event or in connection with such redemption, as the case may be, in certain circumstances.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the close of business on the business day immediately preceding December&#160;1, 2024, the Convertible Notes will be convertible only under the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on June&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2)&#160;during the five&#160;business-day&#160;period after any five consecutive&#160;trading-day&#160;period in which the trading price per $1,000 principal amount of Convertible Notes for each trading day of such period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3)&#160;if the Company calls any or all of the Convertible Notes for redemption, the Convertible Notes called for redemption (or, in the case of a partial redemption, if the Company makes an election to redeem all Convertible Notes, irrespective of whether they are called for redemption, to be convertible, all Convertible Notes) may be submitted for conversion at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date as set forth in the related redemption </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">notice; or (4)&#160;upon the occurrence of specified corporate events. On or after December&#160;1, 2024, until the close of business on the business day immediately preceding the maturity date, holders of the Convertible Notes may convert all or any portion of their Convertible Notes at any time, regardless of the foregoing circumstances. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the Convertible Notes prior to March 5, 2023, and no sinking fund is provided for the Convertible Notes. On or after March&#160;5, 2023, the Company may redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive&#160;trading-day&#160;period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of a fundamental change (as defined in the indenture governing the Convertible Notes) prior to the maturity date, subject to certain conditions, holders may require the Company to repurchase all or a portion of the Convertible Notes in increments of $1,000 for cash at a price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes do not contain any financial or operating covenants or any restrictions on the issuance of other indebtedness or the issuance or repurchase of securities by the Company. The Convertible Notes indenture contains customary events of default, including that upon certain events of default, 100% of the principal and accrued and unpaid interest on the Convertible Notes will automatically become due and payable. Debt issuance costs are amortized to interest expense using the effective interest method over five years, the contractual term of the Convertible Notes, with an effective interest rate of 3.3%.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company monitors the provision of the Convertible Notes that allow for certain conversion rights at each quarterly reporting date in order to determine whether the Convertible Notes are convertible or subject to an event triggering potential redemption during the prescribed measurement periods. As of the date of this report, none of the outstanding convertible notes had been redeemed by the Company. Based on the closing price of our common stock of $7.97 on the last trading day of the year, the if-converted values of the Convertible Notes did not exceed the outstanding principal balance as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All future principal payments related to the Convertible Notes are due in March 2025. The outstanding balance of the Company&#8217;s Convertible Notes consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal of Convertible Note</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Convertible Notes (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,547&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Agreement</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an amended and restated term loan agreement with Capital Royalty Group (the &#8220;2018 Term Loan&#8221;), under which it could borrow up to $100.0 million, which was due and payable in September 2024.&#160;The Company borrowed a total of $80.0 million under the 2018 Term Loan. In March 2020, the Company terminated the 2018 Term Loan agreement. The Company used $88.6 million of the proceeds from the Convertible Notes to repay in full all outstanding principle, interest and fees associated with termination of the loan. The termination was accounted for as debt extinguishment and the Company recorded a charge of $6.6 million associated with the elimination of previously deferred financing costs, and for fees and penalties incurred upon termination of the 2018 Term Loan and other costs. These costs have been included as a Loss on extinguishment of debt and termination of revolving loan facility in the Company&#8217;s consolidated statements of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Revolving Loan Facility </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Company entered into a&#160;$15.0 million secured revolving loan facility, with availability subject to a borrowing base consisting of eligible accounts receivable. In November 2018, the Company entered into an amended and restated loan and security agreement to increase the borrowing capacity under the facility to $20.0 million, amend the borrowing base to include finished goods inventory, and extend the final maturity under the facility to November 2021.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company terminated the revolving loan facility and paid termination fees of $0.5 million. There were no amounts outstanding under the revolving loan facility at the time of termination. These costs have been included as a Loss on extinguishment of debt and termination of revolving loan facility in the Company&#8217;s consolidated statements of operations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest expense for the Company&#8217;s long-term debt was $7.5 million, $7.5 million and $15.4 million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165325984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock and Preferred Stock</a></td>
<td class="text">Common Stock and Preferred Stock<div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Offerings</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company completed an underwritten public offering of 5,750,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase 750,000 additional shares of common stock. The Company&#8217;s total gross proceeds were $230.0 million. After underwriter&#8217;s commissions and other expenses of the offering, the Company&#8217;s aggregate net proceeds were $215.8 million.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of other classes of stock outstanding.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the amended and restated certificate of incorporation filed by the Company immediately prior to the completion of its initial public offering, the Company&#8217;s board of directors is authorized to issue up to 15,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, redemption rights, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing change in the Company&#8217;s control or other corporate action. As of December&#160;31, 2022, no shares of preferred stock were issued or outstanding, and the board of directors has not authorized or designated any rights, preferences, privileges and restrictions for any class of preferred stock.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company&#8217;s initial public offering, warrants to purchase preferred stock were issued related to certain financing transactions. All preferred stock warrants were converted into warrants to purchase common stock upon the effectiveness of the initial public offering. In addition, the Company has issued common stock warrants to third parties in accordance with the provisions of certain debt and collaboration agreements. As of December&#160;31, 2022, there were 470,510 common stock warrants outstanding with a weighted average exercise price of $24.70 per share and expiration dates in 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165235008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation</a></td>
<td class="text">Stock-based Compensation<div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Plans</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2013 Equity Incentive Plan, 2018 Inducement Equity Incentive Plan, and the 2022 Equity Incentive Plan (the &#8220;Plans&#8221;) authorize the grant of stock options, restricted stock units (&#8220;RSUs&#8221;) and other equity awards to employees, directors and consultants. As of December&#160;31, 2022, there were 15,057,772 shares authorized under the Plans. The Company has also granted RSUs that include service or service and certain performance conditions, or performance stock units (&#8220;PSUs&#8221;). RSUs generally vest over service periods of 1-3 years at which time award recipients receive shares of common stock equivalent to the originally awarded number of RSUs. In the case of PSUs, the number of PSUs that vest will be contingent on satisfying the service period and also based on achievement of all or part of the required performance obligations. All stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options granted have a ten-year term and generally vest and become exercisable over four years of continued employment or service as defined in each option agreement. </span></div><div style="margin-bottom:6pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit (RSU) and Performance Stock Unit (PSU) Activity</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and PSU activity under the Plans is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-vested RSUs and PSUs</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Equivalent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average remaining<br/>contractual<br/>term (in&#160;years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic value<br/>(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the year:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759,305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,850)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the RSUs and PSUs is determined based on the closing price of the Company&#8217;s common stock on the date of grant. The fair value of vested RSUs and PSUs was $18.6 million, $11.7 million and $7.0 million for the years ended December 31, 2022, 2021 and 2020, respectively. The intrinsic value of vested RSUs and PSUs was $20.1 million, $44.5 million and $12.5 million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, the Company modified certain performance conditions of its PSUs for approximately 10 employees in each year which were originally granted in 2020 and 2019. These stock award modifications resulted in incremental stock-based compensation expense of $3.0 million, and $4.7 million for 2021 and 2020, respectively, recognized from the date of the modification over the remaining vesting period of the awards, adjusted for performance conditions and forfeitures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Option Activity</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s stock option activity under the Plans is as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average exercise<br/>price per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average remaining<br/>contractual<br/>term (in&#160;years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic value<br/>(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,017,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value per share of options granted with exercise prices equal to the market price on the date of the grant was $18.89 for the year ended December 31, 2020. The aggregate intrinsic value in the table above is calculated as the difference between the exercise price of the underlying options and the quoted price of the Company&#8217;s common stock for all options that were in-the-money at December&#160;31, 2022. The aggregate intrinsic value of options exercised was $2.3 million, $26.9 million, and $39.9 million during 2022, 2021, and 2020, respectively, determined as of the option exercise date. The fair value of options vested was $2.2 million, $3.7 million and $4.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the Company&#8217;s stock options outstanding at December&#160;31, 2022:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.92 &#8211; $12.56</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.77 &#8211;&#160;$14.99</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.21 &#8211;&#160;$18.55</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.68 &#8211;&#160;$22.71</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.00 &#8211;&#160;$66.91</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,860&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth stock-based compensation expense related to stock-based arrangements under the Plans as presented within the consolidated statement of operations for the years ended December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, total unrecognized stock-based compensation cost related to non-vested options and RSUs was $36.7 million for awards with a service component and $0.1 million for awards with a service and performance component. This cost will be recognized on a straight-line basis over the weighted-average remaining service period of approximately 2.0 years, for stock awards with a service component, and less than one year for stock awards with a service and performance component. The Company utilizes newly issued shares to satisfy option exercises. No tax benefit was recognized related to stock-based compensation cost since the Company has not reported taxable income to date and has established a full valuation allowance to offset all of the potential tax benefits associated with its deferred tax assets.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation assumptions</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants RSUs to employees, directors and consultants and PSUs to employees and values these awards based on the grant date fair value, using the closing stock price of the Company&#8217;s shares on the date of the grant. Stock-based compensation expense is recognized based on awards ultimately expected to vest using actual forfeitures when incurred. The percentage achievement and vesting of PSU awards are contingent upon the achievement of predetermined tiered revenue performance goals. The Company assesses the probability of the awards expected to vest, based on the performance goals, and if probable, records compensation expense over the estimated service period. Updates to the expected probability are recorded cumulatively and remaining compensation expense, if any, is recognized over the remaining estimated service period.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to January 1, 2021, the company granted stock options to employees, directors and consultants. The fair value of each employee stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.648%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.54% &#8212; 1.69%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 &#8212; 6.08</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0% &#8212; 59.6%</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rates are based on the implied yield currently available in U.S. Treasury securities at maturity with an equivalent term. For purposes of determining the expected term of the awards in the absence of sufficient historical data relating to stock-option exercises, the Company applies a simplified approach in which the expected term of an award is presumed to be the mid-point between the vesting date and the expiration date of the award. The Company has not declared or paid any dividends and does not currently expect to do so in the foreseeable future. Expected volatility is based on the historical cumulative volatility of the Company&#8217;s stock price.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2013 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides eligible employees with an opportunity to purchase common stock from the Company and to pay for their purchases through payroll deductions. The ESPP has overlapping offering periods of approximately 12 months in length. The offering periods generally start with the first trading day on or after March&#160;1 and September&#160;1 of each year and end on the first trading day on or after March&#160;1 and September&#160;1 of the following year, approximately 12 months later. Within each offering period, shares are purchased each six months on an exercise date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An employee electing to participate in the ESPP (a &#8220;participant&#8221;) will be granted an option at the start of the offering period to purchase shares with contributions in any whole percentage ranging from 0% to 10% (or greater or lesser percentages or dollar amounts that the administrator determines) of the participant&#8217;s eligible compensation. The participant&#8217;s contributions will be accumulated and then used to purchase the Company&#8217;s shares on each exercise date. The purchase price on the exercise date will be 85% of the fair market value of the lesser of the Company&#8217;s share price on either the first trading day of the offering period or on the exercise date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, shares issued under the ESPP were 150,341, 64,809 and 89,477, respectively. The Company recorded share-based compensation expense for shares issued from the ESPP of $2.2 million, $1.3 million and $0.9 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. A total of 2,204,647 shares of common stock have been reserved for issuance under the ESPP, of which 883,793 shares were available for issuance as of December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165213728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Retirement Plan</a></td>
<td class="text">Defined Contribution Retirement PlanThe Company maintains a 401(k) defined contribution retirement plan covering substantially all of its employees. The plan provides for matching and discretionary contributions by the Company. Contributions were $2.4 million, $2.0 million and $1.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165334080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes for the years ended December&#160;31 consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,542)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,226)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,087)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,825)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our provision for income taxes for the years ended December&#160;31 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory income tax rate to the effective income tax rate for the years ended December&#160;31 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on repatriated foreign earnings and other nondeductible items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in federal and state tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option exercise windfall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RTP and other true-ups</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and foreign tax, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,613)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31,&#160;2022, for income tax return purposes the Company has gross federal and state NOL carryforwards totaling $860.1 million&#160;and tax credit carryforwards of&#160;$16.2 million. The gross federal NOL carryforwards generated during and after fiscal 2018 totaling $389.3 million are carried forward indefinitely, while all others, if not utilized, will expire beginning in 2025 through 2037. The research and development credit carryforwards generated prior to 2018 will expire beginning in 2028. The carryforwards may be subject to limitations under the Internal Revenue Code and applicable state tax law. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not expect to utilize any of its net operating loss and tax credit carryforwards in the near term. The Company may have already experienced one or more ownership changes. Depending on the timing of any future utilization of its carryforwards, the Company may be limited as to the amount that can be utilized each year as a result of such previous ownership changes. However, the Company does not believe such limitations will cause its carryforwards to expire unutilized.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes in the Company&#8217;s stock ownership as well as other changes that may be outside the Company&#8217;s control could potentially result in further limitations on the Company&#8217;s ability to utilize its net operating loss and tax credit carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of temporary differences and carryforwards that give rise to deferred tax assets and liabilities for the years ended December&#160;31 were as follows (in thousands):</span></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 capitalized costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets before allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,817)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State net operating loss adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,690)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets and liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the amounts in the income tax rate table and deferred tax assets tables above reflect reclassifications of prior year items to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a full valuation allowance related to its deferred tax assets due to the uncertainty of the ultimate realization of the future benefits from those assets. The table below summarizes changes in the deferred tax asset valuation allowance for the years ended December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of ASU 2020-06 on debt discount (equity component) deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total balance of unrecognized gross tax benefits for the years ended December&#160;31, resulting from research and development tax credits claimed on the Company&#8217;s annual tax return was as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,176&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,009&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies applicable interest and penalties on amounts due to tax authorities as a component of the provision for income taxes. The amount of accrued interest and penalties recorded in 2022, 2021 or 2020 was not significant. The Company does not anticipate that the amount of its existing unrecognized tax benefits will significantly increase or decrease within the next 12&#160;months. Due to the presence of net operating loss carryforwards in most jurisdictions, the Company&#8217;s tax years remain open for examination by U.S. taxing authorities back to 2004.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165387120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">10x Genomics</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2021, 10x Genomics, Inc. and Prognosys Biosciences, Inc., or &#8220;Prognosys&#8221;, filed a complaint, and on May 19, 2021, an amended complaint, and on May 4, 2022, a second amended complaint, against the Company in the U.S. District Court for the District of Delaware. The amended complaint alleges that certain of the Company&#8217;s products, services and components sold by the Company for use in connection with its GeoMx DSP system (the &#8220;Identified GeoMx Products&#8221;) infringe seven patents owned by Prognosys: (a) U.S. Patent No. 10,472,669, &#8220;Spatially encoded biological assays,&#8221; (b) U.S. Patent No. 10,961,566, &#8220;Spatially encoded biological assays,&#8221; (c) U.S. Patent No. 10,983,113, &#8220;Spatially encoded biological assays,&#8221; (d) U.S. Patent No. 10,996,219, &#8220;Spatially encoded biological assays,&#8221; (e) U.S. Patent No. 11,001,878, &#8220;Spatially encoded biological assays,&#8221; (f) U.S. Patent No. 11,008,607, &#8220;Spatially encoded biological assays,&#8221; and (g) U.S. Patent No. 11,293,917, &#8220;Systems for analyzing target biological molecules via sample imaging and delivery of probes to substrate well&#8221; (the &#8220;Asserted Prognosys Patents&#8221;). The amended complaint seeks, among other relief, injunctive relief and unspecified damages (including treble damages and attorneys&#8217; fees) in relation to the Company&#8217;s making, using, selling, offering to sell, exporting and/or importing in the United States the Identified GeoMx Products, as well as the alleged infringement by others of the Asserted Prognosys Patents through their use of the Identified GeoMx Products. The Company has evaluated the plaintiffs&#8217; claims and does not believe that its activities infringe any patent rights held by the plaintiffs. On November 17, 2021, the Court granted the Company&#8217;s motion to dismiss the plaintiffs&#8217; claims of pre-suit indirect infringement and willful infringement with leave to amend the complaint. Discovery is in progress. A claim construction hearing was held on February 17, 2023. A trial is scheduled for November 2023. The Company intends to vigorously defend itself in this litigation. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, 10x Genomics, Inc. and President and Fellows of Harvard College, or &#8220;Harvard&#8221;, filed a complaint, and on May 12, 2022, an amended complaint, against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that certain of the Company&#8217;s products, services and components sold by it for use in connection with its CosMx SMI system (the &#8220;Identified CosMx Products&#8221;) infringe five patents owned by Harvard: (a) U.S. Patent No. 10,227,639, &#8220;Compositions and Methods for Analyte Detection,&#8221; and (b) U.S. Patent No. 11,021,737, &#8220;Compositions and Methods for Analyte Detection,&#8221; (c) U.S. Patent No. 11,293,051, &#8220;Compositions and Methods for Analyte Detection&#8221;, (d) U.S. Patent No. 11,293,052, &#8220;Compositions and Methods for Analyte Detection,&#8221; and (e) U.S. Patent No. 11,293,054, &#8220;Compositions and Methods for Analyte Detection&#8221; (the &#8220;U.S. 10x CosMx Case&#8221;). The complaint seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees) in relation to the Company&#8217;s making, using, selling, offering to sell, exporting and/or importing in the United States the Identified CosMx Products. The Company has evaluated the plaintiffs&#8217; claims and does not believe that its activities infringe any patent rights held by the plaintiffs. Discovery is in progress. A claim construction hearing is scheduled for July 2023 and a trial is scheduled for June 2024. The Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intends to vigorously defend itself in this litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. On August 16, 2022, the Company filed counterclaims in this action alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe the Company&#8217;s U.S. Patent No. 11,377,689, &#8220;Chemical Compositions and Uses Thereof.&#8221; On January 24, 2023, these counterclaims were consolidated with the claims of a separate patent infringement case that the Company filed against 10x Genomics on October 20, 2022, as discussed below.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, the Company was notified of a complaint, dated March 4, 2022, naming the Company and its wholly-owned subsidiary, NanoString Technologies Germany GmbH, which 10x Genomics, Inc. filed in the Munich Regional Court I in Germany, alleging that the Company&#8217;s CosMx SMI system and associated products and services infringe European Patent No. 2794928B1, or &#8220;EP 2794928B1&#8221;, which is owned by Harvard. The complaint seeks, among other relief, injunctive relief and damages in relation to the Company's selling and offering to sell its CosMx SMI system and associated products and services in Germany. The Company has evaluated the claims and does not believe that its activities infringe any patent rights held by 10x or Harvard. A hearing is scheduled for March 2023 in this proceeding. The Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intends to vigorously defend itself in this litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. On July 29, 2022, the Company, through its German subsidiary, filed a nullity action with the German Federal Patent Court in Munich requesting a judgment that EP 2794928B1, as in effect for Germany, be declared invalid and be revoked in its entirety. On February 10, 2023, the German Federal Patent Court issued a preliminary and non-binding opinion in this nullity action finding that the subject matter of the asserted independent claim 1 of EP 2794928B1 potentially lacked novelty and lacked an inventive step over prior art. The preliminary opinion further addressed Harvard&#8217;s seven patent claim limitation requests, referred to as auxiliary requests, which 10x and Harvard seek to have applied in the event that claim 1 of EP 2794928B1, as granted, proves not to be protectable. The preliminary opinion stated that the claim limitations in Auxiliary Request 1 could potentially be used to defend EP 2794928B1 over the cited prior art. The preliminary opinion further stated that Harvard would potentially not be able to use Auxiliary Requests 2 through 7 to establish novelty over the prior art. A hearing before the German Federal Patent Court is scheduled for May 2024 and a decision in the nullity action is expected following the hearing.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2022, the Company filed suit against 10x Genomics, Inc. in the U.S. District Court for the District of Delaware alleging that 10x Genomics&#8217; Visium Spatial Gene Expression system and related products and services infringe the Company's U.S. Patent No. 11,473,142, &#8220;Chemical Compositions and Uses Thereof.&#8221; On January 24, 2023, the Company&#8217;s claims from the U.S.10x CosMx Case with respect to U.S. Patent No. 11,377,689 were consolidated with the claims in this action. The Company seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#8217; fees) in relation to 10x Genomics&#8217; making, using, selling, offering to sell, exporting and/or importing in the United States the Visium system and related products and services. Discovery is in progress. A case schedule has not yet been set.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the pending litigations with 10x Genomics and its co-plaintiffs, the Company is not engaged in any material legal proceedings. The Company is involved in other legal proceedings from time to time arising in the normal course of business. Additionally, the Company operates in various states and local jurisdictions for which sales, occupation, or franchise taxes may be payable to certain taxing authorities. Management believes that the outcome of these proceedings and any amounts that may become payable to certain taxing authorities will not have a material impact on the Company&#8217;s financial condition, results of operations, or liquidity.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022 the Company has non-cancellable purchase obligations of $70.0 million related to binding commitments to purchase inventory and other research and development items, $62.1 million of which is due within the next 12 months. In addition, the Company has construction contracts, associated with one of its Seattle area facilities, of $5.0 million, which is due within the next 12 months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165137056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding. Outstanding stock options, restricted stock units and common stock warrants have not been included in the calculation of diluted net loss per share because to do so would be anti-dilutive. Accordingly, the numerator and the denominator used in computing both basic and diluted net loss per share for each period are the same.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock participating securities as of December&#160;31 were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165277120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsIn February 2023, the Company&#8217;s board of directors approved an amendment to the 2018 Inducement Equity Incentive Plan to increase the number of shares of the Company&#8217;s common stock available for issuance under the plan for equity awards granted from 250,000 shares to 425,000 shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170521824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Accounting Principles and Principles of Consolidation</a></td>
<td class="text">The consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying consolidated financial statements reflect the accounts of the Company and its wholly-owned subsidiaries. Each of the subsidiaries operates as a sales and support office. The functional currency of each subsidiary is the U.S. dollar. All significant intercompany balances and transactions have been eliminated.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and that affect the reported amounts of revenue and expenditures during the reporting period. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying consolidated financial statements include the estimation of stand-alone selling prices for its products and services, the estimation of the valuation of inventory, the estimates used in the valuation allowance for deferred tax assets and uncertain tax positions, and estimates used in certain of the inputs and calculations associated with stock-based compensation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">The Company considers all highly-liquid investments with purchased maturities of three&#160;months or less to be cash equivalents. The Company&#8217;s cash equivalents consist principally of funds maintained in depository accounts. The Company invests its cash and cash equivalents with major financial institutions; at times these investments exceed federally insured limits. Restricted cash consists of customer deposits which are secured through letters of credit until performance obligations have been met.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its debt securities as available-for-sale, which are reported at estimated fair value with unrealized gains and losses included in accumulated other comprehensive loss in stockholders&#8217; equity. Realized gains, realized losses and allowance for estimated credit losses are included in other expense, net. The cost of investments for purposes of computing realized and unrealized gains and losses is based on the specific identification method. Amortization of premiums and accretion of discounts are included in other expense, net. Interest and dividends earned on all securities are included in other expense, net.&#160;Investments in debt securities with maturities of less than one year, or where management&#8217;s intent is to use the investments to fund current operations, or to make them available for current operations, are classified as short-term investments.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments are presented net of an allowance for expected credit losses that are remeasured each period and any impairment recognized as an expense. The Company has considered all information and factors and noted no indicators that a credit loss exists as of December 31, 2022. The Company has not experienced any significant investment credit losses to date. Accrued interest receivable is included in prepaid and other current assets and was $0.9 million and $0.8 million as of December 31, 2022 and 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">Accounts receivable are stated net of an allowance for credit losses. The Company uses available information over the life of the receivables including analysis of past credit losses, recoveries of past credit losses, management&#8217;s expectations of future economic positions, as well as market conditions and other extenuating factors to support the allowance estimate.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risks</a></td>
<td class="text">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. Cash is invested in accordance with the Company&#8217;s investment policy, which includes guidelines intended to minimize and diversify credit risk. Most of the Company&#8217;s investments are not federally insured. The Company has credit risk related to the collectability of its accounts receivable. The Company performs initial and ongoing evaluations of its customers&#8217; credit history or financial position and generally extends credit on account without collateral.The Company is also subject to supply chain risks related to the outsourcing of the manufacturing and production of its instruments to sole suppliers. Although there are a limited number of manufacturers for instruments of this type, the Company believes that other suppliers could provide similar products on comparable terms. Similarly, the Company sources certain raw materials used in the manufacture of consumables from certain sole suppliers. A change in suppliers, however, could cause a delay in manufacturing and a possible loss of sales, which would adversely affect operating results.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text">The recorded amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities. Investments that are classified as available-for-sale are recorded at fair value. The fair value for investment securities held and for convertible senior notes are determined using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventory consists of finished goods, raw materials, including certain intermediate manufactured items, and certain component parts to be used in manufacturing or servicing the Company&#8217;s products. Inventory is stated at the lower of cost or net realizable value. Cost is determined using a standard cost system, whereby the standard costs are updated periodically to reflect current costs and market represents the lower of cost or market (replacement cost or estimated net realizable value). The Company&#8217;s policy is to establish inventory reserves when conditions exist that suggest that inventory may be in excess of anticipated demand, obsolete, slow moving or impaired. In the event that the Company identifies these conditions exist in its inventory, its carrying value is reduced to its net realizable value.The Company outsources the manufacturing of its instruments to third-party contract manufacturers who manufacture them to certain specifications and source certain raw materials from sole source providers. Major delays in shipments, inferior quality, insufficient quantity or any combination of these or other factors may harm the Company&#8217;s business and results of operations. In addition, the inability of one or more of these suppliers to provide the Company with an adequate supply of its products or raw materials or the loss of one or more of these suppliers may cause a delay in the Company&#8217;s ability to fulfill orders while it obtains a replacement supplier and may harm the Company&#8217;s business and results of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets. Expenditures for additions are capitalized and expenditures for maintenance and repairs are expensed as incurred. Gains and losses from the disposal of property and equipment are reflected in the consolidated statements of operations in the period of disposition.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prototype systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or lease term</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases and Leasehold Improvements</a></td>
<td class="text">The Company determines if an arrangement is a lease at inception of a contract. The Company&#8217;s leasing portfolio is comprised of operating and finance leases primarily for general office, manufacturing, and research and development purposes. Operating and finance lease liabilities and the corresponding right-of-use assets are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Operating lease right-of-use assets are reduced by lease incentives included in the agreement. As the existing leases do not contain an implicit interest rate, the Company estimates its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The Company includes options to extend the lease in the lease liability and right-of-use asset when it is reasonably certain that the option will be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company elected, as an accounting policy election, to use the short-term lease recognition exemption on all classes of assets. Leases with an initial term of 12 months or less are not recorded on the balance sheet and the Company recognizes lease payments as an expense on a straight-line basis over the lease term. The Company has lease office agreements with lease and non-lease components, which are generally accounted for separately. For lease equipment agreements, the Company accounts for the lease and non-lease components as a single lease component. The Company&#8217;s lease agreements do not contain any material variable lease payments, material residual value guarantees or, any material restrictive covenants.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">The Company recognizes impairment losses on long-lived assets when indicators of impairment are present and the anticipated undiscounted cash flows to be generated by those assets are less than the asset&#8217;s carrying values. The Company has not experienced material impairment losses on its long-lived assets during the periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt, Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted &#8220;ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-06&#8221;) effective January 1, 2021. The Company uses the if-converted method for purposes of calculating dilutive earnings per share, if the Convertible Notes are dilutive during the period. In connection with the issuance of the Convertible Notes, the Company incurred certain financing costs associated directly with the issuance of the Convertible Notes. These issuance costs were deferred and are amortized to </span>interest expense over five years using the effective interest method.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text">Operating segments are defined as components of an entity for which separate financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company&#8217;s chief operating decision maker is the chief executive officer, who manages the operations and evaluates the financial performance on a total Company basis. The Company&#8217;s principal operations and decision-making functions are located at its corporate headquarters in the United States and the Company operates as a single operating and reporting segment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the promised goods or services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of a product or service to the customer, meaning the customer has the ability to use and obtain the benefit of the product or service. The Company recognizes revenue for satisfied performance obligations only when there are no uncertainties regarding payment terms or transfer of control.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically generated the majority of its revenue from sales of its proprietary GeoMx DSP system and nCounter Analysis System, and related consumables. Services consist of instrument service contracts for maintenance, repair and other support related to customer owned instruments, and also certain service fees for assay processing and data analysis and reporting. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from instruments and consumables is generally recognized upon shipment to the end customer, which is when control of the product has been transferred to the customer. Performance obligations related to instrument sales are reviewed on a contract-by-contract basis, as individual contract terms may vary and revenue is recognized as performance obligations are satisfied. Performance obligations for consumable products are generally completed upon shipment to the customer. While the Company typically completes installation and training of its customers with field-based service personnel, these services can also be provided by distribution partners and other third parties.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument service contracts are sold with contract terms ranging from 12-36 months and cover periods after the end of the initial 12-month warranty. These contracts include services to maintain performance within the Company&#8217;s designed specifications and allow the customer to receive certain preventative maintenance service procedures during the contract term. Revenue from services to maintain designed specifications is considered a stand-ready obligation and recognized evenly over the contract term and service revenue related to preventative maintenance of instruments is recognized when the procedure is completed. Revenue from service fees for assay processing is recognized upon the rendering of the related performance obligation which is typically the delivery of data and analysis of the samples that have been processed.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements with multiple performance obligations, the Company allocates the contract price in proportion to each performance obligation&#8217;s relative stand-alone selling price. The Company frequently sells bundles of systems and consumables and, in such instances, uses its best estimate of selling price for its products based on historical sales or similar products. For service, the best estimate of selling price is based on historical stand-alone sales, as stand-alone sales data for services are more readily available. The Company reviews its stand-alone prices at least annually or more frequently if facts and circumstances significantly change.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally recognizes expense related to the acquisition of contracts, such as sales commissions, at the time of revenue recognition, which is generally in the same period products are sold, and in the case of services, revenue is recognized as services are rendered or over the period of time covered by the service contract. The Company records commission expenses within selling, general and administrative expenses.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales to customers through distributors are recognized consistent with the policies and practices for direct sales to customers, as described above.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text">Cost of product revenue consists primarily of costs incurred in the production process, including costs of purchasing instruments from third-party contract manufacturers, consumable component materials and assembly labor and overhead, installation, and packaging and delivery costs. In addition, cost of product revenue includes royalty costs for licensed technologies included in the Company&#8217;s products, provisions for slow-moving and obsolete inventory and stock-based compensation expense. Cost of product revenue for instruments and consumables is recognized in the period the related revenue is recognized. Shipping and handling costs incurred for product shipments are included in cost of product revenue in the consolidated statements of operations.Cost of service revenue consists primarily of field service technicians and the cost of providing repair and maintenance services including parts used in performing those services for instruments covered under warranty and service contracts. In addition, cost of service revenue includes lab personnel labor and overhead, stock-based compensation and materials used in performing data analysis services. Cost of service revenue is recognized in the period the services are performed.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Reserve for Product Warranties</a></td>
<td class="text">The Company generally provides a one-year warranty on both its nCounter Analysis Systems and GeoMx DSP instruments, and establishes a reserve for future warranty costs based on historical product failure rates and actual warranty costs incurred. Warranty expense is recorded as a component of cost of service revenue in the consolidated statements of operations. Warranty reserves were $1.0 million and $1.2 million as of December 31, 2022 and 2021, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">Research and development expenses, consisting primarily of salaries and benefits, stock-based compensation expense, occupancy costs, laboratory supplies, contracted services, and consulting fees are expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative</a></td>
<td class="text">Selling expenses consist primarily of personnel related costs for sales and marketing, contracted services, and service fees and are expensed as the related costs are incurred. Advertising costs are expensed as incurred and are included in sales and marketing expenses.General and administrative expenses consist primarily of personnel related costs for the Company&#8217;s finance, human resources, business development, legal, information technology and general management, as well as professional fees for legal, accounting and other consulting services. General and administrative expenses are expensed as they are incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the liability method. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether a tax position is more likely than not to be sustained upon examination based on the technical merits of the position. For tax positions meeting the more-likely-than-not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">The Company accounts for stock-based compensation under the fair value method. Stock-based compensation costs related to restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;) which are granted by the Company are calculated using the grant-date fair value using the intrinsic method and for stock options granted in prior years, stock-based compensation was estimated using the Black-Scholes option pricing model. Stock-based compensation expense is recognized based on the number of awards ultimately expected to vest, using actual forfeitures when incurred. The Company uses the straight-line attribution method over the vesting period for recognizing compensation expense for awards with a service condition. For awards with service and performance conditions, the accelerated recognition method is used over the graded vesting schedules for the awards.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Guarantees and Indemnifications</a></td>
<td class="text">In the normal course of business, the Company guarantees and/or indemnifies other parties, including vendors, lessors and parties to transactions with the Company, with respect to certain matters. The Company has agreed to hold the other parties harmless against losses arising from breach of representations or covenants, or out of intellectual property infringement or other claims made against certain parties. It is not possible to determine the maximum potential amount the Company could be required to pay under these indemnification agreements, since the Company has not had any prior indemnification claims, and each claim would be based upon the unique facts and circumstances of the claim and the particular provisions of each agreement. In the opinion of management, any such claims would not be expected to have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition or cash flows. The Company did not have any related liabilities recorded at December&#160;31, 2022 and 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive loss includes certain changes in equity that are excluded from net loss. Specifically, unrealized gains and losses on available-for-sale debt securities are included in comprehensive (income) loss.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a financial liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is used to measure fair value. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div>The recorded amounts of certain financial instruments, including cash, accounts receivable, prepaid expenses and other, accounts payable and accrued liabilities, approximate fair value due to their relatively short-term maturities. The recorded amount of the Company&#8217;s long-term debt can be determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market, which are classified as a Level 2 financial instrument.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding. Outstanding stock options, restricted stock units and common stock warrants have not been included in the calculation of diluted net loss per share because to do so would be anti-dilutive. Accordingly, the numerator and the denominator used in computing both basic and diluted net loss per share for each period are the same.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy</a></td>
<td class="text">The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary balance sheet accounts are remeasured using exchange rates in effect at the balance sheet dates and non-monetary items are remeasured at historical exchange rates. Expenses are generally remeasured at the average exchange rates for the period.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal Use Software, Policy</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain development costs incurred in connection with software development for internal-use software platforms used in operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once software has reached the development stage, internal and external costs, if direct, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over the estimated useful life of the software platforms and are included in depreciation and amortization expense within operating expenses in our consolidated statements of operations. Unamortized capitalized internal-use software development costs were $11.8 million and $4.0 million as of December 31, 2022 and 2021, respectively. Amortization of capitalized internal-use software costs was $0.3 million for the year ending December 31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs associated with the implementation of hosted third-party cloud computing arrangements are recorded as part of current and long-term other assets. Maintenance and training costs are expensed as incurred and are expensed on a straight-line basis over the term of the related hosting arrangement. Costs are recorded within the consolidated statements of operations based on the functional use of the software. Unamortized capitalized software implementation costs were $1.9 million and $3.2 million as of December 31, 2022 and 2021, respectively. Amortization and write-down of capitalized software implementation costs of hosted third-party cloud computing arrangements was $1.3 million and $0.3 million for the years ending December 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification, Comparability Adjustment</a></td>
<td class="text">ReclassificationsCertain prior year amounts related to inventory categories have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations, financial position or cash flows from operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165164240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a financial liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is used to measure fair value. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div>The recorded amounts of certain financial instruments, including cash, accounts receivable, prepaid expenses and other, accounts payable and accrued liabilities, approximate fair value due to their relatively short-term maturities. The recorded amount of the Company&#8217;s long-term debt can be determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market, which are classified as a Level 2 financial instrument.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160966096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about disaggregated revenue by major product line and primary geographic market (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.725%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe and Middle East</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,959&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.725%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe and Middle East</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,085&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.725%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Europe and Middle East</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,632&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,316&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue in the United States was $79.5 million, $91.0 million and $77.5 million for the years ended December 31, 2022, 2021 and 2020, respectively. The Company&#8217;s long-lived assets are primarily located in the United States and not allocated to any specific geographic region.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166651072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Short-Term Investments Available-for-Sale Securities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consisted of available-for-sale and equity securities as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized&#160;cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized&#160;cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair&#160;value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Fair Values of Available-for-Sale Securities by Contractual Maturity</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of available-for-sale debt securities by contractual maturity at December&#160;31 were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one to three years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes investments that have been in a continuous unrealized loss position as of December&#160;31, 2022 (in thousands).</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,061&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810247652336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Company's Available-for-Sale Securities by Level within Fair Value Hierarchy</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments by level within the fair value hierarchy were as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2022</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value measurement using:</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market fund</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,576&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of securities as of December 31, 2021</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value measurement using:</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market fund</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-related debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166679312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of the Company&#8217;s lease cost (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases for the year ended December 31 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.399%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Operating Lease Payments</a></td>
<td class="text"><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5">Total</span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Summary of Finance Lease Payments</a></td>
<td class="text"><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:7pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5">Total</span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165329920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intermediate manufactured components</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,273&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165353136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful&#160;Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prototype instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,457&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166876848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term debt and lease financing obligations</a></td>
<td class="text">The outstanding balance of the Company&#8217;s Convertible Notes consisted of the following at December&#160;31 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal of Convertible Note</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Interest Expense</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Convertible Notes (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,547&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810171283296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity and Related Information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s stock option activity under the Plans is as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average exercise<br/>price per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average remaining<br/>contractual<br/>term (in&#160;years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic value<br/>(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,017,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Company's Options Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the Company&#8217;s stock options outstanding at December&#160;31, 2022:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.92 &#8211; $12.56</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.77 &#8211;&#160;$14.99</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.21 &#8211;&#160;$18.55</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.68 &#8211;&#160;$22.71</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.00 &#8211;&#160;$66.91</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,860&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Stock Compensation Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth stock-based compensation expense related to stock-based arrangements under the Plans as presented within the consolidated statement of operations for the years ended December&#160;31 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Employee Option Grant</a></td>
<td class="text">The fair value of each employee stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.648%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.54% &#8212; 1.69%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 &#8212; 6.08</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0% &#8212; 59.6%</span></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160801936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Loss Before Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes for the years ended December&#160;31 consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,542)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,226)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,087)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,825)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Significant Components of our Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our provision for income taxes for the years ended December&#160;31 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory income tax rate to the effective income tax rate for the years ended December&#160;31 are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on repatriated foreign earnings and other nondeductible items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in federal and state tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option exercise windfall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RTP and other true-ups</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and foreign tax, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,613)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Effect of Temporary Differences and Carryforwards</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of temporary differences and carryforwards that give rise to deferred tax assets and liabilities for the years ended December&#160;31 were as follows (in thousands):</span></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 capitalized costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets before allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,817)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State net operating loss adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,690)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets and liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock', window );">Summary of Changes in Deferred Tax Asset Valuation Allowance</a></td>
<td class="text">The table below summarizes changes in the deferred tax asset valuation allowance for the years ended December&#160;31 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of ASU 2020-06 on debt discount (equity component) deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total balance of unrecognized gross tax benefits for the years ended December&#160;31, resulting from research and development tax credits claimed on the Company&#8217;s annual tax return was as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,176&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,009&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Deferred Tax Assets Valuation Allowance Table [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Effects Of Temporary Differences That Give Rise To Deferred Tax Assets And Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160597376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Shares Excluded from Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock participating securities as of December&#160;31 were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165149152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>platform</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_NumberOfPlatforms', window );">Number of platforms</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_NumberOfPlatforms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Platforms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_NumberOfPlatforms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160371696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory reserves</a></td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets, finite lived</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves', window );">Warranty reserve</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ProductWarrantyAccrualPeriod', window );">Product warranty accrual period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_StandardProductWarrantyPeriod', window );">Standard warranty period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">$ (45,814,000)<span></span>
</td>
<td class="num">(176,962,000)<span></span>
</td>
<td class="num">(306,948,000)<span></span>
</td>
<td class="num">$ (104,151,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(809,296,000)<span></span>
</td>
<td class="num">(649,753,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest Receivable</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized Computer Software, Amortization</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(855,694,000)<span></span>
</td>
<td class="num">(827,028,000)<span></span>
</td>
<td class="num">(848,891,000)<span></span>
</td>
<td class="num">$ (535,954,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,012,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,543,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized Computer Software, Amortization</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized Computer Software, Net</a></td>
<td class="nump">11,800,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized Computer Software, Net</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_ManufacturingEquipmentMember', window );">Manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of the assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_PrototypeSystemsMember', window );">Prototype Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of the assets</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Capitalized software and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of the assets</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of the assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ExtendedProductWarrantyPeriod', window );">Extended warranty period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ExtendedProductWarrantyPeriod', window );">Extended warranty period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ExtendedProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The extended product warranty liability period. Does not include increases or decreases in the standard warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ExtendedProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ProductWarrantyAccrualPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of accrual amount as of the balance sheet date of the aggregate extended product warranty liability is amortized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ProductWarrantyAccrualPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_StandardProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The standard product warranty liability period. Does not include increases or decreases in an extended warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_StandardProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_PrototypeSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_PrototypeSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170245136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 127,262<span></span>
</td>
<td class="nump">$ 145,085<span></span>
</td>
<td class="nump">$ 117,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent', window );">Customer deposits</a></td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">10,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Performance obligation satisfied in previous period</a></td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">$ 14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms', window );">Revenue, Performance Obligation, Description of Payment Terms</a></td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Proceeds from Customers</a></td>
<td class="nump">$ 15,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">79,500<span></span>
</td>
<td class="nump">$ 91,000<span></span>
</td>
<td class="nump">$ 77,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities</a></td>
<td class="num">$ (3,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Customer Deposits, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810161166432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers Schedule of Disaggregated Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 127,262<span></span>
</td>
<td class="nump">$ 145,085<span></span>
</td>
<td class="nump">$ 117,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nstg_ProductInstrumentsMember', window );">Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">37,589<span></span>
</td>
<td class="nump">55,616<span></span>
</td>
<td class="nump">47,830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nstg_ProductConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">70,367<span></span>
</td>
<td class="nump">71,846<span></span>
</td>
<td class="nump">50,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">107,956<span></span>
</td>
<td class="nump">127,462<span></span>
</td>
<td class="nump">97,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">19,306<span></span>
</td>
<td class="nump">17,623<span></span>
</td>
<td class="nump">19,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nstg_ProductAndServiceMember', window );">Total product and service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">127,262<span></span>
</td>
<td class="nump">145,085<span></span>
</td>
<td class="nump">117,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">21,989<span></span>
</td>
<td class="nump">31,467<span></span>
</td>
<td class="nump">30,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">47,566<span></span>
</td>
<td class="nump">50,421<span></span>
</td>
<td class="nump">34,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">69,555<span></span>
</td>
<td class="nump">81,888<span></span>
</td>
<td class="nump">64,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">13,404<span></span>
</td>
<td class="nump">12,472<span></span>
</td>
<td class="nump">14,849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Total product and service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">82,959<span></span>
</td>
<td class="nump">94,360<span></span>
</td>
<td class="nump">79,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">6,054<span></span>
</td>
<td class="nump">9,312<span></span>
</td>
<td class="nump">6,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">3,938<span></span>
</td>
<td class="nump">5,209<span></span>
</td>
<td class="nump">2,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">9,992<span></span>
</td>
<td class="nump">14,521<span></span>
</td>
<td class="nump">9,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,090<span></span>
</td>
<td class="nump">1,034<span></span>
</td>
<td class="nump">980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Total product and service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">11,082<span></span>
</td>
<td class="nump">15,555<span></span>
</td>
<td class="nump">10,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe and Middle East | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">9,546<span></span>
</td>
<td class="nump">14,837<span></span>
</td>
<td class="nump">11,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe and Middle East | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">18,863<span></span>
</td>
<td class="nump">16,216<span></span>
</td>
<td class="nump">12,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe and Middle East | Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">28,409<span></span>
</td>
<td class="nump">31,053<span></span>
</td>
<td class="nump">23,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe and Middle East | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">4,812<span></span>
</td>
<td class="nump">4,117<span></span>
</td>
<td class="nump">3,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe and Middle East | Total product and service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 33,221<span></span>
</td>
<td class="nump">$ 35,170<span></span>
</td>
<td class="nump">$ 26,897<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nstg_ProductInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nstg_ProductInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nstg_ProductConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nstg_ProductConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nstg_ProductAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nstg_ProductAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810171396608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term Investments - Available-for-Sale Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;cost</a></td>
<td class="nump">$ 84,871<span></span>
</td>
<td class="nump">$ 242,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(589)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair&#160;value</a></td>
<td class="nump">84,282<span></span>
</td>
<td class="nump">241,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</a></td>
<td class="nump">14,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</a></td>
<td class="nump">66,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</a></td>
<td class="num">(521)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Debt Securities, Available-for-sale, Unrealized Loss Position</a></td>
<td class="nump">80,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(589)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;cost</a></td>
<td class="nump">62,862<span></span>
</td>
<td class="nump">177,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(359)<span></span>
</td>
<td class="num">(195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair&#160;value</a></td>
<td class="nump">62,503<span></span>
</td>
<td class="nump">177,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</a></td>
<td class="nump">10,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</a></td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</a></td>
<td class="nump">48,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</a></td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Debt Securities, Available-for-sale, Unrealized Loss Position</a></td>
<td class="nump">58,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government-related debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;cost</a></td>
<td class="nump">22,009<span></span>
</td>
<td class="nump">33,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(230)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair&#160;value</a></td>
<td class="nump">21,779<span></span>
</td>
<td class="nump">33,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair&#160;value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">US Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</a></td>
<td class="nump">3,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</a></td>
<td class="nump">17,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</a></td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Debt Securities, Available-for-sale, Unrealized Loss Position</a></td>
<td class="nump">21,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">$ (230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166554912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term Investments - Fair Values of Available-for-Sale Securities by Contractual Maturity (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Maturing in one year or less</a></td>
<td class="nump">$ 81,004<span></span>
</td>
<td class="nump">$ 174,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Maturing in one to three years</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="nump">67,287<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total available-for-sale debt securities</a></td>
<td class="nump">$ 84,282<span></span>
</td>
<td class="nump">$ 241,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after one through three years fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810164461984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Company's Available-for-Sale Securities by Level within Fair Value Hierarchy (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">$ 84,282<span></span>
</td>
<td class="nump">$ 241,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">188,576<span></span>
</td>
<td class="nump">340,068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">62,503<span></span>
</td>
<td class="nump">177,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government-related debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">21,779<span></span>
</td>
<td class="nump">33,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue', window );">Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">104,294<span></span>
</td>
<td class="nump">98,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">104,294<span></span>
</td>
<td class="nump">98,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. government-related debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue', window );">Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">104,294<span></span>
</td>
<td class="nump">98,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">84,282<span></span>
</td>
<td class="nump">241,821<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">62,503<span></span>
</td>
<td class="nump">177,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. government-related debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">21,779<span></span>
</td>
<td class="nump">33,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue', window );">Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | U.S. government-related debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue', window );">Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Money market fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value as of the balance sheet date of firm holdings in mortgages, mortgage backed securities (investment instruments that represent ownership of an undivided interest in a group of mortgages, where principal and interest from the individual mortgages are used to pay investors' principal and interest on the mortgage backed security) and asset-backed securities that are primarily paid from the cash flows of a discrete pool of receivables or other financial assets (such as credit-card receivables), either fixed or revolving, that by their terms convert into cash within a finite time period. Includes both pledged (to counterparties as collateral for financing transactions) and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42546-110969<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166994928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt instrument, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_TermLoanAgreementMember', window );">Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 88.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810161430768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>Lease</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_NumberOfOperatingLeases', window );">Number of operating leases | Lease</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_AreaOfSpaceUnderLease', window );">Area under lease | ft&#178;</a></td>
<td class="nump">162,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease cost</a></td>
<td class="nump">$ 5,572<span></span>
</td>
<td class="nump">$ 5,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 5,911<span></span>
</td>
<td class="nump">$ 5,488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_AreaOfSpaceUnderLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area Of Space Under Lease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_AreaOfSpaceUnderLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_NumberOfOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_NumberOfOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810164504144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Lease Cost and Other Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 6,983,000<span></span>
</td>
<td class="nump">$ 6,276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">333,000<span></span>
</td>
<td class="nump">236,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">2,126,000<span></span>
</td>
<td class="nump">929,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 448,000<span></span>
</td>
<td class="nump">$ 524,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">7.30%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170582848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">$ (10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Deferred revenue and other liabilities, net of current portion<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total</a></td>
<td class="nump">$ 326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">6,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">6,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">7,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">2,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">1,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">4,660<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">29,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(5,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 23,880<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166542528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Schedule of Inventory (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 11,013<span></span>
</td>
<td class="nump">$ 5,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Intermediate manufactured components</a></td>
<td class="nump">14,715<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">17,545<span></span>
</td>
<td class="nump">14,614<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 43,273<span></span>
</td>
<td class="nump">$ 31,486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160198464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 80,690<span></span>
</td>
<td class="nump">$ 55,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(36,233)<span></span>
</td>
<td class="num">(28,460)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 44,457<span></span>
</td>
<td class="nump">27,043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_ManufacturingEquipmentMember', window );">Manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful&#160;Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 22,094<span></span>
</td>
<td class="nump">19,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_PrototypesAndOtherEquipmentMember', window );">Prototype instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful&#160;Life (Years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 10,421<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Capitalized software and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful&#160;Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 18,670<span></span>
</td>
<td class="nump">5,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful&#160;Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,153<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">20,297<span></span>
</td>
<td class="nump">19,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 7,055<span></span>
</td>
<td class="nump">$ 7,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_PrototypesAndOtherEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nstg_PrototypesAndOtherEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810165142896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810159106656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,535<span></span>
</td>
<td class="nump">$ 7,490<span></span>
</td>
<td class="nump">$ 15,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,622<span></span>
</td>
<td class="nump">225,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
<td class="nump">4,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_TermLoanAgreementMember', window );">Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 88,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="nump">15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_SecuredRevolvingLoanFacilityMember', window );">Secured Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_ExtinguishmentOfDebtTerminationFee', window );">Extinguishment of debt, termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_OutstandingPrincipalOfConvertibleDebt', window );">Outstanding Principal Of Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="nump">$ 222,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt instrument conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Percentage of redemption fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Senior Notes | Convertible Debt Triggering Event 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Senior Notes | Convertible Debt Triggering Event 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ExtinguishmentOfDebtTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extinguishment Of Debt, Termination Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ExtinguishmentOfDebtTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_OutstandingPrincipalOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding Principal Of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_OutstandingPrincipalOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_SecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_SecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ConvertibleDebtTermsAxis=nstg_ConvertibleDebtTriggeringEvent1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ConvertibleDebtTermsAxis=nstg_ConvertibleDebtTriggeringEvent1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_ConvertibleDebtTermsAxis=nstg_ConvertibleDebtTriggeringEvent2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_ConvertibleDebtTermsAxis=nstg_ConvertibleDebtTriggeringEvent2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166526224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Long-term debt and lease financing obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 3,378<span></span>
</td>
<td class="nump">$ 4,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt, net</a></td>
<td class="nump">226,622<span></span>
</td>
<td class="nump">225,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_OutstandingPrincipalOfConvertibleDebt', window );">Outstanding Principal Of Convertible Debt</a></td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_OutstandingPrincipalOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding Principal Of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_OutstandingPrincipalOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810250144176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Interest Expense (Details) - Convertible Senior Notes Due 2025 - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="nump">$ 6,038,000<span></span>
</td>
<td class="nump">$ 6,038,000<span></span>
</td>
<td class="nump">$ 4,897,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_AmortizationOfDebtDiscountAndIssuanceCosts', window );">Amortization of issuance costs</a></td>
<td class="nump">1,477,000<span></span>
</td>
<td class="nump">1,429,000<span></span>
</td>
<td class="nump">8,650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="nump">$ 7,515,000<span></span>
</td>
<td class="nump">$ 7,467,000<span></span>
</td>
<td class="nump">$ 13,547,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_AmortizationOfDebtDiscountAndIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Discount And Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_AmortizationOfDebtDiscountAndIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nstg_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170405104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Preferred Stock - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 215,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Overallotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of Stock, Number of Shares Issued in Transaction</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=nstg_PublicStockOfferingMember', window );">Public Stock Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from underwritten public offering after fees and commissions</a></td>
<td class="nump">$ 215,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of Stock, Number of Shares Issued in Transaction</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction', window );">Sale Of Stock, Gross Consideration Received On Transaction</a></td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_SaleOfStockGrossConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Gross Consideration Received On Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_SaleOfStockGrossConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=nstg_PublicStockOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=nstg_PublicStockOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160138144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under the Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value for options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 26,900,000<span></span>
</td>
<td class="nump">$ 39,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit recognized related to share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,908,000<span></span>
</td>
<td class="nump">30,173,000<span></span>
</td>
<td class="nump">19,374,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Share-based Payment Arrangement, Plan Modification, Incremental Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember', window );">2004 Stock Option Plan and 2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under the Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,057,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock options grant period, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,600,000<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">759,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nstg_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EmployeeStockPurchasePlanOfferingPeriod', window );">Length of offering period, in months</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EmployeeStockPurchasePlanPurchasePeriod', window );">Length of purchase periods, in months</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price percentage of fair market value of shares</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,341<span></span>
</td>
<td class="nump">64,809<span></span>
</td>
<td class="nump">89,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,204,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nstg_EmployeeStockPurchasePlanMember', window );">ESPP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EmployeeStockPurchasePlanContributionPercentage', window );">Contribution percentage of purchase shares on participants eligible compensation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nstg_EmployeeStockPurchasePlanMember', window );">ESPP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EmployeeStockPurchasePlanContributionPercentage', window );">Contribution percentage of purchase shares on participants eligible compensation</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nstg_ServiceComponentMember', window );">Service component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, weighted-average recognized period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nstg_ServiceAndPerformanceComponentsMember', window );">Service and Performance components</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, weighted-average recognized period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options vesting period and exercisable period, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_EmployeeStockPurchasePlanContributionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan Contribution Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_EmployeeStockPurchasePlanContributionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_EmployeeStockPurchasePlanOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_EmployeeStockPurchasePlanOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_EmployeeStockPurchasePlanPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan Purchase Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_EmployeeStockPurchasePlanPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nstg_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nstg_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nstg_ServiceComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nstg_ServiceComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nstg_ServiceAndPerformanceComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nstg_ServiceAndPerformanceComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160849920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Stock Option Activity and Related Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December&#160;31, 2015 (in shares)</a></td>
<td class="nump">2,017,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="num">(122,304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(128,627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December&#160;31, 2016 (in shares)</a></td>
<td class="nump">1,766,860<span></span>
</td>
<td class="nump">2,017,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest at December 31, 2016 (in shares)</a></td>
<td class="nump">1,766,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at December 31, 2016 (in shares)</a></td>
<td class="nump">1,682,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- average exercise price per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December&#160;31, 2015 (in dollars per share)</a></td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in dollars per share)</a></td>
<td class="nump">21.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">11.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December&#160;31, 2016 (in dollars per share)</a></td>
<td class="nump">17.01<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest at December 31, 2016 (in dollars per share)</a></td>
<td class="nump">17.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options exercisable at December 31, 2016 (in dollars per share)</a></td>
<td class="nump">$ 16.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract', window );"><strong>Weighted- average remaining contractual term (in&#160;years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest as December 31, 2016</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at December 31, 2016</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Aggregate intrinsic value (in&#160;thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">$ 51,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested and expected to vest at December 31, 2016</a></td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at December 31, 2016</a></td>
<td class="nump">$ 265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options Outstanding, Weighted Average Exercise Price, and Additional Disclosures [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810164434368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Company's Options Outstanding (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding - Number of Shares (in shares)</a></td>
<td class="nump">1,766,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable - Number of Shares (in shares)</a></td>
<td class="nump">1,682,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeOneMember', window );">$1.92 &#8211; $12.56</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding - Number of Shares (in shares)</a></td>
<td class="nump">299,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding -Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable - Number of Shares (in shares)</a></td>
<td class="nump">296,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable - Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeOneMember', window );">$1.92 &#8211; $12.56 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeOneMember', window );">$1.92 &#8211; $12.56 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeTwoMember', window );">$12.77 &#8211;&#160;$14.99</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding - Number of Shares (in shares)</a></td>
<td class="nump">465,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding -Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable - Number of Shares (in shares)</a></td>
<td class="nump">465,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable - Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeTwoMember', window );">$12.77 &#8211;&#160;$14.99 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeTwoMember', window );">$12.77 &#8211;&#160;$14.99 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeThreeMember', window );">$15.21 &#8211;&#160;$18.55</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding - Number of Shares (in shares)</a></td>
<td class="nump">232,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding -Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable - Number of Shares (in shares)</a></td>
<td class="nump">224,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable - Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeThreeMember', window );">$15.21 &#8211;&#160;$18.55 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeThreeMember', window );">$15.21 &#8211;&#160;$18.55 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFourMember', window );">$18.68 &#8211;&#160;$22.71</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding - Number of Shares (in shares)</a></td>
<td class="nump">297,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding -Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable - Number of Shares (in shares)</a></td>
<td class="nump">278,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable - Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFourMember', window );">$18.68 &#8211;&#160;$22.71 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFourMember', window );">$18.68 &#8211;&#160;$22.71 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFiveMember', window );">$23.00 &#8211;&#160;$66.91</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding - Number of Shares (in shares)</a></td>
<td class="nump">471,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding -Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable - Number of Shares (in shares)</a></td>
<td class="nump">417,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable - Weighted- Average Remaining Contractual Life in Years</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFiveMember', window );">$23.00 &#8211;&#160;$66.91 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFiveMember', window );">$23.00 &#8211;&#160;$66.91 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Maximum (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 66.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nstg_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160862736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Restricted Stock Units (RSUs) Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested at December 31, 2015 (in shares)</a></td>
<td class="nump">1,333,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">2,067,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(759,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(260,850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested at December 31, 2016 (in shares)</a></td>
<td class="nump">2,380,622<span></span>
</td>
<td class="nump">1,333,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested at December 31, 2015 (in dollars per share)</a></td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">24.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">34.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">36.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested at December 31, 2016 (in dollars per share)</a></td>
<td class="nump">$ 29.93<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</a></td>
<td class="nump">$ 20,100<span></span>
</td>
<td class="nump">$ 44,500<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total value of shares vested</a></td>
<td class="nump">18,600<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="nump">$ 19,031<span></span>
</td>
<td class="nump">$ 56,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170600624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Stock Compensation Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 23,699<span></span>
</td>
<td class="nump">$ 28,863<span></span>
</td>
<td class="nump">$ 18,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=nstg_CostOfRevenueMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">1,870<span></span>
</td>
<td class="nump">983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">5,972<span></span>
</td>
<td class="nump">5,723<span></span>
</td>
<td class="nump">3,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 15,330<span></span>
</td>
<td class="nump">$ 21,270<span></span>
</td>
<td class="nump">$ 13,643<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=nstg_CostOfRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=nstg_CostOfRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160804400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Fair Value of Employee Option Grant (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</a></td>
<td class="nump">53.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">0.54%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</a></td>
<td class="nump">59.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">1.69%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170412784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Retirement Plan - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Contribution for retirement plan</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166701440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Loss Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (160,542)<span></span>
</td>
<td class="num">$ (116,178)<span></span>
</td>
<td class="num">$ (111,101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">1,276<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
<td class="num">$ (159,226)<span></span>
</td>
<td class="num">$ (115,087)<span></span>
</td>
<td class="num">$ (109,825)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160855040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Significant Components of our Provision for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Changes in federal and state tax rates</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Geographic Distribution, Domestic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Geographic Distribution, Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160335184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_IncomeTaxesAndTaxRelatedLineItems', window );"><strong>Income Taxes And Tax Related [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Changes in federal and state tax rates</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (110)<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=nstg_FederalAndStateMember', window );">Federal and State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_IncomeTaxesAndTaxRelatedLineItems', window );"><strong>Income Taxes And Tax Related [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">860,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_IncomeTaxesAndTaxRelatedLineItems', window );"><strong>Income Taxes And Tax Related [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 389,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_IncomeTaxesAndTaxRelatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes And Tax Related [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_IncomeTaxesAndTaxRelatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=nstg_FederalAndStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=nstg_FederalAndStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810161392864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax provision at federal statutory rate</a></td>
<td class="num">$ (33,706)<span></span>
</td>
<td class="num">$ (24,168)<span></span>
</td>
<td class="num">$ (23,063)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts', window );">Tax on repatriated foreign earnings and other nondeductible items</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EffectiveIncomeTaxReconciliationSection162Limitation', window );">Section 162(m) limitations</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">5,824<span></span>
</td>
<td class="nump">5,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_IncomeTaxReconciliationChangeInTaxCredits', window );">Change in tax credits</a></td>
<td class="num">(3,501)<span></span>
</td>
<td class="num">(2,514)<span></span>
</td>
<td class="nump">3,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">36,163<span></span>
</td>
<td class="nump">36,550<span></span>
</td>
<td class="nump">21,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Changes in federal and state tax rates</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall', window );">Stock option exercise windfall</a></td>
<td class="nump">1,758<span></span>
</td>
<td class="num">(9,761)<span></span>
</td>
<td class="num">(7,683)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</a></td>
<td class="nump">1,665<span></span>
</td>
<td class="num">(2,823)<span></span>
</td>
<td class="nump">2,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">State and foreign tax, and other</a></td>
<td class="num">(3,613)<span></span>
</td>
<td class="num">(3,411)<span></span>
</td>
<td class="num">(2,329)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings and Other Nondeductible Amounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Stock Option Exercise (Windfall) Shortfall</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_EffectiveIncomeTaxReconciliationSection162Limitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation Section 162 Limitation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_EffectiveIncomeTaxReconciliationSection162Limitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_IncomeTaxReconciliationChangeInTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_IncomeTaxReconciliationChangeInTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160197264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Effect of Temporary Differences and Carryforwards (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 146,108<span></span>
</td>
<td class="nump">$ 131,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">15,529<span></span>
</td>
<td class="nump">12,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_DeferredTaxAssetsSection174Capitalization', window );">Deferred tax assets, Section 174 Capitalization</a></td>
<td class="nump">17,076<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_DeferredTaxAssetsDeferredLeaseLiability', window );">Deferred tax assets, deferred lease liability</a></td>
<td class="nump">5,736<span></span>
</td>
<td class="nump">6,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">6,561<span></span>
</td>
<td class="nump">6,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</a></td>
<td class="nump">659<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Accruals and other</a></td>
<td class="nump">12,603<span></span>
</td>
<td class="nump">10,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before allowance</a></td>
<td class="nump">204,272<span></span>
</td>
<td class="nump">167,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less:&#160;Valuation allowance</a></td>
<td class="num">(198,980)<span></span>
</td>
<td class="num">(162,817)<span></span>
</td>
<td class="num">$ (114,335)<span></span>
</td>
<td class="num">$ (106,438)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">5,292<span></span>
</td>
<td class="nump">4,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Deferred Tax Liabilities, Leasing Arrangements</a></td>
<td class="num">(4,329)<span></span>
</td>
<td class="num">(4,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments', window );">Deferred Tax Liabilities, State net operating loss adjustments</a></td>
<td class="num">(963)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred Tax Liabilities, Gross</a></td>
<td class="num">(5,292)<span></span>
</td>
<td class="num">(4,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_DeferredTaxAssetsDeferredLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, deferred lease liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_DeferredTaxAssetsDeferredLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_DeferredTaxAssetsSection174Capitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, Section 174 Capitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_DeferredTaxAssetsSection174Capitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, State net operating loss adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160336976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Changes in Deferred Tax Asset Valuation Allowance (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 162,817<span></span>
</td>
<td class="nump">$ 114,335<span></span>
</td>
<td class="nump">$ 106,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at End of Year</a></td>
<td class="nump">198,980<span></span>
</td>
<td class="nump">162,817<span></span>
</td>
<td class="nump">114,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at Beginning of Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at End of Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Valuation Allowance of Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">36,165<span></span>
</td>
<td class="nump">36,440<span></span>
</td>
<td class="nump">8,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Impact of change in tax rate</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="num">$ (586)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170388912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at beginning of year</a></td>
<td class="nump">$ 10,009<span></span>
</td>
<td class="nump">$ 9,171<span></span>
</td>
<td class="nump">$ 4,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on current year tax positions</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">838<span></span>
</td>
<td class="nump">4,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of year</a></td>
<td class="nump">$ 11,176<span></span>
</td>
<td class="nump">$ 10,009<span></span>
</td>
<td class="nump">$ 9,171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits increase decreases resulting from current period tax positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nstg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810170624336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Non cancellable purchase obligations</a></td>
<td class="nump">$ 70.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase Obligation, to be Paid, Year One</a></td>
<td class="nump">62.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=us-gaap_ConstructionMember', window );">Construction</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual Obligation</a></td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=us-gaap_ConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=us-gaap_ConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810160187904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">2,271<span></span>
</td>
<td class="nump">3,379<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,920<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Common stock warrants | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">471<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139810166991744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under the Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under the Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under the Plans (in shares)</a></td>
<td class="nump">425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under the Plans (in shares)</a></td>
<td class="nump">425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>nstg-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nstg="http://www.nanostring.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="nstg-20221231.xsd" xlink:type="simple"/>
    <context id="i043751235d134593932bc4d1798772f9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1e8f6c8902ab43e899d5fe51c87bc281_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icf955021de6a4586adc1a655a9dc0f7f_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="i8451f817802047b4ac1d9188ce3a1a70_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e05f468d67d4e158506601ffba408b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib6fb5a9c83554516897179bdc578a26e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia0d76b57e37a47d9993ee86018d00cce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic69d192ea60b4dd99f62ed25f1930652_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2dcc651b739c4a8797ff28c930d6411a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i386de87196f44b13b5fbbfb2f76610bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f559acbf7a94475909e3c1663266216_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id90f105c4d55494b94cc0ab76173b5fc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b9f3b07c6934ad3a071ba90567014cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76e439fcce3243a282b799121be03534_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91d3517a5cd04697bc20f69fca9c1aea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02f27c9fc5a14f6a9ad7a0207ca76205_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i340b839d193a417b9994bc351dbdcd6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82b26d4493e6499daf1af61adf60e137_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc30b4ddea0947eeadd32b726a42601a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4679a98afee44ff854f9a3fe34a94e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21fa537a67cc4008a5f886347dd4fca6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27aa7b231862406db76f50681fa18e57_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1a626949d3a48359028bdd61bb4b96f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c1797d70c2647f984286d05d5bef521_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95a95c99a0394cb69b14efb2f1306862_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i895d001213eb4fbdbfe3970d1d470a5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i920455eea78d4de0b3a820010c833f50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i444d8e8a93bb4467a4ce845e986e6410_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24476a394b0d460abebd9ddff5142056_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i68c123b35bc44c839c2818e081176609_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63cda06a33214436ac73d2d0c4af2fa8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i187572d253d54fb6b91f8db3fcb8f370_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib08fc922969543ebbe9caf9316b0f2af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9403952b5e824b5794d4bb6ed1b3c7ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idfa5c83df28b49dd8e19aa82d32557ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e3db979b8cc4c70acfae0b6db21e315_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e88f609f3f146ceaf78b4e74394ba1b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i278bf40cbb204af4a52b6898794206ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypeSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i88f1ce22f43b4f6ba059a7cff32daa29_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f132592e8314b41869081ee86000fca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaef01beba6684f59958c4b614e147f05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82bf014bbac5492db1175791d6facd7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e1e72e2e1254b52a9ce1f62c4a096cc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i18117518f24d42deab5e444d999956b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie22262b3c6e443298a7bfef3925d13c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8b904e260de493cad16322d5349cd06_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c7acaf4b361496386e2cab8954e8f6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i73fa25c9cfad44209056603a0dc281bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1530276adeb46edad26c44010100eaa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i67acad69085c486998c2baaf6125dbb3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57df71b94ca142fdaca927a766348294_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7881895472d449e994899c6bc6580f05_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i713c836ec9944621af76e4eae6676d6b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i13689abdf06042ddb61fe7e5dde76571_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6199bdcbfda84b76b59695fbd415666b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3b4cc48ab884deb9ac79ec4f88a41b6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0379bf7b398f48e4b7eb5e0d0e117124_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60b0d645787549928cc28c4236afb570_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i55d209ba775a4742bb51365dce4d0e27_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id43e18e2336e4176a4c6d0b1837d8ab8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08998380f6294f76a8041abec23394b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifeeae230b2594a1b942b9d452bd93424_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i250e7fef9d9e4aa4bae1f66f612bb047_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifb01752d3d024e9cbe624ff2311e1e86_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i51f5ff287b4347d1befb9409e6d22447_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3bf083ef64fc4b2d84ed1522343a92d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c31fff231034b729e619b1e5ddad70f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7884244270dc438fb94c45d2b041e5ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7a2ec65972a6419abe9a03a19e5ca95e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i94493508e1514eb89d02a2be8a07f60b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79fa8408bcb64e98b3b17b2bb9a06863_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icedfeb39178b47b0973327433aeaf39c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib388af030dc445f1b7cfea35477d3be7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab1f01e51b674ab4ad411dde4e1e0d89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8071ca8672d449bd949728204b07a2fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74d86a75d4d54b8b9ca2f0ed1e4dacf9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i444caf10ca684a0aa194a919b86211e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f366fc7210642de991dae318729cecb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i373fc6e51acf48be9c6990e509965c68_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4cda942559fe4cc4a3fca242a605e4b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if47b8c1b821a4938a48a69fe46c6555a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45ebd85ce49641b1bdcfb50f620c8c7f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i809c69b254ec43d4b295def456b0bcb9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic2d61518cf22490287052068a75aee69_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i87797cb7eb2d4e539e26bf057f66d572_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieae0f86555864368b0aea5d051ac1266_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia52a0df2c7f04de89a0e5830fdb770ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d04035e9e28485eb3acf369367687f8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5ce94de1d746480a975bbf68e8d2ff1a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id47ab74aed5247f7a85777c81bd4cb68_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i837b13ea09c546889d1c1f1898e0cb63_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib14cac7c7a3349a2abe346fa98dfc66e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f8abb7a1a694dd4b9681e6a239af1f5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30a7b631fee1428b98faf94c3babda50_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f05c9834f4542e9b3cdf441d7ded71a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57da356bd80040d28979b0ee90029081_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i989ed5565898409da03fcb97e7c4573a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e7328fd0fcb413d860b955b14b25b47_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c61765d11da43eaa6620b24fb7a3b84_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8421365accd4534bbc761089b030e05_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdf2ffe55aec47f69e976f20986eb3dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i534ef05250b74206a3469e1b8edd612a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if93686ec4ea743a4ba48bb454b4a79e4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nstg:ProductAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73ce0b36a12d45cf88cbf303484474d8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7695a3a71d2e46c78f0a9751fa7e65e4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae168f9ba93c4702893c848d0c6e17f8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4584c877dc647338dc50887089aa8d4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c3446b18c3f4429b947c80eff58cea1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaaf0fb528f60478594ef2414b62f9d04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i204d5e8d1d3846dd9f94223ddb56342a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25d9089997454bb1a0c3539505c1c38b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if689c091da7e49acac49fa4109fec584_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51ae9afe71f74d379d16ab886a404393_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2492355e51654bb090ebf5513f607ae0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f16742116dd49ddb8104eb5bdbcfcdf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec61848f7a3942d2950cae11486a1ecc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i98ca246e843540f4822dd96a53d66eed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i322cd850a2794ba0ba08d821a4e1df1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9582990fa8164d3a9f1fd4b0ec0ee75a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i874d8d32e3cc4d7f840e2d1ff4b5d402_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i80ba8b859f55484eaada3a17ad6a664c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2436c4e22c584140bdea10494b55b14d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e1c9aa8e85842fe9bf0570307ef0b9b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d931bc716374b53be3b0b9cefccbf8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5dc6ee5fcb0649249deb7816da0e2c05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id8cc509eb60a411cbd96922835a08932_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd17be89ff4140d9a06669daa9ea9181_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fa5e6f26b86406fb5758deca06ebe9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7acddd71ba8140ab8c19a8a1975fb542_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ea99fdfabbd4242aee0a5883d8beefd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if449a99cfefe4c7cb63f39a6b7429081_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40784678c00f45dfa31384ea5da6ec61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i715feed5faf14f819a69f74e70a51b89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie950f8641c7a4192bee03c298f4d3e9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib11be0a2463245cfbe3d860c3f4e66f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ided2f9286c924c4f97ec0724c5a6a4e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f4bf01fc4bc4bc5812e10affa2f9f7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i023ed3e85c01469e986ad2ce472a4307_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f3530905bb7474ab307f49b7ea1e2b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23c3281ffb1a419384a2c48110d22e1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5057ef90f9c4541a9b859fbaa260c6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0419d16a85d2463b8a5cf1ac63c939d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7550093a293240458a48f07f2c8c4626_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7b7ef4b161684e7cacf3f6408767bb84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2a1951785ab40e68ae969d7cd3c9742_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3cf29bb1eb74475e896a6511b6cf0035_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie616f0cefcbf4b0fadfa0ca79acf005d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypesAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0646dd1f77534091a7aac4d721b6769d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypesAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c89b21a66a04e8d9b27819c58bef518_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nstg:PrototypesAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fee9a686a43435ebd9b2af3f2b0bf38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41ab44c9e5dd45638f78be80ead6cb26_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifae3e7e9820c46b380d5dbba63c1ba21_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b1160c699fb41ab8078959aa2b71645_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1906cd27a926473f97dd96ae306e6ea7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if39bb1b648b84d1b8ea0e830f2e097ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad8c07047cd941898973b031735aea40_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i041f0c1d8b534c149cf8210420c68583_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8879a77916d4282a46de289bb9dbdd5_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i03a3e574978345dfbe106d6fac6ec50f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="nstg:ConvertibleDebtTermsAxis">nstg:ConvertibleDebtTriggeringEvent1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="nstg:ConvertibleDebtTermsAxis">nstg:ConvertibleDebtTriggeringEvent2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i14f75101ca484bf6bac4dc7226b1113e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i379a102945f149ae9e804e66bfdccfc8_I20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="i10abeac0df484f369c951c1d61608b8d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27c6ea2f53ac4990ae5f60cf96224bb2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fe33f52f67b4687bbae5622f4312c40_I20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:SecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="ie024cf12bf5b4458adc486ea3637775c_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:SecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="ibb55eb3463fb43ca895bce6ab03389cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:SecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d2647f818e343a1b49e1a59ad9b201e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nstg:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84093a4322da469e83641848f0ea172b_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="id19896e0ae0e48948f3db0dc516f3674_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i2faccbe8dbb44a7a885e478bce74de3a_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nstg:PublicStockOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i61e1f1159955427aa959883a212aa815_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37b3847550434762972bebc67656a85c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie882436ff3ec4475b183dab55fc70afc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i06a3e3cb294548d8844d3e900432255e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if662b112600744f887c0f7a89393ea18_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if9bd905f155547fca3f7022d826550f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9ca6a450312485eb2653adb71cd9f5e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8090e4620bb54d97b89cb0dc5214c2ac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if150562d534e43d7a0be36122ba6294b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c11cf0a91ac4e2a801affae1032e3d3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e84ed8c801a4c209b5bcdc1b70b5652_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id6c402dc94d04e52bc03498acfaae727_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i06cb2e813155412ca9d4aa066e0dbf5f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib8338f87419c456caacda88b6cd45d60_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5c0f72610203463a91933df13c0ef863_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i363fd23d862d49c197424ef927db40d5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifdbe64c654004a0a9c1b1eb652e096c2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e02806cedd34a0fbaa454cc75f64d39_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia12bfc1b8c634d16b3b4fe87b81c81ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae43c7b0912d44d4adbf7a74d6cc5170_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie35e27d21c994c8f8ed1289ffa420eba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id93d18101d134e09b27b73519d3e467a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b5c097161754a66a79ba216e1fe8e69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifbc4a5733a414b0ca670822be669b552_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if75c1d4d9c4747288ef5603464fb5fbb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i39adc3163bb94109b81e6d5dad488eb1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7eb61034aec1476781aa07ee2f8562ab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2dad374da0b48fa915dda42f71ff71b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nstg:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60e0592e249f4ddc84797c7db1802798_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nstg:CostOfRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id359d7f10c7f4650a3ccb3e59f28b9b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nstg:CostOfRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4c5d477f82ff4c8699615becd441e2e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">nstg:CostOfRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i171d7573fd21497682c5ce64be7a7416_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7ad73584ddef48af83fd9e76216c9ed8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0f546e62eb5d437190c5f925abdd1993_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b370a0aa7494558a2684df873b92e31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic4cf23c2148a4d728f391d7591fed46a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54234098f2fe415b99bdab8bf1fb6f00_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74ec37816d5d4d1c9be1f2cc76135e4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07c9b03e212c4b068eb66593b05efda9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceAndPerformanceComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i838d0bd0b6124f28b27371e25ba13e46_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i846bf5f2f89540e68b6c2e2336234f13_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:ServiceAndPerformanceComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-07-01</startDate>
            <endDate>2013-07-31</endDate>
        </period>
    </context>
    <context id="i3ebcaf345b284e6e9623117669975e74_D20130701-20130731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-07-01</startDate>
            <endDate>2013-07-31</endDate>
        </period>
    </context>
    <context id="i7999389f78ad4a51b40dceb35494cd61_D20130701-20130731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-07-01</startDate>
            <endDate>2013-07-31</endDate>
        </period>
    </context>
    <context id="ic623892b482d42ae931b372405773674_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07b5aa174a6345a0b151fb3b490d437d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icad6d38c8f7c4d89a92280b9e15d04b8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if555a5dd86134313a260b8b540a5deb3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nstg:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bc2480d9afc41299a0dc200f9614cef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9e8993d263434600a013126584291fad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58bff15771ac47c3a9eb0fe25cc0fdea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i35672bdf7a8344d580057c105d3a35f4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id186117bd3474f299cf9daa35048c269_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib1acfbe546b94ee9add32ffe159ea86c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28ef8872ca69434cb82b4ce55d15bd25_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">nstg:FederalAndStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifffa3e3faf9c444ba7d318f1c005e08d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i83025943657d49539ea6888045a339de_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i21a2f01c1b5040569d99fe2b4cc5881b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icccc75f297f9487aaf6af93a9682218d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis">us-gaap:ConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3ed46b1479f4064896cb2ff583b50fe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ec5ee0bad2343278a6de1b6fd2cc457_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i547b52c74b7d404a86d2976b1d0d428d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iecc395aad27d4e279fde1f41cf731f43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79b5e44fa71c4cdd99d7ef0f4caeaae9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71dfb62de0ed48e8a1bf6ac8a7dc0277_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia62e3cab8f2e4c3cb75f270e19d7bece_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifab9ad4b738c40b1bad40a93b5d022f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i044b09e095b341cea037a0552518fa44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc345a5e318943deb1b776d29eab9f21_I20230227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001401708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="lease">
        <measure>nstg:Lease</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="platform">
        <measure>nstg:platform</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="day">
        <measure>nstg:day</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl8zLTEtMS0xLTQ4OTA2_e0efd76b-5ec3-4c49-a4eb-573c0dd4e125">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl80LTEtMS0xLTQ4OTA2_89a45d95-e5b5-4b01-9f7f-abfea15be8ba">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl81LTEtMS0xLTQ4OTA2_093dacaf-bef9-4ea9-825b-79147150c82e">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80L2ZyYWc6YTRjMzgwZGE2YTIyNDkxY2E4OGNlMDI4NzhjOWU2ZjgvdGFibGU6ZTdjOThkYzM3OTY1NDIxMmIyODZhOGU5ZmYxZTRkZTYvdGFibGVyYW5nZTplN2M5OGRjMzc5NjU0MjEyYjI4NmE4ZTlmZjFlNGRlNl82LTEtMS0xLTQ4OTA2_df43736f-a8d2-4443-977c-8657a2e41c35">0001401708</dei:EntityCentralIndexKey>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5">http://fasb.org/us-gaap/2022#DeferredRevenueNoncurrent</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc1_38f70ff5-feb4-4b67-85fb-c77566cf15a7">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTgwOTg2YTkyMjA3NGE1Zjk2NGE0ZDAxODMyYzFiMWIvdGFibGVyYW5nZTo5ODA5ODZhOTIyMDc0YTVmOTY0YTRkMDE4MzJjMWIxYl8wLTAtMS0xLTQ4OTA2_f9b91cc5-3203-4b7a-be64-30935ed199fd">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8xMjc_1eaf4a29-5c12-482a-b21e-906cb11049e1">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8xMjc_e8dee7ed-edb9-44f3-a3a7-df33baee943b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6MzRmYTg4MmVhNDY4NGU1OWE3MjgzMWU5NzRhMmRkZTkvdGFibGVyYW5nZTozNGZhODgyZWE0Njg0ZTU5YTcyODMxZTk3NGEyZGRlOV8wLTAtMS0xLTQ4OTA2_75a4be8c-652a-4891-946d-20a51c0e93ce">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc4_bea84820-e0f3-4d83-8d66-8c1d274e8ce2">001-35980</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODgz_e9340bf5-173e-4a57-a9e0-424c3d446127">NANOSTRING TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6NTVkNTIyYjlkMGQzNGZlZGI0YjdlNzE2ZjQyNTU5ZTkvdGFibGVyYW5nZTo1NWQ1MjJiOWQwZDM0ZmVkYjRiN2U3MTZmNDI1NTllOV8wLTAtMS0xLTQ4OTA2_b2675cea-60df-454b-ba55-86440f5e782e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6NTVkNTIyYjlkMGQzNGZlZGI0YjdlNzE2ZjQyNTU5ZTkvdGFibGVyYW5nZTo1NWQ1MjJiOWQwZDM0ZmVkYjRiN2U3MTZmNDI1NTllOV8wLTItMS0xLTQ4OTA2_41c70642-43f5-45ec-a089-8c46ecf335d9">20-0094687</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc2_5605ae77-5c09-46d1-b775-d3e588c9d4c1">530 Fairview Avenue North</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcw_cc13abee-5a42-49b1-8e8b-2b50b6a8a0b8">Seattle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcx_44be8fc0-8f14-46f6-af9c-9be9d9433075">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zNTk_4a28f1cf-261b-40d3-b6a5-a2bc900fc342">98109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV80MDQ_5adb3087-5188-4fc4-b427-885019822729">206</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc5_1de782b4-2c0d-4172-8713-301a3c90b43a">378-6266</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6ZGRhNzQyN2ZkNjg2NDAwOThlN2M0YmE5NjdiYmU1ODYvdGFibGVyYW5nZTpkZGE3NDI3ZmQ2ODY0MDA5OGU3YzRiYTk2N2JiZTU4Nl8xLTAtMS0xLTQ4OTA2_b535e568-9769-4e59-a9f5-d811ca72e046">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6ZGRhNzQyN2ZkNjg2NDAwOThlN2M0YmE5NjdiYmU1ODYvdGFibGVyYW5nZTpkZGE3NDI3ZmQ2ODY0MDA5OGU3YzRiYTk2N2JiZTU4Nl8xLTItMS0xLTQ4OTA2_bec80869-f675-40cb-bbe1-9d0648cb9961">NSTG</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zMjk4NTM0ODg3MjYz_892f4ffd-c400-4df9-a001-f1382b09bd15">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcy_ef5f7062-c64e-4878-8a0e-a3d88626f790">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODgx_e668f254-855d-4082-b22c-003d7e976b47">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODcz_f8eb854a-2259-4935-a61b-1f938be8cbc6">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTBjZGU2NTdkZDJlNDNhMWExNDYxM2U1OWVmMjEzMzUvdGFibGVyYW5nZTo5MGNkZTY1N2RkMmU0M2ExYTE0NjEzZTU5ZWYyMTMzNV8wLTAtMS0xLTQ4OTA2_78c91226-2e76-4df1-a5c7-9c59242cee9a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTBjZGU2NTdkZDJlNDNhMWExNDYxM2U1OWVmMjEzMzUvdGFibGVyYW5nZTo5MGNkZTY1N2RkMmU0M2ExYTE0NjEzZTU5ZWYyMTMzNV8xLTMtMS0xLTQ4OTA2_61fdc293-ed2a-441d-ba9a-f155fcdeed24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGFibGU6OTBjZGU2NTdkZDJlNDNhMWExNDYxM2U1OWVmMjEzMzUvdGFibGVyYW5nZTo5MGNkZTY1N2RkMmU0M2ExYTE0NjEzZTU5ZWYyMTMzNV8yLTEtMS0xLTQ4OTA2_89166393-e226-4b66-aa3f-6a8d45950ab6">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc3_5864d30e-d80a-454b-8d35-ad400d450231">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8yMTk5MDIzMjYyMDEz_751fc23c-87dd-45b5-88b3-19309496c08c">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i1e8f6c8902ab43e899d5fe51c87bc281_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8yOTQy_92e8d3a9-3a3b-4afd-9a54-9f3b2b240d48"
      unitRef="usd">585700000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="icf955021de6a4586adc1a655a9dc0f7f_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zMjY4_ee65dc94-729c-4aa6-9182-dc358b228250"
      unitRef="shares">46791027</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xL2ZyYWc6Y2Y4ZDQyNWE3YmJlNDg0MWJhNWI2ZDg5MTgwYzdlODkvdGV4dHJlZ2lvbjpjZjhkNDI1YTdiYmU0ODQxYmE1YjZkODkxODBjN2U4OV8zODc0_92cd1f07-e6ff-4e6a-975c-125af6c274ae">Portions of the registrant&#x2019;s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the registrant&#x2019;s 2023 Annual Meeting of Stockholders, which will be filed subsequent to the date hereof, are incorporated by reference into Part III of this Form 10-K. Such proxy statement will be filed with the Securities and Exchange Commission not later than 120 days following the end of the registrant&#x2019;s fiscal year ended December 31, 2022.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <nstg:NumberOfOperatingLeases
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV80MC9mcmFnOjkzOWIwMjQ1N2RmNTQ0MDc5YWQ2MTFiMTliY2YxMDY1L3RleHRyZWdpb246OTM5YjAyNDU3ZGY1NDQwNzlhZDYxMWIxOWJjZjEwNjVfMjE5OTAyMzI1NjQxOA_e3b79b33-0571-4540-9178-d9dd5a409dc3"
      unitRef="lease">5</nstg:NumberOfOperatingLeases>
    <dei:AuditorFirmId
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV84NS9mcmFnOjAzYTU5Y2M0ZGRmMDQyMjc5NDQ3MTBmNWRkMjY0MDBjL3RhYmxlOjM3MWIwNWU0NmZjYzRhNjBiMjhkMjYwM2Q3NmQ0NjgyL3RhYmxlcmFuZ2U6MzcxYjA1ZTQ2ZmNjNGE2MGIyOGQyNjAzZDc2ZDQ2ODJfMi0wLTEtMS00ODkwNi90ZXh0cmVnaW9uOmRmMjhmNmU2NTQ3ZjQ0ZDg5NDQ0ZWU1NGI4MDU2NmQ4Xzkx_887321ff-3c01-43f6-8bd7-fd97643ed23d">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV84OC9mcmFnOjlkM2IwNjQ0YjQ2ZjRhNDc5YzYyZmViN2UyYzYwMzI5L3RleHRyZWdpb246OWQzYjA2NDRiNDZmNGE0NzljNjJmZWI3ZTJjNjAzMjlfNzY0MQ_0d0dcb71-87d5-41b2-a6af-c7f2b60d123e">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV84OC9mcmFnOjlkM2IwNjQ0YjQ2ZjRhNDc5YzYyZmViN2UyYzYwMzI5L3RleHRyZWdpb246OWQzYjA2NDRiNDZmNGE0NzljNjJmZWI3ZTJjNjAzMjlfNzY0NA_ca659b39-b3cb-4dc1-9a15-6429ce0061db">Seattle, Washington</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNS0xLTEtMS00ODkwNg_849ac9de-2334-41d8-a86f-3ad061ad79a7"
      unitRef="usd">112250000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNS0zLTEtMS00ODkwNg_bfe07c9c-fd8c-4f8b-ac4f-89bc75b3c301"
      unitRef="usd">107068000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0xLTEtMS0xMDE0Nzc_b365a849-bd7c-43ca-bb23-131549f0dba8"
      unitRef="usd">898000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0zLTEtMS0xMDE0ODU_c66ce6dc-393d-498f-9eca-62b6bf40964e"
      unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <nstg:DebtSecuritiesAndEquitySecuritiesFairValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0xLTEtMS00ODkwNg_5f0d253b-f899-4800-af09-44c7a20382ef"
      unitRef="usd">84282000</nstg:DebtSecuritiesAndEquitySecuritiesFairValue>
    <nstg:DebtSecuritiesAndEquitySecuritiesFairValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNi0zLTEtMS00ODkwNg_11532d76-f47d-43f8-977c-f998a06ba2f1"
      unitRef="usd">241821000</nstg:DebtSecuritiesAndEquitySecuritiesFairValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNy0xLTEtMS00ODkwNg_d86165f6-65ec-4749-aaa9-fae1054560bf"
      unitRef="usd">31506000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfNy0zLTEtMS00ODkwNg_013e20ad-0c1b-475d-8c12-d25121e58939"
      unitRef="usd">40130000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOC0xLTEtMS00ODkwNg_251e5c18-1c17-4f24-a867-520a22def87c"
      unitRef="usd">43273000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOC0zLTEtMS00ODkwNg_3d17e443-1fd2-4ce3-9bec-fec0fac7d8a7"
      unitRef="usd">31486000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOS0xLTEtMS00ODkwNg_e18b5475-748f-4ef8-b835-6f198652bc4f"
      unitRef="usd">14565000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfOS0zLTEtMS00ODkwNg_a5fec996-976a-4033-9180-79f8b2abd4db"
      unitRef="usd">7115000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTAtMS0xLTEtNDg5MDY_ceb9463d-417f-4537-b95b-0e301c52cb2f"
      unitRef="usd">286774000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTAtMy0xLTEtNDg5MDY_ed269ca9-e4cf-4be1-a497-c1db0c85b34a"
      unitRef="usd">427620000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTEtMS0xLTEtNDg5MDY_3f8b0d62-1e24-454d-bd33-52d88bc3afa9"
      unitRef="usd">44457000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTEtMy0xLTEtNDg5MDY_ec33c86f-8c91-4ffa-8dec-36fa988a5b79"
      unitRef="usd">27043000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTItMS0xLTEtNDg5MDY_01f60487-5e88-4eba-b1e7-0f60ea81afe6"
      unitRef="usd">17581000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTItMy0xLTEtNDg5MDY_fefdd299-d706-455d-bd03-1027dfadddc0"
      unitRef="usd">19226000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTMtMS0xLTEtNDg5MDY_48ae6c8c-f118-4250-994d-9972a54ce684"
      unitRef="usd">4600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTMtMy0xLTEtNDg5MDY_a070f8c4-994f-49c4-a7ab-e5d74040ec6f"
      unitRef="usd">5592000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTQtMS0xLTEtNDg5MDY_5ededa6a-7504-4a1f-8342-6a2c43ee7cfc"
      unitRef="usd">353412000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTQtMy0xLTEtNDg5MDY_0658fcaf-a49c-487e-8441-56d8313146f4"
      unitRef="usd">479481000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTctMS0xLTEtNDg5MDY_07e3145b-28a5-4a4d-a142-fa5c41d74178"
      unitRef="usd">16619000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTctMy0xLTEtNDg5MDY_da843ef3-85ec-4ad6-9273-0b4f4b9c5e95"
      unitRef="usd">14283000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTgtMS0xLTEtNDg5MDY_049ded09-1eb3-4cfb-83e7-356a51d3aadf"
      unitRef="usd">7884000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTgtMy0xLTEtNDg5MDY_781d2962-19e8-4a89-bb36-9066a289e698"
      unitRef="usd">6765000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTktMS0xLTEtNDg5MDY_16fe9bec-5053-48c5-836b-f12ca8a233a9"
      unitRef="usd">17494000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMTktMy0xLTEtNDg5MDY_e86c06b1-da75-4351-ae7d-8cb7d8552175"
      unitRef="usd">17466000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjAtMS0xLTEtNDg5MDY_cf8ec8fa-031e-4b3e-aab2-f30a5f2e7582"
      unitRef="usd">1757000</nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent>
    <nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjAtMy0xLTEtNDg5MDY_629338e3-e81f-42fc-a9b1-67151ac50b82"
      unitRef="usd">1278000</nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjEtMS0xLTEtNDg5MDY_a0338993-5cea-45c3-a698-fa1497675e92"
      unitRef="usd">9588000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjEtMy0xLTEtNDg5MDY_35d693cf-19d3-402c-bed5-c8d79863d5d9"
      unitRef="usd">7474000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjItMS0xLTEtNDg5MDY_18046887-21ab-4c98-9d79-edf1be71f846"
      unitRef="usd">5518000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjItMy0xLTEtNDg5MDY_e9009f90-ae5c-4621-8f33-128a0582a61a"
      unitRef="usd">4889000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjMtMS0xLTEtNDg5MDY_7d9848d9-bd59-43b1-9eed-5f925f40053f"
      unitRef="usd">58860000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjMtMy0xLTEtNDg5MDY_e2d95d7e-44d3-43ba-a253-a076127a0289"
      unitRef="usd">52155000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjQtMS0xLTEtNDg5MDY_44cca372-2dc7-4742-9c88-e927902cf471"
      unitRef="usd">3754000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjQtMy0xLTEtNDg5MDY_be733fad-d744-4479-911d-bce3d30841aa"
      unitRef="usd">3527000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjUtMS0xLTEtNDg5MDY_3d613be7-34a2-4ab0-b79d-08aca3d83c3e"
      unitRef="usd">226622000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjUtMy0xLTEtNDg5MDY_ff323046-4744-4d63-b94a-0f38b3c12ac2"
      unitRef="usd">225144000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjYtMS0xLTEtNDg5MDY_330e48c0-c0a9-4f96-b1c9-14c7728a42ae"
      unitRef="usd">18362000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjYtMy0xLTEtNDg5MDY_fe36d1b3-305a-4ed2-a1b6-3f2bf9a6a087"
      unitRef="usd">21693000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjctMS0xLTEtNDg5MDY_b4a45e62-969a-4857-b5fe-b8ca4142aac2"
      unitRef="usd">307598000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjctMy0xLTEtNDg5MDY_2662e059-fb67-4fc2-8947-af124e618198"
      unitRef="usd">302519000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjgtMS0xLTEtNDg5MDY_b9f4b839-b02a-4855-acee-281bd8164617"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMjgtMy0xLTEtNDg5MDY_70f424e0-5235-413e-8356-d7caa8c7f9eb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8yMQ_8d931896-bbb6-499a-9749-2053ecac3c76"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8yMQ_a7144921-14ed-4888-931e-369a57f8b458"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8zNQ_5c7d3d28-e2a0-4cf2-90b1-29f78178d6c8"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl8zNQ_6eb21f7a-02d9-4bc3-8614-6bc03995af69"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl81Nw_06f32b9a-e83a-4ab6-8089-4a8489782e5d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjplYTcwMzAxZDA5Y2Y0NThjYjdiOTljYTQyMmE0N2VjNl81Nw_df2c446d-bdee-45cf-8d73-acb0661b50c7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMS0xLTEtNDg5MDY_51a17315-61db-4b33-a58f-1bb7d8dcb46d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzAtMy0xLTEtNDg5MDY_385c091f-6b04-4421-8317-40293df8e168"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8xOA_377fa6ff-a2b5-4a72-9498-1fbb9c8e72c4"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8xOA_a3043dd7-25ad-4500-ac16-1cedf0faa7bd"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8zMg_5a8ffb91-4d2c-41be-86dd-40e04db76d57"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl8zMg_d203e568-26a5-4619-b725-29bb40308eed"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl81NA_10566667-f413-4e9d-8661-a63792166c7b"
      unitRef="shares">46719000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl81NA_b05e8adb-71b1-436d-b427-eadd69acd544"
      unitRef="shares">46719000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl82MQ_9ff25f12-9f90-4143-a55b-3613e8ec2ea8"
      unitRef="shares">45729000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo3Mzc1OTVlNWRiNGY0ZmNjOWFhMTQ1NTRkMWVkMDgwZl82MQ_e3702523-6dc7-4052-954d-92923078a9ca"
      unitRef="shares">45729000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMS0xLTEtNDg5MDY_38481718-9e3d-4823-bf10-1bee7436090c"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzEtMy0xLTEtNDg5MDY_a2fd263c-736b-445e-911e-739631da2eee"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzItMS0xLTEtNDg5MDY_22b3ac29-ad81-4b80-9008-dd5a9f578d5f"
      unitRef="usd">855694000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzItMy0xLTEtNDg5MDY_a3ecaa90-4284-47dd-ada3-cb4f0ff086f7"
      unitRef="usd">827028000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzMtMS0xLTEtNDg5MDY_6e5cb5dd-00b6-4523-9e96-3dabb1c584c6"
      unitRef="usd">-589000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzMtMy0xLTEtNDg5MDY_32829164-939b-42e9-8884-59748552f8ed"
      unitRef="usd">-318000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzQtMS0xLTEtNDg5MDY_b00e5d25-8b2a-4315-95c8-b74182903c68"
      unitRef="usd">-809296000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzQtMy0xLTEtNDg5MDY_5bfeff87-1118-423e-8bf8-87c5ed48f654"
      unitRef="usd">-649753000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzUtMS0xLTEtNDg5MDY_16801bbc-9e15-4205-afab-762787e25661"
      unitRef="usd">45814000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzUtMy0xLTEtNDg5MDY_01f3287f-e02f-47f3-b3c8-953af8c32ef7"
      unitRef="usd">176962000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzYtMS0xLTEtNDg5MDY_f5187ac1-c6dc-4687-af8e-b049862a680f"
      unitRef="usd">353412000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85NC9mcmFnOjA2YWY2MjE4ZTM0YzQwYzY5OTZmMTA5MjZhNTU4YWZjL3RhYmxlOjFlYzZmMTU5NWRmNjRiNzhhZTM5ZGY3YzAwNTBlOWZlL3RhYmxlcmFuZ2U6MWVjNmYxNTk1ZGY2NGI3OGFlMzlkZjdjMDA1MGU5ZmVfMzYtMy0xLTEtNDg5MDY_ed08f806-1d2b-4a1c-8bd6-663b311a4acf"
      unitRef="usd">479481000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNC0xLTEtMS00ODkwNg_ec9118db-e814-4e1f-a26d-6cac248a3651"
      unitRef="usd">107956000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNC0zLTEtMS00ODkwNg_6d022805-34b9-4f3c-b051-f69dcc0cae6f"
      unitRef="usd">127462000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNC01LTEtMS00ODkwNg_b45265e7-13b7-46da-bdf4-8f1c38ea1a5a"
      unitRef="usd">97927000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNS0xLTEtMS00ODkwNg_a8ef693d-8710-4d29-92ba-71c55e6fe1b6"
      unitRef="usd">19306000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNS0zLTEtMS00ODkwNg_905207b1-3146-430c-9613-12ae12c2152a"
      unitRef="usd">17623000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNS01LTEtMS00ODkwNg_ff3af847-3745-4a40-84b9-df760353b217"
      unitRef="usd">19389000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNy0xLTEtMS00ODkwNg_344da33f-7045-4259-958c-dfee126b5280"
      unitRef="usd">127262000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNy0zLTEtMS00ODkwNg_d2cd6443-147a-4f74-bf72-da343f2a2196"
      unitRef="usd">145085000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfNy01LTEtMS00ODkwNg_82ea41af-42f0-4a9b-99cf-519c3668e48f"
      unitRef="usd">117316000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfOS0xLTEtMS00ODkwNg_870f13d1-aec5-4659-b962-81a71f3faaba"
      unitRef="usd">50204000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfOS0zLTEtMS00ODkwNg_1c078074-26a6-4fae-9385-fce5342177a9"
      unitRef="usd">53668000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfOS01LTEtMS00ODkwNg_9ede7b9f-28b8-4bac-b0b3-b012f031a5c7"
      unitRef="usd">45001000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTAtMS0xLTEtNDg5MDY_5e4a71b1-d647-431f-8938-8baa36054974"
      unitRef="usd">15271000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTAtMy0xLTEtNDg5MDY_8cf2921d-7cf5-4d96-abc5-8eb0ea7951f5"
      unitRef="usd">14636000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTAtNS0xLTEtNDg5MDY_ec2af9ba-aaef-46ce-93d0-e0270179c03d"
      unitRef="usd">7408000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTEtMS0xLTEtNDg5MDY_4264c2f6-569d-4c2a-8a55-c1d49c4c2f74"
      unitRef="usd">65475000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTEtMy0xLTEtNDg5MDY_2642bbf9-b03d-4d26-aa01-5077258c5d20"
      unitRef="usd">68304000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTEtNS0xLTEtNDg5MDY_a76304e0-f988-4c3a-96fd-0314eb9611af"
      unitRef="usd">52409000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTItMS0xLTEtNDg5MDY_0d9a12aa-1165-43b9-b92b-47ecd4b73611"
      unitRef="usd">70841000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTItMy0xLTEtNDg5MDY_e2cdc77c-b98b-4604-bfa9-7e1c57313584"
      unitRef="usd">69504000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTItNS0xLTEtNDg5MDY_c8fbf110-a611-4944-badc-44d9f3695552"
      unitRef="usd">62857000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTMtMS0xLTEtNDg5MDY_60e349ff-3d81-4285-9f0e-bfd8031f6d0b"
      unitRef="usd">143129000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTMtMy0xLTEtNDg5MDY_304badf8-41ae-48cf-90a5-f3b2e862baee"
      unitRef="usd">115503000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTMtNS0xLTEtNDg5MDY_c9616602-eb38-4956-9030-4b4d7172c956"
      unitRef="usd">90097000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTQtMS0xLTEtNDg5MDY_b97c0e40-b5da-4550-94a7-ec1efcc9e3e6"
      unitRef="usd">279445000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTQtMy0xLTEtNDg5MDY_86d7d955-fffa-47bc-a4c5-1d888e7a7ddf"
      unitRef="usd">253311000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTQtNS0xLTEtNDg5MDY_8d420322-dfb8-4231-9ef9-5b95c0f17962"
      unitRef="usd">205363000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTUtMS0xLTEtNDg5MDY_ca0f4145-11c3-4466-bb1e-b754f3e31b52"
      unitRef="usd">-152183000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTUtMy0xLTEtNDg5MDY_99211532-33d0-41d6-8294-b359487bf0a0"
      unitRef="usd">-108226000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTUtNS0xLTEtNDg5MDY_7a0e4af2-6179-4b23-a509-367cf8f657b1"
      unitRef="usd">-88047000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTktMS0xLTEtNDg5MDY_924e9acc-0ffa-44f8-954e-d53e23516199"
      unitRef="usd">2409000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTktMy0xLTEtNDg5MDY_ba8669fe-69b7-4949-8650-ff939c7dd545"
      unitRef="usd">649000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMTktNS0xLTEtNDg5MDY_54d04c4a-ba87-4ef4-a37c-8cd1e5d32db8"
      unitRef="usd">1744000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjAtMS0xLTEtNDg5MDY_03d8a96b-4888-41dd-a783-f81309d8542a"
      unitRef="usd">7535000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjAtMy0xLTEtNDg5MDY_d55c0870-3946-42f4-b930-6be93212021c"
      unitRef="usd">7490000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjAtNS0xLTEtNDg5MDY_641453e3-4d50-455f-bb89-71ad7aee6d6e"
      unitRef="usd">15408000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMS0xLTEtNDg5MDY_9e9a276d-b010-44c8-ad58-c0d36eeffb92"
      unitRef="usd">-1917000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMy0xLTEtNDg5MDY_4855e7ad-2b61-4852-a0eb-8f0a500f5d7e"
      unitRef="usd">-20000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtNS0xLTEtNDg5MDY_21186b74-a572-4f85-b4f3-8809f04aa9b6"
      unitRef="usd">-971000</us-gaap:OtherNonoperatingIncomeExpense>
    <nstg:GainLossOnExtinguishmentAndTerminationOfDebt
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMS0xLTEtNzA3NzU_a4533da7-4dda-4cfe-ba22-fbee5a6c872a"
      unitRef="usd">0</nstg:GainLossOnExtinguishmentAndTerminationOfDebt>
    <nstg:GainLossOnExtinguishmentAndTerminationOfDebt
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtMy0xLTEtNzA3NzU_6757c261-9df9-4c56-9c98-4598fcda4db8"
      unitRef="usd">0</nstg:GainLossOnExtinguishmentAndTerminationOfDebt>
    <nstg:GainLossOnExtinguishmentAndTerminationOfDebt
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjEtNS0xLTEtNzA3NzU_f024d077-6aec-48a9-9e86-9e3cdd4c7ce9"
      unitRef="usd">-7143000</nstg:GainLossOnExtinguishmentAndTerminationOfDebt>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjItMS0xLTEtNDg5MDY_073e8e73-544e-420b-9997-b86d4da0066d"
      unitRef="usd">-7043000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjItMy0xLTEtNDg5MDY_0c27c8e3-db9c-420b-a8f8-b4ef12121666"
      unitRef="usd">-6861000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjItNS0xLTEtNDg5MDY_29d786bc-20ea-419a-b9cc-76a8e735a85c"
      unitRef="usd">-21778000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjMtMS0xLTEtNDg5MDY_a1e575f0-20d4-4a91-81c1-f0a47c685504"
      unitRef="usd">-159226000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjMtMy0xLTEtNDg5MDY_e6db8bbc-448f-43a4-a173-6b2598049fad"
      unitRef="usd">-115087000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjMtNS0xLTEtNDg5MDY_09aa941e-c199-4ed0-adc7-1a009f59ad1c"
      unitRef="usd">-109825000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjQtMS0xLTEtNDg5MDY_52abb126-083a-454e-86a6-5ddfdf6f5df2"
      unitRef="usd">317000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjQtMy0xLTEtNDg5MDY_6e742530-c631-4fdc-bdf3-ddbfabf3af7d"
      unitRef="usd">167000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjQtNS0xLTEtNDg5MDY_469075e1-99de-415d-ad20-8f179a21b038"
      unitRef="usd">253000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjUtMS0xLTEtNDg5MDY_5f95fbd1-aa02-4531-85e5-458ab616dc7d"
      unitRef="usd">-159543000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjUtMy0xLTEtNDg5MDY_3d3799eb-0fdc-4d25-a079-b5922a0eb225"
      unitRef="usd">-115254000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjUtNS0xLTEtNDg5MDY_8b8d7e84-956f-4bcc-abb5-aaca4bc53c29"
      unitRef="usd">-110078000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMS0xLTEtNDg5MDY_5e51b840-32db-4c1e-bc42-abcfc6c072bd"
      unitRef="usdPerShare">-3.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMS0xLTEtNDg5MDY_8a92e521-aa12-4eea-b6d2-8a1f05b15d6b"
      unitRef="usdPerShare">-3.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMy0xLTEtNDg5MDY_72fed3b0-037a-4af8-97a5-c9ca11f23cc8"
      unitRef="usdPerShare">-2.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtMy0xLTEtNDg5MDY_f6c0d721-06e5-47b2-899c-b2ff9aca458e"
      unitRef="usdPerShare">-2.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtNS0xLTEtNDg5MDY_68963622-ce3a-4cf4-8ecb-298a0be6a14f"
      unitRef="usdPerShare">-2.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjYtNS0xLTEtNDg5MDY_af464dba-eb02-4020-8344-888e9d2eb8d8"
      unitRef="usdPerShare">-2.82</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMS0xLTEtNDg5MDY_03329ca3-6224-4030-9f90-69a7107451c2"
      unitRef="shares">46406000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMS0xLTEtNDg5MDY_3e60c997-2e9b-4718-aa17-deb1a08e1100"
      unitRef="shares">46406000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMy0xLTEtNDg5MDY_3b7daeb4-97fc-4e6e-9de9-db841b0c9e3f"
      unitRef="shares">45299000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctMy0xLTEtNDg5MDY_4ba2fda5-2f4e-4ab6-98a5-2375eea6d11d"
      unitRef="shares">45299000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctNS0xLTEtNDg5MDY_92947a73-b835-4cd6-b561-89e8f6d73c6e"
      unitRef="shares">39083000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV85Ny9mcmFnOmY0YzU0NWMyMzkxYjRkYTRhYTc0ZWJmYjU2MTMzZGVlL3RhYmxlOmExMDY5NTFmM2Y3ZTQ2N2M4MDFjNDA5NDA4MjIyZmUxL3RhYmxlcmFuZ2U6YTEwNjk1MWYzZjdlNDY3YzgwMWM0MDk0MDgyMjJmZTFfMjctNS0xLTEtNDg5MDY_d8306f36-6e80-48cd-bc05-aaaa4174b37f"
      unitRef="shares">39083000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzMtMS0xLTEtNDg5MDY_f098db0a-8130-4108-bd5b-0d7d46a8c860"
      unitRef="usd">-159543000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzMtMy0xLTEtNDg5MDY_242a0a55-5ecb-43da-aeb9-8c865b07a077"
      unitRef="usd">-115254000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzMtNS0xLTEtNDg5MDY_f4da29e6-dc4c-4266-80e9-17db59b6c6d4"
      unitRef="usd">-110078000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzUtMS0xLTEtNDg5MDY_0d4f616b-8a8c-45ba-966d-8811454e3b1f"
      unitRef="usd">-271000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzUtMy0xLTEtNDg5MDY_747b2a5d-bb92-491f-9408-9cbc37cc3f40"
      unitRef="usd">-401000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzUtNS0xLTEtNDg5MDY_da1699d6-6ad0-4858-8dbf-ba1cd638d5e2"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzYtMS0xLTEtNDg5MDY_86bd0468-7a64-4e54-86f8-2c80d1ed3553"
      unitRef="usd">-159814000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzYtMy0xLTEtNDg5MDY_444626ee-0ee2-4ba3-aad7-80f2b753da71"
      unitRef="usd">-115655000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDAvZnJhZzowZWIxODMzMWZjODE0MDA0OWZkNmViNWIwYzIzY2ZjYS90YWJsZTo5MDE5MDYwYTYwNjc0NDcyODNhN2ZmMDg4MmVmN2UyYi90YWJsZXJhbmdlOjkwMTkwNjBhNjA2NzQ0NzI4M2E3ZmYwODgyZWY3ZTJiXzYtNS0xLTEtNDg5MDY_763ea2dd-e531-474c-a3dd-35814bf762f6"
      unitRef="usd">-110140000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="ib6fb5a9c83554516897179bdc578a26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtMS0xLTEtNDg5MDY_c06e6fbd-09f5-4457-9478-7348fb4185c1"
      unitRef="shares">36298000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib6fb5a9c83554516897179bdc578a26e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtMy0xLTEtNDg5MDY_8a679a03-9b8c-41a8-88cf-712b9004b63d"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia0d76b57e37a47d9993ee86018d00cce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtNS0xLTEtNDg5MDY_15e9eb40-a446-4fd1-9c9a-9c9ebd1da371"
      unitRef="usd">535954000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic69d192ea60b4dd99f62ed25f1930652_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtNy0xLTEtNDg5MDY_b12ef64f-9603-451c-82d2-a7abb3efff32"
      unitRef="usd">145000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2dcc651b739c4a8797ff28c930d6411a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtOS0xLTEtNDg5MDY_a59db6d1-3fe8-4c32-9a35-3ce4772b15ae"
      unitRef="usd">-431952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMtMTEtMS0xLTQ4OTA2_fef26843-9ff4-4219-8b9b-ff175b0103ed"
      unitRef="usd">104151000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtMC0xLTEtOTk0MzAvdGV4dHJlZ2lvbjo5NmNhNmRiMTUzY2Q0OGViOTM3YjlmNmM0YTA4NTk2Y18zMjk4NTM0ODgzMzk0_f2b67079-f367-4db7-a297-93f7a816e08b"
      unitRef="usd">14200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtMS0xLTEtOTk0MzM_128a7e3b-62c0-472b-b26b-492dc97fa565"
      unitRef="shares">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtNS0xLTEtOTk0NDU_ef6cae17-ff0a-4b53-9eaf-46606913e180"
      unitRef="usd">215765000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzQtMTEtMS0xLTk5NDYx_0ca04135-e912-4055-98a9-65da40f66875"
      unitRef="usd">215765000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzUtNS0xLTEtOTg1ODQ_b31175a2-0795-4ad8-9bb4-2bc59d0d53fe"
      unitRef="usd">58543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzUtMTEtMS0xLTk5NDAy_25e1a3c9-a044-4d80-b8f9-f4b3ab9a5899"
      unitRef="usd">58543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzYtMS0xLTEtOTgzNTg_aaf7948d-23ef-4776-912c-11ea9b363ac2"
      unitRef="shares">1890000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzYtNS0xLTEtOTgzNTg_9880bf83-c875-4f65-9445-3d2a1d1eb928"
      unitRef="usd">18751000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzYtMTEtMS0xLTk5NDA0_e48fa4e6-a425-47c3-a3d4-c1acb5974e2c"
      unitRef="usd">18751000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzctMS0xLTEtNDg5MDY_cb87175d-4eba-4c32-be7d-d6d72ecaa04d"
      unitRef="shares">89000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzctNS0xLTEtNDg5MDY_f327b0ce-65ed-47c3-9e20-9c46b6f3c4d1"
      unitRef="usd">2190000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzctMTEtMS0xLTQ4OTA2_f3edb304-8992-4cc1-b80f-17fec4a6a803"
      unitRef="usd">2190000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktNS0xLTEtOTg3NDg_cc615a83-f2e6-4b8d-9aa8-08412b25f78a"
      unitRef="usd">737000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzgtMTEtMS0xLTk5NDY3_cbe3121b-bcf2-44aa-9b16-452f89ba4682"
      unitRef="usd">737000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i5f559acbf7a94475909e3c1663266216_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktMS0xLTEtOTg4MDc_7d4c1179-0f63-483f-9309-2c787deb32b2"
      unitRef="shares">414000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktMTEtMS0xLTk5NDY5_7d9b3cd9-b0fa-4db9-a736-a701295aa97c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzgtNS0xLTEtNDg5MDY_03ed6629-c397-4989-a15c-adb2a17834ad"
      unitRef="usd">2012000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzgtMTEtMS0xLTQ4OTA2_1ed09313-cd7c-4607-a05f-905376e1c800"
      unitRef="usd">2012000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i600cfb5bd3a2477d87a868750da19e62_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktNS0xLTEtOTg0MjM_ddf5cead-708c-4019-b75b-ce9e4d73b230"
      unitRef="usd">18963000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTExLTEtMS05OTU1MA_87208b08-80d9-4eb5-b2f8-55b0753f7e3c"
      unitRef="usd">18963000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="id90f105c4d55494b94cc0ab76173b5fc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTktMS0xLTk4NDIz_27d9e180-b58f-47a8-bcef-1d3c8d6b7ade"
      unitRef="usd">-110078000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTExLTEtMS05OTQ3NQ_bb8ddac6-86b4-4a2e-9e08-cd585710039d"
      unitRef="usd">-110078000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b9f3b07c6934ad3a071ba90567014cb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktNy0xLTEtNDg5MDY_f6da655f-7092-41aa-8a11-8b9667305166"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzktMTEtMS0xLTQ4OTA2_37ce9c4a-7eeb-4200-861f-2084a5baa1b6"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i76e439fcce3243a282b799121be03534_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTEtMS0xLTk4MTUw_c2d17223-9dbc-4ef8-8fd8-370c15d7cf72"
      unitRef="shares">44441000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i76e439fcce3243a282b799121be03534_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTMtMS0xLTk4MTUw_3601315b-e7ba-4a55-a158-46668539dcd1"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i91d3517a5cd04697bc20f69fca9c1aea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTUtMS0xLTk4MTUw_2e57f07f-7776-409a-a3fc-77662da94231"
      unitRef="usd">848891000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02f27c9fc5a14f6a9ad7a0207ca76205_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTctMS0xLTk4MTUw_0b183513-3f2a-4cfd-862b-3c11c8f7f51f"
      unitRef="usd">83000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i340b839d193a417b9994bc351dbdcd6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTktMS0xLTk4MTUw_20bd5890-852f-4a59-8849-927d130e064e"
      unitRef="usd">-542030000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEwLTExLTEtMS05ODE5OA_25cacfcd-2731-48a7-a273-4f35a40a463e"
      unitRef="usd">306948000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc30b4ddea0947eeadd32b726a42601a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE1LTUtMS0xLTk4OTUz_d09d45e0-2cc6-431f-9403-5dff36974a24"
      unitRef="usd">-58543000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4679a98afee44ff854f9a3fe34a94e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE1LTktMS0xLTk4OTY1_6cc09835-f89e-4c19-bc6b-23087a3ea4ca"
      unitRef="usd">7531000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i21fa537a67cc4008a5f886347dd4fca6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE1LTExLTEtMS05OTQ5OA_036fc3ad-727f-492c-827f-49bf56e02a51"
      unitRef="usd">-51012000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTEtMS0xLTQ4OTA2_1bb3f26e-d176-43ee-956c-7198036db5ee"
      unitRef="shares">1223000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTMtMS0xLTQ4OTA2_737b4d4c-e58a-4599-871e-25603c743d97"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTUtMS0xLTQ4OTA2_82b40bae-79c0-4618-902c-5c8ed2c15abb"
      unitRef="usd">6452000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzExLTExLTEtMS00ODkwNg_0529c575-006d-4b9d-a40a-28172fbbe5fc"
      unitRef="usd">6453000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE5LTUtMS0xLTk5MDQx_e05019e6-67bf-454d-a5ea-d85a0c036c53"
      unitRef="usd">2585000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzE3LTExLTEtMS05OTUwNg_1bccc5df-35ad-4d16-be02-1e4c776471be"
      unitRef="usd">2585000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="icc0e21501abf40e6a853a5bc7d604ca6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTEtMS0xLTQ4OTA2_1113f970-9046-4f4b-945b-1b9a571859bd"
      unitRef="shares">65000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTUtMS0xLTQ4OTA2_755d28e8-2168-4542-a8a7-f88d1e69e123"
      unitRef="usd">2428000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzEyLTExLTEtMS00ODkwNg_aaf8dc3c-e8fd-448f-877a-e5bcf03d6088"
      unitRef="usd">2428000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i27aa7b231862406db76f50681fa18e57_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIyLTUtMS0xLTQ4OTA2_4606b9e9-fce4-49de-a3e1-44b799d9e5a9"
      unitRef="usd">30385000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIyLTExLTEtMS00ODkwNg_ad4aa1d6-04fc-4e84-908d-135cb88cc7ca"
      unitRef="usd">30385000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="id1a626949d3a48359028bdd61bb4b96f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIzLTktMS0xLTQ4OTA2_32d359ce-8b7e-4793-8f32-4114a40847ef"
      unitRef="usd">-115254000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzIzLTExLTEtMS00ODkwNg_50489fa7-212a-4e6d-991d-bf895ace4137"
      unitRef="usd">-115254000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c1797d70c2647f984286d05d5bef521_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI1LTctMS0xLTQ4OTA2_58f33def-2674-4f58-b34c-3622e92087cf"
      unitRef="usd">-401000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI1LTExLTEtMS00ODkwNg_f50920ec-c35e-461b-bff8-5c3efac83e08"
      unitRef="usd">-401000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i95a95c99a0394cb69b14efb2f1306862_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTEtMS0xLTQ4OTA2_59c843a4-afe5-4dd4-83b1-14dfb196973a"
      unitRef="shares">45729000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i95a95c99a0394cb69b14efb2f1306862_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTMtMS0xLTQ4OTA2_6672050a-276a-4c5c-936f-1715ab093b8b"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i895d001213eb4fbdbfe3970d1d470a5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTUtMS0xLTQ4OTA2_c77041d4-f574-465b-a03c-d5a8b829f2f1"
      unitRef="usd">827028000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i920455eea78d4de0b3a820010c833f50_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTctMS0xLTQ4OTA2_8977587f-8f18-41ee-a226-e55b62ce6673"
      unitRef="usd">-318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i444d8e8a93bb4467a4ce845e986e6410_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTktMS0xLTQ4OTA2_244989a3-c966-4372-b4aa-cd5a20ca7b68"
      unitRef="usd">-649753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTExLTEtMS00ODkwNg_a64bb8f9-ba84-4733-af63-4edffbf1d5cc"
      unitRef="usd">176962000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i24476a394b0d460abebd9ddff5142056_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTEtMS0xLTQ4OTA2_e229e8f7-e7fc-4599-be03-a3afc61dbae0"
      unitRef="shares">840000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTUtMS0xLTQ4OTA2_8978f4f9-3ba5-4aa7-bdc7-26e1b4958b95"
      unitRef="usd">1440000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTExLTEtMS00ODkwNg_c61f7c40-0e9d-48dd-b60a-316513697f7c"
      unitRef="usd">1440000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMwLTUtMS0xLTQ4OTA2_b97d0581-3eb0-4f09-93fb-d2a3037d7288"
      unitRef="usd">1504000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMwLTExLTEtMS00ODkwNg_4f1fcbc5-0f24-47ac-b124-d50eaf01ba0a"
      unitRef="usd">1504000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i24476a394b0d460abebd9ddff5142056_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMxLTEtMS0xLTQ4OTA2_340880c6-95a2-4a6f-89cd-6fbb1b00a98c"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMxLTUtMS0xLTQ4OTA2_2a10843c-256f-447a-95a8-662edd33be30"
      unitRef="usd">2669000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMxLTExLTEtMS00ODkwNg_84c2ff52-f05d-4dd3-8c3c-d7547b248daa"
      unitRef="usd">2669000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i68c123b35bc44c839c2818e081176609_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI4LTUtMS0xLTk4NDIz_53d9d999-c00d-4e47-95b1-58f0b34287c1"
      unitRef="usd">26061000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI2LTExLTEtMS05OTU2Nw_4d056709-6461-47c5-af04-cf880b54f02b"
      unitRef="usd">26061000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i63cda06a33214436ac73d2d0c4af2fa8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTktMS0xLTk4NDIz_d28c081d-a214-4b7e-b2cf-2c8c57c03d12"
      unitRef="usd">-159543000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI3LTExLTEtMS05OTU2NQ_063da6dd-212c-4c94-a487-c30ef9e967dc"
      unitRef="usd">-159543000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i187572d253d54fb6b91f8db3fcb8f370_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzMzLTctMS0xLTk5MzYz_06376eb0-b7da-4e4f-8bef-0a5a558053ba"
      unitRef="usd">-271000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI4LTExLTEtMS05OTU2Mg_e4af5006-849a-4d65-98dc-3ab3015910ad"
      unitRef="usd">-271000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="ib08fc922969543ebbe9caf9316b0f2af_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTEtMS0xLTk5NTM1_b6d13d4a-b26e-4f0e-b4b5-233a98b68da7"
      unitRef="shares">46719000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib08fc922969543ebbe9caf9316b0f2af_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTMtMS0xLTk5NTM3_0703788f-205b-486a-b17d-41aa4d3aeb32"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9403952b5e824b5794d4bb6ed1b3c7ba_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTUtMS0xLTk5NTM5_ebb34c83-d388-4e6c-8bcd-1f2eef1f9874"
      unitRef="usd">855694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idfa5c83df28b49dd8e19aa82d32557ac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTctMS0xLTk5NTQx_326173f3-84b4-4756-b216-43af91950860"
      unitRef="usd">-589000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2e3db979b8cc4c70acfae0b6db21e315_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTktMS0xLTk5NTQz_8e50f7f6-1f02-4ede-a55d-a0b190268e8a"
      unitRef="usd">-809296000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDMvZnJhZzpkZWZhZDZmODc4YzU0NjY5OTc5ZWVkZDI0YjMyODIxMC90YWJsZTpjMTZhODRkYmFkNTc0NDliYTY5MTM5NzI4Njc0YjFjNC90YWJsZXJhbmdlOmMxNmE4NGRiYWQ1NzQ0OWJhNjkxMzk3Mjg2NzRiMWM0XzI5LTExLTEtMS05OTU0NQ_90dd5197-f444-4fce-86e4-136822e5a13b"
      unitRef="usd">45814000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQtMS0xLTEtNDg5MDY_f098db0a-8130-4108-bd5b-0d7d46a8c860"
      unitRef="usd">-159543000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQtMy0xLTEtNDg5MDY_242a0a55-5ecb-43da-aeb9-8c865b07a077"
      unitRef="usd">-115254000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQtNS0xLTEtNDg5MDY_f4da29e6-dc4c-4266-80e9-17db59b6c6d4"
      unitRef="usd">-110078000</us-gaap:NetIncomeLoss>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMS0xLTEtNzUxOTM_37dfeee4-88ac-45b9-8300-e3c242389a6a"
      unitRef="usd">25908000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMy0xLTEtNzUxOTM_125f6d85-962e-49ea-80ef-d0d13e34354a"
      unitRef="usd">30173000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtNS0xLTEtNzUxOTM_4a006387-25ae-487c-9bbd-7fe4cb1cc9ab"
      unitRef="usd">19374000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMS0xLTEtNDg5MDY_0789a2bf-a96d-43bb-9098-7aef4d447fa3"
      unitRef="usd">8116000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtMy0xLTEtNDg5MDY_ccac8f5d-6115-4fb9-a3aa-968e1aec6d30"
      unitRef="usd">5871000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzYtNS0xLTEtNDg5MDY_fde7fb57-8863-4f1b-9db9-685486a29750"
      unitRef="usd">5738000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzgtMS0xLTEtNDg5MDY_df81c3e3-3c6f-4f86-af58-5a321dca6ef3"
      unitRef="usd">4089000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzgtMy0xLTEtNDg5MDY_3443ed5c-380c-4d2e-a3db-1779aa7960f0"
      unitRef="usd">3450000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzgtNS0xLTEtNDg5MDY_7ea3800b-64d8-4ed3-ac7c-e51b36544ff1"
      unitRef="usd">3238000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <nstg:InterestAccruedOnLongTermNotes
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMS0xLTEtNzUyMDY_64cfd684-2728-4073-85d6-cf3e64ad3c80"
      unitRef="usd">1477000</nstg:InterestAccruedOnLongTermNotes>
    <nstg:InterestAccruedOnLongTermNotes
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMy0xLTEtNzUyMDY_bdb27ca0-d093-4cf1-bd69-80324c7ea565"
      unitRef="usd">1429000</nstg:InterestAccruedOnLongTermNotes>
    <nstg:InterestAccruedOnLongTermNotes
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktNS0xLTEtNzUyMDY_5f9553e8-a282-4341-9bc2-3699f099edbb"
      unitRef="usd">8881000</nstg:InterestAccruedOnLongTermNotes>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzEwLTEtMS0xLTc1MjE4_b6257eca-b123-4592-9116-f6ccc9c1455b"
      unitRef="usd">-1706000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzEwLTMtMS0xLTc1MjE4_d18bda7a-f69c-43ce-8716-da2c776f12ff"
      unitRef="usd">1765000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzEwLTUtMS0xLTc1MjE4_30f266da-6115-424f-ad9e-e3ba8ade44fe"
      unitRef="usd">121000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InventoryWriteDown
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTEtMS0xLTc1MjM0_86b5c2a7-84c8-4ad2-a3b0-91a5c5f6d7a1"
      unitRef="usd">4023000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTMtMS0xLTc1MjM0_90c3ce75-4cb1-4e3c-80df-af9485be3a00"
      unitRef="usd">2040000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTUtMS0xLTc1MjM0_1c011004-cb75-4a8f-b679-0f96f1f217ff"
      unitRef="usd">886000</us-gaap:InventoryWriteDown>
    <nstg:RepaymentOfAccruedInterestOfLongTermDebt
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMS0xLTEtNjQ2Mzc_4e4d1f29-bbc9-4333-a091-9a4f1cf28a80"
      unitRef="usd">0</nstg:RepaymentOfAccruedInterestOfLongTermDebt>
    <nstg:RepaymentOfAccruedInterestOfLongTermDebt
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktMy0xLTEtNjQ2Mzc_f5d7ef2c-1881-4de5-92cb-4929d37b59fc"
      unitRef="usd">0</nstg:RepaymentOfAccruedInterestOfLongTermDebt>
    <nstg:RepaymentOfAccruedInterestOfLongTermDebt
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzktNS0xLTEtNjQ2Mzc_da806e73-a240-41b3-897c-625d5440f3d7"
      unitRef="usd">2593000</nstg:RepaymentOfAccruedInterestOfLongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTEtMS0xLTY0NjQ1_29e60428-2c22-433d-88e1-3732358e3c69"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTMtMS0xLTY0NjQ1_b7ba0f6e-6f48-4561-b243-faecced24cb0"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTUtMS0xLTY0NjQ1_0182c611-e5df-4312-a56c-9a4cc19c2b07"
      unitRef="usd">-7143000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTEtMS0xLTQ4OTA2_35766391-48ad-4939-b035-179066d64e88"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTMtMS0xLTQ4OTA2_1af85e19-7be8-4d2f-bf2a-46255191f81b"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzExLTUtMS0xLTQ4OTA2_b48b26c6-1593-4b15-8b33-7445be11c63d"
      unitRef="usd">-300000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE2LTEtMS0xLTQ4OTA2_9e52c704-1915-4cfa-9b65-11f5075e608d"
      unitRef="usd">-847000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE2LTMtMS0xLTQ4OTA2_dd983e44-cc9f-4e95-8ae8-2d220f0f6752"
      unitRef="usd">-5000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE2LTUtMS0xLTQ4OTA2_934fe796-f55b-4398-87d8-e76af2e99b19"
      unitRef="usd">-119000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE5LTEtMS0xLTQ4OTA2_e9d60929-a070-4149-a22a-91da0e016cd7"
      unitRef="usd">-7414000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE5LTMtMS0xLTQ4OTA2_6fbd4222-693f-4e18-bd5c-8d680049235b"
      unitRef="usd">9526000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzE5LTUtMS0xLTQ4OTA2_d5b1f622-ad04-48c0-a6f0-0afc1bba3acf"
      unitRef="usd">3949000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIwLTEtMS0xLTQ4OTA2_7b722f42-3a97-461a-8cc1-2501b17b774c"
      unitRef="usd">15271000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIwLTMtMS0xLTQ4OTA2_68180c7e-46fe-4342-b65e-a349fbdf3c74"
      unitRef="usd">10520000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIwLTUtMS0xLTQ4OTA2_294ef778-f720-40bf-b4bf-b9e184024911"
      unitRef="usd">4909000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIxLTEtMS0xLTQ4OTA2_9095346a-2dc6-4dc2-8788-bb5ec42809c1"
      unitRef="usd">6942000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIxLTMtMS0xLTQ4OTA2_8126cca4-f62b-4801-8f6c-a6b7a0a77a79"
      unitRef="usd">5443000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIxLTUtMS0xLTQ4OTA2_3554d2ac-5208-4076-a43f-1ebb6a7d23e2"
      unitRef="usd">-4321000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIyLTEtMS0xLTQ4OTA2_2f54e0b6-d594-40f9-a892-eaa7f63b38d2"
      unitRef="usd">1396000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIyLTMtMS0xLTQ4OTA2_9e8a1cb7-8714-4f33-a17b-cecb3c16f86b"
      unitRef="usd">8687000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIyLTUtMS0xLTQ4OTA2_afc7015d-3cd2-42eb-9a6e-5c6a79df1bb0"
      unitRef="usd">-3170000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIzLTEtMS0xLTQ4OTA2_e45f4778-ef7d-4687-a8cb-24f3b436afb6"
      unitRef="usd">-407000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIzLTMtMS0xLTQ4OTA2_e969b14e-28ca-462d-8429-ff70fc254e32"
      unitRef="usd">-914000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzIzLTUtMS0xLTQ4OTA2_f49107ea-3a4b-465c-880f-fec223200ae5"
      unitRef="usd">-21000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI0LTEtMS0xLTQ4OTA2_39987fc6-395f-48bf-8d44-51159195ffea"
      unitRef="usd">256000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI0LTMtMS0xLTQ4OTA2_ff268d55-f7df-4330-a4d0-c7621c29e44e"
      unitRef="usd">2497000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI0LTUtMS0xLTQ4OTA2_937e5af4-efa6-4ba4-936e-ab6097b3f203"
      unitRef="usd">-936000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI1LTEtMS0xLTQ4OTA2_7ebee0e1-bbc9-45af-8587-bb16a76338ec"
      unitRef="usd">479000</nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits>
    <nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI1LTMtMS0xLTQ4OTA2_1e72d686-106c-46ec-9183-c925ee0c30c6"
      unitRef="usd">-353000</nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits>
    <nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI1LTUtMS0xLTQ4OTA2_ab7a24b4-c889-4636-8aae-c95397b1017d"
      unitRef="usd">-4758000</nstg:ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI2LTEtMS0xLTQ4OTA2_f071e4d9-c399-4806-a73a-7f34a018e11a"
      unitRef="usd">2674000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI2LTMtMS0xLTQ4OTA2_53836426-2166-4c04-9c3a-cb09cd288ff3"
      unitRef="usd">3336000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI2LTUtMS0xLTQ4OTA2_8bd752bc-47e5-4ea6-b73d-a5ba39d98c0c"
      unitRef="usd">2033000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <nstg:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI3LTEtMS0xLTQ4OTA2_bca761f1-ef67-45a1-be5a-a1d5e81f3292"
      unitRef="usd">-4828000</nstg:IncreaseDecreaseInOperatingLeaseLiabilities>
    <nstg:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI3LTMtMS0xLTQ4OTA2_7f35e44f-ad83-4827-b1e5-9bc09aa1d67f"
      unitRef="usd">-4262000</nstg:IncreaseDecreaseInOperatingLeaseLiabilities>
    <nstg:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI3LTUtMS0xLTQ4OTA2_30291b69-ed94-4e4e-9e67-f665680abd71"
      unitRef="usd">-3160000</nstg:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI4LTEtMS0xLTQ4OTA2_7fd47cce-ba28-47b2-8f53-24deadcdf7a3"
      unitRef="usd">-128606000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI4LTMtMS0xLTQ4OTA2_f1c5ae07-3ce1-4881-822b-6c84db7d71db"
      unitRef="usd">-90549000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzI4LTUtMS0xLTQ4OTA2_714af7e8-2d60-4eb6-8af3-79ecdd2812e9"
      unitRef="usd">-81662000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTEtMS0xLTQ4OTA2_bd1d8244-33d1-4871-83dd-0378850c4e37"
      unitRef="usd">14364000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTMtMS0xLTQ4OTA2_fe2717b1-2322-425f-9c4e-a92fc809b7bf"
      unitRef="usd">6348000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTUtMS0xLTQ4OTA2_5b28aad0-df1d-4681-a1f8-d4e2612600bf"
      unitRef="usd">7457000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForSoftware
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMxLTEtMS0xLTQ4OTA2_df3fb1c2-e269-4f20-aa3e-98736cd6aab7"
      unitRef="usd">7952000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMxLTMtMS0xLTQ4OTA2_875ed1ab-ea53-404b-b6dc-c1c26b6f746d"
      unitRef="usd">2299000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMxLTUtMS0xLTQ4OTA2_0e3d493b-3996-456d-8345-28ac778d649b"
      unitRef="usd">0</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTEtMS0xLTc1MjUx_c2058428-ed2a-4dfa-ae23-7e21471209a3"
      unitRef="usd">750000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTMtMS0xLTc1MjUx_f143ef0e-4ffd-4c38-b20e-fbed3eda629d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMwLTUtMS0xLTc1MjUx_08514cd7-87f2-4eeb-b348-d4f43c1ca14c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMzLTEtMS0xLTQ4OTA2_2b690e99-50ef-4c93-a6c0-8c2aa03cd8b2"
      unitRef="usd">7700000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMzLTMtMS0xLTQ4OTA2_d66638bc-8255-4b12-ac72-92133a14e473"
      unitRef="usd">4000000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzMzLTUtMS0xLTQ4OTA2_72de91f9-0bdf-440d-a885-db8cd85daea8"
      unitRef="usd">21218000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM0LTEtMS0xLTQ4OTA2_98c67bf1-0402-4d4c-b017-fc40861e649a"
      unitRef="usd">197363000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM0LTMtMS0xLTQ4OTA2_21d9067b-6b95-4187-b453-b4b91e84485f"
      unitRef="usd">44664000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM0LTUtMS0xLTQ4OTA2_f62cb79f-fb41-4ef2-84d0-177edaa49dee"
      unitRef="usd">116284000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM1LTEtMS0xLTQ4OTA2_861440aa-b361-447c-b3cd-74e92d4c1e8b"
      unitRef="usd">49500000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM1LTMtMS0xLTQ4OTA2_2c9bd83c-548c-401f-b8ba-9861961e1818"
      unitRef="usd">260239000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM1LTUtMS0xLTQ4OTA2_ba58c694-5cbe-42b2-832d-dedc4fc9a6f3"
      unitRef="usd">38804000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM2LTEtMS0xLTQ4OTA2_69cc7077-c7eb-4177-9968-7e1026222c9b"
      unitRef="usd">132497000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM2LTMtMS0xLTQ4OTA2_ee50f34c-9711-466a-8d45-623ca7660498"
      unitRef="usd">-220222000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM2LTUtMS0xLTQ4OTA2_6f57a8f0-735b-469b-8a68-01447a3ee109"
      unitRef="usd">91241000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM4LTEtMS0xLTQ4OTA2_27e3a5eb-ee69-4046-b5f8-a1111b60613b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM4LTMtMS0xLTQ4OTA2_51c3398c-8f5e-4d8b-b5c6-db319213ac75"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM4LTUtMS0xLTQ4OTA2_e0626d69-3434-4952-997f-0735eed158e8"
      unitRef="usd">230000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM5LTEtMS0xLTQ4OTA2_db50c1ca-a536-41d6-97bb-80784ce31f8a"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM5LTMtMS0xLTQ4OTA2_d635e252-73ad-422f-b974-3bbe1470208c"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzM5LTUtMS0xLTQ4OTA2_fe813769-afcc-4015-8557-894c75c34447"
      unitRef="usd">7403000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQwLTEtMS0xLTQ4OTA2_f6c0fac4-cb23-4f20-801a-0749ee45717f"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQwLTMtMS0xLTQ4OTA2_a92ef66d-b88e-4dce-933f-37f773c563e1"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQwLTUtMS0xLTQ4OTA2_d5517391-e425-431d-a462-9ba6b71d07a1"
      unitRef="usd">80000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQxLTEtMS0xLTQ4OTA2_af27ea60-fc75-44f5-9d3f-3c0e46eca93c"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQxLTMtMS0xLTQ4OTA2_c74fdf21-d88f-4b80-be8b-97f9031a5e76"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQxLTUtMS0xLTQ4OTA2_c3b87fee-7c2c-46dd-8db8-e8ccbf2e3a2d"
      unitRef="usd">4845000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQyLTEtMS0xLTQ4OTA2_170d48f1-36f7-4c9d-b544-62c07123eed5"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQyLTMtMS0xLTQ4OTA2_e054c29e-4306-45bc-aa96-239e38866132"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQyLTUtMS0xLTQ4OTA2_2b6b4c84-e90f-473c-a67a-97bd9390dd97"
      unitRef="usd">215765000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQzLTEtMS0xLTQ4OTA2_dcf1ad25-f91f-4e3e-b391-9b7d69dbfa86"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQzLTMtMS0xLTQ4OTA2_a95e2d88-9b0c-43d1-bdba-be21a84939e1"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQzLTUtMS0xLTQ4OTA2_ca714c31-542b-4940-8062-23b5bb1c3289"
      unitRef="usd">737000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ0LTEtMS0xLTQ4OTA2_4892250b-c66b-48be-8721-c1f1d0d71920"
      unitRef="usd">2669000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ0LTMtMS0xLTQ4OTA2_23873641-f8d8-413c-a901-8481fa2f01df"
      unitRef="usd">2427000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ0LTUtMS0xLTQ4OTA2_67bb3773-0d4f-442c-be63-08e31176cdd5"
      unitRef="usd">2190000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ1LTEtMS0xLTQ4OTA2_8c77651b-fbe0-473d-8ee7-14fc37f64c6f"
      unitRef="usd">1504000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ1LTMtMS0xLTQ4OTA2_e1faf012-d756-450e-b4ed-3a4ede21d50c"
      unitRef="usd">2585000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ1LTUtMS0xLTQ4OTA2_f1621f0e-db74-4459-80a0-7793024da575"
      unitRef="usd">2012000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ2LTEtMS0xLTQ4OTA2_6c06b5f4-8280-4d8b-810f-21d869c224b1"
      unitRef="usd">1440000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ2LTMtMS0xLTQ4OTA2_3a6d62ec-b72a-4d1a-a497-a3387c0174ef"
      unitRef="usd">6452000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ2LTUtMS0xLTQ4OTA2_827f235e-56bc-435e-96c0-fd06e8ce3dc4"
      unitRef="usd">18751000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ3LTEtMS0xLTQ4OTA2_f47901af-6144-4cbe-9994-6cf9bae3bc8f"
      unitRef="usd">333000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ3LTMtMS0xLTQ4OTA2_f44c5871-755f-4676-a8f6-faea3676b906"
      unitRef="usd">236000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ3LTUtMS0xLTQ4OTA2_ddfd665c-a44f-4690-a794-12694714dfb9"
      unitRef="usd">135000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ4LTEtMS0xLTQ4OTA2_192b7d5f-51f6-40c1-a985-41d58a1241d6"
      unitRef="usd">2272000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ4LTMtMS0xLTQ4OTA2_985bf772-1de6-4a7f-8699-0c0c8bd3c8c8"
      unitRef="usd">6058000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ4LTUtMS0xLTQ4OTA2_78081425-08e9-4ad0-a8f9-b4b21c79a562"
      unitRef="usd">373048000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ5LTEtMS0xLTQ4OTA2_6089ec4c-4fac-44a6-990d-7d112785e8af"
      unitRef="usd">-83000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ5LTMtMS0xLTQ4OTA2_3ce35cd1-2490-4bdf-93cd-55fb555908e9"
      unitRef="usd">-67000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzQ5LTUtMS0xLTQ4OTA2_e108c167-8bee-4886-98de-0ef22c848352"
      unitRef="usd">188000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUwLTEtMS0xLTQ4OTA2_b0363083-5f78-4639-b787-14815fe0149a"
      unitRef="usd">6080000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUwLTMtMS0xLTQ4OTA2_ca10fcdf-d542-4a6d-a51b-7b255b230356"
      unitRef="usd">-304780000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUwLTUtMS0xLTQ4OTA2_1c6655f4-d4e7-4e99-8425-dfb9b2fa5e40"
      unitRef="usd">382815000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUyLTEtMS0xLTQ4OTA2_6a1e4b4e-a618-41e1-94f8-2039c0401b59"
      unitRef="usd">107068000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUyLTMtMS0xLTQ4OTA2_801930fb-08c2-48d1-81e4-c27d1e4324cd"
      unitRef="usd">411848000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUyLTUtMS0xLTQ4OTA2_410bfea0-df3d-436f-8e8b-521d040f3795"
      unitRef="usd">29033000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUzLTEtMS0xLTQ4OTA2_41390a62-bcb6-4641-b3b6-51b10dc0caf6"
      unitRef="usd">113148000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUzLTMtMS0xLTQ4OTA2_89c883a7-78c7-4551-93ca-0fcf578d38ed"
      unitRef="usd">107068000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo1MTFhZTBiYTcyMTM0MmUxOWNhN2M0ZTc0MjQyMGMyMC90YWJsZXJhbmdlOjUxMWFlMGJhNzIxMzQyZTE5Y2E3YzRlNzQyNDIwYzIwXzUzLTUtMS0xLTQ4OTA2_affa77f4-9b47-4805-b5c1-233d45bf24b4"
      unitRef="usd">411848000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzUtMi0xLTEtMTEwMDMz_849ac9de-2334-41d8-a86f-3ad061ad79a7"
      unitRef="usd">112250000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzQtMy0xLTEtMTE5MDE0_bfe07c9c-fd8c-4f8b-ac4f-89bc75b3c301"
      unitRef="usd">107068000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzQtNS0xLTEtMTE5MDIw_b14489fe-55fe-45d9-8eba-08d79045d5a1"
      unitRef="usd">411848000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtMi0xLTEtMTEwMDM3_b365a849-bd7c-43ca-bb23-131549f0dba8"
      unitRef="usd">898000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzUtMy0xLTEtMTE5MDE2_c66ce6dc-393d-498f-9eca-62b6bf40964e"
      unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzUtNS0xLTEtMTE5MDIy_f5062f84-82a2-4de4-8963-6eb15f93984f"
      unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtMi0xLTEtMTEzNzY3_ec5f5d10-300c-4d80-8dd9-77c2a0a778d6"
      unitRef="usd">113148000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtMy0xLTEtMTE5MDE4_79cabbdc-554d-44bf-9ea6-188c146328d2"
      unitRef="usd">107068000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTo4N2FkZjM5Zjg2NjE0NDg3YjNkZGVkNDUxZWI1NTA2Yy90YWJsZXJhbmdlOjg3YWRmMzlmODY2MTQ0ODdiM2RkZWQ0NTFlYjU1MDZjXzYtNS0xLTEtMTE5MDI0_a8279025-96c8-42f6-9cff-245221d9747e"
      unitRef="usd">411848000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzQtMS0xLTEtNDg5MDY_b991d68d-ba63-48a3-8295-91e4205ba7fc"
      unitRef="usd">6038000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzQtMy0xLTEtNDg5MDY_19130ed7-6b8d-4de1-95f1-9bd3c73080be"
      unitRef="usd">6038000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzQtNS0xLTEtNDg5MDY_a055a264-f6f9-4707-8838-3f607f29da17"
      unitRef="usd">4571000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzUtMS0xLTEtNDg5MDY_c9988375-eca9-4092-8376-ce6d2cda98ec"
      unitRef="usd">180000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzUtMy0xLTEtNDg5MDY_457a0465-7b8a-4488-b201-ef5f58fedfa8"
      unitRef="usd">189000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzUtNS0xLTEtNDg5MDY_e895fd7a-cc66-46d3-b369-b054fdd4c0a8"
      unitRef="usd">357000</us-gaap:IncomeTaxesPaidNet>
    <nstg:RentalInstrumentsReclassifiedFromInventory
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzYtMS0xLTEtNDg5MDY_4b2992e0-2387-4e76-98f4-240f7ba4b2c1"
      unitRef="usd">665000</nstg:RentalInstrumentsReclassifiedFromInventory>
    <nstg:RentalInstrumentsReclassifiedFromInventory
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzYtMy0xLTEtNDg5MDY_c86fd537-453a-40cf-a22e-e9b9939f07ed"
      unitRef="usd">525000</nstg:RentalInstrumentsReclassifiedFromInventory>
    <nstg:RentalInstrumentsReclassifiedFromInventory
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzYtNS0xLTEtNDg5MDY_11b07e1a-e6c4-4818-bb9f-b83eb114e66b"
      unitRef="usd">854000</nstg:RentalInstrumentsReclassifiedFromInventory>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzctMS0xLTEtNDg5MDY_a2b3205a-93ad-464e-a0a2-b44f03e4869c"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzctMy0xLTEtNDg5MDY_84ec3734-5590-4fba-a58e-67b8fda61c1b"
      unitRef="usd">448000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzctNS0xLTEtNDg5MDY_80d06a00-2d85-4a7e-ab47-ba1590a4ed72"
      unitRef="usd">524000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzgtMS0xLTEtNDg5MDY_73c2158f-fea6-41c4-97a5-2af3e3693965"
      unitRef="usd">2126000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzgtMy0xLTEtNDg5MDY_3fa7dd07-4f3c-49be-9fcf-2f5f78a37c16"
      unitRef="usd">929000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMDYvZnJhZzo5MTE4Mjk2MDM1Zjg0N2RjOGNkN2I0YTQ1MjM2MDJjYS90YWJsZTozNDU1OWQ2OGQzNmI0NDY1YTRkMjQ0ZWFiOTRjMGE3MC90YWJsZXJhbmdlOjM0NTU5ZDY4ZDM2YjQ0NjVhNGQyNDRlYWI5NGMwYTcwXzgtNS0xLTEtNDg5MDY_c1ebc455-8969-4586-bc75-cac2f6090a7e"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTIvZnJhZzpmMzEzNDdhZDRjMGM0Y2IwOWRlN2UyMzJiYjJlZGVmMS90ZXh0cmVnaW9uOmYzMTM0N2FkNGMwYzRjYjA5ZGU3ZTIzMmJiMmVkZWYxXzczOA_4e78e67b-1dfc-43d0-8db4-39aecfb3ad69">Description of the BusinessNanoString Technologies, Inc. (the &#x201c;Company&#x201d;) was incorporated in the state of Delaware on June&#160;20, 2003. The Company&#x2019;s headquarters is located in Seattle, Washington. The Company&#x2019;s proprietary chemistries enable the direct detection, identification and quantification of individual target molecules in biological samples by attaching unique molecular reporters to each target molecule of interest. The Company currently markets and sells three platforms based on its proprietary technologies, its nCounter Analysis System, its GeoMx Digital Spatial Profiler, or &#x201c;GeoMx DSP&#x201d; or &#x201c;GeoMx&#x201d;, and CosMx Spatial Molecular Imager, or &#x201c;CosMx SMI&#x201d; or &#x201c;CosMx&#x201d;, all of which include instruments and consumables, to academic, government, biopharmaceutical, and clinical laboratory customers.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <nstg:NumberOfPlatforms
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTIvZnJhZzpmMzEzNDdhZDRjMGM0Y2IwOWRlN2UyMzJiYjJlZGVmMS90ZXh0cmVnaW9uOmYzMTM0N2FkNGMwYzRjYjA5ZGU3ZTIzMmJiMmVkZWYxXzQ3NQ_16c043a0-71c3-46b9-aadf-265172e357cb"
      unitRef="platform">3</nstg:NumberOfPlatforms>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTMy_eb2ed03e-44d0-498e-b9ee-7974b249966f">Significant Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Principles and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). The accompanying consolidated financial statements reflect the accounts of the Company and its wholly-owned subsidiaries. Each of the subsidiaries operates as a sales and support office. The functional currency of each subsidiary is the U.S. dollar. All significant intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and that affect the reported amounts of revenue and expenditures during the reporting period. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying consolidated financial statements include the estimation of stand-alone selling prices for its products and services, the estimation of the valuation of inventory, the estimates used in the valuation allowance for deferred tax assets and uncertain tax positions, and estimates used in certain of the inputs and calculations associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly-liquid investments with purchased maturities of three&#160;months or less to be cash equivalents. The Company&#x2019;s cash equivalents consist principally of funds maintained in depository accounts. The Company invests its cash and cash equivalents with major financial institutions; at times these investments exceed federally insured limits. Restricted cash consists of customer deposits which are secured through letters of credit until performance obligations have been met. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its debt securities as available-for-sale, which are reported at estimated fair value with unrealized gains and losses included in accumulated other comprehensive loss in stockholders&#x2019; equity. Realized gains, realized losses and allowance for estimated credit losses are included in other expense, net. The cost of investments for purposes of computing realized and unrealized gains and losses is based on the specific identification method. Amortization of premiums and accretion of discounts are included in other expense, net. Interest and dividends earned on all securities are included in other expense, net.&#160;Investments in debt securities with maturities of less than one year, or where management&#x2019;s intent is to use the investments to fund current operations, or to make them available for current operations, are classified as short-term investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments are presented net of an allowance for expected credit losses that are remeasured each period and any impairment recognized as an expense. The Company has considered all information and factors and noted no indicators that a credit loss exists as of December 31, 2022. The Company has not experienced any significant investment credit losses to date. Accrued interest receivable is included in prepaid and other current assets and was $0.9 million and $0.8 million as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of an allowance for credit losses. The Company uses available information over the life of the receivables including analysis of past credit losses, recoveries of past credit losses, management&#x2019;s expectations of future economic positions, as well as market conditions and other extenuating factors to support the allowance estimate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Credit Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. Cash is invested in accordance with the Company&#x2019;s investment policy, which includes guidelines intended to minimize and diversify credit risk. Most of the Company&#x2019;s investments are not federally insured. The Company has credit risk related to the collectability of its accounts receivable. The Company performs initial and ongoing evaluations of its customers&#x2019; credit history or financial position and generally extends credit on account without collateral. The Company has not experienced any significant credit losses to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that represented more than 10% of total revenue for the year ended December 31, 2022. The Company had no customers that represented more than 10% of total revenue for the years ended December 31, 2021 and 2020, respectively. The Company had no customers that represented more than 10% of total accounts receivable as of December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to supply chain risks related to the outsourcing of the manufacturing and production of its instruments to sole suppliers. Although there are a limited number of manufacturers for instruments of this type, the Company believes that other suppliers could provide similar products on comparable terms. Similarly, the Company sources certain raw materials used in the manufacture of consumables from certain sole suppliers. A change in suppliers, however, could cause a delay in manufacturing and a possible loss of sales, which would adversely affect operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recorded amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities. Investments that are classified as available-for-sale are recorded at fair value. The fair value for investment securities held and for convertible senior notes are determined using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of finished goods, raw materials, including certain intermediate manufactured items, and certain component parts to be used in manufacturing or servicing the Company&#x2019;s products. Inventory is stated at the lower of cost or net realizable value. Cost is determined using a standard cost system, whereby the standard costs are updated periodically to reflect current costs and market represents the lower of cost or market (replacement cost or estimated net realizable value). The Company&#x2019;s policy is to establish inventory reserves when conditions exist that suggest that inventory may be in excess of anticipated demand, obsolete, slow moving or impaired. In the event that the Company identifies these conditions exist in its inventory, its carrying value is reduced to its net realizable value. Inventory reserves were $7.3 million and $6.5 million as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company outsources the manufacturing of its instruments to third-party contract manufacturers who manufacture them to certain specifications and source certain raw materials from sole source providers. Major delays in shipments, inferior quality, insufficient quantity or any combination of these or other factors may harm the Company&#x2019;s business and results of operations. In addition, the inability of one or more of these suppliers to provide the Company with an adequate supply of its products or raw materials or the loss of one or more of these suppliers may cause a delay in the Company&#x2019;s ability to fulfill orders while it obtains a replacement supplier and may harm the Company&#x2019;s business and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets. Expenditures for additions are capitalized and expenditures for maintenance and repairs are expensed as incurred. Gains and losses from the disposal of property and equipment are reflected in the consolidated statements of operations in the period of disposition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prototype systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Internal-Use Software Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain development costs incurred in connection with software development for internal-use software platforms used in operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once software has reached the development stage, internal and external costs, if direct, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over the estimated useful life of the software platforms and are included in depreciation and amortization expense within operating expenses in our consolidated statements of operations. Unamortized capitalized internal-use software development costs were $11.8 million and $4.0 million as of December 31, 2022 and 2021, respectively. Amortization of capitalized internal-use software costs was $0.3 million for the year ending December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs associated with the implementation of hosted third-party cloud computing arrangements are recorded as part of current and long-term other assets. Maintenance and training costs are expensed as incurred and are expensed on a straight-line basis over the term of the related hosting arrangement. Costs are recorded within the consolidated statements of operations based on the functional use of the software. Unamortized capitalized software implementation costs were $1.9 million and $3.2 million as of December 31, 2022 and 2021, respectively. Amortization and write-down of capitalized software implementation costs of hosted third-party cloud computing arrangements was $1.3 million and $0.3 million for the years ending December 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception of a contract. The Company&#x2019;s leasing portfolio is comprised of operating and finance leases primarily for general office, manufacturing, and research and development purposes. Operating and finance lease liabilities and the corresponding right-of-use assets are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Operating lease right-of-use assets are reduced by lease incentives included in the agreement. As the existing leases do not contain an implicit interest rate, the Company estimates its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The Company includes options to extend the lease in the lease liability and right-of-use asset when it is reasonably certain that the option will be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company elected, as an accounting policy election, to use the short-term lease recognition exemption on all classes of assets. Leases with an initial term of 12 months or less are not recorded on the balance sheet and the Company recognizes lease payments as an expense on a straight-line basis over the lease term. The Company has lease office agreements with lease and non-lease components, which are generally accounted for separately. For lease equipment agreements, the Company accounts for the lease and non-lease components as a single lease component. The Company&#x2019;s lease agreements do not contain any material variable lease payments, material residual value guarantees or, any material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes impairment losses on long-lived assets when indicators of impairment are present and the anticipated undiscounted cash flows to be generated by those assets are less than the asset&#x2019;s carrying values. The Company has not experienced material impairment losses on its long-lived assets during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted &#x201c;ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-06&#x201d;) effective January 1, 2021. The Company uses the if-converted method for purposes of calculating dilutive earnings per share, if the Convertible Notes are dilutive during the period. In connection with the issuance of the Convertible Notes, the Company incurred certain financing costs associated directly with the issuance of the Convertible Notes. These issuance costs were deferred and are amortized to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest expense over five years using the effective interest method. See Note 10. Long-term Debt, Net for additional information regarding the Convertible Senior Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an entity for which separate financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company&#x2019;s chief operating decision maker is the chief executive officer, who manages the operations and evaluates the financial performance on a total Company basis. The Company&#x2019;s principal operations and decision-making functions are located at its corporate headquarters in the United States and the Company operates as a single operating and reporting segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the promised goods or services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of a product or service to the customer, meaning the customer has the ability to use and obtain the benefit of the product or service. The Company recognizes revenue for satisfied performance obligations only when there are no uncertainties regarding payment terms or transfer of control.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically generated the majority of its revenue from sales of its proprietary GeoMx DSP system and nCounter Analysis System, and related consumables. Services consist of instrument service contracts for maintenance, repair and other support related to customer owned instruments, and also certain service fees for assay processing and data analysis and reporting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from instruments and consumables is generally recognized upon shipment to the end customer, which is when control of the product has been transferred to the customer. Performance obligations related to instrument sales are reviewed on a contract-by-contract basis, as individual contract terms may vary and revenue is recognized as performance obligations are satisfied. Performance obligations for consumable products are generally completed upon shipment to the customer. While the Company typically completes installation and training of its customers with field-based service personnel, these services can also be provided by distribution partners and other third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument service contracts are sold with contract terms ranging from 12-36 months and cover periods after the end of the initial 12-month warranty. These contracts include services to maintain performance within the Company&#x2019;s designed specifications and allow the customer to receive certain preventative maintenance service procedures during the contract term. Revenue from services to maintain designed specifications is considered a stand-ready obligation and recognized evenly over the contract term and service revenue related to preventative maintenance of instruments is recognized when the procedure is completed. Revenue from service fees for assay processing is recognized upon the rendering of the related performance obligation which is typically the delivery of data and analysis of the samples that have been processed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For arrangements with multiple performance obligations, the Company allocates the contract price in proportion to each performance obligation&#x2019;s relative stand-alone selling price. The Company frequently sells bundles of systems and consumables and, in such instances, uses its best estimate of selling price for its products based on historical sales or similar products. For service, the best estimate of selling price is based on historical stand-alone sales, as stand-alone sales data for services are more readily available. The Company reviews its stand-alone prices at least annually or more frequently if facts and circumstances significantly change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally recognizes expense related to the acquisition of contracts, such as sales commissions, at the time of revenue recognition, which is generally in the same period products are sold, and in the case of services, revenue is recognized as services are rendered or over the period of time covered by the service contract. The Company records commission expenses within selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales to customers through distributors are recognized consistent with the policies and practices for direct sales to customers, as described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of product revenue consists primarily of costs incurred in the production process, including costs of purchasing instruments from third-party contract manufacturers, consumable component materials and assembly labor and overhead, installation, and packaging and delivery costs. In addition, cost of product revenue includes royalty costs for licensed technologies included in the Company&#x2019;s products, provisions for slow-moving and obsolete inventory and stock-based compensation expense. Cost of product revenue for instruments and consumables is recognized in the period the related revenue is recognized. Shipping and handling costs incurred for product shipments are included in cost of product revenue in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of service revenue consists primarily of field service technicians and the cost of providing repair and maintenance services including parts used in performing those services for instruments covered under warranty and service contracts. In addition, cost of service revenue includes lab personnel labor and overhead, stock-based compensation and materials used in performing data analysis services. Cost of service revenue is recognized in the period the services are performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserve for Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally provides a one-year warranty on both its nCounter Analysis Systems and GeoMx DSP instruments, and establishes a reserve for future warranty costs based on historical product failure rates and actual warranty costs incurred. Warranty expense is recorded as a component of cost of service revenue in the consolidated statements of operations. Warranty reserves were $1.0 million and $1.2 million as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses, consisting primarily of salaries and benefits, stock-based compensation expense, occupancy costs, laboratory supplies, contracted services, and consulting fees are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, General and Administrative&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling expenses consist primarily of personnel related costs for sales and marketing, contracted services, and service fees and are expensed as the related costs are incurred. Advertising costs are expensed as incurred and are included in sales and marketing expenses. Advertising costs totaled approximately $9.3 million, $4.8 million and $3.4 million during the years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative expenses consist primarily of personnel related costs for the Company&#x2019;s finance, human resources, business development, legal, information technology and general management, as well as professional fees for legal, accounting and other consulting services. General and administrative expenses are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary balance sheet accounts are remeasured using exchange rates in effect at the balance sheet dates and non-monetary items are remeasured at historical exchange rates. Expenses are generally remeasured at the average exchange rates for the period. Foreign currency remeasurement and transaction gains and losses are included in interest and other income (expense), net and were not material for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the liability method. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether a tax position is more likely than not to be sustained upon examination based on the technical merits of the position. For tax positions meeting the more-likely-than-not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for stock-based compensation under the fair value method. Stock-based compensation costs related to restricted stock units (&#x201c;RSUs&#x201d;) and performance stock units (&#x201c;PSUs&#x201d;) which are granted by the Company are calculated using the grant-date fair value using the intrinsic method and for stock options granted in prior years, stock-based compensation was estimated using the Black-Scholes option pricing model. Stock-based compensation expense is recognized based on the number of awards ultimately expected to vest, using actual forfeitures when incurred. The Company uses the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;straight-line attribution method over the vesting period for recognizing compensation expense for awards with a service condition. For awards with service and performance conditions, the accelerated recognition method is used over the graded vesting schedules for the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company guarantees and/or indemnifies other parties, including vendors, lessors and parties to transactions with the Company, with respect to certain matters. The Company has agreed to hold the other parties harmless against losses arising from breach of representations or covenants, or out of intellectual property infringement or other claims made against certain parties. It is not possible to determine the maximum potential amount the Company could be required to pay under these indemnification agreements, since the Company has not had any prior indemnification claims, and each claim would be based upon the unique facts and circumstances of the claim and the particular provisions of each agreement. In the opinion of management, any such claims would not be expected to have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition or cash flows. The Company did not have any related liabilities recorded at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss includes certain changes in equity that are excluded from net loss. Specifically, unrealized gains and losses on available-for-sale debt securities are included in comprehensive (income) loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI4MDEy_c0d365df-2d62-4d01-8bde-fa8271112b83">The consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). The accompanying consolidated financial statements reflect the accounts of the Company and its wholly-owned subsidiaries. Each of the subsidiaries operates as a sales and support office. The functional currency of each subsidiary is the U.S. dollar. All significant intercompany balances and transactions have been eliminated.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTg4_ce6dfa84-b083-4836-8737-e980295afd4f">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and that affect the reported amounts of revenue and expenditures during the reporting period. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying consolidated financial statements include the estimation of stand-alone selling prices for its products and services, the estimation of the valuation of inventory, the estimates used in the valuation allowance for deferred tax assets and uncertain tax positions, and estimates used in certain of the inputs and calculations associated with stock-based compensation.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTE4_b6fbb8ee-043e-467e-8fcd-bb4245c030d4">The Company considers all highly-liquid investments with purchased maturities of three&#160;months or less to be cash equivalents. The Company&#x2019;s cash equivalents consist principally of funds maintained in depository accounts. The Company invests its cash and cash equivalents with major financial institutions; at times these investments exceed federally insured limits. Restricted cash consists of customer deposits which are secured through letters of credit until performance obligations have been met.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTgw_0d1db71f-06b1-413f-8925-52dcc84d3912">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its debt securities as available-for-sale, which are reported at estimated fair value with unrealized gains and losses included in accumulated other comprehensive loss in stockholders&#x2019; equity. Realized gains, realized losses and allowance for estimated credit losses are included in other expense, net. The cost of investments for purposes of computing realized and unrealized gains and losses is based on the specific identification method. Amortization of premiums and accretion of discounts are included in other expense, net. Interest and dividends earned on all securities are included in other expense, net.&#160;Investments in debt securities with maturities of less than one year, or where management&#x2019;s intent is to use the investments to fund current operations, or to make them available for current operations, are classified as short-term investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments are presented net of an allowance for expected credit losses that are remeasured each period and any impairment recognized as an expense. The Company has considered all information and factors and noted no indicators that a credit loss exists as of December 31, 2022. The Company has not experienced any significant investment credit losses to date. Accrued interest receivable is included in prepaid and other current assets and was $0.9 million and $0.8 million as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:InterestReceivable
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyODk1ODI_6483b345-a94f-4761-98bc-c065c2eaa29d"
      unitRef="usd">900000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyODk1OTk_99bc6806-6621-48c0-aa57-063250ff1998"
      unitRef="usd">800000</us-gaap:InterestReceivable>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTYw_164dce59-0eff-4887-9b56-4974e5ad04de">Accounts receivable are stated net of an allowance for credit losses. The Company uses available information over the life of the receivables including analysis of past credit losses, recoveries of past credit losses, management&#x2019;s expectations of future economic positions, as well as market conditions and other extenuating factors to support the allowance estimate.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI4MDA4_9026b335-5ee0-4d2c-b5b8-a543f97ccb77">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. Cash is invested in accordance with the Company&#x2019;s investment policy, which includes guidelines intended to minimize and diversify credit risk. Most of the Company&#x2019;s investments are not federally insured. The Company has credit risk related to the collectability of its accounts receivable. The Company performs initial and ongoing evaluations of its customers&#x2019; credit history or financial position and generally extends credit on account without collateral.The Company is also subject to supply chain risks related to the outsourcing of the manufacturing and production of its instruments to sole suppliers. Although there are a limited number of manufacturers for instruments of this type, the Company believes that other suppliers could provide similar products on comparable terms. Similarly, the Company sources certain raw materials used in the manufacture of consumables from certain sole suppliers. A change in suppliers, however, could cause a delay in manufacturing and a possible loss of sales, which would adversely affect operating results.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTgy_1a0ed9ec-1e43-4619-ae3f-ee8a0278d0d8">The recorded amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities. Investments that are classified as available-for-sale are recorded at fair value. The fair value for investment securities held and for convertible senior notes are determined using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTc1_4687b36b-2bb6-4967-afcc-dcb09a974de9">Inventory consists of finished goods, raw materials, including certain intermediate manufactured items, and certain component parts to be used in manufacturing or servicing the Company&#x2019;s products. Inventory is stated at the lower of cost or net realizable value. Cost is determined using a standard cost system, whereby the standard costs are updated periodically to reflect current costs and market represents the lower of cost or market (replacement cost or estimated net realizable value). The Company&#x2019;s policy is to establish inventory reserves when conditions exist that suggest that inventory may be in excess of anticipated demand, obsolete, slow moving or impaired. In the event that the Company identifies these conditions exist in its inventory, its carrying value is reduced to its net realizable value.The Company outsources the manufacturing of its instruments to third-party contract manufacturers who manufacture them to certain specifications and source certain raw materials from sole source providers. Major delays in shipments, inferior quality, insufficient quantity or any combination of these or other factors may harm the Company&#x2019;s business and results of operations. In addition, the inability of one or more of these suppliers to provide the Company with an adequate supply of its products or raw materials or the loss of one or more of these suppliers may cause a delay in the Company&#x2019;s ability to fulfill orders while it obtains a replacement supplier and may harm the Company&#x2019;s business and results of operations.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzczMjc_b735a500-5a9f-440c-b3ac-26dd80faedec"
      unitRef="usd">7300000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzczMzQ_4f2b132a-85ac-4599-a4a5-25aabc2d1a03"
      unitRef="usd">6500000</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTM5_a03c0142-3efd-45d3-80f5-73dcf26d82f7">Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets. Expenditures for additions are capitalized and expenditures for maintenance and repairs are expensed as incurred. Gains and losses from the disposal of property and equipment are reflected in the consolidated statements of operations in the period of disposition.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prototype systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3e88f609f3f146ceaf78b4e74394ba1b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzEtMi0xLTEtNDg5MDY_ebf42e27-4063-46f8-9e4c-f461018a8cee">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i278bf40cbb204af4a52b6898794206ca_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzItMi0xLTEtNDg5MDY_cef947b2-a529-4e66-874a-4c6645d60798">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i88f1ce22f43b4f6ba059a7cff32daa29_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzMtMi0xLTEtNDg5MDY_e6984498-cd83-46ff-b9fa-48396b6a1975">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1f132592e8314b41869081ee86000fca_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90YWJsZTpmOGVlYjZhNDM2Y2Q0MTUyYTUxOTg4ZDQwMzIxZGI1MS90YWJsZXJhbmdlOmY4ZWViNmE0MzZjZDQxNTJhNTE5ODhkNDAzMjFkYjUxXzQtMi0xLTEtNDg5MDY_3b4bafba-8542-4c82-ad2f-d7ce8f43d3a6">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTIx_aa0c6a95-eb36-488c-9120-c99bfac772c2">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain development costs incurred in connection with software development for internal-use software platforms used in operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once software has reached the development stage, internal and external costs, if direct, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over the estimated useful life of the software platforms and are included in depreciation and amortization expense within operating expenses in our consolidated statements of operations. Unamortized capitalized internal-use software development costs were $11.8 million and $4.0 million as of December 31, 2022 and 2021, respectively. Amortization of capitalized internal-use software costs was $0.3 million for the year ending December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs associated with the implementation of hosted third-party cloud computing arrangements are recorded as part of current and long-term other assets. Maintenance and training costs are expensed as incurred and are expensed on a straight-line basis over the term of the related hosting arrangement. Costs are recorded within the consolidated statements of operations based on the functional use of the software. Unamortized capitalized software implementation costs were $1.9 million and $3.2 million as of December 31, 2022 and 2021, respectively. Amortization and write-down of capitalized software implementation costs of hosted third-party cloud computing arrangements was $1.3 million and $0.3 million for the years ending December 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="iaef01beba6684f59958c4b614e147f05_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzk2NjA_8cfeb12c-1851-41ba-bdd5-e7e8c77a4fd6"
      unitRef="usd">11800000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i82bf014bbac5492db1175791d6facd7d_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyOTA1MjI_50844aae-ae46-4ce7-b2bd-fef64542f370"
      unitRef="usd">4000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i9e1e72e2e1254b52a9ce1f62c4a096cc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3NDg3NzkxMDQ2MzE_6f5acb14-962a-4672-a6c3-781f0d3c043a"
      unitRef="usd">300000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i18117518f24d42deab5e444d999956b2_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzEwMjUy_f17b723b-9ce2-4613-a0f5-5b653b7209ea"
      unitRef="usd">1900000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="ie22262b3c6e443298a7bfef3925d13c7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3NDg3NzkxMDQ0NzE_09fb2b09-efb8-41c4-bc26-d34dd69a4f66"
      unitRef="usd">3200000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ic8b904e260de493cad16322d5349cd06_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyOTA5NDE_1a766d9b-d86d-4399-817b-181ba7f20310"
      unitRef="usd">1300000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i1c7acaf4b361496386e2cab8954e8f6b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxOTkwMjMyOTA5NTg_a88abfd8-31db-4b95-9b83-330e85af3e05"
      unitRef="usd">300000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTUy_525ff171-1dcd-44f3-bae7-37d0260d263c">The Company determines if an arrangement is a lease at inception of a contract. The Company&#x2019;s leasing portfolio is comprised of operating and finance leases primarily for general office, manufacturing, and research and development purposes. Operating and finance lease liabilities and the corresponding right-of-use assets are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Operating lease right-of-use assets are reduced by lease incentives included in the agreement. As the existing leases do not contain an implicit interest rate, the Company estimates its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The Company includes options to extend the lease in the lease liability and right-of-use asset when it is reasonably certain that the option will be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company elected, as an accounting policy election, to use the short-term lease recognition exemption on all classes of assets. Leases with an initial term of 12 months or less are not recorded on the balance sheet and the Company recognizes lease payments as an expense on a straight-line basis over the lease term. The Company has lease office agreements with lease and non-lease components, which are generally accounted for separately. For lease equipment agreements, the Company accounts for the lease and non-lease components as a single lease component. The Company&#x2019;s lease agreements do not contain any material variable lease payments, material residual value guarantees or, any material restrictive covenants.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTEz_7f425e57-14a5-449c-83f6-c7b961024d65">The Company recognizes impairment losses on long-lived assets when indicators of impairment are present and the anticipated undiscounted cash flows to be generated by those assets are less than the asset&#x2019;s carrying values. The Company has not experienced material impairment losses on its long-lived assets during the periods presented.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzEyNTkz_1fd06f93-93ad-4ca9-9386-1e54383a8b1f"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzEyNTkz_ee171dd8-8804-4222-8af7-2e0a554c7546"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTQ4_f682070e-46e2-4e79-9100-bc2c4c2c8bd3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted &#x201c;ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-06&#x201d;) effective January 1, 2021. The Company uses the if-converted method for purposes of calculating dilutive earnings per share, if the Convertible Notes are dilutive during the period. In connection with the issuance of the Convertible Notes, the Company incurred certain financing costs associated directly with the issuance of the Convertible Notes. These issuance costs were deferred and are amortized to &lt;/span&gt;interest expense over five years using the effective interest method.</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DebtInstrumentTerm
      contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE0ODYw_89fc7a1b-9774-496f-800d-624e0d1a3a39">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTY0_5a5fcff9-477d-46b9-8ab3-e26b4cf31a20">Operating segments are defined as components of an entity for which separate financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company&#x2019;s chief operating decision maker is the chief executive officer, who manages the operations and evaluates the financial performance on a total Company basis. The Company&#x2019;s principal operations and decision-making functions are located at its corporate headquarters in the United States and the Company operates as a single operating and reporting segment.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTUz_d06b816a-37c7-4850-b317-ad5931e27f90">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the promised goods or services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of a product or service to the customer, meaning the customer has the ability to use and obtain the benefit of the product or service. The Company recognizes revenue for satisfied performance obligations only when there are no uncertainties regarding payment terms or transfer of control.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically generated the majority of its revenue from sales of its proprietary GeoMx DSP system and nCounter Analysis System, and related consumables. Services consist of instrument service contracts for maintenance, repair and other support related to customer owned instruments, and also certain service fees for assay processing and data analysis and reporting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from instruments and consumables is generally recognized upon shipment to the end customer, which is when control of the product has been transferred to the customer. Performance obligations related to instrument sales are reviewed on a contract-by-contract basis, as individual contract terms may vary and revenue is recognized as performance obligations are satisfied. Performance obligations for consumable products are generally completed upon shipment to the customer. While the Company typically completes installation and training of its customers with field-based service personnel, these services can also be provided by distribution partners and other third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument service contracts are sold with contract terms ranging from 12-36 months and cover periods after the end of the initial 12-month warranty. These contracts include services to maintain performance within the Company&#x2019;s designed specifications and allow the customer to receive certain preventative maintenance service procedures during the contract term. Revenue from services to maintain designed specifications is considered a stand-ready obligation and recognized evenly over the contract term and service revenue related to preventative maintenance of instruments is recognized when the procedure is completed. Revenue from service fees for assay processing is recognized upon the rendering of the related performance obligation which is typically the delivery of data and analysis of the samples that have been processed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For arrangements with multiple performance obligations, the Company allocates the contract price in proportion to each performance obligation&#x2019;s relative stand-alone selling price. The Company frequently sells bundles of systems and consumables and, in such instances, uses its best estimate of selling price for its products based on historical sales or similar products. For service, the best estimate of selling price is based on historical stand-alone sales, as stand-alone sales data for services are more readily available. The Company reviews its stand-alone prices at least annually or more frequently if facts and circumstances significantly change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally recognizes expense related to the acquisition of contracts, such as sales commissions, at the time of revenue recognition, which is generally in the same period products are sold, and in the case of services, revenue is recognized as services are rendered or over the period of time covered by the service contract. The Company records commission expenses within selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales to customers through distributors are recognized consistent with the policies and practices for direct sales to customers, as described above.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <nstg:ExtendedProductWarrantyPeriod
      contextRef="i73fa25c9cfad44209056603a0dc281bb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE3OTIy_9bd293a9-e38e-4666-a9d9-bb6c41beb0d4">P12M</nstg:ExtendedProductWarrantyPeriod>
    <nstg:ExtendedProductWarrantyPeriod
      contextRef="id1530276adeb46edad26c44010100eaa_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE3OTI1_fe3f2164-b950-422e-8840-32722035583f">P36M</nstg:ExtendedProductWarrantyPeriod>
    <nstg:StandardProductWarrantyPeriod
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzE3OTc1_3649d67c-4885-42cd-b62f-4985963dafba">P12M</nstg:StandardProductWarrantyPeriod>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTk0_75cbd87e-5833-4587-9094-8da005a99638">Cost of product revenue consists primarily of costs incurred in the production process, including costs of purchasing instruments from third-party contract manufacturers, consumable component materials and assembly labor and overhead, installation, and packaging and delivery costs. In addition, cost of product revenue includes royalty costs for licensed technologies included in the Company&#x2019;s products, provisions for slow-moving and obsolete inventory and stock-based compensation expense. Cost of product revenue for instruments and consumables is recognized in the period the related revenue is recognized. Shipping and handling costs incurred for product shipments are included in cost of product revenue in the consolidated statements of operations.Cost of service revenue consists primarily of field service technicians and the cost of providing repair and maintenance services including parts used in performing those services for instruments covered under warranty and service contracts. In addition, cost of service revenue includes lab personnel labor and overhead, stock-based compensation and materials used in performing data analysis services. Cost of service revenue is recognized in the period the services are performed.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ExtendedProductWarrantyPolicy
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTYy_ebd7cbb9-fc56-4962-b92c-807c9b0854ef">The Company generally provides a one-year warranty on both its nCounter Analysis Systems and GeoMx DSP instruments, and establishes a reserve for future warranty costs based on historical product failure rates and actual warranty costs incurred. Warranty expense is recorded as a component of cost of service revenue in the consolidated statements of operations. Warranty reserves were $1.0 million and $1.2 million as of December 31, 2022 and 2021, respectively.</us-gaap:ExtendedProductWarrantyPolicy>
    <nstg:ProductWarrantyAccrualPeriod
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTE1_06d0194b-255b-48a1-b7d0-022b6821f079">P1Y</nstg:ProductWarrantyAccrualPeriod>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxNjU4_449e2049-a41e-4f65-9c92-34979bcc51f7"
      unitRef="usd">1000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIxNjY1_8675a0e4-60cc-4289-bbe3-0db7c2be90f8"
      unitRef="usd">1200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTQ5_e4eb41a1-7a3b-47d9-94ed-690cdf91c0ae">Research and development expenses, consisting primarily of salaries and benefits, stock-based compensation expense, occupancy costs, laboratory supplies, contracted services, and consulting fees are expensed as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTU0_8679ada1-88f8-471f-a8bb-e686bd6abe08">Selling expenses consist primarily of personnel related costs for sales and marketing, contracted services, and service fees and are expensed as the related costs are incurred. Advertising costs are expensed as incurred and are included in sales and marketing expenses.General and administrative expenses consist primarily of personnel related costs for the Company&#x2019;s finance, human resources, business development, legal, information technology and general management, as well as professional fees for legal, accounting and other consulting services. General and administrative expenses are expensed as they are incurred.</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIyMzAz_9d9ee89c-3de8-4d7b-8f54-6d0ba89b56e4"
      unitRef="usd">9300000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIyMzA3_64f8d10c-cd2b-4c93-8c1f-9b1632c9d3dc"
      unitRef="usd">4800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzIyMzE0_51672898-0512-4088-a7c4-c2fdc6226ac7"
      unitRef="usd">3400000</us-gaap:AdvertisingExpense>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTk3_3234d2eb-6efb-4b92-9dd2-e4114780f8d1">The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary balance sheet accounts are remeasured using exchange rates in effect at the balance sheet dates and non-monetary items are remeasured at historical exchange rates. Expenses are generally remeasured at the average exchange rates for the period.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTY5_48ca9cf8-3baa-44ec-a366-dfaaae2273eb">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the liability method. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether a tax position is more likely than not to be sustained upon examination based on the technical merits of the position. For tax positions meeting the more-likely-than-not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTIy_5aa30b44-a16e-4fbd-ac97-b41bbd234074">The Company accounts for stock-based compensation under the fair value method. Stock-based compensation costs related to restricted stock units (&#x201c;RSUs&#x201d;) and performance stock units (&#x201c;PSUs&#x201d;) which are granted by the Company are calculated using the grant-date fair value using the intrinsic method and for stock options granted in prior years, stock-based compensation was estimated using the Black-Scholes option pricing model. Stock-based compensation expense is recognized based on the number of awards ultimately expected to vest, using actual forfeitures when incurred. The Company uses the straight-line attribution method over the vesting period for recognizing compensation expense for awards with a service condition. For awards with service and performance conditions, the accelerated recognition method is used over the graded vesting schedules for the awards.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTUw_98f5d031-9611-4903-b1a0-6994e0bb768a">In the normal course of business, the Company guarantees and/or indemnifies other parties, including vendors, lessors and parties to transactions with the Company, with respect to certain matters. The Company has agreed to hold the other parties harmless against losses arising from breach of representations or covenants, or out of intellectual property infringement or other claims made against certain parties. It is not possible to determine the maximum potential amount the Company could be required to pay under these indemnification agreements, since the Company has not had any prior indemnification claims, and each claim would be based upon the unique facts and circumstances of the claim and the particular provisions of each agreement. In the opinion of management, any such claims would not be expected to have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition or cash flows. The Company did not have any related liabilities recorded at December&#160;31, 2022 and 2021.</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzI3OTU5_411977e9-6c46-4444-8424-7f245082c941">Comprehensive loss includes certain changes in equity that are excluded from net loss. Specifically, unrealized gains and losses on available-for-sale debt securities are included in comprehensive (income) loss.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTUvZnJhZzpkNjU0ZDA0NWM1MTQ0M2Y1ODU5NDllZmFmOGJkZTJlYy90ZXh0cmVnaW9uOmQ2NTRkMDQ1YzUxNDQzZjU4NTk0OWVmYWY4YmRlMmVjXzMyOTg1MzQ5MTk4MDU_35193185-2dc8-4850-b2dc-0ca29b6bc0dd">ReclassificationsCertain prior year amounts related to inventory categories have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations, financial position or cash flows from operations.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzI0Njg_3d9a468a-c72c-447b-9ee3-922ae680cd97">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about disaggregated revenue by major product line and primary geographic market (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Europe and Middle East&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Europe and Middle East&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Europe and Middle East&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue in the United States was $79.5 million, $91.0 million and $77.5 million for the years ended December 31, 2022, 2021 and 2020, respectively. The Company&#x2019;s long-lived assets are primarily located in the United States and not allocated to any specific geographic region.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i67acad69085c486998c2baaf6125dbb3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtMS0xLTEtNDg5MDY_e2a7e056-f964-44db-9025-39d3f4d37b06"
      unitRef="usd">21989000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57df71b94ca142fdaca927a766348294_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtMy0xLTEtNDg5MDY_ebf47be2-b2c8-4262-95e2-4a9c6fd039db"
      unitRef="usd">9546000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7881895472d449e994899c6bc6580f05_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtNS0xLTEtNDg5MDY_60c86374-6174-4f42-b522-17fbd61073b5"
      unitRef="usd">6054000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i713c836ec9944621af76e4eae6676d6b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzMtNy0xLTEtNDg5MDY_7ef51e38-f335-4eea-b0ca-7f58b798f23c"
      unitRef="usd">37589000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i13689abdf06042ddb61fe7e5dde76571_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtMS0xLTEtNDg5MDY_2ce10dcd-8023-4089-bf09-87ff69aeae95"
      unitRef="usd">47566000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6199bdcbfda84b76b59695fbd415666b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtMy0xLTEtNDg5MDY_31681800-abee-458b-a3ce-ec4b89025498"
      unitRef="usd">18863000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3b4cc48ab884deb9ac79ec4f88a41b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtNS0xLTEtNDg5MDY_0e0ba084-0015-445c-9757-ee6652910ef4"
      unitRef="usd">3938000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0379bf7b398f48e4b7eb5e0d0e117124_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzQtNy0xLTEtNDg5MDY_2c36f0ed-34d8-4175-9b61-4b97c52f7b3e"
      unitRef="usd">70367000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60b0d645787549928cc28c4236afb570_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtMS0xLTEtNDg5MDY_eb784229-2856-45c1-afa7-fd3a188039c3"
      unitRef="usd">69555000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55d209ba775a4742bb51365dce4d0e27_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtMy0xLTEtNDg5MDY_5698b15f-66a4-44b8-8a21-37724b7589e2"
      unitRef="usd">28409000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id43e18e2336e4176a4c6d0b1837d8ab8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtNS0xLTEtNDg5MDY_2ac6c39e-0a95-4ec5-8004-1aef72785056"
      unitRef="usd">9992000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide1f5b55a9b84a5aa2e522b93b38df43_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzUtNy0xLTEtNDg5MDY_6dc79303-c57a-4ff7-9ccd-d27012d1c046"
      unitRef="usd">107956000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08998380f6294f76a8041abec23394b0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtMS0xLTEtNDg5MDY_b0704f6b-2445-4dc9-a76e-4b1e19c25331"
      unitRef="usd">13404000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifeeae230b2594a1b942b9d452bd93424_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtMy0xLTEtNDg5MDY_6d1df848-d01a-4373-affb-82ae132a1f9a"
      unitRef="usd">4812000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i250e7fef9d9e4aa4bae1f66f612bb047_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtNS0xLTEtNDg5MDY_3f2235db-425f-438e-8267-922baa3d06ae"
      unitRef="usd">1090000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic847fb73fb034674afc2bc0ddc99cce1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzYtNy0xLTEtNDg5MDY_1224b5e8-ab34-4beb-a522-eb2d795e7599"
      unitRef="usd">19306000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb01752d3d024e9cbe624ff2311e1e86_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctMS0xLTEtNDg5MDY_71caaf52-655c-4346-975f-71088dec27cd"
      unitRef="usd">82959000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51f5ff287b4347d1befb9409e6d22447_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctMy0xLTEtNDg5MDY_0021ef5a-e1e1-4c0f-afa4-2460dfbc97fb"
      unitRef="usd">33221000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3bf083ef64fc4b2d84ed1522343a92d0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctNS0xLTEtNDg5MDY_770acdd8-08db-49af-9292-ce9652d32027"
      unitRef="usd">11082000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c31fff231034b729e619b1e5ddad70f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTo5MmQyY2Y4ODRhYmY0MmFlOTlkOWI5Zjk2NzUwNmVlZC90YWJsZXJhbmdlOjkyZDJjZjg4NGFiZjQyYWU5OWQ5YjlmOTY3NTA2ZWVkXzctNy0xLTEtNDg5MDY_6ec8bdc7-31d2-4554-8d52-d8883f76a3e9"
      unitRef="usd">127262000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7884244270dc438fb94c45d2b041e5ed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtMS0xLTEtNDg5MDY_400a87b3-84fe-4e6c-b524-ea1e31c1e5c2"
      unitRef="usd">31467000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a2ec65972a6419abe9a03a19e5ca95e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtMy0xLTEtNDg5MDY_7ed56cbe-12c7-4b96-b64c-603b6974a90d"
      unitRef="usd">14837000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i94493508e1514eb89d02a2be8a07f60b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtNS0xLTEtNDg5MDY_22a0fd9d-0043-406d-a372-695647492f8d"
      unitRef="usd">9312000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i79fa8408bcb64e98b3b17b2bb9a06863_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzMtNy0xLTEtNDg5MDY_1fcf93cd-8b73-4626-8d0f-99cbb67ed47f"
      unitRef="usd">55616000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icedfeb39178b47b0973327433aeaf39c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtMS0xLTEtNDg5MDY_3bbffd9a-618b-4472-af9d-399f02d2ac1a"
      unitRef="usd">50421000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib388af030dc445f1b7cfea35477d3be7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtMy0xLTEtNDg5MDY_52ac9be4-9579-4394-b53a-5198a269d686"
      unitRef="usd">16216000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iab1f01e51b674ab4ad411dde4e1e0d89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtNS0xLTEtNDg5MDY_52a81548-f930-466f-b963-e31aa85034cd"
      unitRef="usd">5209000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8071ca8672d449bd949728204b07a2fe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzQtNy0xLTEtNDg5MDY_c41c56e8-971d-4760-a62b-f1f7841bc5b1"
      unitRef="usd">71846000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74d86a75d4d54b8b9ca2f0ed1e4dacf9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtMS0xLTEtNDg5MDY_ff1e026b-5eb4-4ce6-bc65-047d27e91c67"
      unitRef="usd">81888000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i444caf10ca684a0aa194a919b86211e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtMy0xLTEtNDg5MDY_6ccab7d7-c50b-4a15-bbeb-5ba3ded8ccc2"
      unitRef="usd">31053000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f366fc7210642de991dae318729cecb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtNS0xLTEtNDg5MDY_b970ebe9-6a12-4c95-a0e7-e276f8cd6e58"
      unitRef="usd">14521000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic24b193464c24d08a3ff5a40d2812eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzUtNy0xLTEtNDg5MDY_bc2edf22-1631-4d77-a24c-151e6f4d3d09"
      unitRef="usd">127462000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i373fc6e51acf48be9c6990e509965c68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtMS0xLTEtNDg5MDY_bb7bc65b-62a7-448d-9ebd-49a8f809bb08"
      unitRef="usd">12472000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4cda942559fe4cc4a3fca242a605e4b1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtMy0xLTEtNDg5MDY_4a7a30bf-162f-41f0-96e0-9273cc4fbbdf"
      unitRef="usd">4117000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if47b8c1b821a4938a48a69fe46c6555a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtNS0xLTEtNDg5MDY_4ff77dab-ef4c-467e-ba7f-d7b8c1d2e8b8"
      unitRef="usd">1034000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3a95954bd7641d4919c06151fa4088c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzYtNy0xLTEtNDg5MDY_64708f00-189d-4be4-94a0-a5d7e6396aca"
      unitRef="usd">17623000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45ebd85ce49641b1bdcfb50f620c8c7f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctMS0xLTEtNDg5MDY_ed7898ca-c4ca-4c75-bbdd-635cc9affe03"
      unitRef="usd">94360000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i809c69b254ec43d4b295def456b0bcb9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctMy0xLTEtNDg5MDY_eb15e35a-1c2f-4dec-9827-954169534a1a"
      unitRef="usd">35170000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2d61518cf22490287052068a75aee69_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctNS0xLTEtNDg5MDY_77ed5737-a67e-4dba-94de-2910afed3e94"
      unitRef="usd">15555000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i87797cb7eb2d4e539e26bf057f66d572_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTowNDRjN2U4N2U4NjI0OTFhYWM2Nzk2N2Q3OTI2NjRlNC90YWJsZXJhbmdlOjA0NGM3ZTg3ZTg2MjQ5MWFhYzY3OTY3ZDc5MjY2NGU0XzctNy0xLTEtNDg5MDY_5582f0fc-6dea-438a-a798-f6a9765d2386"
      unitRef="usd">145085000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieae0f86555864368b0aea5d051ac1266_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtMS0xLTEtNDg5MDY_e16d72f9-99d0-4a81-9839-3daa39e8ed00"
      unitRef="usd">30016000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia52a0df2c7f04de89a0e5830fdb770ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtMy0xLTEtNDg5MDY_17c448dd-1e1d-47f8-a0e6-a002cf2ea2e8"
      unitRef="usd">11134000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d04035e9e28485eb3acf369367687f8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtNS0xLTEtNDg5MDY_cb6b06de-e421-4359-8218-cc483c763b1e"
      unitRef="usd">6680000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5ce94de1d746480a975bbf68e8d2ff1a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzMtNy0xLTEtNDg5MDY_a2a01596-c7cd-4c43-81f2-e6c7394852b4"
      unitRef="usd">47830000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id47ab74aed5247f7a85777c81bd4cb68_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtMS0xLTEtNDg5MDY_729ef9be-220e-4b84-952a-391b888e26fc"
      unitRef="usd">34922000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i837b13ea09c546889d1c1f1898e0cb63_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtMy0xLTEtNDg5MDY_e003259f-c7fb-4be0-b0c1-6cff782a31b5"
      unitRef="usd">12203000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib14cac7c7a3349a2abe346fa98dfc66e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtNS0xLTEtNDg5MDY_f026126a-d490-4909-9944-67c05d950aac"
      unitRef="usd">2972000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f8abb7a1a694dd4b9681e6a239af1f5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzQtNy0xLTEtNDg5MDY_b9698a94-d35f-4468-9a7c-dcde206d73bf"
      unitRef="usd">50097000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i30a7b631fee1428b98faf94c3babda50_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtMS0xLTEtNDg5MDY_092124d8-da36-42bb-b971-ce26fe214a16"
      unitRef="usd">64938000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0f05c9834f4542e9b3cdf441d7ded71a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtMy0xLTEtNDg5MDY_37ee3dfa-b0dd-4484-a8bf-3c530a7a1669"
      unitRef="usd">23337000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57da356bd80040d28979b0ee90029081_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtNS0xLTEtNDg5MDY_18546199-c2af-48aa-9035-cc14d9994137"
      unitRef="usd">9652000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93c5f3cdfea848308ecc371efeac1919_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzUtNy0xLTEtNDg5MDY_23197d96-0118-44ba-a420-17da239566e6"
      unitRef="usd">97927000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i989ed5565898409da03fcb97e7c4573a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtMS0xLTEtNDg5MDY_b33f90e2-fe15-485a-81bb-51f222cd93d1"
      unitRef="usd">14849000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2e7328fd0fcb413d860b955b14b25b47_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtMy0xLTEtNDg5MDY_28666f43-1f63-4159-bd2a-b68abda8e8c2"
      unitRef="usd">3560000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c61765d11da43eaa6620b24fb7a3b84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtNS0xLTEtNDg5MDY_9100fcd5-71c6-43e5-b659-42af91911383"
      unitRef="usd">980000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a037c8077dc4e119948a8de5ebdb6fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzYtNy0xLTEtNDg5MDY_af63afe6-6e59-4e15-ae10-94458ef6d9b3"
      unitRef="usd">19389000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8421365accd4534bbc761089b030e05_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctMS0xLTEtNDg5MDY_2bbb322c-efd4-49f4-a43f-62fd612e2940"
      unitRef="usd">79787000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icdf2ffe55aec47f69e976f20986eb3dc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctMy0xLTEtNDg5MDY_c2c24ee1-e485-4617-b5fe-de91d84623e3"
      unitRef="usd">26897000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i534ef05250b74206a3469e1b8edd612a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctNS0xLTEtNDg5MDY_ac8872d0-9eef-4779-88ce-1643249084b1"
      unitRef="usd">10632000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if93686ec4ea743a4ba48bb454b4a79e4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90YWJsZTozMDhjMmNjZjg3NGY0YzE4YTA0OWM3NjIwODBkZWJhNi90YWJsZXJhbmdlOjMwOGMyY2NmODc0ZjRjMThhMDQ5Yzc2MjA4MGRlYmE2XzctNy0xLTEtNDg5MDY_81d0e989-e554-4e75-8785-fd12c30095cb"
      unitRef="usd">117316000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73ce0b36a12d45cf88cbf303484474d8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEwNDA_c23d7d35-eac2-486b-b8cf-b1fc0841d402"
      unitRef="usd">79500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7695a3a71d2e46c78f0a9751fa7e65e4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEwNDQ_1ad83a78-7ef7-42d3-8555-4c74f6819e9b"
      unitRef="usd">91000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae168f9ba93c4702893c848d0c6e17f8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEwNTE_4ca2251e-eb3f-4fc8-8a52-30ef1c542320"
      unitRef="usd">77500000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzEzOTY_e29e2d7a-0d29-46a4-953e-3c4b4812c28b"
      unitRef="usd">13000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE0MDM_e2edc119-1ac3-44ba-8d1c-06f96802c937"
      unitRef="usd">10300000</us-gaap:ContractWithCustomerLiability>
    <nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE0NjI_ad5c0a3d-d278-4e5f-a1d9-e98bedb0bf90"
      unitRef="usd">1800000</nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent>
    <nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE0Njk_f4e8bf40-c7a7-4383-82b4-0d651ed50f07"
      unitRef="usd">1300000</nstg:ContractWithCustomerLiabilityCustomerDepositsCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia4584c877dc647338dc50887089aa8d4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE1OTI_72ef48ab-8511-4e39-a0be-447717c5803a"
      unitRef="usd">-3200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ProceedsFromCustomers
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzIxOTkwMjMyNTgwMzY_f11cb759-4366-41a2-9714-aa2eb2e1cdf3"
      unitRef="usd">15200000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzIxOTkwMjMyNTgxMDA_a8a3c055-322a-4d88-b6d3-6c6aa0401730"
      unitRef="usd">12000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzE5ODY_267dd237-4092-41bc-a9bc-03968e45ed90"
      unitRef="usd">1100000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzMyOTg1MzQ4ODU4ODY_223c9b09-1e49-4e17-b5ed-f01e373c8486"
      unitRef="usd">700000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzI0NjQ_65869ed6-0fcc-4465-9634-dd8d8e299f82">45 days</us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMTgvZnJhZzpkNTUwZDE4Yzc4ZmU0NzYzOGNiM2IzY2Q3ZTg5NjIxZC90ZXh0cmVnaW9uOmQ1NTBkMThjNzhmZTQ3NjM4Y2IzYjNjZDdlODk2MjFkXzIzNTY_f55ba104-3873-4dcf-9aad-2fb50eafd233"
      unitRef="usd">14800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjk_8bf78a79-9856-45d2-8701-6c64043bca4b">LeasesThe Company is obligated to make future minimum payments under five primary operating leases which approximate 162,322 square feet of space used for manufacturing, research and development and general operations primarily in the greater Seattle area. The operating leases have terms that expire from&#160;2026&#160;to&#160;2032&#160;and include renewal options to extend the lease term at the then current fair market rental for each of the lease agreements. None of the options to extend the rental term of existing leases were considered reasonably certain as of December&#160;31, 2022. The Company&#x2019;s operating leases contain rent abatement periods, scheduled rent increases and provide for tenant improvement allowances. In addition, the Company enters into finance lease right-of-use assets included in other assets and lease liabilities included in deferred revenues and other liabilities primarily for equipment used in its operations. The Company&#x2019;s lease agreements do not contain any material variable lease payments, material residual value guarantees, or any material restrictive covenants. &lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of the Company&#x2019;s lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases for the year ended December 31 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <nstg:NumberOfOperatingLeases
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzc4_e3b79b33-0571-4540-9178-d9dd5a409dc3"
      unitRef="lease">5</nstg:NumberOfOperatingLeases>
    <nstg:AreaOfSpaceUnderLease
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEyNA_812527fd-4784-480b-9974-17534628714e"
      unitRef="sqft">162322</nstg:AreaOfSpaceUnderLease>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjY_01669cf7-9acd-4f8b-bb9a-debddd07d221">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of the Company&#x2019;s lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases for the year ended December 31 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzEtMS0xLTEtNDg5MDY_28033dc2-c5ac-410b-9ebb-0ab5109e6620"
      unitRef="usd">5572000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzEtMy0xLTEtNDg5MDY_72696535-cba3-45bf-badc-ecd0505868d7"
      unitRef="usd">5210000</us-gaap:OperatingLeaseExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzMtMS0xLTEtNDg5MDY_d61f8d83-98e2-41f4-aec6-ed9a1e9d7a9e"
      unitRef="usd">319000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzMtMy0xLTEtNDg5MDY_79e68bc9-f6e0-40c2-9f8c-12833b827587"
      unitRef="usd">255000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzQtMS0xLTEtNDg5MDY_30b426c1-97bd-40a7-8f14-9f3c30f66210"
      unitRef="usd">20000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzQtMy0xLTEtNDg5MDY_c33829c9-53e3-4c7d-8a5a-69f445e69d2f"
      unitRef="usd">23000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzUtMS0xLTEtNDg5MDY_f7f70a0e-630c-42fe-9fd5-ef6475004b8c"
      unitRef="usd">5911000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTplYTc1NjFhNDAxOGQ0NjgxYmM4NzdiMTUwZWViYTE5MS90YWJsZXJhbmdlOmVhNzU2MWE0MDE4ZDQ2ODFiYzg3N2IxNTBlZWJhMTkxXzUtMy0xLTEtNDg5MDY_e2c29049-bbb3-4777-bead-c2ad18ceacdd"
      unitRef="usd">5488000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzItMS0xLTEtNDg5MDY_49cedacb-f834-4b7c-857a-6244b285e644"
      unitRef="usd">6983000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzItMy0xLTEtNDg5MDY_743dd7f1-020f-4a60-9397-403d783993f3"
      unitRef="usd">6276000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzMtMS0xLTEtNDg5MDY_e6ce9d12-a773-4162-9520-4b9fcdccdf43"
      unitRef="usd">20000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzMtMy0xLTEtNDg5MDY_4573d879-b99d-48fa-bf7d-88eac851ca68"
      unitRef="usd">23000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzQtMS0xLTEtNDg5MDY_ff175d29-bbd5-48c3-ac36-f1c8d9a351cb"
      unitRef="usd">333000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzQtMy0xLTEtNDg5MDY_92142a03-2307-49c5-8452-7470b4284e56"
      unitRef="usd">236000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzYtMS0xLTEtNDg5MDY_50dd02b0-60e7-4157-9dcd-ce2d49c9cbd9"
      unitRef="usd">2126000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzYtMy0xLTEtNDg5MDY_63b9bc20-c437-4b15-9f74-9ae615187d09"
      unitRef="usd">929000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzctMS0xLTEtNDg5MDY_a7006d65-28f8-4cce-bd50-f02f657f27c8"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzctMy0xLTEtNDg5MDY_c8e8cb58-4915-44e2-86cd-2c4f754833d6"
      unitRef="usd">448000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzEwLTEtMS0xLTQ4OTA2_8dab03c8-5a41-4b9c-aee3-9678fb25344a">P4Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzEwLTMtMS0xLTQ4OTA2_87157f62-0289-4b65-b72b-4cd0443b46ee">P4Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzExLTEtMS0xLTQ4OTA2_a29ed195-328f-417b-8e96-dc37d5b1bb6a"
      unitRef="number">0.073</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzExLTMtMS0xLTQ4OTA2_8fbd833e-1807-4814-bf88-e2703e3d341c"
      unitRef="number">0.070</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE0LTEtMS0xLTQ4OTA2_fc23cf1f-d896-48a6-8d53-294444e370e7">P1Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE0LTMtMS0xLTQ4OTA2_213bc2f5-d7e8-4c01-b39d-2d161781ff1e">P1Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE1LTEtMS0xLTQ4OTA2_916b738b-0f75-459c-b105-55da903c01ef"
      unitRef="number">0.038</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpjNGMzYTRiZDA0OGQ0MTQ4YTM5Yzg0MzJhMDNkYmE3ZS90YWJsZXJhbmdlOmM0YzNhNGJkMDQ4ZDQxNDhhMzljODQzMmEwM2RiYTdlXzE1LTMtMS0xLTQ4OTA2_e1f47efd-ef3f-4580-8ae8-ac2ec217549f"
      unitRef="number">0.043</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjg_5ab11d80-14bc-4ad2-9456-9545d0e17b85">&lt;div style="margin-top:1pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90ZXh0cmVnaW9uOmYxMGYyNDM5ZDczMTRjY2ViYjM5Y2EyYzY2MTAyM2FlXzEzNjg_9ce7a912-fffd-4d60-8525-3b42679d4878">&lt;div style="margin-top:1pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the lease agreements as of December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMC0xLTEtNDg5MDY_1a420f08-4e4d-4ce0-b350-f9791e95fec5"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzEtMS0xLTEtNDg5MDY_b9d31669-5773-430d-9a8d-b935c6261caf"
      unitRef="usd">223000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzEtMy0xLTEtNDg5MDY_3b2db6f2-2106-4537-9ba4-4176960ee5e0"
      unitRef="usd">6844000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzItMS0xLTEtNDg5MDY_ac913bd2-e944-40f7-b2c1-75d0dec64a76"
      unitRef="usd">113000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzItMy0xLTEtNDg5MDY_90c69e4c-ccc8-40bd-a759-acb7bb8f1f54"
      unitRef="usd">6899000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzMtMS0xLTEtNDg5MDY_8a9f3b89-8887-41c8-9056-8bed2e08b7d8"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzMtMy0xLTEtNDg5MDY_33a02c83-b1d5-469e-b2cf-ff2b6983e008"
      unitRef="usd">7079000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzQtMS0xLTEtNDg5MDY_6f04765e-18ac-49b9-9b5a-02093b9209d7"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzQtMy0xLTEtNDg5MDY_517fb1df-2b32-48d2-81a0-b33871b9340a"
      unitRef="usd">2211000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzUtMS0xLTEtNDg5MDY_5ba7514b-563d-468c-ae66-c7a77804ea46"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzUtMy0xLTEtNDg5MDY_e4411e3a-f592-46e3-aa32-d1c719cdaf34"
      unitRef="usd">1317000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzYtMS0xLTEtNDg5MDY_efe3fd66-b3ef-4b6f-b2d3-0b16a5425539"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzYtMy0xLTEtNDg5MDY_566b4831-5f40-49e3-b5d2-530a0f9fad54"
      unitRef="usd">4660000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzctMS0xLTEtNDg5MDY_a99b79d0-15b6-4c41-a062-beb233fd8917"
      unitRef="usd">336000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzctMy0xLTEtNDg5MDY_5a5771a1-67e7-48f9-bf62-5506cc304337"
      unitRef="usd">29010000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzgtMS0xLTEtNDg5MDY_97dca7fb-6a25-44e6-af9d-3e91acda92b6"
      unitRef="usd">10000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzgtMy0xLTEtNDg5MDY_e4a9da09-ef6c-4f0b-88ab-f0ceea431cf2"
      unitRef="usd">5130000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMS0xLTEtNDg5MDY_f83d2b8b-4a09-45ce-b777-74204a5083bd"
      unitRef="usd">326000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjQvZnJhZzpmMTBmMjQzOWQ3MzE0Y2NlYmIzOWNhMmM2NjEwMjNhZS90YWJsZTpmODg5ZTM2NDJiNTU0MzcyODM5ZjJjMjg0M2ZmM2Q0OS90YWJsZXJhbmdlOmY4ODllMzY0MmI1NTQzNzI4MzlmMmMyODQzZmYzZDQ5XzktMy0xLTEtNDg5MDY_82549cb7-dd87-4bd6-bcbc-8a90be6bc8c8"
      unitRef="usd">23880000</us-gaap:OperatingLeaseLiability>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1NDk_58aac524-773e-4943-9743-5dd936f476fa">Short-term Investments&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consisted of available-for-sale and equity securities as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&#160;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&#160;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of available-for-sale debt securities by contractual maturity at December&#160;31 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one to three years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has both the intent and ability to sell its available-for-sale debt securities maturing greater than one year within 12 months from the balance sheet date and, accordingly, has classified these securities as current in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes investments that have been in a continuous unrealized loss position as of December&#160;31, 2022 (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invests in securities that are rated investment grade or better. The unrealized losses on available-for-sale debt securities as of December&#160;31, 2022 were caused primarily by interest rate increases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the individual securities in its portfolio for impairment when events indicate the fair value of the investments may be below the carrying value. The Company reviews the individual securities in its portfolio for indications that unrealized losses are credit related and require an allowance to be recorded at the present value of the future expected cash flows. The Company determined unrealized losses were not for credit losses and so did not record an allowance related to its available-for-sale debt investments for the year ended December&#160;31, 2022. The Company did not record any impairment charges related to its available-for-sale debt investments for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1Mzk_13f026fe-4154-447d-a24e-e4b7a63fc058">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consisted of available-for-sale and equity securities as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&#160;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&#160;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtMS0xLTEtNDg5MDY_a4400130-938e-40c0-8db4-3b1f01df3e42"
      unitRef="usd">62862000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtMy0xLTEtNDg5MDY_1c7d32d4-553c-44df-ba87-3c5bf933dca5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtNS0xLTEtNDg5MDY_1146ba00-b9f3-47cc-9c2f-f993e7a184df"
      unitRef="usd">359000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzEtNy0xLTEtNDg5MDY_4c9b95de-d0ba-4cb3-a472-06289c4c508d"
      unitRef="usd">62503000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItMS0xLTEtNDg5MDY_dbeeb7e6-3b9d-4c56-a2b9-82583d9dde37"
      unitRef="usd">22009000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItMy0xLTEtNDg5MDY_bd1bb143-556a-4367-86b8-a16484b05d7a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItNS0xLTEtNDg5MDY_a8a647cd-4149-499c-aa72-7d2626c6add0"
      unitRef="usd">230000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzItNy0xLTEtNDg5MDY_e98dffc2-4a25-40e2-b104-c93cd446852f"
      unitRef="usd">21779000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtMS0xLTEtNDg5MDY_34671ce1-3aec-4ce7-be8c-871fdd546b13"
      unitRef="usd">84871000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtMy0xLTEtNDg5MDY_af9b7941-a524-425d-b3ed-8cf9f8c79a77"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtNS0xLTEtNDg5MDY_9cf3cd93-27d9-4135-8229-f4984cbd88d3"
      unitRef="usd">589000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo3OWMxNjM0OGM3YWQ0ODUwOGNmNGMwZjhhNTE2NDllYy90YWJsZXJhbmdlOjc5YzE2MzQ4YzdhZDQ4NTA4Y2Y0YzBmOGE1MTY0OWVjXzQtNy0xLTEtNDg5MDY_1585588f-ef8c-49ce-948c-f9760283ad69"
      unitRef="usd">84282000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtMS0xLTEtNDg5MDY_4acaf2ac-c33e-4b81-bbd8-b136378a3eea"
      unitRef="usd">177375000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtMy0xLTEtNDg5MDY_0c8b682b-46d4-4f70-81c2-28f83d0c134f"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtNS0xLTEtNDg5MDY_2f7a33af-bc5c-4f72-81d6-6254ec4b408a"
      unitRef="usd">195000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzEtNy0xLTEtNDg5MDY_d1613761-66dd-4976-9ae4-a286f1ff9173"
      unitRef="usd">177183000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItMS0xLTEtNDg5MDY_c2318989-6530-4694-b9b8-9f1e5da919e1"
      unitRef="usd">33134000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItMy0xLTEtNDg5MDY_1feafe49-cef4-4aa0-a3b0-a9c4faa3b68f"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItNS0xLTEtNDg5MDY_3bfa1463-9c4f-449d-bb11-bd5dc0385aab"
      unitRef="usd">97000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzItNy0xLTEtNDg5MDY_a4094087-4f59-419e-8555-544f781fc35e"
      unitRef="usd">33039000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtMS0xLTEtNDg5MDY_3ff5a056-3227-441d-9302-aafa9d6d02d9"
      unitRef="usd">31631000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtMy0xLTEtNDg5MDY_7713e5ac-a7d1-4cc8-ac56-d65d99d9e034"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtNS0xLTEtNDg5MDY_557561ee-1a24-4447-b26c-7afc5c983129"
      unitRef="usd">32000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzMtNy0xLTEtNDg5MDY_782a4e98-dab2-41e6-838d-80804ff51b0d"
      unitRef="usd">31599000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtMS0xLTEtNDg5MDY_a4124024-babf-45a9-b882-316de033712f"
      unitRef="usd">242140000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtMy0xLTEtNDg5MDY_14011c34-b3a1-45dd-a8f0-014e922a440f"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtNS0xLTEtNDg5MDY_e5cb6556-1c9c-4b1c-827b-6591cf860fb9"
      unitRef="usd">324000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1NGVjZjVkYWIzYTI0YWI0OGNmYjMwN2JiYWE1NjdkNC90YWJsZXJhbmdlOjU0ZWNmNWRhYjNhMjRhYjQ4Y2ZiMzA3YmJhYTU2N2Q0XzQtNy0xLTEtNDg5MDY_cc68fd95-b6dc-4527-b206-ad7854c13615"
      unitRef="usd">241821000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1NDE_2a248ffd-b7e4-4a20-b5ff-afe0c4b7e944">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of available-for-sale debt securities by contractual maturity at December&#160;31 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one to three years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzEtMS0xLTEtNDg5MDY_e9390a9c-5425-4247-adfa-13c57b2e2ae8"
      unitRef="usd">81004000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzEtMy0xLTEtNDg5MDY_e33ca2dc-a26c-483a-9b23-16bfe7a2e0b4"
      unitRef="usd">174534000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <nstg:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzItMS0xLTEtNDg5MDY_0925b473-1b6e-41be-a7d0-ce820be60fb9"
      unitRef="usd">3278000</nstg:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <nstg:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzItMy0xLTEtNDg5MDY_f2be01e4-4571-4a5a-ab67-2a4077ac714a"
      unitRef="usd">67287000</nstg:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzMtMS0xLTEtNDg5MDY_23e307b2-f179-4484-b443-82391515a309"
      unitRef="usd">84282000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTo1ZDU5NTBmOTJhN2I0ZmI0YjY0ZGY2MzI4NTM1YTc2MS90YWJsZXJhbmdlOjVkNTk1MGY5MmE3YjRmYjRiNjRkZjYzMjg1MzVhNzYxXzMtMy0xLTEtNDg5MDY_4efe7a99-1f35-4450-a44a-aa5bc0b0b8f0"
      unitRef="usd">241821000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90ZXh0cmVnaW9uOmVmMGRiNDc0ZjI4ZTRlZDM5ZDQ5OWQ2MTI3OGYzZjk0XzE1NDg_88032624-bdb3-4c07-851f-a76d94763d84">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes investments that have been in a continuous unrealized loss position as of December&#160;31, 2022 (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItMS0xLTEtNDg5MDY_a65c7852-a6c9-4483-9104-5bfa7ee64f44"
      unitRef="usd">10232000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItMy0xLTEtNDg5MDY_a06bc807-4a34-4138-9a11-bcc3bb3c8ce7"
      unitRef="usd">52000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItNS0xLTEtNDg5MDY_6a3505b2-2b5e-43e2-859d-49154a8bace2"
      unitRef="usd">48271000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItNy0xLTEtNDg5MDY_713b2e73-03c9-4445-b4da-14a143f0bb30"
      unitRef="usd">307000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItOS0xLTEtNDg5MDY_d3147663-62a2-46fd-8515-033d026fb2e7"
      unitRef="usd">58503000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzItMTEtMS0xLTQ4OTA2_1addeacc-9be3-44a1-8aa5-8eb402b0d72b"
      unitRef="usd">359000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtMS0xLTEtNDg5MDY_22cfbfaf-8c8f-4aa5-af6b-170d5a628f17"
      unitRef="usd">3988000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtMy0xLTEtNDg5MDY_5b6260f4-8cda-402c-8864-cf07974657dc"
      unitRef="usd">16000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtNS0xLTEtNDg5MDY_82d2e1ca-e011-447f-b8b3-0867716f1ef1"
      unitRef="usd">17790000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtNy0xLTEtNDg5MDY_52fbc5e3-b070-4193-9991-fcc73d4bcfbd"
      unitRef="usd">214000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtOS0xLTEtNDg5MDY_a7c0b974-4048-419c-b581-d1ba18664e18"
      unitRef="usd">21778000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i204d5e8d1d3846dd9f94223ddb56342a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzMtMTEtMS0xLTQ4OTA2_f4fe1cb2-6bde-46dc-a017-0b6a07c5b395"
      unitRef="usd">230000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtMS0xLTEtNDg5MDY_b84a1c6a-7b57-4e33-999e-3f5d397e1f43"
      unitRef="usd">14220000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtMy0xLTEtNDg5MDY_4d0889bf-c31b-4e2b-911e-daf5c2642301"
      unitRef="usd">68000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtNS0xLTEtNDg5MDY_e45949e0-38fe-4628-a299-3e8943863e7a"
      unitRef="usd">66061000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtNy0xLTEtNDg5MDY_ad7eec02-3346-49db-95fe-fd52d9bf2a2b"
      unitRef="usd">521000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtOS0xLTEtNDg5MDY_3d4a3699-7ac7-4fd6-a5b0-63cb60077603"
      unitRef="usd">80281000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMjcvZnJhZzplZjBkYjQ3NGYyOGU0ZWQzOWQ0OTlkNjEyNzhmM2Y5NC90YWJsZTpiNWZiNDVkNTNlMjY0Zjk3OGE4MmEyZGZjZDU0MGRhNS90YWJsZXJhbmdlOmI1ZmI0NWQ1M2UyNjRmOTc4YTgyYTJkZmNkNTQwZGE1XzUtMTEtMS0xLTQ4OTA2_6038bed1-ccfa-4b8c-a140-b451001ad610"
      unitRef="usd">589000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3NzE_a3a87b48-e246-4a22-aa5f-8e1a2748f4d3">Fair Value Measurements&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a financial liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is used to measure fair value. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recorded amounts of certain financial instruments, including cash, accounts receivable, prepaid expenses and other, accounts payable and accrued liabilities, approximate fair value due to their relatively short-term maturities. The recorded amount of the Company&#x2019;s long-term debt can be determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market, which are classified as a Level 2 financial instrument. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments by level within the fair value hierarchy were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value measurement using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market fund&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value measurement using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market fund&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Company issued $230.0 million of Convertible Senior Notes of which $88.6 million was used to repay amounts owed and fees associated with the termination of its term loan agreement and revolving line of credit as described in more detail in Note 10. Long-term Debt, Net. As of December&#160;31, 2022, the fair value of the Convertible Senior Notes was $182.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3Njc_3c9b5f1e-f424-4cf7-8987-8b4e8b254f1e">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a financial liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is used to measure fair value. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;The recorded amounts of certain financial instruments, including cash, accounts receivable, prepaid expenses and other, accounts payable and accrued liabilities, approximate fair value due to their relatively short-term maturities. The recorded amount of the Company&#x2019;s long-term debt can be determined based on the estimated or actual bid prices of the Convertible Senior Notes in an over-the-counter market, which are classified as a Level 2 financial instrument.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3NzQ_b37fc840-551f-4d0a-93ee-8e38eb98544b">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments by level within the fair value hierarchy were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value measurement using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market fund&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type of securities as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value measurement using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market fund&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-related debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i25d9089997454bb1a0c3539505c1c38b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtMS0xLTEtNDg5MDY_3ba5498b-49ab-4457-91c5-61f40ccab1d8"
      unitRef="usd">104294000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if689c091da7e49acac49fa4109fec584_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtMy0xLTEtNDg5MDY_ba1f5ffb-4e02-4d5a-8366-cb31739b6390"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i51ae9afe71f74d379d16ab886a404393_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtNS0xLTEtNDg5MDY_c24f506e-f6ec-479e-879e-323f4be699dc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2492355e51654bb090ebf5513f607ae0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzMtNy0xLTEtNDg5MDY_4880ad4d-554e-4f64-bb79-76037c97a91c"
      unitRef="usd">104294000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6f16742116dd49ddb8104eb5bdbcfcdf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtMS0xLTEtNDg5MDY_fbe8bfcb-baf5-429d-8e98-2d72891d191a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iec61848f7a3942d2950cae11486a1ecc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtMy0xLTEtNDg5MDY_83e71dee-c761-4671-a7e4-652a2f2692fe"
      unitRef="usd">62503000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i98ca246e843540f4822dd96a53d66eed_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtNS0xLTEtNDg5MDY_a51e26bd-0dad-4d43-bfd9-c2c6c4fddb34"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic6fc704c7fb546f0b4b6e51fb8daaa2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzUtNy0xLTEtNDg5MDY_a9fd2a6b-b4b0-4321-927a-441c9c5f6fc3"
      unitRef="usd">62503000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i322cd850a2794ba0ba08d821a4e1df1d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtMS0xLTEtNDg5MDY_5229ff1b-0277-426e-b90a-0d0683dec9ee"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9582990fa8164d3a9f1fd4b0ec0ee75a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtMy0xLTEtNDg5MDY_b37eaea6-7ca8-4f82-885a-806ff30b2e73"
      unitRef="usd">21779000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i874d8d32e3cc4d7f840e2d1ff4b5d402_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtNS0xLTEtNDg5MDY_7c0f3b0e-b893-47d8-ae4c-b5b92a7c7e47"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i20faeb25382f4327a0f2e3a44b01c8c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzYtNy0xLTEtNDg5MDY_b5cfa338-29db-4526-bd6c-3e4e049fa5aa"
      unitRef="usd">21779000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i80ba8b859f55484eaada3a17ad6a664c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctMS0xLTEtNDg5MDY_f3b0e858-eb56-406e-87c8-3151cb4a5063"
      unitRef="usd">0</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i2436c4e22c584140bdea10494b55b14d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctMy0xLTEtNDg5MDY_c5899d2a-9c79-41e4-9dba-1714212ba40a"
      unitRef="usd">0</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i3e1c9aa8e85842fe9bf0570307ef0b9b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctNS0xLTEtNDg5MDY_c03ba1c9-5e04-45aa-96c0-a14598734715"
      unitRef="usd">0</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i7d931bc716374b53be3b0b9cefccbf8b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzctNy0xLTEtNDg5MDY_14d3a559-711f-4fb9-a6ca-0e2c083f7376"
      unitRef="usd">0</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5dc6ee5fcb0649249deb7816da0e2c05_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtMS0xLTEtNDg5MDY_dac4c007-dad6-47f7-bbfd-a990ee32725d"
      unitRef="usd">104294000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id8cc509eb60a411cbd96922835a08932_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtMy0xLTEtNDg5MDY_7c4af7cd-1e1f-481f-86ef-4d5591cb0e66"
      unitRef="usd">84282000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idd17be89ff4140d9a06669daa9ea9181_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtNS0xLTEtNDg5MDY_d174f6a0-1326-4830-8a85-430c2c3d16ca"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTpmZDNmMDljNDFlM2E0YmIyODEzZGE2NGQ4NjQxNjg3Yi90YWJsZXJhbmdlOmZkM2YwOWM0MWUzYTRiYjI4MTNkYTY0ZDg2NDE2ODdiXzgtNy0xLTEtNDg5MDY_23f86b9d-75c9-4470-b6cc-8ead05d7ddeb"
      unitRef="usd">188576000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6fa5e6f26b86406fb5758deca06ebe9e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtMS0xLTEtNDg5MDY_34bbd8a7-8598-401d-8cc5-a1b6abc6dd7d"
      unitRef="usd">98247000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7acddd71ba8140ab8c19a8a1975fb542_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtMy0xLTEtNDg5MDY_be9db5a1-3e02-4b80-bbcb-4560f6ab6d3d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0ea99fdfabbd4242aee0a5883d8beefd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtNS0xLTEtNDg5MDY_1d6eadd8-ce0e-420f-8857-89256d74f79f"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if449a99cfefe4c7cb63f39a6b7429081_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzMtNy0xLTEtNDg5MDY_b4b4c783-a38c-4311-8e4c-6f75c46d688c"
      unitRef="usd">98247000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i40784678c00f45dfa31384ea5da6ec61_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtMS0xLTEtNDg5MDY_736e8552-5683-447f-928d-5509ed107ead"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i715feed5faf14f819a69f74e70a51b89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtMy0xLTEtNDg5MDY_5d261da3-ab05-42a9-b7eb-60341e98bcfd"
      unitRef="usd">177183000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie950f8641c7a4192bee03c298f4d3e9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtNS0xLTEtNDg5MDY_82573743-bd3d-43b8-a88d-c2a7bebff378"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6c3446b18c3f4429b947c80eff58cea1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzUtNy0xLTEtNDg5MDY_5c3f6387-4a96-4781-8452-1e7184caf2fd"
      unitRef="usd">177183000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib11be0a2463245cfbe3d860c3f4e66f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtMS0xLTEtNDg5MDY_0d31aa42-4d82-4eaf-82be-55f0bded4b64"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ided2f9286c924c4f97ec0724c5a6a4e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtMy0xLTEtNDg5MDY_a23bd4ca-46f4-4b84-adf2-01f2e3f3c78a"
      unitRef="usd">33039000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8f4bf01fc4bc4bc5812e10affa2f9f7a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtNS0xLTEtNDg5MDY_ac3120d2-c937-49e6-96bc-e2b085cf5803"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4eb854fed69c4c2e8d7d00a6d54d708e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzYtNy0xLTEtNDg5MDY_1995a47c-9967-47da-8d3f-a95b4bb1005d"
      unitRef="usd">33039000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i023ed3e85c01469e986ad2ce472a4307_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctMS0xLTEtNDg5MDY_0b072587-042e-4d8a-b51c-72bf8fdb100d"
      unitRef="usd">0</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i6f3530905bb7474ab307f49b7ea1e2b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctMy0xLTEtNDg5MDY_21d4ffa8-6528-4cae-ba38-35fcd4ced13d"
      unitRef="usd">31599000</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="i23c3281ffb1a419384a2c48110d22e1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctNS0xLTEtNDg5MDY_d59b57d2-b434-4c54-ac83-d08552950a9e"
      unitRef="usd">0</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
      contextRef="iaaf0fb528f60478594ef2414b62f9d04_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzctNy0xLTEtNDg5MDY_2703eab2-8395-4fa6-a49b-bf243f99d1d2"
      unitRef="usd">31599000</us-gaap:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic5057ef90f9c4541a9b859fbaa260c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtMS0xLTEtNDg5MDY_f0bcaa2e-0886-4300-aa89-57435decb837"
      unitRef="usd">98247000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0419d16a85d2463b8a5cf1ac63c939d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtMy0xLTEtNDg5MDY_bf2fcecd-486f-4902-a9c4-e4824b5b294c"
      unitRef="usd">241821000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7550093a293240458a48f07f2c8c4626_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtNS0xLTEtNDg5MDY_08aad07f-b131-47b1-8fb2-2015456be2ab"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90YWJsZTplMGYwZjYwYmJjZDM0NDI0ODE2OWE4ZWVkZTU0OTE1Ni90YWJsZXJhbmdlOmUwZjBmNjBiYmNkMzQ0MjQ4MTY5YThlZWRlNTQ5MTU2XzgtNy0xLTEtNDg5MDY_ded25db2-9b7e-47bb-be7a-1ac2c4ef7185"
      unitRef="usd">340068000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RepaymentsOfDebt
      contextRef="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE1MzY_02e05b59-f2f8-4b0e-a6f3-1ce50ae1b861"
      unitRef="usd">88600000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7b7ef4b161684e7cacf3f6408767bb84_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzAvZnJhZzo4YTI1ZjY1YmMzMjA0NDY0OThkYjIyNWQ4OTJhMGU5MC90ZXh0cmVnaW9uOjhhMjVmNjViYzMyMDQ0NjQ5OGRiMjI1ZDg5MmEwZTkwXzE3NjM_ba262ddf-fdf8-4375-b3a1-e31e50d8da1b"
      unitRef="usd">182900000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90ZXh0cmVnaW9uOjkxZGE3YmM2MWM3ODRkN2JiMTQ1YzljNjBmZTMwNmI0Xzk2_3dbb67e0-4a72-4a09-b72f-8eb8748f5f5c">Inventory, Net&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following at December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intermediate manufactured components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90ZXh0cmVnaW9uOjkxZGE3YmM2MWM3ODRkN2JiMTQ1YzljNjBmZTMwNmI0Xzkz_579a6d8e-60d6-435d-b5a4-8a646307992c">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following at December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intermediate manufactured components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzEtMS0xLTEtNDg5MDY_c13d08bb-9f16-4629-9bce-3ac41b145b0e"
      unitRef="usd">11013000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzEtMy0xLTEtNDg5MDY_fa308d9b-bfbc-43b6-b378-afe4b88170bf"
      unitRef="usd">5985000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzItMS0xLTEtNDg5MDY_526c7b4f-9b83-4f99-8b54-37b283a6fdd0"
      unitRef="usd">14715000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzItMy0xLTEtNDg5MDY_e3d71eb4-20f0-411b-8bed-028f3cea1a9f"
      unitRef="usd">10887000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzMtMS0xLTEtNDg5MDY_38080517-f559-49a1-a63b-ae4a0143ac85"
      unitRef="usd">17545000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzMtMy0xLTEtNDg5MDY_f6cce83d-969d-496b-b1f5-3cea851c0c76"
      unitRef="usd">14614000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzQtMS0xLTEtNDg5MDY_0e6dc72a-3f5b-4d9c-9681-8cf90da633e9"
      unitRef="usd">43273000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzMvZnJhZzo5MWRhN2JjNjFjNzg0ZDdiYjE0NWM5YzYwZmUzMDZiNC90YWJsZTpiYTEwOTVkOTNmYzk0MTU2Yjg3MDJkNGRkNzAwYzg1OS90YWJsZXJhbmdlOmJhMTA5NWQ5M2ZjOTQxNTZiODcwMmQ0ZGQ3MDBjODU5XzQtMy0xLTEtNDg5MDY_7fcb7779-5935-4a6a-8f6d-281062d76145"
      unitRef="usd">31486000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQzNg_0479c6d4-df62-4fb5-a1d4-7fad8cbc8116">Property and Equipment&#160;&#160;&#160;&#160;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following at December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful&#160;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prototype instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prototype instruments consist of various CosMx SMI , GeoMx DSP, and nCounter instruments used in internal testing and other development activities. Depreciation and amortization expense related to property and equipment for the years ended December&#160;31, 2022, 2021 and 2020 totaled approximately $8.1 million, $5.9 million and $5.7 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQzNA_948bb1c8-16a9-4fa7-8b19-dac8d31e1b5c">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following at December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful&#160;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prototype instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3e88f609f3f146ceaf78b4e74394ba1b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzEtMS0xLTEtNDg5MDY_c10144d6-c1b9-4c65-8a57-cae8e40d0279">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if2a1951785ab40e68ae969d7cd3c9742_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzEtMy0xLTEtNDg5MDY_8a981812-c826-4336-85ba-846140bc9cd3"
      unitRef="usd">22094000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3cf29bb1eb74475e896a6511b6cf0035_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzEtNS0xLTEtNDg5MDY_4c8a40d8-8e9d-46eb-a7ed-0ede67b29dea"
      unitRef="usd">19067000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie616f0cefcbf4b0fadfa0ca79acf005d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzItMS0xLTEtNDg5MDY_e222b1eb-c656-495d-9810-d97f0a83506e">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0646dd1f77534091a7aac4d721b6769d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzItMy0xLTEtNDg5MDY_07105816-b786-4970-812d-98ff6c11d4ed"
      unitRef="usd">10421000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4c89b21a66a04e8d9b27819c58bef518_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzItNS0xLTEtNDg5MDY_4a8b2273-0691-44fa-9ea1-7373cd5ae3e7"
      unitRef="usd">2128000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i88f1ce22f43b4f6ba059a7cff32daa29_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzMtMS0xLTEtNDg5MDY_096444b9-368a-4a8c-b171-6ce1e1edde9c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4fee9a686a43435ebd9b2af3f2b0bf38_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzMtMy0xLTEtNDg5MDY_92dd5576-b805-4b60-8423-419d4520127b"
      unitRef="usd">18670000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i41ab44c9e5dd45638f78be80ead6cb26_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzMtNS0xLTEtNDg5MDY_5d475949-3701-4401-8189-13648b1f18e0"
      unitRef="usd">5597000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1f132592e8314b41869081ee86000fca_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzQtMS0xLTEtNDg5MDY_8f578b48-1971-4fa6-ac00-2fc0bce8dfbb">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifae3e7e9820c46b380d5dbba63c1ba21_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzQtMy0xLTEtNDg5MDY_a3f22ec3-5f4b-4d11-8185-2a194308e7db"
      unitRef="usd">2153000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8b1160c699fb41ab8078959aa2b71645_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzQtNS0xLTEtNDg5MDY_9a2b049c-cf21-43a6-b637-41fe8c6c75f5"
      unitRef="usd">1927000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1906cd27a926473f97dd96ae306e6ea7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzUtMy0xLTEtNDg5MDY_fc581c27-b430-40cf-98d5-83784d761167"
      unitRef="usd">20297000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if39bb1b648b84d1b8ea0e830f2e097ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzUtNS0xLTEtNDg5MDY_ae5f874d-5a08-4efd-b9e7-e9ff768bdbf5"
      unitRef="usd">19641000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iad8c07047cd941898973b031735aea40_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzYtMy0xLTEtNDg5MDY_15ea146d-3e71-40e9-ae6b-8385e04291fa"
      unitRef="usd">7055000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i041f0c1d8b534c149cf8210420c68583_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzYtNS0xLTEtNDg5MDY_eb672922-fd3f-42e1-b865-dd203b8e6583"
      unitRef="usd">7143000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzctMy0xLTEtNDg5MDY_70d2af98-01ca-41b5-b30e-0c1f1dac408d"
      unitRef="usd">80690000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzctNS0xLTEtNDg5MDY_2c341cc0-e616-4347-9cb1-81eb993c9774"
      unitRef="usd">55503000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzgtMy0xLTEtNDg5MDY_4de78bc7-7533-4442-a032-12eac2e79e9b"
      unitRef="usd">36233000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzgtNS0xLTEtNDg5MDY_32def9c2-db06-4be7-af64-693fe2265631"
      unitRef="usd">28460000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzktMy0xLTEtNDg5MDY_9b9b6dc8-6551-4d99-bfb2-a84628b56b50"
      unitRef="usd">44457000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90YWJsZToxNTMzYzc5MzNmMDI0ZTJiODMxNzc0NjRkZjU4Mzg2OS90YWJsZXJhbmdlOjE1MzNjNzkzM2YwMjRlMmI4MzE3NzQ2NGRmNTgzODY5XzktNS0xLTEtNDg5MDY_0a472cf1-810b-4302-a81e-598580e4184e"
      unitRef="usd">27043000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQwMw_fa80de26-3dd0-4422-92a6-d9425b46f635"
      unitRef="usd">8100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQwNw_3aa470f8-18e9-481a-a1c5-0ebdb930ac02"
      unitRef="usd">5900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzYvZnJhZzo1MTZlZGZmZTlkOTM0MDk4YTk3ZWZjNjc1YjExYTYxOC90ZXh0cmVnaW9uOjUxNmVkZmZlOWQ5MzQwOThhOTdlZmM2NzViMTFhNjE4XzQxNA_5e0dbe99-2b28-41f6-be9f-8a08abe725d5"
      unitRef="usd">5700000</us-gaap:Depreciation>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTgx_b6bef295-6d67-421f-9a9c-8f9363d1a4de">Long-term Debt&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Company issued $230.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due 2025 (&#x201c;Convertible Notes&#x201d;) in a private offering. The Convertible Notes are governed by an indenture dated March 9, 2020 between the Company and U.S. Bank, National Association, as trustee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received net proceeds from the offering of $222.6 million. The Company used $88.6 million to repay in full all outstanding amounts borrowed, accrued interest and fees owed in connection with the termination of the Company&#x2019;s amended and restated term loan agreement (&#x201c;2018 Term Loan&#x201d;) with Capital Royalty Group, and the fees owed in connection with the termination of the Company&#x2019;s revolving credit facility with Silicon Valley Bank.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Notes bear interest at a rate of 2.625% per year, payable semi-annually in arrears on March 1 and September 1, beginning on September 1, 2020. The Convertible Notes may bear additional interest under specified circumstances relating to the Company&#x2019;s failure to comply with its reporting obligations under, or if the Convertible Notes are not freely tradeable as required by, the indenture governing the Convertible Notes. Upon conversion, the Convertible Notes will be convertible into cash, shares of common stock or a combination of cash and shares of common stock, at the Company&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Notes are general unsecured senior obligations and will mature on March 1, 2025, unless earlier repurchased, redeemed or converted, subject to satisfaction of certain conditions and during the periods described below. The initial conversion rate for the Convertible Notes is 20.9161 shares of common stock, par value $0.0001 per share, per $1,000 principal amount of Convertible Notes (which is equivalent to an initial conversion price of approximately $47.81 per share). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that may occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such corporate event or in connection with such redemption, as the case may be, in certain circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the close of business on the business day immediately preceding December&#160;1, 2024, the Convertible Notes will be convertible only under the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on June&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2)&#160;during the five&#160;business-day&#160;period after any five consecutive&#160;trading-day&#160;period in which the trading price per $1,000 principal amount of Convertible Notes for each trading day of such period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3)&#160;if the Company calls any or all of the Convertible Notes for redemption, the Convertible Notes called for redemption (or, in the case of a partial redemption, if the Company makes an election to redeem all Convertible Notes, irrespective of whether they are called for redemption, to be convertible, all Convertible Notes) may be submitted for conversion at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date as set forth in the related redemption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;notice; or (4)&#160;upon the occurrence of specified corporate events. On or after December&#160;1, 2024, until the close of business on the business day immediately preceding the maturity date, holders of the Convertible Notes may convert all or any portion of their Convertible Notes at any time, regardless of the foregoing circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may not redeem the Convertible Notes prior to March 5, 2023, and no sinking fund is provided for the Convertible Notes. On or after March&#160;5, 2023, the Company may redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive&#160;trading-day&#160;period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the occurrence of a fundamental change (as defined in the indenture governing the Convertible Notes) prior to the maturity date, subject to certain conditions, holders may require the Company to repurchase all or a portion of the Convertible Notes in increments of $1,000 for cash at a price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Notes do not contain any financial or operating covenants or any restrictions on the issuance of other indebtedness or the issuance or repurchase of securities by the Company. The Convertible Notes indenture contains customary events of default, including that upon certain events of default, 100% of the principal and accrued and unpaid interest on the Convertible Notes will automatically become due and payable. Debt issuance costs are amortized to interest expense using the effective interest method over five years, the contractual term of the Convertible Notes, with an effective interest rate of 3.3%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company monitors the provision of the Convertible Notes that allow for certain conversion rights at each quarterly reporting date in order to determine whether the Convertible Notes are convertible or subject to an event triggering potential redemption during the prescribed measurement periods. As of the date of this report, none of the outstanding convertible notes had been redeemed by the Company. Based on the closing price of our common stock of $7.97 on the last trading day of the year, the if-converted values of the Convertible Notes did not exceed the outstanding principal balance as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;All future principal payments related to the Convertible Notes are due in March 2025. The outstanding balance of the Company&#x2019;s Convertible Notes consisted of the following at December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal of Convertible Note&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth total interest expense recognized related to the Convertible Notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, the Company entered into an amended and restated term loan agreement with Capital Royalty Group (the &#x201c;2018 Term Loan&#x201d;), under which it could borrow up to $100.0 million, which was due and payable in September 2024.&#160;The Company borrowed a total of $80.0 million under the 2018 Term Loan. In March 2020, the Company terminated the 2018 Term Loan agreement. The Company used $88.6 million of the proceeds from the Convertible Notes to repay in full all outstanding principle, interest and fees associated with termination of the loan. The termination was accounted for as debt extinguishment and the Company recorded a charge of $6.6 million associated with the elimination of previously deferred financing costs, and for fees and penalties incurred upon termination of the 2018 Term Loan and other costs. These costs have been included as a Loss on extinguishment of debt and termination of revolving loan facility in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Revolving Loan Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2018, the Company entered into a&#160;$15.0 million secured revolving loan facility, with availability subject to a borrowing base consisting of eligible accounts receivable. In November 2018, the Company entered into an amended and restated loan and security agreement to increase the borrowing capacity under the facility to $20.0 million, amend the borrowing base to include finished goods inventory, and extend the final maturity under the facility to November 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Company terminated the revolving loan facility and paid termination fees of $0.5 million. There were no amounts outstanding under the revolving loan facility at the time of termination. These costs have been included as a Loss on extinguishment of debt and termination of revolving loan facility in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total interest expense for the Company&#x2019;s long-term debt was $7.5 million, $7.5 million and $15.4 million for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="id8879a77916d4282a46de289bb9dbdd5_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzM5Nw_c294ad28-4777-4354-a60a-847ebfdfc243"
      unitRef="usd">222600000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQxOA_02e05b59-f2f8-4b0e-a6f3-1ce50ae1b861"
      unitRef="usd">88600000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzE2NjM_0572c3fc-838d-4d46-98a0-97fac424b105"
      unitRef="number">20.9161</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i03a3e574978345dfbe106d6fac6ec50f_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzE3MDA_030db5bd-e0c6-4203-90b2-11254aca05de"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i03a3e574978345dfbe106d6fac6ec50f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzE4Mjg_849e2f35-7bd7-419a-a2bb-aa3e5742de19"
      unitRef="usdPerShare">47.81</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzI3MTA_3bb49ac1-ea01-4494-bd46-ac0aa24ca9d0"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzI3NzQ_edb92aa3-a238-42f1-b51b-34866ea47a00"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzI5MjM_83bc7fb4-7421-4f08-8201-44ebe9861537"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc2_169cd0fb-ed97-4ec4-9496-fe4240aa3f34"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc3_ce47c2b3-0e30-4887-aafb-7e9bd3308fd3"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="if213e5eb1a0a4200b5a0f51930d8fc80_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzMxOTA_2ca91bed-401c-4aba-ae16-5a4069e84a0b"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i606a69ebc4a8447883e6090ba9b2e44d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQ0NzY_65f961c6-6bb3-4198-83d2-ee12e375bf51"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQ1ODc_d1317097-84ef-42b1-b397-a82d3d404701"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzQ4MjY_2240bf76-6af9-4c1b-86a3-9c4da0879ecd"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzUyNzQ_2240bf76-6af9-4c1b-86a3-9c4da0879ecd"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i983f70ef41f945ac8fc82bcaab4f684c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzU3NTA_2240bf76-6af9-4c1b-86a3-9c4da0879ecd"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzc1MTc_89fc7a1b-9774-496f-800d-624e0d1a3a39">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzc2MDM_8997f1f3-d572-441f-a80d-f4d1c42b6650"
      unitRef="number">0.033</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:SharePrice
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzg5MDQ_2be41761-db21-47a8-844b-86ffc90a613e"
      unitRef="usdPerShare">7.97</us-gaap:SharePrice>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc4_a5220c4b-bbd1-453a-89a1-84b24f2b98ce">The outstanding balance of the Company&#x2019;s Convertible Notes consisted of the following at December&#160;31 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal of Convertible Note&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <nstg:OutstandingPrincipalOfConvertibleDebt
      contextRef="i7b7ef4b161684e7cacf3f6408767bb84_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzItMS0xLTEtNDg5MDY_d4cf4c75-037c-4233-baaf-dcaf38885668"
      unitRef="usd">230000000</nstg:OutstandingPrincipalOfConvertibleDebt>
    <nstg:OutstandingPrincipalOfConvertibleDebt
      contextRef="i14f75101ca484bf6bac4dc7226b1113e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzItMy0xLTEtNDg5MDY_969cb229-5e9c-4a11-a918-5c943dc83794"
      unitRef="usd">230000000</nstg:OutstandingPrincipalOfConvertibleDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzMtMS0xLTEtNDg5MDY_60375939-5093-49ad-936b-ca086262007a"
      unitRef="usd">3378000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzMtMy0xLTEtNDg5MDY_1d55f2b2-5ae5-430c-a731-738ae00777c3"
      unitRef="usd">4856000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzQtMS0xLTEtNDg5MDY_91225477-c0b2-4dac-b058-d7104f56c4e2"
      unitRef="usd">226622000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTplMjU5NTE1MzIwM2E0NDczYjZkZDBjY2ZjNWI4OGM5My90YWJsZXJhbmdlOmUyNTk1MTUzMjAzYTQ0NzNiNmRkMGNjZmM1Yjg4YzkzXzQtMy0xLTEtNDg5MDY_b67c4a0c-ee23-4564-8be9-6107cda09cb8"
      unitRef="usd">225144000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTc5_67d78ec3-033d-4136-bddf-6f8b2ad37ec8">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth total interest expense recognized related to the Convertible Notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzItMi0xLTEtNDg5MDY_9a599353-ec20-4f44-a1e9-916a9599a61d"
      unitRef="usd">6038000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzItNC0xLTEtNDg5MDY_813d9cba-e3a5-4c12-9a7b-287b6c9c9ab8"
      unitRef="usd">6038000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzEtNi0xLTEtNzA5MTk_d88f8146-9052-4bc2-87e3-696c44f6f5a9"
      unitRef="usd">4897000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <nstg:AmortizationOfDebtDiscountAndIssuanceCosts
      contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzMtMi0xLTEtNDg5MDY_e5d42599-990c-472f-9720-621e1fc83664"
      unitRef="usd">1477000</nstg:AmortizationOfDebtDiscountAndIssuanceCosts>
    <nstg:AmortizationOfDebtDiscountAndIssuanceCosts
      contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzMtNC0xLTEtNDg5MDY_5dbf6a62-86bd-475f-8127-33d0c39c8f56"
      unitRef="usd">1429000</nstg:AmortizationOfDebtDiscountAndIssuanceCosts>
    <nstg:AmortizationOfDebtDiscountAndIssuanceCosts
      contextRef="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzItNi0xLTEtNzA5MTk_d9eb4aa7-fa1b-4b05-934d-59b83a634b27"
      unitRef="usd">8650000</nstg:AmortizationOfDebtDiscountAndIssuanceCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzQtMi0xLTEtNDg5MDY_13e552c7-995e-4115-ba5b-aaab83ec3b3f"
      unitRef="usd">7515000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ia7cf78618eeb4bdf90fec0e7b9705c15_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzQtNC0xLTEtNDg5MDY_68120534-beb3-47c0-9612-108ad5cfaf83"
      unitRef="usd">7467000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3218cbc292a34877ba52cac4212c4895_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90YWJsZTo5NjFhZGRjMTZiNWM0NmJmOTcyZGFhYmU1OTc3Njk3MC90YWJsZXJhbmdlOjk2MWFkZGMxNmI1YzQ2YmY5NzJkYWFiZTU5Nzc2OTcwXzMtNi0xLTEtNzA5MjM_f165dde1-308b-4f38-ab91-f45843392d2f"
      unitRef="usd">13547000</us-gaap:InterestExpenseDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i379a102945f149ae9e804e66bfdccfc8_I20181031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzk1NjY_2bc860cd-de2e-4d0a-80f4-6dc4e050bbfc"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i10abeac0df484f369c951c1d61608b8d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzk2NDc_5f446c12-78f4-47e6-97e1-52c25ac1e7b3"
      unitRef="usd">80000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfDebt
      contextRef="ifbd2eff7df8f4b31af5e594b0321b4fd_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0Xzk3NjA_02e05b59-f2f8-4b0e-a6f3-1ce50ae1b861"
      unitRef="usd">88600000</us-gaap:RepaymentsOfDebt>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i27c6ea2f53ac4990ae5f60cf96224bb2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwMDAz_1b5b6189-6df3-4701-94e8-5c42fa560ebf"
      unitRef="usd">6600000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8fe33f52f67b4687bbae5622f4312c40_I20180131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwMzM5_2ff18068-f805-4a2e-8e97-b2200c1ce05a"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie024cf12bf5b4458adc486ea3637775c_I20181130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwNjE3_2cad2904-ed57-4d8d-9364-043d0c1a1273"
      unitRef="usd">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <nstg:ExtinguishmentOfDebtTerminationFee
      contextRef="ibb55eb3463fb43ca895bce6ab03389cd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzEwODQ1_9f2e551b-4b08-420b-8367-1663b4365ab9"
      unitRef="usd">500000</nstg:ExtinguishmentOfDebtTerminationFee>
    <us-gaap:InterestExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTAw_a8f94ada-ce08-4dc6-8ca2-0d07ddd029c5"
      unitRef="usd">7500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i8d2647f818e343a1b49e1a59ad9b201e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTA0_13103d87-1bce-4ac2-8606-65baf3bfa042"
      unitRef="usd">7500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i27c6ea2f53ac4990ae5f60cf96224bb2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xMzkvZnJhZzo5YWQxODhhYjhlZjI0M2EwOTI4MWEyOTFkMjRmNDA1NC90ZXh0cmVnaW9uOjlhZDE4OGFiOGVmMjQzYTA5MjgxYTI5MWQyNGY0MDU0XzExMTEx_0904b3f0-e378-4d9d-a587-29c222c1e591"
      unitRef="usd">15400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzMxMzc_3a51d3ff-c1bb-4f94-8cb8-eee372310de3">Common Stock and Preferred Stock&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Public Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company completed an underwritten public offering of 5,750,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase 750,000 additional shares of common stock. The Company&#x2019;s total gross proceeds were $230.0 million. After underwriter&#x2019;s commissions and other expenses of the offering, the Company&#x2019;s aggregate net proceeds were $215.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of other classes of stock outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the amended and restated certificate of incorporation filed by the Company immediately prior to the completion of its initial public offering, the Company&#x2019;s board of directors is authorized to issue up to 15,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, redemption rights, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing change in the Company&#x2019;s control or other corporate action. As of December&#160;31, 2022, no shares of preferred stock were issued or outstanding, and the board of directors has not authorized or designated any rights, preferences, privileges and restrictions for any class of preferred stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Company&#x2019;s initial public offering, warrants to purchase preferred stock were issued related to certain financing transactions. All preferred stock warrants were converted into warrants to purchase common stock upon the effectiveness of the initial public offering. In addition, the Company has issued common stock warrants to third parties in accordance with the provisions of certain debt and collaboration agreements. As of December&#160;31, 2022, there were 470,510 common stock warrants outstanding with a weighted average exercise price of $24.70 per share and expiration dates in 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i84093a4322da469e83641848f0ea172b_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzcwNg_0b4f4957-9390-46fd-8a3d-109fb6487584"
      unitRef="shares">5750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="id19896e0ae0e48948f3db0dc516f3674_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzgxNg_dc27932b-adc0-49f3-b7d3-a64b1cebc70a"
      unitRef="shares">750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <nstg:SaleOfStockGrossConsiderationReceivedOnTransaction
      contextRef="i84093a4322da469e83641848f0ea172b_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzg5NA_7bc6a311-6db4-4e04-8de9-b3613b4f0020"
      unitRef="usd">230000000</nstg:SaleOfStockGrossConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i2faccbe8dbb44a7a885e478bce74de3a_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzEwMDg_4500071c-33ad-4971-962e-40f8964b9ddb"
      unitRef="usd">215800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:CommonStockVotingRights
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzEwNjc_1e9c3ae1-7911-4f02-997b-eae690b7fe82">one</us-gaap:CommonStockVotingRights>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzE1MzY_80e13ebd-4a9d-45f6-aa50-c598afd2535a"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i61e1f1159955427aa959883a212aa815_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzMwMTk_6d79cbee-ca63-4acf-b700-0935e2bcadd2"
      unitRef="shares">470510</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i61e1f1159955427aa959883a212aa815_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDUvZnJhZzpmOGNhODQ4ZTMwNjQ0NzBlYTU4N2ZjNjVmZDgwZTM4MS90ZXh0cmVnaW9uOmY4Y2E4NDhlMzA2NDQ3MGVhNTg3ZmM2NWZkODBlMzgxXzMwOTg_dd9f4202-3792-4581-b0ae-34df06e4f95c"
      unitRef="usdPerShare">24.70</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2Mjg_19b6fc61-69f9-4a5c-a61c-bbca92643827">Stock-based Compensation&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2013 Equity Incentive Plan, 2018 Inducement Equity Incentive Plan, and the 2022 Equity Incentive Plan (the &#x201c;Plans&#x201d;) authorize the grant of stock options, restricted stock units (&#x201c;RSUs&#x201d;) and other equity awards to employees, directors and consultants. As of December&#160;31, 2022, there were 15,057,772 shares authorized under the Plans. The Company has also granted RSUs that include service or service and certain performance conditions, or performance stock units (&#x201c;PSUs&#x201d;). RSUs generally vest over service periods of 1-3 years at which time award recipients receive shares of common stock equivalent to the originally awarded number of RSUs. In the case of PSUs, the number of PSUs that vest will be contingent on satisfying the service period and also based on achievement of all or part of the required performance obligations. All stock &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;options granted have a ten-year term and generally vest and become exercisable over four years of continued employment or service as defined in each option agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Unit (RSU) and Performance Stock Unit (PSU) Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU and PSU activity under the Plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-vested RSUs and PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Share Equivalent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average remaining&lt;br/&gt;contractual&lt;br/&gt;term (in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;intrinsic value&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of the RSUs and PSUs is determined based on the closing price of the Company&#x2019;s common stock on the date of grant. The fair value of vested RSUs and PSUs was $18.6 million, $11.7 million and $7.0 million for the years ended December 31, 2022, 2021 and 2020, respectively. The intrinsic value of vested RSUs and PSUs was $20.1 million, $44.5 million and $12.5 million for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021 and 2020, the Company modified certain performance conditions of its PSUs for approximately 10 employees in each year which were originally granted in 2020 and 2019. These stock award modifications resulted in incremental stock-based compensation expense of $3.0 million, and $4.7 million for 2021 and 2020, respectively, recognized from the date of the modification over the remaining vesting period of the awards, adjusted for performance conditions and forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Option Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s stock option activity under the Plans is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average exercise&lt;br/&gt;price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average remaining&lt;br/&gt;contractual&lt;br/&gt;term (in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;intrinsic value&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,017,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value per share of options granted with exercise prices equal to the market price on the date of the grant was $18.89 for the year ended December 31, 2020. The aggregate intrinsic value in the table above is calculated as the difference between the exercise price of the underlying options and the quoted price of the Company&#x2019;s common stock for all options that were in-the-money at December&#160;31, 2022. The aggregate intrinsic value of options exercised was $2.3 million, $26.9 million, and $39.9 million during 2022, 2021, and 2020, respectively, determined as of the option exercise date. The fair value of options vested was $2.2 million, $3.7 million and $4.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the Company&#x2019;s stock options outstanding at December&#160;31, 2022:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life in Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.92 &#x2013; $12.56&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.77 &#x2013;&#160;$14.99&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$15.21 &#x2013;&#160;$18.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.68 &#x2013;&#160;$22.71&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23.00 &#x2013;&#160;$66.91&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth stock-based compensation expense related to stock-based arrangements under the Plans as presented within the consolidated statement of operations for the years ended December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, total unrecognized stock-based compensation cost related to non-vested options and RSUs was $36.7 million for awards with a service component and $0.1 million for awards with a service and performance component. This cost will be recognized on a straight-line basis over the weighted-average remaining service period of approximately 2.0 years, for stock awards with a service component, and less than one year for stock awards with a service and performance component. The Company utilizes newly issued shares to satisfy option exercises. No tax benefit was recognized related to stock-based compensation cost since the Company has not reported taxable income to date and has established a full valuation allowance to offset all of the potential tax benefits associated with its deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Valuation assumptions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants RSUs to employees, directors and consultants and PSUs to employees and values these awards based on the grant date fair value, using the closing stock price of the Company&#x2019;s shares on the date of the grant. Stock-based compensation expense is recognized based on awards ultimately expected to vest using actual forfeitures when incurred. The percentage achievement and vesting of PSU awards are contingent upon the achievement of predetermined tiered revenue performance goals. The Company assesses the probability of the awards expected to vest, based on the performance goals, and if probable, records compensation expense over the estimated service period. Updates to the expected probability are recorded cumulatively and remaining compensation expense, if any, is recognized over the remaining estimated service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to January 1, 2021, the company granted stock options to employees, directors and consultants. The fair value of each employee stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.54% &#x2014; 1.69%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 &#x2014; 6.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0% &#x2014; 59.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk-free interest rates are based on the implied yield currently available in U.S. Treasury securities at maturity with an equivalent term. For purposes of determining the expected term of the awards in the absence of sufficient historical data relating to stock-option exercises, the Company applies a simplified approach in which the expected term of an award is presumed to be the mid-point between the vesting date and the expiration date of the award. The Company has not declared or paid any dividends and does not currently expect to do so in the foreseeable future. Expected volatility is based on the historical cumulative volatility of the Company&#x2019;s stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2013 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) provides eligible employees with an opportunity to purchase common stock from the Company and to pay for their purchases through payroll deductions. The ESPP has overlapping offering periods of approximately 12 months in length. The offering periods generally start with the first trading day on or after March&#160;1 and September&#160;1 of each year and end on the first trading day on or after March&#160;1 and September&#160;1 of the following year, approximately 12 months later. Within each offering period, shares are purchased each six months on an exercise date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An employee electing to participate in the ESPP (a &#x201c;participant&#x201d;) will be granted an option at the start of the offering period to purchase shares with contributions in any whole percentage ranging from 0% to 10% (or greater or lesser percentages or dollar amounts that the administrator determines) of the participant&#x2019;s eligible compensation. The participant&#x2019;s contributions will be accumulated and then used to purchase the Company&#x2019;s shares on each exercise date. The purchase price on the exercise date will be 85% of the fair market value of the lesser of the Company&#x2019;s share price on either the first trading day of the offering period or on the exercise date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, 2021 and 2020, shares issued under the ESPP were 150,341, 64,809 and 89,477, respectively. The Company recorded share-based compensation expense for shares issued from the ESPP of $2.2 million, $1.3 million and $0.9 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. A total of 2,204,647 shares of common stock have been reserved for issuance under the ESPP, of which 883,793 shares were available for issuance as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i37b3847550434762972bebc67656a85c_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM3MA_74c70cf4-4f98-499a-8175-c92df25d873b"
      unitRef="shares">15057772</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ie882436ff3ec4475b183dab55fc70afc_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NDk_fa548721-ef1a-42f0-bc80-6798c0d7a0de">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i06a3e3cb294548d8844d3e900432255e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzk5Nw_f108c92d-9788-42ba-a1e5-05fc5836b4c8">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtMS0xLTEtMTEyMTA0_42e76206-c044-4044-a08e-c63cbf2c68bb"
      unitRef="shares">1333215</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtMy0xLTEtMTEyMTA0_090718fd-9ae7-4acb-a8cc-b3295ac4cb84"
      unitRef="usdPerShare">41.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtNS0xLTEtMTEyOTY0_92bb9efe-6c63-41e5-82af-278555b3e0bb">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="i9ce562fc4e8c4ae6b3b28359e7046a30_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzEtNy0xLTEtMTEyOTE0_9fc76c75-be85-4780-a084-d5c80548f6ad"
      unitRef="usd">56302000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzMtMS0xLTEtMTEyMTA0_f66a05a3-9946-4af0-9418-adc849965697"
      unitRef="shares">2067562</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzMtMy0xLTEtMTEyMTA0_20d74eac-cbd8-46c3-9d70-98d92c558f86"
      unitRef="usdPerShare">24.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzQtMS0xLTEtMTEyMTA0_970f55ff-a02c-4c3d-9493-664a88ed03a2"
      unitRef="shares">759305</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzQtMy0xLTEtMTEyMTA0_88e6a329-ebfc-491d-8633-630aebb5dbf4"
      unitRef="usdPerShare">34.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzUtMS0xLTEtMTEyMTA0_43d9cc13-195f-47aa-982a-fcb3ae23f37e"
      unitRef="shares">260850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzUtMy0xLTEtMTEyMTA0_6c2669d4-a62a-4ef1-8717-f1217322283d"
      unitRef="usdPerShare">36.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if9bd905f155547fca3f7022d826550f6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtMS0xLTEtMTEyMTE0_bc326583-2aad-42ca-880a-1f418bb92997"
      unitRef="shares">2380622</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if9bd905f155547fca3f7022d826550f6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtMy0xLTEtMTEyMTA0_d140966c-913c-46b7-b2cc-01222b202744"
      unitRef="usdPerShare">29.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtNS0xLTEtMTEyOTQ1_195f64e3-fbb5-4cba-b896-e2a4606a98c9">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="if9bd905f155547fca3f7022d826550f6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0NTk2NDFlNGMyMDY0MGMzYmQ1NmNlOGExOWU1MWU5Ni90YWJsZXJhbmdlOjQ1OTY0MWU0YzIwNjQwYzNiZDU2Y2U4YTE5ZTUxZTk2XzYtNS0xLTEtMTEyODUz_c6ec5f12-5a79-4e8c-9178-912c6815f133"
      unitRef="usd">19031000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNzA2MTY_d87823c6-c395-42e7-a275-4041d199a93d"
      unitRef="usd">18600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id9ca6a450312485eb2653adb71cd9f5e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNzA2MjE_a42785b2-d56e-46fd-92c7-5dd1a346747e"
      unitRef="usd">11700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8090e4620bb54d97b89cb0dc5214c2ac_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNzA2Mjk_1685c55e-d533-429b-87b5-01a2f5577d7b"
      unitRef="usd">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="if662b112600744f887c0f7a89393ea18_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM2MTA_c29edcd0-5700-466b-8b4a-4a1637b251df"
      unitRef="usd">20100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="id9ca6a450312485eb2653adb71cd9f5e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM2MTU_78e068b3-293d-46db-a0d7-b64877dbf9f3"
      unitRef="usd">44500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i8090e4620bb54d97b89cb0dc5214c2ac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM2MjM_9ddfe8d6-2ae6-4486-87fa-f91dfcb6d934"
      unitRef="usd">12500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjM5NTc_2806bf23-7517-438b-acb3-0c866ce969ab"
      unitRef="usd">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxOTkwMjMyNjkwOTA_27552e52-9b72-46c5-b419-89f6a47775e2"
      unitRef="usd">4700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NTA_45093632-54a8-41bd-ac0c-0c0deb5960ab">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s stock option activity under the Plans is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average exercise&lt;br/&gt;price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average remaining&lt;br/&gt;contractual&lt;br/&gt;term (in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;intrinsic value&lt;br/&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,017,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtMS0xLTEtNDg5MDY_9bf065ed-d96a-41c8-9b5f-d5a6189ccc47"
      unitRef="shares">2017791</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtMy0xLTEtNDg5MDY_add7e4b8-9284-4694-8e98-641506fdefd0"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtNS0xLTEtNDg5MDY_e68c600b-39ea-44a7-b694-72cb70adb727">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzEtNy0xLTEtNDg5MDY_927e6ac7-0b7d-45f3-9698-a5462c93f4ac"
      unitRef="usd">51105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzItMS0xLTEtNDg5MDY_d28086f8-c00a-41f4-b511-09256b63df1d"
      unitRef="shares">122304</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzItMy0xLTEtNDg5MDY_acea953d-cbec-45a5-9571-8320871d1dc2"
      unitRef="usdPerShare">21.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzMtMS0xLTEtNDg5MDY_5a40fa56-9f5f-4730-8280-b1b4bc316d80"
      unitRef="shares">128627</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzMtMy0xLTEtNDg5MDY_4ae34e5b-94ca-472b-bdd8-6f50b4675689"
      unitRef="usdPerShare">11.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtMS0xLTEtNDg5MDY_afd74cdd-d580-424b-a09f-ea4f842c1d9f"
      unitRef="shares">1766860</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtMy0xLTEtNDg5MDY_f09522f8-81ba-4578-a903-b78ab979f41e"
      unitRef="usdPerShare">17.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtNS0xLTEtNDg5MDY_e339fe04-02e6-4a99-8c22-d1d6f62a687c">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzQtNy0xLTEtNDg5MDY_972ab722-f1ab-4efc-8b49-1dd7bac12790"
      unitRef="usd">265000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctMS0xLTEtNDg5MDY_200eb4a8-a8c5-4674-b45f-ac72dd80f23f"
      unitRef="shares">1766860</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctMy0xLTEtNDg5MDY_881e175d-29cb-4edc-8729-1ac1b1bc7f9c"
      unitRef="usdPerShare">17.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctNS0xLTEtNDg5MDY_275dd4b4-7fa5-4f87-9046-4c2b12c4d658">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzctNy0xLTEtNDg5MDY_2b1a663a-6933-422e-a9fd-6de267199e04"
      unitRef="usd">265000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtMS0xLTEtNDg5MDY_8334764e-593f-4de2-886c-96dc0c252d04"
      unitRef="shares">1682399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtMy0xLTEtNDg5MDY_9e3b980e-2669-4e83-aca9-d5a73fa5f68e"
      unitRef="usdPerShare">16.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtNS0xLTEtNDg5MDY_b735b398-9a5f-47a5-9cf8-61da97d03aba">P3Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTozMThiMDE1Y2NkYzQ0YTgyYmNmMzMwZTliYmVmMWM1Ny90YWJsZXJhbmdlOjMxOGIwMTVjY2RjNDRhODJiY2YzMzBlOWJiZWYxYzU3XzgtNy0xLTEtNDg5MDY_af9111c0-dc53-417a-ba4b-5131bae7eac6"
      unitRef="usd">265000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzE2NDg_14722c92-f981-4798-a800-f81e9bf6b2b2"
      unitRef="usdPerShare">18.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIwMDk_4b99656f-a516-4ecc-ac27-cbe7f0e67746"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIwMjM_d910e52c-283c-4e20-b656-963382c49817"
      unitRef="usd">26900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIwNDE_7cc788a4-3299-4885-a54b-7fb5d8da1c8d"
      unitRef="usd">39900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxMzU_1e11749e-efb9-47c9-b7af-6c9622a79b17"
      unitRef="usd">2200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxMzk_e406c75d-0c0d-49ac-ac4e-4f90b0d66c1e"
      unitRef="usd">3700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzIxNDY_7ca40f2c-ee5e-44ec-a538-09af09b4fff4"
      unitRef="usd">4200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NDM_8affb07a-5181-4f7a-a74e-5fcd87ac744a">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the Company&#x2019;s stock options outstanding at December&#160;31, 2022:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life in Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.92 &#x2013; $12.56&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.77 &#x2013;&#160;$14.99&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$15.21 &#x2013;&#160;$18.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.68 &#x2013;&#160;$22.71&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23.00 &#x2013;&#160;$66.91&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="if150562d534e43d7a0be36122ba6294b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo1ZjBmY2Q3NjhmZTQ0NjI0YTcxMWFlYzAzNGQwOTA2YV80_674e36b8-a966-4f41-a03d-80100c54df03"
      unitRef="usdPerShare">1.92</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i4c11cf0a91ac4e2a801affae1032e3d3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo1ZjBmY2Q3NjhmZTQ0NjI0YTcxMWFlYzAzNGQwOTA2YV85_aaccb34e-e8c0-4e60-8ecc-df2fb8afc2a2"
      unitRef="usdPerShare">12.56</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i3e84ed8c801a4c209b5bcdc1b70b5652_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMS0xLTEtNDg5MDY_394046fa-d184-4740-8337-550fae786110"
      unitRef="shares">299786</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="id6c402dc94d04e52bc03498acfaae727_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItMy0xLTEtNDg5MDY_e1b8efb3-bdc0-49c8-82bd-0cc771d20a13">P4Y6M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i3e84ed8c801a4c209b5bcdc1b70b5652_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItNS0xLTEtNDg5MDY_b744a89b-091e-4568-ac4c-7a1dce278f07"
      unitRef="shares">296765</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="id6c402dc94d04e52bc03498acfaae727_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzItNy0xLTEtNDg5MDY_3a68f501-6da6-4e62-af91-462f12f1f907">P4Y4M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i06cb2e813155412ca9d4aa066e0dbf5f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpkMTU3YTU5YTdkZmM0NDI1ODhmODk2OTQxMmFlYWY0ZV80_527a02b3-ff29-4620-9749-122712baad5d"
      unitRef="usdPerShare">12.77</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ib8338f87419c456caacda88b6cd45d60_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpkMTU3YTU5YTdkZmM0NDI1ODhmODk2OTQxMmFlYWY0ZV85_892f541b-c4b0-4f63-8030-da42cdb50c24"
      unitRef="usdPerShare">14.99</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i5c0f72610203463a91933df13c0ef863_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMS0xLTEtNDg5MDY_a697fbbb-1bc0-4c29-bd55-527be8d6a572"
      unitRef="shares">465815</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i363fd23d862d49c197424ef927db40d5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtMy0xLTEtNDg5MDY_78999de4-2641-49df-b16f-6e26859fb457">P2Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i5c0f72610203463a91933df13c0ef863_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtNS0xLTEtNDg5MDY_0b7ba4f9-0aaa-4017-9e38-1b81fbfb6376"
      unitRef="shares">465681</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i363fd23d862d49c197424ef927db40d5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzMtNy0xLTEtNDg5MDY_48fc6e30-8fdd-4eb5-9c4d-f813013039ba">P2Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ifdbe64c654004a0a9c1b1eb652e096c2_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjoyZDlmYjgwZmUzYWE0Nzk3ODdmY2M4YWY3OTE1Y2RiNl80_a8d4a283-0cfd-4e88-b0cc-4ab30f351dd3"
      unitRef="usdPerShare">15.21</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i5e02806cedd34a0fbaa454cc75f64d39_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjoyZDlmYjgwZmUzYWE0Nzk3ODdmY2M4YWY3OTE1Y2RiNl85_765c4c21-aed7-403a-8adf-d8ebab2e3399"
      unitRef="usdPerShare">18.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ia12bfc1b8c634d16b3b4fe87b81c81ed_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMS0xLTEtNDg5MDY_a87b9777-c1de-477f-a945-bd8d650ab1f1"
      unitRef="shares">232108</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="iae43c7b0912d44d4adbf7a74d6cc5170_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtMy0xLTEtNDg5MDY_8a4e07d9-0e5e-46b1-90b6-faeb6a3c3c74">P2Y6M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ia12bfc1b8c634d16b3b4fe87b81c81ed_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtNS0xLTEtNDg5MDY_a035680c-2154-4183-b5b5-57fce4eda489"
      unitRef="shares">224001</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="iae43c7b0912d44d4adbf7a74d6cc5170_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzQtNy0xLTEtNDg5MDY_dc7e7b39-8600-4809-b3dd-fbdd89515f35">P2Y2M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ie35e27d21c994c8f8ed1289ffa420eba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo2ZDczZDNjMzA0OGI0ZjYzYTMwZjJhNTQ3OTE5ZGZhZV80_0bc079b7-764c-4a94-b76c-b61d5857369b"
      unitRef="usdPerShare">18.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="id93d18101d134e09b27b73519d3e467a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo2ZDczZDNjMzA0OGI0ZjYzYTMwZjJhNTQ3OTE5ZGZhZV85_ec0adbc8-9616-4dfe-b004-ae2c26240360"
      unitRef="usdPerShare">22.71</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i1b5c097161754a66a79ba216e1fe8e69_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMS0xLTEtNDg5MDY_5c0fc4df-faff-41b9-a526-151d4f330696"
      unitRef="shares">297348</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ifbc4a5733a414b0ca670822be669b552_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtMy0xLTEtNDg5MDY_9f5a97cf-6db3-4a67-8d77-e93b535e9ee7">P4Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i1b5c097161754a66a79ba216e1fe8e69_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtNS0xLTEtNDg5MDY_8425ed2c-3e31-46e7-b126-031ff6dd6daf"
      unitRef="shares">278562</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ifbc4a5733a414b0ca670822be669b552_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzUtNy0xLTEtNDg5MDY_faf96910-32e2-4561-a163-139a0442cefe">P4Y4M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="if75c1d4d9c4747288ef5603464fb5fbb_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjphOTkxODlmYjgxOTg0ZDczYjdmMTg2ZWU2MzIxMTZlYl80_7d9e03f8-27d5-4f97-af19-15ae82f15c6e"
      unitRef="usdPerShare">23.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i39adc3163bb94109b81e6d5dad488eb1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMC0xLTEtNDg5MDYvdGV4dHJlZ2lvbjphOTkxODlmYjgxOTg0ZDczYjdmMTg2ZWU2MzIxMTZlYl85_c9316ea3-4cc0-4e3b-a338-aa058bbfdd3e"
      unitRef="usdPerShare">66.91</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i7eb61034aec1476781aa07ee2f8562ab_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMS0xLTEtNDg5MDY_9bc0f652-7965-4b79-a6b2-52652cfabdae"
      unitRef="shares">471803</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ie2dad374da0b48fa915dda42f71ff71b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtMy0xLTEtNDg5MDY_d231d039-3298-41ce-a266-d3f208a6e64a">P5Y9M18D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i7eb61034aec1476781aa07ee2f8562ab_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtNS0xLTEtNDg5MDY_9c4ff304-8697-4a95-9d31-9a672f71ce57"
      unitRef="shares">417390</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ie2dad374da0b48fa915dda42f71ff71b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzYtNy0xLTEtNDg5MDY_9f375b57-70a0-4609-9400-3957d4743b16">P5Y8M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzctMS0xLTEtNDg5MDY_34380a48-fcb2-43ed-a25a-4d6e0eca9a83"
      unitRef="shares">1766860</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo5YTlmNjQzMjQxMjk0ZGNkYWM0OWYxMDBiM2QzYzIzZS90YWJsZXJhbmdlOjlhOWY2NDMyNDEyOTRkY2RhYzQ5ZjEwMGIzZDNjMjNlXzctNS0xLTEtNDg5MDY_4f9ff0ee-c501-40ef-9b2b-3d8ca7c4e5ff"
      unitRef="shares">1682399</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2NDU_a788bf30-2c7a-43d8-a2c6-32335cabaf91">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth stock-based compensation expense related to stock-based arrangements under the Plans as presented within the consolidated statement of operations for the years ended December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i60e0592e249f4ddc84797c7db1802798_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzEtMS0xLTEtNDg5MDY_b9139bcb-f255-46b3-a968-edd458ab20a8"
      unitRef="usd">2397000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id359d7f10c7f4650a3ccb3e59f28b9b7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzEtMy0xLTEtNDg5MDY_409b726c-68a8-4ac4-9d2c-2e80d25f2d7b"
      unitRef="usd">1870000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4c5d477f82ff4c8699615becd441e2e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzEtNS0xLTEtNDg5MDY_c22546e0-0809-4275-93e1-e1905354ce6b"
      unitRef="usd">983000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i171d7573fd21497682c5ce64be7a7416_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzItMS0xLTEtNDg5MDY_833bac30-e681-4c84-8770-68b5a794d8b2"
      unitRef="usd">5972000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7ad73584ddef48af83fd9e76216c9ed8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzItMy0xLTEtNDg5MDY_2704ce55-cd8f-417c-bf3a-0a5864182a98"
      unitRef="usd">5723000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0f546e62eb5d437190c5f925abdd1993_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzItNS0xLTEtNDg5MDY_fb201711-e877-4911-851e-dbd5396a1c70"
      unitRef="usd">3864000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8b370a0aa7494558a2684df873b92e31_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzMtMS0xLTEtNDg5MDY_282c587f-72d8-4884-9def-67d0716757bf"
      unitRef="usd">15330000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic4cf23c2148a4d728f391d7591fed46a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzMtMy0xLTEtNDg5MDY_a8d5d005-9315-43b3-bb49-6ec3f7c05c95"
      unitRef="usd">21270000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i54234098f2fe415b99bdab8bf1fb6f00_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzMtNS0xLTEtNDg5MDY_993d1085-4808-449c-92dd-0e9d8cc8d5bb"
      unitRef="usd">13643000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzQtMS0xLTEtNDg5MDY_e4ff73f3-89c2-4256-ae21-cc883d832173"
      unitRef="usd">23699000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzQtMy0xLTEtNDg5MDY_d6b41fe1-d46d-4c4a-8330-af3e0b37d98c"
      unitRef="usd">28863000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZToxOTc4MTJmOThmYTE0MTZkYTdiMGEyMTdjMzNkMDM4MS90YWJsZXJhbmdlOjE5NzgxMmY5OGZhMTQxNmRhN2IwYTIxN2MzM2QwMzgxXzQtNS0xLTEtNDg5MDY_2d42e6d4-f634-4caf-b6cd-3c6d6ab73823"
      unitRef="usd">18490000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i74ec37816d5d4d1c9be1f2cc76135e4c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM0OTU_04ecaa51-f182-400d-9fbf-c1437fd69ad9"
      unitRef="usd">36700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i07c9b03e212c4b068eb66593b05efda9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM1Mzg_e97af877-26a1-4975-ba0c-491c6991cae1"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i838d0bd0b6124f28b27371e25ba13e46_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM3MDI_49143ceb-cb16-4378-bdd7-7140f3f5cf3c">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i846bf5f2f89540e68b6c2e2336234f13_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM3NTM_9cdf3c2b-b611-4011-9295-33098605bbdf">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzM4ODU_f1f0d9b8-6027-4815-80f2-1d479ffd1b1b"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc2MzY_19938974-368d-4e81-b951-8fdb19b98191">The fair value of each employee stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.54% &#x2014; 1.69%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 &#x2014; 6.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0% &#x2014; 59.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzEtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpmMzUyZjdkZjRlYzU0Y2I4OWNhNDNkZmVmZGJkNDE4Ml80_d50149d9-09d5-47ed-a693-754cff819b00"
      unitRef="number">0.0054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzEtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjpmMzUyZjdkZjRlYzU0Y2I4OWNhNDNkZmVmZGJkNDE4Ml85_23ceaa39-a2b8-4997-810c-7e88857d1787"
      unitRef="number">0.0169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzItMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjowMjhiYzBkMzM3OGI0NGZmYmE0MTIwOTM0MWEyMjlhZl80_ada6823e-ce10-4932-aec2-de5c16d5c0b3">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzItMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjowMjhiYzBkMzM3OGI0NGZmYmE0MTIwOTM0MWEyMjlhZl85_2cd7e771-c624-4de6-b4fe-6dbe9ad142d4">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzMtMy0xLTEtNDg5MDY_b4d3b463-8e5a-4ad7-86a3-d3d773206e69"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i041fc1d56c8d4ac398e5c9410bb59543_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzQtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo4YmZmNDRkZmUyNDY0MGY5YTA5ZjM2MTM1Nzg2OGY5Yl80_a114aa2f-e675-4192-b00a-65bd4b1f05ae"
      unitRef="number">0.530</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ie58a6f41d5754926aea77a7ab03ba076_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90YWJsZTo0ODYwMWYyYTMyYWQ0ZTNjYTlkYjNhNDllOTI5NTUxMi90YWJsZXJhbmdlOjQ4NjAxZjJhMzJhZDRlM2NhOWRiM2E0OWU5Mjk1NTEyXzQtMy0xLTEtNDg5MDYvdGV4dHJlZ2lvbjo4YmZmNDRkZmUyNDY0MGY5YTA5ZjM2MTM1Nzg2OGY5Yl85_b156867b-5b3d-4df4-99d8-bb152856e05b"
      unitRef="number">0.596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <nstg:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzYyNDk_0c7297de-c577-4ee3-9a73-046218ad5a2c">P12M</nstg:EmployeeStockPurchasePlanOfferingPeriod>
    <nstg:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY0ODI_0c7297de-c577-4ee3-9a73-046218ad5a2c">P12M</nstg:EmployeeStockPurchasePlanOfferingPeriod>
    <nstg:EmployeeStockPurchasePlanPurchasePeriod
      contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY1NDc_a6638ada-6ee3-4d12-bb95-3c51a74e1ad8">P6M</nstg:EmployeeStockPurchasePlanPurchasePeriod>
    <nstg:EmployeeStockPurchasePlanContributionPercentage
      contextRef="i3ebcaf345b284e6e9623117669975e74_D20130701-20130731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY3NzQ_14d4c870-13ae-405a-aaf8-463afed85121"
      unitRef="number">0</nstg:EmployeeStockPurchasePlanContributionPercentage>
    <nstg:EmployeeStockPurchasePlanContributionPercentage
      contextRef="i7999389f78ad4a51b40dceb35494cd61_D20130701-20130731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzY3ODA_eac3fee3-7984-4f56-ae3f-4ecab0d41aca"
      unitRef="number">0.10</nstg:EmployeeStockPurchasePlanContributionPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="id3b0ed017c604cd685acc5e0d6f04515_D20130701-20130731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzcwODQ_1025c57e-d8c7-4b48-b791-17c76455a5cc"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ic623892b482d42ae931b372405773674_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzcyOTE_74be076a-25b2-42dc-8b29-70810e38759e"
      unitRef="shares">150341</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i07b5aa174a6345a0b151fb3b490d437d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzcyOTU_6c02e40d-b089-4756-836f-da4178b4843e"
      unitRef="shares">64809</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="icad6d38c8f7c4d89a92280b9e15d04b8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4XzczMDI_4826cb0c-9bf0-4734-b73d-78edb451e282"
      unitRef="shares">89477</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic623892b482d42ae931b372405773674_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0MDk_7a087715-d921-4e25-ab1c-048eee364cbc"
      unitRef="usd">2200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i07b5aa174a6345a0b151fb3b490d437d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0MTM_2b2088c7-df5c-4a5c-b679-536c68c5c2d3"
      unitRef="usd">1300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icad6d38c8f7c4d89a92280b9e15d04b8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0MjA_9b860ccf-c4a3-464a-9b75-9f6d00c57e88"
      unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="if555a5dd86134313a260b8b540a5deb3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc0OTY_cbf25ae5-db03-499b-9dbd-220dd5897f7c"
      unitRef="shares">2204647</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="if555a5dd86134313a260b8b540a5deb3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNDgvZnJhZzowMWQ1NGFiOGVkOWE0NWY1YTU3NmQ0ZDI2ZDE3NTZmOC90ZXh0cmVnaW9uOjAxZDU0YWI4ZWQ5YTQ1ZjVhNTc2ZDRkMjZkMTc1NmY4Xzc1Nzk_b3c16709-352f-44da-a4bf-d59d26a56fd6"
      unitRef="shares">883793</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzMzNA_81919b52-3734-42b0-a5ca-c877033b5f39">Defined Contribution Retirement PlanThe Company maintains a 401(k) defined contribution retirement plan covering substantially all of its employees. The plan provides for matching and discretionary contributions by the Company. Contributions were $2.4 million, $2.0 million and $1.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzI1Nw_d774aafc-c2f5-4e0a-add1-fd5e642a685a"
      unitRef="usd">2400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzI2MQ_629647c9-8103-45c8-b1a2-ec1712438f6a"
      unitRef="usd">2000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTEvZnJhZzo5YTQxNThkOWVhNDA0YjZhODhhOTBhNmU4M2E3MjMzOC90ZXh0cmVnaW9uOjlhNDE1OGQ5ZWE0MDRiNmE4OGE5MGE2ZTgzYTcyMzM4XzI2OA_3cc1358b-6e87-4313-b370-32294b01f0f4"
      unitRef="usd">1700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNzE_2148130d-e5f8-4281-99b4-90265133c5c8">Income Taxes&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before income taxes for the years ended December&#160;31 consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,087)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our provision for income taxes for the years ended December&#160;31 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory income tax rate to the effective income tax rate for the years ended December&#160;31 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on repatriated foreign earnings and other nondeductible items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 162(m) limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in federal and state tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option exercise windfall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RTP and other true-ups&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and foreign tax, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31,&#160;2022, for income tax return purposes the Company has gross federal and state NOL carryforwards totaling $860.1 million&#160;and tax credit carryforwards of&#160;$16.2 million. The gross federal NOL carryforwards generated during and after fiscal 2018 totaling $389.3 million are carried forward indefinitely, while all others, if not utilized, will expire beginning in 2025 through 2037. The research and development credit carryforwards generated prior to 2018 will expire beginning in 2028. The carryforwards may be subject to limitations under the Internal Revenue Code and applicable state tax law. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not expect to utilize any of its net operating loss and tax credit carryforwards in the near term. The Company may have already experienced one or more ownership changes. Depending on the timing of any future utilization of its carryforwards, the Company may be limited as to the amount that can be utilized each year as a result of such previous ownership changes. However, the Company does not believe such limitations will cause its carryforwards to expire unutilized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future changes in the Company&#x2019;s stock ownership as well as other changes that may be outside the Company&#x2019;s control could potentially result in further limitations on the Company&#x2019;s ability to utilize its net operating loss and tax credit carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect of temporary differences and carryforwards that give rise to deferred tax assets and liabilities for the years ended December&#160;31 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 capitalized costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets before allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&#160;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State net operating loss adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the amounts in the income tax rate table and deferred tax assets tables above reflect reclassifications of prior year items to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has recorded a full valuation allowance related to its deferred tax assets due to the uncertainty of the ultimate realization of the future benefits from those assets. The table below summarizes changes in the deferred tax asset valuation allowance for the years ended December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of adoption of ASU 2020-06 on debt discount (equity component) deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of change in tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total balance of unrecognized gross tax benefits for the years ended December&#160;31, resulting from research and development tax credits claimed on the Company&#x2019;s annual tax return was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies applicable interest and penalties on amounts due to tax authorities as a component of the provision for income taxes. The amount of accrued interest and penalties recorded in 2022, 2021 or 2020 was not significant. The Company does not anticipate that the amount of its existing unrecognized tax benefits will significantly increase or decrease within the next 12&#160;months. Due to the presence of net operating loss carryforwards in most jurisdictions, the Company&#x2019;s tax years remain open for examination by U.S. taxing authorities back to 2004.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNTM_de2488bf-cd81-4d8f-a2d8-03f512d64ec3">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before income taxes for the years ended December&#160;31 consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,087)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzEtMS0xLTEtNDg5MDY_937efbe1-4a67-49fd-a65b-bc42c04f9a77"
      unitRef="usd">-160542000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzEtMy0xLTEtNDg5MDY_4d65c6e7-067b-4bd3-ac3e-c507edccdf24"
      unitRef="usd">-116178000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzEtNS0xLTEtNDg5MDY_e13fc0b6-1696-408d-ab6b-ce2110dae65b"
      unitRef="usd">-111101000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzItMS0xLTEtNDg5MDY_c11a9835-6a2b-45d0-b389-6902d462fd63"
      unitRef="usd">1316000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzItMy0xLTEtNDg5MDY_3ea04c2c-0042-494e-9983-a6c526331839"
      unitRef="usd">1091000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzItNS0xLTEtNDg5MDY_0eaeb5e7-40d4-465d-9d32-f91948a3c14a"
      unitRef="usd">1276000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzMtMS0xLTEtNDg5MDY_b4408d33-6840-4585-898c-0b6ee49186a9"
      unitRef="usd">-159226000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzMtMy0xLTEtNDg5MDY_9603f3ae-d1c5-4b3c-b174-77d62d04ced2"
      unitRef="usd">-115087000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo2Mjg3YWUyNTBmOGU0MDdlOTUxMjZjM2ZlN2RkNjMxNi90YWJsZXJhbmdlOjYyODdhZTI1MGY4ZTQwN2U5NTEyNmMzZmU3ZGQ2MzE2XzMtNS0xLTEtNDg5MDY_2735eaf5-5dd8-4a09-acd9-df754a34d5b0"
      unitRef="usd">-109825000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNTQ_04be94fb-5068-401d-a5f0-bdb456f76b5d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our provision for income taxes for the years ended December&#160;31 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3bc2480d9afc41299a0dc200f9614cef_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzItMS0xLTEtNDg5MDY_001b48ec-b840-445f-aae1-414daf5daebe"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i9e8993d263434600a013126584291fad_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzItMy0xLTEtNDg5MDY_01f70ab7-defa-4402-bed7-436370a1f5ad"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i58bff15771ac47c3a9eb0fe25cc0fdea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzItNS0xLTEtNDg5MDY_14924ca9-210e-4d27-a43f-2d1cb3837e71"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i35672bdf7a8344d580057c105d3a35f4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzMtMS0xLTEtNDg5MDY_4eb20571-fefc-4443-a08a-8ffd9131e5b4"
      unitRef="usd">317000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="id186117bd3474f299cf9daa35048c269_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzMtMy0xLTEtNDg5MDY_1d40f2aa-0c23-4a81-96fa-894021f8076b"
      unitRef="usd">167000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib1acfbe546b94ee9add32ffe159ea86c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzMtNS0xLTEtNDg5MDY_a0022612-3de6-4820-88e7-c17c01251e65"
      unitRef="usd">253000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzQtMS0xLTEtNDg5MDY_96e68616-3437-47e8-9403-bd1a51d82fee"
      unitRef="usd">317000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzQtMy0xLTEtNDg5MDY_ed948eb0-6082-4922-a40e-4635b5a0e8a5"
      unitRef="usd">167000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo0NDU5YzZiMjQ0MTU0NDQyODg3NjI2MGMwMzYyMDA1YS90YWJsZXJhbmdlOjQ0NTljNmIyNDQxNTQ0NDI4ODc2MjYwYzAzNjIwMDVhXzQtNS0xLTEtNDg5MDY_5a137cc9-ce9e-47ee-b6c0-ec6056610892"
      unitRef="usd">253000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNjc_4839c8e1-3f30-4892-b38f-bf27f5b14420">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory income tax rate to the effective income tax rate for the years ended December&#160;31 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on repatriated foreign earnings and other nondeductible items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 162(m) limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in federal and state tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option exercise windfall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RTP and other true-ups&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and foreign tax, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEtMS0xLTEtNDg5MDY_a1f2cb55-d6bc-442d-b1cc-bf0205283cb6"
      unitRef="usd">-33706000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEtMy0xLTEtNDg5MDY_ffd50bbf-6165-4f2c-8add-4071fe877400"
      unitRef="usd">-24168000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEtNS0xLTEtNDg5MDY_cb3d7e97-967a-401d-b7b4-30420795d594"
      unitRef="usd">-23063000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzItMS0xLTEtNDg5MDY_c002495f-f286-4416-894b-17ad249e532e"
      unitRef="usd">284000</nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts>
    <nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzItMy0xLTEtNDg5MDY_d7d38431-08b3-4c64-a7ee-d0ab805dcc5a"
      unitRef="usd">580000</nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts>
    <nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzItNS0xLTEtNDg5MDY_75c06355-708b-4232-88fa-f211ff0f11d6"
      unitRef="usd">348000</nstg:EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts>
    <nstg:EffectiveIncomeTaxReconciliationSection162Limitation
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzMtMS0xLTEtNDg5MDY_ac76585d-9242-44b3-b73c-516db18b41cf"
      unitRef="usd">1265000</nstg:EffectiveIncomeTaxReconciliationSection162Limitation>
    <nstg:EffectiveIncomeTaxReconciliationSection162Limitation
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzMtMy0xLTEtNDg5MDY_c97d2c21-6128-4676-b169-cbd941cf39d6"
      unitRef="usd">5824000</nstg:EffectiveIncomeTaxReconciliationSection162Limitation>
    <nstg:EffectiveIncomeTaxReconciliationSection162Limitation
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzMtNS0xLTEtNDg5MDY_d0cddb0a-49e9-49d8-af77-7906d56b0eec"
      unitRef="usd">5044000</nstg:EffectiveIncomeTaxReconciliationSection162Limitation>
    <nstg:IncomeTaxReconciliationChangeInTaxCredits
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzQtMS0xLTEtNDg5MDY_ed39b20e-ecce-4309-a7dc-9619f93cb173"
      unitRef="usd">3501000</nstg:IncomeTaxReconciliationChangeInTaxCredits>
    <nstg:IncomeTaxReconciliationChangeInTaxCredits
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzQtMy0xLTEtNDg5MDY_cbbd2421-25d7-4138-a5de-efeb21ce381b"
      unitRef="usd">2514000</nstg:IncomeTaxReconciliationChangeInTaxCredits>
    <nstg:IncomeTaxReconciliationChangeInTaxCredits
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzQtNS0xLTEtNDg5MDY_0af7992d-ccd6-447d-9231-9ddeb6bc43f0"
      unitRef="usd">-3123000</nstg:IncomeTaxReconciliationChangeInTaxCredits>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzUtMS0xLTEtNDg5MDY_3fea8448-9f7c-48df-80e6-f387c425754b"
      unitRef="usd">36163000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzUtMy0xLTEtNDg5MDY_118ad5ed-76ff-45d0-b61f-cae2c329cc57"
      unitRef="usd">36550000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzUtNS0xLTEtNDg5MDY_06909f75-c5e9-4929-a4bd-4377ced83161"
      unitRef="usd">21766000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzYtMS0xLTEtNDg5MDY_ef75f42a-2fb9-47b0-98b2-e3b0c15feabb"
      unitRef="usd">2000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzYtMy0xLTEtNDg5MDY_4aa22498-48a5-4550-89a6-869f26f06c67"
      unitRef="usd">-110000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzYtNS0xLTEtNDg5MDY_1071c529-8030-4d4a-9600-370fcb693c0b"
      unitRef="usd">586000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzctMS0xLTEtNDg5MDY_9b3796f2-321a-4872-a2fa-fedddc3c37fc"
      unitRef="usd">1758000</nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall>
    <nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzctMy0xLTEtNDg5MDY_16fcb68e-7ad0-4972-ba63-0bca21eba25a"
      unitRef="usd">-9761000</nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall>
    <nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzctNS0xLTEtNDg5MDY_dcf187f5-3d63-481d-b519-48c6affbfa92"
      unitRef="usd">-7683000</nstg:EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzgtMS0xLTEtNDg5MDY_2db961f1-bb84-4dce-a845-01e97de846cb"
      unitRef="usd">1665000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzgtMy0xLTEtNDg5MDY_062d1d51-71d0-4127-ab23-07d7c0f44194"
      unitRef="usd">-2823000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzgtNS0xLTEtNDg5MDY_598db505-3ff4-4a15-8aa9-c3900b14b13b"
      unitRef="usd">2461000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzktMS0xLTEtNDg5MDY_64c0750e-0d46-4206-9bf6-af2510408141"
      unitRef="usd">-3613000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzktMy0xLTEtNDg5MDY_27427769-e75b-4ba1-b500-1ce47f9d59bb"
      unitRef="usd">-3411000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzktNS0xLTEtNDg5MDY_0ff9a238-362b-4eff-b354-74181758950d"
      unitRef="usd">-2329000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEwLTEtMS0xLTQ4OTA2_4e0ddf47-c330-4271-8976-003243523ce2"
      unitRef="usd">317000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEwLTMtMS0xLTQ4OTA2_42215c85-aac0-401a-960a-56c2e4ae5001"
      unitRef="usd">167000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTpiMWVkZjcwNGQzMjQ0NDFhODZlZTk1YjNiZWE0NDkyNC90YWJsZXJhbmdlOmIxZWRmNzA0ZDMyNDQ0MWE4NmVlOTViM2JlYTQ0OTI0XzEwLTUtMS0xLTQ4OTA2_3b672941-5e6c-4643-90b1-4b5fd689f902"
      unitRef="usd">253000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i28ef8872ca69434cb82b4ce55d15bd25_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzUyMA_8887bf34-b15d-4752-8ceb-0f047b11ef94"
      unitRef="usd">860100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i28ef8872ca69434cb82b4ce55d15bd25_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzU1NQ_eae7a2e5-9c84-4428-9074-50d720664ca2"
      unitRef="usd">16200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ifffa3e3faf9c444ba7d318f1c005e08d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzY0Mw_d9eb6bab-489d-4694-990b-639a7884f50d"
      unitRef="usd">389300000</us-gaap:OperatingLossCarryforwards>
    <nstg:ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNjE_973937a1-4d30-46b1-89a3-516a26dcdd80">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect of temporary differences and carryforwards that give rise to deferred tax assets and liabilities for the years ended December&#160;31 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 capitalized costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets before allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&#160;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State net operating loss adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</nstg:ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzItMS0xLTEtNDg5MDY_442c33dd-701e-4925-9b40-950229bcb3b6"
      unitRef="usd">146108000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzItMy0xLTEtNDg5MDY_bd1f4ae2-b345-4f0f-a47f-ca3dc9574daa"
      unitRef="usd">131971000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzMtMS0xLTEtNDg5MDY_f5030ba5-531c-4b8e-b7c0-7522ab8e16de"
      unitRef="usd">15529000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzMtMy0xLTEtNDg5MDY_234e8889-107d-468d-a343-1a45af8048e8"
      unitRef="usd">12028000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <nstg:DeferredTaxAssetsSection174Capitalization
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMS0xLTEtMTE0NTcz_09fae95f-12e1-4f64-8ff1-0cadd525fed7"
      unitRef="usd">17076000</nstg:DeferredTaxAssetsSection174Capitalization>
    <nstg:DeferredTaxAssetsSection174Capitalization
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMy0xLTEtMTE0NTg0_8c633d99-b067-4f22-ad48-165c8f50ae1c"
      unitRef="usd">0</nstg:DeferredTaxAssetsSection174Capitalization>
    <nstg:DeferredTaxAssetsDeferredLeaseLiability
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMS0xLTEtNDg5MDY_d147fa87-3d97-41f5-8d8b-29651c758a0a"
      unitRef="usd">5736000</nstg:DeferredTaxAssetsDeferredLeaseLiability>
    <nstg:DeferredTaxAssetsDeferredLeaseLiability
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzQtMy0xLTEtNDg5MDY_47066252-ff3d-4f60-9960-8350fd35b74b"
      unitRef="usd">6423000</nstg:DeferredTaxAssetsDeferredLeaseLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzUtMS0xLTEtNDg5MDY_4923071a-02bc-4e0a-a8e2-66e577f54f7b"
      unitRef="usd">6561000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzUtMy0xLTEtNDg5MDY_f1f96eac-6598-4c9e-94ff-d1d8ff79f164"
      unitRef="usd">6287000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzYtMS0xLTEtNDg5MDY_65c0a8de-d4df-4e5b-b96b-6bbd8f5499dd"
      unitRef="usd">659000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzYtMy0xLTEtNDg5MDY_6300e886-fbd9-4458-984a-af9f74b26167"
      unitRef="usd">659000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzctMS0xLTEtNDg5MDY_bd71d7b7-a190-4c6e-9bd5-a379333b96b0"
      unitRef="usd">12603000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzctMy0xLTEtNDg5MDY_a66de2f9-1d20-4bba-8500-b1daddb11f67"
      unitRef="usd">10139000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzgtMS0xLTEtNDg5MDY_8614e35f-c3d2-4700-b2bf-c5e9f8cb88de"
      unitRef="usd">204272000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzgtMy0xLTEtNDg5MDY_de8a04ac-8ae1-49f1-87f1-c2f78ea6a364"
      unitRef="usd">167507000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzktMS0xLTEtNDg5MDY_d046b65e-5313-47ec-a496-11800ff993df"
      unitRef="usd">198980000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzktMy0xLTEtNDg5MDY_e1202610-1a5b-4eb7-a3d3-f8ff4f65dde5"
      unitRef="usd">162817000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEwLTEtMS0xLTQ4OTA2_e7d4cf7f-35c7-40a1-8e21-9024d9bfda1e"
      unitRef="usd">5292000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEwLTMtMS0xLTQ4OTA2_7d812d6e-98a8-4fda-81f2-3679a500c7b0"
      unitRef="usd">4690000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEyLTEtMS0xLTQ4OTA2_cfeece9c-dd9f-4971-81a9-3534e48d67c3"
      unitRef="usd">4329000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzEyLTMtMS0xLTQ4OTA2_0b7bf64d-27a0-4d54-9915-0d283bfa7839"
      unitRef="usd">4690000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <nstg:DeferredTaxLiabilitiesStateNetOperatingLossAdjustments
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTEtMS0xLTExODY4OA_53d87601-9b90-41ca-b798-085dd60a791f"
      unitRef="usd">963000</nstg:DeferredTaxLiabilitiesStateNetOperatingLossAdjustments>
    <nstg:DeferredTaxLiabilitiesStateNetOperatingLossAdjustments
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTMtMS0xLTExODY5Nw_9742e70e-60bc-4887-a5c9-657038da3e5c"
      unitRef="usd">0</nstg:DeferredTaxLiabilitiesStateNetOperatingLossAdjustments>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTEtMS0xLTQ4OTA2_ac94ec33-47b6-4fb7-b849-30cc1da20a1c"
      unitRef="usd">5292000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE0LTMtMS0xLTQ4OTA2_52fec60a-bec0-48e4-88d5-006555435502"
      unitRef="usd">4690000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE1LTEtMS0xLTQ4OTA2_4aaac981-6851-418b-800a-9a2c70ee42bb"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZToyYmRhMmI5YzhjMzU0OTJjYTFjMWFkOTY0NzQ0MzQyMC90YWJsZXJhbmdlOjJiZGEyYjljOGMzNTQ5MmNhMWMxYWQ5NjQ3NDQzNDIwXzE1LTMtMS0xLTQ4OTA2_d3d5ab8d-7636-496e-aaa2-0c287d7171e4"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <nstg:ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNzU_5634fe85-c983-4ed6-80dd-2d8beb14d5ce">The table below summarizes changes in the deferred tax asset valuation allowance for the years ended December&#160;31 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of adoption of ASU 2020-06 on debt discount (equity component) deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of change in tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</nstg:ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzEtMS0xLTEtNDg5MDY_1eee864d-7195-4d34-8414-dd18c95fc20d"
      unitRef="usd">162817000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzEtMy0xLTEtNDg5MDY_33d95793-80c8-4ecf-a499-63a38e2dd573"
      unitRef="usd">114335000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzEtNS0xLTEtNDg5MDY_b62b9721-a6b9-4358-9dd4-39cd3b33a63a"
      unitRef="usd">106438000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i21fa537a67cc4008a5f886347dd4fca6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzItMy0xLTEtNDg5MDY_e0fcd561-6cbc-4b4d-bed1-df88dead5bf2"
      unitRef="usd">11932000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzMtMS0xLTEtNDg5MDY_6d3eee11-1cda-4a36-9579-0bab0b127245"
      unitRef="usd">36165000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i83025943657d49539ea6888045a339de_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzMtMy0xLTEtNDg5MDY_5152b0e4-3cb7-4a66-9dd7-b81cff2d62cc"
      unitRef="usd">36440000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i21a2f01c1b5040569d99fe2b4cc5881b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzMtNS0xLTEtNDg5MDY_8694c7db-f4a3-4196-8be4-694225966326"
      unitRef="usd">8483000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzQtMS0xLTEtNDg5MDY_76b32250-99ef-4a57-9ab2-8128c4d62d86"
      unitRef="usd">-2000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i83025943657d49539ea6888045a339de_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzQtMy0xLTEtNDg5MDY_42490353-85e6-4dd0-865e-d60478fc5215"
      unitRef="usd">110000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i21a2f01c1b5040569d99fe2b4cc5881b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzQtNS0xLTEtNDg5MDY_b3ac1d0b-8c0a-4009-b6ca-99df48be6b3d"
      unitRef="usd">-586000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzUtMS0xLTEtNDg5MDY_0d99576b-4efd-44dc-b833-163d0258ceaf"
      unitRef="usd">198980000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzUtMy0xLTEtNDg5MDY_9d573c2f-7fc9-4e63-9ddb-63d7c63ced4b"
      unitRef="usd">162817000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTo3MWZkYTcwNzY5YWY0M2Q3OWYzN2ZiNWRlNTI2ZjE2MS90YWJsZXJhbmdlOjcxZmRhNzA3NjlhZjQzZDc5ZjM3ZmI1ZGU1MjZmMTYxXzUtNS0xLTEtNDg5MDY_aaf1d87c-9d4e-4e32-bb62-bc3e188925fc"
      unitRef="usd">114335000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzMxNzA_b13a3675-5028-4117-9492-36bc48fffba9">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total balance of unrecognized gross tax benefits for the years ended December&#160;31, resulting from research and development tax credits claimed on the Company&#x2019;s annual tax return was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzEtMS0xLTEtNDg5MDY_ec8ea41d-81eb-49f8-ab50-4de3cfe3f415"
      unitRef="usd">10009000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzEtMy0xLTEtNDg5MDY_c3f598fc-8935-4cc3-817f-234e24d1b648"
      unitRef="usd">9171000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i386de87196f44b13b5fbbfb2f76610bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzEtNS0xLTEtNDg5MDY_f317ef12-71ac-46a6-aa09-707a3eccb1cd"
      unitRef="usd">4212000</us-gaap:UnrecognizedTaxBenefits>
    <nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzItMS0xLTEtNDg5MDY_4406bd0d-33a3-4f3e-b759-a1acc24a1869"
      unitRef="usd">1167000</nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions>
    <nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i01d2bde15ccf4bbeaaf520cdbe6c3096_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzItMy0xLTEtNDg5MDY_d3c3a0e6-a49e-4f13-a273-b9f70b88951b"
      unitRef="usd">838000</nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions>
    <nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzItNS0xLTEtNDg5MDY_2fadac7a-e02f-45c4-a351-43feb6f52167"
      unitRef="usd">4959000</nstg:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzMtMS0xLTEtNDg5MDY_a0929c4a-4aac-4d54-ac18-3b245cb2ebc3"
      unitRef="usd">11176000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzMtMy0xLTEtNDg5MDY_aca97906-6bbf-460e-9a06-597263e9c2ca"
      unitRef="usd">10009000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90YWJsZTozNTY1Y2Q2ZjRhNTE0N2U5YTkwYjI3MDZjMTdiNjNhZS90YWJsZXJhbmdlOjM1NjVjZDZmNGE1MTQ3ZTlhOTBiMjcwNmMxN2I2M2FlXzMtNS0xLTEtNDg5MDY_5bd23970-6f1c-4e17-8a93-ac6bb3fb2455"
      unitRef="usd">9171000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i82b26d4493e6499daf1af61adf60e137_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzI4MDg_7fbb678b-9ca8-4b83-8dd3-178a7e5febac"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzI4MDg_c253e574-21d4-4dfb-9a1f-5381b6d77b81"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i9e05f468d67d4e158506601ffba408b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTQvZnJhZzplMWM0NDA4YTA3ZmQ0ODQzYjkzMTEwZDg4NTZkNzNkNy90ZXh0cmVnaW9uOmUxYzQ0MDhhMDdmZDQ4NDNiOTMxMTBkODg1NmQ3M2Q3XzI4MDg_eccde94c-691e-4d2c-82c2-37cbf76952bb"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzQ0MTY_4dd9056e-6a26-4633-9317-295f64b5d177">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;10x Genomics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 6, 2021, 10x Genomics, Inc. and Prognosys Biosciences, Inc., or &#x201c;Prognosys&#x201d;, filed a complaint, and on May 19, 2021, an amended complaint, and on May 4, 2022, a second amended complaint, against the Company in the U.S. District Court for the District of Delaware. The amended complaint alleges that certain of the Company&#x2019;s products, services and components sold by the Company for use in connection with its GeoMx DSP system (the &#x201c;Identified GeoMx Products&#x201d;) infringe seven patents owned by Prognosys: (a) U.S. Patent No. 10,472,669, &#x201c;Spatially encoded biological assays,&#x201d; (b) U.S. Patent No. 10,961,566, &#x201c;Spatially encoded biological assays,&#x201d; (c) U.S. Patent No. 10,983,113, &#x201c;Spatially encoded biological assays,&#x201d; (d) U.S. Patent No. 10,996,219, &#x201c;Spatially encoded biological assays,&#x201d; (e) U.S. Patent No. 11,001,878, &#x201c;Spatially encoded biological assays,&#x201d; (f) U.S. Patent No. 11,008,607, &#x201c;Spatially encoded biological assays,&#x201d; and (g) U.S. Patent No. 11,293,917, &#x201c;Systems for analyzing target biological molecules via sample imaging and delivery of probes to substrate well&#x201d; (the &#x201c;Asserted Prognosys Patents&#x201d;). The amended complaint seeks, among other relief, injunctive relief and unspecified damages (including treble damages and attorneys&#x2019; fees) in relation to the Company&#x2019;s making, using, selling, offering to sell, exporting and/or importing in the United States the Identified GeoMx Products, as well as the alleged infringement by others of the Asserted Prognosys Patents through their use of the Identified GeoMx Products. The Company has evaluated the plaintiffs&#x2019; claims and does not believe that its activities infringe any patent rights held by the plaintiffs. On November 17, 2021, the Court granted the Company&#x2019;s motion to dismiss the plaintiffs&#x2019; claims of pre-suit indirect infringement and willful infringement with leave to amend the complaint. Discovery is in progress. A claim construction hearing was held on February 17, 2023. A trial is scheduled for November 2023. The Company intends to vigorously defend itself in this litigation. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2022, 10x Genomics, Inc. and President and Fellows of Harvard College, or &#x201c;Harvard&#x201d;, filed a complaint, and on May 12, 2022, an amended complaint, against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that certain of the Company&#x2019;s products, services and components sold by it for use in connection with its CosMx SMI system (the &#x201c;Identified CosMx Products&#x201d;) infringe five patents owned by Harvard: (a) U.S. Patent No. 10,227,639, &#x201c;Compositions and Methods for Analyte Detection,&#x201d; and (b) U.S. Patent No. 11,021,737, &#x201c;Compositions and Methods for Analyte Detection,&#x201d; (c) U.S. Patent No. 11,293,051, &#x201c;Compositions and Methods for Analyte Detection&#x201d;, (d) U.S. Patent No. 11,293,052, &#x201c;Compositions and Methods for Analyte Detection,&#x201d; and (e) U.S. Patent No. 11,293,054, &#x201c;Compositions and Methods for Analyte Detection&#x201d; (the &#x201c;U.S. 10x CosMx Case&#x201d;). The complaint seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#x2019; fees) in relation to the Company&#x2019;s making, using, selling, offering to sell, exporting and/or importing in the United States the Identified CosMx Products. The Company has evaluated the plaintiffs&#x2019; claims and does not believe that its activities infringe any patent rights held by the plaintiffs. Discovery is in progress. A claim construction hearing is scheduled for July 2023 and a trial is scheduled for June 2024. The Company &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;intends to vigorously defend itself in this litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. On August 16, 2022, the Company filed counterclaims in this action alleging that 10x Genomics&#x2019; Visium Spatial Gene Expression system and related products and services infringe the Company&#x2019;s U.S. Patent No. 11,377,689, &#x201c;Chemical Compositions and Uses Thereof.&#x201d; On January 24, 2023, these counterclaims were consolidated with the claims of a separate patent infringement case that the Company filed against 10x Genomics on October 20, 2022, as discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 9, 2022, the Company was notified of a complaint, dated March 4, 2022, naming the Company and its wholly-owned subsidiary, NanoString Technologies Germany GmbH, which 10x Genomics, Inc. filed in the Munich Regional Court I in Germany, alleging that the Company&#x2019;s CosMx SMI system and associated products and services infringe European Patent No. 2794928B1, or &#x201c;EP 2794928B1&#x201d;, which is owned by Harvard. The complaint seeks, among other relief, injunctive relief and damages in relation to the Company's selling and offering to sell its CosMx SMI system and associated products and services in Germany. The Company has evaluated the claims and does not believe that its activities infringe any patent rights held by 10x or Harvard. A hearing is scheduled for March 2023 in this proceeding. The Company &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;intends to vigorously defend itself in this litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. On July 29, 2022, the Company, through its German subsidiary, filed a nullity action with the German Federal Patent Court in Munich requesting a judgment that EP 2794928B1, as in effect for Germany, be declared invalid and be revoked in its entirety. On February 10, 2023, the German Federal Patent Court issued a preliminary and non-binding opinion in this nullity action finding that the subject matter of the asserted independent claim 1 of EP 2794928B1 potentially lacked novelty and lacked an inventive step over prior art. The preliminary opinion further addressed Harvard&#x2019;s seven patent claim limitation requests, referred to as auxiliary requests, which 10x and Harvard seek to have applied in the event that claim 1 of EP 2794928B1, as granted, proves not to be protectable. The preliminary opinion stated that the claim limitations in Auxiliary Request 1 could potentially be used to defend EP 2794928B1 over the cited prior art. The preliminary opinion further stated that Harvard would potentially not be able to use Auxiliary Requests 2 through 7 to establish novelty over the prior art. A hearing before the German Federal Patent Court is scheduled for May 2024 and a decision in the nullity action is expected following the hearing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 20, 2022, the Company filed suit against 10x Genomics, Inc. in the U.S. District Court for the District of Delaware alleging that 10x Genomics&#x2019; Visium Spatial Gene Expression system and related products and services infringe the Company's U.S. Patent No. 11,473,142, &#x201c;Chemical Compositions and Uses Thereof.&#x201d; On January 24, 2023, the Company&#x2019;s claims from the U.S.10x CosMx Case with respect to U.S. Patent No. 11,377,689 were consolidated with the claims in this action. The Company seeks, among other relief, injunctive relief and unspecified damages (including attorneys&#x2019; fees) in relation to 10x Genomics&#x2019; making, using, selling, offering to sell, exporting and/or importing in the United States the Visium system and related products and services. Discovery is in progress. A case schedule has not yet been set.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the pending litigations with 10x Genomics and its co-plaintiffs, the Company is not engaged in any material legal proceedings. The Company is involved in other legal proceedings from time to time arising in the normal course of business. Additionally, the Company operates in various states and local jurisdictions for which sales, occupation, or franchise taxes may be payable to certain taxing authorities. Management believes that the outcome of these proceedings and any amounts that may become payable to certain taxing authorities will not have a material impact on the Company&#x2019;s financial condition, results of operations, or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2022 the Company has non-cancellable purchase obligations of $70.0 million related to binding commitments to purchase inventory and other research and development items, $62.1 million of which is due within the next 12 months. In addition, the Company has construction contracts, associated with one of its Seattle area facilities, of $5.0 million, which is due within the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzQyNzM_f19c9dd6-eecd-4088-b062-8e1c1d64f8a2"
      unitRef="usd">70000000</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzQzNzE_901769fa-cc0b-4b90-bb00-18153a9dc5f2"
      unitRef="usd">62100000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligation
      contextRef="icccc75f297f9487aaf6af93a9682218d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNTcvZnJhZzplYzU0NzkyNmM1NDg0ZTBjYmU0ZWVhN2RjNmJlNWQ4My90ZXh0cmVnaW9uOmVjNTQ3OTI2YzU0ODRlMGNiZTRlZWE3ZGM2YmU1ZDgzXzIxOTkwMjMzMDQyMjk_e1705d9d-1a17-4a70-a64b-dc4d8e4ce303"
      unitRef="usd">5000000</us-gaap:ContractualObligation>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90ZXh0cmVnaW9uOmMxZjg5YWQ5MTNmYzQ1NDFhYzA0MTdmZjU1MjkwNDFkXzcxMw_6552e741-25e5-4ffa-acba-637ceb5ef2fe">Net Loss Per Share&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding. Outstanding stock options, restricted stock units and common stock warrants have not been included in the calculation of diluted net loss per share because to do so would be anti-dilutive. Accordingly, the numerator and the denominator used in computing both basic and diluted net loss per share for each period are the same.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock participating securities as of December&#160;31 were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90ZXh0cmVnaW9uOmMxZjg5YWQ5MTNmYzQ1NDFhYzA0MTdmZjU1MjkwNDFkXzcxNg_09ae29d1-a257-450e-964e-8b7ee06eddf8">Net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding. Outstanding stock options, restricted stock units and common stock warrants have not been included in the calculation of diluted net loss per share because to do so would be anti-dilutive. Accordingly, the numerator and the denominator used in computing both basic and diluted net loss per share for each period are the same.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90ZXh0cmVnaW9uOmMxZjg5YWQ5MTNmYzQ1NDFhYzA0MTdmZjU1MjkwNDFkXzcxMQ_83fd955b-95ea-490a-9fe9-84a8be77c59d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock participating securities as of December&#160;31 were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib3ed46b1479f4064896cb2ff583b50fe_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzEtMS0xLTEtNDg5MDY_816e2e15-2039-40d1-b59b-cc119a8570c3"
      unitRef="shares">1837000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8ec5ee0bad2343278a6de1b6fd2cc457_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzEtMy0xLTEtNDg5MDY_7787c723-4a65-4276-bbf0-6d2b6efad744"
      unitRef="shares">2271000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i547b52c74b7d404a86d2976b1d0d428d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzEtNS0xLTEtNDg5MDY_930208c7-4167-426c-bff0-493c4454f8e0"
      unitRef="shares">3379000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iecc395aad27d4e279fde1f41cf731f43_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzItMS0xLTEtNDg5MDY_866d4539-34e8-4f52-a8d1-5a3edf4d5e28"
      unitRef="shares">1920000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i79b5e44fa71c4cdd99d7ef0f4caeaae9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzItMy0xLTEtNDg5MDY_f2cd10f0-e6cf-46c5-9cb8-f80fc5c357e3"
      unitRef="shares">1344000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i71dfb62de0ed48e8a1bf6ac8a7dc0277_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzItNS0xLTEtNDg5MDY_e888669d-be67-4f27-b9b6-ccdee5e6c48f"
      unitRef="shares">1574000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia62e3cab8f2e4c3cb75f270e19d7bece_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzMtMS0xLTEtNDg5MDY_6d789c75-b470-4d32-b9f3-cb9eb573d8be"
      unitRef="shares">471000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifab9ad4b738c40b1bad40a93b5d022f5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzMtMy0xLTEtNDg5MDY_38c68284-47f0-4af9-ac88-fd1bcb0ff871"
      unitRef="shares">471000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i044b09e095b341cea037a0552518fa44_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjAvZnJhZzpjMWY4OWFkOTEzZmM0NTQxYWMwNDE3ZmY1NTI5MDQxZC90YWJsZTpmNTI2YzE3YjFjMGY0ZGQyYTllMTZlYWVmNmI3NjA5NC90YWJsZXJhbmdlOmY1MjZjMTdiMWMwZjRkZDJhOWUxNmVhZWY2Yjc2MDk0XzMtNS0xLTEtNDg5MDY_fec576fe-b4d1-4689-a843-e5ff4319b719"
      unitRef="shares">508000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i043751235d134593932bc4d1798772f9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjMvZnJhZzpmMDc1MmE4ODRkNzY0MDc0ODdjNzNkZWQ2MjI4ZjU2Yi90ZXh0cmVnaW9uOmYwNzUyYTg4NGQ3NjQwNzQ4N2M3M2RlZDYyMjhmNTZiXzMyOTg1MzQ4ODM2Nzc_db6bd4bd-ac5b-489d-b67d-dad84d3e25c7">Subsequent EventsIn February 2023, the Company&#x2019;s board of directors approved an amendment to the 2018 Inducement Equity Incentive Plan to increase the number of shares of the Company&#x2019;s common stock available for issuance under the plan for equity awards granted from 250,000 shares to 425,000 shares.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8451f817802047b4ac1d9188ce3a1a70_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjMvZnJhZzpmMDc1MmE4ODRkNzY0MDc0ODdjNzNkZWQ2MjI4ZjU2Yi90ZXh0cmVnaW9uOmYwNzUyYTg4NGQ3NjQwNzQ4N2M3M2RlZDYyMjhmNTZiXzMyOTg1MzQ4ODM2NjU_cf96192e-14d7-4a3c-ba04-942a8167185c"
      unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="icc345a5e318943deb1b776d29eab9f21_I20230227"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk5NTlkYzMwYjVkNzRkOTlhNzBhMTIxZWIwOWE0NTE1L3NlYzo5OTU5ZGMzMGI1ZDc0ZDk5YTcwYTEyMWViMDlhNDUxNV8xNjMvZnJhZzpmMDc1MmE4ODRkNzY0MDc0ODdjNzNkZWQ2MjI4ZjU2Yi90ZXh0cmVnaW9uOmYwNzUyYTg4NGQ3NjQwNzQ4N2M3M2RlZDYyMjhmNTZiXzMyOTg1MzQ4ODM2NzU_e25610eb-cfe4-4e6c-8005-f194f42eb07d"
      unitRef="shares">425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>125
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( )>"7%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "7@EQ6F1^%V^T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)OITU!EM#-1?&D(+B@> O)[&ZP24,RTN[;F\;=+J(/X#$S?[[Y
M!J;70>@QXG,< T:RF&YF-_@D=-BR(U$0 $D?T:E4YX3/S?T8G:+\C <(2G^H
M P)OFEMP2,HH4K  J[ 2F>R-%CJBHC&>\4:O^/ 9AP(S&G! AYX2M'4+3"X3
MPVD>>K@"%AAA=.F[@&8EENJ?V-(!=D[.R:ZI:9KJJ2NYO$,+;T^/+V7=ROI$
MRFO,OY(5= JX99?)K]W=_>Z!2=[PKFIXQ3<[W@K>"+YY7UQ_^%V%W6CLWOYC
MXXN@[.'77<@O4$L#!!0    ( )>"7%:97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M&!$,B84Z 7Y?,";W!^H"155\__]02P,$%     @ EX)<5G[$PE(Z @  NP4
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M=)<;2A1\Z #U^YHQ^?Q!O_NZ?SEZ^7]02P,$%     @ EX)<5N3+\TZB!@
M9"(  !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6RM6FMOVS84_2N$5PPM
MD,0D]<X2 ZNU8076-4C:];,BT;906?1$VDG__:B')4N\8NU"7VQ+/O>8Y_+J
M\IC2W0LOOHD-8Q*];K-<W,\V4NYNYW,1;]@V$C=\QW+US8H7VTBJPV(]%[N"
M14D5M,WF%&-WOHW2?+:XJ\X]%(L[OI=9FK.' HG]=AL5W]^SC+_<S\CL>.(Q
M76]D>6*^N-M%:_;$Y)?=0Z&.YBU+DFY9+E*>HX*M[F>_D]O0LLJ "O%ORE[$
MR6=42GGF_%MY\"&YG^%R1"QCL2PI(O5V8$N69263&L=_#>FL_<TR\/3SD?W/
M2KP2\QP)MN39US21F_N9/T,)6T7[3#[RE[]8(\@I^6*>B>H5O318/$/Q7DB^
M;8+5"+9I7K]'KTTB3@*(.Q) FP Z#+!' JPFP#HWP&X"["HSM90J#V$DH\5=
MP5]04:(56_FA2F85K>2G>3GO3[)0WZ8J3BZ6/!<\2Y-(L@0]2?6F)E4*Q%?H
MTXX543DY EVC+T\A>OOF'1*;J& "I3GZO.%[$>6)N$)O>L=W<ZD&5M+/XV80
M[^M!T)%!$(H^\EQN!/HC3UC2)Y@K1:TL>I3UGAH90Q;?((M<(8HI!0:T/#^<
M .'A^>'8H,9J)\FJ^*P1OD=V8/F>W4*9K2-M.++L&K=B%\7L?J;:@F#%@<T6
MO_Y"7/P;E)4IR<*)R'H9L]N,V2;VQ6<NHTSUI2IO4-KJ<*<*+WOC016A1UU5
M*X?3A  PV\&^TX>% (QX%G%;6$^$TXIPC-.^Y$)=B>J20NQ5]7G!!%@!SI05
M,"59.!%9+WENFSS76 %E\LHNMBMXLH^EJ19J(O=D]ES']@9SO 10OH7M027H
M*(?:.( +P6NU>$8MCRH[41%OJEI(E)",[\HV#8GQM %XV+?)0(R.<@-'$P.@
MJ.]XL!B_%>,;Q3RI-3[-UU=HS7*UP&25J"A1:ULJ9+G@',!)\K6Q$-LB-!@(
M V#$<; U4*;# HR#$65!JRPXH^G$VE4+R0FT 5 OL.UAT0$PQ[+(8#I# (8=
MR[5@/01WY@ ;%?W-A4"K@F\1;\T N+QC;0#7Q*'$'^1]"0*Q3ZD[4 0!?1_;
M(U-$3OP.,3;53W+#"N578KYEZ&TS1>_ QMHP3=19)V4+IV+K9Y%V6:3&POB0
M2Z9X99-(,'M4+\K33MAD14>Y=C L!AU$/-L>*87.51&C!>E$-%4 JK#T.O0<
M:WB=@C [P$,A (PX-O9'I'1VAYC]3EW5C8XKE#-P;6A(^C\?$&\H!H!130H
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M#F]L+"&8Y;K^L"1TF.U@/-SDFI_<?M^R8ET]QB"4Z=[GLKYEW9YM'Y7XO7I
M8'#^/;D-ZP<>.IKZ^8N/4;%.<X$RME*4^,938RKJ1QKJ \EWU4W^9RXEWU8?
M-RQ*6%$"U/<KSN7QH/R!]L&2Q?]02P,$%     @ EX)<5O&VR*$) P  H0D
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M;D]"U$F(3B;&%U6"0/E>1AA) YNFZ)Q9<$ZR[$QD>R&,NQ#&)[-@4F*V /.
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M>@9D:*MG$$W>Q$[>3NL9]FN=G$"<$C@Q"]ZV>@;1;$WL;/U6>W1BUI@']NB
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M,,R4OD9JWX[4+SZ38/=[LEQ.#W#X)H)+=++(I1'<MR.XV_VG_6(G:QB:!QV
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MB3U 9X!P3E#L'K"P(2;L)Z;K@1$F!B9LX\J<AL!< @E3H/]ED-!710: L!^
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MR/]?"]$=OJ@?.+X>>?4_4$L#!!0    ( )>"7%9T>BNLQ@,  $8(   8
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ML5 \Z0#^@U/ZF3FO@EV^1%N%\ JSQNWQ/T3*A#!]A(,H A@,SCR:JO6_*47
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M3J@ON/)(U\Y2&KM J:T=@MFFV,LYS,JD''+R^IX"2"[(2]&'G%NWY9QZGI1
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M.I*P9!*62,*2>0!2O*,\3-@CZ4LX!=73-Y"FD]F260%31T?.8SF;<ZL('K?
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MFS_AG.S*5 Y#* VZIH.YG'V7[N/0;.)2%SC=28.WF%$A#\0:N\H&3@GP:5
MZ1B,L"&-=S/4K3)4M6]TI"+61V-1F5PI>HUXEQ)><1;<GW2>/-*!C7AO7VIS
MRZ]+QLN6R*'2A>1<DU3'9&SI[$DA'$6COS=3745(&5XP1G?+D1D:C\'+E$0+
MLI.^D,N?UN$D3JQ$@LG]%;.?,X49\;\\1DCU$;?0T+H\2VOE0OGLK)'(NCU
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M3"#X%H,G/,,M5('46+6FHU#PK8\;?<-%4\*S\D+)HC#Z2> )^*S:4_RCWLT
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MX0O,#S-\\H(A ?R^TFAY/:$-VD?T\E]02P,$%     @ EX)<5G3U8>#%!0
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MJ@45#9/KI4J7)%8KH^\@XB1%XSA(XA@M50N@YCQ,=$[>.:HM[&)ZP'!5YTA
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MHG8!M%\H9?<3EV!\?-=_ %!+ P04    " "7@EQ6D[/>=,,#   M"   &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6R=5EEOVS@0_BL#;;!( ,$Z+)]K
M&TB<=K= #1C-MONPV =&&ME$*5(E*1_]]3ND;,<!'!?MB\QCYIMO#LYXLE7Z
MJUDC6MA50IIIL+:V'D>1R==8,=-1-4JZ*96NF*6M7D6FUL@*KU2)*(WC?E0Q
M+H/9Q)\M]6RB&BNXQ*4&TU05T_L'%&H[#9+@>/")K];6'42S2<U6^(3V<[W4
MM(M.* 6O4!JN)&@LI\%],G[(G+P7^,)Q:\[6X#QY5NJKVWPHID'L"*' W#H$
M1C\;G*,0#HAH?#M@!B>33O%\?41_[WTG7YZ9P;D2__#"KJ?!,( "2]8(^TEM
M_\*#/SV'ERMA_!>VK6Q&%O/&6%4=E&E?<=G^LMTA#F<*P_@-A?2@D'K>K2'/
M\I%9-IMHM07MI G-+;RK7IO(<>F2\F0UW7+2L[.EIOQJNP<F"WCWK>$U1=Q.
M(DO83B+*#S@/+4[Z!DZ2PD))NS;P3A98O :(B-2)67ID]I!>17S$O /=)(0T
M3M,K>-V3IUV/U_V!IR$L!9/VM</P[_VSL9IJY+]+OK?(V65D]V[&IF8Y3@-Z
M& ;U!H/9[[\E_?B/*[RS$^_L&OI/9.A7<.#5,9Z.<T7OSE@L0)5@UPBE$O2
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M'.S8&*_RAC3B Y:FRJ:S61P4)J2BWK788>89MI?*XT3I2@TW@,T:/$<! Z
M40K8@F2+RJ"??;/X#_@CDWN<XY<R[P3&$AD",CA:8*%H7&L6Q(&VP+Y"^=SI
M!1F22KX@J3;8!)EZ&X4P0E5YQ%;:0X[1X\G5Y*B.-_#[.UDBMYPB6XW'$XY%
M7IWQQ]-)AI\',];A@6?W:PW]X5QR1- E/(,F.*<<< ^:.:. W #U/VF8@3SZ
M]/)Z=)/P<1[$WQ>[=<1$X;+X#](+@RC4[&VEA+I3C.]-'390Y&!36 G]DO(X
M@478)X,T9B-UGP%&E.Q;;,BPHX1)&!<[>SK$,O$43ZO7<%V"%9O#^4A.,E&
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M +^O+.X][8(5]$_AF[\!4$L#!!0    ( )>"7%:/VOZ%G X   (I   9
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;*U::V_;1A;]*P.O6R0 3?.AI_,
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M3[!O%$YGXK,[Z<5T/ >!\4N1CL)D+%"'K)3F)\DD"F;C"$\F830^8N\)(N&
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M"- 6&H#G4PL:E2YH@?:#Q+/_ %!+ P04    " "7@EQ6\[E:UW@#  #M!P
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M/4;'"G1>6QNV&[Y@]\(O?@!02P,$%     @ EX)<5G2\5+V: @  Q04  !D
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MH!M?RI]A)X)OJ!<+*\.5(_E+HR6P<7*6),FN+@D;L?%>9'#HZ\5[UI)H5F&
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M/V=VF.U%>B*#'UJ4L89,+4!@*U+67S><MDQA2>TE"\!,V9>3YN%B0JB&H,V
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M3Y:Q& D<GUL4:]M^0AF @0: TM)CB>.A:EBF(5S0.[B29T;25^ QNK8AA-?
M*36;.;@Z![\Q1=&4QUEJ3M)H%_<&&B@8.$JS#WPWB[, I1JW0X>W;2LTUU+!
MDE&LD#:9[WO0"$@^B;#!I(7>2PC1/XSR#1Q$U-O*=C[^Y<55+CL V1P8]<'A
MH3+V@I,)D(\"4ED,8(EE@PG'(IW# )8,8_;JZ8Z$X*[P6^-.J41Q-%?9BE=P
M1S!4]@OV;-='=OW3)YC:^@-'CMG9 Y<(%2B<UB=\O/\B;S2!#H&OV>-TX^#+
M8U_!<[4J.8_@OXN1DK%#?CT>5F0#2CQQ6 %>,&B5!91*1A$#;KI)C6ER&9GA
M7;_=:O]'?'6O4"7BU6+LCV4_.(<&K4D$L])PY17PU1JU3P=RS<&!BSTH2"8
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MP9-\46*[1&A$9 .3A;*!3$>C$EKX  VQ!J=@DI[J2=,ANR46&7CU-DK$6*A
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M:;7*Z!DI@\)'D.J<Q*&N$BF4/N0?&1)8;+!=2%"X!':V$BV)30 "N!&?.1P
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MB)4?5_!6G*B0?*TJ9-2PWSAL:#C#EZ^ONC0WE^\CHU)\(#FM64K?)^]16&H
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M'_$L*?]'UQ[H)S3!U^G:/?T3JQ2UQ0?@^TW;=OX/W"#\J.K+_P=02P,$%
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MR8?W"=CX3,4)F38\#;DA?FC"L.:7':W?P-\KPZ703WR X7^%S;]02P,$%
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M86C'49+ %[11 J]<$7/UI*":9:"%TU/H,6E=\<BH!&9B&3 26;E"S2B$+;)
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M!B:- .[G0NC=Q!S0_0U9_@U02P,$%     @ EX)<5G HH-F; @  C@4  !D
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MNV5% Q.U"R!_J93=&:[ ,(*SOU!+ P04    " "7@EQ60> F&3$#  #3!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R%55UOG#H0_2LC;G652"B
M@?WJ[DI)VJJ5&FG5SX>J#UX8%JO&IK;))OWU'<.&)-)F^P(>>^;,.3-X6.ZU
M^65K1 =WC51V%=3.M8LHLD6-#;<7ND5%)Y4V#7=DFEUD6X.\[(,:&;$XGD0-
M%RI8+_N]C5DO=>>D4+@Q8+NFX>;^"J7>KX(D>-CX)':U\QO1>MGR'7Y&][7=
M&+*B$:44#2HKM *#U2JX3!97F??O';X)W-LG:_!*MEK_\L:'<A7$GA!*+)Q'
MX/2ZQ6N4T@,1C=\'S&!,Z0.?KA_0W_7:2<N66[S6\KLH7;T*9@&46/%.ND]Z
M_QX/>G*/5VAI^R?L!]^,,A:==;HY!)/="#6\^=VA#D\"9O$+ >P0P'K>0Z*>
MY1ON^'II]!Z,]R8TO^BE]M%$3BC?E,_.T*F@.+?>&.JO<?? 50EO?W>BI8H[
M./O"MQ+M^3)RE,2[1L4!\&H 9"\ )@QNM'*UA;>JQ/(Y0$3L1HKL@>(5.XGX
M!HL+2),06,S8";QTE)SV>.D_)(>PD9RT/E?^XW)KG:&/Y><Q[0-R=AS97Z"%
M;7F!JX!NB$5SB\'Z__^22?SZ!.]LY)V=0G^A5<=8GL0YSO(9.([5*#1=/^NP
M!%V!JQ$J+>D>"[4#[H Z@\T6#74'SH0B!]U9 K#G"_AJL>HD?!05]HWSCP1N
MN.HJ*FYG/,1CGAQ> 6-A/,]HD<S#>#(%HN2TNV\1A**6=-[1 H,D#C."8F'"
M9G#-6^&X%'^(HM65VW.#O89"-VWGB-MCDA2263B9QI"'^7P*[SJC!#$9_"MQ
MY]>6J!!R3K[AG$WA(]*5K[4L032MT;<XL/C&C2"M)"ID!$6,)UD"U[HG.LP;
MJ@<%[ C2PC2,\YR>29;"%TU\_=&1>H>P,YK\9W$XF1-/(AJGQ,':!5P61==T
MDOMFE$B=*P0?!ALA\$8;)_X,&V?I)&1I>@YG;!9FD_C\'SD5S?Y7D&5AED]]
M'X@M\3SVQ49/!DV#9M>/4TNU[I0;9LZX.T[LRV%0/;H/X_Z&FQWU%216%!I?
M3/, S#!"!\/IMA];6^UH"/;+FOXZ:+P#G5=:NP?#)QC_8^N_4$L#!!0    (
M )>"7%88-FZ>30,  )P'   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM
M;'U5VX[;-A#]E8&R"'8!=76W',<VL)<$#9"TB^RV?2CZ0$ECFPA%JB2UWO3K
M.Z1LQ5G8?A$OFCES9@XYG&^5_F8VB!9>6B'-(MA8V\VBR-0;;)FY5AU*^K-2
MNF66EGH=F4XC:[Q3*Z(TCB=1R[@,EG._]Z"7<]5;P24^:#!]VS+]_1:%VBZ"
M)-AO?.7KC74;T7+>L34^HOVC>]"TBD:4AK<H#5<2-*X6P4TRNRV<O3?XD^/6
M',S!95(I]<TM/C6+(':$4&!M'0*CX1GO4 @'1#3^W6$&8TCG>#C?HW_TN5,N
M%3-XI\1?O+&;13 -H,$5ZX7]JK:_XBX?3[!6PO@O; ?;O R@[HU5[<Z9&+1<
M#B-[V=7AP&$:GW!(=PZIYST$\BSOF67+N59;T,Z:T-S$I^J]B1R73I1'J^DO
M)S^[_*SD^I<GU"W<8V7A\HE5 LW5/+($[DRB>@=T.P"E)X"2%+XH:3<&/L@&
MFY\!(F(U4DOWU&[3LXCW6%]#EH20QFEZ!B\;4\T\7G82CQ*\YZ86RO0:X>^;
MREA-Q^*?8]D.6/EQ+'=59J9C-2X"N@L&]3,&R[=ODDG\_@S3?&2:GT,?1+%.
ME,9Q9K(!@73T8,4EDS67:U"5X&OF#K8YQOXL_G'V3QL$NK7&4C@7H6*"8M'>
M"BS]NE-MQ^3WMV^F:5*^-[26SZ@MI^,"ORF+!FKBPHW%9N^R4H+NO,-B5'BL
ML:U0DZ)PR249J-Y0*',U\P*[3P*_'Q#H-*=<.R8<WNMP< %I%H=Q'!_,/J,Q
M,^@E:Q69_D=,N#&]SZ)6QAJXS,*LG%[!91Y.B\D5_%SH$"1U08)+)^&$&+E9
M$29Y#F<T+49-B[.:/E([;7KAZ_E)4DPT%CZ\4',U>$S!LVBG%?Q1<^MN,ABD
MM*EWVPU89:F6?!\;A]C466NUEKY:&@5S^EFUD_RUQ*>%HT_L'/R%ZH_%N8!)
M&&?3@Y%$>%?"S2"6/\NN.*\D2\*\+-TW?0?3<%+$\'0\CPLHPR(I_)A/2AJ3
M+"SR\JAXT4'';%&O_;O@CG O[= \Q]WQZ;D9.NX/\^'=^L+TFDM#-W1%KO%U
M2<KIX2T8%E9UOO]6RE(W]],-/9^HG0']7RFJ[6[A HP/\O)_4$L#!!0    (
M )>"7%;]:$8WA 4  #<-   9    >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM
M;)576V_;-AC]*X1[60(HLD1=[20&DC3=.J!KD'3MP[ '6J)M(I+HD70<[]?O
MD/0MJ^MN+S8I'1Y^E_-]I"Z64CWJ&>>&/+=-IR][,V/FPWY?5S/>,AW*.>_P
M9B)5RPRF:MK7<\59[1:U39]&4=YOF>AZHPOW[$Z-+N3"-*+C=XKH1=LRM;KF
MC5Q>]N+>YL&]F,Z,?= ?7<S9E#]P\_O\3F'6W[+4HN6=%K(CBD\N>U?Q\+JP
M> ?X(OA2[XV)]60LY:.=?*@O>Y$UB#>\,I:!X>^)W_"FL40PXZ\U9V^[I5VX
M/]ZPOW>^PY<QT_Q&-E]%;6:7O;)':CYAB\;<R^4O?.U/9ODJV6CW2Y8>F^8]
M4BVTD>UZ,2QH1>?_V?,Z#GL+RN@["^AZ 75V^XV<E>^88:,+)9=$6338[,"Y
MZE;#.-'9I#P8A;<"Z\SHP<CJ\<SZ59,;V2+7FKEPG7QFXX;KTXN^P386W*_6
ME->>DGZ',J;DH^S,3)/;KN;U2X(^[-L:23=&7M.CC.]X%9(D#@B-*#W"EVR=
M3AQ?\CVG9TSQLVOG]!U;06.&7"G%NBEWXS^NQMHH".;/0]Y[[O0PMRVBH9ZS
MBE_V4"6:JR?>&[U]%>?1^1'+TZWEZ3%VGR[R:>Y2=&45+<R*L*XF][QA!OY\
MZ'RE G#(^*/TAXV_VE0LD1-B9MSIA'6KMZ]*&A?GFFAGE)SORLP:M4#RE</?
M-:S31&C"-)G(!GU #XG+@29?7=GP^FQO=#6=*CZ%-^33PF@#[T0W)<R07UFW
ML':LE4!H$,5%4 QB\IK$>3A(2!8F&&=Q$$<9N6%=A?*O77P0E0D7-D(G,:5!
M$J6GA,9A'I';9ZXJH?V;,LAI<4KB.*3)O[>'#'D[AE,;*<*0(L^#$B0PH BC
MF*2A-8;FV;?HX3IOFCQQ;=9F\><Y^A,F1KK'1RDWZ[FWV!8H\'D)=P8#'P.@
MDG"PQA\17+857'94<.M<_Z2WF^\%Y9# CM(=%MAG:,3KP@;:.+>\Y,3?D(C8
M*9JP,0Z6'XI0$_F#S U?Y/9V+YX;-9 [)2I.?ENX=5#^3I^'GKV.PP$ESIKX
M'#,:9CFA@T%0E#DRF&&<([,9QJE[711[Z#1$_M(\"\H8R#!WX[R,W?AUG(4T
MWD.780940B'R$@B,:1I$D453]SHO=VB*K?!F4 1)6F)W6%640993;PE-PBC:
MH7-4$117Q$$9V6K""E18,H@P+O:TN5/=$8WE6XWE_Z&IO3A];I_MF!\2V%&N
M_R$P;FPW4F;FI;,^ ZM]*[BW I</WUM1H_M8MCLR]#?M#KW.&=#9A4MA9J)S
M;RO(4S:B=H10H/%'#L2$BY9B7KZPRX%7G"F4NSU&]S5,3AR97&@(6)\.U]TP
M@DKP$R&4VC$J_L2[!;?= +DJ;(<(RL)VED&9X,30H*]FK@_5@#9R[FS)@D%!
M\5N@!29(=TH><&M"Z (RY1V,;-P25N,^(NQ!:2]6),Z")(G04P.*+>(DR-.$
M?)8&Z!\&& 8"[WH8.G"9VR8>ET$*W1W15['55W%47^^94.0+:Q )!.6VG3=R
MQ?GF%/T9232'A':<U&G*$C]MB#E#+/F&_<6A.+5[D"4T@18O6I=[Z?5@A6!7
M>\A".X7B^77#$+.':B9Q"]OPS-&3+*"5-6^<JAQVIVVFT3A]#QQZ+=P+_7@V
M4;!(0(K*'C%(&"BC,$O?^,JGYP0GX>"-*SM_&G'5DA,GOU.2AU&Y!;K)%E?C
MK*^A3[(2O*DWH#VB)XG2$8V]$&1H-;L-LT&8OSF4W/[>9;;E:NJN[!JZ673&
MWVNW3[=?!5?^,KR#^T^*CTQ-!<JIX1,LC<("AY/RUW0_,7+NKL9C:7#1=L,9
MOFRXL@"\GTAI-A.[P?9;:?0/4$L#!!0    ( )>"7%;!*Y!5;P<  &D4   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;*U8:V_CMA+]*X2[6-B =JVW
MI6P2P$FV[0)M;Y!D>S]<] ,MT[&ZDNB25![]]3U#R;*R491<H!]B40HY<^9Q
M9D8ZOI?JF]X*8=A#653Z9+(U9G<TG^ML*TJN/\J=J/"?C50E-[A5MW.]4X*O
M[:&RF/NN&\]+GE>3TV/[[%*='LO:%'DE+A73=5ER]7@F"GE_,O$F^P=7^>W6
MT(/YZ?&.WXIK8;[N+A7NYIV4=5Z*2N>R8DIL3B9+[^@LI?UVP^^YN->]-2-+
M5E)^HYLOZY.)2X!$(3)#$C@N=^)<% 4) HR_6IF33B4=[*_WTG^TML.6%=?B
M7!;_S==F>S)))FPM-KPNS)6\_UFT]D0D+Y.%MK_LOMWK3EA6:R/+]C 0E'G5
M7/E#ZX>W'/#; [[%W2BR*"^XX:?'2MXS1;LAC1;65'L:X/**@G)M%/Z;XYPY
M_5)ELA3LAC\(S:8W?%4(/3N>&XBF#?.L%7/6B/%?$./Y[%=9F:UFGZNU6#\5
M, >F#IB_!W;FCTJ\$-E'%G@.\UW?'Y$7=(8&5E[PJJ'L(M=9(76M!/O?<J6-
M0FK\,61S(S$<EDAT.=([GHF3"?B@A;H3D]/W/WBQ^VD$;]CA#<>DG_XBM69G
M K03K!^D(9QOD+1J).6-)&/#C2?,; 5[%%QI)BAP#&X7Y4HHN)YE$MS3!D_E
MQF[<R (DSJM;-LTK/)&UYM5:SXYLD.C'HQ^774")-GG&WK$I_.%$H3^S:R]V
MO$72KCW'<[T9 [O G8IY3N#%^'53#[_^(F8O(J?C4>KX?MR*BAPW631K-W42
M/YJ-A"#J0A"-.NX:J/)-GO'*L'-9[F0E*J/)&;)6[%+)N]S6)O+C:R$:U32<
M2GWUV3/UNR?J_Z^X<KB3ZS::^K58GM=*0?%1/ZCO?TA\S_\TN-J',_ 6S(L7
MS(\"=B,-+\8@O[/;W]D#[^R1D?C%7?SBT?CU*/_Y 5U,"S8]$Y78Y&:&(K#9
M" 7/;)0LV;*4-3F7PEQ3QJ\>V7*W*QXIV:\--[61ZI']*-9"P9*>Y"MNQ%#
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MG3#V;#8+NWGO8^!P>J=A?.QA.ZZAUS@A\-/9OTSB14?BQ2B)/]N<)BK<"-1
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MB)=]WKNB9(7R 5IS8HY>%I!H$@K-Y%,;:QQ,I350UPV*)J'03%*U\<9.'SI
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M,W)@B2M2,G7'MS^PSL<*3#B3]@G;.M9S("FEXED-U@HRFE=O\E+[T +XT3N
MH 8$GP6$-2"TB5;*;%HSHD@\%GP+PD1K-C.PWEBTSH;FIHIS)?0NU3@5SU,N
M5$^AR. ZWZ!4ND)*0@^N"!7P2%B)$O@*+C:$,K)@V--?3F].&,(<DU)0177
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MPS#,847UHG]0K>TTK%K[!.843(9+AU?-8C+L]_CJ%$R&+9-A7TR&=RGJ.7:
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M;W)K<VAE971S+W-H965T-#DN>&ULK55;3]LP%/XK5H8FD%AS:;FNC=02T'A
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M3=Z3!UKQ%1=M^9W#4$(811N25NB!9 >*]EP0*8$4(RFSC%2U^M2HB[7AL;I
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MOR4+*5/T%/AA<MY;I.GR_6"03!8R<)-^M)2A^F<6Q8&;JL-X/DB6L72G6:/
M'Q#+$H/ ]<+>>)2=NXG'HVB5^EXH;V*4K(+ C9\OI1\]GO=P;WWBUILO4GUB
M,!XMW;F\D^D?RYM8'0TV4J9>(,/$BT(4R]EY[P*_OQ1<-\BN^-.3C\G6/M)=
MN8^B;_K@\_2\9VF+I"\GJ1;AJLV#O)*^KR4I._XMA/8V.G7#[?VU]%^RSJO.
MW+N)O(K\K]XT79SWG!Z:RIF[\M/;Z/%7670H,W 2^4GVBQ[S:VW10Y-5DD9!
MT5A9$'AAOG6?"D=L-:"DH@$I&I#,[EQ19N5'-W7'HSAZ1+&^6DG3.UE7L];*
M."_4=^4NC=6_GFJ7CN_2:/+M3/=KBJZB0-WLQ,W<=98=NN'S3PGZ?:E/J>TJ
M35(WG'KA'/W\4::NY[\;#5)EAA8VF!0J+W.5I$(E)N@Z"M-%@CZ%4SG=%3!0
M]F\Z0=:=N"2@Q(]RTD<4GR)B$8).T  E"S>62;$!--"-FVBF@5:Y20LJW'3C
M/JNP3-%%'+OA7.K]T\)%I^C3DXPG7B+13>Q-)+K55Z"_ORAQZ',J@^2?,G_E
MNEFY;CTNWR=+=R+/>VK@)3)^D+WQVS=86!^ GK%-SQ@D?5QV;\_0;ZO@7L8H
MFJ&[W),_>V'AS=([GNL0F0X]$3R,L2V$(ZS1X*'$.+XQCA]D7.%5]]Z7#8SC
M^\8)A]#AL-PXL3%.@,:=X/Z0H+=O'(+Q!W2"29^+,O6@E(9WU][8:'<8MW8+
M/7,V/7-^0-PZ>Z%!AD/;$>61,=S8-OQ^V[YF@)#3,W3Q(&-%/'0K-3;UGU=J
M/HP5H%:NC[YX,XF4U7])-T[*;(9U,_2L&R*!@FR2!5R-+0,)ZP>,PT+)KK>%
M+7BYM_$6PW #\X[F\!KM:X^SPN.(,#1UGT'/$],U\MV3#/H/7:MN!*N@U%I0
M8,-1B0TH<9>DQ&V@$AM68AB6NS:?HFOW2=^&+/"GD>_K,%BJ(9$-@G?J/IE<
MI+0WN39GFTSJ=E<,!P--#%.S*F9R8TL- 04V=:L!*19=QDP; ,:&P!C$X-%C
MQMZ/F3SS* T:@U,,\U2'B6VOHR;O_PEF?9TEE5@!"FOJ4\-7/.PR8$#"-NP<
M,; EA\'V=9D-V8<M$]S!%; E!K;D,-BVD]S4*"<%:^TU:T4=:HE!+8%1>YPD
MIU#RPN_"P15^-V E(-O:3G)JM#=PO*$J@:E:/?7 F0XLMNDX-9@EO,-)B+2!
M9&*03.#%[9&I56A[02W;KA@4!JX$ABL<.M4)#RRVJ7<-;(G39>BT 6=BX$S@
M%>BQ0V>X'SIY6E(6.M1@EL*8/<&\3_#+T''ZG)>6Z$!A#7U*#70I[K+^"$*W
M:><,>.EAX'U=PD/WP4LHP993$2A;I=_#P-M.PE.CG!Q>SJ$&N/2PFN_K,AVZ
M7_0EA%E61:9##5AIDZKO\3P.:U][G*PS'4SJ4AUJL$KK:L95DPZ<ZL!BFXY0
M@UG:91F9M@%C:F!,X97OD7E5:-OAE;[I%:/"8)7"6(5#ISK5@<4V?;ID,,NL
M#D.'M8%E9K#,X.7HD4.GT+83.GE"4A8ZS "6U161G;YP7H0.49DS+K6BC0(R
M,[AE71:062O/6K<>MOZ0IZTEY!W:E%6D.LR0EQU&WG92G1KE[+M+#,QPE\'<
M/4[&4RC9\;OM<%%1L6>&KPQ>QK:<\=1H;_  BQFZLKJZ<M7< V<\L-BF ]70
MEG59869M,)D;)G-XZ7MD;!7:7F!+5,Q&W-"5PW2%0Z<ZXX'%-O6NH2TG'88.
M;X/.W-"9P^O18X<.W0N=(B\I#1W#65Y34B:T;UDO0D>(_K TXX&%-?7IUDM.
M71:2>1N%9&[(RP\C[^LR'KY/7F9CQZ(5@6+(RP\C;SL93XUR7H!WN"DU.'7@
MY0:\_+ 7I%[Y[MS^&U(,VW18]6*? 2P_[!VIEE*>&NUKSSN'%WF$P:NHJ2Q7
M3CYPR@.+;3A2A<&MZ++&+-J LC!0%O 2^,C<*K3QG6)SQ>NDAJT"9BL<-]7Y
M#BRVJ6L-:P7K,F[:8+,P;!;PHO38<</W\ITB*]D)G<'6"_V!C.?99PL)FD2K
M,,W?[=^<W7P:<9%_$& NS[^KN';CN:?F65_.5%.K;RL+XOQ3A?P@C9;9YP'W
M49I&0;:[D.Y4QOH"]?\LBM+U@5:P^6!D_#]02P,$%     @ EX)<5G$"B;%'
M!0  YAL  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULS5G?4]LX$/Y7
M-+G.#9V!V+(3)^%"9@)N[WAHRT!I'SKW(!(E\6!;J20GY;^_E6P<_T)-P-SP
M K:\^VGW6VFU&XVWC-^+%:42_8K"6)QU5E*N3RU+S%8T(J++UC2&+PO&(R+A
ME2\ML>:4S+52%%J.;7M61(*X,QGKL2L^&;-$AD%,KS@22101_G!.0[8]Z^#.
MX\!UL%Q)-6!-QFNRI#=4WJZO.+Q9.<H\B&@L A8C3A=GG2D^]1U;*6B);P'=
MBL(S4J[<,7:O7B[G9QU;641#.I,*@L"_#;V@8:B0P(Z?&6@GGU,I%I\?T3]J
MY\&9.R+H!0N_!W.Y.NL,.VA.%R0)Y37;_D,SA_H*;\9"H?^B;29K=] L$9)%
MF3)8$ 5Q^I_\RH@H*&#O"04G4W"J"KTG%-Q,P=U7H9<I]#0SJ2N:!Y](,AES
MMD5<20.:>M!D:FUP/XA5W&\DAZ\!Z,G)C62S^Q/%W!Q=L B6DR Z("?HF@K)
M@YF$+UH*W<:!%.CH^N96O$=3%;! /J CGTH2A#!T@FYO?'3T[CUZARPD5H13
M@8(XU3N&07C^NF*)(/%<C"T)YBLCK%EFZGEJJO.$J=A!GU@L5P)]B.=T7@:P
MP._<>>?1^7/'B.C361>Y^!@YMN,T&'2QOSIN4/?W5[<-WKAY*%V-YSX52D5X
M4RBGG)-X26&W2G3W@(IR5^1!#T^WA,^/T8>?B0KI90R13]0'@;[(%>5(KDB,
MOJP5'$3R,XLWL#@H:'S7&PN0IAO*(5&@OV$NB6 M4O21!!Q](V%"T8_I'4#"
M)O^W*>ZI7[UFOU3F.Q5K,J-G'4AM@O(-[4S^_ -[]E]-,6L3S&\)K!3/7A[/
MG@D]B^?YGO$\?T$\OR122-B40;QLB.@U5><'? ,K8AW$A(3H*^51XR8V.^6@
M!TIXD^+%<Q5]H^(S@]3/@]0WFE5(DD(GR40ENR9>C#B'+O(VP?R6P$K\>3E_
MWMM+6I^3Z Z^LT4**]"/:Q:&" H)A=B8HKPVH]<FF-\26"EZ@SQZ ^/J!TY/
M4E(1@:1/9U03FQYJN(^.X,1/ZX#W3:2FX)X&5P7J9H)=UW5P?VQMBGP9C3B4
MKY; 2GP-<[Z&1K[TX0AD_8:788T7Q_8&?<^I\&*<[%!>6@(K\3+*>1D9>?F6
MKJ'?T#*JT7(RZ(]<N[I<C',=2DM+8"5:L+VKSFTC,9"2%C38@YL,IT2.X]G#
MOETAQSSAH>RTA5:FI]"\X!?D'^^WI.'Z1G.'MN=4-UJ#8&.F\LWV/I</9\>'
M\_9.TU9:@,RQE@[85M'\MM#*0=VU==C89>QUR,ZA?H'J&*WA@U[PS>L]G6A8
M6,8]W'5KJ[W5%JHMM#)[NR8*F_N&XI&[)TLI(':+::'7'0RK-+74=V0TO487
M@W=M##;W,843>$^6^G66W%[7J1[&YGD/9NDU>A6\:U:PL9JN',=[$N4U$.5U
M:U6+>>J#B7J-M@#O^@+\DL; .X2^02UG.:/NR*VR5Q=K2&V^V>SGTK(K_[&Y
M_O__?M*9+I><+M41?!E+'L0BF*7G\#%*MWHCUZGU_5+C@>U:"5D7Z_7Z53&_
M00P[1;$RB;M> 9N;A:],DA!M=%$!+7SV._/F::_J?0,>>G6O&L3PH.[5J.85
M"#WAE+,K]!USH?\F5D9>U#71F#E0"N?(=G&%Q@:QON?:U8UHIN/0C6@5+D B
MRI?Z(DF@&4MBF5X'Y*/Y9=547]%4QL_QJ9]>.>U@TANP3X0O@2P4T@5 VMT!
M>,C32Z7T1;*UOF:Y8U*R2#^N*)E3K@3@^X(Q^?BB)LBO]B;_ 5!+ P04
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MHCT292E5=A3/;7&QYDJ7*K:9Z/(3A3'0W[><JZ>.F: N:,-_ 5!+ P04
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MI7:KFET>ICVX<!*L@LULDW32?OQL0RBD)&HE'OH"MCG?YW,^?&R?R8;Q>Y$
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
M  @ EX)<5LJ;$UR&!0  -"X   \   !X;"]W;W)K8F]O:RYX;6S%FEMOXR@4
M@/\*RM/L0S:);YVIFDJ][E;J=*JFZNN*V"1!M2$#N)?Y]7.PFREVDZ-].<U3
M:^R0+X#Y#@>.GK5YG&O]R%ZJ4MGI8.7<^G TLOE*5-S^K=="P9V%-A5W<&F6
M([LV@A=V)82KRE$T'F>CBDLU.#[:U'5K1N&%=B)W4BLH] 4/4CS;]_O^DCU)
M*^>RE.YU.FC^+\6 55+)2OX2Q70P'C"[TL__:B-_:>5X.<N-+LOI8-+>>!#&
MR?Q#\<Q#WO.Y;4H<G]]Q )D.LC%4N)#&NN:)IGX.C$\"'FZO:J<O9>F$.>=.
M_&-TO99JZ:N!7S$*?D;3#IN_;2,>FO_3C'JQD+DXUWE=">7:=C2B](#*KN3:
M#ICBE9@.SO23,.R6+X7_4? M5T7[ QV0!<UE#B7<,%=%PTC'<U(7TK$KU7X8
M[@98$8(5T6*=P;4N90'?7K!37G*5"]9TKPT 8P0P_D3 F8?P'[!,+]B/M3 !
M9() )GN#/-/5.H!,$<AT?Y K'H['#(',]@CY7Q1 'B"0!_N#Y'850'Y%(+_2
M0IX+FQNY]N4>S*T$.ZVM5,*&;_8W!/ ;+>!,+I6$9[ER["3/=:T<R(+=0LOF
M4H20DS$V;X^),5?:N"$HK8+9^TE8U_1U2(=:A5@KEUP:]L#+6K#O@MO:B ]X
MF%TFQ'JY!B9AV9<;B&;L7R$5II0)L5-\/RJGS6L(A.EC0NP/B/; 9>Z5<56P
MBY^U7/L/A'28-R;$XKC6:CF\]R_ N9AWJ#!13,A-454PM<V<SA^;=KLU8B&,
M::9DG8>8F"HFQ*YH^(9S> V*)A80RO;#OPEFB0FY)A;@!,^FG)'SNO'%G7"R
MG4E"3,P5$V)97*E<5X+=\Y>.&2+,#!&Q&?P(E*T.F@'HFQ ,)E1/7Q$FB(A8
M$#=0[[6VEMW"<FBVXB9<#T7HRH/8#;-Z;L7/&AYB%T\]:468'B)B/:"!22<&
MC3!I1,32^*C^=AB>2YN7NM.:F#TB8GO<">A<8%P87;6S#,_AA7F6;L7.Z@XF
MII.(6"?;PSSVY9X#1R=TB3"=1,0ZV1'O;3A#3,PJ$;%5-G'?EM;#+!*16^0M
M\-M&%F,NB8E=LCT"W(J)V20FMDDW%-R*ARDEIE;*CF#K#33$1%-:Y.N/]V!F
M:QMB6HF)M?(Q8-B*B"DE)E8*DMI@-SS,"<:84F)JI:!Q1!QB8DJ)B96""KH3
M[L284F)BI>"8G=;$%!-39[6VQQ%#=O+$9<G#?#7FFV0O62W ; .,$!/S3;*?
M]!9P^NF]TYJ8=Q)B[^R,RLZ%@UX/,3'O),3>>8O*AANNSHR>H/LGQ-+Y0S:K
MJXI#? ;3>E,&_6P="S$Q\234F; _F%!949?"<U[6#CJ<?9=A3B?!Q),0B^<]
MS.V2OI6'F)AX$F+Q[(AY-\,SQ,3$DQ"+9R?F25%(U\'$Q),0BZ<7FF_PM.*E
MWW8.]R Q\:3$XOF V10T(BJZV>44$T_ZN0N=_GL48F+B2<FW[Y$D>"=V2S'Q
MI-09M5WKLG:4AIB8A5)B"R&8O2V%%-W')[80@MD_;8!9**5>_NS&O(. ,\3$
M+)3N:8.FZ?3N*X19*"6V$(+IH\\0$[-02FPA=#NITYH99J&,V$*=#,RPS7><
M"JA*,'\KQ,0LE!%;J(<9)A1Z;WJ&62@CME /LQMXZ'!L9IB%LL],NPW9^R6[
M>(%J0TS,0AFQA7J8%XN%R)T/.^Y%M>ZV)F:AC-A"_;'YOG#SI\F6(29ZGHQ\
M+=3!O-<.AN7FH*,.P^(,LU!&?J0,V4MFPQ 3LU!&;*%MR>$MN80,4U!&G8'K
M[RMO13S ]'/0Z&?4/&R/CXI6:C=0O87RG)?YK6'^3WO *DG]V8A%799G4/9#
M76M>; X];PYL'_\&4$L#!!0    ( )>"7%;;=K!Q,0(  (DI   :    >&PO
M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VDMNHT 4A>&M6"P@N.Z+I!5GU)-,
MHVP .>6'8AM$T4JR^[:<@7U0#WH2<4:H0%S^T0<"'E_RH1WWW:GL]GU9?!X/
MI[*J=N/8_ZKKLM[E8UONNCZ?SD<VW7!LQ_-RV-9]NWYOM[F6Y3+JX79&]?1X
M.W/Q^M7G_YG8;3;[=?[=K?\<\VG\Q^#ZHQO>RR[GL5J\ML,VCZNJ_CQ<=Y?Z
MLDEWY\G5XOEM50W/;ZFJYPX2")+Y@Q2"=/X@@R";/\@AR.</"@B*^8,:"&KF
M#[J'H/OY@QX@Z&'^H+1$&9<$21.L";1.R'4B\#HAV(E [(1D)P*S$Z*="-1.
MR'8B<#LAW(E [H1T)P*[$^*="/06U%L(]!;46PCTELG#-H'>@GH+@=Z">@N!
MWH)Z"X'>@GH+@=Z">@N!WH)Z"X'>@GH+@=Z*>BN!WHIZ*X'>BGHK@=XZ>5E"
MH+>BWDJ@MZ+>2J"WHMY*H+>BWDJ@MZ+>2J"WHMY*H+>AWD:@MZ'>1J"WH=Y&
MH+>AWD:@MTU>=A/H;:BW$>AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z.VHMQ/H[:BW
M$^CMJ+<3Z.VHMQ/H[:BW$^CMDX^5!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>@?J
M'01Z!^H=!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$>L?D9Q,"O0/U#@*] _4. KT#
M]0X"O1O4N_E)O<OX=<CEVO.]QNO_)-7C^=Q\O?QE^;T3[Q?-!>?ZMJ(\_050
M2P,$%     @ EX)<5J3(PW?Z 0  M"@  !,   !;0V]N=&5N=%]4>7!E<UTN
M>&ULS=K+3L,P$ 707ZFR18WK)P_1;H ML. '3#*E49/8LETH?X^3 A((*E"1
MN)M&K>VY$X]T5CV_>_84)]NN[>.\6*7DSQB+U8HZ&TOGJ<\K2Q<ZF_+7\,"\
MK=;V@9B8S0RK7)^H3],TU"@6YY>TM)LV3:ZV^>?8N'Y>!&IC,;G8;1RRYH7U
MOFTJF_(Z>^SK3RG3UX0RGQSWQ%7CXU'>4+ O$X:5[P->S]T\4@A-39-;&]*U
M[?(NMFU93,\MQ7)_B2]Z=,ME4U'MJDV7CY31![)U7!&EKBUW18_V)Z=\P[3[
MY ?GCV7V!>:=M\'YF"<6Z/=Q;R,93D]]+D0A-?M?\3TQES[X_6B8=DWU#[/S
M]3ZYL![G$=GX./R./\[XO?XO^Q @?4B0/A1('QJD#P/2QS%('R<@?9R"],%G
M*(V@B,I12.4HIG(45#F*JAR%58[B*D>!E:/(*E!D%2BR"A19!8JL D56@2*K
M0)%5H,@J4&05*+)*%%DEBJP215:)(JM$D56BR"I19)4HLDH4626*K I%5H4B
MJT*15:'(JE!D52BR*A19%8JL"D56A2*K1I%5H\BJ4635*+)J%%DUBJP:15:-
M(JM&D56CR&I09#4HLAH460V*K 9%5H,BJT&1U:#(:E!D-2BR'O^GK/?.K?\X
M?GR6G6WZMWPV_EEQ\0)02P$"% ,4    " "7@EQ6!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )>"
M7%:9'X7;[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( )>"7%:97)PC$ 8  )PG   3              "
M <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ EX)<5NA1N]3^
M!P  (2\  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( )>"7%9^Q,)2.@(  +L%   8              "
M@4 0  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "7@EQ6
MUSE 9!8(   H+0  &               @(&P$@  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ EX)<5N3+\TZB!@  9"(  !@
M     ("!_!H  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M )>"7%;QMLBA"0,  *$)   8              " @=0A  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " "7@EQ6A!!P0" '  "J/P  &
M            @($3)0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ EX)<5I[:X(AD"   *S8  !@              ("!:2P  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( )>"7%8: ?Q!+ L  "HY
M   8              " @0,U  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " "7@EQ6='HKK,8#  !&"   &               @(%E0
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ EX)<5O_9:TKT
M'P  _68  !D              ("!840  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " "7@EQ6E!Q-V[@%  !'#P  &0
M@(&,9   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )>"
M7%:B$IO5Y04  % /   9              " @7MJ  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ EX)<5G3U8>#%!0  '@X  !D
M         ("!EW   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " "7@EQ6;-CBJI "  "(!0  &0              @(&3=@  >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( )>"7%:3L]YTPP,  "T(
M   9              " @5IY  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ EX)<5M5]I5&Y#0  QRD  !D              ("!5'T
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "7@EQ6AUNK
M._,%   6#P  &0              @(%$BP  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( )>"7%:/VOZ%G X   (I   9
M  " @6Z1  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MEX)<5G&R8^2J @  ( 8  !D              ("!0:   'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " "7@EQ6O-D8L-0)  !'&0  &0
M            @($BHP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( )>"7%;;2.EH3PP  )PH   9              " @2VM  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ EX)<5O.Y6M=X P
M[0<  !D              ("!L[D  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " "7@EQ6=+Q4O9H"  #%!0  &0              @(%B
MO0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )>"7%:<
M[(9,V"(  &!U   9              " @3/   !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ EX)<5E5;U*YZ P  -P@  !D
M     ("!0N,  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )>"7%9P**#9FP(  (X%   9              "
M@9_X  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ EX)<
M5D'@)ADQ P  TP8  !D              ("!<?L  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " "7@EQ6&#9NGDT#  "<!P  &0
M        @('9_@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( )>"7%;]:$8WA 4  #<-   9              " @5T" 0!X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ EX)<5L$KD%5O!P  :10
M !D              ("!& @! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " "7@EQ65Z#UAO("  !6!@  &0              @(&^#P$
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( )>"7%;*\2&#
M1P(  -D$   9              " @><2 0!X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ EX)<5O6Q_Y5G"   5TP  !D
M ("!914! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "7
M@EQ60U#DTEL$  !8%0  &0              @($#'@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( )>"7%8P.8[D60@  .5*   9
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M970T,RYX;6Q02P$"% ,4    " "7@EQ6.F*O'0D#   X"0  &0
M    @('+/@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M )>"7%8H'Z]^T ,  %</   9              " @0M" 0!X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ EX)<5@.GAT7# P  K0T  !D
M             ("!$D8! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " "7@EQ65ZYE_)@"  #T!@  &0              @($,2@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( )>"7%;N<\R&TP0
M -T:   9              " @=M, 0!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ EX)<5B(- H:" @  L 8  !D              ("!
MY5$! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "7@EQ6
M,\-8WEX*  #V;@  &0              @(&>5 $ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( )>"7%;REV;SZ0(  +8(   9
M      " @3-? 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ EX)<5K3EK=_M @  ;P@  !D              ("!4V(! 'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " "7@EQ6AG$M TL%   Y(@
M&0              @(%W90$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+
M 0(4 Q0    ( )>"7%;?@> $K @  %M&   9              " @?EJ 0!X
M;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ EX)<5D3>7VX%
M!0  _1@  !D              ("!W',! 'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6Q02P$"% ,4    " "7@EQ6](W!-K,&   \,@  &0
M@($8>0$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( )>"
M7%9Q HFQ1P4  .8;   9              " @0*  0!X;"]W;W)K<VAE971S
M+W-H965T-3<N>&UL4$L! A0#%     @ EX)<5GX@[Y:N P  HQ$  !D
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M=#8R+GAM;%!+ 0(4 Q0    ( )>"7%;!]DNYBP,   40   9
M  " @6"6 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @
MEX)<5J?=0\" !   O@X  !D              ("!(IH! 'AL+W=O<FMS:&5E
M=',O<VAE970V-"YX;6Q02P$"% ,4    " "7@EQ6Q'5VK>4$   B&   &0
M            @('9G@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4
M Q0    ( )>"7%9@"Y?S\ ,  %H1   9              " @?6C 0!X;"]W
M;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ EX)<5A7;0B8[ P
M_P@  !D              ("!'*@! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6Q02P$"% ,4    " "7@EQ6G@/8MI<"  "V!@  &0              @(&.
MJP$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( )>"7%;^
M'0C4? ,  .</   9              " @5RN 0!X;"]W;W)K<VAE971S+W-H
M965T-CDN>&UL4$L! A0#%     @ EX)<5H>WYG6O @  P0L  !D
M     ("!#[(! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4
M" "7@EQ6I"^!Z%,#  "P%0  #0              @ 'UM $ >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( )>"7%:7BKL<P    !,"   +              "
M 7.X 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( )>"7%;*FQ-<A@4  #0N   /
M              "  5RY 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "7
M@EQ6VW:P<3$"  ")*0  &@              @ $/OP$ >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "7@EQ6I,C#=_H!  "T*   $P
M            @ %XP0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     3@!.
+ %D5  "CPP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>263</ContextCount>
  <ElementCount>411</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Short-term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ShorttermInvestments</Role>
      <ShortName>Short-term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Leases (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.nanostring.com/role/LeasesNotes</Role>
      <ShortName>Leases (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Common Stock and Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/CommonStockandPreferredStock</Role>
      <ShortName>Common Stock and Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensation</Role>
      <ShortName>Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Defined Contribution Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/DefinedContributionRetirementPlan</Role>
      <ShortName>Defined Contribution Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Fair Value Measures and Disclosures (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/FairValueMeasuresandDisclosuresPolicies</Role>
      <ShortName>Fair Value Measures and Disclosures (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Revenue from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/RevenuefromContractswithCustomersTables</Role>
      <ShortName>Revenue from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Short-term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ShorttermInvestmentsTables</Role>
      <ShortName>Short-term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/ShorttermInvestments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/FairValueMeasurements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/LeasesNotes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/Inventory</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/PropertyandEquipment</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/LongTermDebt</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationTables</Role>
      <ShortName>Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/StockbasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/NetLossPerShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Description of the Business Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/DescriptionoftheBusinessNarrativeDetails</Role>
      <ShortName>Description of the Business Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Revenue from Contracts with Customers Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenue from Contracts with Customers Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Revenue from Contracts with Customers Schedule of Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails</Role>
      <ShortName>Revenue from Contracts with Customers Schedule of Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Short-term Investments - Available-for-Sale Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail</Role>
      <ShortName>Short-term Investments - Available-for-Sale Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Short-term Investments - Fair Values of Available-for-Sale Securities by Contractual Maturity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail</Role>
      <ShortName>Short-term Investments - Fair Values of Available-for-Sale Securities by Contractual Maturity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Fair Value Measurements - Company's Available-for-Sale Securities by Level within Fair Value Hierarchy (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail</Role>
      <ShortName>Fair Value Measurements - Company's Available-for-Sale Securities by Level within Fair Value Hierarchy (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Leases - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LeasesDetails</Role>
      <ShortName>Leases - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Leases - Summary of Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails</Role>
      <ShortName>Leases - Summary of Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Inventory - Schedule of Inventory (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/InventoryScheduleofInventoryDetail</Role>
      <ShortName>Inventory - Schedule of Inventory (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Property and Equipment - (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/PropertyandEquipmentDetail</Role>
      <ShortName>Property and Equipment - (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Property and Equipment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/PropertyandEquipmentAdditionalInformationDetail</Role>
      <ShortName>Property and Equipment - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Long-Term Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails</Role>
      <ShortName>Long-Term Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Long-Term Debt - Long-term debt and lease financing obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails</Role>
      <ShortName>Long-Term Debt - Long-term debt and lease financing obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Long-Term Debt - Schedule of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Common Stock and Preferred Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail</Role>
      <ShortName>Common Stock and Preferred Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Stock-based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Stock-based Compensation - Stock Option Activity and Related Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail</Role>
      <ShortName>Stock-based Compensation - Stock Option Activity and Related Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Stock-based Compensation - Company's Options Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail</Role>
      <ShortName>Stock-based Compensation - Company's Options Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Stock-based Compensation - Restricted Stock Units (RSUs) Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails</Role>
      <ShortName>Stock-based Compensation - Restricted Stock Units (RSUs) Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Stock-based Compensation - Stock Compensation Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail</Role>
      <ShortName>Stock-based Compensation - Stock Compensation Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Stock-based Compensation - Fair Value of Employee Option Grant (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail</Role>
      <ShortName>Stock-based Compensation - Fair Value of Employee Option Grant (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Defined Contribution Retirement Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/DefinedContributionRetirementPlanAdditionalInformationDetail</Role>
      <ShortName>Defined Contribution Retirement Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Income Taxes - Loss Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Loss Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Income Taxes - Significant Components of our Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Significant Components of our Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail</Role>
      <ShortName>Income Taxes - Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Income Taxes - Effect of Temporary Differences and Carryforwards (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail</Role>
      <ShortName>Income Taxes - Effect of Temporary Differences and Carryforwards (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Income Taxes - Summary of Changes in Deferred Tax Asset Valuation Allowance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail</Role>
      <ShortName>Income Taxes - Summary of Changes in Deferred Tax Asset Valuation Allowance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Income Taxes - Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail</Role>
      <ShortName>Income Taxes - Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/NetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/NetLossPerShareTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="nstg-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nanostring.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nanostring.com/role/SubsequentEvents</ParentRole>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="nstg-20221231.htm">nstg-20221231.htm</File>
    <File>nstg-20221231.xsd</File>
    <File>nstg-20221231_cal.xml</File>
    <File>nstg-20221231_def.xml</File>
    <File>nstg-20221231_lab.xml</File>
    <File>nstg-20221231_pre.xml</File>
    <File>nstg-2022ex1010.htm</File>
    <File>nstg-2022ex108.htm</File>
    <File>nstg-2022ex109.htm</File>
    <File>nstg-2022ex231.htm</File>
    <File>nstg-2022ex311.htm</File>
    <File>nstg-2022ex312.htm</File>
    <File>nstg-2022ex321.htm</File>
    <File>nstg-2022ex322.htm</File>
    <File>nstg-2022ex43.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>nstg-20221231_g1.jpg</File>
    <File>nstg-20221231_g10.jpg</File>
    <File>nstg-20221231_g11.jpg</File>
    <File>nstg-20221231_g12.jpg</File>
    <File>nstg-20221231_g13.jpg</File>
    <File>nstg-20221231_g14.jpg</File>
    <File>nstg-20221231_g15.jpg</File>
    <File>nstg-20221231_g16.jpg</File>
    <File>nstg-20221231_g17.jpg</File>
    <File>nstg-20221231_g18.jpg</File>
    <File>nstg-20221231_g19.jpg</File>
    <File>nstg-20221231_g2.jpg</File>
    <File>nstg-20221231_g20.jpg</File>
    <File>nstg-20221231_g21.jpg</File>
    <File>nstg-20221231_g22.jpg</File>
    <File>nstg-20221231_g23.jpg</File>
    <File>nstg-20221231_g24.jpg</File>
    <File>nstg-20221231_g25.jpg</File>
    <File>nstg-20221231_g26.jpg</File>
    <File>nstg-20221231_g27.jpg</File>
    <File>nstg-20221231_g28.jpg</File>
    <File>nstg-20221231_g29.jpg</File>
    <File>nstg-20221231_g3.jpg</File>
    <File>nstg-20221231_g30.jpg</File>
    <File>nstg-20221231_g31.jpg</File>
    <File>nstg-20221231_g32.jpg</File>
    <File>nstg-20221231_g33.jpg</File>
    <File>nstg-20221231_g34.jpg</File>
    <File>nstg-20221231_g35.jpg</File>
    <File>nstg-20221231_g36.jpg</File>
    <File>nstg-20221231_g37.jpg</File>
    <File>nstg-20221231_g38.jpg</File>
    <File>nstg-20221231_g4.jpg</File>
    <File>nstg-20221231_g5.jpg</File>
    <File>nstg-20221231_g6.jpg</File>
    <File>nstg-20221231_g7.jpg</File>
    <File>nstg-20221231_g8.jpg</File>
    <File>nstg-20221231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="950">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>130
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nstg-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 26,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 950,
    "http://xbrl.sec.gov/dei/2022": 36
   },
   "contextCount": 263,
   "dts": {
    "calculationLink": {
     "local": [
      "nstg-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "nstg-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "nstg-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nstg-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nstg-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nstg-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 620,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 5
   },
   "keyCustom": 32,
   "keyStandard": 379,
   "memberCustom": 23,
   "memberStandard": 43,
   "nsprefix": "nstg",
   "nsuri": "http://www.nanostring.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.nanostring.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.nanostring.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Short-term Investments",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.nanostring.com/role/ShorttermInvestments",
     "shortName": "Short-term Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.nanostring.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Leases (Notes)",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.nanostring.com/role/LeasesNotes",
     "shortName": "Leases (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Inventory",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.nanostring.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Property and Equipment",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.nanostring.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.nanostring.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Common Stock and Preferred Stock",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.nanostring.com/role/CommonStockandPreferredStock",
     "shortName": "Common Stock and Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Stock-based Compensation",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.nanostring.com/role/StockbasedCompensation",
     "shortName": "Stock-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Defined Contribution Retirement Plan",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.nanostring.com/role/DefinedContributionRetirementPlan",
     "shortName": "Defined Contribution Retirement Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.nanostring.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.nanostring.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.nanostring.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.nanostring.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.nanostring.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "24",
     "role": "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Fair Value Measures and Disclosures (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.nanostring.com/role/FairValueMeasuresandDisclosuresPolicies",
     "shortName": "Fair Value Measures and Disclosures (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Revenue from Contracts with Customers (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.nanostring.com/role/RevenuefromContractswithCustomersTables",
     "shortName": "Revenue from Contracts with Customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Short-term Investments (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.nanostring.com/role/ShorttermInvestmentsTables",
     "shortName": "Short-term Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.nanostring.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.nanostring.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Inventory (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.nanostring.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.nanostring.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.nanostring.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Stock-based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.nanostring.com/role/StockbasedCompensationTables",
     "shortName": "Stock-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.nanostring.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.nanostring.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nstg:NumberOfPlatforms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "platform",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Description of the Business Narrative (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.nanostring.com/role/DescriptionoftheBusinessNarrativeDetails",
     "shortName": "Description of the Business Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nstg:NumberOfPlatforms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "platform",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Significant Accounting Policies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Revenue from Contracts with Customers Narrative (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails",
     "shortName": "Revenue from Contracts with Customers Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Revenue from Contracts with Customers Schedule of Disaggregated Revenue (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails",
     "shortName": "Revenue from Contracts with Customers Schedule of Disaggregated Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i713c836ec9944621af76e4eae6676d6b_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Short-term Investments - Available-for-Sale Securities (Detail)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail",
     "shortName": "Short-term Investments - Available-for-Sale Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Short-term Investments - Fair Values of Available-for-Sale Securities by Contractual Maturity (Detail)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail",
     "shortName": "Short-term Investments - Fair Values of Available-for-Sale Securities by Contractual Maturity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Fair Value Measurements - Company's Available-for-Sale Securities by Level within Fair Value Hierarchy (Detail)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
     "shortName": "Fair Value Measurements - Company's Available-for-Sale Securities by Level within Fair Value Hierarchy (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i7b7ef4b161684e7cacf3f6408767bb84_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.nanostring.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i7b7ef4b161684e7cacf3f6408767bb84_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nstg:NumberOfOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Leases - (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.nanostring.com/role/LeasesDetails",
     "shortName": "Leases - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nstg:NumberOfOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Leases - Summary of Lease Cost and Other Information (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails",
     "shortName": "Leases - Summary of Lease Cost and Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails",
     "shortName": "Leases - Schedule of Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Inventory - Schedule of Inventory (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail",
     "shortName": "Inventory - Schedule of Inventory (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Property and Equipment - (Detail)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.nanostring.com/role/PropertyandEquipmentDetail",
     "shortName": "Property and Equipment - (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Property and Equipment - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.nanostring.com/role/PropertyandEquipmentAdditionalInformationDetail",
     "shortName": "Property and Equipment - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Long-Term Debt - Additional Information (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
     "shortName": "Long-Term Debt - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Long-Term Debt - Long-term debt and lease financing obligations (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails",
     "shortName": "Long-Term Debt - Long-term debt and lease financing obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Long-Term Debt - Schedule of Interest Expense (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails",
     "shortName": "Long-Term Debt - Schedule of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i75a0ba5de62e4ca798bb2006d7e7760c_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Common Stock and Preferred Stock - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail",
     "shortName": "Common Stock and Preferred Stock - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Stock-based Compensation - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i9e05f468d67d4e158506601ffba408b5_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Stock-based Compensation - Stock Option Activity and Related Information (Detail)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail",
     "shortName": "Stock-based Compensation - Stock Option Activity and Related Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Stock-based Compensation - Company's Options Outstanding (Detail)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail",
     "shortName": "Stock-based Compensation - Company's Options Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Stock-based Compensation - Restricted Stock Units (RSUs) Activity (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails",
     "shortName": "Stock-based Compensation - Restricted Stock Units (RSUs) Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Stock-based Compensation - Stock Compensation Expense (Detail)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail",
     "shortName": "Stock-based Compensation - Stock Compensation Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Stock-based Compensation - Fair Value of Employee Option Grant (Detail)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail",
     "shortName": "Stock-based Compensation - Fair Value of Employee Option Grant (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "ib6fb5a9c83554516897179bdc578a26e_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "ib6fb5a9c83554516897179bdc578a26e_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Defined Contribution Retirement Plan - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.nanostring.com/role/DefinedContributionRetirementPlanAdditionalInformationDetail",
     "shortName": "Defined Contribution Retirement Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Income Taxes - Loss Before Income Taxes (Detail)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail",
     "shortName": "Income Taxes - Loss Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Income Taxes - Significant Components of our Provision for Income Taxes (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail",
     "shortName": "Income Taxes - Significant Components of our Provision for Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Income Taxes - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate (Detail)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail",
     "shortName": "Income Taxes - Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "nstg:ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Income Taxes - Effect of Temporary Differences and Carryforwards (Detail)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail",
     "shortName": "Income Taxes - Effect of Temporary Differences and Carryforwards (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "nstg:ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "nstg:ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i9e05f468d67d4e158506601ffba408b5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Income Taxes - Summary of Changes in Deferred Tax Asset Valuation Allowance (Detail)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail",
     "shortName": "Income Taxes - Summary of Changes in Deferred Tax Asset Valuation Allowance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i2fb8bca17b47449e95636383b6b5d1ef_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i9e05f468d67d4e158506601ffba408b5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Income Taxes - Total Balance of Unrecognized Gross Tax Benefits Resulting from R&D Credits Claimed (Detail)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail",
     "shortName": "Income Taxes - Total Balance of Unrecognized Gross Tax Benefits Resulting from R&D Credits Claimed (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i386de87196f44b13b5fbbfb2f76610bb_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "ib3ed46b1479f4064896cb2ff583b50fe_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.nanostring.com/role/NetLossPerShareDetails",
     "shortName": "Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "ib3ed46b1479f4064896cb2ff583b50fe_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i822d0d944f224ca9818f6be1576e4fa8_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i8451f817802047b4ac1d9188ce3a1a70_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.nanostring.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Description of the Business",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.nanostring.com/role/DescriptionoftheBusiness",
     "shortName": "Description of the Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nstg-20221231.htm",
      "contextRef": "i043751235d134593932bc4d1798772f9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nanostring.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "nstg_AmortizationOfDebtDiscountAndIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Debt Discount And Issuance Costs",
        "label": "Amortization Of Debt Discount And Issuance Costs",
        "terseLabel": "Amortization of issuance costs"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountAndIssuanceCosts",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_AreaOfSpaceUnderLease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area Of Space Under Lease",
        "label": "Area Of Space Under Lease",
        "terseLabel": "Area under lease"
       }
      }
     },
     "localname": "AreaOfSpaceUnderLease",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LeasesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "nstg_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.nanostring.com/20221231",
     "xbrltype": "stringItemType"
    },
    "nstg_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt maturities after one through three years fair value.",
        "label": "Available For Sale Securities Debt Maturities After One Through Three Years Fair Value",
        "terseLabel": "Maturing in one to three years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_ContractWithCustomerLiabilityCustomerDepositsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Customer Deposits, Current",
        "label": "Contract With Customer, Liability, Customer Deposits, Current",
        "terseLabel": "Customer deposits"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCustomerDepositsCurrent",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase (Decrease) In Customer Deposits",
        "label": "Contract With Customer, Liability, Increase (Decrease) In Customer Deposits",
        "terseLabel": "Contract With Customer, Liability, Increase (Decrease) In Customer Deposits"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseInCustomerDeposits",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_ConvertibleDebtTermsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Debt Terms [Axis]",
        "label": "Convertible Debt Terms [Axis]",
        "terseLabel": "Convertible Debt Terms [Axis]"
       }
      }
     },
     "localname": "ConvertibleDebtTermsAxis",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nstg_ConvertibleDebtTermsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Debt Terms",
        "label": "Convertible Debt Terms [Domain]",
        "terseLabel": "Convertible Debt Terms [Domain]"
       }
      }
     },
     "localname": "ConvertibleDebtTermsDomain",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ConvertibleDebtTriggeringEvent1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Debt Triggering Event 1 [Member]",
        "label": "Convertible Debt Triggering Event 1 [Member]",
        "terseLabel": "Convertible Debt Triggering Event 1"
       }
      }
     },
     "localname": "ConvertibleDebtTriggeringEvent1Member",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ConvertibleDebtTriggeringEvent2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Debt Triggering Event 2 [Member]",
        "label": "Convertible Debt Triggering Event 2 [Member]",
        "terseLabel": "Convertible Debt Triggering Event 2"
       }
      }
     },
     "localname": "ConvertibleDebtTriggeringEvent2Member",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ConvertibleSeniorNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2025 [Member]",
        "label": "Convertible Senior Notes Due 2025 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2025"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2025Member",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails",
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_CostOfRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Revenue [Member]",
        "label": "Cost Of Revenue [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenueMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_DebtSecuritiesAndEquitySecuritiesFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities And Equity Securities, Fair Value",
        "label": "Debt Securities And Equity Securities, Fair Value",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAndEquitySecuritiesFairValue",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_DeferredTaxAssetsDeferredLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, deferred lease liability",
        "label": "Deferred tax assets, deferred lease liability",
        "terseLabel": "Deferred tax assets, deferred lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredLeaseLiability",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_DeferredTaxAssetsSection174Capitalization": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, Section 174 Capitalization",
        "label": "Deferred tax assets, Section 174 Capitalization",
        "terseLabel": "Deferred tax assets, Section 174 Capitalization"
       }
      }
     },
     "localname": "DeferredTaxAssetsSection174Capitalization",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_DeferredTaxLiabilitiesStateNetOperatingLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, State net operating loss adjustments",
        "label": "Deferred Tax Liabilities, State net operating loss adjustments",
        "negatedTerseLabel": "Deferred Tax Liabilities, State net operating loss adjustments"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesStateNetOperatingLossAdjustments",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings and Other Nondeductible Amounts",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings and Other Nondeductible Amounts",
        "terseLabel": "Tax on repatriated foreign earnings and other nondeductible items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationofForeignEarningsandOtherNondeductibleAmounts",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Stock Option Exercise (Windfall) Shortfall",
        "label": "Effective Income Tax Rate Reconciliation, Stock Option Exercise (Windfall) Shortfall",
        "terseLabel": "Stock option exercise windfall"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStockOptionExerciseWindfallShortfall",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_EffectiveIncomeTaxReconciliationSection162Limitation": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation Section 162 Limitation",
        "label": "Effective Income Tax Reconciliation Section 162 Limitation",
        "terseLabel": "Section 162(m) limitations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationSection162Limitation",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_EmployeeStockPurchasePlanContributionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Contribution Percentage",
        "label": "Employee Stock Purchase Plan Contribution Percentage",
        "verboseLabel": "Contribution percentage of purchase shares on participants eligible compensation"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanContributionPercentage",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nstg_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_EmployeeStockPurchasePlanOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Offering Period",
        "label": "Employee Stock Purchase Plan Offering Period",
        "terseLabel": "Length of offering period, in months"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanOfferingPeriod",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nstg_EmployeeStockPurchasePlanPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Purchase Period",
        "label": "Employee Stock Purchase Plan Purchase Period",
        "terseLabel": "Length of purchase periods, in months"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanPurchasePeriod",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nstg_ExercisePriceRangeFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Five [Member]",
        "label": "Exercise Price Range Five [Member]",
        "terseLabel": "$23.00 \u2013\u00a0$66.91"
       }
      }
     },
     "localname": "ExercisePriceRangeFiveMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Four [Member]",
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "$18.68 \u2013\u00a0$22.71"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ExercisePriceRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range One [Member]",
        "label": "Exercise Price Range One [Member]",
        "terseLabel": "$1.92 \u2013 $12.56"
       }
      }
     },
     "localname": "ExercisePriceRangeOneMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Three [Member]",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "$15.21 \u2013\u00a0$18.55"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Two [Member]",
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "$12.77 \u2013\u00a0$14.99"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ExtendedProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The extended product warranty liability period. Does not include increases or decreases in the standard warranty liability.",
        "label": "Extended Product Warranty Period",
        "terseLabel": "Extended warranty period"
       }
      }
     },
     "localname": "ExtendedProductWarrantyPeriod",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nstg_ExtinguishmentOfDebtTerminationFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extinguishment Of Debt, Termination Fee",
        "label": "Extinguishment Of Debt, Termination Fee",
        "terseLabel": "Extinguishment of debt, termination fee"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTerminationFee",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_FederalAndStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal And State [Member]",
        "label": "Federal And State [Member]",
        "terseLabel": "Federal and State"
       }
      }
     },
     "localname": "FederalAndStateMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_GainLossOnExtinguishmentAndTerminationOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Extinguishment And Termination Of Debt",
        "label": "Gain (Loss) On Extinguishment And Termination Of Debt",
        "terseLabel": "Loss on extinguishment of debt and termination of revolving loan facility"
       }
      }
     },
     "localname": "GainLossOnExtinguishmentAndTerminationOfDebt",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_IncomeTaxReconciliationChangeInTaxCredits": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Income Tax Reconciliation Change In Tax Credits",
        "negatedLabel": "Change in tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInTaxCredits",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_IncomeTaxesAndTaxRelatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes And Tax Related [Line Items]",
        "label": "Income Taxes And Tax Related [Line Items]",
        "terseLabel": "Income Taxes And Tax Related [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesAndTaxRelatedLineItems",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nstg_IncomeTaxesAndTaxRelatedTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes And Tax Related [Table]",
        "label": "Income Taxes And Tax Related [Table]",
        "terseLabel": "Income Taxes And Tax Related [Table]"
       }
      }
     },
     "localname": "IncomeTaxesAndTaxRelatedTable",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nstg_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Liabilities",
        "label": "Increase (Decrease) In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_InterestAccruedOnLongTermNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense incurred, not yet paid, on all other long-term debt, which may include (1) interest on long-term notes, and (2) amortization of issuance costs not otherwise separately disclosed.",
        "label": "Interest Accrued On Long Term Notes",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "InterestAccruedOnLongTermNotes",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_ManufacturingEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Equipment [Member]",
        "label": "Manufacturing Equipment [Member]",
        "terseLabel": "Manufacturing equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_NumberOfOperatingLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating leases.",
        "label": "Number Of Operating Leases",
        "terseLabel": "Number of operating leases"
       }
      }
     },
     "localname": "NumberOfOperatingLeases",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nstg_NumberOfPlatforms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Platforms",
        "label": "Number Of Platforms",
        "terseLabel": "Number of platforms"
       }
      }
     },
     "localname": "NumberOfPlatforms",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/DescriptionoftheBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nstg_OutstandingPrincipalOfConvertibleDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Principal Of Convertible Debt",
        "label": "Outstanding Principal Of Convertible Debt",
        "terseLabel": "Outstanding Principal Of Convertible Debt"
       }
      }
     },
     "localname": "OutstandingPrincipalOfConvertibleDebt",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_ProductAndServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product And Service [Member]",
        "label": "Product And Service [Member]",
        "verboseLabel": "Total product and service revenue"
       }
      }
     },
     "localname": "ProductAndServiceMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ProductConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product, Consumables [Member]",
        "label": "Product, Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ProductConsumablesMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ProductInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product, Instruments [Member]",
        "label": "Product, Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "ProductInstrumentsMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ProductWarrantyAccrualPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of accrual amount as of the balance sheet date of the aggregate extended product warranty liability is amortized.",
        "label": "Product Warranty Accrual Period",
        "terseLabel": "Product warranty accrual period"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPeriod",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nstg_PrototypeSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prototype Systems [Member]",
        "label": "Prototype Systems [Member]",
        "terseLabel": "Prototype Systems"
       }
      }
     },
     "localname": "PrototypeSystemsMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_PrototypesAndOtherEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prototypes And Other Equipment [Member]",
        "label": "Prototypes And Other Equipment [Member]",
        "terseLabel": "Prototype instruments"
       }
      }
     },
     "localname": "PrototypesAndOtherEquipmentMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_PublicStockOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering [Member]",
        "label": "Public Stock Offering [Member]",
        "terseLabel": "Public Stock Offering"
       }
      }
     },
     "localname": "PublicStockOfferingMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_RentalInstrumentsReclassifiedFromInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental instruments reclassified from inventory.",
        "label": "Rental Instruments Reclassified From Inventory",
        "terseLabel": "Instruments reclassified from inventory to property and equipment"
       }
      }
     },
     "localname": "RentalInstrumentsReclassifiedFromInventory",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_RepaymentOfAccruedInterestOfLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of Accrued Interest Of Long Term Debt",
        "label": "Repayment Of Accrued Interest Of Long Term Debt",
        "negatedTerseLabel": "Payment of accrued interest on long-term debt"
       }
      }
     },
     "localname": "RepaymentOfAccruedInterestOfLongTermDebt",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_SaleOfStockGrossConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Gross Consideration Received On Transaction",
        "label": "Sale Of Stock, Gross Consideration Received On Transaction",
        "terseLabel": "Sale Of Stock, Gross Consideration Received On Transaction"
       }
      }
     },
     "localname": "SaleOfStockGrossConsiderationReceivedOnTransaction",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nstg_ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Deferred Tax Assets Valuation Allowance Table [Text Block]",
        "label": "Schedule Of Deferred Tax Assets Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Changes in Deferred Tax Asset Valuation Allowance"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsValuationAllowanceTableTextBlock",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nstg_ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Effects Of Temporary Differences That Give Rise To Deferred Tax Assets And Liabilities",
        "label": "Schedule Of Effects Of Temporary Differences That Give Rise To Deferred Tax Assets And Liabilities [Table Text Block]",
        "terseLabel": "Effect of Temporary Differences and Carryforwards"
       }
      }
     },
     "localname": "ScheduleOfEffectsOfTemporaryDifferencesThatGiveRiseToDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nstg_SecuredRevolvingLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Revolving Loan Facility [Member]",
        "label": "Secured Revolving Loan Facility [Member]",
        "terseLabel": "Secured Revolving Loan Facility"
       }
      }
     },
     "localname": "SecuredRevolvingLoanFacilityMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ServiceAndPerformanceComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock award with service and performance components",
        "label": "Service and Performance components [Member]",
        "terseLabel": "Service and Performance components"
       }
      }
     },
     "localname": "ServiceAndPerformanceComponentsMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_ServiceComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock awards with a service component",
        "label": "Service component [Member]",
        "terseLabel": "Service component"
       }
      }
     },
     "localname": "ServiceComponentMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options Outstanding, Weighted Average Exercise Price, and Additional Disclosures [Abstract]",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options Outstanding, Weighted Average Exercise Price, and Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- average remaining contractual term (in\u00a0years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nstg_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nstg_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of information pertaining to the Basis of Presentation and Summary of Significant Accounting Policies disclosure as a whole for which no other established gaap taxonomy identified hypercube is available.",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nstg_StandardProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The standard product warranty liability period. Does not include increases or decreases in an extended warranty liability.",
        "label": "Standard Product Warranty Period",
        "terseLabel": "Standard warranty period"
       }
      }
     },
     "localname": "StandardProductWarrantyPeriod",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nstg_TermLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Agreement [Member]",
        "label": "Term Loan Agreement [Member]",
        "terseLabel": "Term Loan Agreement"
       }
      }
     },
     "localname": "TermLoanAgreementMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Four Stock Option Plan And Two Thousand Thirteen Equity Incentive Stock Plan [Member]",
        "label": "Two Thousand Four Stock Option Plan And Two Thousand Thirteen Equity Incentive Stock Plan [Member]",
        "terseLabel": "2004 Stock Option Plan and 2013 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandFourStockOptionPlanAndTwoThousandThirteenEquityIncentiveStockPlanMember",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nstg_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits increase decreases resulting from current period tax positions.",
        "label": "Unrecognized Tax Benefits Increase Decreases Resulting From Current Period Tax Positions",
        "terseLabel": "Additions based on current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://www.nanostring.com/20221231",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r190",
      "r248",
      "r255",
      "r261",
      "r330",
      "r488",
      "r489",
      "r490",
      "r514",
      "r515",
      "r537",
      "r540",
      "r542",
      "r543",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r190",
      "r248",
      "r255",
      "r261",
      "r330",
      "r488",
      "r489",
      "r490",
      "r514",
      "r515",
      "r537",
      "r540",
      "r542",
      "r543",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r190",
      "r248",
      "r255",
      "r261",
      "r330",
      "r488",
      "r489",
      "r490",
      "r514",
      "r515",
      "r537",
      "r540",
      "r542",
      "r543",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r365",
      "r447",
      "r634",
      "r655",
      "r682",
      "r683",
      "r726",
      "r737",
      "r745",
      "r796",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail",
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r365",
      "r447",
      "r634",
      "r655",
      "r682",
      "r683",
      "r726",
      "r737",
      "r745",
      "r796",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail",
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r305",
      "r636",
      "r727",
      "r743",
      "r791",
      "r792",
      "r797",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r305",
      "r636",
      "r727",
      "r743",
      "r791",
      "r792",
      "r797",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r365",
      "r430",
      "r447",
      "r478",
      "r479",
      "r480",
      "r610",
      "r634",
      "r655",
      "r682",
      "r683",
      "r726",
      "r737",
      "r745",
      "r790",
      "r796",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail",
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r365",
      "r430",
      "r447",
      "r478",
      "r479",
      "r480",
      "r610",
      "r634",
      "r655",
      "r682",
      "r683",
      "r726",
      "r737",
      "r745",
      "r790",
      "r796",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail",
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r306",
      "r307",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r728",
      "r744",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r306",
      "r307",
      "r668",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r728",
      "r744",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r17",
      "r742"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r309",
      "r310"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r94",
      "r199"
     ],
     "calculation": {
      "http://www.nanostring.com/role/PropertyandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r205",
      "r650",
      "r663",
      "r667"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r28",
      "r31",
      "r143",
      "r600",
      "r658",
      "r659",
      "r762",
      "r763",
      "r764",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r778",
      "r779",
      "r780",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r249",
      "r250",
      "r251",
      "r252",
      "r261",
      "r314",
      "r315",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r488",
      "r489",
      "r490",
      "r512",
      "r513",
      "r514",
      "r515",
      "r525",
      "r526",
      "r527",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r571",
      "r572",
      "r575",
      "r576",
      "r577",
      "r578",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r638",
      "r639",
      "r640",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r130",
      "r131",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r108",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Issuance cost"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r102",
      "r108",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Adjustments to Additional Paid in Capital, Warrant Issued"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r734",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed Securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r156",
      "r174",
      "r201",
      "r234",
      "r290",
      "r299",
      "r303",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r528",
      "r530",
      "r552",
      "r742",
      "r794",
      "r795",
      "r810"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r194",
      "r208",
      "r234",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r528",
      "r530",
      "r552",
      "r742",
      "r794",
      "r795",
      "r810"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r317",
      "r338"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized\u00a0cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r75",
      "r318",
      "r648"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Maturing in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r72",
      "r316",
      "r338",
      "r642"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "totalLabel": "Total available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsFairValuesofAvailableforSaleSecuritiesbyContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r71",
      "r338"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Fair\u00a0value",
        "verboseLabel": "Short term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Accounting Principles and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r62",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of the Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/DescriptionoftheBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r182",
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized Computer Software, Amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "terseLabel": "Capitalized Computer Software, Net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r58",
      "r197",
      "r704"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash, restricted cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r52",
      "r58",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of year",
        "periodStartLabel": "Beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r52",
      "r148"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, restricted cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r234",
      "r264",
      "r265",
      "r267",
      "r269",
      "r277",
      "r278",
      "r326",
      "r366",
      "r368",
      "r369",
      "r370",
      "r373",
      "r374",
      "r404",
      "r405",
      "r407",
      "r411",
      "r418",
      "r552",
      "r685",
      "r755",
      "r768",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Class of Warrant or Right, Outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r25",
      "r161",
      "r178"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r98",
      "r357",
      "r359",
      "r669",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r778",
      "r779",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/NetLossPerShareDetails",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r8",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r742"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value, 150,000 shares authorized; 46,719 and 45,729 shares issued and outstanding at December\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights",
        "terseLabel": "Common Stock, Voting Rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r32",
      "r213",
      "r215",
      "r223",
      "r644",
      "r652"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Capitalized software and computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r171",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionMember": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building or developing real estate. Includes, but is not limited to, improvement to land for drainage, utilities, grading and subdividing.",
        "label": "Construction [Member]",
        "terseLabel": "Construction"
       }
      }
     },
     "localname": "ConstructionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r421",
      "r423",
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r421",
      "r422",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Performance obligation satisfied in previous period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Contractual Obligation"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r734",
      "r736",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r37",
      "r234",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r552",
      "r794"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of product revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "terseLabel": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r142",
      "r510",
      "r518",
      "r771"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r232",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r391",
      "r398",
      "r399",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r157",
      "r159",
      "r173",
      "r238",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r574",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails",
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r104",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r23",
      "r109",
      "r110",
      "r112",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt instrument conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r389",
      "r551",
      "r722",
      "r723"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt instrument, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r22",
      "r150",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails",
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r24",
      "r238",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r574",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails",
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Percentage of redemption fee"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r24",
      "r109",
      "r111",
      "r112",
      "r113",
      "r149",
      "r150",
      "r152",
      "r170",
      "r238",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r400",
      "r574",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails",
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r151",
      "r387",
      "r402",
      "r722",
      "r723"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt, Policy"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r324",
      "r342",
      "r720"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r324",
      "r342"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r324",
      "r342",
      "r720"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r324",
      "r342"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Short-Term Investments Available-for-Sale Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r322",
      "r339",
      "r720"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r323",
      "r340"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r321",
      "r720",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r158",
      "r172",
      "r505"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred Tax Liabilities, Gross"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r757"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue and other liabilities, current portion"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r758"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue and other liabilities, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets before allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r803"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Deferred Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r803"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r140",
      "r804"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r140",
      "r804"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Accruals and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r139",
      "r140",
      "r804"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r139",
      "r140",
      "r804"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r140",
      "r804"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves": {
     "auth_ref": [
      "r140",
      "r804"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves",
        "terseLabel": "Warranty reserve"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less:\u00a0Valuation allowance",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail",
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r140",
      "r804"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Deferred Tax Liabilities, Leasing Arrangements"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesEffectofTemporaryDifferencesandCarryforwardsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Contribution for retirement plan"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/DefinedContributionRetirementPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r56",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r56",
      "r288"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r427",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r452",
      "r483",
      "r484",
      "r487",
      "r492",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe and Middle East"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r224",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r262",
      "r264",
      "r267",
      "r268",
      "r269",
      "r273",
      "r543",
      "r544",
      "r645",
      "r653",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Net loss per share-basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r224",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r264",
      "r267",
      "r268",
      "r269",
      "r273",
      "r543",
      "r544",
      "r645",
      "r653",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share-diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, restricted cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and other employee benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost, weighted-average recognized period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit recognized related to share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options to purchase common stock",
        "verboseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r108",
      "r190",
      "r217",
      "r218",
      "r219",
      "r245",
      "r246",
      "r247",
      "r250",
      "r258",
      "r260",
      "r276",
      "r330",
      "r420",
      "r488",
      "r489",
      "r490",
      "r514",
      "r515",
      "r542",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r568",
      "r600",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/NetLossPerShareDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.",
        "label": "Extended Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Reserve for Product Warranties"
       }
      }
     },
     "localname": "ExtendedProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r546",
      "r547",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r144",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Company's Available-for-Sale Securities by Level within Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r389",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r547",
      "r607",
      "r608",
      "r609",
      "r722",
      "r723",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r389",
      "r432",
      "r437",
      "r547",
      "r607",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r389",
      "r432",
      "r437",
      "r547",
      "r608",
      "r722",
      "r723",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r389",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r547",
      "r609",
      "r722",
      "r723",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasuresandDisclosuresPolicies",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r389",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r607",
      "r608",
      "r609",
      "r722",
      "r723",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r582",
      "r587",
      "r741"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r584",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "verboseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r580",
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Summary of Finance Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r583",
      "r588"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Repayment of finance lease obligations",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r582",
      "r587",
      "r741"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r591",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r590",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r319",
      "r320",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r341",
      "r343",
      "r344",
      "r400",
      "r416",
      "r532",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r720",
      "r784",
      "r785",
      "r786",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value as of the balance sheet date of firm holdings in mortgages, mortgage backed securities (investment instruments that represent ownership of an undivided interest in a group of mortgages, where principal and interest from the individual mortgages are used to pay investors' principal and interest on the mortgage backed security) and asset-backed securities that are primarily paid from the cash flows of a discrete pool of receivables or other financial assets (such as credit-card receivables), either fixed or revolving, that by their terms convert into cash within a finite time period. Includes both pledged (to counterparties as collateral for financing transactions) and unpledged holdings.",
        "label": "Financial Instruments, Owned, Mortgages, Mortgage-Backed and Asset-Backed Securities, at Fair Value",
        "terseLabel": "Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value"
       }
      }
     },
     "localname": "FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r349",
      "r351",
      "r352",
      "r354",
      "r637",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r85",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "negatedTerseLabel": "Loss on equity securities"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment and other assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r56",
      "r105",
      "r106"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r646",
      "r647",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r646",
      "r647",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "auth_ref": [
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic.",
        "label": "Geographic Distribution, Domestic [Member]",
        "terseLabel": "Geographic Distribution, Domestic [Member]"
       }
      }
     },
     "localname": "GeographicDistributionDomesticMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "auth_ref": [
      "r646",
      "r647",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as foreign.",
        "label": "Geographic Distribution, Foreign [Member]",
        "terseLabel": "Geographic Distribution, Foreign [Member]"
       }
      }
     },
     "localname": "GeographicDistributionForeignMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "terseLabel": "Guarantees and Indemnifications"
       }
      }
     },
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r767",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of intangible assets, finite lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r235",
      "r519"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r34",
      "r153",
      "r162",
      "r180",
      "r290",
      "r298",
      "r302",
      "r304",
      "r647",
      "r716"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net loss before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r235",
      "r519"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r500",
      "r503",
      "r509",
      "r516",
      "r520",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r237",
      "r259",
      "r260",
      "r289",
      "r498",
      "r517",
      "r521",
      "r654"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r216",
      "r496",
      "r497",
      "r503",
      "r504",
      "r508",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r495",
      "r499"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Changes in federal and state tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail",
      "http://www.nanostring.com/role/IncomeTaxesSignificantComponentsofourProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax provision at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "State and foreign tax, and other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesIncomeTaxExpenseBenefitDifferedfromAmountsComputedbyApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r709"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and other employee benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r350",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r86",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r151",
      "r165",
      "r220",
      "r287",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r41",
      "r395",
      "r403",
      "r724",
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r43",
      "r396",
      "r724",
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Interest Expense"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r227",
      "r229",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r759"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest Receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r89",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Internal Use Software, Policy"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r84",
      "r706"
     ],
     "calculation": {
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r207",
      "r705",
      "r742"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r196",
      "r206",
      "r275",
      "r345",
      "r347",
      "r348",
      "r635",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r84",
      "r708"
     ],
     "calculation": {
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r83",
      "r760"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r84",
      "r707"
     ],
     "calculation": {
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Intermediate manufactured components"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/InventoryScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r346"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Provision for inventory obsolescence and bad debt expense (recovery)"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r39",
      "r286"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.",
        "label": "Investment Income, Net, Amortization of Discount and Premium",
        "negatedLabel": "Amortization of premium and accretion of discount on short-term investments, net"
       }
      }
     },
     "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r325",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Fair Values of Available-for-Sale Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r82",
      "r155",
      "r168",
      "r181",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r592",
      "r741"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases and Leasehold Improvements"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Operating Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r19",
      "r234",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r529",
      "r530",
      "r531",
      "r552",
      "r715",
      "r794",
      "r810",
      "r811"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r160",
      "r176",
      "r742",
      "r770",
      "r787",
      "r806"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r195",
      "r234",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r529",
      "r530",
      "r531",
      "r552",
      "r742",
      "r794",
      "r810",
      "r811"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r18",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r4"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/LongTermDebtLongtermdebtandleasefinancingobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r24",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market fund"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r228"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r228"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r52",
      "r54",
      "r57"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r35",
      "r57",
      "r163",
      "r179",
      "r193",
      "r211",
      "r214",
      "r219",
      "r234",
      "r249",
      "r253",
      "r254",
      "r255",
      "r256",
      "r259",
      "r260",
      "r266",
      "r290",
      "r298",
      "r302",
      "r304",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r544",
      "r552",
      "r716",
      "r794"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r290",
      "r298",
      "r302",
      "r304",
      "r716"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r585",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r767"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r591",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r590",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r33",
      "r108",
      "r212",
      "r215",
      "r222",
      "r562",
      "r567",
      "r568",
      "r643",
      "r651",
      "r762",
      "r763"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Change in unrealized loss on available-for-sale debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Overallotment option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForSoftware": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments for Software",
        "negatedTerseLabel": "Purchase of internal-use software assets"
       }
      }
     },
     "localname": "PaymentsForSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Fees paid upon extinguishment of debt"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "terseLabel": "Fees paid for issuance of 2025 convertible senior notes"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Payments to Acquire Intangible Assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r430",
      "r431",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r448",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Defined Contribution Retirement Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/DefinedContributionRetirementPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail",
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r7",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail",
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r7",
      "r742"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value, 15,000 shares authorized; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r761"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification, Comparability Adjustment"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Proceeds from Customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from sale of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail",
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r765"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuance of 2025 convertible senior notes"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r47",
      "r128"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock for employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from issuance of common stock warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r48",
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from lines of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r70",
      "r225",
      "r226"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "terseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r47",
      "r128"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Total product revenue"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r93",
      "r198"
     ],
     "calculation": {
      "http://www.nanostring.com/role/PropertyandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r95",
      "r177",
      "r649",
      "r742"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.nanostring.com/role/PropertyandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r95",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives of the assets",
        "verboseLabel": "Useful\u00a0Life (Years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Non cancellable purchase obligations"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase Obligation, to be Paid, Year One"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r766"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r133",
      "r183",
      "r818"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r58",
      "r61",
      "r197"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted Cash and Cash Equivalents, Current"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "negatedTerseLabel": "Tax withholdings related to net share settlements of restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r114",
      "r175",
      "r662",
      "r667",
      "r742"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r190",
      "r245",
      "r246",
      "r247",
      "r250",
      "r258",
      "r260",
      "r330",
      "r488",
      "r489",
      "r490",
      "r514",
      "r515",
      "r542",
      "r658",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.",
        "label": "Revenue, Performance Obligation, Description of Payment Terms",
        "terseLabel": "Revenue, Performance Obligation, Description of Payment Terms"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r221",
      "r234",
      "r284",
      "r285",
      "r297",
      "r300",
      "r301",
      "r305",
      "r306",
      "r308",
      "r326",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r552",
      "r647",
      "r794"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r589",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r589",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.nanostring.com/role/LeasesSummaryofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Proceeds from underwritten public offering after fees and commissions"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of Stock, Number of Shares Issued in Transaction"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Shares Excluded from Computation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Stock Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Significant Components of our Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Long-term debt and lease financing obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r126",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Loss Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r14",
      "r15",
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/PropertyandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r449",
      "r451",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Company's Options Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r116",
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity and Related Information"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair Value of Employee Option Grant"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General and Administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsDetails",
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service revenue"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations",
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockCompensationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock options vesting period and exercisable period, years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Non-vested at December 31, 2016 (in shares)",
        "periodStartLabel": "Non-vested at December 31, 2015 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Non-vested at December 31, 2016 (in dollars per share)",
        "periodStartLabel": "Non-vested at December 31, 2015 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Shares vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rates"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized under the Plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "verboseLabel": "Aggregate intrinsic value (in\u00a0thousands)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable at December 31, 2016 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "verboseLabel": "Aggregate intrinsic value for options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at December\u00a031, 2016 (in shares)",
        "periodStartLabel": "Outstanding at December\u00a031, 2015 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at December\u00a031, 2016 (in dollars per share)",
        "periodStartLabel": "Outstanding at December\u00a031, 2015 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- average exercise price per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Options vested and expected to vest at December 31, 2016"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable at December 31, 2016 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested and expected to vest at December 31, 2016 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested and expected to vest at December 31, 2016 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Share-based Payment Arrangement, Plan Modification, Incremental Cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail",
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r456",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r491",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Options Exercisable - Number of Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Options Outstanding - Number of Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Exercise Price, Maximum (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationRestrictedStockUnitsRSUsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Stock options grant period, years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationFairValueofEmployeeOptionGrantDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable at December 31, 2016"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable at December 31, 2016"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested and expected to vest as December 31, 2016"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price percentage of fair market value of shares"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options Exercisable - Weighted- Average Remaining Contractual Life in Years"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options Outstanding -Weighted- Average Remaining Contractual Life in Years"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/StockbasedCompensationCompanysOptionsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at (in shares)",
        "periodStartLabel": "Balance at (in shares)",
        "terseLabel": "Shares, Outstanding"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r62",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software Development"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r234",
      "r264",
      "r265",
      "r267",
      "r269",
      "r277",
      "r278",
      "r326",
      "r366",
      "r368",
      "r369",
      "r370",
      "r373",
      "r374",
      "r404",
      "r405",
      "r407",
      "r411",
      "r418",
      "r552",
      "r685",
      "r755",
      "r768",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r27",
      "r108",
      "r190",
      "r217",
      "r218",
      "r219",
      "r245",
      "r246",
      "r247",
      "r250",
      "r258",
      "r260",
      "r276",
      "r330",
      "r420",
      "r488",
      "r489",
      "r490",
      "r514",
      "r515",
      "r542",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r568",
      "r600",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/NetLossPerShareDetails",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r276",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for employee stock purchase plan (in shares)",
        "verboseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/StockbasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Exercise of common stock warrant, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/StockbasedCompensationStockOptionActivityandRelatedInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Stock Issued During Period, Value, Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Stock Issued During Period, Value, Other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "negatedTerseLabel": "Stock Issued During Period, Value, Restricted Stock Award, Gross"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r108",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock Issued During Period, Value, Stock Options Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r69",
      "r742",
      "r770",
      "r787",
      "r806"
     ],
     "calculation": {
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedTerseLabel": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balances at",
        "periodStartLabel": "Balances at",
        "terseLabel": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.nanostring.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.nanostring.com/role/SignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r233",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r420",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Common Stock and Preferred Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r569",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r569",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r569",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r569",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r601",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommonStockandPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r135",
      "r137",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Total Balance of Unrecognized Gross Tax Benefits Resulting from R&amp;D Credits Claimed"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r732",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r732",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r311",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r319",
      "r320",
      "r400",
      "r416",
      "r532",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r784",
      "r785",
      "r786",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r249",
      "r250",
      "r251",
      "r252",
      "r261",
      "r314",
      "r315",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r488",
      "r489",
      "r490",
      "r512",
      "r513",
      "r514",
      "r515",
      "r525",
      "r526",
      "r527",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r571",
      "r572",
      "r575",
      "r576",
      "r577",
      "r578",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r638",
      "r639",
      "r640",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r713",
      "r734",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government-related debt securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/FairValueMeasurementsCompanysAvailableforSaleSecuritiesbyLevelwithinFairValueHierarchyDetail",
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "US Government Debt Securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ShorttermInvestmentsAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain": {
     "auth_ref": [
      "r357",
      "r358",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the unconditional purchase arrangement.",
        "label": "Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]",
        "terseLabel": "Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]"
       }
      }
     },
     "localname": "UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r494",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of year",
        "periodStartLabel": "Unrecognized tax benefits at beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesTotalBalanceofUnrecognizedGrossTaxBenefitsResultingfromRDCreditsClaimedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties recorded"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis": {
     "auth_ref": [
      "r357",
      "r358",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertinent information about unrecorded unconditional purchase arrangements to acquire goods or services, by category of goods or services. arrangements to acquire goods or services, by category of goods or services.",
        "label": "Unrecorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]",
        "terseLabel": "Unrecorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r279",
      "r280",
      "r282",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Valuation Allowance of Deferred Tax Assets"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r777"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "verboseLabel": "Impact of change in tax rate"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/IncomeTaxesSummaryofChangesinDeferredTaxAssetValuationAllowanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Common stock warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/NetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r263",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average shares used in computing diluted net loss per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r262",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares used in computing basic net loss per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nanostring.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42546-110969",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25383-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL108322424-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498357-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r746": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r747": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r748": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r749": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r751": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r752": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r753": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r754": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>131
<FILENAME>0001401708-23-000052-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001401708-23-000052-xbrl.zip
M4$L#!!0    ( )>"7%8\0*MKR-(# #R?)  1    ;G-T9RTR,#(R,3(S,2YH
M=&WLO6E36T?7+OS]^14ZW&=(JB+<\^ D/D4,]DUN"QR0XP?>.N7J834(-)"]
M)0;_^G?UEIAQ @D@;:%4;$O:4^^^UG"M[M6K?_J_I[UNXQB*LC/H_[Q$E\E2
MX_^^^>E_-)O__<O6A\;J((QZT!\VWA;@AA ;)YWA?N-SA/*PD8I!K_%Y4!QV
MCEVS65WS=G!T5G3V]H<-1AB_<;!X+0D8 TDWM5*L*42R3:=U;#H2$M&,,9[,
M#WNO4U( EIBFBB'B:5HU/56ZB;\'1H6E,LH?XFMKI8V!$R^C%M%:IXFCC((G
MU@E)97[L_A#?#M^P7[X^+3L_+^T/AT>O7[TZ.3E9/N'+@V+O%2.$OOKOUH?M
ML \]U^STRZ'K!UB:7!7A\JI37W272PC+>X/C5W@ KV7L_,2R&%Z<F%SIJYOC
MC]=.RG>XWHKJGI-V\%<WG]XI!X)1_6=7C,^X^H!XH\63<]6K\<&+>Y\.[[YO
MI]_M]"'#_VI8N'Z9!D7/#5$\\JN0)F%->O%"V-Z]:W?IN_Z@'!:=_MYR&/2J
MEZ>,T_/S\<Z'?_(V^;!WY<7[G]XZ?X(:M=:^JHY.3OWV25D$+M_Y6P^G_,I[
MGY\>!J/^L#B[6P F!Z_A.RJ;>\X=W1:$R8'K)P^+;W:%?85'KR#5Q*=>._F\
M%7\&%JH *M&D\U]W71^A@G[ST_82*@:X^.:G'@Q=(]^U"7^,.L<_+[T=](>H
M[LWVV1&"$,;??EX:PNGP5=61K][\UW_]UT_#SK +;S+XS7.$?WHU_O&G5^-;
M^T$\>_-3[!PWRN%9%WY>BIWRJ.O.7O<'?< &=$Y?YQ.A&'_LQ C]ZB,>WT";
M4W3"^/FGPRU(/R]UB.!:XI-DI%Q(RRUG/HA(M35:LV2_K.:F$$IH\U+J^JZ7
M'PV=URMHQF(V9>^Z;F^IT8EXR\A_/_.K@^,/;.MXA[=&\6#M>/>]/=@\.)0;
M[>[ASM?6R<[![X<;7[<.-]O=_8VOO^RWVNNGNY_73S8_KY&-]AK]P#>Z.U\'
M<K/]2>Z^;WUMO5^GNZN![*X>RIUV.-EIKYVU/O_>::WB]:N?3C=^-^0#VSW;
M^1S43GOKH/5U[V3W_1K;::^?;:P>GNZP-;'Y?J/;6ET7&U_W#S8_?V*[!WO'
M\?V[CG__2>VVX\%F>S^WC6^V=^C&ZOIIJ[=^MKFZN[_Y'MO0VSG=;6\=[K9W
M)M?\CL^2_=WV47>#M>3F^_S,(#<./I'6P=K9S@$^I[<F=MO=WN[!N^[&^ZWN
M1M=\_=!>&[:VR>F']F]BL[W"O@"!%+7R30F!-T40:+P%X%?- XE1 &5RZ4UR
MW1)^>G4-QZ>$]=Q!O>N4P75WP!7O\)=R ?!? 4QN 6RRVXQ6-D%ZV10>>]PF
MG9K.)W!4>C#>+;W)($P-WX]X_T%<('POA.DMA(GET067FAZ0>@EPMFF8]$UM
MJ=!4DF 8FN9W.\^([UH?W<;96T2X<-WU?H33_\#9 MN_PI;=PC8F!((K5%<3
M,[<6O&FU#DVCI'8,! T<S3-!MBL(U<0\!&.#=#H9J@WR/Z&]<(%&2XT)P!U%
MVOUE_2:T$[[S^EVGG_GL!T!2]Z'C?*>+:&\/,93(2KV9QL<[J-F#LI-IR]HI
M,HZRX[MX>CF<KB"<M@Y^.][M_[J_^_6HUVK_TL/O7S<__\9;7]?(#L/[]=;Q
M^\9^J]=B&P=K)ZV#C?W=;4MV/O]:(J"]S=4]N=O&8ZN_=C;:".C7@(+0DKL'
MOQZT#O9(B^WBE;^1S?-K_OO7?=^+W<W>CMA<[79;7W<("@_=:/_V=>/KNFA]
M[?;P67B/W[ZB('W=7?U-_O?7PV'K;1:$M>$&/J^UNO.%.L%(0NXG0&  %8 T
M/9>DF2QJ.EB9(* L_!E'_=<J)"@*B%MP#/T1; SZ883?^\-;<O/J.GTK\H6
MF)=WL,Y,V%^75:2%DM6H"/SK(7+-GY?*3N^HFXE_]=M^D07O&L%</BTCWN+5
M]7N,GW_YT$D;RL&HJ+Y5$=?KB32/I>GO6*SS&T%EKLZ_=6+^GCI0-*H&P9T4
M_>WZ?ZXKWLV+WYS_=/WN1Y6S._^&@6$Q7$7%J3QP$QM'Z/EUE\<NFADO3Z6L
MR>GE(\9'SK^?/^35M8ZZL]\H& S C27,><'!6!M1DB0-1OO #*VL ,:9G,Q
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MLC/V9/V\Q@I=&P:FF0!EB@3]<NPC<P(/'JI2,B^>?E5Z+WSFS1I517DU$ZA
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MUBZV7-X<;[D\'E5\>[Z78N/] "')4SZ+69[Y$8"%D9YWD,4U([W8<6 &VO)
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M5L_Z9H<P:_=OY)NM_#A-/]J_P;F?H<1DRO:6 W4@AN##WNN,CD;,Z3LX"N)
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MRTHC _6M;$-6U[O]J_R>:KY,X(2R8(\BZ7YIG3\+".<2CZ!(37@2_&+H3CW
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M"V"W,]8R-][%EK?R*T4FE97_;F;^P1.-N*&%20;")5CFK/LS\;N/HZO"']+
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MG%&+D*T-W]C QR3Q_<7GG>.39TZ"FB0L =&+N&/<H$1=PV?TEX;3M<P=CH>
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M8N 73(G7ZL5&#6[H)J,5!PF.[*:ML#.34;^M]MJX#0>.TE2U".PX_A_,,FN
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M35[]+Z2?2H[C7J?5339>;][^)X<A][DRTF9I_R R<%LY?K9!CI_U-J ^>_G
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MK.V%6#LL[4%C? L:XRF4Q6L',OXU+=J=.Z!?YPD\K.Q!JN[]RA^DZEJI^K>
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M>RLL4'W$5I2E35 (3'V@OWMLC9$V4.?>G@PB(]/&<2XZGAP'-L#JI@>2,7I
MA'='[-A'8QT[8F;UC2$1!$R!U,J7OF5KHFQH+:/<26Q0VX[F^7(0$-U(X$'B
M\<54B[$T:%>W0&6OYS3;-ICV?*^":7]C>_.5%)OMWYE\Y_.G<WQFVIHN=XR)
MRB1NQ V@%U(U4R"-)=4P&CDRV-4JE5;A'+:95L JQRU0@$TVYMX6\7R4&7ZV
M:5JTAK-*4*S"_^2A^KEN@.._/"IM0ZALBC-MP:K=K4PEGXYX=4AUVBBI>UM(
MIP(+QH@;U-<FANUQK+6[B&*SFUFP>>M?A(&MQ)18@'#2L.=H$.!N%AP<P2B
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M<U:C"7\N)/Z2QI?PGR"3-IN#4RS:N\2#_"G@/MJZ5PLQ28BZ3S@+'E[_1!H
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MN5!RR7+;8YF^7OMW#J; ?TUHT[VDX?E&HM9??6+.[MG$T*TO2_9#WH0K \Z
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MO/P '2/(,47F5^7RB4V$*2>U$+6NT8Z_/\EW)Y>D9M\594?M\:O73)B\=JQ
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M5$[ 4=NAZP>&T2+_O=_R]CQ\*WS/7\K(<9J$%PI2.=?"*XWQ^_,7YQG/Z=^
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MZH6<NDVP+VY<3#@F^8WD[Z;9\Y0CV9P37(> WRC=AJ=(F8S&_FI:;K82>G2
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M_;A%QY0;,1)F=Z9N\/2B<]DA^$#G:[X 'Y(KT>3@NY(6 </ )FNK/.?3&H[
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MDP*^0@<2M*M5C^6-?Z]QPA;XP'Q5#E'Q>%FU#JC*QIU[1E9Y42JB*)(<@8L
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M+#H4Y[*@R +68%0:FKI;/._.E@ZLQ;8ZG!1CC(9A2(ZK,.6"Z#Z'B_@OZ]4
M<BW[]&//JN.#>'\8ZG)0;[<?GI?QM.)R A90QG3$CF\]B5%3KPI'H)@1>>_-
MM*Y:&XW?$&(PJ="%B*&JJ6;$!:VD"^5''8AZMVDMO%I4]&3_Y;_KBW&4Y79W
M[L=E5$!=Y3W;(@YUY?;WMD4<ZS&6+2>0U@.AC1%QX225>UE%Q?]%=!P851F#
MYD"N BH-'(%2S.+K &P?_S/PF,(R]9ZOF B@R-QSPDI:3EHBNV9Z!53L0J0H
M=)M2/';M*$K IV5G7MO",/HFEU&1.$>C&64A56Z -H"\F9?R7>-2?2Q6 IM
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M^K5"_@2RKUK8KY$SN.CE67%=W3 $+/,&<=W!^^BQ;;2@ 8#QPJZJ='/5FJK
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M&CSB/Y"&;3O^I\29.=CK'SMS^[=_H6_KJ3RL<3WV1 >9WP*BS>#V=_:(N:
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MW0-8"P[S@V.HPG7_:>PI@*P1,EPX#NZE*DJ"__K#,*I\6QB&[2;>9Q.#TKD
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M 2T2L& FOD*RO=[5\I.!.+%@.KJ-PX*"B?7JQP13/^Q'H):)\,7^XSA2!#%
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MND$;?"*<B4X5]D"8%W<<R^TQ+_I'@T=_?Q,#-],+Q+K8V$GT-GOX7,BUV9,
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M?:VDF#0QA!AV\"9<(XI K?A^=)"R'=TALV-A%;3^%ZN1:V/;E=:JL.4/P6K
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M:IZF()UKAPN3&M1IW_4:B*6/#%.P0"3,U0ET?-MI10 0 2<7PQ.N-5..<8A
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M3:W07N_X%(Q/,BCP:^+8Z0V+E ]D> /QC<MZ;95+1[I'MSU-S/"8Y(/!7N]
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M#:F2VFP$O4>^&F2Z(SSUAB&AF0D3I)D$<9^/\LF<8- ,0>X;;A"Y^HIR$+X
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M0S@;<X B-^/:W*K$Z1%5/+P?49/Z<YDB_=6 V4]6G%W0GMU#I$[AN-JS1'W
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M8DD6%P._E+TL8W;9C*O .R)'TT+6'1L/A+L\FN*:"L<*A"CA+ULE6<U3M)I
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MS8.;D()*5XLK).PZTJ4C&IV\&R1<N!1J#%,$?4.7O$4C*8CCKGN26'3ASB\
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M&0L59]P*DB@QLS1,3"\+8Y,E7F:&49P$?NPFKF6#A;("PT*FM:VQ4!MR['?
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M$B$I2;C@CE$U];W7S'+;CDF3; /:&8=3+-0Q#'>B)H)<B4PX(E".PG##LRK
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M?F\T'D[VI-6.B;4)BIDU?IG:(M/5XV\L41FK<<;:7U 6DD2.)B7@06?&8EJ
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M>H#:K]DX.RU.FS;16*9D*"NR,CNAUV"#T.!)X+(PBC.E3+!K: ,5 ?4XLI7
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M>G"Z3UZ_?(P'+]^SUU1_WG_W/G^\3P[WWG[.?XL<)>:D(LI XE(!!J? ,J/
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M;VCK<4]88LIGG M+,4EK;% V(UUYJR0C8AG<5VC?$MK^6V@31W4F90X\L;*
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M[J$]QW/B,(1HB4$58[Y9SIQBTB*3A/[)8615+_<1RM"KIY+Y_CX?!6("BDB
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M-GX]$I%0ZB!5P$B%%D1*0E-RI4#2B1K0MP7RBTU?$IW3R8"S.H?TBG.P27+
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M#O*E?9Y\85OV36Z S+AJA_SQ22P?/.Z'QU?,4:EJ)2)C=DY'5-81S"6P1@9
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MWO^QDW_L?=9M^6!8@'H^C&#>0W,Q#3_5/_SL!].+H;GZ:3#*H\\W_7QN)J<
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M[@-1Y\G@;9>(_?3P=ED!9R=2.V,M*."<,U# F4T*N!$H':N$B8(J3Q_:%?E
MC-:![?:@2@>VVV( Z<!V:\!VQ2:"3XRB4F/*D19.(4:C0-K%B"CCH+=X+9D,
M#^U3_<Y@>W/R=95 EU]/-R5$?//\/.#;75SR[I<DZ/&OD4@F-/\J26_7O_-'
M&:OJ$O1N2,LX#F8R[;T8^>![=;)>"4)=QMZV9NQ56+?^J"=%V.^0T?=C$'9C
MQM]# -_3H=+?7B9/R'@.C_#3OW\)O;9+H=L\RZ6*#'Y#188'28?<SDN?? AA
MSGB[,,"!H.[U!HG#0".\C[?UJ5DI-DWQR9@:'KPC[LMJ!_T!6^H@_!B=WS[!
M<\CA7W_2P]_^_'1P_A(?/#\FQT>OWN^_^Q.__>O7P>'1JW?[O[THUJNX[<.8
M89S/C]G;Y_OT&*X_>/?OLX/?4O6V5\/COU[R@]]@SC#NG#U261$.GI]R&/.)
MU9IXH3RR1A2(*5,@135'F@1&,;=&1I<[UA9/,!2RPZ2GBDGW[Z7;8=*WPZ2K
M94PBFA0X>(F$!6!B/K7"XA'^LKYPLL *V]!A4H=)6S"W[]F M\.DKXA)!RMR
MDL&<&RH8BB)JQ"262*E"H2(*+"/5WA"YL\?Z7)(MPJ0G'WZZK'O.S,<;; H_
M?+.QKZ"IN?%Y.$I4;T"HPYG/P)DW:_J8TQIP17(4X(A #&N*X%>!4EX+=1Z.
MC0#Z&%%/L-A(QZA?47WI&/6^C+JBI# N#6:"(VF508PIA2Q@)PJ11ZYB\#%E
MD!*E.T9]NHSZ%63ZCE'OR:BKDGM0FD<O#7).I)9LOD"V$!I9S%GTGCF<&+7@
M<HL8]<G[C%Z.IK/)O"Q[/PEN:*;301P$$.,GX_/>8/0!OAE/KGJS<>]B,KZ
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M2C3QP<Y*#JWD9OC_@QD,D\L$ 3NB9!'HM[AY(0\O9%) #3.89%&M,J;,1Y,
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M?W$%GW\Z(=%C$76!=&% 2X)%@9^40"1P5JC"*$MB@TMW6>,O@JENC;_F&H<
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M^25Z5<C1.212EBA.9[DV'C!$J:@ 0TA$1EF+@E#">F%LP&L.">L*28J",2)
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MM)U4:7F+3N;5P =5BE(S 3@0DHI6SV/JSD F'[;L9^4@GJ2I_[=%6^Y$UI?
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M-PK\4@/3?N\74,.]Z??VP\>!&^=9O![/ 6.J!_Q<YI=.!Z;WA\D2\$*<_MW
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MP233-"J?ZMX4]T]3[<"H Z-O)1KI:!3#RCHX6H-6MK!$6FHM2$A"B:(#H^T
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MJQT@$PZ>!.:-BYV$L0T8M=[-)T80 *FPB ?+$'-!(.L$1YA)3V70Q FYLZ<
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M)1$,52(8M> 7[6\E@+$< /J\V'G%624(=TA(%L#!T;DRH93(*ZM@=7FT7)8
M1M'HQ^$7"YI=^,4#U7N.7T3."8$51$D8X!<R,F0M,(U O"+&!YL87]LDZXRH
M&BGW:XA?[!S$0;1I% <EBO'<+.-M7H9"-9:*18M-WF**+ 7@%H[%E.NX)N1H
M8 @[(JW@5 AF2BBCJ/72J<8MZEWXQ@-U?#Z>(:7CFA$D$L>(&^ ;3@2*!,,6
M)Y-LR!D9?%W*!]=3K%\\HWJVVE"B[M2C/[*=1KKMP.=#(A\/2-XOL'8'ME)
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M]Q>B-L%Z[C%6*-@@$5=)(>=20-88'".CBHJPM+.=->C_6IIH%_BL$WP&[;W
M)CJ)+2?$NV"DH50S8;$V[.X[]04^GP0^3^<WYKE-R@=$8F:_&GYH&7-; J#$
ML)HX2F"_&M!3TX*>!3T+>BX7/0-1+FJ34MYH",9B*:4)UIIH#=%DR>A9P@8_
M#9SS,4-8.)ZDQ8@P"KQ3,XRTU0)QACWU+!#IE[=A4)"S(&=!SJL9&ER0I(G2
MF&*N'+>>!$!,[2.SQ*H[EV@JO/-IX'..=U*6M'0F("6\09PKC)ST'NEH Q9!
MA1 =N.U:KPLE7P!\5M':?U:-I#;OT+AJ;:4Z54DL2C^E,MA'&JS2NG2J^KE.
M53>W*BJ=JJYCLR^FX4WI5%4Z595.52LX@:535>E450;YB(-\/8=^2J>JUUJ^
M7"8KHDQ4.BTYELD))72(WF(973234DVDE"^_7ZRLTWR_>P+7G.QV_WVXM]6$
M:S[@[1SC^O*.[WWYZVAOYS/<XQUI+<3*/L-UOW9;A[^V=[NMH^;91]P\_,B;
M.[LPUH/.WI=/G=;.1]'<^4RO[53%G0O:*J2%T8AC$E#>=$>6.&F=ER&HL+9I
M]#KEJD8)BJ7)0D&I6Y.MK0\@NL1933BV3GMBK+;$*)%+S-%'1JF7MQ?Z=  U
M?_X[FN"$)8A5C:J<QL@YGT^"2YP HF1@H8XIU 6A"D+=AE X6F-22!;L+Z><
MVABQ%5JSH!VX'Z$@5%T1:CY;@P09040U\A%'Q"E.N:X4,"I#A0R*)V520:B"
M4+5XM_LT^^3< $;Y%%/D7GDG66+&2J<X-7B:/U8\O=K"U#R1X@Y643-DF?:(
M,T*0SF6R9%+"<QFDUKZ&GMZ+#U&7/E6O^QZO)VA<^E3=VP9SK#272GN,$Q?@
M+3#"<LDH$:S,K6[N:H-+K<KG,,*+?:H4DU$+09&08(DY5PD9JG/S2&QB(%B!
M)_&"?86BV.<!2B)2C$$DFPA/F@"O-DGQJ+ 5Q&GS)(I=*/8#M7N.8HM )0D6
M*+;#N0N=-<BIZ)#$C)-HM/,IGQ=6:IWH.K6\*-J]["YT1N"D)2=>64X,=3%B
MYJG1B0<6C2UFN]Z*/1_BTU0HIG)[JL "^,Y.(ZO!;'MJE8LN):9T,=NO0+&E
M9YQ+1[1GB7-JG.'*:PS.G= ^VJ?AX\5L/U"[Y\TV+*9D6B%N32[SH0G2'#@Z
MB8IH[FVB]33;I5-5Z51U1]QRA+B(<_-,1KGPR446M,09Q:*4J<01:@U9BYVJ
M<&#$6DX1#QI^1)N0!I:)A$BYI'#@3BZO<V;I>5%?Q8:UILE0+;VAW/-D5/18
MP3^%E99'5@C)*FCW?.=,REP XH&X3#SG/'%D0Z((D]S0)#&OM%W;9&P=LSKU
MO"C*O>PZ!(F[!(ONN<O_$YK02+!-R8+.)U7""#77ZX5^UYX1B@-%WC#P-DR4
MR$CG4:0.:V!E0N/E=8$HBEU?Q>;1:<%3#-)X[FG4006,K0R"!X7UG0]1%*O]
MG-H]7^S9&&&Y\L@8J7(?.HMT8 E9(QQW#H0D5PNMG=5^/?D'I5/5?7.4*8N!
M13!-F'!IHM'2!NHC5]1RAM5=8:J4K*\KBBUVJL(.W$>A%<*<QAQ>L,@)XI&B
M+ND4,HR5#(77H/PR,<&PP<(YQ16W#A0^<>-4M 0(ZYV/4#VZ\A<>\T $F"^?
M1@('%U,C*:A&W-L(-I-IQ$3R@?L82#YQQ<BZ, _F,04 Z@L E'E&-4G)D9S$
MP#2WU'--"'BP-!)?&P HUO^G=7^A\JPP3JA D>.,@^X+CJS7# 6<LQ:-P-;$
M8OU?@?);FW!R8 "2Q%QI87A,E!/N)$TF8%X;Y2_6_X$(,&_]%6;1.HHT,P+Q
M9"6RP/J0@^5GR9A  JVA]2\=J^Y2RZB4OBZEKV_'?2^P4#$9G(SG@A-KJD[E
MSEHJL9?ISI'I5UWZ^HG0>[%C5<+.PU)%A+66N5\ 1M9J@X3B3, D.\W4L@YY
MUJ#R=6D<4-"S3NB)P4\.1%HM0DZU<]H*GXCUDGG#3! %/>N%GO-'Y!--/OJ
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MG,D5A;,'-!L[;9WN)JMQB%0B%@)&G%.*#+42!<.I<%PFR41N.CB=X]L _>K
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M.HR GQ.%X0XS2AQ/X<ZB\"D>V[,2+:@%X#H!@'N\V<4T8N&$08F"QP.S'D$
M$D/$1X%M)$Y+L+E:7[/^.532RW.>T3B== #JX;_=DT%_ &!98C,%^OL-U^WU
MNJ<Q $!ZWSLID1P@%[$_J*K71<"P_'F^$,C(4:R$Y[0]V"]HDXE(^ZAB%\.F
MV$.QRP:!J-\ XP^K@$R^7KYP%<O)!*;3M=DP]6*IRG%A6X!RZL9V_L*_X0L7
MAJ7<<UC_&C#US'8&9XUWO>[)<16<*@VY%S#>7OS>[7S/D^1[,;0'C61]N].&
MFY6K_ 6OX<J-OV%*XUFQ.>NK:E FS;&+MC<F /"?1J\RXR.&<!Q[)<K6;(!T
M54W)XV$;V2.@F)U.D3?;ZY4P7'?$4JIPVU_Q>% "<@W2A!O!M!P5*W5T]9,,
M*//8PB$(=!EBCNH.C?S%:$]@3GN-[/:U4QL$P+=[_N0P"[R/_2J&F.\'FC%K
MT9-M=S+G@(]S)?7.<+';@_S3XQR4S&-UG?9>D9U^=;MF QA2>R1&L\C-41?D
M!P0<+CCHV1#+E-E\T?^>M'N%]%0$[I+V5'RHC'769=<;GX^[1;CA_7[A-K-O
M?PI8 -,U_&;U"<P6/*#M[S<;_7T87S\O+3SP83=+('AN^8%L?L>-:4G^05G#
MV;]I9DF9-:FQ4ZG?L]&/0E?C4>R!X)T<]:,_R4O8KYCRN'3DR2KS#T8NK^FE
M+A0)%TWX>2?V88ILK],&N04A.X'/;3]#,5PT0V+(BS%<O?QV_\0=P(1F&>W#
M??II:,GS<L!7; 5YE6940PA5L^:\-J"X[2[PQ #>9*_MLN3%3O>T4K4V<($V
M/-.E4%5Z/XJK3\]$N]^82RC GH,R3V[^:984CHF39+BP7B>OJ?/6YJK\FOL;
MPN1J5N3A_<4NQ-@ _[AXAD]Y,<@%G< OCDZ\I9L'K5TL%/4L^7S0.R >N$1&
M6XR, @'BE#N"1:YLLP[,?T:H?)[.'P,.?[<=< ROI98?8N^O?(7)6#JS+ K%
MC=*,BY!<)%@&"2.2T0N<9J?7\$DI^*,,Z:\\H@^VM]7[J["+O_.P+F_\<M>?
MM3: 3S(<G' !1>PEXA0S9+"CB! JN/46BQ#77N-U -09RY\-?A&!9GGYOZ0)
MWYL90Y@&B5].]]N >8 5V=J!L&26!^A5O/PIQ(%K^D(U[K 7MU#IHO? F ]Y
MT"\:8SB\OZNYB30Q@90+N>:AL<A2YY"MUH&&2,S::Z[6]74B]FMEC2:MT(C(
MC-D_&PY.^H/B-8#5ZW</8R-^+[O1[F10_2 S+_A1]4TP=]F6E6C1T,_)]O'D
MZ-BV+UV>]<;[HPMNV81?=,!"%D?@PKSV@ OF,0WO-M@'ZI-I:=<#%\@BG"UF
M13&+Z<]N0R@4>HPHCH7JP$[GD0XE/QO^P^/!&*FKOEH>"#2NEZL9ED]F66K;
MR(4.83)/][L5]^I7?+;(;>&R,PSYM)_4/P&EG7C4,OXY7QT?=0ZSY>'E<59T
MO5E^-YK <5*^@K3PP_@"YUV/LFSNI _?[!>7)W]P\7?('O@A,+EVA65Y!S 6
M__MJ=D+%"OE=F'SW"*Y7^3S%\;V4U?$I?M7XA?Q:W6/(!;,X9:PZ"F"__WMB
M>SF=(UOV"(">/T^#X26GOA6KT $\Y+].CN(PKP(/ [._E&R//*CAC2HIFKC&
MK\V1%G0L^&R5:Y4I-'SOT@!4 C[FE!3I'C0Z,?]HKCV V9ZP Q)+*TUTGEO-
MN=*:18G!^%GC:.1\=G_62X/P?O//6YN$[7U D*Q_V^#FP?-OV+/^"S8+[UEK
M^\TN<XX;ZPF*MG2H,!RYS#^MQ]:6;?6 ,_6<M@F#:A:S!A4>$4L>$8A!AO6<
MM 2^5][>_74D;G;HX63Y67()^>-R^&/"\I))Q/N<?;@;@S,4& -0!Z:!J":"
MG" .,:ZEC)8KBT%:V QI&1.(JY)S 5E5B!!,:.<DO].\Q*"Q[X^P9S9D3^$A
M\-H]L,@57H(MZI;F>SD!KGM'Y_B!4GA[XGHA@T"<<[5BNQ>W4N4^9?#=[K7W
M]O+HAI*(Z,L317B_M:N9\RHYCH"[YHX76"--"X1%%XV61#"U]IK,D,7_NS1@
MDY[-42-:L(G@WG3:O@0"QV3OM\8O]*JESA>Y Y(E2H!K1T<LMN#D82<L3H(8
M\/YRK 4_NJV;[+D"DG[:[85^/'IQ0I3303S=)=+X@)-#,1CPBJ+GR' C48J<
M<K" +#&^]CH!:LU)EAX1203+7;TS-'(52\M<;LDE9*ZMJZ7EJK2P71^Y\M0Q
MA&.N0*VU O<9A$=%XP)C6*? YDC+N &LY&2(+%." SY8%90IFV%#^*GPZ<[A
MG<S*"Z)-F-#"_(?W.P6'L 2ZBX6\FU5\H+S65G&!F0D_MH#.4R#LQ,6 ."8>
M<>LLLI%()"S'0%\TM]BMO3;3#:$OC.)QKQM._&#TYYV<P-$>[V3H8V17B]A=
MM:AL:%$G(B^PC)U^0<_L5^:=\7E;>%G$IX,RD]_*UQM&F"Z_W/BEVRNQCXMX
M2 YMYK!Y"7R.7W5B>(?V6XX+'5WLGU7;^7E/J(QV:@!PA=YEQFN^S\AA@G_.
MRJ[5S"$V\X6OQA6:L^_PZS"8DV-PA^W!*)XVMA1YLQC&/F@?QJMAL+E1DK[?
MC^$DCVH</V9S[_S]L:DM$35 EGXL9S_R1NW1\#O549&Q[]XF^W<811J&>CA=
M5_FD_G&W7R*!KZK-X^_QM]-V&.R/#KZ-_7 8J,*7/[&NW^V<#.;_9*IMR$^*
M:&D],4%C_^[W1J,Y!DA$#IR=;ZA0CU>V<YI)WS^NANW:1VAB#B<??^Y#IO1H
MB=!5\! ,0XYGYL4I8;/\+1B379JQ-, *@=G[GYO3T,'UV"[^0V66!U5+&_MZ
MUDK.3 &^,:5W(@58@1U.26#O".=..LLTO-8Z8!>$L.RGI0!?*]I57/VW#/*_
M\*$E.#D>HD\)V/?B465LQM)&)D+\ZXVMXME7C'M.V!8H4KOSX)CPU*9!<QC0
M[\\W4!F61P'^8LDJKZ!DK%RD.+5[LW(9+@$[9QSLV5XH1&UX*X#5N->="BBO
M>O)LGJ\<0AR:T]F3>F&_JIP-49:9#8] =ANPD-_RQ*23'%+*7^]^;X>A29R3
MLS,N1.6JE01=7'HP,<;A^(J1+=DW\]9V%ANPU69/]RJ]N!/9VK<Y&RP>W2+L
M7D>TEIN[?\2;YSN[4B0CB9=(.E?:O6ND6: H1D(C4\*!9W77B!:\6<X6Q)3R
MONR579I\MO;.,?R[Q3,>F%)4Q^X7(UYD:\/O!N ."AN%-(^Y(KTCR#'XTVH:
M6."8*TQNC-U?'[KXY2)Z/S=X/Q9Y^/6&V/_M?(XP=# O8R8CD!Z"_KS]^V'R
M[.7?E<;<<W_@@9)^ YI^NAAE@<Q+('W1J,E;!SN[E'+LD@+4M,D@H,H.:6D9
M,IX'B[4RT0= 37P-:LZ*I<VF'94S/DK^;#:..R?]FU)6X$?-DO,2?UP1[PEG
M>15IV^?95-T6WI4/%>1S '[?'NW%QB\V9[:F]E&5^7^GA.I?KTG;N9)T.YUD
M>TG0*\Y6<KJOP$1U$&.8VGO!XF[D<%4]#=^KVI66HUQ59/:2$ ZJ8W8UJ*P0
MJ'P^R_O</P54QM++'X(K,W1O3+X+U*P>TLQ.]@_=$5$M6I\G#  &O. <OLWY
M_D TJC,E'@ &/LB*6KEH>09!ZJM$_"&*M8='(/-2555Q\H,[\,6J,$%OXEOC
M9P(*M\FG#4K=G'Q0=@QCYIV6N03 X2/T&_X$O#M8AK-1_B)<%V#3GG0&S<8X
MO0)T*9&2$>3-^'H--LL.-FPS[]DL%&QRB:9K0*-[- >%2@:C/<G"5PIM=?)F
M@L]IN_ED>;[4\#C9>JEJ<*D&OML?5.=NAJ6AJCI0%W<<U8C*T;7*OE?.:-X'
MN?C2(7B>.3,,!G5M00PE+'96A"AIY-XJHYVC&,N@HE(2SQ;2Z^0R'V*<WNH&
M;_>E;G5[TMKVN]HDKRQ(8FZL@;B1"6F, Y*41QR(93;76<D[W55%K\DB%\U1
M.&*09;60GWQ:='Y K.0JVZ-9LC$ZWW@W.+/*)Z4ET3$Z[D(R&"Z,HW)&8>&)
MN*$4U-0YEJMB\WXXN$\PMHT2&OE0?-J7C&:>MC9:(#E&)9(8"D)1Q,&:H%P$
M#"4>B.?429EKNK+UZ>J#_W<77C)6OL<L&TT9QHB[()_=7G^TJ_Z]W;_6GR@F
MW>8<\<J%N'1E+O;2\YW*MD#931\F.7;.QLZ_EFA(.T>R2]IY%R2Z.D\=QS><
MYYR;O)*\WKMRF&/(+QJ#*EA;4E*Z>5?KZD;YE>.,O8MSC(?1YN)#Y3#(\)3C
M>N/-Q49&&"KX8+\].LO;!&)W=!'W'C\6/S[(HS+T?1NJ0/C%H<Q)]O5[9M4C
MTY?W?RY3:C+5.^E-'+"]H2S'G"--]ZM'/<6;RJ4+27K!(<M<S!3<,!<Y49*@
MX'*.I[(::<XS/4K)&VPE87'MM5HW,PJ-#5=[7@)Q=4*^\/F$+D[P5L<EK]G,
M"^U07 [PN6(,4\)YR<.<[11V9,O%9E>ZO*\?1M7/ #@B .#> $E,)\5EN7S6
M4>60\3*@\U$FT\GV6'DD\>@ET/X:IK%4E4W*OOS+KH/F^:X5,&D>=,FY *HE
MF$7:6 +ZY2A/U!GMI\J,@3=B C;>BL2YYE%K)XU3P,0-9YR;R3IHVQ/:,=*)
M.54]9F1M5:5O8[C<\AZ=H0(C.*E4>?L!OM4] 0$/_5]?75]X;:ZVL:OL0A1=
MFYFC<>-\O/[GH"K ,<I!*G6005<[]K@?7XU>_!;:_>../7O5/BH:5W[TV]51
MY4R=R3XD&1*JCR^3>/(9X9S(,VR),KSS\./U\M%$7>?J,\77E5)S/\;K9.YG
MUUV6X'5AQ+TN>_UG@LV_Z8,&JV]UV1O:SMRAE\HUW?RJK+.GJ25O;LJ,*F*5
M$?86/6:>\>.3*X^_H.Y#R]MQ:&LFN9F1:_YHW36?=_>)E]1<0CD5$W=$$@G&
M4GGK$TN28ZVD<D[SF_KU'/4'>Z_&!/+#2!ZWTI@TWKYXW<]O,7$_[E>UF#CN
MM X^BWSOUOG[4_@^WMSPYSL'7[]]W?C]8(=^/=C\\AXX84NTSB9:3!Q^/MO<
M_D9:VY_/6P=O@"OF_*/-]N;AIV^M=YL'7P];9.=@C^^<?SO_S_G[06NBQ43@
M/G&O!,),><0I8\A9FU#P-C&MM9!2 U8RG+=#5Z49[]-VY:EA[^7 'N$)'-C<
MO1Y\!)<DS T/7E$J'2&$Q9MZZM2P]Y-@;[)9F33>46J0B"8?K2($64,T$AZ\
MO> U4X:O'.R]D![D)T>7>Y-7-R[G>C-UZ]]%]5>\NG/V^7(I<EN"G!KSH1</
MVR>';XY"^>IP??[(R[-"_<)6 =5:4V1. HG+454DL&&(&QN08=(A;[&65%*,
ME5U[S9I,39\9K5M\/PL]7U33OUK/ETG/)]@+"4(DZB@2-HK<%] CJQA!BFD;
M0<F5\FSM-6^"][8<>OZB&GM?=HS)^88S6WG7GF7M63X20<O2E_/@,BH#. \+
M^/\[5[+<NJR87>/SXO#YXQ0/,X12P95"/A?^Y<%ZY+#0*"B">1+2\TAS3Q'9
ME'D+9C6\RSJH5D/?<C>JKJ'O)T#?!#5U4GEN@9#F)G>("\F1=M$@2;#R.<?"
MN[R?0$63<+XJT'>U)?5429N+RA^/F/8TRE%^?Y33^$&Z1V^\K3+RQ[I"UBE1
M7NP"E"@=/4.8L8 X81*Y$!*223MJ U/1Z\D4IUNG$:GE2E*^3*0:9BC%07]8
MIZGTVYX^OM&+OKMW5"*H-Z;Y325BW3_Q:F42J"1=EYRN3@(5T_S%#U;BVR61
MU=E>=;;72WQ\_+*2W?X8.ZXV:?_J<%SMD]Z4WW:?LZF7SNF4;SI)U\%%?3LZ
MZO^FVELIWL1+\$Z[8O/@S_VO[SX=M+:_MC>_M/#FX;\.M[;]V==W?^[O''XF
M\)IM'GQCK3\FO-.#;[3UY<]O,,X?FX?OR<[Y1[ISN",VS__U;>?+G^VO\ R;
MYY["[T]+VD=[(C!GA3%,,!0]Q8@GSI$EX)T:(JV!CZPD8>VU;&(VO4&ZI+YI
M'9:K(?!Q(/"!AZYK"%P*"-S\XRH$:L*"\<ZBR*S(!2HH,E8Y1+5RTAMO; [0
MU1!80V -@6U&B?;.4T,MXUHI8(34YRZNA'JN306!> 2!N(; )81 @+X1"SQ_
M(UK;WW:#UDF3W)<7"XHXK"_2*C(DC?2<)YF$-25]9L91]"6%P&>?^CNN'?G(
MVHM._/T)?FPYN#"^"-7Y^U$V8-Z0&D\!K %L<0#6FG)CHPB<@KN*C,$><443
M,@H<6DE)),EK)B5?>TV:7#T8P.IDW^75[44Y:+5N_T3=GO3/1'!)6@F41+H
MNBT2TH0JQ%C GAFODY!%MZFI=?OYZO:B/(]:MW]F[&72\3  U-8JD"[BP/'
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M6QL?R:Y)- I1I?IJQ"EV2#.I$)&2P;)(89U9>XW7I]/!1FI8_,1>;)SF?X[
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MOA=[>O$G/%(\K (/H[<Z[?^>Y.WS_-Z5H??;1]_R;[,-*)OT_8LS%$<E.E#
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M&:7S46UGD251( SZ#% E'?=Z[77JGO0J+C4E,84M#?%NZ,Q4Y&.,">::=@G
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M@JD<L?M@S&/A_6T=\><)$,^:&5Z%B)H9+APF)IDA0(&TC!H470*8,"0@+1G
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MHYDF^GJ.V8$\LG29HWT'F[@T?9ZJWDT50YO3M^F1-_C]?@PGG3CLFSNEP66
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M,$1K'YDE5N''KV9>9[ ]/O!_G.* -@7%?0@H"&!^G/)<I< D%"U/FM,L!0F
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M._[6@G'"6&$\X=O7PQ;>W'A/MC;V#[<VOM&M;1C;X9^=G2\[^&L." NJ+*;
MS%.B)FL@1D;E5DV4*D*=M4&$$FQ3,S+GAQ'ARK3?1U*=9DPGK3@Q'@B%M]8'
MJ[63/G 1)*XEM9;42E+%KC8T 9PYY+D#'S))AC1F& 7+J0].8$]S<4"^/J,P
MX /"PB^EYJ;P."DJ":9 TR2SAAC&0B+,XYBT9'7D]UEKZF3#<VE4<LXAXG+
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MA$LQ,ND(,MA)$%%P*RSS(#:Y?>/R)<K69KL.M#YC/9T,M%K,A-38(TH$1YR
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M=61>1,X%==@NE9<M:KE.L3T!2@#@FA+1''E5\N"\U%,JYEH ]/*2*PGQ1]<
MJ@,Y#+H)_<OG)$&1+N@-?.B66LEHKJ;LC/Q^?6V'D3L49H4G5<M5HDI!5C]=
MLE]=T)5@O(7+LZ_;5G15J4"HNFG=T14'N9,YP(*'N]8]O5F!TEO5/15;_(:%
M:M=7]_2:I:C+:3[CQ+V/G?PKBL.0##38C*0\#I-"<X.:JC<GEP?M3G:;H\H;
M1T0L*DFS!+MI80']HD?&DB.'1$>\D$YY;AS3*@B7&H=;*[3@/TMVYC<+#)BI
MCO_'Q6K%YT^0M4GA"3/*3B*Z/X'F=BN2^P@4-_7D(/I$M9\JC@#O[1S ?0<7
M!_NMBX,O<-U^^_0@C?>T#>_H=O?V=V'\G[^W.HMQ!!]X.VE-I_\Z:5W"^W<^
M=ENT?;+WY6.G1=_AO2^?1>OT*X%Y7:PH&+?8,KS7NOQ\<7CJOQZ>?H0U $V,
M[O*]+VD,[:^'O;][A^__];6]\XZW4G-[+S#H EXCK%-S^RR=KTC-4":XBQ$4
M+XMQ.@P2RVG5_[=L;D]_O][1N))$@U!&1@Y$"B_15)I@LLQDQF)F#<YD3:(U
MB5Z1J#BBS 5CF$:&6H6XUAE2!#N4!:64R,!<4]FK-Z /+D=T_]\57>V??>6N
M=U/O2!CV&K\5IUS_>&"Y_@!]<9Z/Z+[&]W '07V3EJ3+P&=O GP3JDE=1I_=
M&?.OQ;^E2D0+^ =C/SWI'%S^\15FS?;>[^+V^\/>02^%'L+Z[+=PZPO,_;1[
M<IA$M/%&*LH"<H%@P#]&D0F.(@\$DT*[P'1GK][(+;S46GQ10*_NC7L7<5P3
MXHLC1!#$SF<ARPARDG+$?9#(\AB0]#9HXPFGGJ\FQ'6(X:=F84_%,,RYXT/?
M-RXZH>N?CH&](1Z<!S&3[QE _[ VR(1R=BK"*6V0GP1"U+;)C2!QN>:'Y9Y9
M+AD"!<P@;CR8%](PY)G/,D:Q#%*_>E-)TA]8&"_+MO@V2(>9Z9BSMBPV'NWN
MZ12\8;;0'='N2Q77NUV&]?X]):S:]7)[>%O*W5S4^/A![[#7WOGX];#W^:*]
M<X!;[P]@SMOB\+1%6_LMTKX\IGOIL\+T((0;0R,*,A.($TV1Q=@@*:SGED0L
M##"T8%O+"4J/Y!VL:?5ETJHXLD1()3.+A&4>K)/(D=9>(0M?4"5DP,("K>HM
M>7,WX311;>$\_4:'\AL299,"'X;7G/85(4ISL5.=WEFW$RI;I5'$B_5'*6+I
MF^ETJX#.QN>M3UN-_6$P.1CC#;#*Q\/.J),>-VJ CIK^NJBBG?N-\+_CSC?@
MB_ZH<$AN-?X<#!MGX^'9( 5Z#6)C$BTVB:0(<_[+^<BOJAFNL7GHER%X^3C&
MCNNDQY]T\M%@F"1XBM(P93AK\=1)/.MBC'1S+H;5G*6YYRE$NUB&F!:BR"1)
MD2+PZO.3CCM9/493Q>>E<*W4OQ<,WR(\S99ALKV.1V<#6'SX8'0>0CF-29S=
M-#*V>G2G[.<[%SQ8/'T^6FX2<POHUS4IRBXMK.GX%#<VM3K+D"@_".6U5SM:
M3J$(S(7E&4R6%LR,D(=0;'4<I^C!K<8*K2_-<XYP9A;_*M1M]H;KPB6O(BH7
M M:6F6Z&W2H2YW0K2Z$F0$Q%&L/K<L^_A:L(D_\[K\%5#(JO;@%B&G3'H^MO
MV0"EK^!D31<6:.;GR? J\.(X( O,^169"(-];;KGYB)_]<]YN *L6EC#Q>E?
M.\D8US+)I5 ,F&0)FCX%319[_KIHCYVN@C&9C1E+XV28E)7_ZF@MM'<,6^$S
M[K4V&3:$DF"Q-EP0<90! !>\!.3_-NDY_5'^W_\TBQZQXN?*H"T9+=..42=,
MY)$&Z[&Q.G(N'1BMS+QZFB'LD_20,AJZ\==XZ #.RB;HMPA\VR 9NPALH)NR
MQH^FV?@M74OQ[^\^_?57\2OY_1\I@#@!=]X( #B=1#E7L>P3D3HX2TD628^^
M2/A]-GFJ&_1Z@WX%J7$XZ,V+MWXAD<[,Q:1/?&<XO3>%7(/-?'R2OA\.NB!"
M@Q\7ZE$5HYU&68B<%(+<!;%81HA'6#'XI0PYSF^7>^F9Q<%CDCF)N?-2">.<
M"-C+B ONV4F+B+-"UT^_7!T]]//1\56.49KP9&W3TNY5PRHSW58>(L!"C4Z>
MJ)Y^]WC; ]"COQYAEU&=^8"<2,7T0V (D(LAS"4ERGAAJ'OUAM"E\Z1BT0HM
M#/2YX]%)21E+1% 5@X?=ST=F.)H)?.T,0?4<#8TOU9Z+I#VD7.(DJ!JMU&^J
MK*5 "FK]%,Y&,P46R#1J-YT %5<DMWJE@*SAV?.QN>DES9J:-YF:P5+=O3<U
MIYRWX5;C"Q I$'9!7PL4W9PD]21S:8*8OKST42AB^OOU%/%24W</2'O''1DI
M&6R]03*1 _>$(FM3ZJX3Q&0\$./5JS=YYWM%!$NTD?*MK@S%PA*[3>+@AN@E
MV_VK!(?0!1NNLH;/3/)T=\Z2?5G9?85X_\TT*IUD>D5_-%5-)F4;)ADYA292
MIB&.BF>4:%\!Z0(/S2DJ%3L5<B%QS+!CQV5>3Z=?6*_G*8UB-D4MN>O2PPJM
MYG8>11:L,Y%Q8:GB008M*2,DDU+K3(2,K^3"E;G-/V;*MS,3^6LZ\J?O%;P'
M+[+VY8<CPCUW*L.(,!,0Q\(@8Z)"8+Z8&+P28#"]>K/*@PPD<[NMSG21210S
MX'UN!+$<>Q<L$UPG_"7U5C_<5N_M;!^!1&0Q(6ZF%4<\%N5W642ID)'%GA/C
MP& EJ_;Z-U#5CH<AR>*DM:4J&_#;%0+DZ5.?,I! I>L-QBGC=W12 <],QZ%T
MU23]-/_'-&5\'LX* VUJ8,WF7U:YL2LNG\>I"1:"0"^]704>%AX\(-(\S./=
MC_.$RT2T.5%3CF)R>Y5OW*_\@S,73L=Q.SZYDV)RQ2=T;0%@4Z9*,]R+;PL#
MMF2W<N=?,D^Y\[T=@$],!6BV 7GE0+VU7"&;:8)@\S+)A3#"@7JKQ J>FI@T
M*>T1=)2O8725_9B^J)CL1XGL5[070%A7N<<K3*W5,A^8<175/D%-:F=<S*NL
M[Y>2E MN3R>04^.@JLQ2> FO5*KS,/P!=Y:W+K82 @5%:0H[G4I$FJ 9L2RC
M(#FSC,E28;E=,9:"HW:+\943*0V'@B?S:Z5<?K,Z:B^O!(N[V-M_=Y1Q&W F
M#:*@62).O4/*4HTRK @.3&5"A]3Y"S<97ZZEUKPE4>#,"F-(QHT$5=9@2P2)
MEEFN<>IJZ7]22+LFBE]!%)^/I,,T@-:)+%8:\0PT(,5D1-YPDBE@:<Z *"1O
M*KR<KE)@RBVQPGCIF7(J9HY[I8VF5&&K Q$><_NS0,::+!Z<+"Z+(G6*2F>Q
M0]I&#&3!. AQYE&F@K>@<06J* AQW>39<C'/5*TD3R>P1?&0^3/@:7V1@CI^
M5%6F*$<V)ZFF)P2%H (1?ILBH/<44LO50+>[W8%+>O3JB)V5!<'JTIY3,L.M
MG:]'F<$JRXA 7E,"5A<5R%CB$.8J@%DFN;-%+<3EWO63TI[-6U:"O9=0JHE@
M[42PWSJBEF*5; 4?A4,<[ -D9::18-))Y82C/M45WUINU3"M[WK;BL#WE$(U
M':R=#DZWC[15$CL7D>.&(2ZY >F3":2C]!@GDU*IE-J]0@^9K?.;!$210YH.
MVT!J7%?T?,$HFA=9VU5-=! RM]-OHD@6KO=*$L89889*;)45',.GP;+5M:97
MJ#4SKH6WYBS%*90:S<>0JF:%5 [USR+<*:D^J718K=!<1UQ[^P='SD8J3 !)
M8S%+2=D6:6\] I'OO5 Z R0 2=.DF#<E7U&@?.+^BO-1"R?F6VC8%" WK#:F
M(,).M2D+UG4SW5]&Y3T26=TYO+A=^.6JLF'Y]B2\$LCP?3I>J:GO&NHC[<NO
M1Y8Y(C.L$1,T(LZ]089;L+*$]E0:(:.7H$XKULST"C$W.7Y*KIFKP-8Y.C,_
M:/!PHSC%8E]^&AX&^M*KVU;X(O07>,%6!<2E0_0'+ZCW%_!0XJ"^WTO^QK\&
M^6@81IUAR4Q5K=>=3IXJ<@):;TSIO/UW$TY(% Q_GP 7 !7O;..#T\.3O9V3
MD[W]/T[:O<^\1=^QUFGK<ID3TO/>D;WW'\0AC*6U\['3[KWC>^_?B=;[=_1P
M__@2WG\!(TIU@"_;VT>I,IZV@B*63$I.+4:@[QGD8+TQ8U9$IA<KYUDC,.4<
MM$$;P2 (UJGD4.98124$98N5\W9@R5,IS]E#K\;'Z9Y4(7MWKEVW(0[>U=&7
M/UVKN:JUJ2+G"/Z?0L@Y)K]]_4<J0%PLWNSI4>.*H!MG*1#0I9"ZHKSLV.:I
M;F6G")ZJ2AZG.L;3&,#J9"C=-8T43, %HL*=%!4%4[0WL$=ZQZ"?JFK.'US9
MBUEG_];<KE:0>"L+\)Y=4Y<T_XK:YDY8BQ/7_.DU^/CEF+!+VN='/@-[W$2'
M'(T"\8!!.'I/4/0B2$Y-.NU+3H#EBDYW= +<L\5C30)K)0':^G DJ0:EV^E4
M* FT<^$4LL10%!S)".5,16GF>F+<WP5PWY9T-16LEPKVMH^8<X0)99$,*D/)
MS$&691@Q2C6WF$0<>7($_:1]U#H< *LRZ!8UA)MJS/Q):<SLP37FW:+#PK[Y
MOHE:\8>*\,^ZK2\M# 3/#_:WV2'8A'L['RX/3K]>MO;?G1_N''.P#>'][:_M
MBP7"[WW^?G#Y 0C^Y*2UXWN'.Q]X>Z?=V=MO?6_M__%U;^<8;,,/K$4_,-"*
MO[<OWQU1PA5AV*,@4J 9501I;3G2F$I!&'. B(MJL69"D$@HM3%R@ZFUU#L%
M0&HDB%.E%]7B<MD;L.YA*7QTGKA7:I8_?]W\\)*+-6/:!!4]!S)12DF!F<F\
M"]JED^9?5NF\G/D?(:4*7A$?_)./.@X,MS_A\\YQ?[-*FS\&)>ZWCGR@7*G4
MM,\#$7*O(C+4*X19A/WP,G5H7*2L#2S5_^]!#J9#L>/3CBZ)\&\D((J"_)VR
MI>5BDL5O1?CQ8 R#\_D_7M^GYOFOK5VN]982["ZERX7>HC>L\7VKTN%D2[+L
M3H_]69WS>K"2WZS6^_J*LF](]:T;UT^G-Z@#](RG3U[V]%]8]?R)LG/C_MNW
MK5F/&[<M4O48R_!_'F[^-V\K_A@3_^T7>D@3W\"$X;?5AE]2S<KNB86Y "NX
M=Q;*B@7Y@HX>\@GAWLQOPIZHTE[5,:*MTV-V\.7S17O_C][>^\^@N/ON7JI;
M=)HJ"!UVV_3CU_8I*.I+=8P.+O9V_,GA_BYIO3_@A_L?SMOTLTAUB]J]UN5A
M[S,[?/^!MB[?T:+<^:?YDH*:92': /J^D1GB.J:B^L(BV'?J,(_:9*EBN<1-
MP9=#L99J=:^S$T;CEMRUSN*C-3K6Z+CNPX,:'3<?'1<*KG(OA9,A0SA5:^/6
M,V1<*F\N<!:\<S[2Y)8FLDDR5:-CC8XO%QWO>ZA6H^/&HV-[07<,A$6'K41$
M:HDX5J [6FF1"S3U;S1!IC*6A) F[/H30,=G7Q*[.NVXUO]#;S?7E>B]>2CV
M:PW@>V-7M4DU=*T/NG:7S%Y'"(@H)I T%!0[X3&R3&DD-::>2QJ]3(DG34:6
M2_"69T4W1J_5(/&@ZMM-"]'7_'Y_DZ[F]XWD]P5#C@6#N:,.8<PIXIH'I('_
MD9%.4,D844PG?L=Z65&I^?W9\/L:C)2:WS>1WQ=-$QQ,L")D8)5XCK@4'FG/
M*(J::*X,<X2GZDY-FFV2?%_3863)MG2+BDTV1JZ+T[FC65@%Q#"8OA^,4WC-
M9 JU-VIM"[39@N#)'G6^^SX:&MB$3DJ"V1V%7MX>](M<F$$7IGD\Z?!<RXSU
MR8S6DDUH>7)A,8:DXAAL0B60T@I41BM#X)HH:9*.*'23TF6I<5=WUAK8\FF<
M!M0 70/T4SUMK0'Z40!ZP8C7$K.8"O-ZX@3BECED2<91EGD)=AUWP=-TWB":
M6"TG"M4 70-T#=#/],"W!NC' .A%KPO-F @@IU$J5X.XP1H9YS7R,1/<,.Z%
MQ:FFMFXJNEP$^ D"]'SGQ6F)E=GTNE^5Z9:J) SZJ6?7).L-&*,J/E;5(JFS
MW/8_'&%N@^;1(H$ET"BHF<B(B)%-Q2UES*05_@EDN7T"8NQ$(,S^J*BA66Y]
M2EH;C(=EO8U\DA5]^RRX5$W;Y%7N6UYGOKW<9+(G-=@Z\ZW.?*LSW^K,MW+&
M;\O^P:]OL.GWBSF\ :G<VF:O![FN<,RG<1IZZS3-F\9K/&'ORZHI;K;_Y!;N
M$V8=Y0I[;:+CA&IML'<4XZ@EX2[$6X>:5G!WC>TW[_B(G>_!H\LP'#P7GP=<
M_UD<7!YV6J=@#^Y_AK\_7(#]Q]JGN[3UOG7>NCRX:.ULDX-/BSZ/#S#F[FF[
MMWL!]Z1QP+V[?&_'T=;IP?G!Y?8E/..\M?/WR:I(4HR)Y2HX9(M30RXB,B;E
M4Q+N313>! L69-&IB/Z^0;$F:XHMJ_'IF>*3#DIKYJEDG'&)L<&$$2J%XE23
M:'[:+Z'&IT?"IX5#,TQBAHW-D _1 #YABFSPJ<8>V/;8D"B,K_&IQJ>-F-LM
M\$DH&R,164:,XYEC1@>+8Z#".1Q],+<.Y:WQZ9?@T^*9$>&Z.#Y$($P"XIYF
MR' 6$?7$6:98%C*RB?CTHF)U[Y,XN&+>SR^Q@ F94>MC9A3CW N%L<@<P<(S
MPT3\:8NQ6Z-1C3JW0)WE6$\>+(4=(BB&Z$ KX@P9K Q2,7H-BFX0EK]ZP\AR
M&-$M$><'7/](T4 UTTY;2Q,E"<FL9SSCD6KMHO8&^!5SY:C4:S=Q:J:]'=,N
MF#+$<QRI,0@[RA WJ52R!*-&:;!J2%0XDZG>@*R9]ADSK05]/]H@N+2:AZ!A
MLHS&&(C0P2CIUJ[WUTQ[*Z9=U.\-!GU'$HJ8#Q)Q13%2*F3(D<S![@@2I'CU
MAHKEWE>/Q[1K/7G2FZS8[Q>M#J\/%[JM956'$O^Z!7HVD+[VJBLUI*\1TC\L
MUPR508+F+!&#C4,\"PJ!!L:0]<0(XA6-(:S%>%H[SVRX,[I&SQH]'[^&38V>
MZT7/!2LV>,U5L!A)K%(I&DJ1X<GU+9FPPN"@C%B+%5NC9XV>-7K^ZHI -7JN
M%3T7W0G"$)8YIY$+.B3=,R K'4;!22RD)%AINA9WPL:@YP;EF+V+L6R3.*7N
MCV844HO+ONMT.T5N9IUD=NJ.N&+:J4 0BPPC#C29RDM&9"/-HK"$<XI_E&2V
ML:VGMQO#N=V>=DD+P 2F"\,QH_%H,+R8\2(UAD DC=&@N#!,2&CI@CHQK4Y,
M>ZZ#K1/3ZL2T.C&M3DPK9[Q[)?FN3E[,:(4038*Q;MQ6-]]X[&J&2=.?T_NN
M,6^W1W^6-/QI0L)SEL)+J+YRUH'G?3T\=>?M]Q\NDWG<WOGS9&_GL'NX_Y4<
MG+8[AVEL.U\OVF\73.->&OO'7OMR&\;72N8Q;GUYQ]N]O[M[^S!&^J_N 9C+
M>_N[>%4K-T,B=58(Y*5-,6W4(TN< Z,#$%90Q9R5K]XPULSP^LH7/K[7L.Y5
M5,/EAM46K.%R$^%RX1PF1B^PM1%)(@7B@)U( ;DCCC,2 \A-H#/03GF3R+JU
M6PV7+Q@N'[K27PV7&PB7BP<OSC*?!9TA+3-3UDVSF>6(84YQIH47F@-<LB:6
MRV<OFP>7S[[7&S!% ]AZ&,[,: AL%7QBCY3%U0AFV(<YY W3]XW!Z"0,&[!9
M/O@Q[%;R@G=2 <VZ2]R#QROV\]'QZYL<JGV<["+\/HA5-MZ[:AMA%_?2)K9G
M]W"[!]LRRFO8NQ7LK6@4AS'E6D04J9)@5!.9TDTL(IGQ\$40C : /<4W*#6U
M;ANUJ2%V-<-O'L,OF(4^\TQQ1A!6EB'N)$<F19EX;*S"PCLGS*LW0N&:X9\O
MPZ\M*JQF^(UC^$7#)A,.3!8A4 8<CSAE%"D5#0A\0F+$D1"?W.9\V0GTY(M/
M;*[U\BF4/$HD_:WWCT:WT^N,RM+_=0V*1S-+Y@"KVB'8H']/-Z?VP*P/J)9K
M5AB72:%2)TN:>MAR4$]LQAP21'I+E.7$Q:*GI5SNK5 GP#\?-G]H8Z1F\U_+
MY@L&B-.9IXX2) E5B,M,(DND1LZ"0@HLSG321T13T7O['&HVWUPV?W 3I&;S
M7\KFBV:'!\CV%AO$==#PPRMD8I:A3&/IA;0X!)?8'/--8O-G?VSR]L3TCU-R
M0A&>Z8;!=T8O[2CD%T<>SL#4->A4;LIN'[YX6^Y(C4WKPZ;E @_!,VTI#B@
M="#.4A^WS#ND)=%1,V=)QEZ]84V!R3V.>FL'Z";S]5JMC)JO'X>O%TT+:SWE
M8%I0D2J $P8ZA_# YC%82EQ@BMA7;VA3D&6=H^;KC>7K1PWEJOG[\?A[T:;
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MOO".ANEVPS&L?\%,+@Q'A:H15ZHDP'E^[!([IT+K'5>Q[=1MD"?7C4\ZR>R
MTZC&>5C%2DDE>Q\&K>^-G4]_-6"=1Z'7^"W=7&W ;J*GY.7PU75_54.H-N0?
M\-0X3(P(0_H&G)_TPS20P7D_%".9;N'KQF_F'^6R_55<U&@/MH ^FCRC32EA
MYZIW?H)G=&!9 !S 7$BK93M O<?)NY1 S5SDS>KUC=_LRD=J29I"RKL]TJU^
MI&)-0MC='NE7/U++)B5WG'A8\4C2Q)@T5:;N]LAXS2-54^+L3H],U/G;\<K'
M@G!N:C+SV(+X2@EG0"A=7":!-DJMR$:S;^@-NL&-NT#ZWSK N@;X"$B[9XX+
M];NHTM/M? O#B\1$250EWAHT\K$%GDS&RWGH=J=3GB'U5%)P"()H!IO*$4]I
M_3H6SD/XFN0I&"?'E0P=PB!"; )WG([[+M5XJSXJACCNYV=@/!=LY0V,/11%
M@%QW[(M)#T,2KY-OTAT&<'[8#R40 A8T8@AY8KY&64,NE1X:K,2,GOD*SVP"
M A3_Y##[XI=!C&%8O&U0?-A, G0P'%7+^,_D;^Q-/IA@7K^3%NC3"-8E+SZY
M%A^2^E$L=?JWT  *G/-3O"BJ* $^%.N53Q#O^DV KX>#\?%)NJQ3 EIUS[5C
MF#=DDW(2OA45(T.IE)3;UXEQNJJEZE22T<3NM6G?OE7:3A&,EO:S5,>FX)=>
M4$)?HW"'YXV3<(7$5R_::H" ; ^^%56G&HG\2W%5[ER2(<=#,(NK 2[MY6"R
MT[Z3]SIY_N-I% P04#Y.>EO?=T"9&\VO?YIH,LGCN#O_1:EH!?.M,+,+DB_>
M-27Z0O:Y0<%HG<*N!EX[!E,<IKA=#B!)&^"Y<2EO3L"43J247,W%VL!G?P8[
M'!MX0K40+-T+DA/8')Z9NY/@QTG<)TR8+EIYW?Z<1(:%]P6;?^L<#X!,<D G
M'V(:->Q8Z,:2@N&A5WKPPC-RX,I2JQU,E5+0#89%RS=8R:1U C\G!KYH5M)Z
M,(9YE!7#@-:'B4:*GX.DY"8-Q,/Z *&"P@U32OZRPI<_&8LS>;B%AKI!*MYT
MXZB:J%'7*GHA[_@)K?T9RHIGL)[_8X;?S##9B 4PS&I]U5<WU?GH5)-;K?.M
M6X=[:-VM,_J9RO9VD /,?6KM_D1E*Z^[7F6+22XM:6S5\E^KKU&:-26[4EO2
M3"=QZ\6<6F%T,O"E*-].HAPX:2>,REG,ZP:KU#=0.0 2,Y;=]PTK-;E2\\""
MW/'I4ZI<J=1-GD[7LCJK=;SR#?Q^XY\CF>(EB8%+@GD+N#2O\SR<KO,$%)MY
M+MI(I>*.LGA)R/YK#((S"=A2Z;Q.%O]KW _I,CZ_&!-1-BN4KLV(^%72ZF[*
MP:JI_*H1;XABDC35[?'Q&$0GD1,1.^=7*,2R2XZ],*R(?/*$ZJ2Q$) %+Z9A
MS:H($^;X&]X\[C4JHS)]'1KOOJ<SG6)$E7Q+U%C@ ;QP(DB+#Z>R=,HTJZ!B
M!8BR#(28FA%B)Z%7V)=+:/HYA\?OI_4;Q*T)>L+:_,OT2Q6H]"2Q8G'RL+ @
MQ>HGYDLQ-<7X"RE>Z-)3+3VYH,Y,89U6_#ZGC*?MN#ISFU_^B78SN[9),]IS
MHT&I+4^UHSQ9#6Z<)Q\IX,_@_$:'4B^YA+FH2YAOQEA^80GS^YXA;8Z1EHPC
MO0JXDPD.2DBIW13P,V,NE2#5*HI>3WWD_73@?3SW$%.*S\;Y"1AP%ZBT'I*7
MK>,[ (O-1MOT!Y]&A9ZQ']Q)O_#@A>1O'O;2 ][W[/\TX?8.O&B%\5C"6Z6?
MM<;]=-E'$":#?@'2R53;35]7CVLNR)I58F#);"J4G#P?N,Y-),N[\7!P%F K
M9R0)S5+]=/4'F;5?W_UU]?G47"@GVEFVL^ZM84^TZNMUYO^73]3CTG!>T)!7
MVY0W7)S)!OQ,+WX +3A1#:SZ=!VWKU=L2WHN--N)B@(3<B$D(Z368I^W%EM:
M-:N@L#GU*I<G88F2YT!LXGKJC[O%";>9\<2DYU2W_!E 4L$8*F0HX0G&4>'6
M,/SO.)2A4:9Q.O;'90N!-,E9K&B61]>- /SI2B?0%-U@QC#!KBG/Q(&S.N7A
M>G&:_FWPM<3*(@H+)-HPC"Z*J5]Y6/&,EOKC8>?YN)CS6<*8%.@T+-&^/P!!
ME_S("9?..OW9M5Y8GUA=-H5B6-/3-"?8=E"1)CXR,_'V)WEY%@JA6=FK)%TS
MNSB-LT$:9'GRU 5^#&E$WT)W5(ZN^LBD,7U+%WY+?1#"62/9Q3"73CI7&E;!
M;;-3FTPEPN03V!KOD_4!SYKQ0Q;R8_:$LQIF>LJHA-QJD_/40Z+L4U6XS@'4
MQM\[W41.,Y=<B;TT]HDO-$%_NNDD^=V+J/(K$9C>7=',-2M4D$]U?- L0L<K
MF"T9!CY(+J#$A-<O0CZJ +O:M\59%O2Y/9W0QW)",):266?W"%XYSLM%J'!J
M;CN+;2E>T2G%RXTW:':,DY4[7WI]*5\:$\Q)WM2E<><-.@6 K$(FN*&3GTQ)
M:SK,F0%>R1D;@$G##5AJ21P5;A9>N5GFH2LL<E,G+X);W*BX.WG0)\I8-8ZG
M>8BP;*(NF[?%V=4J&[?2$N_HR']DQ\3_6^F2X!EK$D[7[9)84H,K3:R(%9LL
MWKSSMY1O,-5$=(DOKG>@W,#!,>\3FM<+'L>=O&J_']:=7%'33:GF)Q[=M$43
M0"E4[01V%RE.(@7?Y6%T&T"8#WK<F#"XA=C1)X=O!2T#NI04D92;(B1]JIOG
M)9_,^>TF-K4;H"OO_CPL=LK-#OUC4T93%/91TJ8+5WVWB*&\,FWR)34<M*-!
M]UMY:\EP2_=4T-#IE3'VZ=])@.E$0*4,C12K.1Z6<1@VL4U)GE7]T22$YX=>
M!N:71B,([0[8,*4L+R?>'22LFPO,+S"\5)5RTTT!@@/GQF=5&"M\%T';<8 M
M55(<K$.A=YR9BXG<GYS*+L?G;X$4[IM)($IIB>97FL]@/"JR[4I5-0]S"U2(
M[>0$J9+ZBKO*EQ<WW6@ 93)$VLU2W[O:10 4DP36ZGYBR=P!KBC6OU\N]J1O
M6>%-KA(@BL2&%"[<^=\QF#-@$#Q]4/AK#&9\0K^92/.GAPW;HVGCN4;J.9>4
MGSE.*2&]CUSJ;=?M%J1T-IGZ !34"83 ;O^?AT_E$XL)%Y-MV)L.Y68IX_+E
MY5Y<M"];1Y%HI[V7* 3G$<=*(8LE12H0V ')HS+TU9L,;^&ES*P&T%^W-"]+
M?2$9<Y5U[6;2+>#C*864!O"@,MLG6M4UC0P[*>JRN2%DM#,.N_TVO&C_/("0
M:A797C5M74-;E^W+=T<:DTSJ:)!SV")N-4;68HR((H(9[9V(0%N2;BU7$YC2
M%L#(U#V=\M.7L^\:D\2[W>1VFPB=1<R:"S)())/>5&:B3-S(A=(SZ(=)SN"G
M "I[-RD8P32B<56B2_.VT.;@?QE,56=1<Y49$Z6)&A9 )NM(^9O2Y-MJU&/3
MK='M9Q2X^WUO_^MYZQ3&M_/AHG7Z]2B0# NO/2*&9(@#&" CN47><:\"!X3
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ML438E82UC%9W/8Y]79M028?7QL3N2^)6[LY+)=[?0$?9\E++W%[QVR=AKSS
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M//$#I(XN1.>$":D+*-T7 QZ#Q 2B3!D/!//\"!@/=C*&@B-MGOW8M9GK?!=
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MRMZOJ&7YH2P2:4W:[$XD[6^]$R<^6_#?;[G_C]]E=AS55W;%\VO@1X_ [2W
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MKOKJ]0&0D/"F:$E&J[3O8B  @) D?=/EAB\Y<6TXD B8I#30_^_;[^'0M?U
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M>I0XX-+,Q@K.T28X)7ZH8(@RCCT"Z(X\DB@F*GD*YD1R[$FADJJ7L9!L ;/
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M2%@ ?8MG,TYFZLA02K=[W-O)LRK#ED< ,NEJ!EB3G]/W44FJ@M_C1^@%Y=&
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M]!I:FFV*EEV4V7N54G>"^6!^D2K\ZV)%$^!SMAD2 1+<LIH;S$*Q]=B]3TF
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M;&/:D'MR)FTLK+U1Z4XFA$TV9I5KL,? >3<Q8>H9!,C@C;':MR[;MBG&,>W
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MTUL +V,H-\#5S&FZV^'$VX2@=&%>(OFQ$4FG%T-:EY2P=C886P9GT^,0QQ2
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M^FR <B;LV4_$/>Q??^#L5K"&&2X#SPZL2JINT8$6F!-X4V0T 67VMO7Y=1O
M5Z_EW<5Y7[=F7]W^'":CZE^]PLF;]V&"/X;I, VTD))LZ0 :.8%2P4.(,D$*
MB0<EK32A]:FR%LA7K^O]Q7M?Y[:USG\:7ES-, \*-R+3_X#K2'Z43&0F9<>
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M)Y>@P\,.;P>T4<NX1YGV4,'ZVWCTCHS5R[KXZ[B&S-Q[Z36X'#.1V]*"LV6
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M GP@ :GLR/ZC+T')@-%@4JYY$X7]43\!CO6HQA[Z,ZQ;P=SIJ"W;1<;$; F
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MJ"(L1,0 AK%47);"\DY9[(]42&T$<#:&1CLQ-[P4F(-:V+>W(:VJ/CN :EB
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M$^96+^KK(Y^G3FW[,:1_8;X'+>60N2X1HK&V=CF-$+124+ D(TP,SK0>T_@
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M?2Q9&W11DK?O#7KL*O3^-+^7?'NOE[I5[+'XLD8$7]>ME0^R=N1T6PXL%CI
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MKATH34=&(-<1$@FF."%)9MWN?[9_]EEPY!!R[\%NOCVG=Q7DJ]E-U_O\H/B
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MQVE]OE&*WA"NBC>FL)\FUF'#2P7:9P5Q(8_O35;G!?JOG;^L.OBY+RW?8M<
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MM9R=M@K@^(E2@8P=XD<JX&I-!2@IGOA0\?2UP 1I#^FTJ$+Y'WT6 ,V/G+G
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M!:BW=J\?!8A><OI 0]FFDR-WH;ZOD=J/3D(OFA ;J !LRIV2V(0:F8KWT=@
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MR9:;T_\KZ!K,E3J>!4^U']F#:N^X^$NZ_DS<[M3#D*JZ"CW0R9.;"[R8U2-
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M[E7F,(,7'X(3X< C #\J$OM[%/\BY[2+ 6$#OV=TY0@0D^8'.A3/0#$X"$<
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M=FCQLIKCA!TLKA6'U^!N2?]3=8K]_EIWE5ZNE690X'?<-9>#K!L]/RYA/(\
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MK#C;3GIJ@#\*'UM-;O<96RA.'3]15F_;ACV^_3F&FO<"L-2#PFL;#:L56J]
M'Q=B8>';D) V27V!RK&",OL[*]W<K))CW_?1EKN'4)E,2GSXTO7MY5S9][5D
M$WPEL!.YF+[?UHC3972O>QLKZBBN98/&AE5]D.3208GRZPG':Q!":"5UTSA,
M.E]S2S)V<4M-4EJTIR62?2LZK#Y0BVYZ?5EXQWOF=?7?.OCB(V9_?459]5S@
MOK)+N.N,A*U,?2W,N9@W*]1VRWG^8T%]N_]D<MS@)TEZ<V&7DPDOQ[1B2P3%
MC#![(<Q7=M:FWLUX#BW'T9%<SD85=:5&9#4@RG'Q6H\MXX+2/FC.^;<QA9;U
M-GL6[#UN]'!CA2@N3+#[?FUM==VXW$$> /('^&KO.C/KGVN(\$]!1T:(\]LV
M;A_(]3;Z1J3VIGRZWQ85^YKII05EJ29BCQ9@_NYE.AIW<-]N3E/ ES7>48!)
MT?QL83UMM/A^E5%J,BYIOT!,,L!/<!8+D^A2[^2RX&@ =9C8_^,LTA3C"W C
M1I[%SZC]Y8\(LUS>$@93PN%$TFF+X5Q(U)+7EXYI[2L]VF$AJ[0SR%GC>]M5
M/63"=S=;#@HB[J+U?N66N)8M?\9N"*U,&M^:<-"=JS%6OD4G&1JP?'Q_EOD.
M&?GKC/W1;J^<V84N7#KO*/(%8#.9VK00H3>KE?&5IQ22. OQ^\>3ZEDE)+S/
M'X]=;,DDI\H#23 0O+=T6>.MK[WLMPX[MRBG3C64Y!CE9@GO=#(@."R)0VJ*
M*3N,C;"%O*&M:*2--Q-Y*]!G1W6%9\"\]T;/!(HE'5\D[S]Z+]1 S^KY.IWH
MH>*:.%P45"'#%Q N\(9HH-$5P6/-159L79<V9@W5WH9<+?:]W?P5__.UV("R
MO-!V8=/L*S>= 1^ZT+D%]<XGU)*#_<]2K#=,&P4&G3 "_+)6J7F$_I#].UNX
MN\)-I8XJ3&7[F8M(<Y-HOM@UUHIO4Z%8PE]A4HW=F/&\6O:$(_P@P/,,*A&2
M6]1:VU*5WNMMS5N7;3+ 8TIVQ8OJ@1YTWHBY.BEL6@FS! NJP4/?4:>YB[JM
MK%@<W1*+W@:#&0D8S%3-F83^+&6>;&5%+)OE*F_TX?J:ZY+C"#A,5B.L8+N>
M"_EBPAH<]//3^=7\P\(_2#0]_ 47!M7:MSI)K/0)FG *UJCHT]OKLGAL;RDZ
M\M":++_-S*-#@\<8*%C**@]F536(-E\ H:F0,!>=K^"@7 C<<WA5RG?1Y@4@
MWSG>*G-=@"&V+'5O,1NH>2VVAHJOI/S]7[T!_M]347]]Q:*!:]W@:XQ.3VLF
MA!^3Z;T%L,;L6ZE6"  [SE,C ;:S#7<)TA/JB:B5YX)ZS[U[ 50)<MX?W59J
M#&R\MX'+TB>1JHA4)F"@O*7<66M'?P)E-2+I)V*SMA]GV6]N7W]X'@;Y/N"M
MKBEX.MP3.4H+3U-,T$=H_7Z*5U(">Z"'-BEI(Z@N.BJV/2=JCP@CV7 F@/;D
MOG\_B=V<G.FWYGBQ7KP @G)E._&^ID9.[DKVWG]^8E2'N]T11,I,!65X4JAR
M)%I9UNDM[5%27=BT;IM3+:FS79JGA8I*#8#617P"/K1_DH2Q%VJR*&Q;?UFM
M$N#H\6J:J :Y(8@KPU4NQPH2Q-\(J*("6/K1AT$QCXZZ-CG;UN+/4::<S(BC
M(?@+H)=@;$P?VGN>U\%35??I/FO354G?S;RGRMU#+[&^ 7U=#7/L%N1>]N%I
MFPX/G,M)6<H7 $M/W2()YS2CCY^-GX\KY9?Z^\E^A$BI# +>M=&#-:JT('CE
M/:X&;LN/G&6/7@#S>C+> =]\Q$NQ:U'!;*.?,?/HXR?5RB+9E>O]/C3-5.9&
MKEC6]D%$ FU*9J*&B 54,UL2EY;&]<*I'%.M+=;<?*[6UUVU*LQ2YUQ75\!L
M1S040\3= U[OHVY9[X/GY]CBWL@#P],TU;<U4;XV19P)8+L)<_#J3]/=J9P:
M3VFW!(6UZ&I[W;NR&38IW060:WVG^N[]Z_T"=E&Z:\F'*5:\D].[Y5_3@CID
M)<(CBCDJP]?H0A,B:"*'=[$XQB(1=G_D56.\2_NT W<9[UV5H0W7T<,95H5Z
M^BO+(J6A]*VI4GG11:N8LN\G<=)N>!G6HQTM8X?(D^ZKI1D3Z.OB1Q6?$^Z'
MGCT55RDC$C$*G,+YUIEFS])$O\<_;T7OA:U5PP*%/<'3G,A02?0'JOFFI1U/
MJU":#!=I,GQGD1!^VM^O18 "AD>R.?85ZCB2'ND^=).W,-2./%M;AZ+(N&Q;
MN',SO"QKK@,79JNMPA;@\.BTN(7_$'LP6^8 >H5>;U^?8UIIL%CSX$BH!&=S
M? $L$ 3/';RQD%K;IE'2KE,1B,;UXKLD"D:6Y2U:/E/]U\O_5.HB+= [&Y00
MWU?*=P1,P7W*U86VZBZX#J*?3N"^@B[-FPK8;N-\J6O@P"?LT(HNLN@GV:F.
MO"P/^[[AMW-*$54<Q5!Q@P]>MV G!,O%V_JM3USZ$@=+YEBN.,PO@%?G19G_
MUKO5[\K%(6D]2I,M%H>]U%I\O/QW=A#JJ+FCCM>P9N>"WZ?"7R=<S7L*)K2,
M*%\ ZU30A0+W2 +N(M*P:;9(RP33,31O1U-/Z^*E 5=C05V=X4_TL0T2F)D=
MIA>N4<[LZ.O[2Q%WRGQF=8Y7C4V($T^$.S2G361;1*CO4=G 0L56HC=G:]OV
MO.K4-\OR"JB8R+CKS4=$@BW>,'UJJ00F&'?]QS"?_]>I2M38\.@<L9!<^Y'O
MHL2=WK@G#&59YC1:=?;TQIK/ZEG&U'^=8/7<-X9BHM[K;">+4A_6\P+XOF9;
MV+?1U#!A<)<VUYELLPN-]G)TW*%0P6BAX'OE,X$DXKMB>Q=]R'_+& ?5P0E6
MU)U>?2AW$9CWBH'Y<N2&51L:.I=L@,V+NJY7OZXH\Y#0OP R;Y>J]_)7:J@!
M<0 2QFR"(P0V#,)[:E'B5EZ?4?2VH7F%+JJ3$X%TMG"D!_GEA53H]F&.5\X]
MKV6.,X%"_?UA0/._YT(0_TW;CJ:0\Z83,^FB%HE2];V$;!0X,LNW[A4T.LX&
M42:1BL[@=H(1YN 2&%3F8LY_\;O='^SO3>!(3IC?L\*)OFLI+.A)+3&BIB;/
M&:D9I(( FPG51>E+?AR(DQ[B@9"-L?S!Y(D3Z,F-2!+]J9$#P9(/Z_C;/!#2
M/P<]KR RT:J+9U&\I6#IYB=(CS*VZZW_;G=Y.1FFEF>ARS1^67NHKT=[L::[
M+$?2T!2$E@[ABC'!&D+>( $%6NE;-+3HVNOV%@[9FU5@]U_M&X:^.S,J3D?N
M[C[9*-!1P \QG&:OW(FZ5/)J-EX+S8GE7RV:2HB(;G$_&C-5*#\Z(U<JC&D$
MF9K+NK/E?T,!CS"9J R1#&A?_U564/7PJLNN\UW8UO9?EJ50Z=-VHD>5DEO]
MB+;WO(+Q[O(X/[H?JC]D;.%>UI#%_5SI$G09=PY6=;O'L*>R[J7^=C<.3$W6
MG"V:2>K7&2)=^DQI0.XW)7W\^>9#R::W3[W^4*/+"Z "-)AE$U>G<0M]2-O6
M8YM1;YO_-IODG,' J>W^@YZ5-K;^BM.OZ3H^787M=C9U?QT%LP&-F*Z%\W.N
MEGCIN?) '%?325AO+G2I;"WER4)[1,+R!=#'>=S@\8M(VXG#.U=!E)EF55,&
M!S7T!U5"U:;KD8*<CY"WPY-BW7N:I"Z=[J[5*%PBQJP[.4,E2&UD.>6R:^?M
MLZ53E5ND386UX5SE[^&[>_6KB7\BO_2:[XP1.?;J.EH[OO=RR>)>/=5WY>S<
M+/6236^''DS:5ZYJ\XVK+W6O!#-@5K5%9HPVB6:-K])V67O#0LGR,?*LS-="
MO/C2O928*3;JR,Z-OY][YD-1W,23@73-;'WR%05=JE5H'E@CB8#E?13:]NAG
M1F@',*N^I:FZ2>OT( Y#U1H[,DI$9*!>)T SZRP9[]BS_G5E[E61-!5*I1BQ
M2 @=79@\7ON44@F6U@M W^0H?_F8:+XA545/9W6L[>'3L"#**C$'<H"_H+IF
MF&TM:Z\$;<^IF@F+2S7%9Q&@QXIVD)Z5;!PDDXR5Y</W>2WA(7H;'9*NO2BB
MF5?5?^O)(F4,&;K5U,B,@CCK:0W.BT]9\L8\N5A87%HV$,1^1([JB4E%SM\V
MNVF6W[I09CU;YI%N>8\)\6;(2B_]_C#3(H(C>1GQJ?HY65%Q)6A>HWOPYL;P
M;+X92N1%7S>[[2W;?1HS[#!FIH/;?'*5M24Z$%U@Z W,GH2K.!;)E G5#LRX
M&DS,^M2/# G:IJ8LEO64NP/+'FZ%+<^GMWN.9:T6]3&VA?0%B+"+CA07IE+_
M\>N-0HCV=_,5U,>B\TJ5),J!IY&SE>4VNCY1\EDOSE*1J#(,21+.00%IC:=A
MS^A9U\IAWAT5^2(T1@P6T:MYD='2A8N-4&<J+,LA[T+9@&FIM'.9SC5#A+T6
MOOK9A_)QJ:$_UQ#'8P-,6&GOGY;/[3,K5M 1'FR?[VF33Q[_^/IW1<N#1J\/
M7<=%1S5E3F$'B5L<EX^61DO6]1]OYJU.W$58'CA<:29KSX8^(BN5\;P(?JTO
M21M0>-X@FH<:H1ER-;(M68^OI%N4^[\2=C0TJDG4 "[I,WWD2]! Q;:(6%T[
MES)/J_E>PK\>UAN]_0)P<H$_<\[!]2^;JQM$*688_O0=OUD-<X_$^?*8B=C0
MOA2\J:KSW=OM@/BE&)T_1XCZ[N(KJ7_\8>,,//QQ:FA1^<$NMC\OB?>0DE:N
ME5:.4;I]_I:_G&>0U#-4G@!BJZSP3<1JO0VTM<:XU1%FDC!@7S*:DN0XL EJ
M";A%0(*%A8J\^"\>XAS)E].'4HK.$(>,N3@+#W;Z-)<HCW,[<:=&:_V^X1M'
MA\!4SB06=0-,N(*>)#&QXX16>[*1 2XL]T"[Q8Z>EFZ W(9JTM/'V0^LUSC#
M3E\K^,O%;'^>B-(A+[++>4]L%8GB,NPVCU@Y,BGDBH$E\6#TUJ2%,-@>JO_
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M*2>3>J\@SA8O48(W:C*#-]#GV_?;9&8SF#4?3]EH^<.\1GQRP/CJC(I*8'S
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ME,:JG:P@@&Z2(JX02OKI^$_J4R^ ?-HHDPC7%X"[;Y(WJEN@JU)IJ>0!VH>
M')7DHL_0; 2!VP "CQ7]E&CZ?/8'/I!0@&M@RF V<^!"Y.1@>/ZBO]-^*PM7
M^SAI253%2.HZFA,'NS,$'O5&[A]#$AZKX[P[5%,^O!<MS<VN;@]0JO*_&A>C
M?]]/'SE@)PE6T*>Y'2JL] ]CRC8$XRLB_?=$)[N4^$>]%U%NDFJ-WHW)2_[D
MSHJ0\8V?SU+0=*L:6-XV^]D+@%2^FM]*A^K&S7XRQL<,KB/\B*1K[:EIZ94
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MD\2> NG.F1'L)0@#[9/C_,$(CZJCZ3"FXO_V\\%8YU1N2]J9>J4U>_+YJJ2
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M[C%7[[N.]-G=6^C1I;:OQJ:=BV]#/YI,I*-LG%,+9[=>#DI^O+^6Q/SHVJJ
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MD)&GUJ:+^#\F"/^[0#=__@=02P,$%     @ EX)<5BI7F[0G:0  '6L  !4
M  !N<W1G+3(P,C(Q,C,Q7V<Q,2YJ<&><NW547$'W+=@$@B80 @2'! TTDN#>
M =*XNSM!.KAK!P@0M)'@%K1Q@C3N[MJXN[O[Y/O-O)FWUKPW,V_.7>>?6W+7
M7E5USMY5MYYGGE< ;V0DI"4 *"@H *-_#^!Y'B .P'CY$OTE&@;Z2W1,# Q,
M;'P<;"PL;"*\-Z_P28C(2$F(2(C)J1@_D%/24Q*3T+#1T']D K( R=ZS<[(S
M<S R YG_TPD*!B8F-A8V(0X.(3,%"07S_[(]MP+P,5%L40)046@ +_!14/%1
MGCL!U   RDN4_S+ _V$H+U#17J)C8&)AX_RK@'@#>(&"BOH"#?7E2S2T?Z4^
M_\H!:/@OWW[X+(I.H&R,0>- R.$7G8E)*U;>1J0R=D+':>+HCX7]CIB$E(R>
M@?$C$S,7-P\O'[^ ^%>PA*24M(RJFKJ&II:VCJF9^3<+2RMK)V<75S=W#\^
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M]N6((%+?[+N+$GJL+NLJVH7?9<@,Y29]0;FZIFA9UD;Y#\K(%0NBGA[(&J6
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M@FH!)RTESO6V&7:Y5J.SVJ4SQOI%Z7!DAJ-'D;I,[+V<0HY&;]>HLU<*><K
MHHR466,#,UX4;J<Z"< BPTE735E7@IFYMU_%T<U8;V$C@WC1 [3758'5LMPW
M_R]#3DOK=8KWGC+ 7\&WH^/-1DZ92![QB-HBYW!&+BR^$1RVL$^^H\4'VX]E
M11WQ4HMKI!+-%<]2NN?]52JJVDAOG@1P>HR;X;'@)2"3MVZ((II9I4K9DH[(
M@$1H[*]I+S F%I"^+ILUQZ3Q+A11Q&@^3-6"X&(CGRUR6%W1J_DO(TZA9TTE
MTO?7Y2FQ"NT*)TOSB3H*;&_\(FMI<L=<[( #XY>@17T)'HGMHV$,,;PRA&C>
M5RI^>Y2S7*.<*T*]N;S,5U%Z756H9R(>&.54<<LRN;(256Y0IZ=Z3HB8\D;\
M<L+ES"Z0O(O79 3\C58P)<\'!31>;$G,L62I,:''L_NI?^CQL%@3E.L$Q6<7
M:J#S4\#2>W1T>/ KRVSOT]A,GIU-5Z 1&4EFSPL&L+]Y7&E/9Z,!]=Q.^1 =
MZ]U>!P=P=0!]IC!VK";C%-[R[0R"R-B^G2PF[::CPO ;KIB7!_%V#:C7^GX^
M<4S1J<9!9O_Z2)P;[*YLW^,%V=IN@N@<[.BNVN-!P\TN;E9T%H[:B1NQ"]/"
MKZV'Q7O89+A6]^BU_M9 FF3F9OFM\J1ZD%',3<Y4J-6\OB)CV:A\]=J@8UC*
M,\"\M$X07#D I[+*O[:8$/?[I]Z&,^S_\Z<;8=^J;)C'ASAQNE#EW]=H1J$^
MA"AGYD-%<XM#=A^93P5I46<" I2_EU:NB20['U-;RX;3';&]N3LF!95*KNHU
M W>,V2P+J/%5< GL#X;8<0RAYNZ5<DT69^/DOSEXLPB"'K'*-&X01CHDI?ZG
M58["HFV/))IAA\\ _C*/IBCWC%6?B'N?<^P0S.V,?_'^YAH4Z#1U;2T&I9T8
M6!;F'[]-9]5'1.0EP;7RFC 1EFOCO]0]B&:68FL29]*31N2,_K=&SONK"2C:
MTE%0$"DBO:-!6@ %I)< 2A="3:0KO87>6T2D"(%(EQH1Z272.RA(E4X@TGOO
MO8?AO3<S:]:L66_-#^<_N&>?;]][SR8PULV*45*BM^*@-.'Z]"SV1R8Q^\B\
M8+8Q)'^Z;:6J41VYK=OA/H*,<\@M/'62U!PN4_[CUN;MZ^P/O_/9B7]1Z&?X
M7^6OW(]IZ#N$UZ?&%#TG%CH7'AH5_0TTTVK(_$V((3N2)U!2,=D/Y>!>]ODU
MAP/J:\R(<GZO+/4W:R/3,EGK<^I<T6(FV#Y +X$E=QQ:\2R;X/'4B>QJRAB(
M>)>TV!$XU#_/<+_,XYS7+W.&-D^&P_>D!F1L?RHPG?[M@ISHX%:U]#=+G:P&
M3%;/1\7H11H]H$R\*B]&J9 E!HENO 2&3]5B7MCSW#.(Y7W,._1,A_<!W?T2
ME5H9>R[CR$IU.HU&N)1>=:/&>)A^ ,]O=E;E!7&,#Q'P:3/"JMV_+Y:S=2I3
M];/[.8Q6T+$OW_/UD;:B"\L317G?0(>\R93=4F!-!((921TH6]7?MW@M:!7+
M5^*,:=TK-_J=X+[V #Q<^"*A6EG&6(-14B].65?19=@AB*?^%8=U1Q=5G3FW
MY3LI'J?T4W;]2PKFUZ>/C.Q/A-</5+P8T*R:-P"Y\37[:1Z.]\R!M-L@C/ZU
MT:I%83$%36N4LYU72T.JU"?Y%QN1$(F3B[$MMTXAY] Q1?"?O*?9C95A^'YU
MA\1IYA!"A.'"GV%/.[6'".RQRS&-9"P:,MBE'S]@;7-.? <V7.RH[RCLU?6T
M@.6A?H1CS6AB-@&)U2=:@LW93>VWTW\];9YVT0C,<TKH7A:#<WSM=4*6TPV=
M6Z[N>]<6@%I5;P"F(:8/2E(^<5N&QB@4M'&-3*32KNA>UAI0G"Z#O??R^O*_
M1AK)M=@WOP\F#405R(1JI@I@N&=EBY@)CV- +K\1C]V-'4CS. MRKQ(KSUMZ
MYN;I-T639S%3<J>4ZV7M\,>JKJY/SI\BK=)/N0;]L5&YFXP?%Y871N:=&\LR
M#BC7,T,V#?V<HFC1H/[A;G=W]C:-YUHR@"V04I.D.!<W_E1QW.O0_[JWPR>1
MR-X>[WST6C2I[.V$,MRIP1SY7M'7)L:3HFJ3-%)5:YSYA)EB";)HFE(T\Y!%
MP*XBK .[6G?;8E>@/[NELJ/^'$V?%]<GFL.)-/AUAEAE>>$EWE9^O.H>L+IH
M2P.6AV1_Z<\C=E%^:[E[ 7'_FG8R^#X_1G[%?'\A?D%U4+-J<I :LTH2E=0I
M# D3YNNFW]BB33$,8JMT:#)_9OIM?P="<'MPK5P53?YM7:F*#S4_-A-][>Q*
MEY2-\WUX2U^'IO?*FZ(6%2\FU_V@T70*'=:K7ZCA9@/\Y[ O"Q6M&/>TNM45
MW15,3_U3F<39 .:R2^68YD&]6 ?' X(U3;ISP5(ZFBTT8>5*E"JVBHX9(M2:
MV<+>?0,8O &H-;ZILQ-F)I38ISS [<@HW)HGTHNY_[D\2] M*V+'KIYGOQ:^
M<G\"NMW9B^Z[=0,'Q;"A&>FA_IJYADM;;.507L8C[3@#B5^G0. ^)MWA7RLD
M-:.!33!%9PG3-R5HVK07HJ5^3:0S:&-Q0/74_8K\A=P%)?J,QI?,0_8>#CS/
MMA^:,15=3>3,&9 .B.Z #,[A:4I\W$?LF/])-O>4QT^^QW./S$)PULKT4ZI
M%F)Q</ZU/1F%+EQ8BZLK9H4IHI=*'@@WH&QPPK/*L9^PP[Y=Z0T] "%(XNB=
MQ8^9Q=9#SA@/)NJ%].V @Q@ZM:*RM;Y<PPTJ==&*_%=YORTL@:D#;Q*ZH,_
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MBM\U1>EA/.!BVBG/6LIJ:N/ ]<-*]"CG/!F0_DL<7^+0RMAO,3%)3=RT3%,
M>L5EQ,Z+N*Q8\M-:3*-2#2'!EO!8E#J+4%_4[V4Z%I-T0;9Y$P4?8%OLCXAZ
MO=?JIS7"CR4&"-')>^TJ,^1[AX[]\? #C];%P^,K!_'A-L5#)<D+($7A@FDU
M:N8&T+7\7AU-U</_,L>C@D]V*$!>_^&T+C8S<W1J/54_$V7-[[$6D%]#"W3E
MB,?&^8I8<V=_I(ZD?KLH1Z-]_V[P/Q)/XY7EO%<5%*%Z:.FJ9,20[SUJ/3KO
M+P8*5G5?GIX<@^4-=KSBA>_I],H!+./\8!0+ _0<KE4E\99BA#< _RNBP^)=
M*I_1'6\C@X""3/3B1F ]C'IG6,54B:_73777Y,CE!F"OS&)X_92OO'&X,JYZ
MQ2).PW#X9;=(H"9(98IS*\E<.)2 BZ! ?$MRQ/'E9+22ZKWZZ+(GOASNH='*
M;OZP5_PY1;8OIM=/29-$YUA^8BY>F;#>7_SGQ[S((B&"XS%Z[=8A-AK;9IU$
MJ5ADJS4SI5!>5=5+1VG3:QPPZ_W]B^O *[VJ:T-5IZ7*LGK7W$^O(PF?:7$#
M/L :"+"9QS:&.)%G*N\:?+>KN 'D>Y J PJP4,'\@>^U0]KF6"ZE\XR5&G3H
MGM<,T=Y^'7H;QG- 2H76;-O'ZP?/;S.:&%[3Z'(SM2@@6NM;F,_"GI/8/LQ>
M=X[:3)!*]XR&P"XR0T;V\HLX9RMBMER7\^B@_D#46=H"8KO/]JU!=WU/>T27
MM"J7 H(\9/^X% @'4\/>L&?14/O0V*L53RUCK6=S_,"M9F37>3KQQG60:<,5
M<2'9HT]N" #"S'[>HT]T$8K=WN+#>8S4ZI\<<_TC=UAK8E*K&7KI'R@[&+1#
M.)GNUMG YN9;ZJAO^O:@9'PV^?UUCJ9W^=7?VSGIJSP42JTM=^__+!_8'PH2
M-/FFDI%E>^@0/R7+HU-(6TW-(*Y^S*OI^Z1/B'(:I)&-+X1WSIV)'"F+OK:?
M"36S AU)"/IXFF;4EZ#2UHHFFN,]O]O'OS7C'#=WM*D@[Y6)UFGWM\LM1279
MM8]G* <W&N/I1T6-:>&R<\%"Y%ZL_3*=".TSF-DBAK@M?SP:IC8Q5#O#($$@
MO7H]<@%+,&_  'S^V?:^S#"IL2N/HYQ$<V2V[%'-CF!*W/4_93^W([L!" ^V
M+@"=+6 V-;&_NYG:0,J\B9[B["<%1YOY6U7$3M95,=M/X3-O?FQ;3(IO"(?$
M'*_+2NP)U2-L[=Z]M+2D[&+]<^''>' .]+&T7=8IS2-D'1W1_&'?L598F:-D
MF)&9D6MX%K:A?@W1T3"#IC\ CEA\Z6S@RG)[(8J:,W41%S'2'Z*(D-8OR LO
M@<]5E=^5#J/LZ*V5NR/M9$U$((VOZE]/15YH9M-LY\Y*\FWQ"=UA1UXKN<EL
M%I=A7T:UD$[_DT&VC$\$4$YUK3]/?EES;_3!CNC5']*0#S*;$CSRTW1T#$7@
M,W=DY@.X$^O#KQ,\%N:E,2_T8O[H*/)]Z>(('6?Q$THW;Y"QE^&\V/?D#S+J
M*L5DJ8X]?/:8OU)*(2LV+8D#X!]4]7?&3M>HZD_2?&GQMZ_M)UU?OOX[69WR
M*LD6>5:0L%[;1#8-;.^C!3:=(R8)EL':DWNE]9/:-8U(&A<QCU7V:S)?&8B#
MOZOE94F.Y3$+"@MU_Y93*)83F>"1E%?\TMBUS\D'ZDZ#K=[RB?7F/F6[=EXV
M-<H[ZU'YH/Z#W2\/>" #)C!Q"E](X\2R)UJ9)79X9<I)LU+(@")+&/(KA]9T
M,9H0)>,QOO;F$G?Z.6<^HK(EA.1:(VN#QWKGM0C^8\7Q9,/#\ZS:JKH8!9B%
M@(N2!#.K_Q@Z](,1SZ\;0&;*-2@37N^705DC&K9-K6T<EO6?*\! R>_+_[B/
MN6C0[AB[L1YUXZ+8"7#:\;H&YPG-\$N[<I78)[X,VLI0BP^@:&PS^V1;G2.6
MZA_Z*_[5K;_?AK1[7T2E=^G9(-,7UR1)UL(8W69?,< ^:=X #/8S,M$,1EZ/
MP=8RX#O8&P#O89/9'^_4XF)3)1*?S6ZV07^2;F\[^HHR:QE5"<ZXAH(A)+G$
M6$)KZ?J$S$GQL #Z3DJV26_6!_%^H3O2>!JRT823(-5:C>^V?\J^R)/FM="T
M9-M3N#LPNU)K*/UF*/E[/1E17\F_V:%RI4SC%J^V%M$N9@T!F:T9>C;U?7)3
MMBZI/NB9ER!7(@Z2M7PG+E/N!S5.C5QG#)]HE/#8[W1E->1D$*1")ZR&Q'R[
MYC6Z 5!.$4@S6BW_+JM#D3F['D8<2.AS29/_,?]I;T&Q@F]22V@@Z>_?VFE/
MB5'EXDBMR5T?WH"I4ZNI=!$&7P3:U0>A1;-<@*&:0G?$^\$7Q^NB8Q?.P4?"
M^?:.M'*U>AOMJ#T45+:I.4&OH*NXAE@!?U2I F_O0WV0%G5RNEN%C2KG#EY.
MNVS17+H!'!>U'[,HK.ICK9N:OG1+]]5]O0$\V9*\ PM0Q,SXQ$/])T>"3\TC
MV))$CM@69\K+8$K)3U>2M@[*?-!PD/*\T0-% 5#YF?_<(68#X=@$.4LVK'Y+
M^5]A$LLS5>E88&^_WW]F24C> ,)8:?!](S> :F>+]M'A!1KP;S;,:/VUX(9#
M2W8.S;Q>6H& =: 5HW;V/>);<=2R_\_'F_^KW/#B>Y^".$>\?]%X/G1Y(^ S
M ZZ%Y.5E73FT6=?$37B'^?2Z=;2;O'U7P%*T7K@0X#T7BGL*5]:0J__D<,A.
M?_AK&W^:=24C.!F&Z=Y1M^CI?'?]_>3+[*&TA?,P4F^726DK)L= DT'E-]%P
M6N0QQ=U.ASD4JVA<4<[FZ[X\L9Y2WQ<HB.?)]@6T$RG]X-YURTD24G_1:B97
MN($ -XU(]$T"Y>\E1V.D1=@_FN 8_=E2'_M"=#+1FN''I78C"58#$$3OD<M9
MSM^M(ON&$XF'10;%JX+&3Z!LL:<TM X3QQ!R6_S+$=G9;&G'OF[M#J;:&X!5
MRZL+7**#*7/34"D+5W0DS]+V;[-\?!/H>Z(/=FCM;U%X@LS:1K01!8U1Y^,N
M.(NGO#6?CO:+1RJUQ*01?O.!71R6D:-CF.0V+RV[D\<SADSB-P!WKB0,O,"Y
MXP28*YQNX_*+A<SW^HVSDT;J>-6?W%&SWD=T4@1^B[F^FQI#L/IG4*\*25"?
ME J"S'!VAN'EM-*ZE<]BM'>GN"D2%L*ZTD6_B%);H15S40.^T(X/3M??=M /
MM-"ZE/_\+AKX-BN4',JA_2'[ZK3TKR9*6^6(!2S?D*;Y<0,W<*E'26M0ZN;-
M]\G+V")]SFLEQD;S]IBT423J):'W5M':)HV,+^G\".Q/ZX5GU;U=@64_O[Y^
M'^HS51#RY2U8^THD*G"^.JIMSP'J=&!D/%6I_7I#NOW-%^0_&54HBY3G2H%^
ME->3X3B8\+M1YY*R9>/NX%^DWA1=8SG)R"H'OG.=;:+25BUT%U:YE7%2W2WI
M1,/]Q #YF)XX0!SPA4@7-UQN69W)%?LL[+7MU^+('GD%<?8+1J\\V5Z)PK9Z
M*7I9;H=''\2D$(WS+:FI#6SM<-4,_>"EX%/=*]" W> -H!1R&GZ8[^,'V4KE
MTW!>D5'%/[5G:T-W*Q\5QONLZB:?30?%45Z5&?=QW_MZCS!^D&15SZXTW*8Z
M;</.V"=<J]9\X'G?)A*-$U$R2LF[ 9B 6BI$[1W@O/B#^6\U5;%+^E-_:YB4
M"P;4DN"T!S,3*W;Z@"I+ WUC09/SWXO :LGCPE/HIV:;.K1F) ]GHGDHHRKS
MO+Z2JNP'?=P([O(^OQ+/0S:9K!2*/>:[/_PIT3V5+XD7AW>WJD!_BSPBE2R)
MR^_'$H $#NZ[W#E>"0>!LK@WK84&VN("RVVK=)_5A1&XF".)XA2)B C$V5!Y
M:F77R2Q_Z S]U@\,3>&7^G$][AP1]QD>+'($UY)ZR591B])E,C9H:*I'O7OW
MA5Z?D]1)7ES*]4J\7[73,.P& *TPRA:(<GZI\[EQR-N5Q\X=Q_K!?0=28K.K
MNM;W4ET'RQUK6S;ND\)5'4$EDU88PL[ -&(G?7_NHT\7Y\_2I8_J>0XJAL20
MJ6BT*[,WN$3(+J<V)2=3*4E9PL8]#C*66FCP,9\C\P-YU0\+^)LIS+?$[!]K
M.,:2UA\JDZH=<DO7(*,V/$4=-H="<AO)ZCX8"#FBP=I?X&/G', 5D[Q3&Z3?
MB(,[9/[= (A/;B5S3+<(PR=B'4DBN)J_]9GF)?JN[0W $<L0L&4NCDNR6&O.
MP^+BSU!_O&<XL=%]FW#%KK![8#[U-1E(P>XY"0HVNNO9)X\184"6BP$0)!1R
M4B39D<.)K&9^AA6]?Q8RG+TD7T<Y#T=7"8"47PUB1*Y5^;9T^7R]P5XB.QI.
M$VI;BTCCC*3%*\'Y-/3CC6X')]'6EI>'%A&XJ\![_C,9>49VA@&B4,&(N5"O
M0M1*H.J&AOZ@!Q.$PL[.QK))(DY!UH[I=F1F@C0;_8XS8+F=P_,O"C\YX3EO
MY=6=)>N_B7,DHEETOLM9C<FWLR_;(!'J'H3@R79OW?X7#=*D0VGA;.6G@E E
M>EYE"S,UV/.%6<()GSC.3/[JBX^8OR^8P=\09ACM"QB<%/*\008%H@L^R;R6
MN:7'/]Q%J9F)OMFS,KE9!*]X3V3H_4*F]-6.J31,6*DTI(1.8DO,UKR_KVID
M?$<LF!8N#H6[FJ;E^%2\VO_TP*ZX(\E[FH[K#NKR%D3+T6.-<4BH"'>'W]9E
M!K6@</;W42^I%JH H22R4T;GWHP@Q;E 6 T6AC:U.Q45@M=%8*3%M!",FU<R
MB]=&K_3"=$\F%>DIU:;RCZ ;LNF1.T]:]O*B'^4N5S?$AS!_ )9=>#BO:A6.
MYOP8Q;G7\=*C@@^:.R/T&P)A6I6526-C)PM,OL&/%9E_@);>+9%3,,.^;:))
MEJ-3-<1WC5=/+6ZE'#R((_.?WU9K'[>JL9[$O>L'DU>-DF W^!D2UO1SCU\?
M;E;73!B+3H1])6LO:8EU=B?L#97K9DI8$N.(1WJ61BGL:R;4MS=5[9P=U3I^
MT^A_T?'6J(\LQJ_.%?7*F(&0F3)$44('F1@1;:<X=72'N&4O\$=?#J2P\7#
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M1,%2TIXX1>5D[- ZKY=+E;Z?I.1'Y_/?FRP]:?I, 7)4'W'^?P7K:SGN3:Z
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MYJ+G>37O)7'5J[=7TH'@^0J'F0>&L#(0#9Q-L&6'=>W^'[5*-TW(5- E*$I
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MLMFBR&>.%MCVI]F"@.*-XV=*<:2S-K(,#<F0":IA9 I_U:E'EGS:Y#*Y V4
M4/8%,*1-:0WT!!E1F#6D^@1 :$[<?IT+L[ZE,LU5F"1J3VJG0#V@A71S>\9N
MB:T^.NX^S-&[4<O.YNQV"/W^EQ?*S)H!'(/JKW#%:NY>$Y8G[2'-JM8:R6XG
MBG!3F7%>J^'6#JL275&&&GH[O])+"F.WG];^N4U[:$0]%B-#U7 (!UJ;9&V"
M[SGQ-C.F1A+)M[/ZK3ZGG[4^KK24A7 5_2N!1#+"WUURR _4%D1>5S:/3[-G
M*,UJG.%TH/9KL^3#+:T?V0L9YAY#+ E\JC;LKWX;U\EHE+GZ8-:U<0>^DF7F
M;YM[1-UY_L(>&F_HTN'(&AC6!BL:]80VDKJ:H5>45*3&GSTF)N8].&6<+[PE
M<TBDM8%AL7JE")4):OSS6^VGAN&X4 11KH6\6HHQS\FJKS0EP/"N]HDH2\(W
MN1J36U)&C\T,_UG<M]+F2=\1UW!&/C<J:!Z77"8L(Z0Z"ZDKMI% Q<W_!"Y.
MW*U*\;MKI>,>"]I*%8]MQ5J$,-F2%CD/.,-82#R0#-QG_0OWO-5L3TEU, J
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M)TA+37)HF!#IJ-4X"0B%IFQ'4U#?1O'REPP\V+M<)J[SYVE]\;LR9C/8B1P
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MZ.BLD XA67I(?1U3[U7G!MZ[=W"G^QS4=UM$5ZE@ 2I1P4<7G/_HE8;Y%QL
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MF_D$. 0 ;  <*.-R="=;#+"!T:*X'XC^YSF-U5?+8#6G93:3#G +N;*Q';K
MN/\M31 T(8P;/A!S%D:)V-9#:."86"4K<;31J8#14\-N4&92%$%8/.B80^]M
MT'?&5AZ-8=L_Y<0+J1ZU2U\'R["XOJ.#9'K>:I3HJ;)'JE&)AJO#8F-;Y?'%
MHBJ.R'\<:6%F+(_U.8X/;?=(3P"0S5DA$3)6+X#A(/YA3[)'V2Z$>[!@YVI#
M:22<_*C"4FLE\OS;EPPIXL$(4O)Q6NQ=BI_@T(.?UO3 4A]O/UEV:R^;DX_'
M[2-3Y'\,,6B^"J"F%Z5[)1DO;%$AC'<:,8Z3:X !BC&KL!I=:776NH@]NI[?
M[7O$^!L.7OKLPYY88[LS^HJ:W-3OZS]Z>-H\O!OH2\N2[O#8Z"V%8=+J8*2Z
MW//0DR/J86,&2U6]__0XD<GX?=O(FC:+E;!2><Z&-M4':-5D'\@M'9;Z648\
M_$'*]9FSM_>;W\PK=?K974]+O*1/7T )G]HCSU+*6#M0:>V/OH60[-Y=XQ'?
M6\K[S48Q9%7)%S!>4CA;V/O31&#,Y%X1Q# @_W7NI;$)8T*8;9SX=PA);,J=
M3762;>_W3V#0T<AX+24 )A?\<&:,H0&?+JZ5S"X/!H]XIH?1OL;'VU^?(-;8
M=M?7)>70@=K#:_X4X+K<_CZAL4IS5QQ'LBT0 VLS&;O'GW<<("U\15WKMS.[
M>/C041U@BCFAGWGP:R>RP:Q!$W7[%AOI\/@N4&!=H!PQD-X3>WAWPI=R6Z/C
M6U4">:'>0H\?L^8Z*#CI7^1HWK3US/=RP\.'F]OR=4S-?FX[+#6P9:]R:KTF
M%<KXO8,^)VGA3]DG'MWZ L !^NQJ)_K&=J=:]/<W)?PY.R^W9_56G0:R(RD]
M1@#0M_#=UMWE2(&O?LX^+XXII6QMZ[9J2'=""@U)WGP=E/#L&^.]C9]@S7!]
M6OLD(QE<?@AV7"WHGWN=P>F+>+S#2%M(8AK_T(YQ&S\7!(!C/LJ7 F_"X\"W
MJ:(NIWZ:)#I 7G[<9I+R(:I7K]2R8A2E.\\5UR/5JV5,;XK(0W037U-;/,LO
M\OBJO6^.OAYI-FVF\/OM]8G%(<WKB?MW[VM8WN SUUIXN]\%P;!/F%+,5PW6
ML/=;>2N4Z++-@_D *0!7./&C,"P@L:0ET7K>_9P<)$C6\64.*1[C#;I0E?-I
M'X:M N4 2M4J&\()U^P4;M'7-IVV/D7W:)Q70LF%VR2HI_+V>FY2@M:XU%"6
M7?W'?&M>J+!::\KLY&\Q95R-:-TG=4G60G760M?]__?.^>I)USF;_N+ZE*$^
M2!8="*EUCM>@!!^] 'HEK.?Z#&PY/\1]@:(%"@<E0+>M5MGE>RY+Z!.^/?LQ
MW*2TY3\U#5R 7P#1[M>! 2H,IK%O9A<3]EC@Z(U(]*ZC4K>3[O)?7P#8R\UP
MY8IAS/.AMC3XU=-BV !4GTLXI0+4RU;2H<S\PQ%-2_%0F=?.X[\^%EDR9%/J
MW_927-><*?AK1"$:G>E\#"#4*Q74[ERF53[)I>OEE*TH9+%>/E\PP1RC?^I6
MNW3.U#I?]FV6$"4?7WW&Y@1L[FRVGO7.96V1XM.86H5,J],2.X]<N3\96TPQ
MK\&HC(8(KK=NS,=0%;<]27H,$HZI]ZWA.8\DF!IE&X6@2]"VCDN34,RL<"2%
MJ-L(\JOLI6D)U+21\( $U>76="K.]W6;L5]*F_G.]WH[A:;&;,J*Z;,*WC95
M*2]U!YQ:*^W-NR!C"&R^74235L1 ?0%LB]94:N,U?,Z4_-D08+\F.FVXCO?Z
M]%-9KF@NAJ2#;6&HLM-KXA+]W D7&VV]T?JS+]1Y%NY?T=FIAD"N<W&3E&?C
M0W9:<ODZX.P,ELG?M>*.EU^,E/?7M[3_J$< ?E8?EBVVUN@)E'&%3&S_\.78
M>@<#-WW2F/VE9D]GI2)A^*A.=A0D5]BME>AD$_NQ/=J>]PF"P0Z7E$_VVB):
M7#=8R3'Z)C_OCH.C%[[?VH>3>F/@@+*1><C=UQC.,RQ%ZLF[WW@7;F57WG#W
MO/-/EBV+8W.41OPGN'"FUH,Q9=9KD/D^8NB-S>/_:798%J791MP:-L6V2.!Q
M/DKQGRC0M%%U1=!2E6$L 1L"6\<K_YS]Z?8T+>>1YRNJD' 1DW@!I$K(7_PJ
MQH\W$9A,4ZT6:9L)=S#C]DC@9^L1X=%)G:Q,T=2:^NJ!MF'_;&KQ<3LJ]1@/
MX+E@\,'/A/_K:$S,KHH9%CIE<*KN.=?U_[(3\V1H^WMBY/6R4^[*CQ-_R20E
MJ&2P(6TTJZM^,C4SK:QQL?;'*_5<(1?CD_5:RI50CPN/MJZ!H'?^=W?,=/(,
M^D;U?Z^5)P;'ZDU;6C$C\@$8[(MY'^'' KQ]WZ=8>1F)QVNC'6G3"$)@$@TY
MTBYT1)/%6\TK::$-"P,!#E,^'\>PJ'W93Y;()!>O/^8]3JEX]!MG*]Q[S/VM
M=^.(1-,I(5.=!("XX&/O5O';^X\63H-;\N+MNZ*"^;\,9@$WDFKQR[9J+5V^
M*]ZI[IOGF!D6C"1=F2ESRQLY3M2=&#SP+G>'+(IM4?\:]WZ;/GG0+W@]:N%Z
MK:)?Y3Y]@J=UH/R5A3Q[N5"G4'\C/-I?[);(TKQ\7L+7*TW9)V<U^!.TS7"!
M/^_=LG)K%?E5N^0S^MG=BD%D?F!99XFXED7SKU/GT@2HM-)_Z19C@U.*W+\?
M79E:C?U1%#JSS6>P([ C8+QA[KTR7/)X%.<POW4Y-8%PGW6./0A!H^7/?.7&
M$OY.JN@<&PXZVD9BCC-WP2E=@5^]#:S_)%5IYQF6R0P2*C#NT7_6M12]_<2S
M";:DWO_;X?%.[=,.^]J4Q/I?O=*F*MA:7+TZ\NKJG:I*1Y$] P(GB>#A<&W&
M:.)DZ/E\T=KG,7SGFY4&Q+KF;8*#E^OB\=)1?*DES130OM! 6#%:G6H%/V2:
M]FM12AGM-=5B!ZPCSN,K%O&<MM89:XP3 XQL\ 4P5HNY#^R2]E[_$Y77'.XC
M7)[.G%QH;*!,Q3,&"!/U5)WWD'DG,X&;W6T,5X]LMDA]\WS\ FA;OKEN2-6$
M:16Y"&VX$JO7;#!-TD3(=,Y]!Z'+DV3(NI4W>F)D*27J?[\KVGT!H%9HZ2%:
M7S/%2 -98E!-(,E*S!R#.N@ Y")ELM,")&52G?^$H1\.XN^#I^!0@'V[Q%IM
M1W&M)7=!@O49]\& AYW%V =9BIY0]2=!!1R\WHRYFYX;XDT!*(,_T]/*"X"^
ML@&U0GFBX<WCFY@;EU+8[*?:DV3<9)(97&8.E)HA>K<T"5'=Q.R?WAH^#5B&
M'J*60K/W-#0S2JLX/:G7.AI"M0,+ZA,-*"9P\3@^PLKZ.I=^BHYG#I'?<NLA
M6^O]$(8@B&<;/\$HS9#[;J<GX[<K+Y^:R27+#88+JO"(!U[_A<'EZD;[A':I
M9/;W<\73P&/.:#>0" .9M4M"S>X<(<MZ"GH6A)R5O34 )3]8U \>HM[5%CL-
MQX@6I0%^<6QHO=485[B>3%-XY*;^:I;F[PPN9"Y0]IWM/Y[A,_#@R6":]N;'
MC5VF;JDXUM-@:NG_N0D2HL3EF7K:?5)UK:]T-<I=S72O<6D.;,_1C6<.K0C@
MO)%)</Q+P,S3?N ^S=O_ZO:OW%A)@WN'%-X]5U\TQ/K7J _E8+JWP;7^1AA&
M0M/__;,L9&,AVG XPFN7=77MW?,2KV\V!$D^ZS:*]AR\O7F4<CT+5(4,)#PJ
M0VIYN0T0UG7.V3EHGW-N7UGST3+9%LQ7[T5(I;0B'7\Q)H/=0I0[DGM1GSD&
MVA/?M">8LGS1]*5B,0"9=!D"?#:,%2D20N3%$OF:\'LJ)RJ5UAWZ-,:G.;S1
M<;^!\=4N-G30Z\ER0U1+L7@(3Z2 H>H!)C7=[S;Q)5.+\KWESH,2=CSE!.:J
M$%ISIMWS[J8-;=<+(V+=T\9<)5\Z<AV235! ,BU1%PKT)<I.+OU,"WYYB7$B
MR58_G]WTXZ%M7>IF+!D"0^K<X[*A>#[6!/VL8,3:H#:D0&F+#A_,69ZB+7<J
MI$+!(.C]'7"P&"'MRE7XK?:H>[,(_-==:4VG?<-XMK7 \5U*F7>&L 7%2&/"
M;3\*G#RKS"6,K!..MU6!,T%KM-0\<5FHH)P\Y96)T,$H7[!RW-%.*H)] 58C
MW$;"J/IA[2VL*FYN;C^U"R,<H-XL*!%C-&H_"X&C_G!$RW#S";M:HO7BMCZ^
MO9A&(%7>Q^,>X1X6C"3_8CQ7[OC%,,Y#L[F1>HV?Y$M*+2:ET9W!Y:/3&]DI
M;!B\K7X'C#&44/;B5KA3K.?U^\53OR>^ QTC1S<U3Y9 1>M>,93\)%HXB /%
M+ $+N[QID#8CV#@O1!HQ90O'&#5K3\0O7+5VQ./],B,&#\4>UQE'7^A  *?\
M9!Y;D8Y$C#0/$F6DJRPL%:O=[BWK5FTUIWVV5)(!']RWL"8/6*A.TO75&P]A
MAU&F.49-FCS5MB%K'(R,^2A_G#RP&/&#<@'SI5VA/F.YAK$1U]:DS@%B06?]
M>33"O 609F%<XNBUC_HQ&%5>1C+L4#SIT2#9Y!$*\B;K#=/7@6+Y.=RL[5/,
MZ#010V/3DHSO(Z2PN?FT20Z)S+>U^;HJRZ5"(KDGJ,\%VF>UYIMI=_&!0T,S
MACUPC\)GXF6_;0++H_MI(R]I%/P28J79VH)DL;?LNAE!3B)(?<H^JV'"2Q0_
MNSW:(-)GPF\HX+5H>7KQ$%P5_[K!Z,SCMC:G8+?JWZ,!51O#?NY"YRG.K/@I
MLJ_Q,8NQ#DL3 !S_'>-PWMVVA4T=B/I<=N>Q\/*S87SE8 WA^T& =RC77,)V
M6(D3@4W="Z":+(LA_E$6-Q[W_D]^M$4\BB4C:&NLR.PL<K^R=Y:JW[5Q?'6%
M6ONTL6=_B#4N960W@9P*VN8!KC;Y61J-,PBP)S,#:]"YO=WV%#'.#L!6R&#'
M;9#ZJ-I97?)CN4Y_*O*2LPP%ZP"D0:"@)O/DAB7G:%_*.;JQ)+#?4MBZ1&1$
M*5I $.>N=!?0S%L_':).6N5!T%%]6T&]$7Z2*T[>AS;$P"F_>[%8EJ%\-=95
MUR=9UTC$ZJ3<Z7]G)KJ5NFGB37"@.]<P)I/H62%DL2')$)"EN/DUP3=7<^7O
MN)_T%R!1%":S4DG<46>&S]\JRL[6WT(9&:Y224*2D<)^E&C+=,.5VO9')MT5
M[0;0J&/NXE51/&G-UNU:*W.P(M/E\(8:D3I+,?N ]6179]LFNS&]9DR-4X!4
MB5,*U<HZ .J/-"L5YM?'Z>:#/;\X9EAJ17/VBNKK/KSMN2S*C&P6J*2]L3G\
MFPT78SG\NK:LCFLLVYUF,4>$Y)^2;!']/\C*?Y#LD9/C<J._YXT]DCU K*E;
M;'8PD(G*AY+/_2T\>'0K_S__M^#,WS]6-<M.(L..Z?7Y&,,4.^S[#Y6F-^D@
M@6KD3X=H\E:2>5J)+1;D\I&B7-B 7*8K_M5>/1#B5XA &FC=(<>X_XU<[*R5
M:C_2X\EZ"8/0D]N@XPL@P\?]K&$[ZNQJK20B(<N@R.^^,,R6G9K8K>..LDF9
M;>2(].VB!C>:(6VV'9"LHQKAH[XTV+8B\YK6^/A7!H=[[INX>^&HY8!1UQ 1
MV!.H'@)L+'->Q1-3SM;<-,G?(9AL%4W]G//=*F#E;");[Y>@6.#$=:-_.U>^
M:["XM/G]Z5SA\*[KVZ)6G;[MZQ5ZO^\N/D?BE> #-\?78ZQ.G,ST257SJU51
M!6N&W<K^F!_XA(IAX?[!1MN)CYP^]KL]6(^(/]2^<N_*D7&0]R)E8[P2?L+"
M'Z//PT]^'KP E'.UOM?&?LGL_]-4?F1G3U[?=,J ,_9HUHC_ EC+> $(6PHG
M_'FF2 KAA)V''TR$?VM(/]G_'N)]+?>= 9MIP7IBF=]=BIOH8]33.<TUU:.;
MZP_>/*=X7O@+@)=W3Q]!)CJ@H_-?OD8B'131/&K6(.QWZQ8/]6G<3DZ^GMIU
M8J S"$O:!-,B(]$F[7ESIS"TY-^SKE*/?9:QKEX'9G!",\XOSX95!=AOR[DB
M-O(+ZJ9ISC-G=X^MI&'N.:DA#('%KGSS=3LB^L53KYGS:S]M8U1#&=/3\]>R
M&3Z_ ,A$)WA\4RF SU@RTHXRWMRF^Q[YJK=8<F89&RC9_L.V_78<*%4KO7Z0
M)^NQ[MCH,#H3YTN-,J74&FO7,X[$::^L9'+A3EJ'O;V/JI03@RMR,MO#L%4Z
MLW75CN95E<:G])".N@MW>Z[+V77T/WIEQ7NT3V<#8C?U.P3DAX72RR':L#6]
MQ?2V.&+I!U[GM^-T !PN*<=X$%!V0F8/B2SGYP4A(GP7ZM*-WN<HUQ88<@ON
MN$G.F'"I^28!=-##X;)!RMI[W,#;YD!_7P-Y 3"XRF.%F/J_ '[AL.6SU?OU
M$>BX\!ZD>EZ\"389SZBR^X@EBR[D)T<"C ^1AV4JR4FLBM )<1;K5I+X[7UC
MQ!X(GV;APY)<!V'^JW0$(72KS(FC5R?ZSD$6SXQ+YMHIPPJ?%F<9,I'UZI V
M"X=74KR!\[ 7P$_1%1F22F=K,AZ1OG>'Q:-58GD^WA%O#!7YO+OLC)<H4;8B
MA!X-X46Z<ES+(HUH5@@MG%"^WZ\RKBS[?W5,'](9;;L!-NC+=_:\T;&@86S
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M6H6A[94JOLOGO2K(/L\(IIK(G:0:YZR>H@.SR])6AG\YZ1M6(9&^E^0]%F*
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M$^Z2-2CQII&BET3GG?*8:ITLX9L5S<7<:AQ;YK=2V?< A)B$]>LQKHDQKU<
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MKV<IC%Y9-<WR,N(0P<0I,'-CE_ ;O9#R7%)FGS7W>R&I)+:4 V;FJ36[]8I
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M;=J3>\O#'!98ZH(X92-8VV6)!XCBO^Q^*WY3 H>!0NE/:DY5N'QWUJ,MV:4
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ME$THSE%*K<U)^KRP?*_4W\U4T4L$=-LJ=>YXF*U6?T-"N)'TEK$4M?>QN1=
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M59L]OI.3,<]+3#C0%P5<ZPB/@B O0@KOXV<SY]'EVS&5D^LR=UW&0,4W?C\
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M&[4'/GI:LU] WQO,# ULK[I7]5\O%_XT*TQ]\R^YG:4U@HI(F:7[0^>)P3F
M$T"VU\BB'Z'8 VR)9Y1FN:1_EY/BDU*>#T$!=LKN;6%H<N>Z?!I6[^E'-)#(
M06!JC $AZ%D,(?7+A5LJ0B^RJM&>LJS7='R=E*>J;=;-$2\=+T+*W]H.;/AH
M3"-Z#BRVBI7=AK,ZW+2[0;536Z]'\K<X'#,&WGXIX=##8*&S4UB>G(\4$P0Z
M6;C>).D[@I(]*Y':(V/*D:FQB>&Q2VE=$D)%"QUSR>ZW4WZUAV5\HD/N+H?\
M<N_W@.:1RZ4I1,IEMQCQ_?B8:XNG8C9SE_@W<^DL?Y'$]Y/_B.%ZQG]&RX1R
M/TM$7 Y4FW4^O3#2]YJ4,#C]K5P&"$755LKP2/="1RA=TJ 0G3U?W5,.<@FT
M,QOSK0J_,Z_R[AY%QR/7I['^C%]QCH4?@(]O:%=6_H,X(7[12]0[1^JYC)7/
MT9)X@:94_2F].G2ACTG(NX,_RF*J\:]-N8N)!S%"(/JO0LLGG^(RY@1C=7>L
MH@:1!?<&2H<J[X'6XE'!A\*D.^=$ZHB&+HYEO#]!UK4D65;Q;W<#-*F]-EJE
M>,I_WU']1[&1)<PXJD/.S*5]+3A&M (DEI?MK2S.9B_%,@[YVZ&_,7])UGFM
M?+1QS(,/L\H?U^6CBP:HE3\Y5QF"Q<O(_*+ !B]_(Z<+P1>T*R(>9I%,K_66
M5=I]6/-,##+R$TK8>=XYN]9S(^-0HW]"'4K7! 1VS$LR"WCSHD(1.H?J W?W
M2AM<Z/4&F^6W(SATD8=]71(' P7T5,#OGX/UHM\9T5NCT7*%GYFZM3C25N>:
M\KQU/?Q@)P"![;ZV8QK#81G#+(A.W'C\8ZSG^Z8TC^+.VC&>R2PO>/FXK.DS
MJ3#5.<*]CE@'5!S>T%$8ZDM;@-2%DZ.%\KD??B:%8%V2 &DZTM<>K+471,&E
MB,34J;GDKANR4S'-R]8\MF;**B Q]6_O,E(J\%/C=)9@_8>=WAR,4T32-W^'
M#:GPH;LR<CGW;6ZN%L78;$BQU";9R=V7MPZ6(]WJLAQ=L9.W@HF!?4A+XKF:
M-Z[)"+>8O-BZ'#VHVJW"VUW]1S2,H'@SIF+W5%]5ZL3.PR+5U5I/8K3RV[KR
M4+*%S;@"2N5@>F6DT( S4-+V%<A NXB[5*'%\\E,$)3GZE+IFWG2VB,$<LBG
M=ED:>50X<%[A:/=3J;0 CYF-2$D4YQ1'WX*@5A[[": ^ZUB_C/@H1&3@/)@N
M]>9F)'1E"\,(+2:?ZD-5R!.'']BXK,4FGN\<+3L!1(Z> !2T;7\_-/6ACPN4
MO+MU(%9>O1.V9Q4K3K*<-J3@#.]LVZR_ZJMP ^8YT =>]@!-UCAOO<^PRNT%
M;O1H)!Z:/]@'@^$PUF(=:>]T4<'/\5PRG,W_'V,:?Q<=ZQ>385L3#G>$Z^\>
MU#_Z$24(@KI@[::]1V#PN,LV_-Q!%9IW5Z&]%E#;"=\K\]=&V;U[/7DZ* -Y
M*^+XB,XI+YR&0^J24F5RT'6?6CN-MM[]%+9S^P(G@.>!.^B8^3PY5!1<5.9X
M8%9Q+T>CI++V(D179:OBJ#U3B>^;0TD+D*30(U$"9C5CRAJS$9LTAUCXWO+1
MM4)F\CY4NN3;3ZEU-+!RV5;W<I<X\^5S6ONC&_'V^Q>3\*%>=NY,URPB@U3A
M'CBJ8'/?Q&59+"W\K+#20='RLJ/KN\)$;2[M9H#SA9ORZO:V_C_3F=W/\[(
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MFJ:M'YP@/=?0?V<W^E<C>#+V'U!+ P04    " "7@EQ6<@0/_,[.  "WV0
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M=4WW^--,<SWR3=E^-.31%WI&.UZ!*O0I1FFW);GM>L4N5+P^33^\\D![#JR
MD@PGE6_T<S_^NC_%[5.H8+V:B6//1V^\7E4/WP$00\K0F?'F .FUQ#H/3-/:
M5_9^HHLKW^^!/S^Y:N4;+S+>&VT0%Z F.%,R[\\^L0Y87M'@/V+&P#F'V ;2
M(9U)S@QK"Z>5#>X S-K[G<2S:AFL/M?C3R\]3X"A9._L^ )%I:=#3C1":=_M
M\@52,_2/7_?X$>^='H&$->Q?JZ05,]X &T9.MKO=@R)8PZZAG,1;:A;+_BP3
M>5ASYHNR?H_(1- )*JW4O,1"5=N)].S3B,6 >.U&/89?(TU@9E.S9+CU-2U/
MJ0UYUR4HN@_5K">IN.;<9(MO)$A9(L[LY-)_!XAR \X[':4+)X =N%NNE8+=
MU2>WY/<F)*&*\/90B),!3\]+ABL+Z?Z54 LD4,9<($ :TY0U:'W)1I8C0G@>
M$HJJ^KF-.7O.,%"=R'"EEOT-;;&T4^[>G2$\WOH&RU7YPJ_5W86]4UINN5EL
MT]75R\;$,J_\2SA;'M__>&#_C4HNA>T OZXR)\9S6UI/3V,#CK;':Y2?;Z1E
M^C;VW<3-[A;XI+JG7?OB13Z X@EHO-?IM+\DA.*)54&4N',_!\J,>$G:I\61
M MDZ"UK<^><E<8PZR%LU8V(!4FU[*IRO%CBF[['VO>N?(VWIB 4V=.6M\&52
MD#Y;[CN^\MKDG$'YF]Z+_2M]'UCS?+%WH9R'@,)OZ59.>:D-D0N^0Q>K6L<^
MM[9)A%"'G1_YO!41E:?.)%#:W8&[+-7*3)QOQYYM Y1'3.-DM2.O$_X]WG;?
MMD0L,*?!H>JD^O/$=(6^FL$H6T[XZ_\<1\F-+JYIJ!I4?*0]%74T]XQ2#*!U
M'\^$Y1&70H-#@DFDR:P?_OBEC/.UEZG%K]CKK @/>T'G<#30;3K%ATZLK4F6
M^)DZLT#5][F=UIB5I*JW,+$ 3D46ND>+?=6C1SP?Q]%;TOJTF5T-W!ZIJF_)
M8OSN_<^5D%?X[Z'JLOO7O_[7K[)D8+3,P\.D+[V\ Q:KD@>X4RY3Q_&9_49U
MWO:MHCV#GKO@_TA0$3C1C03F3!DOB2VC)6L*)=,^RCL\C2GF>4'BX"/YHTO5
MFRU G*&HO$9EAJGC@:@KV1U@Z6!%9=M3\FF : /)EEP&+?&VX:^$=T#&H,Z'
MM:[:LBV*>5HF%]\JKO*=*G[B[,0QP"ZDSD=GQ-4D5=JZ_BL4%?$<,U8UV)7G
MX0;-=%06>:II$W),#HH.,C0&E3X].]30;9SB(6@@A)XP[N34?J7]YMQ[:],S
M\_2;+>0,NR-+HF'R#J#2)<1%<;KTMG*A;_CPEQ[YW Z:-&22:SZ$-;5(8\T<
M#EF()'E:DSPA(>E7\GBL,(G8Q_PSTG?&M!"IH5'=_;;#[CN8+%V:8Q' !B#
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M(V^Z:NS%/">%9TAR2Z[6WKQP%;'BC'-'E*U0FW87(+L[&RXC+>I#EJ@W.D4
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MR3!<]S%,X=V_[I2F-.7MJ>7;XW\LHONH%UJ%*.36_^2K1XZ=?D!Y,2A9$ZJ
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M1@E6>#$?Z>]B&O)-1$QJ^],&CZ"K<BI3E!MI]H;U2>SJ>XX^K9-]J,:WMW
M3)\OVXDP._*"JX#._P0*WS=11J\=19#"%%&<1U,?O&'">[I4X;^;Z1QX5*11
M*A,K$YZ1@D:E=?QH+(!3P.5J@C*M:';! 7&['D64.Y[Q6ZZ-<B;N6L ;QKLD
M"$2J/J,E84%><_G1(<Y#L0#SW)!-=KQIV[\]B..#KX@01,7FWH,U1\L6+,"[
M!I3--0*'K107)VV[?@FZ1W/8.Y/3T)"T;9F0V%NU[) >X;1OJ:NKRS;\3BVK
M"&%X(YKYE^AH'IIKMIGP%S%@42_93WA4:@85*2]W:6[&<Q?8[H.!#C2PQMF9
MZA(J#]?T^.%(*UH;YX=982K6)4SCW O-LK*^6\W5IO9(*^V9UBRC&5>,AE?*
MRINM4U0$Z2GD/]A/!/U"V%(RS@]_Z$ID85IWQ?AJ!<D1>'_9.E'LKSAT3 D)
M=BI\0O_V@I0BQIJVS#+"Y_XYG-Z=?<TH&)]*.M*?R)1_)5(0)=A!MF<L]]YO
M]=H',BBL;3UC%VW(P3P\[L<[]J7RD:$O,(GMX:]S:;#&U:2O*7!)V@CUN-WC
M@MB%#/C4[$(=F(-_"'^/S\3TS4%BN!QF0FTJ@NO $I'_B4YY.V.KNMYOI)4^
MQYEY83M5A%T9Y^_:#RIETJRMB,?P8!\I3S[NK=67'D)66$#(Z)TR</%IT]4M
MG!_ST1$+:)\$9OB]K1D1,E*5LGO=QY-.&GJ_P_/&T J%+^91Q2#ZQALLH#D0
M0[YV9\;S6BGR97JL^OY;PZJ@ ZNQ-5\2$JZ9G^_>1-6LC(:5+,&)MCWF68M3
M'0'/HOL*1_RP /:SU5'0DB_.71JB)+DF "W]B4Y"KV[BAO\3_C7[:H"9M^FP
M!]A5\@=X%6X,GGH".C7/Z+BJ3]+-LW"<D!6J'$TOE3>SZ7\DA;=E:@JE=-+K
M&'& 3A?'LN16'ON--A/]W*!O'(?_B=5M8#X6@Q=Q74#(IOK;0":E^\M(P^A"
MF:0)R>N1\C$[)Z<U,D$+>=NWCZ<6W_[T:\L61#LX8QZ:<&$"@)AKI3_]D !N
M/:_!L3DS$/D W)KPKU]/P1D7E[!N5FX"G1U45R>W>\C@5FNM*4 0_(( 9YOM
M0T+/'ILH--?.&/2N$^RE&'%J!U9)$U!L+!PVP,";=_$QMX"'^8:#G2HIEG)U
MHP-QMQC7!:EC!]AL9:8*(FABP'D"N3\-E=!]9I]!QZ)F.('-P?15[.LL0?$&
M#B@7HD=WH2B!R9JQ,<]DVWR.?!?U4IPHE G_)0\GH B?ZG"UTI$,YR2;DTS@
M+ASO#*.S]25(4ZF9-M9,PFO&"+-P9#6'$#'76I/%+!^2K$P>P2*DG"7/Q?FU
MUG*<U@DSE!C3[Y<]("=>;TP<$EK*1 9TMKM_IM#:=QG<23H\")'@F)"R<FP0
M),I#O:QW.48/7RXW?BKB%QA_V7O['AM#>AA7Q.E_CCK=8A#XYD/3GBIXOR^D
M2GDVWS#B\<I#^+QIDW)N';] 4<2\:B<)X2S-)"R@HM!):M.CY'(2WB#^-#V<
M!P?R_TN=\_]H3'PZW%V ^[$J!C1SY]V8?NK+'U9'4SY:RONM/M2B%_+[>ZL8
M^C#IVR#E"I3.\6>!T!-A+5B&4AF*Y=<LR.NZJJK"D:TGU+#TC%Q#_R\2I^C9
MT85:-UEK'*N<D,!]MO/C"ZS.9UA?@[R:!/S].1=WVP<L>K8*]T>L=KWIT^N8
MW6.$W<1UJ>]4:[6T[,Q7E1/)0DJ5O7>H03WE>8\+0A^/:<B]^2LPID=])-K:
MOPRZG\BCY;X7+=".KP=L;_J*T9D>UJ$6JTMGNRU6W9@3Z\=X]/E'5X@P6_M7
MI7+/?<F<,XH=X96FA_4WA.-FD.%MW2UXWK$=C_1G8&?G9Z=%D)M^FE5CRQ"U
M(_)P9Q^^O/>SS MF\F@B-^W/2>??Q-G'W: E!<?^@\KIZ1^[9Q"O'-E6\4:R
M8%K5 ^-8P'C7F7"<D<07'M<21DX#;X;4<4-IUA=@K^V,F:3RD9?"><]NJ@%^
M%_G> [)=E$*@Q:<Y+*4()>HPZ:4H:@BS'LN*<ZBN#&VPBJIXS($6TPWM-4:9
M0G___)CO<^FOLF@<DEYE':ET?+-->IND^W/1_E%OJ#*]9<09V^SI]4[+FO/2
MM?U$1JZQ_:.8>=.^D=E7,RDS><(CUZ*';U,Y)^.-?@R>.Q;<21E4D/[F[XO2
M':?) 5HWV@A3]12BRRLW(7I(U:7U82EJVM'LF?#SDUG2;F._C..-(]ARM#9C
MT.N;GS[BVQNN2OYC[R*7H,E89XJ%!W!!Z?C7Z07.__NX4:^:ZP]#=4>LBWE=
M5?GTE%?Z]G8O0@X4IZY\QUZNKIZ8Z 4)S457G&:L@^-!YK.3*N6,-G425!;Z
M#(H95-JO,PYSAO]>0W3!"(U6_J:[M@R^9+XZ%Y[2?C01O3"MXL@[%^T"E9T:
MES>&+=MO'D^M>EDI,8FY,>2=,C:(JC2IJJB%K4D4MY'([W/U/]W++*N-F;=J
MZYP2AB\Y6J)D4-TI);<V;D&7G#JK\NBMW%Z:)&[^V;]/<]O5C)2\J@VM'>%7
M4O#SYWM8)N9SK>$ZAB$"^>CU(%H0"Q@.?T8;T+!N-MTA7*])?JR73ZI#T[I3
M_TXF']S:0(S"/"\%U^DZF'JH0OA$'H%.^B&+]H+F;CYI>)L.8YL9*4$0=@GW
M80P)_,X/M]XT+(#[! D\A!OV4^-^BE[%5\6!>*H-YA*TI%&9XHX0 .-A*';=
M-/HHI4S*9YHN5[LP-\&M&2*3'@FD:N;.T64]WR1HSGMR<HVR%F*=V>:^UY)-
M4LL#)V*_,7M/?JT(5TG^P=8TS..4S7]CG3J%6%JL4*%I!&>D#);"1>@O-"?U
M\I&/M&ICA(,5;W;6?1CPWMC2QF^+-*NO7+B8QBEZ0[P:_)"S?EZ5>KO=>I"S
MHTBK5/>ZA]BU73P)3]?7<G(O>M$$78/OI=_JGOUND0J@R+$\/-'"J7I_Z=J\
MQ6_M6(#RUK7"3<.NI3JO2_T*A[?XDX PM;D[40-A['E4&G(:$^[Z;HY/C7H#
M6^]S7ECO<F1YOIE:E6':,;>$*'ZJ>:<D0_)\"FS64W^FD]+*SMWW'K!O[S#S
M&WY@55OM.*+<\6-2=9&(!"6K*WH">U,N;AQ%C0HP 7/NZ>;@1<Y_D#P@VI*5
M'W+<4Z2W%E7VUS_# DA:*VS3JY/K:B;BXOZJ9PZ376:-<"<B,'U1D]07+^4N
M.WGM ,^NY8XN%9LM)&"XH-!(X*H1,.[I&L0/.P?>V,G0&]*E-A(5^2A_N:V'
M5#^]YNJOUTJ7"82I.-TXUC\(@KA+@YY"@P3;#%>3[E10C.SSQ5:^Q1Q#=Q:N
MD_9^ZBANNK0:QXQ=*'-*^GZ%%66DSK5U, ;KTK7D<7W<_P?#\89Y)DF/'?:"
M'39ZOF1*&F=0T"DQN/7[\(8*:X^Z37(O"626D5UHNPN?-%;D5U;D#N:5*:QV
M+C'J$8T6=WI+]PO=S+ 5<-0>L1(0M'1&S!QB:-QD7\3+/\]2^D9,@IBA!3?[
M"VKO_V1IYHOK1]P4 'K_WIF,B!X=&DVQD(C=.I0*>/9]]1I-_L$5^LSN:PGI
MT-JL?#3K^.,?Z*)JX$7_[7+&J*W,;DM=/-:]F@&7:YEQ!3_7S&3">_I4C3)^
M2S](3-75>S)\DSW=(R@HMU=SVS9NH?W9\52C/O.,:&3VR#[,0?-4,V'PML+N
M#L7?CBY/E#\YAE14,34=HKF$88Z9=>JB=^:HG@+>>]CL3))OPM,P(RJA/7$+
M\0!1]6S;FQ@W"J[U+8'\TOU;)B578)(B+B)2)ZG83*4Z!G#7BB44260]797X
M_DE0!JM&&3Z8"28Q]G6X"?'E,5'MM]VB)H^A*;JKDV>/NH>25MOH8SG$F_MG
MB/UE]ACI"%^R""7>8^?6VW,<'?-KVJ!0K.>B4?1H2$ 0WS'SVCIH8;I\W7_?
M5-.XM)Q5Q-9$=-4F!ZS1?36$G^_'T3B\U[?<.6:DQ'0KV37!'#VO2*M7,-EG
M:%W&&K0L5Y,R2O1)-/XQ<0AME+\X/%T*E,^:E9.F1]SSZS,H5%U6*6+\3W:]
MAIR<NSM17&:5J";!4JA*7<GBC6>TT';X0R*2-F=GO.5])-4H?IS9LG,OI+.>
MIDK*:)G#3P7>[W/Y !)S"]0:F+,R#UU<(&X*]5,@RB:9'KJ,+=X-K%H9:9!P
MT4[+6]%-+M(<EE98T@O! DKKA9RS5<L6OJU$14-J0?3J:R;C(F(3[!-B8YP,
MA+\\;J:8NJVNL4[OO" DU7@N1ZX=_U\.BR&-#AP)8\>CV9^=Z?UTH<YISVYE
M^Y:X0<$>D4J1RAB)!,KJQW0.*VIT$@@7F@P3Z<\&ZR3Q;7J!LF2*]YR2$*_.
M9,=TQSYPY](1/\^-*5&:=?^3Q_O_/E<@>'M;4O%5#/37OBI  >Q3J;L&>>JE
M<R;<J\2DPB05PMW%/%:EIVDR\/8;&O]7^L#PP=-;=LW;_9M<7C!M64^>S0F0
M+73@6\"^#'2/9G/K6VO\8:%&!&>8OQ6'R?<_NB"/ZN]P:O\. APKBK  UKF>
M6)84!GE$MJ6U<70SUH5:**7;KCZ."R: @32*?>]]CNRAURD9TSV,&T_DH1-)
MR.5!5[/=U*%RQU1X5/LZ)/*P&9B+,<&K3V&-G5=<R%O1/_E0O7.J+U<<Y1.M
MP]@+._^Q.DG Q'!VI]YS^5'KI66\B5G;ZX/(TE%#AC7U#X'5YW"+=!C9=[IE
M&\V?G%Q*0#$OWV6VKU*B7QFK47*UM/ZIJY3W=B7##MQPON;Y0W::[ 0IGKE?
M[U>.Q6"Q'4"B4UZR^)1E$<\<C*ECYSW@>8CL]4Z?,"1PGF5T.EG-UIV][ITC
M!'*A?LI:=?Y]XZAK7]P_TA[<%I]JX]/TR(]K/3'<-)@K,IL$TZ#9A)S)>AF"
MDE2KK0Z8MR.%[)BJNBXY/S3D)]M,Z%$P-BH!_LBU/,0T"#J&*S2R2=\NPP*"
M@-4F7>^TMJ-'O0*7$[X*5\\SQ[FAK!>S*I\SS=5B]&%/U@?5E+95W9-L6A<H
M[:-$]1^_E#;=:ETYW+G22T<Z+S8FYD@8.XRFR%NMOLQX]PP+$+S2C'/@>J[O
MTII]F2]C[0T/E+J1YU6[9\QEM+6]T%!CWG)NIF7VTA8A'1^8U9&S5?SUU]?W
MDB7[2OOV8P_D'&_*.CZ4>WB?DW&1_9R"Q37ETS\R=-Z.*CC?4Q&\)4?-/(3W
M%)9>5NF]X9B;<7(.P]=HBM6HMUM;D>+$ MQ\=%(L]?S55M9ZFG-6U;?MOSQ0
M<I60)8SW% /HO63J@74[K:6PJ?DK7UI0D\+[F7P(#U;DPH05FW4T/N*;ZP@5
M"0OU\C]<K%F;&1M']'Q8MV+Y:\'D[TGE2L\['-G1-+,W*?"2GP'O@!>^9"SG
M<P3X3- M+>=]$5K.E#V;'.Z.!<A]/X(LRL0UB+M9?S!1'23<67CWQ< $=+ "
M9"*[F+R6<ZM8U>@Y["EM[Z CEL4;FDQ#^K:3;@\19#UY^LVO%WW@HIS)DT]K
M-80H;'JXQ0M#>ARHA>D$*WU_YT%](_ .]7EWD3+7PP$28QG^XB'>IYF!"G$,
M7^J8Y37[\*5T>0.OK9:AU"IN\3X>R>]XQE6$UI\1^][7*W#?423GG0/XWZ:9
M5> X=Z8!N\KB_+;LC-UY(<PZ3NGXJYI8D>\+QJ!$(T$U..Q9T,3)!W_A]?O^
MN%A9C2W4J$D0N3&QZ*Z,.(Y_$$#T"0O0_&CP^GP("SA(Y"I-_T;K/.7GB@5(
MEZNCUI5E<[RFLR+G54GK2Q6!#=2+D!V3%/+F5<S@BOK^)OAB;,P_N1,Z]^?:
M/'!K;0][-;W<(XB4-D98YC&-SL<:LA]^"_/O5E(6E'?4@I:EU5^/SNC'O@I#
M#&P]A4S[M>[JB0%%J=9KT05U'G?\75147A.R9UH39/T(>BV@M/?L+G?>?57F
M0M('E-9L'[FZZTV612;=Z8ICN)>87S;-8P'VY7Y6RP=[(@Y$XMWE6B?56$!\
MSC4HQ65)A4_G5HD8P!-6J[U7()ZO=L7H+]/IKXSA4M&9XR[ZM'=P2K%G*)]
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MPWX*V3N'=X5003:=AJQ+D]N@(GL])E5)P3RAL[_RN[1=U2G*Y8U"-=DG"^H
M^,L.24>0R"(_7N<U>4K?RSN6(5+LF!-?L,0Q%)GGYYE;*;63D>H]0VXV!)9
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MR]1$_C,G'BA(["N#;*PM0.,8[)R#/OL^!"4A"Y!<$-#?9F+XA1/5@&W#ZON
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MER@7)TH;<]CLG)!/V"S[U2G.LT!B8&?NK101<4Y5;Z!NY'&O$]: 'RXO-S1
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M\[,PQ5W,VTV'YV[GO(VI_MD,;@D,[,GPS*2G55E[ S=\);Z)"#=<%*=>E*:
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MDE:FK-^_04E\0$V.[&LMJLIS'R?K9EUJ^2#U-/+M3<VINXQ;<7WIJD59LT7
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M;N_-;>66C_FY7(%!X _<XLH7/>>U3$)B'[@=Y,#@&[CCKGS"N+ZE3E&[$1Y
M#$"SG6^,B?'R/Z5:@NPD'T=:\(=X%J&3!JRIUZ<<9]J=JN[9) RQP?-CEH5\
M[PJUIV-F"]5660:#Q-SKWSY?F#VN/'V]_?W[M/$K>Z[[4J #0S_)EN(82\J+
M<YM)36B#3MQ7AQ.F<HA*[H)?QL./&YG#D14[*7@ #48>.C6[!=I/\^)<89,%
M"_3S,B\*NWN#O=>O9G=FH,@4Q'5,/"I\*(K:&2X$(3-0JU%^)-Z'??%+[&%
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M3Z]ERO(XMP44=!4N-JAJ@YWZO1),EN70K!,C9KRO7]<(L??.LI=?FAAZG[;
MZ(JY#IBVD;.= C/A:M6[- P0+8F-Z$+JP'R>JF7BSR)[(H1X@% NU<[KU@>,
M_@@:X5VQZN@K@QL&RX@2Q1G.$9US@\2#XX>7)4A)37&-5)\3R%78N>7T7"3U
MTD+F!9R$!0]@,[NT1IK>3#7?UNC9,3R@WKT,_/[X?'@?,>26#69J@+:&62\
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MX,S]CSBDK,U.)OSEE$-3C-J7#/WQ(68:1OMCN="9C%!7IP=[.L!!P4YF]8[
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M-')@7>..$O  EQW#!#Y_S"CL(^_>+@_AZJ]_>(!;A&I6O&Y#/;#U10G=*AY
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M?_4 J+"^N)Z[_A<XR#+JAK?VHO^#!G(YGE;^"8KZ!.IMF+JKE_7M&V:*GPU
M!R'$;+16Z8: '+X5@N\2J"&%+H\0)4D:-!=-@\1)8Z,I[=A"S8)VZJ'2O VA
M\UH9,@7[V$R=)M^7[2?X]86\I:,O$A%8CWBF5W8E)L Z?/!G_Q2!>(H&L;RT
MLH9][;?FX1 )3J?%=&EKV/$#,D[87()#CA47_WUVGNY5;4* ,_5%^U8,3/B$
M< 9$M\"[=HH.776Z%QL]?-(HWK$N'_5A@ ;=\=@BHNO?X@R+DZ!+GY%!]J6L
M:]P1.6V";H_I9II<, =-7@RU>T<Y_/80"VXW@!FL+V/,][?D&9L/#@CZ3:T5
MY%HO\UE_?U)UJ^RA+/U1?E[F<7.&,H5AEZY+U4G\&;6Y@7M*7EBIKHN^:CZR
M,,\^H9MMY<ISM6WM8)V\V[>G*M_IFOMWH1HL;-[.%J;8M#)&>4BI#.R[.!&;
MZ>]_^IV%,>] 1O3*_;!O*4]6K[,E/7>*Z@\FL9S,XTD*JJX4#./&NB2*N>NR
MGZHTL='.L&PZM:L"Q!(<HBV9GV?^O3-,GO%<*W8I[T<;8>]J*F&J1.[+=_@!
MP7J6(O8]-!M'=J2Z1E:B\1[YMS^/1AT'T*W7=B1?0XO-%\W63C%C!9N,(UD<
MVK[\_L 4O_Z%!L79H2/HYLH)*ZR5-*A GY*;?F$NL0; J=T.0-L=F[.+D^<\
M>R Z/M'U>$.Z;"9 X^CX'4A.Q #7O8"E!"!<;/H /E!P".2;:$CQD^[I'4Q+
MYYN9 ]C<>_*BNEE5CUO>CY,KC(Z=][OR*2<KF<-5K%)S:G-<</YZ)NBR>7BJ
M?,;@&^N:.;SQ$TO9H(HB0P!VDO$9AZXZ&UG1H"%?]&K_6MJ6>S/BC\1:!;]5
M=Z)!;C]  K?OBMGR;2@RDCY*KW'!"^&T"D[;*1N VPV[L O5TJ09LM%-IA N
M'+7\!@VZ "P#[$G^UP8PWJYCOY"+7NR\R4@6#]UHPVU.(P/%"/705?O4;/C6
M(!R(77AFN)AXL@ZO;H3\*$%(Z:!\+UW,KK719Z>D.TWQI?GHJ:QM9I6U28-T
M3M95JYL@O:4(%348CR>D?F.--3-<.&^_B,3"&!L87DNMLTG-S5^3[(@AFHQ5
M:*-<II1'(P]TJG-"1G\?Y@_^RCD=[PX )O&9BDD!.?PF *6CU7CRZ$X2/Q_^
MK4>3HBN%GWM&@Z:%L^WV#GG1H -;\'9VJ;U/?-O>P$H@,B//K,DLPS2HH8J
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M+(&*WYI\4A$<^^[/L!^?Q3OIT#5#,J,-XH;([<M)<5[&R)]1SU2)/GD]EWZ
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M^\]SCWT"RR-A.F?M;:+-VBJ\=NO4 ;XESV[ETBS,N-U0LY*TF#;3Q+<(1&Y
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MG*B[^NF.D2(\^)^*_\ 1XX?@?DY$-4,XY0-Z60I :H'8-H6]3 =  F##*7H
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MIQL;08=.L&1:,4T*9&:ZMCJ<JW@,N/-%V\F,D8K2^T^S:A,MHH7$G[_H_"V
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ME7@\='WC5Z!):?" %Y<+RLVP/@6NKU^=-M<1/57)+\?;OD5Q.=-OO\;Q$>Q
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M,&\E)I*/A]//D^I7-P*7+]W*SYPU3V*HM':R'V<S,PSZI? S3#JO:)B:3X-
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M3D?4??2_[3]H_3\\4+2!_P%02P,$%     @ EX)<5@ #+B=Y&0  ^!L  !4
M  !N<W1G+3(P,C(Q,C,Q7V<Q-RYJ<&>]6'LX5.N_7Z)L))5;4>8DE4AV17:%
MU67;DFTC,:',WDEN,;LD#<.J%-$N!R'LFJ3(?9>&8IA=2"Z3W',=N=]GQC#7
M-6N=USYGG]]YSG/^..<\YSGOS#O/K%EKO>O]WC[?SV?P+_@0M/;$#W8_0')R
M<M#/X 7A?= Q2'[%BN4W& K@O?*;E2L5%%8J*RJN^F:U\NK5*LHJ*JIKUJ]5
M7;-NC8K*6JVUZ]0U-#4U5ZMI;]#2V+!>0U-C>1$Y>7"/PDJEE2N5-%155#7^
MQP/_$UKW#50NIRXOIP^M6"<GOTX.KX4($"2W4NZO ?W;D%L!]KA*\1LE915P
M 7TMM$).7GZ%@OSRKL'92' >4EBW<OV6/4=6J3O_HJA_26/OC<2L;[8>??E.
M\V0KUV#?N<LWE92UM#=LU-FV?8?A3B,S\_T6WQTX>.Q[FQ]LC]N=<#GEZD8\
M[>[A?=[G@J^??T#(E="K8=<HX=&W;L?$WHF+3TI^D)*:]C ]XVGVL^<YN2_R
M\E^5OJ:7E;]Y6_&^IK;N0_W'AL:V]H[.KNXO/;U?AT=&Q\8G)J>F>0O\Q26!
M4"26+-LE!\G+_3W^2[O6 ;M6*"C(*R@NVR6W(FSY@G4**[?L6;7^B+/B+Y?4
M]??>^$;C:&+6RW=*6_>=Y&J>N]RJK&5@]G4;;]FTORS[[QEV\W]EV;\;]@^[
M>J'5\G(@>/+K(!B2.3V--X3^7V:<44& VZ]+;W]#_IQ<T:F9T2NCH4LX5&]4
M.&@8C;G7;9&@K^7>VEPNO59&%OMH("*^JQ+#E8)#5@BO$9H/V+E;OYQ0E?0=
MDQW.3Z>+B^%00<DA+%W<Z5[\0KZJFN>6^#,<&;D6#7,S14U*E.,8)7-W2K%>
M&(?4O2X-Y^%0ZTQ#\'D<<LR7GXVT<'W5.5=7=Z\Y[%<<:CG.#O4LR405AXU9
M\L(R)O<0,I02.(#"P\:P^NFXN?M[A%_AJ/VYC:M8&LY.<C8:_VEJ;A*N[>,;
MO*S#I'-/E P+&Q@V.7T)(DD"O-@RGI\PLMD"RT#8&G)5-I<319-G/.MV[7_#
M5T<X>EG)=6E!6*&-)G35C+AJ\)\8;W HE:["=KB$E;G#G IH?G!Z@RUG&W#9
M-"-C[!$3I1?K-F<W/UE3Q7#PQR'+432_\EH!1K'9B$,WNO?8IA_6?25*FKVR
M(?_R3%K(8M)AXT/-.90'<C[S.3F4%+7THW:'-7,ZJELNC=F'>OLNF V>N=^,
M><R+&57,V7(>HGJ!-1QD,;O0),LS:+UXKWWV:E^8L3CBZFN:*5J6@$F*C!\9
M;3[6F.I.I25[HXG[Q_K9QL%NV$8#'*K.N-5^<0Z'QJ8GA&!GN^:]8/3J?M>B
MJO?*GQO,Z]"7D:GC?MD9&GR#].R^37=8E6.DJK>N5W'H-=W=@/&F_'6JL:H%
MZ\W"V9$WR.LY\<:<>YZB=,\FDD@S0)QZ5:A'3I%^P4:3J)^8\W1"[S^#H!G5
M*H=?S$CK63I=@C*-#J5(37O: RB'B&1NN]Z)C G7C.'!4J]PE7U41QS26QI3
M1^IQ"%U3=:B6CT/9W0^9*-*9_G'6C" 2%L?:=YJ:W9TL#GJ^\#P!APBD>7I(
MKQH:T55$7O>8_17>X"'*8,L++2[)1([8+>9L]S'2P;X!^U\LB?M?-:S.$^H=
M7&(J7ILFK#W7-2/4'A$IB;?AD#\BRGCOO&MF\FG\=67#I_^8?&2C'0YI[F+.
MFV(WZ5.:X];[D[$=;3CT)[*H ['L##.010K2'U"8Y&(*/'LX3?8!AS[[R9_H
MD^D-&C*_Y#$:<\==T$;H[;CSN"N\-V'O]=V4!Y04SV9A=K/PB4KFU&,?-[N=
MF _D,.YBV5BXX#SNI-"R3<_GV/(AE#[Q5RHXB1_([6L G_5)611#.<ZVH^ Z
M%X,GJY'U=EB"%QF'3)<F*Q9IDTL3I 4<\OA^3<T1'$H(_U(8J8A9S9PK<=JP
M:$#SE<V29KQS.UR?Z/5PI:3,6AVEU G9E1"S0SC$7"@(!O5=D%<"BZQQB*?/
MQ*$2FBPQ\+/QX\,:SC:'5VHX_^NDD!* H7&+].F4T6K+?W,&<]$(J@?.<%Q$
MI&,P;[HPR=F,)M'!H<E3<L^27(2=\+[!A'V#UTV? =L=FW-E3Z_O$C]8-@V4
M@1:UT:A\^8LZY>^?UI\DOZ V>OG)Z9WP;OB1LM-0KMIGS^C3],.*Z> H0/')
MZJ)PQ\7PH:W 2LE\*%,DU'PGIDTM/3L\NZ@#K%Y59K0$Y5BI.60[61T;FL&A
M)]/,I5Y8MJI*B]$^U(1#'XG8%QR:.[%8\7[9/.COJ3EB;4G[RR;:<,F%$@5>
M<QJ-FWPV2M!+D)YC+<QCINE^*U[9'6O "F0X)$LI,&[!H<?E/!QBZR*+VP-N
MH[;94\!_2X5]41PL_,S3SXIVXRXS,0Q1W= C&+-F.#^KP2%RG+NC]'NJ%4 0
MKZUE#.#J*_[PHN8SQ5S* QS:RT@=$?S&+6)*"LX&\[&JQ8A4'.H)^)W]N@LD
M_*[7F\G8X!9[LFQ#DPMKQ8$G$1; 8UY*H=)3Q\!9AND.&2/PJ@H.W1=W'IT0
M/ .KIWIXQ:G)J %%.["X>_E6=--QM4#U2?9?(:D^FREXW%T,CY7<GL6AH; %
M&+,*IA_E"U*[F9/>[;^ O45N?@8 .=G$MOR97M>.+FO?*CW?*FJ0Q=S&0J2)
MI-N/0WW5"1JP]-?.! IO9HXP0_49=I3Z4@+5L#ZZWN"6YLBJ<=>'@5\35E_C
M8UJ*<5=*UOCUYMXQ-R&>9,1T;GW3Z5I]=F9\'^77^@5Q1&9H)"AYD=H['%)=
MW%#D(W6<Q] T[>2/LRS9',OSAS,X='[K5L+L8GT"V.^,3]%.AC?W UM&%I!E
MC(MDF5)^-'I.9)^+0TW=L5]QJ#CA(E-J3MKIHT0WV<^6!<E>PX*> (V.0@!_
M*1TA2+<%'U[4>0N>9L>M!^CC6N)'$WP:0P2N^=JTLK":"$3\6[V%+"2& B]N
MF!9?4&B T84_.G+ RN%!3<CDGDZK\.D@@ETE,\V^.J9MP(*1IM6B;(HJ.] _
M4P_(GID1[NJ\?,G]FLIINF+7G!KRKO0J9SB1&#9 KO0RQ:&5RJ(Z'/J&>>L<
M=ZQP\%1I;J\O*.!*$,AN'#I*%JEZNPSH%[[5OW2PNS[RW,C<)9NA'LL76%C2
MR$EZ[!BF)1N]>^9#'*_=H<,4+2@R/<E')A[1$L-PZ.GY -%[?KU.:A;RPG[7
M2_$K@T/HZSZALQMM"(<V!>I8%XU_(8GWXM";(AS*,B&5UB)76MBP+74;[^[[
MBMOU/3X5;]L!)$P\SKHH8(OX5/J4DJ6%%G:15%W"RB3'9RQ]J-(H)SH/VI=B
M'OHE6+17-ECXOKH?#DT_?]N.3/U.KM#"H>LX)#"_=(]4MJF^3Z.7QU1&P['/
MT3(C0XX^*+%[H (6#7N8@H#%>^IUO>0[\,A[[ !SBC80"FXM9QW)W0-J=Q5-
MMO44#EV&QSNG74=IJ]C8]FX>T@[Z[^>"KLG$7VPT3D'.-AI_3>)H]QR+=Y*L
M@O[:87+1NGWUR>W"^X<:!,']C6RCC_ET21/I#J'\ME 06W^/B )D/^/]R7=K
M=(6(1;FT7#T<R92T1;:Q E"0]QV9V(VKL$A5&X=T2ZSL=DYY1+JE)Y3&3>;Q
M[GJ5@U0Q3<:A,^,^RX"?.2R,VPV/88Y2_WWE&.O,"CM'OA%69"\^EKH#U) 2
M]A+0A-,XQ(F'OYIWP1/ K"/%K@:9:-6/C\/$X4P?>[']6%P;\MXU#VE!F<(!
M0E\:C;]D*A-T1DNG,X5L/LB'33@T^V+T.JMD;B=SHI F[#LIRR]UP2HZ&@@R
M<["7S3@T[/=JOUE2>+I!84<"EM$ (M)5'V-VJ$4CL"MC?YIVG[F*].%<D#>V
M>*^<C-VV/VP-2N3F):HQ#AWOPK9-)R)/OVSUER -0E#RJ6VFV$$F=WOQQ$B_
M#KDN0=U?XE4Z#,]&&AWZ0(]ASZJ&"9K&'=AA\_GUNI'C8H2"L<*[!9:P/+9^
M\K'JYW/\XKDM]SL!1#\6GK1HJI1-Z88@54Y]5*V,$3NL"6":T,M^:[_M0J7=
M#DE#%&?P0M(%'"I+:6'!=Z)KK3='-6)JO ^)6J79U^[;LZQMDS22K-:K!#47
M-O:Y'<>AJDI,7%Q30WA%BT:/D$TZ8^^&5C8='_>C-EG$F_4S*40A;![!CK'4
MSA'![\.1V%WZ"U>D*M_-)GW'%KE>E7$X")VX6*3FP,62-6_?<N[IM16: $YT
M]2X_&-.I/M>BP&7/+G'9==HZ1<5IPP/DTVEV;Z5:69NKGVO/[]Y?0'$8^\#<
MW^51C_0L)_X=2X>PKP@]$.$F??AMRO]% +'I+3*1G_\ZZGP$,\XS,(B<427U
MXBG&8+I?**]Z^\7$D.,<\O,^NU_GME+;CC<1>/L0S1!_GHM#E\D2:39(MW;M
M],N^BS$C3G^D*ERXX.KJELRALBK)4A,BYX;C$%Q#4$8!?-Q*G:E)?355L8W1
M=E%JTURNFTZ\F$1)*K7@ELN62)EP&:'.KMJ ^GW';@9[P&[?0:14!WU9%'43
M:ZTVPJ';,%>O_4@\:8=31W(#PIGKJW"4I00NF-:5MP=J"\-ST5=)08]]L6@,
MZ2T^C4E*1#^Y1_#W;*^06E?AT-DMH!D=*3J[WG%1,A8* '0X2%MVB21;5<ZP
M@"4VX3D9C\9^I_$L[LH^%"<:%+OU.HHR;7!H17%R<X&JO:#;Q;.?\M+>8.]?
ME#[HJ@Y<6W2"W2@EIE'&9"W[Q@  A*:^.9^4$W/BD_.M&I=%;<$VT6-+[^*9
M@V?:^EFAFO&?:!<C/R5RE)LJ1=472%6DGXD3,*K>R"%L,C_-G,B)AK%#EIJ2
M/5Y71AKTAT%O/_++WR* %(U#]+EE#% -)@EFA#>9-&;O_AGIL>'4 E.QM+,S
M=E_BQ*:.O%-MA;D>,SM.GL^:S&WX(2MOKVM^?LI>YQ<![B?2C:KL-Y]W]S'(
M2SI1<-+@@?C8[V^2B*51'[W,/D<1T%]?=],GGS'B60;279=R)J3']/,!2RI[
MG3+LWW77'VX#E#,GF"E1[EJ?8$F!9'Z=2$#"K0K0"7I+9LW?%H_@4.X!8F!0
MGXQ3A1[*+T?-;=][(N+K,WRD#X!JS[.2&PR+?%:A_YZSD?D3+ QFPX. UN>C
MGQV ! .ZJ;KW;>1M9%Q^/DQ67+T!]$+35:*;9*FW-L8R!RQ!-6WH$+)$4J.3
MI?ZJ ,DVE5PWWVG=,H:TV_9(6SAN05@L14 )KGZW(T6'S+<F51)G0;I\2\@B
M2X.ON;%EQ)I,CM1? )"OI\#835:]:U&*B)*I!^[K,H<>+_"V@CA'7 P5,T,,
M8'[CP2+!'63B 4GXOO5?5SD<]9FPT9P0U[70SPZ@]4H*ITIEJOM[>FID'Y$J
M3(A#I:1O69;[!4*OBZ2JQ/T[9$N@'_H4\QVJ8X;9C<5J=6Y,7T!/BU.Z3]SR
MJ[WW$[$66=!Z#7XP]HS:D"S3UWG'4T.17J1;YPNWEC:USNUK'AN0KBV!)R:I
M+>'CVAA<9)S%WQFRZGEM4N&SE =)+FWAX3>6B+/R$:-1G]>"*%@M%H#U6H-P
MZ%7WU*,HEZCWO;&)4OMK)P&8F2I%J&$G&ME2DZC";E7'.U\,G\;_N2+>\,GR
M_,:4,"O89R^K]949B^=$[^!>2\H+>]+GJ\\W66A9.#=A><-!4FM!/W&45LO\
MDFG;OC057((9^E=8$G49#Y>.NUGXD*3^_,BQHBPWC9'=EPVHIQ+;VPY*LF!O
MIB+8D3^7C0&V7F_\[#,R1!-$&99+W=)XN@X=11:S4IM'F<<SJTEIEUG":I^G
MW^6[B P4ZW>Z;(O\@\;]24WR:([)!6T4#<]Q%.U0E/T$NKH1@EEY2IVLMQR?
M;K3%PNB1(!?6@.3+&S1%-8$8U\M+QI2 %'-A("(C,G8\N_=/M3M4)K\J_WP"
MEHZ,S)&"<E'UQP3)9G#3.Q<<6K"!L<V=:K(U/&0HWW'YAAL\_>65K:L'P5.O
MP(N'P'(W@90<!8UPH SY#\=6A9#HD>5TN"T)^+V&<1&(!\!C&@\A"ZY@T2E?
M'#K&Q)S[<"@ICW_X3&XC;0T]85;F.?L*A_+_X@+M.25G<2@VRKU/?+)N!%D*
M9DXO7L6$LDBBX@@9"B2H+056[<:Z[*H_S8T.?+@W.F"+[C5%%45(3/'>B8UC
M@P8)<UH+=:8H"/WU[D<!3J"6CMA/,8<"<:BV.^M:T@%FA#0/YL246'2>S\0H
M0!=2S4^OK5HZ*NS,-$MQGRC\V#&URYQ4VN^6%O\$^]Q&_5(09Y\_3U7/F?;Z
M%FC#/_Y(XC?CD/<H29@Y7Q3X(H!R'^ H08NY].$UXP#XMK:[8(906C71-Z=?
M47%_8]@L9CI?2GQV;8? (=9I@3$ '+PIH.6AN>5ELD@47V;=2OKI=%1=15!]
MBJ#H F#<@!YTU:-[<J+)6+E[->BE$; HX\!=:QO^I-0U$JC$U<E#4D2,=# Y
MP,9A_RFIB6@'1@-<M@Q(HMK69L6TJ _A)3TX%. 82UIL6UA&DB)?DBR#>2YP
MB'0#AQ2HA"':73W=+I-=/JGS*O0%U=JZLGU1G+ FE&0>N70FQ6(7*(?:O\M!
MV:,>O0F>._,;3:)*+1B!8SS@6A6I7:AC.:5,FFC=<KE5-E=9S9'2EU)JO^WW
M;-H4+0S.])3UC@<SC+]Z1OG$#Q($K"93C.7>N.=WR@7%1D?I 1%12*KJ9(;Q
M<]$?:6/%+>\P^7:JVB\F1;&]%^*'R0=&WV0V1_:Y1@FE^?2O['+?.=T2[)/U
M06YH^8WS[:&;35U*,Z8%@SSK5KY!?J7;]^2!>3<RAYB#M<#:A9@%5:^-&I0?
M.$C@NG9*/R4\&^@7)VBG6"8&]S<S(YH&A$A\_.F#3L*1]6HV4BOX8[&WERA[
MB*;6US2..G%_;/M FQ[M2+)BR=B,3GX!* H@2'%(A$-<,B!H7E%;7@(L:]W5
MV3E;\U#2_C'[8TDB(#TW$Z\%L['S\'J0<EX<=63RQ]< I5>:<1&4SB7<!03R
MNJ<%UI']X$!",2,>2289YZ(:(7\BOGP?+C-^2SS\"(="%$$,$PW+P&JIZ+8W
MY?RH=\/'D3D6+!J#??5;\BTS+#/$]ULP91MNU/#P!N;P$_[Y2-J":H E2.25
M:[AZ-/+X9*_7\T)['+)>V.IAS1&M?]4F^#GRP&CK:/?]:]Z"5]RHET^FB$1!
M>6]P%G*A(O:+2?M<]:F+S05OLS'3M/F.P2VR/ZPU15Z#;6=]3U6W1[56GK]\
MVEK@BD.^'&?!6V@IXB'<"D0F**@LXK81E4E0Z*'(+YO'<K'H,SI1_02%);4!
MFV&V (=&WB/8]E>,8U)WZL8N$]!.1JX!IEH.JD24T?[@QN,MG68$B3PR:3[A
M\:$@&W"(VRZ\'?5(M)# F^'I])*E(:F,2D\1:P@6A_*"?F-S5WFP']S[Z1/?
MM13H#H\GDA0:*NE^S.(=JPDC3-,S_9F<_-O8-C]X4:/LF<[CNX(Y"RPRT-Z!
M9W801L/KO(!35'8<P:$GS\ME KK7R+ @VMM;((YJ%Y#>+-BJI9>/]_&-4!"!
M%4_,K8[R3V8Z=19M2Y-=3+; ;FR+L*CI@3N)']W8>@S"I4L:3/);61\'AQ(L
ML!FD%.L,YUR'_4L4^\3.2&V3+&'1BBG1M'8:MZYI!P5HFT-J\=J2@W5[J0')
M81)3KI:V0$G3^IA7B4F*O>M(96FW@SCHBZ)@D$<YM(B@"SJ/A2%6+I29$?9F
MK->#TX>6*$U=%:96GV#VSEL<*W/,'%O @IJ$44'L.I(#=8\LRUKNC-_!4]5;
MK0TZZ'DF6=+S87KDGJ21)M(>[],]Q. Y=GB<CM[MH0W!\Y:^3YN"@D(,[V.*
MR4T_!-VM"@ON$P;.YO/8L4R"M=Z,UK=?1)>-,^U/MX_>V*5CICFC$_5<*TLM
M4SL]0>)7&9AZ<L*0_A_5VJD(170AS_#)*H,K]\C:*#\!$X$C95:N.XAH(6 ,
MG6[<\40 G04$5/%$^]/KWV[G$F+FX2Y1B%TF5G&Z%G3A4^1;F!)(* O0XD5&
M@-G%%>?'0R.[K5>C\)OHQK0_HW138?&XQ*82F:4WPK.Q7'/F^/UK0-0IS8#,
M[ V=Z7!2O \ZCAX*'.Q)>$]:56,J'&[]>9G>>IQGOV2_\[S14N.PFB#Q54L#
M&4"/,-&0^QHG54<URS,_1?]9UI6,M-C;5[[P! KLG]U^R)-"J%+7;NOVL*&&
M[31=RP;SN^-D-#Q 8A0O_U </X(IO>/JCY3$F)X#E,7C>0L0H:>!N./^2+C1
M;5P70Y<#<0Q/)LB4/*K+GEZWW@@ X^9AJOK#J)E3O-_@^0 G"^RVJ@^0=@J!
MHL-(IXA6EXU5G.DKQUI+JE\4C/],50H!YV*YN^%6R\ BX)6S1<, >^(**VDB
M@U7 JMVT=<]CL6JS(SNPZ%_I$H+-IF8U5AYS**%J1!3G:RJ[\GDCDE)W+I#-
MM1TX-_S>#_2*S7XY[M:C2?ZO<M@-&4PGP^ST&V)=4,8*(:+,7';-KJCON%7]
M=C."ATQ!IELY>I YG$/#"MRY_>RE3PN(+$-'=N;I_0N*HV,MJ#IA6%9SSK-H
MNQ]S5I\M6=/;R>U&U]=_* +Z6_U0U?Y/IA*Q/[RH(_OIZ?V?K3=S8U%UQ9KP
M:W>EONY\YM0C!HRZ1M1'(^?A&$QM@5&D.Y=4WV8?+\@W@CZV48VS)[\57]7Q
MH3\$3KQ4%-CZCW_V_J\F@O?\"U!+ P04    " "7@EQ6HGCOL2HB  #^(P
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M)[B-=L,TGEJ1+*K'D DC^H.'/QZX<OUX,%5^(8M/^343$WR@<=/.>^ENA]?
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M0LRLPSRC'; ]N?!AQ/"4(X< = SE.'NL&CP!+"_J[8=M[9XQ*__8]K7GPU$
M'PZ1D0'J=Q)ZS<I'XN>N\[?+RQI40A??P%- ?YHAA"J<D >'@^O^[Q<O7X+=
M0O^F=%LDKCG)6KU5 YR:M@";;^LOES@3%7_W!8M^F^*76'IP[XSN!&L?M/3I
M5TVJ+0W^+)&1M3.UP=5X)7IM+%ZBNL\!SK_2?&5,_K#,OVKA)4=MU)]WG1IB
M@/&4;03NW!$V(_Q0J,+VVFK7^VXWNUQBWG^CT14R(4@T-*BQ^058=OM^?N\*
M<+TE2H&9(3AU'3K@7UGX&/@%</[ZTEG[UDQ:TP0[NW< /QRKZE?LWS*+2C]
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MQ,G:4R%.(:M6-6W=HC9\3SV;K8YH<1TQL72$X*_P=UR*G*"3+X_5'K@R>63
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M;7/+^\ZN[I[>WS[T#0V/C(Z-TR;H,[-S7^<7&-\6EYB;6]O??^SL[K$.O4
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M=F,_[,D5>NO6+\=8&YN?1L$_R!T."]4K?%JIYG$-T$>A?5(C7:)<$!O^*P2
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M/D/=ISPUQL$WN >E-3&^EYK\9&DPL\;--6#'XI*Q;&F%R;:>NLS*D'0%)/Q
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MMMRBH?4"G$ Q@6M9>)0I2^-LYOJ'70A[/-EV<76975N 4QZO)RT5\),@MY4
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MI/E*67"]=56&79WL5P+@J]??_=#SA"VI/M/F;P,76I"N"2SH!P'0+_;&8)
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MG[J_J7G*RDRA-[IZTES715>]?+.]%0C2B/KYJ/R!#(/"*GM"C5^[6'7_%@'
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MOE"U>JJ=YU3:OYL%<:2 1ZJ(+5J?56I8-&*_MO3XP>HRF39V@]_;T?RT&R,
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MV2=0GT 8*GXWN)"72N]$\]S[?WS<DWP;.6@PBQ .NT>?^GQ:)W*I@Q>LI':
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MW<9T@%^@2*1Y5:(\1@0?1"]NK&Y#  1.N;2( M\ABV8A86WO%S=J()_L2 D
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M3J@/$PY5HZM6+V=PW"MM@D/9SXFT;XA5BGG@:?$:1RP1+SJ&ZUPH+@WE= @
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M3#K_=G[HH9B!LE/;JS\9BW^V_&+#)RO/O9+U%23[867,BF6,2P"F0#C9A_N
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M)]*_O$7'F+_+1(68B=GNF=3/4C_-:O5<U<4S93LAPB&7]Q:P0+PT^]ZIONB
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M8C\@^ZB;"\T+LP^-I]S3G0_[8PH"DA$?%\QEAN^I[3G4>>TN%TGI2>V^^+F
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M]LA)1ENIIMV!9O3YWNS%T[9LPV=DW4ZWE+,\KHXS'Y%!X^!WX%"GF<66VL@
M*QWV%F!&_T9 XEZ*@U)X)W@2S^^K^0WMZYEL7VDVOH&_QC W>J,K<"7"/+UW
M*SD90A*B?3+:R+YQ=GT_66?(JNJ 0;RC._;924GWO(S-P_JT[_$,K$1L"\P"
MSY@VL7'W4<LKL1 6[G68/*&_2<)+:CVUM?_8+RH11%9L*VM9'G%E6MY66"5/
MG/&M5,/H%I.55%A"5V*\C/SQB)5[A#PW,Y>)B?>3CCX>V0J7SP%'FR]:7FL6
MV52-B@*LJ\/B+AUQU9\1'Q:I?:B"-8AV<"JVFHS6;L+H!!5Y,$/M/2M<?>.D
MQI&MH=4NEQUX6?TB0AMD2CZY=R0LMI!*WV6K3I>F99O;R/%.B&TZ0+&@F[4M
MS?7[K.8[3Y9PKS0[_C/WY(?H;V?R7@KN$0RC@@OG (V@[5@1/+K8Z\I1\,CG
MJPLSJHFU$OR_B:RDJ62YO#0+2YT*Y(<1XJEPO^L)3?-E>0Y(T93GJYR'R'+6
MP?)!$7=K"UM['I+/%]./A&$H\4Y>@:@TDX1R78AA=CO,^.21S$SOAM]2*8,^
M)2UU9=L=44U\<>Q.27J 9VQ AY%-6@/?:OC2C3X;J\+XH-M_'%(X_6\.=LE\
M$(1(,(BV_56B<E12_ILX(1+H9O#YWT^#H@ B-.ELV*,839:HKOX<YUS0475]
M(^#--6,R:6*DU?(>\K A?BM ++)5<.)[GCEDQ196V2"/E4CLY-AL"E" &]O!
M(<>BQ@*S;=+=3CDLU[Z=H&I5(MQ[/9M>$:,+KR;FH;Q% GZEY"XFZDPMU!^T
MSSP,;$D],#5&11CF&'+;*AX$,T_Y]_H2_"0*=/=].4.4X@U^+TYM=)&3)XZQ
M&MBA75FJ5H04J<-S0QJ8 A(OO$*]_.&%5Z3O*U:? SYYK(NK+<"8X%Z48<BZ
M@W:-+!HK#[J?L2 D*98Q1%77&*K8-@+CN^=GL"@LL>$Y@0OQZRKM 1K3R#+A
M7][&!(H,ZL[Z!<7WW],@:40_TI*;<)L_<9G%UYP8:D^]<W \-2'W9ZO\E10.
M(GXCY_Z/>SYNM;,BC@N",=<!4S-&[XCAT_FJGU3'V79^/L#QBM"RFW/F<YIH
M2IZ@6 =_K.M'*0U,G6HGMOE$8TX_DLR]E.J!^$63O^AN5V97[M]MN&[123Z
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MR"[_:A2P*5#'ORP36&#+7A'!-?BUDLS]I!T_9UT]$BEO78'+&9$^L*GP.<X
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MYKY-D+IC8(H4B]J$R[H?KZ]^SB:P48#W\?&-7J+C2/N=L_+ GTU4K3)$=Y@
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M\Y;DIWA^ZW4"*U'GWB>'*O>],C4G&H!W].0+H<=5Y=T E\:]A\8/QI\4LUP
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M9R=T6WR2VM>X2="G^N]O#M?7.'\<;NW>($)C\5"\UGJP34NR'7MIR;,[=C<
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MRZ4!(J,7)"=SYG)]JB#EE.ITT$E,(0WPJH?<#R[$85:GPY9\P?BO9&WZ#;&
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MW!"GW2> UJYF31YND91-)MIL4$#5)6%D6O%L)I/$> )8-1.LP)O+:!^E$4
M')845K^$=*.L^B7L_Z8E]*8EV&_+/IBVIF#")F!^D5S+\0F2D4A5$0$T+H)J
MS2AJJ*@S91IICCYH?:8N"?/^0"U'4>0[^O]-J&E,IQ5FX.%#=AG#KR$T \\Z
M5\SOU1Y4Y6G>\)GR@1$L//N4J1Q2(3LW)8#=O/QEDTK8<^*.7@AU0NBJU!#.
MK=D;7*<'%S3'UROBYD@J, )PE@;(UK0&9]U1[!_FF%MRK>N#UP'OGCVX.FZC
M0605W"!C3H]V]EVES^S$0G>+4N6SK#<ZCSTU29@=ZM?^<V $W<970%\GN:FR
MG7:7U,:GC0#46A9ZCQ1G>1 ISEFD5I*)5-\A53GNQ@:5[&RCJ.<3^FGUK4]V
MX&EI'.CY"#A9G]Q=0L'9>56.(M*+>QS.DDK62-I))3U@G$T>2X*A7F2P00?J
M49Y[KM@<MS@F(J5<20#G0-4)+:)'"XU1!!#@N@O?WJ)##B+,1J2US;TK10/I
M_+=),&,(7H#<.%!#KH(VA3;/N+3)'!V<_12/^#*NEP;W<*5Y;P/[$.SMA9^,
MIA@']11YS,3KKB%5U7$MEL^1/OQZ!XCF2$$-A5J*R8SG3&? ,X0,(H?MUYIC
MF@:0B1KL^'_,USQJ[\<-6B-U!",VR,LP[K9P/\LIXT7EEAHCLW35AH?N_.')
M(KO594-=ZOG92DO[("O_S5N7]?QW_.*XZ^_5#7\=N@2?7PAIY9+,A$('M)P
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MW+[:]"^19=:"_LNG!V(@!F(@(*+^3U!+ P04    " "7@EQ6GH3Q0R(I  #
M*0  %0   &YS=&<M,C R,C$R,S%?9S(P+FIP9YVW95P43A3WNTA+2Y<+4E+2
MC2 B("#2W=VL]()T2W>'=$NS@$@N+2 @+ V[(""Y2R[]^'\^3[RY+^Z]OSGS
MZIR9SWQG/G/FS./BXR: 5$5161& @8$!6/W7 (\K 'D YI,G_]D_8?TS;#QL
M;"PL[*>XN#AXA$\)"0F>$A 0$3\C)2(F(R8@(*4B)2.GH*2D)"2AIJ&BH'E&
M04GQWR08F/_&8&'C8V/C4Q 1$%'\?]9C'X ,#Q #B,'$> %X0H:!28;Q" 4
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MGMM8B7)P^+3,\;2D,S[]%07 )]^&[D)]V;%\YA'@,*EDK+!F#>;QEL(O\5"
MRKRS_ODVOCYL;XLY??N3DM'9="R=9A-*=UN+;=O*8=82%%@D0VF+I;C=PA :
M>O7EHG\46 XO]U8[=S<OOC;E[ACRHW\$M!%#[.$;*P1#$-B-X8++[Z41WI@4
MEC/=0V8M,<E&L\XI08%^7)SNDZ&4Q<'-AA:C-<?.EOGM4.N6]G"OVDSFGX\
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M;1I&=G2NNB;[J+')LH [1*V^:)JSPGJVA;$$N4.<(16XP (&?I_TR_Q>HSU
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M^'F[?M_9!"+RJWN;JCD@W=7X0OCXZZT8B<AS#9T*9&PT^!7Z&<JQ;/Y&-(.
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M+T3$@53%$X.8#K&U,QVCD[T2;* .81:.B?/2'($J0[Q@LOPOWVG=:?QGM"$
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MXI3=A<S%)?B>/TZ].<%1TMW]+8:CB/"?E/PN*,:,@R"8\+R;0?/$&!(SZY0
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M2T_&<0@.UZ8OG"N6HVWR7>HAJBO\IOM0"@Q62FWG>N90U$N=2RWNAVOW<;P
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MKT]"0HE[A-14_N69O8D4?S:OT3V: J%UW'X[06-3/;^YC02QGW/F"^#7J'M
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M+=U^N%P.5#9VB<\8ML8^% IYSX?'75D <PJ99$/*HS5?  Q08:U%Z9-IPQ>
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M?,2JY9-JVGZ/> 6F;/K;CF=[[VTB7/<"<(SR4(/P%SC\4<%EB2=/R%_Z<D(
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ME5MW!H?+CK6239,"ST2\<+K*'^MH'1O7:YN,]F++_9=<(O7>M&3/YE+\$GA
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M\V8R[2-;;Y#9J LV"(I1/0];X:A5PD&7HR2O#WB?H!Y,T<L:^BX\QHF<P>Y
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M "H   D5Z;\"\-^!] H9!14-_?4;#,R7"5!<P"LD9.17*,BHJ"@H+Z/^+^,
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ME6B(W5U+9)J@(B]ZP'"B.'Z?3=[YJ6?= NK[1II 7:SIA;4S(V%RI<0LPTZ
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MB5A#5=J-SN=M&%.+S/ZNG+D@B@?/I'PZ!'<3['YCOJY::KT^J'X>I(LDBH/
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M5WQJ 19TFZ8/C+,["771;]=EGA8FS:>.:&'Y=3\R#?:5M^KZG2II8U601)R
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MC.N%H=<2GJADE4R\R9QI)Y:CL"LBF/\664:1FR']/KK_KY/.G:]VKAX>.J&
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M;>%JBR.YP-) 2Z+HZS%G$_/P+P&<+=1()_%C/KO09\ 1"8]>P80!;1OC?5%
MT'5?NY!ES QZOG75NB"]OZ0NW)[ODD_*KW,;;TVQ[R,'B2)6U3AIBQOR[W'6
MPGLL=+6$/C6B(-;LW-=#0ALDHDZ^3BJV[PU^N =_K,D[P%T7Z.:69C[\&GS-
M=7Q (M#):]D#*J.S+MA[5[;TYNN /1YG;?$R)R08JAMA(D'+FU;8Y;@NW%&W
M,LNCS6'/C__;*G2@A89(_?HJMHFAG:DUW-'ZAT>*H4.1QI)"SY(VBLP;.FK:
M$N0..-1-\5VI#:)7]GC\)'%7.(!70;:R0RE<'/O&1W&A&B6F9=;S&6 >.%9A
MS3!$QCKHT+_UQ.P5;&\'[WW?53+0=QVY<4;"NY[<M+YDH6RJE[QTC6J:($1T
M\D059JQ=&%%\N!H_K2)2@_&IH#+DF-7&RV7@Q+U1\[U'5PME<<-!U&"5XHUB
M;D:6G*&<F(:8\1TV^@M=,DUNAEJH)^?Y$F59L;@M^!H_ UCR,9P/ELLGI/T.
M/#T%0D*X.*SR?E+B(<0_/XU.QR ^X.U4W3,4;[HPAU;EB[CG5E;E"INRXF<M
MNFA</C2_&+Z>Z99Y WF4_)W8:O^#LIC*<G\9=+PC1MWCR)*\E&86#T%4VQM'
M'7\R37G-JWR\QF> 6US$:7D4X]F2;IH"3,L29G/J5=75.5Z2)?MX^@Q8M8WO
MZF*6_32_Z_3WJM)V;2;&2*E53R^%Y;M]WW7J@[2/1T?AQWR[YI2<"/_?/SMZ
MVSM F[7?FW3/IQF;WVWY4OI7Z"H2=J=#"R!8'9:<RBX/&5ZI+$JV<3KW<.!W
M$47*^,(%64B__>]DTF_79-G6:1GTIV+[6!L,5: #S:Y7Y4@4KVEJ'/FM^-.S
M:^BL72V=,7[08BA%:=AC"-N)JOBX:GZZY$RH;0HTJK%-J[B4@QE($F"@MNJ(
MZ5!OFR&?-/;W!F) 5Y4_VC-+12GFB#'N_%""GW%2"_2SAT[\^A9_H)N-GPC:
MJDKGA6Y)-WXFP@7,;7&=#C10^$8=P!2TVHM\TYU2XJ??)ZB@VG&S9I50 !U=
M-7DR'-FHZH8ZC<]VJB_+4K5SK!KI_#O_18WL'ZH<5M,MNOA.!>]'#:BQ)!VB
MCE_D[O].R=K6F,74VUW1]!L4F6=!#;F 7>H/*7&I5[^K2Z8O')?G$[S5R[W@
ME2@H20?Y-2 KJD4,B;D\P@\.;1DW*S*8P]JA5N9;05V^8-"_MM@C!U*&H_&[
M**?#O[&;9:.#Q-6 =U,;%3CT6@D*2Q\R*VO7@.*J>M$D6=\2-I6=;<P_85Z<
M:T9\B-!W$Z@HD+!WB&=N^?Z57VXAK6W@V,::KM1MA,\>="%%)(EM%G@,1I3)
MRZI68#Z1P )6O*]*9S@DO=!O,E[Z#U44)1M&Q[?:G[@%,:'3S>]NW.YFU-?'
M<$$WVI+W]!!O%V\OXOWH@TO>5=+8B_38C3'&^[XMRE!87=>D.\,1?8.4@O.V
MI[D-XZ>JKWMVG_(20L@^U@<?5^:'<*9X]/B3K!J0\%1A]W;RM?[E%TWR7T$\
MV X$D-TX0^T-Z)TC.S<W\L"M@86^9R6:&/D +("P=G(<I(I&L$SA#E.:0/N7
M&8&J-. #4E(X"<JWT.56\76CL 7EJ;>+F/>U_7_W.QX=<I)]8\V]HF7 >C"S
MX&2ELC<Q\2N3NS9K;+KZ^_]FW&R,<L\)"?,KK;FL21/_[7=R>>"+<UX29J1?
MY%M4@@NVE0TPY=,!+)T:^/^Y8FM;E_A/C'(\-X2=V#81M,]=XFIO2_0,H*;,
M&.&GIQAFTOJZN($O$R?M-0MA[*>MJ=*[\=Z SK.XH_V[?@:8/0.\?'UFTKT2
MI3*Z0 _I?G_*]Z!FX>;$^+U+I"6=(BGG+-5-LNH__R7EDM9PEN0:HH\W/X4V
MDCWRH&'QB]BN/.;JSS=^DP)(K(8N_SZEZJ;_E (*OI5U//8%JQ[-M[PUZIHP
MDKTZHBZU)(MBO#6[I@QO4G?RJQ7Q[M5888ES&!6P9X5A6L$__31610-4M%&.
MKQ@ NJ[EAW+V=%3IBE8E:EIA"QYXH[;U1LQ==VQZ:"HOY-]4K#JGB\>*9JN]
M3D\43XXOYN=!F?SSSS1:D_7_Z.,\P]E@OS^>UJ.T?8PJ;:A5U*Q9*26DJO:F
M8FM1-%*4VBLM%16;VA4S1FRE-JV]M4;LE:!VK6@0\??\KNMY\U\O/O>K\^I<
M]_4]WW-?]SD8&-_K+^P)>F8PP2E3:&5.U3.3DXR6Y()!?Y\5FU#O1U0"NQR#
MCZN@)N%;8L1 #N<23D:\SXI]2FQ9X?>O\9=X^:[IT(Y&=)K+3YUAB+0O(@;W
M36>Y!(L)\NJO&=V&Z)S4O-FQ?[OS!F>_A])P'T(T#T1-VOV6OT0I&8[ NY.T
MZFUG6AC[;_40VE]\=?<E%KZL:!RM;LQX.-]W9"9^N.D/]V;\+#2_^GCY3<K"
M0D71F%JQ;S7RA?Q$BL6"#@P_:5>/@A%O%E9;F)L]4W..Y.6)B2V;34 3E3O\
M=.L#W?#/*RVUG:%+]O W5\6@H)=7MS0>49WFQ,88.QO^= U-;?A@);7#R'IE
M7\&+B#U*&T_*=?.FSNCK%?V,?K8F=4VFX!Q@72<RR':B55PXJN,K+C!&: HQ
M.GZ, A=QQWO39;',1#M18I::5;NM JW*DV32\*YR,_W4YOQ>-@?T6B]#AG55
M#)N_;:=I1F&PVZ)/1W H;JO:9KA68J(\IUKA86FS[I2G*,A%M,71>+:%4%>F
M@2E%T#NUB<14#BSPA2WS';KJ=>6[(9C6KDC'^XW#^$HSF6%=?81MB4AER66&
M)5=*LR/,'#14+MX#KKMTC.$]]DO#2<6(2]PP-;5TJGURQV9GQT^0"!K=D L-
M"_'0^?ALP(37&PJ9=W5R*2I>1]./#.AO/: >&O$[!U1W-<ETS O43_RV0JM*
M)O2"7<X!FW[7/-;[&BGK>;8K:RIX/4:]L@V&^]$#Z5\2R&JXRE?\)=:PB>G
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M3DRI/*!Q2Z2**36K&=D6O5OU='[!=O:NHXOJHM+Z1 CT\I-D*4L^)_Y8:E_
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MVZH^A@#C.,X!'1FV![R#L513&%DRDMHPU]I::2O?__81).PP<2%0Z@'#\;8
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MP<TF=K\*  !2"P  %0   &YS=&<M,C R,C$R,S%?9S(X+FIP9YV1>3S3_Q_
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MT?7F$=,!P( +G:\Q/(!_CSQ.'LY,"J-E&:VB:I2/>%:BCS[CLH0&C4Q[[/;
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MAZW8L_$D NU> Y+RDHF:XFS$& *3"2EXNB.2TBX2EE0KPB;M3LP"S5VO+G-
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M7','M532ZKE"1<GR2?7W[@.Q]=0_H75'90Q#1QLV57LU4=;$?"]G&5@$]XC
M+UIHNQJK55+@>AY25,+\S,*-*L9HY(*3&8WH0M;FQAGJ"D"R)D;F.Z88,Z=8
M[D>[U_/AR=DA>*C&@^7M.-CZ!8[1+5@@@_N2A'_$MS5+9TAYG:]A*CF_WB%Q
M[=[T8"9%#Q39\>/._09I3^<0FK&,BZ]^0MF[1O@FVII7IPZYH+U;<)!U:L>O
M-=<3K4%;+X2I 2J93YD>L?_]^99B+?\ -3I:I*7/BN\ ^]+3<@;/L64L>P?W
MS+ZN$F,[M0/U52>_F.T(D"C+.0*ETN=3"\9H^ZFP<M%K&3)G"L5DSI_T=HW6
MQ0S-HBBG_5BS+U]<>HQL>&Y0UUJ&=+K./8X_!W<Q!TQ3*7@0&_^]?@YI+(#I
MD+U-#B<XW#2T'-?FK<&J.6&@9)]Z6QTF=':QK7K#97]!Z &;"H%_M!W&9\F,
M@I2OZG7JM/%JH/R"4A=L D=O_M+&S6>P[DYE#?4MIDL]89XXK=/CI"*TO+TY
M<.^H5 *O%8&GC86*;(RY]C%O?!34"Q7_8ZKH@_#I][7)Q/6Y8K!Q"ZD[O!Q6
M*X]4C$S[.",+##)3'/DWRB:-%]7GWU<^NP+<AH]I&VQB<A1#'R%4U)R%0T++
M5W\8A!(Q$5?#MW#4;URQBD[ZWQH&,E"DL=V*>=+/FCEJ<>I5V])+E$1D=U-V
ML-_JF/:C/#A G:'MZ1N']>$I/+.0WI8GQ3SS4[(BZLW"!M,BRG[ A."2HZGK
M.U2]0B=O_M<; OOE_FQS(]-SV6+O,XLFON-C2&%H9;Y@W!7 /*Z_?PP'"__R
M\4;L.&(>7O#TVQ8'-FLSB'TRJ+'F81#57["<<98$[L[$1*L-_2_'<:=5IHRO
M--@MDXX46Z'T6>$_=E-^PD7;V\H_C]LNJY8L4#QU&F ;2,85@&/CB7NNK)'K
MN<;N8% &YXE/P1>P0N*2/,;OY^O2[J)M<!$!GH>)%A*PKDFPEM+,I;5X I=0
M@M$@;(&S!JFG.I6-]L-&U1*,$I1N9!89XY(S-&0KGF*#JA29')">%;2V7G%O
MR>:U03<OL#2''7=:!BQ.Y^XCV%NZFR1A1RP25X#B1K^6J<51&0&'-=#\JR:3
MX*,92;'5U#\['W3KXU=3^O>E1B-A(?5[77 ;E='(2(*FP%*:$;6\(&R 9^*\
M?6+ADKW65@)H@[]O+HATV5A*+-H56/O4O+,%/Y[#!A2J'9?$C##CE[41,+J
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M)RI*M>T'8W5:#/OGE[""DH1%<AWU+F# .H1".FAF+CN495CD;\$!]CNXJOU
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M]PV[JUTIF%KQN$2N@X4]K.ESWI6ASN1JG-S$4!3V]S0]I, <KK>@6;:_UD"
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MQ,@.&2$W0Y<&AD'=][+IQ0C@XB.@O]KG"(=<.;C[@78"(\PK[_/W.$+=HD=
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ME%0B2;>\&_65:.NOY5UAQ(&Z&M63Z&HR&+>WJ$+=5O"HGE/ELM4MD_[<*=+
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M$49?;X5(/O/6)Z$9H'+>$"9G'*P:K7CT"O'\1(4?*C6B%]HP[72I]_6U,CM
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M?,IAVB]O2 EJI#,A(1T\=8SX)<,F:\)6,::>X8+^DG$Q^[$B9BT3^CA\!5F
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MFV7L#4IS3)&V5\ PBI1(TW:<21V"Z]);<#Y%YP?+'&GG'6?J04L2TO&*EH<
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M/,8!LB'8%HSA63LV"9C>WO[+M,1(-&C!#1)&)VG57]O "@FEM)\%BR*:RF"
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M,3GXC5(R@V17^-'_H/V+['\']NK_1?:?8/_%-0M0$Q%<;QX1'0 &KDP*8H6
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MA"A5Y4M%4&[?;L3AV-\ 4$L#!!0    ( )>"7%:P&3J>(PD  +()   5
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M4)?PIB!%HSDF"7'ZHO72NXVAOP-02P,$%     @ EX)<5A-1,;%0'P  "R
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MC&ID0RSLU"599%]:(JN5;A,B_%UQ(/5Z^I:3E_$S\R(!V1V!F8*CU^6P^&D
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M_X0K/+&0>&1T=@5HD_,Y*DAA\9B/Q+@8<!I^F/"43)D]I.FA_4&YJ"6WCYB
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MPPB3-\53.Y\YF]'TDR4Z>) S'KX93IA$#V.IU*FE^S&V[/+F;;L=V_0.GF9
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M+IBY)W28(UIR6EOQN,ZM;4X=:^<9?K9-[F5&?$.P8TN[C36B)T'*#E,0*@#
M589C?9TY_I%*FXD_TTG77]S'?2+K3-R7MNR$;!X"J42;EL4JSEG!Q[B5-JT#
MQT5V/EAT9[@8QJC._STQ ?X4R5YIF=G%O$2KI]N_U\&?;]8V^N19Y>-_7QCJ
MM-(A *Q/WCJ*TR@T+X@P,!O59WS_TN#M@6U8(8_5%U+6#C==#/((L.6LMPQZ
M;7FMM#W84ETLY9KWO6K*+6XD<<2K];23D7?ULI3]#ME_461^:S$"?7'G:\?8
ML[XGA)U]OW/)[Y>P>JL<2>9#F8+$V_:PCV :Y'V<))=1/C$F *Y'M6&\T.S\
M!F\&8M7/9_@T[8'/9Z.370X?ABQ_G*E57*Z[^#G/!*W;V!.;API0<,T )QU<
M@BE:CO3/'HN1TGW66U(_:1I@Z,9!.[7"$$E/<]4ENYJ&K.SJUFH3^6BO'5LV
MI<D@IV3"VK^[+^28+IU. GJR+[3I29EGPE3P'X:G#,6BY)<\8FT<[;##ZB:<
M$LR6+UUZD;!\+)?C/-5HJ6>IRZIPI->Q5O)\)4(2&GG1*]>O%!5HOYSDKIS$
M9XU0]=ND _&AICS'M3D+?!1(5[H/=.K[-V[AULY:VJW1M0MO2LMTRLD%=N^H
M\42*^R33\HR/3G3HHK=O?#):18E,-J9G$83S%.D/4ASGS01 5QJ9*UK[1#^'
M2YBIF]E5N3L:9+-,,E X,-\/XO3PLO%5M3ZZ'<QD1:)[P'EL<P1.JZU@J;_\
MV>MN?66&-V+@CX#RXYG5@;0C2X<F54WXJ[0+_B4MGK_.8@UD/3!AS.?A.DX.
M-R/PSRU#L%S)&G]&GFU+"O9WOC+^K6;:R1-;F/=('C8N96;7#S/T\)N2PZ7?
M4VODW?2+,J,(9Y%;Y;&O1I4HP44ECQR5O(OZ\R9I6>OK#56.GH0*9YWPEBH!
M()PW$Y$;)S2\(:5XI3ZIC90O*P R%_@ES?$27#4,BZEU*MCP:&+HP07X6;57
M5KCH0[5X[=G+S;J+E8XGWMU8&*1Q71ST%W+0$=4!;M&_(>6<<?Z$1X*Q/P%0
M2P,$%     @ EX)<5H,6RF5W"@  " L  !4   !N<W1G+3(P,C(Q,C,Q7V<S
M-2YJ<&>=T7L\T_L?!_#O;#-F1.YU,G=JR!D2N91J&DI$;KGE4JB$W'(KCGLE
M<CET(BU2:">,B"FFA4SFLLQE6BZQ8N[#9D?G\;O\\_OC]_N]/N__WN_/Y_%^
M/C[\S_P)0-P*@\4 (! (\-HY '\$. Z !01^UDX@.P45@D(A$"@<!A,40L 1
M"!&XB(BHV&YQ43$),1$1<1EQ"4DI:6EIQ"Y9.1DIN=U2TE(_'P&!=^Y H,)0
MJ+"4J(BHU/\<_EM 0@@X IB"0<J @ 0(+ 'BDP D ("@H+\#_",@@9T=!6%"
MPG"1G0&"."   H,%(."?6^]TXW;Z $0"NEOIUV."DG;>,.40*?3M[%(A%8M7
M[Z3M^]BJ>A=#$X7A,K)R\GO4U#4T]Q_0-SAD>-C(^/B)DQC+4UBK<PZ.YYV<
M75Q]?/W\+UT." R[$1X1&15],^FWY)34M/2,G >Y>?D%OQ<6/<$]+2M_5O'\
M14UM':&^X75C4UL[J>,]^4-G%[5_8'"(]GF8_H7Y=7)J>N;;[-SBTO+*ZMHZ
M9V/SIPL$@$'_S']T2>RX!" 0, 3VTP42B/PY( &!*OTJN/N8'<P[1%(9?5M(
MRB*[]-4[814]>[;TQ= ^N(RJ_A>UQ9^TOV7_'2SQ_Y+]"_9O%QU @$$[GP>6
M ,P!WKFJ!,FH6AOVW50ZX<AM^"M22,68:C5OT.,I']!9*=99/(E/6MG[R/Z[
M7M51K>O/&$68PZ=HHSDP%IWHTSQHD* 0E3Y_K<SM$28")67W8.JDN,D$'T $
M]1_N1MJ?C)&/![-.4W!ULJM\0*RWN*?6\K;5([EEA_SNAH<\6;MQ$UYE[#G#
M- VJ_C[C7HOTO8&CXS7=*(2OH2KF5I8[P[6'P'G.=,=,6&MDZLS8&\FLFVN:
M.Y>.>-Q^S-5A#PZ5B?9P93;S*QHSC'3.BG?$^TN4=CUJH0@KX,INVI@A[VFV
M/;EBU^=P'T5_?O>MG56Q0D9_)&TA,B&;:=<==L%R(20J!?_"7?M;5:L>^49)
M9O'^_BZ3/=]=<X]RV6-7?M^Z!+]G;KR2A=C^Y+IO;#6_D G+/#[PDO)!GJ%K
M,WI=CM?>"WIM"E*O8BF(U S@E)F#ZJ:9.J<V%7!L9:(_IX^=OS8>0-B25R/V
M^WCJ,"E^O!]%]_C #PTCC0I*O/<RO/275G1.F;T9Q=:_M3*.M:A+X@-!OJP1
M:@DA<<QL+);6N4'PF0]$S9@/DYF$CV&N''.7EAA6@ _E[O,S0I%PLZ!(U:4N
M$-DT;06/0TW_^CMV8J[IW(89:W.K<"T*$6[2EEAM._W&C,&^66U;9!X0_(L!
M^9X^'C[R1K.^WC 4_0<D>PF,7+_H(L0'7N8NI*YY#L>+N@<&B71W$L1KHB.\
M!%,858%81>6T;9]>)[-;M.+8./8A'-,V8URCU?J;-^8RT\%KV-%9/!R9->-I
M87GY/@?#'-9OKWROS;W]3 6Z9<'K*30!+.UC_(F9NM:B^7W)LE5YC)F-UK<;
M=XH\/2B5 _B]%5:=5\LV8JN?S#=\N][TC&2+^,QYT^:AGD4JBJ6K"%\]G8.!
M=A35G8!=;\Y=EA:DZBW[8:6_)8AR+:L#Z7E3%/Q%K946EY[WN339#-4E1T?'
M$W*0:W!?5E_*42.\_N+".[<LF:@$Y\5=Z=6*5,)#9('UJSXOV;.48X+H]N!"
ME5IO8,,"T 74&[;W<0UKWS03AK1O:)M18EQ.YE=>"E=J2OV8ENA;EYOXX?@E
M12CBYE(COGMVH$/+>L;5,+PI&-<4V7^ZKC^(3EZ(*I*_\J=PFVM'J"<FKP2-
M?28U7A]:>[KRB,>"-=.)-&;&;2^-\O&D4DIO%EQO:1M%Q14Y-$0KCR4M5:*E
MM3GAY5&&YQZ^'Y?O-W _/[*EY]":$O3TU0-H3^G]M.X[7K?DH\F*6T6+"QD*
M8HM\@!R4)3ZW&4@O3\)U:T6H8QV?YMY"]'4H'FLYKF/\'2&'TH70@MD>E'77
MUYFDM7BTI_3EAHA,:'?/-14B(=\ JNTWBG5^OW9%$_(*D@\SF#M+<HQ*E6D9
M+Z&M;B"S+ A6>?206'SPF;4EGJW)(BS%[5V\<DM-W7TZ&9%>,5N%MD&#VY*^
M.Q:,'I@FMK++FXK5V4.%+Q[3#VI3[7$<YZS"!' VQXGBN== U-!J2)]&;+3V
MSS%RC 0O SZFJ95(2DOJA$ZI6!F;?#I_W+%XS.^12G98(J27#\QQ4?/+1VAO
M[4G=,70^D#J;T,Q&1ZY>H$DDI;8';>_'\PXP0J9+]M2MU2V6/TD5:OC4'BZO
M 4Q$VVYXVWYU;VCGA82[[Z;&,9I'ZH_Q:$A4UM8WPUE7Y-YFR1!FEJC:VD/0
MZ\&Z'BI98/5U>HI:6LQ]$/*'YBK^4>S>15<DA"7.J\$B,0/HWE"'^SG@AH\J
M>$6 -7 5H7='UNKA1UV[NZ9^8B4'!U&;Y:G&V5UA^\]4UAT(GZULG1CQP);W
M5L^KMC93Z=IHIHC;>Z43-(E":=E&N% GV>:/2]6QRWC6GM0DKHO?EQ)Y3HG'
M9YUKP?,&(M$^,@U%85I$>R'<Z39;7>6F/,4O'PZ'9+EF=B3?"$DHKW)-^USS
MHKKM22<R%-]5;!Q6M_*!Y2'+_#S!*?UZ%TE2.-"_FGG$O-[Z:4?Y\;)NXGC?
M>4P&J]?Q*E6?Z*)T^.S1F0"?J8G9EP$',L=H0VNS/.?-N0?-3B@^H#)B)CG,
M*9XYO8>(>UYG+,T2UN?M7AJ7S1=!W[)L.I68'+:><;?K<?+DY%#+^\RR ..\
ML=7DW$-.LF<[(#T"O[G(:+>95'P]('?KYE?P8^D.KN%B>760%U%N0)_566"M
M/#1R/B;D<L&AM*3N/&9VDC!LS.O%,47=MU=@'!;9+N#0#RF;FO%3YI'RDT!"
M>NLP'_C4)#;ILQH]B.^6QEM'\(&4A64T/@V74O8C\(UJ%(.L:9O1[ Z'.?_0
M4KX\[K\MXSUMOH^=:++UAQ,U <PUU4C>EHJZUN8P;#A\8NG@=:JD$FPTF/S%
M S71*]#]-5BJPT\SQUJSMZ0"J[G17#/2]6J;VS,0<39H3E'@%O 6;ZU/TOPR
MZ\5<N==*JQY>WE#?-T :^NA+R"\IF/)-Q@,<QI91#].V86Y;0F:1,>8W7_>F
M)%]^D@\4]S5P:PMH'#?B+@W&-[RD2$9E4L4+^YO;B$T;?_@]LP<X=_=XU"?.
M>GO^>JO8U8M]0]'ZC=[VO=!)RZ#&R?JVPYW;:ER6O6V:<?)+MGZ+PFQK.G6A
M2Y1Q/\SS[%R13LE+MXT]R7DM*^:CK],O[/KHA QG'WS;<,?5=A=)V"1M.@\V
M^1(:PP?HKR\<GR%1UYL)O(M\0&]*)<?GS\P'PIYCLW'FV(.-*E-X.>Z%1:D(
MO6K"?'8I(FX$R; A?S+JPM/ +'?;=PQ!3@$3DP7MZ"%TY+K5][SPQ,5S$^+
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MXG5LYV_K#U0>Z'Q%/U\IKVFI:ZZI4]$7%9![G&CO]Q?)!^Y4;;&%7'H]!Q#
M:U2M1^6?*O2??4.0NL5U0ZSTVR 16#Y;\W$IRZDV]9:BXBOO%.&3*)\4Y2XC
M:#+/LN[1G?=RC>5:UG-A$O XG%9T4:G+<[P3Y4?O9N_J$98'E>CD<,W9:4GI
M5W>.?E^^9)[; +S20/Z;>11;R9[NK4M?Z*_.X_>19/Y>VIXZ L\)HR%A'9?O
MNL7W):_:6$L*)I<0?UO2[HXHG&XP6UGY23EA_RU(M2+(#'+Y?NPAR -?+>0
MU%>[3<.B9#-H]=3'W*E*&\>9"5Z5IQJBW$TUI.'5KVSL3+RC.!JQ;O,AQS6=
MNB+J>Z[PP2$CB8=3+*3SW!JAL[O+&5)5GYRJ#WOEKN"/N0+:M?/<]>JCJ%<$
MTW)A61L:1(SW]?Z$*V*P<P$S1S[X1/19J>',;:TP%UKU"*M/.,"*'3WS+$K'
M!6E#NO"+2+?]HZ*XHDE^'#_PLD_<+_.X[@_GG>K6\.N$8TXY'@S90@Z Q1L/
MWB\V9QI<&F+^?$;DFDOI@:+/)W* =B^OK>LT[_M)7,N4PZT(]2Q\O[$57TBR
M3K_?'^,[]QR9,W'30/R\:>2J>KK\<=K."B:;[=#7&ICG]NYL)^U=Z+V62IQ6
ME\6RBDD6(8:9<0W#<%=P;Y:.&;/@<[L-I-"^2.;8#;I)*U2CJT2VL<$KA-A0
M<BPZT3D_=W$5%G;U208IVS<B\?OAVB2W90.W.;W3/YB_\O6ZV"^GYX(6"8'U
M"\<-HW,"G(/G9[APV5;5]2.%->F:SXW/L!/Z3,NC+>S0S\A6++_U:"/6TSOQ
M/KKC=]ZK:&;[MEVLT&6PU[8E8H2G:+21,M,C9EDY9-&Q73I)P<3%A5@1XH%^
M2K#;/&LQ/,$/_G1,0_5.AD491KKE,[@VI,TP75E^D"+*ND(0N,,?7NHHY7C7
M 3OV1'];1B]@"NC_;7:=EL54O#:WE1%>KEE6X_WULW00X.;[E5"UD$?RDQ",
MT)P<F^PM9-V94]J_?*<H"6SZ:*C(U&#*RF!$6F\"U?5UH_ZF4Y,2N2>87>D5
MU3X?H+O[9G1RBNGL\YJ=THF_L7[U:&O2*NE)&H,IKQFICXQZGJ@;I@;B  #9
M8B^/*3,4<6P"(\<@[I@V+@:\F3W#UGW!UIC+A:^Y4PQI#'6O0.S?:MR42D+J
M-1>:<I17<EQ#='H,RE?BPW ,Q?E((60'ZK&Q<]R+&R"6'75M\VA]'_9WZLL1
MEUU>VY;F F+2=+ASN&VN(,+\3/'F,#MNJY65[<^LD@YI[?*)W"%T>F=LC1R7
M[U16.M&:$+X;Z  L)IW3D2"%7A#>'DLP4+#1NO2R\:P:(OY5Y,MRUR^]TGL.
MV\ZFG13YM;,-<T=0AJC;P<B?,G=#J3D(6<L<5$>B]DHD^.'#JTR7.+;B"-U>
M4=^\-#S3_K$#"85O7ECU$+?[7 $!<[_3%_ 267F+/D[)^% _&#A.Z@]N*<*V
MZMMUV\U-U/GP.TXW&K;X;$N$GX\__5[\69]J1F'C3Q/,Y.( L;(9&SZO'>3E
M^(E<UJ0I0A5MUZ+5S8HTDGEVT>NB">EBBZ_1QX9 ?,._%YF=$>L?Z147I$%R
M-YFU>7-[9S!WQSUKTST^<0L?7I(_5]6Q1F[YD%#^87JRU4%SJD7!]Z9V]I7K
MTDK.M/'0"U)D^O>;++/VHQZ1@3%,AM)A.>F?SR<S4IJJT?3:T@+*<MIIB\@2
MC*.\>U)LF=7]XN6KP3Y! YSQOP-02P,$%     @ EX)<5M>(HLAJ(    2$
M !4   !N<W1G+3(P,C(Q,C,Q7V<S-RYJ<&>=F658%$#[[I>2!D&6;A9ID :!
M151*4I!.14!8NI$4%*2E07&1DG8EEY+N6KISZ=XEEUH.[__4E_/AG'//?)NX
MYC?//'/-?<W=S-T*X.$K%745  X.#F#AO@#NY@$O 'BXN/^I]\*_KP1$! 3X
M^ 0DA(0/B,A(R,A(24A)R2FH'Y)34%&0DCZD?4CUB 8(!))1TM'3TM!3TP!I
M_C,)#M[]&'P"8@("8AIR4G*:_V?=M0*HB #? 0%X.)P 7"H</"J<NTX &P"
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MS=]M<=,?#I9,Q-$_3?91.\F>TU]S[O[:T\[*U'3LS:#_-'6?_&1.196J&,M
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M*L?>8NW_J02/$?]#I(0X)5 );47)R_[J 0D+ODW"OM<+[%V\ _BR!CC;GH0
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MB..H7-_]VBX]<_R##'[A,O[6%YSFFG,6(,(TNBS)U::SRY;>2<-#(TVGY [
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MS3:O3:9>&X5?:7I[T%;KT7&7*:>/>D=$$FJ$GI8_!XD"<?SF(@:PPE,@<C+
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M[[?33-_VZ)[8L$*@/_+;;5VA.02HL[Y4 [$C4 L53[D*-1)Y1L^/^!C1SH>
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M.6U_A:$W[TE8O-*@?UDE;VG2,N=13]$'D8I:B?M'\%"D!5>XE$$D;[(5K<I
MO(8^.% 9C)%=0VU#1 );#&6ME6I^5[>_&,AT:C13GJ'LL>D;+'58-K"3</OZ
M3XXK1"7#%L0&\?30RC[X A\SA=-BXD"E65"RVYX'<[7I+:EAQ2?#%LP[LRDQ
M!E/HT1"1YN1#\Q(3)985RZN2>G(0:!>^@3AT!L;$<IYT*W$GG]JF?)L,01]$
M0JT8ZLWY]TX56)]:JZ:T.;M,0U;C[5[$07*?.47"L_&X2K:,!07.EK+G[KG
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M*@=@>Y&[QZ]/LX]3H!(_9]\2W8K.7/LX%1I2GA4QHK0N>_F68Z+T'OG[$$X
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MN',*S4](7Z>;X +(2/L$VZDURLP?K_+E=ANC98+QB_==\=H05:TQK8:=Q[I
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MB2AL*@GL6.N$4XIW[BMT8GBV3[BLQKD+1XDV'8_%.5=;%GUI*;PG[7MN *4
MWH#)G=J&[ 1M12YLOZDQ>HHKVC['56>K,!H ^W?+!^=0IS6*!#*OK=LK%[^R
MD:RP7-AIJU9VX/[DKA['!T\AG-RZ%%WP^5OP%)Y0SE,GML3& +8QEM;<43-T
M\F,1-1@F-72FB"!ZE'HMV_S^<RL9PBF16T\.[G]VXI7(LA3]S1Q7."I*<]67
M!><)"BCA$!G*LD ]>4S;@5.A#Y-:_,$D^#T)?O6BAESR<8>T;FBNV^*B2FS1
MO8*FC&C\X_?;D&/<^6B! 3%IT-I\0?/3O_?400E(IWZG;HEL15V)Y4!ME#XP
MGO1WA\D(WULK#?%_W4Y/'O=W"%<]][DA1HS67M?D[DEBQ: )GJK@8+2@IV#T
MRW""/S-UNOO0#]C>Y-<8,EP*F6"#2["+<_G5S/2U:LZ2KDZ+5)0^\*8)?N!L
M/]2(DPX+U@6T<FCW>:Z6\Q)#*GK+BWSA:H1[3'?B&)")\->=HF5+0>TH64)7
M3=/NI=E9M0W&,?,"AP=1:+]I%WGU3#[F[W0VZ(43HF"D!EB3X0 >T"329!B1
MS!7&W_$L+#/6*OQ^G15".G*N_79]6UNPX_$WU=D*'\]FOZO?B,\[7VNR0M9D
M2VMRA4ZP+H$/5T3SLC3]B<R6N4Y=*D8 V+(G87;\: ^_3Q\HR4$8E#0XCP7K
M=%B%>82&[GAJ)?*\PM?E=D\<S )&JB/2K_-*DO/@._3AA O]Q!VU)G?(2[;]
M$P%.N3^[5:VU.ZR?>#T-<+90V]MPT7'9;JS+Q<U/)D$2?QX]#I6KQ@? XI1W
M YLO?S3\;%XVI$<\J5OX.?5!+>9Z9U/VUYM^D-U::D*6$,D3\%0BW6-\ 0T#
M#HVS%4_3(YGO"L\E7)HV<6!87+:Y=QGG=]PMR.#M+V:AM3+%V=SO_CR?9(3>
MEX<C?[8A"R"WJF$,,0^!DQ;#[<,WR*V6UO4]1YT#R/2-7D<]H-=M3RWV[)19
M=M&MR7/2[R>:UD?N[FRLVN7L\R]23R\./785#J*B_U3 8: PTA,BW7TM"4J_
MLK:??9<AUU^7B%7LU'S955%B9##U:QDZ^[M.]U89,O1YLD:!O"8N(>Q:J /K
M@O1G\<-#G'Q\")ZPR14"=P!_ :<"YC,&IVY#TM'2*&/@H->;0+34)Q,)I1K<
MTFSI[K)FP3<>X_J29]ZI^SRY,9PAMD?KW>D'?'][T]GN8%?V<V?@= <,H"VP
M:L,8'^3E[<8G @6C%+'DW^J?V,+A(21=T7,O>U[O46UK;M73>*K@X"<J,F%*
M4LWWN-3&[P?^_3"FQW4;$FA+L&5*<%[^02RH,A,9OG-#T*3($XK.99--5<8+
MR&4I_GQ<<;M+M<U=0N:UA?;W>:+K[SH1.^-@_L%?NS#,-<X+')Y I$!7^^@"
M3*%I%+P29:C@$TW,P4&AKH%&MPJ=FL67:ZJ#U735\BKN'27=CX]_D;YV-K:*
MZ4?7',A)QN_HU"81L[<A(/\,IUJ?4=A!P4H371?.(NK>\QFK14R8[;\C*+QG
M6N,\OXA+PU!-_2?],\K4J]-AQ<H$ M6Q7<[UV:>SKS;OI7K'61_D.THYY)5S
M9V1!4M<,?$5>EFTQGGY'H!_<=1< PA33 NQWV*_HXN]QJR%'<3%*<$I25N;#
MC((G-RU=K6,S^]_]6QP6V+_AF<9 <(6=J- $$!#PLBR+D95,S1F=L#,G/+LF
M.@-)(1:#AT-J @P+MOX05 ]>")BX;#HEOK11KOMX]VS/R7\X$/:?QHQ8<LHQ
MJP)D+$?IM=,/&%N)C\P1[L/0SV.R'$V5)VBW;A0Y? K]FCS)G^49Q;:M'-.O
M. 3I>/][=<FE.&U$(^X(6PM\]#(J!,"S=E:RI1M[X'2;+(P#X%F@D,7Y,<%5
M=;:I6G#Y[#Z.B+Q]ZVOZ@17YEOQA%V%I]_MS4#,><L>07L :-=DRJB0(Y_DV
MQ,_&V\X@8HY6N?)4MBWH;9#1&4I96SQR8NFTA:.31=@-Y*UD82"7!;++@";0
MK,#9BFET%A,]"_/%*!.#,9*=AM00U1YE_;8<6V6%MKP0[ZOID7I#89L':=Q/
M@O'62,)Y[.'/O1>VU,'N#X///W9R'+S+ZE4,%2J/<OB$<JAF>[77,\2QO9%9
M]UZZ!?8N<$15GN2COOOF+RU"\$9O?@MVQ<&L#I6E0_Y_:UJU.$SDBT YH_SL
MM/#7-KM$&(%,6\FQV^]\S)/]+?N4$V+>;#TX777=3F ,1K_R!!90K#5'N9+"
MV&#:,73[2M^@'!ERJ2:PR&IDPH7N=-:5SLZ-FDV,/WS1Q)YVK]O (^,MQ7RX
MK@"#6 ,.UJ1DP$AOB'PPTNMM2,-X2@TMW$.74@ BWIP^)LO;>L6G]1RG49P4
M-0R1 NVS\^-'HB,''_Y93X>P>6(9BUQ>^-S!EL#'%3K-@B%9($GB]V)$DF#Q
MZB"/7DM1J,RLT:_1^^Z6S/3/"S'SOS5<8C'?6;E>NW/?EYTJ'@57G+B"H G;
M!:+5^ +T*)$.%\L"H?OF$&R^X_PV)%&54IOU.JW3HQ1)6+8Q&K1>6-&F/Q@D
M>;I+&ZSM5EY6^L!7G&Z.\3KT7*P7#QQV8DL^9.;Q!'!1!G3S1@H4T#3'DW0)
M+\)9VC )ML?4WU@%L;W!KD:RYC,G99L[EC4ECB"^"M^YFR=VF*]?7,SQO[1S
M]? ANDD8NL/:?3C="?-YDQRR-LA'6A$UO@3DDH,]KA$6'-MD&=;!ZJOP@%S)
M"R>K5Q_O>I1WK%_ZKM/?+7!D7%HYZ7C2*Y@,AD1%\(&+UQZW]MEQ[2(04_[S
M]H5(?\-L_>3.^N9"B[:W"\<,#_JV7[CS;62_LH]USI%+7Q"AY8/@5 BP92\X
M@Z\#(/N8)7-X_QQ1E 5P Z4358K28,AEFD2)EF218MQ:0^9HL[/U:;7HS_&G
MJ?F2D"GY+YQ?JFK_E5VI@>F1PI"R8"T"O>.?%9F\G*5([CPXW%[TH\4,<P*%
M>([QF&%3O#X:,8OU3[>LJ?$T#[@ZXZ>K:FY)N"]XU'ZL4Y[>QYM:7O4.V *P
M@*8_388E$E0P@<1<F4/H=&L.49;T?XA6N$OG+AE<WK2_XB.YC^I\[&*J>H !
M#LUUR@"O/ ?SA4F@%Z$-_IDP7QU%2G%+ LWDSDN#)S7!UX"P7]>&_(#EMY6$
M&]<?D""K[A#;T6?B.]9MV0H@MCET";BS#?$62,7_6;OGR3LUHH"GPXY4Y K-
ML: >Z/&M\=3R3R8V%;^TJY%R_9-G?:Q%S22F?-[C3YP[$LIHW9]9%3>FD, K
MK.*5WT0'8>C6VY#Y\Z-,\QRJ._K4A'[LE5]K%Z=]Z$/,D&F5;_XE 5\'/HSJ
MKNW//Z QT;,T'7O\+/0IG&Y=EP&E7\L!-/&K4^1MR&<$<X$7*V"?9V3BQ6C9
M#TG$5/P>G(ZJ$[C&CNH1_:WR*%L$-[^LXT)RY]HD#+7V%VP1WVW9TN19UWZ8
MG@#1;R Q:18KU@T%JGKG%&2?T)D>YX5I490VBVS*AEU[<Y1.R.+@LGM$\YK1
MJR-K)QJ/W(G!2>\ 8ED&F)Y3H"\JA=%MUP -#,T&[%G)),RW.(8B6\F >7;#
MA#MCR5W6-CD6T[?^*FJ'F%K5*5-^G3ZBO*\F,6=_VLC-5^Y>.:7_^?"NRYV"
M@UM_ >0CI )B([&O$LAEV/83:I(K*:?ULX)MZQN2@5],0E)?5'O20.NQ(9GV
MA5+WCD>.ATJSB;P20'#0>"%&=]X1$UR>V&TWIK&.+37U#E8?T; -D3+9075&
MH!PJW8&%OCL+KFZNA%\/TF1)OV+4-VS89C*"!RPTZ(\]-D$LSZN3A0&'X;0.
MUC'N$%24NQ/=__3K<B,]H=<-%17R"B#V.8[ZANG\6;AS*YM0HGGSEF_LST?S
M:G #R@]LJ[Z= &F(K911!91M0Y@?.2E_EU1[0X)K;*J7QH-+5R)S!V^V&15D
MCR),FK_YN)O*+)_0RKZTMF^\'CV/>8NGU8'+*A;L1RN;'ZAD2#'/,Z"]MHE8
M/L?ES8'HNBQ<U]' \.#/:P6_W:QEWK9CQ]/M=TD<(6I(#Z^*)YIO68"H$)R$
M*S/@*+Z"-L'ZH#D*E337;B';Q,;8RMYV,^Q]?D;>U]H#Q5]:\]>\-Z2[FLYJ
ME7F=DU?[$CM5>J'6[<?L6V3AU::.:4E^N4)' QN$2(/W-Y^T+[GEUZ(/1ZJR
MAFH@Z!LH<*+C;[.C.;EX4O<$B+>Z1=AJ,]T'4:>!^^2.+&/*[@QR("V[ALPY
M5^W=+">QX&XC1PCY$A,3J6'@;Z\V?UDKM)>G287IT<7<0MR'*\%N00&MEFS4
MOF5QH)21OC  HU>B!,Z,O: Q\Q&1X1JEH7/=;B,AWTTFG ]EQ/"O8]&&(=#J
M/W8"%/A0': &&Q#CX4]^EBEZ%KMG&W)#5Q+]$2\9AM@_CTQA)LQ1Y_1?TE>$
M79ZW!F?L;NS,KZW]EJOF$$ ]S_5;B:N6KVIA$%=%69@@.#T,F@(CO8R&KV)J
MW5'03S0W*RP<+H>,\L]WZVMQ]2=,SN .&N9IM#KVG-,MJ/@7\Q:WQ0*-VSG@
MX7^Q86%.,9[T!2/%T_1 [^5^8((0&ZW,/D^?:,+-'& D91<K9]W>\J@IBL7Y
M8TZIV 1W91Z_-"8=]SQ*>L@9TXQ=!0T;_R%.*I[4PL#TP/$W$/-;L$Q3!49M
ML5)=/W17(&&I*VO:MYK<U)X8]5MQ],%"W[W]K]3FM?)SS]_',V^F0];7YKT'
M,4W$_G&!1;8%YZ6I^&?VZ8X99=U51,JGE:M!A=$V[8<7-PL?W!<IE.R0^CK0
MIGHQ$^'O/W0?TX,RY>=.$'$Y;"E#"L@G6$=1NV8Z$12\XM#+"S=U3G9I]1(^
MN/UJCKRKOPY?/GOV^#OR1:^1F\])DA;STW8"WX;8$L),'T[C-N0F%E!S;&2I
M<3]A&S13_]3M#Q2D"#8MF<[U<Z'M&2Z&V>,B=C9[*T84'QX6&#]^Z/.5W^8\
M"<+X:$S/(3RI$M\8R9:P9[[BI':KHP=<.]%G &RX%*#W?FI(6;% >*!@SXV[
M4Z*VMSR='GFTY.9[-=X9AG:";T U[+4%5(9H]QB%7-&F(J[@0T85V1O)1QE/
M8IM%U2(]E>#PJ;HC=;^37YS\HJ7QMJWXJEIRE,Y(;))2G[C#750'\S$G'T.J
MA^-:V.)X\AQ;ZB*FQP"7Q1.T$#U9K&HS$V[C-/CT?%^5FW,UG8!+=2M[<='\
MA/Z4R9W79U5/R MF;+X!?2Y/10+T_#W[,+>P"T[</3C6*=01.J)O^ \T&]Y8
ME]RT=-I$/9QB;.#A>$I_)<8X%Q&Y_R5_[M/)9>1H>YS$IP>7GK(,N8(__U.L
M<QT6 !,%(N:8/9PD;^ \=S]HKRFXN9-0:9=E6TI'T_W<FU/5I; ?P6HO_*+\
M'P;QKY=+(O0&F&:@A>: BXGW/3*,2P#1 SY!^1C#B#NL?(R^F<E5 )('IY@8
M^M)<AHF>E,/;QZ4S:VL:.==]$L=P._MI[<>]0J]+W3EEVXDGY7MJ<%IQMI\7
M>DM OAB?PA:9-E%BP'JWPEROM,2$4Y1.7,OHWRDSK_P\S]G#-@4Y(U)UX,*W
M0BVA!\$_0,.\ >?NA7,*,:27&-SXZA@)FXBGV];LIL(G:E&VAX%RLK68Q+F7
M-E7SJ[8-0VH/;?;D?8(5?^N'YDT<OR;>P*96@UX&3WH-@D+^48 ?_-W;PDE@
MRY<#L'/TV((GL63X;I1YHU%DXL'TWO5WKM;Z]>=_W[2B%G(49J8"UZEZTD<P
M(:^>BPW#LV%O!6A_*7C@-/X=D7X5G%/TB-$ L1<JXMKW HY\@&PY:Z5N7[$T
MCUN,J'N5]L%:_7VSD."E<@GY4]<P/2=@-Z +*R0G]GX)$-ZN P,LM6 %L3YH
M>K0GOO*'PFJWSJ>C:BV&"B^QD;M:9)F$S(=:)A%7CJ6NUJCLA"Q:\*KU@8'_
MI%@GXDEE<+H9?&&#.AZ'EN$.16)D3&51-UM;6NF:F6%XZ<\NA)]Y;NX>5@'M
MA=@#!<NG*-U/-'W2+334CPT9D,I!M)O@CB%AH2TM;*D->V!>CI;$,APCNXFE
MSFWY<E/>Y$@$SLG'F'=)6JAW&HKIGQN8;)"5_[?OV'ZI+889)*J2EA##4!";
MKQN,=NJ%)SS%9W=>J$*&;D-L)YM$%:].T92MON'R5?T+N-^6U7*B[,8ZWXH^
MR$IPV8;4=]7EX'3G-7O0 L :7?L:/;3Q)6#49\X02#:Y$/N26#4B\^SV!YG5
MT-"#!;(W2*$W/N"CY$[5N97%P?0PI&+0L5[TY@T!N(K&4><YI:9\@4%X?E,5
ME-KTS0F:[-6.ONBJ((+/^$OQ*]\2*^Y:\6TDFF>U99J4G'S%[</37<5D,#W>
MW6?8P4 "RP3I-N0IPD DX(A"*%7&9B8[5K2[B)2E_&=7O)NV94',_3O,\ "_
MM!NI(ZK#8T9J216<(O ]%$'/F(RMGV/+@"8;=+:[QH Y.L*)DU>C3TR%T4MR
M))"2XW:,B"?WH*E? OZL1!VY=''=0D1,Z=G[.4G+Q".DLJ_6U3 1#"E[ZR.O
M>JH6L&)%<$?Q]8@,O+^N"#)(> Q.E2VN#7*]^7,C*$<Z5Z?DH6C2(L7LF>7*
MB0/67K+RYSOV+3!=03L1S'D$^JIMR,(:5Y!7LI,!S# R2..K26]0-X%SC#'$
M47T;BSY/]:GJ%Q.AW[M9/G;+PB,/!J1UU1@GXA;*?7(-VYM.&K+%Y;B"#/!R
M'4X6)CB'X$V9 U&QH0O@-T>9&9CF*C*$@*>#WSX: W4(_ZRG2QJ&<+\'BZ+5
M$U5D\R^*:5!>)?'&& D!J%NPY6PIB%4IEC-[#X]7^Q#%@O"2ID=7")XUX0S;
M 8S4D6^SN#]3.&'KBLEJ:NK(OH3P#I,0_=D)<[5#KXBZA30,3U<.VOR=%@E2
MY2_LXYPL$Q=Z]%0/5AXM%@PE=.^G#VRFAX3"FJD7(G)$'EZ\+-M@K435.YP;
M%Z"ZE[$6@L7Q7@:S#1$09CMPZE!>X/S<X11S]Z.GL/7H#GK[1D_)X<D_L8AK
M#&6\U^$9G'6(Y*^=3$=FWH=MB)^/16[%LWZ')Q*R5]O-N/$8/\0_@VU("I&I
M%@C;LI!!@;N/_PFX],X3>8D*W/V $VDM%42_,G3-Y,[C(&ZZ5>UH*LJ*_3JV
M^5 ?\J1D7=\Y\9[AL.I21]X7+XL9V,Y.?@HB";.;?9P^/JBLTS2'$Q,+:-X*
M(PQDY\T>7ZH^I&IEDOS46U':8=%DD+]%HDG\.=]Z(7=O(?A,).\(*Q!:8.BO
M._E9BMR1Z):TD$[!J.K%%:._Q(PP4=-9!&[(IUY-./R5Q0GQ&X41/SZ)'#7T
M5[W %9IG\;YEVH.\&%-?UU?W&4K69$O]WH:09_)QOQ_&4!'[V;9  KDO.%BG
MN.KBP>:,2].Z_ODB>;(G]LTT#S59;.3A:YM K%3'EK'@[LEAN9\#A_4RP,N*
MJ^6DHV6#H-)_\2DEI^#BR(Q^S$+[E?S -O),R4H OBN)&UQC]R^@E*& ^K '
M\I<GAC<.J.%I3JQSJ%.<;'R(6 )V=VC* &)^D-@W@>PC>[ZH#1R)>CW_V2;0
MV"+DGE(?0;]^-.2PPXD=*N[A3N<4T5T39Z'YT2EL*2PSCA=+Q/1$HWBE'D;
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M#*?L3O<'W65;8U\F+6Y5C$;=:79YXIRD>EI@[>$L7H-1>&2\$2U6H'CTF:K
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MUV>6Y.*>:RK@@HL"3R7B*F2SL^X*,=O<%U<G?3[!T\J2&\<<W F=@57"NMV
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M<="S_WON/0#;N3,%(B'(O?A4(J83<ZREH$B#F;DNR&GWJLC-W>)<'ZG"'UF
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MR9DH_+V,-M!YJMS@U=G[1$L7*27A+1D33)N)'H=/,]>V=V]]/Y1GWL(/7,]
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MR'U]R'ERH$G8GM&HC'U]>5/MLZ%!MBA!41.U$LD30HL3'1""=?\.V^01H T
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MY,@<JBJA.SY[/76Z.G,\U;_D9XW*FG3IRL='@CC'2'.NS(<NN:'^O&?=W3^
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MQN^&%0874M,S'+42OS9GNU^Z<W"0#""!,*[,X[L+<(P5 10? Y(B<I*C<"Q
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MCC[G@Q'(\^W%>U[0*-')D\8\W^XXYT?L;S-%CK  MJ?8-B*7!0B9WH:E75#
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MQB)*5T53G ?AM#;4\G+]6&V[/X/JL"XYXLNVA;O;>_^4PES\4*;O<OO#"!;
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M!K@U=6-938@"%81V.: >P$[Z<.J.Q=R =IM59-[6"(C;<6@W,DQDKJ%Y4ED
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M$[>37(AV^?'T2K0Q7!$3[<5YF;?_R#KF[0KKFP#[!HW-'EG&! 4V@#O3J</
M.5W8,>T<B_'1$:J]\Q./FDM51PK(QP\QDD!'G<99[,H%>@J)2V&"E@G(S5XF
M:+V&T?8!B!8X2F([/5-BV7\S_E*YO/!21_RULN@X[78%@WCPYVJ1+KNU -,\
M54E3D&N\7UBJ[,E@XZL2TC:B&K>B8=H/E\<=&Q::=QB\"#56%R("FJ$GZRI)
M+JN5TU59X0+&@^NA_+-+402+M^L<#8Z;^5JL+\F/+_-D7C)%EKDO\94<]:H@
M::5<0QG#*HJ(:Y_A&"SI3\ ))NC;PUK65^VA35@HV6OI]$P/[Z/&(JYNRS0V
M8V-MT_1R"B+!^"H,;6_>/FZ%P6 ^O^8Z-W<A=X<NE#0W-W1AP__9G'-*D:?O
MRX3O=A7Z2S7J*4>SRNZ>LQB_4YS.\7<>B%/M]7^^$8IJ!SW"@AH1JX-%,N@9
M^%MUJ9EJE3I+"""X;**;B-E[ ZE:SX^G#I),_W51&5)5R.$X^#\N*O0:O\I:
MZ8&+JO>@O.[^V?7Z?;S$J;7&7]?Y-O[3E?7A0&\ 1WE)_/QI-JLX8D1)"R-V
MI>I=O^LTAV^-I>.G)WEMY[1X+W>?UM:18>6>[$OE>FJ&YOBGJN&R>=5"M\NV
M2\U5=AOBU?VH02Q:\H7U^":(6R3:RMCNZLQRQ5 [4<T6L3%JY%^ZI0;*F-F@
MGW\.G# CB^"6,';0TN#TB7%HQ$X*">KQE-+S:_M:/OT.-8C $:I^Q=_/&CWH
M5/B)_DG$1I_>8V!']2.?; :?KOL[D1((9?U.:4_DX3)N3^#;<",3U-SOVK;/
M8D^"IV ##6"B\0*>B@8#NN._]['4H&HXQ924MA,)7-X\B+LV[.<=KD;X>^R_
M!CG;1GQ@ \\_!KD%I*T]WND??UST@5>B+O*KD.?>%Z+G,1#(0WYAS"4*N$7-
M:Y72NDVU>)I]5YGMHQ7<^'J<VHE[CW!D3BB=E;W+CA4R05<Y0I2%8SGTLY8T
M$?ZJ1+B7:=C"5^-XX13VG3G]:B5%Q6HEA]DYL_Y:IZFUE?J>6#.MP>'27)/D
M\WT3P^4UYNP6GBIY8>N4[B:(^OZZZ",/GQ?L4%E+4[I8H:W^0C/^LJJN![J>
M/ZMOK!5O_+<WW4$7-KHR\^!\>!*>H]U?P0>S81.+SI%"]66L3&A94!\KXH &
M8VW&P(P^<K9S &G:L43W8(W 4Q!J>]NF7#D\ GJR[%7XAH#]5^O\T[_B@J>_
MRF]MM$&B>%#-7??^F0=/'V__\E15'G<F^I\9R_V[.B3P>SE5?G 3CTTQOP#O
MY4'L#1G'6.H,2>$A]6LVOZGV_;6=?&_RJ9&F[@S #+OMC->A3BG_H@ZK_A(W
MR#!G'ZMY'1&3"%C[Z,)%-XN<,6GK),K33S9[L;8&YU>SA NY\'&0UO6VSOV7
MV3EV-1\.9CJ%ZKOJWLTD"N,$SQ :(JA(VFWOI&9KGH_[&S,O2Y'B >N.7=*@
M7AUB+K<@V\"IZ>%$^C5&*OTV$796EY5)K"(H/$X?YE5Z;GK6%2FWH@=K_NI/
MW'_^H%^.P04+UNXK(%965$9<O]%<9:0_8MI"A>%4C353+.&5\0(1V_JN>EW9
M6,FX: OK8;]7?A.V22^V8D5I\B;I*YZQADL>];L5OXC0F3?+[;_QQU0MV9P2
MW2J!+BVZ]%(_ ]F(YSVUO;G]-YZFYF5DNHH?_;H\+@"XS^P_IL(*Y_#;+#(1
M\VL&.>,[#MG?" J0CZ!P?.-#']1:X>;*9 A+NU]* U86]= ,]MH\4:"'<+1"
M"7%@B(N^O9-<"KS# \=8A(7D$H4LT\SVRL($T44R'7P?UT0PBE8>5=SH,/S>
MS#TML$9E)[/3( 0N')Z#KDVB+2IO"Q0ZN04NO*/)H.>5S\$5D#@U^FTF*"CP
MX%BK$>12-B6J?]:'N^TKNM_%DKP!?^>=TE1G9:&4'9(K$AJD>X>ON%("L#8:
M,\4G[N_X@C-?Q[M&W_U+V54G-L-+HG;2JR&ATCGE3/^T2QLL),'7EGZU8NHD
MNMGK4L[IND[OJS?;_DA&_8SP/)),F:\_3+.E! VT[8,#$2I9"\![GHB8<TQ0
M0) S78UZL+O8QRFP'MOMP-XB9TO$%M;S.3WX;PE/[+.9*9Z>U]7R/-Q13_6[
MQ;MOS&I[6G:?<:L8GM_6PKWT*;*RX%?^8BEWT6)RRVIO_*L&O#R*"S@'1_&@
MZ1_4Q99J7JN9ZO7>P[Z52485@DG?RY, Q%UR> L7-ZW=WK/B%_[1-[+5(.<:
M$Y2W9\D$12P;,4'\YB5PZDDT9"**8PWQ(N#HP5*\L["-.2SA-0GHQI]\\-[?
M4+MFX 7_=>S ]S=[SH>W"RV0'^ GUYQ2^\"@)8OK=PK,V[E_(,<$!;>*HL*F
M4*=)%+"YMXY]0]WGVAW/VKVO UUOE+'\]EB:#Q/T=8NM96-THUG@)/D(G!3V
MN ?Y'=\M6+HY_*9Y(=.%P9O&[X.QIO*35&!4F^Q("^/'Z_+Y(60Y7%RE(8N9
M]>]7(K-\3W-N*4$^TE4^+Y3+*M^L]6V"S'S?WP02J"8A.\5TX\27W.ZOX_BC
MJ8E35IC]W8/CIOY6MQ.7M;7S'6M],RPJKB.FF%W#X_3*8$!5889ATF&EHM_K
M]/+]"S%)ET,S[^@2\_ HZ.%RCH_F[P;+LJ*)&E4Q9W_[.'I"-[M8"M5K?WA@
MYUCV=_O](?2MF+S1-E<G5V[MM#BWHNQB3#A1^D2G=R6$XJ;#F4'2DT+;3D'R
MEFH&=DM8,H8SFN 3,Q](S<!W>3H"?'O(::^?:W<)SM_DG8Q?5/8ZS3;WG^&9
M"::7PI8G&\HWN. @@&.R]5K"SXJW(-!-E33ZX+NBC/_QZ#;:Z6P"^&>YCYG\
MV%EL*M=V5'HH;NH?'>T9MEBSWO4F0.1WJ22\+%O),(QJ9&%B[3F)I3YGY;:/
M/J2C6/J[(H](%7YU7(%.%1/4$)H!7!PJ9S'@*_"(!O%PL+O55.%/<*!HT7+8
M+G;PH0"*1%H&3[L% Y\(/OAQI21JGA(RK(\)ZHM1A%-O _*/62,72C3R8E?6
M\O^FP02EB;5G_&)D%$ 'IZ@Z#"WX+9609"8(KVKJH0%>GN(!-V+,P;L\F=@3
M'7;0<O%.8K8>$S2AB&$("<[!(L%<=!^B(VX&>=[L>Q)G1);MC[<W.*Y ?2K=
M_(,?[C0O)::FI2^?71XSGHW?O;7)]M$NZ52$2MA^(!'U<PU*<$[U<!)[7CE4
M2&R6%;@THT4O12Y.-L3-0H]C;;%GO?N;SS-!3:;/U3XF/56*VOIMA9&(*L[>
M<7[K/H]-5JQ\3^VPM.)Q-L"(8W8]/'N]'.\K2EEWYDTP8$(])4+1U==S<R"^
M BZ56V^0/VV_T^48V:J"17:N6L3.[7[YZWM6J<*;V6WD7%#0+MME-8GZ/L2;
MZ7IOCE7X)?OA>]N/(?I)FVS7"L;M>/A38RX%N62.%R:?^Q VWG&44^L53\L@
M<!HA.;3I0C^1;=.P=1L4A"(*],/_5$DJ7'YRPWUIH%#WG&AF4G3*+7QR3&)
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MUH#$YB(WA[S1=#4%[8.FT5KEHCW 1ZW9DU)"#A>K%+$=PUYC#20FZ()SP\V
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MYZ1^'.%*]HE\.8K=4*1#E6]QOHY)]*#\GX/2+ Y_%G&+?/@_C#FS*2H'QIQ
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MW4VVH%;:[U*)IT"9!\*)#!%+%ILQ7 #46 \--UE<[)+&O?&V9LRTM ?[6TJ
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M=W%WS#)NYWS^Y^D?N4>=8Z-^V'=GW_1^IIX^PED=.PVF0#</LF:+CE'H#'<
M1^6Q8-.WQ*H@TU[2'@@$M*U>E(A\4@=O;2N:F+2D*?MGF7._BWJB"]?JA*%1
M7?*H.]BC## 5CA].AO RX(LQKEWY23U-E.:XL;ZB,YV3,VN[LG=&=Y?.!7V/
MZ;SS;O>IA<]A3<7OBVBV0O-'IW3J KIT \0R&8U#'?PEKTK52B&E#6#X@&CK
MVNB4/YJ7+W=/SGF=MQ0XG6'Y\YVU+,C&GHEF<;BR!C!U>Z"'$!_@#[C9#0'#
M14SFOWESS=46.].Y045'YI/>/$='/![A+/F_:RX5RI#5%\WW80C++()[Y 2N
M=XR%[X'X?!UV.L%38173FG"]OZRYNZ6O\U4=;3Y;O>?D+8D[6G,>L*;;,.29
M1<86E(,TM0\4M>0J?7AJ)V]K*R6SEO<4U"M2J_"-650,+26CJT7D;OBM+7-D
MWY--V=/R1NRC+::J]4$)L(7FGDU E;-[<]J+?)A62^4DT0H-XED*,S]%H*3V
M@FG]9*7\/O*6RNU:Q"U8@ZZ;Z W)NZ'O+;UH?RE@-.L0:PI2F[2N^9IQC(K-
M-):AI$+%?.5U4""$P[+S^%W'&R.OZAO:SCB\VS8V#6P5-BP_*BDR?H#C5Y$R
M.SBJD!R4R(<L(X#8P\[KV&,S M.3?S0[%5:"?4^YS69,WOKCW4PWZ<GJ@/EX
M*F3-GWI):BHZL7^/4P7J($L!&0AX4^Z@XO= (AU& GTVX@&;B9TZ5(-$S\:O
M?UH]ZR3JG?''6ORRO1_4:QAK\+[B2G2^66'05W2"DK0N11Y.(E)NR+C6?-L#
MD7,+(7URBOI )-P@P2-B4C6O^_TW_*&+L_U+EDM9'YZ$V0K^VCIR46.T4QT1
M2C:O(*, M=B*-TA!(,$8(J!_J)6Z:,:.RYMJ."J&S[H,52I0OZ2HY:9P8XB(
MD3DUSK'3W#=\ %%,1G4S'4F;CTP5_4U%VB>%-9R1EXK?N\X8.>0<[F\*$7AR
M[Y]MAW/WD.52RETS\114(L3K+?8?+* Q]7$/=)35@Q5$ADO$=RH!EWJ;,;+&
M?&1M.7^7/\\;:YOBUUR&PKF6LGF2QK5>/NI<D-55/WS@.O$>:Q0BK0WQ&8YK
MV^FMTB89I!F'1Y<0),882@N%\M;KUC=?/*[%B?KRCSAEC)X1DS@)E82HQN+9
ME4([O<."FCVQ/U]RB,I\?8,,Z:FZ2!"0 +;[4/QYYB-ZFJ8<RBF^>3JS1KT^
M@3+0[WU*FL'!&KIKT;G>H&WB PF7'8;HDX7A=1^Z P+7V]:;B64G;(KI"4K9
MQSEKZ,2=AQU2/J\(?;F135;IAPQTW?\VBW1R/1-+&+@<9[AF;$:W <9H"WN@
M^-#&X1GAQ3[IS02&,XI^;M5#L77"6*YRN'10O-&S=.XO6C9WK3I+ICT"=?+4
MX7L9.9_.[AL8B"/]F0]-A5D3L+J\1%,N1'NO 0M"74XQ=J1H;>(ZY5K;QO[H
M357=&*AM[<C@ZWPQF3?O;[43<O&-<'9Y\(M(>0UF%EM+37.RCO*1P=]<NW?/
M5)"'1;[%#A&&$P(UC35?SQ('W@7DY=M_/I5XW,O'Z7O[<UK[@W>5[=]"? _6
MC"@R2QCN[)V[,E+,S&N<%B%7%]/U5O!=;8]V#@X%.O\^GGY-^?&ZB)3 YXV(
M)/4O]_B0FW0.U@B8&Q4PG,&6='#VJ?,$>!R>C)7%O\71G7Q-CVU7;59!O_DT
MH*TF["*V]6TN-)Z=1&S,?$&,3K*3^L[6[9UH^-'8\5A5=E:!IQD:S.>!X1AN
MI&<3$W.WP81_QNU]@=6']Y.>HYX))%A#Y1VI^ J\[*QB?R-N(:A&_3TSBR4+
ME-%JF<\A?O!O\304%8-CG[:1M$5O0(97E\&N6 .+SUT=\6.L\4AKXME&C=(.
MU[,DW_P[0RO-DHN6H@=_._PW"V$!0?8WR/$UO-/,W@ 6,*S_^YK:F*D$(O[Z
MZ*;F$J*LKB/>IB5;)MG[HOP)VP?JOR[(=^3_1;.X)NA'&#K,8LC"4\@11F@H
MU8 <F= 10ZY)N'^M+)0JTXT5#:\(=-"T<K4/#8,2TF\@URP3;R*>"9>>'OL%
M8Q=H6A5Q[005A?.0H[QIK?8G[.!L(JV^AJ$%?/.D$R9^_!@J#!85.NGP<\W
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M%&=_[X(,]X;:RW.B''^_LI_ BOTY*""-AF06H=<'*2*T!"!/>]W>9]'D<)B
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M]Y>[#-;]PZUC7+9VHQ7T;(WAZCC#F#[OB,]*1KS7.4<QM<1U'TH%C<0L_"U
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MG/:%8,J.!WO7V,ET:12U\"H/)6#LZ4E97LCK"K1F4WQ:<WPCCZ:C^U2X5,=
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M/<Y]/KJ#4SQG?GIS&SO]>8J6L"_56+C8D\"3&+H6L-P'$6>9,(*H$NAPV!%
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MTD^.5_<-L&^E6P@KH$UP!R+_-(Q6&YFD"(I63;[E['!5NVF;<?FS3$DKH@"
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MHV$T>"PJW7% FZTVD.OXEW:S8.%[\)[H)09_J?2)"*OMY,QS/PL2UB'!,-#
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MTQ64P:-(R9S0:_7KD*FFB,G5#Y<IV-%#[EJ,'?9K<XF:#XY(+@UM9,3U<^^
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MO9?]WV#41G<:* +"=P+GUB&R2*'*$!O)W*@ .D7X3+TJ(OU!4BB>_4<>?NC
M@*06*G<Z8AUBXV53_H>Z?8\?!Z')*IM\76;+,^PM,Z/><6)O^[;\9]AF]1,'
M>_-"0L2I<\0#:_6C?U$Q.EQ\3?.=69@L[@SPA'X/%QQHWOWDCE9_$KOZ96/V
MSA1'\1>9;Y8^M&9T-]LS,$O!G+56Y-9(TG:P4"@CR8%V<M7O?,I=/#)^E>TZ
M\_>(3O^#Y\OBCSD_4<<G :W N+9+"Z\8-?LK"MY'I#&SV:'=\"%;_]44\WUC
MJ3?BB.7.OZ[R,2)P@19^(< V&A52ZR60=01V+VL@V!<4X^0QW9+_#-U%;>,[
M5PZ]<F14GN_PH8P2WC08OL\-EMU3[Z$3?5G<X:U2I67F&BJ9HH;U)("&A/B&
M8)*;X@#@[#G^<B0;]=X'X72,[C%2G,"IE* </UUF_5KSY35AAZ;:AGLS$ [2
M@7,D4 ^3)&*/*^F'[S2^8V"4^ [@O9J9SWWI%J1(BNE$@6Q_Z"'%(665J/"C
M$N5;[ ,1HNE*/)P@A*V() *<[Q_Z?('+ON>$]@4-@ ,7:T0L<@2%2<<=BJKX
M:=?.)@<?L&M<D4M_V_B--O=$R_YW.K$:)P)@FT,%*<*=GFC\/@XLW9P*'F_>
MSW(!B"D(;1K6E8N!_E3OS=]E43?S(G";T4B/[,?WSS+LI7X9;A$?%>X3CL'D
MA=NPRSV,P!E2]>+,7NKP]_'1#LJV3\%C)L]&GV?ZQ[QSW9U4_'N[]O+NDDO]
MZN_L9<&2_[=;.!26H%RH[(Z?(C5()B#,"&T62,P/_$[\L)8J>!035>Q;1A[C
M'V)A9 ?*?.VYCH],9W#G4)Y.3=AQ?G:$1MC-D#[(G4!)]CC/%+DT7BJ<F/2U
M:JH'7*NQ1G]24[]NXFKP%AO?HP^R=X_2%*/UQO*D_!W]U!X/='_\!DWD'^=@
MVE#*R%D6_2X=((8BK(;-L4(Y['/45FQ,]\W;Z<^[9>R,PXUGW_I#[,^9YC7.
M-H=7)[J*=^#W";_0E:PQL\Z?X5RVX#5"-;1( E"+IX80MWW&!60?<<5 IQ>[
MO5)EG2(TC#:7>S\Y1CB4NCDX>QZ7@'E&"$'1#+C1$X19!FHJ[OPGH06(X.B"
M2.:T3G0PT]!CZ]"U2VAWV?),RI'MW?G]P7.2UK%WC%E$T-!^R0W@CKISG).:
M0RM%Z[R3,:1.E *S_]<V'3?G_]RF.[NYX"3C5O</G<QVZY2VV%5B.K6^M)T8
MZW98*Y65?NK?O#?']F.C4 V@W'TQ]&JAH#E3_R\NU2LR5"[BF;SN1]4]<7LS
M/_UGP-'@<@3E%&G\& $X5BVB$G@Q$;"*QV^G^>*.O$\\(7C2O'MS3LL:39MC
M4_:6,O&@V,<QVD1]*0F7I.VA[:J4 T7Y@&3N$+@;B!'*TF=7TM8AFHC](18P
M6:&NL!_^%&< QL>4GVC:5E!QF%,D',?LN+_7*'7;B7>7-,*: G*/'H&%X@>H
M9/K23]Y%_D4.J74H_A\QR9@?#"S/]*$TP>!.RC;*R/(?_YM!/.OKE6,G=SSQ
M"Q5+:WHT8RGG,D82L9![&ZG"QYJ]1-;%$B15X??@](<KHV!)^/\X>GEQ0@T:
M:A<6V0C'M6>?I';6V&X;B;<^\'QOZV5T+W56A*J4*#"<M^@M+"'-UP;T8D[+
MQQQO!C =\743D?F=$^08,UY]<(K+7WVG/K?;JN<OSCYV60$/P;E.8#_/0=C6
M!.]$3?UNC];:+=(T3/)A%'&);QFL8?VOH:7 >6>GHO8]GW;G^<V0.BF95T&7
M7HA_H2@0VDPI\B":P7V,0&!3.T53P&OW!Q"9J.2"=4AJ@\K8,GSJ:*[77NTG
M"GE;":MG:;<,U5^+_=[4C8HM$.'M>Y%\*3"]$C].JO<MJP!1SAS!<GDQ.-G=
M5#Y#I^3=;'P^,>$J]J(@()\V:.9B>MJ?>"7W@?%-0NT0>YAG+/Q,%8M<A]#@
MLXG=\LIG@=6)@CQ/8G[9B>P?'R_N,%[Q-R[T\+_L,LZY9W5/&J0*97,XA1<X
M;DNCP,;M2=7,L@64M%!5.$Y1Y-@3&S30EX&%(LW:_-2%B'US+VN\$EW<=*Z6
MG ^@2V>X0GC05A2Y9^DO"Y/1"*M#5"*3^'JL2O3)/!=@*!$7Q? :T Z[V;<[
M/[ 6G31NHK[_XX/R6\/5'SFOOK^M/"Z4$;G:K?9,0I*O!#"4@O-AHA3Y^]\U
MD#G."=;& -UCS-P\%SN7@RL\&79ZM#NST]=A_+1B16;N XPW6,U7(7?<)-03
MV(8\V2Z>S2+W=G6JL8@-P=0\KMPV'QFH:YN8J$94W]1-R^1Z;/6TI5KIACX_
MG36K@02<WE?JSPMEG42^5E8U6G5EWR)!/N[655DY['47OY[B!,DO6G_$?C31
M^6H&0NG>$K[LIW5(J(\.DY2$.SZ;[CL<OM)\E(%*_$<IE4RL_,@6RW-%QP2I
M7U(JUI].S^@ZTW5-NOHX^%/T]O\$R=2@=8@JJ--&4*-8TD+)!$6C[RW PY^E
M7P9"8T)5RGT<(KBO6"&*$OM@WZ\-M%C$O0W^7<XU>PLL$MIJ2 U&N1<\'B$&
M.-?"D_."?JW-N)TQ/4K$U'C?K(0F:^T& I]4\T4,R9>34%9:5<2EW2X9YR?/
M:21;&P3EKD,.1#0/#F]>H88?ZH+<8?.T1$9TGNH/G\YC(E/P\CAI#O<593]P
MU3&B"NO8Y:M*&8[:P][^RK&AD9*R5TO)9\NL*>4R1K;%TJ 3">ZS7(H'>NS&
MFV\PD<K8!,QF;+3O';5.JF(]5?**&AXV@LG":)_\3DE0)0;<4)3+UO_AE_T_
MB7B@*#;(8]\SJ_EJI':$N>#1]Y3)KB(%01[?$4HT?^]*RTW'!<8=([_+Q"HU
M] \<UL'-^+P_J'%1G26*_7ET%;R<R';;R,)]H VGAAV)WJ@(L8F3>!\!!U%>
MACLG<EXEP_D?3"X3'CD>S-]I9[IB,9S[X2GTTU RL@'>CDE8*U(;5OVU#NF\
M34VO-&@&BE(9&EO&PJ.L#BH9%"TC#?<T?JAK:XH.)![H?)9Z*F5&A1> GZ "
M9S#IH@<*AEWA5DWPG3% T#_F6D>1J0?N0.7G*UN_T+[^5?:R5CQ&OKE$/B=%
M-GVMVJI;?.,7O WU&2T"*,@ V.?IV6+\)%X'5.-Y@]#9F;+7_,/C)8TIWS72
M]W^KL_34$SS\=J?D<HJ3C;J2=-(Q=D/GU08O;K:@1'A0^(D 8*#L,!C;#9AO
MG]'BK,1:7Z@ X5VWR7%M3K!.6OP3=@JE#$U][*A+\5*@1)I>2UP+$5O%L#=*
MP)L#A"4_)GVJ?Q;>@8G''Q@W0NQ=;%2]=H6KI31FOKVB_B3;TW_;U63=O.@1
MW8BG\=:]*G)9E-&YE352$K(1V4Y(["T)77F&[?&:7"4JF+2$S=(5L/N$OSWB
MSEP5LQDHL/WND3Z59L2T"%5DG1U,*V:L0\ ]I6G-.K/5&B)160KUP([.?_@\
MQC0R>>+RBL\87$GCH/4*]&U2\^"Q/?Z?LL2JO+K6(?712^5 ME#6@^.P#@F'
M9AQ>N8=3Y) 9Q+A5XMUUB*(Q8B]::\>G:K:1<95.4T/6K_9?,ZKZZ+RB P?"
MSNEL/?K6^3_Q/S%<7\%KO#A^BB"YA#\L'/1%)'8B-"E%:$*]<7WC;\\OG=/Z
MC6_O!3J$?;=C%&>Z)!SMEC+X5/Z="NH[=U1_1K>2Y/CHC>(7B.9#A[$:G:2M
MU5&.0]O@*5'REX>Z/.LZ-LU<<26[D97K.3N4/X3Z8XSG&A]61;RC/'RZ*66.
M[S:+5 +CW,+L'<'"UZ'GMH_;ECS??<3^PM A\TR1"+O5XQ\V'A#1\5...^RT
M/.7NV;R) "?CDS_^ON)BH.Z^8\!PZO>( _?VX$^D.4%GN.1^VYF]0UN+[TP:
M3:,BP\#';FQIWC%"-: 66]WB/Q:UO1#8WVW_S0O8.0"KH[.EA<6MOC:4/\0S
M8X&85OO=R >85J[Y'&PK10N,8Y"38$<GGZZBT0]ANC^G'JY#]H^I([3X-O^C
MZ;%^W-.V'Y.6)HB3RN_W"X^7F?,'A$T<ZK\5]M] ]M]W-@G-S630&/R-(=SF
M(MV%K2(1KQ*FOL98W8@Y0Q:BA22=I2;#V#>@)4L>T6>X'6&)?J:=IDTT5H!H
M_3W(1\>T%2E,-A^(,OM'):[*^P6F[;.]G2(1?.C#] SU)7 K%^U;X>>U>5_H
M\I>?]?6_LC&-2?P"BIKD&86+'!FGJ^\""GGC5.5Y.&@,;[\#[R&(C#%5RZR.
M@TQJ1C)1TECH^7$<G F7Q1:LG6ZJ>7]/V2B,,N'^,<D#$D+?UW>R^YI]'J%-
MEX!Q3KL]F69M+X(-Q:*@FFE]DU0/;Y_>F7FE[AT/V>D,%6N4#QK_##U\7(M^
M\ YK[8/\O*[OAMN.&C?[JB&4OLM9/#N^PFB\BU>[LC#JO,MV<^63BP%K1D>T
M7MSUAO%5W@NEZ\KQTS-BP$K/RE1BUS"(Y": 3A&".H#0DUN[#_,0QW[I3=5V
M=+R;L[OVM9>NJ5F90>.MN>K/XWA%_* ;H4&R&YF$L'@_:@:5Y'N/J\Z[<Y#)
MX<N5]4Y:QFH.S5G;*<.&J5@E!_T'VA#3S^)/15$%M5&H49"/WXOS!*+;K-#5
MVT(.KW42H-YHJH((G\2M1'[@G_.3<#0;F6KFO H^Z:,7@@KHUTC8S]+%Z?%L
MA%\/YZSP%8NY]8*Z=<A5V.>_YCM=X4D%S;"M"(6%<Y:9)L^T\HM#R18CR2H%
M5H1ZPY.="2%,B;F4;[^1VX0(OB9YHS"HR%QL*(;88NX4@$D-JV3S@RTJ< =L
MXDD).&.5H?CAL# C5B)\TTEWN^0HZU'*&.1N T3RQU G%=R3MS0'5&!)YR<)
M#"/*L+5*A;Q.%][@D_6..Z]":4$O<-0_#OKW]/O+<O4RQ\S.UK%S3_:]]:UC
MP=G.0.$L-2T2$U_PI8E2QQ3YAZDO/AN5 JN(%L_*G$/%7 K8Q?<5-S<=>)X_
M%\*:^7$WM;:,/R!X_8>4!JM52.6L"&5L1)I $Q37$[?S]Z<R3=Y2ZU%+'1S3
M&:M4C4I/JU&_UPWW/W@Z6J7>DR@7CS =T! "V]F+PP@H?N2PP<;>J3^SF="0
M\)HBG\J<;*5*]P.^BUVCE15V(\.R])\1_;NE#-2RO4]^BLNZ[)_AMDN%,)M.
MW8F7PAYGN;%_<OIX/055.;,P*.YB?0ME'!=M\\_[I\6GT,"JK!]7#KU+?O[P
M=*4FR31GG^11E#\?+EKG!_B/ZY!M%&-0!#H:AE+,H%MQML#2OY6.<H(:]MC:
M:6+G/YQB19UCT._N9T4'G_Q?DL9? ;VX@X)'B*VV(G6Q Y]58H/;Z:KU6)Q?
MZ8(D@^_Y4+F#:>A@!AK1CJG=7'0I.MUO:B@AT[,BY@7;AD?@-!M$_UY$$ EY
MGTC(-)&0V>PE/D:_TB"A]$T=,)2@\PZH#T4'!VH>PBK974K*.S!@Q3XBM?DL
M!)^+.R\@XV5P<$Y5#3"C 5/%UOD"XVF6E'TCS>*SB^PK/@HS+G!EGSNYENXO
M(C>/T/5O*<^?G+I529RRY]:"BKPPG$J-X)F(=5-W6"99PUZC?#U_-KT/_4U+
MS6UXET5S=9\_\0">KQSK87=$XAIZE@[J)K(K 1TN'BSGN0L'88VP[C#QUG6(
MBC$R5(2[P83ECF[U>M<#BYY.:U/=3Z)"] ,M]S_2SCC((M[8)W7DK.Z1F!70
M(LB]5/3))["F(8HYL&Y?DP"WI&<04,3B(>60B[RM4D\5+(6RO<5.I<(10DWY
M#RU3CETB+(,:(C!H%YJF=A29C)EU3IB535GWAW95<!*W>V_A]4E#T@I$T/]>
MUP*-S%?V=P'W<^RY$N PRQ&>4J0'5K\,.<O?\9;#+:D,%1X:#?Z]N?-Z:!Y9
M62HES%;M0<75HG#9\)"^+^N0N!0V8L<B?0?!CRZ)\VCXM!)I[,@M'7'S'.';
M:IIZ?'673[YFD'&UN*/1UDU!AM%J@^Y'SK:L0R37(7ZDJ0NSY'B\!:'-,I(H
MC;,0E(UV%P22VF,P=W,;)P[W)%G_G+ J=ZBH!S9_K8FMP5A8G._5#& >RQ!;
M([+C6<C/6L[3.MS;@ ';X-7".@2H?\8)FYMO2[7:TW#B[DI![PAC+NN+K)LL
M]&)^LD:>;.*E.X9,,CL9B&.@B.$(I4IR$O\"DV>L&)5NWSXC"0Q,5,;XE[X_
M;!]Q>/J9NT2ZYCVSFTJG_0E[4?XL%A7<JUK)/"%H1,X^'N&[6JCZ&KP%\U\U
MDL,P^_ZB;].V>HP@SIP]S;"3YO4O[,. !IBT54P\"?#$3"-GG7O>5[\!ZWIH
MQ$1K'^ 7FCLMH#+>&@4TP *-A35A"A^>N"W79!-SDB"K(FJ$%LK,\9"X_T32
M"<>2A#(&/&2Z/3,H\>7/2<,7T]@8NW?^6L5:WWXU; MP&SV_%_)[H#6]6%S,
ML58GFBJ-#(<G-/4L-3 P1)@R-#DROR'D#_N@QQ7*YK&*E=5TWQCWDE]7C;2^
M.&,UW]=NUXDTU+R_L^80ZB-<BV\\N5$L]HEH(2^*>.#,EN078!B+E%30-7^W
MZ^E PQ+W56KY@BH/[Q:_'+T[YWI%&(R4U2(IXN\OA;)80AOJ#9D=5<D_/M9
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MMA=HD53\BH4 5Q7VN'3_2H4(74YK8Z[:S*LNL%JJ5Z);D+BCJ3YB>7($D;8
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M']7AQ%^.J\Z-UXV+657OYCI'UK0:"JG%$UVSW:ULX?FY>AZA[@-5V4H<,WR
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M>7(:.V$^?:]'>LKE'#5'\[<'(7%99VHQ"6-<%]Z-U*\B!EM-"IT+=CY1(#Y
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M9EC[$W><V#J:ZDLF@GG,X[=  ><3(@-GB^FNJZJ[G]A ^*JPGF[S1\U7_>A
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MO<\?!&X%C(G%-MXD E038ZW3GQ$&RKP)ZNBW&?"$P-NSK#B0V^SZII:)D4X
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M4=W. (L4Y$LO4GI$6CB;0:S% NT^W]3YA3TI\5;;-EV3NMD>%0KD &=VLJ+
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MB]LR+N8<QF4'B> L1@B7_/3G!TQ&-GE'TUPO1K#!WGLB8T'R._01I%BNW*;
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MFLG#7#08$=U>X-&5H)XH/:(][HKKM[C*U)5BT6_1?[S74)7T9C^7Z6CD1(*
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MP=#@1)R[K*SLRM@7O?8GR]-)?4#B8?B^@<;S-8+)3L@8]&NVV)+3#),U@!C
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M''+]R]!U_>KR\JNX1_NWGE]H^<&T$S,P0C'-6ZN?/?@*+IR865,%I1],6Q0
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M8$$^B@2Y-OM<DUU&-TG\)J*=3QX1'J9RV72)%'>? 1SJJU\-+ZB5#CTBT\T
M![,$X,X:IOB^Y3"8638T5(L.IDW4RCAVSQ'YW%B1ZG[;8@OB_FHF0D]XJN#J
MRMI0C@2#=R]%XS1VOT%-)F:J-D[=$5P&'<&/?\[0WIS[GA/+J/2T)N;:SP]2
MF[W)*M/+#97Z$O*L<86 :T!@,%P#CFIO]C<X X"P1P(>CB?N,%UR/.Y4^IPC
M9*%><UIQ5'%5K3;=ILIT2#["PWUGH-26$9<OEVMBP'!3AZ[J9@U7TC",_;2
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M'#\<FR%I6BM<$=7NH36>.YG-2%\$+M:TJ+2[R4)(\D(^^>?<@(YYVO7I#VI
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M'V5TN51>^^:G.<-**6D&,&\R)^#O\-)\ETV9^:9[&<: !,>+=31_A-?4))6
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M^OZA;+4GI=U,O+SO;TVE4U@K#<;*W*L:4(*41VBR;W Q'#RP\/5K3T!59_H
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M]-?-+("6']4N\-R?<&/L$F 3 ^I9%,1*Q:%$PN"/)O:/+@$U<RT:9TA-/^8
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M_SP"AGB?7'FW3LV'&28 ^^67\A!8#K'!$0WG<3AP0.CUMJ0^R?F%4&%@B.I
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M#UUE5 1Q('D=/][F$-&&;:S*?.#DB'S#QS5^4C!7HZ=C$8!3I91C+.G2&LV
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MW$0$93$&#HYG7?64%M\TZ&QN8GI2MC?AF91DZ)"-?)9B_,#X^D+Z]9+4BR
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MG+3(?*I"DRX^/3*\PNH&SLS$U,SB!8(K:$5)3/WFHXD<E;\]=);Y<!1X0X#
MPCQ) =)NAJ9:TT_)SRSZ#$,XO_^.ZG+Q63PLLMA?FJ/S%5Q6[9(UM%\WQVZ4
M']^PQURF/"*)MM >$D-#"E;AK'+&)6M366%EYRM2%]6[G$/%HZ)SH$Z$#*ST
M#?#=>0!#I8H>L=;>H&"D:+IAHP+IYCBU9Y>L -.ZK^=84-RNVKUMKMLT"W79
M#">RSR=O-!X_IS@[6:N2'M36^.EW_U.X.+1M9^1U8F)_GZ5([2NN+>ZQ3?_V
MTI]XV0!"724^%K>S_L>2" :&/G?,9!_#\%E ;ITQVPAH..+Y+8)]MM$*8[-I
MKZC-E[]<M(_?/"S!9VP_C,9.&_K=GUX,;6UU=S2<4LB22'20X\Q?BFQW>*3[
MA![7P[/H'IGX,1AIZ$!,QV<&$[/P!>%X!/.J]Y%%<.Y4WBT#MR2;(,#\^;9*
M^1V0@/2#JI;W3P>UC"*<G;K)C8EE>R.F,W-+UF_T&5^/6K^"%0MM^O@C6GKV
M%21/<N#6P!"34\!FQK%"IT#0QXV-!FN>7UZFK$^(Y2VXU3CD]2[.O^P'1@!&
M5U6V2F(]V9UHN>E :(KR@&E!UDMCST.37)C_>9\"ICPF8AD<DLB#XLCQ9FY8
MX;=GZ0/23U[M?CF/J2&QM'+3M5N(G6F!KR@FB=EU$V)EK8PF+GC9*'7A>E_U
M#]B_\S^"VUV;.$X!5@,A<*1())<IR><+?G1?NGQX>-EHV_EC1_:5&P:"B9]?
MFW[M4+O\U.M<BC5]\(I"CU/@V=>K[=4A#>>:X.M["IHGN31NBM(",I#%)0PC
M0$*W*T;,"@\BF^?[;,W5E6N(7E$WHFGWOG7$Y5E8':;^N%7GJ3;DO=691MDF
MJ(8K7*'>.BE#"0Y<@XA2+#MY[I$,(NF'9S1. 3=IE1=JCT5?3YZT25X/??,(
MH'$'VK%KZ0/%TB[O$F,[,8K)[>RS[+7H\144JBI^X<TX8J\=*A1D"NWU'ND(
ML:8/X7(])SX(C24K4UP66$(5!(D6I?-GMYV(CA%>:L(B5\<RN;4(.N5\B(2,
M]CBME_1L]#I@@^,Y$H2*V<GEBS=/@[O#L=D=U+L4K:9SGHT";30NS(BG"-V<
M_:HOP8E9C5HOQ:=AWG+4]]8I])7>9=US?$#%[K4W6<RT@2RB/I._1CTEF^ K
MYY5+65OIL* ?"[Q/L6Y=+5'UP[ F]?ORFMYZS9][5N/'[91B4Q_(@Q## Y%
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M%'-V<?2/_^%)G*6PO-G90^VF;S-[F '#RB8+C#H]0IM7+:KQ&4*P6AVV79O
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MNY&I*U>#7;K-5;28F*G"$F\"8@[T'F @6%)XMX,:M(\-+& JM6,H^SW<ILJ
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MNT=?'1Z_$-B)=$VGT^-W3#V<]KK#H>KP6W4,U?1'>U("?H^D )M469<P?O'
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M;I6$DO=.?7[#+#KF2X/ZZWQNNA-M&+B;ALC?TKK,>#'7<N-(6QZ3\MGYXR6
ML@<C*^G=M31[. 55%&*.N#XPK/2WK(T\UP.(UP#?(6G^/O]^ 5R"<$C@<7^"
MTS2^S3NXPMYIF6W[+6C2><S5_S/_P?TL:1%G:8V^!-Q%P68N[M@B'>J[4I<V
MY49B_)0</2!RSI%;C/C8K[&?.9C5N8'=E3,&:_ NT4FA%KK=^<RH#.9R0G44
MNE!RZ*G'WGU3;7B>L?>6?5--E%6"_IL^E:7OSIE/B@/N$HXC"(RO4D^4IDHD
MH^1]"TMR,H9M4R4RF%EDK87R6>.GOL9VW@=S7 +:Q%OLYLTRJ4GZ8#JG^I$(
M$0D+PTL VCG1RQ-'-147)L2&:"K2S%'$KI=Y*]U=>TVH-'*]$G,,7C4-/W]L
M.-D(RMXD;/JH1F'!M'.S<[^^)./5BA<%^!?[6)^OKF94BOZ;8JL/^5U$F/=,
M/H#F2&W2((I B>&(PQ>WS: N6ORITW(=-YL=<_JVGAL8, OM= K\"AH<!-SX
M(IA K#DSA %7IE8FJH2M1!LUQ"D0"L]R"YNG17.LDM1QUH/IJ[:S0DX4]K:6
M$$KT21L[O.="M(PPT[G=73N) .)\1#^C'5;'_01Y*4RD;U*YP^ZA\SSYHXU?
M%H@-Z47%;GSKTT+;R>#C(N#O31@N 9T113!=M!E;%UJK01Q:"/M^BR+Q]6*$
M\(K=)2#EU2T/8!/GTW"?E.@ 6J(7IB7X<)&OD\6@.2O?>,'4B>%X]1LVU-?+
MQ.K#O>CW'GKD.D^C7<'?X;]3<**$GN-XXB7@%Y$2HQ9!LD"#0^L74%7#P<65
M$?9PK& 4Y=_KIF9+#P\,)=[4329Y<^FF4+!**=XCV1*,NEP88;PC72QAN-M8
M2ED%KJ(E5C@9)!$U6)$?CA0>-PMF[V3]%$(KV??^9C>Y:?VD-QNMXX'@YH36
M]GJ)@)O;6ZAD/PYI <V//_4@,**;@PGN;2E+[ 2I1%N$@T^"MY=4RIN]V.<4
MG&?WGC\,O?.%@O,39%#AV95\#XG*Z$7&3@8(VM%#')/F4%*EU00V:IH2+47\
MBK>)I:E<&#P0$GP4>K\X9'%8S-W2!+U\>PM<*8VC1)*D&PDIG7%WB=)H9.A'
M1]S['9*2NW7IEK11GWSE24W!A5\H3[@JW:" >1VT4^0A\0S_I\L'OK,"KP@0
M]GM%#/%>H?!@?5F#_SA]G+J>7R 84B5=T2,0=L;?WA]]K7=9(5Q]]H-;=5Z1
M<!5PVT(W3U'$CQ:/[,D$#*%=&!V.3]<#/Q"T>-('MV+'Y/J8>=1!@@(93<4#
M))6KK^HC DLW\X#$YQ(-9G$[48N4.*F*!3-S+5M/$/Q&><^CQK*R-M2.9_P^
MIF%O#M)3 WP OY+]-6+DMO&$G[)WB8.GEY%<<D:(L$N>@WX?M]-S@=P3MGL4
MFX'C#5L;QTF/\S6D(5OUBJG9F7/MGFFFB$R##3_$U;CSYV%^X#-.74PW 1PM
MZ4(GDO-/U<3#.L*MK,(>B LU20PQ&5W&<#?;B?H:6>W,)"-PG^X*,SPN ;DF
M13/_<V,H2">DHF;HR'LF*%J;+L4A\;C(%8J4]C3Y%3E L(^NS"3;2' RG<ZW
MRM[$?^%8W_<(>L"]8OLML ^+L&*JWHE9XTZ:.VCITF7V,R?JGAE;P)"FTQ(_
MI%=X$_.]:\HUK16-]_&JHW>[W9^RNB8)/-_N\JUI!T<ML1/_K&B!:&'6>G'Z
M8WLU%'DJMFL:AH:&9$F!-^X]?Y1+N 0$?@3&@&A<*H6=4,N&HQZU4MH,I)R-
M#ZVA;V<_M06N?%)1PH>MG(0%W"#>&>FP9)S(GOCHR]XM8S#79\?S_?NW9#ON
MU00-R0W,TP<":$RZMY/JP,L$1^%E(\$CA1U%CBJYH6[ST:2E4ISTF+?QEF#&
MOY&(:L0Q_)XAOKG)><94L8JLIB[&/)N^ES-(]L8]"L6?1LHJWH2OV3S\#9)%
MSVZK:(J(S64^(J8=TQ'R R5=PN3@;9< IB$TZ!;1>5?CR$QC-\<1R9Y/Q3T2
M&#'P\W$9/KM@"[+]Q1,I>>N;J_TEX/J_Q;T&6BKSNZAHCL?3NL W_&BP9BW4
M1*SZ=]X,,*\Q;O>EB,*&0A?G%TJJV5WR-ZE'UG)_/V>S-*B>)"%MEDH-IV;W
MUW1BKXDE":]5NC1HO6P &EQ/O5)QC"O"RFBO=AH:F*_A-"_A5G:.B1K4M4#K
MQXE.=O)JXHZ8^R=Q"ZBWQZ-L:::&TG/2B&9Z^L]<'GMHPQ5=?.WP 5[I%51%
M R3)A.E.*&A= BA^C&^;:L^U'+ \([05F WQ-"L_/C]5'<7**#I3<*Z<)*UG
M5L6%D7@P+I^GCYNEIOC&#@T(U!$*7O?9Q"W5BDS[[(&+SMQUQJ\)8R-<!8?U
M_^W!$OCOS"PE4Q#P7XI%>"LH"6#RW_4,1(]C\3$G<1< V(SR.$GIZDTRLDL<
M4I(]ZY<.@,>O$E[TU\@G?8T3^C)WEV9@TLC1$GYF[!# 2 #M=!$H=0C5V5+Q
M*V=[U,MMB.67KCRY:6:UJ2KR9DDO>G9K=,)R 5XL+ZD@N:;=^W_WV-01O/#I
M>P!AXE$I$,N(4UH!?S)=#\N#58!KQEW\5$03K5FSGP8\%^I2HOA4'C04.&*Z
M93,CT4(.DY/?;GJ!&E$KJU:%-!0:\F.CR4+MW@.>QNH(1A)3SN3\9,\+=A6D
M,>SN6K\)?,?RE B1?<$@:P]N:7UHN:KZV\HU'<%B2A:%+>.T?4CU277:AALF
MUR@EA7H&E G9\K%$1X\'IQX 47LKS36$LQ5%!!I. PL%W]TRZA9+"3>^9?!A
MB/7!PZ#?3#S>2-;S0+A#YKT^[-#;E=*F[&WI%" UCN6V@MK'X65GFT2')2:_
MHK:*^PM:CVPP]?QKNZ4,QI%NVCVP(ZV6C'KC]E*K'<+3+#TY+?NQYF6\;DG!
MK\@#W9<%H%6YY:-6^(9JH8D?:/3P$L"PL'U\JOB=NL[[7JB_DG"\<Y[2F.ES
MZ2=,;'2S!IV7@"]CEX!2@/W%#:<UO:_)@]]5Q1;9[+M!<R=M+94,/ZSML<+7
M>BQK)IP5)][7 -;Y-C[H!P?)(96[E;H\CJOC9^?5[C[->=V>=?\>5/_U$P#[
M)_8B3?PE8+X"Z]6I&PBGEAA20X]\CHL\$BP^"EI3B!!1'&(85]K'/HQ=)_.R
MITQ/W>B8*(Y(_S"6DKN8L-?<\\Q;KZ/;.+3I?95][1MS9& S[QPLVGBS9L8'
M&A?%JAMZ? EX:5:[6E\F$FDL=KW!P3IFMHT$*2KUGOC*G@/5R;&K^^4=AX/C
ME[O!#(HWME"B@9*7 *(J2<5M[)LSJ3O*3? :X6\XI5J=FS1_+T)T;J^-Y>1S
M !G1ZP4AMA 8(=G@2W8KR[/#;9$N@WK7^.9##85J,9\9"\RS@)'V)6#3E.3M
MZ:4>G9J$=8P=^?LWOY+M9 X!F>VUP#GX<18^#*>QDA:CU2Z=8L1P:MX^C!81
M'A1[>:9\3?_8EC,X=2>Z>. .ENDL/FF^>FBC=-CD1;2KPGA*"P\$_&M?*H F
M8&2)BDB6MSQ'!#TO&T4</1X:&F^K_3MN#4CH3"=K??U!MI6Y]/H*^0X/>GEN
M#]L3K>";MU7?M78)B'J5ABME?V7X2\-O#L!IN[_R3\TBFU'MRNE8\+9)B>>C
M"?.]Y7&CZ>,]MZ5;P6LG1@U%^PP5?K8(73228BLU!!&-^M$5DU-SWZ3MHAPW
M1DDQ<Y['=7UA.HE^B"&Q0<[6LR2.YOSS)<!QCS9@LH6J2MBZ,^-^6KN7H1$.
M0GN?,W;S17"=7RNK@,[$/%?DL2_R+P7JOTK@)'E+XVH([CW@&\V44A7XDPX0
M/G$[\WTD8W!O G8'7^VEM::JW/+0"$!H>496.H_V"O> ,\+H.ECRPR5:=IXY
M773Q-?]>;-A)%+LV=G$C'F=!K-=T/5V4*6C7Z7^\6"S:B&Z?_I R9;>0DS1?
MA82W;E_IJ8.1Y_^GQD+F7@)ZBN$S&J!#<<M_X?_T$I#X;QD9M[I+P'AA\<S'
M%N*1R^DFWT4HI+=E)1.\;[]$>;4:C$"G!I( 7^'_%Q/]?]<%3(#CO5M(O^ =
MF<=O#I?/'TY"_KH@MY0O:*0O 5]UB>X7_8IIEX <N1BX\.%_EI<FXT%4+)GW
MW(74:Q@_"ES(N.EO@$>N(#(#%>D[_#WNE!;LD]?&?SN4:8>W:LABFV![;;IA
M-2^82-H*\B6X]:>MZA@-P(T+I4!DDR(K23-*E>B;O=6C7-G8^%7!>?Q6AZW^
MQV'Y&<17+=HR_4UTX>-A%ZT&4]2%5!G:KC;G$N#%6/TGPD^^L6HT0-!DT>)5
M];';R[,^&:.S6F"<Y 3)9OI6WK[:S4EIJ9K;;2&U!BOWW\).5DBFF9$Y4Y4G
M$<Y(I23$ZTQA2C=]&WL^!??(=4SYF=1ADHD%];3R),NY%F7*C'%1^D@*2OC=
M\421 J1HO%YFF0:F-V-:"\/:H=*KM3VF<QL?HK?G[W-#76"->#%UKI85 2 U
M[%GV3#(KPTO1 WEI)3U834?JY_K/;U2J5<#?3TG+FD?\JX33!N<?JQD;2_I6
MO-F"7@H])OC)T652<9WQZKN:$NO:U&FR\XQF&_GG'B,RI>6"#BM-!O5AB6-E
M74[]T,.&=WTU>0%5:STAFX9IB#>H]J\VP\X]G?:J=!;@%VW8UURO \RQEP"$
MQI61J'M!1Z6W-%OIN97#?^,<K>?D\U6[4.T/I\.JC%7< :I& D2VD?\V\N_#
M"&._KJ^9*0>2VU9X8OW>+-HI]\:1!7AP^%?DR<R*<I'N>13U):"B6'I);WM_
MVB4R0%X-(TK5%'(<EE_5":F6_0KEFL3?]%J2(72G>:$W?\ES67QZ[]KWIUHP
M$4\>V"B( 5-MZ3FET"K[!T&),E].J:O0A%(-G:+/V7LR..C,@CM&4#,)Y(Q9
MK!RSR##Y10RL;%+O5>M?N!\[M<%BV6 -!Z ZA.3NC]<)@]&KR=%=7F*[[>?B
M9IEW&YF*2SKH.T2%:+:OS+O"WDV,H[ZQ]]'>Z&Z("J1Y1KZ)IKWZ- =RMPQG
M%L*CS@X?AM03Z?'=PZ+WMMPT:,W[<N?_]F8G+=:I83M8!@F&V=;VV<I.S*9H
M=2;=QF#RJ]]HG(^I+D.#:$:N&ES>3; -?)"62/!-7_7Y>(BL&-KV-TWZ?:C_
MYX1G>\O=]TC4/FL;U=-)<X/T$'^^L\1;TU@_53J;9L:9;3>LZ'YP?610SA.9
M1@(3.E0(P$A3B/\M5FTQU8>XJ0'7K=NRYY#:L)ZWL)Z54J1+L< 0@MQ0FKI%
M/,MFQ7J9+]<[,Z290:M0QR;.J;MV86@/'(EV2^^0&RS68LEE].7/^ZNW:9N_
M]+%0P%&5+]?O.A&(C\-*QZ&KIOS>%L-T^C%\24NP[#O1LG=NN_>8MA+3SF0V
M4%Z1HK_PPX52A;FH?NO(M4_7;(%=;9+#L.(.1A3YKL'7/#7!+ZXXLWJ>5)2)
M&K<;O>&;QC(^T@D2T0MCMZI@GNS4>1LGH"GF:'*B+?B[\+94/F,6,-@/Q/CY
MB-]RY6);9C&#;-N"IG.$R:0Z_L'3WO(' ^*Q[C.1V*.X"-K-ZI-4/R\.V_3\
M]3@'^3AV0N9T+>M>>.283DFSW2TZ!6?%H\,I\6]H*P5Y#=7=X1.)&,$^'?^[
M\U&2!(XZB<_>#HATCJ,)>/L>@3RD\1GOC[RJR@\"#_3&"AUZ=,3RD*1G1,><
MK0NRALE2)#=+BM 3'[:[U)FF!T,.$KZ,;H5O0V\UBU4S D.;Q>B_&JAX."^]
M6W,KF/?QE!<-!=*B_1\CD!*S>U4:/$*)&=^Y,^"T,EW.Q/DSY9[JXU$)#:"B
M<3AGMVXM\R7@:.9K&P8">8QV('HXJY\>E^9K$.LD,\.%G0-\"ZRX^#L29 X1
M3V2[Y+Y>Y,:DB"4E.KILG4;JGV_OH]9Q5]AT:[0$BJ2O\2;=Z'D[0C3*A=FO
M*(9!T.%K+3$&-MI#?4P@TX-+P#V_CVD&4^\?.([/F[0J/^@9](D^.BF^!-Q7
MY%K20'>IK[J5/YTU O)C4\_8V-S\Q H-HYVSQY 'XDER,9;K-%'-]V9[W#],
M2]-2M-E%WY^UI_]3+[7A81==5/&87U7.LW1/95S!$;-\V]Q\TU3X(LN>:8YG
MT#'I%=[W$J")8=2LQ\=FEY\R/ZP]ZV*SJOO3Y,=@GV:;1'B=KU2\A!/)4'OI
M-)YNSL6-6J[;L60CVMO[Y[?G,20X A[68;G&D8X^G8JW:L\4TA%UCQ3(@C/@
MW;57G'S;)WKZKG6=%<MAZZK! .AV3<2-D#R[$0(=&![:.?'Z\V]]A+S+PLAL
M'G*TC7"1[5((EACK6>MW;\BH:MOV D&2C(A&Z5B$3T ^OGQX"2B@%9%J?VI
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M?TO@R626'M0P4Z#"J\++GW&P4<7T*^8'_X%3$M(ELQ<3\#A@SE+^BC<\2.L
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M(=D=,&8I--E(CJ?I3EV*N5HR1,TC*)]*0V/YF*?X)<!IB$VHSZ5*B6_P'T8
MW<%'";+U3/QK4%AJ9M?>+-)LW$\\JP]A:=X!D41$NWW](M ;E\3,^EW?YJ',
M>^M4U/FG9J#3\EV0#?B60^KZEU..0GNG=5^^K[T$QJ1EX3Y4YY-WV2'<L5-F
MQT-$=P(?YJ0U2AX86K]%!'<*N][L_(.C<1I7J=P-URPR>=*E>_U+CA=2APC.
MWN;@(+IGS1+#7FN;F5>4A[*>36H7>\C]I.%DKY'2Q5IVE@G;QG<<J Y#YRUM
M<ZLVK?MBV16Z#5)]5 0W[1$7!P'9QE-LU5-WSW5D)7G<P?<"GL+>HC51F72P
M*)51E4TK\OD]KIJ#ZJ/YVF@LE\P14B"=3WK@IM>JCP$?DXAC9<KW\5%=>K6.
M -X)DM4O,Z=4;5QI=OY2-T_0.NH-]]O'&P:A2D!-/,T\.1K9!?7%C 0K:*Q<
M EA[T)DWB2[2<B0JP0+^6.X$596W?X+O"9:% _;EIHGFHE7%._D\[$<!%L\L
MNV72C<IS<=:,PM6DON:[ 2.@^XTT9];$B:[3DSA6(WQL%>4/D(:8^M)K^[<L
M7UT20/S7?N9I[?9U^>X6%Z$V/&D7P>9*CA# (O>$.E<,>2$?($#R +DC?N:V
M$##'(4IP0X:LCE<VW8Y_CYRV%O)ZTR UY1=8;?%3ZI8JDU%^P.0EH (1A]/&
M0U[C/;,++#<_@!7<$$/5E*J$W[;]&<QNLF^G&\HFMX3,'; (2OY\FTK#I0$O
MZ[B;>FGM_:74^TVH!I^6[TN.+%UY+7D]7M8>+KZ0)X/N2IP)LK=<.ZXI%5,%
MT6@>@.= QY#?YXD7U"B8FLXDLLH!^N>*W3@_-_3ZLHI[TUZ O?-LQ ?C 0\&
M,9;"G:- #/.P?ID+QAX'6@O@D%7B6M+3OS(HX[ZP XU>H*B2>5G'FR33^!"5
M@0<H%QW(>\3B#]I.@Q@9S8_+$JG:PM" YG \<FZ@W2>VY1)PDX58A=T> 1 3
M=1KQYU4=FUOC<O.+0S5]U]U%V/-CO#C?5MV"\=UJ$D4SXBX!F"&M8PO"2*<H
MJY_<I(0WB<>U?*G_1@)70$[!)O]"LYD4.]X(\$6FRU_?:$VQ19-X<.QU'JXH
MZ)!99;L7U\P)PSM-2^UYN%#EO-40V/(<=YYC[?X0_[*A8NW30L%ZTRSV=^V4
MW+><[#XF_N*&*G9,2]=44RFLO WS(2'ZR=# ]_[=_KYFY$3-VZ5+@-U(S'%F
M%;SU&:A+.&LH#[4=K_6@FO%;DKJAPWPZ&3<T./@3Q3-!R$I-F\L=OWOXS&/X
MYTI!JEO]N(LI"<."YPFJUX4TN#-U=*\'6@AHV&?G,#A-'\^WJ3^\P?N<G=X_
MS$IGO&65SN428)[RUVAX&N'%HTGX_ /GY2)JYJ48E 3T%,G-E4'@3D[-*]+'
MP(H!O9> 6Q>B)%EB&79(#<,8C24P!!<O.(\+?T;P)9UU/YQ2OW;O7LC^#&=\
MQM0A.U/1_>RW">)ZID[54P&!(0B!RK]KC(QSNP]>+W^<&<DLG^ENB<J\=R%#
M/%$G+ >E=%PPCZT)YEA29(#D:>D-J#LC@E6E]UX!8+N/W[3WY\I.:OL6[>X.
M+<ZK3!J4O<F7F7 \6TQ9][^EZM34PQ)2\V_.CDBD^Y62I'0A O=+W7/*_J.F
MPTU_T8MG9A?U&I> K-1]42+?#.G[2= E8#MIY"))V[+A_SL(I^#ZG,/_I0KU
M_^Z+E'@)"!ZZ!*S17;!= LKC\BX!F]39X %_N![P_QZ \S\9/VJ:V6&/#C!\
M43N':3*#"0O--)PWW_3U*7R\]1NRC9P5;ZOG^T22_5^TO6=44T_?+AP+8J$(
M2B]!0#HBO8/"GRZ@](YT(02D28  *M*;=*6*]!(B)72"$" 4Z4TZ"1T$$FJ
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MWP/(]YDQ2"ZBSA7@4Y@Z6&G8^Y9RZ^=L431CE< 4U@%\^&O,X9OSE@T/E\*
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MD+W!B/ 82TT+M2 TX.\391.FN]D?C+?*![MB3FLN=&%KM6\^*JKJ-( _RL;
M;[]\K?,02I5VS)J'>W4%B) S;M'"FBO8+<N;G-DUXUT^'0O3+VX-A6CF8NFH
MEBG26#\,B=J$XRI.XG'DW16Z2B(4A&&4W%KW6F,F2Y"UBE2C[XWT@]IU +E"
M:;<-%^VVNI1)JG%55DO]-#&,6LT@=1&?TI93V=P2 ,RU)7.L]9P!+OMWM'']
MS>>MXBM2$ZTLV*^S?UF%ZJTR6BLU'W_Y_H>5GAZ?:WI3'CJYD]VDL4F\>![R
M:WJZG5[9#2:"68I@T4'BEU#R=^QSQW5_9TX5<9^GZ&:\IG5=T"ZC0$<\>RMJ
M^XVQRK]'F:Y5$G=HA2-E5>UDVB250LIQ6^>*;0N=W3Q%WERN%$\_AOC_CIO3
MD#$T-X$)P/HM^QI."]O_<=43N-OGZD20SQ,B=3#/9R:B8?:AU-NYDGCICPZX
MMFSIYKQ8B2U,6_44=.-0"#S[IL#Q@_VU3,:.<-;X0L>84<+&%8#L'4[YO410
M#RX^;2/>CTW$D)[ALSK[E(SI^JU7CU28=/C5?IYE)0C.A B29D/OAI!;VUH2
M:M$A["/K8VLZ01--C>NCBR*R)B]NU(KFK+R366\MP:!W'UWP007&)#U9()[=
M-M?'_D#-RX014_D/*QTFGM37864ZR)7Y7>88YQ9;?M#AO#P@I;*S4UHSH(7]
M+8=(%@T&00W*QRQ[LRVCOA<(.?CL'#:CFYK@,LAE05 K&)".0MP1+FE$-"+,
MG\"$5W6[;L^'/V$L_R'[<V'>] MIM+W!L]MS9K@KETYG.*+ ;!P=6= ^705.
M]J%=H+L\T!"HX'9]<"UY>57: W'$\%'9'1B^1$-D)'&,$/TP@ZIJB:]B-8,*
M6XS-]M8$JI]U_##1>-+RG$D^0MP\M"X/;7N'X(-""N'FE^ZWRB]? 6AG"&X;
MALF@N51RS0_5S-;])>\_]-Y0J+[X-JU.#HS\5*"'8.R7#EI0#$+,@/.'XWY.
MISK)25JD93C7_6F=@5\\#1D1O% CTHZVVO$D!F!.)XW[:AL'4@76_ 7!+$G5
M398W.&+VKP"(U\H]2Z<=?W7860'I#MX'JZM_HC"Q6DU(^@95GRIL;-,5,:AO
M#1JPY$]3*:35W&;=_>SQNO\V]7O1F#^A=M;**[=R<.,O]>,RZ$^9QVV;:@1&
M)2IND2^)0K\LM'C(SL5-R?QB>RR X.M7J$Y+;FG11YSJ-!53,[SJR9&KA@ZZ
M[7X'M3OW$"TOXX@T^,23<-QP5[Q!L+TB",7^*H:16]#3V]Z'6ZUG+,24FUCH
MDM\+=[8V6=!8]+SX&Z%PB^^-%?9NDW$.!KJE%2+<[\90AB7\VG>']/9_P2YA
MY*=9)((RQDAB4%Y]Y/C>0(6\H(Y.SO.N# ,4N'K/S-?ED7>7XX'/5.O^R31^
MOTL_$GC30U(D0HYY9Y';LK3@Z=DM3/[[%*1:U'W'U^_BJ'[IN^V&4()"./ ,
MG7G42Y *O40M/-M"G,&VU)NY]%G[;S4);1<N"6GZU'PCQGN5"[!@WVGCWXF5
M*L8++/)%07/Z[4WPHNW/EW%0]'X[+F\?Z+9R!7BS3[X=2H^\#4E$(=FFBW&+
MB J++V#$3=-;MWJYG4)>,UXO3'AFK\'9$LQ+4M"X^#M>^<R_"+%X%C6"QG*.
M1I?-(V2L[NA1:>M.Q5<Q$\G>&Q^2M;@! .YDP'H!-7]YM>_DFI]'\Y*N7*8]
MUQW#Y-(_E?OCJI&7R4A64-Z-$+(W)!:\:30W7@IA[WCH>3OIO8FWB:3+V5>C
M^]<\] 3'E>LPI,/0)7*B(#E&NGN)BNB->YP7K2!2IE'^YG3NDR%GC7<)167E
M#<'KMSG>J_EVOR_OUBZLT#8V+O+W X&V1K(E7'M2'707I4QV\FTO](#[TI>X
MT,[$79G0UO_XY:HS!;,W98")S8FQO#@*P65985,;TO0X19ZKV@&I4^2;=#O4
MP7\&>MEV&.<3LQN*@*'Q>1>K?T?>*Z\N-$R2FITH&Z8_#M6] MR.[P<%ZF+^
MFY&/<2KIDNN-5S90^B9-QS[?]8:3MG;BD?*_GZN,V+T";.1? 9#4!./,__<Z
MN&>%9>Q%8O9A T&_9*S.[7^9_+RGW@T*/=L,W0\C/0P%S5T!AE6O % @KD+B
M)9GG_TL571\T> *JXX63[[FSS"2,CL_2:&:^T_1J-7:?OS7^HF<!Z3R_M\(&
MJO^W<U#::2+R7\Y!X]"_?=U.S_^W<]#LTA<'4E^RIKG)BG=-TEHRRZ,/9X$Q
M@"T)F"'I<?H5P"WT*(\?.L_?0X3^7IF6Q"XU2.\^6DE\KW1K])@: )'39[2Q
MM8T-*KI0&!>N#/(62R+.^!Q$;+;I@>9]HYBG=>KCUPX799(L7EP!*CD EO@=
MD]N#OG8@E31CN:1UG8*Q*X!7A$!JN<';3TV6V\U,["QX%K<0MNKF5D2*?FM3
M0X+YKAD]R)7IN2,OZZXLTPD\ZPK@"GP?2J[L"8^I*+*"]#OA_3_:!055@'FV
M*$9[_MPQ-5$G!_D)]O*2_X"7]?;",TE\H1W*=9=/QK$,T4J,BU806RQO_&M'
M:Q6=)H4*\*%0;26D+W9(<( BC9>+3;"%'ZZ7XV^8,YXQ W+R!T,KWZZGNL@)
ML,9X;>?N+;3N^?T=4#_JB-!J9!A&.?PI(7UQZ!QCY3K5'-XK[5^Y]^L7!$#O
M_9L1D$L6V#VX!EMK3=*^F:199,TLUK]\?-,A'_ZK_??XR6O\K8:_J>Y:<S6A
MQ %K'62 2PYNN- V=TJ>TL+PK\KK<E!RN\@^N[T6P'C3=)OJ*6*TBU$.XH9_
M6;;[^/$@OV_+M#Z!AXE=H)@SKBF_C['E\=1 TX;R;:(([@J T:LHAP1UI,_>
M2AZY A0M;9V_ZQ RD,6LQGL/),4Y7DM(FX)4]+PDV':>IQ?6GYJVSTPE+P1G
MWA[04>H6KB9_Y_Z:VD#P)^D6:4B9"DIS 2;L=%L X[*,\>%'^CSYWR^KI.5<
MOTX6"I'_>N[$2'EZ#1UXI#\'U"9\@).&9R=+4/SVD=VF=Y.Z>HP3]/E^T)[I
M+0GT-<B;)87-LYHJNMU/%[B_X9F5OF=JN>\_]VLQ/@!-*<M7N!+$-[-[?L9.
M=\%U!>A05_#Y2_O?U8VC4?5C1&HOL&C6*ULY!R<A!V6)N7]<A!%2UQKIA_0$
M=_XR^#?4^'\#!%+C,LWWDI=T)^E"V1R%=^@>W3I=%)F(P\^P'7;;/7K5+/&;
M,9M"(OEM2Z+-IXO377(,2VA"*-FQY^W?A*^^+'!ZL[IWTO4'B:*1E*F C_T:
ME'4'E0'KS;4QC 'VTY,% ^HG!J:N<_Y5)SL>:"E3B[JWL.D,2=TSZQ33F0"K
M;5]EX&8N_X7^B7.97>EE@B$9>L;Y00 M5>F%#R(ROP/.>MD,#<#[H-C)1QT)
MTL6JY6X&;M<D[T_M2"2AZG8[FVZX>C UE_:(OOB7!Y"=I?+O@6>3[=@ GZH=
M=@Y1R:-NA2R_ Q28IEB+)*8CRHW?LB$%FE*L1:+L]U4F[=B:TA/U2O<^@>R?
M3L$"O8-S*]:A<_B\$PG/6885$51>%#,ZQD^8W @7]U1Q/<LQ0I,[S4J[DW=X
M[^#,Q%UJ%> UA0P;1VBJ?9)U2 [C>+1R!'^"*]E%+.<QD\8"&SHK9/V !"W?
MU,^]^^#Z*=,X02UF)9\FU>O> (7ES.-X7M+S=U> X\'0-#VY8IZ1HB@3K:#R
MJ=%M!4H%Q0V#L!9/TY#2@_8Y8(_R?05%G/BK9H*I<V9D+*W9)Z\O-VN$'K=#
M1@OLK']N4C,.%_FV7U?0^4LFEC<B/12\/"D38WFJXX\U.51K9*-6O3Y3O_CP
M4Y9N;M3JH(OW^:LUT[:SYMV&_&94N_N.CR+,(Q=9%+H+"OV/A)%R83 ?2O.?
M@"P>LR%W]PHP.W4%^$\68-P\:4<:09QE$6H/@/I%KL:@_[)4 @!G1T(#VO\#
M>Y]?KO\W5*\#_N?]_ZL)G7,,X+]X@\9_M3#__I[/-3".AZTEP<(4W1]P%A^@
M07RP0WIQT1%ZW/,WC6L7PVW^/T]CFKCVI^Z_'=WT_T<)T?H[W?Y^X$'T%8 J
M=$9C//0H\A5\#=E>1OU_GL,T\C_7HY$;XX)^"N.YT":! ?,_7*!_;KWCV Y]
M=3;]FUV1-#BFP#.J,@>VB[L9[C"W=D&-/IM.)0WGWK:]"7'N=VY(A829./ E
MJ,W5W]=$VQ ,Q]I$;..&I5/\;ZA7RLD%[^/A4S(&$"N>6[ZL!;MN@G/![.C>
M]2^;QEWETK\/<J1WY4Y^Q#I7PEINL#K0;2)%II9>$(+9PE>$%R:^@/</:WSW
M DW0'^K8I#4RM9BX#,XZC-=KCJ\ Y%> SN>5O?W#JQO[?\?;5R?L-<X_-:"$
MMR3IU^K^FR.%74FMJK5PIW<'!1S@A8,/UBZ11Z7%C>:PU5D'(+_A5,4VZ9XU
MI_IOZ>IC19!A1Z9_$HMV]1_*"?KR_IHFN^+2?D%5)SW]1>?I&,F=J+INYZ1"
M=P>6VIA"J#46[(+R5@7Y!( I?GJ:#7!X;?[>EJD<]+1(X%^U+*-G7%%^HB]L
M+96!O6TR)+.2K,S+>CZ-Q!WYW!UBC-X,EQ,8R/#U8:<@&/ICX7*@,ZX(&5R
M0K5DP4I>6#H[%>(C5K",7NM^<LP&;PEY;EJ;0]GB,T?28'05ZQ5@0%)W01$4
M@5<AE%A/K09KT$??7?782NRO[GF-DU'@;='JM][U=B!GLL4!,;L>BH]:&PP&
M.#;)=.&$\B%9KEQ-8E'4VX4=GY\VUV.N %H7[TKDD5:<A:\<XS9R%],&H'_C
M[BRIE1^#SP,^!>!DSB^F_/BQF\O&1FFY _"D-KGH%C^9?7JH 6ELTCB?N[.5
MX@K 8-O?1HTIB?:]=-!^-LBB.YH6-8]@Z$R,7*1$-B0+>[5F]5[(@V\&)H"
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M_\)+/,C$%9]B@=LK @<7HS##]ZAOF@^P\ME/^ODW-=SC"J5Y(.!IPBV2O)(
MHJ*>(\>VQ[0[@>\]B[CH/I_N:B/'/D3>P8?4+@??'2/AOR%H]3Q68HQ!;]2Z
M&\,HEOE<-5F73<NWEW":B1$DCLMODHG,;@QRZ67Y.[,+[5$B4&#00P9FUM.7
MEO/_?(T>26%,7C<_H34=!,_[5OZ%,F!UZ/M0QT/L<+3-0WQZ&<ZD!VO)@@)C
M%N3F7=^=)FD\+LOXPZG\Q#F7WT1*PT!:@R7NZ:"K7E:9DAGON\GD8Y-+T]P(
M/P$5&F^//N&EHO:^RXT"HA"A!&O+2OK5K#N-:ME2\,+JU_<5V2P21@O&2\9Y
M8LQI5VVZ7>\;"CV)$'GR$% _WN)A4SP2:E^A3+=#/[O1G7C?!FHR+9PW^)%2
MA:Q^Q'=C+O$(+*GS3Z$3[E!B#-,K=O\A9=[O%E3N@Q$DP#5#B7*R&'_K*US?
MIW+>K?9; ECO8-T_?=WEV4,NIJ^D9X 7X!O7VVS*"YV8&@?4&X[%2_CZ%48F
M%=OD6!D^2NA?(]),V^%RPX 11&FE4K@_59J[?4/F;HU_;W6<^&NJ1ID;(T:V
M=Y2=X->)%'B/MBJ(K4K#V+$R;=^Z[8NJ_?9U880J+8T_[;NJ6[I0ZPM'XO6I
M]C>)L_O=M@^AU &EPGD_=UC,) 7EG95<HA&W<SQ*ZAM2'ZSV>8(0S^]J):^0
M,;Z>7D+>Q!=GX8$=@7KM!?.P]328A5J JUA<0))F?NI*J8Q"6*\".ZB%QE@]
MT[>\218>#/JKD[)E CV,F2MT'Y/OM8N,' +G@DX*6R^3D30HK(X(I14DV1Q>
M4"O*'2$#0]U2<HPK[Q(9J/,:$(LYNP*<+!-B5_1G&4AW5LJVF4\C_3S#WRWR
M3$.E/8NYY:I)\Q_O'.L\&]>V__D!MT(3X<SX^O>6[=N^N\/L4\9.BE&#=E!-
M@MTWJ#5N^$0Y6J(EV/8%@\EINW.6/'3SL59^R&U9+2YU]FW!Y")M[WQFK_#"
MG'EX\[@.6ZJ=@4RDB4$K^'O]DO@A\&2 T(W5I[<E[*#.UR97"*B.I;M^E$"K
MVH:FY"'!LVG+\9NF6KVS#4]E['@9:>567\<<>]X)[9"7M(VQ$6A'1&+ZB==P
M-OF8V#9I0VO!;ECI LB_1D',;)ZSL\,>),OI:J(R]V6@@<S?=#KO?JAC8L02
MG8)+.22VBYUZ]%C7TV(T S5]6I/_P'IK1VY>N.6S^LL7^>BW02N<;31<9O9&
MK\)?O5<D\U$_J5T<QGL2ATJ$/=G@YR('2GR7X5!Y/,M)[HB")9ZK)Y?'^AZZ
M.3AM&A7,OJ*G[%8WSM[C\O'0R-*_"RPY..'\K(J14X/Y0/K& >_[2B(YGNO$
MCW#O&^K;9CL]DM><J#$A#%6EO.R2DEMLSD>H'3Z!FS]$JA1(W3$,MZ).I6Y5
M!NO/6'9]#AGV=KT"D#UYHB#NY5!I!?EXJCNVQWX'$>#LGPZN\>C]W+_+,Q_N
M@/X&9[X,#WE 9"$\7VDGWT+*X083(Y'22_H\1:Z.N_+WF I=M?OBOBSG^CF_
MB\O5ZKW!8=JB*E!B>A.O,)W<T,(VF3,'JITVGL +KJ<4Q9ZW/_Y.&I\ISM2^
MG,KSLCQAN\SZHR1)="? N)\2]I?5\S L+=94^I'G# E5F/2ARQO:LX5]-W-U
M-'Q84&LT38Z:T7;9I7_:P?"9SI5NI/QE%I$&2TU/2.F63H:DF&6*T-AT@-GS
M7;V;K7_53]\[>6,?;L%T'?SHELKR!J^R^0SQ 2XMLL=R.(K^7+*277Q"HO<H
MJ$U/K$]XLM##,8$?(&\E*$XG=.\)]AH@R<;X;WBX+HO\1&;R3J 9+T>%JQ*:
M8'H2<RP3<0J![@F5+P8_:RP8/'1(YVS]Q4Y5+ !34%2.1ISMAZ('\C=-NU7O
M:?MMU.CC34@M>3)$>GP58N4*0!TRE\'..<XSKJ#O4&"Q%=AU78JF;0T9QJF)
MJ[X!-8#6<%$0:ZY-,&\J<;S)Y9]J%;]X,$?0-QLGRE<%?_G4/B&1/K'\(?2'
MWO)(M!UWTD_Y'FJX=O]E]-\\MS0KC]7OHKZ[%9@1N2<I<G=N'E'?4NYF88=(
M-XL27E>(;]A0X^ S1KVE#'E?Z?7#-HUJ] !_"JJ0ZM]^#0IBKHD-V>_<;U@+
M04M9?QWO,3Q)Q6(1%E5;(1IKMEU+!%W)>\#80-O88Y@4<)::1 \,^]Z<OJ3V
MIDY]S $9[SNH,C7WRR6-B?T5?X".4&^O=GE5H @3:?(*0'D%6,Y>I,2C/_Q]
M1V%VY8>09K9 95K7V<+FMUYX/H7M$^D_0R_>#H#%"L4><<HH-,X 5 "73R&<
M:0,U/<-Q'C]Y$P.)5X#+*B7*D!&D #XQ#HZ@IB+88GD_+2,?0/SU6NHC=F$/
M(/<>MW*!]HTZ>ZNZ+;UD9!@K,T2*HBOZ++['[/B#_J0UVVSOK[MD.93;;?D8
MA*4<F-;O+O4/]4[\S:-.4-K)5O.+YX3IE0RB\/YM0B>0?5YQK[H 8FH@?1Z2
MY\4M*B05WC&[^ \_(Y61?'8R@,-TT?A ^4\WSA3KCUI*."$I$L)6='G51J$:
MQ1H>"L*L/8ROFWV?U??1*%F<!>G=I1W,=J [_BE;/K@R8/+4T$";GR<]TQ5T
MW/"VO]QG/#7;RA)<=SH-S_AF:'Y2=L)4PJX&C70J(;2<T.#]NY9B;&FA/L'8
MQ%O;!N7_@[NWBFKKB[Z%4Z5X6XI;6ZQ%BSLI/XJ74J"XI+@$*1X@D!:*6X$"
M+5K<"1:"NQ0O&AP27 ()&OSROV/<^_2]? _?R_>P7L[#&?NLM?::<XY]QMSV
M#;K(WR*+5@FQ/(]6E8EUY<R>89_'J[25F[!0S1TJJB^.#92F>E5)"4(*_AOJ
M79C:S]7W\FJM<L'V^ERH@*_E$!--M,40BZ5V=^JG@T::DO)?M'I&:S]3<3R$
ML*7@08RW1-?"N>4YP8M'X/LUV21"@%;=M\W0;$:V9T>$7IB[8Z9/XH'J S=5
M>$7+0ZCI:(LLE'L,"OI3.I /CJ//-LPY6-.F*^&A_-BO?#\HAICZT!;+A_;W
M0R.[L$3=F=6G7R]?E#B<-Z],0T*U:P(E4WB?=6DBO@8;\UK](.]TV(#+79M5
MZ'0/4]NYM83WCVKP?4K=NP'\Q>''NCO)B<?+/$X=Y XUMOJ;8HM:&+>]9S>^
M>J0.:7=>".@T(53+=Y'[%^R#XC)^C5@+)?\2VI-H7&)KC-P#0HEZW3\VO/:\
M??6S,3,%NM:X3U5*=&ZY#>6/5IF>#/ED[LJC6Z,;'N:LT!+JBPVV:9"TWVJ"
M U56#\Y@;_+;Q+H"WA8OO6G?,CN#CG/\'"(I3>"F8DCX.A1SYQ+<U:5S7LO_
M+SXQQ;Y[:TDYY]_)JT_G/30'&J:BQ:C:WK[6RI8B/,/("3FJK 88.B5'A-=+
M0FG9T5 I\@HNBI-Q6/V.W.,=%L*&<%,J&$J=[B[@QT^05\E-7&#,/C4R$&J=
MMWTP/Q_6^],9V_!N+-*+A/.#RKTU2?KU9H43IEM)U./"I(S9)Q@'L-;^ZTXG
MQ*H)=KP4$AAJ?DOFW5.G4<5B[+H3<;J+:>:UL=:A#$_];CXT-#38O&/JF+H
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M:H:B]Y+_!'N=S:AT"LI,]08?G36%-"000OME98.U\<BPV[8N13D<_@LRRZV
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M\TVBPIV=]_A60QZM.6T7"\9(NQLMD5R"W-&F;!]'UP,5$XRTJ.8EM^_HS=T
M8E"I6PU#:U\5HSGCC./:>WA&\^HNO$/G/,"-M\3-8P/A<] Q/J2/2!^/U$8J
M317O(+KIE@PRXG !C#M\^A]Q5XTMJ:XESPWW1A^!H>[Q?A3 =,A2MY^L#GJI
M6SI2XO+][.J4[6K+UQ^4LI+GGH4N<B\@":H3G"[8R$G:+V'6<9S60CW$RVF'
M$\<E2P_E6.8N/Q 2\[=XH&P7_A-O>%3;SN9?RV3,# 7XIUF7[.@,"6II>4UR
M^,V5G1I1Z5#W/8R^ 83\+];>,ZBI+_P:#:*B%!$4D!H%%*5*[T3IB(CT3D0Z
MD28=0J+TCH" @! 1$)!>0B>A=T2Z=!*:E$@"& ()</W=F3MS[YW_._-^>#^<
M+_O+.;/G>=:SUIR]USKUC!=58BAUBXD7S>&L:<IV!O+)K.46AOF$00(P6QUT
M^ZR[*W:3%)UO*V";AY\?X(H_>P_?R*D!/SM?!-5XY.)IB-9-4_6Y;[>1UY;O
M5&*35*M?O+<2?BDC 5 ZG)KML+TS*TJ1+>L/*EZVMEQ6#^"OEM<RF@V3+_I
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M6EBB_\L@#BP'[WP*HZ68DV:QZ*ALV>[M*A$*T+-6-U=UB+QW8*G;_"3;H#E
M4./P(6 C_I(\RQ$CCN<@$$ZT)J3I!H5L6I#\=T-'6X2LF1MPF29*K,I>@:/!
M/SLFXO(-C0RW@GL]TG%EATK?/PVE$G\F6 >QIH;:M 3SV)!!4&E2$!E,RNF&
MUPM0^+(;TK"N?.*%;&P"PX?WEF@'C+W6156;.OAH;N_/%YQ?S\& _PF?%E*K
MR:STJ,PA69&L_+7!0;R!.LA#]I(F';.QU]+N)GB.39U41# [OXX31>#'>F>#
M-2N*2$7I\SO[>X2*JH_1@XTY]"9J+<U<#ONVT8A2E.CY0@:H5N2X&W&--,&M
M"_['JT4P40?G72SFID\,!7)<.Q4+^7$&'Q3-FN/R$[OMK;VDQ1XV:XJW+[Y&
M-K0+!WZRUKS%%/FOK"+3ZCP=UH]^0]?(ZO^:2_$"@$E',M) U?%GBV9YK"1G
M=X;-\D3V\\FI!W'KP^W^E=V;GM=T[FK&4YZ\1@V<9<) VQ< Y%A'*^BV1L'B
M=D-P?O8\1&A$^\;,PU\>J7S^<IVC09ZX G*(&[!.JV=4K(MX 6#T8V2QW.5P
MF$W]D=#)W^&]\3WBU8+_YO,CTQ\,P<Y[KH0:% @V=@J*Y>R6"-3%7=6.0C0R
ME6@*\H#2?3CM[^)8QK*-^\R&M['B*:WH5L6RN17-S.S%W\.E&)>U8C4&(2$(
MIY^-APOT$4EV%3Q'W(0SDLQT)WRO2;O/ZCMS(90GCT2B[G^Z<J=C]<9C(93Y
MS/+"&\'O)8^_%P!"A0[MSVF-OLS!QL&WA2EV>(3I5)MSI8L F<:L=EQ6]\''
MIW!1C85HVCT;NDJCC8TR'.+7 B:O#F]/#,'O1[5I58Q60#+\-ZTR\_0.GFZ*
M>]_0X2\/^G5="5?Y9EB$&&C^>L?D[>?&>/VLH%9*X_*6*<UCXJ<L3.GD,Z9Y
MG3*06N391XH/(7S-BJ(^?BX8: NBWQ[FFW?UZ6?,L "/F!H//TXW\4^YNYI1
ME0NCI\C^4_*WXHF5>'3$WR5!<K^M,,'XM]2HAZ+!94MA"<DG^7S"?5I*67?L
M7Z]QW4)\@[OM+ZB]/,LY%R8Q=IOFT4VU:3 FB*I+V'2-E%UU4)]_]XCQ[E)3
M*=\&-Z0+&GH!N/*^!M\8IV3B7$J1SE+2P>1LU8VS;C[A><DO/N#X.B=_P/K=
M^T9GEMV-^IJ_!;*J<40_LV[VA[BO(<NSTY7M^@+<1C0O#$S<T*YZ%$.]_3*;
MAE^G%X .>%U5&(R=M&])4 G'+(%T9]LT ]S8O$I7O-.:_LI9-XZHOD\;'*P8
MXX&J_CQG([F%0GHLD4GQ10NO=/V")'J9F;VH['<@0JNR/=LH"0H7?C_.0RJG
M@M;][:!H7M>6BF.S<C)U^!07?9@<2PI9'_8CC_.L1(5M$(.XK1/D65S1$^ ]
M!I&+L@HR4C1GICURNO-*2Z6IZF-=QGTU-H&"NA"DN]31[U"9E.Y#C.&TC:_E
ML6*%@"62P)I\A8CP9MA(7U<U%XCL[A=\/.#(%W9MW] 5>$#;> &HA%#*;F&2
MNRLD5R\ W38"W0JWWXIFYL_?K_C>EK/X-4FBOU399]]6F<Q$"2+E$N)-"9%5
MR6W,T$?.7Y>$%1Q0SS^<[&8R '_H9]4+(L2]BOWN1VPE/JM'M-[ /9@,=CU)
M_UNIHYJKL:_;4&H!*3VZSW*XW[62#&91,O@G;LNZ.%;>+>CA;V1RYC X#Z:H
MM_J?N&^FU>I+"ON7#-GG_3UBA2B]8#7F+Y!!ZOS>1^^X1O?TU;Z-"Y9!FO["
MP%W <VO=X/K][G[\6-S=IAQ]UXE-F<9/W5+,W[QVNO,[[0;XZ"'OSTJ50KZ=
M=ZY4%\>(*4E[\NMA0CG)LMT9!F7ZTJ-'G\(F;AMDI"P'\7$^X5\GV!*R3X#$
M;P3&)"G]^0*M*27';R2;<RI2$ [I*B8MQYON+KIVN7!X!HP4WH!6OTMXM2;=
MP),(M>9AE:PU2\]9N@#X^:7]MH\ITZ*3COTHNI3FZGMX\ =JA6&,/85W@"+R
MQ$CW2]SRA"?7$3TH1H)6=')<?>LHQ[%)QL[YC/)S->Z)@MK06G:'$\UQ8O@^
MV [>:=#&+=##F "JZTL#ABDI$M@]H#JEDK\Y<*OUU:UTWYXOY,X_BC+:!]C+
M\S5:XD N8K\$5I,IM^,-\)[)2GKVC'$5ON27#48+8S'2=&J"([PPR?IG[ZN+
MS&]J:CW]N?)/>,"N+9*<QKIK_W4EY51*=K],PY-W8%EC-G,C*R7>P_3A,WPP
MEZG<)R.#N,03U(3;C&N19W/HYJ_@=*Z-1U89\U+[(17GQ,#,/1 !-DLT(H$(
M$Z!;@;;'W>)094*I*T4Z?Y'!Z,6X>Q7S]*HNN_B=QY&?='GW$C1'!88 [']
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MK'[E5B"CR63]OH*N^5!*JWCXWR.6N?#3/I:67X&X]I2B%^KM^TW;4IS#<,[
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M2F;PI3(F87&^FY_/=H[,BRR^FIK2ETM<4V+:!6<@;OTUFU#26+-Q(_B)A2N
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MO[KE^L][=K^]ZW\O^OK_^= /  G*R^270/0H\<$9F/QQ4X:$F#FZQ"BJ[ O
MH!!)X0+@Q*M_ 1CGUD1FG &$%X!..31Z^N(OIIC;&K_&F"^#A2X 3WL@"2]/
M:\LO )!W]J90<=P:(II$6=);<7!*L^\2V98$*PH+HGJU:.-0,2Z,E\>GU8LN
M3#3'8<XS_:.D#9[8';:$)P40U^M>KNLNT/1-*YLTR@D$H<WO1868OUSAS,FD
M+55OU*1 :O*DGSFSSIK!!TYRI0M3?:T_JPH2'I:Z-JKZ<.8K[U+E5XN=Z(7J
M6#K2(*?;(WORF-"*=QHEU+F;-K'*-1O+2VTPNRF-R>Q/)R/"G9CGM^QUS;_[
MAHZ&C?J=9W9(+T/T?H:41'LZ6J!S7RMW4SJGZ+R@4@$(9QWF[;AB)PK;#.M&
M+((-$@P$%GM]=K[.]%D9-(AE^[2PL_-S=\*?X,2[E;9H_^R)4=B(/UH@_?G7
M8Z">@!JB5&X(K4D+2EVT]Q70]++.R>EM+86P=B-2+?HX+49^?@+ZR\&@CEFS
MOP-&";K*^G0]O>R$TR<_[7*$TZ=)#K<:B@;Q==*I%(GG6@V!Y*N$Y.(?#/$:
M=1:O;Z?T_J._]C%L!+0M(:-:99=T_?W7?_-F2]/VI68)7Q6JRO+PYMUZQ7;6
MI[Z:".^/.H8&$)DML[SK;??P\5TOMO2Y%'GRZ9J;LVX\7ANQ8.;T2\OI:_XK
MO :,/][/8Q@N?:QS'!I[_3?]<]A9Q2[OG^SCD!FDVUZTE5=906V?@Z?[F+WV
M1LR7%XA2H?+#82B,V<521MFDY.OHGUXEG5;A2[>^XS:4XBMJF*:LAWNC9S(/
MV;[TIJG($96R.7VB6R/NGQRC!ACD(=4\PG49BG8[^&STVC*J(J!M2G1.CVV7
M@ZV$PGW0G.OM C9ETGQT^;9,S!'M-&3FYG#3E7_V:G'YG][@?O>LK+$W;4\\
M?Z@_95,K.X,.S*ZV..\X,)L0B5@M],T4%521+;L "-8[$PHN9<A&M+7NN.C/
M..TYUJ:TO0="0"%Y4H]?+C7N4'.X6M \Q2)A9S6I881DP/@WM>NX=B=)/94>
M:\S%[2'+8]%2.VXK^[OTJ9C9Q]6X&9M)QX33UR^<]1?+YO)00];T#.K!X 8S
M P/5OWQ"P"H?&"YUX'KA#$V/;=/K7-XM6YGDI.H _?OH8@M2*K-W"5?D+J@O
MR>_=FD]IILRA,WFLZB6R@M"X95B3K6J3$-_ %L"\SI%^H!/*]_R78TI\'G2F
MU#5CNF4]J[4#)NEMZ&.3%]=V=;HE.9/K;<5^,W-Q6&3?FQ^X*NHE%>4/;/;&
M>6,!+N-P%D/I[UZG=>/M;WBYW!!GC*=Z0CD)"MO+NON)05T(J[#\ U,+^,C5
M0P_S;P2P?M(>2F+P& -.HPQ3_>1]6',87*HY5P4NU?WZ93B^M8K5RO;I<%L_
M-FR-WF>I]8C0G+]U=B=BB5=L$WO^1I+XGJP"^M0\P:K])5TOV)?NC\,@T4P\
M3G3G\)S[$N,R4KE*N8/A3Y.$;[][?ZJXB^POB=;QT_-KQXF5BAXYU[\5#H[1
M>16^>=+C!1E%=P.9&W* VA->69RMS07O+%;WG-D.9= 9/-S3HOY1'8Z0G4Y
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M0L_MWM%85>CVJ]1,(P:*RA5N(Z"PQ#T>0@BVVY"Y*K>B>('^(>;4S+;S<]D
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M^^1QC]WY9[+TDEL>M3)E(>D%_E8:",_:G>'L6-N4(EJ]VZOSO#LP3T+P]T^
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MHRJ@DO,$&*A"?)X)/7R,!.4ONPH9=H#87S5]U*WL-(WD?PM W7S<1W4_YP)
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MI4U?GL"YD3_HFD^<S?6A-W98\<(8H9][!$&7.* +@<S2AX'=1&&!M590_8F
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MI)S*9<PVXDG>(M2*E0=^W)ZFD!>B /U%BPP@7\QG6I!%.4IG>:P5%M<\IB\
M10&9.7W46PT,@Z3@PW*"^!>8H@U9!C6!3^UD#5370EP78Q+*_G$-[^IM=,O
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M%>\@/GT-ZH\Y3P3VU+?6MTCL$K&N#:+*NFR%TJ>6IN#>YRNDNN(4?V]TB=M
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MCKQFT;^$&!:&AAS_8H<^\(=%1+A+"Q<>E)1\.9![9?F V2C(J]9YM^1<+"
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MY:\^<(K+I6@,[[-)3T'>I'[: #9=_FDMM.+[*3=<-X(#]8;<>_)<ODLOY@S
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MN1#@/9\5+!G&EI[0H?JF[6=YB:.K@?8M<H\&#?<2L+U0X;7N8]YUI8/H _C
M&$4IAUB9F;\YPN)RWD QAY,;3DJTH7!OPGI"I!E?5.XJXF;V!W7!S5Z1;W>
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M6KS :9=\+VVXG/1BJ_T<#G@!K"$D?GQY#$F,2C=]8N)PS)=?XHBXOL=@9=9
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M!IC<0!!.P-Z!A>@3J2E\59Y7,C'I("1CV>4%\"^H\R= J9F1?5043IZY)'I
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M9>C5UPZ#!F:<TVZ^4)=F?*CD?SQ^B0!E<0JZ3<=8[#-<F8P>G/FEREF/[&Q
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M2, 5XY"=9&#YZXV7"]"S(1!^)SL;)3G;K6NM&>K#3[?P>YV@FO)W/$_X8WZ
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M*&IVB$+[YF?[N\9A3X)I#'K$G2>J;DA.1%!&V5=-:(P^'WM>E/<.6R.,N$^
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M;QGA=S'+FLAS=2A<KW'"ESI8#>L[N5VN?[J'<+</HA8(X,MX:I&>_GG]_4T
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M-G>"[ 1V<)^L]7HV*AW+%B:Z&(!7S/4Q,K4MP<4"GQ'XT_(67#."*\HK HI
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M(PA4.-/P+DL+NK177?'<)=?MK_F;OE[,((A]#&&*;U6<R.X8W)-\E))%X]G
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MJ!3]<^\K(VO?/1LWC1EMGTVPBJX%HZOH#SO&A!6C"<NYC)0A,]K"OJ?0$N,
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MM*Q/!G$F]4%1'\8.U7=XHW-MGGD%!\<Z^Z*)EDAGQ+P@K]-+(&9\OBQY*Y0
MQN?U@_S5B:$KD?C;( 7L*T25J'54C#MO5.D]V;9[!\6D!,DD794_0E0W3CRK
M>+W_[/3_WC 0&]I:'#\QOKB+\)12JE&#5^:5:/O_>?>+($/?!5$F.G=Y$[M'
MM400-0LZ\5Y+@7R8J0LY0DD"(:-1@P!_-?*Q^I%SCH<9[J9?KW]C_0_7(0.V
MHP%_L2)'9"9S8^/HKI'ZCDB_6;WB"U5CWFN^$01Q$FS%O[9Q!5A1P/3(=+:V
M&>%Q(&>C^F-I)A&[IQAYGN%/]XOLA^$=\Z0NJA,39?GPL:3P[RJ (F[FN&33
M^#S8WY2 W5E:DX=.C/9HWK0TF;9KN6:MX'-8FA1(0\K<[*@_W4 ;'TO+@/SN
M1^/>P^5Z^&)5A-9WPW@(NO,\,#"*N1*BKYQODG_]S_.W@\$4#&[>UG"<):W2
M SPW=Y'PZKT?-MK3"A@R1="LV\6Q]?(0-YF;:!SF;^@IF@.?Z\0P0.\/1V7I
MC#;0A;7002\!Y=;Q./_R^W_K<,-QZ^NCS4W$^6WE;#*(D(A&2&7$%' U_E2W
M2V&WE;U@5O)N<5R]X"8_)<F<O2:YN4**(-S4Q'3F/7.?N^8G2<=F!C5=5PPH
MVG8"$R=:9UPCHQU6V)*H^D2PVD)IB<TU<W->3([2Z#1%':)8^/*(TTYH;I"#
MB?:5GO6$L;W"U-AO'%T@A1]"?T#K^Z9%JD,,B3Y#%*)N/HO3!:6OJD:W%X:Q
M+*:6F@[4S)0?,YKUGB2,UO'0DZ6)4IO]A2;KTY(GYE:FK6[N4[Y9?2WV^,<V
M)$KMY@>_(Y-Z&YS<"E3<]>*]OW4VQW&'"V3P5I2?E/GM8VL:Q4JG-S>LH_>K
MW"/:T>8;R7IF\T[[O,^DD1QTOF.$Y.#<$2<C'.WDZX4%8T6PI13_@)I)1M6&
MJFO=P,6()7T8ILTXN>@X3FTQZ6I+\2[IP2<4F>'%_W$7_5"Z=+SX%U$,HW[[
MC8^:TQ&>2;("HUG(]&H7NO?/Y"X!DY]S+P'K3XW;B+GORONG$,*^M3R?Y^L.
MKS/J@KF]_UV?_U<$6EX"VE0N!-3.Q(+:M$J!/KAYK-G"4-L\/220KFKD4(R6
M!.] ^OZH_TO?+_Q]1MTZSD=EZTZWP2<3Z:V(<_D)3TT+NC>U34VU7P8'!Q^F
M^JRX<KJHY@AOH4+?7N'+!#"=3)^9^YLG'+E> KY$.EP"V"5/FMG\082AKT"Z
M&\G0WW.PU=>CGLZWZ:16S&85G/E,5KYLF[ZH$+=>%J72C<A"LFR>*/T=E5E*
M_DW&D.7F@]ID@A9R3F508%;'3!:B\387008?%"&601MIC>-2#."VN55LJZKY
M+?WO.>W=1,"2=RE2B'B,T]D*6A2;IL"KYBU> F@=6FX=/(ME]?] .(Z6TI+I
M4!0IGU@B!<'7O;;8O9/FA?AW?AE;Y[Y\1,E7P\%3IMF*D(EP5IM>RMK ]* <
M' K_K>02T$^\]>AW;L[_1S:D_^)6SL4+D4N N=I%B..$(<\>F_,I7NF URC_
MOPU@>4FG<XI$IQ8XR;A]_S:EQD2N^J&6VZ.I71'H36>9+<0Q;SK.T&*_[(D+
M]75*S)4!UJ*0'Y:%*X8.=7E]VP5&?6T>38(<GCZY9K D\7WU4?4V8S8[ZR3K
M& V^A &-=YHF[28[PA$:"J2"AY< @_D7NNLM>[3(2T )A!RJ7""JF)4H\C^'
M>-F*[+D?9N$S,K:;?\6M/?G%T);9Y'9K,1[6-L0T/M0-_Z@TY7]VCJTV=%):
M>@RYV+P$;%6[Y2\[\PIZ&' XGC9LO,(KT9F12I7KQG8F4K'KMV3U@V.M#<EW
M%_J5KM@_63]2M J3%GT379<2RY>*^9TLL;R\IF3'[>0'*=-]Q?0P1 ^KYM(W
MJAHUDM%GJHP-4,N#P;M2Q,B\Q B=.VIP<\W;B/J?RSZWV@>0SN#G.C,;+CJ^
M:X'2_A\FFKD=B5-84Y6RH1O+]3\9J+VQ\OZ-+@&.0O-<)J3@YR,>/*R@/L_;
M]L(ASQN,@'7TY7(] A2?T]W3C7-"X?)>^1-CHW,6.I3BB->5'@].;)@SMO-.
MV7FH)<^5\$YI=G@M32WD!1KI':7>4%,SZN*5^8R8OH@NM<^B3^OBH?>DHYNQ
MWQ-F9K/)5*[3T!-7YZ60ZY%3$$H9/80,2.!WDG&S++I?1(1TOA;7P"?+WVFP
MV:W!@)ZE( H>T-"=<1OO2A"D?"18V[7*(MTB=ZMIU7HP4)S\<%SQ/BE+,YX2
M&:L3PE0KL!SGYG-O<:4' /!]GT>"XYQODS1QH5V--66@SN>:WB9(I72U/C<Y
M@1@=U]21,:E81DVB]@X:/RA%V%-]XVX]^6X5&.\>A\U! ZUP05_GV-"(E;3M
MI'I'B1FH"IOTEQ?PTA=?% 07]7Z[:,T)#NE(R/^PE]+3 .G5'S<V^'!;GSV#
MK?!0DS(U-?M3<I#C3 _"%-^\UYOA#*)UCSJ;V(T"TU?WBT6(0:PEAU'.%8^L
M/(QBU)SQ6%5:#<#=,:9HGX(U119"4E80CF2;IE];YW%WOIO;1)KV]><]BGU1
M.@7W<>,G"#.PZB4 .@[:4U#9>/' AUC1^,G3/]UZI97U8.M)%BB#5;NR&)T&
M.<F2 AJ^-K$)US'8]9RN[N.I84Z!$/L7_N0V*Z9J"6+:3]'?ASE$*QUYL$;S
MMB$E/,FU)L;WWH7Q\LIQ#YT!_=G+1T2*R;I^>3-KIV,JA.J&OI>0A*K>ZCJ]
M!;MKZ791_VG/MM*28P^^Q9<,KFR<J"J*ME8+15@O]'H_S'9*&NQPF2F?:=3S
M%%@:I%HX3KV[R2U&LD*8.K(G_I66KNQP=7 -\+"NCG_[QA8P,/[=&T![)39U
MSYW=B4ED%,NC&8<^JN+,/!X_8VAV)65(^*N?YT*W_05XCIR_2AHI09I_;FM(
M0U<Y5QWCY7C$9==U[2\!5?,1%URS#JG<U;E3KY-69+EQL\$S:M\IBI:*_'.Y
M.NYAZF#3K5[-TH2Y @@U?S0:X;PD=7#SVC2LV\2M?SLSK'$?*X,/(!;=,+KF
MR75;OJXTI(5NJ(.' KNV'2#]"[W\LV_1>4ZN/2K]T=932-ZOJ__'I+-PP*CZ
M$O ]^I\L.'E[/?4_#<I7+D0<V'<:%LSZG6DM16(*'LZ+JDQ3 ;[T<5 Z\#9Y
M)*Z JXS#&I7Q?E @# (ZX[K(:EZ;S$,E2JT\J2JA>Z8.Y/FQ\DD$9HT/;?G\
M<-A?  ]],T/*Q,^^J2BVR9EQKY)8+*!@VXU*-^[EX2"S+("YR,*D5J 57J/J
M/S;[<8%.3I^G)),J;IC:4-[NN_\>0*-#29GG74J\JSO1+ R"<#^JK I;['#]
M',3QHD(CT8QU4N<IUP) ELO7MG'LZ#<:2"W6$<ML7AIV2-7(99UM.;MQ1">0
MIICM^!V8T%UH<OT<6_&Y(7-UM("L.3Y8T20G,'GP3 ;"]?B^R7B7)#UK1L[U
MOBM[B0JJ:G!0=8&]##/[=G<6>_5$5\./3G4-?YITVNH;*2((>+AD'0*DOI.-
M-?"B#U&-;I*A5:7\593J&4_Z8E:WXPGQ,^U>-RV1V4D_E+W'B2Q?PDQ9Y+GO
MLZF*FA?IUQ"2._R4;D\[*/(V$J\C$ANZ-0"4\7(IIBH%>LK=[IM=;HI\(R(>
M.@QJU[ 5&R.5C^MJJ_O%*4NH.26LYZ_F8]O@-;&N?!@6:M]<:IC>/6MGO8%,
M!5FV=4RJ=SB^,OZ _T FWFS@K-HOJ.7N!\[/7S@H2!#6L1]FZ7E!B=%PH[M1
M#NU4GK,MC5C2YP*2D?V[\(Y3_]XYR+>E -3Y]]S%S-P+0X%.YV^:Q!L*@NC!
MOU/3Z^4W\<^7ET15HBC6Q &[Y**'*-U*PM WA%/QY(;1T79=$OZZ\J,E>J1(
M&Q?5X;IE'F&Q^X*#V% P[A$@/6U2;I>*E;5"I0)ZIB>1Y0<]Q8X7VX_SZ\P0
M9QDPS\-OK[/DPZ6J-+6  Y> :^2WL7H3'P\:2-BA3@;3VX2G7(7DLFM'_"Z3
MVUF@):#.HI;?R^&'2&)2+->2?,@VC7:HM7T"A=?HKS.F0:JV 7M_L8I@O'-G
M?RRS %8XNJ"MQH7#_>/4]QFOC2??_="AJU\/YJ./ZY'A3I(GT!+)T2$(7_SV
MS,;K58JX<4[W[Y"!*&OV-(><0,OPAL>&1<J6H(T<K.8 YR4@NIDUR-Z>7:LE
M9-4"--AG=/:JKDZ-8YK2;X^R_( GVO?Z$1*7-GSD702?M5P3YPA'J@?_E!;5
M;HN9"X:SE<H0_@FU:+]6$-=1]<,\:.X&,[%"-4QY.5'V6N4!&ULKRMQ0<^@N
ML@-=/GZO$CD.?%4$ H[-ASU]\46][_I"#4 XH&E30_\H*<K&#^JT:Z'MZYE!
M/>AQX@R!%U:,F'H?LOW93'5**9R%X=$/H*DXQ,)8JGAM2C*PK&<ZJN;Y(*PP
M%163Q//M:.Y!YM#@V:N*@2/ICS\GN]\*??#HF1W+H17*P$AIEK)I\"^^<&:?
M>I[Y7@58VRK,XF+Y*<DJW;B,+$ARSB;%(?RUQS2\_1YI9#YMTZ/Z=!(S,C1W
M[1-LX7U]D>Q(K(*6!>(20'%!U19F^$3BR.-CXN[F["6@]9E.N*7 )2"DH:W&
M>_O#1^"R4AUO:!MO#"4E&Z='$4MR,KM=<&[FX/RV\=MIYPC.Q;_O&F_UDTJM
M\4+SM*K-'"GWZTV5_;\7]V[I4*3;86O(\@ETM":(#B&MI7O?\Q=J1M(#I19Z
MQ:*])\_8W9*J,G:2NT9^@F\V0GT6P72]#_-HI#%'^Y)N+\.OT7;]2"_8$ \0
M*BXQ;E.ZY7$)N +QC3XO3F;0S.=^&1W'VBO+Z9L)?UA?:%C'.0TO([CF%_ ;
MX_])Q0IYE:*9?RE39?J"DES895SW+V6&(LET_U)FQ']2YO^$T'H0<6/^<%3G
MG 83%_3_Z&Q[."MVH6!V4?]/_V>G[HF1!##DE.-_6G0S<>@B4>LY=___Y2'^
M_U-0+L')W/^P[M$OPOS_]J,B,Q(2![-P_N:O_U:J <0?N#;5;J@Y-1KOVI&Y
M(4-DAO".H",]R:'_-/@D\."\XO)(*'T_"SW2E-,G'SUU\>S:A7W+;O"W/,W;
M9EC/\B4[YB,'"?>.>7:$L*5FP?942?;*HT\G'Q3D9(\/2LN5%E*S*K>'MM?I
MOMFES@UUG'('L_?[^-0^L0T@O=))YBRAHHPZ* V5O 2$&WMSRX:-VD\9<OBE
MO[O.)D=V!0===,]7O0'37-SP?TZX".=JSH(4*%/D1ISQT35]DT/)+5@#C5?(
M-DF+1-8@ZP0+@X)'>2*@Z*7$[>IM/_/]LOWV-K]-;13]F6=0&]\*26FAR0R5
M24DT2L-O4[[QA!K-/2AR_],0[UIN,35NM8<"7!\*5.0>]?@SSF=CT"_.YXYN
M[B,D;]O@Z0".H)5XI*8[Y3?A$F&G7_4=KUP2>._+WHMNE6OK5@:R$\Z=6[^3
MK)J'AX7Y,[ZV\0&T_]/#M.5!^ZJI%'BK&%M1?* ;;^3GF+H7X,=Y2/QQ8A!?
M&4"G1 !_$<W!Z-E]DG1-_^Z'R9G9%,HVW9UM<&GE_G&FP7[H;58A^5$^AHI<
MQ&(Z_,?X!BZM;\CQO$BP?W.A0$9K5L')1L.@0&^_^FM8#;8X\L'A'-5JM8?B
M/2)_2?BOO[Q",AD\@-+[_R@&4\*B3^1D%Y)\ A^8^T=#[68W<MZC]UV[KY34
MVBEV/_V3NA+_;,.M%W3&N3V4)EGQIA^Y(O!Y3"H/-_#T3*\Q1LA01$"OXX_"
M1OK@O33GMZC/FQ;_>).Y(QO"T.%6_GN&+K$O&#F=2HJ"4SU><<Q\8%[N[)ZI
M7]%4+3QO:N%P%,TT;FD>(2?P/? 'BA2)5[IE.MUAY<WYB_9.5^/GL=0FHC?^
M>C%F\W:QFWI?#M\G"3.E6^1'I\LA,NZ@5;<PE_E6H0-VF(]!5S]=</Y$?9Q@
MA&[C*6N]8@->AQY"3WWF&:\9'-W]1DQQLG5SM"J0UY\64RRY[JGN27>_6\F=
M8WL(3W=09"F!\=B]Y>CVN,Y<!=5_OWZ_6^A9QS^X;<$)UY^)C/\=";^J,! 5
M=4"&E12_+*O*FB@WY,R=36@NB*C6F)(5H7M,_"!_F%&!6+2H"IKSLM4_F7AV
M;H0_NIGD]RW/I%L]KA<U)G7 \LWC:_4YK;WM9T.SJXIRO3<:#_R%PW6>!B 2
M6Y?>'3#MU\&IC?+ 6!4G78C919ZJ_U'%L]WK,/W7X\T<D_5B*7QE._$&;(]F
MCOYEB.-27B)( U(R=*M2Z?NT1I?'W"W,):#BSQE_U9Y(EO*@ <]K](1DFD9(
M_"/5I!>UY;N6?^0EB3"31_PL7#PI>K_1T6MN@7>;:2[,H0\D7)3?,V*"?CF@
M3_789!@^ &HO/'M-819.I88YMJKZ<9_;$$4-*57V(1^];_!D&)GIF7@./5JK
MD2P@["%N#QB9F7[0_*J6Q&M>>1==YXH/T#$;_T!?'#;NPE&D8 4)E*A%TR35
MN&Z_9(NK''R&<<=)50>_%!Q8^IOCEJ5OP>@ZC,*XA-3ID8KMN%\BFJ)8&U_P
M_--I[)> P=@AMID^;]L_8.[UTP:1C"+DX)2M:]2YA'E+%QT]_)L45WG-VG;W
ML [;IGES!N\K@9_%A@EQ,8<+Z*&\T&)"5<":0,M;^(<JA2+=$82SL'2%:G\,
M%=N W5K]BRFU&C3D:YE[1QD3I+5FV_L7BG^ZG '>CYJ5Q5=+%G1E=.;%?5#5
M^WDP$)#:WG&G )VZ7'\2+N& &'3O DDF'Q$1G7_]6^H#+NI*#4<N 1 >+H=
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M%H;HX/-DW"(-W8JS142KD;F$&5=HMM2CM;/4;O&T\:D:HK#O=VJ>9&1FA,2
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M0O%2BEM;M+B[M*5X@>(.I10-'B1H@-Y T2 %6K04UQ0)+L6+>X)+@A0))&B
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MEM,II;D%<;!)N%0L @+7Z:N*:U+&GC?HLA]<.3$X<E]5!KBUQ3L2Q?X)95G
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M_-7Q#Y1EK;H%6''< B9& ^@(U'LW;Z^Z(*=#V[< S6*8U=0M #W;N5>8=\D
M>_[_L2'FR?]%"]6\!71M=1[]D^+D_V D]6FEDV@]V/:HCUR<!=A:PJ.I9/.P
M#_(J#QL (_R _)?9"R%=W)+LAT4-7X_G&+TTVT\)\)-L.2UR?8.H9XM 5FM[
MAQ]YWZ:"Y29\B3V*6UH>,WRT?+RZS(RL#)9H@[YM:XER9H]:V:0#Y3Y)&Z19
M/X?0?03F++@*,EAL)K=(J)6ZM&S'IOH@2>EMS]4T+_F')&RC<LW25*2U2\9G
M)=R@6;VV%9I^GXP)NH4$7:\UH>@MEB#KCNE3TK])^8U)]LF^;9P,- 9>+)[]
M?9W/W_$"W+XYY9JA,=4=F3BK(?T+D)VBJQ!X7MX"Z<'#Z>M\O3AJA3<<8_^(
MVT0S"D:3MTJT+&FSVWEA<M,V-D-9T7L?.AH_PP($883$S[;Y=(>[_00A'&?+
MCLO0(K3(5\"#HNX]E5F:!3X+_MX&;-R_\=85?>1.5S"PDJ$[*Q@L^_@%RCY:
MQE@1?D7[5^'/&01C2YMDR]SD=)SUUK8">CSJW-QH6,Q!NX=7X;XW[@^ULFAE
M36T%LS<? F[S6+M,5&%LR^@761#TF+#;,S=GM?/#JGS^7O89C)NJ1SKP=%E3
M'PZOXTY-L[92][&):I!-_.00T:N[72HD\IOX$-D T=P.EED?9J$>$&#.:TMD
M^T8LCWUY ^?,@SK6Y;HIDD;4''V_LYA9W\%HX,]RIO4VNV9<;\G$M>!U?=E0
MI,0H^8UJ8JK6Z@6C]8N&5.-D=_8:&P&=5XNF7N 5+>E"^+%\E%Z\(P/-KGEG
MC-NSR0+)0^;$#W?8><&*IZB6\^YV3;1!^AZ&ZF<JOY%<B)A)YF299GE9=*OW
MRH BJZ;^9EJE=R@W8E%_QCY%U5'OEV)$N1E1'/#UHM1[J'EG)5Y_3QMTU6";
MR-"*"*F*3S_Z)SYY;R(Z>49X4/;Q[C_\)+\4.+3DQJRS4=N4]YS%L#H5*/G8
M)?'5-DVOXQ*3?<7<P_W6<K?:MKM;"CU_E3%YL!. /R<\W-,::BM4MZ4E+MW5
M$G0R2_2.50A=KZ1?J(%D%4BFNQE]XIX)U1T^DE$\?8D/6]U]R(_92&$)2[]A
M/C8.Y9T?#?EP+J/HYV\?F O4_<7*](T@<5?CN1IW.E,>"E5WV59N @X4J37/
M/.9DBOY[MF/I:O&#$!$-R#I6KFE!W,/RL0(P&T%PO6&>896,&]G&0W*,&W&'
M9^GYK,\_&G1ME>R=.$]?9N<VBJ;45\YK'FHT8<E/D'K]7%%'8M0'^\1$ER9N
M)1H>I7\:CM5:04(C"I02"C/O]A9$'@L-]="?5BNI9CKE9\Z]?1O;RQJ(X+NK
M*]0K,XV0H+EQ\(HL&8FG9'/F6C7-&+1?V.8@V6(_QK@;92"SD48HT\)C1C^W
MQ43%J)H%]0;RU1<W6%CX&)\L.-&GLMI*9G<V\:J[0P LOAGG.?@.H-@QZS)M
MTI+H_-YM59C_[T3X"$&Z$SY-T/#@6/3;)M'5\4*TVPUP(11HY?HS9^?5Y^Q^
M_]Y&=+X9XI.W)D:<I6_L;"A5<O))Y_*AM]))X>]*0-YF%>QO<RU(2S?4G#8L
M:=XO>EG72/6HX2-)K%3G5.1S>I0TM]O,L!,)^G)RX%F'A)^+@52Q%]GH:!$:
M9(.66N,W:X1 *^/*P^O"TU4R<+@[5TO*):=5?&KPD"KE*_Q6"QLUN,'C<]U
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M^;Q_!'PWL_J'C(29.1HH2E8= JZ<@R_V-HKTD#:L["V4+UPTBGT3%"UK)5,
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M=&DD 0@2^-<BJ_]+QI;2^?^B4D7/ MJ<[4E=/G.U)W(:B$&SW*4'=FPZ(-B
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MP6RSE+T)^HO:$YB/B5*\*L6(]^TMU-8[5_*$MU@V*,P]DW:VL[%*(%-+SJG
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M]AGU$(U_[GL3>NJQ/CO:\.-CRA$5YPR[YV,08<>.YSVNKD S6\:>+M1Q(]Q
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MZJH8R31Z]Z?"B@))#+$!U&/K4LX;H!O DRH!:J,NJ'/)M&BG.#UK..\\JE:
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MD.-L+:\&9KJ]4"L&50'?!=MRE.LW,J.#E+SI.NK1;*.B=A^CD32HF6'C0^O
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M$O]"U4@E([BE;2\F( #7XYD@SH^8/ZN=.;$0DUZC67MB7Q^[-?DGP8#RN>C
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MZFIYL!% ZBOZ&^:X$;!H2IRTR+S%I#/QT<?]12-U!PI[S5-=.W;9'30[?WW
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M.:]5H?CNHS6@]T$;;C%^CV[$=]*D.V?'+;*CTU8'_\4.3!@%9A_?>%;S]N4
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M\&=]X156'Z)3CA&<,X.@NGCNV3Y-TR@S8071ZM()RQAIMYJ0YY1W5B'W&VL
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M%*A2++/"=NS1TEOZIQ\W<)[WO?$9367U]6QS-3)4_-#R);3M63:W),=?;TQ
M.Y1T#B:V"@&9C3]#0AS^B=<1CZ=4DB[_ZEQK2T,U,V76X5FJ4J[*$,3YNA9(
M9#$-DPLJOWY^R35VS4[_HCEF4?AC5T+?!W&"\&\H7S+EYW5<&.")RZCLQ :F
MO=G:+*V$1]&/=$?>H ;#\G+2Y(TKS<><3*?-^YLOI<<+E_S)\9X*^]6I5VEA
M^:0*WU=*'OP29K4$?+#,8(YPFYQ%0A8&7_AL]0+I0>YSK$L25($JQK[E4OGC
M+GG#TOSGZQ:^:O@BV_UN:>IZ9&WZSI"^;X;<>Z$8UV,&=U%T!_?P0Y46]\\6
M>(Q92+%=P*,J0X%;3(W/02I914DS,+C)WA<M1X=,\(.,CA_ZHF/311=W/DHG
MQ4S.S"KI1=SA[=S/<%$M;KD'R]+":?Z(V3C5GF%C45J1#_R\KH#@F3+<*UX)
MLJ94?/G+7;[S?AM5Q/YIFQ3T:Y40=?J#$,=RD227KL0OTW]*S S\!MEW)-'
ME:WI@1$9^46P?(AWX,IJ1N4G5ZX#%M)3;\@=YX/H(4VODKY0KB%'XW+M[(+<
M6)^Y]YFAW*2OBZ9O=>OUU#7196&70=T-X&<@\I+\[/T]>2J\M":N))Y/E,>]
M-M!$XFX<=T<MR[)[$08HN%'C/-4:]D0PXZWB>B@A@$KTR=FM L5I<IOTVC_1
M5GS^]5^,<6Y[Z9W^OXQ"3[H!,.5=UZO> '[##P3P'-C+I-.O-X"MN.'K_T+;
M6T:UU;;;PND#+<5;BFM;:"G>XDY+'[Q <8<6*1+</:6XIGCQXAI2)&AP=R=
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MK%T8#D_\D3SY":S+.%^_A+%T&;61@6GW0!CP2N;B\\94#T1-UMS7]M6XSL8
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M<+3_BQ+Y<O?X81I'I;GWIN((=GI+]ZI3)DF\A-C* S^SQ@K;05(UA0#4K7R
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M-$ZHE\^O-]<2'Z08$+*>5)YTMA(UU&(&Y-^EZ)S0N9V0(,C1]P! #V0)-O6
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MXLZH<T2U#5EC>;:;KIZ67-7D3=;IV=HKNH=@/DO]H$'4?9F&9M):NP=TR5
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MBVC$P;F069CQ;;FV7B-G0E)CQO3)FOQ3,)MN5I0T,^8@)]2]8?_TDGIY@?M
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MU1\,W ,(P<$..()"_1V]=+7L[T(7\RB#@@ XKD.%61_<L@#GZ@Q\,(DC+%8
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M %V(-XXRKW(A?78'^MJM27JP,$=K "Z$IJO ^5X,.4Y^?(TXH73I$YKRGM*
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M%$/KW_64I4*[5&V@8,JEN4UA6K]4KFM^19U5[SSF\@B(YI+PMG<W<A#NW8[
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MC=3%_QIZV;-1\1X[Q7AB6DD@V(D6*XPH]WATY[G8ZZIABA(#/;OT4YD\>VU
MN89X[B@!WOO\,:^C;*' TPO"Z%AL%YP=GK-GG!,# T*^717%IU4KH2^!;FO9
M$>:QCD4I<M]&IT\W6PUU2BS>!8X*(EY=<(XG7$35V*7WA0I%'.@Z25/)N+^Y
M:E/>$SH(<._5/WOCQM1Y!=SP[Q:9BA*"<(H=I.5KLNW2GCVJRD>H1\RJ1$?@
MZB/L\>H"0(P(B!H?22$!UXKEF9*G\ 0#"R'<Q&FM\565!/K;SUK^MXPW]/78
M#&T8ED$!]M/XC=@Q]D _AP1N2UH?A76>Z*OG>OJ<49@<NF:BWLUDV.NG_^L
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ML3/96!6OF2M:[\"\'-;@(SH3;3+1:[PS:4MQFV#[(L'(0]LK[L/+&@<Z,<9
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M^##UB'#-QW"OE? R7V4<_@S%UE1K%-TK&O)VL$2"X')6JBC9Q;N&OR#4\I#
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MDP1&?/D+ @]VW<)=M=:AS'DGKUS^ANH^=):.@'B.5WD/MAL3>2*1Z7]QZKV
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M%>*V&(R^0YU*!BCUEX <]2PO?WJ\(8*\#'[C\T0SI8V_YCA@R,GI\H1.V*]
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MCC')X\P^3Y>2Q<LGS=^^*VV<%IEU<59:[YQ+ZJ+4'FHR0BI5;2A2$0SR+<D
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MSZIV)@*.=A>T1ZJM+AU 8=Z0;ZI+0"GIGXMOU>A7@1,5D&'7DV,R &M0YD%
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M7<XO4HO6#79GQ;<9D[.]/Y]+V7O/<**^_:?*"!UX!%5!9E%D  O@*-=HT)H
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M%Q?6S.8#,H77UX)YZNOBGFEO:)I)-!K6S<J\Y@^ED7]9=#==WA,KI4)X?]J
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M\PG^RM$T6YP*YSGKL8PE72&''D%4/W?HVT8)^QH.#3UEWM[C_KQE_K.I;R"
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M[WH&'+)VJ=_^0\PB%ZCJX<+!S?5=]N(R85 VR9YD(=XPH7*BN* @HS2(LG?
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MQ+Q#&+4HLH]WK3Y"#(FD5?4@M?X!&,E$VW<7K?=9Y2>LX<>;]FLZAZ!XGVM
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MO#SJW+X^%&C.(U\(]NE_R_9T@?8/\M+_[L^OC7)P97(8I_MUUOJJLY+68*(
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M<?IAMC&BHJ./=\*>M;R2+2WU^NI0>RFG&,:>_DYC37G=<W"DDRG2/+NHTC0
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M=/FT4D*/$2FHFGY!$:7,/[R@8<?-I;T<$PD'^@2F?9*JZ9? '$#DR/"A<W\
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M"$X@!= 3(3?UVAFO >:MAAIX?]%2]"*3 ;X.V8U.7A[9"XN?)[Z!T8C56CH
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M/?XP/(&D'</;TV"9,%?.48=K=3MFQ2\J.R>/OATE]D1IBB!C8PI1#-DF454
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MM -[.K@^@K?30SKW,^:G5I*(CS(.6-969 ^G( X(QAUM(VBRKJS^_;E]OPN
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M[S%COC+VB=<69'<<.24D1P!Z8]#?(<3 LI:="N*]<+Y_A=''SK]#US8VB6=
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M2E/6D,CXMSO>7H<SJLP;I8H\W48< 1%G3XG(%FH"TRY&LQ%Z ^_'XJM_0LG
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MECX4M18LS]H#)ZU#B[8XH6U,9LJH6C,=S)?U,TVQP*;Z@&958="UAT.VA\M
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M78EH)9Y2E8,P#W&K4]_D&1,4@L1:J5H1VVN>TOT6?*L<Z^2Y- Y9(S+Q*I\
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M2)(KGI;VLXA$E3+6M,Q\^_&8"I!HG]E"'EU)/@7-A@V +\AH)S&Y9F#CW5E
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M,/"V+Q6@<8%XFPJXV$,%W'[,B_-E)IM1 9U[YXX <2+/& TC\8!(61D]%-K
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M>3C]B@I@=BW*R,<G/ GD0SHYO/FERF83N&OCKG2;[LVKGRJG!]9 U9W*>W[
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M/:5 )!=?NWP%0C@PSS8FU[EG8<5MK_A('YH_$8M63%F.-T#9)1"*<QFC?*@
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M"0S+?XQ2T'(S/<!M NSH2<-94>NUC9=KT-O*.DX+T(@P%BK@8S&.D66M4X=
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M;+'IQ&=;?E2,:G7TA$_/(4H+^%Q>8SY^1RNB:T54BO]M%E-2?413G=&.4W?
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M#OJRDQMN,\7]G5=J-M]IR-\!?2!TW>BR:G\)"C<0%F!PR9?=JK^\RUSVC,M
M*5WA<\./.VEW0&(04"O0J#GOG[($:YTI[)A[]RQO4X'VPBM4X2D8F1 ="WDW
M5-G&("S6>I>\QS7CSHN>ITV1IBP?7HAV\KSG>SLO;@<R-C;.L+8(/X?QZKFX
M'AI5)5Q5R+GDX:\!QA.?QL241MT7)-@%.;T$QP77I:V?4^GOFTD*)G$^6)50
M_EPZMV76AZ7I0()^7!I*XCX@$"ER%J?J;NQ)?-_F"SBIANN:W-KU*[>:3>Q%
M.N^VM;$^/_#C"X=X_ A*TYD>:K;9\5=MFR[63RD4D"LM7'>Q.Z([:]8[*>M
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M;G]R@Q;3W0JP8DA$VRERN-C#)J<-U42W\"Z'CEBYT3-QG4&M?_^P:/U=[QW
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M,>4FT+H;L00P3B ,+BQ,U,O$#L4'NK[2T7[8U2-ZJ$$JC0E?YQMK?D@86)3
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M)M4C8[W=[,HH(,$32$\7T<,W [_;N=;IU%PVNG&3[^%60UU@C[^96-XVYB*
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M^K?/Y8,L'5:$HFL=\LF76;^&FQWX1?30A,@.A(99ZFM$S/R0.['XN>BP.[]
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M/[25:S+D'40@Q%5S4[;]RB"6-":I#&D'KW"NZ>IA=792%T @,56ME- ,_J'
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MEJR1X&NR.Z-9VZ@5M8"  "FRNY?HT]*JDWZ.1/=H?(P@6V=^1.(D!?W^]>1
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M6;]^FP(-D46<UVUC6=:Y>8>D%[JRIM&<6%C04O<P"C87LV#466^K9^WMGNQ
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M]0\S]'#VZ_G@L)R2;=)SZ#)?Z4$9AR0%5<*-IB;$Q;F3Y=;%;ZQ?A*N6T/W
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M!L1I&0A(,8-2]1&UNF5O\KSK680SW6-9SZV;1ANNP2[1;.Y;Z9I$G.QHL?J
M('1IE8P#Z2I5G+U2G4,+))8&@LW#%?&K  AI(!7U^.9DQL>]M0H=ST+),A<Z
M'E$3:$1^*KW@84#*9^7SIXHX0E<.@9<$$^+C11E(=2.8!44OKU[0H65 '+VN
M""/?0]E_Y6KQ3ZY6[G%UF8RT +DZVE(@-0S5_7V\^N\K 9R5+]F5 B];^!>N
MFMINKR53ZLDYDO78/!WD9)/G3Z9JC\_[8-;Z8<.P3HPAF+X<?U(U7FZ#&;>7
MC%-U1<$+T227$TH]SFN?ODN_<[SUD\ZPQW-#[?N"G-<JS+L+52)N?[N/^'XJ
M/P!YUW0J)I:]*.01\VM"GOG8P78XD[B-JKPQ(QS88$><IL]^P)RD$2-PRT^>
M)5V@SRI]6TCG?"N^,%KQD3&Y>3X0SBQGGS7L>GQ_[K@+SUN&".*+GD%GZJ&R
MDD')5QH--7Y(>C"2WSU?]L1"[51IY(TH/T,C.+U8!!P/,(0 <WK_208K/KR8
M]]$^7$\#<-)_E8,9_FSV+=\U9]8(\O:,.^%CWH (PW-W[L6 T^4=>(ZN_.2\
M*BH#K*4R583AB9O_\>6F!<(U,95758IN&CR4#5,B"I@LN^;OVWL>X[P+!(S
MWMUXZ7ZZK5+3;+8I1 $MF7HC/[9$!#(<I[[#'5'"0#X!34429AF !A71K*-S
M5NXOK2&5J^43&A>)&A/@8Y<8U62C>V+'E]#EH2*NGRMIM&SU:5O252@R>5E<
MJOM&R+EH/&8<-]!TKD=KRM)*@T>$@7>CPBK7;<?$7U;<C-3^FBP>V)HAT\XL
M#A)6D-1^"I1</5S5![/KM"]2Y/.'&O5EX,PO]%>(WW:!',DZ3?Q9LHH]-?\>
MU/ ZUAZ\*K"!A0@DOTO^1,TW\:3%D-]HNVGD 7:XQ\ $"SD:K]8]2>K-#7Z0
MHXKQAXZ6)2#?N0VE@EUBGH+7)A_TC4:",:0WNF^97ZI'.\NIIDQ_7P_Q0_8*
MWNC^U0^V-1Z8K3;@/D4B(&J$J6LTXR1"'G\N2*4,-M_?-]M--Y-@YB95WP>=
MG_%L,!$-.AB$N:/AB6]GEM*Q*MK6,D9GN(Y>,O[>+K<70S*!6]>ZE^WO_>R$
M*P=XS73:4SJV5WF (>2L"Q<[E9B#T'2AL;X-E/Q)(JKAT!9TL1992(.HC=Q+
M]FN<B/XIJ#5T3BM9?DX1LY4.1I9K'6I'D1GHG>^CD=!)[6+YIPY)TIFA)Q]\
MG,C"KR&;R;"E"QO8_5+(2>)7RN9> 40TX1G=IH)\]:_;*X\2_G4[\9\.V[VM
M#< #$(=^^//#^%6\Z4+IFT#NJ0:R2%-9L[K]EH9+&U@)'4=6(!.=OB$Z+,V@
M:Y!G-,)^(M$XBESK1X(<S<#M E-O?G(402O3=32$G.E<SFGH>[K(=4VP"8^^
MP>YWG7KQ5&60-:<45JWA[D*%7J[77R^O4[=:L12C"T4!+5T;\GDKNDN>R]S]
MJ'ZXEY@OFCT[<S8Y-?>9^VE!]9T,#W8D-_#%?-5F'WI<:5CO=ARZV HSZ=V*
M8/(-@/WZHV2XZ"I3V[L9'W1B<%@YC@%VI>-,2<JJVY%1=*KF%'K2\G\HVYEX
M VBS*;TK=:.1//.O7KJ?;R.^2Z>,P!(M7X6(G(]V'F8HZ*AK>HG8Q[\EY$T
M>O/8Z!X-,.P"C//!.:C($KV77:V>Z6;J&H"/1.9U*?,#Q".N',5IJAO'(-L'
M\HM XNK:D>NAEOJE_>RL6R$P0T.5S"K*-C]LY:C:+S$M!I*569VY@U3S4.K<
MZ9?NQ[HI7:<IW"$*Z;S"B38,S@?)Q\'G[^]C>#Y<FA2O.0K7 .PY-60_B#MN
M6)7.XD8U=P'NB(W!T@6/T8>R= DT2M]6$=?(RS2H.U[0HZ]IQD;WPIUM%V#5
M[)4I-X8FNOS(Z%?C7,Z\..P 332-5R\-?E,P94,7$]^*/7S5\X"YWA;6@#2-
M:QO35R%>9NY"+1TR?L -K+^NA5IA"+<7-N3 1-P)(?B43YR[_NH?5.9/?E<^
MMR5@2LPS2OY@F8'@-R5R;SK<5A%]T&&PTL[\Z!-VWI"R8 K3S=V\X/TS$==\
MRN57@0>;')R#EYOWK6$AK#=]22WU\S+Z;8'6J4RYF !!,CYAY-B;9(5RL$,A
MR@^P\538^"[@79<94%W+V#4H_TBJ"Y4N7%]E=-)W:#\C0\6J&I]MX"X [44N
M7_A9<U7IU/+D?(YQ>O)#(,^P:D6#4!N4;':]GQ-[V!75'5]?F8"P_TJ3*%(.
MI-ZOVRS :PWMWG7A490ZP<CPA>(JX>]KM9>^]/KUX2-9..'7"<:)*1D)B4]S
M'*0Y/S6Z?/4]4)BHW#,$'W.J>,J;G'YT0]:B\ *#0.K$?;E@M^=+82/3=>0R
MZ!*8U(-=,&O?D%4&0"&=)B@ [Z6=NAHC_'2S(1-=ZF+A[&-]I"L(S'A]>HZ9
M&A[8TW1JG'Y\4,E+UNO4C_DQ Q_DC9EH^>V./'T,T]78.#7#N/O X1*Z8Y>9
M7<O=;JD,?> Q3[6 :!BFSI8@]UD/+R;#A0;XJF36R[?-W.VS!ES>[)AZY;H-
MQ>015&894CO(1V(7GYG:+?9]NO2.^(+0V\CFI5GX ?4HG<[8CL7W_]<_76(#
MC"QE/:M1HX977X6<=.,Q(_6N[@*C\C@K[6+/'2<PT^5WJ'&A7UIA*M>D)E@O
M#S!O2<)D:<:<1C:ZL &VR:5//) &8XGT$2ER,2MU@65.!'O8I(240>I="P9S
MZ\O[-C3MI\[^S5#M%Z<.S98?W/LQRTW1!$-X69KSL'O7"@@,(S"M]5T9D'MV
MU]0VG3NRA--@*$F=\!Y[V*M9^T;>=#O/MK 1P3)B0REVZXK[]B01OD_TUVN<
M;B8ESQK!J*] E)8[:&$M/!*FO@O0R=(]M^-+/#[(T&T:KFFV3*^:SO8AI'V?
MT3=-Y*\_D0\2\G;*7)8B\"[^4GEP(;H%KS?^S$*QH2[15TC,Y?% B/SK:BZG
M76"M$2F6+A4J@1Z^5G?I>IC]9H8T"E@7#6)&O^5'94J%>20OZ6'P?3DIS)FR
M@U*9P'UR[?%N_KG2ND,F%K*LFJIO;LVZ]4>G\N'%A+HF5>!P9E1MFC]TI"Q^
M#6?)9;1\>7(^J^;U1HH5'M*2HX,=K#-OGE+CN]"5Q[YP=OMZ#Q'LC^&S]WZ>
MN\ 9LQ4VNNE$1L)LT38'P]8EJ?;4SS4K0CTM2F!_^EUNUTV.F>G#?N4UG]:4
MR\O8OC[ N,XM_46I7/8%[M!C";' 3^%T1<H.WKQNV6\Z3I<#BZWW''I+[4K,
MN^U,,M%L[\+$O=)#33F4389A>I7=66N@*H/X] =GE_H18>$2MS=;<4=]+MA4
M[)Q865;[)2MVO&K1_$&T,DZI91)=WUM5(UR?I'@1/-%/:ID47MG(LZ,/8;,[
M'/(_']KY?]'H  (7[D7O,)4L@\&CDE  ;L DGA"J1<I 190H:9)J;U!XR&Z:
M*."C)Z0I^/N2*I8[E R36KGZ<#[#E,!&UU86X5?#Z+[A&K&1T[#@T3RKGH\'
MD\V+SIND%6U5G.OIE(5&O^XH%,TO@ (FE"L-)*N$"DN1-9Y<H%H#K_%8"$2L
M/,TX@#VL!\+>##[ ^IJ4=YIZLEMJ?)Q\@A%9_19[^':CMCU[]0CT.>*3@V>^
MQL4!P8F-:"M*+QM=]'>(;L$]C_-W\YJZ/)ZL>X#?^G4-?\^O,V*:BYD,M#-S
M(5Q?HMG9J]4N]A3>RQ[^W*#A=@ZSZ2!4,$ME[99L)EKRF$=^KQOA_P;?QW9$
MN?.,5[I2.9WQS=2%$B2C$AB0W!]W7WP83U"I8YF7;>-NU7GLGJ%V7M6%)\FS
MJ:"=T;3WC<4[FBB/#A"+,B[YW_]!_S<:=+?__P!02P,$%     @ EX)<5OI\
M/8((B $ 1Z,! !0   !N<W1G+3(P,C(Q,C,Q7V<W+FIP9^RZ!U13W?LN&$5$
M1 1$>E.J]":]B0H("$@OH4@30X#0"?T3!10$%*2%)B7T)%("$IIT >DD2&C2
M:R"TT.'R_>Z_S-RYLV;FSJR96>M^3]9)WKW//OO9[[O+>=ZU<O'[X@^ 5D=3
M6Q-PY<H5P,O+#^!BEG9/ PIZ!0#HZ0&$  # #<"U*TJ JY?6[<N"3C0(<.W2
MOG)I6V1F_?T+8 < : ?7V $4EW6W+LNJ@+\KU_[U[#_X!__@'_R#?_ /_B>%
MGKTWR/G>8V=_9V^W0 " _!/9O_3$W4O=4/CIVG_8F,3/_[+)9*4!@,3$_[3_
M4UO<@/W=WS_:XA_\@W_P#_[!/_B?&U(24E**$M**$I+W).04I2459:3_NW67
M*@1@#_ &@ #.@'N QY??_I>7-\ -<*E( !>S5/=>^_IZ*HJ+>_B(V3M!')S%
M'"'NXE![3W%),0EQ@+(:U-/>$>SL>\_!V07DH2*P5=\L< _DI")@+J,GH>?Y
MQ/DUZ%F0M[-QD+Z)8Q#84<%)0$V5^J8R5!'J[NGN[&M_#^KNYN&C"%7A_E?O
MBI?VW]7BW*K*WDZO%(V>:OY;B\N2"O>_C24@($ L0%H,XNTB+JF@H" N(24N
M)25ZV4+4)]##UQXJZN'#\V\=/'7V<?0&>?J"(![W_B[;.T#\?%6X_?Q 3HJO
M[%_).#@YR8@ZV$L[B4I*.MF+VCM)2XHZ24L[R<E(RDN]DG3@_C=Z)\?_8/?T
M\W;[%[>3H[BSF[.[LX>OSV4T),6YQ?^?Y;P,T7^0_G?#?^GC91O%)][.]K[.
M3R\OU;^G6%1"6E1"TN3?IUA,5DI&6?R_::<L_M\,]/^#:*DJ.SDJ.OX])HCW
M?Z4W=O;ZOS?;;B#5_Y6H_J]N7M;^5^.R_\O%1TE)J2S^OZ3^W\9"_-_6WJ7U
M'ROU\LE[_R_@'Y)_2/XA^8?D'Y)_2/XA^?\7R7^J76>/2XD;<*EE+R8 3P 4
MY.37R:]17">_?H."XL9-.JI+C7&3@8;V%ATS RL+,P,S$QNGP'TV#CX.)F9N
M,6Z^!X+"(L*L]\2EQ86D!(2$A?[NY K%C1LW*6_>I:*Z*\3.S"[T?QD7/P!T
M-Z[@KFJ07>$&7*6[0D9WY:(=P 4 7"&_\B_\>VIPY2K9-?+K%#<H;U)=-D#3
M JY>(2.[>HV,G/S:M<N[H9?W =?HR._<EU2_3F]H3\'M=5?JS>?<&SR/*UH8
MC(:(O-(.WA&4-QF9F%E8^?@%'@@*/921E9-74'SR5$-3ZYFVCK&)J9FYA:65
MHY/S*Y?7(%<?7S__ &A@T-MWD5'1[S_$)"9]24Y)34N'Y>47P N+BDM**ZNJ
MT36UW^LPK6WM'9U=/[M[AD=&L;BQW^/XV;GYA<6EY975M>V=W;U]TL'AT?'?
M?ET!D%WY=_QW_:*[].OJM6MDURC^]NO*U8"_&]!=([\O>?V.NB&%O1<]M]2;
M&W<??\ZM:*'DD38B,CAX#]UDY'TXR[?]MVO_\NS_G&,1_T.>_8=C_^D7'G"+
M[,KEY)'1 =0 )#6V4\V1$,H .'Z--0P>JEKL3,OW[ME"8+"<Q_1Z0I/D(4[^
M<'[V:;92,+JQJB[\R%ZQDR/LNS?%LG4 0;U<%[YR?,=R5LS#UL\2<)3\*,&?
MQFW!O(]Q^.&8K7-O=6)2;UTW0N1+(*RN5]Q= <W4D]K7?$@Q/K =KHOGG'D\
M)N:HO!7UX 979E[=>C/>L04GK2QG9=O(_MZSQSV/Z\2LR>_$?9)66+UX4I/I
M4QD_.?BU*D_-MLK1MVW-'([13X7N2Q_\"3PGTV@=B8S*H31]I  -D^(''>&:
MA.W)@_F3IU!#W][@5=\I5]ZZI-X8N0C1#9^/\WVKQ@;;)ZV#T-@3YM]@&I]J
M2:<HT;<\*B&_SI-WS.#E4];0+!>,'S?>L[A4HC2W435Y&(IT+#S$SP#?&/Q&
M\9C%/R=Z*BS%6^S4Q,19Q93SJ!1DG)8WS:_E;CL^F7R"=Y7\XR+._I+K-"S_
MVV'CUS6Y7C!Y=@'+ARLP>=+V!8 ,Q52!%3E]XL0;,4M)%0'_IF$]%-GX/7L3
M^Y;O:T^/PJVN""'!+IBVM)N-N<Y'. ?)%N4X-G>(_OJKOPQ<?%U32#U.*?S'
MNK39X=9L'#N9GWV9K+Y:P"VMHY_"?89_& ^?'PW+SH6AD^=LKH8:Z.\0!K7%
MI!KFBF!T =E3H=2+?,R[VO@N>,N)+E1S;DT)ZIL56/"YIIB1> '8QN,2YFLC
M%YMA_4IZAO!WU+^CE'TFSIRAR)Q<T#D#L9FTU!%JR[[AKV S,]5A,NQ462L)
MS==)\$.O.YPS*L@.3)Y1^SJHHA3Z[&T_;QUFF]$\A-LV-^54-8N2&IH1]3F/
MBCHYKBS<<-M_*' R=.\",+Y66+O=UH:_*3P-"NKMG.)\X,"S_\F<!3[Q>R;_
MYT8"BTW/CYB.[8(7-H>/+=(?[:1MJ*RS>@AI]]EPUBLMG.4U\.-Y8>4P?S1#
MI>Q0TXU:!=)5X^.YLM7PZN:W?NZ/E93<E:RUG>2->6G_,I@51&4KBX6-Y:YC
M'EX I)[ESHOVMS9L6V]%OHN=(TATQI^(C2C=S98SE>]<1:2W$8I<2[8X&D5S
M]^W/"D*X,5]PXH7@6)%;IMT1[&07@'#7B?-!U3NWGOK#JDNO!Q1(SE^.^Y?M
M/56#!+2O\P-;[T?V$1K@<0OZHJI."<F?Y0L(_GB8-.E+OAR6/WBJB\ S2^4D
M<NSQ_4>X_XWP0\(+-;16!(6-N-T%X <T_' _9+ZTAX&%#:$[.\7UG%7D>+,!
M)9II% B^ZT(.RW18V!#".FHJ_SKV,3S+5^8IM)BP&2A:-^#XV7,M0B0!Z7QW
MBIX43XQO#.9#9V<@\KNHGO>)T+Z)7!\V[@O)G>/PVY_ ^B5TUT1>\VP[PW+A
M$%!A8.U@@_JR+=)].9*PH#9)W;G56CKD4_N$1:?!L]_L8"-48@;-%6%:<9:%
MS($WJ)WZ?VYV-;B&.FV3F;\ >/QKZ1QMAD>SPOO:='-[R?>_1$L^YZ7*^8&E
M_Y-#)_.C6I;93[EF.Z$?[5N7X5_K47MCWI,0 MY1S1L.?SUP8UW0$X</JXZ8
M"E!(N1$5EO9EY"$$K]N"7RJHD<4I_C)NGJ1_0GL[]#J?\EA?P %C&#-QOS/!
MV;LVH/9=:.'3U=MJ[U@79F&ZX/?+M=Z)G2W);Q98N^&,24?QF6NFEQN(:?P"
M(+T.'L"'M^"8JJQL0)SWXE];YY?4OHU0(Z"?-E^&GN4OQ5<-=9ONLQ> >?2?
MA-)#<$>% *FG)KUD@XIOV=1;Z?.ZZ4Q+D%(<*5NP!L9W0EC\7$LL7)V9#= T
M["PN,XN-W7,/@=7M]>></('JFC0PXA@5VS=HZS$MC+]'_41">GY7'';,-NHM
MV*@*3[QEW51B5-6J'; 3%8B^IDB^$,:(RQMUZDJ7C]2I_+JFFJS5@D%$?1S;
M*ND5\:YFKI5,.FBD9OB&QK(FYU;JX,QQ)X%I\Y+TR0HFK0:FD(#D*=7:IJ*A
MU.;JY;=[)V/H^F%E=?:*&F8V*/0"\!/M8WZY3P3RK<:M)T'XT4\S6DN/M]7I
MKH5)Q1P!?U7A9,;9S.MW[ICP]GW\\Z;#%>SDRG5[K_L@_*?"1\KSX21<9G%/
M$LE/]6&2_[CJV'A&J(.KR2AF:\*$=)1C<.@R?_!6V4!D^P?$C?7NM,:Q%N?6
MRR>9L+"2[8DV5AT@&IM='#;<X; S]Z$V^ )0OFK'L"G_9W[5IF^WVX_8]13S
M5_I"Q7<?A35'ZVU8#YU[=^T*R+9@=;3(9;/6Y4!ZU?CRE%[3)*A9  XD.MY<
M #X+#42?*T#-VVO-_3%NBM%XA$GM9U[#J+3PBMU/X7>$EWNY>$R&C?[0/D$)
MKUHWGL&7H_=?H_6$C-D':Q:=SS4SK7TQBL(^&%&C81NV"P#/RFHS:.OZA'4W
MQ*_@,((EWP&9"'Q\@^<</UH37MT5(<Y'AT"B6%06(NZI:5,'7B\I@T(ZSUE8
M-_/AE6N,/_AFW\V[G+B,R71KY$%U7UP #%'A+M\76&@S<97Y+IOUV7ZWNF!J
M387S?/G#QZ<))7R'B[.O$0W;U_.YPRO8 R\ @^OLY\/3=":6MY-01[?.+=*
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MBJ#GZX^9-D.-KA((3LOPMB".Q=HWZ(>8^%#^0VN048(T0:*96W4AOK.F^@+
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M3?^X8I1U-)?5CU;6R#V,M!KK\-=UETY(-?S+NV@$HH,CYKR1T;6Q(\#,4TM
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MZCJ9-C7*-Z&EOMO><.U5/M1ATNH:)I =JCQ2G%?73_SW1. "\+^7"2S\6R9
M3,"[4IS(16T.'*=ES\FI;BVZ7P &]:!._JO>-Y-_$NQT0OQ&U&H>QE(Q=Z5[
M=BNUW/9J[$H=F,W!-5G 2.N:GPG(^]!-ID6A'BU5+*HJ)'/=HTA&^:F+F6\&
M3O8$]KRH%(C([) >@%L1H[Y@D-6OZMC*R\T'OMN9,HR".!F&T1> *Y.V4SIM
MYM*4RG.>G]H5WV[9>"2XS)*JHE2H=& #;0=4"VNLHXA/R]_):F660\.2%01-
M]#0)=H4YL3O?'-@7]3WSR\NK]\_</,%S!-=EXQ2H6/H&M@)RK:'TZXJ:T*IC
MAN:V6Q@DBS,!\;4M:HXE+'L_=TX\ZA/4Y[&>P;/1ZT4N7O=U_>*\O?#?G(@,
M[8-=I(P"=/UG'W;+A>S),0^F.Q6&WD5;HN@1N_2V]_#(O+QY,6U?<#ALK3YY
MOZ)D1786E<M-*:_]9=&JC@*<Y;#M[I8/6OHR:PH>\LTB,R0>1/E1#;#J>)13
M;';FU/_ROP"\YL0:<02W5('F#089#6@RLGGKO]ML-#\6FM\H7 2YY]MX<-F@
MF">28"?:(;);,YL2Z+UX8"A5ZQ"7U!RV9E(Y5*KKV 2SO]$\@<.;P1;4\XN?
M_0IO#V_<1\(F6H.THD),P1".+5+F,+Y;;F)P2<ZA@<;1FBG:[P$AY.EZ2584
MZ&:W<#B%"DBSVM6(%"\VD#^B<>Z8?R/8%CBE8==4V7A.T,L30U/B%01<0*JO
MS#;!F3C??)"@.;-J,A[$HW$^C*G/ <:%_5I^.7%>;2XY)VK+ 31,>?977- 5
M8+E(D:J5H&6C:K 5J7G?IS(NR+CA)0+"'XNQ'D"<JC2-;-U(! HJ]P;:);%>
MZ7EK_4R! ?^ZFP2YLA:<:![HS/;X_M[^'E+$J^7/L>D<$?OMM+3<#2_5"LPN
MC1\[DV&P_(P=3'96,%)BW7)K,)AM],"1S9T "T=%QQPF@9^46\['&CT?^2FP
MORB7;D%:]!C:/I]&WS"K<B^L 8UGH\JG5LZ5:FM9S0HPSVL^+/*:NZ0_VCM
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M[[:^F*M_:*+9WJ;G3COQYU /W%+_ADJ<!U3),N'9V @A=LEB,H%_27KHT_;
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M#.WI61F0RD6_O)GHP &RYKK/A]D23GFJ)EQJ&W#H^%?IURI$^8Y)-4A124B
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MS,FSM02;_8-2$AM#*;*;(P!6EV.::S/WS_5 =O(_*]"[H+F1TA9.C778/G;
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MRN#;HHU *JMYWLKAS%DA43T S'/&^,>ATT\KZXFGNF.I[1(J$A<T"4L&<+E
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M<PY7ZCC%H9(D_MLT_^.L38)5P-_-@UAO;JH)4C8S<DBT_&N$UKK9!XL.]HC
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MQ&[*)>.$*^^7IE)@46'%B@IZO7QEI[ACTVQTY0/"=^%R4Q$U 5S]$0O.A>D
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MG7OTC[&KSA2]/S3TRBY!NHD>PS!Y%@!ZY3N=;6MP^"&JV'2:FO6#('=K5'
MI"?N:BH>Y^QWE%#Q?5DCW^H>X8*&E*;PHVPF,3J>,]Z@KK F8]:'^1/0)E[=
MRR:.===;.!1,"C0KHMX[2I;K^W,E(*-D[^E*_IPEM0P'/6[JV7.S*^_*N3,D
M*\9M&<_)-:JM,E'F,N%A[-G'^*+-:@L4B82=\UA-4#K/LJ_WRPGR1K@XTD2O
M;DPG:&S""H#.B986GLKU(>^58"JE:;E&0]=3O:@O;!NK'#I37^ ,=YU_&'T.
M0H[59!]SJ8GI8+@$HJM\+5W[0\@R&E=4*T2-WIP3OQ7T[GM\JIJ@16$@@!D
MZ[6:U H6JJW]/<63*>I=LUQK].9!A!U^DPC?ZYF59JTS(0XP6@5TP 1?;BG3
M>^'08(>"$ VTEYHB-6S#,HY._TY)E@K%&[Y6@/QEF3NGSH8ND7_KW"6AQ[FQ
MD+1,3O,6')RP@KK=1">-KEV7%#JJC@\%+V(RK^[0O4#'YP\,UR,EC#;;(U7B
M*(D2XW/?E4'?LG]+(!YF6P>JYA7=$*A)\K=C-Z;YTU]<]G0E'%IR.IBQOIN6
M&9@_!K=,<5(4A/D22!MYV/R^1NF*"YHO@>_8,4_>9-*C9A0X2KEUC9%JFFFZ
MAU;E$CFJ8S*#G^X%4TM"G+&V<$@(X["V!5 ISGCVUM<P5?V V&-287K1.'F*
M)=-.9\4P&P>H+]J71=Y\FBT!4:I'BI'K38\FK%[5WTX>*/V8(Y&SY?/=!A6(
M"*X']-OV>T7Q)KPWOT*4G5QFZO9WV1_Q2Q+D-'#N=XMDOO(NPT+-<UQDYXZB
MW7ZY?Y"F=[[E)+A*RM_UW746V391%1TA_0(OMP&=Y%A>L(][\'W0!M':6T50
MC^ -#6_P-S36_I2O'$$%6S[)NK:)W".B"=U.2)&ZN1WS\]Y7;1E5HH;2;LIU
MW,+Q<QG44T?(SY501FKA -!T8Q?"1#!E_M;U+"O $>_I,:9H6C\QOWCNF  L
MB1 0TNG<F.@,&D,@S#5]^4(=4DSMN+WVB[PKW:!^CX(TA4\[1H]'LB#CZ-05
MY3I6K>4P J)V>"[7LY=7Z>[!CQTCB*<_)^5 /G%5:DF.HK+Y+[4S/_#D<643
M7N*"QK+A/%AN5J,>:@:W\V9M8<B-LR"6E\NH76H:+;<4R>Q.2;2CO?J$:N&0
M'>A?OMPLYF; ]N52B!$;U2.XU]=&*%#QY%F&MJO?(<1&2!$'S<B5KAHKWU\:
M/N;8^UH#8]A>-69X_[K5->[4<H\[TLTU" 2%_-0XMQC.:C81_'9:]'%N*&,]
M<?K$=UNPMI;(DWQN0:YZ,%0CN0Q4O5V;W,*L!JDS'1:<9>0YOC+ZSAJBT$<5
MTCFGDG^AR7L^DFTVB*Z"9*.%!C,]C]T1!$K#,_2>W5!RJP;[88["MZ DV_G,
MLY^01GI2_N!&VZS&"+/SC7@)U[UAYQSIZ)7'A8<Q>J^)U)GK"G2W168K7(<S
M885+X/)*!CC<+V+*(/WW.W2J]/?]?B3LK2S<5-_'(P0R43.13_F]8)09Y](G
M[TE\79 Q1MUL[%Q>\)5;M0[]A5Q(]$E-TAUS6E@G_T:P%U;71:OH",2-?/QG
M)X_W9$^1-5CSRW^*S#N:C.<7S&[&95K8P.34!"7-L]P7XEIOZNM+[W](;OHU
M55P&!>6K[7,'B)^OE2%#^BW2/ KK)";R$N\]GXB0M@P4#-\+=C('.SUS;]B>
MI.,S[ (5F*^.N[(6$D8G+V45_U8+5__EU]?RZO/V[E-TAKW(PW2.'G*<QYG5
M.(R_L(FW+U6:73\+KA'F@4$B+!B@[8#\0[=I)"*2K#83P"&SFEN_80YJ^670
M9G5SG2^76JIJ<.:KD[3=;;+EBO0NTDM'S6="-6,O+?<_%RG<9/[DYM7TE<)1
M.[(8T>)0ZCQ0_'X!>*_XYE._SIFL/,-5GQ$#_8BH!M''!O<E@I%-G6YU^_ '
MAB;9FA'GA!!>_.9N"#OT><*MA7E7'N_^'TVXV3W963"E$@%19:T<5E;,+T\/
M#*ZS^U8SDS]!P*?M)X6U[* B+FBF^6IQ7ZYXSIUE^SJ> =?.4Z:G[GAUVM?4
M-!(X7;V<9F]&2">S=@!WR[\J"KOVGU^:G>'5,2D24B]=W],!.]5+A_G3URO'
MFH[._]C61EHQ^D4LMN ^U=:T= @?>;8&:&6WV1J:"!!Q*J;$.*U:;:=^H]K-
MA;CB0_.I0QV%@KITK$*2'O+N^D\@9V38^G0]MF'K]EQ <)9''.'ZM3_'(/9K
M/21"V3>M0=RNL+N1@;]O46?CC&-*AX^*B(YA6$XB#'MF,KNO$,YE %D_J&D*
M70F@(&:3\U<'QIV @ZU9\N/D5^R?5C4PLS #DR90;7(WZ$TXS]&[,W5/+C&M
M?]A-\B2+TWEW%<@RLYJ &B^3_B7>[O/[\7=W,YLG7291ID'R1Q)_N\7S-1[P
M/NFP/'-%LS](>WHX3K&;9(U,!63-&[P1<>UOJ1A;P5)><_-H-\L[CT1J)[RM
MB,O;)FP/!FW:*?!)J!%J4+#IY&:Y1N$JQR0+#?5XK:8OD@KE-VMQ,M;=BJ;D
M$$$#/I*8MA@'^"@_8[A!J9!=!E^' 7&RTI0<7WU6GE"H6=CK?0-->M7YON1D
MG!,?O5\^NE39"9E?32ZCBV>23C9GCII!;WX^*VT95.F9FQ<74.Y8$P&[)V5!
M-8 &H;+SH[-M)\JZ]CIW/4*/A*'(L2Z]+5JKZ@R BKI-!L#G2?T,#=*3K;PR
M$&GA?_QE8J(J_F'(9QSJP6AHLSH<[)>@52.E.^OPL_+6#'@&'J_%)]D3QQY?
MTG(5B.&H<7OEPN&DL-,L!'"H5\T7;L\LM80P=_HB>@9U(GDY&8=\2W;E^\84
MEN.OV97G1.8]*18W%6/XT_B8#$B?K\1"B1<T8ON,\_HUAV$S(LM7#2Y;2<7^
MTG1+:DIQ[V3_CUM81-<^_/0MW]^G-G!S-B;D\0C\? -066*US9T^%7'J<P/N
M*N-&7939O@@A!+%I1Q*OV,$&#U;ACD,NZQP2]/=>:JC]XRF%<#&29*,X>; G
M4AT'&:L'KY9[O7V2#DDFO6O/OO_9&H&Y6)HXGS_9%,-9=1'UT^RD+X4=#GSG
M]RV"*^M=NPE1%Z#"=X^</-P//9OE6OX.!VGR@<(B3:9%2T(P",2A?9!(/N7P
ME^+T$$_, 7"EX/Y.Z%W.RK?:FT=B:^,:+K4K*L*1X5\'3]7YXT;Z'8/97]IZ
MMN\<Z#U8I)/-,VF0XTF1FYRH68:7K*39B#$"$DQ,!8?@.X+?UT4[9,C0/X2Q
MGSFC]_*_+0^]X^N>/K.9U<]\_#.$;OVVVZMR&9)XDO;V+-QF/0<!IV555U@S
M(@JFM8/Y25$E&@)#5*/@@L.6:X9_53&MD(RXOH22%Z%V75BF/DYZ\>>\XS@#
MQBF X^Q7AX_4'6G6 ]HPDT9>='Q':UK-9G#KMYGR7\9")^.[C@^OK;G?@W/F
ME';7D9QSV8+,2B8UMLD\K?6 E_?G;9Z1-..5O?UGQ5P!Y(AVBM8@&TE>B<XP
M=J8N8.E4\=>XRO=Q4JVIBUC\/65/I0!&Y^F\CRV$I/TW.E,C2]ZD4C;WQ=S3
M>VZ71RVF#G,!9DH0SO"NCZNL]J?04N+N2/4AJDC/77EI_T 7S#+[V$XIX!T7
MQQ97OG\)S_*'SOSF*5%N.UVJ:^L0K&B%PKDE.X<CKQ%ZXY:%RWV;3JS" S#V
M&HWB'#OHH7M 4/W"ZD3UBI])R8_H:"^D RFF:?HXBU(Y0_6P /]CSV?1-G,N
MF>4@G8VT25!O,^L2%P?SDLSL)MSE:*1SVDLHD&>^L?G0,P;CFJ$_%S1:F.__
M%/>LWD*3ZRKP!+>V1CB4'_WS;.Q![! P7V'("#3BIOJ?>W]YBK%=F[]:@#63
M73YWVN>F=4I5?9+60VS@K0FRS^S]=S)B4&+JG,/1E@.?WCOO<(\"N<[0ED,9
MI^7CD;LVC])3Z/YE'*0.[Z+N0OB!VT+:'.USGMI#Q<R.^;NR_CYL.@2]TXDS
M@^_>_?1MUX8.QKDS<'XN'5)VMJ/#>-Z7"6:;+@?C\"ZRLX<^S.6?SU&$6@P%
M3]ONVGB[%@)\D*F3-1,(Y&#<C\1_&)=+_#5UV$P$#GCSB%%S^_T67!Y:P;U*
M4OA&*H(J<0L)WE"U9(7*^U[63T8,U-<[O6LZC\X=)0K,1Y=&F'W&>Q'CA9^:
MK_4]?3$'T@\R@I,MM;Q6'U9BO"_!.OL(S[)&)&;(]P[T1MQDKQNZ6WM*:Z5)
M>F3E?#DFHO7 4SJ5@5@LIB$NZ[HV8P]M19D( IR?C9]#@P*=DH;'.\48=;[
MW\:4JGO6E ^?8J;<7@09/LD.^COJLGL]=W,YO)<$+R2KI=CZ7P)$A=8J 9DP
M?K@(N,BH^*B="Q\O%@-]V5UPZ(U>?>#OK;1 [_7.3B-]>0^IB@2'>1:S\S?!
M@GK<W^ZC%8'QP"/_TSBR8/,Y[Z;KK_'L5#C$$2*,!GB8*#KU_]QK8Y++>8BQ
MQZ*C]=RKTQ(;+0.CN[:JSM):F8[Y7-K'V_FV_R@G:>CY6#'^JM)N]95;X?!F
MD#0G['NMR-\H;6S\\@8.NJ\CC91W'(0<[)UJ[V7&_-UMBVRI*,RTK99Z42VH
M!NZIK6^,5!^4\(HA<D[JSDS;*45:Z>QE:P*(J+4O<C\UUO#'H%2]7Q-_9OYZ
MG>G\:W$^8A_8JJ^!!O&&%7>"80(Y]6.[#\T;P]FX",*G\537N0S?/0FQ_>S2
M=KZMZSE)YF'G>%5+U9274'I(7JJ8E$]&+WN/,6^XFXY/_A4(6^2^0T&CJ=I*
MP3DK:(BM!OL!0O)XF6=L9\[Q-LY9G+F4 88DZI__BN!BR"@-2TUXA_(^4&E\
M#9X<H?U#NKS%RP6XRY>^R%EI3FTPO'J)1<JGL_19]J9FS;>%5<B1M1LN!./6
MRHQC8;-ORPIYUW^)^8/$:Q?WZ#V1P=@BHS<-MB*K4 3LOL_8;N.4Y/2PB]('
M=]SP,N%XC/<R@>B AL7<Y>Q@Z>^"JK6G=G)'Z6'0[ *OW_Q2/=RP\&)[")_S
M&8]#KI^I/L[\'X;+@JT)-@RCV"(B@M*EE#0JW9\H[9@TC)B4"&.$,!BM*"&I
M2$A+Y^@-&-T-4AL,1G<,!@Q&?_Z$][J>]S[GQ'8?A_L71S=-\**(-\"X+S)1
M/5$9Z*.R5VI:WP0,FB4>C<[@'(H"[:$2?^D_8DMS@=OY <DU54W?TMFQ?OKT
MY(K1-3&>? =-8_@-XH;%>/)@#DL#2$+.)[>CXNYNV:+%K!E'CG6Y@H"_,SIM
M%@FIF_EO2X+'?U1=%W1Y#^.T$@(WI'6^QT#7;+26"S<9+M'/%ZSF6MT9./)L
M.@Y09U"F810X*R)J+_C6X$DUSJN\:R$(B0Q&"USN5NGZ#;.^=K?X&%!;\U]2
M!(-A'(JY)M.2M(EZ-[W%X*;J\Z.]T*P'),LT+[,M).>OJXR\HJ@2$]'"=^44
MN,TAF?Q8"ND%!0&\WHXUJ"N*51_F "ET/LEGS%%W=*Z()-,HW85;C;B,CE3M
ME^$G^'#Z;#4C/6+H5* -FG]>28>I$(+CVT2Z*R2&'Z]7 !>J?VZ/N(!7[3G;
M%(7Z5[PSZR.&DE7WS01;]I'#I.3"/O&).6/?67P,D YC]6H4 >-U-OW8= :Q
MQ^K;6!#5,N\!LJ>F FU 'I#WM>\#&B'R[0'<Z#U,]E&$-4\(, %N8JO1V.F!
M'6M?BKD/E+\. SRGJ%Q:K04'YKI>KXK+A?$,*T4)ZGU;UQ+<F"(UIYW.9<NO
M[MG%A"'O(L5H9@4WL-3H106_H[5:JMFZ0?5VK!LDQLK*Q4O!\OV;^#]6]<_*
MM 8KQD4/^V.4VKR"7N$!/@S!BPA'11'DH(O>#YZWMRJAS+7<2%ZFH7QQJ+<'
MZ66AL X#0U0.RKCQ/#')V-3DGP\__>LA.Z6RT;^B\VH3J("MW3#"M&'P(EK3
MN&GVH1;[0:8-2V57B0PV<\5+Q+41F&;@A";-C/MDQ8XAS?=SU?F4YFW\^Z3W
M5K^7V4HB-JD=PG135J-G\^H"GHYJQ24*8]4Q9]/9,W/D:JC8AX,_JB= *_.R
M()X:U%^8;)JTG 85S9$\QJAYT6MBF5=M0K&HNWVK=@Q45U6W*E3OI:K3V3,_
MK@<%F$X=WV]3F'3P=O3@$$2-(EGE-0^9#AZIUZ6F_MRQ#/1R?)_XR:\D_TET
M%]J"'VAG+Q+?3J%G0VLYCPGN_KHV47,1]/'I_I@[LQG%A5 Q/;TZ)24F_KC*
M%XD_/U2;-%>>V.A*=9XH*ZVI\U6MJR.61CEC>&\C<Z.B(Z?]#B^)2A/%MT**
M^><>(OM2V=Y2GM]RGZ,QHA97Q\!D>^C4^9$TZ12*CHHOQ_HPHGQC.$T;'6G;
M'S26@O&"G[**!C?Q->=:;0MVVX)RAG1:1IJ(ZGH2,-\F8-NR,TFTA*]E_OGK
M T['KV^2A8J[Y,I">9-G>7F&N7;V&R^14&2C#TQCN>&#QI#QRADR,W]N9C/*
M.V>P(#3$US[I.]/[OI>W'CN\ZQAU!4R7XK:VW-'Z'0M[E2F:6BQ]&!\+Q[+&
M!-1N7G<:9/:%^:#=0FU46E4LSX^8Y-=;.X:7'(/"S8\;!-8 /+\Q3L2Z[U<4
M";WF,Y'#0HFRT&X^=$;(\8N8L":&;RVY0\B/?D-+Q[V6?LO3?_N>?]O4RDDO
M)>QZ#C<49(6_27]VIF;BCYK[S\E6_2@#VW=%<6]O^(ZVF\-B9J[ZP]KJ)B-3
MQ'2V&Z8IBCSY0S(ZV9F-WS U\OB*PA@LZ.CEKE[DG>P1PT9$K>/$0Q:C'=1-
M"#:6$65:!@F[+I;!-+0;(EGP\ .='^_;GS(=[IJJ*@HAB957%!\_HJ70<Y(3
MXR9HJXN%+7-[O3N%Q:E0(=K@0L$X_80M]<UJNYUG_XU+UIEZD%E4@4T7B9N0
M[(@6U B?F (@?UIC1L*N#HPPQ3;@GZF/>5C(J7VQ?/&/:9/V^,ET4B)D =7<
M$'3K)*_6-7S -T/?>) %1%*CA54(I;]<B0&(7E$\JASU>ZIX],5]8;4>-2[2
M>X H_>-TXA(=BJLM_DYJIC)ORH#'L#Z=7]KU#4\TJ,(HW"E3H,4KZ./*>6W\
M,J\H6 X!VKH8/FV 5I\9TR(Z^$TYOHN]:B;RD-[58VM,+^8PFG*8]C-B5Y)_
M>*5LJ6X ;E=&VGVP>0RV:6Y 1R7(V'_9JR L49/*-,G0V_4+P_<VI3AXP^7M
MJFS<;S*F+H1R[Y5:SVF8V)Y9IF7A"S_0B$WM:JD+/7B%HX:\=B_:3#ZO@ASW
MKIB_/H)]3U%ZI]A+@ PEF HB>5DPK@G3>*64C1G8@9T<&#V".,+V@E83LHO7
M$W$^?7RQ2WJU2AZ5:H&>WZXH[I8J=](E24C6&,WQMG\+@\E*4O4OBCWHFGU4
M41[RD<6:J&/@U^=+R -\0KL30F#CDB^EOL8D3&.*J4+BF61TCH">NQ<^'#D5
M<<N)%<<I(-[3(_XYL"4<_#:T_51T1*"C9@=[G%9!-E0EAL5R5I!CU)#)$U<4
M&"!+P&& I.<L^R_&M(;>55DOA5^Z6Z=,#($?54\T5M%X4S @TN9SUL)N<;_G
MD9=L,SW<DYT7BF07?2T5[R/NO+S\=89E#?*W098WBRRM%],QTH!S$D9\_#Q/
M&)8'O+O$[SG/"0*I=:#=_SU[6G5),LADM/<U'TK@*Y$MK)6MK;<P W="9D(7
M5K_# A=]A<9<T%W,@;Y"_B-Z%E110ET'@T4M\Q<Y#59=KT7AYT*Y$]63I!1_
MI:7VXY<FZR$/L_A3'(P/E?+*7A>!34"(DI?3YK>N:9MWL!-)$MH_GP'",S ?
M,**4DKS.9E/%2O5;RTXSY$P8Y&L@RVN*G_\][WB>?6,4#:0:O $/4/])^V[(
M/08,FB_+:+O4B#UX6^M-Q##?^WIB8#3+]??/J.UHEG8CE\"T*SH^0I#%P*$M
MU=MZ F&K]HS6R%'4( ?!,SOLHG[*_@%9L(':[ST;IYRQ1WASAB/-U-%S^:D2
MT#K6OZ>8QBN*K[#\&D9H0;=4W!6%)_GYVJ:\H3PG-=EZVK#J+ "='!9KIX8*
M>Y^: =**3$AAUQOXJ"G+M[*><J),YD,A<AU.\=$_BS=!02:#O$T\X:\/!@(;
M% M_FL!U[K95UP#2J6XO;9G,/N=R8<:#KJ%P'6&(OU<4UVUR5>]:?&%E*DH=
M_?5WK6TA7Y V8"2'I.D!-(!4[-F'DL((?+XI&]RR R+[R5U$SPBVO9KOU1%?
MW/(M-$/,5Q9LSD4,8/+T451J% B7ZV]K'F[B /-SMD>#HK-]\Z[C2[S*GS#W
MJNV"_VV)_B>(+PF<V?DE07?SO]*MCKL5ZCD.6LJPZW>HQGCK2B[D=2KV+N.2
M456,..<\&23J#M.A^Z90;<@5A2HQX6M>&A (1]::A*)CGAJZ=W-J#6N(&C<T
MT^AM&L1M=N78P+N.2=.JF.[,<Z6_2V-^LM2;K6RQFD.C+U4MB<:A$C&//^Z;
M:=[#S=J6N[Y('MX;&9=X7IR'%SGG#5#ESCPL\0_LDJ;T?X;;29]U#;"J63E?
M7XZ7%4R8<!K,!%-_]RO<FEJ_HF ',A(YOOLO(#1BTI]]KXP5Z'+[BX66P/.P
M[_;2/U_R5)GU>V<)P3R_'O?@RR&/NM.?AAK6&- )1\M'3WP8/$Q[MH"HWQJ1
MG)AH_RXB\J5;9PV'OJS2JUZ1E0^@(LB*L[QKE)5!C56B3DLOS9).P4&2(LZL
M:=KMC$^F.I_>JV134@3H_"#/J0*EM[$<H'0>H_D)5H2Q.>:SB\34FVPJ]GQ"
M*P=Y2Q4Q%R9BYB%=\Y)_/5;6[KQ(4)M&6L T__ATM[":.QI4P^KI>[%U'NXS
M'(Z,>NO-\NV7AJ_0=<>C5,1"#!5^DR7(J;X9R$7EQ?0^E+RE11/&\6R,=:5J
M;(Y]=O+1R;C7&.A<XX ]#@</DNS+5.9I";P7/2&!"_>+G?B-+;2H+F[[NSG6
MO%Y27_7[KY]5P3J_%2#1*/\7U%5:/</<J!\^K#%^"06_KHGJ!E;FC9C;[FE"
M7?=T@GFBPBO3.PR\N2H,>>*C>^?7#1(52\X0#\;)LY@^J0C5$83!\Y8$V_ZR
MVN,2"+6EKW:2Z V__>?VPP'N)BDQ"+'?L]47):B$XJII@J@,Z 6 MVDMU_'4
M(UULG(O($9FR!C.26CZ(8W<C&_DU/<,XPS1%TX?[8Y]^5T#B&.E[0([2GI7"
M"8GBJEQL90D=QGD.LT)4\[UE?H:VB6[#3X*MP[R=U>1BA7*'$K@HM9(-Z3QC
MM\KTAU,ZYM]GWQIFS4DT7%G+_Y, ?E0*NJ72DFK#@X%>-AZ=-/2R/I/=,D6)
MDU_1:;AXU/_8?4;(HXNE!?X',=8G.Q2L,NRM+/O$I-8/"+9(O,>81"J4DRP$
M)'#;0TD?'COT"M9$'37->2/SMQ(NGR$M'IE!AQXQN ?2-5ME:*WIZT&TOU=?
MO-M-P*D$A_HT9I$#:"@W,3N+9E&XJ!8!ZN3(;9N1@YUWCDW4%5"]I7[B6_'9
M>@9X18]2$B)#8N/3^ 0".;F8'=X^VJ$]5:\"VMX)0'A[K0/@:.B9F61N.T]&
MYZ^6$FH3;Y:O7:6<+J9WB(9)?HR+9OR7?Q-Z>607,*\&%1L8%XN[8GK'XG\?
M7O]/L\Q8;,!1+Z=@D=7-Z%]?%NW+&W%3L?@8 .8\KRANO&[73_)3+@"UU1-X
MS-4YO!U723V(G7R-$MLY)$5<(*P^?*8&*M^&_OS5XN##;S[;D/LA48WBYL$D
M?/&FOG9^=FY#I(:Z4T97'3'\F[L8?L+ONP4R=WIC?]-]P7P-I!?N5P9^]A>W
MIU-\.VDQ*I%3@O&G9+W]'Y$6"7(_W+A3W-2">HMJ4;K[?E-6G0,3L[1J7&O/
M4>D5A?9'I2<.4!=?ERJ#4<0QH@UULR)F@1L[6YFK5[+5%\^\?R!56O8A8\G&
MIWC2T! !KW^V,G4I)<4W;IU&9PN#+D-;5P#.8)[3T,1<Q\K_T!T_3U#2W\__
M"Z3BU#=_>T,S>1 J$?5RWO&N0<_.T[:#8?J_CN(.F)<EP]EXS8+)H@8Z2NV;
M@?H[I@WT/@Q^&\ZI/DWA_;Z02WM1T6HA)8W6,XVY^(U<]&Z51!FAU&G;JAIC
MJC1*/.]3#FEH!G\Q\K(CP&\TPOY-:V@7 <9NK _@VPO8^1'-ZSQYF,_."MS+
M;7-4XF[4_K[(^J?R!E?@Z^05$_5[VNE9GPXA.E<4(HU:N;\+7NDC$):%(G.)
MVMY)2DQ(Y%ZD6 $<81LMWQ/>Z12Z^MYW0G<!P&J.3 #>!^_4?J>Z2'8_D#GD
M(('-*B>0'YN18DDYFI0O\L\/+%N,Z..P(*G<6Z12O8]L+XF8[T/)CB\F_(<'
MIJP@$$.=,7\YATI!IO"3""F;GS*"[:FGQM""ATTW]_ZX[7M79I1)VAA4H,9%
M1<X-\TPCUD7AZ"_ F40VXJ1^@[Z-A-+CO96<G]Z/*&T#>=AV[L,12ZKCL=D
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M771DIW"WP]8PZ$]BC0]^QM-HRMM.AF-VM<24_%(&T3'+.\$]^CJRG57TZ$<
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MD28+I : X\]C?<K(-Z641!ICVI4G?:*3G1?O:VEST8U<4//]S'>H<0/<?"G
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MK)0/J2;GN]SRI0V\%3)8_UMKI ?IN@_!:0'PFLK*I+8:R<GQHIQ /JM,'=I
MT_[99'(RDOEI]2B!<(YC=7QJ&I^OJ"N<,7J LQ6K&^LHFYQ]'Q2AB-Z<QV$O
MR0_[5PMR_&?#ERLW',+X[QM]8^HW<L4 PY8IUX?KJ-#4*::F<.-D2'!ZPG4W
ME]CE4_WY.G?/7( U $MX['SE9J?LPBCC0AM_BY;X\]1D=R5[@)K!BGU-E_I,
MIZ0=2*W+L'TBI<,_DY X>K0[W4M_FD\1C5UPO: +82-L4R/2V1Y]873&.$MJ
M\X0,_+R@NXF2ZV)#$@K*W_M+4A(5RI^#[[%89O#&C@TK:Q<&:'<QR64"#I8&
M,A;?G@MU^CSAI-M'FT#A47_.M+(5@DZ:9_ 2/U;.+(KX8<X)VLR"_F'6TK[#
MDQVB2PZILHIT@8-PU=V3$V;]6AR^0-4CI#C9XW^]62UE_F1,66%>Q86BZ)L"
M)AH*9N\@INDXENMFO]#:2?QC\\FL\<,_)U'RLYN:OM[RYU21&6R_W)&_3(Y+
M7&:;-X8 I-"FESU0& "SI7Z_[.X+YZ\NP1X:-_>5@<8[+J Q MEP^SSW]TNW
M;;XDF<J/[]Y*ACI8MK5E1E4@VB#L?#KQ;/HQ!O>!T_@+ND=K0*90GD_N1C/@
M<PVQAM^G/=8<_XC*Q0HR($,=$@F-G@8K?@]#:L5BI6:7*@\VO/*V$UVYC$5\
MI.Y)?7I2ZC>96_)SIGS;MH?5X([W<^'0GT3_N:P</:6R)(8N>.!>S[FCS@4=
MF<?^=9"%W)=7;%QU_A#^0F:D]R=_O;"%F2I"3=O;_+OO=^6,(>Q*LP,SZ;1-
MWWD%]][>X'T>O&BYLM7<Q %%_#ZDV(K.TSVC(/ST!5!E;O:>:R[WF(4[YP5=
MX)/)MT[3Z-QQM/XV-MI#7%68W;=N-+W?C4@1\SB.#+_C>+;INEFR_=;S^E&$
MZY -DI!WQ_ #O&G;:?$.\)$4&R.Y-=FOA#\X#,0!4&0)BL4U,);GUC1/G%"?
M-1C.J\BVKH\$[ =T-NQ<2W:?N"^'HXVQO6,^YV]Z2-JL^YKXX5G!JN(M^)S:
MK>FC0PN\3,SFVRAYW4Q-O^.\"<ADB!!]5%R!&DVQ$*YJTHJS?=]?JXUX67 S
M/(KK-B#T@BYY5QG2WL0M*^HO,-N:M=UK-+)_07=OG<VOIK"M=(K]_52EPBJD
M:><VB'Q-QR/#+7M#Q$ZL5%,@I\Q!%QC[NH0;%*/]PZJF4=K%7&>OI1U=!MZ"
MNQ[*2J0L_C77/7^22V^>Y/7F2_V/Q$N?"+BM+ZX9S'YLV<*7!M_'DC:N"^0@
MIK3G<NX2C9+Q'@< G?ENG<&, :DD.TA^5[JAM<30(B+6(X(?TKWFJ8H0ED;J
M3(M"'+V6J^A*>13XSAE74UP5Q3\Y7H_$ .1.U.\=5]I43 [5K=-1D3J('4!N
MG1/XK*2$U$,@P98:[HL?,?Q$HEF/;A';,T-"'V_G9T*^#-W^OLSBHM*IUFAC
M5L4AIU85@4DG3AR'T/Q7G;[ 0082]Y(_GUOLP]B'P6=2U[HT1FS'UFCUR@Q_
M_[+:NY*9I$?<0G*>2S4XH+Y[S\[9.4)$P/Z?%18"G%_N=9XRH@U^X]VW]FOG
MQ2/N#^6F35"D#\T3+!A^H"%R?#@EZQ7WOK]OFD8GT-)=2GOI6DIIS;=6,$AA
MF)^N##?]:S$TW06=7H7_Y'\']DB_D6GK-4)[]2?LAU(%M'+#R(&[:8<%MD:V
M<JHUI4RF+:243GFY5'GV2OJGN();AE,"^=)-!Q.H)BW%(Z!I'5:NZ4FM/KN,
M6H.+)XGAB-[SJ-<R27\[]]M<X[T&V<6X\*?\((=U,$EY.Q&./,JDG4]95.)T
M98^]^)J?_^%P+PU]/ )EW[J]-@GOC^\.1MR_4K,4^)QAGF:!$K^E]W1WP8XE
M9K@$!";7$/Q&86<O <,\C956SDH_:-R@_'F)VW$L+W_^5<77*$,0=NOW^UW>
MI%OT/LC_I'B-$Z#6GLM;,>:;S\%[Y=8"7)JBT(4/:U%-.&8]OY7MJLJ)ET[0
M7@XWB)]I[4HN5X*)_,\:_?G##@3TA/IWMQJ3L"_ A_]N"WD^M$Y4EIA")C2(
M!S'MEWU>:0,J.N5%+C?7U]3]_KI1^T]$Q["/X;<,$2&A-AUR!HIE+#4!>KG+
M>1"(6\$YH25S^65K4?HI'%M" WO=E^H,&8\4N:]KNI0&.)JGZWZ.SGWVX=$A
MUT'!HR!J'.^4IA?]&6X!\FIBO@)3'*)=]EJ,J?OG9\/&#Z>/:9F+B]G3+NP7
M=#_6M1DC<Y1\1*QI0]T[C>7,!#]5@=&%^^HARB6/[H0>:/>YIN6&0] U.0[Y
M3,''ZG+\G4S*_OU^NG.6!X.WQ@.<V\PQP5.LI.!/S5$F:M%C!#-B.E46773D
MROU4W#']L# Q.'8MFW-S)H4,V5>>9(2;<'7&A0Q[S"03^@]W-]ULWM_TG$L;
M"=$L.9;[K5\SLL[TU^E\3C6U7["5#9_P)SF0,LG/7A"0YZ46^5:L<'>-9\#/
M\0;LV#$E,\N@>LSA*_TU\*3;SN_TKA6C!;;4@UEW.:P6#3)>.^=E5M)[&&-W
M@E3[%RJP5)2E0LKW0:Y3-\4H05%)'LN<]!]4Q>ORS!IL-4Q39/U_GC^XV347
M#X0YE$+8E/1A"^Z:B-%M1X@HW6#NOV + TR1E4"RC(JPL1>\WL%:3?D=U75X
M-.+]I!QN;9$%U#O5#/:(%0M1C3E4WI16M;!TS)4"B/[7H;H\E^M_*_2%#M>!
MS0'*=$K&%_;@T+9^U\WHS9WJQ ]E!S(C4P%Z4P:UP/]Y^),[:NC@RS8#(0]Z
M>?S(4V?8ESA.0V]YL!=<'H>)!$W]VS^4_=/FER N:5:'7&+4G=0W3?2M8&0W
M"2FK23QWRS/:7K3C']4<J-W6]&+YSY-BL/+][@]U&_?#"&@_SW,O]\K=F:2_
M0[++O--WT^!><V<^?W"EMNVV>A]>>J-41.QZ-CD-.A>,MQNVX.1G)6#1H27[
ML8\0RUV+4></I@4QK8-I ._ U8P,:&@6FL^;8"=&\'V)Z1OR:_LLW-%47QR0
M9?Z9(-7X(US!XY,VZ.W1^=QT@K\V9NR=Z5X@.3RO%4?/W&G'A*N$W*P.V"_+
MZNO<F]HW-  XO!? G-*7O:V07L-NH$Z*,@\V/<9G=.=SG&&\6G67 9BXI02M
MFUVD[JU^KD>_1\LQ4[W@=+7]O_'/F2Y''Z"5OV'0T;CIN$<)+%_O<_9X5^:O
MA)N)-Q@&RK+)/<?EM'Q:9-.#6Q*\TV?_M]O_V+KHM8H>3@P'(T]/FG-7\NT!
M8(1=KT/Q8^ 7BL("+Z%<(!]&9;>5TJMZZ2F]#MI'*5</]DGMEY\][IC/NV9S
ME&$;F4M^U6G/POQBW]32CW8.GR]AZR1!1]VR/D&8#0>1C$]-/21SNV="XGGM
MBH3TDF.7$Y,]WU%&F^(]$T)82Z8"8C?W#&(5*': (4S!)N_N*L3S3ZA(\D(7
MB6TT! B'%:U!1<QJ:KTJ=;+Z;0MI>[%]&:^((:+'PQA9DU#/KYOGT,9_"> #
M>[8CG_,'R.>%WUUK2%K%<5'@*V48PQHOVUMB+6,)(QXDX(:0:0E 0R8YV:(*
MI$_;<H:%:SX"LFYPP7:D7C;@H9P\2TZ[U;WZP<U8R6P=Q@9DO<JY!5IPFS9U
M)-?1#YZK[\:$,<QJ332#+[/+.<2NAX&Y'[F&<D2WB2!T+$A@1/+2?Q=TE@][
M6\]4?>QNSW/+:7^>LMZ>F:X X[+2=Z5:F[UB]R!.:%:%AE=GO5::OGL'C0.*
M:2Y:O\Q^I60 J["&8@POFD> +9,-0O_3I KUI\3/9.N?W,_3%S_%[J&9[=KF
M<T =(0H. <G:'KR90DJURM\HP+<[C9UE AF.8#9UO_%8,-RV93S[TG77&?Q#
M&TRZK9HM8;]?R.A\<U[^PRX#J('+6B^UP,34(X@*$A,?&45%R[SNJ;:ORGYD
MO>8W"UG-Z6NT!X9K;D/ $@Y7:Y !<1R?G^\]YIPBVT7^@_V'N:"[,KX&*LH3
M;BM2Y_N\PT?'%YW&NV8'])H34]S52E9CMB;9*;0*O:R;^MTM4S:O=C4 V]+$
M5I%I:_=OL)BSTE*=]T%XC1?9TKE6SN+1ZFB&2#W$?WW_('@5^H8\8C/B"6S$
M-XKY2*\:"[8#5&\C06).SBF^NPBE%QND@^E3T>0MDZ,4%,N&Z-:(S#C2[[]=
M,PYZS,HYUS!4XF[ PNMHV^KDOAELC]/"XT-4WMS.Y]%Y_&92*4"FE/3:G$]K
M*OFN]K_W?6^74OHU;"8]&AIO(U .+J<XV$K^FJ)_^/X6$R1LDGAOTDY+RDN9
M[]>]L$B \^FK(=]&1[WH#L5V[+,CCY[1OQ48$^5NCFWTOLQ:KNBPM$B.I#UV
MO,L;Q'3[BIYR=Z(\C9B:<XFT,E=^SKES%\N?/=6$=\O@WFV_W&Z)CNR%! >*
M:J2B??.LQ;(2F@MK5*S*W@?Z1X6$!<\U"FSIQ!)N)ZAN?Q/NJWM#[Q(0IY[Q
M^C/12#>""OQ3?4?)L?A4I&8G^I-OF3W=9$"2SF=K7X<E/3Z%/0ZHPZK(K8DP
M[#DKIOK=C_T,T8K#)W5\P+7O')K"^RYL>I/UASAE&STJ(Z^YVTQ>P<39_-JZ
M\Y%*B'6>B/$+E1>3(O9:$S*QFK6>QL<$AH^>;X+C&A\<[S#NO]-@,%2JD+&[
M'==_VRJY\X@Q=X9:JW)&+@KJT+'T[P;!!1N/,PI4E-KD:F)"J+14GN5K":F=
M6H&\L2U#O@P/!N<A"6IM&5,\\=51D\YG$_9ZA.$MWY(T#X<TQUJ''BS2G"@C
MY.O%3\V"5E)2=Z/1&"_S2'-6O?#JR<JF62^\R?T2+BL^XH\U$M_V*"0./@D0
MSW'T&XI48EX>Q/B$W5.K/E4K;N&@O7-'B+J6*?.6</W"7=#1JT:7S[Y/"':7
MQ^?76']9"HET[N*]H$."R%PY)0$IQA&#U*A_@=[9O[X1+S6I1HG-50#,XY,C
MK/.R/(AVZB^G.C-+-'3)FS0)U95,PW+ ?)8^3-\\1G2_]\6E5^'7WJJ4<9VT
M,P.)FL@%H7LLK\[_H2UWU#[ZGCFDF]>?7'HY_"@D+\U[+\!%,S)3*7@);/9/
M5E[FX(C#@ONAKO;M[>.94-%_*ZG"BN.IQP<6>E1[\9/IA0W2+B4!CO-(?V&H
MM]!@[% \:U.4Y>(H.KJX^<3@>M/_^"\S1]9':K W\EJ;-5<[/]08XBQ'D*H/
MH,$[JI_FS@S^D"HF>(Z#G1*LMV0AO>TKC[;QTT[E%DG!,QY4# :4XVKNJC>6
MODY#-@:=)CTD5M_.VKH)'G3PXBHH 1>\^_TB]+UI$R2O,IU],%UK%\XAB;TN
M0TJ*H'5%8'JS8J"F8.=H(=B8C<+Y TR"KZ^*O5&R&.BF-$S78!8K[>28,GV+
M=H=)BB$QD_H A,*AC\+^+L2+O'%TC<M4FO%HLFV\<W:WUUBQ_6VK@N#ST-U7
M\;!%SC"]6<QV1V?=/#074NN+E-P__CKUO*WR\+:UZI4F;@8)1$J[G)%L2G'^
M3=GIZH*SE,FD+P7:.ZHYA;-';#<WV=H7!F*VGQAJB(#&X\T5SK3@,MT(/IH<
MS'K*(..=@>\.(Z])! 7&OKN:MM]XOI!'1&T>U),3V";81@TPGH*N!ZEW*18A
MRC12BELZD_O#EH8;?0NJP)&::D%L!69/G!*/?-+MV-T/I87(-CMF4B?E)QIJ
M_F/Q/2PIL3!;7F+L]TARF0GBA%S7GA#6!3?GG-!R[4MJD#\#.H/1,@6-W^E2
M$I,97"OF3C@UB!T&4%O9J7-!W:4V:+$62$)J#&@N7E+D:@3&%55X.(5K^]RW
MS/#1?Z)\!V@C\PUE!R9666LZP,,KAVRT6!LNZ'ZN=80L.\66Z0;?\C7SR/)N
M*N'_!?!<!4>7-R9)+_GEY.; [MB*WU:[L6KW& *0[3(:VT_3M7Q1FVB3&T!%
M/3B<=XEIT'3AIRP:60=X;9FP>JL%WA.\ A,):Z\YQ*G%>%+VSS9V46NVJAL1
M^]>J4UII].@HT6I;?[ULDBMB ):PFZPPH 2DEV\QR%74SS3Q6MI,UJ/9^C42
M88!0-,M<J9:UZ]+R[$'^RJ2T4.%1Z:%A/,N39'O%B8_RR8I;*U*VK<I%=Q_Y
MU-2NA=@&.\VS2H/+D9MB3]2<O[A?>I&;509O'$5MH*ZPB;5.3C<X).:(>+AQ
MG>" XWK/4H\=Q(*AQ_[*/?*X5' 7^1G8*G@*G>?LN)YN\B**"F:2MEMNR+#)
M7@?-65[_/G "] S:!WBVY4H1^6(GEV_,169!GGUWT$:ZK.5>QVWCJ26!?@ZX
MY)X'U#G+!UTGXR5&*7DBKT>*G*)BJP6R5E...2[HDN Z$N6BCY^DDR98S_)J
MR[B$M>NV.R/+US;U.B/?_6^113GN)\&]#N4>S,SHJK0QI6N)3AR@"OYD5 &@
MLN'*U\B !I-1Q.E>U\XYXZ_D[$R8;HGFW&HK!$AOGQ=V='V(^W:#XURCO>'H
MC\U?]O>[W<2*^$)V%[+S[-*&%<%L833Q'/J^985>&^GK7[X?./<',$>'J!6]
M5Q6)-M[>BA-SSKRIYH>^>9H0?"VO^$8.6EG?6VRYP1U[WSH<DW(R#6R9W[WU
M76^DW=3;*Z@,XC(%<'=O&-1(=XQ&N[I/-"7(A#64+4A$TR02H->QU4VQ4W98
M0.<K;KZ?^]<)#9[ 867S?YSJCF/E?-",I=A7QVGGW]'0NNHH5I[S3KS8QO[J
M#QM=X12^@J./CH2R(W3GX?VRKL(VSX"(_]P$ >W9L LZU_6>BO$5T*,U5 "\
MS'5 30FT>0+!1)L8MX+,9AMF<=CSC']>=DS#\Q4Q$I@2>OQIGJ1&Z*+5AJ;?
M<$#H0GNZY]6:MR8WGR-NVQQ$3VQ]X\/?_-UT+LN[E'H2!/2<0S^86OT<#"%:
MNCB=3:C<..B'(8$JHZ.TZ=WMRDA0PKP,DIAU0>>^YOFR3R8ITKE'*[WG)>?T
MFV]+*=\LN5B(F&#/^PG,5F#QOO9?^H\'AE=)>/)N'U]M^KY-07;*8:174&.A
M41LTX)-C;0.7I?QB<.Q G"O0T-&F,T<QM<Z)O7NU?O;\OW#8]E8;6]^H1/2I
MIN>U8INMF*3NW'^W5B3..0 %,X&*V"\;C[TE&??^E@&Y'EB.]M6\K7(4>"7O
M1EO^63-V_^/0J?D]7-572N)2E%-,/0?-8JCLKA,_NU3"G-?X^Y.T['DL0-PS
MX_@>V.[)J)NR>A&823(PR(V9?:76 W7V5S4M QWPTN3SH=F88+P8KF^D1#!=
MB^^S, &Q76^'2=8:'5'J5=_3%O[['^\JQ,J7XMA!8F%S(RLK-N7>Q;O-+RDQ
M_+& .H)^U0P<7M!)FRL>!9F:EPSLN(YLULO1LIORJ ?8"[I7C9FBB;'X23!(
M/!^UQJ5-[1C^V];>OYNY=^*NL0#(;H$^U.3AD)1O821/:IZG7?OFX@,GE6>(
M-S?%%8T:V^&6X]]FCLRN!'/AX 9V>[JGWQ(*3]7&0I3*K=?3/QQ_%F@YO!YN
M2N:ZVQ1M 98."!V^VI;(G! ?M%ROHQSL6"BLZZ>\;<G =V<32>ZW-VA*HLC^
M!#F]% [_0\-[CT4X4AX?.U5=T/'F8M@20PD1R6E(ERJ*3_SPO@K'-+N+;F$#
MEB7/G_:;E)8R#Q,!#8L7-HZDRR=#)W]-ORD^0)%&U@D6Z>O]\YDOZA$)-WJ3
M;/"V0*/*,;$TI-QCXYZZ12#LCI/-58_W:.C^9G/??*L)W$[,HKX8"R"1XK".
MK3(6]749?G#1*LE]4N UU!'3V5N\X/"F>C!,]XX^ZRK'OAIH#=KXX*8)9.L9
M7:,IH5;FH=7Z5UNK^-X[G[YIF_@ 32)*=P=OLW<!5V8Z#BMF0*DN6F:DG&8M
M([PH^VL\JMQI";GX/!E66L3L9ZCZJU&[8U(\W*D<M)[9/PKP@KJE (HZ"Q4<
M9V42SN#_TMRQJFQ-D=P?E^WKM^S<2KR[BT:>%21"A;2\(N!%-;9!6P[G@C.>
MS%%02X:_U)5OIU?>O"$6!CAV3@+P$5XSS1.;7DG/N.B]J#@Q^&"4RTA^LS52
M<JZAU[J <#/XE0_9QJ"@D!S$,>O25)UFZ?M4[O)1K'#+[/?L:SQY(@4PTU"0
MYY';X+L=NWH'&$*EI#9Q;MS!T,O.6A@=?0!1T9LT;1)2AYH>9BC'MG]>,(IR
M7R;--15#(-HCJ .11;R,F2P-6A:8+-W@V:7T0A63^O88E?3ROEW>;Z\<)+JL
MV7"79X>2_2$@A>+E;C9VS^8*=TLN/J]PS=O5.]!ONR%A W%,Z,C^<-36X8^+
M''(:=1OK&[[\-][7&"2VH+1V03>\3Z\BNH^?YW$\_GM!%X3L%LX(YGA4BH_@
MU;C?D QTGQ#O[0]W958$_!Y1MD?T^Q?)38<XZX3-J*:]6CUGF*'BQ^"R]GN4
M"SHQU_DC='OZ926Q3:,#YOM;18V)"0O\#NX,5(.JL6O<N%K/%T&WUKUR+'$E
MMO;!X%#BV5VPEJ]3X$G,YOS^ =;0S+#@J+)U^2C XQDAEZONZK,+NH :>;XS
M2')C5</V0+.HZ"UEB98#NUFX47U-W2@Z\W;Q)/L7[C3>?,:9/]1<Q1I,QH#.
M 1DZOJW[I_YR$8-KK $C9ZGO%&W#M_CE;6.SN+-I;/#$!9W<<;.&/<-1>J]Y
MFIN'XU>[ 0V-G@^2,$CSME;BX?^NB9B@<Z0TQ>#FQ[<W_*T>_?];--='@0#"
M<I)M11TF#7@8:NA,^2SR<]LEQJI)\.CMY%\;=?;U](H>@9 M ?,K^+>Y/!%.
M!I'9[[;Z:@!^UDA.#*<A:6 L&.%?BLTHH38^,K81+ IHIC#^TBP#![VJ[.&5
M[?T %$2%-&^CKX^Z"^3-Y6*YX*S/++\2W+2U!+.!5:%CBGGCTK,,/P>.,Q<O
M3UWN&=Q#/QK"L#H?!<^_JO_^Y8?1"^103="M-82<,%BN*B@0=$'W8W'!T73>
MT.#]*<;Z4<A]3_I4?U7>AB_Z3'FM3]:6[[>@HC6W%T[5]1-<+' \JS57 A<8
M#=6QH]))=VW 7$)U >_&J-T<]\]6!^3%UFR9HT+44 &A:M66I>L@:X[JFA7_
MM/-#^*OBCDGWPA'R<0CMB0E2FRQ5HD(UA.,F:)N.KO9WMJ2/>>I^<[U):%L*
M^GP74CK48%JL%H-"A1@_?#50PF,K/\U[/^G@33"-Z(-P]?.C>?DYI6M(5?L8
MD65ILIBK.(T7N1[\5]Z(!=;&^J[S!R.0F3/0L&_K*+VAIN2XT]?UM_MY%]AF
MR3AX<97B+>S$KX3=/CI!K],7:,6Q!H9YR!:]=<#R1%'FKG6SF'O!E\TH50WL
M;HG;QN8I]XYI[^BFVE!%7*?I+DN2$01V:CA/>6S;_P]I00_4W6,=&9LK?!'T
M4?$?\%:+8\G<\6\Q>=G,N-&9FN;@=:_>A]'PN*6R FS'"JPA\1-%ACL*I\S%
MAY?Q)\A8_KK?F-I?_7+9ZQLY'G\[6I6/@(!YN8MOLAN "WB,2A,2U=B63YUG
MI[AO[<_>/\H#.B)[EARP=LHMN?%*;QN:*=YN7=\7SJ] !GL_B,,5S%*1)IMB
M</?<7O?[ZP.V-8KL@X\"4HQ&M:.3@;B:0:8*+:L8:H?VO]L%3O.#5:^12_T/
M._A>/P^/]U;1=%P+HIR'EW64K$D%RGU8<5R0[X<<,5%9E7T]H!;3Q-M",XF5
M<@JGY+7M;2K4_5%RT-HL<E")'>R @/DZ7X-[T#PPRL__^K<)"9,[%5"MLDF=
MM$NX-*['%=RR 7OSG(W]7I/5#R?7#XU(+@-6=S<.4-%MU(4V6:^ S./8 6XF
MB[.9BL,OYQ3?MGGPAL,7>US$_-D!-HNR2OOZPM/Q;1S89T7BVG/6:;5;ZZ<J
M<^[6QF-BFUNL]Y^H>ELKA>Z:J$5[VD%NA7W)[&AKV&EC;!S-_C$<R!A]07?S
M6CEN+ A'^BNQ\*;WJ<J-$H_G!,6*[K?DE^D6D>=N-*FY*.R\V$NC9MQ8]?1X
M8?V3A/]5RZ(?#5BP1J/_S(IJ5Q+XT>NB0O[KZ\F!C9<.%D$SV+(H:[,+DR;^
M^^2KE(?T!YXK#BNS55S0M:J7\<H,7)I"] W]YOA\7>_T4)*VS/U0H55(#Z'I
M[XNCGO]8<W#1\QWC18BG;T#E3#0FP5;,](^[>$O0HH0-E]]-8(V/<KZ,":@0
M6QR^6F0&-'*?,0TYB?S)'4BLD_$CSM_]A#ZG+8<):]G_L"Z"K$N&B-F(WWU>
M7CZSY$%<=62K*%&HW?<[259BN.'Z7U:/BU$+ZT*-SG'JIYDR*9VA-SMWT,6N
M%35Y93/3/YZD#V.E1=AAA*[7!(9H9<>"KH7KUI ?H/<93/\89NI4OE,?4=3F
M_QM2=BD# RUJVLSQ@NH>5'23S-L;_Z.\XO'IU'_VDP,!4!>Q4+)]S^3,%B:A
MQ#R\=)[&?S2[HZ3&9.L:W<%FGETC !-68++2L>WX>\ZC!!,9/)>9&"R942]N
M<0MM80MT/;=3]0RB<@H,D'5&2 LFR?J]G:S?J1=T'T^ EW<,.T &<;\&?P)$
MJ^QG'Z7Q0(\=KT;KS?=4&"'BX'=$ [,946CBO-^:QPK@U;&URW>[-:!BS:?\
MM9U*SZH$DGG:SJ?8I#^T7;!0Z%?])?XQ+5XNJ=HSX;PD-J<=1W7($YV^^Q^_
M!'8S&NK4&3(LTVNT1/Y-Z3-]W-(%#\UA[2)[Q1,EAZW1Z,40/!N4/QQ'S#)+
M3W>?]1FBB/-D:;^*\]P<$VKI[K?/HC2QC=ZA(3;S,R4=^;:G@:QE9)S,-+@$
M?,U:9/Y%9O_US:FQ,\COG6H2Q\X%75OO#=^SP#=C[F:!SP8%_E@??4*KL9&-
MD(9I/D+="'?0'BQ)*YU'LG#=W(")=$%':-)FW1XT&Y/A9IF=!/MH5;'801SD
MGO)Q#J[8$CXMB##<L9>(;K!,MK7O$FJNK4N0*Z(N)*EOV>F76&$_5EN)W>FA
M-1[-![ +5_BSHE]M"\:'"),XW.75\I"&+HLV-G:H2V@UX11BYGS_[UQ2>.%"
MOT!U30($U9S?I5=J'EK%?%)SL#="Q#IB4SJY[JH'<FX6QO ?7]/]./,[C&')
MAH1<.,![>CS4@6:Z"P@DWFY5(PIQU"@!X^0B0C1PJ1768*RDUBYG<@2_5V[=
M/BI+GXMCNU!J@AP4L3LS+3Y!7SQ=DA<4?U=7G\%$1EA.1 )3.3*;'E4[;2.H
MG9R(!O"68?I:_/B:3@"K$KPURQ^"\D#[.6*@M8>F=0P\E5=)AO(TXD/'GP%A
MQC_<]QM-YG6MS^RS_IQ"&I,TB$AI8\@=0OQPHN0I&S5-"/X^,PQL;.R5 E9-
MD%+=[>8R6>-;,E2NFZ^-$_D9^M0RSHHO@ E0M11C6[M%L64J0P24[$\P>OIN
M&UXU4:_GUFL?458H?<_$C'WX2EQ<AN4T$KKD</THA@*\Y6,"*,AX&-?:$Y]_
M4X"4%]AV%-'UO[,C6^@PM7263Z6LQ1-?YJ? CRZ;-L6[->1J)K(J;:@%F.AO
MDX[=<W4P[K*!C]YU</RKH 7A^[7UQZ0'HY^%O;?2]WB2<06WX&?(DJ^E6R<M
M_#V6\8E!J@O,Y"2.=&^T?(0Q\)$G>;31/QU+M!AZ;D7WYU_M3,>'4.:Z1$NS
M=[ZHXZ6:+( PB^=4N&6G@?A:;HZ>V3H*] T0F+'_8W%'*X$O,]ZX]^Q;"GO4
MN#K-'S$]L[8C%D_-:\HUZUM$7<)BO'%W$> "5Q/-8%F3E>?%UX^2+B$JQN8K
MQ\1]IUJO=M2_\?CU*WL6X]&S]:H<LS5;UQ(-UTL4^!"[BO2'*4YA]0M@6[SX
M^)JJ=E7CMO_^HKS7IHPEYJ:(W]ZU0/3A'%V)[33S?BF+V$DK> /[-1V3L%BD
MOB)HS=#O'GO"B]3(:'-.<KYICA!&=9+&^%U37M-ZUG-F%W8F=IB=$!UY:D4_
M]W!FLO=12*KUMQ]TE(.R2K+4.MLO5,%]3#+C+H%IX3*15,1UVQB\,O6:[(T(
M^KHB[&H=J(9).1?6U](5:U*'LAQG)H%U1Q<QS4RG\0@. %LL1I,B-F&%ED8C
MS_?L6CL5\L5M?!?9.MDX&[=BS'C*/]]S?GQB3H8QS7E^;2O6HEEU_7CJF?ED
M:\VB,XXSDG(T"M59?% TSN^WSF!#^!#16!J?D9=!TA)YGB^JW)B*"8+B#I2[
MK*-H*_:YRZ3==U?WV,HCGG+K61"5[3V%]=T#\N>X183WK/TM_.U8T\1E AP;
M,,J!PQP_U4 E;HZX[%Z(,,4QIY!:3$US%.0TGM$<+@.TWI2WDA PKQE#-KA[
MXSQCW,UE= -BSQD7@^^)2)AL8[^<"@5MQX'%WP[V\M=*?#NRB#R+;$QK:1Y%
M"=BJ.]WBB?1)50EC6Q<;J%;F]8+ UR_HG)I.#"=Y$U<IF9I=,RVEYHQ! \)B
MFF*T671&_K)%V8$0O[9FL/26TS(._7=ORO/>]*1.;^##LKLC0E="H?F>"YK6
M7TRV0GX'AO?'<W@8S*>3[7%5==^4-0L[B2;_+5>O8;X<,/+1NC[+.)LU5&49
MW/]48^W;[;-EE\A[]991'%3NE!%#GG6L<!06L<N"X/!W&G= +64 B<A_,%5B
MWS4^L=HS$5Q=IBU0O1+ODK3!O)N3K!6P=QTEDK6]G/+OI+>LK)]KD[I.-OB$
M2F?_LEWI3K$R.DI<L,<38!IA$H&MGUH[5:[ZC)7GJX))7C64F9KZJA_-Y423
MHCH..;\J(AQ7 /]?2H<5OVS6;:S)2"*)5D9,NG*JM2;-D<?9@9^5^DW^>6(2
M!:>_J#5F#J:\BMTRRI3)>R;[;.Y89O9(DH7:530C'./>15/>]-:[H//#04S;
M-(4<5H(+B6F$P3[ST HV5[B5C^D)R&J*B U[@D-$Y2YH8<:@Q28PS7=/ECI5
M#5H;IMIEU[R@/!NWF']>:D28$40]RC=]L:G(:5X_^D M+#4@W4KN<Q ,,E""
MA$^3_]1VY:;Z&1IJEV*_Q?PKBSAQIT8&Z(-(KTB@%7:G<R9& PF6@.BV*@"B
M+8#E18=:T*=!LN%VA,!6!RD(-F4&'C^YU4(03S^T;J@SK!>%1W+TJTMW;( '
M'\KW"!6EA#9O=[V\H+LMUSZ[MW?][ C4A3_5+B6/N!C73JOAPEW/-2I+=IY9
M_>>1=K=PLLH%H"S.E5V7?R4O?_Q(^++7W 7=/?6;N\OZ)ANS)'N]D>W-W^*G
M_)Z(ATQD;[WX$'S.W"N\&)0%O5&]AG+C7JJ=;!9!YR..L"V3>5$8;HJ*I!#?
M[UH!\_>=(>5[U;2WI6;'_^#NB3(F"<J.$9.'Y<12"\C8:KD885/N,R3L>V[M
MFG[@W%09C \$JCV1SQJ0M\^6JRB?O1- 9=?YV_!%;]&1#VB;OQXV=0A8JNQZ
M0-^GN\"5:IHZJB=1&B93L6I.!?N8Z_7:&LBU3TK+$43*(;CPEQ^ /;&,2>F7
M";4OG:"/;OO%KMUWXPN//3",E50/=,T0J>&]13%2E&N4:O5+OSX';\](3[:)
M^>^&LXVPFCN";/Y]7J@TMJBAOW!D8O_0G3BV)V*1>^F6N5\JTJG:=+7<&\>0
M #TJJAF-T"T1YM"^4Y*2.^%Z )!5HT_B" BRGI(&V-GJC:'3#DT,96 JY-@Q
M9=G<>]NQ]FM-3@-5OL^?3M5W:R@\]D,ES0E&AYPY:C4V_2CR;8QUFAGLX[@7
MIMB;FZ-O%I%)68/EI4<]>G9D S4L-_405NN%S^9E+,.L-!^9Y1XOY'%) ]@M
MQTZ%E?5&NQ"=1 W=M_^T\T26'<>][)SF&[5;SKEWF/)^@;_"J9G?KB7\5(K:
M&TI6W+/#[\09Q=)S&XYZH!YC,7A!V4,)88]V&P_>?12OT>@^O:#U")3A[NHW
MP_?%;]*-N<P[GZEQ!^U G*&_CP8L.R8$UP0AZZ1!>$-BT/@MR^]-?ENCMKCW
MDKTMH,!M?'YFJU+S SVRI$U/G57=@-1:HHB_X78]F.T;_NV#"1L;G9 9<8&S
MOO[$VOTRLFS5SR,[0N_KT?/1H+Y7SZ7>=;$J)\-*Q5Q>[CQ8(Y0X!A#SG1_4
MB>WE;T7MH[]98NT:&W_%NPB6!4WMZR-R^S;A=T%Z#X!@OA/6Y"-7VHEA8\-Y
M_WW77EZ6$=XOK53&+KNC3VYN%+YGG3)&':\X4\-/S=>XA&M/[I8Y?*!59P8'
MRG^]-C=8BWZP<_7;.0GV=G)>EU)4>]MO7NH[LUHP-Q*VJ6F7KF( S3P$2HOG
MEIG-TV2(V^L! =-7GP(1)I)>A$GHJ.:BU0Y\TLY:VS_L#>%0JM@*4'O,/5DV
MF\"N63,J)L8??,U\KXG(I"[(#4V"6S3O[+-YP,4B(_M :?&B=Z1PBUPJ(M?;
MN9XW[##FM.N#;VO$*G?IG*\T@G4)Q1G5:<D& Q1K3%K3HA>^A9B2H""B*3ME
M&'RLVO4R4":Z@X'A^\)[WS-3/9,7JU5)QELV,N@(Z.T?C/S)2K!UJ]?1K(QE
MV^UPQ)<IXUHCZN\G#U!27UVQ29IC=H]/7GO+5]3:4N'6'W/3R.K#9A+R=L#_
M@?4'BE6?/C8 Y'TH!SPU.:_F3_ICK'N_*T9Z6.YT1V*/;61(^2JLR$:U*FBX
M%^P,;_:;KNAB03V8)%B7?/S(%++"BX18SY)!G-,^FE#9U8&0.I94-:, %%0Q
MA+BDY/7(2\K$;*5@E6A /-.R?KXCD?!+3FWW\,-EE]$+.KPM_?YMU-%9]7'@
MYRZFG>+5%TC/NZB\!9@KX?P)8Q36_3'8P49XX"?T4H6H>%/OCOBNA5V&($_V
MPGO[^N=M8^;/E1.L6I7\B*>)72;;]#BKSOI+RME":-F=:^%>OV:EF6^8)483
M&D>L%\IMILIR8FL[O+E9!*JS-F)NF$J#8UC\43X$9;0.'BU-_W;6=)3_N<U4
MS:*#7>3U<$J3P+0 TK$8GK T[%QGG=+V;%TS,'P;X!]D4S-IV!I<M]G07M_T
M%9X=.]YR/=LDM>[M!NI,=F]?OL)L*E7P)@B(+5U/$'-L&[9=O;\:RMR0N$PV
MY+,#11T7J9'L7>>OEK5)O53VY/CRH4?]'P$*/\"GS<],3NLR_E'88_PBN(/J
MY([-'#/F89$^%#DUI!,-+:II>)>A&M_SJ((EN#/3U-#6-F^I!!^BO*T\*LKU
MQ%UO0IK(P-EN\&'GWP> MV)S%)23;1Y@K]N09%83ZWU!!ZYQ.W[%);5E)M/,
M[IJYZ" NH!]PTN4J*P)[0;:B27Q!5]]&RW::+LG1_K*G>FV*L($13\<RI(/
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M+80+)DW:&9)&5\HBXUB0+HW+* 4AD.RN2;91WX0V1G:JK_ CB#YAX52VR*V
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M+L"4YCC4QQ&'8\23E8=J0;$0QOGW(67KQK4+T;6I48>V0>.(>-2@AY0[6"E
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M&K,;W*"0!V7HK"K2'G09V+JE,97,T652UN;515_LRFYP[RBT?>UM/%SQ<DC
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MUV6.!5HY_-D7W_-,$2C3%*"*4OT% \)<L?$S111,JT/W!DZ3@VU[\ZXUV"#
M#47W8M:[2CQVZM6*S9XO!<2O:[G4P"!DOSYTBQA!<<<F1(Z__W!<LV:D,JC)
M-E+22]>*.!M*<.)R4O@%@NRH-&>1@Y5_%XXQT2D>FSP^+TA-A%4H.WM3#RR8
MAQ5Z;H!O47F4L3:Y$*6!$WLE]L"AFXO%6*MOA=HBR">Q3^>%(!7M,S.?(VI2
MJP[QP_E[\F5->LZ"=85)07Q8* *BD,M,!F/CI1%J!E]XT+AI0C6*';[63$.]
M5\$T)97X9+X9<_ +LDU1C#CC?5/XH;+JAK)]QI([D\0L;8JGNL=Q+0%[_J=]
M^P'(M?ZS/M9,YP0"WZ*;7E.A"Y8K 0/MXS^SJ <ZB4W[;?2OFYQ9,65"H*+*
M*AQ?2(\%;ET  N0W0?"P]3VES* >%/QKI<+'VC/3/E?"!<#)22*V2U^*8J-W
MXXGEKSZ][A8"]&P-FA3MIM,!W#!X,/[<OVB*78QA97O=R3B\P?",4GOD-7N$
M/+L' \^R+]2UXMUC<771_E</#@<#.3P'@C7L#IB=%UV^7M?OF)Y G1G,Q5#H
M&8:+5E+][//NZ0^RJ/K P!42;;CNWSH;=,!-+;_6OUP@ =,VPH%TFC3038B4
M1J5YOYE Y3G*0Z[3OCBQ^DF%%/5M$>\=\/\A6GUW]6=F(R3.J8"M_AG$1(^[
M"/UE(QH.:,;BA@RG%'#[>FY1P/"+!LQHV*/\+_JWGG:9)^@KFIDA9.(+9N/$
M)[0R22X^RD8^7 _.ZAD7M:YH^C[B9X09U>@%G^4N^O8UZZ! UP*6,^$+5"?T
MH&QM&>CY+#>-*].*G;^[7J>HZOOS^*>$#S(7 $97X#O\>&7^CXY^[X# 3"PB
M<!XZ]$^6=T6J\*]/K:Z*80[%$T"H%>PDI<Q9T705_'JK0T#;7>3!9Y_X^G5;
M-?/K6Z9E]>UR&$<"9F0<7)QY%H\D:\LK-*HVAUP CJ[!=#5?2</T3SNH'$$B
MSMA&-=8TFB2%3>MKT]$0>N9>N$=9E/3*8RY['?.["MSM8^-'6OI$-_='8^LR
M:6/"BXZ[./^?GT-*$,Y'[<++BH497)G72PY(=BWRV<^C6ELSY@):RV<Y[C=5
M(7@G%J!\&2$9UM.K>R7L^G(@CT;Y:4ZPG]>RK-"<B*K86H=]KF/\N/Y\9@,-
MKJG#\J@$)A++!#4=FZQ^85*8]DV,24F <5FQ8<PCY 9PI=IZ'&PL&:G/O!06
M3VK6"#2QN7KW.\C*'%.=QKU*6NQ>L'5*P665"N@(::[M':,@1<,,'K2L?5*I
M9>M5S56HUC+_KD=+U('MQ]PR'OF#HS%#1(ZWIP1,1 Y,7:\Q4Z\_AJ5I/)+*
M6-:DEB^:/-/\:M6HN]+95;F-@_\V+^<=%<$+0+B,[HVZW+H5M)NSJ'Z7F0(#
MO;K-H(Z_"P9,HM*?75'FX],137FZ6[I/&E$ZX*DER @\M+R65177]X,QKFK0
MIW05?+6ZQ[WJANEM):(+K-3U=5[*XU@[P.._E]ZH1:ZY5\[% &M/E0GQ;$)?
M;2SBJ2C$#2,(D@6#1R'SH:[[R]%(6T8-P:3"W()&W;-X)ZL1E/Q>I++,]2RW
M=/ILJ4.?E8R%.'19?N7GSA\3/<_2[V[]D5G+>5#=N'V5V5O7#]\6*##NV;%H
MX(I !#"U3Y!G:?L)V3\[[53HH%+9'!S9@KO:92+Y"WYI3IAA.Y,R?"&2.^ID
M]0+0W]#_JXS4,1M#VX]*59&RK!7OM-Y!X'W,W)#_(>=3*2^2QJ_FSP5#PU7-
M7_M5)0.W]K].<'TNGDP%9SJ/F\1+)(.6PNSN_RE.*W-4RK0_GT2,%@5ZN=BD
M) 45UAV?_-EU?OXF3*@UU&G!<=2VQ">R]HB]?.)! TA;'3G(2C<$:R@)".^C
MS0Q84[:[%+Z@V>,Q^K9ZO9Y83FH3^6W_:1.JE>.#JT]@;^,K*9@D69>FXR.W
M)+77K;>3#1K6B1WXRG\D_X&PO"WRGFB\U9)W$(1,9U^,=CBM$2LM7FV1&(7$
ML+B)H@/?G \V@QNWYIP)J79:1PG0\.M*B2P.<UR9$<]-SQQFA@$NT*2.DBF]
MR]B;#Q1$4E16RY^;9602!_>6O84_E [_(<1X;W(:FS6/M7(-[."F9:%91/,9
M^CNK1*Z'> CS1T0ESL$1&WSMC=#WEJVNA!GN6RY4?HL[Q1D?^<9#@ZL3SV<L
MHG-XMXV5;MI;_)E7I^D+W:H(&[7;!@6ZY2&TS3HUNK("C:UZ0W3/!NG974]B
MR;+UN+TD@MFN*ASR,U>M^V@L;VO8 HVVJ@B<<NJ:034,NA;'J&**2;"J*<29
M5@G@1RU=A>*_5D;EDT73+:Q6+R'$1'[2LW/X[&]JV#@>GT@)7REA@8$J=!1E
MIH<'I<(-&&R .B<&<6_E#FHXBRTU[<.@995J#$=N=2Y&BX/4L>+)W:N4X;.K
MI_^6? (D4P4HWW=-2HSLL*F_1:CPFMF\;#T-*O2_VRO:_\H)U&9//:!W?7R\
MET96_!U@5O[&JM%[+R0[_><:?$/N?/>YF6&JYI5)\_>J3\#?N)>!3M3+]-ME
MCX\^0_S(^J@BBTE+S$EG." NP4Y'/#8[?W]/%N(E ,+;'C&?78FF:$"@F^%K
M?#@XIDE"(G4P8=/M53_I'%;QE5-(0>/7>.8(@FUD,6$8Z_3NKU(]?^KNZU'+
M%[JTTL+=7_YZTA"J MP#KQ=X>?A#4^D]6+V?S,%/']>;^$5K),D*KGH7^LDL
M3_AE7@!H>0Q>S4?YGMO@Q!D6ND;K.3\>'E;E>("?XS"M19F$?E3\;=V3NFS=
M"<GI_B$R3*]9J%.Q >\4P(N))TP\PV'/=PIWHZ>VKQ?8P1BFG?5\9 I?*?='
M*#SMQC4MG/',GDLKJI1L=/>1^(Q8#(N/TJRW)AFL?ME3K6!'$X_[P 7WPMNG
MQ@HV!E62YO4L?6QA'B&V('T=W[*ROBK6-O3!"%4I6V]P;'["1MACZ5F(8Z*!
M,&Q5[=HJ=%Y5=>M,#OHUS4N[W(I'2V#-P3 7X4@*P.OG_-9T&Y"C.7>2YTYQ
M/E*D=E%FN2/0:/93(Y+SX:XYXR#'R[49_9-U>)1H=X$NK7KJ1@;PP):8=T#W
MP-"Z)' 7ONZ1>U2H&7 !>#U'/3,?W-^+6/>X $@FG+=< -9O';?\=TM"0P'@
M]_.M:MVER4CZF.!K-^MLY8QQWXY[QW)4_W!2TI_=B_7AT7BX&B_>L54^X5X2
M6&B#(&<J/9?<<Y A=,\.WN^\6\DE5'.J/ 6DCOGPY'I9!=5.C>=XFWHB=KHS
MZ*;UQLZP!=D8$+:H5NSJ*R$B&22E3A"&L'-J5$%HO[5/6J;\C(,WY^S_6DD\
M4TRP0"6B5#12[&D87CX[<TV(7&K&G9D+$^WNO?(']BA*P\J=]'78=)$&H]_,
MXZRM?5U'@BIL?U.:_'W>E3Y?ZOKXI'M !1RV16Z1=M-&>, #BZ:RD[L";]%O
M7Z*8[NL%;FK>7+<PDO!9U9XMEO3RUX(!#2MH;JX--1V):\R18!+33'+\0^%O
M?+XE/*YS4QV9S>72&?G(X<7]$.JF+P6Z5G?BD!LAX@LR6^ZN(ELA$^6VV@N]
MDB<2;EO0W[)1J4++-I4L--@V\M?+H"R>L(OD7 #F P-#^(R1@W(N&D 5,;+N
MZ.I"+;4?$\ZI<+!^VD=#9VT0'_=M6P.U-V$9,!O&^C@A]L>F3>F'#[.?10N^
M:7,-'@\&NN>5%A=5@E\%MW/154=V.>>78J C6.WU($IQZGK#5$SN$U8UBD_.
M=J-6Y3*;4^3X53EFX=\U=_J:A2*JECJ_E)]);*UVZHKG@,8YZ3R[KR"47W[
M+;A.@,>JBA5\;+I3/F3JCJ@ &$H$=7+?.+<Y KP'P'DX94E>#'6$: \645#@
MC54./4\DHQ@,+EDGWAX.<B_O^%":E8NP+\,T5A=N>\6X2GAC'+PRYDLZ6ICQ
M>U,*3>GN^,$FR.G 5,->I8A0)[8JP6=I?*J6BR) +MF2P9V]P(03C7"+<2TC
M)4WO\I.I4!$?Z/EB)BPXR?F@U2'LX>V<$D**91^CB=%Q^ML9?31[ALX9L7D(
MBPOR8$H6C8&>F#5@J"JTW((^D_'M%9:T_081Y$?,G]0]T[P*5P>>V\ 1GML]
M6Z^3VG_Q:MZN5+IGTY@/FC@J>)XT2W$]KO[FL=N=+O>*4OY9:W  8^L_Z3DG
MT,1K#&RGC%F2B6LG@5F'GW+D$1N%7P!(KGNR2WQ83J=GO_?]XMT426L_*I_I
MY6Q.$MEI5ZETC:DDH^K4NXBV1,\;ZX-0IH3 0LK!3U3WUW"U]/M'<3ZS#D8^
M)X.6(/)DJU__R>A^B66Y]5::)'ZH'U'I[1<G]VE?K'9RD:+=>,P7-63ZG/IH
M)9HPTJ2&# BRD7(VZI!-EY^Z6MMW'\J-L JS(J\^[CK Z<8H\-Y@$=79C3T7
M4'9R$@YY4H-?N"TL/*IUT_CS.Y!DK$IT<LPZ$BXVQN6[JE;U]$UPE<X&I41/
M*16RKF0]AK@RZ#\/9!)D->BQ^LW6@=JZ7ICF]^_)X@I]A!J2WMP $ /+2#&V
MM./C3/3V[ .OI$82H+T-^ ]+XFEA'>QO)6Y#S3D<43X)DR><WGE1KGU(JNX%
MX*I3U-IFW92?GJ:XJ,@&H\4W_?5OG-NF:U4>D-Z7;+YT/#F*GFIL":"6A+9#
M[FV>)G#C^X)@(X[0=9NVHOLTX8^R7-#HNY-6POD./(^B.,&AX@.E[Y9A[_@K
M4&C_D/P"+=:(^?9&%>FTI VL5/36X>?\FFW[?]6]SE5>MIA"^AJGI<RUGS#7
M2L>R_PZQ,I-#F#NW_^S5<X#4W*XJ>J#[X.1#ZM(;M$0Z03TBH)?*#5Q0?1*0
MVR,+1,5-56)!C2+-U*S.FY?<_P:91_TW)#B[_:"Y9B$LV0ST9.H"$+WZR^RG
MHF1 AD%&_B9!)4U/D:,XRW ]1NLA[YW  HN6J#TYT^YOV>?@5"+RR59KE 1;
MS<34TXP''AM<*09FVP[-Y)R1#JYQ]F/B:)^H9#7I!4*QK@$W[<&CWN8O=%Y2
MZLI -TOKIW'5D[UZT/O@@)FYECTJ/</\_:_3)1E</1?W%H?LO=W 2DRV! _=
M':40:1+82==78F\3:/ RW^L=/-"HR#UN'"IVQ,>YEO:#PH1),V[L9<]/9YG_
M?/V?+S@?<G%M%^=661WK%:^.\"=*8EA_#L$5>UI^6,68DY_SFI#O?SG*P'E<
M!]^72V23/L#<]CF -<TM@P6]DLM8NF<(E(6B7#V=7SH/S ELI)U57^BDV(,?
MW0>1Q8G) YT?V*.GMN2B%D=0M$&TZ;,@)K?VV9O,2MZ*T;L5'I?!!V9=IWJC
M(J*/IE"W=%/MEE4HW&]4'];Z*:9DC[*L@FXP#EO1K"\KFJ)V=S?G1Q#"H%L)
MDTDJM29CTGIP]<SG6^3FA<$2O44-M\9^9AZ%IU9[50:FHZ+*6@Z^V,=Z,]RU
MN:([HPV/[3=^$A./\630]SH&E3:/+UK9XTCU;>/5@VE:Q)WB=MVH)[=V!8Z_
MP+TJGCH$V"8X9I]E4DIRAZ:$O4T1D1U#TE\;&NK,IP*/D8V+WB>Y41J(C&4J
M>]*K#P5JRHT-Z8THQY4)E8-J'I:PFKE-"=XQ6N?86EYGA??7@EHCI",K?3-!
MHET2!^G_N63%PRI:C+PGUXHT'Z04'.X[79D)4IJF!T=BGE-[H<7DMTL+IN[[
MRUQ<OZ4I,/53T54#/H*<R/V<%8H5E!SQP+.[9%7\FM/*0\:XRN?78OT.%..(
MJ=-^A'6#^4J88%KK'=WQ/84*_A=(PN.JC+JD,^Y^9"*J-,";9/JE(\_UU5I#
M7X_?EE!:PTA^3>.GU9.WC^.V!1,3,<UV4Q2//)L;^X#W:4=6\@STAB80 P:#
M2E)S2[:;3&<-W<=[/KU5KM*KN.3%-#DW&5LOHH)1A2X<@ACJ.1HXXC=*(OHZ
M&6"Y(-5_ 24GA)=DWI9M]P;&G&P'>1?VH-=WUV\I[IJN;3;)V-U6-(AUF\>V
M8O[39G@Z/'S>M5>9-WON1[!%N42G2FA> %2PEW;Y2Q9 ;G@(,(6Z075*T2D6
M#7 '>C76ZNAMCI-\,-C1-5'4DP86(28F'BIN"VYH@K)E 9%61Z;U35BVF#GL
M396B1"!@F;$S >8)6KZ5M83IN,8O*D*)(I#RHUH]/.2E>!$I]OMJP5ET=*).
MC<=LD-J.;,>L^ 7 [, COS9F6@,QLI'QH"R$9]3(H*;-LZF+WGAR-"/)ZKDX
MTS=+[O ON[^\)NCPJW+,4<X4MC\*H?W#;YJW@9\4-FP%IQ%@HZ+"8\-4YJL+
MFJIDO:KHDR<C@2N3/PG!UPI70QZBWRYJ)ADNUMYI&4N>%;O33L3U^M-DV)WW
M,2@^70$MC((!-1@%9H;7"GM<Q;40WNRJ*IZ&6SV5(5XOWRX8Z)'.Z5]D,RN;
MUQ,245B$_YX\+9BF?BNGHD#V^)9XTN#-GN?3EYMI9O(MM0I_OK_%VF7Y!S:Q
M5/>UJ\5#71@:[%4GJ3^EZBY8Z9?6PO9?H=QEF+ "K<^]H<FL76-!-[R>&*6A
MV^">?HYH$;/(&A%I>NP<)%H-*R:?I^GIR7AT1M %Y I$D)LJNI'%+IC9[L[4
M%EA3JS T+%C:;H6,%;L5D*95BT,Z8D>[<]D6GPQ/(Q6.LF<S11P>18]N.BPD
M%-EI-J?56G5K3MM@U@\Y4[;J*./](7'.(UE4 'Z?92CO._C]KLY_BZN6:?W.
MW=]IRBJG7+<"/AT\J-5+-7-^'';GRL<SB_VRLX=TA^&0.&7[LY9 Z[D2:.C+
M=@O1D:3)6Q-NWE6FX*QOSGJ$I I1=[T6L/^BUO746KDAB?CBO*:1@8??+.Y%
MCX\*+Z(C/U EDJ.+7.$!/-D'%=D-*A7R"@*BYH[0:.6A7[:TE)O?P:\P5U%Q
MPQM5LSR/OHX9,"Z7/-^^2OCY7D -1G\:UT=-L3*/$MF_R1/5&1W7<86 -> 0
M&/-UX^ET2>38IOW ;=$EE%_@@W7A:X0-_*V@B?C5=0%P73E!M!I+M65HM%14
MOCKL/N<B\*5'./)\KPHGN\&[PF*\1=9&UZ/E-7'12O9F_AVPI-7# Y_=!V@C
M#G@=#6/%%JGSWA]8@5X*^I7V1#?*GO3&;/5IEXR$\9+Y@LZT4@83]3)QO9K7
M'.]N\\Q%N_QP A-3]TP[AY7'AO7ULWES_</=VB^8OJ8=74CENI,Q&HU;VLWF
M%2Z$K+H^F$<[O=S:<PWV-)A_Z]*Z%7>T>"Z\\9C:.1HU:\(>UHUG+/M[ ;@U
M#@Q^-B+Z=NPVT@4QP:.!*=LEU&]>?X8_^F%;1N+*HL.?,U4=B9FG;L[QQ? R
M2#X/G*6U9%7Q\2QNY(GZ*F"5(CMM$CB29R8?<4O*54!$CH*!)6!+\Z-G5$(7
M+P 3TU0'[E/8OP_C+@SVZ-3J C!0< 'P:#U]T>+Q_7*ZOLB*WI#S)?5[FG,4
M;0W 4X6_1*N"(_2]X@N 0T 2:1VMOJ%] 1#A.;C><*]WME*D:;/].0^WO8QA
M<LSO+I0@Q,[E M#!"<_<HE!A^[:G&YBZ4X-+*T#@T4<$LFE,;3DUC4;5Q^^#
M/^/BR/AD92D>J+=0<7GZT0JYF1Y8$[]ZJBN7?!Y.7+-Q*$N!)FP07S_ALM0Q
M,]M9#63),(PMH <+*4U;+6.#A[R=12&#FF *2FG1K2WHX1[CA//)^J_X++3B
M?G7SC^<=B6G/UPVB+P!:3:AX]B"[2S<8>]4"3H@&Q2*?7/B8PUYY=; -*8_N
M9X\BRW?V_^PYO$A]G!1;X(#'2C61P%/WN3@)#+B;\J_$V _CUH1"W80,\3++
M<T2W39&"!K?(+2[[08^ !'V#VMK"%RH13]N\$HK,1I5?_#X2%7E_W2G'[D \
M676.]8I2=Q&DR\*OJJ 1_I2TT0CW6B+&\T7'R??G2.)!^!7D<48(_X@#/IC'
MK5"]^'4[,UF4EY74TO"DN7K+D@E]X'>2D]\A54=IN+^B.Y/+!39TO?N'/,6>
M:16^,^6HA#W-2+;9RA[*G&UX7*\OJA;(0J/ R)!<6M23Z055W<:8D"G]>8-A
M>8HR(171<$9RW.DTT2YG3(;VW.^O+K3;];PG;>/[WN4RF8)+/<AG">WU87<5
M5*I-//:8,2\L):Q%,!6J\1*QCPL8[35F&NRVZ2,VE$7@CQ%]N9+M+@93W5OT
M"*\T)KPE2-L-PJXAK8<:B7A(^-P6Q%Y8'[:>Q'RGT.]Q8\+=HS='&+T?1&F7
M L6X3MV#&%EY1X]-1[3V:'QFP5#VJ[>4H*'?N?]"WTMU8IUII3.8U6TPY/\G
M_U-RPUX"[=^K#MO-H1K-Z**9"P"] +8QB2]5-RKPA7$!_Y+U01-R!GY3?:9;
M_7J%5+K8BPL  S=62F_KDJ([AG.9^RD[KVHD=$RCW%L7:9S3K##G/.1RVNK@
MCS$GG]-BM2*5#>7%?#Y@V^T_8=3]:% @-'8+$EZ*D6-2S"X:5TB2N?I0E3Q&
MR>!*='#Q=$3%L;$F#R3$WR@'=H?7(>])Y"S^X7D&+>UR+1N2*"^PM4"<9C_8
MVA,R-G4FR]DZD#;W%%8JUQ?QA:/!(GXXWDGEP.-9&=MN8%3U5E4N!\D^Z^F=
M\[8JG\[W:M<"Y_3N:WEN<+%>"2Y951I=7,1WGH1D5MCV1MZ.QC1M.>YQI;2>
MRDH6'*3I*-DBT"CTOE,Z,$['M*ROJCHV!P$."E'5 -LR]GK=UI::UZ*8[8L]
M*/P-*&%A[#IJZBT)2').[:W,I[#=S^[_LUA;=X3<SYROP1>XE"3GQW<0FL;\
M<6200<'!%\^#-'RKNL[)#DS'HW9"$S_XJ#T_-MEFL\3&E@($A6?/5/SA'0WI
M2\5^;B8*7+ZCW8WP(5_:^L!%A]\(-G]R)D=$7P :@X*=WE&7#Y%:^"8%,"2(
M.3I8@L-/#A-)UZ/"<G@52AQ<8EGC-?]16K5/++3'2K'IH!_G5^A-"/7/&L!?
M>N<R!#]'NF .,GAMN#&-I^^[;RLFB?&&[EY:B9X/-LA;X>(:;1ECDA%Y]YM)
M??<Q!YRY&4K->P?WAU18OVH? 3Z)'^@?ZJ+R&4XT86EU.160;L!Y5X9'2E56
M%1G#$><)O X&OMEGY%P1M4(01!'O6[R6@J;LKGD9!<2)M>'/'.QKGBU],)<0
M&Z;_?F*D&C&3< .%.OB^ZTHGM8&)EVI/.*BPZFP=G^!$M!04377X^PW(D;#S
MCP[+5:51#)14]$? >?OKSMNW?RP+K:Z80QXO$J9L#O>4L?7NKU\ZX]W%D]P*
M3T.LSGIELF_IO9^UO>=\* 0#\TFY1XC1<-XHMO@!]H^-53Q0*9,.J__MGC2G
MG_9N:#'AR'95R&]QB-29.%BV+'Z>:QJ[@47QG[^E[A!2367BSUM[)F3X/]4)
M4@P<1,E&%P"UIJ7%"9/U51J%,A%S QR5$\RWSJL87R 9H_TO TM?#/+*B<GE
M$_VY2:_O]D%##4&M$ZJ<Y_E7FH Z3!_@-_FCVZ6/D\VAKGYV@@+R2D*R:8FY
M;CYPICBFE*NS9.DOKVO*CD--9V;I[P&Y]Z(T2W/WMG=O17<84'%1O&8_2;W%
MKQSJON:CET='Z*>FDW5704#IU7]C*9!AIG:7)WS7L>+[.+#[X1]WD61Z5I5?
M'RI30]BW]KO29DE_]D5XS-2<40%##KW+XU6V)C_BJ0/6+[[UG;6C4!YW^BX
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M%=U*$>-R >VWQ+QLOM-O/IIFZH1'I/#@_RKY\6\G$J77N5PJ1>:I@P+*NOW
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M[.+W@XSR]1^QC@+Q[-Q3C,LSKG_%1SG FC8'\5.;,$6KYD.I,IMLY9<NOXK
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M@U7MOU"".*9Y<,&#L%2P*3N:&I%O"6;+GNX@-69K7I,+& <'7&<I5J A9,^
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M5>4;ZW46;-[6NG?](#[A,V.=^W%;Z+H,_3,GCYI03> W'N#ES2(?%FI/:O3
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M:;HV%+G TYEI_BXJB#--)2H()69>O6M1[+$]2'7I\K*^!46GIA_TVI0U/37
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M=G]A:..^BK]M=7'$Q0/_0(I6\G<296L'2B*J%)$?&QLKJKS#]O1E\).;K-G
M*?G;7;H82[\;ULW%X/KJHD9*49LGZ.4=V\JCI0PB6-KYAFCY?-/_##V5Z#]0
M2P,$%     @ EX)<5H!FA?><>P8 :I4& !0   !N<W1G+3(P,C(Q,C,Q7V<X
M+FIP9^RW=51;S]\U&HI+*5Z\Q0O!W=M"L5*@N 3W$(*[UH 6)Q0H7EP#18($
M:2GNGN!0M$B@6'!Z^_T]=N][GS^NK7OO6F_W62?G,W,^9_;LF3F3?7[/_%X!
M4#Q7U5 %X.#@ *S_'(#?/RA.5 + C@" EA: #P  $ 'P<.0 =_Y$Y'\*SZ/
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M(EQY/')<''; '4H<7$J<WUV !P  #C[.O_ ?GP8X=W#Q\ D(B8A)2/\D("@
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MTP <=6E CJA8["6:RZ6VQ$@<-5KQ]?0\KO1*<O(,*20G=<GHIR@^X<M$@&P
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M@&P2";PN!"@?!=(K> [+L[@\]_+0UJE*;03M0BXD0N/)H+(I5'HNO/[MU9!
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M%W*$IOOAG']DAU#OQ; HBD50FA'43_,F4X^!F+_J'D_\\O.<I:4!B>:6QM^
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M0:CD2OD''&5^DX4J^Q$B)@UYMX>K;6HF;Y9!AT9ON9/P6%_6IIZ>X@.^#Q@
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M*RGD$'ID#'XT:#K45U=OIRM);"^B=T1AM  '+*?0=.M'L\/2FG%6=^FWX?\
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MG[5$EMJL,=]+<SI%'#;19)0DAI"#P5!')%5?'"V]_+=6$]]-<#[1;DZ>5VJ
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MOP]=Z[8W-M!<PQP74X:YE$.PLRGD@=R>.:Y?4K+6/[7LM"O[9I;6U8HJV*F
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MSFR'N)2,,6[8/7CCFN;NM4TB75['3G>9[A"998X)2"B.2A( '3IP#GFM&_\
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MA^4JO']X5JXRD]3,ZR\OU@LY)8&BE=< *9  3Z9KC+YOM&K2E7\S?)P57/X
M=_3WJNPRV4PP(R<+@ X]*GT^$23EWG%O'$I>24M@JHZX_"M5%4TY-B;25V9'
MBY8O^$>AL8)]/.LO=I:K:W\A$95R<JP .21GCBFQZ==6GB.V\AV*V"C*VX#>
M4IX=LXPH/&T#]*=KVGZ?XEU!382&SUW16B8W$=SN(M&.X.Y/RL"!]1^E6?#^
ML7<NDW=Z\JQ326YM[>../RTFD)($N&SQG'/0^E>6\4H/G5E%WU[W)I\N)ASO
M6UFO17WOT]=#G]2UPW/C::RLK&S;43_H%MJ-Q=JEVB.F\LB$?3&3CK[UH>#]
M,O;'P7:Z?JEH)8I93*T4"1L QDQM;9U<8R3[XI8M+U72]-L-;E6+5];;3Q;W
M-I)Y<<<L@DX=F !RJD@=.._-2QSCX>^%+2\U-H+A+F])0VB&)$F=SLRO4C)Y
M/_UL^7*C*LE3HM<SM?T_RUTUTN;*$W5]K6NEKNE:W9^?XZ%#44LX_$B75U:Q
MZ>US*8M\B$2/$6SL 7^(X(%;EIJ+:C:Q!)FU33;Z7R;19("US;R9)<2G^%=H
MQ^5<7XDT%+;6O/TJ"\T_4'<S.\*,\3,[;B\;$D#&3G/%=#$]GX.M?[4ET>*#
M4D5V6Y2:1TCA*9,DBG^+ .1[\5O1@YS<(*W,_GZ?)7LF=<Z=.E_M$I7G9)^2
M6R7E=O[WT.KTV*SN/%44^EVRQF%#!?HFW$05<1JP/0X]/QJ:.=;/6H[BT6WA
M54DC?3K=59Y/FSOR#QCN,=ZR+A]6BS?P+%>KJ4Y;R+8B%7CV J9&;D?45#XB
M^P>%M/DNTM!;2:B\<4,=E&99BSG#LH'./?Z5T<\VDJ5YO9.ZE>V[;L[6OIL[
MW]3SJ+BW*+CRV?6Z6O:V^NC]#FKB/PWJ_BB6_P#$TU_:VM[*LML,D")F!'+#
M.,D<%>F"#6N+1+7P[I^K+)]A-BC6MG;,_FAXA(/WA9AD,0/RK(\(W5Q!I]]#
M-HEH]XMU]ES?%M@"MGE2>"!SP.M=M:>&M)O]6%Q<WU[>M9R%(T)Q;L&&0-O1
MP/6GB986%7W&N7K?S_I_@;QJ8F$(0KRM+73Y75OUTUONK:\]9Q1^,O$?VN:-
M]-MK2\PL$**5EC4D;G7&,-G[WI6]XAUE[#7[17FO)K&:ZVO'' NRWV)D?-D'
M#$\>]8UGI#Z)J$MC#J$&J7T*LMU>E=KQ^8V5A\E3M V\ _RK/U*.:31[C1?&
M$EOIUS?7$D2[9/-S;=G<@Y0$=^V*5:I55;D<HN%M>T=U\^]K=[Z&D*471E[-
M.+5^6RU?6^O;;>UMCJ4T:[?2[&"5KB[\Z:9-\T?F^4K9Y;=RO7K5[2;W3?#=
MJ^DZ?8W7F6[!7>6/'G'.-Q?^+ZFK7AW4H;KPW%::(\+36<20A68E=H  (.>0
M1T.:7Q%+-8^&#%=[+OSY!#([-LPK'J,>E/DFD_9M\S6[V^Y[-^ACRN%*,8V:
MCLNK]7^NIP?QROH;O1;?3[RSDEL%G1IYXE5C$W\/)(P,G\>E<QHCYTF#2_#L
M[+9:M-)%#/),=BL?D(7 WJ"W/)[]A717^@1:I<V UF\@N=,L4^TQQ3!TN)ID
M;"N57Y3'MR,'O6*L^EZ7;ZUKMOI_E2W$ZW,5G:W;!OW.5\U^>8RQ&0HKE]JZ
MC5Y=W?[.KT7=:*][)]+.^G=3C4C*%DU;=77Q:;JVMMK\UM/49'X:T#2/#-Q#
MXKO(;NYDN6\]RWEN[ #@/G+CK@FN=^&?A,-XFN!:LYL0_E2-(HD$C\E%#C(
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M#5=)MOLBRP1B$VZDA8HP0R]2NVN>-)-SDI/LK]/DO/9O7J:\\ERJ26O;_/\
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M-I]SI%AIUE*WVRV6>35(KUL>:@(X3MR1P.Q&2?7Z.\"7MEJ/@72KK2W#VTD
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MM;]?Z9F26T4'BQK3RI_*5BH2-Q&H4KN&T?Q'C&!3K:\G6[65X,+'.\J1ALG
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M&56+>;Z;:L:?-,D;6-S!!(B@[H)?ED(P3QZU/%8W6F^;?"*$2+$74&3('/(
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MM%KTT>V]S25>HY*+U3O?\OO^5CGWEN[[4+I9;"**62$S20J51R",,K' W#C
M)J&UF\/ZMH>GQ6%M:17-G.=MK/O,FV,Y<)T)/3V-;C6\LOBK%^9"/LK2R!8A
ML93_ ,LR^.0#S7,:\-$UBZM-2L[FY@U!(U4PVEQM81EB!C(P,GK7++VE&\X?
M%NKWM?:_EH^]VFS6I[&<;5;62WTVW_3MT$T]I9KJXA>VM)TU>9IGAG*.T+ E
MMQ##C Z?I4]_JEY87'V:2>%;4V^-DENK^4=Q._H<MQTJWJ$>G6CQ"[TAGNA&
M)+VV@.]@N<*Y88SCZ]*T]6T>74-/BB\-6EM;PZB@^TW<J_,B=L*><X)_*M8J
M6)K7F^72V^O1O1K3M?<X*DH2H2H0TNE)6TE:[6NUO^"]F8VN^*XKS0]-DT^V
M>^DFE\J:6WE\J2)QM&1G SSD^V<5T$>ORVBS(;F#4+@E([:!)D5I'Q\RXZ@@
M<X-8-QHATK=J,UO-=Q6[(9GMV E^3 7"] .I)JQ'HFAZ9%<7^A(LAN7>22Y0
MJQBG/.XMS@\XP,54JE+DCB*=^2V_5]->_P!QUT54=Z+:YOR7E_PX1>$+6]MY
MKN68)%)NEDDF<G9+D\D$]!GUJ#Q!-/8:2MMI_E7+06JP>9%@;QU+#KTP.!2V
M>EZIJ6AW\#7L2BXC"R^8PD5L'KM.-I8<$^U5;7Q$-&\-6]GJFD[[VU>,WL3/
MM(0DA'5@,,2 .,]N:5"ESTX1IRYI.5];V?S\W_3)DX8>4_<Y8VW25U=]5W^7
MW#M3U"TU"]\)/J%[,;A'55%LL@5I&7G<,#C ZGH:9+H%Q=Z3 ]T+B#4[2[)A
MD2=EDF5#N4%@3A2">#UK$UC3]2L?$<.M#6]3-C<7<BQQ0VZ;;)60[M^WYMJ]
M1SU-;.DV\,GGZC#->/M3!%PS#<!@9P,#!Z\UA7DH\U3GNGK91=K[I7=NGW=G
M>Q4*?M*RI-:+O;7I=[ZWVM\WH;NK:]'>/;6*QWD,D]JT\<L,.Z&-@=NUV/&<
M] :P;N9;^\GADG;3I8Q'9P(L*N99B<LY4#*YQ@GH0:LLNLVWVF*"U46;Q>=)
M<7MPBH% #94#G YSZ9JI?R:=IAEU;[3;W]PUQ#<Z?,\[$R@CE0R_>10<@"N[
M+J<U*]9?&E;9ZZOY:=.BZ'+C*G-2?L[KE;ONK+;IOKU6^AQVH_;M:>RTZ86]
MF(+A)YYKJ=HI=RMG:#QA3R,?2NIGUB\N?$.G:M!-/)H.GJC?Z-)(RR/*VPH0
MO$BC@CN,>]6?$'B'3YM:L"#IAB:X:2]F> ,88PH/S9'S$XQQ4MMXGT$:&R:/
M:WPBN)=T(M8%4;R=JQX!QTYP<<4ZM.=5IT8-73LF[;V=UY/[C+DE!?O:UXW5
MVM].FFSVWLVC,DU*&&_NAXAGBN+EY_E\E646Z@\[3]Y\XYSGVKMS+I]G921K
M=FYM[F)<"+:IXZDOZ^QKD7_MC3+B0:@L4UQ+)#9V_FY10>2S)QA<CC.>N>M0
MZZ9_+LVCLK>&2.X$E_8RY#11GTQPS-_6L\10>&A&5.[\[JVN]EIU[_H=5+%N
MISN:U6O+;5^KNU^*LO(ZB74=(T[4[><H[6<FY#)( 4SC)8D]0*ET*]T?6] N
MM2MYT6VOPTD2JNTA$)&<=>O:ADL[JVC/V:)V&T0!(0RM'_<52<9'<BJVE!-,
MU6\5XXH+61VC294P1QC/3 /;TJ*-3VE2+F]5>WG<ZYQ:B^39V('M3;WEH;F2
M1DEC;]W$V0H(X8COZ^U4]6\JX>&&P@MK6_=EDEO A_A&W+(.6!7@&M73KV&&
M_:?4-]TT49\K!W%F!XQ]>U1M^[%U?W(DLHY7'V<[ TC$@G!ZE2">]7C5%5>9
MRZ:K;3UN%.2A2O+17W,O2[T373G5;=H(+.XW&22)MAP1SU_$&NJT[4M+N+>\
MU"=XW1[AHUW0A7! Z<<\BN<@NK+5-/N+*UN1))93)'=7)<[GEQG: .&&#VK4
MU*6&YTNVN+*V>")Y&\Q3!Y8,@X+'ZTL(KU'&3V\W;M^@5G>*:V?IZD=N]I#=
M?9%2$Z:,QJNWE5)SD$\YS6MHMQ:1ZG-&H4)*=]NS'UX*C(X/'-8%FCM,NP'[
MR],YZYXQ]*L6]\%U-;M+26/$KL+>1=K+D=QV.>:]:45\*.,[FJ&MSF#29=JL
MQ<B,;3@\G'7M66^OS+I,#K+#]J>0K)E20@'? ].*IM)+JVJ0Q2W!F1LJP@!C
M 4'/?K6,:;3NQD,>GV5WJR)-:Q2P+/L228<$!<%1V))JU>7$ME?.=->/RG(D
M\Y54JJC@KQV!_&LR:XGO=2GN-.N;JZ%LS,+)HUC:')"YP>HX)S5S0K"&:_C5
MH84@*,X@"$+UY('0<UR86G*,I.H[V=_O\CIK3C))QTT"VUJ:WU)[IPTXD&Q]
MHVAC_#].*YWQCJ%WJ3IID4*W2WDRR+<.Y40[>P7L<'KTKT.YTHLO_$OF^QDL
M7;:@(8D=3FN6UZP\E)=,2YGBCD"N)5.QE8$$X;'0]#6]:[M4INTHZKS,8*,D
MZ<UI+0SO^$3@U"RCDM=/FBBC7:R6UP425@<[G7JQ&/6MV&6Y\R[N-.:.)S&N
M^'RSY@ &,@8QG.34^DW\MA;J=HFL"[%I%!+Q_P"\*-:N8+V.*\LV5UAX=P"'
MC)Z$CTJX*,KRA]KKO?U[BMR6@U9+IL4I[*_TZV%Q(64EMPE5SE2PYR/ZTMBE
MS>WD<T$ZR7D?S,L^XC@XZ].A%6A]OU.VM%M?](!\Q+B2:7;Y>>F5'4>GX4VV
MCDTG5X;5YFVAPQW.$1MPP<#OS6D9-W3W0G;H=-;>=]G3[4$$V/GV?=S[5+1U
MZ5EZIKL.G2")4,\O5D4XVCU-8).3T$:E%5[&^@U"W\VV;<,X(/4&J]SK,-F\
M@NHIHT1PHD*95L]Q[4<KO8#0JIJ.GQW]I)&0JR,N%DQRI^M3274$,"S2RJD;
M8PS' .>E8>H>(O\ 1=MF)(I?-V,64$J/7'?/:JC&3>@&=9(UWXFM)+M(6NH
MT8DD@ 95'4 ]>>M<S\0O#@TW25>&TCD$U^\GFN6=EW[<*,G )([@UU$U[J?V
MQ!*TA*AE1MFPNO0D?SK&@US4[F&:UNKB,1$DS72CS!P#CRP>ISC\:YL4U\&R
M>_;K:_?8WI+52W:V_"_H79H-)D\(SSWE@\MVBDAY"J7!'"[U8#( R?RK!\/^
M(+6"ZD-]=WR+)&]O']JN6$.S/WCD<,. #QG-=9ON(]/T[4-3N 9&CD1H4M]O
MGHP^4-G[N.]8]KH<$^C7\5CO>>8 ?9)95V8!!WC(ZCW_ #IQI5E14>;8A>R4
MW)1W-SP]IT$MQ*UUL:2'Y/)(_,GUZUT[0Q/#Y31J8\;=I'&*\YNX]>TB2&6T
M,&I0R1E ()@LZ\CH<8('?VKI;;7KBS9DU)6E8D[=I7((QD8!_')KI;<WY_UM
MW)<;:D&L13:<8X8(H_L:OYD:["P5N.I)]3TJ739IK2SDU"&%;@,#YY9\2%@?
M?@ #M6=J]_\ VE>"6+S/)V957. #W(J&#]S#.[.S1X\MPJDA@P)[].0.:WY?
M=29)H7TPUF\1X0I8?*L>PE@,?-O&>GH11K$J7&CV-S%E(1E!"W8CC/7VIND6
M+W,+>3)Y5Y"PD5F7@HPZ$]2*72YT$UM9748>-)G&'CSANVT]@._UJ5'EVUL#
M=RI:R1Q-]JN9!*8,&*%CM+G@Y^G\ZANKIM1N_-D6.*1E .#A3CZU8UMA->"X
M@D>6WD7*$CA><$#TZ522!I%8Q@R$8PJJ3GWZ5JK;B+%HYM+A)#"MP5"D+OP/
MFZ ^I^M=-;PW)UJYN[MP(&A"0V_RDG');USVQ7/Z5:&:]@BNK>0P,S \,!G'
M>M*[MD%O=7'V:8Q6<1BA@!\MS@]0Y/0^_O7%BI\ME%7;-:<4_B=D0V<S1^(D
ME$(B2Y8[!/G<%/7 [9QT-0^*8M8&L!K.+3GLYH%B <-]H:3=T'.W;CO5J.1=
M0UC3[J*)D9%(G20Y\K XR?QZUG:OK4U_XN2+0KE(VT;<;Y9[0E9M\>Z-5D[#
M/4BN3%<M;#I<VZW_  %*+4G%77IN:L=_>6K&P\FVMY\*0R(=FXGG/'IWK2U>
M*6XTEO),190'.Y=P8#GBO,Y8M2L="@N]:O\ 5=1U&]U,336NGS,T-KD'Y>W[
MO!&0<BNNMO$SZ=:"$VOVE$PJ>6=I ]QWKDIXV%"7)-W6Z?Z:&\J<ITG5Y6FM
MUK?UM;\%<SHRPB CWKY@ 7RR0)<'D'T(JU&]S;VJ0I&(%3]ZTUNVYB>Q;!Y
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M2X0[PD0QD@D@ GD8ZX^@KAC&4'[+2#6UK67_  [7W&LI07+RKF3W]$OT_,]
MCU2SDACD,Z()#M <X.>X(]:QI]7NX-5M-+2R2)IY7/RL&5HP,UGG5%U?23J>
MD62P6JF7"7\/EYE#8W%>N,@<CJ*Y;2/$D%II>EZCJ=S]J2UOG%[>6S,JQ.?E
M)*D;BA) &*[88IQGR5/U,UAW4BI44W?^DO4[>U^R7>I)=2N;6YMQE[41\ *.
M<<5H+K-C?%H9HV\AMJ[Y4PK,W1?K3K*2"XU26Y!:-B3$B%EQ)CDL,=ZK-;'3
M]5CENB98I9F$;%SB/<.A'<YZ4*4:47*"7O/?73U_I XNHU&3>B,[6YB=;:*
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M;.WMS&29027+?=Z=JI6L<4-V%GF\M25V31C.1GJ/;^5)<)<V,UQ;&6)50[F
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MSD^1.WRZ=C0M]/L]-MM6U_4+.%KG4I59I;,M,)$'$38/ .,$XXJEI&LZK?\
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M[WO]SU^[S.;%TJ%:7M'K\M[?UT['#>%/#[WNL1W%O/<+!9E)([N1"XGR"LB
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MOY6_0NR6POHC9V\=NEK Z/$5.X.O<8'2LFWT?0].U&ZU-M&N9+R]S)(TZ;S
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M7F_P.:GAU'$>UDVTU:RMMO\ FNOR.<T;2IK&]O8X;=+B6\C?_33,0[RDYD4
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M<>N]K-IIZ_C^)K0Y81;I6M=][-[/];G.:!J5A;-':ZKJ$5Q%Y>$OXI %1SP
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M21N)[CCTKBP,?J%*I6HRWY;+5I.Z6BW7RT=]7H7BJ=/$58TZL7I?\KV?X/\
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MHTEQI%QH>@P2VB/#!>2%@(?/C/S2)&1QG/7C'6M5!IL5Q/;006<FC8^UW20
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MFFN[_P CLYOMC7ML;9H?LOS>=N!+'CC;7.Z7?WMKI^_3;&WOK?[3*)OLK,K
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M:;:^K\S,NM/L+2X^SZY;2!KCF.>"X9VC8\ '=]X>].N/AM-/)I-]INJ26]C
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MO[ C:VMM681S64,I+QHK9"%\#KC.1ZUNZ=I3:]KFD-#->W5P3NN;RV^] X?
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M428<A)0. CI.[->1EI.7Q& /IY!:0H241H3KT8R]IT+)1[46*>;6A]HRRC'
ML0'^X724^[U6'06OJ@>ORT!EYBV_$F7&>?LI2C%7Q03.>L2_G!6U;$Q+43P[
M@FDF1,[%$<7:#T:9SD1"Z]M\*&_C:8(V$0*Q'I"<9PTMX]1 \[P8YHG'89/_
M:?@\NQ8^GR_5%6S]\GKIFNK#R^ZT'.$43)(K07NFF(1KN/QV8/<MQ7=(R')(
M 4<RG80&S#@XXB=R9!WF%,G>"1]&I;],B,3W<BX5KCUPES])1DV%#WEF+;JI
MY.1ZM3X=4WFT2FIIK2VVL@1WWM?8M;&WQG$(W;SY2)8G:W8ADC""X+P..@;5
MBAZ R)J\()](:.!0(?;OTT516GEJ9&3_)K&5 QP $Q@^D_@'*("X1-R/K_YR
MP@"(:Y8?9#TW+)U?TNX5/$$=:4,#Q(# XA+9FM/N1D$^+YPPM0#_=^;UT-S?
ME:@/>,0C^@UO++.IYYOWT(@/MNA/6ZPQ<>,.02W.TTEETV800HY:!>=2=-Q%
M 9R)%+Q[#4##3VO\;#9:7)X6%6B^4]#YZG3##$@WT.N:\ <56\W38\DLUO;Q
MU:)C%I&]\@+;(<.CG@H]F1W/!]FR 2K7Z_[SG@TL*)_ER%$PK;]AZVZ2!1PN
MD3C+G#X$E6@3,M"_SM;=#[7-%4G3FH?HRW^ M&#269=)U/QM-F JN]A=Y]0-
MMKN@5KFI'!^) P&Y1Q9;@9(+<BX/YS=^%T^S7TP;]K=D]37R&>O0NG\B-3<I
MZ["WN!(8KOVQ(-6F%'N%T\9WC<X*I./M."N?EY4W'11.RS>!+R0DL"8P#EF9
MV%O=]R69!%H?Q69#?YL'6K)_+D3Y$ 1+@D2R+RCSV.VRD;$OZFS2+ +!'XJ
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M-635KC*4:*&1E-<EM\'F*\Q'T<O 9VRW6WK)J:P'55K)23H@,#!E,V,]+81
MT8;,EG6"<M9T2-:G @6FX&E2T=CAHU(G"\&= :(,L\PNZSL(<'(7("0A+\]M
M[VFY>ZQ@%=(QXHS5JO#TKM65SN HO^OS['5<L^_5HTZS$=1@@'IK0^-?VH8[
M+!*HT5^\E=[<+W>_=%T/OEX$LX!X$P^]"8<*586U%D.B@1-)_\W*Z(RY]YV9
M[)>_JMZ:\K.P  *KFH3W]Q2*;NAEQ CR5^;VN_:NU9:%^$AYRVR[]E])F6#W
M@ LGC%R9>K@L7<T >9COS&S*8FH#B>O+F3472SVKH]\)TI'?'X0[95AU?2J9
M!O/UM/RN!J)XK^V.[);EG*\D;1CSQ4M):#.G)D)9:H6FR)4G )I/J1SN)X2#
M BYU^39=&]6VJ:?SG S!PC O4^_=L>78[Z=6;:DB11V6I;<J?R>A[/8J<^^M
M90Q<"HUL[1=@=2*6+L>-R>F&CGWRBWLY*3ZZ=4VC7NGV.7)5CGL^<P"KB&ZV
M[=",QF)+S1#AF0[_>L@>]^Y[1MA3=0-=0U691*/"E*,ZL-_&"MD8L>YHT&QK
M[.%,.=UP/2MQ*!GHTZ5;(PUX6T1KA[@<;HZ!\U(*=GNMFJO=-R&N+NB>:EER
M+Q.II:E#1%M<KR0W\SKY[X:IM&*$V#E9$5C7&9.DY EXN?7Q4_ST1%S^FZ\&
M*5\*]36E8$QD-DKA;KRM_!JN"AKK')U;FP'-AX+:=HDAQYXY6 *,%8>;;%0/
M)E4H K$A"4D_?*$N)->T^:>5E55S7X=B.17\GIEIZ%[=B[:3K\(<F=<TPTPU
MZ=P^8#[?_*UE]'&!!NHEL#96?%^5-A,BD_/8*=2L8XBLH?,U:;KNX#E#+UWA
M[AO\NM"*A+G?E]=TY+H&)1GW09^7NZ(68/@TD7KA)1MS0[7/8 )+]-E813TD
M9$SGAA23(:YQ=KPJ()"G^!ZWL9[1YO.@B-F<">7-IG^ ]$K>4]B7SO+*U[IT
M,H0&N?ZOPV^Y4NP,'5,#G.[)V67G\?,(*BZ$O/#WJK2"ZCQ<E-D#B922Z-I!
M'(EE3S1I)68_[=VY)\^4B])+IF0A*XC;,Z?H&.&R -8&H,$H< :>"T,+3OEZ
M*%8S:<Z[N]II5@;W[%GT!?:,W VV]E^)31YF5"UT.AJS:HF9JE 2OKI+MN6]
MY>8Q.-&XZ>]I)>4#*E[=^\4TT99]G_-'XC/VA.TL$_]C:(=%>/6U@9C#&"U6
M[ZBPQ2T3>9[KT;E#-2N9[EH6YREM3<TM.CD:G3(%)</;(3LWE1290T.*&T=*
M=KFH;SZK"TZ7T]-*DB,G"%**0*V)+_TG$A(W,I;<.(K]M+MK]RNIFEXGVT!1
MKRA%1=P?3?'2$&"KM7@W1\!X8@C$JA=6[+SSHE^A.5'W-N/2W6#],/E]):(1
M5(WZVAP<E+3;2G2\4W(VH:-)#JJ&P=J"&$2(YV*SF;J,@W!7+!WOW>Z'+Z$?
MXMB;!XPTY*_UY33.NAN8^_)T/+0NQ<B>!F+OW;B5C@6D\=[QB_2[-<5UY91H
M:U=\[(<0W':%S24D,G_A-6L'Z-<9_7=E*$B'SG04OA^5"39COKG5OP6C_M>[
MPN/Y\>><FF\56RGU^K8W\>^,*\6?$R')85#V4**"TND5L#761+R\98=23^I4
MT)Y(=I-)YZSCQ%9.-J&2W7(%.>)_[&6,C#/?7V2<I]-PJ=<HQFD"#*ZP>;^U
M$\C*F:Q($_0IPO'G/@BMFOB"K!-C(ZF<K#90]Y$WO2:W7"PM220V9NDW$MQ!
M"X_D;,=PCPU0/%QO)E#; 4'D4YX,.5_S\KIE^!#YU'M7CH[9]!_@\SQ4D=-_
MRSM <$*,!Q,#S/1\+]<1<K_$)A@*526(B@9**J,G]D\C:K]=;\Z8ZN:=MCGM
M-N[RS,EI<0ZO+5HEW-,,H2O$*&15W[J9%6_EX5]Z5?2YM?"/^B8\_)SQ_MK#
MYL,*MQ_ XX^5,>&+5)[HA=TJ'SY! <%= YBP#$YJ;/2YHI\5CYPZHTYADFGB
M!-@:6H5M0?\#?)VJ*' FIIW.:Q[^,9E7U1O)_##/N.?HOBA^O<5P%*&H^'T+
MOD_QU&O&M>*$DBPG PFUS&<_[C[+0E2H\!.],I5--2;++3N#EK=CV3UX8B]?
MX?0=WLE?/2S'/#Q8&DKWM.5,345\/^P.>E<GZ6> T9V^?/R1_LIAB?>!@;9F
M"\+".16[C3NG]S6L,# P%J@:%-Y,[0>7(?X!>&S,1ZKXZR*MWE\NKSVV$^YW
MF><LOW*B6YZK-7SY!UW7\,5+$94#*J8%J2>T&MW\*/GIU$B&:#%4\@[S#T R
MD%2KOM;_^N'W@71YF\R$CR\JZLV"DKLYOX=W@9T>L$DT9B[UBST/$)AN=&0N
M83,P#<J S1!!:T$SLW A0Y/D!Q9A=7!S1>4D>'G 3/""5XPSV7+$8K?O>6WE
M%>K /7 X7T+KAU=^#FQ*!'3CZ!*E>) S&K-,L5!S,':<<I-H.*P*^#6VYOUL
M$G*JU ]=3KS6O+,8+N_8+>#J)R>59I+1FH]]^%X5ZA8Y>*_7M]4(RZ[9T_X/
M !BFQ95VN;D6-5K488<H_P!T,M(5)BI=HNXKWJM5!]8V41-WU_W#RTJ.BPEX
M4"1E<XLG_ANW]M90-IM9EBBMFC)45YVPB8JYM;4\8]#8UH9[Y H%]T9]]WB5
M;,F03),CA$1F'?8?IB],(AB=\A/'9INAK#SRP_*]G<YFOL[S%P[-XZ_!EB?6
MQ@U3-^.NGD_Y$Y2VZ$:+V(?(R+35?P#KL^\++:@Q+[(ED1(HZ#1318CR/X5Q
M3E3ES8-*T;[2$4!4C]TO+/I[>8\_[CE;7_P+SG7- UPZXDR]OA8WX87#,G?W
MO1AM=\^5WNOAVD>69$)!G*);X%)DY<S WGM>MLCSR9Y5R1P&BPG,]Y>(VQ ]
M$8R/J[7?0Q<_ 0Y VQ@FC<>]15NLW/_Y,5SL97OT ON@RMH!;M][%&)+Y:]@
M^IQ9H-J0WM>Y5+ST59D\;O*A9*X'#IN;@&NW4"^0N.X5UM [)=L ]3&T[C?4
M4GUCSK(-'^P[[^K"\BM_>P:+/ </3$;YKQ+0LIE<PJ1WHD_<G(V6<<'5Q"08
M2/L?@!UQF8"+D_1P:U/#FFRTYN[0>YK7MOYE2FF^VS[H;G^&+(EEHKLB'&V_
M?]7]Q#B;19^ 9K@+@GO.E7F=N,PQ=GHJ"JMSK[5HL%[_8_H2%D+7FN. 1U:)
M1A,?.\1DTG]IRO%?&$-:_('X/WC1]>;EW9@Q#<U?+D='TMDBDE[C18H':T4X
M1<NQ"NL9BHDF.)4DNQQ=H:RUWJZ8+LVNT=D>S\GX@I1UOO1QD:N!:@Y':MJ6
M%.6D.T+A3./13,&.>VR-I.MM;W=H51%I#\-3$# IR>$'"4RWN8>O<@EA*MQ_
M'(-!5B!]#1@0J97?O[18//_ CD9I47\3JJB6;8. SVQ?A-#_,8I9VS76=FJA
M9A/SM8:1:.*R08.95,LC*A8"+RG4VZQ_E:MTIR.%8U>SHFAKJ;9F7.H?0+XG
M&HX-26Y0*:@MZ<U;"YGTD3EJS"',OQ:^R-<F@WRN[A^69P37%W8H*>@D!;G4
MFOU6.K;W;.7EWMRX7-NP\BQ0$\?!<]NL"&U!7V]J:O>J/OT'^+FQ:]7)HC"4
M2S?1\4=Z(.U>2 &XO8-Q)_B$.B3A+$;?$>2!]"Q]/HFX'J]\$!\B(Y?)2HI9
MBYU'@D)DBNP"9%+*R.IW7/)$&7VHY/XPE13_&9/:#*?Y,*]$3;7@EZN*I\%2
M^06W58>W9T+VSJ7XL^6+EWSXCL4ZL%/Z7U_B_S<4FB<Y0JSJ3=Z#3?;P9]>7
M]- I5.+A9Q]34SVR4 +'9[J?*XK)#,[#L/?M]A-\F FZ*0.'V23;M)[X.W<_
MC=BA07,AC#JG"C)%MSJO"H$L)1G_5_QOOE-[J9)=(=B7HCEM, IIK0XZQP9K
MD-R6"IYJ*4AMC_)-S( DEB-)5K$)G.,L<*YLN3\)ECNR]X>M/;0-)O)PZ%BP
M/?8A^JR;Q_QDY,J#%W]1\>HO_R"00$^K,9'/=]?=I>8=;1Z_H57U6?_A/<P)
MO6_<W!0IATZ7NC#4QWKM,1/NRJH. 6XP (=MM/I9;@CI&^7/"(.]B!B"-:3H
MS]Z&;7+>+2C%@L\!X9B/=R6U8.7)\'MKU@RC+D"I;(4!9VREQ0&0DOQXB%<(
M#/SH1S/B;L6<EU>H$."LD#U^FM*P^U8<?$_IQ\U%QGZ:'-4/J_YO3'V>67_/
M0YDCI\>>&.'NMXFP,A(Y[F?@PU=,QY640XK_D+I<]\EQ]7$2,E_X: K$7G;O
M5QAXK7MVRIP$K[0D(^HW FQ*7DU8U.L;X]TAF,UM1'&KM@MN>MLN(<F 4MH-
M#2DQMQRHDU3GRN5Y',K3?^^8C;(JA,UV#_+ES=5MA9#&3#'ZMY_4U84]"_D6
MNC&S 6YJ_>2P!#E2:.F,]CDR$,GX[/TB[GD69[3\H^?RE;AJ>@OVSL3)Y?'\
M6[]4\&YG[\F_/@PITH?5E&B/UF%(PBWW=ENCEJK5ZY3ESEA5^[C6,1C\]CZY
M]ONE2$.0?Q_HM?<<\/)WK_LS73E'CH7006M,ZU>]":E#+@[ZO_W*S6(<C7=K
M;)HJ==CE.5\NQUCW30#W05"'VKNXN\4:0^T?SQ>Y"I.Z-,_+)S!E<_=]:%[S
MNNG:!347BC.9956-T&O0E+S0%O(JI"P%P*LH(70':OM_DRU/>"K(V@<6HFEK
M(:*G!:^VIK5%%04P>RHCS X9$-L][:P V0<OL[B"FPD^H:@+GM^G)C_P9E/*
MX]OU)NAQCF:/AD<\=SA@2EQ"V+#?TZSC8F*!VG*M7,'+3C/BI*2LO^NFQZH^
M1X>']YV\W5:/W"S^/-A3^OQZK^ "WSW0G+6,XS,IYKG6<]&K6IP+!OI?,A@3
MNE,V[3A<*(*>:E27(W3N0I!I;PYD?ON>;XGN7^9L1%X7 BS),DGHU\60:C3*
M_<P5J&L=[D0F4U6"V>JAPG+^0X*,B>Q="4D18.K*1@K'P7*+$)WHWHL1?E3\
M9 ]='[+<,NLDX4 XYZ;=T#4/_Z',$HCIW:"<#ZB1S;O]GJP&;P1Y_'<UKRYP
M[:^WRT8[L&,1@_608C18)@4]O7XD3[A%G[TD@$ >38"]4BLFO-?EI==<SZ7S
M0]J!?IYV=B(&O3?)*W[4+*:@\XO-OY%E(7.*N<RKALYIB:CG=CFOKWJ+N_1R
MVW'_IT/OMU"&' 1UG,J2*V$B!XC:W)X$B_7_;K=7_<AR'6I_<3VW'8T"_M=.
MV.I\//$A\0;#5H%?7WU/X3DY)$HI,6"1<'<IPZT"4:YI<\F&P$05G!S.N9ME
M*4T5SF=LE!C/#,X4!B:]/F?\P9\VF][\') Q;7^'-\/IUYTM":TP>1JYY;)I
M:PB7Q [E,Z-JZ0P).9!:;P-67_0#TQ+%LNY&R\UCF[67UKR/6%)E6ET+2F%H
M (YNX?I'=5VD9P:[;_C$DR@3O"/X=F(_L'GWIE;7@QU:W].CJAXA]V:Q\G.6
MXIFRL,QL<^,R40B"V#(]4V;ZYB]7ML-<D.R;R!MV-8FJJ'J-JF"[?C?RD/N7
M@Q5I0]W8H'O]O;7X:!-9,=XOB1>.&7>[O<_%214),048J*,1>J<J-36C^X]K
M88)^%0QU/#<U7.O^Y96<T@H2MK8+"3N=IGNN]84KP$'6/4WO<)2I[[I.\^YS
MA07#_PG46Q7"3X)(X8-RVJ2F5Z1O]J&F"JD/]I>@Q@6FWJTM^IV^7"M:8*28
M-F[L^\S)6"HN_ON @\?J#P[FV16:4!!B/DK;NC.13G$(AZ^V/^-HA?JE]KPD
MNQG7XI:[^P>]?0PG5\7)11/(KA_O!E*//'X$10]BG7-^TYR8*C(7N<]_:=+T
MZG_MYZFH_M_%#XE>ET:ZL]^<_MF-LV/1X\NE> AZJ2@WM^\?P'T=_]NPC,KW
MJ!Y:+1L *3J]Z'(M\PEROYJ16DF\!PD;#2:-324;/DI]Z3O_.FS \]=!>9-
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MW;<]RPQT;/7-4K_PYJGB*[@3Q%;PJ(W%Q'<VN-T(!YASU8-US5OFU<%J^O\
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M&9E6S64W(>.&5BK+;'^(@<Y/:O'O&=OXEU3QUK>I06%Q9:-';+'<:E#"T@N
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M5C"-NG?OKM\OG>_WGIDC%(F8;<A21N.!^=<O%J]]<W,:+,VZ5PXCC48"#(8
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M#'I5BW\/0Q.C7;1W*B 1R>;'G<P&-P)Z<5EV<VD/?*-'MUD6WD4%C/L6(D\
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M;G@$RZ=SJMK]5W.DRBZ/19S4]YSHFCM(,_Z91P6Q3']Y=C8^ZE#?V/2E9VM
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MD7I%_DG*2:7]D;RG9JHI5T8S?>4]!!GI0@'#+3CEL,>KA$Q0T_)<7DU%CM)
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MPH]KSS1R3C#.GOU'E7*"3H?.'.6@26J8[?IQ6Z]PT<#M+/: L"XS$F@2W &
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M)MN*"^;C\T 'Y4>:B8"S.'96@4ES'Q?3++Y$#@QD9[,V5\D=6'A&>KO)@HG
MO,AQTNAD882^I(3N]*N*@-=X9M5M<\]@VTNJA4<CU6G<VWQ^FY]%?DW<*1%_
M%^>;D'&K="R5DX%C0!0I7J#7&@IY/GJ*$//^)O$/[43!S5@F$T@:TY4AS1_2
M'PG^/K$%SQI?UZU>-0G^/GU.5ZI]Y[6_ET$2GON(8/_Q1,F-(CU6B84^=_WH
MN+8YE=W!34X5U6&ICO31W=E%4VQ7S@";+.@8!)?=*( E0\:C@NU+%5.CNH/C
M)^0QJZ22[EBP''1V^ 8E .9FRJ+(7Z_DW[_5;>G2I\T\Z<JJVZ-<UH7_,+6L
MHZ<A3QD.ZW/;5Y,PBU?URJE$M]#&-11F()*5/[?=3LP\9Z$^\S;5=<ES<T<Z
M,9)?YB"O8"EJ3A?,LQWK\<1DEA"KV;))!4&FE0;?Q]"%S$GN?)'D*'Y&=6)_
MYO)'  QC>7N49"O]2Q3[ZSWY9Q*=1T,J<:#O+T];QH&_+R3P'_59GG%#,FF2
MQCD08VIP;Z5/([256L'Y667Q=@YI?,800"+!ZRE MNB\)B/9&,,?&JJ>\.EI
M<E#.Y8$7]3784JF42V+ROF\')V[:T/9288ZUV4 2V?W8K\<,]C+7UF)88UA_
M)<M+>T)VXH\@<!Y5U52'S:/I+4P9B)-,=QVW6])%Z#M6>OFL;BL^S(P3S=\@
MS?Q_8M436XH*"E,(PY?<J_VM+AKH&XP+IGAO[???#+@4%]RTDGM0B-]-;6Q+
MM\:+1-I*O+)&QW^.?4O]=+$R>'S0\SFR56R5&P9;3PZ&QC]LXE5_H/%VIZ0N
MD07X"IST5/ZJ\Z6'=_8%Y@6!))GG O:!2FU]$')9^]*+@D#[S!$DV6_G1/XD
M[C#8Q-O7FR,WIV#3SZH/4G0UN?*D[B??>X9EZY&#&5W5L200Q=@9C'JH-^LV
M;I(HS"W^R7@^R63E:$PU*EI^7OH+H" !E*6<JR@U\D*3519=J;_X)W/5XOCR
M*E ' O;B6?%\SYDN%SR<QI?4VX[R&V"T@Q,E3#(;AK>5'[4^8?=OR=_P%"^P
M(G][330A8CWKLS1K^F'JN^V*O]YU+FAS+2_2Q0G"("6$A?&=^#MD,% /U](<
M.]C<\A%F.,W%ZF.LPDVS)J5]*Z76*_K;\6E!BB:FY6QB>QX"QGA#_YF,T?\'
M;:N5(<5@KP.!$.'G;)2K,)/U-ZTM#K?O=A0ZA6+J_/A/D5/.EMA7I56C9,^!
MD2)"XL;=!VBC\%25R8966FC)8=#)+V0[C9<;H:%V[+[5L[EH&MIMP'>/N5ON
M/Y?PX\8D7B.OA@J!N.PH!BR*G5=.%Q+X8W'9'EYTL*_9\WS7X@*4J1(U/UER
MPSWY(L$5LI[2V5[)5U864WL8L(^,F=Q)^7^W0:L/$Z^3NV*S OD*(DT?3-)G
M%_?MEU??/)W[L(Q=S*>A,"O0F;#DKG[S8KTM7P,T4BGL@-=O6]&C19WDDA?4
M(&<WA1F;"/"M&I!>.XSQT;U$)UGI+<NE'@N_^X+Q2Q5S@2#&Y\%*T-"W8O7Z
M<SH' ][[;#NT]>$[CF=530Q%#Y[#:]W%UI\WC"YI@SF^V$A*EM*4A?E/)2,_
MFQ<,[;2FS?Q3'-M9Y)+ %%-G^NQF_,[IY#X2U)\S)N\;-=>D&0SPQN_1^#R.
M'PLS/^[EVR;5K.]2K4_$18A^(U-=JNILA@67WO0;$9Y8*4OT*I2$S!+"7V8B
M(<W-3"6FNDN!C#D/>M4"^:]_51AB-#-6%4O4J$L#6M#*.E@*+<MN^4PM)-M&
M#7*KZ4U32D:^Z;"NO.;U\]L):B"=V<L^T"]T%XVVG29/VT-S<7NVK+'?MP=$
M^EZ'O?;U^_#5(+ZLYK*%VM,''2+SV>\&H0.B/\:J21VQ'P<>)LAQ/>=2=ACX
M';.DKC3[:N=#<QK3EPK4$]T V*_WE[Y#D]D#A07OKVE "L*[:L!SH(Y2@TM$
M*[:!6Q44!TL')6G*6Y[%[@'2N/Z-10-__/# ]O$027Y<U<<L3V/#Z9RN<NLX
M-O3&J$ODW+'9V&R2 K>36ZQLA+T46]T]_L93279;-:M&XI]_Z1^Q8@3XP%]I
M:1FFR<^7E4X^BECR>O?R4UL;,Y('*=,%8,5%)<4+"M'%TN&N<RR25H3"F!G+
M@%S"Y*\XCG>\&2$:6Y VQ"U4/Z7]VW(I2YE6F*VQ_$'X[--9:I;_J&=1&N.K
M 8W6_8UYTH/BKX@[7@\,@?\H&<AO![WZMI#%3+_[''5.JL63WQW:5[\S"&OJ
M_]X<'^S]>"+'VHPR@'A"79Q!M>I,WEBM2X]T[C"[)@1RA)([+4O03[UGR]JK
MJ<!/,=XE@Q<RXB#OM077%]@U0B!I?O$Z_):4K)G-$=#8#-7@QJ$S;Z/DM*C_
MI!VIL+)T+>FOR;-//<+1'&Q!$G$77E5U^'YM^^:/"$.4H*:',V[)U#%9]$[9
M[^FTND^?X(+),US1-8OU?M3<&>"_4WO[]K91Q\]3APU)NAW\/[>^7;YVZ!:6
MZ+60._&3:O?9;5L+.TH._%NG7$HT7T@9;VX-QKJ&E,QH1D,!3M#K@PE\0]#%
MSXR]%JQ?E"6)1(5!C>0VV ZQ/6=]+N 6:E2+O]SU??GCX7X=_NV8DEF-NX0>
M$&/O1YAS:U/*FD]Y=\O+!88'W1.79/A"%8!+R[3KQ3K>GF!FRZ,RP <V1IV,
MNHO^Q=RFQD*U"=@?ID8!47J*Y4=_RX] H66;S:KWS*-J]J+M#:&M-!S2_R2I
MU3??_4QHDZ-<Z2CG1ULTGW>7$Z!Z&69SV_7S=N/\)]68G7ORQU">SOFUP<7N
M;SGTCAXV?CL< PPIICA<P[\Q0]?R29)(B<(O9H^,&>Z.5=T.#K/NL_M1K_#K
M\CFR2VI-CA8&V 2M&^)WDLM]L]GVO5,R8Q[FB91:^AN43@(J#S/'4A^% B6M
M1G9#HJ7J) T&/0W'*A2RRJ#ZC$XWJAM-I3EZEA)A7M[4L6M19@>:7U<)>""_
MT8XM6X83^%E\LF_R]:H?CN3>VWGHU12=UW#21,0+'V#O$J#JGK=((!?@K9&V
MEG)%N#;A4X LP%0M*T<?5(:XZ+,JEO0R>,A['Z3R<[<\O<9\?GP:$_8'7)$7
M:+-5NH!:+ZJ?)%=D[0N63E.!%MVC*V]X!\39NC,1:W=%XX2ZDP_#-]C5'$\D
M*.@"O3)(23FH"]X-/&2[ASOM,WWJN76JH[_L, + 4F^60/ZMIJ><?C5P(1H>
M%][OOW'KE!+($$/\_2>9,'2UO#Q3HX%7G6SI\C!=Q44H>O[0W,HS;W4+VK>>
MVJX1$L0:&^/N';LXK82T_^?6BNJ:N\],H$%1TEEIYO>%N1E93FP<E0?UYI[
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MW28V,T]+G_-^KI>E2RJYH,=-Y^ JW%[OGEJ7&5]1[0"M0V9\M38 &_+/JQG
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M(1^TI5D.ATLE;!A6]&)OS^J,LP$[XOH^@.,BK[6S;?(]SR^YK2KR\U__X^$
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M:'Y+C_@) $U!"?^ -*,"^%ANBP9N(\_<%]LHE$)N9[\9B=<W]FI2IC%.J7G
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M:6N^?PJS@4RYVI4"_<V?F^9D8XMC_-'X73ZIL?R.ZE:]/$O.&5%[3/YI>?&
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MF8AS?O8=_TA09ER(C3K,U^=Q=U7O[]SK5M_ZX=6MNV@6>U+X!ZP4Z<6T'E[
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MKX./(S&OG1E\W4O)[H8*&7$KYH8;MOT=G0@:HT4,#15X<]AVBGQJ_W@OR.F
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M:V3346.72$>Z"NTQ4X5E?+$@ X/Y>U'39Y];6&]U"WU"WU#4#*NG/-<'R8I
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MJ<5FFC6=MI0=PDE_*ZRR$+Q(@7& ,D<G/%6YH->LM>DBU>6XU;2];_=M#%&
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MT)[BWUCRFLKMX[5[N.0H57R\+C9_#\P/Y]^]T;3+GPI=&^%Q<1W&N!!]A?\
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MQTPW!Y_&K%IHPT:WTVR&H7BM;029F!_=%CU9P?0G@5VJ<?91U:MI9^?7[_\
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M_P"M..!GMSZ5>GO!INB_:9823'$#Y,8 );'W0.@YXK*DOTOM(EUBS>:VN4B
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M:6T\TMSI\"0275S:O$DCY8<%OO<C\15IM6TV&XDTN";S-16R$Q$1*JJ;RNX
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MM+6614O9O.MFE(C VLJOG'G9/'3O5>ST*2?XI6<\FGWUSMM0?M3@?984R=Z
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MBN6K.[:J.S^SIOY?GH9^W5-I4%=M.Z;M^/W+T+F@2W,-PT=Q;M&MSF1<G 7
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M- K3&(.7&")!W]O3M2Z?>6WFQ&]O)VEB/F)"GS%5'\1_E6?N0E%06K_+UO\
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M<*ZJG&=W;/(/.*J:?XE;5M9U:&*Y6?5H+8!%VO&C*YW9*G@#M54XQE2G7O\
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M 6=&'(8*,YX[&N=8KVT)*VG>_5M:;7_KS'&/L84YU/=O:Z?1_AU[FEX@DO\
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M^9M[.*2;?]?UH>>W<J:D\EE!>H;.??'.\+%=[#[T0]#R ?8U)8^+F;1CIMK
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M'SY;HPY[U5O+R;Q)J$R:!?:?<W-K<)Y<J$B2TB;AV!(PQ.,8Z5;Y5&^]]_\
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MVD;CP?I7I5>1R@J;T>B?E_5CG7NIO$;W]+RUT_KL0NVF:[X-N9[S6#=:1J$
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M]*5$D?5MF.2V.E8?C&YT_3Y9;ZVM5^W& PS74=MYKPI_"<'C@UIZ9I.D:O\
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M.XD<Y'>O0[B&.X@:.:,2+UVD9YKBIM+N[>Q6XEA81G=N&T;DYP,_6NFC))6
MGTVSA1!<ZB_E!"AA4,,L2<@G'.*DUJ\:]M+1IXEB<,WF1D#((^O(!J2#4; 0
M?:I(5DOX8<[\$*QZ >Y_"J-S<1W-[<3R8D!VN%4<DXQC..%!]:RA&LZKG/9;
M(T;ARVCN7M%LIY[V-YXWCC0^>DBJ &/3 /ICM717MO;W$*B[.$1@^2VW!%$
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MN?\ %6FK!>:/;+#K%TTEZ)_M-L_RPF,%OWF.=IYX[XJ:>&Y;.7O)==ONZ_\
M!U-\154TNCOMY]+_ -/L2ZCI_P!OO$U?PU%##J4>G@P27BR1PA6.\ J.G)R>
MA]:T=+US5'TNY_MVR@TRYBE\F"0R;HKG"@^8N.0I.< U%JDT]PQW7+,DH!^S
MJXC,:'[N]3SSS^5<Y?W\R7-QIUNF[4X1Y:"[;9$PX.5;_=S6LJ\XSDH1>O\
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MMQ<6,K(1$JOV0GT[@CO7FNG67BC5/$FBZI\0I[#2HK:;R+2W95)GF<$#(^8
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M?GWK6$\"[ "[:PLY]4RA5%\\[GY\58).J-E J-%!OBHV9*-$H&,D9NLI!FE
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M0L>_:/W#-R6KJQ;31Y^O:ODI.M'ESD"7D2M)F'Y2N'+4WU[4&KL^;MWQIN:
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MJ(F*<DHX3$+D_]IB8KH7VA6GO,5(&)N5,Z7ZQS\7Q70D;TA-IY5ZS]K.VCF
M^I+ JVZ@[S\EAYB'@GX+>'^' L[8XO?Q;EDKJ8IGLK'R(G'EZC<X.14\NE&6
M>&J.O5>VMD22,HFG>9A+\8>FW.T^J,ND@OF"/I(\;!#SF'+AJ:JFNI:&/S\]
MX'C"2D;;6<+ECTYKUYZKK__G?H)B$PWOHDTK!4WY= Q(*RC7%C/=Z$I_%_ I
M'-_?O#_Z^$P+R?-1J"EGS;69?J47T9U:4AAEQ;?8>C;.>1P*$GBEN9VRG[,J
M46)C5Z37'-N(S R,OO=>Z&'<$2(2!/S'7$?^GBJDG_R=QYL(PYVB3A3M&I)T
M/O3LV)+]%9I*)EZ;:@D[BUE7R1"WK$IV0N)G&Q53Q%8;/(#'"YDZGWH6DNXM
M_U#0T9I&]#8XL!+G@+E?J'@2%\G41?;1^8>;#Q_U8]#WKG\LMC=H-'B+!?<Q
MAJDI+IAJ.\%LZO?<?W1/KB4O&/E*$8,C">6&"H2MW[A;*RKVFZEX#5)HM*)R
M;^KZ^M"N DXJ^.BVML^F3[>J&N"]:T;8E2_+O!:YPZU0K1;&6^Z6)U2I/W*5
M_3OIO\-^P@><K4LC?%P;P%XK='=\%"MH:J\K*]>Z_H0X9SQ#?WYE-^=;$&'4
M)Z>X<>O*63_G0"VOUH,JEA)B#O14 ;H%K9,Q^ZYL:S^V2:;$M,O'A)VA5/)5
M^OKP8WSZ!@E+EJ"-H?D78?ZT9>H2FJ98*D+'H/JOE \5>^ $<Y;C;/DU?W"]
M 5&AB3H7DK^(-7"KSUHF2.43AV#7()F0P74=HS_PDY444RPM O%N7! 6*T^K
M)7&PM07:"R;C"W_A#&4F5PB5*>*6 :T&%D=A#D+TXSP$+Y3I<S4.[M<](R*3
M=Q^5.,O"4G5T#BO@"E1ZR\0#!)0]!^J9AC=9D.6T+MN&-SORQ]YT];<)!VI-
MR8Q.J7@4/D(D8AX(9FDO?"0W[YB0;#3J*A(V#B@5&M/ND)6W)-&9U;#,W$HE
M'G!9J>[H[K !]1)P]2)&^V:F>:%D.V32\!( ']H*T"B>IY@5#?C< GW/LLHW
M*;%O,552.]Q*;&@*V_LI9[@ZR/A+Q4ZE?W?T=83$'Y9^/K *3C^149J@Z^DT
MQ3I]CFC6T_MD%+>BMNU/5R'OD(!.*8,'%!^_[17>E?MA5Q/?-FTOUR7]//+4
M4K;'I&QA[!]]M<+Q?D>!;23KYV(.J@>\L&U.1FX"!4%LS6C*=2ER\S5E%Y-#
MK0)^AM 3JH!==K;HE!G?P"OB+:L(>2(3J4]*Q@SWSBKRXIW< -SS_:V%8V<S
M)7%?E5.+KVW-!X07J>*)JSMJ)PMOQD5B^2-Y+>6#UA55^$:Q&?XACU$]0?;>
M1BX$IEU7GX+USN'MFGPC6ZP)HA3J-?G_JQ8&=JFR%B6Y5E[2@X3SVO.Q]V>@
M:6?P\U(;_)S4]) ;8U?*$NJ?\L.8'0?OTB7-6R](G*T&9LJIND$BG\YK*XSH
M[ Z.#BNE( @#W$0(G.%G1,@R0C$L&>B5D-=I]*@_-K)K6LTLH)(P6F7SYZ=T
M"N];[(1K2G$.,&4%)* F&<4/+@JJJ-P*19T?_4-S_,?L58LAG&\8%EE[AW9P
M$(KEAD99P#:V_[W3U>71X=U6S<%NH_ 'UE3\)K76>?(IZHN=3C9L(6;/@^:[
MTO@SB=N6Z-9<K:;6*4OZL-1UI5 Z.\[%#, EH/JHZ]H;D.9[I_;P_#HD_2"W
MQ->7_K-"Q3?VXJ\Q?7-Y"\ZF,7+HR<:C5K"7 -4($8BMV>IG5UC3*/@B5![9
MJ&)33#"0]^%E>):;Y)%LP4?["QV:O7 )J'_J.4%GLQ+PZ*2VME]D4^.B6B]$
M0%"(&Y;DY198]6V3EF\/GT2T[",-#$H=M#TSABE&/'OOK 0XQ7WW#LS(B%:\
M!+P.ZO#L]4*9NVI=4]%,D#][#@D*QMTX\V477.DR=\W2**LF>5I&QJ^D%I?W
MAL.]'F4WZ;4A,OS[7,VFP@1L@[F-BBN\(D.HI;.A.(H<8K=9CD[8]*D]-)U4
MU-J*W3CW4DK2%1K2,A9:O!\6L4$[NBICT>]7&BC*B3%;0<0<>?A)G65*ON V
MS8TD!&-1$_)-%_RK[[]"KM1GD8"#2]D2O$FK+L.^W\VQXBE;;I,']+&2UL22
M[F$P>-Z_9[NJ)%@D&0;VTYN:Z^' U=M[!@)M\0/OZ;^"K.T4E>\R::L$O9S>
M_-8^5399@^'R*]*22Y.EN:=,V,(G)LW\-BVKJT*B_O\(T4H]PF/<HM*K?=-Q
MO'+=W[.Q]YJ*8B9#>MV,0:5L*[^_+"[YD&(>0H$#[=$_#.BA[I.6<HHOOQ?+
M07BLRTD#RA*GV*SR!;"ZA#'29N1M']N@EXA<A#@L6L,>&=1U6O.X %(?YY,;
M]<<U\?8R0OD76Z"R.MFT_./JJXK)2:NR=D3G'*6^IUA^UJ-&JAA[A#G"$'P"
M#@]?9F<UY706JO8"$MW1B!G?<4[BJO3F'4!L7>2?2?$I4P,<!E+>8J-?K<<B
MDM(&&53B"^KWGMMA_W"]WBV:U=OJRC1*[JJU\%)R19^VJH4, _FPMM[@&]'.
MU@!,E_(MZB2,(> K7^2:<K^:N56*2J;0=PT;*<F<5CU?Q(G-Q2EO4/>8PGU,
ML2@_<.AP6@H.W[=JQ1 >"9M/($.._:1S*_&C\A1-//N+JY9:>TJ\+M?NBW?(
MVJ(9ZQ(8LS,8<7@IJ<-9/'&8N]I^68#8<&#'&S7]&W_\'O=JLHW@%=4"*OFH
MMG^/OOS:Q2-#3U]I"..2MQ3=BP&6])7W-!F;$DUVGRF!K2TVY["__PXZ.C^N
M:W@]&QMD;D' %C$\7W_9>O?=9C7DG%MN#.F+3%P],*8"ST"A0W@GJ5_X[\^#
MYT5\E:1^1 W=&-R'BW7"]NPF:I8;SU[\4LSQ@CED74G+;%YHT#&.+'4J[Y5N
MKP8!A^GMT F^OB))_,XRM"(NZ6].K-1M8:LKR*E#!^E2DVX3Q"S:;X8"@2R[
M_3T4^$,MZWQ7U(Q&YDQ_[3%C3QL1>1NHQWGM@C3]EQM,U,BE\68Y"1/5#&^A
MI=VNY?A)XFSZ\"K7MF6J5IH?JPT-7\C/D>6Y/V;UB6@D"UI)V;!-2;8*/7L7
M6+M":M;,]'N'V32V 7M@\)K]07$S9MT6^4ICY^,YQ"PL"#M7GN-M;WP(Z<>;
M(Y[2.3+1U49++T_6""E:R4B:7?DQSF^J>:C'1Z<P:<@Z3M]S@E\WGY]?;'&2
M.62<^Y-EO2F<_C/35NYFW-9^G5%!56^FM!JE'6=BV+ZLV1$7?HU-#:"98''&
M9_5*U])(/"W4;J#+E_A;&!K4ZSK,>;OEQ4.1P-M[@BX":O>%3RQ[#W-DY)NW
M)(L^&]P%3?R'9_:A4BG]<(B$YY?W0&^4W#H\\$?[8(BJH-[K!QT42L'!M49#
MC9+!R,V1'@G@LUD#<O_3U /5YV)IY6SI+VX3#5_O\#N;_)LXM72:@KM,">\Z
M>W(M.?L;V=#A@6%/9JCV[BIM%15#N0;GG?-\7VQ-*O"PE@#M[*L&O)< +U1+
M_!C.2@I%F\S2JZW0KC]Y!!LC^ >MW>VCC5&=;DX^/"U^?NV1W4SQZR=/]Q1I
M1XPI.:L*?(_/9/KP^5WMK8C$G?221#TV>#Y:FCA;?"".;2,L!JCA\EO\( ?1
MB'--82_] GZ3H]NFR /"%F%L ]^YDUH(+?+++ )'$(Z"M FM.[L'Q'[]T1W:
MQ-(,'81*:+J?Z&Q-^@B*\:S'+#V3?BJU>8"SAL\2R\B/_8/76GGP$&KC=))<
MTTD)>W.NM"8.MRY\I=-0WY'UI\LM=V7/_)'0WOC2!=A+OUW%OPJ5?S#I5G4"
MKG-HM8^8^CYJ*9=9;$0";F[M[C>U!W^EGC\/^N;-'?VOW TJW,5*4.QEF]O,
MG\VO>MI'Z]#7PL(.+UUGT2G[A7K6]R1;[B=,*%E&U:ISLO:_R+ /"IX'X&^.
M+.F0^WL%XA8/.E+5']E12? BPG&BX8/-L6D8G:NGNXX);_+ 4^9D%ZX^9KO#
MZN%ZZ?S[Y@&K:Y;X?]G&H^?G^W*]IN5)P6OZH?KCH1EZOFU4.#4:S7[^O!I$
M.(YY\7N3_3[UR\N,A$RL2,BOUL@]<]BJ,6^X_C_\J)]'[LOFIP$BZ44\6:_H
M9+^K2;@6&($9HUS4^+D,-22<7$1[E-"IUG%MG#X^IC&6G#27@!IO\2FW"7D*
M5.*>3$@2X0O_?5:29D.W_V/6OI>[-^.FF(+,=.CHG(IOIK?5YI\4ER(:9X(G
MS37!MEF*@4EMMAV5FYF;F059T_O$W*-Q_N;AA4>AIS'%89S-:8/-N\,^OBZ,
M8TR_P_M?XOYC_U"Q;O]@PN=V=X!7.OD((DKLS5SZTO:I-]]N!R5"D[?KU12)
M]N1NF NO[D:E>S?^EV(A\DN'XR:<7SG06X8G?-1//O^%5CG(C@R1:QUDFWPF
M+%D:*O=#]7U ?_VYXO"T?E!X</LJWI8<W4Y051< KF<'_>EQ6E'ZA83SFZ]
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M8@LUMM>QY&.P^I+Z2'F^2=7"9K!2C_K[\T:-P_8N"-X287\=]<F-7?#(*("
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MG.0?6LY8/#J\(.[5KJ_3HO+NC.=23DJB24N^SWOO_6YA>%C<IK-N+P-;7CP
M3*2AB&#S$I7@MQN_&M"R^V:O=:U:HEU;V]M<F.,7*_N[C(!W*PYV@U#XOM[.
M/4].FM]$M[W5+/=+9NTXB:$'"R./HO<]\5/$9+'3%D6[DM8+B1%@##<QD)Z'
M'\)KCY:-"T$F[7;U>_SZ/[BZ<(T*<JG,HJ]]?/N][_B=)%/'&J02S1>>J@,H
M;OCWYK@?%GB;7-)O%Q%!+H;RK%)J N%38SOMV;.I(X_.NEN_,CD:2>"T-QYD
M:F5%W$(1\Q;^[WYJMJ^D&?3#9Z)<26J2NETMR(TGC(4@[ &R.0.#U[UUUX3D
MES:+R;OY!HD^1^]Z+Y[E!-($^OVEI97<=L\-M_I>GJP_=+D[90/[QZ<FK\_A
M&X@CUHZ;J#[;^W BMG'"2@?>W]>?ZU"VM1Z'ILM]!IJ7=S]F,@B@.9Y6W<1@
MGM[=N:U!?+,L>I3:??0W$:*@A(YRZYP0#CCI7-26'Y%-)77^7IV\E<TG2:FH
M6TC\.BTZ:=NV^B,W4;VXCL]$TC46DBO;R/RYD@@$T3D)RK$] :R-&ET^?PW_
M ,3_ $>.PDBN UI:W^U=DR9\O'<9QD>U7':XN[:><NKW*E&<ME2BAB"2>F?:
MLGQ-H4TWGOINFOJ%O> >=/$0TPD'$9(/W@._M62KQCBH1K1:OMOM:VVWGH3*
M"4*D:3N^N]F_)[=/U>Y5O_[9U#P[+,9(;2Z0L\PMYRIG!8;=I'"<X'X5TFG^
M#[&'4K.74+:2ZNFMA)+>SNS.), 'Y@<55T35XUT6PLM+M(4EC18;NVDC)99A
M_"V?SZUUNH0VEPL/]H2-'Y@:#:KD EQ@CBNE.3<J<K))JZ2LM7=[[]"E&*4:
MD;MN]FW=Z*W3YF"-/U23Q<H5HT@M66=KII@7G0C&P1CH!TR>M9NHR7<FN1SV
M&MW4:)&1,(H1MN"QXY/(*CL.M4[:#^Q/'UUJEVK:-;F$:7%$["3[:@_U<V_.
M4P>,=:G\+WCZE/J5AJEQ#)('B19[8LR>=@\ GGCN#6&(I2<5"CI:]W?_ (;7
M5*^K_$(5%-?OXMJ3LK=M7?NEITZ].I9@EGN;W43'#J%J\,J0O//*'6X0<B48
M.5 _SWK7TRTTS28;NY%U+J4M]<^;('?S0KD=$4_=7V%8]OH][?\ BA4746T_
M2[::.2#[/)MDO74$21R*?X,^GKW[;VCZ#>VD-XVLWT%Q,US+):S00"(P1-]U
M?0D#O5T*=1)SA;7SV(_=0_=N+LFW>R5[[W^9GR:IIUYKE]9)/?1WFG212W#6
M\;;55OX0QXVXZ@5IZ!9Z<FFW5C9B(1R2O+(L(91\YSGGG-<C/XRUG0K&>:QT
MFQN=-M\-)-/>"*0C?\[$8Q@+SG/?\*W'\2F'Q1#(MV)M+N[=52&./[I^]YH?
M^($$"HPTJ<*<'S73TUU;<O/U\O1)&,L535-SOII9ZJZ;M&RMUN3Q:8MI*^F6
M][.5F5S<+;J!LR.#GL?YU#:ZGI2:;97,EE=VL^QXT@G4).RKG+;,_-G'&/6I
M_#^B#3+A4MC?W$"S22FYOK@L[;^<#CE1V':N;T32M/G@LX6G74/L=^TJW**)
M#@N3Y>0QV@'W_"KC[.G!TIKW7=6^[O\ /\;'3)/EYHQU26BMY^B\SHIM1M=:
MT"'4+66;RKV$&WMKF,JPVGKMZAJRY](#ZK;NES+''%&O[IAL(N"#@[LY[]!5
M[4--U$7$SS[IH5FVQ,(\E4)SC Z@&LITT_PY#=>(K@R$378DD0L2]TZC"K&A
M."YQT&,_A7!SS=2SARR:MIK;O9M/Y.VVFC9TTYN.'4F[=[_AM?\ /_(V[;0A
MI>H/J%EIQBE:5?-CB*[9B5PTGL?4]ZA2QM+/7I_$U_86MA]ACEA::%MS,I;/
M(7N3STS6/?Z[87GBO3=9TKQ']AG\Z*PO-/O-VT[E\SRU3&!*1QD].E=)>*]_
M9SQ:=ISQJQ\Z3S4VL[8S\ON<8_&O2G'DDFFWY=[;=#BIM5Y7>BCITM9_Y=+%
MK3]<N+_1H+D6:17<XWQVK3J2T>>&'X<US<=B$N&M=%O&U:TU"]EN)[B6_60P
M2# ,2CT'IVJU9K:ZBUEKDFG7&FZS9V14)=J&E$7.4X..N">]<YI?A[5KA+*"
M_M]-72;&9K^YETJ-K>:2Z#[D 4<%2"-WKBM:E2G6<H.VJ>CVTWMYKS[#C&<)
M*I&-_P#@['HUE="W62TFD22: CY(@<A#T)S^M<T/"VB26=Q<^);:;43/*\3>
M?$0-F[<!M7C QP>M;B,X6!H";Q;V4EY'7_5Q]=I(]*Q-=34M=\4Z5#H6H:MI
M]M!;S2M=6JH;61ONB.0,,D@C('_ZZFA4J*;3:Y;:+K]_:S6S*JJR]=_Z^\VK
MC4G;PW<36\<<1(,=L,Y##H.!@_A[5D)::7<ZKHT\MQ=?-;/"J03'[-*Q^\&7
MJ2".#VJ+R+R^FL])U*XA6U\LBX(4K+-*""C(R\#H<@8[^M9NJ^&]0U9+);5+
MNW$E^AGDAO#;,D(!!90!R1GIWKSE6G7<)2Y6EUT>M[66SN[VM;KN^M5H^RC=
M1;U[VZ.S6CO9HZE+?3=-N;B);W;+<9C1(R2T?&2.,\_6L+3+:3Q-I4L][<W$
ML:;);:8P^3(#&Q^4@\\D546RT/PGJT%A9R3?:;NXCB>\D+W,MQ<!?D\TC[O'
M?@8KNH[-A!)/-%&;V6+9(5)VMQP.:Z8T(U)^ZK*+=M_1_CMIZ;:Y.4:G+5E*
M\EV>GS2T>G>]F<P(;V7Q5::E8P7TDD]N+>=Y9B;:-1SNV XR3W'>LY=)AT/7
MM5O;R"R:^Q-,E]';>1Y,$G\)(^^V1DL?SI;+Q)J.F0R:5#IY;5T7;<[I<V]J
MQ0M&1W8'C.*UH+/6M2TN"XUF&!;I;;R;I8E.),CYB@/4'T-$Y3]DHQOS]>O_
M  Q;HQE6337*G?;?R^_UL8VF0KXA\*V-CIUWJ5C*A14U(A7F*AMQW=@&QP?2
MG>"M+UK2[;4)KR761+(DBQVEX8W4$2'$H90 68'//;UXJ]I::5X12ZN-/MWM
MXIXU9O.?"9'/+'@=3TK2NO"VGZ_)J%]/>WD\.J62VTEM'=$0J!SN3;T8^N>:
M6%G&M3?(]5?96\M.X\3#EJ*IR_B5VU;3]&N$LK?5[:.^WQI-8RR ,TD@^4>V
M<$@5G:]X0O;?P4S)=7VLZU:DE+A95BFFC,FXPECP%P<'U Q[4_1HM&N([&'6
M="31]6>?RK5+E!+-*+<;4DWX/13P2?SK6UR.]T[1^MUJK&7:D"?+O!' =NPS
MWK>E*<$U"#M;NONM>Z\_P,OXRO4=OOV93TG3[&U.ZXBBAMMY1+<N"H/!*XZ;
M!V%:']J7TFBR&_A@@O#,1#%;D3@IN^1CZ9 KGWL=0EBANK:41&Y,<:6[1C9$
MX/S@#OD<9SCBI=%U>/3_ !9>69602S(C):XQM&>6)/ QZ5Y^%JUJ4W%?"];O
M6WGYW]?O/1JTH-)O6VEO3IY&\FIQQW5E;ZM;6]L\S,T6\X(;.!@8ZFO,O$+I
M+XDUZ9?LMUHN] +I[>2=[:=2 \87HJG!Y'M7J%QK>GGQ,^D3-&]W#;?:U61>
M(USC=GMS6=IFW48[[3KBV$T%\S&<QD!5##!(]2378ZNJIO=MK5*^FG3OW[=C
MF]E4?[Q>ZE9V[IW[_P!:&1+>1KHB7VGI"EIY9F2TN!]F5-ZDKDCCMR?2GVUT
M9-!L+G6'A$EV$6%DNUEB+$9VQ?WAD8X["MB+2K&UT>PT74[>WU"".3[.HE<.
M53&!N!Z\<$=*\XL/!>GZ9?P>(X)-16#2-5E6>WN;':@C'">5'T&,@!NG? Q6
M2PZGS7U;:_'O^&S^X=7$5(2BJ:O^'7=>?]:G;_;K:+PK;#Q=I$-_>7MY';7D
M%C;F:,2EOE8ANPP.?6J]O:ZS#";ZZU.%)?WPC>WM0N0S81=OJH'7O6AI5_>Z
M-X;$<DE[XADDF.RZ>-49O,8D C(X4<&J^C6VD2:8+O2+A);&V>6.80,P"S#(
M(0'W/^%;UN=4XSIVNGV5O-_UZW,Z4;-\][M;7U>FW];!'9Z=HGB"*VO-65);
MZ-IHE)6-UDZE@H[8K2@O+?3T>VAG@G25F(EQED..,C^+FN=-AI^F:J;LQVQU
M2Y01B2X/FW)11QUX4@'J #5NTL%GL)YH99[AHY/G5U"LJ^H'<=:\NKB)0J)T
MX.[UZ_/Y?UT-J%%QA&-9:/SNE]_KI;3R-!]2OM2M[FPAEA;4543102$Q-(@^
MG3)Q^=1RW6N7O]F&[N8M)DMBTVH6440N%GCVXV$]N372)%9[$U*&U\R98-J/
ML_>%.NW)YKF]1NC'J$]S#%()RH/ED[!RG*EAW^M>C7D\/",HR;;_ !W_ *W"
M$8XAN/+9+\]#)T"%[4"&QM[JS>.YF,"3G<L@+9#(.B(<G [5F:Y+J-[XBM+2
M[OEN1,L[BVD@(%OR,9 .&QC@]174^'%U"6R)4PK*%,;N1EX5.3P!PP!_.J-G
M8)>W5AH<,Z2JEK))>W D\JYC9C\KA.>"1]*SITZL4U"27,_/I;5?J^NFG;9^
MR2Y9*Z7IYZ?\ HQ'5K+PFEQH<'G7Y,=O)<VT))9PV,D-U5>_N*ZN!(-"LKR]
M1+B_O/\ EHSMS(YQ\JY^Z,]NU7[:]T[3-0M?#Z2,+IK<RQJRD[U4X+%L8SFJ
MVI7>D>#K.YU.Z65([JY7S3&C2$NQP.!G KL5":DI*>V]U?I\K?GZ'#4K1_EL
MONT.:C\4O+']B\0E#<K??9EBGA:'S)2N]4C(X8!3C/<U>%G;ZAI2VUA%9SZG
M;/'=-!.F1G/RDD]#CTK#U'Q,=>_XF3&\6+2+HQ7.@1V2O=,[';&YR<H.X8=C
M6I;1ZK+?P6MYIQM+J';+;RPS!%E &=C@#.!T//-955;$N<H[_P"?]65]2*-9
MV6'5^]^EEW=][OUT;Z'=IN\M=X ;'('3-<1JB:;:^*H[J_\ ,.M7RR66G,6;
M;+&,.R#;\JGKR<$UJ:O<ZA=W$<%D;=X0C+*!OW1W"C<N2/X/7O6=#J%QHGA[
M3M4N].DU'4;EUBEM-,4^6KLV&D57.0!W-;5[5G[.^C6NOZ>6A2_=1YGOZ?UN
M0^!Y=GAF*ZDN[W5'MKV:$230?9R@+<@KW"] W>MVVT"%=;.KRZ=8Q7<X_P!)
MF0'>^W.PY^E2ZY8+>6%V)KI5CE14$<Q_=HV<@\<YJOIOB!;C6;C2+@VL;V=M
M&T\0DRZ%N%R/0@9K*4HPFU4TCH^EOG966R,Y5)JS:O?1/5N[O?3MYW]?//'B
M+5[S48)IK*"PT9)9X;J*[&^:Y"\(\6TX*GW]ZU]+T0V5_<:B;J662>)8T@WE
M88U7[NU.BFM2*UMXHT2*&-43E %'RY]*CU+4[/2+%KS4KA+>W0@-(_0$G _4
MUUJ$K\TWL":2Y8]3FOLFHW^JD6\QM&CD+72K)G<2, CO@#M5RT6VTK5)EAMY
MY?+"H\H;."WMZ<9S5K15DFO+N\#1>7*Y5E4'.Y3P>?:KVIK;MIEPMXC/ Z%9
M @.2#QVKBAAU[-5;ZJ[OY:_=YLZJM:2;IQ7RO;7\2#4Y[![?R+F+[5YV4$2#
M+$'K^%489)9=6GTRPM'M[*U@(\Q@&BD=OX2/O9'7WK-N%>VM$N(KAH$E?R+)
M5@9MBD8(<>O'6J:>,;K3M/\ [-L--DOM5C03?9R#%Y=N7V^8S,,$CKM[BLZ&
M*E4GRUXV=KZ;6O\ ?KOT.2-:DH\JE:?6+W]?\NNI-;:>FC7+VR6UQ)<R% !$
MYW/@D[BW9,UTTGGN]Q$ZV[++!E;7/S,Q&#D]QVS6997UQX@@EME:XLY83AKN
M,*-_'8?C^E-BT35+*#59HIS<WTL8CM)I9<L!MQGD84YY]*Z:<4_?A)OF=_3[
ME]U[ZFM6;IR]G./]?\&QQMS?CPM+<RM-)8IIR"&*:6 N1GJ@4?>!)P#CM7IN
MDW$EUH]I/.'622%68/'L;)'=>WTKSGQEHFNZ3X$4QZG=7%U%;[9KJ-E1WE(
M#OP<X/3'_P!>O0M!BG@\.Z=%>7$EU<+;1B6:7[TC;1DG@<YKJI0FE*<^K\]/
MT\_F<SC%2O%]%I?\;7T73Y=2S?-,EC*UM&9)-ORJ#@GZ&N,V27-X(3;NTI(V
M"7.]L<?,:[JH_(B^T>?Y:^;MV[\<X]*Z83Y1E'2-+?3EG$TBRF5]V<<GZU87
M&GV\TMW=,Z;RY9_X >P]JM5D^(+Z6RLT\D*=[$,&0L,8_2HMSS38[M*Q1N;^
MSUO4([0KF *S>80P8-CM_P#7K.N)(K>>>*WG9H5=25"J2W&">1U_QJG8RI%>
M(\OF%3D.4;!P1BMC3HX=2A$&HO -JCR65MLIYZY[Y J:V&YJT9/X4OG?_+R_
MX8UA5<(-+J17FL7%_)&ME'%%/R(&:XP!D?Q =_05R^L75G)>7$>I22S3-A90
MT8E\LKV(YV'#=<<UVVIV26TZR1V,DEO!$&PC;5+!NN!SFN:\1:]HVAWB-KC1
MV=WJTGEV]HB%9)LL%WLP'4<=:Y:ZC&LI4N;FMLM/G>S_ %V0X4Y3@[VL]-==
MNRTWOJ[G,R2/9:3'>-::@IAF$<4%U,BLJG@Y(XQC\ZQM6LTU@O)=:EJ%C#]H
M5D\@^:+<C[V['56^7 '3 KHUT%1KL5_?:H T9>*&T8LRW$6TG8RGY=V[!SCM
M7/6?AS^PS>:N;R&U0WTLD4T:%=D,@^995S@_,!R,XQQ7D2Q'LZ<:JG^\>J?9
M:W2UMOUMU"GSPJ23C9?R-<S>VSUV;BD]+K>^ZO>$++0_!]O]IMKY[DWMZT1F
MEG7,YP=R=< #G@\DYJWXKU+2]3TS3]7TK2$OXYR-]O& 1Y./WD@*X.<8&3QQ
M5+7[JPUOP#-;M;K<-%=I]DEDW6;FX49PC,!@XR=Q&#TI+6^;7=;LO[3TQX-)
MNIWMQBXRY*(6RRH.>1USC\*M4;KV]1N\G[W-IMMMW[Z+3J5AEB:[4FU)Q=TG
M9-)73M9VE;6UKZ6#3!H0M[P#5XF5K8VT"7"G. 0%&3RO'&!UZUI0:C=:1>QV
M-W+"VLR+&D$,^0HC7Y02W0_CZ5FVEYITMY8W5KY1C:)H9(W=&",F2K%R<-C'
M;/I73^$K"'Q'JLEW??O+VUA^R2K+(2DD#$MN"= V>_M7?"G7E&2<?=NFTU9O
M73Y/2_W$8BI2NG!^^TTGS72=NKM=M>GGN1ZYX3N/$VD6]I<:I+I]S,X$<UK&
M0K'()^7N, X].M<1XL\&R>$K&\B2$7-LUI)&D4TA:69W9<  ##  9'OGVKMK
MJVU72=<9)KJP%M#/F)F9Q(B8^ZG;<16%XQU'2]7\.VNHZKK,_E:9=*8KN/,9
M!D^Z>0<E"/Y]JY,#S>TC&27,Y6[;NUD_+IV?34]9XFI2IV<WRI)]]4KK3K?9
M]6M="3P=XLTZ"**:71+>QFO+<6=NL$F^X+Q#!1E RJ@9QG/:M]=!*:$RSK+
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M#3H_#%E_;@\16NFF#5;:![2 23,$9"V22HXYYK+NXP;^9Y25B\\AG0[\''(
M/7!-=&'PL)17,]-+)*R5NB7;[O0N53E]V*^>[_K^KG0ZQ/%<Z1#)*CI;RX=I
M<\P^A([UAZ)XDFN[+R=2T^>WM8FD@<3*&:10<))P?ND?7IWJ^MU;74QMI)/(
ML(MJ1Q(/]<"#PWL:HZO<M:Z597>AV-T]K+*MM-%"5'D19.9#UX&*XZT:C;KT
MO3[G^6GJ5&3C)4ZGPVO\WMT?3\;&_9/90V,L>B&*YDC7[H<9;TRU216$SZ?+
M#<2>1YC[U%N IC'!QGO]:S-$DABM;J\L&2XC7@06T)7//7GDFK%EK$5M#*E[
M]J612T@$Z<E<]L=A711YL12]K-[]MO455*E-PC^.YSNKQ2W=_-K^FV4,E_#:
MFVLGOE8Q'<P#*Q7Z$_X5K6M_>&""2[N;:.W@(>7R(]RMQC8H/( /1J9>P+J]
MG=0^'[N33+N7#07$D>8MX/.$)&>,YIEY%:Z=;VEOK,:QP%5MI;EF91(S<X4
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M( 3D]\#-6 <C(Z5Q&JSSB]N?LE\T<OGJR,\>X##?,N#P..X[5S5:DN9)+?\
M3\3HI4U.]WL=!8_V1K%ND]B 5603#:"IW'G)[\U2L;>PT9;FROH!B:8R&386
M#[C@9/KUK.B:Z@U-4,_DRE@=SOE>G!..H]*Z!+A-12VMUNY/-VB8RPKM5P#@
MC\^U<V$QD:EX25K,VQ&'<'S1=TREI\UI:ZFT(M841IWCCF5C\A Z<^OM3;V;
M3M,2![.WAE597+2,Q^5@.?F]:A.GWUW8W7G7,MQ<13[HXG5%* >F/7K65)J,
M=C=6EC>77V*9_,FMHIA\TY&#T[FO3ERV;;L<:W&^'[+2]:MSK$%_?6KV$S12
M2I,=KKNW%#G/'.,5=TJ;%] $,4SK)Y<"OD;5R26]CZ5A:1XAO8=3EMA%]FMV
MBFN9C=;%C8L1C&<9 %:5I>W%Y:RS-<1W#1$2)<1+Y8^5L$J,<\5EAZJG'V=[
MV6_];FE2#3YFK7._KE-0U"_M/$%Q%=+BU>(>3))S$V2,KM'.0.]=3$XDA1U.
M0R@@UF:EJ8M]1M[?";""\S2#@+[>_%<]?DY/>^7J]/F70<N;17,_[<+G1)((
M)(UF5UCS&OEKM+< $^U<3J^K:A8C5+&.TMKNVF@\N"&*4K<7#YQM;@A%)_BK
M>DFEN%DM[8L8Q*TJ$*2>>A-<U)JUT-:MX-(N0-35C#*_EHN><[=['IGTKBP5
M*=;%PYE>RO=/1?/6W8TQ]>%"C*.NM^BU>BM9VOO?T3U.MOFN+?PAIFG:CYFE
M7=T\<>80;G81@E6;N3C&ZJ$$>JMXEN]-TVV$VE3;;@M*"C1L,#!S]\$C/!XQ
M71S>(VCM%CECMA?(T:W<+7 58=W!8$_>P:P;W7GM;[3-$L]065)WFCN+BV#2
MM!*!E=Q_A7.,YKKKTO:Z=+.[^>US&C6C1]Y[W5EKIYVN&H1V^IW]I_;T7VT6
M5QYR>7+Q&ZG@C;Z<\?G46H:M%9,';8NV/;'"DV-RGJ5!.<X-5-#L;P2W5SI]
MU)<S:LH>4O:,JQE24?:&/R ^@]S5+5?"VIZA>V>HP73"VB:8RVMR1%-$HQL5
M, @@E3DL>E<CHTJ$9JM)2L]WHEMU?7IZFE#%>WBIP7*^MM=5Y?/[C)U>2TM]
M8&N7MQ_9M^;?9:0[F$\H;.-Y&0H([]Q@5!!>!?(DT\,QP55XSM+-ZN&Y;],\
M5Z#9X7Q$UY:K#>:A>(@,+96."!>& .,%@?TK*T*YTJVUVYD+7,THGF>:/RP(
M\Y]QSC'!!Q7HRQ=##4TE91MHK73?F[Z_J>=B*-:JKRE:;=KM^?NI+2WHGZ&9
MX-B-G-+;:C9W=^\%S)=SEVQ]E9AN"R;N"#C*@=.<]:Z77_%36*365I=6+7=L
MB7]Q'<Q,JVUH3\SJP&"XZBNCFO$OM-B"0&)KU,NDC!'1.['UQ67<66NW5O!_
M9OV&2-IA!=)>@LDEL.I0#^(^_%<E2?M:[G;XM=%;^M+'5##1P]%\FDKZO=NW
M]?<4O"GB:[U/S/.O(=5N[9V5TT\GRQ$QW1,Q;^,KCBNTMI6GMDEDB:%F&3&W
M5:H>']+&DZ8(#&J2%R788)?G@D@<\8'X5J5K0C)1YI/?IV_4%*3@E-6EU_K8
M*YSQ.\1NK5)U.T([94<L>@7I6_<7$5K TT[A(U')-8^H3Z7JEL));YHXH7^;
M:<;CC([5VPT=R2@RZO9V]M::9HF(KEV%U,+L*\("##CCDD\8J_ILXM;D6U]:
MV]M(J )(KKD@]CWR32WVJ3));Q:<LCQX5Y)1&7^4]!0V@23S"6ZO2\GF;RRQ
M@' ^Z >V*KOS=1&A/+::3:O,4$:,V2$7EF/TKEKF6)H+AKIBMS<R!D29CB%#
M_$<\=*ZF6[M9_,MH[I!,0R@*PW C^M<U!#+JOAN\LH[59[A =IEFP22>>2"5
MXHCHFQEG4QI"_8;9+ZUBO/),ENA((F4#D_3/>JJSR+<2#5[J6W@DC+2),<J5
M(Z@CIS^E5YXUTR.QM-4NK5L(42Z\@,Z =8Q@'CH/?%4]4GMYXQ##<":<.HD\
MYQ^]C(Y4+V^E>74S-4I2IM-NS?W?\'T\MC>5+DI>U=VM-%J]_P _+<ZMM6@T
M_2[;[$?MZ<*'$B_<QDOGN /2N/UBSD%X\^F--9+J5TC)<P3L&DD(R3WS&<#A
M<5I0(MHJV\6VW@(V1;TWA PP0,=^>14LMO8?;K:V349(+C3"P!E0[1D9! Z>
MPKSJ-:KBZO-4;4;Z+1==+K5];/7IIN:U<(Z:O&;OO]U[]-;_ -6*5QJ6IW,I
M6[BL8!LWQ7=J-SL^<'*GL0,<^M65ETN]B>+7K/[;#(ZS,9E##>ARN%'I5[6-
M-NA' 0%DA@A.ZX& 6[\BL:"%KN9(4#$N<*0N<>YKZ*GAJ;2E+5_U_6NISRJ-
MIQ6QI^*_/L;(ZE;0R3Z>$\R6&%<,I./FP,9XY.?2LBW4ZI!97$;6UQIP8S$M
M&&9",%9 <?+QN%=_:VWD:?';2-YFV,(3CKQ7-7&G2>';Z"ZM)T>"8B&:&1.J
M]MH& /RKQ,5@)5*T94N^OD==+&2A#EM<ZJ*1)H4DC.Y' *GU%9^M6;75HI@A
M#SK(I5N,KSR?_K54\.WXE\V*9G\Z21G4-R-OH/3%;M>K5I<T73D<<)N$E*)S
M8FM1:SZ3K#"V-K&9RT?RJT0Y+?3KD5AV'C 7FM7B:1<6-U8Q1QRPI"P+21,!
MAF&,@9.!76:WS9/)$=QA(,L:D?.AZJWMCM6;'JUG#?%=,TZ$;HEC0I&$9R.B
M<#A1[UY=50I^Y*5GI9];:V7G8ZZ'MI7DTI)WT[;>>_F9^HZ,VI:?<V=Z+BV6
M]"I)%#((%*L> K>H ]*B>VM;JY^S271B73;E0L;.065,$DMCYB<<YZUIZM>R
M/?)EBP@(8Q#Y1&^.F[NW/%8.IRVL&J#3M19VOWA%V]O;2D3.H.,].2<8QWKD
MJN[Y%\*>NGXZ>?Y'1[.,O>G976W?RU+D$^M7VF202:A')J432S6]Y'"%\M"?
ME'E?Q8''-4KO5[*2QUZRNKJUBFGMO,EGOGW1@[0!^[_4@=,U)9^)Y6M7UZYA
M&EZ:D2GR+BW"2VJ9*MO;MG@CZBM>*UTF66SN-0M/-G>-MKR*CK*O)4,>G(/
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MA;34TW3=>CETN*WF658K=5F225R4D4C@!0>G?%-!U8SZ/IXU@7<%FC17,DT
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M+;S0P(90<D<\]30H[*;=[:V_RV]-/4AU9\\596NO^#J=YJ%Q93:7I]U=:E#
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M]6$DHNYQE^#7YI(Y6DBMX_)1MVZ7&7[8'<'UK'GN+B_CGF>&:6,N2A5B44X
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M.IW<NEVT@NM3WZEJ1*V<EW&))$.0<*!R47KCW/6G>(=>UJ?6+;3?#T\4C7$
M1(Y;=\B8'.^1U.%0J&'UZ^M79;635-%L+/6?#4\%WJ#&W^T:;*LOV+@_O?-'
M(& ,_7%>;1@Y<JM=-ZV?K_P+[N[W9O4Q46Y66L=/)=-^_P#5B[/#;VU_I U'
M4+J[DFMI3=6UJ@>UO)-JAF;/3!R0*JZOJVG:=(PM]+U.<FV>>!K:!I5?8.0V
M> WH*C\-1WJ6L4 GTV_N;:62)+BS=FA:1,X5QG*L,#)[UJ6,6K3:6]I<)&]S
M(-UPEH<1PS9!8!CR:TJ.%6-IPVTMO=_/6S\D^^PZ*FH)QE9R2;?3_+[W^)F2
M:?INN2++<Z:UM<21Q^8T+O'.P3YPN!PIR.?RJSK,%OJMY9QZ=/(DAD\\+;LB
MEV[JV0<^]:&LWUSY%F='NX]/N!<1M?>?;>8SPCAE..A(_P BL#5/LEEJT^E>
M&6MHW6,*T$T#MY0?+,58<Y*MV-<M:C#EA)ROROTM?RV?S6_0=6O*+C:'5)7>
MFMDWNO16W=C1N/$]Q?>(6T=VT]XH8XI':*4^8)2_$>TC'(&0:9J>HH/$ MTN
M"NH>0;UX#;E)4CSM!W=#C&,=:I:);7&DVUGI)GMYY'9!'/%" 54#/)^\0.^>
M1[5:\86&L:O&T<D6B7-M;VS3/#.SJTLBD-$=XQA-PY&:ZG%5D^=OIKTNC.I[
M6FFZ?>]NOSMT;Z=M&:6HWU]<6NBO:M;I#)^^O/M-ON\^+;\R*.SGUZ5%J>J7
M2VEQ;Z191^6D>RVLX75&GRI^4\87D8J#1M4B35=5M=:>]N#/!%?%G7-M'N 4
MQ0/P6&1[?H:CL]+M(]0L[71HYK;3(97\Z'!9V:0DYW9RH#<U56&(FXJG)-=>
MC>G?Y?/Y:S",4TVWINTM+V[/;5_>EJ8\$">(!'J]U;ZI87%C_HDFGW'R)$VS
M:S C[X_VO6MOPWI1TNT:(W<M]$+EIH6,P,JGM&.^W&>M1:]I^HZ)HL0N-=O)
M+RYU58H;V"Q64PPN^1$PS@+@8+>].\33Z_;7T$NC>'([Z*1B98UN5BFB<, &
M'J"*G%4ZD?>YDMEY=E\^G>YK3Q*=-1J7;CU]?)'0KXB"O$GE2,H/[]I%VE,G
M X^M8>LVOEZ^GB32EOQ=NWV:>"+$@NHAT"@G"X//')P:BOM/?4+RPCFO[FW(
MNV9-]RD;W)P3Y3+U95Z[:U-&87'@^2X?3KNRF#NKPW)\F3Y7QN]@<9'M1&>(
M<%&*]U+=WOI][;"G*$;77+)]+I_EH=!IEH]CIL5O+*)608+A @//H*MUB>'M
M4M9].V^8T<BW#PM'-,'<.#T)'?&#CWK;KV*22@HKI\SCJ7<G)]3@->O_  [X
M:74+:66ZN=1@A6]D5HWE;8\FS(QP>35"[^U+KJ);PZ@CV%K]HFMYD L[T.VU
M<OU#*"3C^5:WB#72GBZ+1X+?4)WN5!:2WA5E@ SRQSD ''48YKD8M<GTW4;F
MVU?4M5OF2QA2ZU"Z3;:1RE_DVQ@$DMT+#T/H:\Q>SIRDZ<=DU;H[?\&W7U*C
M^[A"DW[B:[Z?TOD=%>Z-=M9:E>:3;3:G>ZA*LB1SWN(8<,%*(<#:-N3CO4U_
M#%:>*K&"ZN+_ .VW5I+;VMC9N1:JBX8^9V#=@36;:ZC ;?4KG0[/4;JXO=8-
MLYN3B"RF1"#*JY_U0(R1_A71:=8>)3?QRZC_ &9/BP7-[ S+YMQT.4Z%-O3W
MK2G3E!^TC\5M7Y?=KY7+]M&:Y5\-_5;][]>I;L=,CGMKK3YYYVBN[=E(A<A$
M5LC"N/XJS;NV;0WL=!\/:K%#<BR,$8N&66<#HLK9.6 /X<8KH])N,B>S,$<+
MVK!=D9X((SFN8O?#.G2R3ZY-<FRU,VTD(N8'$DRQ@EB%;O\ 2G&G>G&$.^_:
MSU_7_(NI"-2HY5'VZ[]5M\O+N=+;"\M]$L[=[@ZE<[%BFNXPJ9.,-)CH.><5
MROCO6TT6QLK>5KR\E\\0-;JB$W0=3_"?O8]/_P!=3W$^DM<6+1:[<6UO86Y>
MXL4&SS=ZAE:0]NF?J:X_5+K5;S5+>32M-O)+:ZECG:]O%22&U#JQ!0D[F]R
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M5BT<PB=G6T60\*K=&) S[9K3N]1N-)A=-#L(;@W=Q#%;_:;U(1*&'S;,C.X
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M/U9.FK\UNFDFMGT>JL_>3NM#S734TR^M98?$-S)!96L3-;VEFF6N)SE<*Y&
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MW[UII+6%V9754PN.PQGD5TMO>Z=K"[H]LWDG>H*\_4#N*]*,E3G93O*VS?\
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M,;+Q*E]J"^$_,O['4(!'';V\XCDM2%_UBGN">H/-;3E.I:2LD]K/I>ZV_P"
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M?US6$==&,B5+1O#ME<AKR:)(Q%&DX^9R3@%E/4@C-;]LLJ6L:W+B24+\S*N
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MEOGV2T]3LA+#X6NG&]W9^772W;1/=WOW1YCX3OK2PGADFU.U;46E99K:-_\
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MM;>6W3R9C),S"2$@YP,_>S@#/]*HZ2;FTU<ZA>J+N%8_+M8-O,;?W@3SR/;
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ML<$XN IA7=NW28.&VCG([AJU->DNM/\ !:/+;@QZ?:;5O]-1()(H\A?E5NG
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MX!#JEHVJV5W%:JT8<@HQV,W1@.#Z51U6/5[631+70IX9[JS9HY'E5V#,PY)
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M7MK?0.UQ=64/F20/T5-V["KA>">:Z.XT/3]-\*^%=3:WO&32(]L:F M.6;*
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M[YGV@LS?,JA_7'/TXKN;;3%N_#IT^-Y]]L&CM[NZ.]B<$!^.O7]*\]L9-?\
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M9/9]==/07M'&"BM_S[:'DR2K8Z18%O#Z2Q:,LGF6Q"2SSL02Z(I^]UR<4_\
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MG2TTF2!+F'5K<&*WBAPL(SEI&;TY''6M*_U+6-,OK>UM--5M/M85DN)U&3(
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M>6MQIBPSF\%A)YFV*01>8)BPZ8'*D#/YUO0>&XXY(9XK@,T<FX84;67/ _\
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M8Z=^/6N0\3^(-/D\-_9/$$EQ9?VM*J?8+R!I&?+X$8V] Q'7M72:G<2W&J6
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MV/2G^'KYDG%N[((I@S@,2"C9QL'-71J1KT5-*SZKJCLG!PE8V[RVMI3'/<
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MV?ENE:W](G%4%)\BEHM':RMM;N][O4\JL_#>LQZ?>2>,]7MK98;D);1PP"1
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MU<)(L*#&55R0 6/8#/6LW0O$FH6VH0:5XJDM_.N$'V:X08-P_)8;1D #@!N
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M+0>?IP2=;AH+J*:,*"Z#&6]1@],^U;#^!]*17U%K*UFU98@B73KCRE'0+V4
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M;['ID5@%@CM>,.3]W'=2 /I6_I>LOX3OY;"\L/$-W:WLR7"7UR?/$<DS$>2
M.0JX]\5QX2O33G1;UCOUW_X%CLQ5*I)4ZKWFMEK9]KV5^^W^;[VBBBO2/..?
MUW4;=(Y5U":>QA@RS/NVI*GKNJMI+:)K^FW.DF2&X:,;YHHI68!7'!W=\@U+
MK&GVUU!?6EU'?&WE8-+M.5EW<;1W J+P]#>:<85U#2A:R7*F)Q#+Y@7:3MR?
M3;BO-G&4<3>>JM;9:7^7?N^FQW1LZ7NZ/_+_ (!4L]*N-.\,ZH?#]BEE<%]D
M0O+AKB-XT& XYXXSQZCFJ&CV.H7OP\LK>6[U&_*AG+22""[E&\LI)'W1QC'I
MBNUO+-$T::VM(VC7:<)#P3WP/K6!HUC<V?C&2YN;:SB6[M B.)"9_E/"8Z8
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MW^F7< FM[ZW=(D>2-&C<MC)SZ#/8>E<9'J,2:;#!86D"2.A5XKH,40AL[OE
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M6=UJ>8;M)\F:+ X4%1CKZD=:[!8T61G5%#/]Y@.3]:KZO2JN+WY6[>5U]W_
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M(1;1BUVF$* FTY&*DHJV[D'_V5!+ P04    " "7@EQ6J/>BX*9K  "F;0
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MXX%0QAHZE5LY&XDY*Q,B7C W96H;#8%-U1$S/]-=0\! K^GI=X]QT1RP[."
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MK\Y+-A>*)"*:[D(#OD)DN WR',!D'AHDRX]Q9K5ANN#6\F_A6S'(?I#(Z6&
MRL$ET-9CMT+$NOL :C\G36K?O$/HOW%\U6 EL"-!%768W5ITG%W@:]:T.6;<
MDPJVF^/.;["^-8G.0P.:>T*,WM5RY*[ RS8=_R+FLD:;$PDB*NR43PM\;.5^
M)@IS#0?*,G") W5^7J,!V$AKL=B>OM;8J* H-.!W,<H:SJ#F=R4@[XJOYL*L
M2A[B)O[&UO+HZ;'Y2P/CC8X?XJG?>;$L,BK$XLYY3)O!M>$(C0.PT69%J,9'
MQGXJOI^!PTN5^U,>^LXA6X02O>E&Y@X"$5;.-!J$=&#/<&N4(D6!&4A-0N"
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M7R<Q6W5HIYMYS?WRLM+B&T3P%A/:+K[=SJ='=\EK.D"W+K>O08[0T(;%EMR
M=E?I OZ:Y-S9,JY]]V90G,:ZI^K)CNB7(XK84FYW)EV#3ZQ=&4BWQ]S=SV.6
M^DR8SY[8U,Y<8[ICA;.Q1A 1%]_YR'PPD#([*1&OO7-T]G/BBDKTSS;5,G.
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MF'0KYFEP)!?!84",^)X9Q.3#>CS[-RF2B[ "UYLVH[-]L<LB7X'C%/;22?E
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MCWIA49SQ>#3\$29LX%X*W2Q1"[!KQA&V#A,V&A<67-":9AXC[Z?5UKW'E41
M[+RV>920;N#O%)]L)O^2W4%BI,$I)YOEF\;QD?"2U2NR[9IMAVGWJWPH,R].
MC4@:O^O/8Q_%J,O,1WE:'>HXU_>LU>#H&?E3.<Z!2_"X\5^Q]1V\CF@4_8?(
MB<PZ29HD^NUR@>+)"%:'[PHA9023,15R&RNA%E^/MI4EF^U+L'X5P_.*+F)
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MID))5V-/7SA5V42YVZP_\="=)%W9_M#HNRNX>_ ',_5GDWZ:KQSXFX<^B@Q
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MC.]ZL0<DA79^06%IRO.%Z(0D26-[\'6Z^JI>-)VMG<-(;019GI,7<T+P:L@
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M$5*"*N$F*"*0/]K27QZ-]&VDQHO1#=--S1JMP^FE/I]N!7QF-/V;]%?/:XD
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M26NR-+'Y?>6T&";;PPJ"7>>:F6Z\1>]F ;!:]P1F^6>#,>>TNEK1>H$:24I
MI+ZNF4-KML@P*0P5%!I,F7ZL\&IY3"''(#'&O>_H(SZ3,(MM;[X*K9];0SZY
M8+\![$UGK<5V826^L7NO7-ZKR;6PW1<F[_'+JP^V;MK%"X) FV:*0&7.3I?%
M:R3HF2N?]KD;;4%,T3\AVJOT_]AH-0YJ2^03:(SMZ]@! CDS(8$ESB(BQU$]
MU ?/R O/DT]&C>V>R*E2/OZ=TRQ,AU>:K!=P8CSB/J8B^FV@MW:>_!TNCA7N
MDUO2EY=TLE=/>&H2SKF/6PT&W_'Q4U@LU\YF53]5@/XI^1@\)9'(.S6)E4I
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MVC@T(IZ*],36<5$I&WT4,)SLLT@L21CD =P F"B3*PC-U6F>" 9W9,'&5,-
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MM, F^<%3FU%?AB-PQ_(JQ8*I^%F5.0S2F,1;P)3HJ(,5>T(TRVT?E/ 11':
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M&&N1'+U!O(L[Z@MH+/!WWU^CS3O<(?M^H=ZD=9C@Z^7B44VLXZ%NU%U4Z=
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M [D5,\47<90%.60T3""26$""40Q%'J-0;3RC$ FK$HAF\TZ-/K:2->$RG=A
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M@F%*8\9XA 3+K%Y(IZ>;VGND$>_R.,;*-@S&'4R>F?A(9&(%?O<2EV*&B\=
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MI.B0HXV3J!IN]1UAY7M[W\'T[7GEU?8 HZE(N,G+JOVUS5$W^'"J5[K]CM\
M+E>[_%-3C;NS-U!Z;S=O<LW M+E'4LSU&?N[9?F5S'M]EW26]?:W&2=A&G.6
MPA@SJ:.+<XBQC)25BV68(2H9SV<K'5EAQBNF$UMQS&9ZW\$CI),>JJ<#5DI^
MP'59@6V_.LN\.]-E,",B'^!Z)J6Z*L-6,L5&SR#66CC,S;/$QU6JGNFTXV;N
M68*QE\AG>_W0,+>'AWEG4)'J[IUZ/[U?J'OCOK'0:%5SY"S&,B 1BF$><P*1
MB"4D@F-(\Q#1/,"89K%=E)O1O%.SA?IB [Z)3;3D)5/0#7>V[J'TO3GMHZA%
M!EIFT!,:_-Z)[30TS0HH9Y%I9K..')AF!<5^7)K=Y0,:GGPNE\KP4!=6UPO^
M:74G2EU1[T'/V;;?"A%*HRP0, ]R#E&*&<293)45A66&" YS8D1)9M--C8DV
M H-B4[3'IIW)>7Q/LX][U#R3SE96H(0%M;1@(^Z0GG#G(;3H/^(4RI&:C5P*
MJ5U;$6.$3O80.3_*> U#C#5ZUAW$_*J!FU?^WVHW7//)S?*:\T+?1&2N&RN\
M7[1'X#O533_)U]M(,VV?*GL1J[TK)E#7;8!(M]VD/%8;6R%2DH2,AJ&5P\R%
M4%.C\)Y.NGG%5JNZB86N"=4J=@7VBO@N)>AI![1ZEGMC%ZMLN&\>>>T\OTC&
M6C;[_;=#G%WMS5V(-.Z^W2&(>WMZEV,/W.\KFZ VW-7 K>%>;?:;2$8H3%@&
M$4L%1)FD:KN?,)CE8<:"',4XRJTV^2<FFQH9;V2MG]%N3UJ9;$3M@3;<V#N"
MS_=N?CAR]EMX TA<[=M/337N9MU Z;T=NLDU=A3"13%[NU@I=E+4I6Z@JI[C
M4ZGLT<="%_J,J20!BS%DH=Z&AQF".>84L@0GF!,L4FI44_K<1%.CCD96T I[
M!6IQ%:2@$]B,.<[B>YHU7*+FF3&& V9,&*9H'""+2K"?;I>//ZLA&IY0/VSI
MX>S HU"#J7H=+1A__\*(Y?>+A_6J^B >Q3SLW'2QQ#$AF=H)!@E$B8QTY!Z#
M-%&\$"&.61P.BE'>GVMJQ%#+!L*!8<@'L#2S&QPAY)D$MJ'&.O),"WH%6L <
M>HXL,'$=3GQ@II<)(#ZN\M&0X1.77! D3,\'@-'= +"VR%NO[-M?A<XO%?Q:
M;8O(K?@B=-N,.E^LB>=8D_F-*.^C&<JES!.L=C*"(H@"98^0-,\@D9002AD.
MD'TMT7%UF!JC#>^O^ +K;[C+FO:J^MZ\]>*$^_KW@X4!?0('XXDU"EVI4<7>
M/22N0(<%:,$ &S1 #PZ@\7 <9_PR:^DR['AD#<:/0GZ9)3H8E/Q"H@PX$7_[
M75=^61?57;.OU]Y /6BQJ.5^)\0LS8G:9P<QC$2((8H"70$AB:$D"8W"E"-L
MUM7)<+ZIO9V>2ZS=43I\\ JLME*;-W8RQ=S@F-PMDKXWY\]!_"3K4XHKT!,8
MO',-HL5!N5LP1SHIOQ14NY-R<XA.'I4;##/>6;FY3L\.RRTN&WA:KE\(NGW?
M]?>BFH5YQ*(LC& JDQ BQ .(8XEA3FF4)TDLLXA8'7OW1Y\:W=;"M0TDM7R6
M)R3/D3,\2AZ*A^\S86,H[$]U#ZGLZGCVV=CCGK,>4FOOP/3@EP;83MN>W@8]
MD^KJB-ML?R9)1F(<088P@2BC6#W3+((9D;$RK!+]/V.CZ@)!IO;X]RI--@VI
MJL-MS YU,;.P'BY9.@/;;*0%\;V-;[5H+ NC1G(V54#=KHJ%L3?2ZHQD!0Y9
MI6:1W#83< 7M2>OQDO'',RL=H/#,WG0QWC!#]*-8Z9/^^D2/"_[JZ;=*\/>+
M3>^#:]V0LDEWBQ$-8VVE1G'.=+&S!%). AA%2<K"$!,IB$W6H?G45N^P$?(.
ME>2 Z9"5M79LJM?7<M/&@VR$MC-K+=;!S.;U@Z[G%Y(&MHX%ZL363N0??FM0
M_K'7+>7Z/,S6)K,]8H[L:8N)1S6V[0'9M<0'C#",QI[W:MD4^W^]5ERZ6,UX
M$LHLB2,H(JD/]IB$.8X3&,:A#&B6RHQF-AOLT]--S>3>/C9S+2Z8M_+6J;VL
MD1D\Z$ITMN49S\!NQE3NP/3,3CO-FJ[ZG4A::=VQD1DJCACHS&2CLHZ9XKM,
M8WC5P#"$C7GV]OYAOGP2XJLH'PLFCA2HF=?+JW[Z)+]LFEE\%F6QY'5YVMJ"
MFU%%1E%*0AB$)($HXQ@2S@-%2ER$>99EBK.L @U\2#DU+CM;C>SM=ZVA;@>T
MX*!7>K/K@-YN8&WCLKW< 8:A!B^]KB,&$_A94ON( )^0NSKS]R+CN*?Z/F'>
M.[?W.MFP%\OSHAR[Q3MV'&!JPXT0SP4,2)Y!% <"8I&F,$EX*+F0<6[7K<!F
M\NF]!I2Y"O61''B_>!1=8MU^G9I>&1L[QK=:&C,B]P6X9WXVJ ;DM3?4$-@<
M<:S5U*-2YQ!0=AEQT!AV1%>5J]G6@[G@_^]:O;KE4[WU9_K=76U;]7W8M+WD
M@D:4\5!16T8ADNHG2E@,)<XP96'"4&H4_#]H]LE1W=O7H'MW78$P@D%^U?/Y
M:YMHJQ?H%.OUSAS0PW38LIUF0>^+X=M,'6<=C.GQ(CQ/\:,:N,>-ZK<M+PZ;
M<Q1BO B.CADO&^3BPAD?E8JDNJM'O5EJJW/!BKGX*%9-)S]=\O-F:>A1W:0-
MLS#&.$0YQ&F80Y0S#'/&4LBS)$[23.!$XH%%-;P(/#4"WJG<4'9:@H58@;EN
M4*H^7;@_$O)^8YA9K5-:;L\4WU-5]Y:NE6WX^DJO\49AH,^IVCZI/VBE?]1_
MMCRX\I+I/M9BN2_TX4?<ERH"XA7\$P5"_,Y[J??\>K$J>#%?JPEZE4G??F?S
MM9+DG0*T:9#4NEW>DE)G0U2?15G[:!JGJ<PQ)TD>02I0I#8'L?J)X@0FDF%,
MPDCM&^PZ9SL5;VHOKTWPT%*"OGZ]#3WH-&PZ:O=TU!=U6H+/NN^8UO-2#[J3
MN\#6=3[VVOK>C+S LE[@17>)OG/WN1/A7LAO[A+8XPYSI[,,>XEL6IEW[[2B
MF4P7,MQ\M+AM'!%)1,.$X!3F*$@ABJ4^,<08,AG2.,G"."56'<=M)I_<"Z"N
MDJ*]$W)9BN)V 5;D^U7]P5++;\?B5LM@QM&^P/7,P&^E%*RFW'8CH"-ROVBL
MG^MQU18X[:G2;2F:TTMW?#L$24=L:C7UJ%PY!)1=)APTQM!^0M5*5VAMS[Q[
M7IQ4BE!D!'(:YVU9BH1(2%,6R2@D28RLS-YC$TV-OVHY:[H2K:1_MNTE= 11
M,WIR@9-G*MI"U GIQ;=P#@EG[8&.3#-R:Z#3RNZW!3KS??NJ>6_:])+KQ6)-
MYE^$CM"<Q1R%C'(.0Z0[6N:ZD'T82YCP/,L1)B+.C(+&CDTPM<>_DQ$T0H)&
M2O/2> =!//WDNX#&]Y&\'2I6]>].J3ZH[MW! 4>K=W=*G7Z=NY/?NRAWM+$4
MJT_R1MRK44GY]*90'Y5"R5[=W)'5+\J*_%)4XF:YE_VC&.7#-EI[)^I$YI0G
M/ M@0J(((J%^(D(&4(8,HYC1D&1&W6U'DG=JU-+HJ9TA&T5!3],VVK LG]3&
M26<4V_3)&&'U3Y/8!-=T+)?8)PE:=?6/A]=6JPRTSD K#6Z6!S,K=7N*GNJN
M<E^]W1*#4F2G<&N\0":MGUO$>9:M[]4Q3,;U)L9+Y.SZQO1(:J_W:9UZ5C^7
MQ;+\+T'*S=]UXU$4IH&@%'(<91 %$8<T3A!$:<:#-$NR6%KU\[.8>YK6@XG_
MK]8&:'5Z7Q7G_7\7K]9%_M=+UV R[M>A\+MROYX"TJ_W]>#,4W"^GH+$T/=Z
M<HAA1-@CV!G.4\P$#2!.1*(K<DF8TR"$-(^$>D5*D0>)3:V#WMA61#9:$^6Y
M@0US%C4SPAF(A6="<6K$G5#5T2/?'WG41_J 2KN/[*&ON$CK/U8NM?ZCS@4*
M9QD)9!PF 8Q#K R44*@G. @1C!CCF(<Y#H,+$OW/"S U*V533YFT]93+33WE
MIA: +G(*?GA21%K]>$GNO\':F+&#3\0]4\A>?8 3U:SK;SBN8ST4.B]%! RF
M?\&R N;@G"XT8#'.!1T0]I-3]ZI-O]JM-OUADY83HI2R/,X@SV,*48Y32!,1
MPR0D')-<T"BS;VAPD4A38\E^48'SY>QWB@_4-3SM4ZP<+K 9L8Z[;+Z=O9<V
M('"<C.4>9)>= 2X3:/Q"_TX /%BWW\W(]CFPF\9ZOXCE;4D>[@I&YG4%8ZZ+
M[(M00(93"1%-$22$QY#CE"MN%F$LC;IGGIQE:H3;E\^J"O1I+$\3H3.$/'.;
M#3A6V:)GE;\@*_3XV*-E?YY5KY_E>?[+0[WI736*QC'U4:RN[W5IM7^TP=$Z
M@53[':\7_+/:C!7K^YG(1(PY(U"@-%>;UCB'.%*_RDC]GA,2,!3/%N)62<Q-
M_>K64A@] 'GS /1E\?<<]"76I_0/C:#UN3QAK!3='WBK#%"_5G5AD'I76VP+
M@USI_$Q;1[O]0IHZW/TLSCCLM)6^=:=?Z6S(VIO^;+4Z)>KE:M5PZ6L?C*$S
MG[N]!"/[W@=#M.^#'S[4D- I;QV6WGX7)2LJ\;DLF%#";KNI;_/ZMP'"0F1)
M&L88"A%SQ<M,=P+DBJ83%&&$6$")4>+\E)2:FB78Z0(/>"A9K^-;XZ<L%O_R
MSV$:_)N-OW)*Z!L%;4U#U F]<BYVSVRZ#9YI-M@!!&J$FB2I+4B]4BY& ?;3
MO0MMXL2F(?(4@\G^F'>E92#:M);_=+3:1&0=,:1M(AH?C'N;F&P#CU]62_:W
M]U6U%OS-NE2R- 5 ZV[7'\6W^B_5C"&4BCR+("+*1D0D41OX+(DAP5&&>"R"
M( RL3EA,9IV:):>EJGO/J,V?VB3<Z\VXUJ,NC:0^*[J_,YTJ97E(8K0,AN<@
MKL'U;?W4(#8"@T9BT(C<E)^K-^#?FB\X#%VQ@LG58871G..>1]C L'?D8'7Q
M!0?$0WCV[=_7Q>KIO2+KLC:7JCJ=^>:.+%H&OKZ]+6M'WWNU#2L65<%JP?\B
M*L7%,Q;*F.:Z[DZ"0HADQ&$>D0 *PC!%A 2A6=/@%]9C:BSJH+-Z PCH(=*6
M(%@I3+9]US>P@ TN'9\TT PXQWZ!^]#B\'O:=]?43\Q'N+&&';>_W+*Z/*-_
M 2W&/]A_N:4Z& WP@N(,<(M_+I=\S59_)5K(U=,U8^6:S!N38B8#*1@6 8QI
M&D D<@I)$C 8X)CS-)>4!.:^ZE,S3>V%V<H*OK7"UD>#VF/\4(MKX9T[B:^!
MX]85:IY?!!U@G9R@%;3=5+@"S,+'Z JXD1Q_-W>BO;GTMK:[W4C3BH94^D-%
M"8"2>;W=K>Z$V@!S_3YL_T(V+TCQ?246ND3?P^Y=W.5C/*E]LQY;'[8)_I,C
MMYX)XB=];2<'&,\!9J+',Z^4T07VI5K>+E:ZV5CM]:@W??6[H^_#FA$1T2A(
M,.29KDD7\AB2. ]@SD@J<)@&-#;:+YE--S66;B0&C<B@EOFJ,36?>;_-Z[H8
M('Z:LMWCZ)FW+X70J@B,.3*#2L(8##]:@1AS5?OE8BRN&N;7>4>*LC8<?Q5$
M>[1K6W/SX?\J1*F&O'MZL]2GY3/%(7&:"P%CI#@%T3"$.,QBB F/A8BR,$'$
MQAMC-?O4R$;+V>PXP4;2^M3LX_5?P.^-S)91^G:K8>:3\(:Q9R*Z#%[K/?X@
MF!SMS.WF'G4_/0B6W5WPL$$&[%U?+Q>/0MFP="YTUZF;LKB]%=HC_O9131G]
M*NZI*&=)IG:K,6:0XCR$2.UG84YH N,T)92$)!*2&F]BC::<&G7UA 9UW[6M
MV*"6&T06&S0SU VVMLZQ]$Q1!C""WQNI;>)WS/"TV/DZQW6D+; 3?.VVK%90
MG=R[FHTTWB;62K-GNUF[*X?9H5_$XW+^J,9\70I>K-X15KLEVGL])$%  A+!
M7-:]I9"R.UG*H53DC0*<I4EHE5MZ<K:ID?5&6-!("SIQ[6S+TPB;V9+.</-,
MS$<A<T@75I@X,A1/SS6J86BD]JXA:';1, ;Y7.I>:*NGS^I.T!D"^@3E0;^D
MMH4+%560*%0[US"F'**,(ICC0,"$T(#@G F)C2J9FD\Y-2[I)&[*>'?BVA&)
M =!F;.(6/O_G&;6P5Z 6]SF 7AL3F\/DB&4,)AR5:LP!V.4;BRL'=M7<Z6:\
M;5OSO.OQZW59JFEG 0]B&288,AICB%(20!I+"F.*\IAD0L3,:.LY</ZIT9'V
M 32I-H_:$V#9N-(2>QYF.98*["2+$-0!LY PM118)"B(HUA9E&*F#%VZG #Z
M?3E\1NLLRQ7836/UNPQF[P:/T'I^41CTL;\"K=@..W(.P\M5@TW+V<?MESD,
MFKWVEP.'&6K-MK5Y>Z<^38CO+)$D3+.4PE#P6/$88I F&$$2"!2D/&0ALZJ.
M>WRJJ;TN-I(V(?]7H&K.)8LF:OV'8M%^8EEC[@38II:L"PB]6[ =>L]/=1M!
M7=JKY\!P9J<>G6AD^_2<POMVZ=DKAC?RN5&7SE(F211+ K,@5L8.(S'$RKR$
M(@IPR$4DHM3(T-P=>&J4L&E1HX6S[]=38W7Z&;\$ =^FAI'R@]KR]#6]J!U/
M/=#H;7CZXA]JO_/L[R.73+3+//RRG,_;SC S&0N6)#* 21H1B!*L=C!9&D$>
MY$&4H9Q)%(Y28G&P"E.CC_VZ$*)+@W[0HNL(S,:F&*G<XO";P\Q2F?:2>^9+
M!\DIF_03FV1Z+WT27VXE7[IFY' %_A@U)B]>(&<U*2^7Q$$0CRCOJS;B+6 D
MH6DB8!I(M?4-DPQB2B@,1!1F/" LQN;I)\?GF=I;:C\.0LMJ&6-X#MO3[P^'
MB'DF^5' NB#X9AAH+Q9QH\7U%%NSCX150$WO\I>+HMG7X63HS(&O.S[M_JT2
M<CW_4$@QHR%1Q!CG4%%C A'.4TA9BF&>A01'B:0RM-HN&,PY->9\6ZV*>UU$
M%*QK&<&\>!2;W"E2-SUS=/K= YYE B.>$A@CD>HFZA3F0<)@3'*:1%$D),%V
M)TV.H1_G=*F1K3G?TQ*"'_YK0 ,0$\!-O;1.0?3NKCT1<' %&IF!%GJ$4(-]
MA'S'&O1FG$:PP3X$QM$&!RX=V>=T-IW\X[(^_Q5<&_'O6I="E,6(AT+9UXR'
M$-$\@ 3'"'(4,\0SS$AL5#3^9<2?VKO(024_P](8&S34CVL=6J=?>.UIS^\:
M(=!"-%83D6&WGV>/EO>;:OK>K/'NI_'<6Q<MZTN[MH8)_\=P:UVT,,Y<6I=)
M\3)'14H**8I577!2F17?'XJR'J%ZOVC+8(0BC<(@Y'J#ET,41?I-372CESA/
MX@0'28SM>CMXE]F(24?M!/%:%]*8ZRZ&RM26C?R7A)7X7_9QSGS<+.4?YJ6X
M>>WU]&YV7UO-@;HGSA2R&?U QWB97OHE9RSO'^.]9@N_Z],9\XD'EH@H%HH'
M/Q2/@K]?K)10VIMY7;O.?B7_O2Q?STE5?53/9.L;9Q'%24I3*!D2$$D:0)I%
M"<P)HR@5.$/,:M=H.?_4MGV-^+"6'VP5 (T&5Z#6 =1* *W%T-(1EJMD]NKP
MB+WG%X%[V.U+2@P#SU51"<O9QRTK,0R:O<(2 X>9K/=MYWC]%UT^[(TR?3?%
M,F9))G+)DAB&- R4I<]B1:R!XED<(2$)8R%ELZ9NW-<5*5>3\<R=5<V&/'85
M],<C2G[8* #("KP1K,Y5!7%X!:(@3.K= 5<[15)6VV"QL38*+F\L%.0QUV>$
M&8^$[M\L8(X)@Q'+8Z4UR:-4M#?6VX7O3>2+WE:=>B]U4Z7_]]Q4DW'A.KU-
MIK^'M7?L[H4PUA !C1'8EN*:P&[7PYJ_](;8I4I_C#VSAT5\ 0^QN6S##$X=
M,K1M-K0MKQ!% F,:<!A(@2"*<0PIT\D]:9H%21Z$.68V.^PC\TQM)_UAN;B%
M.H2J#DVS>QL>@]+L!>4 (,_OC#I8;RLB^-U+*8HS.#CBT6.SC$IM9U3=99MS
M7Q\0!WTZX?A7LFI_NY;JX?NT$#=WY7)]>Z?^(T0=:+4UPYA@69;B"(;J!V7;
M1PDDN;+MPS!+$>4B3X+$.&[:G5Q3(YA&]L6M]NXO%P*LELI>4E*#NA&L1>2P
MPZ4[35 ON"">"6VCE#Z& 5JM7E&%)C9YJQFH50-*-] J!VKM0*V>B?WJ=0TM
MHL5?9BU'BB[?KJE4:UKI-:VV:\KUFMYOUY34:UH_A^V:]AY&(/6:UE5C7'4K
M< _]R7!VA].-%_[N'J-GX?(>AA]\YJ6# 3X(M3GXT/;(4/.VVX3JS5ILNARG
M+&2(2P:#"',=<!%!G(L41GF(>()DG".KKISF4T_M]=E*#FK1KT GO(Y@;H2_
M DIZZY[6 ];$^'#+ ]+^S[6.@*RL%2H4U 7WDF]JCY:[@RS3B<<^P[($Y,#Q
ME>T(=G16E:NN%XV.#?@JRL>"B2Z)C011*+. PIRD:E= !8$T#6*8"!GQ-(S4
MYL"H5\S)6:9&4EU?*AW0TTIJ>>)^&M33U.,,*L\L,P@E8THQ0N$4>Z@!>LRA
M?MNRQNFQ1R$((_4Z+C#[\L#JE(SI;F%J1_M5IV^3DE>_/>@685$0HB#O"LD3
M*61.,$0)R712M3[X"U(H X$89:D(A%6+7:-9IT8+6Z'!1FK0B*V/Y! ,<LNR
MB$;8FQDJSA'UO7<_#Z:'0MQ6*+DJ?&@TY[CE#FU@V"MR:'7Q,%;Z*%:O276G
M2.^QX(*_>OJMTN$[GQZ$CEM<W%ZS5?'8E%)<:E'6ZK/VC[KO:6?CRRA%/$X(
M)$2'O(=2_92($"8ASG0UW93+S(:VW(@U-5[;B _(1GX[(G.T7&9,-_XB>*9"
MI1#0&H%.)7UP_X/6"A2+'\%V>;::78&M;F"KG)=-G5N\'9&J(Z%&95VW0.[2
MLN/1AW8>_7HGYG-]FDX63[,@$0E'<0;#G")E.W("L8@CF.5!AN(H3M0[PZ[3
M:'_XJ?%H(R&H102MC+9M1)_!=YH/+P?%,Z]9X3&@)^@AM2_H ?ILN)%[?AY2
M9;_'Y\%O#3.PWB]8J5U*;T3SW_>+N@&QX#T?TPS%>49BF<,L)3%$:IL'B9 2
MBBS+>!Q21)E5*T^32:?V4+<2;KI@6]M&1DB;63ZN\?/\_'?B@A\Z@7_4I^8=
MHA\,$+4V5FP@<F2*&$TYJJ%A \*N&6%UK2ON>=.6NOXB'L5B+69A'HN8QP@&
M.%=V V88YG$60B9S(=(<TR SBD4QGG%JK-.)!\I&OMK)NJRC<QT2T2[L0UGH
M C!?AH(V\+82^^2?(^!X(Y_=^5Z8>8ZH?YYVCEWH,B^KJ4]RO5[=+<OB'X+_
MME CUO7VFS!>7:6I>O7TO(*IC@V^_EY4LS1*PH@%(>0)"2&*PQ@2'7&;Q1&1
MB=K;H-2*I3S(.#5>VZEY7,L)?M>2.BDS=-EZFM'?"Z^2[SW;@ 5RE-?A!$*O
M:1J723B!K LG$)LE4;B9:AC9?Q!5)<3&\_4L=N*I%SGQ47Q?W7P3\T?QZW*Q
MNE.,'H@T4[8GC%#=$47M=7,:Y%!$:11RC$4<6S'Z4$&F1MOJ^0CM^'GP$IB1
M\!C >F;:1H6KGGO_5+C651VFK*.7W='PI2 ZXMK!8HQ*J)>"M<N:%X]W2=!J
M0>;;W+7:]D%Y%C.>9#".$%>V+,H@";7/GD99D$4L3W!D'Z&Z-\_4B&TC9B\-
M=I ]>@Q7,SIS@)9GMAH"U,#PT:,P.(T5W9_E!0)#CZIZ. KT^->'D8&.@F\R
M7N?SY3<=9JK#R[Z(2I2/FV!%G+% \BB">9U(&D4QQ$G*(1<9#1+UOPA9V40F
MDTZ-)KZ^?0V^LCO!U[HQ:QC!(+\"&T7 5I/:3]?I,K!*D]&JF/&*:ZP]DXPO
MF*V)R 8W1ZQD-.6H%&4#PBY?65T[(.]U?]OXKE 64A,P*=.8I7KOAA,10R35
M!HY2SA1CQ1(G+&9Y9)[)>FJFJ='4_XCBGX( _,L_XR@,_ZUIJO _TO2GW'#S
M=A[:T[3C%+"7<'1I2<]'G5IB9I'9Z0J[D7(U+\#0+NW2!)>3B90G!Q@O-=)$
MCV?)CD87##/^ZHHEVF-7BCNQJ-2P[Q=L>2\^+*OJAGS?!&52G FU_ 3B.)$0
MA5$(21*RFE(#]7^11-+&_C.<=VK<VI1&8GVYP5R)_&<[X\X4=3/[S@.6GFFW
M@?&9R*"1&?R@I?[Q"BC!O<2Q6H+ER*XSG754T\X2BEWKSO9R=_G53U_5.ZVN
MS/1);O;$GY=5H5]T;[^OM#1TKKY>K69<[5*C/.<P981 %.<4TB!3/*9X2Z @
MI3PR:@3I2)ZI$=KQ).&-3KJ%Q];QTZD%?M\J!MXNE*'1Q! [2-6V65X;S]HH
MBS:*!VZ4]7*2]ST 98_)X#;2O'B&^ #H3-+&APP[,-IF32OQ][6:Z>VC^J?=
M".5I'J01(C /F*Z"(3@D$@D8Q5QBE-"<QU;96 =GF1K-;H4$M92682X'@32C
MOHOA\>WMVT'&0[KG20A<A8H<G&/<8(]3:NZ%:YS\LGW:SYO6U_"YJXNLJUO.
M$)54JLTB#-4%$(DD@!A)]=3CC)(HHV%$D6GFS\$9IO:<=T*V+5_4BY;7A7'-
M$X . WGZ67<"C^?GW!H9JU2@D]H/R@8Z/.)H"4$G%>KG!)W^XNAALONNJ@_%
M0KQ7!D<U2U/,\BRD,$HHABB5#!*A;("(Y5Q&0889MMJ*^1%S:I1RL,GGMC9Q
MUX7J"AP.VM1Z@5JQ\6)K3]T$AE;+BR^M;[/G4$5VMZLZ9D"N >@O'Y-[2L@_
M2EBN = .(W--9AM8<(C_][I:U>%M-\MKSNO=I]J'DH*_7[PF#\6*S&MIWE?5
M6G#]K][)OEY6JVH6D!BE413"%&<11 $FD"J[$M*4IFK[&.4,6P6C7"+,U%X7
MG7" *>DL"Q%=LB9FO#X6TI[9NZ>&CL[=*M(452P6H-5%N^64-J!1YPIL5J?6
MR&%%(P>XNBIT=(DHX]8_<@#:7EDD%V,.H]1?2+'09R^?%KH@[B?YONX]48LR
M2T(9Q5F,(<WR0&V_TQ12*6(H29S$,0J02+.NZ^^-.7&>F-+H:7W>M/=F!'K4
MTH+E HBF[<VVJ+0=59["VHP)+X5N'*+34K9'LAJUNKCZ4H*>L.XXS  11Q1U
M:J91&<A Y5V",;ED0"C=^X4R3M1 ;9K_IX5NH:([J'Q<KH3FCYQE8:9V[4&<
M081$#G$4(9@'.4Y0@L+<S&EO,-?4#*KK^V6Y*O[1!)^J>Y]W6>.R.3Q9W-:F
MEDW3AS-@GR80QQ!Z)I!.T$V]CT\+H&4%=7>>6EIWP%G$V+D#<*0HNPV0XKO>
MPPEE9*I75ZF-RL5R!9[$"CS4&6+J+B7S>5<F0C="6FFH=<^$*_#MKF!WX)X\
MZ<OG:R[ #Z&NA=".K:[=7K'02%S50=8_1#\"LO,<%/V-1E4+4<_Y33LK*O%
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M1#S'D.0R@CF1>1+@*&'$JC_0L8FF1@.=G#HTH&E5/)@)CF)KQ@4N$//,!L/
MLB:$<T@XHH2CTXQ*"N>4W:6%L]\?1@PW)>'B>L'KP/JVOG[U13!1/.I.9Y^7
M\X(]S6(69&G$.$RQ2"'"00)SQA"D.$618)C&S*I&@]&L4Z.,3DZP%;3>J&X2
M3>N^@6^6:[J2ZSGHOFY')F;K8<8LSE'VO4<X /#OC93 2\-@*X <L8_9G*-2
MD14,N[QD=_'@LJW+>[&)(?^@%U9G>.LR)W$6);G0 =VQ#O=,\A!BJ?8S,@Z2
M).<QQV:%W@WFFAHAM=EKVR2,3MA!=61.@6S&-XZ@\^X='HC:D(JLY_!P5XOU
MZ$QC5V$]I_*!^JMG+QGH6%RL"E[,UZOBL=>K]>WWV@G-WRGA=7#2NO&B?Y*[
M%M:KI\,#U$]$%*0)HDQ '& $419BF*.(PCS0#<EHQC"SHAV/LDZ-MOJ2]KMF
M#R$MGTMLZ&F=QL+Y-LV&K9F]6]<_FJY\Q1XE'=<![1_R/:_V"%,.[DFYTW'@
MM3[P7*QF&1(T8$BH/:^D$$5(%R-+& QHC 4GA*,PM.Q#>7BFR='UI6U(CF-J
MR+ ND/*_==WM+'(%6C&=]I \C82[OI%'YAF[5^1I=0_TASQSP8 HI:_%[:*0
M!2.+U;;_9+VM5>/?Z#WN3!(2Q9+DD O"(&(9AD1P!F,D<Q3'42*148]:P_FF
MQA ]B<%69-#)#'ZOI;:I:F6 ^6GN\("D9P9Y$1 M@I?<@CE2 -,UJ-;W]Z1\
MJH.'%G)9WC=;_0=1KDBAK0H=2[^Z$^ 5J8I*?^VS$J"3K.DPOAWBW"+Q[8DI
MJ0 !W^Z4LK5;N F"6BS;&"E1K11D176GWAF:NL"*?%\NEO=/:@G5Y&H.]8<[
MA4?)UE0 )1EY),5<P^PJI,E\04^&-1D,,UYHD[E.S\*;+"YSF=S:R[VK7CUM
MO]/FYEU_(R5O$J,V25'5^T63=/M74=S>K02_?A0EN17/DJ9F 68H(UD 68 E
M1$'(( E(""7'@J9$ABAAER>]^A)_:J^W3C@.?B@6@"_G<U)6FD% I77^T46*
MJ[=;P<S$GNX"^W[K]E)B^ZKW\V(KW13Y8.ZL!J#+FJVV:;.53L9J8+@"'1"@
M16(GN=9W)JWO-?2:8>M-^ EDWOI>&+.,7.]2^&VCHSN3Z+*D,QHD.1>"0HJR
M$"(4ZZ(O*(9IB*(PI%F6LMQ'^YQ.@*F]L]0#EOAIF[.!W.S-XA-(S^^&06UR
MM [C]\G916_D_CB;Z2?9%V<7G*']</;&&<9M'\7J-:GN/I?+1[77XZ^>?E-\
M^W[QKLOLNF:KXK'IS1QA+&,D,(QD1"$2N@&&B%(8DB0)*0HRE*0V*1'F4UOQ
MV0AI$TIRP)3HX*&57=MDVV0XLA'<CO0LUL*,[OP@[)GH-+A::O"Y!^X/6G)E
MR/X(-L*#Z_,P6U.</6*.R,UBXE%IS1Z074(;,,+@T[(=9\DVKCS, Q2'!.8R
M4@99%&"8\XS#(%&$%N X1XF5079\JJF97@>=MP-#RT\ ;'QVY@ V_X=G0Q ;
M<GQV!@QWYV?')AK[ .V,P@=.T,Y=,>0(31_1U_VTE_-';6(MR>(=8;6!U57H
M%0D*:!3!$+,$HC1.=/:G@ ''(251+ 0Q3_8_/]_42*.5&&Q$!EIFT EM<^IS
M'FN3HS.G"/IVXIT&;TA;'0,4;<[.G*(YTMG9Q:A:'D<98W3Z..K\,",>1QGK
M]/PXRORR@56;Q/*V) ]W!7M3*'8OZ%K?2F^6ZF98%:R]OR,NLS2E1%=.32&*
M90!QEC(H&<>QB/(8V?5E-9ET:K2\E1GTA;X"G=B6W&*U &86GFM8/7.U T3M
MBSQ90.2JVI/)E..6?;( 8:_^D\VU0U-\F@HC;YM*,SH)>L;CE&01)I AP30#
M91#+.(:I(A^.@B! U*I P8$YID8X37F08J?NCFTBSSZ49EQR(4">J6-3C:@5
M3W&&$M!ENLY1[9VEZ>S/,')ZSE$5]]-RCG]U8 T"W>>%"_ZY7/(U6_V5Z+/'
MU5.;TIJ%8283'$'$DAPB2@)(>8Q@AE!&6<1REMH5(C@UV]0>^[8];1TIU@H,
M6HFM?=JG838C F?@>::$3LY=T)ZN0)LW[#5_V @F5U4+3LXU;ND"$[7WZA<8
M73206>X?YLLG(;Z(N:[I>B#3@.<HXFK# AF3!*)<_823F*N?=!MY'G(1<RMV
M.3?CU!BF2U!@_2 G'=W:QJ.V^@ J%D(6ME4+SB^ (>^XA-4W][2RPK(1UG/N
MAS$TKOCF['SC<HZI^GN\8WSA!=4+7Q'V-\&WF6CM#CZ-<YS'&$/* F788!I
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M87B+A_<+99*LM9_PM6X\4:X*.A?-C]JE^$6?N(:S4&+"XY#"6$8)1$Q22*.
M0!H+BN)41#&2=K:#X<Q3>VKK6O_%1G+ -O*".G7;ON."V0*8V@T>8/5N-2A$
MMT+7I10ZL;M?:GR_G,1W4',$*ZP<MD PFW?T1@=6<!QJ9V WP##2VM;XT_45
MKA?U?W1%KT<RUTDRUZO:,%%&2AV:/,,XP E"""+*B?X'P3QDL=H !1&B 9&4
M6-7_MIQ_:@36JXQ9%SG1YQCU#ST5U&.W5G:?;4BQ[<J8<9I'O+T?OKJ VIK8
M!@+FB-YL9Q^5Y 9"LTMU0X<96@>"K$33@J&M'D/FFWXPW6D%#5!"(TE@'I,
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M(;D&1:RPD8OC#!LJ<DW=D_"0JS<,O)]N/Y/:B]RM,[>,0JI@VEB6X120E G
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M N<8 4@LBQ))A#4&-0*Y0EENM]J*D[1#H8".( ]?&6!(K#U/=&YZ/_L^;8D
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MZ],!E!/?3)=G=,@P>_-MK>=*JP_+A=K(=5TC[WN5U3K1&&EI,@8@9L1:/E0
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M^&KQ]+28ET$\]1Y;I@I!# G(N,H 890"JI0",L^S# K!N/2*(+\XPMB6_TK
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MBB+3L'6S8L)X4F KZL.[<?:'Y4)MY+H.A^2<V(THRP!.76\6+#F@!A/ [;<
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M0/9&>!G_QZF*%[T?9R[M&'TUETOG27FMJS_?S=_-O]I%:+&<ZM4$TP))G2K
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MC,]"K:5.ZJ+0JY(ZJGK179+A.\Y/5Y,V&N8O:NLV<] 4/W-34&4-7TF]B&
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M)SQ?P#/_SG7;/4C22][WCG" @ZPGI =RFD5$/,R5U@&V5O=:R/.&<[EUT/+
M#=?E_LY]!>R3U]\_V-=C71>*>Z[2O#_;)Y;]("'4EO-A 5#!K16>:0:8E RH
MS&"90I23L&Z<'F..C>P;D>^24NBJ $0CMC7X[("=.G+ZP.]G64<&M6?&WZNV
M]MG^?NH2)$K;)WHCS@!<XK4ZN#KBT T0?"$XTQ;!^];.,25GNZT)+ A-"P0T
M,M!N_5,#J*$:0(&@QAKI/*?!02.=6[(-'!42IY_=)6A3)I#,,PH02SD@1"'
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M4;WETV7I)[U?K39/C5OU64MK='[6RR<TD119MDPE*!3*K%5G(& HRT$.LUS
MU!"MO/HA]"_JV(BX$2ZQ@STE/WW7?!GJP>QQ7@,.TUY\ML9_A.;4K3.>]Q2^
M2[;O@--Y!,66O*?EI8LI71?TQRB6Y UXM&)(_B-VS>JP?*97ZZ87SV*Y7/PY
MG3^N)LC:U) *#H14RI4EQ("F' -9T$(7.4Z)-*%MRBZ,-3Z_;"-JHBM90U,Z
M+H&J-%':N<4-=1TRH-9 Y H"991R]:(X*H)";V^#=-!]3#^ ^BU\46#J>=W:
M(K1MJ[X3,V:BS!4DHJ7*7!IGX&29*^J>ILM<N^$&GIWSV>\K_6EAUI;:=57
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M33*%?(+'DO7W-?ZL'Z=SYT]Q'Z,K,1B8@W+3+'&C=&JP ';!H8 4*0:ND0.
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MNX/XSM![;Z/UO=HB93E-=RQ0]>^>/[KCG+T.CQ-&C:0T+0#-+=63 G) E9%
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MB;F5[T?0X??TO0)^=G/?[X@=C>+IBM<'95:@!_-1?]7SC?[LW B35"B-*$)
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M2[WPBG:Z%"9]Y+.E7M"<GBSU>TP8W56K]>R?_,_RZ?FI#1SA*3*9:S*D4TD
M$=9+I?8W *>8BTPJ*9%79,[)DZ=&4:UR?NQSBE,WK]QD_<",T>H5,6#FHK5=
M\]W>M#?7[=]V\_ST>:/,X(MF;.;FY0OZ.1GWTKJOSW-W[EAO;9V9W^^7E:O6
M^\$\\#]G.<IRS@P"O% 0$,)30'E! ,]S@S*AL2Z"TA<"Y4]M!N^IGRSK;5MY
M\/V;6]W#G(O0 ?%S+@:$>6"JV$>XV1@_ZV'\X-3_L4ZC<EZ(M2&>I]$3O$B>
M1JCT43V-GM <>QI]'Q.U]NWZ%5^MOI>+QSIT9J9=31E(<\ H,X!P9ID.XPQD
M,M40IQF%A$4H@WLH=6K\MJWN>ENM!#_$/;?<8^,X].;[I0*Y=ZXQTD;K)BQO
M\&*YYU$:MF[ND<PIE- ]#X-G-=T+-_?TOZI*KZM7SZN5??;,(,$+5F  2<X!
M<:VK!:420,G2'!=(IK (22P_>'H0MXR622X;Y1)>JQKH*QV Y^D)]85D:#^G
MUNLN:36+Z+V<,SB6;W+P['$]CW-FG?@59R_J>SA?!Q/)O0P7A0J""^LBR%1*
M0 1-@1"&@31%5**<I]JHL#/Y8Q&3\P?V- P]:S^!S_-[?Q,H0W_<]Y0;(/WG
MLNW1CM%/!(Q\>G[)P--#\XM7]C@K?ZV-MJ2@[&*BX8C/NGXR+,@K_K6T'Z;R
M?YKS1"52.[F- @5-[2>9979!4! )4J5I7E C<.'5+"A,[-3F_4;Q9,W_;#_5
M=TFK?&*U3P[5#SCE]1^);KH8#M^!*60*T 8<H0\"\4B'Z+&@#CM'#T:L\R3=
M_VGCG:4'6WAPFAY^=]]^<6X?R4K1E2L\[0I,$6TH$;D&&$%743C%@ K"@>%9
M(:T/ER."PSK!'8N8&I'7FQ!?K6Z)6:[</ BMN',&13\_[C9L!B;A=A>YUJXM
M2QZU(-=EXZ,U3SL1,');M$L&GC8\NWAE#T?NLUY]*UU+R:>ORX7]@FR*.\"4
M"2,4X(87@&B,@*#NK"K54A0J2S'RBH7ID#&UF=UJ61] U6H&> H74/3PN&['
M9N"9?0++]66:-SX!;M/M.(WD(S7QA=SE4%7)'^7Z2\*3ROO5"O.,ND'I=(,N
MW#J>S].M^X&#<^72OKVA/C_Q^?SGYZI<Z*J:I9@Q:"@'U!@,K%,C %5" (:-
MDDAFF>1>?=DN/']J;->HF-0Z)ALE0[L\'2+8S781<!F8Z<(@Z=&OZ:SA-_1G
M.GS>R/V8SAISVG_I_&4WI(BZY(]R7:>DU@U=9Q@6DA<I!*R@&A B*!!%)H%2
M*>&$Y@**(C@S]%C*U*;O-I)CHV7;X#@P$O<\HG[KD9MQ&G@ZAT/4+_?S$@0Q
M4SY/9(R?Z7G)S+,)GA<OOJ%D2O7A>5VM^4*5B\>9@8;P7-E9GLL,$(52P*#&
M .4%(_9+GF.J9DU&TN<U7ZW]IOZ)G)#7^5C:<&_VSWQ>MP7CZQNKCQQ R@6!
M!!48,+OXLPZ0H8!KD@-H_\"LX*G 10OIFX5G&=4(@&YD_=7@U%FF:<HY$ PR
M0 HD ,\R!8QAJ5M;:Q[6Y_<F*$=9/]<*WB5[*MZ*H=^'Z"9DAEX]!X#2K^3+
M.<-C%F8Y>/[XY5/.F7>VR,G9"V\H7OAE.;=W5$T=E%^7:_VZK.1\63VO]*Z#
M&]1099 +( TR+A4X!S1E!&A-I?T^(6Y,4#2WM^2I3?[]#/FVE][FK.AS>$U4
M_P'P9(@A8!V:.?9T_E^;"E-.[62GM_5HA^BC%PQ7S(J#7G+'KS08 L?9"H-!
M#XC1,>-3^?AE_<'\5NGZ5/#^:;E:MP>!F[H_"%E?&4L,"D4Q("D50%C/VGHK
MQOHN")L,H?Z]-*XK,#46&Z?+AL? >*[ !X1[Z,7Y<6>.6GNP-,#JG]0&W"7[
M)B2M#4-U[O!';Y">'A[B7[#;AS\XW7U  I[3MT/(-[UXUM4NIQ]SHF3&@#90
M X(A 33+"J HS*0F&4FSH,W!8P%38[!6O_\3VOKC"#8__KD%C('Y9:/:()GS
ME^R.UMGCZ/$C=_0X;]QI)X\+U_6;N6]YN:KS079NT0?3L,1";3NG6[_IGY9(
M[#^J^_7VEF;7FC(EI;93/9/.F2F( H(0 F2.!*0&\TP'E>^X6:.I<8/3KDF3
MVE]"N#[=SJAZU;8URZTTDHUA;F=L[^9>)PVWCZ\?)XTZ:@.3V%@#%DR T4".
MQ)BWZS,JQ4:#[YB3XSVX3_F\MC[^QU4I]2=77_CACV4;Z(.8A2EE!1 \E8!P
MN^04@D# 8<8XIRI5?F>TUP1-C7+_ Z*?BB+Y^]\H@O ??_\;S--__ <D/S$6
M4L>M ]AN4HP)U\!<M]$RJ=5,:CT3JVB?:+,NP$**W<4!;JP"=[T!#*QJ=QV5
M[DIV'?>/6+WNNA6'%>L\KN_G^+XO%Y:D7UDR+BT9RYJA&X>G2%5N-*> $DX
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MU^"-MNUU55#?_:URN6IVRCYIZ=J/;K](N_)3KW4E5V6]NS;+"H(+G'-08*X
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M@"%+3TCS3'*!H%(ZK$.6M^R0Z3-.DZQW3U_=.M81T[9S[YK_F:SX.O! Q'\
M_,AH$%"'YJ0WKY+/\HM6SRX8!B*0LKN]I@ [2^J"NAM;]IS+'U[KYJ<??8)L
M@PDL&--(/.8O=U0Z"X;CF-7"']#W2$6L=]4AWBVLTZ*K]2<[1_?)=)9C#34N
M%$@50H!@*(#(< $@DD@3BNVP!'E:?F*GYFW5#=-V:KO9U2B>.,T/78704Q:O
M8? ];XD-[N G+Q%P[7$,$P)3M ,9+Z$C'\V$ '%Z2!-T=S^:>ELWQ-5UQ[N-
MB'93Y<-B<RKT?::,QDQ9<L(26@<,0@I$7@@ L6M\D.=&D4 'S$_P]+RO#U^U
M=;3J$#177-_8CTA;+:7I+:R3N3,I\##8<QC\:"H^M /35*MPTRYSCZ0VNWO6
M#]NJ'8^FPF"*1%.>0D>EJ3 @CFDJ\.Z>>U:MA_[!O#%&RW7Y36_/KATCNMVQ
MA;22:M?N***+Y\H0IJUK#Z$"A!8(4,TU2*7@A58"JL*K&D4,9:;F>>W:(&ZB
M1Y,??M8+;<KUC\GKTMKG C=J?KM_<FVRJSK=[=DE#(COR?W7K_/OC@P_K_GZ
MN2[Z\E;;8>7S9._)GX)7IC>-M^?.V4BC./3ZM37#[0=L#3D&/SDT9M"8OQBX
MQMJ+NT65<7?I(H!VLG\7XYG]Z-HUF3EJ-'/2GN;P%WM7-G[M9G]EL[MB_SY_
M5G7T=;/MY4QH#)ME.>.6T"60)G.I$#('+$L9$-((K3.!L,AG:__0Q''5#_HD
MC!#E^*M>)^5V=TMM=[?*1>WRWKG&HJWIC0_L-L;J'_0.A3"Z'_E]\?M 3/<M
M&/B3\JH>Y>/>87?)SMBDN:3=$=W_Y>$=#0KG]DKK#=0&BV0#1O.I:N"(]SUZ
MF6&,] 4;6?E1OWDO,S#'7\D7TJ)OQ;U7VH7!S=\ME/[S_^KO,RPS2>O4H!3;
M/ZC&@.6"V>^?_?9A@3*=>]5!N2AA:@N6MEY<JV52JYE8/4,KZQT#V?U-B +/
MP+0=C$R/"GH7K+^A<M[Q$T>NF'?!H--*>9<N[!ER:I^IROFS<\H_:_F\JD/O
M?[6CVS3HG&&1,4HT!8QG.2 %18!"S0!D@@C7<];(H()WUP1.;9KOZYOL%+Y+
MG,H]&\A>!=W/+XP)Y<"4<".*X:&0GM#$BF&\)F[<X$-/XT^B!GWOZU_:NSG2
M;E;_FSW:F3$%3MW1,RY0:OT'(@#%K "Y*JRODF(I%0ZMZWU.T-2H97N\4-9J
MAA?Q/HNF'W?$P&A@SMBIV.XB[@YDXI;N[L(A8MWNLV)&+]K=9>RYBMV=U_=N
M=*_M36Y!\UI_T_/E5R>BW?5O*M7-D"22,@I!1B !A&4:4(0(2%EN*$Z-9CBH
MK**'S*G1PT;E>G=C3^G@9O57P?:CC,@0#LP>E]#;G"[=)6U-Q$%K(P9@%J_W
M_%6)8[>8]X7@3"=Y[UNGUK_QU^6B:3)X5)CI%Q>T_YJO]5M>KEP,H/ZTG,_?
M+E?NJ;/<8%1 :@#AT+6]I=*NMF@!*!'49+G(A4#3://8R[ZI46R3P24\JUV+
M&[K(;>$Z4^>NABQQF"4.M#KHMW]WEXD-^8NW,!S\11WZ7'VT3H>#O*,3ZHIX
MTYOPTG7A![+NKU%5?MBA':\5XVUJ]@ZL+=?Z??G-55E96Q-*,=?W5:77U<_?
M_\G_WW+URI63OO^SK&:2&(E@6@!!F0#$Y#E@!$-@?Y=R!K5U0](0]R- ]M1<
M@T9U4.N>[)1/&NT=X=;Z)[4!E@BM"8$?ZI"!\?N(#@3WP!^XJ$CW";X-Q2Q>
M!*ZWY+'#<$,A.1.+&_R(6P-RK])V=8FWZY"S&<Y5 66N #7"5;A$V!6WI(#J
MU*2J0(B$=?*(IMG4J'$_TM-G!55U+J':&-#054ZT8?=<G[S$8 Z]LC@9Q^Y5
M1M6YS+@ZCC<$\$;"/'HT[ZUZO5!H;R0X+\?YQA+0,^C7X>&"))S03V7U7Z]6
M6I5K]],L+U)!"VJ J1/X"66 :5QW%:&I2+'111#)=\B:&FT?J.KF?*-JXG0-
M#9/M0-B/3R/A-C!#'D+FE+O;1VV<,P0/J&(%>79(&C<B\[K))^&3'K?TS2&H
MZR6Y[@QMQM'J\]*L+5OI7_5ZEBM=I 56H, I! 11 00S!&C.A<%VX8S#.H)V
MBYL<J>RTW>1CK9*-OG>)U3@T +\3;$]RB0;AT/S2'[T>X><^H$0+%^\4-G)X
MMX_AI^'87G?UHY0'>]L'<Z^6];;@/W7=2CLMJ-"(N^#IU/Z!E !<&@UREK%,
MBYSHC(40R3DA4Z,/IZ-S139:]@RH/(NG'U?<BM+ #'$OI4MV;3-;%\JZR%7R
MVU?E#F+BATUV@1&)&<Z*&)4/NHP\9H'.:\-3)UZ5Z^_W*\U?+96>2:@(QSD"
M HH"D#PK ,\I!5)HF>82(46].JH</WAJ<_Q5W8S4*I<X[?S3(P[ ZI[,MT P
M]"?>S_J@%(ASIO;*?#AXT&@)#^?4W\]S./OO/=,;ZBWG;8%YDMJYQB '-(?2
M?F*9 4R:'#"LJ2H($5FN@Y(9#AX_M8G7:!>8FG (F-\WM#\,0W\]FR.D(<(4
MSML<*Y_@\.'C9@^<->PD5^#\5?UFZ?OEXM%.B"=7:,I]<3>I1RI#5!L$4JF-
MG:W( )I!"'"N)25%1BD/FJWGQ4QMUCHM@5,S<7K>);6+W,\MOH"KWZ2^':V!
M)W<-U$,H4,$3O1N'2!/^@I!1)WZWH<<$<.7JGH>Y>F[_]?$7O7"5>^X7ZEX]
ME8NRJK?UONDV\K=J=EMW=79,3ER2D 3(N-J5HI" 49H#BC+"$"\(9F%UE7JI
M,34B::VX2UH[ZDCX0TL"SUS[C8[G >O@F ]]FGH=[DWN037.P<%MD,8Z+.VG
MQ+@GHS<!=7(,>MO3^IYY[IVSND(1ZW)5G[2^+BLY7U;/*[UUZ@5.6:YQ!K3)
M!"!8(2 044#G(BMRF%G:##P#]98]-8[<Z9JTQ>:\5@LW#X'O(>D@P Y,A#TQ
M[7$N&HQ.M'-2?\DCGYL&0W)ZCAK^B'Z450='6W%/95/G_'VYT._6^JF:&<5Y
MQC@$AE)L_3G#@5 X!3B3),LH,44:=*1Z4=+4Z*C)RMC3-/G=Z9K4R@;2T65X
M_<@G"F@#4TU/O(*IYBH6D8CELIQ1:>2JN<>D<?V&?A3QT;XH7WBE/XAYV;2=
MG@G&).:" R1< %=:"$!U[GI#4<6%D%JKH#X%IR*F1@J_+EV]0SMP\WE=+/5K
MJW&RW*H<N,E[!E8_3K@-K(')8*-<LM,N'@-<MCS2U#\C8-0Y?]G X\G><67/
M6=[$?U9OE]L0BUFN"4ES3D!&C=O[S1"@18& Y 8:Q@G-*=GV>@^8[:>BO-[@
MHQ;O(\SZ[=N\-$GIZFXL^!P\V[]7K=X)[W&\<PYJSZG?$[F1YGZK7=UA<Z-?
MQ-E_V?A8T_^,A''G_V433PB@X]*^G2#MM*H+]9NZV=N7Y=S>7#7YE-M%,\H-
M+5!F0)9""H@6&C H,J"40(R[X@@HK#B"C]2I>0-;I>NLC3VU_]<FS;MWX0"O
M0?#<S8T-[=";MS%0[=$3,@"E:&TA?62.W!DR (;3YI A-_>DIV=1E:KDJ^^?
M>9W>X@35>;FIH;F&5 -8N.!O)A7@DF.@->1*TYQS&=1)_:*DR=$0;_/&ZDZJ
M?=*?+X/J23$QH!J:5D)0"J>/:PC$HHR+<L:EB6OFGE##U1OZ%K+<-*\X:%RQ
M_75[PM-N?M^OVT8TV\XT!\TO9I#(7"BWC2'<:8QB&6 Y3$&1<IQSS?__ZJZM
MMW$;C;[W5_"Q!<*%+J0N^U @G7@6 ;)P$+0H%GTP2)%,A#I6(#G&S+]?DI)L
M.9E8I$0IZDLP$T3DX:%T^/'V'2^(K:(:I^B6)CN-G8QRF7TIBT->J3/C9 ]$
MX_53'=U_[$UHW7:KF8A]6F=-+'S&!D"R[UJ?II-STYMGKAK')Y=9/R>@W5FJ
M4)?89LXO.@&M[Y.23E')P)6KLE +SM572<5_9?EUQN3[DK\T4^3K'?M"MMMJ
M+:X/)-?KMVK6+(>C4X+E#<M8@D7*(2:>2K&.?9C$7@ )8F' .$V])+):TG:!
M:FG*WS:JMH![KIOU7057U5-1[NL3D_DQ8:WMNIB3CC1<29N[>Z9>>SOKF5.+
MKD"G3?HTE&Z5ZC)M!]Q- W]L*!1%"553'2[>N>3;U7*?$TSS+A"ZI/'=DJ+3
MPNW$?%?M'S?_(?GNKJBJ]6[U3=VV>\VK)YV48J=6^Y_SG1YDUD*]N1N!O(BB
M+(7$CQ-UY=M7-S4C&)&0<4]@GB"C-&G6-2]-E!5N98K+SY"K+YRI+UQ]\_M3
M&]3O2WXHM@=UG7%;D!T0)+MLICNRIRXK\J3\3ZRZ"C;X60'_!:QWX!P[D.!!
M!SU8UYH[%<VLR'3"PWHO^5/H/H/P3Z'=>"P;3%T]7JG']2#D!Z&O!R+[ F<9
M; :WLQU0AA<PW&!4CTUG=FS7^R^D+)4?L4[F>=P\8:$?(111&(8LA@BE!*:1
MAZ%/8\:C!&,FK ZO6-6^M,'CRX0>GN9=8A:S3T;TQ*/$EY;2]Y:89 ]:]!-F
M<QY$G$//2O.Z9[><M*;E1XZ1]H4,"(ZO7UF^O]W)J=ES?2[8[..Y^.R"/A(-
M$70P6F^A7V;)(CIRP=9,D= [UAQ%.7T47(QH/GQXONBE#_]9I-+[Q\.BDA4I
M=U( E"VL3K/X]DJ>)QB+!*$P(5$ 48I\F,99)N>SB4@X80EG5A<F>^I;6N2A
MC,7UU/5>I=MZNG14;!"]9C&%0]*FWLUID)[XFN<"HR%#CL*%OMIF#1 ,F_XV
M)#!]S*5;TB9A0HA$9##P(P$1CPBD/DHA13CPDHC0(*6; R]I,<ZVR.:+Z%8W
MY;$Q26J3U#KK9DWF]2:4"^>>408Z"Q*1'R:./F4$UO8S>N*WZN'.D:.,ZT,R
M/ZYD ?XJ'QZ/N?S7,QNJ-0XIV@FENMW5AO:]-BF;T//#0! "?:PN 0F?P30(
M$OG?,*$H9"E-K:X*SHQ_:9%1"QB2QO?I4?L^Z72#0OD^'?1*P8N, RI% _@Y
MWP%6;+>DK$Z__64FQ[*![\P805W$FS"C4@]T'#MZBM4L /F6U#R86HLMP$]L
M7#]^ME_80/0+&*\F[QIG?E\C80R]*R-CSMNJ>N7LYK64P7Y=K2Y:W\/=<$QH
MQ) '!?<P1#A)Y#P_91!3DJ* \L0/D-T]F9X:ES:*U<>M:\2@AGR4'XWZJO8_
MM+T?TT>\X<#BDLZIAX*Q3 ZX$V/(CK/[,'WUS7P7QK#Y[^_!F#XX<*-3^76M
MQ9]$R>)^73XHE5N_[BN5E5I6M\$))7*BSZ''?955B"-( YQ"X05)A#V<BD!8
M[6WV5+@TT:GMZ0H!&L227: QRT_DA-IR*[./=,/=2X=43KUA.8Y%^_U)0VI<
M;4GV53?O+J1AX]]M/)H^-]BQ5*6[N.,RWKK+"=4GQ/Z0)5<Z%SYGJV\9KZKZ
M4L FXEC$,1,PY+$/4<PII'Z40>1S*3V(IAE.!F0*L )A] '-GT/@3@+\-\BU
M>P6KLPCPRM*0Q:XSS/3(/;>S.94JW$ #OP)'Z%>@"Q[4Z)U?6AG$FCNO4HNZ
MYW8KM:?E!WZE PH9<)1B]?RR+;YSKL.U-L?'O7S+UD+P4]BVR5B48L0RF 44
M0:EB<@X7RY"*A+Z'(\K3-#2Z6&Q3Z=(BJCN^>]P_J6"@:'"J)48]]\AWX+G8
M[9\,CX9947]9PZ8B=.HMW 9Q<Q7YF%U&@08MZF9J-P&G%D=@)N!VIA,Q3CBV
M.RQC2=;%LS.F9<UWE,:R=6<G:VR?':#E#^J5VM[*?Y?Z]:H>>*8BXUSDG*F;
M++>[@_QU47[?I#@B01#$D <J=8U/?$A3.3FFW M1B.-,F!W\M:QW:8K>P0S*
M#NCZZEC>P@;[0EWOEF*__ZY/KZJSP"_J,0MILN@= \6?AO.)1;\&#;JL=V$#
MA1L<@4_#K87R3\/Q3.+?<)V;O>'_<J3_]I1=' (LBIMO%+!OX]E ,.#Q<6D,
M?R^N,ZE7);]O)$R-.NKNR:I5L4V B1P0,@$C3XX)B",,4^:G,/)C1(,$T8CB
M=LW";+G"O/(!:Q43CPKMZ*S7_<;H_H">,%NP<,SNS#D1Y6C:P 8M[BL=E.ZO
M-,NK7I8')TPT)\QQ'D6#BC\EO:(Y(1]E7;0H89B./?"*RX?4U9(;?N#;0A?:
MG,IKO%5YZ D_C6(9Q=((HB#"D(J(PP@3P<,P#3&+;39[#.I<6BS;0M:?$#N!
MMI,J$[+--,HQA9.'IAWV.GC;TY_@KQJRP]/D%@0Y$B.3&F=5(0L*WLJ/S:/#
M=.<FK\CC8\D?F]NY#[*:W2N_._H6<,YCA@2'0F2IC)J"$"9!PB'U@B1.,":I
M;^5;TU?ATA3G'*\*EAK$(UPB>DDW$Q^75$ZL/"-9M)8=4VH<:4YO=;,*CFGC
MWZJ-\7,.=YC; .OFE5\+^3W_3^K=U_S -P+3-$9A (.0!A!%80)37\J0'X;"
M3^3$+4RM,C1:U;XT$?K]B9><*(0.]I$_I'S$/K(+(C]M'UE.U:B<I9&<R:F9
M0@\4?/#UDE>CFXWD/MJFW$C^L.[/WTCNH\5H([FWD($3-7WL1OQ1<>W&O*9[
M(O61W>Y6W[(G=7;Y:U&NY121J!PHYX@V44B]4& .8\I#&4N%""9)AF",TXBS
MD,<AMCHC/ ++TA1.-P460KMMU"8;H&C:HS:>>=,B[351M&T"6]4HL&U:E7/+
MK"5C.M-P@CA/%TT]<6Q[1[8#Z(: =:=S5MW..;:F5MJ3T#J<5(XGU=5D<P22
M>2>AXRE[-SEU4.0P#?[MM9(U5=4-K[(R?VE<$W\C55ZMQ;U\\=N=IU-V '4'
M0U 6*LLR^0-C"@E) QB3)!:,Q3Z)K9) V4-8FN)VD*OYV/Z)@[91=B(ZH#?,
MM'-:CB>6S!8\Z/*LUMTT?L5XMP7@KTER.0QGT)$^#@ PJRP.)^BM&HXHZ2,1
M[+X'<A+^]Z\_M;^1/U3^@U]_^C]02P,$%     @ EX)<5@S0<_K7KP  R/H'
M !4   !N<W1G+3(P,C(Q,C,Q7W!R92YX;6SLO5F3&TF2)O@^OR*W]G6UTNZC
MI7M&>&4M95A)"LF<FMT7B!UJ)+H0 !M ,,G^]:L&Q'W1 S /-\ZLI&0PB BZ
MJZE^IJ:JIL>__K=O)XM?ON)Z,U\M_^TO_*_L+[_@,JWR?/GIW_[RQ\??P/WE
MO_W7__)?_O7_ /B?S]^_^>7E*IV>X'+[RXLUABWF7_Z<;S__\H^,FW_^4M:K
MDU_^L5K_<_XU /S7W3]ZL?KR?3W_]'G[BV!"WOSI^E\T0^>P6+#&"%"J> C6
M9@@L%6:%$+*X_^O3OY1B$#US8'+*]&O60.3& GV>!%>>ZZQW#UW,E__\E_HE
MA@W^0HM;;G9__;>_?-YNO_S+K[_^^>>??_T6UXN_KM:??A6,R5_/?_LO9[_^
M[=;O_REWO\V]][_N?GKQJYOY7;](C^6__L^_O_F0/N-)@/ERLPW+5%^PF?_+
M9O?AFU4*VQW/?TC7+_?^1OT;G/\:U(^ "Y#\K]\V^2__];_\\LN>'>O5 M]C
M^:7^^<?[U]=>N0S+U6:[)G'_-:U.?JV_\NN+%0'B7?A4"=X]8/O]"_[;7S;S
MDR^+B\\^K['\VU]H99_HQ4)PL7_M_WGYCW^]I.#+&C<$FMV*W] '9\^H;SN4
M&ORVQ67&_3K/W[-8I6N_M*A<7JW/_^4B1%SL/IUEG,]V3WX6Z84A;6><^,=B
M+"!4C*"23>"C-&"3$3P:J;4IUQ=?"=\0Y3NA;##]]=/JZZ_TX%\K0^HW.\[L
MN'+K=7ON'$;W^1[\2+\[\TH$G:.$X(P!%0V1K5.$)%Q(*L@<G3F*[*MONT[U
M5:D^6Z=?5NN,:U(BYZ\+ZW1+PM<!?/8;OWX):WH0I,_S13[_UU6;M)#5=M6
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M8BDZ1$%G5NOJCSL)Z00SQPOZYOW5T5SO #I7.OF>-2NBY=L@G*@UE>1+^!#
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M=[5KV,5 =YEK-XQ0Z, 0@M:D:Q\QDR!KIH0V3)KFH[>'T#4,F3_+U5!S272
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MN"O > AUI+D#5RT<*35WRI>H6>L>Z@_1<W1=T1W/OL2W2E%EIPTD7KN22Y7
M">M!85$<,=F K2\3'R1H6FW5#!>WBH6:":%?);,+N!YNQE[]YXT4RKT4-5(C
M^^=? (1A$%G7(66LD*-B/7UGHP%N4VWL:Q**UCU/KE-PK*IX@W0.XO4(^A68
MNARQD+QH:9*#$H+6)^F+X,QGFS.*U#HB\#!%TRJ+(Z1_4STT9'R_^N'R\O\
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MS&_BGJO@K27(%U;G1YHH( 3A $4)3,F:>=P\I#.$L&F;E8X$J/8BZ0!GEVT
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M6+PMM<SZS?PKYGT'P9MK%%&RK&V-RPE=&_<$"$G5FRP6L3@3C6]=_'((G</
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MW@99#]V7CRW'KH[P>F2LEO5(.%\Z+?<L?/D<EUCFM](R>>1!<DDV2FV]&UB
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MTC,/TIH BFL!H=17344H-)+8:MX%:5?:=@/9V6;4!U%1W]#[,Z\FCF<ODW+
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M!P](&Q4HI=VFQ[)Q9+52*:::OPI]@IQ.<-8>!(_![4B-= HN<372(SCF30S
M67:@=*: 4U;.I.1!IJA#;-V5X0ERQLTCC0NN0S32*;CDEA4>;$H&"WB7:^\\
M8<EU3@*\EN2*>)N8'2P.^9&<<9- XX+K$(UT *Z?<?F97-KZKYHR^X87ZWY\
MU95@P@66E(&H5 )EG*C]?!TP<C&X<L$'W?I4?)R:3O:M48.$1KKJ '7O<\V;
MQ55.#_/T\$^O6D((ZU2PM3PF9E!%DX5IGNM\I)2Y=]ZPUF.%CJ%W7'>N%69^
MZ+MZ(@5V -8_YK/\_0]<_'=>O;Z<I2LN+$I3LM? @JE3MG4$+$9 G981F T\
MLM8=$QZF9.S)K*="PKRY6CH UV,=\K0M)8A(?H,QY)[DF@G5]&TRTAH*\BUW
MS;-U1S2^'-ZI&S<]UT!+'8"M::\=,E19,&DH12(HD1,X;PT='\E;7GS4S4./
ME]\8<R] #=D8<Q_M=H#LIWLL2O3!%R5KA*]!A6S 80Y 89I/AD=M>.M>A/^4
MQIA[X62OQIC[**T#!.[>33$BQJ#((UE/QQ!10Q F =>8<F11)-ZZWOT?V!CS
M&%P.HLH.(/I4GT6*!17W@CSFP 0%@R414SJ I3"069:MB*VCF7]&8\QC@-A*
M81U@KX4?__O-@Q871,':#D0F8MX51[Z\YU"XS0&M%3JW/M";,C!NFY=.8JK1
M$-&!.3R<%7F@-FIB0D;/N814:@F^4!Z<L1*$$SX'S5"EG88@'YV%?X"X3FZJ
M3P^@G1+SQVJS YCNW:9)2XQ9&1!TVH%BWH%/=#)I%'3,47!K?.LA9T,TV.KZ
M'JD-9(?4;!<S'1]RR=[^9Y;3'_/%ZA-^(GEOO]@X6"3J!]VM5ZN;=R4.BS$H
M&="95T!I8<$'D4@F6BE6LO2R-;P'8./\$[IM3&!LA/2POZ]U\-!!I65]I9(]
M:%/;G 8G )-"X*)$H6.T/ \R*.%@-Z-K;[G1GMU$6_U.OWRP@&?S]&79[+W0
MU><-^=[G09I/\EXGVZA5M%"PWJ>:P@!E2O0'LYY+)E1N?D"=XKW.S6>_+6LK
MN&6%W_^<KZ[,\-96O E0@XU>>9E \4B&P8T"IZT 'K-5*7L72^OHZ6BB.XFJ
MCL77H_'^2939P>%:'>E[UWM9<*V"8<"*4N1%\PP^!@WD6%NM;-;D(#2&XX]4
M=(>O(6'P0#>;(W32':K^Q"]YFVCV2A,#%)=)(<DV;23;9"J#C%8CBYK$,BRV
M;F@9>>#XD3I^$C('"GSLYA@_SV<47*^FH4;ZL^E\009&H?YE)IWJJS<7$9.L
MI5).9 :JU"YYQI&08F!*%4G_]L^Y7+LNUA-"#E7I?$#YCHV7CWGQY?<YSEY]
M6N2U3WMUXZF9,BYY*(R.?14$@L_$B$PR<V\S^0!F)XP\LL"XZ;GVN&@AQPX.
MG=I;LS;SJ@*J5YZ;355&YIPF*',100F?@/S#VHF9)>^+%YFW3A$\1$<G&=U1
MW)FC]=(AMJY,CG',/CH0-=Y8OP!T02*%&B5'YFLA;^M>:P]3,NY1=;R&GX',
M >+N #2W#MGMCLILR4%)!T4@F5&T-;$6.1@OT :DC=NT+JOZ@8B^H'*(9N]/
M)#Q*S!W@Y('M><?-^29EFX,(-@ERU)#5"IX0R6^KDT6EM&A0N'**I-J^9'=R
MRS/*L7AJK7< ]/?Y*W[?7&&5N@%,"AEYMJ@!3:S#O.AX"!HC&:HR!5T1,K:>
M"7&?ANX23<."X(<G<D=HI -$W0V&;JXX T4KN3:S,]Z33+*TY'SH (;SQ*,,
M(39OEO$(*=UY_B?%5PO]]'L7^#N)+1]S^7?W QK=]CU!5:/KO<T*UQ<NECRL
M$IT'HUFF4S C>%;+S(N513K!O6P]+OXN!4=ED?Z\K#[CV_+V:UZ0O&>?-I\]
M,0ZYRD)"MEG75TZ1N*(@1E!48Q43SL;=LDB/+#"R'WZX"N_DCEI(;^P\XJM%
MQK?EPU>,^2^RCL6:A0FWVDOG A0TJ?;>*.",2A!42A16"&,"VTG_#W[\N,="
M*^T?+[D.?(B[T/WU[Z]Y1DR$R&2PA4/PD9B(K(Y09@52XE[':&1PK5W3!PD9
M-T1J )1V8NX *YMRO+QFX?WTT^?5V_+7<NM2;2;,KU4SL<EF9;@%KVH&PB<.
MR)P!@KY00A6M>/,V@;N1-FZ=6D,\#:&*SA#V9D:?FY>K*V.Q4;O"(@>GC*ES
MPA@@H@$D0D20/KO0_$71X^2,.R]W("0=(_(.T+/FX6<*"28B%ZWIP(4Z08X.
MX5(?@#(./!L2B4,23.N$X/7BXTZ-;8B,P\39;[/\C6@^7'[Y@HOO\W+-'L[2
MV]7GO'@S*_/%E_5"1T>U>ZW2-/0]G+]AXF,="B-\!!"^8+T.\Q"85G7D DO.
M1)UMZVV[37S\L.OV;ILQG&3.O.(A G(GZAQ !8$;"QIY\EQZ.G=;-PU]F)*N
M0NE]M/VTCWR0H#LXA!XZ3[>\O)U=IQTG(C!FL;;03YF#$JAK^]P$F:LLL\I>
MA]:O^7>CK*O8_!@X#:"(CI[-;?AZ1R= G'[%BVMK":(H(IS.9@H?03GRUBC"
MU" 3L28ENAR;-\I^BJ"N(OA6<#I.[!UL4O="QK>!W(%93F]FO_X=/^/L4WUS
M>G<[OC$8CZ)H@8Q"REA(=)F!0RSUIHQY9IG+I?7.=02Y747\Q^#O5"H[$W3>
M-L<;1I,4*E)04EL[1_(5/ 4J4C-@.68F?<HLMRY).YC8KC((0R/S>'5U@,N[
MYO7O7/G.Z14=[OB)(M%:RW7URUI5S"?:)(J;@P2,M?E*$36"-@B1._08I;:J
M]=NV?6GL*EO1+GIHK)S>P5<+'.:7L]5[7.5W>1%K/XB2R+AD0MKE:](FYPS!
MIP22I<"=]M*XDX+O 1IW I\]=_ =JYP.P'=[^][!M!!K;RGF*:8R#A0J$J4C
M2PL8R \ISC#9_$WO7A3N!#QW!L ;4#%]P^XAHTJ<8[#1 !=(@JQ=R[V7#(K4
M0I)C$;0^(>P.W>_\></N6,7T7O#V(7[.Z?(BS\OKR]7E(O]!-O;E\LN=G.7Q
MUP=[+-+V]N!0[H:Y/$"C D_HP4EI-V/"$6V%D-%.Z:B%;?UDI.WEP4-QSS0O
MKT5YF6_L46#PQF=P@AGB-00(EOR"Z%$5Y#X[50;<O9ZFKJM+AGU0\=3.U5 A
MG1V6UR'V+;[^)!/]^)]\\2W_,9^M/M><92Y&4MAC?/4(UB,X,&60)F.AC5K8
MYGTK]Z6QAQ$ [;&R R2;*>X,@/E?&1<?_S.?<"8P%N; VJ1!.4\&;B,';RV+
MF:&*S:=&[4C:R,\8^H#A(6HZ%_01G/(D6J\I["8W.-6)IEQHP$*NJL3@K"&.
MM6D^J7%7XD9^*]@1 O=6U9E@\/7\<C$IW,K$I8)D+=F6K;5VAMC4A>PL(E<.
M6_N[N](V<HO'?A"XMZ+.!8#3;[D^'O>YU@L6QW-MP\3 NR2!IRPX:F;4H"F4
MIV@;][ZL)P#NJZ@S ."K0FM=,Q="%(XLBT1&CH4R(@ *;X%B/LMSL%K(4X3"
MCQ(X[J59)U \7&5G@,>)4CX6+A/P8HF?S&O),[D9*J:8D[,HV\\O>8:F<6_+
M.D'=7HII5HO>&&A_S=(V2Y[3KW_'O%R^^E*_FV@?LW<A 6(@OU:6^M#<*?#(
MG:;_&:-;UZ_L1>"X]V9C0K")RO;'H]_@<98_(2W\<=C][P.I<MT"[]:XK'?S
MY;3J]]>:WU_6[HF_3Y>K"8N!<2$$.%;EZ[R"@-J!E=XXZT11HG7U^Y$DCWOW
M-B9T!U)KKZ?XQ'KMR/T-P$UMP*;K"^Q" 1KW2KD8F9/-Q]X>7N!WTP;N)4%N
M+QUT *1'"F>O!20R8\+8!#&+4IN!:O"F7F!K*1CW7G';^EQ^AJ2NGFD<<R'7
M4O0=(.EW\@QR?H2IIRYU2G2!6\$AHW"T]2KBTT9)-BB%9JRV5VO]:/Y06L>]
ME6L*F!^>O)Y >V>$TJL['Q8<\Q(3F)!JA1!BG2>9041GN4[26-V\D?!^)(Z[
M'_: R4-T=6Y07%_^&"$D3S*#]-5;J:V^?3 (R245M.>:_-8QP3C^?5TW<-Q;
M7V<&R/5=$":T(=*.;]>MYX6(%#3Q $Y'(670P8KV+]SWHW'<R[M>X+BWMLX-
MC341S[W+17L-+-2;R3H%*K@0(24;?,:D5-)CHG'TF[QNT+BOMLX(C7?OA@K6
M#'WRD(J*H+A&0*,]8'&!.>ET$>U;9!Y Z+C7>CW@\G"]G1$X)U)J6<LW:K4&
M)TF& #X:!A3!>9.4]'8T/(Y[Q]<#!/?23@<7?$_R]>BM$7)A3=3D#N=U?M24
M.@[6 O.L&&FMI1#NE!#L\\)O-#PVT=NQMWU#9K8GJH1<> R@LR,K\YZ#9V@@
MQB*\SJF8.&S[JOVN20:[F!L28BUD_X*>PTWNY>D'>A WX:,]B;O/X?6CN/]S
MN)C?S+[1"O/%]QLZKG^T6?80J>[PJ8V$N"_]C1X2WJQQ,_OARJ:9-D$J&T%@
M"G7,AZ*@2P<0L107E?&F>4O")\@Y=H>__NCW^)\_Z-Q83/%B^6=>O2WO26N+
M;WDY<3)FZYVC ZO4 5,B V9>()LD4'MI@VSM;3Q/U;BW2*WP<7_/;ZR-#L*J
M:X[^/5_\]YO9N\6\^D-W6=*B)$>R 50V@RJ8P E+@2-/$K&V&+!B*( ]3M:X
M=T*#(ZR1/GJ"V&LZ6Y=T3/PVGZ=[+$F3I2^A]B_/$I2AV#!D8<%&Y%)QPUGS
MBK,=R!KWGF=PB#721T\0(RYJ%"=T?<(HM).U^XX%7U0![;+60ABN<NL*L=OK
MCWL;,SAH]I5POQW#:6^E$&[U'6?IU_^YG'ZMOO[A/O<3G];(U]Z5WD8^]M5R
M[RYP5H>J7:]YC2=OE75)(?#D31V#:P$Y,L#B THNK<+6=2//$G7T8-MM'/.V
M/+K49CXF4]%'%A0PY<B84K 0>'3@$G>E9CA1MJY3V)6V<7WOMKCY82+N$/KI
MX 1[E)N?OE^/G>8FTYXM*:!PDN06)(E,.?HJ>B:<LSR%UG6J.Y U+MJ&P<-\
M6.7TC+=;DZM9BBFQ&"#5.@JE.0/'-)+[(&Q*SGNC6R<6=B"KT]WM4"CL"K4#
M]3+V ,(_<'99:-._K+[,-3/;8>9%T-^66H),WH&2Y)4BTPY"8"$(S20YK,_Y
M7<^NTBE>#M7G? CACHT2DA*Y^_0WEZ^VXVSN<R.3]$F+ LGR&G*H.G33>* M
MW$I) 8R/:B>H/+O4N'FE0?'25LP=G&(_S[]\O5P]P :+R:MB0%B?0+F4('B5
MP:'/F>FHE6C=Z.(14L9-(0V%II;R[P!&KR\7LVF]_2,1O9[^7;]:7G&"Z+RV
M%J3UM16,". =HUVT8#*Q)":P^22?1ZD9-[4T-)@:::$#/*UOCS_/+]*;+U\7
M\V_KY[E7K 3%2G'6@6&Z-EASY"8:K*;!K56<MM_F3:">(&?<8MVA$=5*#QU
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MV7*6R+;X_?Y=CU3Z/K) 3T@X5'7SQG(<&PL?<J1 ,5V?H96?>R>HS(9.955
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M,1MSZ>[E\;-,G6GCBGZMJ2V,]K<NO[&N6?Y4#^GA+\5NN=W7;T2)1\5*("U
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MV=\AH._710.!8-Y*(QW Z7#!W; ]2]6Y^A._7)6A*8Q"6Q$@8YU574P&%#8
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M Z9U 85:0PC"0:IQ3PI9<MYZO^@E;_[LE=DSS6PS%T$GVA.24)8\*F'!85+
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M27'0QLDZ<8T;TWIXZ].4])LL:^O5[BWU'K'S]R7YY#,>R?J(=>2G<G0+<Q;
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M4?31.;ZV)S,P[;SE!I(3EC@*":*NP\?))8TN:F)VIZOM2(1-^9".H_T]H'6
M*CH'UUT4>WLQLQ1XB$4",BM!>4>B8XE!YA%-XCR%)K[IOG3U"[A#,+'/;7:,
M@B8&WZ[OP:_?1[PR+I)7Y.L'<OE!E:S 6R?!*:]4'?NJY$X1H4:1D5_WVF#0
M//MPNC=U7$UUX$3\<_%MR __X^KG9O!OBXN+OVUJ.V>&685"(5C&S&:!2*C;
MLY-.B*@<:MTZ>'( F?U'4@X$S>*T&NP I+M48]ED=<@I0[&VSB9-'")# 1Z3
M0>**>$J-0=FJ.FXTSW9T:!Q0-;>/G@Z&WM?!6/AX'9;7)XCMG7\)R\\U55R[
M+NCGVX:-6>':)22+)!M!HI2:@W?1@2'19IV*=K%U1O<@0J?M4STU2,?790<W
MYL^9O%^B(VH?9609N-)UA[(<YDAJ8"%DR^C/Q,!)0;IO)=5HM2U] ?-0G1T,
MQF^XC(L3/N 2A6&UG+IP>@X4%PXBUI$MW)#3*#!H,7J?Q($/^&@E,#T^X/OH
MZ<@'_.W5_<+W,4MDAC*O7\)%Y7!1[B]%&=I)/MUM1B&1KR]JK6/5UF]OMN-X
MSR_"_!)SDZJ9MK2T+Z09458GJ*WAR:>@)+G^J.MD*!; DTD*(6@>HW4NJU>T
MP^/!++7RS#J?MW^FBW6N3NAFT/T'7)+PZSS\3XNW?X9+<D0WFX6NU\NK'VZ3
M$)SW6C*(+BBR>U*"((,#)F5TRF3.5.OVD+%YZK>B9Q]L/KRZNT)"!Q;P,_S/
MN$439>"0HXJ@F*/GD6."(I@+S&O,H;69\0PIT^*P+[SLMI5L+^5-'CP8&B>>
MWZ^VK"-*WN#FOW=/Y=](4^?K957A)N5!_]>'Q6I>M;2:R<(#YXR!5)QNB((6
MHBX<K!.!%322!_^2J3$"7=-&$+J$\M3:[_@*QJ)M8CE"4B+7OOX"41$OP8N4
MF$)?THE6/TX;8.@2MRV5U[?[=[ZXO)QO(BIUENCBJAY )(748$L>CEQ=.U@6
MR\OAVPYW[@[\ID:N6PL^&SEF]T@Y>T#*$^9P)$ HH1/(.KY!U3GX,1I%R M<
MENQ2P=9%BWL1>.S]^&&]3%_H^G\?+^:?-W/N2M*:YT0GM@[N5(HE< 45!".U
M#UX*A:T'1C^F8EK#=#R,/+SBCI1_!R_L8P[>K/$?5^_HN'[Z#UY\PW^2^+ZL
M9MYATD9(8*6.PU8A@O,\U?PRLY:>B/:-^3N2-JWE."76CM=4!P <!C7=D^*F
MVB8KK7SR%J3.I0Z>\T2_MH \%>8,,Y&WSL4_2<BTYMWIP'6\%CJ TL;@))WD
MWZ_(+KXU3!X?G%]NSL,U?EXL;]Z76CYS^R_R4.(:O E*I  L"0^*3A/$H!6Q
M+G2Q%C'JU@'+-I1/^^HV@-"3#L1)]=D%BG_*ZQVG?U\L\NK]\B,NO\UK,B_]
ML9X3N=NJ66&T5$$B*)_I&; I@F<A0"HD_Z)C[0-ICN(6E$^+XBDP]PCV)P=
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MKJ(H3HBB%1J2-DVX,F%'!PG&^? =U3,?OO7:?ZWLQ1?^2YG96,6>C=B-$9*
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MD-3FCIU\A<MEFTB!4)_ (%B+F]Z&6,=QE,/!6T0[Z3*V-;RRT9P=:PI/%](
M']41WRR+@'"^YX9+-6SJIXN)!,AV)4<_.3L)6YXO$.U%L3;T;5$7FLMC<2Y9
MD)0+==IR>44Q+;7U"MS3\U+T:R\D25V1X5BEOP7R.@M3N7N+JZ#EE2AG\17&
M,9-L3-QO[GO@)&#GH@?B6U.0TSVX<Y2VFT>+$24'C%#PL3N@')^R]J#U> GS
MLI.FQ+CYF$+'Q0N,Q\@A&)N4OB\:HCF[2P,R.)Q8A4L"^T0ED6HS1G!\.(9]
MN5ZJKJC<-@.P'',5;YNI5:S740,=%3#FNK7Q7--5P1;&2^7Q@?F0T4R@N'*U
M66.;9EG@TUQXFBQ 6F5HVKI#UIZN,YFFQDRC8!TB,#%#2OD6^0[**7> -7?1
M3J-CB38GE1]A]5<NSZOH'_AMP5A?/)CBUE(#]2PJA[/$ FW&9EJMB*:\,+ Y
M)6'!3>():D*FRI(P/J8J6,,=K]D=Z>;K5B/X@:TS#O- <4LN' SK%YE[%*&=
M:F/88M2>LOP:Y;#JUSO@[X=3>$"P ,;%D%]XTP6KN_K9)!Q3,;[:K^C-;;]U
MU1RT^W58/??G=XU;F@/QT9.+G2UT'=;T/OZL/0<-*+TJBU4=5LO]^7KYDTW^
M-#]KSR8W,6@WHBMGM>.33IK4?/6^H.KJ;O&&-=3$OG!+2_BU'[EPCV'AZ!:.
MO@D+W&>HX?%(^TOX9YK.PE?_#U!+ P04    " "7@EQ6&0,B(91!  ",$@(
M$@   &YS=&<M,C R,F5X,3 X+FAT;>U]ZW/;1I;O]_M78#.ULU(5)$NR_(B=
M395B.S/>\CA>VYG<^72K231)Q"# X"&9\]??\^H7'I1LRR%(Z];>B4420*/[
MO,_OG//#?SS_Y=G[?[UY$2WJ91:]^?6G5R^?1=\=W;OWV_UG]^X]?_\\^OO[
M?[R*SH]/3J/WI<JKM$Z+7&7W[KUX_5WTW:*N5T_NW;NZNCJ^NG]<E/-[[]_>
MPUN=W\N*HM+'29U\]^,/^ G\KU;)C__GA_\X.HJ>%]-FJ?,ZFI9:U3J)FBK-
MY]%OB:X^1$='\JMGQ6I=IO-%'9V=G-V/?BO*#^FEXN_KM,[TC^8^/]SCOW^X
M1P_Y85(DZQ]_2-++*$W^^[MT\N#\_%R?ZP>/9M/S^]\_?/SH^T1/9LF)FIS.
M)I/)_SN%1=Z#G_,U5;W.]']_MTSSHX7&YS]Y<+ZJGUZE2;UX<GIR\I_?!;^K
M]<?Z2&7I/']"JX5O9T5>PRI*N"O_DV_>?80JY_"425'7Q?+)0WC(P,W,!=,B
M*\HG?SFA__<4OSF:J66:K9_\U_MTJ:OHM;Z*WA9+E?]77,%Q'56Z3&?\PRK]
MMX;EPT/HSRM^M4=PGRS-M7G5TS-\OQ?_]^\O?WKY/CH].7X<OD-W]76Q>G)R
M?'H6KGX*QZ++/W_Y=#RO+U[_\N[]VY>O_Q:]?_'L[Z]_>?7+WUZ^>!='+U\_
M.[[N??I/8UOO0\=Q=G+Z&-;^_-=G+_[QXO7[Z,7__OKR_;_P;>"OE_]\$;UY
M=?'Z\][K]Z:JT]F:/TKS!%[SR7WXS5=_T_/>-SVUQ_/G/_WI2B4)R*&C3,_J
M)V>/CQ^8K4KTM"@5BKXG#6Q1B5=^]^.;IER!D*NB8A;5"QV]R52^O=5_]^-Q
M%+V'9:R"9:45K2M2I8[J(E)U7:II':D\B4I=JS2GI4]T!9]=JC13DPQNH<NJ
MR'.=1;.BC.!N)/;ICE4SJ6J5UZG*X ;5"CY.)VF6UNMHLHY697&9XA[" R*@
MIF:J2<XO0<J7> DL 3Y.X4>-RJJ(F I_GN;PC5ZNLF)-%URE]8)6]JQ8KE2^
MCF =^)\W\![P-?SU#A8"CU+EVNR__/0S&7QDC/!>" K/8IG6%;WA'%1PC:_[
M&K:]5G53%_#Z[^IB^B'Z945G%$=OX2S+=(IJE;[I?A+]FL,=8_GC8K4J]30E
M\H[>XA+@JS>ZA*.'MYAJ_C51C/_INP4<104T]T)-%]'%E2I!C2-S6%Z(@/;@
M7#5\F.#!_P%'#CL<*;R9?]@>H2CO/J\OWCV_^-_H50H' R3RM@'*?/#P_H.#
MZ>'!^2$M"!]5S&;IE,EQWF2**16^*#7?YJ NYAK_CNGG?_W+X[.SDZ=;%#,;
M1,I+MQ/^:V]3JM!^G3X]W ^V.MLA_?)<S]*<)>^6U<I%!18Z,#$R59HS'\V*
M+"NND$(3MTZ0VUD6J=4J6__U+P\>/[T]FGETMC6:.5"'HR&:\^/O3W$C1BW%
M+A+PG4!\P3=%.0+9%2VU8IT0_52@?A%C A0I:C:P&T##UAJ>JX2")SI2\A)L
MGQB=%H.RBM04WCHA+4AVRCL])>5Y[EN"MR@OMTG[DS'1_OWS\=,^R+YT2E;T
M*W6U5<'=I?Y,S\%.8MN?;"4T'TO]1Y.69'14\ =:4$CP!5VA'"LCA0-]XZ_K
M]=%$H4(@<ZU"IIAF#=G]DZ:.\J*.LA1XBNR^6,RY7X_?'4=HM>H(-FZ%>P<K
M@CV*^:N9AE_)\OAGE9XV)2@6V!+^'5OYB8Z)?2LR7_7'Z4+E<XU,_4=3U+S0
M:@V<NXS@7U>+=&I=B25\P%8OV*89<G=BKL.W$8M2N3/$Y^);X_/ ](7MS6'U
M35Z7Y)+\#NNKDI39_PK5(UO"%?I;,?Y"Q$G,MKMNV\A[(B6F8Y(2NZ AD4A&
M(QMBSR?/B*YA&1DJM4N=K8'9Q/%LN7? %M;IW.!*WMP?[3J=L)0>GW,_>"89
M$\_L@F:ET,#%O-2:8_XCX1YBB*L2+<@<"58CYY1%GDXC918+JJPFM0JD+($M
M,"R7'%6AH%E%[I.G>3 >YB(K ]J#(WZMG4'=5C63WV$91HV[ATT+8'4;S=LS
M-:3'Q%([H(;(&QH7(XF#-HN>@TTZ!0.U^GKAW6V2ZFP\I/KP^&3\I/J,C7SP
MOI_!7<HB&Q?9%E-P54J-1HIX"T*U+DRF+]'#NN6PV.G9]F*I!^EH:/CQ\8-'
MN \7T=32"1W+5:[+:I&N6D+D*Z^;[O@DK>'<IC?8R&B;M,S^,=%OA?XR[E*"
MWG>]4#53<FXR@N31+HN2OLR]+R(U)?,&4SM@JQ3-*CH8M3AY0\L>@0PY!/=J
M2@&8JDNM'.$(29?.)8Y,4LME2OG'"YTEF(FM&CC5-W)J4TP7IG53PT/<\<W2
M6;W& T1L0W3PX.0_#__ZE].')T_E@74!!!Q=%G2RJ^(*'K9A72#8OG\J"6"=
MQ-$"+KCDI!O0$>61VXEIS"5SZ)1#.[01G&LF*9HD C>2!\)K&7HT;W:U*-#<
MQ1>$QY:<:(1]_&JOR0$=C'!-M/]8%74T%.\(O/B^B/OQR/L'QX_[Q+V>S3AJ
M@2>#1] YO,W"+EJJWXL2L0QPW5(O)]J9GVR8IA@B765J"D>>-"4C'8 GKW0&
M3STX/1/:6L+S%TAT:4'LZ*Q9H-B*0HQ%FM=+ 3.0SXAD#_='VM)Y K_5=&FX
M*EQ*[\I6\*C2^'OT3O+UP*/ =_RYCRFGF6I@@7C:<92R+</<UF6T">W\=;M^
M'7,/G-5DS4RHEH;=/X/W]H;UQL-[]X]/[N-.1!N-+14@A59%:0X^4!F/STX?
M/<6T6Z7KZCKN=(1H->8!4/ "C0[^P/(DR?6-/ D<AC_TGV*XJZAJ8'+2%C[1
M&J4J%@_R#OVKDMO+2\S*8MG1U[!(6(H270,&4@4_5"D84ZK\H.OH4F6-QM0*
M0Z0"*^MF^FOHGG@4F>4M66.+T]+E4B<I;$&V=F*$WC5@VM+_L_HB?1\11;>!
M!):]G;T">W:[1$;^5W1P80XMJA'6/-/TS@A+@GO5<F@L[U"<9"R*^VY+1L*B
MR!*4R/Y.JEDMH3KS"#*?#W[J/AI?A4\F? BL2=9[:B_RGM<^QP/_\1,]8Q*2
M4[=/DSNAX#:I,SRM0DQ)!/5YD</>UXVC \-4=LOB#80JY!P:7$R>9<?R8BF0
MLCD,A)60ZN2\!.8I^*^XM56PI/MVCXQU2*<(MZF&[W)+BT8>(_)L:J1'DBU]
MYB.3P'EW\V"AF58@>6YHKM["[IE]BA)=3<MT C1.3-;#J4"TL+U#)D.7KX>D
MD0N86.DT*)9HJX9^.M&$/$HK7 G&"^%--4:Y074E1,AP$ICE1M.(.'L=9:DB
MI&I*0(^JP$25_%BD'=U[.,!HJ@$>'*,M\-3@8I]PTOQ2#Y8(B)5QXBY1DZK(
M0+YU+KEE_?Z(0&8;%?P)>Z-(8MW_[>S%-<4-_+^+TKS 2LWUT:34ZL,1R<,G
M*KM2Z^J[SZJT&"@X$ /MY-C#%7YQ]46O"7CR>&LF8"_C.>1=;(P1BU_J6.K=
M$$U*++4F;#CK55:J!IZ1DG6D:H9I5PS2!G=$EW-49OB$(DL3)0MH2E GE6X9
M"@0:9Z4!7U0I[(TJHPE6_&B0$:25E  H6J#O6PSU;_/H7A<UOIG5"VST@&P"
MMVR.V?5P#YR+DV ^K]>]B9H\H]TSUH5<S1!K%G"!Z61\+ I"TT:+/842F0SA
M&2%K#):-N?_\Y/N+&&^5UF1F3[3.*8NX5&LBJ26#N]GFA3TCJP'^&].O4.B"
M@2@BN@35AN[>>Y &55.NH[<>7AM__A*I#'_Q%E?9X%K*RW2JHWF3,MI.3&E9
M"-QZV61S)2 >69/_J8<"[RQQ3XCKYZ:D,"!NX$P4IKHL9,/@5).BF=2#5!98
MVETR2V=B?Z;&:@3="TQOJTS0TH -%4+CH)GG2[6MQS3W9 O;0NEUMZ8205@=
MVKQ(J5/?KS+2CJP=7+GG$&1> ('(L&1:$\/1"LQ%P5'37G/70=!ZC&NR&KQ]
MW9/<Y'PTL8;=0*:@X!Q!*L&SKCNBE&0[,.7I]X\?DD07T0TF_5L-3B%E+DF[
MH_<'*F0:&9/>LG)"JMU5V?CBM5J@!\0P4.$+>[U_#2,WP:)/$_].OM"6&WJW
M<-J$>+_D&C6#FK'PS*9N2L*XII7<-EPNO3*IW*I9K3+"RI#JPZ>A--#LM@TN
M?D_8>W''WI_(WE(?,!X>1QM=%M7"RE 0H""3P"^TK."MJMD:Z;N%4#?Y 1?A
MHGP"*6<5)0U&LAIPITM8;!(^UOOQQJH(%!/%;$^X9SR!^+.'@GH8/?<8U/UX
M& A)=\HKZPO3[0FM_GY'JY]*JW\".N@3R/2URHMW-:6TWNOI(H=%S,$7B<'
MFQZC4_=<9UB#HZ.V7T4%,LUTJJN*O<)2U\6>D/6'\9#UCA@P>=5DZ!6/A[(I
M-B1I&E<]AHTJ$C#KBS*.=#Y7\T[>C<V2WC80X+Z4FIT'#AQ5-H_)698](?]L
M/.2_$U+=6,<C(GZ!\ 1&])Y0YW(\U'FZ&]19<5IR1&8'YYBI-DECZ1W*VL2N
M$\-'E'GBB&N0,3@[.]"'-A/OA8YB"Q7AP"U^'O0)P%MA"!B>,P5;!3U'C.C;
MK"Z6UW*DVUL45>S28KWEZ8]PSZK/)6WR%&L)Z;*\R(_H62G<G2NA*4/#U;M)
ML?(\XG"AW51"=(L0SVWR;CX>WMT)P^H%]3 :56"HUZSZ!5LD8087"=\&BV+I
MP=1O8]VPV58$[Y$27XK1Q9E'\Q!@LS):*>[S1,GE1+ZQ*9:9UNWGFZQ.U5!O
M)[P6,T$N5R54X7I(F5T(;P2K^[N!I6U,CF6(%YDO6+80TI1QY6"/FC.&'U6%
M37S:%XS#:U16:I6LJ003]\,DW.U^6'S=!"AJ*3:O?8:?_=4@(E*I!)UH6P$*
M/^]MMB4986X7%I:*#G25DNI1L^D<PG?R%N3GO"@21/& Z$3*,2CKC[J<II4V
M_5,\B6UE=.Y%'R5C"Z]+"03\:ZJI?80 $_Q-EA8,#E-LH)EDQ[N;6O+Q^HCA
MQM+B7;,*^R4E/2CJ@Q %/L8>/%.P</N,4DK9&0X=M[=>6>@2:86!W*?969,'
M@<VF=PH^[R  ^51@ERAY'D>3-!=/B6IY@<,KV*48B:8%,A EV^+I:=&4Q(F9
MNL+/Y@5P1XX[A!I_KO/IFO%<?S3P6;:&K?J@.>"<@_XKU^%Z]\1H+>X4WZ<I
M/H,<O9B.**: Y/[.)>S]17+N\_YYD/O<#]I=W='NY]'NF[( I;H<#_TJ])%P
M2:)@&,MKL3<^MMAU&0)I77+8BV%04[1M"+#>1GASLR9;W(:PF'J]TM$!/P=U
M(I4I+&"!F@#A&:&*K;X'VP6#:JAZDG1&J(&:6TM@%:.]N_*_A0=0^OZO?SE_
M])265RUB#_4#-F8-)AZH*"P *9HLX440F'J%F!UPVFH*[EFX/*FS[F80? '5
M9$[M0%.Q%B6-SSE15[PA0/^*ZJ$&7+U@Y01MYD4'5A#MBM@.G55QP1B:7PBU
M>-.45:-R"Z[W.G_ ]39A&O<XG7@Z:!BF#J^51VU2WA.)]L>=1/LDB?8SXNS_
MP3C[?R)8?C0B+1;;&#D6#?DX!/0''=D\_#Y<Q%5!=^T2OFJ[A)?64^EMC)?3
MN6F0:!/X:*&3GI9[*F)'  2N5'IPZST__&#*,:@GH(6.T8O]JR@_R(.-,&,:
MD>;/?\N*"=SZ'4EIH?&^'PCUBX\OWSU3*^S!8+^<D;\K7_)#S1W1C^VPD8U#
MD-^8%32DHE+@9XO0GQ4&J$8W.Y#'FY].TH1\QKR0JZZP06"I4:OIQ)8-FO:#
MB$6@9)6WO:Z/(9<I4ORE[4E6]IZH\\?5VP)W_#=T8=_5I8:-_1_P/X%8MBFA
M(G-J;!)4L"(.6W6U+B+PJ2EFBG@I*GG<:G60N>3/'TS17S9T=';T[54!W?5@
M\'LP#.@01LV6V=I(-RHX+,%^F>>$)/20]8D&Z5A2ZU@PQS.J9Q17 ^0E6KU&
MOK'H[PIJ\CJH.V0@L]$&@7_75U@N@A^@:X-BF7P8L"^ ZS_HQ#S-A(B#=VE5
MB >R%R6^D?!P5W:-X)8M21^9.BHV@93?YR\V#\BP^!/$#FE,>AK)J VW/;P3
M_7^NZ+_K)_%5^TF\9$8 Y>?ZJ 76IQB8?6PZ)!B,-/"<BS"OT>?V[\>H"V2_
M4%K!CG9+LCN=&M1',MA-N95DO)8JL3T8@LUR^0V7!O*ZCW;0YGEBFMQ(XW&3
M!J*"5;!V<V_Z3V?]W1.>N=B.O,6>1$'*T7#H;G2(_!GH#YR]?VDU(J07U?KR
MPM:PL/V$F5?CH=0'Q^</1D^I+W-TVC"Y[8_N&@_1@MKE)=DV.#UCO*0H;UIS
MTWA;>1[+?*_4OJ046*QLC7^W]#RL.C\[\XL.]X1)ZO$PR4Z@=@='W(V63\"4
MI$%]U&L]*31;.6;J'2(<*TGA#,W$ZQ<,>\( S7@88">R.@+:&Q&Y=\%Q!:^Q
MVR/U6B%_^M!<%, T#/ZK;#+)-/M3'?M[>^P)?US>\<>G\<?8M$%HZ!B\YJJ5
M\Y>Y'1=99J;G# SWL+&+X6&O>T+Y5^.A_#/**(R<\AF7/2;*E^U:,6#<KT4U
MOS3(X+P@V"D*;VZ02=4:W AKN*SD_.S\0'>+2O:$_C^.A_YW0O)[F+'Q, &E
MEVQ;UCXLV)Y0Z_J.6C]UU$0XP&X\-&MK28"H"@JSB^RE.7N1PX5B.8HJ13*#
M^9]I[B<;@<2OHV:%4*&Z5FENZGQ6WDO/"^Q 8\/TEYI+4*9EBL-U57_Z+:S]
M\XTH Y,\/=D3AOKWF!AJ!Z:6M<=$CI"?QL,YZ$('J\%)A(@.GUDPMG"[?8R'
MS"" W[183KP47-"^=+\Y4ZG#:*@S\MA9!(<<P&F96:NC<I6E_28N408VN"G-
M?E-\0YFS[LA8KGRP:>;2O69E@D@E->ED9(#<J755.#^@3"OJ P57S72*S03!
M3W^':)'@[L)'/ !;P#LK555JSJ5_U/Z6@ S31:HOM6'L&BA?8Y?W2YU5+4ZW
MO<[#.7+,CSPXCMTCBV+XRKB%K8Z<GQSN)M-E:E0\EE;1V<GI8[_\]P4-;_?R
M#'LT_'4ZW4VR:8NV\9"0",VTJII6(%/U"&2O*-T8 H_\&<,QI\ Z]Z)B*D**
M^H7E-K>V)]29)/M!G6.SN*-)47SXH/6*1JSF=;E&1"R0K33WQ?+\9=' .NUT
MI4$(,0X6))J/>Z/WAJH?@UGP D=S]^Z->SSY TT^:RC9BT9)DY-MC7;#!*@T
M,*GW"Q*D]8Z2>P,.VNG#R=']\="X6U-ORK3;[+'P+N'Q#69('X;A<Q^IF9I1
M.D;V)KU3H/;(3)C-=I,R6]GS@\D6HT8=0Z&SMB!5XY/KGE#1?+ZK5,1-FMYP
M,[8QH4M<%Z#8M4N"_W/=2_>$=A:+':6=D24OL#=2Z;=;\JI!$$^7X,%SX'6H
M-_WI?=]#V1/ZLFTJ=HV^R(:^6('YC*/Y\'S>XH4C(CF)[SO_0&7H-'!$?UKD
MN?8FF5D75@91]O@2?"K?1S3+K0)BH@P<=8P;VHWMCB<<70'R_6^O 'FK$P5^
MWU'98AM8CDB:&-A4Y;IK?AWHU.RK0J>V6.-X_WB+Y!:FSA_3I-7KU!N?PSM.
M04DSJ<(VE9*66%O.(^Q-.V,U-F#%OI#'.Y="'6YC%MK6G!)=JH_ILEE&:C['
MV<RUCO+&-,*7; .92I)CE6Q!"Q<-QM+YV8,8WE*VBRZ$9;W$Z1&)S,.5V_&=
MJ/>LNE1I1I7(,\E$D$/0NGM?Q/?^P>10NN4&M_4F8\74OJ+)><DQ#XZC,;@8
M[O6=DSWQ,K89?^J% 6YBKE=JA:%-;A2X9>9Y.7,X(?UQE0KVAHFT A*24"Q1
MJFF=M5#42YKFWKI0+>CZ69-E2&UQ)V[;SD[$_?F**H[:@"I:3P>VB/V/*P..
MH.HUH7(S^!E!"7%0!Y0TU+UZ!GR'HQGAGPAAXM\TN;M.F K[9R%K2C]'1C^
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M,S8O9^VY\&4X'&M?R9,C7@.;&\EUU&#F:@<^5OT64[>*EG1+N\IM$R,Y8\\
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MZFH!**PI/8VMU/+SC[A*SR@4D4\Q3+IW41JQ#Y>3/]3C!P<5<W@BV&F9^G/
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M=/6#&7/CS\;RY87#TO?T^U2VUB'<3?8CT:$?D$1[$HK:*2 E6A!92D%J=/7
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M'L[GV5F-C5B9>+3?8<(BM8,9C]B\R.OUW-N7P?R\E1L*RG(#M]D[IKMYTR'
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MD77#E)+QD(U[>1"+'Z5&)I7NY0P86BS$UV<JG67!$AB!%Z>AB)9".(/+<Q8
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MNP2FQI9H$2D'C9<9H)BLFW.!I7;!]R8E'4A501)B]H>372(A[5Q_P0#VD_8
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MP&J)#CB-V[E:8:DR:MFZ)9/VSY<(\F1+(LC]21JMX3_S8A&_^G]02P,$%
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MJ5M:6QYX'E-A63P072E5?3*YJP94E*9 3%M?HL2Q-L([X(O6*>18>2B$-K9
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M5Z'NDGSEWK9ZEK?(YC[[^"]02P,$%     @ EX)<5B8GRPK#$@  ,FT  !$
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M[W;JC=\5V2H7$&0-01&80F-45CGQTPQB"A+\JER/GN;2V8VV8CA'""(%@K)
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ME:RC_DX#?"]4K2_KS<KOS60^9(--"T%"D(5\!'7KY2AF@UPZ98.I[EGEJ/%
M3YW%0^E66<@[R>)*95?!870+MIH N?,!^!O6[+2K[+NZ]\ ),2JS3&2K,[ S
M3LC?K/.=;AH785.M;^&[,-8O&KL[*G.3_FRPU_W+E>&9B,@4BJAVIA$F:RU$
M@/ 3@9@4\5.9B60JFFQ*(DU(EBV)X3I)2=EHY\<Z%^QES5=^^[#5GR+ &RFZ
M7REJH3;7!(09>I><;@-@2ODZ"&\"@F^R@+J6LV 2.H+@RXIK0/B?9^H\\MR8
MHT<L2-_ XY&LAF)9DW\&N*/!4(:I <UB(SH>.+0BM'BVNJ_"<OSA&-TJB_=8
M.E?9:=8U$07@K]A%2[< FR[T 5^]D=![DU *;;%&5=KKF1%X[)AHZY8BQ4FB
MDRON"H73BE,[$=4[R;V:QK\"^H;',/CQPYA.1R4EO+2JIK-E<7J<'10W'58Q
MG7,86,?\ R4@<C&A_N.]C3^\]CAWYX[ECE;!YUT(SMKE@*/8/KW@$VO1KK\T
M;56T(LP5:7>0J 2&8\XI P\AXHHB>I?0\NVD"FM=2<1DCDFU;M, 9N&$MAS%
MH?$G!K3+SH5HODP!G,IIT=8HERW#2CR5TVAKFB0$U3==/JS*N,\TWH)#Y+"^
MO#L^BCHU&E]!L< F83N.J5-L"<MM^\J5VDUXR(_9IJ .ZMN;T2WGM-J6IV!I
M2JK6UBE&3(8L>RG3A_!#$J5I_0TYWE42,?OC%\MC[%&F%@.:,UI7/4I1#-K%
M(_*E]+KQ-6?? +W22*W;C[42K4OIJM56\9Q.EEU#B3_@;?KJ')TB">7-T$$T
M"QFR"Z0@" 5VF[8%%FVC3[W ?N4*;: OCF +^"8=\W#I&-2;J!,9(V==A&L5
M*7P[Z&DWA*:A15+A-ZC)_I3(DAILPI#[9Z\K6M3!Y\&*20MED&L, )U4]Q%O
MG>M8X:4W$DM6J,>(.L/D4/Z&^_?'_7!@NH]=[3.@+M TW2 PX'UB_9V"LTW7
MVD9P_Y#@UOUV+B)RYW7J-,FJ>7J"Q:FCNC,($=\ $9]'@1&JVPW8EF"3Y9=4
M6(XQ[PSA E;M >WYJPT0FG:P=<HE!1WQ\AT!+LG#Z:@>^?0&+MZQ@OD$^?!%
MU&5YNE;$%>:O"5P"<#>JWO+KHSG<4!_+8133#@;!B!+ I?Z'+B[',1O'3 ?-
MA*&>@P[/1#>^I.-LP:,[ETM=T]BVCKWQQG>?WSB0,_+84K&Z+,N+J<03/0X+
M1B -W%3^ &;N;J6A>U*B=AS;=+JL6S6E2)HU__5@AP'#,X*BX)9FM-SNW+<8
MO'97[-G><U?=*VH@4M\IXMG G[<60,#%D=PYI >?@>-46.]OL>7&)3R;K!O<
MA6F4<J7<:#/!9.''JWD6ND+8L_@Y&]&!A1:X^CUK?8)*>YK2N2LP0OY<02J+
M)D+I#<4IC?'N^.CW)^,XJ[MS0C;NNTB_W6]C]0-*R>>.E[O#W3W^1!\(A$<?
M,;P,&+*;N6AJ-^@B8^M=9*FL:PQ;W\#?_0+HA+%S:O)IW8[1G<JGJ#JZG5-C
M6OL<O$?S*+6Y;,[;RV!CHKHXR>O#1]@#M6PUED=.A,@Q7IB$XXT2NQ2-K2L&
MA@[?:('I1M*U;@+\FH,W#I $_G2.\QRM9(-N/MK?XN(F=73/W=&85[#KVI]_
MQ_FZJ&F\O\4A.%?17'1/WR[?+U/W;GI$ZU2UE9ZH3]/TZ>HF.W7?_?7NSAXR
M0JVSG-@[V;0+-S+ESP,Z7N&MB&!* "&!--6W.:3KY)$GJK3K$N!6X:THU\^^
M$89O* QX#/2*QU@R%IU+HPHQ!Z:'JXQKYLQDB7$(7_1?WK-R0\P$P^XL:_H0
M;KZ^J&7:\%X,M!04WD5TT0AV"?JJ#)H8?^'-1F;N5V;<V=IU*@_@1/G36-2V
M(C8Z_$UUN&8%&6YGK5$7<THMN1L%UX"'Y>O(Z%8W[++=</!^.>@MI><@7H45
MAP9Y/+C"+P7=I[ :,500#4Q"0.TSARRIT%AS,K2W3B(VIR!:$RX=A]B4CKZE
M)G>X8X2@^R#<M:5T)QS5C0S/L/T$(T#TG&MXZUH%"D452;R0KD@PT2],Y^I#
M]-XMZ&:O&9 $+ZP6I(82K@7)2WWD%[L2,HP4B@)[O^OC8Y1 (FD$1QY @K^C
MP826!KP)F%[!H"#<R+5\#ICJGF[VC6C>LVC>]K9/NNQ=>X%L5T*_P7V?V/;[
MIUWW^7PC4M_4VG7=D^G-JX=0U/FV$(E2[^J,8R31C45]XFHF1;I2'Z+.F_6W
M*9>5QAX;E\5HQ[JWB&B;,+85VW8CVDV7]0/Y4:S'N!1:N#49_Q*$DP)_,RE*
M%9TI=YE=?RQ[W5%/M$K=NYM)0 VU=[=M'IJDU9O/**I=L7+-S1ORVBN%O>6U
M:NJ.0KNF$?@H\\'7$ZPR80LO,:6^B+,(^M5-;WOD$.KFV.2^6/$T_8Q;OH:N
M^X<K_*[^D<U\H*M^QN$$U-$4-P_QTSG]P13-[W*@_1%)0GVFB]<4Z4 1.?+E
M @;6_8]RF! O_Z:[]UB]*S_]L/?R-?R*X-6W\D?LX\=C=X?9=5,U779)HC'A
M!+.\V-T9L=&!G;&C*U%@W?V=5NHR6P"HP!WXE]*7;#3:';U:+SB/HV=KV_TU
M,?J[9F__'U!+ 0(4 Q0    ( )>"7%8\0*MKR-(# #R?)  1
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M=&<M,C R,C$R,S%?9S$N:G!G4$L! A0#%     @ EX)<5MQLE.G89    6<
M !4              ( !Z-$$ &YS=&<M,C R,C$R,S%?9S$P+FIP9U!+ 0(4
M Q0    ( )>"7%8J5YNT)VD  !UK   5              "  ?,V!0!N<W1G
M+3(P,C(Q,C,Q7V<Q,2YJ<&=02P$"% ,4    " "7@EQ6E$=J0MAO   J<@
M%0              @ %-H 4 ;G-T9RTR,#(R,3(S,5]G,3(N:G!G4$L! A0#
M%     @ EX)<5AL?X(B^E   ;J,  !4              ( !6! & &YS=&<M
M,C R,C$R,S%?9S$S+FIP9U!+ 0(4 Q0    ( )>"7%9R! _\SLX  +?9   5
M              "  4FE!@!N<W1G+3(P,C(Q,C,Q7V<Q-"YJ<&=02P$"% ,4
M    " "7@EQ6KLU3#T<F   ")P  %0              @ %*= < ;G-T9RTR
M,#(R,3(S,5]G,34N:G!G4$L! A0#%     @ EX)<5M#4P4D3-P  MSP  !4
M             ( !Q)H' &YS=&<M,C R,C$R,S%?9S$V+FIP9U!+ 0(4 Q0
M   ( )>"7%8  RXG>1D  /@;   5              "  0K2!P!N<W1G+3(P
M,C(Q,C,Q7V<Q-RYJ<&=02P$"% ,4    " "7@EQ6HGCOL2HB  #^(P  %0
M            @ &VZP< ;G-T9RTR,#(R,3(S,5]G,3@N:G!G4$L! A0#%
M  @ EX)<5FZ+P0VP"   1PD  !4              ( !$PX( &YS=&<M,C R
M,C$R,S%?9S$Y+FIP9U!+ 0(4 Q0    ( )>"7%:&P%0ER,D  );=   4
M          "  ?86" !N<W1G+3(P,C(Q,C,Q7V<R+FIP9U!+ 0(4 Q0    (
M )>"7%:>A/%#(BD  , I   5              "  ?#@" !N<W1G+3(P,C(Q
M,C,Q7V<R,"YJ<&=02P$"% ,4    " "7@EQ68?R'P,0(  !4"0  %0
M        @ %%"@D ;G-T9RTR,#(R,3(S,5]G,C$N:G!G4$L! A0#%     @
MEX)<5K)3./1$"0  S@D  !4              ( !/!,) &YS=&<M,C R,C$R
M,S%?9S(R+FIP9U!+ 0(4 Q0    ( )>"7%;^^ QT@QP  !H=   5
M      "  ;,<"0!N<W1G+3(P,C(Q,C,Q7V<R,RYJ<&=02P$"% ,4    " "7
M@EQ6Z+8C&8,*   4"P  %0              @ %I.0D ;G-T9RTR,#(R,3(S
M,5]G,C0N:G!G4$L! A0#%     @ EX)<5BK'&]O]50  D%<  !4
M     ( !'T0) &YS=&<M,C R,C$R,S%?9S(U+FIP9U!+ 0(4 Q0    ( )>"
M7%9(#BMP@@D  !(*   5              "  4^:"0!N<W1G+3(P,C(Q,C,Q
M7V<R-BYJ<&=02P$"% ,4    " "7@EQ6/BKI>-A2  #\4P  %0
M    @ $$I D ;G-T9RTR,#(R,3(S,5]G,C<N:G!G4$L! A0#%     @ EX)<
M5L'-)G:_"@  4@L  !4              ( !#_<) &YS=&<M,C R,C$R,S%?
M9S(X+FIP9U!+ 0(4 Q0    ( )>"7%9CKF##B!L  %<<   5
M  "  0$""@!N<W1G+3(P,C(Q,C,Q7V<R.2YJ<&=02P$"% ,4    " "7@EQ6
M,]Z%<?N6  "=L@  %               @ &\'0H ;G-T9RTR,#(R,3(S,5]G
M,RYJ<&=02P$"% ,4    " "7@EQ60G 12%P9   7&@  %0
M@ 'IM H ;G-T9RTR,#(R,3(S,5]G,S N:G!G4$L! A0#%     @ EX)<5FD
M60)#"P  T0L  !4              ( !>,X* &YS=&<M,C R,C$R,S%?9S,Q
M+FIP9U!+ 0(4 Q0    ( )>"7%:P&3J>(PD  +()   5              "
M >[9"@!N<W1G+3(P,C(Q,C,Q7V<S,BYJ<&=02P$"% ,4    " "7@EQ6$U$Q
ML5 ?   +(   %0              @ %$XPH ;G-T9RTR,#(R,3(S,5]G,S,N
M:G!G4$L! A0#%     @ EX)<5O,\63!7"0  Y@D  !4              ( !
MQP(+ &YS=&<M,C R,C$R,S%?9S,T+FIP9U!+ 0(4 Q0    ( )>"7%:#%LIE
M=PH   @+   5              "  5$,"P!N<W1G+3(P,C(Q,C,Q7V<S-2YJ
M<&=02P$"% ,4    " "7@EQ6EO=)@LD)  !9"@  %0              @ '[
M%@L ;G-T9RTR,#(R,3(S,5]G,S8N:G!G4$L! A0#%     @ EX)<5M>(HLAJ
M(    2$  !4              ( !]R + &YS=&<M,C R,C$R,S%?9S,W+FIP
M9U!+ 0(4 Q0    ( )>"7%9<HZUG5-8! #8< @ 5              "  91!
M"P!N<W1G+3(P,C(Q,C,Q7V<S."YJ<&=02P$"% ,4    " "7@EQ6I/S&)/A/
M   55P  %               @ $;& T ;G-T9RTR,#(R,3(S,5]G-"YJ<&=0
M2P$"% ,4    " "7@EQ6ERT/")2T!0"0#P8 %               @ %%: T
M;G-T9RTR,#(R,3(S,5]G-2YJ<&=02P$"% ,4    " "7@EQ6QL[-IJ)G  "&
MCP  %               @ $+'1, ;G-T9RTR,#(R,3(S,5]G-BYJ<&=02P$"
M% ,4    " "7@EQ6^GP]@@B( 0!'HP$ %               @ '?A!, ;G-T
M9RTR,#(R,3(S,5]G-RYJ<&=02P$"% ,4    " "7@EQ6@&:%]YQ[!@!JE08
M%               @ $9#14 ;G-T9RTR,#(R,3(S,5]G."YJ<&=02P$"% ,4
M    " "7@EQ6J/>BX*9K  "F;0  %               @ 'GB!L ;G-T9RTR
M,#(R,3(S,5]G.2YJ<&=02P$"% ,4    " "7@EQ6\Y(S6"DC 0"=*@P %0
M            @ &_]!L ;G-T9RTR,#(R,3(S,5]L86(N>&UL4$L! A0#%
M  @ EX)<5@S0<_K7KP  R/H' !4              ( !&Q@= &YS=&<M,C R
M,C$R,S%?<')E+GAM;%!+ 0(4 Q0    ( )>"7%:3'.9)01T  *7%   3
M          "  27('0!N<W1G+3(P,C)E>#$P,3 N:'1M4$L! A0#%     @
MEX)<5AD#(B&400  C!(" !(              ( !E^4= &YS=&<M,C R,F5X
M,3 X+FAT;5!+ 0(4 Q0    ( )>"7%;GJE"-(24  (W'   2
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M,#(R97@S,C$N:'1M4$L! A0#%     @ EX)<5E,=*03"!0  *A<  !(
M         ( !_68> &YS=&<M,C R,F5X,S(R+FAT;5!+ 0(4 Q0    ( )>"
M7%8F)\L*PQ(  #)M   1              "  >]L'@!N<W1G+3(P,C)E>#0S
:+FAT;5!+!08     -0 U +,-  #A?QX    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
